0001292814-24-000771.txt : 20240311 0001292814-24-000771.hdr.sgml : 20240311 20240311170215 ACCESSION NUMBER: 0001292814-24-000771 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 185 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMBEV S.A. CENTRAL INDEX KEY: 0001565025 STANDARD INDUSTRIAL CLASSIFICATION: BEVERAGES [2080] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 000000000 STATE OF INCORPORATION: D5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-36165 FILM NUMBER: 24738963 BUSINESS ADDRESS: STREET 1: RUA DR. RENATO PAES DE BARROS, 1017 STREET 2: 3 ANDAR PARTE CITY: SAO PAULO STATE: D5 ZIP: 04530-000 BUSINESS PHONE: 55(11)2122-1414 MAIL ADDRESS: STREET 1: RUA DR. RENATO PAES DE BARROS, 1017 STREET 2: 3 ANDAR PARTE CITY: SAO PAULO STATE: D5 ZIP: 04530-000 FORMER COMPANY: FORMER CONFORMED NAME: InBev Corporate Holdings Inc. DATE OF NAME CHANGE: 20121219 20-F 1 abevform20f_2023.htm 20-F
false 2023 FY 0001565025 0001565025 2023-01-01 2023-12-31 0001565025 dei:BusinessContactMember 2023-01-01 2023-12-31 0001565025 2023-12-31 0001565025 2022-01-01 2022-12-31 0001565025 2021-01-01 2021-12-31 0001565025 2022-12-31 0001565025 ifrs-full:IssuedCapitalMember 2020-12-31 0001565025 ifrs-full:CapitalReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesMember 2020-12-31 0001565025 ifrs-full:RetainedEarningsMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2020-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2020-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2020-12-31 0001565025 2020-12-31 0001565025 ifrs-full:IssuedCapitalMember 2021-12-31 0001565025 ifrs-full:CapitalReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesMember 2021-12-31 0001565025 ifrs-full:RetainedEarningsMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2021-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2021-12-31 0001565025 2021-12-31 0001565025 ifrs-full:IssuedCapitalMember 2022-12-31 0001565025 ifrs-full:CapitalReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesMember 2022-12-31 0001565025 ifrs-full:RetainedEarningsMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2022-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001565025 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001565025 ifrs-full:CapitalReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-01-01 2021-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001565025 ifrs-full:CapitalReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-01-01 2022-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:IssuedCapitalMember 2023-01-01 2023-12-31 0001565025 ifrs-full:CapitalReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-01-01 2023-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:IssuedCapitalMember 2023-12-31 0001565025 ifrs-full:CapitalReserveMember 2023-12-31 0001565025 abev:NetIncomeReservesMember 2023-12-31 0001565025 ifrs-full:RetainedEarningsMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2023-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2023-12-31 0001565025 abev:TenedoraMember abev:ELJMember 2023-12-31 0001565025 abev:TenedoraMember abev:TrancheAMember abev:ELJMember 2023-12-31 0001565025 abev:TenedoraMember abev:TrancheBMember abev:ELJMember 2023-12-31 0001565025 abev:GrupoModeloMember 2023-01-01 2023-12-31 0001565025 2021-05-01 2021-05-31 0001565025 abev:BoardOfDirectorsMember 2023-05-18 0001565025 abev:BoardOfDirectorsMember 2023-05-17 2023-05-18 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2023-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2022-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2021-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2023-01-01 2023-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2022-01-01 2022-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2021-01-01 2021-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2023-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2022-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2021-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2023-01-01 2023-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2022-01-01 2022-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2021-01-01 2021-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2023-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2022-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2021-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2021-01-01 2021-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2023-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2022-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2021-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2023-01-01 2023-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2022-01-01 2022-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2021-01-01 2021-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2023-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2022-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2021-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2023-01-01 2023-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2022-01-01 2022-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2021-01-01 2021-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2023-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2022-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2021-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2023-01-01 2023-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2022-01-01 2022-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2021-01-01 2021-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2023-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2022-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2021-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2023-01-01 2023-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2022-01-01 2022-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2021-01-01 2021-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2023-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2022-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2021-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2023-01-01 2023-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2022-01-01 2022-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2021-01-01 2021-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2023-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2022-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2021-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2023-01-01 2023-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2022-01-01 2022-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2021-01-01 2021-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2023-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2022-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2021-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2023-01-01 2023-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2022-01-01 2022-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2021-01-01 2021-12-31 0001565025 abev:Brazil1Member 2023-01-01 2023-12-31 0001565025 abev:Brazil1Member 2022-01-01 2022-12-31 0001565025 abev:Brazil1Member 2021-01-01 2021-12-31 0001565025 abev:CACMember 2023-01-01 2023-12-31 0001565025 abev:CACMember 2022-01-01 2022-12-31 0001565025 abev:CACMember 2021-01-01 2021-12-31 0001565025 abev:SouthLatinAmericaSegmentMember 2023-01-01 2023-12-31 0001565025 abev:SouthLatinAmericaSegmentMember 2022-01-01 2022-12-31 0001565025 abev:SouthLatinAmericaSegmentMember 2021-01-01 2021-12-31 0001565025 abev:CanadaSegmentMember 2023-01-01 2023-12-31 0001565025 abev:CanadaSegmentMember 2022-01-01 2022-12-31 0001565025 abev:CanadaSegmentMember 2021-01-01 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:Brazil1Member 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:Brazil1Member 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:Brazil1Member 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CACMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CACMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CACMember 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:SouthLatinAmericaSegmentMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:SouthLatinAmericaSegmentMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:SouthLatinAmericaSegmentMember 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CanadaSegmentMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CanadaSegmentMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CanadaSegmentMember 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember 2021-12-31 0001565025 ifrs-full:EliminationOfIntersegmentAmountsMember 2023-12-31 0001565025 ifrs-full:EliminationOfIntersegmentAmountsMember 2022-12-31 0001565025 ifrs-full:EliminationOfIntersegmentAmountsMember 2021-12-31 0001565025 ifrs-full:UnallocatedAmountsMember 2023-12-31 0001565025 ifrs-full:UnallocatedAmountsMember 2022-12-31 0001565025 ifrs-full:UnallocatedAmountsMember 2021-12-31 0001565025 country:BR 2023-12-31 0001565025 country:CA 2023-12-31 0001565025 country:BR 2022-12-31 0001565025 country:CA 2022-12-31 0001565025 country:BR 2021-12-31 0001565025 country:CA 2021-12-31 0001565025 country:AR 2023-01-01 2023-12-31 0001565025 country:AR 2022-01-01 2022-12-31 0001565025 country:AR 2021-01-01 2021-12-31 0001565025 country:AR 2023-12-31 0001565025 country:AR 2022-12-31 0001565025 country:AR 2021-12-31 0001565025 abev:BeerMember abev:Brazil1Member 2023-01-01 2023-12-31 0001565025 abev:BeerMember abev:Brazil1Member 2022-01-01 2022-12-31 0001565025 abev:BeerMember abev:Brazil1Member 2021-01-01 2021-12-31 0001565025 abev:NABMember abev:Brazil1Member 2023-01-01 2023-12-31 0001565025 abev:NABMember abev:Brazil1Member 2022-01-01 2022-12-31 0001565025 abev:NABMember abev:Brazil1Member 2021-01-01 2021-12-31 0001565025 abev:CentralAmericaAndCaribbeanMember ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:CentralAmericaAndCaribbeanMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:LatinAmericaSouthMember ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:LatinAmericaSouthMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:CountryOfCanadaMember 2023-01-01 2023-12-31 0001565025 abev:LuxembourgMember 2023-01-01 2023-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2023-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2022-12-31 0001565025 abev:TemporaryDifferencesIntangiblesMember 2023-12-31 0001565025 abev:TemporaryDifferencesIntangiblesMember 2022-12-31 0001565025 abev:TemporaryDifferencesEmployeeBenefitsMember 2023-12-31 0001565025 abev:TemporaryDifferencesEmployeeBenefitsMember 2022-12-31 0001565025 abev:TemporaryDifferencesTradePayablesMember 2023-12-31 0001565025 abev:TemporaryDifferencesTradePayablesMember 2022-12-31 0001565025 abev:TemporaryDifferencesTradeReceivableMember 2023-12-31 0001565025 abev:TemporaryDifferencesTradeReceivableMember 2022-12-31 0001565025 abev:TemporaryDifferencesDerivativesMember 2023-12-31 0001565025 abev:TemporaryDifferencesDerivativesMember 2022-12-31 0001565025 abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2022-12-31 0001565025 abev:TemporaryDifferencesInventoriesMember 2023-12-31 0001565025 abev:TemporaryDifferencesInventoriesMember 2022-12-31 0001565025 abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2023-12-31 0001565025 abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2022-12-31 0001565025 abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2023-12-31 0001565025 abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2022-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2023-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2022-12-31 0001565025 ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:UnusedTaxLossesMember 2022-12-31 0001565025 abev:TemporaryDifferencesProvisionsMember 2023-12-31 0001565025 abev:TemporaryDifferencesProvisionsMember 2022-12-31 0001565025 abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2023-12-31 0001565025 abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2022-12-31 0001565025 abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2023-12-31 0001565025 abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2022-12-31 0001565025 abev:TemporaryDifferencesOtherItemsMember 2023-12-31 0001565025 abev:TemporaryDifferencesOtherItemsMember 2022-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesIntangiblesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesIntangiblesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesEmployeeBenefitsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesEmployeeBenefitsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesTradePayablesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesTradePayablesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesTradeReceivableMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesTradeReceivableMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesDerivativesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesDerivativesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInventoriesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInventoriesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesProvisionsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesProvisionsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesOtherItemsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesOtherItemsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:DeferredTaxesNotRelatedToTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:DeferredTaxesNotRelatedToTaxLossesMember 2023-12-31 0001565025 abev:DeferredTaxesNotRelatedToTaxLossesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 abev:LaterThanThreeYearsAndNotLaterThanFoursYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 abev:LaterThanFiveYearsAndNotLaterThanEightYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 abev:LaterThanNineYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:PropertyPlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:PropertyPlantAndEquipmentMember 2022-12-31 0001565025 ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LandAndBuildingsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember abev:PlantAndEquipmentMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:FixturesAndFittingsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ConstructionInProgressMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LandAndBuildingsMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember abev:PlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:FixturesAndFittingsMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ConstructionInProgressMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember ifrs-full:RightofuseAssetsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember ifrs-full:RightofuseAssetsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:BuildingsMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:MachineryVehiclesAndOthersMember ifrs-full:RightofuseAssetsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:MachineryVehiclesAndOthersMember ifrs-full:RightofuseAssetsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:MachineryVehiclesAndOthersMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember abev:MachineryVehiclesAndOthersMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember ifrs-full:RightofuseAssetsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BuildingsMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:BuildingsMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:MachineryVehiclesAndOthersMember ifrs-full:RightofuseAssetsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:MachineryVehiclesAndOthersMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember abev:MachineryVehiclesAndOthersMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:BuildingsMember 2023-01-01 2023-12-31 0001565025 abev:PlantAndEquipmentMember 2023-01-01 2023-12-31 0001565025 abev:FixturesMember 2023-01-01 2023-12-31 0001565025 abev:FittingsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:BottomOfRangeMember abev:ExternalUseAssetsCommercialAssetsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember abev:ExternalUseAssetsCommercialAssetsMember 2023-01-01 2023-12-31 0001565025 abev:CountryOfBrazilMember 2023-12-31 0001565025 abev:CountryOfBrazilMember 2022-12-31 0001565025 abev:DominicanRepublicMember abev:CACMember 2023-12-31 0001565025 abev:DominicanRepublicMember abev:CACMember 2022-12-31 0001565025 abev:PanamaMember abev:CACMember 2023-12-31 0001565025 abev:PanamaMember abev:CACMember 2022-12-31 0001565025 abev:ArgentinaMember abev:LatinAmericaSouthMember 2023-12-31 0001565025 abev:ArgentinaMember abev:LatinAmericaSouthMember 2022-12-31 0001565025 abev:BoliviaMember abev:LatinAmericaSouthMember 2023-12-31 0001565025 abev:BoliviaMember abev:LatinAmericaSouthMember 2022-12-31 0001565025 abev:ChileMember abev:LatinAmericaSouthMember 2023-12-31 0001565025 abev:ChileMember abev:LatinAmericaSouthMember 2022-12-31 0001565025 abev:ParaguayMember abev:LatinAmericaSouthMember 2023-12-31 0001565025 abev:ParaguayMember abev:LatinAmericaSouthMember 2022-12-31 0001565025 abev:UruguayMember abev:LatinAmericaSouthMember 2023-12-31 0001565025 abev:UruguayMember abev:LatinAmericaSouthMember 2022-12-31 0001565025 abev:CountryOfCanadaMember 2023-12-31 0001565025 abev:CountryOfCanadaMember 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:ChileMember ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2023-12-31 0001565025 abev:PanamaMember ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2023-12-31 0001565025 abev:CountryOfBrazilMember ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2023-12-31 0001565025 abev:IntangibleAssetsInArgentinaMember 2023-12-31 0001565025 abev:IntangibleAssetsInArgentinaMember 2022-12-31 0001565025 abev:IntangibleAssetsInBoliviaMember 2023-12-31 0001565025 abev:IntangibleAssetsInBoliviaMember 2022-12-31 0001565025 abev:IntangibleAssetsInBrazilMember 2023-12-31 0001565025 abev:IntangibleAssetsInBrazilMember 2022-12-31 0001565025 abev:IntangibleAssetsInCanadaMember 2023-12-31 0001565025 abev:IntangibleAssetsInCanadaMember 2022-12-31 0001565025 abev:IntangibleAssetsInChileMember 2023-12-31 0001565025 abev:IntangibleAssetsInChileMember 2022-12-31 0001565025 abev:IntangibleAssetsInLuxembourgMember 2023-12-31 0001565025 abev:IntangibleAssetsInLuxembourgMember 2022-12-31 0001565025 abev:IntangibleAssetsInParaguayMember 2023-12-31 0001565025 abev:IntangibleAssetsInParaguayMember 2022-12-31 0001565025 abev:IntangibleAssetsInTheDominicanRepublicMember 2023-12-31 0001565025 abev:IntangibleAssetsInTheDominicanRepublicMember 2022-12-31 0001565025 abev:IntangibleAssetsInPanamaMember 2023-12-31 0001565025 abev:IntangibleAssetsInPanamaMember 2022-12-31 0001565025 abev:IntangibleAssetsInUruaguayMember 2023-12-31 0001565025 abev:IntangibleAssetsInUruaguayMember 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 ifrs-full:BottomOfRangeMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001565025 abev:PISCOFINSExclusionOfICMSMember 2023-12-31 0001565025 abev:PISCOFINSExclusionOfICMSMember 2022-12-31 0001565025 abev:ICMSMember 2023-12-31 0001565025 abev:ICMSMember 2022-12-31 0001565025 abev:IncomeTaxAndSocialContributionsRecoverableMember 2023-12-31 0001565025 abev:IncomeTaxAndSocialContributionsRecoverableMember 2022-12-31 0001565025 ifrs-full:OtherTemporaryDifferencesMember 2023-12-31 0001565025 ifrs-full:OtherTemporaryDifferencesMember 2022-12-31 0001565025 abev:PiscofinsMember 2023-12-31 0001565025 abev:PiscofinsMember 2022-12-31 0001565025 abev:IPIMember 2023-12-31 0001565025 abev:IPIMember 2022-12-31 0001565025 abev:InventoryProvisionMember 2022-12-31 0001565025 abev:InventoryProvisionMember 2021-12-31 0001565025 abev:InventoryProvisionMember 2023-01-01 2023-12-31 0001565025 abev:InventoryProvisionMember 2022-01-01 2022-12-31 0001565025 abev:InventoryProvisionMember 2023-12-31 0001565025 ifrs-full:CurrentMember 2023-12-31 0001565025 ifrs-full:CurrentMember 2022-12-31 0001565025 abev:LessThanOneMonthMember 2023-12-31 0001565025 abev:LessThanOneMonthMember 2022-12-31 0001565025 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2022-12-31 0001565025 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2022-12-31 0001565025 abev:LaterThanThreeMonthsAndLessThanSixMonthsMember 2023-12-31 0001565025 abev:LaterThanThreeMonthsAndLessThanSixMonthsMember 2022-12-31 0001565025 abev:LaterThanSixMonthsAndLessThan12MonthsMember 2023-12-31 0001565025 abev:LaterThanSixMonthsAndLessThan12MonthsMember 2022-12-31 0001565025 abev:LaterThanAYearMember 2023-12-31 0001565025 abev:LaterThanAYearMember 2022-12-31 0001565025 abev:BadDebtProvisionMember 2022-12-31 0001565025 abev:BadDebtProvisionMember 2021-12-31 0001565025 abev:BadDebtProvisionMember 2023-01-01 2023-12-31 0001565025 abev:BadDebtProvisionMember 2022-01-01 2022-12-31 0001565025 abev:BadDebtProvisionMember 2023-12-31 0001565025 abev:AuthorizedShareCapitalMember 2023-12-31 0001565025 abev:AuthorizedShareCapitalMember 2022-12-31 0001565025 abev:AuthorizedShareCapitalMember 2021-12-31 0001565025 ifrs-full:CountryOfDomicileMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 2023-12-12 2023-12-31 0001565025 2022-12-05 2022-12-31 0001565025 2021-12-07 2021-12-31 0001565025 2021-11-01 2021-11-30 0001565025 abev:InterbrewInternationalBvMember 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2023-01-01 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-01-01 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2021-12-31 0001565025 abev:InterbrewInternationalBvMember 2021-01-01 2021-12-31 0001565025 abev:AmbrewSARLMember 2023-12-31 0001565025 abev:AmbrewSARLMember 2023-01-01 2023-12-31 0001565025 abev:AmbrewSARLMember 2022-12-31 0001565025 abev:AmbrewSARLMember 2022-01-01 2022-12-31 0001565025 abev:AmbrewSARLMember 2021-12-31 0001565025 abev:AmbrewSARLMember 2021-01-01 2021-12-31 0001565025 abev:FundacaoZerrennerMember 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2022-12-31 0001565025 abev:FundacaoZerrennerMember 2022-01-01 2022-12-31 0001565025 abev:FundacaoZerrennerMember 2021-12-31 0001565025 abev:FundacaoZerrennerMember 2021-01-01 2021-12-31 0001565025 abev:MercadoMember 2023-12-31 0001565025 abev:MercadoMember 2023-01-01 2023-12-31 0001565025 abev:MercadoMember 2022-12-31 0001565025 abev:MercadoMember 2022-01-01 2022-12-31 0001565025 abev:MercadoMember 2021-12-31 0001565025 abev:MercadoMember 2021-01-01 2021-12-31 0001565025 abev:TesourariaMember 2023-12-31 0001565025 abev:TesourariaMember 2023-01-01 2023-12-31 0001565025 abev:TesourariaMember 2022-12-31 0001565025 abev:TesourariaMember 2022-01-01 2022-12-31 0001565025 abev:TesourariaMember 2021-12-31 0001565025 abev:TesourariaMember 2021-01-01 2021-12-31 0001565025 ifrs-full:TreasurySharesMember 2020-12-31 0001565025 ifrs-full:SharePremiumMember 2020-12-31 0001565025 ifrs-full:OtherReservesMember 2020-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2020-12-31 0001565025 ifrs-full:TreasurySharesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:SharePremiumMember 2021-01-01 2021-12-31 0001565025 ifrs-full:OtherReservesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:TreasurySharesMember 2021-12-31 0001565025 ifrs-full:SharePremiumMember 2021-12-31 0001565025 ifrs-full:OtherReservesMember 2021-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-12-31 0001565025 ifrs-full:TreasurySharesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:SharePremiumMember 2022-01-01 2022-12-31 0001565025 ifrs-full:OtherReservesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:TreasurySharesMember 2022-12-31 0001565025 ifrs-full:SharePremiumMember 2022-12-31 0001565025 ifrs-full:OtherReservesMember 2022-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001565025 ifrs-full:TreasurySharesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:SharePremiumMember 2023-01-01 2023-12-31 0001565025 ifrs-full:OtherReservesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TreasurySharesMember 2023-12-31 0001565025 ifrs-full:SharePremiumMember 2023-12-31 0001565025 ifrs-full:OtherReservesMember 2023-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2020-12-31 0001565025 abev:NetIncomeReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2021-12-31 0001565025 abev:NetIncomeReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2022-12-31 0001565025 abev:NetIncomeReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2023-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2023-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2023-12-31 0001565025 abev:NetIncomeReserveMember 2023-12-31 0001565025 2023-12-28 2023-12-31 0001565025 2022-12-29 2022-12-31 0001565025 2021-12-30 2021-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2023-12-31 0001565025 abev:SecuredBankLoansMember 2023-12-31 0001565025 abev:SecuredBankLoansMember 2022-12-31 0001565025 abev:OtherSecuredLoansMember 2023-12-31 0001565025 abev:OtherSecuredLoansMember 2022-12-31 0001565025 ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001565025 ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001565025 abev:TotalLiabilitiesMember 2023-12-31 0001565025 abev:TotalLiabilitiesMember 2022-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:NonCurrentLiabilitiesMember 2022-12-31 0001565025 abev:CurrentLiabilitiesMember 2022-12-31 0001565025 abev:NonCurrentLiabilitiesMember 2021-12-31 0001565025 abev:CurrentLiabilitiesMember 2021-12-31 0001565025 abev:NonCurrentLiabilitiesMember 2023-12-31 0001565025 abev:CurrentLiabilitiesMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember 2023-12-31 0001565025 abev:SecuredBankLoanMember 2022-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember 2022-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember 2023-12-31 0001565025 abev:LeaseLiabilityMember 2022-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:MaturityTotalMember 2023-12-31 0001565025 abev:MaturityTotalMember 2022-12-31 0001565025 abev:LeaseTerm20232027Member 2023-12-31 0001565025 abev:LeaseTerm20282035Member 2023-12-31 0001565025 abev:TwoHealthCarePlansFromFundacaoZerrennerMember 2023-12-31 0001565025 abev:TwoHealthCarePlansFromFundacaoZerrennerMember 2022-12-31 0001565025 abev:TwoHealthCarePlansFromFundacaoZerrennerMember 2021-12-31 0001565025 abev:EmployeeBenefitLiabilitiesMember 2023-12-31 0001565025 abev:EmployeeBenefitLiabilitiesMember 2022-12-31 0001565025 abev:EmployeeBenefitLiabilitiesMember 2021-12-31 0001565025 abev:EmployeeBenefitsAssetsMember 2023-12-31 0001565025 abev:EmployeeBenefitsAssetsMember 2022-12-31 0001565025 abev:EmployeeBenefitsAssetsMember 2021-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2022-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2021-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2020-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2023-01-01 2023-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2022-01-01 2022-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2021-01-01 2021-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2023-12-31 0001565025 ifrs-full:PlanAssetsMember 2022-12-31 0001565025 ifrs-full:PlanAssetsMember 2021-12-31 0001565025 ifrs-full:PlanAssetsMember 2020-12-31 0001565025 ifrs-full:PlanAssetsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:PlanAssetsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:PlanAssetsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:PlanAssetsMember 2023-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2022-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2021-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2020-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2023-01-01 2023-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2022-01-01 2022-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2021-01-01 2021-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember 2021-01-01 2021-12-31 0001565025 abev:EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember 2021-01-01 2021-12-31 0001565025 abev:CommercialExpensesMember 2023-01-01 2023-12-31 0001565025 abev:CommercialExpensesMember 2022-01-01 2022-12-31 0001565025 abev:CommercialExpensesMember 2021-01-01 2021-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember 2021-01-01 2021-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:BottomOfRangeMember 2023-12-31 0001565025 ifrs-full:TopOfRangeMember 2023-12-31 0001565025 ifrs-full:BottomOfRangeMember 2022-12-31 0001565025 ifrs-full:TopOfRangeMember 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2021-12-31 0001565025 ifrs-full:TopOfRangeMember 2021-12-31 0001565025 srt:WeightedAverageMember 2023-12-31 0001565025 srt:WeightedAverageMember 2022-12-31 0001565025 srt:WeightedAverageMember 2021-12-31 0001565025 ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001565025 ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001565025 ifrs-full:TopOfRangeMember 2021-01-01 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2021-12-31 0001565025 abev:PlanAssetsGovernmentBondsMember 2023-12-31 0001565025 abev:PlanAssetsGovernmentBondsMember 2022-12-31 0001565025 abev:PlanAssetsGovernmentBondsMember 2021-12-31 0001565025 abev:PlanAssetsCorporateBondsMember 2023-12-31 0001565025 abev:PlanAssetsCorporateBondsMember 2022-12-31 0001565025 abev:PlanAssetsCorporateBondsMember 2021-12-31 0001565025 abev:PlanAssetsEquityInstrumentsMember 2023-12-31 0001565025 abev:PlanAssetsEquityInstrumentsMember 2022-12-31 0001565025 abev:PlanAssetsEquityInstrumentsMember 2021-12-31 0001565025 abev:PlanAssetsCashMember 2023-12-31 0001565025 abev:PlanAssetsCashMember 2022-12-31 0001565025 abev:PlanAssetsCashMember 2021-12-31 0001565025 abev:PlanAssetsOthersMember 2023-12-31 0001565025 abev:PlanAssetsOthersMember 2022-12-31 0001565025 abev:PlanAssetsOthersMember 2021-12-31 0001565025 abev:RestrictedSharesMember 2023-01-01 2023-12-31 0001565025 abev:RestrictedSharesMember 2022-01-01 2022-12-31 0001565025 abev:RestrictedSharesMember 2021-01-01 2021-12-31 0001565025 abev:DeferredStockUnitsOfGrantOneMember 2023-01-01 2023-12-31 0001565025 abev:DeferredStockUnitsOfGrantOneMember 2022-01-01 2022-12-31 0001565025 abev:DeferredStockUnitsOfGrantOneMember 2021-01-01 2021-12-31 0001565025 abev:RestrictedSharesMember 2022-12-31 0001565025 abev:RestrictedSharesMember 2021-12-31 0001565025 abev:RestrictedSharesMember 2020-12-31 0001565025 abev:RestrictedSharesMember 2023-12-31 0001565025 abev:DeferredSharesMember 2022-12-31 0001565025 abev:DeferredSharesMember 2021-12-31 0001565025 abev:DeferredSharesMember 2020-12-31 0001565025 abev:DeferredSharesMember 2023-01-01 2023-12-31 0001565025 abev:DeferredSharesMember 2022-01-01 2022-12-31 0001565025 abev:DeferredSharesMember 2021-01-01 2021-12-31 0001565025 abev:DeferredSharesMember 2023-12-31 0001565025 abev:TradePayableMember 2023-12-31 0001565025 abev:TradePayableMember 2022-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2021-12-31 0001565025 abev:ProvisionsForLaborMember 2021-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2021-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2021-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2021-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2022-01-01 2022-12-31 0001565025 abev:ProvisionsForLaborMember 2022-01-01 2022-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2022-01-01 2022-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2022-01-01 2022-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2022-12-31 0001565025 abev:ProvisionsForLaborMember 2022-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2022-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2022-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2022-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2023-01-01 2023-12-31 0001565025 abev:ProvisionsForLaborMember 2023-01-01 2023-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2023-01-01 2023-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2023-01-01 2023-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2023-12-31 0001565025 abev:ProvisionsForLaborMember 2023-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2023-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2023-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2023-12-31 0001565025 abev:TotalContingentProvisionsMember 2023-12-31 0001565025 abev:TotalContingentProvisionsMember 2022-12-31 0001565025 abev:IncomeTaxAndSocialContributionMember 2023-12-31 0001565025 abev:IncomeTaxAndSocialContributionMember 2022-12-31 0001565025 abev:ValueAddedAndExciseTaxesMember 2023-12-31 0001565025 abev:ValueAddedAndExciseTaxesMember 2022-12-31 0001565025 abev:PISAndCOFINSTaxContingentLiabilityMember 2023-12-31 0001565025 abev:PISAndCOFINSTaxContingentLiabilityMember 2022-12-31 0001565025 ifrs-full:OtherContingentLiabilitiesMember 2023-12-31 0001565025 ifrs-full:OtherContingentLiabilitiesMember 2022-12-31 0001565025 abev:UncertaintyOverTheTreatmentOfIncomeTaxesMember 2023-01-01 2023-12-31 0001565025 abev:UncertaintyOverTheTreatmentOfIncomeTaxesMember 2022-01-01 2022-12-31 0001565025 abev:IcmsstTriggerMember 2023-01-01 2023-12-31 0001565025 abev:IcmsstTriggerMember 2022-01-01 2022-12-31 0001565025 abev:ManausFreeTradeZoneMember 2023-01-01 2023-12-31 0001565025 abev:ManausFreeTradeZoneMember 2022-01-01 2022-12-31 0001565025 abev:IPISuspensionMember 2023-01-01 2023-12-31 0001565025 abev:IPISuspensionMember 2022-01-01 2022-12-31 0001565025 abev:SocialContributionsOverProductsMember 2023-01-01 2023-12-31 0001565025 abev:SocialContributionsOverProductsMember 2022-01-01 2022-12-31 0001565025 abev:ICMSZFMMember 2023-01-01 2023-12-31 0001565025 abev:ICMSZFMMember 2022-01-01 2022-12-31 0001565025 abev:ICMSProdepeMember 2023-01-01 2023-12-31 0001565025 abev:ICMSProdepeMember 2022-01-01 2022-12-31 0001565025 abev:ICMSFAINMember 2023-01-01 2023-12-31 0001565025 abev:ICMSFAINMember 2022-01-01 2022-12-31 0001565025 abev:ICMSAMMember 2023-01-01 2023-12-31 0001565025 abev:ICMSAMMember 2022-01-01 2022-12-31 0001565025 abev:ICMSFiscalWarMember 2023-01-01 2023-12-31 0001565025 abev:ICMSFiscalWarMember 2022-01-01 2022-12-31 0001565025 abev:ICMSMIPMember 2023-01-01 2023-12-31 0001565025 abev:ICMSMIPMember 2022-01-01 2022-12-31 0001565025 abev:ProposedClassActionInQuebecMember 2023-01-01 2023-12-31 0001565025 abev:ProposedClassActionInQuebecMember 2022-01-01 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetCashAndCashEquivalentsMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetCashAndCashEquivalentsMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember ifrs-full:TradeReceivablesMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember ifrs-full:TradeReceivablesMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:TradePayableMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:TradePayableMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:InterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:InterestbearingLoansAndBorrowingsMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:OtherLiabilities1Member 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:OtherLiabilities1Member 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:PutOptionGrantedOnSubsidiaryMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:PutOptionGrantedOnSubsidiaryMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:OtherLiabilities1Member 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:OtherLiabilities1Member 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001565025 abev:TotalCostExposureMember 2023-12-31 0001565025 abev:TotalCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 abev:TotalFixedAssetExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalExpensesExposureMember 2023-12-31 0001565025 abev:TotalExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalCashExposureMember 2023-12-31 0001565025 abev:CashUMember 2023-01-01 2023-12-31 0001565025 abev:TotalCashExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfThCashExposureMember 2023-12-31 0001565025 abev:USDollarsCashMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalCostExposureMember 2022-12-31 0001565025 abev:TotalCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalFixedAssetExposureMember 2022-12-31 0001565025 abev:TotalFixedAssetExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalExpensesExposureMember 2022-12-31 0001565025 abev:TotalExpensesExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalCashExposureMember 2022-12-31 0001565025 abev:CashUMember 2022-01-01 2022-12-31 0001565025 abev:TotalCashExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfThCashExposureMember 2022-12-31 0001565025 abev:USDollarsCashMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2022-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2022-01-01 2022-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 abev:TenedoraMember abev:ELJMember 2023-12-31 0001565025 abev:TenedoraMember abev:TrancheAMember abev:ELJMember 2023-12-31 0001565025 abev:TenedoraMember abev:TrancheBMember abev:ELJMember 2023-12-31 0001565025 abev:TenedoraMember abev:ELJMember 2022-12-31 0001565025 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001565025 ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001565025 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001565025 ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001565025 ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001565025 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001565025 ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001565025 abev:InterestRateRiskBrazilianReaisMember 2023-12-31 0001565025 abev:InterestRateRiskBrazilianReaisMember 2022-12-31 0001565025 ifrs-full:InterestRateRiskMember 2023-12-31 0001565025 ifrs-full:InterestRateRiskMember 2022-12-31 0001565025 abev:InterestRateRiskWorkingCapitalinArgentineanPesoMember 2023-12-31 0001565025 abev:InterestRateRiskWorkingCapitalinArgentineanPesoMember 2022-12-31 0001565025 abev:OtherCurrenciesMember 2023-12-31 0001565025 abev:OtherCurrenciesMember 2022-12-31 0001565025 abev:InterestRateRiskUSDollarsMember 2023-12-31 0001565025 abev:InterestRateRiskUSDollarsMember 2022-12-31 0001565025 abev:InterestRateRiskCanadianDollarsMember 2023-12-31 0001565025 abev:InterestRateRiskCanadianDollarsMember 2022-12-31 0001565025 abev:CommoditiesHedgeMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:CommoditiesHedgeMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:CommoditiesHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:CommoditiesHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignExchangeRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignExchangeRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:CommoditiesAndForeignExchangeHedgesMember abev:TotalCostExposureMember 2023-12-31 0001565025 abev:CommoditiesAndForeignExchangeHedgesMember abev:TotalCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyRiskPortionOfFixedAssetsExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalFixedAssetExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CashEffectsPortionOfExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CashEffectsPortionOfExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesCashMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesCashMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalCashEffectsExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalCashEffectsExposureMember 2023-01-01 2023-12-31 0001565025 ifrs-full:CarryingAmountMember 2023-12-31 0001565025 abev:ContractualCashFlowsMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001565025 ifrs-full:CarryingAmountMember 2022-12-31 0001565025 abev:ContractualCashFlowsMember 2022-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2022-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2022-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2022-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001565025 abev:LaterThanTwoYearsMember 2023-12-31 0001565025 abev:LaterThanTwoYearsMember 2022-12-31 0001565025 abev:FundacaoZerrennerMember 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2022-01-01 2022-12-31 0001565025 abev:FundacaoZerrennerMember abev:ActiveEmployeesMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember abev:RetireesMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember abev:ActiveEmployeesMember 2022-01-01 2022-12-31 0001565025 abev:FundacaoZerrennerMember abev:RetireesMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschIncMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschIncMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschIncMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschPackageMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschProcurementMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2023-01-01 2023-12-31 0001565025 abev:BavariaSaMember 2023-01-01 2023-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2023-01-01 2023-12-31 0001565025 abev:CerveceriaPeruanasMember 2023-01-01 2023-12-31 0001565025 abev:InbevBelgiumNvMember 2023-01-01 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2023-01-01 2023-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschPackageMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschProcurementMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2022-01-01 2022-12-31 0001565025 abev:AmbevPeruMember 2022-01-01 2022-12-31 0001565025 abev:BavariaSaMember 2022-01-01 2022-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2022-01-01 2022-12-31 0001565025 abev:CerveceriaPeruanasMember 2022-01-01 2022-12-31 0001565025 abev:InbevBelgiumNvMember 2022-01-01 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-01-01 2022-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschPackageMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschProcurementMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2021-01-01 2021-12-31 0001565025 abev:AmbevPeruMember 2021-01-01 2021-12-31 0001565025 abev:BavariaSaMember 2021-01-01 2021-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2021-01-01 2021-12-31 0001565025 abev:CerveceriaPeruanasMember 2021-01-01 2021-12-31 0001565025 abev:InbevBelgiumNvMember 2021-01-01 2021-12-31 0001565025 abev:InterbrewInternationalBvMember 2021-01-01 2021-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschAfricaMember 2023-12-31 0001565025 abev:AnheuserBuschAfricaMember 2022-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2023-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2022-12-31 0001565025 abev:AnheuserBuschInbevServicesLlcMember 2023-12-31 0001565025 abev:AnheuserBuschInbevServicesLlcMember 2022-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2023-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2022-12-31 0001565025 abev:BavariaSaMember 2023-12-31 0001565025 abev:BavariaSaMember 2022-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2023-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2022-12-31 0001565025 abev:CerveceriaPeruanasMember 2023-12-31 0001565025 abev:CerveceriaPeruanasMember 2022-12-31 0001565025 abev:InbevBelgiumNvMember 2023-12-31 0001565025 abev:InbevBelgiumNvMember 2022-12-31 0001565025 abev:PanamaHoldingMember 2023-12-31 0001565025 abev:PanamaHoldingMember 2022-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2023-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2022-12-31 0001565025 abev:AnheuserBuschPackageMember 2023-12-31 0001565025 abev:AnheuserBuschPackageMember 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-12-31 0001565025 abev:ExercisePUTCNDMember 2023-01-01 2023-12-31 0001565025 2024-01-31 0001565025 abev:NonadjustingEventMember 2024-02-28 2024-02-29 iso4217:BRL xbrli:shares iso4217:BRL xbrli:shares xbrli:pure iso4217:USD utr:D

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 20-F

 

(Mark One)
   
¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  OR
   
x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
  For the fiscal year ended December 31, 2023
   
  OR
   
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  OR
   
¨ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-36165

AMBEV S.A.
(Exact name of Registrant as specified in its charter)

Federative Republic of Brazil
(Jurisdiction of incorporation or organization)

Rua Dr. Renato Paes de Barros, 1017, 3rd floor
04530-001 São Paulo, SP, Brazil
(Address of principal executive offices)
Lucas Machado Lira, Chief Financial and Investor Relations Officer
Address: Rua Dr. Renato Paes de Barros, 1017, 3rd floor, 04530-001, São Paulo, SP, Brazil
Telephone No.: +55 (11) 2122-1200
e-mail: ri@ambev.com.br
(Name, Telephone, Email and/or Facsimile number and Address of Company Contact Person)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

American Depositary Shares,   New York Stock Exchange
evidenced by American Depositary ABEV  
Receipts, each representing    
1 (one) common share*,    
no par value    

 

*Not for trading, but in connection with the registration of American Depositary Shares, pursuant to the requirements of the Securities and Exchange Commission.

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

 
 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:

Title of each class

Name of each exchange on which registered

Not applicable Not applicable

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report.

15,753,833,284

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes x No ¨

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Yes ¨ No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of “accelerated filer,” “large accelerated filer,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x Accelerated filer ¨ Non-accelerated filer ¨ Emerging growth company ¨

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. ¨

† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

Yes x No ¨

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ¨

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ¨

 
 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

U.S. GAAP ¨ International Financial Reporting Standards as issued by the International Accounting Standards Board x Other ¨

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow. N/A

Item 17 ¨ Item 18 ¨

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨ No x

 

 

 

 

  

 
 

TABLE OF CONTENTS

 

  Page
INTRODUCTION 1
PRESENTATION OF FINANCIAL AND OTHER INFORMATION 1
MARKET DATA 1
CURRENCY TRANSLATION 2
TRADEMARKS 2
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION 2
PART I 5
ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 5
ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 6
ITEM 3. KEY INFORMATION 7
ITEM 4. INFORMATION ON THE COMPANY 37
ITEM 4A. UNRESOLVED STAFF COMMENTS 62
ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS 63
ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES 86
ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS 101
ITEM 8. FINANCIAL INFORMATION 106
ITEM 9. THE OFFER AND LISTING 120
ITEM 10. ADDITIONAL INFORMATION 123
ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 148
ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES 153
PART II 155
ITEM 13. DEFAULT, DIVIDENDS ARREARAGES AND DELINQUENCIES 155
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS 156
ITEM 15. CONTROLS AND PROCEDURES 157
ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT 160
ITEM 16B. CODE OF BUSINESS CONDUCT 161
ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES 162
 
 

 

ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES 164
ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS 165
ITEM 16F. CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT 167
ITEM 16G. CORPORATE GOVERNANCE 168
ITEM 16H. MINE SAFETY DISCLOSURE 169
ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS 170
ITEM 16J. INSIDER TRADING POLICIES 171
ITEM 16K. CYBERSECURITY 172
PART III 174
ITEM 17. FINANCIAL STATEMENTS 174
ITEM 18. FINANCIAL STATEMENTS 175
ITEM 19. EXHIBITS 176

 

 

 
 

INTRODUCTION

This annual report on Form 20-F relates to the registered American Depositary Shares, or ADSs, of Ambev S.A., or Ambev, evidenced by American Depositary Receipts, or ADRs, each representing one common share, no par value, of Ambev.

In this annual report, except as otherwise indicated or as the context otherwise requires, the “Company,” “Ambev,” “we,” “us” and “our” refers to Ambev S.A. and its subsidiaries and, unless the context otherwise requires, the predecessor companies that have been merged out of existence with and into it. All references to “Old Ambev” refer to Companhia de Bebidas das Américas – Ambev, our former subsidiary that had common and preferred shares listed on the São Paulo Stock, Commodities and Futures Exchange (B3 S.A. – Brasil, Bolsa, Balcão), or the B3 (previously named as BM&FBovespa S.A. – Bolsa de Valores, Mercadorias e Futuros), and common and preferred ADSs listed on the New York Stock Exchange, or the NYSE, and that was merged out of existence with and into us in January 2014. All references to “NAB” are to the non-alcoholic beverages in our portfolio other than non-alcoholic beer. All references to “Brazil” are to the Federative Republic of Brazil unless the context otherwise requires. All references to the “Brazilian government” are to the federal government of Brazil. All references to percent ownership interests in Ambev do not consider treasury shares.

PRESENTATION OF FINANCIAL AND OTHER INFORMATION

We prepare our audited consolidated financial statements in accordance with International Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or the IASB. The financial information and related discussion and analysis contained in this annual report on Form 20-F are presented in reais, except as otherwise specified. Unless otherwise specified, the financial information analysis in this annual report on Form 20-F is based on our consolidated financial statements as of December 31, 2023 and 2022 and for the three years ended December 31, 2023, included elsewhere in this document. Percentages and some amounts in this annual report on Form 20-F have been rounded for ease of presentation. Any discrepancies between totals and the sums of the amounts listed are due to rounding.

Unless otherwise specified, volumes, as used in this annual report on Form 20-F, include both beer (including future beverages) and NAB volumes. In addition, unless otherwise specified, our volumes refer not only to the brands that we own or license, but also third-party brands that we brew or otherwise produce as a subcontractor, and third-party products that we sell through our distribution network. Our volume figures in this annual report on Form 20-F reflect 100% of the volumes of entities that we fully consolidate in our financial reporting. In addition, market share data contained in this annual report on Form 20-F refers to volumes sold.

MARKET DATA

Market information (including market share, market position and industry data for our operating activities and those of our subsidiaries or of companies acquired by us) or other statements presented in this Form 20-F regarding our position (or that of companies acquired by us) relative to our competitors largely reflect the best estimates of our management. These estimates are based upon information obtained from customers, trade or business organizations and associations, other contacts within the industries in which we operate and, in some cases, upon published statistical data. Except as otherwise stated, our market share data, as well as our management’s assessment of our comparative competitive position, has been derived by comparing our sales volumes for the relevant period to our management’s estimates of our competitors’ sales volumes for such period, as well as upon published statistical data, and, in particular the reports published and the information made publicly available by, among others, the local brewers’ associations and the national statistics bureaus in the various

countries in which we sell our products. Although we have no reason to believe any of this information or these reports are inaccurate in any material respect and believe and act as if they are reliable, we have not independently verified it.

   
 1 
 

CURRENCY TRANSLATION

In this annual report, references to “real,” “reais” or “R$” are to the legal currency of Brazil, references to “U.S. dollar” or “US$” are to the official currency of the United States and references to “Canadian dollar” or “C$” are to the legal currency of Canada.

We maintain our books and records in reais. However, solely for the convenience of the reader, we have translated certain amounts included in this annual report from reais into U.S. dollars using the selling rate as reported by the Central Bank of Brazil (Banco Central do Brasil), or the Central Bank, as of December 31, 2023 of R$4.84 to US$1.00 or, where expressly indicated, at an average exchange rate prevailing during a certain period. We have also translated some amounts from U.S. dollars and Canadian dollars into reais. All such currency translations should not be considered representations that any such amounts represent, or could have been, or could be, converted into, U.S. or Canadian dollars or reais at that or at any other exchange rate. See “Item 10. Additional Information—D. Exchange Controls and other Limitations Affecting Security Holders” for more detailed information regarding the translation of reais into U.S. dollars.

TRADEMARKS

This annual report includes the names of our products which constitute trademarks or trade names which we own, or which are owned by others and are licensed to us for our use. This annual report also contains other brand names, trade names, trademarks or service marks of other companies, and these brand names, trade names, trademarks or service marks are the property of those other companies.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

Some of the information contained in this annual report may constitute forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act. We have based these forward-looking statements largely on our current expectations and projections about future events, industry and financial trends affecting our business.

Many of these forward-looking statements can be identified by the use of forward-looking words such as “anticipate,” “project,” “may,” “believe,” “could,” “expect,” “should,” “plan,” “intend,” “estimate,” “potential,” among others. These statements appear in a number of places in this annual report and include, but are not limited to, statements regarding our intent, belief or current expectations. Forward-looking statements are subject to certain risks and uncertainties that are outside our control and are difficult to predict. These risks and uncertainties could cause actual results to differ materially from those suggested by forward-looking statements. Factors that could cause actual results to differ materially from those contemplated by forward-looking statements include, among others:

ogeneral economic, political and business conditions both in Brazil and abroad, including developments and the perception of risks in connection with the administration of President Luiz Inácio Lula da Silva and the policies his government may adopt or change during his term in office, particularly economic and fiscal reforms, any of which may negatively affect growth prospects in the Brazilian economy as a whole;
oinflation and government measures to fight inflation;
othe effects and uncertainty emanating from adverse geopolitical circumstances, including the ongoing hostility between Russia and Ukraine, the armed conflict involving Hamas and Israel, and other conflicts in the Middle East;
ogreater than expected costs (including taxes) and expenses;
othe risk of unexpected consequences resulting from acquisitions, joint ventures, strategic alliances, corporate reorganizations or divestiture plans, and our ability to successfully and cost-effectively implement these transactions and integrate the operations of businesses or other assets that we acquire;
oour expectations with respect to expansion plans, projected asset divestitures, premium growth, accretion to reported earnings, working capital improvements and investment income or cash flow projections;
   
 2 
 
olower than expected revenue;
ogreater than expected customer losses and business disruptions;
olimitations on our ability to contain costs and expenses;
olocal, regional, national and international economic conditions, including the risks of a global recession or a recession in one or more of our key markets, and the impact they may have on us, our customers and our consumers, and our assessment of that impact;
othe monetary, exchange rate and interest rate policies of central banks, including appreciation, depreciation and devaluation of the real or other currencies in the countries where we operate;
ocontinued availability of financing;
omarket and financial risks, such as interest rate risk, foreign exchange rate risk, commodity risk, asset price risk, equity market risk, inflation or deflation;
oour ability to continue to introduce competitive new products and services on a timely, cost-effective basis;
othe effects of competition and consolidation in the markets in which we operate, which may be influenced by regulation, deregulation or enforcement policies;
ochanges in pricing environments and volatility in commodity prices;
oregional or general changes in asset valuations;
ochanges in consumer spending and consumptions habits;
othe outcome of pending and future litigation and governmental proceedings and investigations;
oglobal political and economic developments;
ochanges in government policies, international trade policies, applicable laws, regulations and taxes in jurisdictions in which we operate including the laws and regulations governing our operations, as well as actions or decisions of courts and regulators;
onatural and other disasters;
owater and/or energy scarcity and changes in government regulations aimed at rationing water and/or energy consumption in Brazil or other countries in which we operate;
oany inability to economically hedge certain risks;
oinadequate impairment provisions and loss reserves;
otechnological changes;
oour success in managing the risks involved in the foregoing;
ogovernmental intervention, resulting in changes to the economic, tax or regulatory environment in Brazil or other countries in which we operate;
oability to declare and pay dividends and interest on equity (“IOC”);
ochanges in government policies regarding tax subsidies and incentives;
oavailability and our ability to secure raw and packaging material that goes into our products;
   
 3 
 
othe utilization of Ambev’s subsidiaries’ income tax loss carry forwards;
othe economic, financial, political, public health and other effects of pandemics, epidemics and similar crises, and governmental responses thereto, particularly as such factors impact markets where we operate, as well as our ability to timely and efficiently implement any necessary measure in response to, or to mitigate the impacts of such events on our business, operations, cash flows, perspectives, liquidity and financial condition; and
oother factors or trends affecting our financial condition or results of operations, including those factors identified or discussed under “Item 3. Key Information—D. Risk Factors.”

We caution you that forward-looking statements are not guarantees of future performance and involve risks and uncertainties. Forward-looking statements reflect only our current expectations and are based on our management’s beliefs and assumptions and on information currently available to our management. Actual results may differ materially from those in forward-looking statements as a result of various factors, including, without limitation, those identified under “Item 3. Key Information—D. Risk Factors” in this annual report. As a result, investors are cautioned not to place undue reliance on forward-looking statements contained in this annual report when making an investment decision.

Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.

Investors should consider these cautionary statements together with any written or oral forward-looking statements that we may issue in the future.

   
 4 
 

 

PART I

ITEM 1.IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS

Not Applicable.

 

 

 

   
 5 
 
ITEM 2.OFFER STATISTICS AND EXPECTED TIMETABLE

Not Applicable.

 

 

 

   
 6 
 
ITEM 3.KEY INFORMATION

A.        Selected Financial Data

[Reserved]

B.        Capitalization and Indebtedness

Not applicable.

C.        Reasons for the Offer and Use of Proceeds

Not applicable.

D.       Risk Factors

Before making an investment decision, you should consider all of the information set forth in this annual report, including the consolidated financial statements and our periodic public information released by Ambev from time to time. In particular, you should consider the special features applicable to an investment in Brazil and applicable to an investment in Ambev, including those set forth below. In general, investing in the securities of issuers in emerging market countries, such as Brazil, involves a higher degree of risk than investing in the securities of issuers in the United States. Our business, financial condition and operational results may also be significantly affected not only by the risks set forth below but also by other risks that are currently unknown or considered irrelevant to us.

Summary of Risk Factors

Risks Relating to Our Operations

·We face operational risks that can result in the partial or temporary shutdown of our operations, which may adversely affect our financial condition and results of operations;
·We are exposed to the risk of litigation;
·Our results of operations are affected by fluctuations in exchange rates, and devaluation of the real or other currencies with which we operate relative to other currencies, including the U.S. dollar, which may adversely affect our financial performance;
·We rely on the reputation of our brands and damages to their reputation may have an adverse effect on our sales;
·Information technology failures, including failures to implement upgrades and new technologies effectively or those that affect the privacy and security of sensitive customer and business information, could disrupt our operations;
·If any of our products is defective or found to contain contaminants, we may be subject to product recalls, individual or collective litigation and/or other liabilities;
·We are subject to risks associated with noncompliance with any data protection laws in the countries in which we operate and can be adversely affected by any penalties or other sanctions imposed;
·If we are not successful in obtaining and maintaining the necessary licenses in the countries in which we operate, we may be subject to fines, penalties, or other regulatory sanctions, which could negatively impact our business and cause us to incur additional costs;
·Our failure to obtain or renew surety bonds and letters of credit necessary in certain lawsuits on attractive terms or at all may adversely affect our liquidity, financial condition and business;
   
 7 
 
·Our insurance coverage may be insufficient to make us whole on any losses that we may sustain in the future;
·We may not be able to protect our intellectual property rights;
·The relative volatility and illiquidity of securities of Brazilian companies may substantially limit your ability to sell our common shares and ADSs at the price and time you desire;
·Our shareholders may not receive any dividends or IOC;
·Future equity issuances may dilute the holdings of current holders of Ambev common shares or ADSs and could materially affect the market price for those securities;
·Contractual and legal restrictions to which Ambev and its subsidiaries are potentially or allegedly subject may be triggered upon the consummation of certain transactions involving our indirect controlling shareholder, Anheuser-Busch InBev SA/NV, or ABI, resulting in adverse limitations to our operations;
·Our current controlling shareholder will be able to determine the outcome of our most significant corporate actions;
·The ability of our foreign subsidiaries to distribute cash upstream may be subject to various conditions and limitations;
·We may not be able to recruit or retain key personnel;
·We rely on key third parties, including key suppliers, and the termination or modification of the arrangements with such third parties or non-compliance with the Company’s ESG guidelines or any failure to comply with laws and regulations by them could negatively affect our business; and
·Demand for our products may be adversely affected by changes in consumer preferences and tastes.

Risks Relating to the Economy Sector in Which We Operate

·Volatility in commodities prices may adversely affect our financial performance;
·Negative publicity focusing on us or our products or on the way we conduct our operations may harm our business;
·Competition could lead to a reduction of our margins, increase costs and adversely affect our profitability;
·If we do not successfully comply with applicable anti-corruption laws, export control regulations and trade restrictions, we could be subjected to fines, penalties or other regulatory sanctions, as well as adverse press coverage, which could impact our reputation, operations and sales;
·Increases in taxes levied on beverage products in the countries in which we operate and unfair competition arising from tax evasion may adversely affect our results and profitability;
·Our business is subject to regulations in the countries in which we operate, and we may have our activities impacted by foreign legislation regarding social, environmental and climate issues;
·We are subject to Brazilian and other antitrust regulations;
·The Brazilian government has exercised, and continues to exercise, significant influence over the Brazilian economy; Brazilian economic and political conditions have a direct impact on our business and the market price of our shares and ADSs; and
   
 8 
 
·Economic and political uncertainty and volatility in Brazil, and the perception of these conditions in the international financial markets, may adversely affect our business and the market price of our shares and ADSs.

Risks Relating to Other Countries in Which We Operate

·Our Latin America South operations are subject to substantial risks relating to the businesses and operations conducted in Argentina and other South American countries;
·Continuing high rates of inflation in Argentina may have an adverse effect on the economy and our business, financial condition and results of operations;
·Deterioration in economic and market conditions in Brazil and other emerging market countries, as well as in developed economies, may adversely affect the market price of our common shares and ADSs;
·We operate a joint venture in Cuba, in which the Government of Cuba is our joint venture partner. Cuba is still targeted by broad and comprehensive economic and trade sanctions of the United States. Our operations in Cuba may adversely affect our reputation and the liquidity and value of our securities; and
·The outbreaks of infectious diseases, or the risk of an outbreak (e.g. pandemics, epidemics, including a potential new wave of COVID-19), its effects and the manner in which such events may continue to impact us are highly uncertain and unpredictable and may result in further adverse effects on our business and may impact our ability to continue operating our business.

Risks Relating to Environmental, Social and Governance (ESG) Matters

·Our commitment to social responsibility may result in the incurrence of additional costs, and we are subject to laws, regulations and other obligations in furtherance of human rights, social justice and labor standards that may exposes us to additional contingencies;
·Our operations are subject to broad safety and environmental regulations, the non-compliance of which may pose significant financial, operational, reputational, litigation and regulatory risks related to environmental issues for us;
·Natural and other disasters and accidents caused by human and technological errors could disrupt our operations;
·Climate change, or legal, regulatory or market measures to address climate change, may negatively affect our business or operations;
·New ESG regulations may be enacted and this may result in increased costs for Ambev to comply with them;
·Scarcity or poor quality of water may negatively affect our production costs and capacity; and
·Seasonal consumption cycles and adverse weather conditions may result in fluctuations in demand for our products.

Risks Relating to Our Common Shares and ADSs

·Brazilian foreign exchange controls and regulations could restrict conversions and remittances abroad of the dividend payments and other shareholder distributions paid in Brazil in reais arising from Ambev’s common shares (including shares underlying the Ambev ADSs);
·The surrender of ADSs may cause the loss of the ability to remit foreign currency abroad and of certain Brazilian tax attributes;
·Certain shareholder entitlements may not be available in the U.S. to holders of Ambev ADSs;
   
 9 
 
·Holders of Ambev ADSs may be unable to fully exercise voting rights with respect to the Ambev shares underlying their ADSs;
·Our status as a foreign private issuer allows us to follow Brazilian corporate governance practices and exempts us from a number of rules under the U.S. securities laws and listing standards, which may limit the amount of public disclosures available to investors and the shareholder protections afforded to them;
·As a Brazilian company, Ambev is subject to different corporate laws and regulations than those typically applicable to U.S.-listed companies, which may result in Ambev’s shareholders having fewer or less well-defined shareholder rights than the shareholder rights of those companies;
·Foreign holders of our ADSs may face difficulties in serving process on or enforcing judgments against us and other persons; and
·Judgments of Brazilian courts with respect to our shares will be payable only in reais.

Risks Relating to Our Operations

We face operational risks that can result in the partial or temporary shutdown of our operations, which may adversely affect our financial condition and results of operations.

We face operational risks that may result in partial or temporary suspension of our operations and in loss of production. Such outages may be caused by factors associated with equipment failure, information system disruptions or failures (including due to cyber-attacks), accidents, fires, strikes, weather, exposure to natural disasters, regional water crisis, electricity power outages and chemical product spills, accidents involving water reservoirs, availability of our suppliers to meet demand of raw and packaging materials, among other operational and environmental hazards. The occurrence of these events may, among other impacts, result in serious damage to our property, assets and reputation, a decrease in production or an increase in production costs, any of which may adversely affect our financial condition and results of operations.

During the normal course of our business, we depend on the continuous availability of logistics and transportation networks, including roads, railways, warehouses and ports, among others. Such operations may be disrupted by factors beyond our control, such as social movements, natural disasters, electricity shortages and labor strikes. Any interruption in the supply of inputs for the operation of our industrial units or in the delivery of our products to clients could cause a material adverse impact on our results of operations.

Moreover, the transportation and infrastructure system in Brazil and other countries we operate is under development and needs improvements so that it can work efficiently and serve better our business. Any significant interruptions or reductions in the use of transport infrastructure or in its operations in the cities where our distribution centers are located, may delay or impair our ability to distribute goods and cause our sales to drop, which may negatively impact our financial and operating results.

We are exposed to the risk of litigation.

We are now and may in the future be party to legal proceedings and claims (including labor, environmental and climate, tax and alcohol-related claims) and significant damages may be asserted against us. See “Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Legal Proceedings” and Note 27 to our audited consolidated financial statements as of and for December 31, 2023, included elsewhere in this annual report, for a description of our material litigation contingencies. Given the inherent uncertainty of litigation, it is possible that we might incur liabilities as a consequence of the proceedings and claims brought against us, including those that are not currently believed by us to present a reasonably possible chance of loss to us. Any changes to the risk assessments of chance of success of our cases could adversely affect our liquidity, financial positions, and business. Our management may also be exposed to sanctions due to legal proceedings against its members involving our operations or due to their involvement in other businesses.

Our tax contingency in Brazil has grown in recent years, and we expect it will continue to grow in the coming years, mainly because (1) its principal amount is adjusted on a monthly basis in accordance with the SELIC rate, or other equivalent interest rate, and (2) of the highly litigious environment in Brazil in connection

   
 10 
 

with tax disputes. In addition, the highly complex tax legislation in Brazil reduces certainty of interpretation by taxpayers. This environment affects the economic sector generally. According to research conducted in 2020 by the Brazilian Teaching and Research Institute – Insper, tax disputes in Brazil reached the amount of R$5.44 trillion in 2019, which corresponded to approximately 75% of the national Gross Domestic Product – GDP. The Brazilian Finance Ministry reported that in 2022, there were R$5.06 trillion of tax credits under dispute.

As the administrative phase of our tax proceedings ends and the judicial proceedings begin, the Company may be required to guarantee the amounts under discussion, through insurance bonds, bank guarantees, bank deposits or other types of assets or rights subject to attachment by law. We will continue to vigorously defend our position in connection with such disputes.

On September 20, 2023, Law 14,689 was enacted (“Law 14,689/2023”) in Brazil, providing for the exclusion of fines imposed in tax administrative proceedings decided in favor of the Brazilian federal government following a tie-breaking vote at the federal administrative level, including any such proceedings that were subsequently challenged in judicial courts and, as of the date of publication of Law 14,689/2023, that were pending decision by the appeal courts. Law 14,689/2023 also exempts taxpayers that challenged federal administrative tie-vote decisions in court from being required to post surety bonds or similar guarantees, subject to the fulfillment of certain requirements that have not yet been set by the tax authorities.

On December 20, 2023, the Brazilian Congress approved the consumption tax reform, resulting in the enactment of Constitutional Amendment No. 132/2023 which completely overhauls the taxation over consumption. One of the main goals of this tax reform is to simplify the tax legislation applicable to the consumption in Brazil by replacing current indirect taxes (IPI, ICMS, ISS, PIS and COFINS – IPI will be zero-rated as of 2027, except for products with industrialization incentives in the Manaus Free Trade Zone) by two consumption taxes and an Excise Tax (IBS, CBS and IS). The new system will be implemented over a period of seven years starting in 2026 up to 2033. The new regime is still to be regulated and tax rates have not yet been defined. Accordingly, we cannot anticipate the impact of the consumption tax reform on our operations with any precision as of the date of this annual report on Form 20-F. However, the effects on our results of operations may be significant and could have negative consequences that materially affect our reported results. In addition, the tax reform eliminates all tax benefits currently applicable to us, preserving only certain specific benefits as the Manaus Free Trade Zone, which could also negatively impact on our results of operations.

Additionally, on February 8, 2023, the STF judged two leading cases (Extraordinary Appeals Nos. 949.297 and 955.227) and ruled that any given collegiate decision by the STF recognizing the constitutionality or unconstitutionality of taxes collected on an ongoing basis will cease the effects of the res judicata of a prior ruling that is contrary to the STF’s position, even if this prior ruling had become final and unappealable in the past. This opinion from by the STF has created legal uncertainty for Brazilian companies, which relied on final judicial decisions to carry out their tax procedures and that are now faced with this binding STF decision that allows the overturn of past unappealable decisions, which could materially impact their business and results. Although this decision has no material impact on any tax credits already recognized by the Company and its subsidiaries, it may impact future tax credits in case the STF changes its binding view on a res judicata in place to the Company.

Moreover, companies in the alcoholic beverage and soft drink industries are, from time to time, exposed to collective suits (class actions) or other litigation relating to alcohol advertising, alcohol abuse problems or health consequences from the excessive consumption of beer, other alcoholic beverages and soft drinks. As an illustration, certain beer and other alcoholic beverage producers from Brazil have been involved in class actions and other litigation seeking damages.

Additionally, there has been an increase in litigation against large companies involving environmental, social and governance (ESG) matters, including claims related to climate justice, net-zero targets and ambitions, greenwashing, climate-washing, supply chain commercial relationships, and diversity and sustainability disclosure practices. As a result, we may also be subject to class actions or other litigation, including administrative proceedings, with respect to our ESG practices since these issues have attracted increasing attention from investors and civil society on a global scale.

If any of these types of litigation were to result in fines, damages or reputational damages to us or our brands, this could have a material adverse effect on our business, results of operations, cash flows or financial position.

Our results of operations are affected by fluctuations in exchange rates, and devaluation of the real or other currencies with which we operate relative to other currencies, including the U.S. dollar, which may adversely affect our financial performance.

Most of our sales are in reais; however, a portion of our debt is denominated in foreign currencies, including U.S. dollars. In addition, a significant portion of our cost of sales, particularly those associated with packaging materials such as aluminum cans and polyethylene terephthalate (PET) bottles, as well as essential

   
 11 
 

ingredients like sugar, hops, and malt, are denominated in or linked to the U.S. dollar. Accordingly, the recent volatility of the U.S. dollar/real exchange rate has had a notable impact on our cost structure in recent years. Therefore, any devaluation of the real or other currencies with which we operate when compared to those foreign currencies may increase our financial expenses and operating costs and could affect our ability to meet our foreign currency obligations. Although our current policy is to substantially hedge our cost of sales against changes in foreign exchange rates, we cannot assure you that such hedging will be possible, accurate or available at reasonable costs at all times in the future.

In addition, we have historically reported our consolidated results in reais. In 2023, we derived 42% of our net revenues from operating companies that have functional currencies that are not reais (that is, in most cases, the local currency of the respective operating company). Consequently, any change in exchange rates between our operating companies’ functional currencies and reais will affect our consolidated income statement and balance sheet. Decreases in the value of our operating companies’ functional currencies against reais will tend to reduce those operating companies’ contributions in terms of our financial condition and results of operations.

We also incur currency transaction risks whenever one of our operating companies enters into transactions using currencies other than their respective functional currencies, including purchase or sale transactions and the issuance or incurrence of debt. Although we have hedging policies in place to manage commodity price and foreign currency risks, there can be no assurance that such policies will be able to successfully hedge against the effects of such foreign exchange exposure, particularly over the long term.

The Brazilian currency has devalued frequently, including during the last two decades. Throughout this period, the Brazilian government has implemented various economic plans and utilized a number of exchange rate policies, including sudden devaluations and periodic mini-devaluations, during which the frequency of adjustments has ranged from daily to monthly, floating exchange rate systems, exchange controls and dual exchange rate markets. There have been significant fluctuations in the exchange rates between Brazilian currency and the U.S. dollar and other currencies. For example, prior to the COVID-19 pandemic, the Brazilian real/U.S. dollar selling exchange rate was R$4.03 per U.S. dollar as of December 31, 2019. However, by December 31, 2021, the Brazilian real/U.S. dollar selling exchange rate was R$5.58 per U.S. dollar, reflecting a 7.4% depreciation against the U.S. dollar as compared to the exchange rate as of December 31, 2020. As of December 31, 2022, the Brazilian real/U.S. dollar selling exchange rate was R$5.22 per U.S. dollar, reflecting a 6.5% appreciation against the U.S. dollar as compared to the exchange rate as of December 31, 2021. As of December 31, 2023, the Brazilian real/U.S. dollar selling exchange rate was R$4.84 per U.S. dollar, reflecting a 7.2% appreciation against the U.S. dollar as compared to the exchange rate as of December 31, 2022. As of March 1, 2024, the exchange rate was R$ 4.95 per US$1.00, reflecting a 2.4% depreciation against the U.S. dollar as compared to the exchange rate as of December 31, 2023.

Devaluation of the real relative to the U.S. dollar may create additional inflationary pressures in Brazil by generally increasing the price of imported products and requiring recessionary governmental policies to curb aggregate demand. On the other hand, appreciation of the real against the U.S. dollar may lead to a deterioration of the current account and the balance of payments, as well as dampen export-driven growth. The potential impact of the floating exchange rate and measures of the Brazilian government aimed at stabilizing the real is uncertain. In addition, a substantial increase in inflation may weaken investor confidence in Brazil, impacting our ability to finance our operations through the international capital markets.

Other exchange rate devaluations or political decisions related to exchange rates may impact our business as well. For instance, during the first quarter of 2021, Cuba carried out the unification of currencies and the process of elimination of the Cuban Convertible Peso, which resulted in a limited amount of hard currency available to transfer abroad and to acquire raw materials locally, mainly impacting Bucanero’s beer volume sold due to increasing costs of production and price of our Cuban products.

We rely on the reputation of our brands and damages to their reputation may have an adverse effect on our sales.

Our success depends on our ability to maintain and enhance the image and reputation of our existing products and to develop a favorable image and reputation for new products. The image and reputation of our products may be reduced in the future; concerns about product quality, even when unfounded, could tarnish the image and reputation of our products. An event or series of events that materially damages the reputation

   
 12 
 

of one or more of our brands could have an adverse effect on the value of that brand and subsequent revenues from that brand or business. Restoring the image and reputation of our products may be costly or not possible.

Moreover, our marketing efforts are subject to restrictions on the permissible advertising style, media and messages conveyed. In a number of countries, for example, television is a prohibited channel for advertising beer and other alcoholic products, and in other countries, television advertising, while permitted, is carefully regulated. Any additional restrictions in such countries, or the introduction of similar restrictions in other countries, may constrain our brand building potential and thus reduce the value of our brands and related revenues.

Information technology failures, including failures to implement upgrades and new technologies effectively or those that affect the privacy and security of sensitive customer and business information, could disrupt our operations.

We rely on information technology systems to process, transmit and store large amounts of electronic data, including personal information. A significant portion of communication between our personnel, customers and suppliers depends on information technology. As with all large systems, our information systems may be vulnerable to a variety of interruptions due to events beyond our control, including, but not limited to, natural disasters, terrorist attacks, telecommunications failures, computer viruses, hackers’ attacks, or other security issues.

We depend on information technology to enable us to operate efficiently and interface with customers, as well as to maintain in-house management and control. Looking ahead, we continue to implement strategic initiatives and new technologies designed to grow our business, which are critical for the efficient functioning of our business. We also collect and store non-public personal information that customers provide to purchase products or services, including personal information and payment information.

For instance, we are implementing a new version of our main enterprise resource planning (ERP) System -the S4 Hana a SAP platform—which will help us book all the transactional data used in our Brazilian operations. Any replacement or upgrades to our system and related process to implement it may cause occasional system disruptions or delays to run our business operations, including to efficiently fulfill orders and provide services to our customers, subjecting us to inherent costs and risks. There are no assurances that our choices of technologies will prove correct, or that our initiatives will succeed and bring sufficient growth in revenue to offset the costs.

Additionally, we may experience occasional system interruptions and delays that make our websites, in-house controls, and services unavailable or slow to run our business operations, including to respond and prevent us from efficiently accepting or fulfilling orders or providing services to our customers.

In addition, the concentration of processes in shared services centers means that any disruption could impact a large portion of our business within the operating regions we serve. Any implementation of new technology or transition of processes to, from or within shared services centers as well as other transformational projects, could lead to business disruptions. If we do not allocate, and effectively manage, the resources necessary to build and sustain the proper technology infrastructure, we could be subject to transaction errors, processing inefficiencies, the loss of customers, or failure to attract new customers, lost revenues resulting from the disruption or shutdown of computer systems, unexpected failure of devices and software in use by our IT platforms, operations or supply chain disruptions, alteration, corruption or loss of accounting financial or other data on which we rely for financial reporting and other purposes, which could cause errors or delays in our financial reporting or the loss of or damage to intellectual property through a security breach. As with all information technology systems, our system could also be penetrated by outside parties with the purpose of extracting information, corrupting information or disrupting business processes.

We take various actions with the aim of minimizing potential technology disruptions – such as investing in intrusion detection solutions, proceeding with internal and external security assessments, building and implementing business continuity plans and reviewing risk management processes – but all of these protections may be compromised as a result of third-party security breaches, burglaries, cyberattack, errors by employees or employees of third-party vendors, of contractors, misappropriation of data by employees, vendors or unaffiliated third parties, or other irregularities that may result in persons obtaining unauthorized access to

   
 13 
 

company data or otherwise disrupting our business. Unauthorized or accidental access to, or destruction, loss, alteration, disclosure, misuse, falsification or unavailability of information could result in violations of data privacy laws and regulations, damage to our reputation or our competitive advantage, loss of opportunities to acquire or divest of businesses or brands and loss of ability to commercialize products developed through research and development efforts and, therefore, could have a negative impact on net operating revenues. More generally, these or other similar technological disruptions can have a material adverse effect on our business, results of operations, cash flows or financial condition.

We, as with all business organizations, are routinely subject to cyber-threats, however, while we continue to invest in new technology-monitoring and cyberattack prevention systems, no commercial or government entity can be entirely free of vulnerability to attack, or compromise given how rapidly and unpredictably techniques evolve to obtain unauthorized access or disable or degrade service.

If any of our products is defective or found to contain contaminants, we may be subject to product recalls, individual or collective litigation and/or other liabilities.

We take precautions to ensure that our beverage products and our associated packaging materials (such as bottles, crowns, cans, and other containers) meet accepted food safety and regulatory standards. Such precautions include quality control programs for primary materials, the production process, and our final products. We have established procedures to correct issues or concerns that are detected.

In the event that any failure to comply with accepted food safety and regulatory standards (such as a contamination or a defect) does occur in the future, it may lead to business interruptions, product recalls or liability, each of which could have an adverse effect on our business, reputation, prospects, financial condition and results of operations.

Although we maintain insurance policies against certain product liability (but not product recall) risks, we may not be able to enforce our rights in respect of these policies, and, in the event that a contamination or defect occurs, any amounts that we recover may not be sufficient to offset any damage we may suffer, which could adversely impact our business, results of operations and financial condition.

We are subject to risks associated with noncompliance with any data protection laws in the countries in which we operate and can be adversely affected by any penalties or other sanctions imposed.

In the ordinary course of our business, we receive, process, transmit and store large volumes of personal data, including that of employees, dealers, customers, and consumers. As a result, we are subject to various laws and regulations relating to personal data. These laws have been subject to frequent changes, and new legislation in this area may be enacted in other jurisdictions at any time. For example, Law No. 13,709/2018, the Brazilian General Data Protection Law (Lei Geral de Proteção de Dados Pessoais), or LGPD, was enacted in 2018 and came into effect as of September 18, 2020. Inspired by the General Data Protection Regulation of the European Union, the LGPD sets forth a comprehensive set of rules that promise to reshape how companies, organizations and public authorities collect, use, process and store personal data when carrying out their activities.

If we are not in compliance with the LGPD and other personal data protection laws in other jurisdictions, we may be subject to administrative sanctions, individually or cumulatively. In addition to the administrative sanctions provided for in the LGPD, failure to comply with any provisions set forth in the LGPD regarding the personal data collected by us may expose us to the following consequences: (i) the filing of lawsuits, individual or collective, claiming damages resulting from violations, based not only on the LGPD, but also on the sparse legislation that address data protection matters; (ii) the application of specific penalties foreseen in the sparse legislation, such as the Consumer Protection Code (Código de Defesa do Consumidor) and the Brazilian Internet Act (Marco Civil da Internet), in case of violation of its provisions, by some consumer protection bodies and public prosecution offices. Therefore, we have designed and implemented a privacy governance framework to comply with all the regulations. We have also implemented security measures to protect our databases and prevent cyberattacks, thereby reducing risks of exposure to data breaches and information security incidents.

Additionally, as a result of the remote work option implemented by us, an increase in cyberattacks through our employees’ personal computers may occur, since the cybersecurity of the networks used by them

   
 14 
 

in their homes may bear the same level of security as that of our corporate work environment, which may impair our ability to manage our business.

Despite the security measures that we have in place, our facilities and systems may be vulnerable to security breaches, cyberattacks, acts of vandalism, computer viruses, misplaced or lost data, programming or human errors, or other similar events, and individuals may attempt to gain unauthorized access to our database to misappropriate such information for potentially fraudulent purposes. Our security measures may fail to prevent such incidents and breaches of our systems could result in adverse impact to our reputation, financial condition, and market value. In addition, if we are unable to prove that our systems are properly designed to detect and to try and detain a cyberattack, or even if we fail to respond to a cyberattack properly, we could be subject to severe penalties and loss of existing or future business, aside from damages awarded to our customers, dealers and employees whose personal data might have been mishandled or breached.

If we are not successful in obtaining and maintaining the necessary licenses in the countries in which we operate, we may be subject to fines, penalties, or other regulatory sanctions, which could negatively impact our business and cause us to incur additional costs.

Our business is subject to obtaining and maintaining the necessary licenses and regulatory approvals issued by the competent bodies in the countries in which we operate. We cannot guarantee that such licenses or regulatory approvals will be granted, renewed, or extended. Such licenses or regulatory approvals may be withdrawn or made subject to limitations or onerous conditions. The absence of such licenses or regulatory approvals may result in the interruption of the activities of a specific plant or distribution center, which may adversely affect our results. Additionally, for the granting or renewal of such licenses or regulatory approvals, the competent authorities may determine that we must make certain changes to our operations or facilities, potentially resulting in additional costs.

We may also be subject to the regulation and control of other public authorities, in addition to those that we currently understand as the competent ones and cannot guarantee that such authorities will not require further licenses, permits and authorizations.

Furthermore, if we are unable to timely obtain, maintain or renew the licenses and permits necessary for our activities, we may have to incur additional costs for the payment of any charges or even compromise our regular activities.

Any of these factors that impact the non-obtaining or non-renewal of licenses and permits may cause us to incur additional costs, which may force us to revert resources to meet the legal requirements or compromise the regular operation of our activities. Furthermore, the development of activities without the proper licenses or in non-compliance with the licenses and their technical requirements may result in adverse consequences, such as: (i) infraction notices; (ii) application of successive fines; (iii) impediment to opening and operating units, even temporarily; (iv) interdiction or closing of units, even temporarily; (v) exposure to additional risk or loss of insurance coverage in the event of a safety and security accident or similar event; (vi) affecting an installation while a license is pending; and (vii) exposure of us, as well as our representatives, to other civil, administrative, and criminal sanctions. We may be adversely affected if one of our establishments closes, even if temporarily.

Our failure to obtain or renew surety bonds and letters of credit necessary in certain lawsuits on attractive terms or at all may adversely affect our liquidity, financial condition and business.

Certain agreements to which we are a party and certain legal proceedings in which we are involved require us to obtain and maintain surety bonds, letters of credit or similar financial instruments (e.g., bank products known as fiança bancária and/or seguro garantia) to secure the performance or payment of certain obligations and potential losses, respectively. We may be required to pay higher fees, post additional collateral or otherwise be subject to unfavorable terms and conditions when negotiating these products with financial institutions or insurers. In addition, if those negotiations fail, we may be required to use a substantial portion of our cash to secure such agreements and legal proceedings, which may materially and adversely affect our liquidity, financial condition, and results of operations.

   
 15 
 

Our insurance coverage may be insufficient to make us whole on any losses that we may sustain in the future.

The cost of some of our insurance policies could increase in the future. In addition, some types of losses, such as losses resulting from wars, acts of terrorism, or natural disasters, generally are not insured because they are either uninsurable or it is not economically practical to obtain insurance. Moreover, insurers recently have become more reluctant to insure against these types of events. Should a material uninsured loss or a loss in excess of insured limits occur, this could adversely impact our business, results of operations and financial condition.

We may not be able to protect our intellectual property rights.

Our future success depends significantly on our ability to protect our current and future brands and products and to defend our intellectual property rights, including trademarks, patents, domain names, industrial design, trade secrets and know-how. We have been granted numerous trademark registrations and patents covering our brands and products and have filed, and expect to continue to file, trademark and patent applications before the relevant intellectual property authorities in the variety of markets we conduct our business, always seeking to protect newly developed brands and products. We cannot be sure that trademark and patent registrations will be issued with respect to any of our applications. Therefore, events such as the definitive rejection of our trademark applications before the authorities, the unauthorized use or other misappropriation of our trademarks may diminish their value and reputation, so that we may suffer negative impact on the operating results. There is also a risk that we could, by omission, fail to renew a trademark, domain name, industrial design or patent on a timely basis or that our competitors will challenge, invalidate or circumvent any existing or future trademarks and patents requested by, issued to, or licensed by, us. In case of judicial questioning of any trademarks the judicial decision may negatively affect their use and may be prohibited from continuing to exploit them.

Although we have put in place appropriate actions to protect our portfolio of intellectual property rights (including patent applications, trademark registration and domain names), we cannot be certain that the steps we have taken will be sufficient or that third parties will not infringe upon or misappropriate proprietary rights. If we are unable to protect our proprietary rights against infringement or misappropriation, it could have a material adverse effect on our business, results of operations, cash flows or financial condition, and in particular, on our ability to develop our business. In addition, any dispute or litigation related to intellectual property assets may be costly and time consuming due to the uncertainty of litigation on the matter.

The relative volatility and illiquidity of securities of Brazilian companies may substantially limit your ability to sell our common shares and ADSs at the price and time you desire.

Investing in securities of companies in emerging markets, such as Brazil, involves greater risk than investing in securities of companies from more developed countries, and those investments are generally considered speculative in nature. Brazilian investments, such as investments in our common shares and ADSs, are subject to economic and political risks, involving, among other factors:

·changes in the Brazilian regulatory, tax, economic and political environment that may affect the ability of investors to receive payment, in whole or in part, in respect of their investments; and
·restrictions on foreign investment and on repatriation of capital invested.

The Brazilian securities markets are substantially smaller, less liquid and more concentrated and volatile than major U.S. and European securities markets. They are also not as highly regulated or supervised as those other markets. The relative illiquidity and smaller market capitalization of Brazilian securities markets may substantially limit your ability to sell the Ambev common shares and ADSs at the price and time you desire.

Our shareholders may not receive any dividends or IOC.

According to our bylaws, we generally pay our shareholders 40% of our annual adjusted net income, calculated and adjusted pursuant to Brazilian Corporation Law in accordance with the mechanisms described in our bylaws as presented in our consolidated financial statements prepared under IFRS. The main sources for

   
 16 
 

these dividends are cash flows from our operations and dividends from our operating subsidiaries. Therefore, that net income may not be available to be paid out to our shareholders in a given year. In addition, we might not pay dividends to our shareholders in any particular fiscal year based on the opinion of the Board of Directors that any such distribution would be inadvisable in view of our financial condition. While the law does not establish the circumstances rendering the payment of dividends inadvisable, it is generally agreed that a company need not pay dividends if such payment threatens its existence as a going concern or harms its normal course of operations.

Future equity issuances may dilute the holdings of current holders of Ambev common shares or ADSs and could materially affect the market price for those securities.

We may in the future decide to offer additional equity to raise capital or for other purposes. Any such future equity offering could reduce the proportionate ownership and voting interests of holders of our common shares and ADSs, as well as our earnings and net equity value per common share or ADS. Any offering of shares and ADSs by us or our main shareholders, or a perception that any such offering is imminent, could have an adverse effect on the market price of these securities.

Contractual and legal restrictions to which Ambev and its subsidiaries are potentially or allegedly subject may be triggered upon the consummation of certain transactions involving our indirect controlling shareholder, ABI, resulting in adverse limitations to our operations.

Ambev and its subsidiaries are a party to certain joint venture, distribution and other agreements, guarantees and instruments that may contain restrictive provisions that our contractual counterparties may try to interpret as being triggered upon the consummation of certain unrelated transactions of ABI. Some of those contracts may be material and, to the extent they may contain any such restrictive provisions, our counterparties may seek to enforce certain contractual remedies that may curtail material contractual rights and benefits that we have thereunder under the argument that ABI’s consummation of certain transactions has triggered the referred provisions. Similarly, unrelated transactions consummated by ABI may subject us to further antitrust restrictions in the countries in which we already operate. Any such restrictions may limit the amount and quality of business we conduct in each of those countries.

Our current controlling shareholder will be able to determine the outcome of our most significant corporate actions.

Our controlling shareholder, ABI, together with Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência, or FAHZ, held in aggregate 72.0% of our total and voting capital stock (excluding treasury shares) as of December 31, 2023.

ABI indirectly held shares in us representing 61.8% of our total and voting capital stock (excluding treasury shares) as of December 31, 2023. ABI thus has control over us, even though (1) ABI is subject to the Ambev shareholders’ agreement among IIBV, AmBrew and FAHZ dated April 16, 2013 and effective as of July 2, 2019, or the Shareholders’ Agreement, and (2) ABI is controlled by Stichting Anheuser-Busch InBev, or Stichting, a foundation organized under the laws of the Netherlands, which represents an important part of interests of the founding Belgian families of Interbrew N.V./S.A. (as ABI was then called) (mainly represented by EPS Participations S.à.R.L and Eugénie Patri Sébastien S.A.) and the interests of the Brazilian families which were previously our controlling shareholders (represented by BRC S.à.R.L.), or the Interbrew Founding Families. For further information on these matters see “Item 4. Information on the Company—A. History and Development of the Company—The InBev-Ambev Transactions” and “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev’s Major Shareholders—The Shareholders’ Agreement.”

Our controlling shareholder is able to elect the majority of the members of our Board of Directors and Fiscal Council, and generally determine the outcome of most other actions requiring shareholder approval, including dividend distributions, the consummation of corporate restructurings, issuances of new shares, sales of materials assets and bylaw amendments.

Additionally, our controlling shareholder may have interests that differ from ours and may vote in a way that is adverse to the interests of our other shareholders. In addition, any reputational issues associated with our (direct or indirect) shareholders may adversely affect the trading price of our shares.

   
 17 
 

Under Brazilian Law No. 6,404/76, as amended, or the Brazilian Corporation Law, the protections afforded to non-controlling security holders may differ from, or be less comprehensive than, the corresponding protections and fiduciary duties of directors applicable in the U.S. or other jurisdictions. See “—As a Brazilian company, Ambev is subject to different corporate laws and regulations than those typically applicable to U.S.-listed companies, which may result in Ambev’s shareholders having fewer or less well-defined shareholder rights than the shareholder rights of those companies.”

The ability of our foreign subsidiaries to distribute cash upstream may be subject to various conditions and limitations.

Our foreign subsidiaries’ ability to distribute cash (to be used, among other things, to meet our financial obligations) through dividends, intercompany advances, management fees and other payments is, to a large extent, dependent on the availability of cash flows at the level of such foreign subsidiaries and may be restricted by applicable laws and accounting principles. In particular, 41.9% (R$33.4 billion) of our total net revenues of R$79.7 billion in the year ended December 31, 2023, came from our foreign subsidiaries. In addition, some of our subsidiaries are subject to laws restricting their ability to pay dividends or the amount of dividends they may pay.

If we are not able to obtain sufficient cash flows from our foreign subsidiaries, this could negatively impact our business, results of operations and financial condition because the insufficient availability of cash at our company level may constrain us from paying all our obligations.

We may not be able to recruit or retain key personnel.

In order to develop, support and market our products, we must hire and retain skilled employees with particular expertise and considering diversity attributions, whenever applicable. The implementation of our strategic business plans could be undermined by a failure to recruit or retain key personnel or the unexpected loss of senior employees, including in acquired companies. We face various challenges inherent in the management of a large number of employees over diverse geographical regions, with its particular social contexts. Key employees may choose to leave their employment for a variety of reasons, including reasons beyond our control. The impact of the departure of key employees cannot be determined and may depend on, among other things, our ability to recruit other individuals of similar experience and skill at an equivalent cost and our ability to convey, maintain and monitor the culture of a safe, friendly and non-discriminatory work environment. It is not certain that we will be able to attract or retain key employees and successfully manage them, which could disrupt our business and have an unfavorable material effect on our financial position, income from operations and competitive position.

We rely on key third parties, including key suppliers, and the termination or modification of the arrangements with such third parties or non-compliance with the Company’s ESG guidelines or any failure to comply with laws and regulations by them could negatively affect our business.

We rely on third-party suppliers for a range of raw materials for our beer and non-beer products, and for packaging material, including aluminum cans, glass, kegs and PET bottles. We seek to limit our exposure to market fluctuations in the supply of these raw materials by entering into medium- and long-term fixed-price arrangements. We have a limited number of suppliers of aluminum cans, glass and PET bottles. Consolidation of the aluminum can industry, glass and PET bottle industry in certain markets in which we operate has reduced local supply alternatives and increased the risk of disruption to aluminum can, glass and PET bottle supplies. Although we generally have other suppliers of raw materials and packaging materials, the termination of or material change to arrangements with certain key suppliers, disagreements with those suppliers as to payment or other terms, or the failure of a key supplier to meet our contractual obligations or otherwise deliver materials consistent with current usage would or may require us to make purchases from alternative suppliers, in each case at potentially higher prices than those agreed with this supplier. Additionally, we may be subject to potential reputational damage if one of our suppliers violates applicable laws or regulations. These factors could have a material adverse effect on our business, results of operations, cash flows or financial condition.

We have also entered into contracts with third parties to provide transportation and logistics services in connection with part of our products. The early termination of these contracts or our inability to renew them or negotiate new contracts with other service providers with similar conditions could adversely affect our financial and operating condition. In addition, the majority of our suppliers of transportation operate under

   
 18 
 

concessions granted by the Brazilian government and the loss or non-renewal of such concessions may also adversely affect our results of operations and financial condition.

Moreover, if any of our suppliers and/or service providers fails to comply with laws or regulations, or applicable corporate policies and/or specific contractual clauses determined by us, including binding sustainability and ESG (environmental, social and corporate governance) practices, including social, environmental, climate, integrity, and labor laws, we may be subject to fines, administrative and legal proceedings, or other measures with an adverse impact on our business, results of operations and reputation. For further information, see “Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Legal Proceedings—Ambev Third-Party Supplier – Labor Investigations.”

Additionally, we have licenses to bottle and/or distribute brands held by companies over which we do not have control. See “Item 4. Information on the Company—B. Business Overview—Licenses.” If we are unable to maintain such arrangements on favorable terms, this could have a material adverse effect on our business, results of operations, cash flows or financial condition.

Demand for our products may be adversely affected by changes in consumer preferences and tastes.

We depend on our ability to satisfy consumer preferences and tastes. Consumer preferences and tastes can change in unpredictable ways due to a variety of factors, such as changes in demographics, consumer health concerns regarding obesity, product attributes and ingredients, changes in travel, vacation or leisure activity patterns, weather, consumer concerns regarding environmental impact caused by the products and its manufacturing, negative publicity resulting from regulatory action or litigation against us or comparable companies or a downturn in economic conditions. Consumers also may begin to prefer the products of competitors or may generally reduce their demand for products of our business segment. Failure by us to anticipate or respond adequately to changes in consumer preferences and tastes could adversely impact our business, results of operations and financial condition.

Risks Relating to the Economy Sector in Which We Operate

Volatility in commodities prices may adversely affect our financial performance.

A significant portion of our cost of sales is comprised of commodities such as aluminum, sugar, corn, wheat and PET bottles, the prices of which fluctuated in 2023. An increase in commodities prices directly affects our consolidated operating costs. Although our current policy is to mitigate our exposure risks to commodity prices whenever financial instruments are available, we cannot assure that such hedging will be always possible or available at reasonable costs at all times in the future.

Set forth below is a table showing the volatility in 2023 prices of the principal commodities we purchase:

Commodity

High Price

Low Price

Average in 2023

Fluctuation

Aluminum (US$/ton) 2,633.8 2,075.8 2,260.4 0.1%
Sugar (US$ cents/pounds) 28.0 19.0 24.1 2.7%
Corn (US$ cents/bushel) 6.9 4.5 5.6 (30.5%)
Wheat (US$ cents/bushel) 7.9 5.3 6.5 (20.7%)
PET (US$/ton) 1,138.9 947.1 1,035.0 7.1%

Sources: Aluminum LME, Sugar ICE, Corn CBOT, Wheat CBOT and PET IHS (formerly CMAI).

Negative publicity focusing on us or our products or on the way we conduct our operations may harm our business.

Media coverage and publicity generally can exert significant influence on consumer behavior and actions. If the social acceptability of beer, other alcoholic beverages or soft drinks were to decline significantly, sales of our products could materially decrease. In recent years, there has been increased public and political attention directed at the alcoholic beverage and soft drink industries. This attention is a result of public concern over alcohol-related problems, including drunk driving, underage drinking, drinking while pregnant and health

   
 19 
 

consequences resulting from the misuse of beer (for example, alcoholism), as well as soft-drink related problems, including health consequences resulting from the excessive consumption of soft drinks (for example, obesity). Factors such as negative publicity regarding the consumption of beer, other alcoholic beverages or soft drinks, publication of studies indicating a significant health risk from consumption of those beverages, or changes in consumer perceptions affecting them could adversely affect the sale and consumption of our products and harm our business, results of operations, cash flows or financial condition to the extent consumers and customers change their purchasing patterns.

Key brand names are used by us, our subsidiaries, associates and joint ventures, and licensed to third-party brewers. To the extent that we or one of our subsidiaries, associates, joint ventures or licensees are subject to negative publicity, and the negative publicity causes consumers and customers to change their purchasing patterns, it could have a material adverse effect on our business, results of operations, cash flows or financial condition. As we continue to expand our operations, there is a greater risk that we may be subject to negative publicity or fake news, in particular in relation to our businesses, environmental impacts, taxes, labor rights, corporate transparency, local work conditions among others. Negative publicity or fake news that materially damages the reputation of one or more of our brands or our businesses could have an adverse effect on the value of that brand or our businesses and subsequent revenues from that brand or business, which could adversely impact our business, results of operations, cash flows and financial condition.

Competition could lead to a reduction of our margins, increase costs and adversely affect our profitability.

We compete with both brewers and other beverages companies. Globally, brewers, as well as other players in the beverage industry, compete mainly on the basis of brand image, price, quality, distribution networks and customer service. Consolidation has significantly increased the capital base and geographic reach of our competitors in some of the markets in which we operate.

Concurrently, competition in the beverage industry is expanding and the market is becoming more fragmented, complex and sophisticated as consumer preferences and tastes evolve. Competition may divert consumers and customers from our products. Competition in our various markets could cause us to reduce pricing, increase capital investment, increase marketing and other expenditures, prevent us from increasing prices to recover higher costs, and thereby cause us to reduce margins or lose market share. Any of the foregoing could have a material adverse effect on our business, financial condition and results of operations. Innovation faces inherent risks, and the new products we introduce may not be successful, while competitors may be able to respond more quickly than we can to emerging trends.

The purchasing decisions of consumers are affected by factors including brand recognition, product quality and performance, price and subjective preferences. Some of our competitors may have marketing investments substantially larger than ours. If our advertising, promotional and marketing strategies do not succeed and if we are unable to offer new products to meet the market demands, our market share and results may be adversely affected. If we cannot introduce new products in a timely manner or if our end consumers believe that our competitors’ products are more attractive, our sales, profitability and our results of operations may be adversely affected.

Additionally, the unfair pricing practices in some markets and the lack of transparency, or even certain illicit practices, such as tax evasion and corruption, may skew the competitive environment, with material adverse effects on our profitability or ability to operate.

If we do not successfully comply with applicable anti-corruption laws, export control regulations and trade restrictions, we could be subjected to fines, penalties or other regulatory sanctions, as well as adverse press coverage, which could impact our reputation, operations and sales.

We are committed to conducting business in a legal and ethical manner in compliance with local and international laws and regulations applicable to our business. Nevertheless, there is a risk that our management, employees or other representatives may take actions that violate applicable anti-corruption laws, such as Brazilian Federal Law No. 12,846/2013 (known as the Clean Company Act or BCCA) and the U.S. Foreign Corrupt Practices Act (known as the FCPA).

The BCCA imposes strict liability on companies for certain acts against the public administration, including corrupt acts involving public officials, whether foreign or local. Under the BCCA, companies may

   
 20 
 

be held liable for such acts and face administrative and judicial sanctions, including severe fines and disgorgement of profits, among other sanctions. When imposing sanctions under the BCCA, Brazilian authorities may consider whether a company has implemented an effective compliance program.

Notwithstanding the BCCA and related Brazilian enforcement efforts, Brazil still has a perceived elevated risk of corruption. To a certain degree, that may leave us exposed to potential violations of the BCCA, FCPA or other applicable anti-corruption laws and regulations. For example, a number of high-profile corporate corruption allegations have surfaced in Brazil, especially since the beginning of 2014. See “—D. Risk Factors—Risks Relating to Brazil and Other Countries in Which We Operate—Economic and political uncertainty and volatility in Brazil, and the perception of these conditions in the international financial markets, may adversely affect our business and the market price of our shares and ADSs”.

Additionally, in the ordinary course of business, we regularly contract and deal with business partners and consulting firms. Some of these third parties have been managed or controlled by former government officials. Because Brazilian authorities are conducting ongoing investigations that target certain firms and business partners that we previously engaged, we have been cited as clients in connection with such investigations.

In the third quarter of 2019, there were news reports regarding alleged leaks of statements about Ambev by a former consultant, Mr. Antonio Palocci, in a legal procedure to which Ambev subsequently had access. In this regard, we have not identified evidence supporting Mr. Palocci’s claims of illegal conduct by Ambev and remain committed to monitoring this matter.

As a global brewer, we also operate our business and market our products in countries that may be subject to export control regulations, embargoes, economic sanctions and other forms of trade restrictions imposed by the United States, the United Nations and other participants in the international community.

We have implemented an anti-corruption compliance program designed to detect, prevent and remediate potential violations of applicable anti-corruption laws. Nevertheless, there remains some risk that improper conduct could occur, thereby exposing us to potential liability and the costs associated with investigating and remediating such potential misconduct. Our existing internal controls and compliance procedures may not be sufficient to prevent or detect all inappropriate conduct, fraud or violations of applicable law by management, employees, or other representatives (agents, and other business partners).

If we are not in compliance with anti-corruption and other similar laws, such as the BCCA and FCPA, we may be subject to administrative, civil and criminal penalties. This could harm our brand and reputation and have a material adverse impact on our business, financial condition, results of operations and prospects. Adverse press coverage also may result from having our name or brands associated with any misconduct and, even if unwarranted or baseless, could damage our reputation, brands and sales. Therefore, if we become involved in any investigations or other proceedings under the FCPA, BCCA or other applicable anti-corruption laws, our business could be adversely affected.

Increases in taxes levied on beverage products in the countries in which we operate and unfair competition arising from tax evasion may adversely affect our results and profitability.

Increases in levels of taxation in the countries in which we operate could adversely affect our profitability. Increases in taxes on beverage products usually result in higher beverage prices for consumers. Higher beverage prices generally result in lower levels of consumption and, therefore, lower net sales. Lower net sales result in lower margins because some of our costs are fixed and thus do not vary significantly based on the level of production. We cannot assure you that the countries’ governments will not increase current tax levels and that this will not impact our business.

For instance, in May 2018, the Brazilian Federal Government enacted Decree No. 9,394/2018 reducing the rate of the Excise Tax (Imposto sobre Produtos Industrializados), or IPI Excise Tax, applicable to transactions with concentrate units and, in so doing, effectively reduced the value of the IPI Excise Tax presumed credits that we had recorded on acquisitions of soft drinks concentrates from companies located in the Manaus Free Trade Zone from 20% to 4%, which was later revoked by the Decree No. 10,5454/2020. Since then, other decrees were issued with temporary rates applicable to transactions with concentrate units. In 2022, Brazilian Federal Government altered IPI Excise Tax rates levied on transactions with several products,

   
 21 
 

including beer, soft drinks and soft drinks concentrate units. As for concentrate units, the IPI Excise Tax rate was fixed in 8% (Decree No. 11,182/2022).

In 2022, the States of Acre, Alagoas, Amazonas, Bahia, Maranhão, Paraná, Pará, Piaui, Rio Grande do Norte, Roraima, Sergipe, Tocantins increased their ICMS Value-Added Tax rate applicable to beer and/or soft drinks (increases ranging from 1% to 4%), while both the States of Minas Gerais and Rio de Janeiro decreased their ICMS value-Added Tax rates with effect from early 2023 (decreases of 2% and 1%, respectively). In 2023, the States of Minas Gerais and Rondônia increased their ICMS Value-Added Tax rate applicable to beer (increases ranging from 2% to 5%), while the states, Maranhão, Pernambuco, Roraima, Paraíba, Ceará, Bahia, Distrito Federal, Goiás and Minas Gerais increased their ICMS Value-Added Tax rate applicable to soft drinks (increases ranging from 1% to 3%) and the States of Rio Grande do Sul and Rio Grande do Norte, decreased their ICMS value-Added Tax rates applicable to soft drinks (decreases of 2%, respectively), with all effects from early 2024 on.

In addition, certain tax laws may be subject to controversial interpretations by tax authorities. If the tax authorities interpret the tax laws inconsistently with our interpretations, we may be adversely affected, including the full payment of taxes due, plus charges and penalties.

Furthermore, as mentioned, the Brazilian National Congress has approved a tax reform that revamps the existing consumption tax system, in place since the 1960s. The core of the tax reform is the substitution of current indirect taxes (PIS, COFINS, IPI, ICMS and ISS – IPI will be zero-rated as of 2027, except for products with industrialization incentives in the Manaus Free Trade Zone) into a so-called “Dual” value-added tax (IBS and CBS), charged on the consumption of goods, services, and rights and an Excise Tax which will apply over goods and services considered as harmful to health or the environment. See “Item 4. Information on the Company—B. Business Overview—Taxation.”

At the national level, the VAT will be called Contribution on Goods and Services (CBS) and at the subnational level, the VAT will be called Tax on Goods and Services (IBS). The Dual VAT will be charged at the destination and, in practice, will be the sum of the national VAT (CBS) and subnational VAT (IBS) rates. It will also be charged on imports, but not on exports. In addition to simplicity and transparency, the new Dual VAT system seeks to eliminate the existing distortion of tax-over-tax, and the so-called “tax war” among states, that compete with each other to attract investment. Besides the Dual VAT (CBS/IBS), the reform also establishes an Excise Tax (IS) yet to be regulated but that will apply over goods and services considered as harmful to health or the environment. It is still pending the regulation of the IBS, CBS and IS tax rates and detailed regime.

Also, the Constitutional Amendment No. 132/2023 provides that the Executive Branch of the Federal Government has until March 2024 to present a suggestion of bill of law related to the tax reform concerning income taxation. The implementation of a tax reform or of any modifications to the current applicable tax legislation, altering the taxes due and/or the tax incentives enjoyed by the companies could directly or indirectly impact our business.

Additionally, Provisional Measure No. 1,185/2023 was converted into Law No. 14,789/2023, which became effective on January 1, 2024. The law provided relevant changes in the federal taxation, such as:

·Federal taxation of tax incentives: Apart from specific federal tax incentives for the development of the North and Northeast regions (“SUDAM” and “SUDENE” benefits), all other federal, state and municipal tax incentives will be subject to Corporate Income Tax (“IRPJ”) and PIS and COFINS taxation. A Corporate Income Tax restricted tax credit may be granted to partially offset the federal taxation impacts, provided certain conditions are met and an authorization by the tax authorities is issued;
·Deductibility of Interest on Shareholders’ Equity (or Interest On Capital – “IOC”): Law No. 14,789/2023 also brought specific limitations for the deductibility of IOC payout mainly by means of limiting Net Equity’s accounts that could be considered for the calculation of a fully deductible IOC. Thus, as of January 1, 2024, our IOC basis was adjusted downwards by the value that was recorded in the “carrying value adjustments account” in connection with the stock swap merger carried out in 2013 that allowed us to move to a “one share, one vote” system.

Our business is subject to regulations in the countries in which we operate, and we may have our activities impacted by foreign legislation regarding social, environmental and climate issues.

Our business is regulated by federal, state and municipal laws and regulations governing many aspects of our operations, including brewing, marketing and advertising, consumer promotions and rebates, workplace

   
 22 
 

safety, transportation, environmental aspects, distributor relationships, retail execution, sales and data privacy, among others. In addition, as a public company in Brazil, we are also subject to the Brazilian securities law and the oversight of the Brazilian Securities Commission (Comissão de Valores Mobiliários), or the CVM, in connection with our public securities. We may be subject to claims that we have not complied with existing laws and regulations, which could result in fines, penalties and additional obligations such as disclosure of additional information, change of current practices, among others.

In Brazil, the Ministry of Agriculture and Livestock (“MAPA”) and its local departments are responsible for the registration, standardization, classification, labelling and for the inspection and surveillance of beverage production and commerce. MAPA regulation sets forth that the registration of establishments and beverages products is valid throughout the country and must be renewed every ten years, except for imported beverages that do not require registration with the MAPA. Moreover, some products and beverages (i.e., energy drinks) may be subject to prior registrations or post-production regulations issued by the Brazilian National Health Surveillance Agency (ANVISA).

We may be subject to laws and regulations aimed at reducing the availability of beer and carbonated soft drink, or CSD beverages, in some of our markets to address alcohol abuse, underage drinking, health concerns and other social issues. For example, certain Brazilian states and small municipalities in which we operate have enacted legislation restricting the hours of operations of certain points of sale, prohibiting the sale of CSDs in schools and imposing restrictions on advertisement of alcoholic beverages. The Brazilian Congress is also evaluating proposed regulation imposing hygienic seals on beverage cans, as well as regulation on the consumption, sales and marketing of alcoholic beverages, including beer which, if enacted, may impose restrictions on the advertisement of alcoholic beverage products on television during specified times of the day and the hours of operation of certain points of sale, among other things. Furthermore, there are legal proceedings pending before Brazilian courts that may lead to restrictions on advertisement of alcoholic beverages. These rules and restrictions may adversely impact our results of operations. For further information, see “Item 4. Information on the Company—B. Business Overview—Regulation.”

We may be unable to timely comply with recently enacted laws and regulations in the countries we operate or to comply with laws and regulations in countries we recently started to operate. There is a global trend of increasing regulatory restrictions with respect to the sale of alcoholic and CSD beverages. Compliance with such regulatory restrictions can be costly and may affect earnings in the countries in which we operate.

Additionally, the trend towards the multiplication of regulations aimed at regulating ESG issues in the international jurisdictions where we conduct our businesses can result in complex regulatory obligations, with compliance actions to be implemented throughout the value chain, which may lead to high compliance costs and, in the event of non-compliance, reputational, financial and operational damage, as well as limitations on accessing external consumer markets.

We are subject to Brazilian and other antitrust regulations.

As any company operating in Brazil, we are subject to the Brazilian antitrust law and regulation, which sets forth the conducts that should be considered a violation to the economic order and the penalties applied. We have a substantial share of the beer market in Brazil and thus we are subject to scrutiny and enforcement by Brazilian antitrust authorities (mainly the Administrative Council for Economic Defense – CADE). We are committed to conducting business in a legal manner, having implemented what we understand to be a sound competition compliance program to prevent anticompetitive practices. Nevertheless, from time to time, we are and may become involved in litigation, investigations and other legal or administrative proceedings relating to antitrust claims arising from allegations of violations of laws, regulations or acts, either from competitors, clients and other third parties or initiated by CADE. Therefore, we cannot assure you that Brazilian antitrust regulation and decisions will not affect our business in the future.

We also have substantial share of the beer market in other countries, such as Argentina, Bolivia, Uruguay, Paraguay, Panama and the Dominican Republic, in which our operations are subject to scrutiny by local antitrust authorities. We cannot assure you that local antitrust regulations will not affect our business in such other countries in the future.

   
 23 
 

The Brazilian government has exercised, and continues to exercise, significant influence over the Brazilian economy; Brazilian economic and political conditions have a direct impact on our business and the market price of our shares and ADSs.

The Brazilian economy has been characterized by significant involvement on the part of the Brazilian government, which has historically changed monetary, credit and other policies to influence Brazil’s economy. The Brazilian government’s actions to influence the course of Brazil’s economy, control inflation and to implement other policies have involved increase in the Central Bank’s base interest rate, changes in tax policies, wage and price controls, currency devaluations, capital controls, fiscal adjustments, limits on imports and exports, as well as other measures, such as the freezing of bank accounts, which occurred in 1990.

Actions taken by the Brazilian government concerning the economy may have important effects on Brazilian corporations and other entities, including Ambev, and on market conditions and prices of Brazilian securities. Our financial condition and results of operations may be adversely affected by the following factors and the Brazilian government’s response to the following factors:

·devaluations and other exchange rate movements;
·inflation;
·investments;
·exchange control policies;
·employment levels and labor regulation;
·social instability;
·price instability;
·energy shortages;
·water rationing;
·natural and other disasters, including large scale epidemics and/or pandemics, including governmental and other responses and business restrictions related thereto;
·interest rates and monetary policy;
·liquidity of domestic capital and lending markets;
·growth or downturn of the Brazilian economy;
·import and export controls;
·exchange controls and restrictions on remittances abroad;
·fiscal policy and changes in tax laws; and
·other political, diplomatic, social and economic developments in or affecting Brazil.

Uncertainty as to whether the Brazilian federal government will implement changes in policy or regulation affecting these or other factors in the future may affect economic performance and contribute to economic uncertainty in Brazil and to heightened volatility and lack of liquidity in the Brazilian capital market and securities issued by Brazilian companies. For example, the deterioration in federal, state and municipal governments’ fiscal results in recent years has led to an unprecedented increase in gross debt as well as in the gross debt to GDP ratio, which led Brazil to lose its investment grade from credit rating agencies, decreasing the influx of foreign capital and contributing to a lower level of economic activity. In addition, the Brazilian

   
 24 
 

economy has experienced a sharp drop in recent years due, in part, to the interventionist economic and monetary policies of the Brazilian federal government.

We cannot predict the measures that the Brazilian federal government will take due to mounting macroeconomic pressures or otherwise. Recent economic and political instability has led to a negative perception of the Brazilian economy and higher volatility in the Brazilian capital markets and the securities of Brazilian issuers, which also may adversely affect us. Indecision as to changes in policies and regulations implemented by the Brazilian federal government may contribute to economic uncertainty in Brazil and greater volatility in the Brazilian capital markets. Prior to the COVID-19 pandemic, Brazil was just emerging from a prolonged recession and a period of slow recovery, with only meager GDP growth in 2017, 2018 and 2019. Brazil’s incipient economic recovery in 2020 was torpedoed with the onset of the COVID-19 pandemic and governmental measures in relation thereto, all of which have introduced an additional level of economic and political uncertainty. These dynamics further impacted 2021, 2022 and 2023, which, coupled with government stimulus reduction, amplified the uncertainty by adding volatility to the market through accelerated inflation, lower disposable income and higher SELIC rates in Brazil.

Economic and political uncertainty and volatility in Brazil, and the perception of these conditions in the international financial markets, may adversely affect our business and the market price of our shares and ADSs.

Our most significant market is Brazil, which has periodically experienced rates of inflation higher than expected. Inflation, along with governmental measures to fight inflation and public speculation about possible future measures, has had significant negative effects on the Brazilian economy. The annual rate of inflation, as measured by the National Consumer Price Index (Índice Nacional de Preços ao Consumidor), was 10.1% in 2021, 5.8% in 2022 and 4.6% in 2023. Brazil may continue to experience high levels of inflation in the future and such inflationary pressures may lead to the Brazilian government intervening in the economy and introducing policies that could adversely affect the Brazilian economy, the securities market and our business. In the past, the Brazilian government’s interventions included the maintenance of a restrictive monetary policy with high interest rates that restricted credit availability and reduced economic growth, causing volatility in interest rates. More recently, inflationary pressures have receded, which has led to the return of a more expansionary monetary policy.

Inflationary pressures in Brazil present notable challenges to our operations, affecting both our cost and expense structure and consumer demand dynamics. For additional information on such effects, see “Item 5. Operating and Financial Review and Prospects - A. Operating Results - Brazilian Economic Environment and Inflation Impacts” for more information.

The Central Bank’s Monetary Policy Committee (Comitê de Política Monetária do Banco Central do Brasil, or COPOM) frequently adjusts the interest rate in situations of economic uncertainty to achieve goals established in the Brazilian federal government’s economic policy. In the event of an increase in inflation, the Brazilian federal government may choose to significantly increase interest rates. For example, the SELIC official interest rate oscillated from 2.75% in March 2021 to 9.75% in the end of 2021, with further increases in February, March, May and June 2022. As of the date hereof, the SELIC rate was 11.25%. We cannot assure you that inflation will not affect our business in the future.

Consumption of beer, other alcoholic beverages and soft drinks in many of the jurisdictions in which we operate, including Brazil, is closely linked to general economic conditions, such that levels of consumption tend to rise during periods of rising per capita income and to fall during periods of declining per capita income. Consumption of beer and other alcoholic beverages also varies in accordance with changes in disposable income. Any decrease in disposable income resulting from an increase in inflation, income taxes, cost of living, unemployment levels, political or economic instability or other factors would likely adversely affect the demand for beer, other alcoholic beverages, soft drinks and other non-alcoholic beverages, as well as our results of operations. Moreover, the instability and uncertainty in the Brazilian economic and political scenario may continue to adversely affect the demand for our products, which in turn may negatively impact our operations and financial results.

In addition, Brazil’s political environment has historically influenced, and continues to influence, the performance of the country’s economy. Political crises have affected and continue to affect the confidence of investors and the general public, which have historically resulted in economic deceleration and heightened

   
 25 
 

volatility in the securities issued by Brazilian companies. For example, presidential elections occurred in October 2022, with Luiz Inácio Lula da Silva defeating Jair Messias Bolsonaro, in one of the closest presidential races in history. In the aftermath of the 2022 election results, there were mass protests and demonstrations throughout Brazil by supporters of former president Jair Bolsonaro disputing the election results and a heightened state of political and social tension has persisted in Brazil following the election and the commencement of Luiz Inácio Lula da Silva’s new term of office on January 1, 2023.

Further, during the term of the former president Jair Messias Bolsonaro, who remained president until January 1, 2023, there were several inquiries related to potential misconduct. The potential outcome of these and other inquiries, as well as potential new inquiries involving Jair Messias Bolsonaro that may arise, are uncertain, but they had a negative impact on the general perception of the Brazilian economy and have adversely affected and may continue to affect our businesses, financial condition, and results of operations, as well as the market price of our common shares.

Ultimately, we cannot predict the scope, nature and impact of any policy changes or reforms (or reversals thereof) that the president’s administration will implement, particularly the scope, viability, and effectiveness of much-anticipated tax reforms, which could result in further political and economic instability and negatively impact the regulatory framework in which we operate, which in turn could adversely affect our businesses, financial condition and operating results. Likewise, we cannot predict how the president’s administration may impact the overall stability, growth prospects and economic and political health of the country.

In addition, any effort on the part of the Brazilian government to preserve economic stability, as well as any public speculation about possible future initiatives, may contribute significantly to economic uncertainty in Brazil and may heighten volatility in the Brazilian securities markets and securities issued abroad by Brazilian issuers. It is also difficult to assess the impact that turmoil in the credit markets will have in the Brazilian economy, and as a result on our operations and financial results in the future.

A failure by the Brazilian government to implement reforms may result in diminished confidence in the Brazilian government’s budgetary condition and fiscal stance, which could result in downgrades of Brazil’s sovereign foreign credit rating by credit rating agencies and the rise of risk premium, negatively impacting Brazil’s economy and leading to further depreciation of the real and an increase in inflation and interest rates, adversely affecting our businesses, financial condition and results of operations.

Risks Relating to Other Countries in Which We Operate

Our Latin America South operations are subject to substantial risks relating to the businesses and operations conducted in Argentina and other South American countries.

We own 100% of the total share capital of Latin America South Investment, S.L., or LASI, which is a holding company with operating subsidiaries in Argentina and other South American countries. As a result, LASI’s financial condition and results of operations may be adversely affected by the political instability, fluctuations in the economy and governmental actions concerning the economy of Argentina and the other countries in which its subsidiaries operate and, consequently, affect our consolidated results.

The results of our Argentinian operations have been significantly impacted in recent years by political instability, fluctuations in the Argentine economy (such as the devaluation of the Argentine peso in 2021, 2022 and 2023 relative to the U.S. dollar), governmental actions concerning the economy of Argentina (such as Argentina’s selective default on its restructured debt in July 2014), inflation and deteriorating macroeconomic conditions in the country (See “Item 3. Key Information-D. Risk FactorsRisks Related to Other Countries in Which We Operate - Continuing high rates of inflation in Argentina may have an adverse effect on the economy and our business, financial condition and results of operations”). Continued deterioration of the Argentine economy, or new foreign exchange, price controls, export repatriation or expropriation regimes could adversely affect our liquidity and ability to access funds from Argentina, our financial condition and operating results.

The 2021, 2022 and 2023 devaluations of the Argentine peso relative to the real, and further devaluations of the Argentine peso in the future, if any, may decrease our net assets in Argentina, with a balancing entry in our equity. See “Item 3. Key Information-D. Risk Factors—Risks Relating to Our Operations—Our results of operations are affected by fluctuations in exchange rates and devaluation of the

   
 26 
 

real or other currencies with which we operate relative to other currencies, including the U.S. dollar, which may adversely affect our financial performance.”

In 2020, the Argentine government implemented multiple measures in response to the economic crisis resulting from the COVID-19 pandemic including increased health spending, financial support for workers (including funding of wages), vulnerable groups and certain industry sectors, as well as price controls. In 2021, these actions were further enhanced with the freezing of housing rental prices (coupled with the prohibition of evictions upon payment delays), temporary suspensions of service interruption due to non-payment and the extension of credit card payment deadlines and reduced fees on public transportation. Argentina’s inflation reached 211.4% in 2023 with the Central Bank increasing its reference interest rate (BADLAR) by 25pp, ending the year at 100%, in an attempt to prevent further devaluation of the currency that went from 177 ARS/USD to 809 ARS/USD (a 367% devaluation).

In light of the country’s ailing economy and market’s concerns, including as a result of increases in corporate income tax, our liquidity and operations, as well as our ability to access funds from Argentina could be adversely affected to the extent the economic or political situation in Argentina deteriorates, or if foreign exchange restrictions are further implemented in the country. It is also difficult to assess the impact that the changes to the Argentine political scenario will have in the Argentine economy and, as a result, on our future operations and financial results.

In November of 2023, Argentina elected Javier Milei as its new president, with views to fix an economy battered by soaring inflation, a looming recession and rising poverty. However, there is no guarantee that Mr. Milei will be successful in improving the macroeconomic scenario in relevant ways, or at all, and, likewise, we cannot predict the scope and effectiveness of any reforms he may implement, which are considered radical. If the economic or political situation in Argentina further deteriorates, our Latin America South operations may be subject to restrictions under new Argentinean foreign exchange, export repatriation or expropriation regimes that could adversely affect our liquidity and operations, and our ability to access funds from Argentina.

In addition, on November 8, 2020, Luis Arce took office as the new president of Bolivia, having won the elections in the first round with the majority of votes. With these results, the Movement towards Socialism (Movimiento al Socialismo or MAS) returned to power. In October 2023, following a power struggle between Arce and former-president Morales, Bolivia’s president Luis Arce was expelled from his own party, MAS. In 2023, Bolivia faced economic challenges, particularly regarding its dwindling net reserves and escalating country risk. The Bolivian central bank experienced a substantial decrease in its net foreign reserves, primarily comprised of gold and foreign currency, marking its lowest value in 17 years at $1.709 billion by the end of 2023. This decline in reserves triggered concerns about Bolivia’s financial stability, prompting investors to divest from Bolivian bonds due to default risks stemming from the depletion of dollars.

Furthermore, in December 2021, Gabriel Boric was elected Chile’s new president, defeating José Antonio Kast, in an election marked by political polarization. Boric’s government plan included promises to increase taxes on the highest income bracket as well as large companies, ending the current pension system, and creating a universal fund to finance public and private health. Mr. Boric was sworn in as president in March 2022. In 2023, the Chilean economy showed signs of recovery following a negative macroeconomic scenario in recent years. Nevertheless, Chilean GDP decreased by 0.2% in 2023 as compared to 2022, reflecting weak private consumption and higher unemployment rates, which increased by 0.7% in 2023.

It is difficult to assess the impact that the changes to the Bolivian and Chilean political scenario, as well as other Latin American countries, will have on their respective economies and, as a result, the effect on our results of operation and financial position.

Political developments in Latin America, including government deadlock, political instability and civil strife could impact our Latin America South operations and have a material adverse effect on our business, financial condition, and results of operations.

   
 27 
 

Continuing high rates of inflation in Argentina may have an adverse effect on the economy and our business, financial condition and results of operations.

Following the categorization of Argentina in our results for the third quarter of 2018 as a country with a three-year cumulative inflation rate greater than 100%, the country is considered as a hyperinflationary economy in accordance with IFRS rules (IAS 29), requiring us to restate the results of our operations for the year ended December 31, 2018, in hyperinflationary economies for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period.

Historically, high rates of inflation have undermined the Argentine economy and the Argentine government’s ability to foster conditions for stable growth. High rates of inflation may also undermine Argentina’s competitiveness in international markets and adversely affect economic activity and employment, as well as our business, financial condition and results of operations.

Argentina has confronted inflationary pressures, evidenced by significantly higher fuel, energy and food prices, among other factors. The National CPI variation was 211.4% in 2023, 94.8% in 2022 and 50.9% in 2021. On February 6, 2024, the Central Bank announced that the new inflation estimates for 2024 and 2025 are 227.0% and 58.9%, respectively, pursuant to its survey of market expectations (Relevamiento de Expectativas de Mercado) which was carried out between 29 and 31 of January, 2024. The Argentine government’s adjustments to electricity and gas tariffs, as well as the increase in the price of gasoline have affected prices, creating additional inflationary pressure. If the value of the Argentine Peso cannot be stabilized through fiscal and monetary policies, an increase in inflation rates could be expected.

A high inflation rate or a hyperinflationary process affects Argentina’s foreign competitiveness by diluting the effects of the peso depreciation, negatively impacting employment and the level of economic activity and undermining confidence. The efforts undertaken by the Argentine government to reduce inflation have not achieved the desired results yet. A continuing inflationary environment could undermine our results of operation, adversely affect our ability to finance the working capital needs in Argentina.

The main impact of this hyperinflationary environment in Argentina on our results of operations is the corresponding impact such inflation effects have on our cost of sales and operating expenses, particularly in terms of increasing costs of raw materials, labor, and other operating expenses. In this way, such inflationary pressures have direct impact on our gross profit margins and overall profitability. See “Item 5. Operating and Financial Review and Prospects - A. Operating Results - Argentinean Economic Environment and Inflation Impacts.” In addition, inflation impacts pricing dynamics due to its impact on consumer behavior and purchasing power. As prices rise, consumers may cut back on discretionary spending, including purchases of beverages. We may face challenges in passing on increased costs to consumers if they are already feeling the strain of inflation on their budgets. This can lead to deterioration on profit margins as Ambev may be unable to fully offset cost increases with higher prices.

There is uncertainty regarding the effectiveness of the policies implemented by the Argentine government to reduce and control inflation and the potential impact of those policies. An increase in inflation may adversely affect the Argentine economy, which in turn may have a negative impact on our financial condition and results of operation.

There can be no assurances that inflation rates will not continue to escalate in the future or that the measures adopted or that may be adopted by the Argentine government to control inflation will be effective or successful. High rates of inflation remain a challenge for Argentina. Significant increases in the rates of inflation could have a material adverse effect on Argentina’s economy and in turn could increase our costs of operation, in particular labor costs, and may negatively affect our business, financial condition and results of operations. Also, see “Item 5. Operating and Financial Review and Prospects - A. Operating Results - Argentinean Economic Environment and Inflation Impacts” for more information.

Deterioration in economic and market conditions in Brazil and other emerging market countries, as well as in developed economies, may adversely affect the market price of our common shares and ADSs.

Economic and market conditions in Brazil and other emerging market countries, especially those in Latin America, influence the market for securities issued by Brazilian companies as well as investors’ perception of economic conditions in Brazil. Crises in emerging markets, such as in Southeast Asia, Russia

   
 28 
 

and Argentina, historically caused volatility in the Brazilian stock market and other emerging countries. In addition, global financial crisis originating in developed economies, including the subprime debt crisis in the United States and the sovereign debt crisis in Europe, have had an impact on many economies and capital markets around the world, including Brazil, which may adversely affect investors’ interest in the securities of Brazilian issuers such as Ambev.

Our businesses, financial condition and results of operations may be materially and adversely affected by a general economic downturn and by instability and volatility in the financial markets and commodity prices, including as a result of the conflict between Ukraine and Russia and the armed conflict involving Hamas and Israel, and other conflicts in the Middle East.

More recently, the COVID-19 virus pandemic resulted in significant financial market volatility and uncertainty around the globe, evidencing that the market value of our common shares and ADSs may be adversely affected by events occurring inside and outside of Brazil, such as the emergence or continuation of widespread health emergencies or pandemics, military conflicts, including the ongoing conflict between Russia and Ukraine and the armed conflict involving Hamas and Israel, terrorism or other geopolitical events. Additionally, monetary policy changes and/or implementation of protectionist policies in the United States and other relevant countries for the international economy may impact, directly or indirectly, the economy in the countries where we operate, generating several risks, especially exchange rate, interest rate and increase in the price of commodities, and, consequently, affecting our results.

We operate a joint venture in Cuba, in which the Government of Cuba is our joint venture partner. Cuba is still targeted by broad and comprehensive economic and trade sanctions of the United States. Our operations in Cuba may adversely affect our reputation and the liquidity and value of our securities.

Ambev, through its Canadian subsidiary Cerbuco Brewing Inc., (“Cerbuco”), currently owns a controlling interest of 50% in Cerveceria Bucanero S.A., or Bucanero, a Cuban company in the business of producing and selling beer. The other 50% equity interest in Bucanero is owned by the Government of Cuba. We have the right to appoint the general manager of Bucanero. In 2021, Cerbuco initiated arbitration proceedings regarding potential breach of certain obligations relating to the joint venture. For more information regarding the arbitration proceedings, see “Item 8. Financial Information—Civil Claims—Cerbuco Arbitration.”

Bucanero’s main brands are Bucanero and Cristal. In 2023, Bucanero sold 1.03 million hectoliters of beer, representing about 0.56% of our total volume of 183.7 million hectoliters for the year. Although Bucanero’s production is primarily sold in Cuba, a small portion of its production is exported to and sold by certain distributors in other countries outside Cuba (but not the United States).

Based on U.S. foreign policy, the U.S. Treasury Department’s Office of Foreign Assets Control and the U.S. Commerce Department together administer and enforce broad and comprehensive economic and trade sanctions against Cuba. Although our operations in Cuba are quantitatively immaterial, our overall business reputation may suffer, or we may face additional regulatory scrutiny as a result of our activities in Cuba based on the fact that Cuba remains a target of U.S. economic and trade sanctions.

In addition, there have in the past been initiatives by federal and state lawmakers in the United States, and certain U.S. institutional investors, including pension funds, to adopt laws, regulations or policies requiring the divestment from, or reporting of interests in, companies that do business with countries designated as state sponsors of terrorism. On January 11, 2021, the United States government designated Cuba as a state sponsor of terrorism, a list from which Cuba had previously been removed in 2015. If U.S. investors decide to liquidate or otherwise divest their investments in companies that have operations of any magnitude in Cuba, the market in and value of our securities could be adversely impacted.

Also, Title III of the Cuban Liberty and Democratic Solidarity (LIBERTAD) Act of 1996 (known as the “Helms-Burton Act”) authorizes private lawsuits for damages against anyone who traffics in property confiscated without compensation by the Government of Cuba from persons who at the time were, or have since become, nationals of the United States.

The Helms-Burton Act also includes a section that authorizes the U.S. Department of State to prohibit entry into the United States of non-U.S. persons who traffic in confiscated property, and corporate officers and principals of such persons, and their families. Although Title III of the Helms-Burton Act had previously been

   
 29 
 

suspended by discretionary presidential action following its inception in 1996. On May 2, 2019, the former Trump Administration activated Title III of the Helms-Burton Act, thereby allowing nationals of the United States that hold claims under the Helms-Burton Act to file suit in U.S. federal court against all persons trafficking in property confiscated by the Cuban government. As a result of the activation of Title III of the Helms-Burton Act, we may be subject to potential U.S. litigation exposure, including claims accrued during the prior suspension of Title III of the Helms-Burton Act. It remains uncertain how the activation of Title III of the Helms-Burton Act will impact our U.S. litigation exposure. ABI has received notices of potential claims purporting to be made under the Helms-Burton Act.

The outbreaks of infectious diseases, or the risk of an outbreak (e.g. pandemics, epidemics, including a potential new wave or variant of COVID-19), and government and other response thereto are highly uncertain and unpredictable and may result in further adverse effects material to our business and may impact our ability to continue operating our business.

Outbreaks or potential disease outbreaks may have an adverse effect on our operations. Historically, some epidemics and regional or global outbreaks, such as the one caused by the Zika virus, the Ebola virus, the H5N5 virus (popularly known as avian influenza), the foot and mouth disease, the H1N1 virus (influenza A, popularly known as swine flu), the Middle East Respiratory Syndrome (MERS), the Severe Acute Respiratory Syndrome (SARS) and Dengue virus, have affected certain sectors of the economy in the countries where these diseases have spread.

During 2020 and 2021, as the COVID-19 pandemic progressed in the countries in which we operate, including Brazil, Argentina, Canada and several other countries in Central and South America, states and municipalities adopted guidelines that varied in terms of scope and intensity to control the spread of COVID-19, such as the restriction on circulation of people and social distancing, which resulted in the closing of and operating restrictions on stores, restaurants, hotels, shopping centers, crowded areas, parks and other public spaces. In 2022, most of such restrictions were lifted throughout the first half of the year as a result of improvements in the control of the pandemic. While these restrictions were in effect, they have changed consumer behavior and the dynamics of on-trade (e.g., bars and restaurants) and off-trade (e.g., supermarkets) channels, which adversely impacted our profitability. This changed dynamics had a severe effect on emerging market countries, such as Bolivia and Panama, where the on-trade channel is the predominant consumption occasion for consumers. See “Item 5. Operating Financial Review and Prospects—A. Operating Results.”

The dissemination of COVID-19 made us change our business practices (including additional hygienic practices for workplaces and employees, in addition to canceling in-person meetings, events and conferences) during the pandemic. We may take additional actions, as required by government authorities, or as determined by management, considering the best interests of our employees, customers and business partners. We cannot guarantee that these measures will be sufficient to mitigate the risks posed by the pandemic or that they will meet the demands of government authorities.

The extent to which the outbreak of pandemics of infectious diseases will affect our business, financial condition, results of operations or cash flows will depend on future developments, which are highly uncertain and unpredictable. These developments include, among others, the duration and geographic distribution of the outbreak, its severity, actions to contain the virus or minimize its impact, and how quickly and to what extent normal economic and operational conditions can be resumed. Even four years after the COVID-19 pandemic started, our business continues to suffer adverse and material impacts due to the global or regional economic impact, including recession, economic slowdown or increase in unemployment levels, which may affect the purchasing power of our customers.

In addition, we cannot guarantee that other regional and/or global outbreaks will not occur. If they do, we cannot guarantee that we will be able to take the necessary measures to prevent an adverse impact on our businesses of equal or greater dimension than the impact caused by the COVID-19 pandemic, in case of new regional and/or global outbreaks or new large-scale waves of COVID-19.

Any outbreak of a disease that affects human behavior or that requires public policies to restrict the circulation of people and/or social contact may change consumer behavior, having an adverse impact on our business, as well as on the economies in the countries in which we operate. Disease outbreaks may also make it impossible for our employees and customers to go to our facilities (including for preventative reasons or avoiding large-scale contamination), which would adversely affect the development of our business.

   
 30 
 

The impact of outbreaks of infectious diseases, or the risk of an outbreak (e.g. pandemics, epidemics, including a potential new wave or variant of COVID-19) can also precipitate or exacerbate the other risks described in this annual report.

Risks Relating to Environmental, Social and Governance (ESG) Matters

Our commitment to social responsibility may result in the incurrence of additional costs, and we are subject to laws, regulations and other obligations in furtherance of human rights, social justice and labor standards that may exposes us to additional contingencies.

We aim to operate our business in a manner that upholds corporate social responsibility standards, which may vary based on the specific characteristics of our various business operations and the geographies where we operate. We are also subject to laws, regulations and other obligations that require us to comply with social impact and diversity standards and, accordingly, we are exposed to certain risks related to noncompliance.

In general, social risks arise from the potential and effective adverse impacts to our business related to the human rights of all stakeholders involved in our operations, including our employees, consumers, suppliers, investors and the local communities where we operate, whether directly or indirectly.

If the measures we adopt are not sufficient to prevent, manage and mitigate the social risks applicable to our business, we will consequently be exposed to legal, regulatory, operational and reputational risks, which can materialize in different ways.

We are also required to guarantee dignified working conditions for our employees, ensuring their health, safety, well-being and their right to associate and participate in unions, in compliance with local laws and regulations, respecting human rights. A workplace identified as dangerous, hostile or discriminatory may result in legal contingencies and inhibit the Company’s ability to attract and retain talent, negotiate with associations and unions, prevent incidents of health and safety at work, and drive innovation.

Similarly, if we do not take well-structured initiatives that are integrated into long-term planning to foster diversity, equity and inclusion, in all levels regardless of the hierarchy, we may be challenged, including judicially, about the absence of clear goals and effective actions in this area.

There is no guarantee that we will be able to properly manage the social risks mentioned above, meeting all national and international laws, parameters and guidelines, which, consequently, may harm our operating results and reputation.

Our operations are subject to broad safety and environmental regulations, the non-compliance of which may pose significant financial, operational, reputational, litigation and regulatory risks related to environmental issues for us.

The Company’s operations are subject to a wide variety of federal, state and municipal environmental laws and regulations, related to the licenses or authorizations necessary for the development of the Company’s business regarding the installation and operation of its projects and activities, the use of water resources, solid waste management, removal of vegetation, impact on protected areas, use of forestry products or raw materials, among other aspects possibly related to its activities.

The Company’s activities require the constant obtaining and renewal of environmental licenses and authorizations, which depend on the installation and operation of activities and undertakings considered by the competent environmental agency, under the terms of current environmental legislation, as effectively or potentially polluting the environment. Technical difficulties, non-compliance with the related environmental legislation and the technical conditions established in the environmental licenses and authorizations may have harmful effects on the Company’s business, since they may subject it to the imposition of various administrative sanctions (such as simple or successive fines, interruption or suspension of activities, embargo or closure of undertakings, revocation of licenses and authorizations, as applicable), payment of costs for the recovery of degraded areas and environmental regularization (resulting from environmental compensation and embargo, for example), as well as accountability in the civil, administrative and criminal spheres, as the case may be. There is no guarantee that the Company, even adopting appropriate practices and processes, will not incur environmental liability or that these applicable environmental laws and regulations will not change or

   
 31 
 

become more stringent in the future. In this sense, non-compliance with the applicable legislation and the technical conditions established in the licenses and authorizations may harm the Company’s operations, reputation, operating results and financial health.

As the scrutiny of environmental authorities, society and investors regarding the Company’s practices in relation to the environment, as well as the Company’s compliance with environmental legislation in the various federative spheres, as well as in the countries in which we operate, has become increasingly rigorous, the Company’s costs to comply with environmental regulation, improve environmental practices and repair possible environmental damage can increase substantially in the future. Furthermore, processes related to environmental compliance can become more complex.

In this context, for the purpose of complying with current environmental legislation and addressing other environmental issues relevant to the Company, the following are considered material issues from a regulatory, operational, financial and reputational point of view: (i) the use of water resources; (ii) climate change and a potential regulation of carbon markets and greenhouse gas emissions in countries where the Company operates, such as Brazil; (iii) solid waste management, reverse logistics and circular packaging; (iv) sustainable agriculture and (v) responsible consumption. In view of their relevance, the Company internally manages the material topics by establishing and monitoring appropriate performance indicators to assess the variations, evolutions and challenges related to each of the aforementioned topics.

Natural and other disasters and accidents caused by human and technological errors could disrupt our operations.

The economy of countries in which we operate, as well as our business activity and operating results, may be adversely impacted by natural (including floods, fires), social, technical (technological or human errors) or physical risks such as large-scale epidemics and pandemics, including the COVID-19 pandemic, the occurrence of natural disasters, terrorist events, military conflicts, including the ongoing conflict between Russia and Ukraine and the armed conflict involving Hamas and Israel, which could disrupt the operations of our suppliers, affect the price or availability of certain raw materials or commodities required for our products and adversely affect our operations, as well as other actions that may result in significant widespread disruptions to commerce and the ability of businesses, including ours, to operate normally. The exemplified events and others can affect our business in general or be specific to certain strategic locations, where our plants, distribution center or logistic hubs may be located. Such disruptions may result in reduced economic activity and business sentiment, both in the Brazilian market and internationally.

Climate change, or legal, regulatory or market measures to address climate change, may negatively affect our business or operations.

There is growing concern about adverse impacts caused by emissions of carbon dioxide and other greenhouse gases into the atmosphere such as rising global temperatures, changing weather patterns, and the increased frequency and severity of extreme weather events and natural disasters. If climate change has a negative effect on agricultural productivity in the locations where the Company operates, the Company may be subject to reduced availability or the offer at less favorable prices for certain agricultural products that are necessary for the Company’s production process, such as barley, hops, sugar and corn. In addition, public expectations for reducing greenhouse gas emissions may result in increased cost of energy, transportation and raw materials and may require the Company to make additional investments in facilities and equipment due to increased regulatory or social pressures. As a result, the effects of climate change could have material adverse long-term impacts on the Company’s business and results of operations. The Company’s operations are subject to physical risks, with impacts on the production capacity and delivery of services and products, resulting from the effects of climate change. Tropical cyclones can cause disruptions and damage to businesses and breweries. Wildfires can cause malt barley crop failures, as occurred in 2021 in Canada, which led to significant crop failures. Non-seasonal rains can cause malting barley harvest failures, affecting barley quality. Changes in weather conditions can result in reduced malting barley yields. This reduction directly affects inputs for production and may consequently increase production costs and indirectly costs to markets. For instance, the growing demand for aluminum for packaging, combined with sourcing challenges, may result in higher procurement costs.

The Company’s operations are also subject to transition risks such as: (i) regulatory changes on water use and prices, which may increase the price of water or cause interruptions in supply, affect the availability

   
 32 
 

and license to operate in certain localities and countries; (ii) carbon pricing mechanisms (both taxes and emissions trading systems) that affect both direct operations and emissions from packaging materials throughout the supply chain, may result in higher operating costs for the Company. For example, the aluminum and glass production process are energy high and greenhouse gas emissions intensive. Depending on the country where materials are sourced from, there is potential associated with a high carbon cost and carbon pricing mechanisms; (iii) current and emerging energy and fuel regulations and taxes may increase direct operating costs, given that the Company is exposed to such fuel and energy taxes; and (iv) fluctuations in demand for inputs prone to low availability, such as aluminum, may affect production capacity and increase the cost of purchasing packaging for the Company’s products.

We established sustainability goals focused on smart agriculture, efficient use of water resources, circular packaging, carbon emissions reduction and use of renewable electricity that we aim to achieve by 2025. While we continue to work towards meeting our sustainability goals, we have encountered, and may in the future continue to confront, challenges in relation to achieving these aspirations by 2025 or otherwise in the same manner and to the same extent as previously planned and reported.

Adding to our 2025 climate goal, we also announced our ambition to achieve net zero emissions across our value chain by 2040, which require ongoing investment, and there is no assurance that we will achieve any of these goals or that our initiatives will achieve their intended outcomes. If we fail to meet these targets for any reason, there is a risk of reputational damage, as well as possible questioning – including through litigation – by interested parties. As a result, the effects of climate change could have a material adverse long-term impact on our business and results of operations.

New ESG regulations may be enacted and this may result in increased costs for Ambev to comply with them.

New ESG regulations continue to be enacted and proposed in countries where we operate. These regulations brought by governing and regulatory bodies could be comprehensive in scope and cover various matters within the ESG framework, including, among other areas, reporting, disclosure and due diligence processes.

The enactment of new regulations may require that we adapt our business, activities and current practices in order to comply with such new legislation and other requirements, which may result in higher operating costs that may negatively impact our operating results.

Scarcity or poor quality of water may negatively affect our production costs and capacity.

The Company faces risks related to water shortages. The availability of fresh water is a limited resource in many parts of the world, facing unprecedented challenges relating to climate change and the resulting change in rainfall patterns and frequency of extreme weather, overexploitation, increased pollution and poor water management. As the demand for water continues to increase worldwide, and as water becomes scarcer and the quality of available water deteriorates, the Company may be affected by increased production costs, capacity limitations or significant changes in water quality, which could adversely affect the Company’s business and results of operations.

Water shortages can result in business interruptions and/or reduced production and increased treatment costs. The availability of water is critical for the Company’s operations, as it is an essential input for the production of beer. Reduced water availability can also affect legislation regulating water use. In addition, water quality affected by scarcity can also affect water treatment costs and the ability to operate around the clock.

Droughts can cause malting barley harvests to fail, especially in South America, where most barley is rain-fed, so-called meteorological droughts (short-term droughts and impacted by precipitation) can significantly affect barley crops yields.

   
 33 
 

Seasonal consumption cycles and adverse weather conditions may result in fluctuations in demand for our products

Seasonal consumption cycles and adverse weather conditions in the markets in which we operate may have an impact on our operations. This is particularly true in the summer months, when unseasonably cool or wet weather can affect sales volumes.

Stakeholders concerns and changing consumer preferences for sustainable products could also result in reduced revenues if the Company is unable to meet these requirements.

Risks Relating to Our Common Shares and ADSs

Brazilian foreign exchange controls and regulations could restrict conversions and remittances abroad of the dividend payments and other shareholder distributions paid in Brazil in reais arising from Ambev’s common shares (including shares underlying the Ambev ADSs).

Brazilian law provides that whenever there is a serious imbalance in Brazil’s balance of payments or reasons to foresee such a serious imbalance, the Brazilian government may impose temporary restrictions on the remittance to foreign investors of the proceeds of their investments in Brazil. Such restrictions may hinder or prevent the Custodian or holders who have exchanged ADSs for Ambev’s underlying shares from converting distributions or the proceeds from any sale of such shares into U.S. dollars and remitting such U.S. dollars abroad. In the event the Custodian is prevented from converting and remitting amounts owed to foreign investors, the Custodian will hold the reais it cannot convert for the account of the holders of ADSs who have not been paid. The Depositary will not invest the reais and will not be liable for interest on those amounts. Any reais so held will be subject to devaluation risk against the U.S. dollar.

In addition, the likelihood that the Brazilian government would impose such restrictions may be affected by the extent of Brazil’s foreign currency reserves, the availability of foreign currency in the foreign exchange markets on the date a payment is due and the size of Brazil’s debt service burden relative to the economy as a whole. We cannot assure you that the Brazilian Central Bank will not modify its policies or that the Brazilian government will not institute restrictions or delays on cross-border remittances in respect of securities issued in foreign capital markets. For further information on this matter, see “Item 10. Additional Information—D. Exchange Controls and other Limitations Affecting Security Holders.”

The surrender of ADSs may cause the loss of the ability to remit foreign currency abroad and of certain Brazilian tax attributes.

While ADS holders benefit from the electronic certificate of foreign capital registration obtained in Brazil by the Custodian, which permits the Depositary to convert gains, dividends, profits or other payments under Ambev’s shares with respect to the shares underlying the ADSs into foreign currency and remit the proceeds abroad, the availability and requirements of such electronic certificate may be adversely affected by future changes to the applicable regulation.

If an ADS holder surrenders the ADSs and, consequently, receives shares underlying the ADSs, the investment in Ambev’s shares would be registered with the Brazilian Central Bank either as (i) a foreign direct investment, subject to Brazilian Central Bank Resolution 278, dated December 31, 2022 (“BCB Resolution 278”), which will require an electronic certificate of foreign capital registration, the Capital Information Provision System of Foreign Direct Investment (“SCE-IED”), or (ii) a foreign investment in portfolio, subject to National Monetary Council’s (Conselho Monetário National) (“CMN”) Resolution 4,373, dated September 29, 2014 (“CMN Resolution 4,373”), which among other requirements, requires the appointment of a financial institution in Brazil as the custodian of the preferred shares and legal representative of the foreign investor in the Electronic Declaratory Registration of Portfolio (“RDE – Portfolio”).

The failure to register the investment in the Ambev’s shares as foreign investment as described above (e.g., SCE – IED or RDE – Portfolio) will impact the ability of the holder to dispose of Ambev’s shares and to receive gains, dividends, profits or other payments under Ambev’s shares. Moreover, upon receipt of Ambev’s shares underlying the ADSs, Brazilian regulations require the investor to enter into corresponding exchange rate transactions and pay taxes on these exchange rate transactions, as applicable.

   
 34 
 

In addition, if the SCE-IED or RDE-Portfolio are not properly registered the relevant holder may incur expenses or suffer delays in the application process, which could impact the investor’s ability to receive gains, dividends, profits or other payments under Ambev’s shares on a timely manner.

Certain shareholder entitlements may not be available in the U.S. to holders of Ambev ADSs.

Due to certain United States laws and regulations, U.S. holders of Ambev ADSs may not be entitled to all of the rights possessed by holders of Ambev common shares. For instance, U.S. holders of Ambev ADSs may not be able to exercise preemptive, subscription or other rights in respect of the Ambev common shares underlying their Ambev ADSs, unless a registration statement under the Securities Act is effective with respect to those rights or an exemption from the registration requirements thereunder is available.

Holders of Ambev ADSs may be unable to fully exercise voting rights with respect to the Ambev shares underlying their ADSs.

Under Brazilian law, only shareholders registered as such in the corporate books of Brazilian companies may attend shareholders’ meetings. Because all the Ambev common shares underlying the Ambev ADSs are registered in the name of the Depositary (and not the ADS holder), only the Depositary (and not the ADS holder) is entitled to attend Ambev’s shareholders’ meetings. A holder of Ambev ADSs is entitled to instruct the Depositary as to how to vote the respective Ambev common shares underlying their ADSs only pursuant to the procedures set forth in the deposit agreement for Ambev’s ADS program. Accordingly, holders of Ambev ADSs will not be allowed to vote the corresponding Ambev common shares underlying their ADSs directly at an Ambev shareholders’ meeting (or to appoint a proxy other than the Depositary to do so), unless they surrender their Ambev ADSs for cancellation in exchange for the respective Ambev shares underlying their ADSs. We cannot ensure that such ADS cancellation and exchange process will be completed in time to allow Ambev ADS holders to attend a shareholders’ meeting of Ambev.

Further, the Depositary has no obligation to notify Ambev ADS holders of an upcoming vote or to distribute voting cards and related materials to those holders, unless Ambev specifically instructs the Depositary to do so. If Ambev provides such instruction to the Depositary, it will then notify Ambev’s ADS holders of the upcoming vote and arrange for the delivery of voting cards to those holders. We cannot ensure that Ambev’s ADS holders will receive proxy cards in time to allow them to instruct the Depositary as to how to vote the Ambev common shares underlying their Ambev ADSs. In addition, the Depositary and its agents are not responsible for a failure to carry out voting instructions or for an untimely solicitation of those instructions.

As a result of the factors discussed above, holders of Ambev ADSs may be unable to fully exercise their voting rights.

Our status as a foreign private issuer allows us to follow Brazilian corporate governance practices and exempts us from a number of rules under the U.S. securities laws and listing standards, which may limit the amount of public disclosures available to investors and the shareholder protections afforded to them.

We are a foreign private issuer, as defined by the Securities and Exchange Commission, or the SEC, for purposes of the Exchange Act. As a result, we are exempt from many of the corporate governance requirements of stock exchanges located in the United States, as well as from rules under the Exchange Act that impose certain disclosure obligations and procedural requirements for proxy solicitations under Section 14 of the Exchange Act. For example, our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions under Section 16 of the Exchange Act. Moreover, we are not required to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. Accordingly, there may be less publicly available information concerning us than there is for U.S. public companies.

In addition, for so long as we remain as a foreign private issuer, we will be exempt from most of the corporate governance requirements of stock exchanges located in the United States. Accordingly, you will not be provided with some of the benefits or have the same protections afforded to shareholders of U.S. public companies. The corporate governance standards applicable to us are considerably different than the standards applied to U.S. domestic issuers. For example, although Rule 10A-3 under the Exchange Act generally requires that a company listed in the United States have an audit committee of its board of directors composed solely

   
 35 
 

of independent directors, as a foreign private issuer we are relying on an exemption from this requirement under Rule 10A-3(c)(3) of the Sarbanes-Oxley Act of 2002 that is available to us as a result of features of the Brazilian Corporation Law applicable to our Fiscal Council. In addition, we are not required under the Brazilian Corporation Law to, among other things:

·have a majority of our Board of Directors be independent (though our bylaws provide that two of our directors must be independent and, in certain circumstances pursuant to the Brazilian Corporation Law, our minority shareholders may be able to elect members to our Board of Directors);
·have a compensation committee, a nominating committee, or corporate governance committee of the Board of Directors (though we currently have a non-permanent People Committee that is responsible for evaluating our compensation policies applicable to management and a Governance Committee that is responsible for governance matters as related party transactions, antitrust matters, strategies related to ESG issues and cyber security and privacy and data protection matters);
·have regularly scheduled executive sessions with only non-management directors (though none of our current directors hold management positions in us); or
·have at least one executive session of solely independent directors each year.

For further information on the main differences in corporate governance standards in the United States and Brazil, see “Item 6. Directors, Senior Management and Employees—C. Board Practices—Differences Between United States and Brazilian Corporate Governance Practices.”

As a Brazilian company, Ambev is subject to different corporate laws and regulations than those typically applicable to U.S.-listed companies, which may result in Ambev’s shareholders having fewer or less well-defined shareholder rights than the shareholder rights of those companies.

Ambev’s corporate affairs are governed by its bylaws and the Brazilian Corporation Law, which may differ from the legal principles that would apply to Ambev if the company were incorporated in a jurisdiction in the United States, such as Delaware or New York, or in other jurisdictions outside of Brazil. In addition, shareholder rights under the Brazilian Corporation Law to protect them from actions taken by the board of directors or controlling shareholders may be fewer and less well-defined than under the laws of jurisdictions outside of Brazil.

Although insider trading and price manipulation are restricted under applicable Brazilian capital markets regulations and treated as crimes under Brazilian law, the Brazilian securities markets may not be as highly regulated and supervised as the securities markets of the United States or other jurisdictions outside Brazil. In addition, rules and policies against self-dealing and for the preservation of shareholder interests may be less well-defined and enforced in Brazil than in the United States or other jurisdictions outside Brazil, potentially causing disadvantages to a holder of Ambev ADSs as compared to a holder of shares in a U.S. public company. Further, corporate disclosures may be less complete or informative than required of public companies in the United States or other jurisdictions outside Brazil.

Any dividends not distributed would be allocated to a special reserve account for future payment to shareholders unless it is used to offset subsequent losses or as otherwise provided for in our bylaws. It is possible, therefore, that our shareholders will not receive dividends in any particular fiscal year.

Foreign holders of our ADSs may face difficulties in serving process on or enforcing judgments against us and other persons.

We are organized under the laws of Brazil and most of our directors and executive officers, as well as our independent registered public accounting firm, reside or are based in Brazil. In addition, substantially all of our assets and those of these other persons are located in Brazil. As a result, it may not be possible for foreign holders of our ADSs to expediently effect service of process upon us or those persons within the United States or other jurisdictions outside Brazil or to efficiently enforce against us or them judgments obtained in the United States or other jurisdictions outside Brazil. Because judgments of U.S. courts for civil liabilities based upon the U.S. federal securities laws may only be enforced in Brazil if certain formal and procedural conditions are met (including non-violation of Brazilian national sovereignty, public policy and “good morals”), holders

   
 36 
 

of our ADSs may face greater difficulties in protecting their interests in the context of legal, corporate or other disputes between them and us, our directors and/or our executive officers than would shareholders of a U.S. corporation.

In addition, a plaintiff (whether or not Brazilian) residing outside Brazil during the course of litigation in Brazil must provide a bond to guarantee court costs and legal fees if the plaintiff owns no real property in Brazil that could secure such payment. The bond must have a value sufficient to satisfy the payment of court fees and defendant’s attorney fees, as determined by a Brazilian judge. This requirement does not apply to (1) the enforcement of debt instruments or awards, including foreign judgments and arbitral awards that have been duly recognized by the Brazilian Superior Court of Justice (Superior Tribunal de Justiça); (2) counterclaims; and (3) circumstances where the plaintiff or other intervening parties (regardless of citizenship) resides in a country that is a party to a treaty in force in Brazil that establishes that no security, bond or deposit of any kind is required by reason only of their foreign nationality (e.g., the Hague Convention on International Access to Justice). Furthermore, Brazil does not have a treaty with the United States to facilitate or expedite the enforcement in Brazil of decisions issued by a state court in the United States, which shall necessarily be previously recognized by the Brazilian Superior Court of Justice in order to produce effects in Brazil. As to arbitral awards issued in the United States, it is important to note that Brazil has ratified the New York Convention on the Recognition and Enforcement of Foreign Arbitral Awards (Decree No. 4311/2002), and arbitral awards rendered outside of the Brazilian territory are enforceable if the requirements provided by such treaty are fulfilled, and the arbitral award is previously recognized by the Brazilian Superior Court of Justice.

Judgments of Brazilian courts with respect to our shares will be payable only in reais.

If proceedings are brought in the courts of Brazil seeking to enforce our obligations in respect of our common shares, we will not be required to discharge any such obligations in a currency other than reais. Under Brazilian exchange control limitations, an obligation in Brazil to pay amounts denominated in a currency other than reais may only be satisfied in Brazilian currency at the exchange rate, as determined by the Central Bank, in effect on the date of the effective payment. The then prevailing exchange rate may not afford non-Brazilian investors with full compensation for any claim arising out of, or related to, our obligations under our common shares.

ITEM 4.INFORMATION ON THE COMPANY

Ambev’s principal executive offices are located at Rua Dr. Renato Paes de Barros, 1017, 3rd floor, 04530-001, São Paulo, SP, Brazil, and its telephone number and email are: +55 (11) 2122-1414 and ri@ambev.com.br.

A.        History and Development of the Company

Overview

We are the successor of Brahma and Antarctica, two of the oldest brewers in Brazil. Antarctica was founded in 1885. Brahma was founded in 1888 as Villiger & Cia. The Brahma brand was registered on September 6, 1888, and in 1904 Villiger & Cia. changed its name to Companhia Cervejaria Brahma. However, the legal entity that has become Ambev S.A., the current NYSE- and B3-listed company, was incorporated on July 8, 2005 as a non-reporting Brazilian corporation under the Brazilian Corporation Law and is the successor of Old Ambev. Until the stock swap merger of Old Ambev with Ambev S.A. approved in July 2013 (see “—Stock Swap Merger of Old Ambev with Ambev S.A.”), Ambev S.A. did not conduct any operating activities and had served as a vehicle for ABI to hold a 0.5% interest in Old Ambev’s capital stock.

In the mid-1990s, Brahma started its international expansion into Latin America, and since then we have been buying assets in different parts of the continent including in South America, Central America and the Caribbean.

In the late 1990s, Brahma obtained the exclusive rights to produce, sell and distribute Pepsi CSD products throughout Brazil, and since then we have been distributing these products throughout that country. In addition, certain of our subsidiaries have franchise agreements for Pepsi products in Argentina, Bolivia, Uruguay, Panama and the Dominican Republic. See “Item 4. Information on the Company—B. Business Overview—Licenses—Pepsi.”

   
 37 
 

In the early 2000s, we acquired a 40.5% economic interest in Quinsa and the joint control of that entity, which we shared temporarily with Beverages Associates (BAC) Corp., or BAC, the former sole controlling shareholder of Quinsa. This transaction provided us with a leading presence in the beer markets of Argentina, Bolivia, Paraguay and Uruguay, and also set forth the terms for our future acquisition of Quinsa’s full control from BAC. In April 2006, we increased our equity interest in Quinsa to 91% of its total share capital, after which we started to fully consolidate Quinsa upon the closing of that transaction in August 2006.

In August 2004, we and a Belgian brewer called Interbrew S.A./N.V. (as ABI was then called) completed a business combination that involved the merger of an indirect holding company of Labatt, one of the leading brewers in Canada, into us. At the same time, our controlling shareholder completed the contribution of all shares of an indirect holding company which owned a controlling stake in us to Interbrew S.A./N.V. in exchange for newly issued shares of Interbrew S.A./N.V. After this transaction, Interbrew S.A./N.V. changed its company name to InBev S.A./N.V. (and, since 2008, to Anheuser-Busch InBev S.A./N.V.) and became our majority shareholder through subsidiaries and holding companies. (see “—The InBev-Ambev Transactions”).

The InBev-Ambev Transactions

The “InBev-Ambev transactions” consisted of two transactions negotiated simultaneously: (1) in the first transaction, BRC exchanged its Old Ambev shares for shares in Interbrew N.V./S.A. (as ABI was then called); and (2) in the second transaction, Old Ambev issued new shares to Interbrew N.V./S.A. in exchange for Interbrew’s 100% stake in Labatt.

Exchange of Shares Between BRC and the Interbrew Founding Families

In March 2004, various entities controlled by BRC entered into a contribution and subscription agreement with Interbrew N.V./S.A. (as ABI was then called) and various entities representing the interests of the Interbrew Founding Families to exchange their controlling interest in Old Ambev for newly issued voting shares of Interbrew N.V./S.A., which represented 24.7% of Interbrew N.V./S.A.’s voting shares.

Upon closing of this transaction in August 2004, (1) BRC received approximately 44% of the voting interest in Stichting, which thereupon owned approximately 56% of Interbrew N.V./S.A.’s common shares, and (2) Interbrew N.V./S.A. received approximately a 53% voting interest and a 22% economic interest in Old Ambev. Such voting interest was subject to our shareholders’ agreement at the time, as amended in connection with the InBev-Ambev transactions. In addition, Interbrew N.V./S.A. changed its legal name to InBev N.V./S.A. (and, since its acquisition of Anheuser-Busch, Inc. in the U.S. in 2008, to Anheuser Busch-InBev N.V./S.A.).

Acquisition of Labatt

Pursuant to the Incorporação agreement dated March 3, 2004, Labatt Brewing Canada Holding Ltd., or Mergeco, was merged into Old Ambev by means of an upstream merger under the Brazilian Corporation Law, or the Incorporação. Mergeco held 99.9% of the capital stock of Labatt Holding ApS, or Labatt ApS, a corporation organized under the laws of Denmark, and Labatt ApS owned all the capital stock of Labatt. Upon completion of the Incorporação, Old Ambev held 99.9% of the capital stock of Labatt ApS, and, indirectly, of Labatt. As consideration for the acquisition of Labatt, Old Ambev issued common and preferred shares to Interbrew N.V./S.A. (as ABI was then called).

With the consummation of this transaction in August 2004, (1) Labatt became a wholly-owned subsidiary of Old Ambev, and (2) Interbrew N.V./S.A. (as ABI was then called) increased its stake in Old Ambev to approximately 68% of common shares and 34% of preferred shares.

Ownership Structure of InBev N.V./S.A. and Old Ambev Upon Consummation of the InBev-Ambev Transactions

InBev N.V./S.A.

Upon closing the InBev-Ambev transactions, 56% of InBev N.V./S.A.’s voting shares were owned by Stichting, 1% was jointly owned by Fonds Voorzitter Verhelst SPRL and Fonds InBev-Baillet Latour SPRL,

   
 38 
 

17% were owned directly by entities and individuals associated with the Interbrew Founding Families and the remaining 26% constituted the public float.

BRC became the holder of 44% of Stichting’s voting interests, while the Interbrew Founding Families held the remaining 56% of Stichting’s voting interests. In addition, BRC and entities representing the interests of the Interbrew Founding Families entered into a shareholders’ agreement, providing for, among other things, joint and equal influence over the exercise of the Stichting voting rights in InBev N.V./S.A. (as ABI was then called).

Old Ambev

Upon closing of the InBev-Ambev transactions, InBev N.V./S.A. (as ABI was then called) became the owner of approximately 68% of Old Ambev’s voting shares, FAHZ retained approximately 16% of such shares, and the remaining shares were held by the public.

Mandatory Tender Offer

Pursuant to the Brazilian Corporation Law, InBev N.V./S.A. (as ABI was then called) was required to conduct, following the consummation of the InBev-Ambev transactions, a mandatory tender offer, or the MTO, for all remaining outstanding common shares of Old Ambev. The MTO was completed in March 2005, and InBev N.V./S.A. (as ABI was then called) increased its stake in Old Ambev to approximately an 81% voting interest and a 56% economic interest in that company. FAHZ did not tender its Old Ambev shares in the MTO.

Stock Swap Merger of Old Ambev with Ambev S.A.

On July 30, 2013, the minority shareholders of Old Ambev approved a stock swap merger of Old Ambev with us, according to which each and every issued and outstanding common and preferred share of Old Ambev not held by Ambev S.A. (including in the form of ADSs) was exchanged for five newly issued common shares of Ambev S.A. (including in the form of ADSs). As a result of the stock swap merger, Old Ambev became a wholly-owned subsidiary of Ambev S.A., which continued the same operations of Old Ambev. The ratio adopted for the stock swap merger did not result in any ownership dilution in the equity interest held in us by our minority shareholders, including our former non-voting preferred shareholders, who were granted a separate class vote on the transaction without the interference of our controlling shareholder.

The stock swap merger combined our former dual-class capital structure, comprised of voting common shares and non-voting preferred shares, into a new, single-class capital structure, comprised exclusively of voting common shares. The purpose of this transaction was to simplify our corporate structure and improve our corporate governance, with a view to increasing liquidity for all shareholders, eliminating certain administrative, financial and other costs and providing more flexibility for the management of our capital structure. As a result of the stock swap merger, all shareholders of Old Ambev, including former holders of that company’s non-voting preferred shares, gained access to the same rights and privileges enjoyed by Old Ambev’s common shareholders, including full voting rights and the right to be included in a change-of-control tender offer under the Brazilian Corporation Law that ensures that holders of common stock are offered 80% of the price per share paid to a selling controlling shareholder in a change-of-control transaction.

Upstream Merger of Old Ambev with and into Ambev S.A.

In January 2014, and as a subsequent step of the stock swap merger, an upstream merger of Old Ambev and one of its majority-owned subsidiaries with and into Ambev S.A. was consummated. This upstream merger had no impact on the shareholdings that our shareholders held in us. As a result of this upstream merger, our corporate structure was simplified.

Recent Acquisitions, Divestments and Strategic Alliances

In October 2023, E. León Jimenes S.A. (“ELJ”), our partner in Tenedora CND S.A. (“Tenedora”), through which we operate in the CAC region, notified us regarding its intention to exercise its put option requiring us to purchase from ELJ a 12.11% stake in Tenedora’s shares (corresponding to Tranche A in the Tenedora Shareholders’ Agreement). We settled this transaction in January 2024 via (i) a cash disbursement

   
 39 
 

of R$1,704 million that we paid to ELJ, and (ii) the offset of ELJ’s debt held by Cervecería Nacional Dominicana S.A., a subsidiary of Tenedora in the amount of R$335 million. As a result of this transaction, we now hold a 97.11% stake in Tenedora, with the remaining 2.89% held by ELJ (corresponding to Tranche B). For additional information, see Note 28 - Financial Instruments and Risks. Also, see Item 7. Major Shareholders And Related Party Transactions - B. Related Party Transactions - Renegotiation of Tenedora’s shareholders agreement for more information.

B.        Business Overview

Description of Our Operations

We are the largest brewer in Latin America in terms of sales volumes and one of the largest beer producers in the world, according to our estimates. We currently produce, distribute and sell beer, CSDs, other alcoholic beverages and non-alcoholic and non-carbonated products in 18 countries across the Americas.

We conduct our operations through four business segments, as follows:

·Brazil, which includes the beer sales division and the NAB sales division;
·Central America and the Caribbean, or CAC, which includes our direct operations in the Dominican Republic, Saint Vincent, Cuba, Guatemala, Barbados and Panama as well as indirect sales, through third party distributors, in other CAC countries such as Costa Rica, Nicaragua, Puerto Rico, Venezuela and Trinidad & Tobago;
·Latin America South, or LAS, which includes our operations in Argentina, Bolivia, Paraguay, Uruguay and Chile; and
·Canada, represented by Labatt’s operations, which includes domestic sales in Canada and some exports to the U.S. market.

The following map illustrates our four business segments as of December 31, 2023:

   
 40 
 

An analysis of our consolidated net sales by business segment for the periods indicated is presented in the table below:

 

Net Sales (in R$ million)
Year Ended December 31,

 

2023

2022

2021

 

Sales

% of Total

Sales

% of Total

Sales

% of Total

Brazil  46,361.7 58.1% 42,635.8 53.5% 35,586.5 48.8%
Beer Brazil  38,985.9 48.9% 35,857.9 45.0% 30,537.1 41.9%
NAB  7,375.8 9.3% 6,777.9 8.5% 5,049.4 6.9%
CAC  10,044.8 12.6% 9,440.1 11.8% 9,947.4 13.7%
Latin America South  13,797.2 17.3% 17,371.2 21.8% 16,571.7 22.7%
Canada

9,533.2

12.0%

10,261.7

12.9%

10,748.7

14.8%

Total

79,736.9

100.0%

79,708.8

100.0%

72,854.3

100.0%

An analysis of our sales volume by business segment for the periods indicated is presented in the table below:

 

Sales Volumes (‘000 hl)
Year Ended December 31,

 

2023

2022

2021

 

Volume

% of Total

Volume

% of Total

Volume

% of Total

Brazil  126,419.7 68.8% 126,184.4 67.9% 119,530.6 66.3%
Beer Brazil  93,111.6 50.7% 94,042.6 50.6% 90,835.0 50.4%
NAB  33,308.1 18.1% 32,141.8 17.3% 28,695.5 15.9%
CAC  12,174.6 6.6% 11,786.3 6.3% 13,401.9 7.4%
Latin America South  36,039.6 19.6% 38,134.0 20.5% 37,511.6 20.8%
Canada

9,025.2

4.9%

9,645.0

5.2%

9,924.1

5.5%

Total

183,659.0

100.0%

185,749.7

100.0%

180,368.2

100.0%

   
 41 
 

Business Strategy

We aim to continuously create value for our stockholders. The main components of our business strategy are:

·       our people and culture;

·       our strategic pillars;

·       quality of our products;

·       sustainability;

·       permanent cost efficiency;

·       financial discipline; and

·       customer convenience.

Our People and Culture

We dream big to create a future with more cheers. We are always looking to serve up new ways to meet life’s moments, dream big to move our industry forward, and make a meaningful impact in the world. That is why our people are the backbone of our company, and the main source to create and share superior value for our community and ecosystem. We build high performance and engaged teams powered by a diverse, inclusive and healthy workplace, to lead change and transform our business aiming at our long-term success. We carefully manage our hiring and training process with a view to develop capabilities and match great people with their roles to increase the pipeline for the future. We live and breathe our culture in a daily basis due to keep evolving our company and retaining our professionals. In addition, we believe that through our compensation program, which is based both on variable pay and stock ownership, we have created financial incentives for high performance results. Another core element of our culture is our distinguished managerial capability, which is characterized by (1) an intense work ethos that do not take shortcuts, (2) evaluations focused in long term view, collaboration and active listening, (3) the encouragement of our leaders to act as owners (4) sharable practices to create better solutions through simplicity and (5) incentives to grow together with our customers and community.

Strategic Pillars

We focus our efforts behind the following strategic pillars to lead and grow the category, digitize and monetize our ecosystem, as well as optimize our business:

·Brands for each and everyone: Building brands that are recognized by our clients and consumers. We want our brands to be connected with consumers, and our products to the consumed in important moments of their lives.

 

·Thirst to lead the future: Expanding our beverages and assortment, going beyond the beer category and including expansion into categories such as RTDs, canned cocktails and seltzers.

 

·A toast to our clients’ success: Improving service level and leveraging technology to solve business customers’ issues that allow them to grow their business in partnership with us.

 

·Experiences that come to you: Keeping the consumer at the center of our decision-making process. Through innovation and technology, we want to connect with and bring what we believe to be the best experiences and convenience to our consumers.

 

·Together for a Better World: Generating a positive impact in the world and grow together with our ecosystem, which goes from our farmers to our consumers.

 

   
 42 
 
·Sustainable Value Creation: managing our business with operational excellence and efficient capital allocation to maximize our long-term value creation.

 

Quality of our Products

We brew a wide variety of beers, including ales, lagers, clear, dark and full-bodied beers, amongst others, offering consumers a unique set of high-quality beers designed to satisfy different needs and tastes across different occasions. We also produce a number of non-alcoholic products, such as soft drinks, energy drinks and juices. The quality of our products is at the forefront of our priorities. We have strict processes, with more than 1,300 controls and more than 370 tests across our production lines, as we aim to provide to our consumers products matching the highest possible standards. Our R&D team is also constantly working to enhance our production process and the quality of our products.

Sustainability

Brewing quality beer starts with the search for the best ingredients. This requires a healthy, natural environment, as well as thriving communities. In furtherance of this overarching philosophy, we are pursuing five sustainability goals by 2025:

(i)empowering farmers: we aspire that 100% of our direct farmers suppliers will be skilled, connected, and financially empowered as they will have access to an approved variety of inputs, crop protocol for that variety and at least one technical visit during the crop year, in addition to access to digital platforms;
(ii)securing water access: we aim that 100% of our communities in hydric high-stress areas will have measurably improved water availability and quality, especially through our Watershed and Forests program that has been in place since 2010;
(iii)driving circular packaging: we aspire that 100% of our products will be in packaging that is reusable or made from majority recycled content, which we aim to achieve, through working with suppliers to increase the use of recycled content and reinforcing the message for consumers about returnable bottles;
(iv)aiming for climate ambition: we aim that 100% of our purchased electricity will be from renewable sources and we will have a 25% reduction in CO2 emissions intensity across our value chain as compared to our 2017 baseline; and
(v)entrepreneurship: we strive to empower our commercial partners (points of sales and suppliers) so that they will be skilled with the necessary tools to evolve through systems and programs that help them to develop in a sustainable way and to assist the development of their businesses, as we share with our customers knowledge and tools.

Regarding our climate ambition specifically, we have contracted 100% renewable electricity in nine countries; and we achieved a reduction of around 19% in CO2 emission in 2023, as compared to 2017, which we believe places us on track with our target of reducing our CO2 emissions by 25% by 2025 Regarding Scope 3 emissions, which represents the largest share of emissions today, we have been working collaboratively with our main suppliers to decarbonize our value chains, through robust programs such as Eclipse Collaborative Program and Connecting for a Better World – Climate Action. These programs aim to engage our suppliers and partners into increasing transparency of carbon data, training and capacity building within our teams.

The table below shows the status as of December 31, 2023 of the main key performance indicators related to our sustainability goals for 2025:

 

   
 43 
 

 

    BRAZIL LAS CAC CANADA AMBEV Goal
2025
Status
2023
WATER
STEWARD.
Watersheds & Forests
(High risk sites in benefit monitoring phase –step 7- as per 7-Step charter)(1)
100% 0% - - 72.7% 100% On Track

AMA

(Number of people benefitted)

953,000 - - -  953,000 1,000,000 On Track

CLIMATE

ACTION

Renewable electricity
(% of total electric energy contracted)
100% 90.5% 78.6% 92.5% 95.7% 100.0% On Track
GHG emission – Intensity (kg CO2e/Hl)
(% reduction of CO2 intensity versus baseline (2017); Scopes 1, 2 and 3)
8.9% 27.2% 62.3% 7.4% 19.0% 25.0% On Track
GHG emission – Absolute (t CO2e)
(% reduction of CO2 absolute emissions versus baseline (2017); Scopes 1 and 2 – Owned Operations)
40.1% 41.8% +20.9% 40.2% 34.2% 35.0% On Track
CIRCULAR
PACKAGING
Glass
(% of glass used that was recycled)
43.6% 44.0% 44.3% 40.7% 43.6% ≥ 50.1% On Track
Aluminum
(% of aluminum used that was recycled)
78.0% 76.7% 48.2% 68.4% 75.2% ≥ 50.1% Achieved
Plastic (PET)
(% of plastic used that was recycled)
54.8% 8.4% 30.4% - 40.3% ≥ 50.1% On Track
Plastic Commitment 64% - - - 64% 100% On Track
SUSTAINABLE AGRICULTURE Skilled producers(2) 98% 90% - - 92% 100% On Track
Connected producers(3) 99% 100% - - 100% 100% On Track
Financially empowered producers(4) 98% 100% - - 99% 100% On Track
(1)7-Step Charter consists of: (i) engagement; (ii) problem identification/prioritization; (iii) solutions agreed; (iv) plan implementation; (v) governance; (vi) communication; and (vii) monitoring.
(2)Producer must have (i) access to a varieties of crops approved by Ambev for production, (ii) technical protocol for production, and (iii) at least two technical visits during the culture cycle.
(3)Producer must be registered in Agroportal platform or another similar platform (e.g. SmartBarley, ManejeBem, etc.).
(4)Producer has access to the tools to reduce production risks (e.g. agricultural insurance, specific financing, etc.).

Permanent Cost Efficiency

Cost control is one of the top priorities of our employees. Each of our departments must comply with its respective annual budget for fixed and variable costs. As a means of avoiding unnecessary expenses, we have designed a management control system inspired on “zero-base budgeting” concepts that requires every manager to build from scratch an annual budget for his/her respective department.

Financial Discipline

Our focus is not only on volumes and operating performance, but also on the disciplined management of our working capital and our cash flow generation. Our objective is to maximize the return to our shareholders through a combination of payments of dividends and interest on shareholders’ equity, while at the same time keeping our investment plans and holding an adequate level of liquidity to accommodate the seasonality of our business and cope with often volatile and uncertain financial market conditions.

Customer Convenience - Zé Delivery, TaDa and BEES

In order to increase convenience to our consumers, we developed solutions to deliver on demand cold beverages at reasonable prices directly to consumers. Our solutions solve several pain points identified in the consumers’ buying journey: (i) late hours availability, (ii) fast service that is time saving for consumers, (iii) reasonable prices, and (iv) cold products ready to be consumed.

·In Brazil, our direct-to-consumer platform Zé Delivery continued to grow in 2023, being now present in more than 700 cities across all 27 Brazilian states and reaching nearly 70% of the country’s entire population. Zé Delivery delivered more than 60 million orders in 2023 and had almost 6 million monthly active users as of December 31, 2023.
   
 44 
 
·In LAS, Ta Da in Argentina, which resulted from the merger of App Bar with other Direct-to-Consumer platforms named Siempre en Casa and Craft Society, continued to grow in 2023. The platform is present in 49 cities, with more than 1 million orders and growing by 6% in 2023 versus 2022, and monthly active users declining by 11% year over year since 2022. In Paraguay, Ta Da is present in 28 cities, covering nearly 50% of the population with number of orders growing 65% in 2023 versus 2022 and monthly active users growing by 40% in 2023 versus 2022.
·In CAC, Ta Da in Dominican Republic continued to expand in 2023, with the number of orders growing by 84% in 2023 versus 2022, and monthly active users growing by 89% year over year since 2022.

Our B2B route-to-market & marketplace platform, BEES, centralizes different solutions in one 24/7 platform, creating a constant and customized touchpoint with our customers, and improving overall service level by: (i) providing products suggestions based on customers’ profile and product relevance, (ii) enhancing order tracking and real time support through the app, (iii) allowing our business development representatives to be focused on helping customers improve their sales performance (sell out), and (iv) increasing our total interaction time with our customers, directly connecting to our innovation strategy and increased portfolio complexity. On BEES marketplace, our customers can also buy non-Ambev products of different categories, enjoying the convenience provided by our platform.

·In Brazil, we continued to roll-out BEES and currently have more than 92% of our active buyers purchasing through the platform. As part of our full digital strategy plan, nearly 79% of our clients currently purchase exclusively through BEES. The platform helped us reach an all-time high number of clients, adding more than 15 thousand new clients to our client base in 2023. In the BEES marketplace, we currently offer over 650 Stock Keeping Units (“SKUs”) across different categories, such as groceries, non-alcoholic beverages, and hard liquors. The number of customers buying in the marketplace corresponded to nearly 85% of BEES’ customers in the year ended December 31, 2023.
·In LAS, our digital transformation journey is also evolving with the roll-out of BEES. In Argentina, more than 75% of B2B buyers are purchasing through BEES, and over 90% of the country’s net revenue comes from the platform. The number of customers buying in the marketplace corresponded to over 50% of BEES’ customers in the year ended December 31, 2023. In Paraguay, 82% of B2B direct and indirect sales are made through BEES, with fully digital buyers accounting for 70% of the total number of customers in the year ended December 31, 2023. In Bolivia, 47% of B2B direct and indirect sales are made through BEES, with fully digital buyers accounting for 42% of the total number of customers in the year ended December 31, 2023.
·In CAC, Dominican Republic continues to lead the expansion of the BEES platform, actively sharing know-how and best practices with other operations. The country has already reached the status of a full digital operation, with 89% of B2B buyers already purchasing through the platform, and over 97% of the country’s net revenue coming from BEES in 2023. We are also exploring BEES marketplace in the country with 15 different categories and over 300 SKUs available for customers as of December 31, 2023. In Panama, we have also continued with the roll-out of BEES which has reached over 100% of the country’s net revenue in 2023 coming from the platform.

Seasonality

Sales of beverages in our markets are seasonal. Generally, sales are stronger during the summer and major holidays. Therefore, in the Southern Hemisphere (Brazil, Central America and the Caribbean and Latin America South) volumes are usually stronger in the fourth calendar quarter due to early summer and year-end festivities. In Canada, volumes are stronger in the second and third calendar quarters due to the summer season. This is demonstrated by the table below, which shows our volumes by quarter and business segment:

   
 45 
 

 

 

 

2023 Quarterly Volumes
(as a percentage of annual volumes)

 

1st Quarter

2nd Quarter

3rd Quarter

4th Quarter

Brazil 24.0% 22.8% 24.9% 28.4%
Beer Brazil 23.8% 23.0% 24.9% 28.3%
NAB 24.4% 22.2% 24.7% 28.8%
CAC 22.5% 24.3% 25.7% 27.5%
Latin America South 27.7% 19.3% 23.1% 29.9%
Canada

21.0%

28.9%

27.5%

22.5%

Total

24.5%

22.5%

24.7%

28.4%

Description of the Markets Where We Operate

Brazil

Brazil Beer

The Brazilian Beer Market

In Brazil, the two main packaging presentations are standardized, returnable glass bottles largely present in the 300-milliliter and 600-milliliter formats, sold in bars for on-premise consumption, as well as in supermarkets for off-premise consumption, and 350-milliliter one-way aluminum cans, which are predominantly sold in supermarkets for off-premise consumption.

According to our estimates, in 2023 we were the market leader of the Brazilian market in terms of beer sales volumes, mainly through our three major families of brands: Skol, Brahma and Antarctica. Our closest competitors in Brazil are Heineken.

Distribution represents an important feature in this market, as the retail channel is fragmented into approximately one million points of sale. As of December 31, 2023, our distribution was structured under two separate branches, comprising (1) our network of exclusive third-party distributors, involving 165 operations, and (2) our proprietary direct distribution system, involving 96 distribution centers located across most Brazilian regions. We have been focusing on direct distribution in large urban regions, while strengthening our third-party distribution system. See “ —Business Overview—Business Strategy.”

In the non-alcoholic beer segment, we operate mainly though Brahma 0.0% which, according to our estimates, is the leader in the Brazilian non-alcoholic beer segment and Budweiser zero which was launched in 2023.

Future Beverages

Some of our products stretch beyond typical beer consumption occasions, such as the Beats family of beverages and Mike’s, which are designed for new occasions and consumer groups in which beer is not present. Our Nutrl, Cutwater, Palm Bay and Mike’s portfolio in Canada and Dante Robino wines in Argentina and Brazil add to our wide portfolio of future beverages, a market that we have been assessing in different regions and countries.

Brazil NAB

The Brazilian NAB Markets

The NAB markets in Brazil are comprised of many different segments, including CSD, bottled water, isotonic beverages, energy drinks, coconut water, powdered and natural juices, and ready-to-drink teas. The CSD segment is the most significant to our business representing approximately 91% of the NAB unit volume in 2023 and 86% of the addressable market. The most relevant formats for the category are the two-liter and one-liter non-returnable PET bottles which are mainly sold in supermarkets for in-home consumption and the 350-milliliter one-way aluminum can is also an important packaging format for our business and is mainly sold in off-trade (e.g. supermarkets) and on-trade (e.g. bars and restaurants) channels.

Our main competitor in the NAB market is The Coca-Cola Company. In addition to The Coca-Cola Company, we face competition from small regional bottlers that produce what are usually referred to as “B

   
 46 
 

Brands.” The B Brands compete mainly on price, usually being sold at a significantly lower price than our products.

According to our estimates, the leading CSD flavors in Brazil are (1) cola (with 56% of the market in 2023), (2) guaraná, (3) orange, and (4) lime. In the cola segment, Pepsi Cola is the second bestselling brand and is sold under our exclusive production and bottling agreements with PepsiCo, while in the “non-cola” flavor segment, we lead the market with Guaraná Antarctica. The non-sugar CSD market is growing within CSDs and our main brands in this segments are: H2OH!, Pepsi Black (both sold under license from PepsiCo) and Guaraná Antarctica Zero. Between 2022 and 2023, we launched new formulas for Pepsi Black and Guaraná Zero to maximize flavor which improved our presence in the segment. Our NAB portfolio also includes brands such as Gatorade in the isotonic market, Lipton Iced Tea in the ready-to-drink tea market, which are also sold under license from PepsiCo and in the energy drinks segment, we sell Fusion, a proprietary brand, and Red Bull, which is sold under an exclusive distribution agreement (see “—Licenses—Red Bull”).

CAC (Central America and the Caribbean)

Central America

In Guatemala, the main packaging presentations are the 12-ounce and the 16-ounce cans. Our main competitor in Guatemala is Cerveceria Centro Americana, the market leader, which is a private company owned by local investors. According to our estimates, the total annual sales volume of the Guatemalan beer market was 5.7 million hectoliters in 2023.

In the countries we operate in Central America, we sell Brahva, Budweiser, Bud Light, Michelob Ultra, Stella Artois, Corona, Modelo Especial, Becks, Leffe and Hoegaarden beer brands, which are distributed through the CBC distribution network, jointly with CBC’s CSD portfolio.

In Panama, we estimate that we currently lead the beer market. The main packaging presentations are 355-milliliter cans, 285-milliliter bottles, and 355-milliliter bottles and our main beer brands in Panama are Balboa ICE, Balboa, Atlas Golden Light, Atlas and Budweiser. The main competitor in the Panamanian beer market is Baru. According to our estimates, the total annual sales volume of the Panamanian beer market was 3.1 million hectoliters in 2023. Our Panamanian business also produces and commercializes soft drinks, under franchise, being Pepsi, Canada Dry and Squirt the main brands distributed. In Panama, the annual sales volume of the CSD market was 2.3 million hectoliters in 2023.

The Caribbean Beer Market

In Cuba, our main packaging presentation is the 355 milliliter cans. We currently sell the Bucanero, Cristal and Mayabe local beer brands in Cuba. According to our estimates, the total annual sales volume of the Cuban beer market was approximately 2.9 million hectoliters in 2023. Our main competitor in Cuba is imported beer (over 100 worldwide brands) and in 2023 a new brewery began operations producing locally the brand Parranda in PET format.

In the Dominican Republic, the annual sales volume of the beer market was 4.9 million hectoliters in 2023, according to our estimates. The main packaging presentations in the Dominican beer market consists of the returnable 650-milliliter and 355-mililiter glass bottles, which are predominantly sold in small convenience stores. We currently lead the beer market in the Dominican Republic after our acquisition of CND, with a leading portfolio of brands such as Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois and Budweiser. Our distribution system in the Dominican Republic is comprised mainly of direct distribution operations.

In Barbados, the annual sales volume of the beer market was 0.13 million hectoliters in 2023, according to our estimates. We are the market leader in terms of sales volume according to our estimates, with brands such as Banks and Deputy, which are produced locally by Banks (Barbados) Breweries Ltd. The main packaging presentation in Barbados is the 250-milliliter and 275-milliliter returnable glass bottles.

   
 47 
 

The Caribbean CSD Market

According to our estimates, the annual sales volume of the Dominican CSD market was 3.9 million hectoliters in 2023. The main packaging presentation in the Dominican CSD market is the half-liter bottle, in PET format, which is predominantly sold in small retail stores. Ajegroup, which adopts a low-price strategy has the leadership of the Dominican CSD Market, followed by The Coca-Cola Company, represented by Bepensa. We are currently the third player in that market in terms of sales volume according to our estimates.

Our main CSD brands in the Dominican Republic are Red Rock, Pepsi-Cola and Seven Up, all of which are marketed under an exclusive bottling agreement with PepsiCo. Our distribution system in the Dominican Republic is comprised of direct distribution operations and third-party distributors.

Operations through Third Party Distributors

We also sell Brahva, Budweiser, Bud Light, Michelob Ultra, Stella Artois, Corona, Modelo Especial, Becks, Leffe and Hoegaarden, through third party distributors in Costa Rica, Nicaragua, Puerto Rico, Venezuela and Trinidad & Tobago.

Latin America South

Argentina

Argentina is one of our most important regions, second only to Brazil in terms of volume.

As of December 31, 2023, we served more than 300 thousand points of sale throughout Argentina both directly and through our exclusive third-party distributors.

The Argentine Beer Market

According to our estimates, the annual sales volume of the Argentine beer market was 20.8 million hectoliters in 2023. With a population of approximately 46 million, Argentina is Latin America South’s largest and most important beer market.

In Argentina, 39% of our beer volume is distributed directly by us and 61% was distributed through exclusive third-party distributors in 2023. Our main package presentation in Argentina is the 1-liter returnable glass bottles, which accounted for 51% of our sales in 2023.

According to our estimate, the on-premises consumption represented 7% of beer volumes in Argentina in 2023, and off-premise, including supermarkets sales represented 93% of beer volumes. The main channels of volume consumption in Argentina are through kiosks and small grocery stores.

Our most important beer brands in Argentina are Brahma, Quilmes Clásica and Budweiser. According to Scentia, we are the leading beer producers in Argentina, and our main competitor in Argentina is Compañía Cervecerías Unidas S.A.

The Argentine CSD Market

According to our estimates, in 2023, annual sales volume of the Argentine CSD market was 49 million hectoliters. In Argentina, 51% of our CSD volume was distributed directly by us and 49% is distributed through exclusive third-party distributors in 2023. Non-returnable bottles represented 80% of our CSD sales in Argentina in 2023.

We are the exclusive Pepsi bottlers in Argentina and our most important CSD brands in that country are Pepsi-Cola and Seven-Up. According to Scentia, we are the second player in the Argentine CSD market in 2023, only after The Coca-Cola Company.

   
 48 
 

Bolivia

The Bolivian Beer Market

According to our estimates, the annual sales volume of the Bolivian beer market was 4.0 million hectoliters in 2023. The Bolivian market is strongly influenced by macroeconomic trends and governmental regulatory and fiscal policies.

In Bolivia, 50% of our beer volumes was directly distributed by us and 50% is distributed through exclusive third-party distributors in 2023. Our main package presentation in Bolivia is the 620-milliliter returnable glass bottle, which accounted for 36% of our sales in 2023.

Our most important beer brands in Bolivia are Paceña, Taquiña and Huari. According to estimates, we are the leading beer producer in Bolivia.

The Bolivian CSD Market

In March 2009, we acquired 100% of Bebidas y Aguas Gaseosas Occidente S.R.L., from SAB (through Quinsa) becoming the exclusive bottler of Pepsi in Bolivia.

According to our estimates, in 2023, the annual sales volume of the Bolivian CSD market was 10.1 million hectoliters. Of our total CSD volumes in Bolivia in 2023, 87% was directly distributed by us and 13% was distributed through exclusive third-party distributors, while all our CSD sales in that country in 2023 were through non-returnable bottles.

Chile

According to our estimates, the annual sales volume of the Chilean beer market was 11.2 million hectoliters in 2022. Beer consumption in Chile has increased in almost every year since 2009, except for 2017, 2022 and 2023. Our most important beer brands in Chile are Corona, Budweiser, Becker, Stella Artois and Cusqueña.

As of December 31, 2023, we were the second beer producers in Chile, according to our estimates, and our main competitor and the leader in the country is Compañía Cervecerías Unidas S.A. In Chile 100% of our beer volumes was distributed through an exclusive third-party distributor.

In 2015, we became the exclusive distributors of the Corona brand in Chile, and since January 2016 we also started to import and distribute Budweiser in Chile, followed by Cusqueña in 2018.

Paraguay

According to our estimates, the annual sales volume of the Paraguayan beer market was 5.0 million hectoliters in 2023, excluding smuggling.

The market for beer in Paraguay has traditionally distinguished itself from those in the southern cone countries in certain respects because (1) beer has not faced significant competition from wine as an alternative alcoholic beverage; (2) the domestic beer market has faced significant competition from imported brands, which accounted for a far higher market share in Paraguay than in neighboring countries; and (3) the seasonality of our products is lower due to warmer conditions throughout the year.

In Paraguay, 68% of our beer volumes was directly distributed by us and 32% was distributed through exclusive third-party distributors in 2023. Our main package presentation in Paraguay is the 940-millimeter returnable glass bottle, which accounted for 46% of our sales in 2023.

Our most important beer brands in Paraguay are Brahma, Ouro Fino, Skol, Bud 66 and Pilsen, with a leader market position in the country in 2023, according to our estimates. We are also the exclusive distributor of the Budweiser brand in Paraguay.

   
 49 
 

Uruguay

The Uruguayan Beer Market

According to our estimates, the annual sales volume of the Uruguayan beer market was 1 million hectoliters in 2023. Our Latin America South business unit manages both the beer and CSD businesses in Uruguay out of a facility based in that country.

In Uruguay, on June 1, 2023, we implemented a “Route To Market Project,” resulting in 100% of our beer volume distributed through exclusive third-party distributors. Previously, from January to May 2023, 21% of our beer volumes was directly distributed by us and 79% was distributed through exclusive third-party distributors. Our main package presentation in Uruguay is the 1-liter returnable glass bottle, which accounted for 51% of our sales in 2023.

Our most important beer brands in Uruguay are Pilsen and Patricia, with a leading market position in 2023, according to our estimates.

The Uruguayan CSD Market

According to our estimates, in 2023, the annual sales volume of the Uruguayan CSD market was 3.2 million hectoliters.

In Uruguay, 39% of our CSD volume was directly distributed by us and 61% was distributed through exclusive third-party distributors in 2023. Non-returnable bottles accounted for 97% of our sales in that country in 2023. Our most important brand in Uruguay is Pepsi-Cola, with The Coca-Cola Company being our main competitor.

Canada

The Canadian Beer Market

Our Canada business segment is represented by the Labatt operations, which sells domestic and ABI beer brands, a portfolio of ready-to-drink and cider brands.

According to our estimates, Labatt is the market leader in the Canadian beer market. The main packaging presentations in that country are the 355-milliliter and the 473-milliliter aluminum cans, which are predominantly sold in privately owned and government-owned retail stores in addition to privately owned on-trade establishments. Our main competitor in Canada is Molson, but we also compete with smaller brewers, such as Sleeman Breweries Ltd., or Sleeman, and Moosehead Breweries Ltd.

Our main brands in Canada are Budweiser, Bud Light, Michelob Ultra and Busch (brewed and sold under license from ABI’s subsidiary Anheuser-Busch, Inc., or Anheuser-Busch), along with Corona, Labatt Blue, Alexander Keith’s, Stella Artois and Kokanee. Our distribution system in Canada is structured in different ways across the country, as further explained below.

Other Canadian Markets

The ready-to-drink beverages (RTD) industry in Canada declined low-single digit in 2022 and 2023, after two years of unprecedent growth. Labatt’s RTD portfolio in Canada includes the Nutrl, Cutwater, Bud Light Seltzer, Palm Bay and Mike’s brands.

Distribution in Ontario

In Ontario, the province with the largest beer consumption in Canada, we own together with other brewers a distribution and retail company incorporated in 1927 named Brewers Retail Inc., operating as The Beer Store, or TBS. In 2015, we finalized a new Master Framework Agreement, or MFA, with the government of the Province of Ontario that specifies TBS’s role as a retailer and distributor of beer.

Under the MFA, TBS continues to be the primary retailer for pack sizes larger than six bottles or cans of beer. The Liquor Control Board of Ontario, or LCBO, a chain of liquor stores owned by the government of

   
 50 
 

the Province of Ontario, continues to have the ability to sell beer. Most LCBO stores are limited to selling pack sizes of six bottles or cans of beer or less. Under the MFA, up to 450 grocery stores may also be granted a license to sell beer in pack sizes of six bottles or cans or less. The MFA came into force on January 1, 2016 and has an initial term of ten years, subject to renewal for successive five-year terms, unless the agreement is terminated after the initial term in accordance with the MFA.

 

In December 2023, the government of the Province of Ontario provided notice that the MFA would not be renewed and announced its intention to expand the sale of beer and certain other alcoholic beverages in Ontario to the convenience channel, while also expanding the number of grocery licenses to sell beer. In connection with the announcement, a non-binding term sheet was signed between TBS and the government of the Province of Ontario setting out non-binding principles reflecting features of a new marketplace for beer sales in Ontario. These principles are intended to clarify features of the new system, including what elements of the existing system will be retained through at least January 1, 2031. The principles include: (i) TBS retaining retail operations through to at least January 1, 2033, (ii) TBS continuing to be the primary distributor to existing channels and new stores through at least January 1, 2031, (iii) TBS continuing to provide recycling services, and (iv) maintaining current regulations in Ontario prohibiting trade spend in the new retail channel.

TBS ownership is available to all qualifying Ontario-based brewers. TBS’s 15-member Board of Directors is made up of the following members: four directors nominated by Labatt; four directors nominated by Molson; four independent directors initially nominated by a selection committee jointly represented by the Province of Ontario, Labatt and Molson and now nominated by a majority vote of the independent directors; two directors nominated by larger brewer shareholders (other than Labatt and Molson) with TBS sales greater than 50,000 hectoliters per year; and one director nominated by smaller brewer shareholders with TBS sales less than 50,000 hectoliters per year.

TBS operates as a self-funding corporation on a break-even cash flow basis under which it charges volume-based fees for services it provides to the brewers. The nature of TBS’s business requires compliance with laws and regulations and oversight by the Province of Ontario and its agents, the Alcohol and Gaming Commission of Ontario, or AGCO, and the LCBO. The Liquor Licencing and Control Act and its regulations are administered by the AGCO, which is an Ontario provincial regulatory agency reporting to the Ministry of the Attorney General and affiliated with the Ministry of Finance. The Province of Ontario and its agents, the AGCO and LCBO, oversee all aspects of the beverage alcohol sector.

Distribution in Quebec

Quebec is the province in Canada with the second largest beer consumption. In this province there are no exclusive rights for the sales of beer, and both the on-premise and off-premise sales channels are mostly comprised of privately owned stores. The SAQ, a government-operated liquor store, sells a select few beer brands that are not available in the private retail system.

We (as well as our competitors) sell our products in Quebec through a direct sales and distribution system.

Distribution in the Western Provinces

Molson and Labatt are each a shareholder in Brewers Distributor Limited, which operates a distribution network primarily for beer in the four western provinces of British Columbia, Alberta, Manitoba and Saskatchewan, as well as three territories (Yukon, the Northwest Territories and Nunavut). In Alberta, some volume is also sold through a third-party wholesaler. In these Western Provincial markets, there are both privately controlled retail stores (such as in Alberta, British Columbia and Saskatchewan) and government-controlled retail stores (such as in British Columbia and Manitoba).

Distribution in the Atlantic Provinces

We distribute and sell our products in the Atlantic Provinces (including New Brunswick, Newfoundland, Nova Scotia and Prince Edward Island) through (1) distribution and retail networks controlled by the government in the provinces of Nova Scotia, New Brunswick and Prince Edward Island; and (2) private distributors in Newfoundland.

   
 51 
 

Beer, CSD and RTD Production Process

The basic brewing process for most beers is straightforward, but significant know-how is involved in quality and cost control. The most important stages are brewing and fermentation, followed by maturation, filtering and packaging. Although malted barley (malt) is the primary ingredient, other grains such as unmalted barley, corn, rice or wheat are sometimes added to produce different beer flavors. The proportion and choice of other raw materials varies according to regional taste preferences and the type of beer.

The first step in the brewing process is making wort by mixing malt with warm water and then gradually heating it to approximately 75°C in large mash turns to dissolve the starch and transform it into a mixture, called “mash,” of maltose and other sugars. The spent grains are filtered out and the liquid, now called “wort,” is boiled. Hops are added at this point to give a special bitter taste and aroma to the beer and help preserve it. The wort is boiled for one to two hours to sterilize and concentrate it and extract the flavor from the hops. Cooling follows, using a heat exchanger. The hopped wort is saturated with air or oxygen, essential for the growth of the yeast in the next stage.

Yeast is a micro-organism that turns the sugar in the wort into alcohol and carbon dioxide. This process of fermentation takes five to eleven days, after which the wort finally becomes beer. Different types of beer are made using different strains of yeast and wort compositions. In some yeast varieties, the cells rise to the top at the end of fermentation. Ales and wheat beers are brewed in this way. Pilsen beers are made using yeast cells that settle to the bottom.

During the maturation process the liquid clarifies as yeast and other particles settle. Further filtering gives the beer more clarity. Maturation varies by type of beer and can take as long as three weeks. Then the beer is ready for packaging in kegs, cans or bottles.

CSDs and RTDs are produced by mixing water, flavored concentrate and sugar or sweetener. In the case of RTDs, alcohol is also included in this blend. Water is processed to eliminate mineral salts and filtered to eliminate impurities. Purified water is combined with processed sugar or, in the case of diet CSDs, with artificial sweeteners and concentrate. For CSDs and carbonated RTDs, carbon dioxide gas is injected into the mixture to produce carbonation. Immediately following carbonation, the mixture is packaged. In addition to these inputs, delivery of the product to consumers requires packaging materials such as PET bottles, aluminum cans, labels and plastic closures.

For information on our production facilities, see “—D. Property, Plant and Equipment.”

Sources and Availability of Raw Materials

 

The COVID-19 pandemic caused significant changes in consumer behavior and channel dynamics as governments-imposed restrictions that varied in terms of scope and intensity in response to the virus spread. As out-of-home consumption occasions gradually increased in 2021 and 2022, the demand for glass bottled packaging increased significantly, pressuring the supply chain and generating punctual product shortages.

Beer

The main raw materials used in our production are malt, non-malted cereals, hops and water.

Barley and Malt

Malt is widely available, and our malt requirement is met by domestic and international suppliers as well as our own six malting facilities. In the case of our beer operations in South America (Brazil & LAS), approximately 75% of our malt needs were supplied by our own malting facilities located in the south of Brazil, Argentina and Uruguay in 2023.

For the remaining malt demand, our main supplier is Cooperativa Agroindustrial Agraria, located in the State of Paraná in Brazil Market prices for malt are volatile and depend on the quality and the level of production of the barley crop across the world, as well as on the intensity of demand.

   
 52 
 

The barley used in our malting facilities is bought directly from South America farmers. Barley prices depend on local winter crop markets, wheat market prices on the main boards of trade across the world and on the barley quality during the harvest.

To avoid the impact of short-term volatility in barley and malt prices on our production costs, we enter into future contracts or financials instruments. See “Item 11. Quantitative and Qualitative Disclosures about Market Risk.”

Hops

There are two types of hops used in our beer production: hops used to give beer its distinctive bitter flavor, which we generally import from the United States, and hops used to give beer its distinctive aroma, which we generally import from Europe and part from our local production in Argentina. Hops industry is concentrated in a few international suppliers, such as Barth-Haas Group and Hopsteiner.

Non-malted Cereals

Non-malted cereals are purchased from domestic suppliers, the most relevant of which are Ingredion, Cargill Agrícola and Arrozeira Pelotas. Those cereals grow in several regions in Brazil and are generally widely available.

To avoid the impact of short-term volatility in corn prices on our production costs, we enter into financials instruments. See “Item 11. Quantitative and Qualitative Disclosures about Market Risk.”

Water

Water represents a small portion of our raw material costs. We obtain our water requirements from several sources, such as: lakes and reservoirs, deep wells located near our breweries, rivers adjoining our plants and public utility companies. We monitor the quality, taste and composition of the water we use, and treat it to remove impurities and to comply with our high-quality standards and applicable regulations. As a result of advances in technology, we have continuously reduced our water consumption per hectoliter produced.

Non-alcoholic Beverages

The main raw materials used in our production are concentrate (including guaraná extract), sugar, sweetener, juices, water and carbon dioxide gas. Most of these materials are obtained from local suppliers.

Guaraná Berries

We have a 1,070-hectare farm that provides us with 5-tons of guarana seeds (roasted grains) per year, or about 2% of our needs, with the balance currently being purchased directly from farmers and their organizations in Maués, with the remainder purchased directly from independent farmers in the Amazon region as well as other regions in Brazil where guaraná is available. The focus of our own farm is to supply guaraná seedlings to local producers and to promote the sustainable cultivation of guaraná in the Amazon Region. About 14 thousand seedlings are donated each year.

Concentrates

We have a concentrate facility in the north of Brazil which produces the concentrates to meet our requirements to produce of our proprietary brand guaraná Antarctica among others. The concentrate for Pepsi CSD products is purchased from PepsiCo.

Sugar

Sugar is widely available and is purchased by our regional sourcing entity. We use sugar in our CSD products mainly in Brazil, Argentina, Bolivia, Uruguay, and the Caribbean. To avoid the impact of short-term volatility in sugar prices on our production costs, we enter into derivative instruments. See “Item 11. Quantitative and Qualitative Disclosures about Market Risk.”

   
 53 
 

Juices

Orange, lemon, grape, apple, and other juices used in our CSD, and juices products are purchased in Brazil. We also use lemon and grapefruit juices in our CSD products in Argentina and Uruguay. Our main suppliers are Louis Dreyfus Commodities, Cutrale, Citrus Juice, Litoral Citrus and San Miguel.

Other

We buy all of fruit juice, pulp and concentrate that we use in the manufacture of our fruit flavored CSDs.

Packaging

Packaging costs are comprised of the cost of glass and PET bottles, aluminum cans, plastic film (shrink and stretch), paper labels, plastic closures, metal crowns and paperboard, and other materials. To mitigate the risks of short-term volatility in aluminum and some other packaging materials prices on our production costs, we enter into derivative instruments; for further information on this matter see “Item 11. Quantitative and Qualitative Disclosures About Market Risk.” We also set a fixed price for the period in accordance with the prevailing macroeconomic conditions for some materials.

In April 2008, we started operating a glass bottle producing facility in Rio de Janeiro, which we expanded in November 2015. This unit’s capacity is of approximately 255 thousand tons of glass and in 2023 such unit attended approximately 35% of our glass needs in Brazil.

We have supply contracts with respect to most packaging materials. The choice of packaging materials varies by cost and availability in different regions, as well as consumer preferences and the image of each brand.

Our aluminum cans are mainly sourced regionally by global companies, while our glass containers are sourced by a variety of suppliers, both regionally and globally. Also, in September 2020, we opened our can plant facility in the state of Minas Gerais, which has a production capacity of 2.5 billion cans per year. Our can plant served approximately 14% of our can needs in 2023 in Brazil.

We obtain the labels for our beer and CSD primarily from local suppliers; in Brazil, the majority of our beer label requirements are met by a printing house that belongs to FAHZ and is operated by us pursuant to a lease agreement. Plastic closures are principally purchased regionally, and PET pre-forms are principally purchased regionally by both local and global companies. Crown caps in Brazil are mainly sourced from our vertical operation in Manaus, Arosuco. These producers also supply some of our other Latin American operations.

Regulation

All our operations are subject to local governmental regulation and supervision, including (1) labor laws; (2) social security laws; (3) public health, consumer protection and environmental laws; (4) securities laws; (5) antitrust laws; (6) foreign exchange laws; and (7) international sanctions and embargoes. In addition, we may also be subject to regulations aimed at (i) ensuring healthy and safe conditions in facilities for the production, bottling, and distribution of beverages and (ii) placing restrictions on beer and CSD consumption.

Environmental laws in the countries where we operate are mostly related to (a) the conformity of our operating procedures with environmental regulation and standards regarding, among other issues, the use of water resources, the emission of gas and liquid effluents, environmental permits and (b) the management and disposal of one-way packaging.

Governmental restrictions on beer consumption in the markets where we operate vary from one country to another, and in some instances, from one local region to another. The most relevant restrictions are:

·each country or province has a minimum legal drinking age that is established by the government; the beer legal drinking age varies from 18 to 21 years;
   
 54 
 
·some local and federal governments require that retail stores own special licenses for the sale of alcohol; this is the case in some regions of Argentina, Bolivia, Chile, Panama and Canada;
·some local and federal governments (including Bolivia, Argentina, Uruguay and Canada) prohibit the sale of alcoholic beverages within a certain distance from schools, hospitals and other designated areas, as well as place certain restrictions on the time of sale and consumption of these products in public places and private clubs;
·some local governments in Canada establish a minimum price for beer sales, which is named Social Reference Price, or SRP. There is a specific SRP for each different packaging presentation. The SRP may vary from one province to another;
·in some provinces in Canada the off-trade is restricted to government-owned or licensed stores. See “—Business Overview—Description of the Markets Where We Operate—Canada – Labatt”; and
·beer sales in the off-premise channel in Canada in the Province of Ontario are restricted to three retail channels. One of them is the LCBO, which is government-owned. The second retail channel is TBS, which is jointly owned by Labatt and 33 other brewers. The third retail channel is eligible grocery. The Alcohol and Gaming Commission of Ontario regulates the alcohol industry.

Many governments also impose restrictions on beer advertisement, which may affect, among other issues, (1) the media channels used, (2) the contents of advertising campaigns, which may also include restrictions to influencer marketing campaigns, and (3) the time and places where beer can be advertised.

Marketing

Our marketing initiatives are concentrated in off-trade and on-trade initiatives. Off-trade initiatives comprise mass media vehicles, such as television, radio, magazines and internet websites. On-trade initiatives include banners, and all types of enhancements to the point of sale, such as branded coolers and decorated furniture.

Licenses

Pepsi

We have a long-term agreement with PepsiCo whereby we have been granted the exclusive right to bottle, sell and distribute certain brands of PepsiCo’s portfolio of CSDs in Brazil, including Pepsi-Cola, Gatorade, H2OH!, and Lipton Ice Tea. We are also, through our subsidiaries, PepsiCo’s bottler for Argentina, Uruguay, Bolivia and Dominican Republic. In 2023, sales volumes of PepsiCo products represented approximately 34% of our total NAB sales volumes in Brazil, 53% of our total NAB sales volumes in the Dominican Republic and 96% of our NAB sales volumes in Argentina, 96% in Bolivia and 99% in Uruguay.

Red Bull

We have a long-term distribution agreement with Red Bull, providing for the exclusive right to sell and distribute certain brands of Red Bull’s portfolio in specific limited points of sale of the on-trade channel in Brazil. We also have agreements with Red Bull to distribute their portfolio in a few limited channels in Argentina and the Dominican Republic.

Licensing Agreements with ABI

Effective January 1998, Labatt entered into long-term licensing agreements with ABI whereby Labatt was granted the exclusive right and license to manufacture, bottle, sell, distribute and market some of ABI’s brands, including the Budweiser and Bud Light brands, in Canada, including the right to use ABI’s trademarks for those purposes. The agreements expire in January 2098 and are renewable by either party for a second term of 100 years. In 2023, the ABI brands sold by Labatt represented approximately 61% of Labatt’s total sales volumes. According to our estimates, the Budweiser brand is currently the largest selling brand, while Bud Light is the third largest selling brand, in Canada in terms of volume.

Budweiser

   
 55 
 

We also have a licensing agreement with ABI which allows us to exclusively produce, distribute and market Budweiser in Brazil and Argentina. We also have certain arrangements to sell and distribute Budweiser products in Paraguay, Guatemala, Dominican Republic, Panama, Puerto Rico, Costa Rica, Nicaragua, and certain other countries in CAC, Uruguay, Chile, Bolivia and Paraguay.

Stella Artois, Becks and Brahma

We have a cross-licensing agreement with ABI through which we are allowed to produce, bottle, sell and distribute beer under the Stella Artois and Becks brands in Latin America and Canada on an exclusive basis, and ABI is allowed to produce, bottle, sell and distribute beer under the brand Brahma in Europe, Asia, Africa and the United States on an exclusive basis. Ambev has agreed not to produce directly or indirectly, bottle, distribute, sell or resell (or have an interest in any of these), any other European premium branded beer in Latin America, and ABI has agreed to be bound by the same restrictions relating to any other Latin American premium branded beer in Europe, Asia, Africa and the United States. As a result, in June 2005 we launched Stella Artois in Brazil and, since March 2005, ABI has been distributing Brahma beer in the United States and several countries such as the United Kingdom, Spain, Sweden, Finland and Greece.

Corona

We have a licensing agreement with Grupo Modelo, S. de R.L. de C.V. (“Cervecería Modelo” - formerly Grupo Modelo, S.A.B. de C.V.), a subsidiary of ABI, to produce, import, promote and resell Corona products (Corona Extra, Corona Light, Coronita, Corona Sunbrew, Pacifico and Negra Modelo) in Brazil, Argentina, Chile and other Latin America countries as well as in Canada.

We also have a licensing agreement with Grupo Modelo to produce, distribute and market Modelo Especial and Corona Extra in Guatemala, and to produce, distribute and market Modelo Especial in Dominican Republic.

Spaten

We have a licensing agreement with Spaten-Franziskaner-Bräu GmbH, a subsidiary of ABI, to produce, promote, advertise and sell Spaten in Brazil and Canada. We also have certain arrangements to sell and distribute Spaten products in Uruguay.

Michelob and Goose Island

We also have certain other agreements which allows us to sell and distribute Michelob Ultra, Michelob, and Goose Island in Brasil, Argentina, Chile, Uruguay, Paraguay, Guatemala, Dominican Republic, Panama, Puerto Rico, Costa Rica, Nicaragua, and certain other countries in CAC, as well as in Canada.

Cutwater and Nutrl

We also have licensing agreements that allow us to produce, promote, advertise and sell Cutwater in Canada, and that allow ABI to produce, promote, advertise and sell Nutrl in the United States.

Can supply

We have ABI’s subsidiary, Metal Container Corporation, as one of our main can suppliers.

Taxation

Beer

Taxation on beer in the countries where we operate is comprised of different taxes specific to each jurisdiction, such as an excise tax and a value-added tax. The amount of sales tax charged on our beer products in 2023, represented as a percentage of gross sales, was: 42.3% in Brazil; 22% in Canada; 11.1% in Central America; 36.2% in the Dominican Republic; 18.0% in Guatemala; 14.3% in Panama; 1.0% in Cuba; 8.1% in Barbados; 18.1% in Argentina; 36.4% in Bolivia; 25.8% in Chile; 11.6% in Paraguay; and 32.9% in Uruguay.

   
 56 
 

NAB

Taxation on NAB in the countries where we operate is comprised of taxes specific to each jurisdiction, such as an excise tax and a value-added tax. The amount of taxes charged on our NAB products in 2023, represented as a percentage of gross sales, was: 35.3% in Brazil; 18.0% in the Dominican Republic; 7.0% in Panama; 11.3% in Argentina; 26.7% in Bolivia; and 29.8% in Uruguay.

Changes to Brazilian Taxes on Beverages

In 2022, the States of Acre, Alagoas, Amazonas, Bahia, Maranhão, Paraná, Pará, Piaui, Rio Grande do Norte, Roraima, Sergipe, Tocantins increased their ICMS Value-Added Tax rate applicable to beer and/or soft drinks (increases ranging from 1% to 4%), while both the States of Minas Gerais and Rio de Janeiro decreased their ICMS value-Added Tax rates with effect from early 2023 (decreases of 2% and 1%, respectively). In 2023, the States of Minas Gerais and Rondônia increased their ICMS Value-Added Tax rate applicable to beer (increases ranging from 2% to 5%), while the states, Maranhão, Pernambuco, Roraima, Paraíba, Ceará, Bahia, Distrito Federal, Goiás and Minas Gerais increased their ICMS Value-Added Tax rate applicable to soft drinks (increases ranging from 1% to 3%) and the States of Rio Grande do Sul and Rio Grande do Norte, decreased their ICMS value-Added Tax rates applicable to soft drinks (decreases of 2%, respectively), with all effects from early 2024 on.

The Brazilian tax reform related to consumption was approved in December 2023, and, consequently, potentially relevant changes will likely arise in relation to the Brazilian taxation applicable on beverages, including, possibly, the imposition of excise tax (IS) over alcoholic beverages in addition to the Dual VAT (IBS and CBS). Also, the tax reform eliminates all tax benefits currently applicable, preserving only certain specific benefits as the Manaus Free Trade Zone. Considering the reform is still pending a series of definitions and implementing regulations, we cannot anticipate the impact on our operations with any precision as of the date of this annual report on Form 20-F. However, changes may be significant and could have negative consequences on our results of operations.

C.        Organizational Structure

Our direct controlling shareholder, ABI, together with FAHZ, held in aggregate approximately 72.0% of our total and voting capital stock (excluding treasury shares) as of December 31, 2023.

ABI indirectly holds shares in us representing 61.8% of our total and voting capital stock (excluding treasury shares) as of December 31, 2023. ABI thus has control over us, even though (1) ABI is subject to the Shareholders’ Agreement and (2) ABI is controlled by Stichting that represents an important part of interests of BRC and the Interbrew Founding Families. For further information on these matters see “Item 4. Information on the Company—A. History and Development of the Company—The InBev-Ambev Transactions” and “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev’s Major Shareholders—The Shareholders’ Agreement.”

We conduct the bulk of our operations in Brazil directly. We also indirectly control Labatt and the operations conducted by our CAC and Latin America South units. The following chart illustrates the ownership structure of our principal subsidiaries as of December 31, 2023 based on total share capital owned.

   
 57 
 

Organizational Structure

 

   
 58 
 

D. Property, Plant and Equipment

 

Our properties consist primarily of brewing, soft drink production, malting, bottling, distribution and office facilities in the countries where we operate.

As of December 31, 2023, our aggregate beer and non-alcoholic beverages production capacity was 259.2 million hectoliters per year. In 2023, the total production at the facilities set forth below was equal to 178.9 million hectoliters.

The following is a list of our main production facilities as of December 31, 2023:

Brazil  
Plant Type of Plant
Almirante Tamandaré, Paraná Soft Drinks
Anápolis, Goiás Mixed
Aquiraz, Ceará Mixed
Camaçari, Bahia Mixed
Cuiabá, Mato Grosso Mixed
Estancia, Sergipe Mixed
Guarulhos, São Paulo Beer
Itapissuma, Pernambuco Mixed
Jacareí, São Paulo Beer
Jaguariúna, São Paulo Mixed
Juatuba, Minas Gerais Mixed
Jundiai, São Paulo . Soft Drinks
Lages, Santa Catarina Beer
Cachoeiras de Macacu, Rio de Janeiro . Mixed
Manaus, Amazonas . Mixed
Pirai, Rio de Janeiro Mixed
Ponta Grossa, Paraná Beer
Rio de Janeiro, Rio de Janeiro Mixed
São Luis, Maranhão Beer
Sapucaia do Sul, Rio Grande do Sul Soft Drinks
Sete Lagoas, Minas Gerais Mixed
Teresina, Piauí Mixed
Uberlândia, Minas Gerais Beer
Viamão, Rio Grande do Sul Mixed
Crown Manaus, Amazonas Crown Cap
Glass Rio, Rio de Janeiro Glass Bottles
Label São Paulo, São Paulo Labels
Malt. Navegantes, Rio Grande do Sul Malt
Malt. Passo Fundo, Rio Grande do Sul Malt
Cans Minas, Minas Gerais Cans
SAZ Zitec Research Pilot Brewery, Rio de Janeiro Research Plant
Wals, Minas Gerais Beer
Colorado, São Paulo Beer
Bohemia, Rio de Janeiro Beer
Pratinha, São Paulo Beer
Joao Pessoa, Paraíba CO2 Plant
SD Aromas, Manaus Soft Drinks Kits
Agudos, São Paulo Beer
Carambeí, Paraná… Glass Bottles
   
 59 
 

 

 

CAC
Plant                                                                                                     Type of Plant
Ambev Centroamerica, Guatemala Beer
Santo Domingo, Dominican Republic Mixed
Hato Nuevo, Dominican Republic Mixed
Saint Vincent Mixed
Cuba Mixed
Barbados Mixed
Panama Mixed

 

Latin America South
Plant                                                                                                     Type of Plant
Acheral, Argentina Beer
Cordoba, Argentina Soft Drinks
Corrientes, Argentina Mixed
Manantial, Argentina Soft Drinks
Mendoza, Argentina Beer
Pompeya, Argentina Beer
Quilmes, Argentina Beer
Cerveceria Argentina, Argentina Beer
Cochabamba, Bolivia Beer
El Alto, Bolivia Soft Drinks
Huari, Bolivia Beer
La Paz, Bolivia Beer
Sacaba, Bolivia Soft Drinks
Santa Cruz, Bolivia Beer
Santiago, Chile Beer
Ypane, Paraguay Beer
Minas, Uruguay Beer
Montevideo, Uruguay Mixed
Malt. Pampa, Argentina Malt
Crown Coroplas, Argentina Crown Cap
Malt Tres Arroyos, Argentina Malt
Can Oruro, Bolivia Cans
Glass Ypane, Paraguay Glass Bottles
Malt Nueva Palmira, Uruguay Malt
Malt Paysandu, Uruguay Malt
Hop Fernandez Oro, Argentina Hops Pellets
Zarate Research Pilot Brewery, Argentina Research Plant
Patagonia, Argentina Beer
Dante Robino, Argentina Wine
Tarija, Bolivia Beer

 

 

   
 60 
 

 

 

Canada
Plant                                                                                                     Type of Plant
St. John’s Beer
Halifax Beer
Montreal Beer/RTD
London Beer/RTD
Edmonton Beer/RTD
Creston Beer
Mill Street Beer/Spirits
Turning Point Beer/RTD/Cider
Archibald Beer
Alexander Keith’s Beer
Goodridge & Williams RTD/Spirits

Banded Peak

Beer

Stanley Park

Beer

Lacroix

Cider

 

 

   
 61 
 
ITEM 4A.UNRESOLVED STAFF COMMENTS

Not applicable.

   
 62 
 

 

ITEM 5.OPERATING AND FINANCIAL REVIEW AND PROSPECTS

A.        Operating Results

Introduction

The following management’s discussion and analysis of financial condition and results of operations should be read in conjunction with our audited consolidated financial statements included elsewhere in this annual report on Form 20-F. This annual report contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those discussed in the forward-looking statements as a result of various factors including, without limitation, those set forth in “Cautionary Statement Regarding Forward-Looking Information” and the matters set forth in this annual report generally.

We have prepared our audited consolidated financial statements as of December 31, 2023 and 2022, and for the three years ended December 31, 2023 in reais and in accordance with IFRS as issued by the IASB.

The financial information and related discussion and analysis contained in this item are in accordance with IFRS as issued by the IASB. The amounts are in million reais, unless otherwise stated.

Brazilian Economic Environment and Inflation Impacts

A relevant part of our operations and assets is located in Brazil. Accordingly, our results of operations are affected by macroeconomic conditions in Brazil, including inflation rates, interest rates, Brazilian GDP growth, employment rates, wage levels, consumer confidence and credit availability.

The economic environment remained challenging for our operations during throughout the last three years. The Brazilian GDP, as published by the IBGE, increased by 4.6%, 2.9% and by 2.9%, in 2021, 2022 and 2023, respectively. Prior to 2020, when the GDP grew 4.1%, Brazil was emerging from a prolonged recession after a period of a slow recovery, with only meager GDP growth in 2019 and 2018. Brazil’s GDP growth rates were 1.1% in each of 2019 and 2018. The rate of growth of Brazilian GDP has a direct effect on consumer demand, which we believe affects demand for our products and services and, consequently, our net operating revenue.

In addition, consumption of beer, other alcoholic beverages and soft drinks in many of the jurisdictions in which we operate, including Brazil, is closely linked to general economic conditions, such that levels of consumption tend to rise during periods of rising per capita income and to fall during periods of declining per capita income. Consumption of beer and other alcoholic and non-alcoholic beverages also varies in accordance with changes in disposable income, e.g. as a result of the level of Brazilian unemployment. As of December 31, 2023, Brazilian unemployment, as measured by the monthly National Household Sample Survey (Pesquisa Nacional por Amostra de Domicílios Contínua), or PNAD, published by the IBGE, was 7.8%, compared to 9.3% as of December 31, 2022 and 13.2% as of December 31, 2021. As with GDP, the level of Brazilian unemployment has a direct effect on consumer demand, which we believe affects demand for our products and services and, consequently, our net operating revenue.

The following table sets forth data on real GDP growth, unemployment, inflation and interest rates, and the U.S. dollar exchange rate for the indicated periods:

    As of and for the year ended December 31,
    2023     2022     2021
                 
GDP growth (%) (1)     2.9       2.9       1.1
Unemployment (%) (2)     7.8       9.3       12.3
Inflation (IGP-M) (%) (3)     (3.2)     5.5       17.8
Inflation (IPCA) (%) (4)     4.6       5.8       10.1
CDI (%) (5)     13.0       12.4       6.4
(Depreciation) appreciation of the real against the U.S. dollar (%)     7.2       (6.5)     (18.5)
Exchange rate (closing) of the real to the U.S. dollar (6)     4.8413       5.218       3.875
Average exchange rate the real to the U.S. dollars (6)     4.9953       5.165       3.656
   
 63 
 

 

  (1) Source: IBGE.
  (2) Source: IBGE
  (3) Source: Fundação Getúlio Vargas - FGV.
  (4) Source: IBGE.
  (5) Source: Brazilian Central Bank.
  (6) Source: Brazilian Central Bank.

 

Inflation Impacts

In 2023, Brazilian inflation, as measured by the General Market Price Index (Índice Geral de Preços - Mercado), or IGP-M, published by Fundação Getúlio Vargas, or FGV, a private organization, was (3.2%), compared to 5.5% during 2022 and 17.8% during 2021. In 2023, Brazilian inflation, as measured by the Broad Consumer Price Index (Índice Nacional de Preços ao Consumidor Ampliado), or IPCA, published by the IBGE, was 4.6%, compared to 5.8% during 2022 and 10.1% during 2021.

Inflation impacts our operations in several ways. Mainly, inflation can increase the cost of raw materials, labor, and operational expenses, causing us to encounter pressure on our gross and profit margins. Furthermore, elevated inflation diminishes consumers’ purchasing power and alters their spending patterns. As prices escalate, consumers may exhibit greater sensitivity to pricing, sometimes prioritizing essential goods over discretionary items such as beverages. This change in consumer behavior not only can impact our sales volumes and revenue, but also necessitates cautious pricing strategies amidst rising costs. Addressing these intertwined challenges demands us to adopt a vigilant approach to cost and expenses management and pricing strategies. We have over the years consistently evaluated and enhanced our supply chain efficiency, explored alternative sourcing arrangements, and implemented targeted cost-containment measures to mitigate the effects of inflation on our cost structure. Concurrently, we closely monitor shifts in consumer preferences and market dynamics to tailor our product offerings and marketing strategies accordingly. By proactively managing these factors, we endeavor to navigate the uncertainties associated with inflation and sustain our business performance in the Brazilian market. Considering the existing inflationary pressures, our Brazilian operations may be impacted by one or a combination of the following factors arising from, or related to, inflation and our efforts to combat inflation:

·Price adjustment: in an effort to sustain our profitability margins, we may pass on to consumers higher production costs driven by inflation, including higher costs for beverage production, packaging materials, transportation, and other operational expenses, via price increase to our consumers;

 

·Inflation-linked contracts: we may enter into inflation-linked contracts where prices are adjusted periodically based on an inflation index, such as the IPCA or IGP-M indexes used in Brazil, and PPI (Producer Price Index) for United States such as our contracts for packaging materials and malt; and

 

·Increased labor costs: Inflation can also lead to higher labor costs for us, both for the wages of our employees as well as third-party service providers. Our employees may negotiate higher wages or demand cost-of-living adjustments to cope with rising prices. Additionally, third-party service providers, such as logistics companies and maintenance contractors, may increase their rates to offset inflationary pressures.

For further quantification and other information regarding inflation impacts on our results of operations, see our discussions below under “—Selected Financial Data by Business Segment—Cost of Sales” and “—Selected Financial Data by Business Segment— Sales, Marketing, Distribution and Administrative Expenses” for the year ended December 31, 2023 compared to the year ended December 31, 2022 and for the year ended December 31, 2022 compared to the year ended December 31, 2021. Our results of operations are affected by changes in the exchange rates of the real against the U.S. dollar. During 2023, the real appreciated against the U.S. dollar by 7.21%, following a depreciation of 6.50% during 2022 and a depreciation of 7.4% during 2021. The depreciation of the real against the U.S. dollar may create inflationary pressures in Brazil, particularly in the category of food products. In periods of significant inflation, we may not be able to pass through our increased cost of goods to our customers to our customers and demand for our products may contract.

Argentinean Economic Environment and Inflation Impacts

A relevant part of our operations is located in Argentina, which is considered a hyperinflationary. Therefore, our financial condition and the results of our operations are significantly dependent upon economic conditions prevailing in such country.

   
 64 
 

The table below shows Argentina’s GDP, inflation rates, dollar exchange rates, the appreciation (depreciation) of the Peso against the U.S. dollar for the indicated periods (inter-annual information-which is the 12 month period preceding the dates presented-is presented to conform to our fiscal year periods).

    Fiscal year ended December 31,  
    2023     2022     2021  
    (inter-annual data)  
       
GDP (%) (1)     (2.5)       5.0       10.7  
Unemployment (%)(2)     7.4       6.3       8.7  
Inflation (IPIM) (%) (3)     276.4       94.8       51.3  
Inflation (CPI) (%)(4)     211.4       94.8       50.9  
Depreciation of the Peso against the U.S. dollar (%)     351       71       21  
Average exchange rate per USD 1.00 (5)   ARS 808.25     ARS 179.25     ARS 104.75  

 

(1) Represents annual growth of the year end GDP at constant prices (2004). Source: INDEC for 2022 and 2021. For 2023, the IMF -World Economic Outlook estimation from October 2023, as data from INDEC was not available.
(2) Source: INDEC.
(3) IPIM (Índice de Precios Internos al por Mayor) is the wholesale price index as measured by the Argentine Ministry of Treasury. Source: INDEC
(4) Source: INDEC
(5) Represents average of the selling and buying exchange rate quoted by Banco de la Nación Argentina as of December 31.

Argentine GDP decreased 2.5% in 2023, compared to an increase of 5.0% in 2022 and 10.7% in 2021. As of December 31, 2023, the unemployment rate was at 7.4% of the country’s economically active population, compared to 6.3% as of December 31, 2022 and 7% as of December 31, 2021.

Changes in short- and long-term interest rates, unemployment and inflation rates may reduce the purchasing power of our consumers. These factors, combined with low GDP growth, may reduce general consumption rates.

Effects of inflation in Argentina

The following are annual inflation rates during the fiscal years indicated, based on information published by the INDEC, an entity dependent of the Argentine Ministry of Treasury.

    Consumer price index     Wholesale price index  
Fiscal year ended December 31,   (inter-annual data)  
2021     50.9 %     51.3 %
2022     94.8 %     94.8 %
2023     211.4 %     276.4 %

 

Continuing increases in the rate of inflation are likely to have an adverse effect on our operations. Higher inflation may lead to an increase in the prices we charge our consumers for our products and services, which may ultimately reduce our sales volume. See “Item 3. Key Information-D. Risk Factors-Continuing high rates of inflation in Argentina may have an adverse effect on the economy and our business, financial condition and results of operations.

 

Inflation in Argentine and our efforts to combat such inflation mainly impact our operations through:

 

·Price adjustments: in an effort to sustain our profitability margins, we may pass on to consumers higher production costs driven by inflation, including higher costs for beverage production, packaging materials, transportation, and other operational expenses, via price increase to our consumers;

 

·Inflation-linked contracts: we may enter into inflation-linked contracts where prices are adjusted periodically based on an inflation index, such as the Consumer Price Index (mostly CPI or PIM indexes are used in Argentina), such as our contracts for packaging materials and malt; and
   
 65 
 

 

·Increased labor costs: Inflation can also lead to higher labor costs for us, both for the wages of our employees as well as third-party service providers. Our employees may negotiate higher wages or demand cost-of-living adjustments to cope with rising prices. Additionally, third-party service providers, such as logistics companies and maintenance contractors, may increase their rates to offset inflationary pressures.

 

In accordance with IAS 29 and IAS 21, we make certain accounting adjustments to reflect the hyperinflationary environment in Argentina, mainly requiring us to restate the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in Argentina for the change in the general purchasing power of the local currency, using official indices before converting the local amounts at the closing rate of the period. . In 2023, the main effects of the hyperinflation accounting for our Argentine operations were (i) a negative impact of R$ 3,887.5 million in net revenue and (ii) a negative impact of R$ 1,275.0 million in profit.

 

Tax Credits – 2022/2023

 

Impact of Tax Credits

Exclusion of ICMS in taxable basis of PIS and COFINS

In 2022 and, to a lesser extent, 2023, our results of operations were materially impacted by relevant tax credits recorded following a long-awaited judgment by the Brazilian Supreme Federal Court (“STF”) establishing that ICMS (state VAT) amounts informed by companies in their invoices should not be included in the taxable basis for purpose of calculating federal social contributions on gross revenues (“PIS and COFINS”). Such understanding allowed companies to stop including such amount of ICMS in the PIS and COFINS calculation basis.

As a result of such decision, following an analysis conducted in 2022, R$1.2 billion in tax credits resulting from the exclusion of ICMS from the PIS and COFINS calculation base in operations with subsidiaries was recognized that year corresponding to amounts paid since 2017.

In December 2023, following a subsequent STJ ruling regarding the exclusion of ICMS under substitution modality in the tax basis of PIS and COFINS, we recorded an additional R$407 million tax credit.

Corporate Income Taxes Recovery – SELIC interest upon the recovery of taxes

On September 24, 2021, the STF ruled, with binding effects, that the levy of IRPJ and CSLL (Brazilian income taxes) on amounts received by taxpayers due to the application of the SELIC rate on the refund of overpaid taxes is unconstitutional.

We have ongoing judicial proceedings on this subject. Based on the binding decision issued by STF and on the analysis of our external counsels, we assessed as probable the chances of such tax treatment being granted with regards to the recognition of the Company’s right to recover/offset the amount of IRPJ and CSLL calculated and paid over the SELIC interest earned upon the refund of taxes accounted in the period between 2006 and 2023, as well as the exclusion of amounts of this nature in the calculation of IRPJ/CSLL taxable basis. As of December 2023, we have R$606 million in tax credits corresponding to IRPJ and CSLL taxes unduly paid over SELIC interest earned on tax refunds that were recorded in 2021 and 2022, which cannot be used for offset until judicial proceedings are concluded on this matter.

Impact of COVID-19 Pandemic

 

The impact of the pandemic on our operations and the restrictions imposed in response by national governments starting in March 2020 and through 2021 and, to a lesser extent, the first quarter of 2022 generated significant changes in market dynamics both in the off-trade sales channel, mainly comprised of supermarkets, and in the on-trade channel, which consists of bars and restaurants. In each case, the more severe the restrictions on the marketing and consumption of our products, the greater the reduction in volume, which is why Bolivia and Panama were the most affected countries, especially in fiscal year 2021. On the other hand, we observed an increase in sales related to e-commerce in all countries, although this channel represented a small portion of our total volume.

   
 66 
 

In early 2022, our operations, mainly in Brazil, were impacted by the wave of the Omicron variant of COVID-19, which, combined with factors such as unfavorable weather, negatively impacted our sales. From the second quarter on, with the progress of the vaccination programs and the greater control over the advance of the COVID-19 pandemic, there was a relaxation of the restrictions in the regions in which we operate, favoring the recovery of the on-trade channel, despite the uncertainty about how the consumption recovery will evolve in each of these territories.

In Brazil, the consistent implementation of the Company’s strategy combined with the context of relaxed restrictions and the return of occasions for out-of-home consumption generated a positive volume trend, with growth in both volume and net revenue compared to the same 2021 period. In the event that circumstances related to the COVID-19 pandemic evolve or new variants emerge, government authorities may implement emergency measures to mitigate the spread of the disease. The pandemic and corresponding mitigation measures may have an adverse impact on global economic conditions as well as the Company’s business. The extent of the pandemic COVID-19 impact on the Company’s business will depend on future developments, such as the duration of further outbreaks, any possible trade shutdowns and restrictions, and the effectiveness of actions taken in the regions where we operate and in other countries to contain and treat the disease. As such events are highly uncertain, the Company cannot determine their financial impact at this moment. Any adverse impacts could result in a material adverse effect on our business, liquidity, financial condition and results of operations. However, we continue to manage our cash and capital resources with discipline and management concludes that there is no doubt about the Company’s ability to continue operations.

See “Item 3.D. Key Information—Risk Factors—Risks Relating to Our Operations—The outbreaks of infectious diseases, or the risk of an outbreak (e.g. pandemics, epidemics, including a potential new wave of COVID-19), its effects and the manner in which such events may continue to impact us are highly uncertain and unpredictable and may result in further adverse effects material to our business and may impact our ability to continue operating our business,” and other risk factors included herein and “—D. Trend Information” below.

Business Segments

We conduct our operations through four business segments as follows:

·         Brazil, which includes the beer sales division and the NAB sales division;

·Central America and the Caribbean, which includes our direct operations in the Dominican Republic, Saint Vincent, Cuba, Guatemala, Barbados and Panama as well as indirect sales, through third party distributors, in certain other CAC countries such as Costa Rica, Nicaragua, Puerto Rico, Venezuela and Trinidad & Tobago;
·Latin America South, which includes our operations in Argentina, Bolivia, Paraguay, Uruguay and Chile; and
·Canada, represented by Labatt’s operations, which includes domestic sales in Canada and some exports to the U.S. market.

Our chief operating decision maker uses income from operations as the main measure of segment profitability.

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022

The table below sets forth certain of our operating highlights for the years presented:

 

Consolidated Financial Highlights

 

2023

2022

% Change

  (in R$ million, except volume amounts,
percentages and per share amounts)
Sales volume—’000 hectoliters  183,659.0 185,749.7 (1.1%)
Net sales  79,736.9 79,708.8 0.0%
Net revenue per hectoliter—R$/hl  434.2 429.1 1.2%
Cost of sales  (39,291.6)     (40,422.1) (2.8%)
Gross profit  40,445.3       39,286.7 2.9%
Gross margin (%) 50.7% 49.3% 140 bps
Sales, marketing and distribution expenses  (18,163.1)      (18,732.7) (3.0%)
Administrative expenses  (5,273.7)        (5,236.8) 0.7%
Other operating income/(expenses) net  2,028.9          2,513.9 (19.3%)
Exceptional items  (206.4)           (143.3) 44.0%
Income from operations  18,831.0        17,687.9 6.5%
Operating margin (%) 23.6% 22.2% (140 bps)
Net income  14,960.4        14,891.2 0.5%
Net margin (%) 18.8% 18.7% (10 bps)
   
 67 
 

 

Margin Analysis

The following table sets forth certain line items of our income statement expressed as percentages of net sales for the years ended December 31, 2023 and 2022:

 

Year Ended December 31,

 

2023

2022

  (%) (%)
Net sales 100.0 100.0
Cost of sales (49.3) (50.7)
Gross profit 50.7 49.3
Sales, marketing and distribution expenses (22.8) (23.5)
Administrative expenses (6.6) (6.6)
Other operating income/(expenses) net 2.5 3.2
Exceptional items (0.3) (0.2)
Income from operations 23.6 22.2

Selected Financial Data by Business Segment

The following table sets forth selected financial data by business segment for the years ended December 31, 2023 and 2022:


 

Year Ended December 31,

 

2023

2022

 

Brazil

CAC

LAS

Canada

Total

Brazil

CAC

LAS

Canada

Total

 
  (in R$ million)
Net sales  46,361.7  10,044.8  13,797.2  9,533.2  79,736.9   42,635.7  9,440.1   17,371.2   10,261.7   79,708.8  
Cost of sales

(23,516.1)

(5,035.1)

(6,657.3)

(4,083.1)

(39,291.6)

(22,736.8)

(4,860.8)

(8,553.1)

(4,271.4)

(40,422.1)

 
Gross profit  22,845.6  5,009.7  7,139.9  5,450.1  40,445.3   19,898.9  4,579.3  8,818.1  5,990.3   39,286.8  
Sales, marketing, distribution and administrative expenses  (14,468.8)  (1,931.2)  (3,463.8)  (3,573.0)  (23,436.8)  (13,522.0)  (1,999.9)  (4,421.4)  (4,026.1)  (23,969.4)  
Other operating income/ (expenses)  1,892.5  26.3  95.0  15.1  2,028.9  2,361.4  (52.9)  192.7  12.8  2,513.9  
Exceptional items

(137.8)

(17.9)

(47.6)

(3.1)

(206.4)

(34.5)

(16.1)

(60.5)

(32.2)

(143.3)

 
Income from operations

10,131.5

3,086.9

3,723.5

1,889.1

18,831.0

8,703.7

2,510.5

4,528.9

1,944.7

17,687.8

 

 

   
 68 
 

Net Sales

Net sales remained relatively stable in 2023, to R$79,736.9 million from R$79,708.8 million in 2022, as a consequence of a 1.1% decrease in volume sold and was offset by 1.2% increase in net revenue per hectoliter with increases in Brazil and CAC offsetting decreases in Latin America South and Canada, as shown in the tables set forth a below.

 

Net Sales
Year Ended December 31,

 

2023

2022

 
 

Sales

% of Total

Sales

% of Total

% Change

  (in R$ million, except percentages)
Brazil  46,361.7 58.1%        42,635.7 53.5% 8.7%
Beer Brazil  38,985.9 48.9%        35,857.8 45.0% 8.7%
NAB  7,375.8 9.3%          6,777.9 8.5% 8.8%
CAC  10,044.8 12.6%          9,440.3 11.8% 6.4%
Latin America South  13,797.2 17.3%        17,371.2 21.8% (20.6%)
Canada

9,533.2

12.0%

10,261.7

12.9%

(7.1%)

Total

79,736.9

100.0%

79,708.8

100.0%

0.0%

           

 

 

Sales Volumes
Year Ended December 31,

 

2023

2022

 
 

Volume

% of Total

Volume

% of Total

% Change

  (in thousands of hectoliters, except percentages)
Brazil  126,419.7 68.8%      126,184.4 67.9% 0.2%
Beer Brazil  93,111.6 50.7%        94,042.6 50.6% (1.0%)
NAB  33,308.1 18.1%        32,141.8 17.3% 3.6%
CAC  12,174.6 6.6%        11,786.3 6.3% 3.3%
Latin America South  36,039.6 19.6%        38,134.0 20.5% (5.5%)
Canada

9,025.2

4.9%

9,645.0

5.2%

(6.4%)

Total

183,659.0

100.0%

185,749.7

100.0%

(1.1%)

 

 

 

 

 

Net Revenue per Hectoliter
Year Ended December 31,

 

2023

2022

% Change

  (in R$, except percentages)
Brazil  366.7            337.9 8.5%
Beer Brazil  418.7            381.3 9.8%
NAB  221.4            210.9 5.0%
CAC  825.1            801.0 3.0%
Latin America South  382.8            455.5 (16.0%)
Canada

1,056.3

1,063.9

(0.7%)

Total

434.2

429.1

1.2%

Brazilian Operations

Total net sales from our Brazilian operations increased by 8.7% in 2023, to R$46,361.8 million from R$42,635.7 million in 2022.

Our net sales of beer in Brazil increased by 8.7% in 2023, to R$38,985.9 million from R$35,857.8 million in 2022. This variation is mainly due to a 9.8% increase in net revenue per hectoliter in 2023 reflecting the implementation of revenue management initiatives combined with improved brand mix, slightly offset by a 1.0% decrease in volume sold. After reaching historically high volumes in 2022, we continued to consistently execute our commercial strategy in 2023, which led to strong sales growth for our premium and super premium brands led by Corona, Spaten and Original, although total volumes sold were down as compared to the volumes sold in 2022, which were boosted by the FIFA World Cup in 2022.

   
 69 
 

Our net sales of NAB in Brazil increased by 8.8% in 2023, to R$7,375.8 million from R$6,777.9 million in 2022. This variation is a consequence of a 3.6% increase in volume sold, coupled with a 5.0% increase in net revenue per hectoliter in 2023. The growth in net sales was driven by effective commercial strategies and product innovation, particularly within energy and health & wellness brands, which significantly outperformed in volumes. Market trends towards healthier options led to strong performance in diet/light/zero portfolio, notably with brands like Fusion and Gatorade, and were key contributors to the volume increase. Despite a slight decrease in net revenue per hectoliter due to the increased ICMS (VAT) taxable base and channel mix adjustments, operational efficiencies and strategic pricing actions helped mitigate these effects, supporting the net revenue growth.

CAC Operations

Net sales from our CAC operations increased by 6.4% in 2023, to R$10,044.8 million from R$9,440.3 million in 2022. This variation is a consequence of a 3.3% increase in volume sold, coupled with a 3.0% increase in net revenue per hectoliter in 2023. The increase in net sales in our CAC operations in 2023 was driven by strategic revenue management, a favorable mix towards premium and single-serve products, and a strong performance in the Dominican Republic. Enhanced focus on premium segments, including brands like Corona and the Presidente family, contributed significantly to the rise in net revenue per hectoliter and volume growth, underpinning our overall sales increase in the region.

Latin America South Operations

Net sales from our Latin America South operations decreased by 20.6% in 2023, to R$13,797.2 million from R$17,371.2 million in 2022. This variation is a consequence of a 5.5% decrease in volume sold, coupled with a 16.0% decrease in net revenue per hectoliter in 2023 driven mainly by the accounting impact of the Argentine peso (ARS) devaluation in 2023 which devalued more than 350% in 2023 from the end of 2022 coupled with a challenging economic and consumer scenario in Argentina considering inflation pressures on consumers disposable income.

Canada Operations

Net sales from our Canadian operations decreased by 7.1% in 2023, to R$9,533.2 million from R$10,261.7 million in 2022. This variation is a consequence of a 6.4% decrease in volume sold, coupled with a 0.7% decrease in net revenue per hectoliter in 2023. Volumes decreased within the context of a weak industry both in beer and beyond beer segments, while positive net revenue per hectoliter performance was mainly driven by revenue management initiatives.

Cost of Sales

Cost of sales decreased by 2.8% in 2023, to R$39,291.6 million from R$40,422.1 million in 2022. As a percentage of our net sales, total cost of sales increased to 49.3% in 2023 from 50.7% in 2022.

The table below sets forth information on cost of sales per hectoliter for the periods presented:

 

Cost of Sales per Hectoliter
Year Ended December 31,

 

2023

2022

% Change

  (in R$, except percentages)
Brazil 186.0            180.2 3.2%
Beer Brazil 208.1            199.5 4.3%
NAB 124.2            123.6 0.6%
CAC 413.6            412.4 0.3%
Latin America South 184.7            224.3 (17.6%)
Canada

452.4

442.9

2.2%

Total

213.9

217.6

(1.7%)

       

Brazilian Operations

Total cost of sales for our Brazilian operations increased by 3.4% in 2023, to R$23,516.0 million from R$22,736.8 million in 2022. On a per hectoliter basis, our Brazilian operations’ cost of sales increased by 3.2% in 2023, to R$186.0 per hectoliter from R$180.2 per hectoliter in 2022.

   
 70 
 

Cost of sales for our Brazilian beer operations increased by 3.3% in 2023, to R$19,377.7 million from R$18,765.3 million in 2022, with cost of sales per hectoliter growing by 4.3% (R$208.1 in 2023 versus R$199.5 in 2022), mainly explained by higher commodity prices with barley price increases being partially offset by favorable aluminum prices, as well as general inflation impacts.

Cost of sales for our Brazilian NAB segment increased by 4.2% in 2023, to R$4,138.4 million from R$3,971.5 million in 2022, with the cost of sales per hectoliter growing by 0.6% (R$124.2 in 2023 versus R$123.6 in 2022), mainly as result of higher commodity prices with sugar price increase being partially offset by favorable aluminum prices, as well as general inflation impacts.

CAC Operations

Cost of sales for our CAC operations increased by 3.6% in 2023, to R$5,035.1 million from R$4,860.8 million in 2022, with the cost of sales per hectoliter growing by 0.3% (R$413.6 in 2023 versus R$412.4 in 2022), mainly driven by higher import costs, coupled with general inflation, partially offset by lower commodity prices in the second half of the year and better package mix especially due to higher share of returnable glass bottles.

Latin America South Operations

Cost of sales for our Latin America South operations decreased by 22.2% in 2023, to R$6,657.3 million from R$8,553.1 million in 2022, with the cost of sales per hectoliter decreasing by 17.6% (R$184.7 in 2023 versus R$224.3 in 2022). The primary reason for these reductions was the substantial devaluation of the Argentine peso (ARS) in 2023, which lost more than 350% of its value compared to the previous year. This sharp drop in the peso's value had a larger impact than the inflation experienced in Argentina throughout 2023, leading to the significant decreases in production costs.

Canada Operations

Cost of sales for our Canadian operations decreased by 4.4% in 2023, to R$4,083.1 million from R$4,271.4 million in 2022, while the cost of sales per hectoliter increased 2.2% (R$452.4 in 2023 versus R$442.9 in 2022). This increase in cost of sales per hectoliter was primarily due to a higher unit cost, which resulted from lower production and sales volumes.

Gross Profit

As a result of the foregoing, gross profit increased by 2.9% in 2023, to R$40,445.3 million from R$39,286.8 million in 2022. The table below sets forth the contribution of each business segment to our consolidated gross profit:

 

Gross Profit

 

2023

2022

 

Amount

% of Total

Margin

Amount

% of Total

Margin

  (in R$ million, except percentages)
Brazil  22,845.6 56.5% 49%  19,898.9 50.7% 47%
Beer Brazil  19,608.2 48.5% 50% 17,092.5 43.5% 48%
NAB  3,237.4 8.0% 44% 2,806.4 7.1% 41%
CAC  5,009.7 12.4% 50% 4,579.3 11.7% 49%
Latin America South 7,139.9 17.7% 52% 8,818.1 22.4% 51%
Canada

5,450.1

13.5%

57%

5,990.3

15.2%

58%

Total

40,445.3

100.0%

51%

39,286.8

100.0%

49%

Sales, Marketing, Distribution and Administrative Expenses

Our sales, marketing, distribution and administrative expenses decreased by 2.2% in 2023, to R$23,436.7 million from R$23,969.4 in 2022. An analysis of sales and marketing and administrative expenses for each business segment is set forth below.

   
 71 
 

Brazilian Operations

Total sales, marketing, distribution and administrative expenses in Brazil increased by 7.0% in 2023, to R$14,468.8 million from R$13,522.0 million in 2022.

Sales, marketing, distribution and administrative expenses for our Brazilian beer operations increased by 6.4% in 2023, to R$12,247.3 million from R$11,514.2 million in 2022, primarily due to higher investments in our brands, which was partially offset by lower distribution and administrative expenses.

Sales, marketing, distribution and administrative expenses for the NAB segment in Brazil increased by 10.6% in 2023, to R$2,221.5 million from R$2,008.0 million in 2022, primarily due to higher investments in our brands and general inflation impacts in distribution and administrative expenses.

CAC Operations

Sales, marketing, distribution and administrative expenses for our CAC operations decreased by 3.4% in 2023, to R$1,931.2 million from R$1,999.9 million in 2022, mainly due to lower distribution expenses, being partially offset by higher investments in our brands and general inflation impacting administrative expenses.

Latin America South Operations

Sales, marketing, distribution and administrative expenses for our Latin America South operations decreased by 21.7% in 2023, to R$3,463.8 million from R$4,421.4 million in 2022, driven mainly by the substantial devaluation of the Argentine peso (ARS) in 2023, which lost more than 350% of its value compared to the previous year. This sharp drop in the peso's value had a larger impact than the inflation experienced in Argentina throughout 2023, leading to the significant decreases in SG&A expenses

Canada Operations

Sales, marketing, distribution and administrative expenses for our Canadian operations decreased by 11.3% in 2023, to R$3,573.0 million from R$4,026.1 million in 2022, driven mainly by lower distribution expenses resulting from lower volumes and lower investments in our brands.

Other Net Operating Income (Expense)

Other net operating income decreased by 19.3% in 2023, to R$2,028.9 million from R$2,513.9 million in 2022. This result is mainly explained by substantial tax credits recorded in 2022 of an isolated l nature related to the judicial settlement of certain tax matters (for additional information, see “Item 5. Operating and Financial Review and Prospects—A. Operating Results—Tax Credits – 2022/2023—Impact of Tax Credits—Exclusion of ICMS in taxable basis of PIS and COFINS” above, with no comparable event in 2023.

Exceptional Items

Exceptional items expenses increased by 44.0% in 2023, to an expense of R$206.4 million from an expense of R$143.3 million in 2022. The exceptional items recorded in 2023 were mainly due to restructuring expenses primarily linked to centralization and restructuring projects in Brazil, LAS, CAC and Canada, including expenses with lay-offs, severance payments and legal fees in connection with litigation related to warrants issued by Cervejaria Brahma in 2003. Several lawsuits were filed challenging the criteria used in calculating the exercise price of such warrants. In 2023, as successors of Cervejaria Brahma, we obtained definitive favorable decisions against certain plaintiffs on the matter, which was already classified as a remote loss. The amount recorded in this line refers to the provision for attorney fees related to such disputes , while in 2022 our exceptional expenses mainly related to restructuring expenses primarily related to centralization and sizing projects in Brazil and Latin America South.

Income from Operations

As a result of the foregoing, income from operations increased by 6.5% in 2023, to R$18,831.1 million from R$17,687.9 million in 2022.

   
 72 
 

Net Finance Result

Our net finance expense increased by 5.5% in 2023, to an expense of R$3,609.8 million from an expense of R$3,423.2 million in 2022. This result is mainly explained by higher foreign exchange variance costs and lower benefit of hyperinflation from the Argentina operation in the financial results being partially offset by lower carry cost of foreign exchange in Argentina due to lower hedging position throughout 2023 when compared to 2022.

Our total debt, including current and non-current interest-bearing loans and borrowing, decreased by R$269.6 million in 2023, while our cash and cash equivalents and current investment securities less bank overdrafts increased by R$1.029.6 million in 2023.

Income Tax Expense

Our consolidated income tax and social contribution on profits totaled an expense of R$75.5 million in 2023 from R$655.6 million credit in 2022. The effective tax rate in 2023 was 0.5%, compared to a (4.6)% in the previous year. Such increase in our effective tax rate in 2023 was primarily due to an increase on taxation of foreign subsidiaries (worldwide taxation) and withholding taxes, combined with tax effects of a lower interest on shareholders’ equity payout.

Net Income

As a result of the foregoing, net income increased by 0.5% in 2023, to R$14,960.5 million from R$14,891.3 million in 2022.

Year Ended December 31, 2022 Compared to Year Ended December 31, 2021

The table below sets forth certain of our operating highlights for the years presented:

 

Consolidated Financial Highlights

 

2022

2021

% Change

  (in R$ million, except volume amounts,
percentages and per share amounts)
Sales volume—’000 hectoliters 185,749.7 180,368.1 3.0%
Net sales 79,708.8 72,854.3 9.4%
Net revenue per hectoliter—R$/hl 429.1 403.9 6.2%
Cost of sales     (40,422.1)     (35,659.7) 13.4%
Gross profit       39,286.7       37,194.6 5.6%
Gross margin (%) 49.3% 51.1% 180 bps
Sales, marketing and distribution expenses      (18,732.7)         (16,968.2) 10.4%
Administrative expenses        (5,236.8)           (4,877.4) 7.4%
Other operating income/(expenses) net          2,513.9            2,124.1 18.4%
Exceptional items           (143.3)              (392.8)  (63.5%)
Income from operations        17,687.9          17,080.3 3.6%
Operating margin (%) 22.2% 23.4% 120 bps
Net income        14,891.2          13,122.6 13.5%
Net margin (%) 18.7% 18.0% (70 bps)

Margin Analysis

The following table sets forth certain line items of our income statement expressed as percentages of net sales for the years ended December 31, 2022 and 2021:

 

Year Ended December 31,

 

2022

2021

  (%) (%)
Net sales 100.0 100.0
Cost of sales (50.7) (48.9)
Gross profit 49.3 51.1
Sales, marketing and distribution expenses (23.5) (23.3)
Administrative expenses (6.6) (6.7)
Other operating income/(expenses) net 3.2 2.9
Exceptional items (0.2) (0.5)
Income from operations 22.2 23.4

   
 73 
 

Selected Financial Data by Business Segment

The following table sets forth selected financial data by business segment for the years ended December 31, 2022 and 2021:


 

Year Ended December 31,

 

2022

2021

 

Brazil

CAC

LAS

Canada

Total

Brazil

CAC

LAS

Canada

Total

 
  (in R$ million)
Net sales   42,635.7  9,440.1   17,371.2   10,261.7   79,708.8   35,586.5  9,947.4   16,571.7   10,748.7   72,854.3  
Cost of sales

(22,736.8)

(4,860.8)

(8,553.1)

(4,271.4)

(40,422.1)

(18,309.1)

(4,727.9)

(8,235.7)

(4,386.9)

(35,659.7)

 
Gross profit   19,898.9  4,579.3  8,818.1  5,990.3   39,286.8   17,277.4  5,219.5  8,336.0  6,361.7   37,194.6  
Sales, marketing, distribution and administrative expenses  (13,522.0)  (1,999.9)  (4,421.4)  (4,026.1)  (23,969.4)  (11,569.6)  (1,993.7)  (4,385.0)  (3,897.3)  (21,845.6)  
Other operating income/ (expenses)  2,361.4  (52.9)  192.7  12.8  2,513.9  2,096.0  12.4  38.8  (23.1)  2,124.1  
Exceptional items

(34.5)

(16.1)

(60.5)

(32.2)

(143.3)

(210.1)

(46.7)

(115.4)

(20.6)

(392.8)

 
Income from operations

8,703.7

2,510.5

4,528.9

1,944.7

17,687.8

7,593.7

3,191.5

3,874.4

2,420.7

17,080.3

 

Net Sales

Net sales increased by 9.4% in 2022, to R$79,708.8 million from R$72,854.3 million in 2021, as a consequence of a 3.0% increase in volume sold, coupled with a 6.2% increase in net revenue per hectoliter, both driven by the continued execution of our commercial strategy, as shown in tables set forth below:

 

 

Net Sales
Year Ended December 31,

 

2022

2021

 
 

Sales

% of Total

Sales

% of Total

% Change

  (in R$ million, except percentages)
Brazil        42,635.7 53.5%        35,586.5 48.8% 19.8%
Beer Brazil        35,857.8 45.0%        30,537.1 41.9% 17.4%
NAB          6,777.9 8.5%          5,049.4 6.9% 34.2%
CAC          9,440.3 11.8%          9,947.4 13.7%  (5.1%)
Latin America South        17,371.2 21.8%        16,571.7 22.7% 4.8%
Canada

10,261.7

12.9%

10,748.7

14.8%

(4.5%)

Total

79,708.8

100.0%

72,854.3

100.0%

9.4%

               

 

 

Sales Volumes
Year Ended December 31,

 

2022

2021

 
 

Volume

% of Total

Volume

% of Total

% Change

  (in thousands of hectoliters, except percentages)
Brazil      126,184.4 67.9%  119,530.6 66.3% 5.6%
Beer Brazil        94,042.6 50.6%  90,835.0 50.4% 3.5%
NAB        32,141.8 17.3%  28,695.5 15.9% 12.0%
CAC        11,786.3 6.3%  13,401.9 7.4% (12.1%)
Latin America South        38,134.0 20.5%  37,511.6 20.8% 1.7%
Canada

9,645.0

5.2%

9,924.1

5.5%

(2.8%)

Total

185,749.7

100.0%

180,368.1

100.0%

3.0%

 

 

   
 74 
 

 

 

  Net Revenue per Hectoliter
Year Ended December 31,

 

2022

2021

% Change

  (in R$, except percentages)
Brazil            337.9 297.7 13.5%
Beer Brazil            381.3 336.2 13.4%
NAB            210.9 176.0 19.8%
CAC            801.0 742.2 7.9%
Latin America South            455.5 441.8 3.1%
Canada

1,063.9

1,083.1

(1.8%)

Total

429.1

403.9

6.2%

Brazilian Operations

Total net sales from our Brazilian operations increased by 19.8% in 2022, to R$42,635.7 million from R$35,586.5 million in 2021.

Our net sales of beer in Brazil increased by 17.4% in 2022, to R$35,857.8 million from R$30,537.1 million in 2021. This variation is a consequence of a 3.5% increase in volume sold, coupled with a 13.4% increase in net revenue per hectoliter in 2022. We continued to seize the moment and grow volumes by consistently executing our commercial strategy, even after having reached a step change in volumes in the prior couple years. Revenue management initiatives combined with brand mix also led to better levels of net revenue per hectoliter performance.

Our net sales of NAB in Brazil increased by 34.2% in 2022, to R$6,777.9 million from R$5,049.4 million in 2021. This variation is a consequence of a 12.0% increase in volume sold, coupled with a 19.8% increase in net revenue per hectoliter in 2022. The strengthening of out of home consumption occasions throughout the year combined with a solid commercial strategy, and an improved distribution with BEES led to volume growth, while net revenue per hectoliter performance was driven by revenue management initiatives coupled with positive mix of single serve packages and premium brands.

CAC Operations

Net sales from our CAC operations decreased by 5.1% in 2022, to R$9,440.3 million from R$9,947.4 million in 2021. This variation is a consequence of a 12.1% decrease in volume sold, with net revenue per hectoliter growing by 7.9% in 2022. Volume decline was mainly due to supply chain constraints affecting the region in the first half of the year, a weak consumption environment in the second half, while net revenue per hectoliter performance driven by revenue management initiatives and mix was partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian real during the period.

Latin America South Operations

Net sales from our Latin America South operations increased by 4.8% in 2022, to R$17,371.2 million from R$16,571.7 million in 2021, as a consequence of a 1.7% increase in volume sold, coupled with a 3.1% increase in net revenue per hectoliter in 2022. Volume growth was mainly driven by a resilient volume performance in Argentina, and Bolivia recovering from COVID-19 impacts, while net revenue per hectoliter performance was due to the disciplined execution of revenue management initiatives amid a highly inflationary environment especially in Argentina, partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian real during the period.

Canada Operations

Net sales from our Canadian operations decreased by 4.5% in 2022, to R$10,261.7 million from R$10,748.7 million in 2021, as a consequence of a 2.8% decrease in volume sold, coupled with a 1.8% net

   
 75 
 

revenue per hectoliter decrease in 2022. Volume decreased within the context of a weak industry both in beer and beyond beer segments, while positive net revenue per hectoliter performance mainly driven by revenue management initiatives was offset by currency translation impacts as local currency depreciated in relation to the Brazilian real during the period.

Cost of Sales

Cost of sales increased by 13.4% in 2022, to R$40,422.1 million from R$35,659.7 million in 2021. As a percentage of our net sales, total cost of sales increased to 50.7% in 2022 from 48.9% in 2021.

The table below sets forth information on cost of sales per hectoliter for the periods presented:

 

Cost of Sales per Hectoliter
Year Ended December 31,

 

2022

2021

% Change

  (in R$, except percentages)
Brazil            180.2  153.2 17.6%
Beer Brazil            199.5  169.3 17.8%
NAB            123.6  102.0 21.1%
CAC            412.4  352.8 16.9%
Latin America South            224.3  219.6 2.2%
Canada

442.9

442.0

0.2%

Total

217.6

197.7

10.1%

Brazilian Operations

Total cost of sales for our Brazilian operations increased by 24.2% in 2022, to R$22,736.8 million from R$18,309.1 million in 2021. On a per hectoliter basis, our Brazilian operations’ cost of sales increased by 17.6% in 2022, to R$180.2 per hectoliter from R$153.2 per hectoliter in 2021.

Cost of sales for our Brazilian beer operations increased by 22.0% in 2022, to R$18,765.3 million from R$15,382.1 million in 2021, with cost of sales per hectoliter growing by 17.8% (R$199.5 in 2022 versus R$169.3 in 2021), mainly explained by higher commodity prices, driven by metal and agricultural commodities, and general inflation.

Cost of sales for our Brazilian NAB segment increased by 35.7% in 2022, to R$3,971.5 million from R$2,927.1 million in 2021, with the cost of sales per hectoliter growing by 21.1% (R$123.6 in 2022 versus R$102.0 in 2021), mainly as result of higher input costs given increased commodity prices (especially sugar and PET resin), and general inflation and package mix.

CAC Operations

Cost of sales for our CAC operations increased by 2.8% in 2022, to R$4,860.8 million from R$4,727.9 million in 2021, with the cost of sales per hectoliter growing by 16.9% (R$412.4 in 2022 versus R$352.8 in 2021), mainly driven by commodity price increases, coupled with general inflation, specially impacting diesel and ocean freight inflation, partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian real during the period.

Latin America South Operations

Cost of sales for our Latin America South operations increased by 3.9% in 2022, to R$8,553.1 million from R$8,235.7 million in 2021, with the cost of sales per hectoliter growing by 2.2% (R$224.3 in 2022 versus R$219.6 in 2021), mainly due to higher commodity prices and the high overall inflation in Argentina, partially offset by currency translation impacts as local currencies depreciated in relation to the Brazilian real during the period.

   
 76 
 

Canada Operations

Cost of sales for our Canadian operations decreased by 2.6% in 2022, to R$4,271.4 million from R$4,386.9 million in 2021, with the cost of sales per hectoliter increasing 0.2% (R$442.9 in 2022 versus R$442.0 in 2021), due to higher commodity prices, and general inflation, impacting diesel and freight prices, which more than offset by currency translation impacts as local currency depreciated in relation to the Brazilian real during the period.

Gross Profit

As a result of the foregoing, gross profit increased by 5.6% in 2022, to R$39,286.8 million from R$37,194.6 million in 2021. The table below sets forth the contribution of each business segment to our consolidated gross profit:

 

Gross Profit

 

2022

2021

 

Amount

% of Total

Margin

Amount

% of Total

Margin

  (in R$ million, except percentages)
Brazil  19,898.9 50.7% 47%  17,277.4 46.5% 49%
Beer Brazil 17,092.5 43.5% 48%  15,155.1 40.7% 50%
NAB 2,806.4 7.1% 41%  2,122.3 5.7% 42%
CAC 4,579.3 11.7% 49%  5,219.5 14.0% 52%
Latin America South 8,818.1 22.4% 51%  8,336.0 22.4% 50%
Canada

5,990.3

15.2%

58%

6,361.7

17.1%

59%

Total

39,286.8

100.0%

49%

37,194.6

100.0%

51%

Sales, Marketing, Distribution and Administrative Expenses

Our sales, marketing, distribution and administrative expenses increased by 9.7% in 2022, to R$23,969.4 million from R$21,845.6 in 2021. An analysis of sales and marketing and administrative expenses for each business segment is set forth below.

Brazilian Operations

Total sales, marketing, distribution and administrative expenses in Brazil increased by 16.9% in 2022, to R$13,522.0 million from R$11,569.6 million in 2021.

Sales, marketing, distribution and administrative expenses for our Brazilian beer operations increased by 15.4% in 2022, to R$11,514.2 million from R$9,975.4 million in 2021, primarily due to higher investments in our brands and overall inflation over distribution expenses, mainly diesel.

Sales, marketing, distribution and administrative expenses for the NAB segment in Brazil increased by 26.0% in 2022, to R$2,008.0 million from R$1,594.2 million in 2021, mainly due to higher investments in our brands and increased distribution expenses driven by higher volumes and overall inflation.

CAC Operations

Sales, marketing, distribution and administrative expenses for our CAC operations increased by 0.3% in 2022, to R$1,999.9 million from R$1,993.7 million in 2021, mainly due to the effective management of our expenses in the region coupled with currency translation impacts as local currencies depreciated in relation to the Brazilian real during the period more than offsetting increased distribution expenses driven by diesel and ocean freight inflation.

Latin America South Operations

Sales, marketing, distribution and administrative expenses for our Latin America South operations increased by 0.8% in 2022, to R$4,421.4 million from R$4,385.0 million in 2021 driven by overall inflation

   
 77 
 

especially in Argentina, despite effective management of our expenses in the region, partially offset by currency translation impacts as local currency depreciated in relation to the Brazilian real during the period.

Canada Operations

Sales, marketing, distribution and administrative expenses for our Canadian operations increased by 3.3% in 2022, to R$4,026.1 million from R$3,897.3 million in 2021 driven mainly by higher distribution expenses due to diesel and freight inflation, partially offset by currency translation impacts as local currency depreciated in relation to the Brazilian real during the period.

Other Net Operating Income (Expense)

Other net operating income increased by 18.4% in 2022, to R$2,513.9 million from R$2,124.1 million in 2021. This result is mainly explained by a growth of tax incentives related to state long term ICMS Value Added Tax in Brazil.

Exceptional Items

Exceptional items expenses decreased by 63.5% in 2022, to R$(143.3) million from R$(392.8) million in 2021. Similar to 2021, the expenses recorded in 2022 were mainly due to restructuring expenses primarily related to centralization and sizing projects in Brazil and Latin America South.

Income from Operations

As a result of the foregoing, income from operations increased by 3.6% in 2022, to R$17,687.9 million from R$17,080.3 million in 2021.

Net Finance Result

Our net finance result decreased by 6.8% in 2022, to an expense of R$3,423.2 million from an expense of R$3,205.4 million in 2021. This result is mainly explained by an increase in carry costs for Brazil and Argentina as a result of macroeconomic volatility in both countries coupled with higher present value adjustment of accounts payables as per determined in IFRS 13 partially compensated by higher interest income due to increased SELIC rate, as well as higher recognition of monetary update of tax credits in financial results, compared to 2021, mainly related to a 2017 Brazilian Supreme Court decision that declared unconstitutional the inclusion of the ICMS state tax in the tax base of the PIS and the COFINS federal taxes.

Our total debt, including current and non-current interest-bearing loans and borrowing, increased by R$670.2 million in in 2022, while our cash and cash equivalents and current investment securities less bank overdrafts decreased by R$3,205.2 million in 2022.

Income Tax Expense

Our consolidated income tax and social contribution on profits totaled R$(655.6) million in 2022 from R$636.6 million in 2021. The effective tax rate in 2022 was (4.6)%, compared to 4.6% in the previous year. Such decrease in our effective tax rate in 2022 was primarily due to lower withholding taxes and the tax effects of the payment of interest on shareholders’ equity – for further information see “—E. Taxation—Brazilian Tax Considerations—Income Tax—Distributions of Interest on Shareholders’ Equity”.

Net Income

As a result of the foregoing, net income increased by 13.5% in 2022, to R$14,891.3 million from R$13,122.6 million in 2021.

   
 78 
 

B.        Liquidity and Capital Resources

Sources and Uses

The information in this section refers to 2023 and 2022. Our primary sources of liquidity have historically been cash flows from operating activities and borrowings. Our material cash requirements have included the following:

·Opex expenses, such as raw and packaging material, sales & marketing investments and overheads;
·debt service;
·capital expenditures;
·payments of dividends and interest on shareholders’ equity;
·increases in ownership of our consolidated subsidiaries or companies in which we have equity investments;
·investments in businesses participating in the brewing, NAB and malting industries; and
·investments in businesses that address emerging consumer’s needs, such as Future Beverages and technology platforms.

Our cash requirements from known contractual obligations within the next twelve months include:

·Short-term debts and the current portion of long-term debts in the amount of R$182.7 million. For more information see “Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources—Borrowings” and Note 28 to our audited consolidated financial statements;
·Lease liabilities in the amount of R$1,344.0 million. For more information see Note 28 to our audited consolidated financial statements;
·Trade and other payables in the amount of R$27,759.7 million, which include amounts related to suppliers, taxes, fees and contributions payables, dividends and interest on equity payable, salaries and charges, put options related to our participation in subsidiaries and other liabilities, except for related parties, with payment term of less than one year. For more information see Note 28 to our audited consolidated financial statements; and
·Sales tax deferrals in the amount of R$21.1 million. For more information see “Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources—Sales Tax Deferrals and Other Tax Credits” and Note 18 to our audited consolidated financial statements.
·Our long-term cash requirements under our various contractual obligations and commitments include:
·Long-term debt in the amount of R$589.8 million. For more information see “Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources—Borrowings” and Note 28 to our audited consolidated financial statements;
·Lease liabilities in the amount of R$2,129.0 million. For more information see Note 28 to our audited consolidated financial statements;
·Trade and other payables in the amount of R$1,057.4 million. For more information see Note 28 to our audited consolidated financial statements; and
·Sale tax deferrals in the amount of R$1,680.6 million. For more information see “Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources—Sales Tax Deferrals and Other Tax Credits” and Note 18 to our audited consolidated financial statements.
   
 79 
 

Our cash and cash equivalents and current investment securities at December 31,2023 and 2022 were R$16,336.2 million and R$15,380.9 million.

We believe that cash flows from operating activities, available cash and cash equivalents and current investment securities, along with our derivative instruments and our access to borrowing facilities, will be sufficient to fund our capital expenditures, debt service and dividend payments going forward.

Cash Flows

Our financial guidelines focus on maximizing shareholder’s value while keeping financial flexibility to execute strategic projects, key enablers of our future growth. Therefore, our cash management policy pursues constant protection of our short and long-term liquidity while minimizing financials risks and volatility. The continuous search for our optimal capital structure enables us to quickly react to market distress and ensures our solid financial position while working together with our suppliers, wholesalers, customers and credit market.

Year Ended December 31, 2023 Compared to Year Ended December 31, 2022

Operating Activities

Cash flows generated in our operating activities increased by 19.7% in 2023, to R$24,711.4 million from R$20,642.1 million in 2022, mainly as a result of higher operational cashflow generation reflecting efficient net working capital management. Cash flow generated in our operating activities before changes in working capital and provisions increased by 8.6% in 2023 as compared to 2022, bringing additional R$2,069.5 million, and the more efficient net working capital management brought an additional R$2,387.7 million mostly driven by lower inventory level.

Investing Activities

Cash flows used in our investing activities increased by 15.2% in 2023, to R$5,766.0 million from R$5,004.2 million in 2022, mainly explained by lower net proceeds of debt securities (R$1,276.5 million less in 2023) being partially offset by lower acquisition of property, plant, equipment and intangible assets (R$529.0 million).

Financing Activities

Cash flows used in our financing activities decreased by 1.4% in 2023, to R$16,115.2 million from R$16,337.8 million in 2022, mainly driven by higher capital distribution partially offset by lower payments on borrowings.

Year Ended December 31, 2022 Compared to Year Ended December 31, 2021

Operating Activities

Cash flows from our operating activities decreased by 9.9% in 2022, to R$20,642.1 million from R$22,901.3 million in 2021, mainly as a result of bonus and capex payments in the first quarter and lower cash generation in CAC and Canada.

Investing Activities

Cash flows used in our investing activities decreased by 35.3% in 2022, to R$5,004.2 million from R$7,735.0 million in 2021, mainly explained by a decrease in intangible and fixed assets acquisitions.

Financing Activities

Cash flows used in our financing activities increased by 1.8% in 2022, to R$16,337.8 million from R$16,042.0 million cash outflow in 2021, mainly driven by higher capital distribution partially offset by lower payments from borrowings.

The table below shows the profile of our debt instruments:

   
 80 
 

 

 

Maturity Schedule of Debt Portfolio as of December 31, 2023

Debt Instrument

2024

2025

2026

2027

2028

Thereafter

Total

  (in R$ million, except percentages)
BNDES + FINEP Currency Basket Debt Fixed Rate:              
Currency Basket Debt Fixed Rate   - - - - - -
UMBNDES + Average Pay Rate - - - - - - -
International Debt:              
Other Latin America Currency Floating Rate - - - - - - -
Average Pay Rate - - - - - - -
Other Latin America Currency Fixed Rate 124.6 144.8 38.9 36.1 61.2 0.0 405.6
Average Pay Rate 11.5% 11.5% 11.5% 11.5% 11.5% -        
US$ Fixed Rate - - - - - - -
Average Pay Rate - -       -       -       -       -        
US$ Floating Rate - - - - - - -
Average Pay Rate - - - - - - -
CAD Fixed Rate 130.1     125.6     101.0     93.5     30.1     -       480.3    
Average Pay Rate 5.6% 5.6% 5.6% 5.6% 5.6% -        
CAD Floating Rate - - - - - - -
Average Pay Rate - - - - - - -
Reais Denominated Debt Floating Rate –TR:              
Notional Amount 13.4 14.7 16.1 17.6 19.2 44.1 125.1
TR + Average Pay Rate 9.5% 9.5% 9.5% 9.5% 9.5% 9.5%  
Reais Debt – ICMS Fixed Rate:              
Notional Amount 136.3 151.5 114.8 4.1 -0.4 9.3 415.7
Average Pay Rate 4.0% 4.0% 4.0% 4.0% 4.0% 4.0%  
Reais Debt –Fixed Rate:              
Notional Amount 892.5 469.5 290.8 203.0 96.4 121.1 2,073.3
Average Pay Rate 11.2% 11.2% 11.2% 11.2% 11.2%    
Reais Debt – Floating Rate:              
Notional Amount 1.2 -       -       -       -       -       1.2
Average Pay Rate

3.7%

-

-

-

-

-

-

Total Debt

1,298.1

906.1

561.6

354.4

206.6

174.5

3,501.1

Borrowings

Most of our borrowings are for general use, based upon strategic capital structure considerations. Although seasonal factors affect the business, they have little effect on our borrowing requirements. We accrue interest based on different interest rates, the most significant of which are: (1) fixed for loans of the Brazilian Economic and Social Development Bank (Banco Nacional de Desenvolvimento Econômico e Social), or the BNDES; (2) the Interest Rate Benchmark (Taxa Referencial), or TR, for Brazilian real estate receivables certificates (certificado de recebíveis imobiliários) and (3) fixed for international loans. For further information, see Note 23 of our audited consolidated financial statements.

The following table sets forth our net cash consolidated position as of December 31, 2023 and 2022:

   
 81 
 

 

 

Net Cash Consolidated Position
As of December 31

 

2023

2022

 

LC(1)

FC(2)

Total

LC(1)

FC(2)

Total

  (in R$ million)
Short-term debt  (1,043.4) (254.7)  (1,298.1) (754.3) (228.2) (982.6)
Long-term debt

(1,571.8)

(631.2)

(2,203.0)

(2,077.9)

(710.3)

(2,788.1)

Total

(2,615.2)

(885.9)

(3,501.1)

(2,832.2)

(938.5)

(3,770.7)

Cash and cash equivalents (net of bank overdrafts)     16,059.0     14,852.1
Current Investment securities    

277.2

   

454.5

Net cash position    

12,835.1

   

11,535.9

 
(1)LC refers to our local currency indebtedness.
(2)FC refers to our foreign currency indebtedness.

Short-term Debt

As of December 31, 2023, our short-term debt totaled R$1,298.1 million, 19.6% of which was denominated in foreign currencies. As of December 31, 2022, our short-term debt totaled R$982.6 million, 23.2% of which was denominated in foreign currencies.

Long-term Debt

As of December 31, 2023, our long-term debt totaled R$2,203.0 million, 28.7% of which was denominated in foreign currencies. As of December 31, 2022, our long-term debt, excluding the current portion of long-term debt, totaled R$2,788.1 million, of which R$2,077.9 million was denominated in local currency.

The table below shows a breakdown of our long-term debt by year:

 

As of December 31, 2023

Long-term Debt Maturity in: (in R$
million)
2025 648.0
2026 603.3
2027 and Later

951.6

Total

2,203.0

In accordance with our foreign currency risk management policy, we have entered into forward and cross-currency interest rate swap contracts in order to mitigate currency and interest rate risks. See “Item 11. Quantitative and Qualitative Disclosures About Market Risk” for our policy with respect to mitigating foreign currency and interest rate risks through the use of financial instruments and derivatives.

As of December 31, 2023, our local currency long-term debt borrowings consisted primarily of lease liabilities (in accordance with IFRS 16) and loans from governmental agencies and BNDES. Long-term local currency also includes long-term plant expansion and other loans from governmental agencies and special BNDES credit lines and programs, such as the Fund for Financing the Acquisition of Industrial Machinery and Equipment (FINAME), the Enterprise Financing Program (FINEM) and leasing of furniture, vehicles, machinery and equipment.

Secured Debt

Certain loans provided by the BNDES are secured by some of our facilities and some of our equipment (mainly coolers).

Surety Bonds

   
 82 
 

In the ordinary course of our business, we use surety bonds, letters of credit and similar financial instruments (e.g., bank products known as fiança bancária and/or seguro-garantia) to secure (i) the performance or payment of obligations under certain agreements and (ii) potential losses in connection with lawsuits. In case we are unable to obtain or renew these financial instruments under favorable conditions, or at all, we would be required to use our own cash to secure those agreements and lawsuits, which could adversely affect our liquidity position. For additional information on legal proceedings, see Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Legal Proceedings.

Sales Tax Deferrals and Other Tax Credits

Many states in Brazil offer tax benefits programs to attract investments to their regions. We participate in ICMS Value-Added Tax Credit Programs offered by various Brazilian states which may be in the form of rate reduction, calculation basis reduction, financing or subsidized loans, presumed credits, effective collection, payment deferral or partial reductions of state tax payable. In return, we are required to meet certain operational requirements including, depending on the state, production volume and employment targets, among others. All of these conditions are included in specific agreements between Ambev and the state governments. In the event that we do not meet the program’s targets, benefits may be withdrawn. The total amount deferred (financing) as of December 31, 2023 was R$415.6 million with a current portion of R$136,2 million, and R$279.4 million as non-current. Percentages deferred typically range from 25% to 75% over the life of the program. Balances deferred generally accrue interest and are partially inflation indexed, with adjustments generally set at 60% to 75% of a general price index. The grants (tax waivers) are received over the lives of the respective programs. In the years ended December 31, 2023 and 2022, we recorded R$3,040.4 million and R$2,535.1 million, respectively, of tax credits as gains on tax incentive programs.

The approved Brazilian tax reform provides that the currently applicable ICMS benefits will be maintained up to 2032, as long as they have been approved through a CONFAZ Agreement and have been validated according to the provisions of Supplementary Law 160/2017. Therefore, current ICMS benefits will no longer apply from 2033 onwards.

Capital Investment Program

In 2023, consolidated capital expenditures on property, plant and equipment and intangible assets totaled R$6,004.1 million, consisting of R$3,365.5 million for our Brazil business segment, R$593.4 million for our CAC business segment, R$782.2 million related to investments in our Latin America South operations and R$1,263.0 million related to investments in Canada. These expenditures primarily included investments in capacity expansion, quality controls, automation, modernization and replacement of packaging lines, innovations, warehousing for direct distribution, coolers, expenditures for the replacement of bottles and crates, and continued investments in information technology.

In 2022, consolidated capital expenditures on property, plant and equipment and intangible assets totaled R$6,533.1 million, consisting of R$4,062.9 million for our Brazil business segment, R$968.4 million for our CAC business segment, R$1,112.8 million related to investments in our Latin America South operations and R$389.0 million related to investments in Canada. These expenditures primarily included investments in capacity expansion, quality controls, automation, modernization and replacement of packaging lines, innovations, warehousing for direct distribution, coolers, expenditures for the replacement of bottles and crates, and continued investments in information technology.

In 2021, consolidated capital expenditures on property, plant and equipment and intangible assets totaled R$7,677.1 million consisting of R$4,645.2 million for our Brazil business segment, R$801.6 million for our CAC business segment, R$1,665.4 million related to investments in our Latin America South operations and R$564.9 million related to investments in Canada. These expenditures primarily included investments in capacity expansion, quality controls, automation, modernization and replacement of packaging lines, innovations, warehousing for direct distribution, coolers, expenditures for the replacement of bottles and crates, market assets from former dealers, and continued investments in information technology.

C.        Research and Development

Although the COVID-19 pandemic created significant challenges for our business during the most acute stages of the pandemic, it also accelerated consumer trends that we had been investing in, particularly reinforcing the need for an innovative, consumer-centric mindset and advancing our business transformation enabled by technology. Innovation has become one of the main pillars of our business and front and center to our commercial strategy and despite a detailed revision of our discretionary expenses in order to ensure our liquidity, research and development is and continued to be seen as fundamental for us to continue providing our consumers with innovations.

   
 83 
 

We maintain an innovation, research and development center in the city of Rio de Janeiro, State of Rio de Janeiro, at the Universidade Federal do Rio de Janeiro (UFRJ). This center (ZITEC – Zone Innovation and Technology Center) commenced operations in the final months of 2017. One of the main features of the development center is the prototype laboratory, which enables the creation of complete prototypes, supporting the process of creating new products. Another objective of the development center is to carry out studies of consumers’ perception and behavior, in order to capture future trends. ZITEC made it possible for Ambev to reduce the time to launch innovations, from eight to four months.

In 2021, we continued to expand our assortment with the launch of Michelob Ultra and Spaten in Brazil, a Munich Helles style, pure-malt beer. In 2022, two of our main innovations were Budweiser Zero, which was recognized as the best non-alcoholic beer on the Brazilian market by the newspaper “O Estado de São Paulo”, and Caipi Beats, a new member of Beats family with caipirinha (a popular Brazilian drink) flavor and made with cachaça. As for innovations in packaging, we developed the exclusive KEG 5L technology, which was awarded the Best Packaging Technology in 2022 by ABRE (Associação Brasileira de Embalagem), reinforcing our commitment to Sustainability.

In 2023 we launched a new version within our Beats line, the Beats Tropical, which has demonstrated strong results since its launch and continued as a popular choice during the 2024 carnival holiday in Brazil. . In the non-alcoholic category, we reformulated Guaraná Zero and launched the first non-alcoholic beer with added vitamin D in the world, Corona Sunbrew. We also introduced in 2023 Stella Pure Gold, our low-calorie gluten-free beer, which performed strongly. Our investment in innovation, research and development contributed to our brands winning 140 medals in various beer competitions around the world, including gold medals for Brahma Duplo Malt at the World Beer Awards and Antarctica Original at the Brussels Beer Challenge competition.

The investment made in the development center in the last three years was approximately R$91.8 million, including the R$11.0 million in 2021, R$36.0 million in 2022 and R$44.8 million in 2023.

D.        Trend Information

Consistent with 2023, our strategy for 2024 will continue to be built around our brands, innovation, technology and collaboration with our ecosystem.

We are implementing a new version of our main ERP System - S4 Hana, a SAP platform- which will help us book all the transactional data used in our Brazilian operations, which, if not successful, may subject us to adverse effects, increased costs associated with diminished productivity and operating inefficiencies. For further information on risks related to modifications and upgrades to our systems, see “Item 3. Key Information—Risk Factors—Information technology failures, including failures to implement upgrades and new technologies effectively or those that affect the privacy and security of sensitive customer and business information, could disrupt our operations.”

Also, in terms of costs, although input cost pressure remains a headwind, we faced less pressure in 2023 than in previous with our average BRL/USD hedge rate for 2023 at 5.09, and aluminum hedge as a tailwind. In 2024 we expect to face less pressure than in 2023, with our average BRL/USD hedge rate for 2024 at 4.97.

For detailed information regarding the latest trends in our business, see “—A. Operating Results—Year Ended December 31, 2023 Compared to Year Ended December 31, 2022” and “Item 4. Information on the Company—B. Business Overview—Description of the Markets Where We Operate.”

   
 84 
 

E.        Critical Accounting Estimates

Our audited consolidated financial statements are presented in accordance with IFRS, as issued by the IASB. The preparation of financial statements in conformity with IFRS requires our management to make judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and associated assumptions are based on past experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for decision making regarding the judgments about carrying amounts of assets and liabilities that are not readily evident from other sources. Actual results may differ from these estimates. Note 4 to our audited consolidated financial statements include a summary of the critical accounting policies and estimates applied in the preparation of these financial statements. The estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the period in which they are realized, or future periods.

   
 85 
 

 

ITEM 6.DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES

A.        Directors and Senior Management

The Board of Directors oversees Ambev’s executive officers. The Board of Directors is currently comprised of eleven effective members and two alternate members and provides the overall strategic direction of Ambev. Directors are elected at general shareholders’ meetings for a three-year term, re-election being permitted. Day-to-day management is delegated to the executive officers of Ambev, of which there are currently thirteen, including the chief executive officer. The Board of Directors appoints executive officers for a three-year term, re-election being permitted. The Shareholders’ Agreement regulates the election of directors of Ambev. See “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev’s Major Shareholders—The Shareholders’ Agreement—Management of Ambev.”

Directors

The following table sets forth information with respect to the current directors of Ambev:

Board of Directors(1)

Name

Age

Position

Director Since

Term Expires

Michel Dimitrios Doukeris 50 Chairman and Director 2018 2026
Victorio Carlos De Marchi 85 Director 1999 2026
Milton Seligman 72 Director 2018 2026
Carlos Eduardo Klutzenschell Lisboa 54 Director 2018 2026
Fabio Colletti Barbosa 69 Director 2021 2026
Fernando Mommensohn Tennenbaum 47 Director 2021 2026
Lia Machado de Matos 46 Director 2021 2026
Nelson José Jamel 51 Director 2017 2026
Luciana Pires Dias 48 Director (Independent) 2023 2026
Marcos de Barros Lisboa(2) 59 Director (Lead Independent) 2014 2026
Claudia Quintella Woods 48 Director (Independent) 2021 2026
 
(1)Michel Dimitrios Doukeris, Chairman of the Board of Directors of Ambev, was appointed by ABI and is also the Chief Executive Officer of ABI. ABI appointed five other directors: Milton Seligman, Nelson José Jamel, Fernando Mommensohn Tennenbaum, Lia Machado de Matos and Carlos Eduardo Klutzenschell Lisboa. FAHZ, the former controlling shareholder of Antarctica, appointed Victorio Carlos De Marchi and Fabio Colletti Barbosa. The three independent directors Luciana Pires Dias, Marcos de Barros Lisboa and Claudia Quintella Woods were also appointed by ABI. Directors first elected to our board of directors prior to 2013 were originally appointed as directors of Old Ambev. Directors first elected to our Board of Directors on or after 2013 were originally elected as directors of Ambev S.A.
(2)In its capacity as Lead Independent Member Marco de Barros Lisboa exercises the role of a representative of the independent members of the Board of Directors, being an important point of contact between the Board of Directors and the external investors.

The following are brief biographies of each member of Ambev’s Board of Directors:

Michel Dimitrios Doukeris. Mr. Doukeris is the chairman of the Board of Directors of Ambev. Mr. Doukeris is ABI’s CEO since July, 1 2021. Mr. Doukeris joined ABI in 1996 and held various commercial operations roles in Latin America before moving to Asia where he led ABI’s China and Asia Pacific operations for seven years. In 2016 he moved to the United States to assume the position of global Chief Sales Officer. In January 2018 he assumed the leadership of the North American business. Mr. Doukeris holds a degree in chemical engineering from Universidade Federal Santa Catarina in Brazil and a master’s degree in marketing from Fundação Getulio Vargas also in Brazil. He has also completed post-graduate programs in marketing and marketing strategy from the Kellogg School of Management and Wharton Business School in the United States.

Victorio Carlos De Marchi. Mr. De Marchi is a member of the Board of Directors of Ambev. He also serves as president of the Operations and Finance Committee, the Governance Committee and the People Committee of Ambev. Mr. De Marchi joined Antarctica in 1961 and held various positions during his tenure, including Chief Executive Officer from 1998 to April 2000. Mr. De Marchi is currently the President of Fundação Antônio e Helena Zerrenner – FAHZ. In 2023, Mr. De Marchi was bestowed with the honorary title of Chairman Emeritus of the Board in recognition of his invaluable contribution and respected role as former co-chairman of our Board of Directors (noting that such title does not grant any specific authority to its grantee).

   
 86 
 

Mr. De Marchi was a member of the board of Instituto de Estudos para o Desenvolvimento Industrial, an alternate member of the board of directors of Itausa S.A. and a member of the deliberative council of Instituto Brasileiro de Ética Concorrencial – ETCO. Mr. De Marchi has a degree in economics from Faculdade de Economia, Finanças e Administração de São Paulo and a law degree from Faculdade de Direito de São Bernardo do Campo.

Milton Seligman. Mr. Seligman is a member of the Board of Directors of Ambev. He served as Ambev’s Corporate Affairs Officer from 2001 to 2013 and held positions on the board of directors of Tenedora CND S.A. from 2013 to 2016 and BRMalls Participações S.A. from 2022 to 2023 before the company’s merger. Mr. Seligman has contributed significantly to the public sector in Brazil, serving in various roles during the presidencies of José Sarney and Fernando Henrique Cardoso, including as Executive Secretary and Minister of Justice, and Executive Secretary of the Ministry of Development, Industry, and International Trade, among others. Currently, he is the managing partner of Milton Seligman e Associados Consultoria e Participações Ltda. Additionally, Mr. Seligman actively holds various roles including president of the board of directors of Instituto Sonho Grande - a non-profit Brazilian institute, consultant member of Fundação Lemann – a philanthropic organization, member of the board of directors of FAHZ, fellow of the INSPER Management and Public Policy Center, and Global Fellow of the Brazil Institute at the Woodrow Wilson International Center for Scholars in Washington D.C. He holds a degree in electrical engineering from Universidade Federal de Santa Maria.

Carlos Eduardo Klutzenschell Lisboa. Mr. Klutzenschell Lisboa is a member of the Board of Directors of Ambev. Mr. Klutzenschell Lisboa is ABI’s Zone President of Middle Americas since January 2019. He joined the Company in 1993 and, since then, has held several positions in the Company. He served as Ambev’s Marketing Vice-President between 2005 and 2011, as President of BU Austral at Latin America South Zone of Ambev between 2011 and 2012, and as President of Labatt, our subsidiary in Canada, between 2013 and 2014. Mr. Klutzenschell Lisboa held the positions of Global Vice President for Global Brands at ABI, between 2014 and 2016, Zone President of Latin America South Zone of Ambev, between 2016 and 2018.Fabio Colletti Barbosa. Mr. Barbosa is a member of the Board of Directors and the Governance Committee of Ambev. Mr. Barbosa is currently Natura&Co Holding S.A. CEO and a member of the board of directors of Itaú-Unibanco, Cia Brasileira de Metalurgia e Mineração (CBMM), the United Nations Foundation, and the Public Leadership Center in Brazil (CLP). Mr. Barbosa was the former CEO of Banco ABN Amro Real, Banco Santander (Brasil) S.A., Abril Media and Febraban. Mr. Barbosa holds a degree in business administration from Fundação Getulio Vargas and a MBA from the Institute for Management Development (Switzerland).

Fernando M. Tennenbaum. Mr. Tennenbaum is a member of the Board of Directors and of the Operations and Finance Committee of Ambev. Mr. Tennenbaum is ABI’s Chief Financial Officer since April 29, 2020. He joined our Company in 2004 and has held various roles in the finance function including Treasury, Investor Relations and M&A. He most recently served as the Vice President of Finance for ABI’s South America Zone and Ambev’s Chief Financial and Investor Relations Officer. He is a dual citizen of Brazil and Germany and holds a degree in industrial engineering from Escola Politécnica da Universidade de São Paulo.

Lia Machado de Matos. Ms. Matos is a member of the Board of Directors of Ambev. Since 2016 she is the Chief Strategy and Marketing Officer of Stone Co. Prior to that, Ms. Matos was a Family Office Director for Varbra from 2012 through 2016 and previously she served in several positions at McKinsey Consulting Company from 2006 through 2012, including Associate Partner. Ms. Matos holds a degree in Physics from the Universidade Federal do Rio de Janeiro and a PhD in Physics from the Massachusetts Institute of Technology and is a specialist in information security.

Nelson José Jamel. Mr. Jamel is a member of the Board of Directors and the People Committee of Ambev. He joined the Company in 1997 and has held various positions in the Company. From 2009 to 2015, he served as Chief Financial and Investor Relations Officer of the Company. From 2016 to 2019, he served as Vice President for ABI’s North America Zone, initially as Finance Vice President and since 2017 as Finance and Solutions Vice President. He currently serves as the Chief People Officer of ABI, a position he was appointed to in 2020.  Mr. Jamel holds a degree in production engineering from Universidade Federal do Rio de Janeiro and a M.Sc in production engineering from the Universidade Federal do Rio de Janeiro.

Luciana Pires Dias. Ms. Dias is an independent member of the Board of Directors, a Professor at Getúlio Vargas Foundation Law School and a partner at L|Dias Advogados. She is also member of the audit

   
 87 
 

committee of Itaú Unibanco Holding S.A. She was a commissioner and the head of the market development department at the Brazilian Securities and Exchange Comission (Comissão de Valores Mobiliários – CVM). She was the CVM representative at the Corporate Governance Committee of the OECD and at the Latin American Corporate Governance Roundtable organized by OECD. Ms. Luciana Pires Dias holds a PhD and master’s degree in commercial law from Faculdade de Direito da Universidade de São Paulo – USP. She also holds a master of the science of law degree (J.S.M) from Stanford University and has a bachelor’s in law from USP.

Marcos de Barros Lisboa. Mr. Barros Lisboa is the lead independent member of the Board of Directors, and a member of the Governance Committee and of the Operations and Finance Committee of Ambev. He has also acted as an executive officer of Unibanco S.A and vice-president of Operational Insurance, Controls and Support of Itaú Unibanco S.A, both companies with main activities in the financial segment. Further, during 2005 and 2006 he was the president of Instituto Brasil Resseguros S.A, between 2003 and 2005, he acted as Secretary of Economic Politics of Federal Revenue Office (Ministério da Fazenda). He is currently a member of the board of directors of Cerradinho Bioenergia S.A., CERC - Central de Recebíveis S.A. and Meliuz. Mr. Barros Lisboa has a degree and a masters’ degree in economics from Universidade Federal do Rio de Janeiro and a Ph.D. in economics from the University of Pennsylvania. Since the end of the 80s, he has developed activities in the faculty of several teaching institutions in Brazil and abroad.

Claudia Quintella Woods. Ms. Woods is an independent member of the Board of Directors and a member of the People Committee of Ambev. She is Latin America Chief Executive Officer of WeWork since June 2021. Ms. Woods was previously the General Manager of Uber in Brazil between 2019 and 2021, the CEO of Webmotors, a leading online marketplace for cars from 2018 until 2019 and Director and Superintendent of Banco Original from 2014 to 2018. She holds a bachelor’s degree from Bowdoin College (USA), an MBA from COPPEAD/Universidade Federal do Rio de Janeiro and a certificate from Harvard Business School. Executive Officers.

Officers

The following table sets forth information with respect to the current executive officers of Ambev:

Name

Age

Position

Executive Officer Since

Term Expires(1)

Jean Jereissati Neto 49 Chief Executive Officer 2020 2024
Lucas Machado Lira 47 Chief Financial, Investor Relations and Shared Services Officer 2020 2024
Leticia Rudge Barbosa Kina 47 Legal and Compliance Vice President Officer 2019 2024
Ricardo Morais Pereira de Melo 52 People and Management Vice President Officer 2018 2024
Eduardo Braga Cavalcanti de Lacerda 47 Commercial Vice President Officer 2020 2024
Valdecir Duarte 43 Industrial Vice President Officer 2022 2024
Paulo André Zagman 47 Logistics Vice President Officer 2019 2024
Carla Smith de Vasconcellos Crippa Prado 42 Corporate Affairs Vice President Officer 2022 2024
Felipe Moreira Haddad Baruque 41 Procurement Vice President Officer 2023 2024
Eduardo Eiji Horai 38 Information Technology Vice President Officer 2020 2024
João Coelho Rua Derbli de Carvalho 41 Sales Vice President Officer 2023 2024
Daniel Wakswaser Cordeiro 39 Marketing Vice President Officer 2020 2024
Daniela Gavranic Cachich 50 Non-Alcoholic Beverages and Future Beverages Vice President Officer 2022 2024
 
(1)The term of office will be unified until December 31, 2024.

The following are brief biographies of each of Ambev’s executive officers:

Jean Jereissati Neto. Mr. Jereissati is Ambev’s CEO. He joined Ambev in 1998 and has held various positions at Ambev and ABI, including Chief Executive Officer of the Central America and Caribbean business

   
 88 
 

unit of Ambev, Chief Executive Officer of China’s operations of ABI, Chief Executive Officer of Asia and Pacific North Zone of ABI and Chief Sales and Marketing Officer of Ambev. Mr. Jereissati holds a degree in business administration from Fundação Getulio Vargas and a Corporate MBA from Ambev.

Lucas Machado Lira. Mr. Lira is Ambev’s Chief Financial, Investor Relations and Shared Services Officer, an area which includes the Company’s accounting matters and processes. He joined the Company in 2005 and, since then, has held leadership positions in different functions, including Head of Investor Relations, Supply Chain PMO, Corporate & Compliance Director, and Legal Manager for HILA and M&A at Ambev, as well as Global Finance Vice President for M&A, Global Legal Vice President Commercial/M&A and Global Finance Director for M&A at ABI. Mr. Lira holds a degree in law from Universidade Federal de Minas Gerais – UFMG and an LL.M. from Columbia University School of Law.

Leticia Rudge Barbosa Kina. Ms. Kina is Ambev’s Legal and Compliance Vice President Officer. She joined the Company in 2002 and has held several positions, including Legal Tax Manager and Corporate and Litigation Officer. Ms. Kina is also a member of the Board of Directors of WILL – Women in Leadership in Latin America, an international non-profit organization. Ms. Kina holds a law degree from Pontifícia Universidade Católica de Campinas and a degree in economics from Universidade Estadual de Campinas, in addition to a Corporate MBA from Ambev, a specialization in tax law from Universidade de São Paulo and a corporate reputation course from Stanford University.

Ricardo Morais Pereira de Melo. Mr. Melo is Ambev’s People and Management Vice President Officer. Since he joined the Company in 1996, he has held various positions in the sales department, including Commercial Manager in Recife, Salvador and São Paulo, Regional Sales Director in the Northeast and Rio de Janeiro regions. Mr. Melo was also the Vice President of Sales at Labatt, Ambev’s subsidiary in Canada, and Vice President of Sales Strategy at ABI, in the United States and Sales Vice President in Brazil before current position. Mr. Melo holds a degree in civil engineering from Universidade Católica de Pernambuco and a Corporate MBA from Ambev.

Eduardo Braga Cavalcanti de Lacerda. Mr. Lacerda is Ambev’s Commercial Vice President Officer. Since 2001, when he joined the Company, he has held various positions, including Non-Alcoholic Vice President Officer for Ambev, Chief Executive Officer for CAC business unit of Ambev, Financial Vice President Officer in Europe for ABI, FP&A Global Vice President for ABI and head of M&A in Europe for ABI. Mr. Lacerda holds a degree in engineering from Pontifícia Universidade Católica do Rio de Janeiro.

Valdecir Duarte. Mr. Duarte is Ambev’s Industrial Vice President Officer. Since he joined the Company in 1998, Mr. Duarte has held several positions, including Director of the Company’s Engineering Center (CENG), Regional Director and Plant and Supply Chain Manager. Mr. Duarte holds a degree in engineering and a postgraduate degree in Global Business from Columbia Business School, in Corporate Management from INSPER and an Executive Program for Growing Companies from Stanford University.

Paulo André Zagman. Mr. Zagman is Ambev’s Logistics Vice President Officer. Since 2002, when he joined the Company, he has held several positions, including Chief People Officer and Chief Logistics Officer in Latin America South zone of Ambev. Mr. Zagman holds a degree in civil engineering from Pontifícia Universidade Católica do Rio de Janeiro and a specialist degree in supply chain and logistics from Massachusetts Institute of Technology and Stanford Graduate School of Business Executive Education.

Carla Smith de Vasconcellos Crippa Prado. Ms. Prado is Ambev’s Corporate Affairs Vice President Officer. In the last 5 years, she has held several positions in the Company, including Corporate Affairs Vice President of BU Brazil, Director of Communications and Sustainability, Social Responsibility Manager and Legal Manager. Between 2020 and 2021 she was President of SINDICERV-National Union of the Beer Industry. She holds a Law degree from Pontifícia Universidade Católica de São Paulo and an Economics degree from the Universidade de São Paulo, in addition to a Masters in Law from Pontifícia Universidade Católica de São Paulo and a Corporate MBA from Insper.

Felipe Moreira Haddad Baruque. Mr. Baruque is Ambev’s Procurement Vice President Officer. Since 2006, when he joined the Company, he has held various positions in the Procurement and Supply areas at Ambev and ABI, including Director of New Products for the South America zone, Director of Product Development at Latin America North zone, Global Vice President of Verticalized Operations and Global Vice President of Procurement at ABI. He holds a degree in Food Science from the University of São Paulo, major

   
 89 
 

in Packaging Engineering, completed an executive MBA program at INSPER and has an MBA in Finance and Marketing from Fundação Getúlio Vargas.

Eduardo Eiji Horai. Mr. Horai is Ambev’s Information Technology Vice President Officer. Before joining the Company on January 1, 2020, he served as Technology, Solutions Architecture and Customer Solutions Director and officer for Latin America at Amazon Web Services and was also part of the Enterprise Architecture department at Toyota Motor Europe in Belgium. Mr. Horai holds a degree in computer science from Universidade de Campinas – UNICAMP and a degree in Innovation and Entrepreneurship from the Vlerick Leuven-Gent Management School.

João Coelho Rua Derbli de Carvalho. Mr. Rua is Ambev’s Sales Vice President Officer. Since 2006, when he joined the Company, he has held several positions, including Regional Sales Director in Rio de Janeiro and Espírito Santo, Trade Marketing Director and Regional Head of Marketing. Mr. Rua is a Brazilian and Portuguese citizen, holds a degree in business administration from the Federal University of Rio de Janeiro and holds a Corporate MBA from Ambev.

Daniel Wakswaser Cordeiro. Mr. Wakswaser is Ambev’s Marketing Vice President Officer. He joined the Company as a trainee in 2008 and has held various positions in Ambev and ABI. Mr. Wakswaser created and led the digital strategy area at Ambev at the start of 2010. He led the acquisition and integration of breweries Colorado and Wäls in Brazil. In recent years, he held leadership roles in Brazil, Europe and the United States, including Craft Beer Director in Brazil & Europe, Global Vice President of Adjacencies for ABI, Global Marketing Vice President of Consumer Connections & Capabilities for ABI. Mr. Wakswaser holds a degree in marketing from Escola Superior de Propaganda e Marketing – ESPM.

Daniela Gavranic Cachich. Ms. Cachich is Ambev’s Non-Alcoholic Beverages and Future Beverages Vice President Officer. Before joining the Company, she held senior leadership positions in the marketing area of other consumer goods companies, including Chief Marketing Officer at PepsiCo from 2016 to August 2021. Also, she currently holds the position of effective member of the Advisory Board of Grupo Boticário. Ms. Cachich holds a degree in Business Administration from Universidade Mackenzie and a postgraduate degree in Marketing from Escola Superior de Propaganda e Marketing – ESPM.

B.        Compensation

The aggregate remuneration of all members of the Board of Directors, Executive Officers and Fiscal Council of Ambev in 2023 for services in all capacities amounted to R$150.0 million (fixed and variable remuneration, benefits and share-based payment, among other categories), as presented below:

 

Management’s Remuneration
Year Ended December 31, 2023

  (in R$ million, except where otherwise indicated)
   

Fixed Remuneration

Variable Remuneration

       
 

Number of Members (i)

Fees

Direct and Indirect Benefits

Remuneration

for

Sitting on Committees

Others

(ii)

Bonus

Profit Sharing

Remuneration for Attending Meetings

Commissions

Others

Post-Employment Benefits

Termination Benefits

Share-based Payment

Total

Board of Directors 7.3 8.1 - - 2.2 1.2 - - - - - - 9.5 20.9
Fiscal Council

 6.0

2.1 - - 0.4 - - - - - - - - 2.6
Executive Officers

13.5

19.9

0.6

-

12.3

20.9

-

-

-

-

1.4

-

71.4

126.5

Total

26.8

30.2

0.6

-

14.9

22.0

-

-

-

-

1.4

-

80.9

150.0

                             
(i)The total number of Board of Directors members in 2023 was 12.67, with 7.33 being the number of members compensated by the Company for their service in the position;
(ii)Others refers to the amounts related to social security charges that are Company's recognized for the 2023 fiscal year.

In addition, the executive officers and certain members of the Board of Directors received some additional benefits provided to all Ambev employees and their beneficiaries and covered dependents, such as health and dental care. Such benefits were provided through FAHZ. These executive officers and certain directors also received benefits pursuant to Ambev’s pension and stock ownership plans. For a description of these plans, see Notes 24 and 25 to our audited consolidated financial statements.

   
 90 
 

The table below sets forth the minimum, maximum and average individual compensation figures attributable to our directors, executive officers and Fiscal Council members for each of the indicated periods:

 

Management’s Remuneration

Year Ended December 31,

 

2023

2022

2021

  (in R$ million, except where otherwise indicated)
 

No. of Members (i)

Min.

Average

Max.

No. of Members

Min.

Average

Max.

No. of Members

Min.

Average

Max.

Board of Directors 7.3 1.0 2.9 14.2 8.0 0.8 2.7 15.1 8.5 0.6 2.0 8.8
Fiscal Council 6.0 0.3 0.4 0.6 6.0 0.3 0.4 0.5 6.0 0.2 0.3 0.5
Executive Officers 13.5 5.1 9.4 34.5 14.0 3.7 7.2 26.6 13.0 2.7 6.4 23.7
                         

(i)        The total number of Board of Directors members in 2023 was 12.67, with 7.33 being the number of members compensated by the Company for their service in the position

Ambev Stock Ownership Plans

Under the Ambev Stock Option Plan dated as of July 30, 2013, or the Plan, senior employees and management of either Ambev or its direct or indirect subsidiaries are eligible to receive stock options for Ambev common shares, including in the form of ADRs. As of December 31, 2023, there were outstanding rights under the Plan providing for the acquisition of 87.9 million Ambev common shares by approximately 538 people (including executive management and employees).

The Plan establishes the general conditions for granting options, the criteria for defining the strike price and other general terms and conditions of these stock options. Restrictions apply to the divestment of the shares acquired through the Plan, which also defines the various duties and responsibilities of the Board of Directors as plan administrator.

Pursuant to the Plan, the Board of Directors is conferred with ample powers for the organization and management of the Plan in compliance with its general terms and conditions. The Board of Directors grants stock options and establishes the terms and conditions applicable to each grant through Stock Option Programs, or the Programs, which may define the relevant beneficiaries, the applicable number of Ambev common shares covered by the grant, the respective strike price, the exercise periods and the deadline for exercising the options, as well as the rules regarding option transfers and possible restrictions on the acquired shares, in addition to penalties. Additionally, targets may be set for Ambev’s performance, with the Board of Directors also being empowered to define specific rules for Ambev employees who are transferred to other countries or to other companies of the group, including to ABI.

Beneficiaries to whom stock options are granted must sign Stock Option Agreements, or the Agreements, with Ambev, according to which those beneficiaries have the option to purchase lots of Ambev common shares in compliance with the terms and conditions of the Plan, the corresponding Program and such Agreement.

Since 2020, Ambev no longer grants its senior employees and management stock options recognized in accordance with the accounting treatment determined by IFRS 2/CPC 10 – Share-Based Payment. However, there are stock options granted in previous periods that are not yet exercisable, as well as stock options that are already exercisable but have not expired yet, which remain valid within the term of the programs issued under the Plan and subject to the accounting treatment provided under IFRS 2/10 CPC 10.

Thus, some Ambev and its subsidiaries’ employees who receive their profit sharing (bonuses) in cash, have the option, depending on their position, of choosing to allocate part or all of the amounts received in such capacity in the acquisition of Ambev Stock. These shares are called “voluntary shares” and are granted under the Plan. As a rule, voluntary shares are entitled to dividends from the grant date and are subject to a transfer restriction period of three to five years (lock-up). These shares are granted at market price, to which a discount of up to 20% is applied. The discount is delivered in the form of “discounted shares”. Employees who invest in voluntary shares also receive one and a half times the corresponding number of shares for each voluntary

   
 91 
 

share acquired, up to a limited total percentage of each employees’ variable compensation. These corresponding shares are delivered in the form of restricted shares, also called “matching shares”.

As a means of creating a long-term incentive (wealth incentive) for certain senior employees and members of management considered as having “high potential,” share appreciation rights in the form of phantom stocks have been granted to those employees, pursuant to which the beneficiary shall receive two separate lots of phantom stock – Lot A and Lot B – subject to lock-up periods of five and ten years, respectively. On the fifth or tenth anniversary of the granting of such lots, as the case may be, a beneficiary still employed with us shall receive, in cash, the amount corresponding to the B3 closing price of the relevant Ambev shares (or NYSE closing price in the case of ADRs), on the trading session immediately preceding such anniversary, with each phantom stock corresponding to one share (or ADR, as the case may be). Such share appreciation rights shall not give the beneficiary the right to actually receive any Ambev shares or ADRs; those securities shall merely serve as basis for the calculation of the cash incentive to be received by such beneficiary. Although not subject to performance measures, the right to receive the cash incentive deriving from the phantom stocks may be forfeited in certain circumstances, including the beneficiary’s resignation or dismissal prior to the relevant anniversary of the share appreciation right.

We implemented a Share Based Payment Plan, or the Share Plan, dated as of April 29, 2016, which was amended on April 24, 2020 at the annual general shareholders’ meeting. Under the Share Plan, employees and senior management of Ambev or its direct or indirect subsidiaries are eligible to receive Ambev shares, including in the form of ADRs. The shares which are subject to the Share Plan are designated as Restricted Shares or Performance Shares.

Pursuant to the Share Plan, the Board of Directors is conferred with ample powers for the organization and management of the Share Plan in compliance with its general terms and conditions. The Board of Directors may appoint a committee to assist its members in the management of the Share Plan. The Board of Directors or the committee establishes the terms and conditions applicable to each Share Based Payment Programs, or the Share Plan Programs, which defines the relevant participants, the applicable number of Restricted Shares subject to the Share Plan Program, the Restricted Shares’ transfer procedure and vesting periods, and any possible penalties.

In 2022, the Board of Directors appointed the People Committee to assist managing the decisions to be taken within the scope of the Share Plan, meanwhile some matters remained in the exclusive competence of the Board of Directors. In 2023, our bylaws were amended to, among other things, clarify that all of our annual long-term strategic plans shall be approved by the Board of Directors.

Under the Share Plan, up to 3.0% of the shares corresponding to Ambev’s share capital may be granted in total in an amount that may vary according to Ambev internal policies. The delivery of the Restricted Shares is free of charges. Restricted Shares and Performance Shares shall vest in three or five years from the corresponding grant date, depending on the Share Based Payment Programs, provided that the participant remains employed at Ambev or its subsidiaries during such vesting period. As of December 31, 2023, there were 119.9 million Restricted Shares offered to approximately 1,200 participants corresponding to 119.9 million Ambev Shares under the Share Plan (including executive management and employees). Participants of the Share Plan must sign a Share Based Payment Agreement, or the Share Based Agreements, with Ambev, according to which, those participants have the right to receive a maximum number of Ambev Shares or ADRs, as applicable, provided that the terms and conditions set forth in the Share Plan, Share Plan Programs and in the Share Based Agreements are complied with.

The Restricted Shares and Performance Shares may entitle participants to receive additional shares with the same vesting conditions as compensation for dividends and interest on shareholders’ equity paid during the vesting period on the Restricted Shares and Performance Shares, as the case may be. The right to receive the Restricted Shares and Performance Shares and the additional shares may be totally or partially forfeited in certain circumstances, including the participants’ resignation or dismissal during the vesting period.

In addition, on October 19, 2023, we adopted a clawback policy that applies to incentive-based compensation received by certain executives (which currently comprise the members of the Board of Executive Officers). Under this policy, “incentive-based compensation” is defined broadly to include any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a financial reporting measure (e.g. variable performance-related compensation (bonus) and annual long-term incentive performance stock

   
 92 
 

units (PSUs)). The policy provides that in the event the we are required to prepare an accounting restatement of our financial statements due to the material noncompliance with any financial reporting requirements under the applicable securities laws, we will recover (on a pre-tax basis) from the relevant executive officers any incentive-based compensation received by such executives on or after October 2, 2023, and during the three fiscal years preceding the date the restatement was required that exceeds the amount of incentive-based compensation that otherwise would have been received had such incentive-based compensation been determined according to the applicable accounting restatement, subject to limited exceptions. The recovery of such compensation applies regardless of whether any misconduct occurred and without regard to whether an executive officer engaged in misconduct or otherwise caused or contributed to the requirement for a restatement.

ABI Exceptional Stock Option Grants and Restricted Stock Units Grants

 

Since November 2008, ABI’s Board of Directors has approved several special grants of stock options and restricted stock units (“RSUs”) granted to certain executives, including Ambev executives. Each stock option gives its beneficiary the right to purchase one existing common share of ABI at an exercise price equal to their fair value at the time of granting of the options and with a term of 10 to 15 years as from grant date. Specific forfeiture rules apply in the event the executive leaves the company before the vesting date of the RSUs and stock options. Each RSU gives its beneficiary the right to receive one existing common share of ABI at vesting, subject to specific forfeiture rules and subject to a vesting period of at least five years. In addition to specific forfeiture rules, some grants of stock options and restricted stock units are subject to a performance test. On the date hereof, none of these options and restricted stock units were outstanding or still held by Ambev executives. Although the exercise of these ABI exceptional stock options and/or RSUs will not cause any dilution to Ambev, we record an expense in connection with them on our income statement.

Ambev Pension Plan

Ambev’s pension plans for employees in Brazil are administered by the IAPP (Ambev Private Pension Institute). The IAPP operates both a defined benefit pension plan (closed to new participants since May 1998) and a defined contribution plan, which supplements benefits that the Brazilian government’s social security system provides to our employees. The defined contribution plan covers substantially all new employees. The IAPP was established solely for the benefit of our employees and its assets are held independently. The IAPP is managed by a Governing Board (Conselho Deliberativo), which has three members, two of whom are appointed by Ambev, and one member represents active and retired employees. The IAPP also has an Executive Board (Diretoria Executiva) containing three members, all of whom are appointed by IAPP’s Council Board. The IAPP also has a Fiscal Council with three members, two of whom appointed by Ambev, and one member represents active and retired employees. Any employee upon being hired may opt to join the defined contribution plan. When pension plans members leave Ambev before retirement but having contributed at least three years to the IAPP plan, they have some options such as: (a) having their contributions refunded, (b) transferring their contributions to a bank or insurance company, (c) keeping their investment in IAPP to be paid in installments, and (d) continuing to IAPP for future retirement under the existing terms. In the event the employee leaves the Company prior to completing three years as a participant, such employee will only be entitled to refund his/her contributions to the plan.

As of December 31, 2023, we had 8,877 participants in our pension plans, including 234 participants in the defined benefit plan, 7,439 participants in the defined contribution plan, and 1,204 retired or assisted participants. Plan assets are comprised mainly of equity securities, government and corporate bonds and real estate properties. All benefits are calculated and paid in inflation-indexed reais.

Labatt provides pension plan benefits in the defined contribution model and in the defined benefit model to its employees, as well as certain post-retirement benefits.

For information on amount recorded by us on December 31, 2023 as liabilities for pension plan benefits, see Note 24 to our audited consolidated financial statements, included elsewhere in this annual report on Form 20-F.

   
 93 
 

Profit-Sharing Plan

Employees’ performance-based variable payments are determined on an annual basis considering the achievement of corporate, department or business-unit and individual goals, established in accordance with the profit-sharing plan.

The distribution of these payments is subject to a three-tier system in which Ambev must first achieve performance targets approved by the Board of Directors in accordance with the profit-sharing plan. Following that, each department or business segment must achieve its respective targets. Finally, individuals must achieve their respective performance targets.

For employees involved in operations, we have a collective award for production sites and distribution centers with outstanding performances. The bonus award at the distribution centers and production sites is based on a score cluster between the different distribution centers and production sites (as the case may be), which, based on their relative score considered together with company results, determines bonus amount.

Our expenses under these programs amounted to R$963,464 million for the year ended December 31, 2023, R$1,119.2 million for the year ended December 31, 2022, and R$1,420.6 million for the year ended December 31, 2021.

C.        Board Practices

During 2023, our management held individual and group meetings with shareholders, investors and analysts to talk about the performance of our business and our opportunities for growth both in the short-term as well as in the future and to update the market on our ESG initiatives. We also participated in conferences and non-deal road shows online. We hosted quarterly conference calls, transmitted simultaneously on the internet, to clarify financial and operating results as well as answered questions from the investment community.

Fiscal Council (Conselho Fiscal)

Ambev’s Fiscal Council is a permanent body. At our annual general shareholders’ meeting held on April 28, 2023, the following members of the Fiscal Council were appointed for a term expiring upon the annual general shareholders’ meeting of 2024: José Ronaldo Vilela Rezende, Elidie Palma Bifano and Fabio de Oliveira Moser. All of them are “independent” members as per Rule 10A-3(c)(3) of the Sarbanes-Oxley Act of 2002.

The responsibilities of the Fiscal Council include supervision of management, performing analyses and rendering opinions regarding our financial statements and performing other duties in accordance with the Brazilian Corporation Law and its charter. None of the members of the Fiscal Council is also a member of the Board of Directors or of any committee of the Board.

Minority holders representing at least 10% of our common shares are entitled to elect one member and respective alternate to the Fiscal Council without the participation of the controlling shareholder. CVM’s interpretation is that such right is applicable as long as at least 10% of our shares are held by minority shareholders, regardless of the equity percentage held by the minority shareholders attending the shareholders’ meeting having in the agenda the election of the Fiscal Council members.

We have relied on the exemption provided for under Rule 10(c)(3) of the Sarbanes-Oxley Act of 2002, which enables us to have our Fiscal Council perform the duties of an audit committee for the purposes of such Act, to the extent permitted by Brazilian law. We do not believe that reliance on this exemption would materially adversely affect the ability of our Fiscal Council to act independently and to satisfy the other requirements of such Act.

The Board of Directors

Most of our Board members have been in office for several years and were elected or reelected to the Board of Directors of Ambev at the Company’s extraordinary general shareholders’ meeting held on April 28, 2023 for a term expiring at the annual general shareholders’ meeting to be held in 2026. These Board members use their extensive knowledge of our business to help ensure that we reach our long-term goals, while maintaining our short-term competitiveness. Another objective of the Board of Directors is to encourage us to

   
 94 
 

pursue our short-term business goals without compromising our long-term sustainable growth, while at the same time trying to make sure that our corporate values are observed.

Under our bylaws, at least (i) two members or (ii) twenty percent (20%) of the total number of members of the Board of Directors, whichever is greater, shall be independent directors. For the applicable director independence criteria, see “Item 10. Additional Information—B. Memorandum and Articles of Association—Board of Directors.” We currently have three independent members in our Board of Directors.

In 2021, Ambev received the Women on Board (WOB) certification, a UN Women-supported independent initiative whose purpose is to acknowledge, value and promote corporate environments in which women are part of the board of directors or at advisory councils. This certification is awarded to organizations that have at least two women sitting on their board of directors.

Pursuant to Brazilian law, Ambev’s Chairman of the Board of Directors and the Chief Executive Officer are separate positions that must be held by different individuals.

The Board of Directors is supported in its decision-making by the following committees:

Operations and Finance Committee

The Operations and Finance Committee is the main link between the policies and decisions made by the Board of Directors and Ambev’s management team. The Operations and Finance Committee’s responsibilities include:

oto monitor the Company’s long term planning;
oto monitor the evolution of the Company’s actuarial liabilities and investments in pension plans;
oto monitor the investors relations strategies and the performance of our rating, as issued by the official rating agencies;
oto analyze and issue an opinion on our annual investment plan;
oto analyze and issue an opinion on proposals by the Board of Executive Officers regarding opportunities for corporate restructuring, mergers, acquisitions, spin-offs, incorporations or disposals of equity interests involving the Company;
oto analyze and monitor our capital structure and cash flow; and provide an opinion on the Company’s shareholder compensation strategy;
oto verify compliance with the Company’s Financial Risk Management Policy; and,
oother matters that the Board of Directors considers relevant and in the interest of the Company and may come to define as attribution of the Operations and Finance Committee.

The current members of the Committee are Messrs. Victorio Carlos De Marchi (Chairman), Fernando Mommensohn Tennenbaum and Marcos de Barros Lisboa. The members of this committee are elected by the Board of Directors.

Governance Committee

The responsibilities of the Governance Committee are to assist the Board of Directors with the following matters:

orelated party transactions;
oany general conflict of interest situations that may arise between the Company and related parties;
ocompliance, by the Company, with legal, regulatory and statutory provisions concerning related party transactions and antitrust matters;
   
 95 
 
oto monitor the Company’s initiatives, as well as analyze and give opinions on issues related to cyber security and privacy and data protection;
oto issue an opinion on the Company’s strategies related to environmental, social and governance (ESG) issues; and
oother matters the Board of Directors may consider relevant and in the interest of the Company.
oThe current members of the Governance Committee are Messrs. Victorio Carlos De Marchi (Chairman), Fabio Colletti Barbosa, Marcos de Barros Lisboa, an independent member, Everardo de Almeida Maciel and Carlos Emmanuel Joppert Ragazzo. The members of this committee are elected by the Board of Directors.

People Committee

The responsibilities of the People Committee are to assist the Board of Directors with the following matters:

oto issue an opinion on matters that require a decision by the Board of Directors regarding the definition and review of the compensation policy for members of the Board of Executive Officers and high performance employees, as well as individual compensation incentives packages;
oto define the targets and compensation for the Company’s management, within the limit approved by the annual shareholders’ meeting;
oto monitor the evaluation of the members of the Board of Executive Officers, key executives and talents, in addition to the respective succession plans;
oto approve policies and/or minimal rules to be observed in the nomination process of members of the Company’s management;
oto select and propose for Board of Directors’ approval candidates to the positions of members of Executive Board of Officers and/or any other positions that may be required by the Board of Directors;
oto assist the Board of Directors with the monitoring and discussions related to diversity;
oto approve the transfer of employees of the high-leadership;
oto coordinate the management of compensation incentive plans and to approve the relevant programs, grants, exceptions and other obligations involving employees in general, as permitted by applicable rules; and
oother matters the Board of Directors may consider relevant and in the interest of the Company.
oThe current members of the People Committee are Messrs. Victorio Carlos De Marchi (Chairman), Nelson José Jamel and Claudia Quintella Woods. The members of this committee are elected by the Board of Directors.

Differences Between United States and Brazilian Corporate Governance Practices

In November 2003, the SEC approved corporate governance rules that had been adopted by the NYSE pursuant to the Sarbanes-Oxley Act of 2002. According to those governance rules, foreign private issuers that are listed on the NYSE must disclose the significant differences between their corporate governance practices and those required by the NYSE’s regulations for U.S. companies.

In November 2016, the Brazilian Corporate Governance Code, which provides for corporate governance practices guidelines for publicly-held companies, was released by a workgroup formed by several entities, such as ABRAPP, ABRASCA, ANBIMA, ABVCAP, AMEC, APIMEC, B3, BRAIN, IBGC, IBRI and Instituto IBMEC, after the contribution and comments made by the CVM. In June 2017, the CVM approved a new rule, which establishes that companies must inform whether they adhere to the principles and practices

   
 96 
 

set forth in the Brazilian Corporate Governance Code, or otherwise justify the reasons for non-compliance with such principles and practices. Our report on the Brazilian Code of Corporate Governance, prepared in accordance with such rules, is available on our website at http://ri.ambev.com.br/, and the updated report was filed with the SEC on July 28, 2023. Additionally, the B3 and the IBGC-Brazilian Institute of Corporate Governance have issued guidelines for corporate governance best practices, including a new edition of the Brazilian Corporate Governance Code in 2023.

The principal differences between the NYSE corporate governance standards and our corporate governance practices are as follows:

Independence of Directors and Independence Tests

NYSE corporate governance standards require listed companies to have a majority of independent directors and set forth the principles by which a listed company can determine whether a director is independent. “Controlled companies,” such as Ambev, need not to comply with these requirements. Nonetheless, our bylaws require that (i) the majority of the members of our Board of Directors must be external directors (i.e. with no current employment or managerial relationship with the company) and (ii) at least two of our directors or twenty percent (20%) of the total number of members of the Board of Directors, whichever is greater, shall be independent. In addition, our bylaws set forth that directors elected by a separate ballot vote of minority shareholders holding at least 10% of our capital stock shall be deemed independent.

The Brazilian Corporation Law and the CVM establish rules in relation to certain qualification requirements and restrictions, compensation, duties and responsibilities of a company’s officers and directors.

Executive Sessions

NYSE corporate governance standards require non-management directors of a listed company to meet at regularly scheduled executive sessions without management.

According to the Brazilian Corporation Law, up to one-third of the members of the Board of Directors can also hold executive officer positions. However, none of our directors holds an executive officer position in us at this time and, accordingly, we believe we would follow this NYSE corporate governance standard if we were a U.S. company.

Nominating/Corporate Governance and Compensation Committees

NYSE corporate governance standards require that a listed company have a nominating/corporate governance committee and a compensation committee each composed entirely of independent directors with a written charter that addresses certain duties. “Controlled companies” such as Ambev need not to comply with this requirement.

In addition, we are not required under the Brazilian Corporation Law to have, and accordingly we do not have a nominating committee, but we do have a people committee and a governance committee. According to the Brazilian Corporation Law, Board committees may not have any specific authority or mandate since the exclusive duties of the full Board of Directors may not be delegated. The role of the corporate governance committee is generally performed by either our Board of Directors or our executive officers.

Audit Committee and Audit Committee Additional Requirements

NYSE corporate governance standards require that a listed company have an audit committee composed of a minimum of three independent members that satisfy the independence requirements of Rule 10A-3 under the Exchange Act, with a written charter that addresses certain duties.

We maintain a permanent Fiscal Council, which is a body contemplated by the Brazilian Corporation Law that operates independently from our management and from our registered independent public accounting firm. Its principal function is to examine the annual and quarterly financial statements and provide a formal report to our shareholders. We are relying on the exemption provided by Rule 10A-3(c)(3) and believe that our reliance on this exemption will not materially affect the ability of the Fiscal Council to act independently and to satisfy the other requirements of Rule 10A-3.

   
 97 
 

Shareholder Approval of Equity Compensation Plans

NYSE corporate governance standards require that shareholders of a listed company must be given the opportunity to vote on all equity compensation plans and material revisions thereto, subject to certain exceptions.

Under Brazilian Corporation Law, shareholder pre-approval is required for the adoption and revision of any equity compensation plans. Our existing stock ownership and share based payment plans were approved by our extraordinary general shareholders’ meetings held on July 30, 2013 and on April 29, 2016. An amendment to the share-based payment plan was approved by the annual general shareholders’ meeting held on April 24, 2020.

Corporate Governance Guidelines

NYSE corporate governance standards require that a listed company must adopt and disclose corporate governance guidelines that address certain minimum specified standards, which include, director qualification standards, director responsibilities, director access to management and independent advisors, director compensation, director orientation and continuing education, management succession and annual performance evaluation of the Board.

We believe the corporate governance guidelines applicable to us under the Brazilian Corporation Law are consistent with the guidelines established by the NYSE. We have adopted and observe our Manual on Disclosure and Use of Information and Policies for Trading with Securities issued by Ambev which deals with the public disclosure of all relevant information as per CVM’s guidelines, as well as with rules relating to transactions involving the dealing by our management and controlling shareholder in our securities.

Code of Business Conduct

NYSE corporate governance standards require that a listed company must adopt and disclose a code of business conduct and ethics for directors, officers and employees and promptly disclose any waivers of the code for directors or officers. Each code of business conduct and ethics should address the following matters: (1) conflicts of interest; (2) corporate opportunities; (3) confidentiality; (4) fair dealing; (5) protection and proper use of company assets; (6) compliance with laws, rules and regulations (including insider trading laws); and (7) encouraging the reporting of any illegal or unethical behavior.

We have adopted a Code of Business Conduct that applies to all directors, officers and employees. Our Code of Business Conduct is available on our website at http://ri.ambev.com.br/. The information included on our website or that might be accessed through our website is not included in this annual report and is not incorporated into this annual report by reference. There are no waivers to our Code of Business Conduct.

Certification Requirements

NYSE corporate governance standards require that each listed company’s chief executive officer certify to the NYSE each year that he or she is not aware of any violation by the company of the NYSE corporate governance standards.

As required by Section 303A.12(b) of the NYSE corporate governance standards, our Chief Executive Officer will promptly notify the NYSE in writing after our executive officer becomes aware of any material non-compliance with any applicable provisions of the NYSE corporate governance standards.

D.        Employees

As of December 31, 2023, we and our subsidiaries had a total of 42,774 employees, of whom approximately 44% were engaged in production, 39% in sales and distribution and 17% in administration.

The following table sets forth the total number of our employees as of the end of the periods indicated:

   
 98 
 

 

As of December 31,

2023

2022

2021

42,774 47,108 52,806

The following table shows the geographical distribution of our employees as of December 31, 2023:

Geographical Distribution of Ambev Employees as of December 31, 2023

Location

Number of Employees

Brazil 25,023
CAC 4,725
Dominican Republic 2,194
Cuba 958
Guatemala 159
Panama 1,414
Latin America South 9,611
Argentina 5,797
Bolivia 1,906
Uruguay 825
Paraguay 542
Chile 541
Canada 3,415
Total

42,774

Industrial Relations

As per the determined under Brazilian labor legislation, all of our employees in Brazil are represented by labor unions, but only less than 5% of our employees in Brazil are actually members of labor unions as of December 31, 2023. The number of administrative and distribution employees who are members of labor unions is not significant. Salary negotiations are conducted annually between the workers’ unions and us. Collective bargaining agreements are negotiated separately for each facility or distribution center. Our Brazilian collective bargaining agreements have a one- or two-year term, and we usually enter into new collective bargaining agreements on or prior to the expiration of the existing agreements. We conduct salary negotiations with labor unions in accordance with local law for our employees located in our CAC, Latin America South and Canadian operations.

Health and Severance Benefits

In addition to wages, our employees receive additional benefits. Some of these benefits are mandatory under Brazilian law, some are provided for in collective bargaining conventions and/or agreements and others are voluntarily granted. The benefits packages of our employees in Brazil consist of benefits provided both directly by the Company and through FAHZ, which provides medical, dental, educational and social assistance to current and retired employees of Ambev and their beneficiaries and covered dependents, either for free or at a reduced cost. We may voluntarily contribute up to 10% of our consolidated net income towards the support of FAHZ in connection with these benefits, as determined pursuant to the Brazilian Corporation Law and our bylaws.

We are required to contribute 8% of each Brazilian employee’s monthly gross pay to an account maintained in the employee’s name with the Brazilian government’s Severance Indemnity Fund (Fundo de Garantia por Tempo de Serviço), or the FGTS. Under Brazilian law, we are also required to pay termination benefits to Brazilian employees dismissed without cause equal to 40% of the accumulated contributions made by us to the terminated employee’s FGTS account throughout the employee’s period of service, among other mandatory termination fees.

We provide health and benefits in accordance with local law for our employees located in our CAC, Latin America South and Canadian operations.

   
 99 
 

E.        Share Ownership

The following table shows the amount and percentage of our shares held by members of our Board of Directors and by executive officers as of March 1, 2024:

Name

Amount and Percentage of Common Shares

Michel Dimitrios Doukeris *
Victorio Carlos de Marchi(1) *
Milton Seligman *
Carlos Eduardo Klutzenschell Lisboa *
Fabio Colleti Barbosa *
Fernando Mommensohn Tennenbaum *
Lia Machado de Matos *
Nelson José Jamel *
Luciana Pires Dias *
Marcos de Barros Lisboa *
Claudia Quintella Woods *
Jean Jereissati Neto *
Lucas Machado Lira *
Leticia Rudge Barbosa Kina *
Ricardo Morais Pereira de Melo *
Eduardo Braga Cavalcanti de Lacerda *
Valdecir Duarte *
Paulo André Zagman *
Carla Smith de Vasconcellos Crippa Prado *
Felipe Moreira Haddad Baruque *
Eduardo Eiji Horai *
João Coelho Rua Derbli de Carvalho *
Daniel Wakswaser Cordeiro *
Daniela Gavranic Cachich *
 
*Indicates that the individual holds less than 1% of the class of securities.
(1)This Board member is also trustee of FAHZ. For information regarding the shareholdings of FAHZ in Ambev, see “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev’s Major Shareholders.”
   
 100 
 
ITEM 7.MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS

A.        Major Shareholders

Introduction

Ambev has only one class of shares (i.e., voting common shares), including in the form of ADSs (evidenced by ADRs), with each ADS representing one Ambev common share. The Ambev common shares and ADSs are registered under the Exchange Act. As of March 1, 2024, Ambev had 15,749,448,866 shares outstanding. As of March 1, 2024, there were 1,410,127,080 Ambev ADSs outstanding (representing 1,410,127,080 Ambev shares, which corresponds to 8.9% of the total Ambev shares outstanding). The Ambev shares held in the form of ADSs under the Ambev ADS facilities are deemed to be the shares held in the “host country” (i.e., the United States) for purposes of the Exchange Act. In addition, as of March 1, 2024, there were 227  registered holders of Ambev ADSs.

Control

Our direct controlling shareholder, ABI, together with FAHZ, held in aggregate 72% our total and voting capital stock (excluding treasury shares) as of March 1, 2024.

ABI indirectly holds shares in us representing 61.2% of our total and voting capital stock (excluding treasury shares) as of March 1, 2024, ABI thus has control over us, even though (1) ABI is subject to the Shareholders’ Agreement and (2) ABI is controlled by Stichting that represents an important part of interests of BRC and the Interbrew Founding Families. For further information on these matters see “Item 4. Information on the Company—A. History and Development of the Company—The InBev-Ambev Transactions” and “—Ambev’s Major Shareholders—The Shareholders’ Agreement.”

In March 2021, our board of directors approved a share buyback program for the repurchase of up to 5,700,000 Ambev shares to cover the delivery of shares under our share-based compensation plans or to be held in treasury, cancelled or subsequently transferred in private or public transactions. As of December 31, 2022, we repurchased 5,700,000 Ambev shares.

In May 2023, our board of directors approved a share buyback program for the repurchase of up to 13,000,000 Ambev shares to cover the delivery of shares under our share-based compensation plans or to be held in treasury, cancelled or subsequently transferred in private or public transactions. As of March 1, 2024, we repurchased 7,000,000 Ambev shares under this plan.

As of March 1, 2024, we did not acquire any Ambev shares in connection with preemptive rights related to stock ownership plans in 2024.

In 2023, we acquired 1,369,957 Ambev shares in connection with preemptive rights related to stock ownership plans at a total cost of R$20.4 million.

In 2022 we acquired 622,520 Ambev shares in connection with preemptive rights related to stock ownership plans at a total cost of R$9.2 million.

In 2021 we acquired 4,011,471 Ambev shares in connection with preemptive rights related to stock ownership plans at a total cost of R$71.4 million.

For a further description of our share buyback programs, see “Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers.”

Ambev’s Major Shareholders

The following table sets forth information as of March 1, 2024, with respect to any person known to us to be the beneficial owner of 5% or more of our outstanding shares:

 

   
 101 
 

 

Shareholder

Amount and Percentage
of Common Shares

     
Interbrew International B.V(1) 8,441,665,818 53.59%
AmBrew S.à.r.l(2) 1,287,671,100 8.17%
FAHZ(3) 1,609,987,301 10.22%
Others 4,410,124,647 28.00%
Treasury Shares 4,384,418 0.02%
Total 15,753,833,284 100.00%
 
(1)Interbrew International B.V is 100% held by ABI Inve. Holding Ltd - UK19, which, in turn, is held 100% by ABI UK Holding 2 UK TopCo 2, which, in turn, is 100% held by ABI UK Hold 1 UK TopCo 1, which, in turn, is held by (i) AB InBev Nederland Holding BV (59.14%), (ii) ABI UK Finance (9.24)%, (iii) Anheuser-Busch InBev SA/NV (ABI) (27.77%), (iv) InBev Belgium BV (3.84%). AB InBev Nederland Holding BV is held by Anheuser-Bush InBev SA/NV (ABI) (67.62%) and by InBev Belgium BV (32.38%), which, in turn, is 100% held by Anheuser-Bush InBev SA/NV (ABI). ABI UK Finance is 100% held by ABEL- Anheuser-Busch Europe Limited, which is in turn 100% held by Ambrew S.à.r.l.
(2)Ambrew S.à.r.l is fully owned by Anheuser-Busch InBev SA/NV (ABI), which, in turn, is controlled by Stichting Anheuser-Busch InBev (“Stichting’), a foundation organized under the laws of the Netherlands, which holds 33.7% of the voting shares of ABI and effectively controls ABI pursuant to a shareholders’ agreement, dated April 11, 2016, as amended April 27, 2023, entered into with BRC S.à r.l. (“BRC”), EPS Participations S.à r.l. (“EPS Participations”), EPS S.A. and Rayvax Société d’Investissements SA. Stitching is jointly owned by BRC (50%) and EPS Participations (50%). BRC is jointly controlled by Jorge Paulo Lemann, Carlos Alberto da Veiga Sicupira and Max Van Hoegaerden Hermann Telles, while EPS Participations is dispersedly owned by the founding Belgian families of Interbrew.
(3)Mr. Victorio Carlos De Marchi, who is a FAHZ-appointed director of Ambev, is also member of Advisory Board of FAHZ.

For a description of our major shareholders’ voting rights, see “—The Shareholders’ Agreement.”

As of March 1, 2024, 1,410,127,080 common shares, or 8.9%, were held in the form of ADSs.

The Shareholders’ Agreement

The Shareholders’ Agreement, effective since July 2, 2019, was executed on April 16, 2013 by IIBV, AmBrew and FAHZ, as well as Ambev, as intervening party. The Shareholders’ Agreement may be terminated at any time upon FAHZ ceasing to hold at least 1,501,432,405 of Ambev’s common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits) or if FAHZ decides to early terminate it. Among other matters, the Shareholders’ Agreement governs the voting of the Ambev common shares subject to the agreement and the voting by Ambev of the shares of its majority-owned subsidiaries.

Management of Ambev

The Shareholders’ Agreement establishes that Ambev will be managed by a Board of Directors and by a Board of Executive Officers. Ambev’s Board of Directors shall have one Chairman or two (2) Co-Chairmen.

Presently, under the Shareholders’ Agreement, FAHZ is entitled to appoint two directors and their respective alternates to the Board of Directors of Ambev, provided it holds at least 1,501,432,405 Ambev common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits). One of the FAHZ-appointed directors shall have the right to also be appointed as a member of Ambev’s Operations and Finance Committee, of the Governance Committee and of the People Committee, as well as any other committee that may be established by Ambev’s Board of Directors. Furthermore, the shareholders shall use their best efforts to allow one of the FAHZ-appointed directors to participate as an observer in meetings of Ambev’s Fiscal Council, whenever such body is installed in lieu of the audit committee required by the Sarbanes-Oxley Act of 2002.

FAHZ may remove a director that it has appointed to the Board of Directors of Ambev, and also has the right to appoint the respective replacement or a new alternate, if the originally appointed alternate is confirmed for the vacant position.

   
 102 
 

The foregoing provisions of the Shareholders’ Agreement regarding Ambev’s management bodies do not apply to the management bodies of Ambev’s majority-owned subsidiaries.

Preliminary Meetings and Exercise of Voting Rights

On matters submitted to a vote of the shareholders or their representatives on the Board of Directors of Ambev or its majority-owned subsidiaries, FAHZ, IIBV and AmBrew agreed to endeavor to first reach a consensus with respect to voting their common shares of each of Ambev and its majority-owned subsidiaries and agreed on the manner to direct their representatives to vote on the matter being submitted. The Shareholders’ Agreement provides that the parties should hold a preliminary meeting in advance of all meetings of shareholders or the Board of Directors of Ambev or of its majority-owned subsidiaries, with the purpose of discussing and determining a consensus position to be taken by the parties in such meetings.

If the parties fail to reach a consensus with respect to a particular matter, the position to be adopted by the parties to the Shareholders’ Agreement will be determined by the shareholder or group of shareholders holding a majority of Ambev common shares. The following matters are not subject to the foregoing rule: (1) election of members to the Board of Directors or to any committee of the Board of Directors, which shall follow the specific election procedure described above under “—Management of Ambev” and (2) matters that require unanimous approval by FAHZ, IIBV and AmBrew, as follows:

oany amendment to the bylaws of Ambev and/or any of its majority-owned subsidiaries with the purpose of changing: (1) the corporate purpose of those companies with a view to causing them to cease the production, commercialization and distribution of beverages, (2) the allocation of Ambev’s results of operations, as set forth in its bylaws, or other similar provisions in the bylaws of Ambev’s majority-owned subsidiaries that are meant to provide financial support to FAHZ, (3) the minimum mandatory dividend of 40% of Ambev’s adjusted net income, and/or (4) any other provision that affects FAHZ’s rights under the Shareholders’ Agreement; and
othe transformation of Ambev into a different form of legal entity.
oFAHZ, IIBV and AmBrew, as well as any member appointed by them to our Board of Directors or any of its majority-owned subsidiaries, are not required to observe decisions reached at preliminary meetings when deciding on the following matters:
oanalysis and approval of management accounts of Ambev and its majority-owned subsidiaries;
oanalysis and approval of the financial statements and management reports of Ambev and its majority-owned subsidiaries;
oany matters or actions typified as abuse of control, as set forth in the first paragraph of Section 117 of the Brazilian Corporation Law; and
oactions and practices relating to management’s diligence, loyalty and other related duties, as established in Sections 153 to 158 of the Brazilian Corporation Law.

Transfer of Shares

Under the Shareholders’ Agreement, the following rules shall apply:

oin the event of a transfer of Ambev common shares subject to the Shareholders’ Agreement (1) by IIBV and/or AmBrew, where such transfer results in these entities jointly holding a total equity interest in Ambev represented by less than 50% plus one Ambev common share, and/or (2) by FAHZ upon making one and only one eligible transfer of at least 1,501,432,405 Ambev common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits) to a single buyer and subject to the first offer obligations described below, then, in either of those cases, the Ambev common shares subject to those transfers shall remain bound by the Shareholders’ Agreement. Only in those two cases shall a third party acquiring the Ambev common shares in those transfers be able to adhere to the Shareholders’ Agreement in order for the transfer to be effective;
   
 103 
 
oat any time FAHZ may elect to release its Ambev common shares subject to the Shareholders’ Agreement for the exclusive purpose of selling them in the stock market or over-the-counter market, provided that (1) it maintains at least 1,501,432,405 Ambev common shares (adjusted for any future share dividends, stock-splits and reverse stock-splits) subject to the Shareholders’ Agreement, and (2) it observes the first offer obligations described below; and
oin the event FAHZ intends to execute the above-referenced one and only one eligible transfer or release, it shall first offer the Ambev common shares to the remaining parties to the Shareholders’ Agreement for their average quoted market price on the 20 trading sessions immediately prior to the date of the relevant first offer (or the last 40 trading sessions if no Ambev common shares were negotiated in at least half of the 20 immediately preceding trading sessions). The offerees will have five days, as of the first offer date, to accept or refuse the offer, and, if expressly or tacitly refused (or in the event the offerees fail to timely pay the applicable purchase price), then FAHZ may either proceed with such transfer or release its Ambev common shares from the Shareholders’ Agreement and thereafter sell them to third parties within ten days.

Specific Performance

The obligations of the parties under the Shareholders’ Agreement will be subject to specific performance under applicable Brazilian law.

B.        Related Party Transactions

Overview

We have executed and may in the future execute related party transactions with certain of our significant shareholders or other related parties and certain of their affiliates. These transactions include but are not limited to: (1) the purchase and sale of raw material with affiliated entities, (2) entering into distribution, sale, cross-licensing, transfer pricing, indemnification, service and other agreements with affiliated entities, (3) import agreements with affiliated entities, and (4) royalty agreements with affiliated entities. These transactions have been entered into only on an arm’s length basis in accordance with our best interests and customary market practices at the time of their execution. In addition, the Governance Committee is responsible for assisting the Board in reviewing, analyzing and deciding on these transactions to help ensure that their terms are reasonable and that they comply with all applicable laws and regulations, as well as our corporate governance and best practices principles. See “Item 6. Directors, Senior Management and Employees—C. Board Practices—The Board of Directors—Governance Committee.” Set forth below is a discussion of our material related party transactions. For further information on our related party transactions, see Note 30 to our audited consolidated financial statements.

Ambev, ABI and its subsidiaries, such as Anheuser-Busch Inbev USA LLC (“ABI USA”) and Cervecería Modelo, among others, have entered into several agreements for the production, import, distribution and sale of branded products, such as Stella Artois, Beck’s, Budweiser, Spaten, Michelob Ultra and Corona (including Corona Extra, Corona Light, Coronita, Pacífico and Modelo), among others (“ABI Products”) by Ambev in Brazil and its subsidiaries located in countries in which we have operations, such as Canada, Argentina, Chile, Paraguay, Uruguay, Bolivia, Dominican Republic, Panama, Guatemala, among others. These agreements were duly approved by the Governance Committee and the Company’s Board of Directors. See “Item 4. Information on the Company—B. Business Overview—Licenses—Licensing Agreements with ABI.”

Ambev and FAHZ

Medical, Dental and Social Assistance

One of the activities of FAHZ, as described in its bylaws, is to provide medical and dental assistance and other benefits both to active and certain of our employees, retired employees and executive officers (including their dependents).

 

   
 104 
 

Ambev and ABI

 

Ambev engages in various transactions with ABI. These transactions include, but are not limited to: (i) the purchase and sale of raw materials, (ii) entering into distribution, cross-licensing, indemnification, service and other agreements, and (iii) import and licensing agreements. Such transactions between ABI and Ambev and its subsidiaries are disclosed in Note 30 of our consolidated financial statements as related parties.

The outstanding balances relating to other transactions with ABI are further described in Note 31.4 to our audited consolidated financial statements.

Licensing Agreements

In November 2021, Ambev and ABI negotiated general guidelines on royalties and transfer price policy for the royalty percentages and mark-ups applicable to the production, import, distribution and sale of (a) finished products of ABI and/or its respective subsidiaries by Ambev and/or its respective subsidiaries; and (b) finished products of Ambev and/or its respective subsidiaries by ABI and/or its respective subsidiaries. All metrics, prices and methodologies were established on an arm’s length basis, based on a study carried out by a top-tier external audit firm, duly approved by the Governance Committee and the Company’s Board of Directors. As described in “Item 10. Additional Information - E – Taxation”, in January 2024 Law No. 14,596/23 became effective, impacting the current licensing agreements and respective rates.

See “Item 4. Information on the Company—B. Business Overview—Licenses—Licensing Agreements with ABI.”

Tenedora’s shareholders agreement and put option

On December 31, 2023, Ambev and ELJ owned 85% and 15% of Tenedora shares, respectively. Tenedora, in turn, owns Cervecería Nacional Dominicana, S.A (“CND”). On July 2, 2020, Ambev and ELJ amended the Tenedora Shareholders Agreement (the “Shareholders Agreement”) to extend our partnership and change some of the terms of the put and call options provided therein. Pursuant to this amendment, ELJ had a put option requiring us to purchase its stake in Tenedora in two different tranches, as follows: (i) Tranche A, corresponding to 12.11% of the shares; and (ii) Tranche B, corresponding to 2.89% of the shares, exercisable starting in 2026. In October 2023 EJL notified us of its intention to exercise Tranche A of the put option, which we settled in January 2024 via (i) a cash disbursement of R$1,704 million that we paid to ELJ, and (ii) the offset of ELJ’s debt held by CND in the amount of R$335 million As a result of this transaction, we now hold a 97.11% stake in Tenedora.

We, on the other hand, have a call option over the Tranche B shares to be exercised starting in 2029. The terms and conditions of these options are further described in Note 28 Item 28.3.1 to our audited consolidated financial statements.

C.        Interests of Experts and Counsel

Not applicable.

   
 105 
 
ITEM 8.FINANCIAL INFORMATION

A.        Consolidated Financial Statements and Other Financial Information

Consolidated Financial Statements

See “Item 17. Financial Statements.”

Legal Proceedings

We are subject to numerous claims with respect to tax, labor, civil and other matters (consisting of antitrust, environmental and other proceedings that do not fit in the other categories). Such proceedings involve inherent uncertainties including, but not limited to, as a result of court rulings, negotiations between affected parties and governmental actions, and, consequently, our management cannot at this stage estimate with certainty how and when these matters will be resolved.

To the extent that we believe contingencies arising from these proceedings will probably be materialized, they have been recorded in the balance sheet. As of December 31, 2023, our provisions for legal contingencies totaled R$1,018.2 million, of which R$978.0 million were recorded in provision account and R$40.2 million in income taxes (IRPJ and CSLL) contingencies, in accordance with IFRIC23. We have estimated the total exposures of possible (but not probable) losses, which are not recorded as liabilities, to be R$95.6 billion as of December 31, 2023. Our estimates are based on reasonable assumptions, external opinions and management assessments, but should the worst-case scenario develop, subjecting us to losses in all cases classified as possible (but not probable), our net impact on our results of operations would be an expense for this amount. Except as set forth herein, there are no legal proceedings to which we are a party, or to which any of our properties are subject which, either individually or in the aggregate, may have a material adverse effect on our results of operations, liquidity or financial condition. The Company and its subsidiaries have guarantee-insurance policies and letters of guarantee for some legal actions, presented as guarantee for civil, labor and tax executions or to enable resources of labor nature. For more information, see Note 27 to our audited consolidated financial statements.

Tax Matters

As of December 31, 2023, we had several tax claims pending against us, including judicial and administrative proceedings. Most of these claims relate to income taxes (IRPJ and CSLL), Social Contributions on Gross Revenues (PIS and COFINS), ICMS Value-Added Tax and IPI Excise Tax. As of December 31, 2023, we had made provisions of R$387.0 million in connection with those tax proceedings for which we believe there is a probable chance of loss. Among the pending tax claims, there are claims filed by us against Brazilian tax authorities alleging that certain taxes are unconstitutional. As these claims are contingent on obtaining favorable judicial decisions, the corresponding assets which might arise in the future are only recorded once it becomes certain that we will receive the amounts previously paid or deposited.

As of December 31, 2023, we were party to tax proceedings with a total estimated possible risk of loss of R$95.3 billion. Approximately 67% (R$63.6 billion) of this amount is related to controversies related to payment of IRPJ and CSLL, and approximately 32% (R$30.3 billion) is related to controversies involving the payment of PIS, COFINS, ICMS Value-Added and IPI Excise Tax, and the remainder relates to controversies involving other taxes. The most significant proceedings are discussed below.

In addition, if unfavorable final decisions are issued at the administrative level in connection with tax proceedings in which we are party, we may challenge these decisions in judicial courts and be required to post surety bonds or similar guarantees. As of December 31, 2023, approximately 70% (R$66.4 billion) of the ongoing tax proceedings with total estimated possible loss are at the administrative level of dispute and approximately 30% (R$28.6 billion) are at the judicial level of dispute.

Theme 736

In March 2023, the Brazilian Supreme Federal Court (STF), in the trial of theme 736 (RE 796,939), established its understanding that the imposition of isolated fines due to the non-recognition of tax offsets is unconstitutional. Following this judgement, the Company, together with its in-house lawyers and external

   
 106 
 

advisors, reassessed the prognosis of the discussion and reclassified the risk of loss from possible to remote. Ambev estimates that the amount involved in cases related to this issue, as of March 31, 2023, is R$1.6 billion. Due to the remote likelihood of loss, the proceedings related to this issue ceased to be reported as possible contingencies in the first quarter of 2023.

Law 14,689/2023

On 20 September 2023, Law 14,689 was enacted (“Law 14,689/2023”) in Brazil, which provides for the cancellation of fines imposed in tax administrative proceedings decided in favor of the Brazilian Federal Tax Authorities by a tie-breaking vote at the federal administrative level, including any such proceedings that were subsequently escalated to the judicial level and, as of the date of publication of Law 14,689/2023, were pending decision at the second level judicial courts. Following the enactment of Law 14,689/2023, were assessed the likelihood of success of fines imposed in proceedings decided by a tie-breaking vote, which resulted in the reclassification of the risk of loss from possible to remote in the approximate amount of R$6.9 billion.

ICMS Value-Added Tax, IPI Excise Tax and PIS and COFINS

Manaus Free Trade Zone – IPI Excise Tax / PIS and COFINS

In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/or zero rated from IPI Excise Tax, PIS and COFINS. With respect to IPI Excise Tax, we have been registering IPI Excise Tax presumed credits upon the acquisition of exempted goods manufactured therein. Since 2009, we have been receiving a number of tax assessments from the Brazilian Federal Tax Authorities (“RFB”), relating to the disallowance of such credits.

We have also been receiving charges from the RFB in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI Excise Tax credits that are under discussion in these proceedings and (ii) PIS/COFINS amounts allegedly due on Arosuco’s remittance to us.

In April 2019, the STF announced its judgment on Extraordinary Appeal No. 592.891/SP, with binding effects, deciding on the rights of taxpayers registering IPI Excise Tax presumed credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, we reclassified part of the amounts related to the IPI Excise Tax cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF, such as disputes encompassing the fiscal classification of concentrate units. The cases are being challenged at both the administrative and judicial levels. Our management estimates the possible losses related to these proceedings to be approximately R$6.3 billion as of December 31, 2023. We have not recorded any provision in connection with these assessments.

IPI Excise Tax Suspension

 

In 2014 and 2015, we received tax assessments from the RFB relating to IPI Excise Tax allegedly due over remittances of manufactured goods to other related factories. The cases are being challenged at both administrative and judicial levels. We have received partially favorable decisions at the administrative level. In July 2022, we received the first judicial decision on this matter; the decision was unfavorable to us, and we have filed an appeal.

 

In October 2022, the Upper Administrative Court rendered a partially favorable decision to us in one of the cases related to this matter which ordered a tax audit to determine the amount of the tax already effectively paid. The results of the tax audit, were partially favorable to us, reducing 98% of the amount alleged to be owed by us in this case. As of the date of this annual report on Form 20-F service of the decision was currently pending.

Our management estimates the possible losses related to these assessments to be approximately R$1.8 billion as of December 31, 2023. We have not recorded any provision in connection with these assessments.

   
 107 
 

ICMS-ST Trigger

Over the years, we and our subsidiaries received tax assessments charging alleged ICMS differences considered due in the tax substitution system when the price of the products sold by us is above the fixed price table basis established by certain Brazilian states, cases in which the tax authorities understand that the calculation basis should be based on a value-added percentage over the actual prices, not the fixed table price. We are currently challenging these charges at both the administrative and judicial levels of the courts. Our management estimates the amount related to these assessments to be approximately R$10.7 billion as of December 31, 2023, classified as a possible loss and, therefore, for which we have made no provision.

ICMS tax incentives

In 2015, we received a tax assessment issued by the State of Pernambuco charging ICMS differences due to an alleged non-compliance with the State Tax Incentive Program (PRODEPE) as a result of the rectification of our monthly reports. The state tax authorities decided that we were not able to use our tax incentives due to such rectifications. In 2017, we received a final favorable decision nullifying the assessment due to formal mistakes of the tax auditor. However, in September 2018, we received a new tax assessment with respect to the same matter. In June 2020, we received the first level administrative decision, which was partially favorable to the Company in the sense of recognizing the miscalculation of the tax incentive credit by the tax authorities. The favorable portion of the aforementioned decision is final and unappealable. Regarding the unfavorable portion, we filed an administrative appeal, and has also received a partially favorable decision. The discussion regarding the unfavorable portion will continue forward in the judicial level. There are other assessments related to this same State Tax Incentive Program and some of them are being discussed at the judicial level. Our management estimates the amount related to these assessments to be approximately R$0.7 billion as of December 31, 2023, classified as a possible loss and, therefore, for which we have made no provision.

Over the years, we have also received tax assessments issued by the State of Paraíba charging ICMS differences due to an alleged non-compliance with the State Tax Incentive Program (FAIN). We are currently challenging these charges at both the administrative and judicial levels of the courts. Our management estimates the possible losses related to these assessments to be approximately R$0.6 billion as of December 31, 2023. We have not recorded any provision in connection therewith.

ICMS tax credits

We are currently challenging tax assessments issued by the states of São Paulo, Rio de Janeiro, Minas Gerais, among others, questioning the legality of ICMS tax credits arising from transactions with companies that have tax incentives granted by other states. The cases are being challenged at both the administrative and judicial level of the courts. On August 2020, the STF issued a binding decision (Extraordinary Appeal No. 628.075) ruling that tax credits granted by the states in the context of the “ICMS tax war” shall be considered unlawful. The decision also recognized that the states should abide by the tax incentives validation process provided for in Complementary Law No. 160/17. This decision became final (and no longer subject to appeal) in December 2021.

With respect to the tax assessments issued by the State of São Paulo, unfavorable decisions were rendered against us on appeal at the administrative level in April, May and June 2022. In these cases, we have filed motions for reconsideration of the unfavorable ruling on appeal at the administrative level. In September 2023, such motions for reconsideration were decided partially in our favor. The favorable portion of those decisions became final and is not subject to appeal, while the unfavorable portion is yet to be reviewed at the judicial level. In December 2023, the STF issued a binding decision holding that the unfavorable decisions regarding tax credits from the State of Amazonas issued by the State of São Paulo in 2022 are to be considered unconstitutional. Therefore, even though we are not a party to this lawsuit at the STF, the central discussion has generated a positive impact on the Company’s assessments. Our management estimates the possible losses related to these assessments to be approximately R$0.5 billion as of December 31, 2023. We have not recorded any provision in connection therewith.

Our subsidiary Arosuco has also received tax assessments from the state of Amazonas charging alleged differences in ICMS due to questions about the calculation basis applied in certain sales transactions. The cases are being challenged at the administrative level. Arosuco management estimates the possible losses

   
 108 
 

related to these assessments to be approximately R$0.6 billion as of December 31, 2023. We have not recorded any provisions in connection therewith.

In addition, in 2018 and 2021, we received tax assessments from the States of Rio Grande do Sul and São Paulo charging alleged differences in ICMS due to the disallowance of credits arising from transactions with suppliers located in the Manaus Free Trade Zone. With regard to the assessment issued by the State of Rio Grande do Sul, we received a favorable judgment at the second administrative level, which was amended by the third administrative level in favor of the tax authorities. This decision is not final and remains subject to appeal at the judicial level. With respect to the assessments issued by the State of São Paulo, we received unfavorable decisions at the first administrative level. In these cases, we have filed appeals at the second administrative level. In one of these cases, we received an unfavorable decision from the second-level administrative authority, which is not final and has been appealed at a third-level authority. With regard to the other two cases, one is pending judgment, and the first-instance decision issued in respect of the other was cancelled, requiring a new trial to be held. Our management estimates the possible losses related to these assessments to be approximately R$0.8 billion as of December 31, 2023. We have not recorded any provisions in connection therewith.

ICMS – MIP

The company and its subsidiaries have been receiving assessments from State Tax Authorities over the years, disallowing ICMS credits and demanding payment of the Differential Tax Rate (DIFAL) on the acquisition of intermediate production materials. According to the tax authorities, such materials are not physically related to the productive activity of the companies and therefore should be considered as goods for consumption, which do not entitle the taxpayer to tax credits. Considering these allegations as illegitimate, the companies are challenging these assessments before administrative and judicial courts. Provisions have been made for cases related to this matter, with an updated value of approximately R$ 0.1 billion as of December 31, 2023 . The Company estimates the possible loss related to this matter to be, as of December 31, 2023, approximately R$ 0.4 billion.PIS/COFINS bonus over products

PIS/COFINS bonus over products

We have received tax assessments issued by the RFB charging PIS and COFINS allegedly due over bonus products granted to our customers. These charges are being challenged at both the judicial and administrative levels of the courts. In 2019, 2020 and 2023, we received final favorable decisions at the administrative level in some of these cases. In 2023, the Lower Administrative Court rendered favorable decisions to us in two other cases pending service, which are not final and remain subject to appeal. At the judicial level, one case is pending decision by the second level judicial court after the first level judicial court rendered an unfavorable decision to us.

Our management estimates the possible losses related to these assessments to be approximately R$1.8 billion as of December 31, 2023. No related provision has been made.

Foreign Earnings

Since 2005, we and certain of our subsidiaries have been receiving a number of assessments from the RFB relating to profits of our foreign subsidiaries. The cases are being challenged at both the administrative and judicial levels of the courts in Brazil.

The administrative proceedings have resulted in partially favorable decisions, most of which are still subject to review by the Administrative Court. In October 2022, the Lower Administrative Court rendered a favorable decision to us in one case. In March 2023, the Lower Administrative Court rendered two favorable decisions and one partially favorable decision to us in three cases related to the taxation of profits of foreign subsidiaries. We are awaiting to be served with these decisions to analyze the contents and any applicable legal motions or appeals before the judicial level. In the judicial proceedings, we have received favorable injunctions that suspended the enforceability of the tax credit, as well as favorable first-level decisions, which remain subject to review by the second-level judicial court.

In December 2023, we received a new tax assessment relating to the taxation of profits of foreign subsidiaries. We filed a defense in January 2024 and the case is pending decision by the first-level

   
 109 
 

administrative court. The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2023 is approximately R$6.1 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

Disallowance on Income Tax Deduction

In January 2020, Arosuco (one of our subsidiaries) received a tax assessment from the RFB regarding the disallowance of the income tax reduction benefit provided for in the Provisional Measure No. 2199-14/2001, for calendar years 2015 to 2018. In response, an administrative defense was filed. In October 2020, the first level administrative Court rendered an unfavorable decision to Arosuco. Arosuco filed an appeal against the aforementioned decision, which is currently pending judgment by the Lower Administrative Court.

The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2023, is approximately R$2.6 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

This uncertain tax position, as per ICPC 22/IFRIC 23, continued to be adopted by Arosuco impacting calendar years following those assessed (2019-2023) in which it benefited from the income tax reduction provided for in Provisional Measure No. 2199-14/2001. In a scenario Arosuco is questioned on this matter for future periods, on the same basis and arguments as the aforementioned tax assessment, Arosuco management estimates that the outcome of such potential further assessments would be consistent with the already assessed periods.

Goodwill - InBev Holding

In December 2011, we received a tax assessment from the RFB related to the goodwill amortization in calendar years 2005 to 2010 resulting from Inbev Holding Brazil’s merger. At the administrative level, decisions partially favorable to us were rendered by both the Lower and Upper Administrative Court. We filed judicial proceedings to discuss the unfavorable portion of the decisions of Administrative Courts and requested injunctions to suspend the enforceability of the remaining amount being charged. The injunctions were granted.

In June 2016, we received a new tax assessment charging the remaining value of the goodwill amortization (from 2011 to 2013) and filed a defense. Partially favorable decisions were rendered by the first level administrative court and the Lower Administrative Court. The tax authorities and us both filed Special Appeals, which were partially admitted by the Upper Administrative Court. For the unfavorable portion of the decision which became final at the administrative level, we filed a judicial proceeding requesting an injunction to suspend the enforceability of the remaining tax credit, which was granted.

In April 2023, we received a partially favorable decision at the Upper Administrative Court for the portion of the tax assessment which was subject to the Special Appeals filed by us and the tax authorities. In June 2023, we filed a judicial proceeding to appeal the unfavorable portion of the decision, which is currently pending judgment at the first-level judicial court.

The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2023 is approximately R$6.5 billion. The risk of loss has been classified as possible and accordingly, no related provision has been made. In the event we are required to pay these amounts, ABI will reimburse us in the amount proportional to the benefit received by us pursuant to the merger protocol as well as the related costs.

Goodwill - Beverage Associate Holding (BAH)

In October 2013, we received a tax assessment related to the goodwill amortization in calendar years 2007 to 2012 resulting from the merger of Beverage Associates Holding Limited (“BAH”) into us. The decision from the first-level administrative court was unfavorable to us. We filed an appeal to the Lower Administrative Court against the decision, which was partially granted. The tax authorities and us both filed Special Appeals to the Upper Administrative Court. In July 2022, the Upper Administrative Court rendered a partially favorable decision to us. The decision did not recognize the Special Appeal filed by the tax authorities, thereby preserving the portion of the decision rendered by the Lower Administrative Court that was favorable to us with respect to the qualified penalties applied and the statute of limitations for one of the calendar years under discussion;

   
 110 
 

this portion of the decision is final. In January 2023, we filed a judicial proceeding to appeal the unfavorable portion of the decision and received a favorable decision at the first-level judicial court. The tax authorities appealed this decision, and the matter is pending judgment at the second level judicial court.

In April and August 2018, we received new tax assessments charging the remaining value of the goodwill amortization in calendar years 2013 to 2014 and filed defenses. In April 2019, the first-level administrative court rendered unfavorable decisions to us. As a result, we appealed to the Lower Administrative Court. In November and December 2019, we received partially favorable decisions at the Lower Administrative Court. Ambev and the tax authorities filed Special Appeals to the Upper Administrative Court. In April 2023, the Upper Administrative Court rendered partially favorable decisions to us, related to the qualified penalties, in the Special Appeals. In June 2023, we filed a judicial proceeding to appeal the unfavorable portion of the decisions and received favorable decisions at the first-level judicial court. The tax authorities appealed these decisions, and the matter is pending judgment at the second level judicial court.

The updated assessed amount related to this uncertain tax position, as per ICPC22/ IFRIC 23, as of December 31, 2023, is approximately R$1.4 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

Goodwill - CND Holdings

In November 2017, we received a tax assessment related to the goodwill amortization in calendar years 2012 to 2016 resulting from the merger of CND Holdings into Ambev. The decision issued by first level administrative court was unfavorable to us. We filed an appeal to the Lower Administrative Court which was partially granted. Given the partially favorable decision, both us and the Brazilian tax authorities appealed to the Upper Administrative Court. The decision regarding these appeals is still pending.

In October 2022, we received a new tax assessment charging the remaining value of the goodwill amortization in calendar year 2017. We filed a defense and in October 2023 received an unfavorable decision from the first-level administrative court. We have filed an appeal to the Lower Administrative Court. The updated assessed amount related to this uncertain tax position, as per ICPC 22/IFRIC 23, as of December 31, 2023 is approximately R$1.4 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

Goodwill - MAG

In December 2022, CRBS S.A (one of our subsidiaries) received a tax assessment related to the goodwill amortization in calendar years 2017 to 2020, resulting from the merger of RTD Barbados into CRBS, with the latter as the surviving entity. CRBS filed a defense in January 2023. In November 2023, CRBS received a partially favorable decision from the first-level administrative court which reduced the qualified penalty applied to 100% (instead of 150% as initially charged). This decision is not final and is subject to review by the Lower Administrative Court. CRBS has filed an appeal to the Lower Administrative Court against the unfavorable portion of the decision.

The updated assessed amount to this uncertain tax position, as per ICPC22/IFRIC 23, as of December 31, 2023 is approximately R$0.3 billion. We have not recorded any provisions for this matter as we consider the chance of loss to be possible.

This uncertain tax position, as per ICPC 22/IFRIC 23, continued to be applied by the Company impacting calendar years following those assessed (2021- February 2022). In a scenario we are questioned on this matter for future periods, on the same basis and under the same arguments as the aforementioned tax assessments, we estimate that the outcome of such potential further assessments would be consistent to the already assessed periods.

Disallowance of financial expenses and Deductibility of Losses

In 2015, 2016 and 2020, we received tax assessments related to the disallowance of alleged non-deductible expenses and the deduction of certain losses mainly associated with financial investments and loans. We presented defenses and, in November 2019, received a favorable decision at the first-level administrative court regarding the 2016 case, which was confirmed by the Upper Administrative Court in April 2023.

   
 111 
 

In June 2021, we received a partially favorable decision for the 2020 case at the first-level administrative court and filed an appeal to the Lower Administrative Court. In March 2023, we received a favorable decision from the Lower Administrative Court, which fully canceled the tax assessment related to 2020, and this decision became final in May 2023. In June 2022, we received a partially favorable decision at the first-level administrative court regarding the 2015 case and filed an appeal to the Lower Administrative Court. The favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court.

The updated assessed amount related to this uncertain tax position, as per ICPC 22/ IFRIC 23, as of December 31, 2023 is approximately R$0.3 billion. We have not recorded any provisions for this matter based on the probability of loss of the lawsuit.

Disallowance of Taxes Paid Abroad

Since 2014, we have been receiving tax assessments from the Brazilian Federal Tax Authorities, for calendar years as of 2007, related to the disallowance of deductions associated with alleged unproven taxes paid abroad by its subsidiaries and has been filing defenses. The cases are being challenged at both the administrative and judicial levels. In November 2019, the Lower Administrative Court rendered a favorable decision to us in one of the cases (related to the 2010 tax period), which became definitive.

In January 2020, the Lower Administrative Court rendered unfavorable decisions regarding four of these assessments related to the periods of 2015 and 2016, for which we filed Special Appeals to the Upper Administrative Court. We received unfavorable decisions at the Upper Administrative Court in respect of the Special Appeals in April 2023, and filed an appeal to the first-level judicial court in November 2023.

In connection with the tax assessments related to the periods of 2015 and 2016, additional tax assessments were filed to charge isolated fines due to the lack of monthly prepayments of income tax as a result of allegedly undue deductions of taxes paid abroad. In 2021, we received unfavorable decisions from the first-level administrative court in two of these assessments with respect to the 2015 and 2016 isolated fine cases, and filed appeals in connection therewith, which are pending judgment by the Lower Administrative Court. In 2022, we received an unfavorable decision from the first-level administrative court in the second assessment related to the 2016 isolated fine case, and filed an appeal in connection therewith which is currently pending judgment by the Lower Administrative Court. In October 2022, we received a new tax assessment charging such isolated fine related to calendar year 2017. We have filed a defense in this case, which is currently pending judgment by the first-level administrative court.

The other cases are still pending final decisions at both administrative and judicial courts.

In November 2023, we received a new tax assessment charging such isolated fine related to calendar year 2018. We have filed a defense in this case, which currently is pending judgment by the first-level administrative court.

The updated assessed amount related to this uncertain tax position as of 31 December 2023, which is classified as a possible loss in accordance with IFRIC 23, is approximately R$14.3 billion.

The company has continued to take the same deductions for the calendar years following the assessed periods (2018 to 2023). Therefore, if we receive similar tax assessments for this period, our management believes the outcome would be the same as those tax years already assessed.

Presumed Profit

In April 2016, Arosuco (one of our subsidiaries) received a tax assessment regarding the use of the “presumed profit” method for the calculation of income tax and the social contribution on net profit instead of the “real profit” method. In September 2017, Arosuco received an unfavorable first level administrative decision and filed an appeal. In January 2019, the Lower Administrative Court rendered a favorable decision to Arosuco, which became final.

   
 112 
 

In March 2019, a new tax assessment regarding the same subject matter was received and we filed a defense. In October 2019, Arosuco received an unfavorable first level administrative decision and filed an appeal.

As of December 31, 2023, Arosuco’s management estimated that the updated assessed amount related to this uncertain tax position, as per IFRIC 23, is approximately R$0.6 billion. The risk of loss has been classified as possible and, accordingly, no related provision has been made.

Deductibility of IOC expenses

In 2013, we implemented a corporate restructuring with the purpose of simplifying our corporate structure and converting into a single class of shares company, among other reasons. One of the steps of such restructuring involved a contribution of shares followed by the merger of shares of its controlled entity, Companhia de Bebidas das Américas, into Ambev. Consequently, the counterpart accounting of the positive difference between the value of shares issued by virtue of the merger and the net equity value of its controlled entity’s share was accounted, as per IFRS 10/CPC 36 and ICPC09, in an equity account of Ambev referred to as carrying value adjustment.

In November 2019, we received a tax assessment from the Brazilian Federal Tax Authorities related to the interest on capital (“IOC”) deduction in 2014. The assessment refers primarily to the accounting and corporate effects of the restructuring carried out by us in 2013 and its impact on the increase in the deductibility of IOC expenses. In August 2020, we received a partially favorable decision at the first-level administrative court and filed an appeal to the Lower Administrative Court, which is currently pending judgement. The favorable portion of the decision is subject to mandatory review by the Lower Administrative Court.

In December 2020, we received a new tax assessment related to the deduction of the IOC in 2015 and 2016. We filed a defense against this new tax assessment in January 2021. In June 2021, we received a partially favorable decision and filed an appeal to the Lower Administrative Court, which is also currently pending judgment. Similar to the first tax assessment, the favorable portion of the decision is also subject to mandatory review by the Lower Administrative Court.

In December 2022, we received a new tax assessment related to the deduction of the IOC in 2017. We filed a defense against this new tax assessment in January 2023. In September 2023, we received a partially favorable decision at the first-level administrative court and filed an appeal to the Lower Administrative Court against the unfavorable portion of the decision. The favorable portion of the decision is subject to mandatory review by the Lower Administrative Court.

In November 2023, we received a new tax assessment related to the deduction of the IOC in the periods 2018 to 2021. We have filed a defense against this new tax assessment, which is pending decision by the first-level administrative court.

The updated assessed amount related to this uncertain tax position as of 31 December 2023, which is classified as a possible loss in accordance with IFRIC 23, is approximately R$27.4 billion. We have not recorded any provisions for this matter based on the probability of loss.

The uncertain tax position, as per IFRIC 23, continued to be adopted by us as it also distributed or accrued IOC in the years following the assessed period (2022-2023) and deducted such amounts from its Corporate Income Taxes taxable basis. Therefore, in a scenario where the IOC deductibility would also be questioned for the period after 2021, on the same basis and arguments as the aforementioned tax assessments, our management estimates that the outcome of such potential further assessments would be consistent with the already assessed periods. In December 2023, the Provisional Measure (MP) 1,185, enacted in August 2023, was converted into Law No. 14,789/2023, which changes the calculation basis for interest on equity from January 1, 2024, limiting this uncertain tax treatment to IOC calculated in accordance with provisions prior to the enactment of the said Law No. 14,789/2023.

Tax Loss Offset

We and certain of our subsidiaries have received a number of assessments from the Brazilian Federal Tax Authorities relating to the offset of tax losses carried forward in the context of business combinations.

   
 113 
 

Two main cases dealing with this matter are under judicial review. In one of the cases, we received favorable decisions in first and second instances of the judiciary, which prompted the National Treasury to file a special appeal, pending judgment by the STJ. In the second case, we received an unfavorable decision in the first instance of the judiciary and filed an appeal, pending judgment.

In December 2023, there was a third case under administrative review, which, in February 2023, was unfavorably decided against us by the Upper Administrative Court ("CSRF") by a casting vote. Due to the outcome of the judgment and considering the reductions provided for in Law No. 14,689/2023, after receiving notification of the decision, we opted to pay the case in December 2023, with the corresponding reductions.

The updated assessed amount related to this uncertain tax position as of December 31, 2023, which is classified as a possible loss in accordance with IFRIC 23, is approximately R$0.2 billion. We have not recorded any provisions for this matter based on the probability of loss.

Adherence to the Special Tax Regularization Program

In September 2017, we decided to participate in the Federal Tax Amnesty Program established by Provisional Measure No. 783/2017, converted into Law No. 13,496/2017, or PERT 2017, undertaking to pay certain tax assessments that were in dispute under administrative or judicial levels, including debts from our subsidiaries, in the total amount of R$3.5 billion (already considering discounts established by the program). The total amount paid in 2017 was approximately R$960.0 million and the balance will be paid in 145 monthly installments, with interest, as of January 2018. All installments due up to date have been paid by the Company.

Despite our participation in this program, we could be subject to tax audits for subsequent periods, which may lead to tax challenges by the relevant authorities on similar claims. In addition, if we are delinquent in our payments under these programs or are otherwise unable to pay as scheduled, we may be barred from participating in this program and similar programs this.

Tax Proceeding Initiated By Us

PIS and COFINS Recovery - exclusion of ICMS (VAT) and ICMS-ST from the basis of calculation

In 2017, the STF declared, in the judgment of RE No. 574,706/PR, with binding effects, the unconstitutionality of the inclusion of ICMS in the tax base of PIS and COFINS. Regarding ICMS under the tax substitution modality, on December 13, 2023, the Brazilian Superior Court of Justice (“STJ”) decided in favor of taxpayers, determining the exclusion of this ICMS modality in the tax basis of PIS and COFINS (Theme 1,125).

From 2017 to 2023 the Company and its subsidiaries recognized, in accordance with IAS 37/CPC 25, recoverable extemporaneous tax credits related to this matter in the amount of R$10.5 billion. The accounting recognition of these amounts is due to (i) the gain being virtually certain given the decision of the STF in RE 574,706/PR and the STJ in Theme 1,125, align with specific circumstances of each case; and (ii) the value can be reasonably estimated with a high degree of confidence through the collection of pertinent documents and quantification of the associated amount.

   
 114 
 

For additional matters, the Company estimates that the contingent asset corresponds to R$0.2 billion, which will be recognized once the realization of the gain is virtually certain given the specific circumstances of the case and upon confirmation of the estimated values with sufficient reliability.

Subsequent Events

IPI Excise Tax Suspension

As disclosed, we awaited to be served of the decision rendered by the Superior Chamber of Tax Appeals (CSRF), which partially granted the Special Appeal filed by us regarding the suspension of IPI. In January 2024, we were served with the decision, resulting in a 98% reduction of the assessed amount, equivalent to approximately R$916 million. Regarding the remaining portion of the debt, we will pursue legal action seeking its full cancellation.

Presumed Profit

In February 2024, the Administrative Council for Tax Appeals (“CARF”) issued an unanimous favorable decision in the administrative process discussing Arosuco’s (a subsidiary of Ambev) use of the presumptive profit method for calculating IRPJ and CSLL instead of actual profit. The amount classified as a possible contingency for the process was R$633.4 million on December 31, 2023 (R$581.5 million on December 31, 2022). We are currently awaiting the formalization and service of the decision to, together with its external advisors, assess any potential impacts on the risk classification of the contingency and take any necessary actions.

Disallowance on Income Tax deduction

In February 2024, CARF rendered a partially favorable, unanimous decision in the administrative process discussing the disallowance of the tax benefit reduction provided by Provisional Measure No. 2,199-14/2001, that benefited Arosuco, one of our subsidiaries dedicated to the production of concentrates, located in the Manaus Free Trade Zone, during the years 2015 to 2018. The decision partially granting the appeal filed by Arosuco recognized the full enjoyment of the tax incentive, maintaining only a portion of the assessment related to the difference in calculation methodology between the tax authorities and the taxpayer. The portion related to the tax incentive amounts to approximately US$0.5 billion, and the portion related to the calculation difference amounts to approximately US$5.3 million. We are currently awaiting the formalization and service of the judgment to, together with our external advisors, assess any impact of the judgment on the contingency risk classification, as well as to take any necessary measures.

Labor Matters

We are involved in more than 21,000 labor claims. Most of the labor claims we face relate to our Brazilian operations. In Brazil, it is not unusual for a large company to be named as a defendant in such a significant number of claims. As of December 31, 2023 we made provisions totaling R$149.9 million in connection the above labor claims involving former, current and outsourced employees relating mainly to overtime, dismissals, severance, health and safety premiums, supplementary retirement benefits and other matters, all of which are pending court ruling and have probable chance of loss. As of December 31, 2023, we were party to labor claims with a total estimated possible risk of loss of R$176.9 million.

In connection with the labor matters, we are also involved in claims regarding the social security charges on payroll. Management estimates the possible losses related to these claims to be, approximately, R$264.8 million as of December 31, 2023. We have recorded provisions of approximately R$97.5 million for proceedings where we consider the chance of loss to be probable. The total amount of the social security contingency is considered in our total amount of tax contingencies.

Ambev Third-Party Supplier – Labor Infractions and Lawsuits

In May 2021, we were notified by Brazilian labor authorities to join certain administrative proceedings together with (i) Transportadora Sider Limeira EIRELI (“Sider”), a third-party transportation company contracted by us periodically and (ii) a third-party competitor that also used Sider’s transportation services. The Brazilian labor inspection authorities determined that we were jointly and severally liable for human rights

   
 115 
 

violations committed by Sider with respect to the working conditions of 23 foreign employees, under the terms of Brazilian Labor Law, including violations of article 444 of Law-Decree No. 5,452 and article 2-C of Law No. 7,998.

On March 12, 2021, Sider entered into a settlement with those foreign employees in relation to the administrative claims paying them severance compensation and moral damages. However, following this settlement, beginning at the end of 2022, 19 of these foreign employees that were the subject of the earlier administrative proceedings, together with additional former employees of Sider, filed individual labor lawsuits against Sider, the third-party competitor and us, claiming, among other things, moral damages for the same labor violations. The plaintiffs in these lawsuits claim secondary liability with respect to us.

In addition, the Brazilian Ministry of Labor and Social Security (the “Ministry of Labor”) issued infraction notices against Sider, the third-party competitor and us related to the same matter in 2021. These infraction notices were confirmed by the administrative authority in 2024, and, as a result, we no longer have any means to appeal or dispute these infractions at an administrative level. Notwithstanding, we continue to dispute any involvement with the alleged facts underlying these labor claims, and, to this end, we are seeking judicial relief to declare the administrative acts void and, also, injunctive relief to suspend Ambev’s inclusion in the Brazilian register of employers (Cadastro de Empregadores) that lists employers that have subjected workers to poor working conditions under the terms of Brazilian Interministerial Ordinance MTPS/MMIRDH No. 4/2016 (“Register of Employers”). The injunction requested by us was granted by the court in February 2024 and, as a result, the collection of fines in the amount of approximately R$50,000 (plus any interest and monetary adjustments) as well as the inclusion of Ambev in the Register of Employers is currently suspended as of the date of this annual report on Form 20−F. The injunction is subject to appeal by the Ministry of Labor. Our inclusion in the Register of Employers may result in several adverse consequences, including, among others (i) reputational harm, (ii) restrictions on our ability to obtain financing through state-owned banks’ credit lines and (iii) potential adverse risk assessments by private banks and other parties, which could, among other effects, negatively affect our ability to access financing in the future. As of December 31, 2023, we did not record any provisions in connection with these infraction notices.

In addition, the Brazilian Public Labor Prosecutor’s Office (the “Public Labor Prosecutor’s Office”) opened a civil investigation to assess the underlying facts and the role of each of the three companies in these labor violations. In connection therewith, we entered into a Conduct Adjustment Agreement with the Public Labor Prosecutor’s Office in April 2022 without admission of guilt pursuant to which we agreed to pay damages in the amount of R$500 thousand and commit to a 3-year plan to oversee conditions of our logistics operators.

Civil Claims

As of December 31, 2023, we were involved in more than 3,700 civil claims that were pending, including third-party distributors and product-related claims. We have established provisions totaling R$324.5 million for proceedings where we consider the chance of loss to be probable reflecting applicable adjustments, such as accrued interest, as of December 31, 2023 in connection with civil claims. As of December 31, 2023, we were party to civil claims with a total estimated possible risk of loss of R$189.4 million.

Subscription Warrants

In 2002, we decided to request a ruling from the CVM in connection with a dispute between Old Ambev and some of its warrant holders regarding the criteria used in the calculation of the strike price of certain Old Ambev warrants. In March and April 2003, the CVM ruled that the criteria used by Old Ambev to calculate the strike price were correct. In response to the CVM’s final decision and seeking to reverse it, some of the warrant holders filed separate lawsuits before the courts of São Paulo and Rio de Janeiro.

Although the warrants expired without being exercised, the warrant holders claim that the strike price should be reduced to consider the strike price of certain stock options granted by Old Ambev under its then-existing stock ownership program, as well as for the strike price of other warrants issued in 1993 by Brahma.

We are aware of at least seven claims in which the plaintiffs argue that they would be entitled to those rights.

   
 116 
 

The holders of these warrants claimed that they should receive the dividends relative to these shares since 2003, approximately R$1.2 billion in addition to legal fees. Among the seven cases related to this topic, one was settled in previous years. Five cases have been finally resolved favorably to Ambev, with three of these decided in the second quarter of 2023. The last case was ruled favorably to Ambev by the Superior Court of Justice and the decision became final in September 2023. With the closure of the last case, this litigation has ended completely in favor of the Company. No provisions have been made in connection with this litigation.

Lawsuit Against the Brazilian Beer Industry

On October 28, 2008, the Brazilian Federal Prosecutor’s Office (Ministério Público Federal) filed a suit for damages against us and two other brewing companies claiming total damages of approximately R$2.8 billion (of which approximately R$2.1 billion are claimed against us). The public prosecutor alleges that: (1) alcohol causes serious damage to individual and public health, and that beer is the most consumed alcoholic beverage in Brazil; (2) defendants have approximately 90% of the national beer market share and are responsible for heavy investments in advertising; and (3) the advertising campaigns increase not only the market share of the defendants but also the total consumption of alcohol and, hence, cause damage to society and encourage underage consumption.

Shortly after the above lawsuit was filed, a consumer-protection association applied to be admitted as a joint plaintiff. The association has made further requests in addition to the ones made by the Public Prosecutor, including the claim for “collective moral damages” in an amount to be ascertained by the court; however, it suggests that it should be equal to the initial request of R$2.8 billion (therefore, doubling the initial amount involved). The court has admitted the association as joint-plaintiff and has agreed to hear the new claims. After the exchange of written submissions and documentary evidence, the case was dismissed by the Lower Court Judge, which denied all the claims submitted against Ambev and the other defendants. The Federal Prosecutor’s Office appealed to the Federal Court, which decided for the annulment of the lower court decision, based on the understanding that more evidence should have been produced before the case’s dismissal. Ambev filed a motion for clarification against the decision, which was rejected, and such decision became final. The case has now returned to the lower court for a new trial, which is pending since September 2021. Ambev believes, based on management assessments, that its chances of loss remain remote and, therefore, has not made any provision with respect to such claim.

Lawsuit Against F. Laeisz

On April 4, 2018, F. Laeisz filed a lawsuit against us for collection of dividends relating to 74,211,825 ordinary shares issued by Ambev and held in our treasury since April 10, 2012. F. Laeisz alleges that: (1) it is the rightful owner of the shares; and (2) the ownership of registered shares shall be based on the registration under the shareholder’s name on the company’s Share Registry Book.

The Lower Court Judge granted our request to admit the Federal Government as joint defendant since it also claims to be the owner of such shares, as the Federal Government was entitled to incorporate such shares based on a decree enacted during World War II. In October 2019, the Lower Court Judge granted F. Laeisz’s claims ordering Ambev to pay the amount equivalent to the dividends of 74,211,825 ordinary shares held in our treasury since April 10, 2012. On September 30, 2022, such decision was subject to a mandatory review by the Federal Court of Appeals, since the Federal Government lost its preliminary claims, and the decision was overturned by the Federal Court of Appeals, which considered the ordinary shares had been duly transferred and incorporated by the Federal Government based on the decree enacted during the World War II. F. Laeisz appealed against this decision, which is pending. In parallel, we have negotiated and executed a settlement agreement with F. Laeisz, aiming at reducing the total amount under dispute. Except for inflation adjustment, F. Laeisz has agreed on restrictions to the application of interests to adjust the dividends in the event there is a final decision confirming F. Laeisz as the rightful owner of the shares. We believe, based on management assessments, that our chances of loss are possible. Nonetheless, irrespective to whom is considered the rightful owner of the shares in question, we have duly accounted for all dividends relating to the relevant shares since April 10, 2012.

Cerbuco Brewing Arbitration

   
 117 
 

Cerbuco Brewing Inc., (“Cerbuco”) a Canadian subsidiary of Ambev, owns a 50% equity ownership in Cerveceria Bucanero S.A. (“Bucanero”), a joint venture in Cuba. In 2021, Cerbuco initiated an arbitration proceeding at the International Chamber of Commerce (“ICC”), relating to a potential breach of certain obligations relating to the joint venture, with the terms of reference being formally executed in 2022. Depending on the outcome of the arbitration proceedings, there may be an impact on Cerbuco’s ability to influence the management of Bucanero’s operations. As a result, Ambev’s ability to continue consolidating Bucanero into its financial statements may also be affected. Based on the opinion of Cerbuco’s lawyers, the management estimates the chance of loss as possible. The amount involved has not yet been ascertained, as it depends on the outcome of the arbitration.

Proposed class action in Quebec

Labatt and other third-party defendants have been named in a proposed class action lawsuit in the Superior Court of Quebec seeking unquantified compensatory and punitive damages. The plaintiff alleges that the defendants failed to warn of certain specific health risks of consuming defendants’ alcoholic beverages. A sub-class of plaintiffs further alleges that their illnesses were caused by the consumption of defendants’ products. The proposed class action has not yet been authorized by the Superior Court.

 

Dividend Policy

The timing, frequency and amount of future dividend payments, if any, will depend upon various factors that our Board of Directors may consider relevant, including our earnings and financial condition. Our bylaws provide for a minimum mandatory dividend of 40% of our adjusted annual net income, if any, as determined under IFRS at our individual financial statements. Brazilian companies are permitted to make limited distributions to shareholders in the form of interest accrued on share capital, commonly referred to as “interest on shareholders’ equity,” and treat such payments as a deductible financial expense for purposes of Brazilian income tax and social contribution on profits. This notional interest distribution is treated for accounting purposes as a deduction from shareholders’ equity in a manner similar to a dividend. The benefit from the tax-deductible interest on shareholders’ equity is recorded in the income statement. The minimum mandatory dividend includes amounts paid as interest on shareholders’ equity (net of taxes). However, payment of such interest on shareholders’ equity is subject to Brazilian withholding income tax, whereas no such withholding is required in connection with dividends paid. For further information on this matter see “Item 10. Additional Information—E. Taxation—Brazilian Tax Considerations—Income Tax.”

Annual adjusted net income not distributed as dividends or interest on shareholders’ equity may be capitalized, used to absorb losses or otherwise appropriated as allowed under the Brazilian Corporation Law and our bylaws. Therefore, annual adjusted net income amounts may not necessarily be available to be paid as dividends. We may also not pay dividends to our shareholders in any particular fiscal year based on the opinion of the Board of Directors that such distribution would be inadvisable in view of our financial condition at the time. Any such dividends not distributed would be allocated to a special reserve account for future payment to shareholders, unless used to offset subsequent losses. For further information on this matter, see “Item 3. Key Information— D. Risk Factors—Risks Relating to Our Common Shares and ADSs—Our shareholders may not receive any dividends.”

For further information on provisions of the Brazilian Corporation Law relating to required reserves and payment of dividends or interest on shareholders’ equity, as well as specific rules applicable to the payment of dividends by us under our bylaws, see “Item 10. Additional Information—B. Memorandum and Articles of Association—Reserves.”

Ambev S.A.

The following table shows the cash dividends paid by Ambev to holders of Ambev’s common shares in reais and in U.S. dollars (translated from reais at the commercial exchange rate as of the date of payment) for each of the indicated periods. The amounts include interest on shareholders’ equity, net of withholding tax. The last distribution of dividends approved, which relates to the 2023 fiscal year, was paid by Ambev on December 28, 2023.

   
 118 
 

 

Date of Approval

First Payment Date

Reais per Shares(1)

U.S. Dollar Equivalent per Share at Payment Date(1)(2)

       
Second half 2021 December 30, 2021 0.1334 0.023
       
Second half 2021 December 30, 2021 0.3996 0.070
       
Second half 2022 December 29, 2022 0.6480 0.124
       
Second half of 2023 December 28, 2023 0.6207 0.128
       
 
(1)The amounts set forth above are amounts actually received by shareholders, which are net of withholding tax. The financial statements present the amounts actually disbursed, including the withholding tax on interest on shareholders’ equity, which was paid by Ambev on behalf of shareholders. The dividends set forth above are calculated based on the number of outstanding shares at the date the distributions were declared. See “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders.”
(2)Translated to U.S. dollars at the exchange rate in effect at the first scheduled payment date.

For more information on rules and procedures for shareholder distributions under our bylaws, see “Item 10. Additional Information—B. Memorandum and Articles of Association—Reserves.”

B.        Significant Changes

Except as otherwise disclosed in our audited consolidated financial statements and in this annual report, there have been no significant changes in our business, financial conditions or results in December 31, 2023.

   
 119 
 
ITEM 9.THE OFFER AND LISTING

A.        Offer and Listing Details

Not applicable. Information regarding the price history of the stock listed as required by Item 9.A.4 is set forth below in “—C. Principal Market and Trading Market Price Information.”

B.        Plan of Distribution

Not applicable.

C.        Principal Market and Trading Market Price Information

We are registered as a publicly held company with the CVM. Our common shares are listed on the B3 under the symbol “ABEV3” and our ADSs are listed on the NYSE under the symbol “ABEV”. Our shares and ADSs began trading on the B3 and the NYSE, both on November 11, 2013. The shares and ADSs of Old Ambev ceased all trading activities on those stock exchanges on the close of business of November 8, 2013.

Ambev has only one class of shares (i.e., voting common shares), including in the form of ADSs (evidenced by ADRs), with each ADS representing one Ambev common share. The Ambev common shares and ADSs are registered under the Exchange Act. As of March 1, 2023, Ambev had 15,741,734,691 shares outstanding. As of March 1, 2024, there were 1,410,127,080 Ambev ADSs outstanding (representing 1,410,127,080 Ambev shares, which corresponds to 8.9% of the total Ambev shares outstanding). The Ambev shares held in the form of ADSs under the Ambev ADS facilities are deemed to be the shares held in the “host country” (i.e., the United States) for purposes of the Exchange Act. In addition, as of March 1, 2024 there were 227  registered holders of Ambev ADSs.

Regulation of the Brazilian Securities Market

The Brazilian securities market is regulated and supervised by the CMN and the Central Bank,, which have regulatory authority over Brazil’s stock exchanges and securities markets. The CMN regulates and supervises the activities of the CVM, which has, among other powers, licensing authority over brokerage firms and regulates foreign investment and foreign exchange transactions. The Brazilian securities market is governed primarily by Law No. 6,385 dated December 7, 1976, as amended, or the Brazilian Securities Law, and by the Brazilian Corporation Law, as amended and supplemented, as well as by rules and regulations issued by the CVM, the CMN and Brazilian Central Bank. These laws and regulations, among others, provide for disclosure requirements, criminal penalties for insider trading and price manipulation, and protection of minority shareholders, licensing procedures, supervision of brokerage firms and governance of Brazilian stock exchanges. However, the Brazilian securities markets are not as highly regulated and supervised as U.S. securities markets.

Under the Brazilian Corporation Law, a company is either publicly held (companhia aberta), such as Ambev, whose shares are publicly traded on the B3, or privately held (companhia fechada). A company is publicly held when it is authorized to have securities traded on the stock exchange or on over-the-counter markets. All publicly held companies must be registered with the CVM and are subject to reporting and regulatory requirements relating to the periodic disclosure of information and material facts. Additionally, the CVM within its regulatory authority may request information or clarification from us regarding our business activities and/or transactions to which we are a party. A company registered with the CVM may trade its securities either on the Brazilian stock exchanges, including B3, or in the Brazilian over-the-counter market. Shares of companies like Ambev traded on the B3 may not simultaneously be traded on the Brazilian over-the-counter market. The over-the-counter market consists of direct trades between persons in which a financial institution registered with the CVM serves as an intermediary. The shares of a listed company, including Ambev, may also be traded privately subject to several limitations. To be listed on the B3, a company must be registered as a publicly held Company with the CVM and apply for registration with the B3.

The over-the-counter market is divided into two categories: (1) an organized over-the-counter market, in which the transactions are supervised by self-regulating entities authorized by the CVM; and (2) a non-organized over-the-counter market, in which the transactions are not supervised by self-regulating entities authorized by the CVM. In either case, transactions are directly traded among persons, outside of the stock

   
 120 
 

exchange market, through a financial institution authorized by the CVM. The institution is required to be registered with the CVM (and in the relevant over-the-counter market), but there is no need for a special license to trade securities of a publicly listed company on the over-the-counter market.

The trading of securities on the Brazilian stock exchanges may be suspended under certain circumstances, including at the request of a company in anticipation of a disclosure of material announcement. Trading may also be suspended on the initiative of a Brazilian stock exchange or the CVM, among other reasons, based on or due to a belief that a company has provided inadequate information regarding a significant event or has provided inadequate responses to inquiries by the CVM or B3.

Trading on the Brazilian Stock Exchanges

B3 is a stock exchange and leading operator of registration, clearing, custodial and settlement services for equities, financial securities, indices, rates, commodities, and currencies in Brazil. B3 is currently the only Brazilian stock exchange on which private equity and private debt may be traded.

Trading on the exchange is conducted by authorized members. B3 trading sessions take place every business day, from 10:00 a.m. to 5:00 p.m., BRT. Equity trading is executed fully electronically through an order-driven trading system called “PUMA (Plataforma Unificada Multiativos).” The B3 also allows trading from 5:30 p.m. to 6:00 p.m. on an online system known as the “after-market,” which is connected to traditional broker dealers and brokerage firms operating on the Internet. Trading on the after-market is subject to regulatory limits on price volatility and on the volume of shares transacted through online brokers. CVM has discretionary authority to suspend trading in shares of a particular issuer under specific circumstances. Securities listed on the B3 may also be traded off the exchange under specific circumstances, but such trading is very limited.

Settlement of transactions is performed two business days after the trade date, without any adjustment to the purchase price. Delivery of and payment for shares are made through the facilities of an independent clearing house, B3 Central Depository, which is the clearing house for the transactions carried out on the B3 and handles the multilateral counterparty settlement of both financial obligations and transactions involving securities. According to the regulations of the B3 Central Depository, financial settlement is carried out through the funds transfer system of the Central Bank and the transactions involving the sale and purchase of shares are settled through the B3 Central Depository custody system. All deliveries against final payment are irrevocable. The seller is ordinarily required to deliver the shares to the exchange on the second business day following the trade date. The B3 Equities Clearing is responsible for the registration, settlement and risk management of trades with shares through PUMA.

In order to better control volatility, B3 has adopted a “circuit breaker” mechanism pursuant to which trading sessions may be suspended for a period of 30 minutes or one hour whenever the primary B3 index (Ibovespa) falls below 10% or 15%, respectively, compared to the previous day’s closing index. If the primary B3 index falls below than 20% compared to the previous day, the B3 may determine the suspension of trading in all markets for a defined period, at its sole discretion, and such decision must be disclosed to the market.

Although the Brazilian equity market is Latin America’s largest in terms of market capitalization, it is smaller, more volatile and less liquid than the major U.S. and European securities markets. As of January 31, 2024, the aggregate market capitalization of all companies included in the IBOVESPA index of the B3 was equivalent to approximately R$3.94 trillion. Although all of the outstanding shares of a listed company are actually available for trading by the public, in most cases fewer than half of the listed shares are actually traded by the public because the remainders of a listed company’s shares are usually held by small groups of controlling persons, by governmental entities or by one principal shareholder. For this reason, data showing the total market capitalization of Brazilian stock exchanges tend to overstate the liquidity of the Brazilian equity securities market.

There is also significantly greater concentration in the Brazilian securities markets. For example, as of January 31, 2024 the ten companies with greatest representation on the IBOVESPA index of the B3 accounted for 55.6% of the total weight of all companies included in that stock index.

Trading on Brazilian stock exchanges by non-residents of Brazil is subject to limitations under Brazilian foreign investment legislation. See “Item 10. Additional Information—D. Exchange Controls and

   
 121 
 

other Limitations Affecting Security Holders” and “Item 10. Additional Information—B. Memorandum and Articles of Association—Restrictions on Foreign Investment.”

D.        Selling Shareholders

Not applicable.

E.        Dilution

Not applicable.

F.        Expenses of the Issue

Not applicable.

   
 122 
 
ITEM 10.ADDITIONAL INFORMATION

A.        Share Capital

Not applicable.

B.        Memorandum and Articles of Association

Below is a brief summary of the material provisions concerning our common shares, bylaws and the Brazilian Corporation Law. In Brazil, the principal governing document of a corporation is its bylaws (Estatuto Social). This description is qualified in its entirety by reference to the Brazilian Corporation Law and our bylaws. An English translation of our bylaws has been filed with the SEC as an exhibit to this annual report. A copy of our bylaws (together with an English translation) is also available for inspection at the principal office of the depositary and at our website (http://ri.ambev.com.br/). Information on ownership of our shares is set forth under “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders.”

On April 27, 2022, our Board of Directors approved the issuance of 5,550,560 new common shares with no par value as a result of the exercise of options granted under the Stock Options Programs approved by our Board of Directors on March 25, 2019, pursuant to our Stock Option Plan that was approved by our Shareholders on July 30, 2013. The issuance price per share was R$15.20 and our capital stock following the increase sums R$58,130,517,165.22, represented by 15,750,216,851 common shares with no par value.

On April 25, 2023, our Board of Directors approved the issuance of 3,616,433 new common shares with no par value as a result of the exercise of options granted under the Stock Options Programs approved by our Board of Directors on February 14 and 15, 2023, pursuant to our Stock Option Plan that was approved by our Shareholders on July 30, 2013. The issuance price per share was R$13.11 and our capital stock following the increase sums R$58,177,928,601.85, represented by 15,753,833,284 common shares with no par value.

As of March 1, 2024, our capital stock was equal to R$58,177,928,601.85 divided into 15,753,833,284 issued common shares, without par value, of which 4,384,418 were treasury shares, with no further changes since December, 2023. We are authorized to increase our capital up to 19,000,000,000 shares upon the decision of our Board of Directors, without the need to amend our bylaws. We have a single-class share structure, comprised exclusively of voting common shares, and there are no classes or series of preferred shares outstanding.

Pursuant to the Brazilian Corporation Law, we are allowed to sell in the open market any Ambev common shares that have been subscribed but not paid in full within the applicable deadline set forth in our bylaws or the applicable subscription bulletin under which those shares were issued. If an open market sale is impractical, any subscribed but unpaid Ambev common shares may be forfeited.

Each common share entitles the holder thereof to one vote at our shareholders’ meetings. Holders of common shares are not entitled to any preference upon our liquidation.

The Board of Directors individualize the compensation for each member of our management (including Directors), subject to the maximum global compensation amount approved by our shareholders. Each individual Director is prevented from voting on the decision regarding their own compensation. For more information on management compensation, see “Item 6. Directors, Senior Management and Employees—C. Board Practices—The Board of Directors—Operations and Finance Committee.”

There is no age limit for retirement applicable to the members of our Board of Director in our bylaws.

General

Our registered name is Ambev S.A., and our registered office is in the city of São Paulo, State of São Paulo, Brazil. Our registration number with the São Paulo Commercial Registry is 35,300,368,941. Our principal corporate purposes include the production and sale of beer, CSDs and other beverages. A more detailed description of our corporate purposes can be found in Chapter I, Article 3 of our bylaws.

   
 123 
 

Rights of the Ambev Common Shares

Each of our common shares is indivisible and entitles its holder to one vote at any shareholders’ meeting of Ambev. In accordance with our bylaws and the Brazilian Corporation Law, shareholders have the right to receive dividends or other distributions in proportion to their equity interest in our share capital. For additional information regarding the payment of dividends and other distributions relating to our common shares, see “Item 8. Financial Information” and “Consolidated Financial Statements and Other Financial Information—Dividend Policy.” In addition, our shareholders may freely transfer their shares and are entitled to be included in a statutory sale of control tender offer upon a disposition of our control (see item “Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council” for more information).

Also, upon our liquidation, and after the discharge of all our liabilities, our common shares entitle its holders to a participation in our remaining assets as capital reimbursement in proportion to their equity interest in our share capital. Except under certain circumstances, holders of our common shares have the right, but not the obligation, to subscribe for our future capital increases.

Moreover, pursuant to the Brazilian Corporation Law, neither our bylaws nor actions taken at a shareholders’ meeting may deprive a shareholder of the following rights:

othe right to participate in our profit distributions;
othe right to participate in our remaining assets in proportion to its equity interest in our share capital in the event of our liquidation;
opreemptive rights to subscribe for our common shares, convertible debentures and warrants, except in certain circumstances under the Brazilian Corporation Law, as described in “—Preemptive Rights”;
othe right to inspect and monitor our management, in accordance with the Brazilian Corporation Law; and
othe right to exercise appraisal rights and withdraw from the Company in the cases provided under the Brazilian Corporation Law, as described in “—Appraisal Rights.”

Shareholders’ Meetings

Pursuant to the Brazilian Corporation Law, shareholders, during shareholders’ meetings regularly called and convened, are generally empowered to pass resolutions relating to our corporate purpose as they may deem necessary. Shareholders’ meetings may be ordinary, such as the annual meeting, or extraordinary. Shareholders at the annual shareholders’ meeting (assembleia geral ordinária), which is required to be held within four months of the end of our fiscal year, have the exclusive power to approve our financial statements and to determine the allocation of our adjusted net income and the distribution of dividends with respect to the fiscal year ended immediately prior to the relevant annual meeting. Extraordinary shareholders’ meetings are convened to approve the remaining matters within their competency as provided by law and/or our bylaws. An extraordinary shareholders’ meeting may be held concurrently with an ordinary meeting.

A shareholders’ meeting is convened by publishing a meeting call notice no later than 21 days prior to the scheduled meeting date, on first call, and no later than eight days prior to the date of the meeting, on second call, and no fewer than three times, in a newspaper with general circulation in São Paulo, where we have our registered office. In certain circumstances, at the request of any shareholder (and as per additional regulations from CVM) and after hearing us, the CVM may (i) order, in a reasoned decision, that the meeting be postponed for up to 30 days, in case there is insufficient information for a vote to be held, which term will be counted as of the date on which complete information is delivered to shareholders; and (ii) stay call notices for up to 15 days in order to review the agenda and proposals subject to a shareholder vote at the meeting. At the shareholders’ meeting held on March 1, 2013, our shareholders designated Valor Econômico, a newspaper with general circulation in São Paulo for this purpose. The call notice must contain the date, time, place and agenda of the meeting, and in case of amendments to the bylaws, the indication of the relevant matters. CVM Resolution No. 81 of March 29, 2022, as amended (“CVM Resolution No. 81/22”), also requires that additional information be disclosed in the meeting call notice for certain matters. For example, in the event of an election

   
 124 
 

of all directors, the meeting call notice shall also disclose the minimum percentage of equity interest required from a shareholder to request the adoption of cumulative voting procedures. All documents in connection with the shareholders’ meeting’s agenda shall be made available to shareholders either within at least one month prior to the meeting or upon publication of the first meeting call notice, as the case may be, except if otherwise required by law or CVM regulations.

A shareholders’ meeting may be held on first call, if shareholders representing at least one quarter of the voting shares are present, except in some cases provided by law, such as in meetings seeking to amend the Company’s bylaws, which requires the presence, on first call of shareholders representing at least two-thirds of the voting shares. If no such quorum is present, an eight-day prior notice must be given in the same manner as described above, and a meeting may then be convened, on second call, without any specific quorum requirement, subject to the minimum quorum and voting requirements for specific matters, as discussed below.

Except as otherwise provided by law, resolutions of a shareholders’ meeting are passed by a simple majority vote of the shares present or represented at the meeting, abstentions not being considered. Under the Brazilian Corporation Law, the approval of shareholders representing at least a majority of the votes granted by the issued and outstanding voting shares is required for the types of actions described below (among others):

·creating preferred shares or increasing disproportionately an existing class of preferred shares relative to the other classes of shares, unless such action is provided for or authorized by the bylaws;
·modifying a preference, privilege or condition of redemption or amortization conferred upon one or more classes of preferred shares, or creating a new class with greater privileges than those of the existing classes of preferred shares;
·reducing the minimum mandatory dividend;
·merging Ambev with another company or consolidating or executing a spin-off of Ambev;
·related party transactions, or the sale or contribution of assets to another company, in each case if the amount involved exceeds 50% of the amount of our assets indicated in the most recently approved balance sheet;
·changing our corporate purpose; and
·dissolving Ambev or ceasing its liquidation status.

Shareholders may not exercise voting rights with respect to the approval of the appraisal report of assets contributed by them in a capital increase paid in kind or with respect to the approval of their own accounts as managers of the company, as well as in those resolutions that may favor those shareholders specifically, or whenever there is a conflicting interest with the Company. Mergers between affiliated parties are subject to a special statutory valuation procedure intended to provide a parameter (based on the net equity at market prices of the companies involved) for comparing the proposed exchange ratio.

Shareholders’ meetings may be called by our Board of Directors. Under the Brazilian Corporation Law, meetings may also be convened by our shareholders as follows: (1) by any shareholder, if the directors take more than 60 days to convene a shareholders’ meeting after the date they were required to do so under applicable laws and our bylaws, (2) by shareholders holding at least 5% of our total capital stock, if our Board of Directors fails to call a meeting within eight days after receipt of a justified request to call a meeting by those shareholders indicating the proposed agenda, (3) by shareholders holding at least 5% of our voting capital stock, if the directors fail to call a general meeting within eight days after receipt of a request to call a shareholders’ meeting for purpose of assembling a Fiscal Council, and (4) by our Fiscal Council, if the Board of Directors fails to call an annual shareholders’ meeting within 30 days after the mandatory date for such call. The Fiscal Council may also call an extraordinary shareholders’ meeting if it believes that there are important or urgent matters to be addressed.

To attend a shareholders’ meeting, shareholders or their legal representatives willing to attend the meeting shall present proof of ownership of their Company shares, including identification and/or pertinent documentation that evidences their legal representation of such shareholder. A shareholder may be represented

   
 125 
 

at a general meeting by an attorney-in-fact appointed no more than one year before the meeting, who must be another shareholder, a company officer, a lawyer or a financial institution. Notwithstanding the above, the CVM decided on November 4, 2014 that shareholders that are legal entities may be represented at general meetings by their legal representatives or by a duly appointed attorney-in-fact, pursuant to the bylaws and related corporate instruments of the legal entities and pursuant to the Brazilian Civil Code.

The participation and remote voting in general shareholders’ meetings of publicly-held companies are regulated by CVM Resolution No. 81/22, as amended, which aims to facilitate the participation of shareholders in general meetings either through the vote or through the submission of proposals, as well as to enhance the corporate governance instruments available in the Brazilian market. For this purpose, this regulation provided the following:

·the creation of a remote voting bulletin through which shareholders may exercise their right to vote prior to the date the general meeting is held;
·the possibility of inclusion of candidates and proposals of deliberation of minority shareholders in that bulletin, with due observance of certain percentages of equity interest, in order to facilitate shareholders’ participation in general meetings; and
·the deadlines, procedures and ways of sending this bulletin, which may be forwarded by the shareholder: (a) to the custodian (if the shares held by the shareholder are kept at a centralized deposit) or; (b) to the book-entry agent of the shares issued by the company (if such shares are not kept at a centralized deposit); or (c) directly to the company.

CVM Resolution No. 81/22, also regulates the rules applicable to remote voting, including, but not limited to, (1) the deadlines for inclusion of candidates in the bulletin by request of minority shareholders and for the company to resend the bulletin in case of inclusion of candidates by minority shareholders and (2) the disclosure of the detailed final voting map of the shareholders’ meetings, including the partial disclosure of each shareholders taxpayer’s registry number and their respective votes on each matter.

Additionally, CVM Resolution No. 81/22, as amended, also regulates the possibility of publicly held companies to hold virtual or hybrid (i.e. physical and virtual) shareholders’ meetings, including certain procedures that must be adopted by such companies when holding these types of meetings. The notice to a shareholders’ meeting must indicate the format of the meeting and the actions that shareholders must take to participate remotely.

Board of Directors

In accordance with the Brazilian Corporation Law, as a general rule, any matters subject to the approval of our Board of Directors can be approved by the affirmative vote of a majority of our Board members present at the relevant meeting. Exceptions to this general rule are provided in the Shareholders’ Agreement.

Under our bylaws, (i) the majority of the members of our Board of Directors must be external directors (i.e. with no current employment or managerial relationship with the company) and (ii) at least two members or twenty percent (20%) of the total number of members of our Board of Directors, whichever is greater, shall be independent directors. According to our bylaws, for a director to be considered independent he or she may not: (1) be a controlling shareholder, or a spouse or relative to the second degree of a controlling shareholder, (2) have been, within the last three years, an employee or executive officer of (a) Ambev or of any of our controlled companies or (b) our controlling shareholder or entities under common control with Ambev, (3) have business relationships including directly or indirectly, supply to, or purchase from, us, our controlled companies, controlling shareholder, an associated company or entities under common control, any products or services, to such an extent as would cause that director to cease being independent, (4) be an employee or administrator of any corporation or entity that offers products or services to, or receives products or services from, us, our controlled companies, controlling shareholder or entities under common control, to such an extent as would cause that director to cease being independent, (5) be a spouse, partner or straight-line or collateral relative to the second degree of any member of management of Ambev, its controlled companies, controlling company, of management of ABI or entity under common control, (6) receive any other compensation from Ambev, its controlled companies, controlling shareholder, an associated company or entities under common control, aside from compensation for duties as a board member (gains arising from ownership of our stock are

   
 126 
 

excluded from this restriction), (7) have voting exercise in the meetings of the Board of Directors bound by shareholder’s agreement whose purpose are matters related to Ambev or (8) founded the Company and has significant influence over it. Our bylaws also set forth that directors elected by a separate ballot vote of minority shareholders holding at least 10% of our capital stock, as provided in paragraphs 4 and 5 of Section 141 of the Brazilian Corporation Law, shall be deemed independent regardless of compliance with the abovementioned criteria. Furthermore, Brazilian law and CVM regulations requires that at least 20% of the members of the Board of Director shall be independent directors, who are qualified as such depending on certain criterion relating to the relationship between a director, and (i) Ambev, its controlling shareholder and their management; and (ii) companies controlled, affiliated or under common control.

According to the general principles of the Brazilian Corporation Law, if a director or an executive officer has a conflict of interest with a company in connection with any proposed transaction, the director or executive officer may not intervene nor vote in any resolution of the Board of Directors or of the Board of Executive Officers regarding such transaction and must disclose the nature and extent of the conflicting interest for purposes of recording such information in the minutes of the meeting. In any case, a director or an executive officer may not transact any business with a company, including any borrowings, except on reasonable or fair terms and conditions that are identical to the terms and conditions prevailing in the market or offered by third parties. Any transaction in which a director or executive officer may have an interest can only be approved if carried out on an arm’s-length basis.

Election of Directors

Each Ambev common share represents one vote at any shareholders’ meeting in connection with the election of our Board of Directors.

Common shareholders holding at least 10% of our capital may elect one member and respective alternate to the Board of Directors without the participation of the controlling shareholder. To exercise these minority rights, shareholders must prove their continuous ownership of their Ambev common shares for at least three months prior to the shareholders’ meeting convened to elect board members. If that prerogative is exercised with the adoption of cumulative voting procedures, as described below, the controlling shareholder will always have the right to elect the same number of members appointed by minority shareholders plus one, regardless of the number of directors provided in our bylaws.

Shareholders holding shares representing at least 10% of our capital, or a smaller applicable percentage according to a sliding scale determined by the CVM and based on a company’s capital stock (currently 5% of the Ambev common shares, pursuant to the CVM’s sliding scale), have the right to request that cumulative voting procedures be adopted. Under such procedures, each of our common shares shall entitle as many votes as the number of director positions to be filled, and each shareholder may cast all of his or her votes for a single candidate or distribute them among various candidates.

Pursuant to CVM Resolution No. 81/22, publicly-held companies shall adopt the following measures regarding voting process: (1) inform the market of the adoption of cumulative voting process in applicable meetings immediately upon the receipt of the first valid requirement; (2) disclose the voting final summary statements, the voting final detailed statements, as well as any voting statement presented by shareholders at the relevant meeting; and (3) register in the minutes of the annual shareholders’ meeting the number of approving, rejecting or abstaining votes for each item of the agenda, including the votes received by each member of the Board of Directors and/or Fiscal Council elected in such shareholders’ meeting.

Under our bylaws and applicable law, the number of directors may be reduced to a minimum of five.

The current members of our Board of Directors were elected by our controlling shareholder. Board members, regardless of the shareholder they represent, owe fiduciary duties to the Company and all of our shareholders. At the same time, any director appointed by shareholders bound by a shareholders’ agreement is also bound by the terms of that agreement. For more information on our shareholders’ agreements, see “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev’s Major Shareholders.”

   
 127 
 

Dividends

The discussion below summarizes the main provisions of the Brazilian Corporation Law regarding the establishment of reserves by corporations and rules with respect to the distribution of dividends, including provisions regarding interest on shareholders’ equity.

Calculation of Distributable Amounts

At each annual shareholders’ meeting, our Board of Directors is required to propose how Ambev’s net income for the preceding fiscal year is to be allocated. For purposes of the Brazilian Corporation Law, a company’s net income after income taxes and social contribution on profits for the immediately preceding fiscal year, net of any accumulated losses from prior fiscal years and amounts allocated to employees’ and management’s participation in earnings, represents its “adjusted net income” for such preceding fiscal year. In accordance with the Brazilian Corporation Law, an amount equal to such adjusted net income, which is also referred to in this section as the distributable amount, will be available for distribution to shareholders in any particular year. Such distributable amount is subject to:

·reductions that may be caused by amounts contributed for the purpose of meeting the charges of the assistance foundation for employees and management of the Company and its controlled companies, with due regard for the rules established by the Board of Directors to this effect; up to 10% of the distributable amount may be contributed under this concept;
·reductions caused by amounts allocated to the Legal Reserve or Contingency Reserves (see “—Reserves”); and
·increases caused by reversals of reserves constituted in prior years.

Minimum Mandatory Dividend

We are required by our bylaws to distribute to shareholders as dividends in respect to each fiscal year ending on December 31 a minimum mandatory dividend equivalent to no less than 40% of the distributable amount. In addition to the minimum mandatory dividend, the Board of Directors may recommend payment of additional dividends to shareholders. The limit for dividend payment is the distributable amount plus the balance available in certain profit reserves, including our statutory “Investment Reserve,” to which we allocate distributable amounts from previous fiscal years not paid as dividends (see “—Reserves”) and retained profits. Furthermore, the Board of Directors may also resolve on the distribution of interim dividends and/or interest on shareholders’ equity based on the accrued profits or existing profits (retained profits or certain profits reserves) presented in the latest annual or six-month balance sheet. Interim dividends and interest on shareholders’ equity are always deemed as an advancement towards the minimum mandatory dividend.

In addition, the minimum mandatory dividend, whether the full amount or only a portion thereof, may not be distributed in any given year should the Board of Directors consider that such payment is incompatible with the Ambev’s financial situation, subject to shareholder approval. While the law does not establish the circumstances in which distribution of the minimum mandatory dividend is incompatible with a company’s financial situation, it is generally agreed that a company is allowed to refrain from paying the minimum mandatory dividend if such payment threatens its existence as a going concern or harms its normal course of operations. The Fiscal Council must opine on the nonpayment of minimum mandatory dividends, and management must submit to the CVM a report explaining the reasons considered by the Board of Directors to withhold the payment of the minimum mandatory dividend no later than five business days after the shareholders’ meeting that decides on this topic.

Any postponed payment of minimum mandatory dividends must be allocated to a special reserve. Any remaining balance in such reserve not absorbed by losses in subsequent fiscal years must be paid to shareholders as soon as the Company’s financial situation allows.

Payment of Dividends

Under the Brazilian Corporation Law any holder of record of shares at the time of a dividend declaration is entitled to receive such dividends, which are generally required to be paid within 60 days following the date

   
 128 
 

of such declaration, unless otherwise resolved by the shareholders’ meetings, which, in either case, must occur prior to the end of the fiscal year in which such dividends were declared. Our bylaws do not provide for a time frame for payment of dividends. The minimum mandatory dividend is satisfied through payments made both in the form of dividends and interest on shareholders’ equity (amount net of taxes), which, from an economic perspective, is equivalent to a dividend but represents a tax efficient alternative to distribute earnings to shareholders because it is deductible for income tax purposes up to a certain limit established by Brazilian tax laws (see “—Interest on Shareholders’ Equity”). Shareholders have a three-year period from the dividend payment date to claim the payment of dividends, after which we are no longer liable for such payment.

Shareholders that do not reside in Brazil must register their investment with the Central Bank in order for gains, dividends, profits or other payments under Ambev’s shares to be eligible for remittance in foreign currency outside of Brazil. Our common shares underlying the Ambev ADSs will be deposited with the Brazilian custodian, Banco Bradesco S.A., which acts on behalf of and as agent for the Depositary, which is registered with the Central Bank as the fiduciary owner of those common shares underlying our ADSs. Payments of cash dividends and distributions on our common shares will be made in reais to the custodian on behalf of the Depositary. The custodian will then convert those proceeds into U.S. dollars and will deliver them to the Depositary for distribution to ADS holders. If the custodian is unable to immediately convert dividends in reais into U.S. dollars, ADS holders may be adversely affected by devaluations of the real or other exchange rate fluctuations before those dividends can be converted into U.S. dollars and remitted abroad. Fluctuations in the exchange rate between the real and the U.S. dollar may also affect the U.S. dollar equivalent of the trading price of our common shares in reais on the B3.

Interest on Shareholders’ Equity

Brazilian companies are permitted to distribute earnings to shareholders under the concept of an interest payment on shareholders’ equity, calculated based on specific Ambev’s shareholders’ equity accounts multiplied by the TJLP rate. The TJLP is the official interest rate defined by the Central Bank and used as reference in long-term loans provided by the BNDES.

Amounts distributed by Ambev to its shareholders as interest on shareholders’ equity is deductible for purposes of income tax and social contribution applicable to our profits. The amount of the deduction may not exceed the greater of:

·50% of net income (after the deduction of social contribution on net income but before taking into consideration the provision for corporate income tax and the amounts attributable to shareholders as interest on shareholders’ equity) for the period in respect of which the payment is made; or
·50% of the sum of retained profits and profit reserves as of the date of the beginning of the period in respect of which the payment is made.

Interest on shareholders’ equity is treated similarly to dividends for purposes of distribution of profits. The only significant difference is that a 15% withholding income tax is due by nonexempt shareholders, resident or not of Brazil, upon receipt of such interest payment, which tax must be withheld by us on behalf of our shareholders when the distribution is implemented. If the shareholder is not a Brazilian resident and is resident or domiciled in a tax-haven jurisdiction, withholding income tax is due at a 25% rate. The amount shareholders receive as interest on shareholders’ equity net of taxes is deducted from the minimum mandatory dividend owed to shareholders.

For further information on the taxation of interest on shareholders’ equity, including the concept of tax haven jurisdiction for such purposes, see “—E. Taxation—Brazilian Tax Considerations—Income Tax—Distributions of Interest on Shareholders’ Equity.”

Reserves

General

The Brazilian Corporation Law provides that all discretionary allocations of adjusted net income, including the Unrealized Income Reserve and the Investment Reserve, are subject to shareholder approval and may be added to capital (except for the amounts allocated to the Unrealized Income Reserve) or distributed as

   
 129 
 

dividends in subsequent years. In the case of Tax Incentive Reserve and the Legal Reserve, they are also subject to shareholder approval; however, the use of their respective balances is limited to having those balances added to capital or used to absorb losses. They cannot be used as a source for income distribution to shareholders.

Legal Reserve

Under the Brazilian Corporation Law, corporations are required to maintain a “Legal Reserve” to which they must allocate 5% of their adjusted net income for each fiscal year until the balance of the reserve equals up to 20% of their share capital. However, corporations are not required to make any allocations to their legal reserve in a fiscal year in which the Legal Reserve, when added to other established capital reserves, exceeds 30% of their share capital. Accumulated losses, if any, may be charged against the Legal Reserve. Other than that, the Legal Reserve can only be used to increase a company’s share capital.

Contingency Reserve

Under the Brazilian Corporation Law, a portion of a corporation’s adjusted net income may also be discretionally allocated to a “Contingency Reserve” for an anticipated loss that is deemed probable in future years and which amount can be estimated. Any amount so allocated in a prior year must be either reversed in the fiscal year in which the loss was anticipated if that loss does not in fact occur or is not charged off in the event that the anticipated loss occurs.

Investment Reserve

Under Brazilian Corporation Law, we are permitted to provide for the allocation of part of our net income to discretionary reserve accounts that may be established in accordance with our bylaws. The allocation of our net income to discretionary reserve accounts may not be made if it serves to prevent the distribution of the minimum mandatory distributable amount. According to our bylaws, a portion of up to 60% of our adjusted net income may be allocated to an “Investment Reserve” for the expansion of our activities, including to be capitalized by us or for our investment in new business ventures.

Pursuant to our bylaws, the Investment Reserve balance is not allowed to be greater than 80% of our share capital. In case such limit is reached, shareholders may resolve to use the exceeding amount for conversion into share capital or to be distributed as dividends.

Unrealized Income Reserve

Pursuant to the Brazilian Corporation Law, the amount by which the minimum mandatory dividend exceeds the “realized” portion of net income for any particular year may be allocated to the Unrealized Income Reserve. The realized portion of net income is the amount by which the adjusted net income exceeds the sum of:

·our net positive results, if any, from the equity method of accounting for earnings and losses of our subsidiaries and certain affiliates; and
·the net profits, net gains or net return obtained on transactions or on accounting of assets and liabilities based on their market value, to be completed after the end of the following fiscal year.

Tax Incentive Reserve

Under the Brazilian Corporation Law, a portion of the adjusted net income may also be allocated to a general “Tax Incentive Reserve” in amounts corresponding to reductions in a company’s income generated by tax grants for particular government-approved investments. This reserve is available only in connection with the acquisition of capital stock of companies undertaking specific government-approved projects.

Goodwill Premium from Shares Issued

Pursuant to the Brazilian Corporation Law, the amount received from subscription of shares in excess of the par value of the shares or the portion of the issuance price allocated to capital stock, in case of shares without par value, must be allocated to this reserve. The amount can be used (i) to absorb losses that surpass accumulated profits and profit reserves, (ii) for future capital increases without the issuance of new shares, (iii)

   
 130 
 

to redeem or reimburse shares (including founder’s shares, if applicable), (iv) for payment of dividends to preferred shares, if applicable, or (v) to support an approved share buyback program.

Fiscal Benefit of Goodwill Premium Amortization (CVM Resolution No. 78/22)

Pursuant to CVM Resolution No. 78/22, when a reporting company merges with its parent company, while remaining a reporting company, the goodwill previously paid by the parent company on its acquisition is deductible for purposes of income tax and social contribution on profits. This future tax benefit is recorded as a capital reserve by the reporting company. As this benefit is realized, the company increases its share capital proportionally to the benefit and is able to issue new shares to the parent company, pursuant to the terms of the merger agreement.

Liquidation

In the event of our liquidation, an extraordinary general shareholders’ meeting shall determine the form of liquidation and appoint a committee to supervise the process during the liquidation period. A liquidator shall be appointed by the Board of Directors.

Restrictions on Foreign Investment

There are no restrictions on ownership or voting rights in respect of our common shares owned by individuals or legal entities domiciled outside Brazil. For a description of voting rights, see “—Rights of the Ambev Common Shares” and “—Shareholders’ Meetings.” The right to convert payments of dividends (including interest on shareholders’ equity) and proceeds from the sale of our common shares into foreign currency and to remit those amounts outside Brazil, however, is subject to exchange control and foreign investment legislation. For a description of these exchange control restrictions and foreign investment legislation, see “Item 10. Additional Information—D. Exchange Controls and other Limitations Affecting Security Holders.”

Appraisal Rights

Under the Brazilian Corporation Law, dissenting shareholders have appraisal rights that allow them to withdraw from the Company and be reimbursed for the value of their Ambev common shares, whenever, among other instances, a decision is taken at a shareholders’ meeting to:

·create preferred shares or increase disproportionately an existing class of preferred shares relative to the other classes of shares, unless such action is provided for or authorized by our bylaws;
·modify a preference, privilege or condition of redemption or amortization conferred upon one or more classes of preferred shares, or create a new class with greater privileges than the existing classes of preferred shares;
·reduce the minimum mandatory dividend;
·merge or consolidate us with another company;
·change our corporate purpose;
·conduct a spin-off of Ambev, if the new entities resulting from the spin-off have different primary corporate purposes or a lower minimum mandatory dividend or such spin-off causes us to join a group of companies (as defined in the Brazilian Corporation Law);
·transform us into another corporate type;
·conduct a stock swap merger of Ambev with another company, so that Ambev becomes a wholly-owned subsidiary of that company; or
·approve the acquisition of control of another company, the price of which exceeds the limits set forth in the Brazilian Corporation Law.
   
 131 
 

In cases where Ambev merges or is consolidated with another company, participates in a group of companies (as defined in the Brazilian Corporation Law), or is a party to a share merger, dissenting shareholders will not be entitled to exercise appraisal rights if their Ambev common shares are (1) liquid, defined as being part of B3 general index and (2) widely-held such that the controlling shareholder or companies under its control holds less than 50% of the referred common shares.

Appraisal rights expire within 30 days after publication of the minutes of the relevant shareholders’ meeting that approved the transaction. We are entitled to reconsider any action triggering appraisal rights within 10 days following the expiration of the 30-day appraisal rights exercise period if the redemption of our common shares held by dissenting shareholders would jeopardize our financial stability.

Any shareholder that exercises appraisal rights is, in general, entitled to receive the amount equivalent to its shares’ book value as per the last balance sheet approved by our shareholders. If the resolution giving rise to appraisal rights is approved more than 60 days after the date of the last shareholder-approved balance sheet of Ambev, dissenting shareholders may require that the value of their shares be calculated on the basis of an updated balance sheet (balanço especial) dated no less than 60 days before the resolution date. In this case, we must (1) immediately advance 80% of the book value of the shares to be redeemed according to the most recent balance sheet approved by our shareholders and (2) pay the remaining balance within 120 days after the date of the resolution of the shareholders’ meeting. However, if the advanced payment of 80% of the book value of the shares to be redeemed is greater than the actual appraisal rights value per share determined by the updated balance sheet, then the amount in excess advanced by the Company shall be refunded to us by the dissenting shareholders who exercised appraisal rights.

As a general rule, shareholders may not exercise appraisal rights with respect to shares acquired after the publishing of a first meeting call notice or the relevant press release concerning the matter giving rise to such appraisal rights.

Preemptive Rights

Each shareholder of Ambev generally has preemptive rights to subscribe for new shares of Ambev in our capital increases (including in the issuance of stock purchase warrants or convertible bonds) in proportion to its shareholdings. A minimum 30-day period following the publication of the capital increase notice is given for the exercise of preemptive rights. However, according to the Brazilian Corporate Law, our board of directors is authorized to exclude preemptive rights or reduce the exercise period with respect to the issuance of new shares, debentures convertible into shares and subscription warrants if the distribution of those shares is effected through sale in a stock exchange transaction, through a public offering or through an exchange of shares in a public offering the purpose of which is to acquire control of another company. Preemptive rights may be purchased and sold by shareholders. Our bylaws provide that if the Board of Directors decides to increase our share capital within the limit of the authorized capital through sales in stock exchanges, public offerings or public tender offers, no preemptive rights will apply. In addition, Brazilian law provides that the grant or the exercise of stock options pursuant to certain stock option plans, such as our Stock Option Plan, is not subject to preemptive rights.

Inspection of Corporate Records

Shareholders that own 1% or more of our outstanding share capital have the right to inspect our corporate records, including shareholders’ lists, corporate minutes, financial records and other documents, if (1) Ambev or any of its officers or directors have committed any act contrary to Brazilian law or our bylaws or (2) there are grounds to suspect that there are material irregularities in the Company. However, in either case, shareholders desiring to inspect our corporate records must obtain a court order authorizing the inspection.

Form and Transfer

Brazilian law provides that ownership of shares issued by a Brazilian corporation shall generally be evidenced only by a record of ownership maintained by either the corporation or an accredited intermediary, such as a bank, acting as a registrar for the shares. Banco Bradesco S.A. currently maintains our share ownership records.

   
 132 
 

Because our common shares are in registered book-entry form, a transfer of those shares is made under the rules of the Brazilian Corporation Law, which provides that a transfer of shares is effected by an entry made by the registrar for our shares in its books, by debiting the share account of the transferor and crediting the share account of the transferee.

Transfers of shares by a foreign investor are made in the same way and executed by that investor’s local agent on the investor’s behalf, except that, if the original investment was registered with the Central Bank pursuant to foreign investment regulations, the foreign investor should also seek, through its local agent, an amendment of the corresponding electronic registration to reflect the new ownership, if necessary.

The B3 operates a central clearing system and a stock exchange. A holder of our common shares may choose, at its discretion, to participate in this system, and all shares elected to be transferred to B3’s market must be deposited in custody with the stock exchange through a Brazilian institution that is duly authorized to operate by the Central Bank and maintains a clearing account with the B3. Our common shares that are subject to custody with the stock exchange will be reflected in our registry of shareholders. Each participating shareholder will, in turn, be registered in our register of beneficial shareholders maintained by the stock exchange and will be treated in the same way as registered shareholders.

Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council

Pursuant to CVM rules, our directors and officers and members of our fiscal council or of any technical or advisory committee are required to disclose to us, to the CVM and to the B3 the number, type and manner of acquisition of any securities issued by us, or by our publicly held subsidiaries and held by them or any persons related to them (such as a spouse, companion or dependent). The information regarding the trade of any such securities (including the name and identification of the owner of the shares, amount and characteristics of the securities, form, price and date of the trade) must be provided to CVM within 10 days following the end of the month in which they were traded.

Such information must include:

•       name and qualification of the person providing the information;

•       amount, price, type, class and other characteristics of the shares or other securities transferred; and

•       form of transfer (private transaction, stock exchange transaction or otherwise).

Under Brazilian law, shareholders owning more than 5% of a company’s voting shares must publicly disclose their shareholder ownership to the CVM and to the Brazilian stock exchange. In addition, according to CVM Resolution No. 44, dated August 23, 2021, as amended (“CVM Resolution No. 44”), if any such shareholder or any shareholder electing members of the board of directors increases or decreases its participation in our capital stock directly or indirectly exceeding thresholds of 5% multiples (i.e. 5%, 10%, 15% etc.), this person or entity must disclose its shareholder ownership to CVM in the terms mentioned above, including the reasons for and purpose of the transaction and information on any agreement regarding the exercise of voting rights or the purchase and sale of the securities.

According to CVM Resolution No. 44, individual investment or disinvestment plans for direct or indirect controlling shareholders, members of any statutory governing bodies of a corporation, as well as any persons who, due to their responsibility, function or position in a listed company, its controlling company, subsidiaries or affiliates have potential access to insider information, are allowed, subject to certain requirements.

Other Significant Provisions of the Brazilian Corporation Law

The Brazilian Corporation Law, as applicable to us, also requires the following:

·upon a sale of our control, the acquirer is required to launch a tender offer to purchase all minority voting shares at a price equal to at least 80% of the price per share paid for the controlling stake;
   
 133 
 
·our delisting is subject to an administrative proceeding before the CVM, having as a condition the launching of a tender offer by the controlling shareholder or us for the acquisition of all our outstanding shares (defined as those owned by shareholders other than the controlling shareholder, officers and directors) at their fair value, as determined by an independent appraiser. Shareholders holding more than two-thirds of the free float of shares must accept the tender offer or must expressly agree with the delisting (for this purpose, the free float of shares must be considered those held by shareholders that have either accepted the delisting or the offer);
·in addition, if a controlling shareholder or group of controlling shareholders acquires additional shares in excess of one-third of the free float of shares in any class (as calculated according to a formula created by CVM), a mandatory tender offer to ensure share dispersion is required for all the outstanding shares in that class. The same requirement applies whenever (1) a shareholder or group of shareholders representing the same interest and holding more than 50% of the shares in any class from March 7, 2002 (pursuant to CVM Resolution No. 85/22, except for public companies existing in September 5, 2000, in which case this date will prevail), acquires a further interest of 10% or more of that same class of shares within a 12-month period and (2) the CVM determines, within six months after being informed, that the acquisition restricts the liquidity of the shares;
·upon the occurrence of a tender offer aimed at delisting a company or through which the controlling shareholders will acquire more than one-third of the free float shares, the purchase price shall be equal to the fair value of the shares considering the total number of outstanding shares;
·members of our Board of Directors elected by noncontrolling shareholders (in a separate voting mechanism) have the right to veto the choice of the independent auditor by the Board;
·our controlling shareholder, the shareholders that elect members to our Board of Directors or Fiscal Council, the members of our Board of Directors and Fiscal Council, and our executive officers are required to disclose any purchase or sale of our shares to the CVM and to the B3; and
·the chairman of any shareholders’ meeting or directors shall disregard any vote that is rendered against provisions of any shareholders’ agreement if that shareholders’ agreement has been duly filed with us, as is the case with the Shareholders’ Agreement.

C. Material Contracts

In addition to the contracts described in other sections of this annual report, the following is a summary of the material contracts to which we are a party.

Shareholders’ Agreement

See “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev’s Major Shareholders—The Shareholders’ Agreement”.

Acquisitions, Dispositions and Joint Ventures

We have discussed the details of some material acquisitions and agreements related thereto in “Item 4. Information on the Company—A. History and Development of the Company.”

Licensing Agreements

Pepsi

See “Item 4. Information on the Company—B. Business Overview—Licenses—Pepsi.”

Red Bull

See “Item 4. Information on the Company—B. Business Overview—Licenses—Red Bull.”

   
 134 
 

Licensing Agreements with ABI

See “Item 4. Information on the Company—B. Business Overview—Licenses—Licensing Agreements with ABI.”

Tax Benefits

Many states in Brazil offer tax benefits programs to attract investments to their regions. We participate in ICMS Value-Added Tax Credit Programs offered by various Brazilian states which may be in the form of rate reduction, calculation basis reduction, financing or subsidized loans, presumed credits, effective collection, payment deferral or partial reductions of state tax payable. In return, we are required to meet certain operational requirements including, depending on the state, production volume and employment targets, among others. All of these conditions are included in specific agreements between Ambev and the state governments. In the event that we do not meet the program’s targets, benefits may be withdrawn. Also, the State of São Paulo and others have challenged, in the Brazilian Supreme Court, state laws upon which certain of the above benefits have been granted, on the basis that they constitute tax benefits created without certain approvals required under Brazilian tax laws and regulations, which would render such state laws unconstitutional (Brazilian tax war). Accordingly, as far as the tax benefits are granted based on the state legislation, most companies apply for and use those benefits when granted. On August 8, 2017, Supplementary Law No. 160 was published authorizing the states and the Federal District to revalidate within 180 days the tax benefits allegedly created without the approvals required under Brazilian tax laws and regulations by means of an Interstate Agreement. Under the provisions of Supplementary Law No. 160, Confaz Interstate Agreement No. 190 was published on December 18, 2017, allowing the states to republish and reinstall the state tax benefits created up to August 8, 2017. The validation of such tax incentives, however, is not self-applicable and it depends on the fulfillment of certain conditions by the granting state. That is, in view of the Supplementary Law No. 160/2017 and Confaz Interstate Agreement No. 190/2017, the compliance by the states with the remission, amnesty and/or reinstitution requirements shall be assessed, especially regarding the registration and deposit of tax benefits and their deadline of enjoyment established by the Supplementary Law. So far, most of the tax benefits programs granted to Ambev have been republished and reinstalled by the granting state. Moreover, in August 2020, the Brazilian Supreme Court issued a binding decision (Extraordinary Appeal No. 628.075) ruling that tax credits granted by the states in the context of ICMS tax war shall be considered unconstitutional, except for the credits derived from tax benefits that have been complied with the validation process provided for in Supplementary Law No. 160 and Confaz Interstate Agreement No. 190. See “Item 5. Operating and Financial Review and Prospects—B. Liquidity and Capital Resources—Sales Tax Deferrals and Other Tax Credits”, “Item 3. Key Information—D. Risk Factors” and “Item 8. Financial Information – A. Consolidated Financial Statements and Other Financial Information.”

The approved Brazilian tax reform provides the currently applicable ICMS benefits will be maintained up to 2032, as long as they have been approved through a CONFAZ Agreement and have been validated according to the provisions of Supplementary Law 160/2017. Therefore, current ICMS benefits will no longer apply from 2033 onwards. The tax benefits applicable to transactions encompassing the Manaus Free Trade Zone, however, will be maintained. Nevertheless, how these benefits will be maintained is still pending regulations.

D.        Exchange Controls and other Limitations Affecting Security Holders

There are no restrictions on the ownership of the ADSs or Ambev’s preferred shares or common shares by individuals or legal entities based on location and/or nationality of the respective investor. However, the right to convert dividends and interest on shareholders’ equity payments arising from Ambev’s shares, as well as proceeds from the sale of Ambev’s shares into U.S. dollars and to remit those amounts outside Brazil is subject to exchange control constrains and foreign investment legislation. Such operations generally require that the relevant investments to be registered with the Brazilian Central Bank and foreign investors are registered with the CVM and/or the Brazilian Central Bank, as applicable.

Restrictions on the remittance of foreign capital abroad could hinder or prevent Banco Bradesco S.A., the custodian of Ambev’s ADS program, or “Custodian”, or holders who have exchanged Ambev’s ADSs for Ambev’s shares, from converting dividend distributions, interest on shareholders’ equity or the proceeds from any sale of shares of Ambev into U.S. dollars and remitting such U.S. dollars abroad. Holders of Ambev’s

   
 135 
 

securities traded in Brazil could be adversely affected by delays or difficulties to meet any regulatory requirement for conversions of payments in reais and remittances abroad.

Investors residing outside Brazil, including institutional investors, may either register their investments in securities in Brazil, (i) as a foreign direct investment under BCB Resolution 278 (SCE-IED); or (ii) as a portfolio investment under CMN Resolution No. 4,373, and CVM Resolution No. 13, dated November 18, 2020 (RDE-Portfolio). Foreign investors, regardless of whether their investments are made as direct investments or portfolio investments, must be enrolled with the Brazilian Federal Revenue.

Foreign direct investors under BCB Resolution 278 registered with the SCE-IED may directly hold and sell securities in both private and open market transactions, but these investors are likely to be subject to a different tax treatment on gains, apart from being subject to taxation on the execution of foreign exchange transactions.

On the other hand, RDE-Portfolio is the usual registration for foreign investments in the capital markets. Under the RDE-Portfolio, foreign investors make investments in local currency with funds held in their brokerage accounts. With certain exceptions, CMN Resolution 4,373 allows investors to carry out various type of transactions in the Brazilian capital markets involving a security traded on a Brazilian stock or futures exchange, or through an organized over-the-counter market, but investors may not transfer the ownership of investments made under such regulation to other non-Brazilian holders through private transactions. Investments and remittances outside Brazil for gains, dividends, profits or other payments under Ambev’s securities are made through the foreign exchange market.

In addition, any foreign investor must also be registered with the Receita Federal do Brasil (Brazilian Federal Revenue Service), or the RFB, pursuant to RFB Normative Instruction No. 1,548 of February 13, 2015, and RFB Normative Instruction No. 1,863 of December 28, 2018.

In order to be accredited to invest under the RDE-Portfolio, foreign investor must:

·appoint a legal representative duly accredited with the Brazilian Central Bank, that will be responsible for complying with the registration and periodically reporting requirements of the Brazilian Central Bank and the CVM;
·appoint a custodian duly accredited with the CVM;
·hold a brokerage account with the accredited custodian;
·appoint a tax representative in Brazil;
·be registered with the Brazilian Federal Revenue, to obtain the enrollment of taxpayer registration;
·be registered as a foreign investor with the CVM; and
·through the appointed representative in Brazil, register the foreign investment with the Brazilian Central Bank.

The foreign investment in Ambev’s shares underlying the ADSs was registered by the Custodian on behalf of The Bank of New York Mellon, the depositary for the ADS programs of Ambev, or “Depositary”, enabling the Custodian to convert dividends and other amounts distributed by Ambev into foreign currency and remit such proceeds outside Brazil to the Depositary.

If a holder of ADSs decides to exchange such ADSs for the underlying Ambev’s shares, the holder will be entitled to (i) immediately sell the shares in the stock exchange and rely on the Depositary’s electronic registration to obtain and remit U.S. dollars abroad; (ii) convert its investment into a foreign RDE-Portfolio investment under CMN Resolution 4,373, or (iii) convert its investment into a SCE-IED investment under BCB Resolution 278. If a holder of ADSs wishes to convert its investment into either a RDE-Portfolio investment under CMN Resolution 4,373 or a SCE-IED investment under BCB Resolution 278, it should begin the process of obtaining its own foreign investor registration with the Brazilian Central Bank and/or with the CVM, as the case may be, in advance of exchanging the ADSs for Ambev’s shares.

   
 136 
 

In the event that a conversion of ADSs into foreign portfolio investments or foreign direct investment takes place, the Custodian is authorized to update the Depositary’s electronic registration to reflect such transaction.

Under current legislation, the Brazilian government may impose temporary restrictions on remittances of foreign capital abroad in the event of a serious imbalance or an anticipated serious imbalance of Brazil’s balance of payments. See “—D. Risk Factors—Risks Relating to Brazil and Other Countries in Which We Operate” and “—D. Risk Factors—Risks Relating to Our Common Shares and ADSs.”

E.        Taxation

The following summary contains a description of the material Brazilian and U.S. federal income tax considerations of the acquisition, ownership and disposition of our common shares or ADSs. This discussion is not a comprehensive discussion of all the tax considerations that may be relevant to a decision to purchase, hold or dispose of our common shares or ADSs and is not applicable to all categories of investors, some of which may be subject to special rules. Each prospective purchaser is urged to consult its tax advisor about the particular Brazilian and U.S. tax considerations to them of an investment in our common shares or ADSs.

The summary is based upon tax laws of Brazil and the United States, the regulations thereunder and other applicable authorities, as in effect on the date hereof, which are subject to change (possibly with retroactive effect). There is currently no income tax treaty between Brazil and the United States. No assurance can be given as to whether or when a treaty will enter into force or of how it would affect holders of our common shares or ADSs. This summary is also based on representations of the depositary and on the assumption that each obligation in the Deposit Agreement relating to our ADSs and the related documents will be performed in accordance with its terms.

Brazilian Tax Considerations

The following discussion summarizes the material Brazilian tax consequences of the acquisition, ownership and disposition of our common shares or ADSs by a holder that is not deemed to be domiciled in Brazil for purposes of Brazilian taxation and, in the case of a holder of common shares, which has registered its investment in such securities with the Central Bank as a U.S. dollar investment (in each case, a “Non-Brazilian Holder”).

The discussion does not purport to be a comprehensive description of all tax considerations that may be relevant to a decision to purchase our common shares or ADSs. The discussion below is based on Brazilian law as currently in effect. Any change in such law may change the consequences described below. The following discussion does not specifically address all of the Brazilian tax considerations applicable to any particular Non-Brazilian Holder, and each Non-Brazilian Holder should consult his or her own tax advisor concerning the Brazilian tax consequences of an investment in our common shares or ADSs.

The tax consequences described below do not consider the effects of any tax treaties or reciprocity of tax treatment entered into by Brazil and other countries. The summary below does not address any tax consequences under the tax laws of any state or locality of Brazil.

On June 14, 2023, the Brazilian government issued Law No. 14,596, which introduces changes to the legislation on corporate income tax and provides for new transfer pricing rules aiming to align the country’s rules with international standards as proposed by the Organization of Economic Co-operation and Development (“OECD”).

In essence, Law No. 14,596/23 (i) is a result of an adaptation effort to conform the current transfer pricing rules to the OECD model which forsakes fixed criteria in favor of adopting the principle that transactions should be valued as if they had been carried out between unrelated parties, each acting in his own best interest. (“The Arm’s Length Principle”); and (ii) brough forth express guidance in relation to some specific transactions.

Specifically in relation to the concept of Privileged Tax Regime, further detailed, Law No. 14,596/23 has a minimum threshold tax rate of 17%, a change from the minimum rate of 20% foreseen in the current rules.

   
 137 
 

Law No. 14,596/23 started producing effects as of January 2024, except for taxpayers who have chosen to anticipate its effects to January 2023, as regulated by Normative Ruling No. 2,161, dated September 28, 2023. Normative Ruling No. 2,161/23 also regulated the general aspects of Law No. 14,596/23, as well as gave more details on the provision of law value-added intragroup services. Regulation on other specific sections of Law No. 14,596/23 (i.e., financial transactions, intangibles, royalties etc.) will possibly be issued by RFB soon and we expect royalty rates applicable to our current license agreements to increase..

The summary below does not address any tax issues that affect only the company, such as the deductibility of expenses.

Income Tax

Taxation of Dividends

Dividends paid by us, a Brazilian corporation, including our Company, to The Bank of New York Mellon in respect of the common shares underlying the respective ADSs, or to a Non-Brazilian Holder with respect to our common shares, are currently not be subject to Brazilian withholding income tax (“WHT”) provided that they are paid out of profits generated as of January 1, 1996. Dividends paid from profits generated before January 1, 1996 may be subject to WHT at variable rates according to the tax legislation applicable to each corresponding year.

In this context, it should be noted that Law No. 11,638 dated December 28, 2007, effective as of 2008, significantly altered the Brazilian Corporate Law in order to align Brazilian GAAP with IFRS, as issued by the IASB. Nonetheless, Law No. 11,941 dated May 27, 2009 introduced the Transitory Tax Regime (Regime Tributário de Transição) (“RTT”), in order to render neutral, from a tax perspective, all the changes provided by Law 11,638/07. Under the RTT, for tax purposes, legal entities should observe the accounting methods and criteria that were effective on December 31, 2007 (“2007 Profits”).

Profits determined pursuant to Law 11,638/07 (“IFRS Profits”) may differ from the profits calculated pursuant to the accounting methods and criteria as in force on December 31, 2007.

While it was a general market practice to distribute exempted dividends with reference to the IFRS Profits, Normative Ruling No. 1,397, issued by the Brazilian tax authorities on September 16, 2013, has established those legal entities should observe the 2007 Profits, in order to determine the amount of profits that could be distributed as exempted income to its beneficiaries.

Any profits paid in excess of said 2007 Profits (“Excess Dividends”) should, in the tax authorities’ view and in the specific case of non-resident beneficiaries, be subject to the following rules of taxation: (i) 15% WHT, in case of beneficiaries domiciled abroad, but not in Low or Nil Tax Jurisdiction (as defined below), and (ii) 25% WHT, in case of beneficiaries domiciled in Low or Nil Tax Jurisdiction (as defined below).

In order to mitigate potential disputes on the subject, Law No. 12,973, dated May 13, 2014, in addition to revoking the RTT, introduced a new set of tax rules, or the New Brazilian Tax Regime, including new provisions with respect to Excess Dividends.

There can be no assurance that the current tax exemption on dividends distributed by Brazilian companies will continue in the future.

Taxation of Gains

According to Article 26 of Law No. 10,833/2003, as amended, gains realized by a Non-Brazilian Holder (understood as a non-Brazilian tax resident) on a sale or disposition of assets located in Brazil, such as our common shares, are generally subject to WHT in Brazil, regardless of whether the sale or other disposition is made by a Non-Brazilian Holder to another non-Brazilian resident or to a Brazilian resident. With respect to the ADSs, arguably the gains realized by a Non-Brazilian Holder on the disposition of ADSs, including to another non-Brazilian resident are not taxed in Brazil, based on the argument that ADSs would not constitute assets located in Brazil for purposes of Law No. 10,833/03. However, we cannot assure you how Brazilian courts would interpret the definition of assets located in Brazil in connection with the taxation of gains realized by a Non-Brazilian Holder on the disposition of ADSs, including to another non-Brazilian resident. As a result, gains on a disposition of ADSs by a non-Brazilian holder to a Brazilian resident, or even to a non-Brazilian

   
 138 
 

holder in the event that courts determine that ADSs would constitute assets located in Brazil, may be subject to income tax in Brazil according to the rules further described.

As a rule, capital gains realized as a result of a transaction carried out in a Brazilian stock exchange can be measured by the positive difference between the amount obtained as a result of the sale or exchange of a security and its respective acquisition cost. There is a controversy regarding the currency that should be considered for purposes of determining the capital gain realized by a Non-Brazilian Holder on a sale or disposition of shares in Brazil, more specifically, if such capital gain is to be determined in foreign or in local currency (BRL).

Until December 31, 2016, the applicable general income tax rate for non-residents was 15%. Law No. 13,259, dated March 17, 2016, or Law No. 13,259/16, increased the income tax rates applicable to gains derived by Brazilian individuals of up to 22.5%. Under Law No. 13,259/16, the income tax rates applicable to Brazilian individuals’ capital gains are as follows: (i) 15% levied on gains of up to R$5 million, (ii) 17.5% levied on gains in excess of R$5 million up to R$10 million, (iii) 20% levied on gains in excess of R$10 million up to R$30 million and (iv) 22.5% levied on any gains exceeding R$30 million.

At the time, there was uncertainty around whether or not the new progressive income tax rates applied to Non-Brazilian Holders, because Law No. 13,259/16 made express reference to the capital gains tax applicable to Brazilian resident individuals but did not mention capital gains tax in respect of non-residents.

Therefore, Non-Brazilian Holders are advised to consult their own tax advisors regarding the possible consequences of Law No. 13,259/16 on the disposition of common shares.

The deposit of common shares in exchange for ADSs may be subject to Brazilian tax on capital gains at rates ranging from 15% to 22.5%, or 25% in the case of investors domiciled in a Low or Nil Tax Jurisdiction, as defined below, if the acquisition cost of the common shares is lower than (a) the average price per common share on a Brazilian stock exchange on which the greatest number of such shares were sold on the day of deposit or (b) if no common shares were sold on that day, the average price on the Brazilian stock exchange on which the greatest number of common shares were sold in the 15 trading sessions immediately preceding such deposit. In such case, the difference between the acquisition cost and the average price of the common shares calculated as described above, may be considered to be a capital gain subject to taxation. In some circumstances, there may be arguments to sustain that such taxation is not applicable in the case of a Non-Brazilian Holder that is a 4,373 Holder (as defined below) and is not resident in a Low or Nil Tax Jurisdiction.

The withdrawal of ADSs in exchange for common shares should not be considered as giving rise to a capital gain subject to Brazilian income tax, provided that on the receipt of the underlying common shares, the non-Brazilian holder complies with the regulatory rules observed in respect to the registration of the investment before the Central Bank.

Gains realized by a Non-Brazilian Holder on a sale or disposition of our common shares carried out on the Brazilian stock exchange, which includes the transactions carried out on the organized over-the-counter market, are:

·exempt from income tax when realized by a Non-Brazilian Holder that (1) has registered its investment in Brazil with the Brazilian Central Bank under the rules of CMN Resolution No. 4,373, or a 4,373 Holder, and (2) is not resident or domiciled in a Low or Nil Taxation Jurisdiction, as defined below (it is controversial whether the exemption also applies to transactions carried out on the organized over-the-counter market); or
·in all other cases, subject to income tax at a rate of up to 25%, depending on the type of investor and its location.

Any other gains assessed on a sale or disposition of the shares that is not carried out on a Brazilian stock exchange are subject to WHT at rates ranging from 15% up to 25% depending on the type of investor and its location. Lower rates may be applicable as provided for in an applicable tax treaty entered into between Brazil and the country where the Non-Brazilian Holder resides.

   
 139 
 

If these gains are related to transactions conducted on the Brazilian non-organized over-the-counter market with intermediation of a financial institution, a withholding tax of 0.005% on the sale value will also apply and can be used to offset against any income tax due on the capital gain earned by the Non-Brazilian Holder.

In the case of a redemption of common shares (or ADSs if understood that these are assets located in Brazil) or a capital reduction by a Brazilian corporation, the positive difference between the amount received by the Non-Brazilian Holder and the acquisition cost of the common shares (or ADSs) redeemed is treated, for tax purposes, as capital gain derived from the sale (or exchange of shares in the case of ADSs) not carried out on a Brazilian stock exchange market and is therefore subject to income tax at the rate of 15%, or 25%, as the case may be.

There can be no assurance that the current preferential treatment for non-Brazilian holder of ADSs and 4,373 Holder of preferred shares will continue in the future.

Any exercise of preemptive rights relating to the Ambev common shares or ADSs will not be subject to Brazilian taxation. Gains on the sale of preemptive rights relating to the shares will be treated differently for Brazilian tax purposes depending on (1) whether the sale is made by The Bank of New York Mellon or the investor and (2) whether the transaction takes place on a Brazilian stock exchange. Gains on sales made by the depositary on a Brazilian stock exchange are not taxed in Brazil but gains on other sales may be subject to tax at rates of up to 25%.

Discussion on Low or Nil Taxation Jurisdictions and Privileged Tax Regimes

According to Law No 9,430/96, as amended, a Low or Nil Taxation Jurisdiction is a country or location that (1) does not impose taxation on income, (2) imposes income tax at a maximum rate lower than 17%, as amended by Law No. 14,596/23, or (3) imposes restrictions on the disclosure of shareholding composition or the ownership of the investment or the ultimate beneficiary of earnings attributed to non-residents. It is important to highlight that, the Normative Ruling No. 1,037, of June 4, 2010 which identifies the countries considered to be Low or Nil Tax Jurisdictions and the locations considered as Privileged Tax Regimes, has not been amended to reflect the 17% rate currently provided for by Law No. 9,430/96.

On June 24, 2008, and with effect as of January 1, 2009, Law No. 11,727/2008 created the concept of Privileged Tax Regime, in connection with transactions subject to Brazilian transfer pricing rules and also applicable to thin capitalization/cross border interest deductibility rules, which is broader than the concept of a Low or Nil Tax Jurisdiction. Pursuant to Law No. 11,727/08, a jurisdiction will be considered a Privileged Tax Regime if it: (1) does not tax income or taxes it at a maximum rate lower than 17%, as amended by Law No. 14,596/23, provided that the requirements set forth in Normative Ruling No. 1,530 and Ordinance No. 488 are met; (2) grant tax advantages to a non-resident entity or individual (i) without the need to carry out a substantial economic activity in the country or a said territory or (ii) conditioned to the non-exercise of a substantial economic activity in the country or a said territory; (3) does not tax or tax proceeds generated abroad at a maximum rate lower than 17%, as amended by Law No. 14,596/23, as applicable provided that the requirements set forth in Normative Ruling No. 1,530 are met; or (4) restricts the ownership disclosure of assets and ownership rights or restricts disclosure about economic transactions carried out.

In addition, on June 4, 2010, the Brazilian Tax Authorities enacted Ordinance No. 1,037 listing (i) the countries and jurisdictions considered Low or Nil Tax Jurisdictions and (ii) the Privileged Tax Regimes. Normative Ruling 1,037 has not been amended thus far to reflect the threshold changes previously mentioned.

However, under the current legal framework it is still debatable whether the Privileged Tax Regime should apply solely to transactions subject to Brazilian transfer pricing and/or thin capitalization/cross border interest deductibility rules. Accordingly, there is no assurance that Brazilian tax authorities will not attempt to apply such regime to other types of transactions. Prospective purchasers should consult with their own tax advisors regarding the consequences of the implementation of Law No. 11,727, Normative Instruction No. 1,037 and of any related Brazilian tax laws or regulations concerning Nil or Low Tax Jurisdictions and Privileged Tax Regimes.

   
 140 
 

Distributions of Interest on Shareholders’ Equity

In accordance with Law No. 9,249, dated December 26, 1995, Brazilian corporations may make payments to shareholders characterized as distributions of interest on their shareholders’ equity (as an alternative to carrying out dividend distributions). Such interest is calculated by multiplying the Brazilian Long Term Interest Rate (“TJLP”), as determined by the Central Bank from time to time, by the sum of the determined Brazilian company’s net equity accounts.

Distributions of interest on shareholders’ equity in respect of the Ambev common shares paid to shareholders who are either Brazilian residents or Non-Brazilian Residents, including holders of ADSs, are subject to Brazilian WHT at the rate of 15% or 25% if the Non-Brazilian Resident is domiciled in a Low or Nil Taxation Jurisdictions, as defined above, or where applicable local laws impose restrictions on the disclosure of the shareholding composition or the ownership of investments or the ultimate beneficial owner of the income derived from transactions carried out and attributable to a Non-Brazilian Holder. As explained in “—Discussion on Low or Nil Taxation Jurisdictions and Privileged Tax Regimes,” the Brazilian Government reduced to 17% the maximum income tax rate that may be imposed by a given jurisdiction for the purpose of characterization of a Low or Nil Taxation Jurisdiction, as long as the country complies with international tax transparency standards.

The amounts paid as distribution of interest on shareholders’ equity are deductible from the taxable basis of the corporate income tax and social contribution on net profits, both of which are taxes levied on our profits, as long as the payment of a distribution of interest is approved at a general meeting of shareholders of the Company. The payment of interest on net equity cannot exceed the greater of:

·50% of net profits (after deduction of social contribution on net profits, and before considering the provision for corporate income tax and the amount attributable to shareholders as interest on shareholders’ equity) for the period in respect of which the payment is made; or
·50% of the sum of retained earnings and profit reserves as of the initial date of the period in respect of which the payment is made.

The distribution of interest on shareholders’ equity may be determined by the Board of Directors. No assurance can be given that the Board of Directors will not determine those future distributions of profits may be made by means of interest on shareholders’ equity instead of by means of dividends. These payments of interest on shareholders’ equity may be included, at their net value, as part of any mandatory dividend. To the extent payment of interest on shareholders’ equity is so included, the corporation may be required to distribute to shareholders an additional amount to ensure that the net amount received by them, after payment of the applicable WHT plus the amount of declared dividends is at least equal to the mandatory dividend.

Distributions of interest on shareholders’ equity to Non-Brazilian Holders may be converted into U.S. dollars and remitted outside Brazil, subject to applicable exchange controls, to the extent that the investment is registered with the Brazilian Central Bank.

On December 29, 2023, Law 14,789/23 was sanctioned , to be effective as from January 1, 2024, onwards. The law provided relevant changes in the federal taxation, including changes on the deductibility of Interest on Shareholders’ Equity payout, limiting the Net Equity’s accounts that could be considered for the calculation of a fully deductible IOC (for example, the Tax Incentives Reserve was excluded from the list of eligible Net Equity accounts).

Income Taxation on Tax Incentives

Also, in accordance with Law No. 14,789/23, and apart from specific federal tax incentives for the development of the North and Northeast regions (SUDAM and SUDENE benefits), all other federal, state and municipal tax incentives as from January 1, 2024, will be subject to Corporate Income Tax (IRPJ and CSLL) and also Social Contributions (PIS and COFINS) taxation. A Corporate Income Tax (IRPJ) restricted tax credit may be granted to partially offset the federal taxation impacts, provided certain conditions are met and an authorization by the tax authorities is issued.

   
 141 
 

Tax on Foreign Exchange Transactions (IOF/Exchange Tax)

Brazilian Decree No. 6,306/2007 imposes a Tax on Foreign Exchange Transactions, or “IOF/Exchange,” on the conversion of reais into foreign currency (e.g., for purposes of remitting funds outside Brazil or making investments into Brazil), and on the conversion of foreign currency into reais. As from October 7, 2014, the general IOF/Exchange rate applicable to almost all foreign currency exchange transactions was increased from zero to 0.38%, although other rates may apply in particular operations, such as:

o   inflow related to transactions carried out in the Brazilian financial and capital markets, including investments in our common shares by foreign investors (including a Non-Brazilian Holder, as applicable) which register their investment under Resolution No. 4,373, zero;

o   outflow related to the return of the investment mentioned under the first bulleted item above, zero; and

o   outflow related to the payment of dividends and interest on shareholders’ equity in connection with the investment mentioned under the first bulleted item above, zero.

Notwithstanding these rates of the IOF/Exchange, the Brazilian government is permitted to increase at any time the rate to a maximum of 25%, but only in relation to future transactions, with immediate effects.

Tax on Bonds and Securities Transactions (IOF/Bonds)

Tax on Transactions Involving Bonds and Securities, or “IOF/Bonds” may be levied on transactions involving shares, even if the transactions are effected on Brazilian stock, futures or commodities exchanges. IOF/Bonds may also be levied on transactions involving ADSs if they are considered assets located in Brazil by the Brazilian tax authorities. As mentioned in the above discussion on taxation of gains, we are unable to predict how Brazilian courts would view this issue, and to date, we are not aware of any judicial or administrative precedent on this specific matter.

As from December 24, 2013, the IOF/Bonds levies at a rate of zero percent on the transfer (cessão) of shares traded in a Brazilian stock exchange environment with the specific purpose of enabling the issuance of depositary receipts to be traded outside Brazil. The rate of IOF/Bonds with respect to other transactions related to shares and ADSs (if applicable) is currently zero.

The Brazilian government may increase such rate up to 1.5% per day, with immediate effects but only with respect to future transactions.

Other Relevant Brazilian Taxes

There are no Brazilian federal inheritance, gift or succession taxes applicable to the ownership, transfer or disposition of shares or ADSs by a Non-Brazilian Holder except for gift and inheritance taxes which may be levied by some states of Brazil. There currently are no Brazilian stamp, issue, registration or similar taxes or duties payable by holders of shares or ADSs.

U.S. Federal Income Tax Considerations

The following discussion is a summary of the U.S. federal income tax considerations generally applicable to the ownership and disposition of our common shares or ADSs by a U.S. Holder (as defined below) who holds our common shares or ADSs as capital assets for U.S. federal income tax purposes (generally, property held for investment). This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the “Code”), U.S. Treasury regulations promulgated thereunder (“Regulations”), published positions of the Internal Revenue Service (the “Service”), court decisions and other applicable authorities, all as currently in effect as of the date hereof and all of which are subject to change or differing interpretations (possibly with retroactive effect).

This discussion does not describe all of the U.S. federal income tax considerations that may be applicable to U.S. Holders in light of their particular circumstances or U.S. Holders subject to special treatment under U.S. federal income tax law, such as:

o   banks, insurance companies and other financial institutions;

   
 142 
 

o   tax-exempt entities;

o   real estate investment trusts;

o   regulated investment companies;

o   dealers or traders in securities;

o   certain former citizens or residents of the United States;

o   persons that elect to mark their securities to market;

o   persons holding our common shares or ADSs as part of a “straddle,” conversion or other integrated transaction;

o   persons that have a functional currency other than the U.S. dollar; and

o   persons that actually or constructively own 10% or more of our equity (by vote or value).

In addition, this discussion does not address any U.S. state or local or non-U.S. tax considerations or any U.S. federal estate, gift, alternative minimum tax or Medicare contribution tax considerations. U.S. Holders should consult their tax advisors concerning the U.S. federal income tax considerations to them in light of their particular situation as well as any considerations arising under the laws of any other taxing jurisdiction.

For purposes of this discussion, a “U.S. Holder” is a beneficial owner of our common shares or ADSs that is for U.S. federal income tax purposes:

·an individual who is a citizen or resident of the United States;
·a corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia;
·an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
·a trust if (i) a court within the United States is able to exercise primary supervision over the administration of the trust and one or more U.S. persons have the authority to control all substantial decisions of the trust or (ii) the trust has a valid election in effect under the applicable Regulations to be treated as a U.S. person.

If a partnership (or an entity or arrangement treated as a partnership for U.S. federal income tax purposes) owns or disposes of our common shares or ADSs, the tax treatment of a partner in such partnership will generally depend upon the status of the partner and the activities of the partnership. A partner in a partnership owning or disposing of our common shares or ADSs should consult its tax advisor regarding the U.S. federal income tax considerations to it of acquiring, owning or disposing of our common shares or ADSs.

The discussion below assumes that the representations contained in the ADS deposit agreement are true and that the obligations in the ADS deposit agreement and any related agreements will be complied with in accordance with their terms. In general, for U.S. federal income tax purposes, U.S. Holders who own ADSs will be treated as the beneficial owners of the underlying common shares represented by those ADSs. Accordingly, the surrender of ADSs in exchange for common shares (or vice versa) will not result in the realization of gain or loss for U.S. federal income tax purposes. The rest of this discussion assumes that a U.S. Holder of ADSs will be treated for U.S. federal income tax purposes as directly holding the underlying common shares.

Distributions

Subject to the discussion below under “—Passive Foreign Investment Company Rules,” the gross amount of distributions (including amounts withheld to pay Brazilian withholding taxes, if any) on our common shares or ADSs to a U.S. Holder out of our current or accumulated earnings and profits, as determined under U.S. federal income tax principles, will generally be includible in a U.S. Holder’s gross income as dividend

   
 143 
 

income on the day actually or constructively received by such holder. Distributions in excess of our current or accumulated earnings and profits will generally be treated as a non-taxable return of capital to the extent of the U.S. Holder’s adjusted tax basis in their common shares or ADSs and thereafter generally treated as capital gain. Because we do not intend to determine our earnings and profits on the basis of U.S. federal income tax principles, any distribution paid by us on our common shares or ADSs will generally be treated as dividend income for U.S. federal income tax purposes. Dividends received on our common shares or ADSs will not be eligible for the dividends received deduction allowed to corporations under the Code.

Individuals and other non-corporate U.S. Holders will be subject to tax at the lower capital gain tax rate applicable to “qualified dividend income,” provided that certain conditions are satisfied, including that (1) our common shares or ADSs are readily tradable on an established securities market in the United States, (2) we are neither a passive foreign investment company (a “PFIC”) nor treated as such with respect to a U.S. Holder (as discussed below) for the taxable year in which the dividend was paid and the preceding taxable year, and (3) certain holding period requirements are met. Our ADSs, but not our common shares, are listed on the NYSE so we anticipate that our ADSs should qualify as readily tradable on an established securities market in the United States, although there can be no assurances in this regard.

The amount of any dividend paid in reais (including amounts withheld to reflect Brazilian withholding tax) will be includible in income in a U.S. dollar amount based on the prevailing U.S. dollar-reais exchange rate in effect at the time the distribution is received by the depositary (in the case of ADSs) or by the U.S. Holder (in the case of common shares held directly by such U.S. Holder), regardless of whether such reais are converted into U.S. dollars on such date. Any foreign currency gain or loss recognized by a U.S. Holder on a subsequent sale or conversion of any reais received in a dividend will generally be U.S.-source ordinary income or loss.

For U.S. foreign tax credit purposes, dividends will generally be treated as income from foreign sources and will generally constitute passive category income. Depending on a U.S. Holder’s particular circumstances, such holder may be eligible, subject to a number of complex limitations, to claim a foreign tax credit in respect of any foreign taxes imposed on dividends received on our common shares or ADSs. If a U.S. Holder does not elect to claim a foreign tax credit for foreign tax withheld, such holder may be able to claim a deduction, for U.S. federal income tax purposes, for such foreign tax, but only for a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing foreign tax credits and deductions are complex. U.S. Holders should consult their tax advisors regarding the availability of foreign tax credit or deductions under their particular circumstances.

Sale or Other Taxable Disposition

Subject to discussion below under “—Passive Foreign Investment Company Rules,” a U.S. Holder will generally recognize capital gain or loss upon the sale or other taxable disposition of our common shares or ADSs in an amount equal to the difference, if any, between the amount realized upon the disposition and such holder’s adjusted tax basis in such common shares or ADSs. For these purposes, if foreign tax is imposed on the sale or other taxable disposition of our common shares or ADSs, the amount realized will include the gross amount of the proceeds of that sale or other taxable disposition before deduction of such foreign tax. Any capital gain or loss will be long-term if the U.S. Holder’s holding period in the common shares or ADSs exceeds one year at the time of disposition. Long-term capital gains of non-corporate U.S. Holders are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations under the Code.

Any gain or loss recognized by U.S. Holders will generally be treated as U.S.-source gain or loss for foreign tax credit purposes. Consequently, U.S. Holders may not be able to use the foreign tax credit arising from any foreign tax imposed on the disposition of our common shares or ADSs unless such credit can be applied (subject to applicable limitations) against tax due on other income treated as derived from foreign sources. If a U.S. Holder does not elect to claim a foreign tax credit for foreign tax withheld, such holder may be able to claim a deduction, for U.S. federal income tax purposes, for the foreign tax imposed, but only for a year in which such holder elects to do so for all creditable foreign income taxes. The rules governing foreign tax credits and deductions are complex. U.S. Holders should consult their tax advisors regarding the availability of foreign tax credits or deductions under their particular circumstances.

   
 144 
 

Passive Foreign Investment Company Rules

A non-U.S. corporation, such as us, will be classified as a PFIC for U.S. federal income tax purposes for any taxable year, if either (i) 75% or more of its gross income for such year consists of certain types of “passive” income or (ii) 50% or more of the value of its assets (generally determined on the basis of a quarterly average) during such year produce or are held for the production of passive income. Passive income generally includes dividends, interest, royalties, rents, annuities, net gains from the sale or exchange of property producing such income and net foreign currency gains. For this purpose, cash is generally categorized as a passive asset and the company’s unbooked intangibles associated with active business activity are considered as a non-passive asset. We will be treated as owning our proportionate share of the assets and earning our proportionate share of the income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock.

If we are a PFIC for any taxable year during which a U.S. Holder holds our common shares or ADSs, such holder will be subject to special tax rules, regardless of whether we continue to be treated as a PFIC, with respect to any “excess distribution” that such holder receives and any gain such holder realizes from a sale or other disposition (including a pledge) of our common shares or ADSs, unless such holder makes a certain election as discussed below. Any distribution made to a U.S. Holder in a taxable year that is greater than 125% of the average annual distributions made to such holder during the shorter of the three preceding taxable years or such holder’s holding period for the common shares or ADSs will be treated as an excess distribution. Under these special tax rules:

·the excess distribution or gain will be allocated ratably over such holder’s holding period for the common shares or ADSs;
·amounts allocated to the current taxable year and any taxable years in such holder’s holding period prior to the first taxable year in which we are classified as a PFIC (a “pre-PFIC year”) will be taxable as ordinary income; and
·amounts allocated to each prior taxable year, other than the current taxable year or a pre-PFIC year, will be subject to tax at the highest tax rate in effect applicable to such holder for that year, and such amounts will be increased by an additional tax equal to interest on the resulting tax deemed deferred with respect to such years.

If we are a PFIC for any taxable year during which a U.S. Holder holds our common shares or ADSs and any of our non-U.S. subsidiaries are also PFICs, such holder will be treated as owning a proportionate amount (by value) of the shares of each such non-U.S. subsidiary classified as a PFIC for purposes of the application of these rules.

Based on our income, assets and activities and the value of our ADSs, we do not believe that we were a PFIC for our taxable year ending December 31, 2023 and we do not expect to be classified as a PFIC in foreseeable future taxable years. Nevertheless, because the determination as to whether or not we are a PFIC is a factual determination made at the close of the applicable tax year, there can be no assurance that we will not be a PFIC for the current taxable year, or any past or future taxable years. Although we do not anticipate becoming a PFIC, changes in the nature of our income or assets, or fluctuations in the market price of our ADSs, may cause us to become a PFIC for the current taxable year and future taxable years.

If we are classified as a PFIC, certain elections may be available to mitigate the adverse U.S. federal income tax considerations of owning stock in a PFIC. In particular, a U.S. Holder may elect mark-to-market treatment for its common shares or ADSs, provided those common shares or ADSs constitute “marketable stock,” which is stock that is traded in other than de minimis quantities on at least 15 days during each calendar quarter on a qualified exchange or other market, as defined in the applicable Regulations. Our ADSs are listed on the NYSE, which is a qualified exchange for these purposes. We anticipate that the ADSs should qualify as being regularly traded, but no assurance may be given in this regard. A mark-to-market election is not available with respect to our common shares, however, because our common shares are not marketable stock.

If we are classified as a PFIC, a U.S. Holder must generally file an annual form with the Service. U.S. Holders should consult their tax advisors concerning the U.S. federal income tax considerations of owning and

   
 145 
 

disposing of our common shares or ADSs if we are or become a PFIC, including the availability and advisability of making certain elections and the annual PFIC filing requirements, if any.

Foreign Asset Reporting

Individual and certain other noncorporate U.S. Holders may be required to submit to the Service certain information with respect to their beneficial ownership of the common shares or ADSs. A U.S. Holder may also be subject to penalties if such holder is required to submit such information to the Service and fails to do so. U.S. Holders should consult their tax advisors regarding any foreign asset reporting requirements.

THE PRECEDING DISCUSSION OF U.S. FEDERAL INCOME TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY AND IS NOT TAX ADVICE. ACCORDINGLY, EACH INVESTOR SHOULD CONSULT ITS TAX ADVISOR AS TO THE PARTICULAR TAX CONSIDERATIONS OF THE OWNERSHIP AND DISPOSITION OF OUR COMMON SHARES OR ADSs, INCLUDING THE APPLICABILITY AND EFFECT OF ANY STATE, LOCAL, FOREIGN OR OTHER TAX LAWS AND OF ANY PROPOSED CHANGES IN APPLICABLE LAW.

F.        Dividends and Paying Agents

Not applicable.

G.        Statement by Experts

Not applicable.

H.        Where You Can Find More Information (Documents on Display)

We are subject to the informational reporting requirements of the Exchange Act, and file with or furnish to the SEC, as applicable, the following documents that apply to foreign private issuers:

·       annual reports on Form 20-F;

·       certain other reports on Form 6-K containing the information that we make public under Brazilian law, file with the Brazilian stock exchanges or distribute to shareholders; and

·       other information.

You may read and copy any reports or other information that we file at the SEC’s public reference rooms at 100 F Street, NE, Washington, D.C. 20549. You may obtain information on the operation of the SEC’s public reference rooms by calling the SEC at 1-800-SEC-0330. Electronic filings made through the Electronic Data Gathering, Analysis and Retrieval System are also publicly available through the SEC’s website on the Internet at www.sec.gov.

As a foreign private issuer, we are exempt from the rules under the Exchange Act prescribing the furnishing and content of proxy statements and will not be required to file proxy statements with the SEC, and its officers, directors and principal shareholders will be exempt from the reporting and “short swing” profit recovery provisions contained in Section 16 of the Exchange Act.

You may obtain documents from us by requesting them in writing, at the following addresses or by telephone:

  Ambev S.A.
Attention: Investor Relations Department
Telephone numbers: (55-11) 2122-1415
  (55-11) 2122-1414
Email: ri@ambev.com.br

You may obtain additional information about us on our website at http://ri.ambev.com.br/. The information contained therein is not part of this annual report.

   
 146 
 

I.        Subsidiary Information

Not applicable.

   
 147 
 
ITEM 11.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our activities expose us to various market risks, including changes in foreign currency exchange rates and interest rates and changes in the prices of certain commodities, including malt, aluminum, sugar and corn. Market risk is the potential loss arising from adverse changes in market rates and prices. We enter into derivatives and other financial instruments, in order to manage and reduce the impact of fluctuations in commodity prices, in foreign currency exchange rates and in interest rates. We have established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial activities. Decisions regarding hedging are made according to our risk management policy, taking into consideration the amount and duration of the exposure, market volatility and economic trends.

These instruments are accounted for based on their characteristics. See Note 28 to our audited consolidated financial statements for a discussion of the accounting policies and information on derivative financial instruments.

In order to minimize the credit risk of its investments, we have cash allocation and investment policies, taking into consideration financial institution credit limits and ratings, not allowing credit concentration. Thus, the credit risk is monitored and minimized because the negotiations are carried out only with a select group of highly qualified counterparties. The definition of financial institutions authorized to operate as a counterparty for us is described in our policy, which establishes maximum exposure limits for each counterparty based on each counterparty’s risk rating and capitalization.

Enterprise Risk Management (ERM)

We have implemented a management strategy to promote enterprise-wide risk management (ERM), through an integrated framework that considers the impact on our business of not only market risks but also of compliance, strategic and operational risks. We believe that such integrated framework, which accounts for different kinds of business risks, enables us to improve management’s ability to evaluate risks associated with our business.

The risk management department is responsible for reviewing and following up with management the risk factors and related mitigating initiatives consistent with our corporate strategy. Market risks, such as exposure in foreign currency, interest rates, commodity prices, liquidity and credit risk arise during the normal course of our business. We analyze each of these risks both individually and on an interconnected basis, defining strategies for managing the economic impact on its performance in line with our financial risk management policy.

Commodity Risk

We use a large volume of agricultural goods to produce our products, including malt and hops for our beer and sugar, guaraná, other fruits and sweeteners for our CSDs. See “Item 4. Information on the Company—B. Business Overview—Sources and Availability of Raw Materials.” We purchase a significant portion of our malt and all of our hops outside of Brazil. We purchase the remainder of our malt and our sugar, guaraná and other fruits and sweeteners locally. Ambev also purchases substantial quantities of aluminum cans.

We produce approximately 75% of our consolidated malt needs and approximately 2% of our guaraná requirement. The remainder and all other commodities are purchased from third parties. We believe that adequate supplies of the commodities we use are available at the present time, but we cannot predict the future availability of these commodities or the prices we will have to pay for such commodities. The commodity markets have experienced and will continue to experience price fluctuations. We believe that the future price and supply of agricultural materials will be determined by, among other factors, the level of crop production, weather conditions, export demand, and government regulations and legislation affecting agriculture, and that the price of aluminum and sugar will be largely influenced by international market prices. See “Item 4. Information on the Company—B. Business Overview—Sources and Availability of Raw Materials.”

 

   
 148 
 

All of the hops we purchase in the international markets outside of South America are paid for in U.S. dollars. In addition, although we purchase aluminum cans and sugar in Brazil, their prices are directly influenced by the fluctuation of international commodity prices.

As of December 31, 2023, our derivative activities consisted of sugar, wheat, aluminum, corn and resin derivatives. The table below provides information about our significant commodity risk sensitive instruments as of December 31, 2023. The contract terms of these instruments have been categorized by expected maturity dates and are measured at market prices.

  Maturity Schedule of Commodities Derivatives as of December 31, 2023
Derivatives Instruments 2024 2025 2026 2027 2028 Thereafter Total Fair Value
  (in R$ million, except price per ton/gallon/barrel/gigajoule)
Sugar Derivatives:  
Notional Amount 280.3 83.4 - - - - 363.6 -1.3
Average Price (R$/ton) 2,145.7 2,468.2 - - - - 2,219.6  
Wheat Derivatives:                
Notional Amount 200.9 - - - - - 200.9 8.3
Average Price (R$/ton) 1,072.9 - - - - - 1,072.9  
Aluminum Derivatives:                
Notional Amount 2,610.9 - - - - - 2,610.9 49.4
Average Price (R$/ton) 10,810.8 - - - - - 10,736.4  
Corn Derivatives:                
Notional Amount 488.1 - - - - - 488.1 -15.0
Average Price (R$/ton) 81.7 - - - - - 81.7  
Resin Derivatives:                
Notional Amount 355.2 - - - - - 355.2 -61.8
Average Price (R$/ton) 5,879.5 - - - - - 5,879.5  

Interest Rate Risk

We are exposed to interest rate volatility with respect to our cash and cash equivalents, current investment securities and fixed and floating rate debt. Our U.S. dollar-denominated cash equivalents generally bear interest at a floating rate. We are exposed to interest rate volatility with regard to existing issuances of fixed rate debt, existing issuances of floating rate debt, currency future and forward swaps agreements, cash and cash equivalents and current investment securities. We manage our debt portfolio in response to changes in interest rates and foreign currency rates by periodically retiring, redeeming and repurchasing debt and using derivative financial instruments.

The table below provides information about our significant interest rate sensitive instruments. For variable interest rate debt, the rate presented is the weighted average rate calculated as of December 31, 2023. The contract terms of these instruments have been categorized by expected maturity dates:

 

   
 149 
 

 

 

Maturity Schedule of Debt Portfolio as of December 31, 2023

Debt Instrument

2024

2025

2026

2027

2028

Thereafter

Total

  (in R$ million, except percentages)
International Debt:  
Other Latin America Currency Floating Rate - - - - - - -
Average Pay Rate - - - - - - -
Other Latin America Currency
Fixed Rate
124.6     144.8     38.9     36.1     61.2     -       405.6    
Average Pay Rate 11.5% 11.5% 11.5% 11.5% 11.5% -        
US$ Fixed Rate - - - - - - -
Average Pay Rate - - - - - - -
US$ Floating Rate - - - - - - -
Average Pay Rate - - - - - - -
CAD Fixed Rate            130.1                  125.6              101.0                      93.5                30.1                      -              480.3    
Average Pay Rate 5.6% 5.6% 5.6% 5.6% 5.6% 0.0%  
CAD Floating Rate - - - - - - -
Average Pay Rate - - - - - - -
Reais Denominated Debt Floating Rate – TR & TJLP: - - - - - - -
Notional Amount 13.4 14.7 16.1 17.6 19.2 44.1 125.1
Average Pay Rate 9.5% 9.5% 9.5% 9.5% 9.5% 9.5%  
Reais Debt - ICMS Fixed Rate: - - - - - - -
Notional Amount 136.3 151.5 114.8 4.1 (0.4) 9.3 415.7
Average Pay Rate 4.0% 4.0% 4.0% 4.0% 4.0% 4.0%  
Reais Debt - Fixed Rate (Leasings): - - - - - - -
Notional Amount 892.5 469.5 290.8 203.0 96.4 121.1 2,073.3
Average Pay Rate 11.2% 11.2% 11.2% 11.2% 11.2% 11.2%  
Reais Debt - Fixed Rate (BNDES & Finep): - - - - - - -
Notional Amount 1.2 - - - - - 1.2
Average Pay Rate

3.7%

-

-

-

-

-

 
Total Debt 1,298.1 906.1 561.6 354.4 206.6 174.5 3,501.1
                       

Part of the floating rate debt accrues interest at TJLP. During the period set forth below the TJLP was:

 

2023

2022

2021

4th Quarter 6.55 7.20 5.32
3rd Quarter 7.00 7.01 4.88
2nd Quarter 7.28 6.82 4.61
1st Quarter 7.37 6.08 4.39

We have not experienced, and do not expect to experience, difficulties in obtaining financing or refinancing existing debt.

Foreign Exchange Risk

We are exposed to fluctuations in foreign exchange rate movements because a significant portion of our operating expenses, in particular those related to hops, malt, sugar, aluminum and corn, are also denominated in or linked to the U.S. dollar. We enter into derivative financial instruments to manage and reduce the impact of changes in foreign currency exchange rates in respect of our U.S. dollar-denominated

   
 150 
 

debt. From January 1, 2021, until December 31, 2023, the U.S. dollar depreciated 6.8% against the real, and, as of December 31, 2023, the selling rate for purchasing U.S. dollars was R$4.84 per US$1.00. In 2021 and 2022, the U.S. dollar appreciated 7.4% and depreciated 6.5%, respectively, and in 2023 it further depreciated 7.2% against the real.

Our foreign currency exposure gives rise to market risks associated with exchange rate movements, mainly against the U.S. dollar. Foreign currency-denominated liabilities at December 31, 2023, included debt of R$ 885.9 million.

As of December 31, 2023, derivative activities consisted of foreign currency forward contracts, foreign currency swaps and future contracts. The table below provides information about our significant foreign exchange rate risk sensitive instruments as of December 31, 2023. The contract terms of these instruments have been categorized by expected maturity dates.

 

Maturity Schedule of Foreign Exchange Derivatives as of December 31, 2023

 
Derivatives Instruments(1) 2024 2025 2026 2027 2028 Thereafter Total Fair Value
  (in R$ million, except percentages)
BM&F Dollar Futures:              
Notional Amount   1,184.7 - - - - -   1,184.7 1.7
Average Unit Price 5.1 - - - - - 5.1  
NDF C$ x US$:   - - - - -    
Notional Amount 1,427.9 - - - - - 1,427.9 -20.2
Average Unit Price 4.9 - - - - - 4.9 -
NDF C$ x EUR:   - - - - -    
Notional Amount 37.4 - - - - - 37.4 -0.1
Average Unit Price 5.4 - - - - - 5.4 -
NDF ARS x US$:   - - - - -    
Notional Amount - - - - - - - -
Average Unit Price - - - - - - - -
NDF CLP x US$:   - - - - -    
Notional Amount 602.2 - - - - - 602.2 17.8
Average Unit Price 4.7 - - - - - 4.7 -
NDF UYU x US$:   - - - - -    
Notional Amount 184.0 - - - - - 184.0 -4.0
Average Unit Price 5.1 - - - - - 5.1 -
NDF BOB x US$:   - - - - -    
Notional Amount 233.2 - - - - - 233.2 -27.8
Average Unit Price 5.4 - - - - - 5.4 -
NDF PYG x US$:   - - - - -    
Notional Amount 776.8 - - - - - 776.8 -40.1
Average Unit Price 5.1 - - - - - 5.1 -
NDF MXN x US$:   - - - - -    
Notional Amount 110.6 - - - - - 110.6 15.9
Average Unit Price 0.2 - - - - - 0.2 -
                 
   
 151 
 

 

NDF US$ x R$:   - - - - -    
Notional Amount 8,402.9 509.5 - - - - 8,912.5 -305.6
Average Unit Price 5.1 5.1 - - - - 5.1 -
 
(1)Negative notional amounts represent an excess of liabilities over assets at any given moment.

 

   
 152 
 
ITEM 12.DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES

A.        Debt Securities

Not Applicable.

B.        Warrants and Rights

Not Applicable.

C.        Other Securities

Not Applicable.

D.        American Depositary Shares

The Bank of New York Mellon, or the Depositary, is the depositary of the Ambev shares in accordance with the Deposit Agreement, dated July 9, 2013, as amended on December 23, 2023 entered into among Ambev, The Bank of New York Mellon, as depositary, and all owners from time to time of ADSs of Ambev, or the Depositary Agreement. A copy of this Depositary Agreement is filed as an exhibit to this annual report on Form 20−F.

The Depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The Depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The Depositary may collect its annual fee for depositary services by deduction from cash distributions or by directly billing investors or by charging the book-entry system accounts of participants acting for them. The Depositary may collect any of its fees by deduction from any cash distribution payable to ADS holders that are obligated to pay those fees. The Depositary may generally refuse to provide fee-attracting services until its fees for those services are paid. Pursuant to the Depositary Agreement, holders of our ADSs may have to pay to The Bank of New York Mellon, either directly or indirectly, fees or charges up to the amounts set forth in the table below.

Persons depositing or withdrawing shares or ADS holders must pay:   For:
US$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)  

issuance of ADSs, including issuances resulting from a distribution of shares, rights or other property; and

 

    cancellation of ADSs for the purpose of withdrawal, including if the deposit agreement terminates.
US$0.02 (or less) per ADS   any cash distribution to ADS holders.
A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs   distribution of securities distributed to holders of deposited securities which are distributed by the Depositary to ADS holders.
US$0.02 (or less) per ADSs per calendar year   depositary services.
Registration or transfer fees   transfer and registration of shares on Ambev’s share registry to or from the name of the Depositary or its agent when you deposit or withdraw shares.
Expenses of the Depositary  

cable, telex and facsimile transmissions (when expressly provided in the deposit agreement); and

 

converting foreign currency to U.S. dollars.

   
 153 
 

 

Taxes and other governmental charges the Depositary or the Custodian may have to pay on any ADS or share underlying an ADS, for example, stock transfer taxes or stamp duty (which currently are inapplicable in Brazil) or withholding taxes   as necessary.
Any charges incurred by the Depositary or its agents for servicing the deposited securities   as necessary.

In performing its duties under the Deposit Agreement, the Depositary may use brokers, dealers or other service providers that are affiliates of the Depositary and that may earn or share fees or commissions.

Subject to certain terms and conditions, the Depositary has agreed to reimburse us for certain expenses it incurs that are related to establishment and maintenance expenses of the ADS program, including the standard out-of-pocket maintenance costs for the ADRs, which consist of the expenses of postage and envelopes for mailing annual and interim financial reports, printing and distributing dividend checks, electronic filing of U.S. federal tax information, mailing required tax forms, stationery, postage, facsimile, and telephone calls. There are limits on the amount of expenses for which the Depositary will reimburse us, but the amount of reimbursement available to us is not necessarily tied to the amount of fees the depositary collects from investors.

The Depositary has made payments to us in the amount of US$ 1,168,055.43 during 2023. These amounts were used for general corporate purposes such as the payment of costs and expenses associated with (1) the preparation and distribution of proxy materials, (2) the preparation and distribution of marketing materials and (3) consulting and other services related to investor relations.

 

   
 154 
 

PART II

ITEM 13.DEFAULT, DIVIDENDS ARREARAGES AND DELINQUENCIES

Not Applicable.

   
 155 
 
ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS

Not Applicable.

   
 156 
 
ITEM 15.CONTROLS AND PROCEDURES

A.        Disclosure Controls and Procedures

The Company has carried out an evaluation, as of December 31, 2023, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures under the supervision and with the participation of the Company’s management, which is responsible for the management of the internal controls, including the Chief Executive Officer and Chief Financial Officer. While there are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures, the Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. Based upon the Company’s evaluation, as of December 31, 2023, the Chief Executive Officer and Chief Financial Officer of the Company have concluded that the disclosure controls and procedures are (1) effective at the reasonable assurance level in ensuring that information required to be disclosed in the reports that are filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the Commissions’ rules and forms and (2) effective at the reasonable assurance level in ensuring that information to be disclosed in the reports that are filed or submitted under the Exchange Act is accumulated and communicated to the management of the Company, including the Chief Executive Officer and the Chief Financial Officer, to allow timely decisions regarding required disclosure.

B.        Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting.

Internal control over financial reporting is defined in rules 13a-15(f) and 15d-15(f) under the Exchange Act as a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the audited consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect material misstatements. Therefore, effective control over financial reporting cannot, and does not, provide absolute assurance of achieving our control objectives. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The effectiveness of our internal control over financial reporting as of December 31, 2023, is based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission. Based on those criteria, management has concluded that as of December 31, 2023, the Company’s internal control over financial reporting is effective.

C.        Attestation Report of the Registered Public Accounting Firm

The effectiveness of our internal control over financial reporting as of December 31, 2023, has been audited by PricewaterhouseCoopers Auditores Independentes Ltda., the Company’s independent registered public accounting firm. Their integrated report, is included in our audited consolidated financial statements included in this Form 20-F.

D.        Changes in Internal Control over Financial Reporting

During the period covered by this annual report, we have started the implementation of a new version of our main enterprise resource planning (ERP) System -the S4 Hana a SAP platform—in our Brazilian operations and updated certain financial processes impacting our internal control over financial reporting to

   
 157 
 

align with the upgraded system functionality. Except for the foregoing, there have been no changes in our internal control over financial reporting that occurred during the period covered by this annual report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

   
 158 
 

ITEM 15T. CONTROLS AND PROCEDURES

Not applicable.

   
 159 
 

ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT

We have relied on the exemption provided for under Rule 10A-3(c)(3) of the Exchange Act, pursuant to Section 301 of the Sarbanes-Oxley Act of 2002, which enables us to have the Fiscal Council perform the duties of an audit committee for the purposes of such Act, to the extent permitted by Brazilian law. In accordance with the charter of our Fiscal Council, at least one of its members has to fulfill the requirements of the Sarbanes-Oxley Act of 2002 for the purposes of qualifying as an audit committee financial expert. Accordingly, our Fiscal Council is comprised of one “audit committee financial expert” within the meaning of this Item 16A, namely José Ronaldo Vilela Rezende, who has an extensive work-related finance background and who is “independent” as set forth in Rule 10A-3(c)(3) of the Sarbanes-Oxley Act of 2002.

   
 160 
 
ITEM 16B.CODE OF BUSINESS CONDUCT

We have adopted a Code of Business Conduct (as defined under the rules and regulations of the SEC) that applies to our principal executive officer, principal financial officer and principal accounting officer, among others. Our Code of Business Conduct has been incorporated by reference to this annual report and was approved by our Board of Directors on August 30, 2013 and amended on May 16, 2017 and on December 21, 2020 (though Old Ambev already had a Board-approved Code of Business Conduct since 2003). If the provisions of the code that apply to our principal executive officer, principal financial officer or principal accounting officer are amended, or if a waiver is granted, we will disclose such amendment or waiver.

   
 161 
 
ITEM 16C.PRINCIPAL ACCOUNTANT FEES AND SERVICES

Auditor Fees

PricewaterhouseCoopers Auditores Independentes Ltda., or PwC, acted as our independent auditor for the fiscal years ended December 31, 2023 and 2022. The table below sets forth the total amount we were billed by PwC in 2023 and 2022 for services performed in those years, and breaks down the amount by category of service:

  Year Ended December 31, 2023 Year Ended December 31, 2022
  (in R$ thousand)
Audit fees 12,862 12,136
Audit-related fees 2,451 2,275
Tax fees - -
All other fees

231

128

Total

15,544

14,539

Audit Fees

Audit fees are fees billed for the audit of our consolidated financial statements and for the reviews of our quarterly financial statements in connection with statutory and regulatory filings or engagements (including audit of our subsidiaries for consolidated purpose).

Audit-Related Fees

Audit-related fees consisted of fees billed for assurance and related services that were reasonably related to the performance of the audit or review of our financial statements or that were traditionally performed by the external auditor.

All Other Fees

All other services consist primarily of fees billed for certain compliance reports to be filed with local regulators and certain comfort letters issued in connection with the issuance of debt.

Independent Registered Public Accounting Firm

Our audited consolidated financial statements as of and for the years ended December 31, 2023 and 2022 have been audited by PricewaterhouseCoopers Auditores Independentes Ltda., São Paulo, Brazil, independent registered public accounting firm. The office of PricewaterhouseCoopers Auditores Independentes Ltda. is located at Avenida Brigadeiro Faria Lima, 3732, São Paulo, Brazil. It is a member of the São Paulo State Regional Board of Accountants (Conselho Regional de Contabilidade) and the Public Company Accounting Oversight Board (PCAOB) and its registration numbers are SP 2SP0001/O-5 and 1351, respectively.

Pre-Approval Policies and Procedures

We have adopted pre-approval policies and procedures under which all audit and non-audit services provided by contracted external auditors must be pre-cleared by the Fiscal Council, which performs the duties of an audit committee for the purposes of the Sarbanes-Oxley Act of 2002, in accordance with Rule 10A-3(c)(3). The Fiscal Council adopts a list of services and amount limits for contracting for each external auditor under terms included in a “basic list,” which is in turn approved by the Board of Directors. Any services provided from such list are deemed “pre-approved” for purposes of the Sarbanes-Oxley Act of 2002. The Fiscal Council periodically receive from our chief financial officer a summary report on the progress of the pre-approved services rendered and the corresponding fees duly authorized. Any services which are not included

   
 162 
 

in such require a prior favorable opinion of our Fiscal Council. Our policy also contains a list of services which cannot be rendered by our external auditors.

   
 163 
 
ITEM 16D.EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES

NYSE corporate governance standards require that a listed company have an audit committee composed of three independent members that satisfy the independence requirements of Rule 10A-3 under the Exchange Act, with a written charter that addresses certain duties.

The Fiscal Council is a permanent body which operates independently from our management and from our registered independent public accounting firm. Its principal function is to examine the financial statements of each fiscal year and provide a formal report to our shareholders. We are relying on the exemption provided for in Rule 10A-3(c)(3) and believe that our reliance on this exemption will not materially affect the ability of the Fiscal Council to act independently and to satisfy the other requirements of Rule 10A-3. In accordance with the charter of our Fiscal Council, at least one of its members has to fulfill the requirements of the Sarbanes-Oxley Act of 2002 for the purposes of qualifying as an audit committee financial expert. Accordingly, our Fiscal Council has designated one financial expert, namely José Ronaldo Vilela Rezende.

   
 164 
 
ITEM 16E.PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS

As disclosed under “Major Shareholders—Control,” we have purchased a number of our shares during the period covered by this annual report.

Ambev S.A. Share Repurchases

Set forth below, in tabular format, is some disclosure on the repurchases of Ambev S.A. shares for the periods indicated. Shares not purchased under publicly announced programs include those purchased from employees when no publicly announced program was in place and those bought from employees who were dismissed, in both cases, pursuant to the terms and conditions of our stock ownership plan.

Month

Total Number of Shares Purchased

Average Price Paid per Share

Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)

Maximum Number of Shares that May Be Purchased Under Publicly Announced Plans or Programs

March-2024 0 0.00 Not Specified Not Specified
February-2024 0 0.00 Not Specified Not Specified
January-2024 0 0.00 Not Specified Not Specified
December-2023 41,481 13.74 Not Specified Not Specified
November-2023 0 0.00 Not Specified Not Specified
October-2023 0 0.00 Not Specified Not Specified
September-2023 0 0.00 Not Specified Not Specified
August-2023 0 0.00 Not Specified Not Specified
July-2023 0 0.00 Not Specified Not Specified
June-2023 780,900 15.27 Not Specified Not Specified
May-2023 482,575 14.66 Not Specified Not Specified
April-2023 0 0.00 Not Specified Not Specified
March-2023 65,001 13.47 Not Specified Not Specified
February-2023 0 0.00 Not Specified Not Specified
January-2023 0 0.00 Not Specified Not Specified
December-2022 7,526 14.52 Not Specified Not Specified
November-2022 0 0.00 Not Specified Not Specified
October-2022 0 0.00 Not Specified Not Specified
September-2022 40,000 15.48 Not Specified Not Specified
August-2022 0 0.00 Not Specified Not Specified
July-2022 0 0.00 Not Specified Not Specified
June-2022 0 0.00 Not Specified Not Specified
May-2022 39,700 13.73 Not Specified Not Specified
April-2022 10,395 15.07 Not Specified Not Specified
March-2022 0 0.00 Not Specified Not Specified
February-2022 516,590 14.84 Not Specified Not Specified
January-2022 8,309 15.01 Not Specified Not Specified
December-2021 0 0.00 Not Specified Not Specified
November-2021 1,812,181 16.72 Not Specified Not Specified
October-2021 84,982 16.81 Not Specified Not Specified
September-2021 5,480 15.30 Not Specified Not Specified
August-2021 0 0.00 Not Specified Not Specified
July-2021 0 0.00 Not Specified Not Specified
June-2021 1,673,389 19.32 Not Specified Not Specified
May-2021 384,904 16.96 Not Specified Not Specified
April-2021 5,474 15.62 Not Specified Not Specified
   
 165 
 

 

March-2021 2,515,780 15.47 Not Specified Not Specified
February-2021 0 0.00 Not Specified Not Specified
January-2021 6,981 16.02 Not Specified Not Specified
 
(1)May differ from total number of shares purchased as they do not include all shares acquired from employees under the stock ownership program.

   
 166 
 
ITEM 16F.CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT

Not Applicable.

   
 167 
 
ITEM 16G.CORPORATE GOVERNANCE

The principal differences between the NYSE corporate governance standards and our corporate governance practices are referred to in “Item 6. Directors, Senior Management and Employees—C. Board Practices—Differences Between the United States and Brazilian Corporate Governance Practices.”

   
 168 
 
ITEM 16H.MINE SAFETY DISCLOSURE

Not Applicable.

   
 169 
 

ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not Applicable.

   
 170 
 

 

 

ITEM 16J.INSIDER TRADING POLICIES

Not applicable.

   
 171 
 

 

ITEM 16K.CYBERSECURITY

Cybersecurity Risk Management and Strategy

Our processes for assessing, identifying and managing material risks from cybersecurity threats are integrated into our risk management system. We use a variety of tools and processes to collect relevant data and identify, monitor, assess and manage material cybersecurity risks. We invest in cybersecurity defense solutions, including (but not limited to) prevention, detection and response tools and processes. We also have a dedicated local security operations center team, including specially trained personnel (the “Security Operations Team”) led by our Technology Operations Director, that is responsible for front-line cybersecurity risk detection and management with the assistance of our critical infrastructure management team. Our local Security Operations Team is supported by a global security operations team, which operates 24 hours a day, seven days a week covering 100% of our footprint via automated tools, alerts, relevant security log review across tools, using analytics to correlate logs across all different tools, and it engages in ongoing monitoring and testing of our systems and defenses with respect to cybersecurity threats.

We engage independent third parties on an as-needed basis to assess our cybersecurity capabilities. The results of these assessments are shared with the Board of Directors, including the Fiscal Council. We also perform periodic penetration testing and drills at least annually.

We provide cybersecurity awareness trainings to our employees which are designed to provide guidance for identifying and reporting cybersecurity risks and promote familiarity with our cybersecurity policies, and we require employees in certain roles to complete additional role-based, specialized cybersecurity trainings. We also leverage internal communications to promote awareness and conduct phishing exercises and provide training to employees.

We have adopted and implemented an incident response plan, which provides a structured approach for managing, escalating and remediating cybersecurity incidents, as further described below under “Cybersecurity Governance.” We also have a business continuity plan in place that covers critical infrastructure. We also have in place a local information security policy and supporting policies and standards covering key risk domains such as asset management, asset control, network security, incident management, third-party risk management and internet and technology use. We review these plans annually and updates them as needed.

Cybersecurity is also an important part of our Third-Party Risk Management Program. Through this program, we seeks to identify, assess and manage risks, including cybersecurity risks, associated with our external service providers. We take a risk-based approach to conducting due diligence in the vendor onboarding process, and we seek to leverage the use of contractual terms to further mitigate risk. We also assess aspects of our vendors’ cybersecurity posture in certain circumstances.

To date, we have not identified any risks from cybersecurity threats that have materially affected or are reasonably likely to materially affect us or our business strategy, results of operations or financial condition. See “Risk Factors- Information technology failures, including failures to implement upgrades and new technologies effectively or those that affect the privacy and security of sensitive customer and business information, could disrupt our operations.”

Cybersecurity Governance

Our management plays an active role in assessing and managing material risks from cybersecurity threats. Our Technology Operations Director and our Information Technology Vice-President Officer lead efforts to identify, analyze and manage cybersecurity threats and incidents, leveraging their experience and qualifications. Our Technology Operations Director has over 13 years’ experience in cybersecurity. Before joining Ambev, he worked as Head of Cybersecurity for one of the biggest health care companies in the world. He holds a bachelor degree in Information Security, Master of Business Administration degrees in cybersecurity and business management, CISSP, CCISO and CISM certifications and completed an extension course in Information Security at the Massachusetts Institute of Technology. Our Information Technology Vice-President Officer has almost 20 years’ experience in cybersecurity in private sector. Before joining Ambev, he served as Technology, Solutions Architecture and Customer Solutions Director at a Global Tech Company s and was also part of the Enterprise Architecture department at an automobile company in Belgium. He also holds a degree in computer science from Universidade de Campinas – UNICAMP and a degree in Innovation and Entrepreneurship from the Vlerick Leuven-Gent Management School. For further information on our Information Technology Vice-President Officer, see “Item 6. Directors, Senior Management and Employees—A. Directors and Senior Management—Officers.”

   
 172 
 

The Technology Operations Director and the Information Technology Vice-President Officer are supported by a team of professionals, including both legal experts and technical professionals who are well-versed in the detection, assessment and mitigation of cybersecurity incidents and events and whose job function is dedicated, in whole or in part, to cybersecurity risk management.

We have also established a cross-functional Privacy and Cybersecurity Committee, led by our Legal & Compliance Vice-President Officer, to coordinate and align effective cybersecurity governance, assessment and reporting. The Privacy and Cybersecurity Committee includes the Directors of Technology, Cybersecurity, Compliance, Litigation, and other internal technical and legal experts. The Privacy and Cybersecurity Committees assesses information on certain cybersecurity incidents including, among other things, to assist in making determinations of potential materiality and disclosure for reporting purposes.

Our Board of Directors, together with the Fiscal Council, oversees the Company’s internal control and overall risk management system. Without prejudice to the responsibilities of the board as a whole and as part of its oversight of the Company’s risk management system, the Fiscal Council and the Governance Committee oversee cybersecurity risk management, review the process by which management assesses, manages and mitigates the company’s exposure to cybersecurity risks. The Technology Operations Director and the Information Technology Vice-President Officer report periodically to members of the Fiscal Council and the Governance Committee. The Privacy and Cybersecurity Committee also provides briefings and updates on its work to the Governance Committee. In addition, the Governance Committee report annually to the Board of Directors on cybersecurity.

   
 173 
 

PART III

ITEM 17.FINANCIAL STATEMENTS

Our audited consolidated financial statements, together with the audit report of the Independent Registered Public Accounting Firm thereon, are filed as part of this annual report, starting on page F-1 hereto, following the signature pages.

 

   
 174 
 
ITEM 18.FINANCIAL STATEMENTS

See “Item 17.—Financial Statements.”

 

   
 175 
 
ITEM 19.EXHIBITS
1.1Restated Bylaws of Ambev S.A. (English-language translation) (incorporated by reference to the report on Form 6-K furnished by Ambev on May 1, 2023). https://www.sec.gov/Archives/edgar/data/1565025/000129281423001979/abev20230429_6k1.htm
2.1Deposit Agreement among Ambev S.A., The Bank of New York Mellon, as Depositary, and all Owners and Holders from time to time of American Depositary Shares, representing Common Shares (incorporated by reference to Exhibit 4.1 to Form F-4 filed by Ambev on June 28, 2013). https://www.sec.gov/Archives/edgar/data/1565025/000119312513276352/d529201dex41.htm
2.2Description of Securities Registered under Section 12 of the Exchange Act.
3.1Shareholders’ Agreement of Ambev S.A., dated April 16, 2013, effective as of July 2, 2019, among Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência, Interbrew International B.V., AmBrew S.A. and Ambev S.A. (English-language translation) (incorporated by reference to Exhibit 9.2 to Form F-4 filed by Ambev on June 28, 2013). https://www.sec.gov/Archives/edgar/data/1565025/000119312513276352/d529201dex92.htm
3.2Voting Agreement between Stichting Anheuser-Busch InBev, Fonds Baillet Latour SPRL and Fonds Voorzitter Verhelst SPRL, effective November 1, 2015 (incorporated by reference to Exhibit 2.36 to Amendment No. 15 to Schedule 13D filed by former AB InBev on March 9, 2016). https://www.sec.gov/Archives/edgar/data/1140467/000119312516498533/d12366dex99236.htm
3.3Amended and Restated Shareholders’ Agreement, dated April 27, 2023, among BRC S.à.R.L., Eugénie Patri Sébastian S.A., EPS Participations S.à.R.L., Rayvax Société d’Investissements S.A. and Stichting Anheuser-Busch InBev (incorporated by reference to Exhibit 2.2 to Schedule 13D filed by AB InBev on May 2, 2023). https://www.sec.gov/Archives/edgar/data/1301486/000119312523132497/d142585dex22.htm
3.4Voting and Support Agreement relating to Anheuser-Busch InBev SA/NV, dated October 8, 2016, among Stichting Anheuser-Busch InBev, Altria Group, Inc., BEVCO Ltd. and Anheuser-Busch InBev SA/NV (incorporated by reference to Exhibit 2.4 to Anheuser Busch InBev SA/NV’s Schedule 13D filed by BRC S.à.R.L. on November 2, 2016). https://www.sec.gov/Archives/edgar/data/1301486/000119312516757125/d276200dex9924.htm
8.1List of Material Subsidiaries of Ambev S.A.
11.1Code of Business Conduct dated August 30, 2013 and amended on May 16, 2017 and on December 20, 2020 (English-language translation). (incorporated by reference to the report on Form 6-K furnished by Ambev on December 22, 2020). https://sec.report/Document/0001292814-20-004846/ambevsa20201221_6k1.htm
11.2Manual on Disclosure and Use of Information and Securities Trading Policies for Ambev S.A., dated March 1, 2013 and amended on August 27, 2014, on March 28, 2016, on May 15, 2019 and on October 13 and 14, 2021 (English-language translation). https://sec.report/Document/0001292814-21-004013/ambevsa20211020_6k1.htm
12.1Principal Executive Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
12.2Principal Financial Officer Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
13.1Principal Executive Officer Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
   
 176 
 
13.2Principal Financial Officer Certification pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
97.1Ambev S.A. Clawback Policy Regarding the Recovery of Erroneously Awarded Incentive-Based Compensation, effective as of December 1st, 2023. 101.INS Inline XBRL Instance Document.
101.SCHInline XBRL Taxonomy Extension Schema.
101.CALInline XBRL Taxonomy Extension Schema Calculation Linkbase.
101.DEFInline XBRL Taxonomy Extension Schema Definition Linkbase.
101.LABInline XBRL Taxonomy Extension Schema Label Linkbase.

101.PRE       Inline XBRL Taxonomy Extension Schema Presentation Linkbase.

104       Cover page interactive data (embedded within the Inline XBRL document).

   
 177 
 

 

SIGNATURES

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

AMBEV S.A.

By: /s/ Jean Jereissati Neto
Name: Jean Jereissati Neto
Title: Chief Executive Officer

By: /s/ Lucas Machado Lira
Name: Lucas Machado Lira
Title: Chief Financial Officer

 

 

 

Date: March 11, 2024.

   
 178 
 

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and Board of Directors of Ambev S.A.

 

Opinions on the Financial Statements and Internal Control over Financial Reporting

 

We have audited the accompanying consolidated balance sheets of Ambev S.A. and its subsidiaries (the "Company") as of December 31, 2023 and 2022, and the related consolidated income statements, statements of comprehensive income, of changes in equity and of cash flows for each of the three years in the period ended December 31, 2023, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2023 based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2023 in conformity with International Financial Reporting Standards as issued by the International Accounting Standards Board. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

 

Basis for Opinions

 

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Annual Report on Internal Control over Financial Reporting appearing under Part II, Item 15. Our responsibility is to express opinions on the Company's consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

 

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.


   
 179 
 

Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

 

Definition and Limitations of Internal Control over Financial Reporting

 

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Critical Audit Matters

 

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

Tax Contingencies and Uncertain Tax Treatments

 

As described in Note 27 to the consolidated financial statements, the Company has disclosed contingencies and uncertain tax treatments related to tax litigations of R$ 30,257.2 million and R$ 63,621 million, respectively, as of December 31, 2023. The Company discloses contingencies and uncertain tax treatments related to tax litigations in the consolidated financial statements when (i) the likelihood of loss of these lawsuits are classified as possible by management and (ii) in case of income taxes pending litigations, management determines that it is probable that taxation authorities will accept the uncertain tax treatment, and for which there are no provisions.

 

The principal considerations for our determination that performing procedures relating to tax contingencies and uncertain tax treatments are a critical audit matter are (i) the significant judgment by management when determining whether a reasonable estimate of the loss and possible outcomes for each claim can be made and (ii) a high degree of auditor judgment, effort and subjectivity, including the use of professionals with specialized skill and knowledge, in perfoming procedures and evaluating audit evidence related to management's assessment of the losses associated with tax contingencies and uncertain tax treatments.

 

   
 180 
 

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management's evaluation of tax contingencies and uncertain tax treatments, as well as financial statement disclosures. These procedures also included, among others, (i) obtaining and evaluating the letters of audit inquiry with external legal counsel, (ii) evaluating the reasonableness of management's assessment regarding tax contingencies and uncertain tax treatments outcomes, and (iii) evaluating the sufficiency of the Company's disclosures in the financial statements. Professionals with specialized skill and knowledge were used to assist in the evaluation of Company's assessment regarding tax contingencies and uncertain tax treatments outcomes.

 

/s/ PricewaterhouseCoopers Auditores Independentes Ltda.

São Paulo, Brazil

March 11, 2024

 

We have served as the Company's auditor since 2019.

   
 181 
AMBEV S.A.
 

SUMMARY

CONSOLIDATED INCOME STATEMENTS 3
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 4
CONSOLIDATED BALANCE SHEETS 5
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY 7
CONSOLIDATED STATEMENTS OF CASH FLOWS 10
1.   CORPORATE INFORMATION 11
2.   BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS 13
3.   SUMMARY OF MATERIAL ACCOUNTING POLICIES 15
4.   USE OF ESTIMATES AND JUDGMENTS 19
5.   SEGMENT REPORTING 20
6.   NET SALES 23
7.   OTHER OPERATING INCOME/(EXPENSES) 24
8.   EXCEPTIONAL ITEMS 25
9.   PAYROLL AND RELATED BENEFITS 25
10.   ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE 26
11.   NET FINANCE RESULT 27
12.   EARNINGS PER SHARE 28
13.   INCOME TAX AND SOCIAL CONTRIBUTION 29
14.   PROPERTY, PLANT AND EQUIPMENT 33
15.   GOODWILL 37
16.   IMPAIRMENT OF NON-FINANCIAL ASSETS 39
17.   INTANGIBLES 42
18.   RECOVERABLE TAXES 44
19.   INVENTORY 45
20.   TRADE RECEIVABLES 47
21.   CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES 48
22.   CHANGES IN EQUITY 50
23.   INTEREST-BEARING LOANS AND BORROWING 57
24.   EMPLOYEE BENEFITS 60
25.   SHARE-BASED PAYMENTS 67
26.   TRADE PAYABLES 70
27.   PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS 71
28.   FINANCIAL INSTRUMENTS AND RISKS 79
29.   COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS 95
30.   RELATED PARTIES 95
31.   EVENTS AFTER THE REPORTING PERIOD 100

 

 

AMBEV S.A.

 

CONSOLIDATED INCOME STATEMENTS

For the year ended December 31

All amounts in millions of Brazilian Reais unless otherwise stated

 

         
  Note 2023 2022 2021
         
Net sales 79,736.9  79,708.8  72,854.3 
Cost of sales 10  (39,291.6) (40,422.1) (35,659.7)
Gross profit   40,445.3  39,286.7  37,194.6 
         
Distribution expenses   (10,750.6) (11,395.3) (9,932.7)
Commercial expenses   (7,412.5) (7,337.4) (7,035.5)
Administrative expenses   (5,273.7) (5,236.8) (4,877.4)
Other operating income/(expenses) 2,028.9  2,513.9  2,124.1 
Exceptional items (206.4) (143.3) (392.8)
Income from operations   18,831.0  17,687.8  17,080.3 
         
Finance expenses 11  (6,280.1) (7,892.2) (5,427.8)
Finance income 11  2,670.3  4,469.1  2,222.4 
Net finance result   (3,609.8) (3,423.1) (3,205.4)
         
Share of results of joint ventures   (185.3) (29.1) (115.7)
Income before income tax   15,035.9  14,235.6  13,759.2 
         
Income tax expense 13  (75.5) 655.6  (636.6)
Net income   14,960.4  14,891.2  13,122.6 
         
Attributable to:        
Equity holders of Ambev   14,501.9  14,457.9  12,671.0 
Non-controlling interest   458.5  433.3  451.6 
         
Basic earnings per share – common – R$ 12  0.9211  0.9184  0.8052 
Diluted earnings per share – common – R$ 12  0.9156  0.9123  0.7991 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the year ended December 31

All amounts in millions of Brazilian Reais unless otherwise stated

 

       
  2023 2022 2021
       
Net income 14,960.4  14,891.2  13,122.6 
       
Items that may be subsequently reclassified to profit or loss:      
Exchange differences on the translation of foreign operations (gains/(losses))      
Investment hedge – put option granted on subsidiaries 302.6  203.8  193.6 
Gains/losses on translation of other foreign operations  (9,637.0) (7,067.0) 2,364.4 
Gains/losses on translation of foreign operations  (9,334.4) (6,863.2) 2,558.0 
       
Cash flow hedge – gains/(losses)      
Recognized in Equity (Hedge reserve) (364.7) 38.0  2,311.2 
Reclassified from Equity (Hedge reserve) and included in profit or loss 152.6  (356.7) (1,829.9)
Total cash flow hedge (212.1) (318.7) 481.3 
       
Items that will not be reclassified to profit or loss:      
Recognition of actuarial gains/(losses) (12.5) 470.7  340.0 
       
Other comprehensive (loss)/income (9,559.0) (6,711.2) 3,379.3 
       
Total comprehensive (loss)/income 5,401.4  8,180.0  16,501.9 
       
Attributable to:      
   Equity holders of Ambev 5,065.5  7,835.5  15,943.3 
   Non-controlling interest 335.9  344.5  558.6 

 

 

The consolidated statements of comprehensive income are presented net of income tax. The income tax effects of these items are disclosed in Note 13- Income tax and social contribution.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

CONSOLIDATED BALANCE SHEETS

All amounts in millions of Brazilian Reais unless otherwise stated

 

       
Assets  Note  2023 2022
       
Property, plant and equipment 14  26,630.2  30,055.7 
Goodwill 15  38,003.6  40,594.0 
Intangible 17  10,041.7  9,222.2 
Investments in joint ventures   289.1  331.9 
Investment securities 21.2  242.2  219.1 
Deferred tax assets 13.2  7,969.6  6,438.8 
Employee benefits 24  57.3  56.6 
Derivative financial instruments 28  1.7  1.5 
Recoverable taxes 18  11,325.1  11,316.3 
Other assets   1,520.7  1,905.2 
Non-current assets   96,081.2  100,141.3 
       
       
Investment securities 21.2  277.2  454.5 
Inventories 19  9,619.0  12,923.0 
Trade receivables 20  5,741.5  5,349.1 
Derivative financial instruments 28  378.0  272.3 
Recoverable taxes 18  3,435.7  2,853.5 
Other assets   1,052.7  1,037.9 
Cash and cash equivalents 21.1  16,059.0  14,926.4 
Current assets   36,563.1  37,816.7 
       
Total assets   132,644.3  137,958.0 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

 

CONSOLIDATED BALANCE SHEETS

All amounts in millions of Brazilian Reais unless otherwise stated

 

Equity and liabilities  Note  2023 2022
       
Equity 22     
Issued capital   58,177.9  58,130.5 
Reserves   98,669.4  92,246.6 
Carrying value adjustments   (77,878.0) (68,421.5)
Equity attributable to the equity holders of Ambev   78,969.3  81,955.6 
Non-controlling interests   1,174.5  1,372.2 
Total Equity   80,143.8  83,327.8 
       
       
Interest-bearing loans and borrowings 23  2,203.0  2,788.1 
Employee benefits 24  2,011.8  2,161.1 
Derivative financial instruments 28  11.7  -   
Deferred tax assets 13.2  3,318.4  3,725.7 
Income tax and social contribution payable   1,487.1  1,598.7 
Taxes and contributions payable   513.3  671.0 
Trade payables 26  307.3  509.4 
Provisions 27  559.6  739.0 
Put option granted on subsidiaries and other liabilities   1,083.2  1,896.8 
Non-current liabilities   11,495.4  14,089.8 
       
       
Bank overdrafts 21.1  -    74.3 
Interest-bearing loans and borrowings 23  1,298.1  982.6 
Wages and salaries   2,128.7  2,335.8 
Dividends and interest on shareholders’ equity payable   1,526.2  1,464.8 
Derivative financial instruments 28  751.4  729.4 
Income tax and social contribution payable   1,340.5  1,118.6 
Taxes and contributions payable   6,236.6  5,812.9 
Trade payables 26  23,195.1  24,328.5 
Provisions 27  418.4  180.7 
Put option granted on subsidiaries and other liabilities   4,110.1  3,512.8 
Current liabilities   41,005.1  40,540.4 
       
Total liabilities   52,500.5  54,630.2 
       
Total equity and liabilities   132,644.3  137,958.0 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the year ended December 31

All amounts in millions of Brazilian Reais unless otherwise stated

 

                   
  Attributable to equity holders of Ambev      
  Capital Capital reserves Net income reserves Retained earnings / (losses) Carrying value adjustments Total   Non-controlling interests Total equity
At January 1, 2021 57,899.1  54,985.6  25,920.0  -    (64,989.0) 73,815.7    1,335.5  75,151.2 
                   
 Net Income  -    -    -    12,671.0  -    12,671.0    451.6  13,122.6 
                   
Comprehensive income:                  
Gains/(losses) on the translation of foreign operations -    -    -    -    2,449.7  2,449.7    108.3  2,558.0 
Cash flow hedges -    -    -    -    480.8  480.8    0.5  481.3 
Actuarial gains/(losses) -    -    -    -    341.8  341.8    (1.8) 340.0 
Total comprehensive income  -    -    -    12,671.0  3,272.3  15,943.3    558.6  16,501.9 
Capital increase (Note 22) 143.4  (134.4) -    -    -    9.0    -    9.0 
Effect of application of IAS 29 (hyperinflation) -    -    -    2,063.7  -    2,063.7    21.4  2,085.1 
Options granted on subsidiaries -    -    -    -    (1.9) (1.9)   -    (1.9)
Gains/(losses) of controlling interest -    -    -    -    (46.2) (46.2)   8.6  (37.6)
Tax on deemed dividends -    -    -    -    (1.7) (1.7)   -    (1.7)
Dividends paid -    -    -    (2,099.5) -    (2,099.5)   (549.5) (2,649.0)
Interest on shareholder´s equity -    -    -    (7,400.1) -    (7,400.1)   -    (7,400.1)
Purchases of shares, results from treasury shares and share-based payments -    336.0  -    -    -    336.0    -    336.0 
Prescribed/(complementary) dividends -    -    -    24.7  -    24.7    -    24.7 
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) -    -    -    11.8  (11.8) -      -    -   
Fiscal incentive reserve  -    -    1,423.5  (1,423.5) -    -      -    -   
Investments reserve  -    -    3,848.1  (3,848.1) -    -      -    -   
At December 31, 2021 58,042.5  55,187.2  31,191.6  -    (61,778.3) 82,643.0    1,374.6  84,017.6 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the year ended December 31

All amounts in millions of Brazilian Reais unless otherwise stated

 

  Attributable to equity holders of Ambev      
  Capital Capital reserves Net income reserves Retained earnings Carrying value adjustments Total   Non-controlling interests Total equity
At January 1, 2022 58,042.5  55,187.2  31,191.6  -    (61,778.3) 82,643.0    1,374.6  84,017.6 
                   
 Net Income  -    -    -    14,457.9  -    14,457.9    433.3  14,891.2 
                   
Comprehensive income:                  
Gains/(losses) on the translation of foreign operations -    -    -    -    (6,772.2) (6,772.2)   (91.0) (6,863.2)
Cash flow hedges -    -    -    -    (316.7) (316.7)   (2.0) (318.7)
Actuarial gains/(losses) -    -    -    -    466.5  466.5    4.2  470.7 
Total comprehensive income  -    -    -    14,457.9  (6,622.4) 7,835.5    344.5  8,180.0 
Capital increase (Note 22) 88.0  (64.3) -    -    -    23.7    -    23.7 
Effect of application of IAS 29 (hyperinflation) -    -    -    3,224.5  -    3,224.5    9.2  3,233.7 
Gains/(losses) of controlling interest -    -    -    -    (2.8) (2.8)   (0.3) (3.1)
Tax on deemed dividends -    -    -    -    (6.2) (6.2)   -    (6.2)
Dividends paid -    -    -    -    -    -      (357.4) (357.4)
Interest on shareholder´s equity -    -    -    (11,999.8) -    (11,999.8)   -    (11,999.8)
Purchases of shares, results from treasury shares and share-based payments -    216.8  -    -    -    216.8    1.6  218.4 
Prescribed/(complementary) dividends -    -    -    20.9  -    20.9    -    20.9 
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) -    -    -    11.8  (11.8) -      -    -   
Fiscal incentive reserve  -    -    2,018.6  (2,018.6) -    -      -    -   
Investments reserve  -    -    3,696.7  (3,696.7) -    -      -    -   
At December 31, 2022 58,130.5  55,339.7  36,906.9  -    (68,421.5) 81,955.6    1,372.2  83,327.8 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

For the year ended December 31

All amounts in millions of Brazilian Reais unless otherwise stated

 

  Attributable to equity holders of Ambev      
  Capital Capital reserves Net income reserves Retained earnings Carrying value adjustments Total   Non-controlling interests Total equity
At January 1, 2023 58,130.5  55,339.7  36,906.9  -    (68,421.5) 81,955.6    1,372.2  83,327.8 
                   
 Net Income  -    -    -    14,501.9  -    14,501.9    458.5  14,960.4 
                   
Comprehensive income:                  
Gains/(losses) on the translation of foreign operations -    -    -    -    (9,212.4) (9,212.4)   (122.0) (9,334.4)
Cash flow hedges -    -    -    -    (210.8) (210.8)   (1.3) (212.1)
Actuarial gains/(losses) -    -    -    -    (13.2) (13.2)   0.7  (12.5)
Total comprehensive income  -    -    -    14,501.9  (9,436.4) 5,065.5    335.9  5,401.4 
Capital increase (Note 22) 47.4  (32.9) -    -    -    14.5    -    14.5 
Effect of application of IAS 29 (hyperinflation) -    -    -    3,269.4  -    3,269.4    8.5  3,277.9 
Options granted on subsidiaries -    -    -    -    6.7  6.7    -    6.7 
Gains/(losses) of controlling interest -    -    -    -    (2.6) (2.6)   -    (2.6)
Tax on deemed dividends -    -    -    -    (12.4) (12.4)   -    (12.4)
Dividends paid -    -    -    -    -    -      (543.9) (543.9)
Interest on shareholder´s equity -    -    -    (11,500.2) -    (11,500.2)   -    (11,500.2)
Purchases of shares, results from treasury shares and share-based payments -    172.8  -    -    -    172.8    1.8  174.6 
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) -    -    -    11.8  (11.8) -      -    -   
Fiscal incentive reserve  -    -    2,552.7  (2,552.7) -    -      -    -   
Investments reserve  -    -    3,730.2  (3,730.2) -    -      -    -   
At December 31, 2023 58,177.9  55,479.6  43,189.8  -    (77,878.0) 78,969.3    1,174.5  80,143.8 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

For the year ended December 31

All amounts in millions of Brazilian Reais unless otherwise stated

 

         
  Note 2023 2022 2021
         
Net income   14,960.4  14,891.2  13,122.6 
Depreciation, amortization and impairment   6,417.9  5,956.3  5,396.7 
Impairment losses on receivables and inventory   358.4  351.8  200.8 
Additions/(reversals) in provisions and employee benefits   233.8  232.7  244.6 
Net finance costs 11 3,609.8  3,423.1  3,205.4 
Losses/(gains) on sale of property, plant and equipment and intangible assets   (86.4) (88.8) (142.8)
Share-based payment expenses 25 331.6  313.9  387.6 
Income tax expense 13 75.5  (655.6) 636.6 
Share of result of joint ventures   185.3  29.1  115.7 
Hedge operations results   (37.9) (466.6) (1,852.2)
Other non-cash items included in profit   (9.0) (17.4) -   
Cash flow from operating activities before changes in working capital and use of provisions   26,039.4  23,969.7  21,315.0 
         
(Increase)/decrease in trade and other receivables   (1,373.9) (322.5) 341.4 
(Increase)/decrease in inventories   1,300.9  (3,088.0) (3,499.5)
Increase/(decrease) in trade and other payables   (223.1) 726.6  6,157.5 
Cash generated from operations   25,743.3  21,285.8  24,314.4 
         
Interest paid   (666.1) (826.3) (498.2)
Interest received   1,248.3  1,095.0  377.1 
Dividends received   12.9  6.6  13.1 
Income tax paid   (1,627.0) (919.0) (1,305.1)
Cash flow from operating activities   24,711.4  20,642.1  22,901.3 
         
Proceeds from sales of property, plant and equipment and intangible assets   154.1  133.9  301.7 
Proceeds from sales of subsidiaries’ operations   -    -    0.5 
Acquisitions of property, plant and equipment and intangible assets   (6,004.1) (6,533.1) (7,677.1)
Acquisitions of subsidiaries, net of cash acquired   (46.5) (3.0) (133.8)
Acquisitions of other investments   (6.3) (30.0) (5.3)
Investments in short-term debt securities and net proceeds/(acquisitions) of debt securities   136.4  1,413.0  (236.0)
Net proceeds/(acquisitions) of other assets   0.4  15.0  15.0 
Cash flow from investing activities   (5,766.0) (5,004.2) (7,735.0)
         
Capital increase   14.5  23.8  9.1 
Proceeds/(buyback) treasury shares   (119.0) (54.1) (44.2)
Acquisitions of non-controlling interest   -    (0.1) -   
Proceeds from borrowings 23 49.8  274.9  315.2 
Repayment of borrowings 23 (227.4) (230.2) (2,454.0)
Cash net of finance costs other than interests   (2,731.1) (3,255.1) (2,089.6)
Lease Payments 23 (1,180.1) (854.7) (663.2)
Dividends and interest on shareholders’ equity paid   (11,921.9) (12,242.3) (11,115.3)
Cash flow from financing activities   (16,115.2) (16,337.8) (16,042.0)
         
Net increase/(decrease) in cash and cash equivalents   2,830.2  (699.9) (875.7)
Cash and cash equivalents less bank overdrafts at the beginning of the year   14,852.1  16,597.2  17,090.3 
Effect of exchange rate fluctuations on cash and cash equivalents   (1,623.3) (1,045.2) 382.6 
Cash and cash equivalents less bank overdrafts at the end of the year   16,059.0  14,852.1  16,597.2 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

AMBEV S.A.

 

 

1.CORPORATE INFORMATION

 

1.1 Description of business

 

Ambev S.A. (referred to as the “Company” or “Ambev”) together with its subsidiaries (the “Group” or “Consolidated”), headquartered in São Paulo - SP, Brazil, has as its purpose, either directly or through participation in other companies, the production and sale of beer, draft beer, soft drinks, other non-alcoholic beverages, malt and food in general, as well as the advertising of its own and of third party products, the sale of promotional and advertising materials and the direct or indirect exploitation of bars, restaurants, snack bars and similar establishments, among others.

 

The Group portfolio includes several own brands, like Brahma®, Skol®, Antarctica®, Colorado®, Bohemia®, Serramalte®, Quilmes®, Patagonia®, Guaraná Antarctica®, Beats® among others, and licensed brands, like Budweiser®, Corona®, Stella Artois®, Spaten® Beck’s® and Mike’s®.

 

The Company’s shares and American Depositary Receipts (“ADRs”) are listed on the Brasil, Bolsa, Balcão S.A. (“B3”), under the ticker “ABEV3” and on the New York Stock Exchange (“NYSE”) under the ticker “ABEV”, respectively.

 

The Company’s direct controlling shareholders are Interbrew International B.V. (“ITW International”), AmBrew S.à.r.l (“Ambrew”), both of which are subsidiaries of Anheuser-Busch InBev N.V. (“AB InBev”) and Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência (“Fundação Zerrenner”).

 

1.2 Major corporate events in 2023, 2022 and 2021

 

1.2.1 Notification of ELJ to exercise the put option under the Tenedora Shareholders' Agreement

 

The Company and E. León Jimenes, S.A. (“ELJ”), as the shareholders of Tenedora CND, S.A. (“Tenedora”), a holding company headquartered in the Dominican Republic, the owner of almost the entire share capital of Cervecería Nacional Dominicana, S.A., on July 2, 2020, signed the second amendment to Tenedora’s Shareholders Agreement (the “Shareholders Agreement”), extending their partnership in the country and postponing the terms of the put and call options defined in the original Agreement. At December 31, 2023, ELJ was the owner of 15% of Tenedora’s shares, and its put option was divided into two tranches: (i) Tranche A, corresponding to 12.11% of the shares, as formalized in the Shareholders' Agreement and ratified by the notification received from ELJ on October 2023, Tranche A was exercised at January 31, 2024; and (ii) Tranche B, corresponding to 2.89% of the shares, exercisable starting in 2026. The Company, on the other hand, has a call option over Tranche B shares to be exercised starting in 2029. The details about the the exercise of the put option by ELJ are described in Note 31 - Events after the reporting period. The assumptions used for these options are described in Note 28 (Item 28.3.1).

 

1.2.2 New distribution agreement of Corona in Canada

 

As at December 2023, the Company renegotiated the licensing contract with Trademarks Grupo Modelo, S. de R.L. de C.V., subsidiary of the AB Inbev, to produce, promote, sell and distribute Corona products in Canada. As consideration for acquired rights, for a period of 100 years, automatically renewable for another 100, the Labatt Brewing Company Limited, subsidiary of the Company in Canada, shall pay the licensor a single payment of R$869 million. The amount relating to acquired right was recognized in 2023 as a commercial asset in intangible assets.

 

AMBEV S.A.

 

 

1.2.3 Tax Credits – 2022 and 2023

 

After the decision of the Supreme Federal Court ("STF") in the judgment of RE 574,706/PR, delivered in 2017 and ratified in May 2021, which declared unconstitutional the inclusion of ICMS in the calculation basis of PIS and COFINS, in September 2021 the National Treasury Attorney's Office ("PGFN") published Opinion PGFN 14,483/2021 in which it brought the agency's understanding about the procedures to be observed by the Tax Administration regarding the subject, especially regarding the impacts of said exclusion on the PIS and COFINS credits recorded by the acquirers in inbound operations. As a result of these events, the Company concluded in 2022 analyses that allowed the accounting recognition of R$1.2 billion, in the same period, as tax credits resulting from the exclusion of ICMS from the calculation basis of PIS and COFINS in operations with subsidiaries.

 

Furthermore, on December 13, 2023, the Superior Court of Justice ("STJ") concluded the judgment of Theme 1,125, confirming the understanding that ICMS collected under the substitution tax system should also be excluded from the calculation bases of PIS and COFINS of the taxpayer's substitutes. The judgment of this decision is still pending publication. Regarding this subject, from 2017 to 2023, the Company and its subsidiaries recognized tax credits in the amount of R$1.4 billion, having been approximately R$407.1 million recognized as extemporaneous credits in 2023 (R$218 million were recorded in other operating income and R$189.1 million in the finance result).

 

1.2.4 Share buyback program

 

The Board of Directors, in a meeting held on May 18, 2023, approved, pursuant to article 30, 1st Paragraph, “b”, of Law 6,404/76 and CVM Instruction 77/22, a share buyback program by the Company (“Program”) up to the limit of 13,000,000 common shares, with the primary purpose of covering any share delivery requirements contemplated in the Company's share-based compensation plans or to be held in treasury, canceled and/or subsequently transferred. The program must be concluded no later than November 18, 2024, as detailed together with other information about it in the Notice on Trading of Own Shares, prepared under the terms of Annex G to CVM Resolution 80/22 and disclosed to market on May 18, 2023. At the same date, the Company had 4,393,610,429 outstanding shares as defined in CVM Instruction 77/22. The acquisitions occurred as per a deduction of the capital reserve account recorded in the balance sheets dated as at March 31, 2023. The transaction was carried out through the following financial institution: UBS Brasil Corretora de Câmbio, Títulos e Valores Mobiliários S.A.

 

1.2.5 COVID-19 pandemic impacts

 

The impact of the pandemic on our operations and the restrictions imposed in response by national governments, especially since March 2020, have generated significant changes in market dynamics both in the off-trade sales channel, mainly comprised of supermarkets, and in the on-trade channel, which consists of bars and restaurants. In each case, the more severe the restrictions on the marketing and consumption of our products, the greater the reduction in volume, which is why Bolivia and Panama were the most affected countries, especially in fiscal year 2021. On the other hand, we observed an increase in sales related to e-commerce in all countries, although this channel represents a small portion of the Company’s total volume.

 

AMBEV S.A.

 

In early 2022, our operations, mainly in Brazil, were impacted by the wave of the Omicron variant of COVID-19, which, combined with factors such as unfavorable weather, negatively impacted our sales. From the second quarter on, with the progress of the vaccination programs and the greater control over the advance of the COVID-19 pandemic, there was a relaxation of the restrictions in the regions in which we operate, favoring the recovery of the on-trade channel.

In Brazil, the consistent implementation of the Company's strategy combined with the context of relaxed restrictions and the return of occasions for out-of-home consumption generated a positive volume trend, with growth in both volume and net revenue compared to the same 2021 period.

 

As required by IAS 1 - Presentation of Financial Statements, the Company updated the analysis of the impact of COVID-19, as at December 31,2022 – last year of the pandemic – which mainly involved, (i) a review of the assumptions of the annual impairment test, as described in Note 15 - Goodwill, (ii) an analysis of possible credit losses and inventory obsolescence, (iii) an analysis of the recoverability of deferred taxes, and (iv) the evaluation of the relevant estimates used for the preparation of the financial statements, among other analyses.

 

Any impacts arising from these analyses are reflected in the financial statements and disclosed in explanatory notes. In addition, due to the protective actions taken for its staff and the donations made by its community, the Company incurred exceptional expenses of R$16.7 at December 31, 2022 as reported in Note 8 - Exceptional items.

 

2.BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS

 

The consolidated financial statements have been prepared using the going concern basis of accounting and are being presented in accordance with the International Financial Reporting Standards (“IFRS®”) issued by the International Accounting Standards Board (“IASB®”), effective as at December 31, 2023 and disclose all (and only) the applicable significant information related to the financial statements, which is consistent with the information utilized by Management in the performance of its duties.

 

The measurement basis used in preparing the financial statements is the historical cost, net realizable value, fair value or recoverable amount.

 

In preparing the financial statements, management uses judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets, liabilities, income and expenses. The relevant estimates and judgments are disclosed in Note 4 - Use of estimates and judgments.

 

AMBEV S.A.

 

 

The financial statements were approved, in their final form, by the Board of Directors on March 11, 2024.

 

2.1 Functional and presentation currency

 

The functional and presentation currency of the Company financial statements is the Brazilian Real, which is the currency of its main economic operating environment. For presentation purposes, the financial statements are presented in millions of Brazilian Reais (“R$”), unless otherwise indicated, rounded to the nearest million.

 

Foreign currency transactions are accounted for at the exchange rates prevailing as at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies are translated using the balance sheet date rate. Non-monetary assets and liabilities denominated in foreign currencies are translated at the foreign exchange rate prevailing as at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies stated at fair value are translated at the exchange rate in force as at the date on which the fair value was determined. Gains and losses arising from the settlement of transactions in foreign currencies and resulting from the conversion of assets and liabilities denominated in foreign currencies are recognized in the income statement.

 

Assets and liabilities of subsidiaries located abroad are translated at the foreign exchange rates prevailing at the balance sheet date, while amounts from the income statement and cash flow are translated at the average exchange rate for the year, and changes in equity are translated at the historical exchange rate of each transaction. Translation adjustments arising from the difference between the average exchange rates and the historical rates are recorded directly in Carrying value adjustments.

 

In the consolidation process, exchange differences arising from the translation of equity in foreign operations and borrowing and other currency instruments designated as net investment hedges are recognized in Carrying value adjustments, an equity reserve, and included in Other comprehensive income.

 

Even when recorded in the acquiring entity, the goodwill and fair value adjustments arising from the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and are translated at the foreign exchange rate at the balance sheet date.

 

 

AMBEV S.A.

 

 

2.1.1 Exchange rates

 

The most significant exchange rates used for the preparation of the Company’s financial statements are as follow:

 

                 
      Closing rate   Average rate
Currency Name Country 2023 2022 2021   2023 2022 2021
                   
CAD Canadian Dollar Canada 3.6536  3.8540  4.3914    3.7048  3.9807  4.2960 
DOP Dominican Peso Dominican Republic 0.0831  0.0925  0.0970    0.0892  0.0937  0.0938 
USD US Dollar Panamá and Cuba 4.8413  5.2177  5.5805    5.0085  5.1644  5.3687 
GTQ Quetzal Guatemala 0.6189  0.6623  0.7201    0.6398  0.6649  0.6954 
ARS Argentinean Peso  Argentina 0.0060  0.0295  0.0543    0.0170  0.0403  0.0568 
BOB Bolivian Peso Bolivia 0.6956  0.7497  0.8018    0.7196  0.7420  0.7714 
PYG Guarani Paraguay 0.0007  0.0007  0.0008    0.0007  0.0007  0.0008 
UYU Uruguayan Peso Uruguay 0.1241  0.1302  0.1249    0.1291  0.1253  0.1236 
CLP Chilean Peso Chile 0.0055  0.0061  0.0066    0.0059  0.0059  0.0071 
BBD Barbadian Dollar Barbados 2.3866  2.5721  2.7510    2.4690  2.5458  2.6465 

 

 

3.SUMMARY OF MATERIAL ACCOUNTING POLICIES

 

The accounting practices adopted by the Company are consistent in all the years presented. There were no changes in accounting policies and in calculation methods used for the annual financial statements as at December 31, 2023, compared to those presented in the financial statements for the years ended December 31, 2022, and 2021.

 

For better understanding, the material accounting policies adopted by the Company and applied in the preparation of these financial statements have been included in the respective accompanying notes, except for the policies described below, which may permeate more than one subject of the financial statements and have therefore been summarized in this accompanying note.

 

3.1 Recently issued IFRS

 

The new standards, which became effective are not applicable or did not have any material impact for the Company for the preparation of these consolidated financial statements. Below are the main changes in accounting standards which, in management's opinion, could have an impact on the Company's subsequent disclosures:

 

(i)On May 25, 2023, the IASB® published amendments to IAS 7 – Statement of Cash Flows and IFRS 7 – Financial Instruments: Disclosures, which establish new disclosure requirements for financing transactions with suppliers, the so-called "drawn risk". These requirements must be adopted by companies that adhere to the IFRS® as of 2024. The Company is evaluating the impacts of these changes, for any additional corresponding disclosures in future individual and consolidated financial statements, even though these transactions are not material to the Group, as disclosed in note 26 – Trade payables.

 

(ii)In August 2023, the IASB® issued amendments to IAS 21 – The Effects of Changes in Foreign Exchange Rates. The modifications implemented will require the application of a consistent approach when assessing whether a currency can be exchanged for another currency and, when it cannot, determining the exchange rate to be used, and the related disclosures. The Company is evaluating the impacts of these standards, the adoption of which is required for fiscal years beginning on January 1, 2025.

 

 

AMBEV S.A.

 

(iii)In December 2021, the Organisation for Economic Cooperation and Development ("OECD"), as part of the Inclusive Framework on Base Erosion and Profit Shifting ("BEPS") project, released the Pillar Two model rules (or Global Anti-Base Erosion Model Rules - GloBE), aiming at a common approach to international corporate taxation, in order to ensure that multinational economic groups within the scope of these rules calculate taxes on profit at a minimum effective rate of 15% in each country where they operate. These rules will have to be approved locally in each country that adheres the proposal, via applicable legislation, some of which have already promulgated new laws or are in the process of discussing and approving them. In May 2023, the IASB® issued scope changes to IAS 12 – Income Taxes to allow a temporary exemption in accounting for deferred income taxes arising from promulgated or substantially promulgated legislation implementing OECD Pillar Two, an exemption which has been adopted by the Group. Considering the legislation already published in the countries in which the Company operates, the Company has estimated the impacts on the 2023 financial statements and the amount is not material.

 

In addition of these, the Company does not anticipate that there are any other standards or amendments to IFRS® standards or IFRIC interpretations that have not come into force yet and that could have a significant impact on the Group's individual and consolidated financial statements.

 

3.2 Consolidated financial statements

The financial statements of subsidiaries, joint arrangements and associates used in these consolidated financial statements are prepared for the same reporting period as Ambev, using a consistent accounting policy.

 

All intercompany transactions, balances and unrealized gains or losses on transactions between consolidated companies were integrally eliminated.

 

3.2.1 Subsidiaries

 

The Company controls an entity when it is exposed to or has rights to variable returns due to its involvement with the entity, and it can affect those returns through its power over the entity. When assessing control, potential voting rights are considered. Control is presumed to exist where the Company owns, directly or indirectly, more than half of the voting rights (which does not always equate to economic ownership), unless it can be demonstrated that such ownership does not confer control.

 

Subsidiaries are consolidated from the date on which control is obtained by the Company, except when the predecessor basis of accounting is applied to transactions of business combinations under common control. Consolidation is discontinued from the date on which control ceases.

 

3.2.2 Associates

 

Associates are companies which the Company has significant influence over the financial and operational policies but does not control.

 

3.2.3 Joint arrangements

 

Joint arrangements are all entities over which the Company shares control with one or more parties. Joint arrangements are classified either as joint operations or joint ventures depending on the contractual rights and obligations of each investor.

 

 

 

AMBEV S.A.

 

3.2.4 Business combination

 

Ambev uses the acquisition method to account its business combinations. The consideration transferred for the acquisition of a subsidiary represents the fair value of the assets transferred, the liabilities incurred, and the equity interest issued by Ambev. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration agreement, when applicable. Costs related to the acquisition are recognized in income as they are incurred. Assets, liabilities and contingent liabilities acquired/assumed in a business combination are recognized initially at their fair value as at the acquisition date. Ambev recognizes the non-controlling interest in the acquiree, either at its fair value or at the non-controlling interest’s proportional share of the net assets acquired. The measurement of the non-controlling interest to be recognized is determined for each acquisition.

 

The excess of: (i) the consideration paid; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired, at the date of acquisition, is recorded as goodwill. When the consideration transferred is less than the fair value of the net assets acquired, the difference is recognized directly in income.

 

3.2.5 Business combination between entities under common control

 

Business combinations between entities under common control have not been addressed under IFRS how they should be disclosed remains unclear. IFRS 3 - Business Combinations is the standard applicable to business combinations, but its scope explicitly excludes business combinations between entities under common control, thus, in evaluating transactions of this nature, Management’s judgment is required to adequately reflect the essence and economic reality of each transaction.

 

3.2.5.1 Predecessor basis of accounting

 

In accordance with IAS 8 – Accounting Policies, Changes in Accounting Estimates and Errors, Management has adopted the predecessor basis of accounting, which is consistent with United States Generally Accepted Accounting Principles (“USGAAP”) and United Kingdom Generally Accepted Accounting Principles (“UKGAAP”), to record the carrying amount of the asset received, as recorded by the parent company.

 

Under the predecessor basis of accounting, when accounting for a transfer of assets between entities under common control, the entity that receives the net assets or the equity interests (the acquirer) shall initially record the assets and liabilities transferred at their parent book value as at the transfer date. If the book value of the assets and liabilities transferred by the parent is different from the historical cost recorded by the controlling entity of the entities under common control (the ultimate parent), the financial statements of the acquirer shall reflect the assets and liabilities transferred at the same cost of the ultimate parent, as a counter-entry to shareholders' equity against the carrying value adjustments.

 

3.2.5.2 Assets Swap

 

For transactions between entities under common control that involve the disposal or transfer of assets from the subsidiary to its parent company (i.e., above the level of the consolidated financial statements), the Company assesses the existence of: (i) any conflicts of interest; and (ii) the economic substance and purpose of the transaction. Having fulfilled these assumptions, the Company adopted as a policy the concepts of IAS 16 – Property, Plant and Equipment in order to provide adequate visibility and a fair impact on the amount of distributable results to its shareholders, specially the non-controlling interest. This policy also includes assets acquired through the swapping of non-cash assets, or swaps with a combination of cash and non-cash assets. The assets swapped may be of the same or a different nature. The cost of such assets is measured at fair value, unless: (i) the swap transaction is not commercial in nature; or (ii) the fair value of the asset received (and the asset assigned) cannot be reliably measured. The acquired asset is measured in this way even if the assignor entity cannot immediately remove the asset from its books. If the acquired asset is not measurable at fair value, its cost is determined based on the book value of the assigned asset.

 

AMBEV S.A.

 

 

Whenever assets distributed are not recorded as cash, the asset, before distribution, is recorded at its fair value in the income account. This procedure is applicable to distributions where the assets are of the same nature and therefore can be treated equally. However, similarly to IFRIC 17 - Distributions of Non-cash Assets to Owners, in the absence of a specific accounting practice for transactions under common control, the Company applies these procedures as part of its accounting practices. We also apply the same procedures to sales (products, supplies, etc.) to its controlling entity, where the positive result of the sale is recognized in income.

 

3.3 Financial reporting in hyperinflationary economies

 

Under IAS 29 – Financial Reporting in Hyperinflationary Economies, the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in hyperinflationary economies are restated to reflect changes in the general purchasing power of the local currency by applying a general price index. On a monthly basis, the Company estimates the applicable general price index since the official release of the index takes place after the end of the accounting period. The financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether using the historical costs approach or the current costs approach, shall be stated in terms of the unit of measurement in force at the end of the reporting period, and translated into Reais at the closing rate for the period.

 

To determine if the economy of any of its operations is hyperinflationary, the Company assesses quantitative and qualitative aspects of the country's economic environment, such as the inflation rate recorded over the last three years. On July 1, 2018, the Argentine economy was considered by the Company to be hyperinflationary, under the terms of IAS 29, considering the increase in the official price indices accumulated in the period (National Consumer Price Index - "IPC"), measured by INDEC (National Institute of Statistics and Census). Since the company does not operate directly in a hyperinflationary economy, but one of its subsidiaries does, the restatement of comparative balances from previous years is not carried out, in accordance with IAS 21 - The Effects of Changes in Foreign Exchange Rates, however, the precepts of the standard are applied to the balances and transactions of the affected subsidiary.

 

3.4 Present value adjustment.

 

The elements of assets and liabilities, when relevant, are adjusted to their present value, considering the following assumptions for the calculation: i) the amount to be discounted; ii) the settlement dates; and iii) the discount rate, in accordance with IFRS 13 - Fair Value Measurement.

 

3.5 Tax incentives and subsidized loans

 

The Company and its subsidiaries enjoy state tax benefits in Brazil, provided by government grants. Referred grants may be as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credits, effective collection, payment deferral or partial reductions of state tax payable. The effective collection incentives are recorded in the operating net revenue, by its nature, as the others are recognized in other operating income.

 

Among the tax incentives granted to the Company, there are state tax incentive programs to promote industrial development either by financing or by deferring payment of taxes. These state programs are intended to promote long-term increases in employment and industrial decentralization, as well as to complement and diversify the industrial states.

 

In the case of these programs, the tax terms are set out in the respective state normative acts and, when conditions for obtaining these grants exist, they are under the Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. The benefits of the delayed payment of such taxes are recorded in the income statement, on an accrual basis.

 

AMBEV S.A.

 

Since it is benefits on financing category or tax payment deferring, as the interest rates and/or terms of these loans are advantageous compared to market conditions, these benefits are considered as subsidized loans as intended by IAS 20 - Accounting for Government Grants and Disclosure of Government Assistance. The respective subsidies consist of the gains identified by comparing the value of these operations under the market conditions to the value agreed in the contracts. Thereby, upon receipt of funding, the subsidy calculated is recorded in Other operating income, following the treatment for the other ICMS subsidies of similar nature. Management reviews the market conditions prevailing in the year to assess such subsidies on an annual basis.

 

Monthly, considering the value of the consideration, the period to maturity, the contract interest rate and the abovementioned discount rate, the reduction in present value adjustment is allocated to financial income, so as to bring the balance to zero by the time of settlement of each consideration.

 

Such financing is recognized as liability adjusted to its present value. When there is an intervening financial institution in the transaction, the financing is recorded at “Interest-bearing loans and borrowings”, otherwise, its recorded at “Trade payables”, because of the underlying economic essence and nature of the transaction.

 

4.USE OF ESTIMATES AND JUDGMENTS

 

The preparation of financial statements in compliance with IFRS requires Management to make use of judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and assumptions are based on experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for decision-making regarding judgments regarding the carrying amounts of assets and liabilities that are not readily evident from other sources. The actual results may differ from these estimates.

The estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the period during which they are realized, or future periods.

Although each significant accounting policy reflects judgments, assessments or estimates, the Company believes that the following accounting practices reflect the most critical judgments, estimates and assumptions that are important to its business operations and the understanding of its results:

 

Note Accounting policies that reflect significant estimates and judgments
3.2.3 Joint arrangements
3.2.4 Business combination
3.2.5 Business combination between entities under common control
3.3 Financial reporting in hyperinflationary economies
3.4 Present value adjustment
3.6 Tax incentives and subsidized loans
18 Recognition of assets and liabilities relating to extemporaneous tax debits or credits
13 Current and deferred tax
14 Leases
16 Impairment
24 Measurement of employee benefits
25 Share-based payments
27 Provisions and contingent liabilities, including tax contingencies
28 Measurement of financial instruments, including derivatives
 

AMBEV S.A.

 

 

5.SEGMENT REPORTING

 

(a)Reportable segments - Years ended:

 

                             
  Brazil CAC Latin America - South  Canada Consolidated
  2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021
                               
Net sales 46,361.7  42,635.8  35,586.5  10,044.8  9,440.1  9,947.4  13,797.2  17,371.2  16,571.7  9,533.2  10,261.7  10,748.7  79,736.9  79,708.8  72,854.3 
Cost of sales (23,516.1) (22,736.8) (18,309.1) (5,035.1) (4,860.8) (4,727.9) (6,657.3) (8,553.1) (8,235.7) (4,083.1) (4,271.4) (4,387.0) (39,291.6) (40,422.1) (35,659.7)
Gross profit 22,845.6  19,899.0  17,277.4  5,009.7  4,579.3  5,219.5  7,139.9  8,818.1  8,336.0  5,450.1  5,990.3  6,361.7  40,445.3  39,286.7  37,194.6 
Distribution expenses (6,428.6) (6,111.1) (5,123.1) (853.1) (1,020.7) (872.7) (1,614.3) (2,159.5) (2,010.1) (1,854.6) (2,104.0) (1,926.8) (10,750.6) (11,395.3) (9,932.7)
Sales and marketing expenses (4,477.0) (4,065.0) (3,440.3) (665.1) (645.5) (693.3) (1,190.0) (1,426.9) (1,542.9) (1,080.4) (1,200.0) (1,359.0) (7,412.5) (7,337.4) (7,035.5)
Administrative expenses (3,563.2) (3,346.0) (3,006.2) (413.0) (333.6) (427.7) (659.5) (835.0) (832.0) (638.0) (722.2) (611.5) (5,273.7) (5,236.8) (4,877.4)
Other operating income/(expenses) 1,892.5  2,361.3  2,096.0  26.3  (52.9) 12.4  95.0  192.7  38.8  15.1  12.8  (23.1) 2,028.9  2,513.9  2,124.1 
Exceptional items (137.8) (34.5) (210.1) (17.9) (16.1) (46.7) (47.6) (60.5) (115.4) (3.1) (32.2) (20.6) (206.4) (143.3) (392.8)
Income from operations 10,131.5  8,703.7  7,593.7  3,086.9  2,510.5  3,191.5  3,723.5  4,528.9  3,874.4  1,889.1  1,944.7  2,420.7  18,831.0  17,687.8  17,080.3 
Net finance costs                         (3,609.8) (3,423.1) (3,205.4)
Share of results of joint ventures                         (185.3) (29.1) (115.7)
Income before income tax                         15,035.9  14,235.6  13,759.2 
Income tax expense                         (75.5) 655.6  (636.6)
Net income                         14,960.4  14,891.2  13,122.6 
                               
Acquisition of property, plant and equipment 3,365.5  4,062.9  4,645.1  593.4  968.4  801.6  782.2  1,112.8  1,665.4  1,263.0  389.0  565.0  6,004.1  6,533.1  7,677.1 

 

 

 

AMBEV S.A.

 

 

(continued)

 

  Brazil CAC  Latin America - South  Canada Consolidated
  2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021
                               
Segment assets 56,974.2  57,353.8  54,609.4  13,692.3  15,385.6  15,351.9  16,085.1  22,044.5  21,583.0  15,856.9  16,093.3  18,016.6  102,608.5  110,877.2  109,560.9 
Intersegment elimination                         (2,162.1) (2,533.0) (2,868.5)
Non-segmented assets (i)                         32,197.9  29,613.8  31,910.1 
Total assets                         132,644.3  137,958.0  138,602.5 
                               
Segment liabilities 28,841.3  29,153.2  27,611.2  4,981.5  5,098.0  5,414.4  5,095.4  6,843.6  7,843.6  5,131.0  5,053.7  6,156.5  44,049.2  46,148.5  47,025.7 
Intersegment elimination                         (2,161.8) (2,534.2) (2,869.1)
Non-segmented liabilities (i)                         90,756.9  94,343.7  94,445.9 
Total liabilities                         132,644.3  137,958.0  138,602.5 

 

(i)The balance of non-segmented assets refers mainly to cash and cash equivalents, taxes and investments. The balance of non-segmented liabilities, in turn, refers mainly to equity values, taxes and derivatives.

 

 

Non-current assets attributed to Brazil (country of domicile of the company) and Canada amounted to R$45.1 billion and R$13.9 billion, respectively, in December 31, 2023 (R$44.6 billion and R$13.7 billion, respectively, in December 31, 2022, and R$42.6 billion and R$15.6 billion, respectively, in December 31, 2021). Furthermore, the net revenue attributable to the Company's operations in Argentina amounted to R$6.3 billion in December 31, 2023 (R$10.1 billion in December 31, 2022 and R$9.2 billion in December 31, 2021), and the segmented non-current assets attributed to the same country totaled R$5.9 billion for the year ended December 31, 2023 (R$9.7 billion in December 31, 2022 and R$9.1 billion in December 31, 2021).

 

AMBEV S.A.

 

 

(b)Additional information - by Business unit - Years ended:

 

                 
  Brazil
  Beer NAB Total 
  2023 2022 2021 2023 2022 2021 2023 2022 2021
                   
Net sales 38,985.9  35,857.9  30,537.1  7,375.8  6,777.9  5,049.4  46,361.7  42,635.8  35,586.5 
Cost of sales (19,377.7) (18,765.3) (15,382.0) (4,138.4) (3,971.5) (2,927.1) (23,516.1) (22,736.8) (18,309.1)
Gross profit 19,608.2  17,092.6  15,155.1  3,237.4  2,806.4  2,122.3  22,845.6  19,899.0  17,277.4 
Distribution expenses (5,171.9) (4,988.6) (4,263.1) (1,256.7) (1,122.5) (860.0) (6,428.6) (6,111.1) (5,123.1)
Sales and marketing expenses (3,969.4) (3,596.8) (3,096.2) (507.6) (468.2) (344.1) (4,477.0) (4,065.0) (3,440.3)
Administrative expenses (3,106.0) (2,928.8) (2,616.1) (457.2) (417.2) (390.1) (3,563.2) (3,346.0) (3,006.2)
Other operating income/(expenses) 1,474.1  1,884.5  1,711.3  418.4  476.8  384.7  1,892.5  2,361.3  2,096.0 
Exceptional items (137.8) (30.6) (202.0) -    (3.9) (8.1) (137.8) (34.5) (210.1)
Income from operations 8,697.2  7,432.3  6,689.0  1,434.3  1,271.4  904.7  10,131.5  8,703.7  7,593.7 
Net finance costs             (2,050.6) (1,110.3) (858.1)
Share of results of joint ventures             (179.0) (38.3) (11.7)
Income before income tax             7,901.9  7,555.1  6,723.9 
Income tax expense             2,214.9  2,787.7  1,953.2 
Net income             10,116.8  10,342.8  8,677.1 

 

 

AMBEV S.A.

 

Accounting policies

 

Reportable segments are consistently presented on the internal reporting regularly reviewed by the Company’s chief operating decision maker, the Chief Executive Officer, for the purpose of evaluating the performance of each segment and allocating resources to those segments. The information is prepared based on available financial data that is directly attributable to the segment or the information that can be allocated on a reasonable basis.

 

Therefore, the segment reporting is presented by geographical zone, since the risks and rates of return are predominantly affected by the fact that the company operates in different regions.

 

Performance information by business unit (Beer and Non-alcoholic beverages (“NAB”)), is also presented to the Company’s chief operating decision maker and is disclosed as additional information, even though it does not qualify as a segment.

 

The Company conducts its operations across four business segments, as follow:

 

▪ Brazil, where the Company operates two business subunits: (i) beer and (ii) non-alcoholic beverages (NAB).

 

▪ Central America and Caribbean (“CAC”), which includes direct operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala (which also serves El Salvador, Nicaragua and Honduras), Barbados and Panama.

 

▪ Latin America South (LAS), which includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay.

 

▪ Canada, represented by the operations of Labatt Brewing Company Ltd.

 

Our chief operating decision maker uses income from operations as the main measure of segment profitability.

 

In accordance with IFRS 8 - Segment Information, the Company does not disclose its revenues from external customers for each product or each group of similar products, since the necessary information is not available in a comparable form and the cost of preparing it would be excessive.

 

6.NET SALES

 

In compliance with the Brazilian Federal Law 6,404/76, Company discloses the reconciliation between gross and net sales presented in the consolidated income statement. The values by each operational segment are disclosed in note 5 – Segment reporting:

 

     
  2023 2022 2021
Gross sales 120,117.7  125,907.2  110,162.7 
Excise duty (25,227.5) (24,851.4) (22,052.6)
Discounts (15,153.3) (21,347.0) (15,255.8)
Total 79,736.9  79,708.8  72,854.3 

 

At December 31, 2023, the Company calculated R$1,467.2 million of fiscal incentives recognized as a deduction of revenue (R$1,245.8 million at December 31, 2022, and R$1,048.3 million at December 31, 2021).

 

 

AMBEV S.A.

 

 

Accounting Policies

The Company recognizes revenue when the performance obligations are satisfied, that is, when the Company or its subsidiaries transfer control of a product to a customer. Revenue represents the fair value of the amount received or receivable upon the sale of products or the rendering of services in the ordinary course of Group’s business. Revenue is presented net of taxes, returns, rebates and discounts, as well as net of the elimination of sales between the consolidated companies.

 

Revenue is measured based on the consideration, which the Company expect to have the right to receive in contracts with customers and excludes amounts collected on behalf of third parties.

 

Revenue recognition is based on the approach of IFRS 15 - Revenue from Contracts with Customers, from five-step:

 

·Identifying the contract with a customer.
·Identifying performance obligations in the contract.
·Determining the transaction price.
·Allocating the transaction price to performance obligations in the contracts.
·Revenue recognition when the performance obligations have been satisfied, meaning when the company transfers control of a product to a customer.

 

Contracts can include significant variable elements, such as discounts, rebates, refunds, credits, price concessions, incentives, performance bonuses and penalties. These trade incentives are treated as variable consideration. If the consideration includes a variable component, the company estimates the amount of consideration to which it will be entitled for transferring the promised goods or services to the customer. Variable consideration is only included in the transaction price if it is highly probable that the amount of revenue recognized would not be subject to significant future reversals when the respective uncertainty is resolved.

 

The gross sales obtained by the Company, in general, are subject to the incidence of certain taxes and contributions, which are calculated and paid to fiscal authorities in accordance with current municipal, state and federal legislation, and does not result in Group’s equity increase. These taxes and contributions are deducted from gross sales and relate substantially to tax on transactions concerning the circulation of goods (“ICMS”), social integration program (“PIS”), contribution to social security financing (“COFINS”) in Brazil.

 

7.OTHER OPERATING INCOME/(EXPENSES)

 

     
  2023 2022 2021
Government grants/net present value of long-term fiscal incentives 1,573.2  1,289.3  853.2 
Extemporaneous credits/(debits) (i) 218.0  1,013.9  1,219.0 
(Additions)/reversals of provisions (77.7) (77.2) (71.4)
Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates 86.4  88.8  66.1 
Other operating income/(expenses), net 229.0  199.1  57.2 
Total 2,028.9  2,513.9  2,124.1 

 

(i)As detailed in Notes 1 – Corporate information and 27.2 – Contingencies, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS, including in the tax substitution form, from its calculation basis, in the item Other operating income/(expenses).

 

 

AMBEV S.A.

 

 

Accounting policies

 

The Company recognizes, in other operating income/(expenses) line, government incentives granted as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credit, deferred payment or partial reductions of due state tax payable.

 

Government grants are not recognized until there is reasonable assurance that the Company and subsidiaries will meet the respective conditions and obligations related to governmental terms.

 

8.EXCEPTIONAL ITEMS

 

     
  2023 2022 2021
Restructuring (i) (109.4) (101.8) (165.4)
COVID-19 impacts (ii) -    (16.7) (134.3)
Legal fees (iii) (94.7) -    -   
Effect of application of IAS 29 (hyperinflation) (2.3) (8.2) (11.1)
Distribution agreement (iv) -    -    (82.0)
Write-off of investments (v) -    (16.6) -   
Total (206.4) (143.3) (392.8)

 

(i)The restructuring expenses primarily related to centralization projects and resizing in Brazil, Latin America CAC and Canada.
(ii)COVID-19 expenses refer to (a) additional administrative expenses to ensure the safety of the Company’s people (increased frequency of cleaning at the Company’s facilities, providing alcohol gel and masks for our employees); (b) donations; (c) Company initiatives providing support for some customer ecosystems, which were necessary due to the COVID-19 pandemic.
(iii)In 2003 some holders of warrants issued by Cervejaria Brahma filed lawsuits to discuss the criteria used in calculating the exercise price of such warrants. In 2023, the Company obtained some final favorable decisions on the matter, which was already classified as a remote loss. The amount recorded in this line refers to the provision for legal fees related to this matter.
(iv)Refers to distribution agreement with our strategic partner in Guatemala.
(v)Refers to an investment write-off of a business line in Canada

 

Accounting Policies

 

Exceptional items are those that, considering their peculiarities, in Management’s judgment need to be disclosed separately. In determining whether an event or transaction is exceptional, Management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence, and the potential impact on the variations in profit or loss. These items are disclosed in the income statement or separately disclosed in the notes to the financial statements. Transactions that may give rise to exceptional items are principally restructuring activities, amnesties, acquisitions of subsidiaries, impairment losses, and gains or losses on disposal of assets and investments.

 

9.PAYROLL AND RELATED BENEFITS

 

     
  2023 2022 2021
Wages and salaries 4,550.2  4,496.1  4,162.6 
Social security contributions 1,322.3  1,239.7  1,016.0 
Other personnel costs 970.7  1,075.9  1,076.1 
Increase in liabilities for defined benefit plans 145.6  157.8  178.2 
Share-based payments 333.4  311.6  391.5 
Contributions to defined contribution plans 91.3  82.0  74.1 
Total 7,413.5  7,363.1  6,898.5 

 

 

AMBEV S.A.

 

 

The payroll expenses and related benefits are presented in the income statement as shown below:

 

     
  2023 2022 2021
Cost of sales 2,629.6  2,510.4  2,247.9 
Distribution expenses 1,289.9  1,396.3  1,286.8 
Commercial expenses 1,321.3  1,504.8  1,480.9 
Administrative expenses 1,907.6  1,798.7  1,699.1 
Net finance costs 114.3  107.8  115.6 
Other operating (income)/expenses (1.3) 1.5  -   
Exceptional items 152.1  43.6  68.2 
Total 7,413.5  7,363.1  6,898.5 

 

 

10.ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE

 

Depreciation, amortization and impairment expenses are included in the following income statement accounts for the years ended in December 31,2023, 2022 and 2021:

 

             
  Depreciation and impairment of property, plant and equipment   Amortization of intangible assets
  2023 2022 2021   2023 2022 2021
               
Cost of sales (i) 3,552.5  3,413.3  3,326.6    13.2  16.4  16.4 
Distribution expenses 1,098.3  893.5  654.1    -    -    -   
Commercial expenses 613.7  660.7  700.3    148.6  113.2  84.3 
Administrative expenses 464.1  474.4  331.4    524.8  372.6  304.2 
  5,728.6  5,441.9  5,012.4    686.6  502.2  404.9 

 

(i)These amounts added to R$2,629.6 (R$2,510.4 and R$2,247.9 as at December 31, 2022, and 2021, respectively) mentioned in Note 9 - Payroll and related benefits, total R$6,195.3 (R$5,940.1 and R$5,591.0 as at December 31, 2022, and 2021, respectively). The remaining amount of R$33,096.3 (R$34,482.0 and R$30,068.7 as at December 31, 2022, and 2021, respectively), recorded in the cost of sales, refers to other production costs.

 

 

AMBEV S.A.

 

 

 

11.NET FINANCE RESULT

 

     
  2023 2022 2021
Finance expenses      
Interest expense (2,432.2) (2,328.3) (1,431.8)
Net Interest on pension plans (114.3) (107.9) (115.6)
Losses on hedging instruments (1,675.1) (3,158.4) (2,540.2)
Interest on provision for disputes and litigation (269.2) (456.6) (290.0)
Exchange differences (1,154.0) (751.1) (453.9)
Tax on financial transactions (178.3) (339.6) (216.6)
Bank guarantee expenses (249.8) (176.1) (174.9)
Other financial results (207.2) (574.2) (204.8)
Total of finance expenses (6,280.1) (7,892.2) (5,427.8)
       
Finance income      
Interest income 2,085.6  2,167.7  1,101.6 
Interest and foreign exchange rate on loans to/from related parties 119.2  37.1  42.5 
Financial instruments at fair value through profit or loss -    95.5  77.0 
Other financial results 289.4  565.3  78.9 
Total 2,494.2  2,865.6  1,300.0 
       
Effect of application of IAS 29 (hyperinflation) 176.1  1,603.5  922.4 
Total of finance income 2,670.3  4,469.1  2,222.4 
       
Net finance result (3,609.8) (3,423.1) (3,205.4)

 

Interest expenses are presented net of the effects of interest rate derivative financial instruments which mitigate Ambev’s interest rate risk (Note 28 - Financial instruments and risks). The interest expenses are as follows:

 

     
  2023 2022 2021
Financial instruments measured at amortized cost (644.1) (764.0) (466.0)
Financial instruments at fair value through profit or loss (i) (1,788.1) (1,564.3) (965.8)
Total (2,432.2) (2,328.3) (1,431.8)

 

(i)Include R$1,231 million (R$654 million at December 31, 2022) as accounts payable present value adjustment.

 

Interest income arises from the following financial assets:

 

     
  2023 2022 2021
Cash and cash equivalents 1,072.2  791.6  329.5 
Investment on debt securities 49.2  175.9  84.7 
Other receivables (i) 964.2  1,200.2  687.4 
Total 2,085.6  2,167.7  1,101.6 

 

(i)Refers, mainly, to monetary adjustment of recoverable tax.

 

Accounting policies

 

a) Finance expenses

Finance expenses comprises, in general, of interest payable on loans and borrowing, calculated using the effective interest rate method, trade payables present value adjustment, expenses related to bank guarantees, monetary adjustments resulting from disputes and litigations, foreign exchange losses, losses on currency hedging instruments intended for the offsetting of currency gains, results on interest rate hedging instruments, losses on hedging instruments that are not part of a hedge accounting relationship, losses on financial assets classified as held for trading, impairment losses on financial assets classified as available for sale, and as any losses due to hedge ineffectiveness.

 

AMBEV S.A.

 

 

All interest costs incurred in connection with borrowing or financial transactions, including transaction costs, are expensed as incurred as part of finance expenses, except when capitalized. The interest expenses component of finance lease payments is also recognized in the income statement using the effective interest rate method.

 

b) Finance income

Finance income comprises, in general, of interest received or receivable on funds invested, monetary updates arising from legal disputes, foreign exchange gains, gains on currency hedging instruments intended for offsetting currency losses, gains on hedging instruments that are not part of a hedge accounting relationship, gains on financial assets classified as at fair value through profit or loss, and as any gains due to hedge ineffectiveness. Interest income is recognized on an accruals basis unless collectability is in doubt.

 

12.EARNINGS PER SHARE

 

The tables below present the calculation of earnings per share (“EPS”) Basic and Diluted:

 

         
Basic 2023   2022   2021
Numerator          
Income attributable to the Ambev equity holders 14,501.9    14,457.9    12,671.0 
Denominator          
 Weighted average number of shares (i) (non diluted) 15,744.8    15,741.9    15,736.9 
 Basic EPS 0.9211    0.9184    0.8052 
           
           
Diluted 2023   2022   2021
Numerator          
Income attributable to the Ambev equity holders 14,501.9    14,457.9    12,671.0 
Denominator          
 Weighted average numbers of shares (i) (diluted)  15,838.6    15,848.6    15,857.5 
 Diluted EPS 0.9156    0.9123    0.7991 

 

(i)Million shares

 

Accounting Policies

 

The calculation of basic earnings per share is based on the net income attributable to Ambev equity holders and the weighted average number of shares outstanding during the year.

 

The diluted earnings per share of the stock option and deferred stock is based on the net income attributable to the equity holders of Ambev, adjusted by the weighted average number of shares outstanding during the year to assume the conversion of all potentially dilutive shares.

 

 

AMBEV S.A.

 

 

 

13.INCOME TAX AND SOCIAL CONTRIBUTION

13.1 Income tax and social contribution

The income tax and social contribution taxes are based on tax rates for 25% for income tax and 9% for social contribution in Brazil. For other regions in which the Company operates, the expected nominal rates are as follows:

 

 
Central America and the Caribbean from 15% to 27%
Latin America - South (i) from 10% to 35%
Canada 26.5%
Luxembourg 24.94%

 

Income taxes reported in the income statement are analyzed as follow:

 

     
  2023 2022 2021
Income tax expense – current (2,077.9) (1,718.9) (1,268.6)
       
Deferred tax expense on temporary differences 279.8  1,012.6  1,072.9 
Deferred tax on tax loss carryforward movements in the current period 1,722.6  1,361.9  (440.9)
Total deferred tax (expense)/income 2,002.4  2,374.5  632.0 
       
Total income tax expenses (75.5) 655.6  (636.6)

 

The reconciliation between the weighted nominal tax rate and the effective tax rate is summarized as follows:

 

     
  2023 2022 2021
Profit before tax 15,035.9  14,235.6  13,759.2 
Adjustment on a taxable basis      
Others non-taxable income (919.0) (883.3) (611.0)
Government grants related to sales taxes  (3,011.7) (2,535.1) (1,883.1)
Share of results of joint ventures 185.3  29.1  115.7 
Non-deductible expenses 56.5  192.8  99.2 
Worldwide taxation 1,171.4  679.3  (360.0)
  12,518.4  11,718.4  11,120.0 
Aggregated weighted nominal tax rate 28.30% 29.47% 27.39%
Taxes payable – nominal rate  (3,542.3) (3,453.3) (3,045.3)
Adjustment on tax expense      
Income tax Incentives 120.4  234.0  213.2 
Deductible interest on shareholders’ equity 3,909.8  4,079.9  2,516.0 
Tax savings from goodwill amortization 17.2  27.2  77.5 
Withholding income tax (489.1) (164.5) (876.0)
Recognition/(write-off) of deferred charges on tax losses 100.9  (58.2) (1.5)
Effect of application of IAS 29 (hyperinflation) (382.3) (249.0) (123.3)
Others with reduced taxation 189.9  239.5  602.8 
Income tax and social contribution expense (75.5) 655.6  (636.6)
Effective tax rate 0.50% -4.61% 4.63%

 

 

The main events that impacted the effective tax rate for the period were:

 

·Government subsidy for sales taxes: for regional incentives and economic development policies, these are related primarily to local production, contributing to economic and social impact, and, when reinvested, are not subject to income tax and social contribution purposes, which explains the impact on the effective tax rate. The amount above is impacted by fluctuations in the volume, price and any eventual increases in state VAT (“ICMS”), reflected in other operating income or net sales depending on its nature. In addition, the above-mentioned amount is allocated to the profit reserve on an annual basis, according to item (2.3.3) “Tax incentives” on Note 22 - Changes in equity

 

 

AMBEV S.A.

 

 

·Complement of income tax on foreign subsidiaries due in Brazil: shows the result of the calculation of universal taxation of profits, according to the regulations of Law 12,973/14.

 

·Withholding income tax: The amount is mainly related to dividends already distributed and to be distributed by subsidiaries located outside of Brazil, applicable according to local tax legislation. The recorded values in 2023 are mainly related to withholding tax on dividends distributed in 2023 and the exchange rate variation of the deferred income tax related to subsidiary profits undistributed.

 

·Deductible interest on shareholders’ equity: under Brazilian law, companies have an option to remunerate their shareholders through the payment of Interest on shareholders’ equity, which amount is impacted by the taxable result, net income reserves of the Company and by the long-term interest rate (“TJLP”). These remunerations are deductible for income tax purposes.

 

·Effect of application of IAS 29 (hyperinflation): our subsidiary in Argentina, for operating in a hyperinflationary economy, is subject to monetary correction of non-financial assets and liabilities, equity and income statement, which, at times, reflects in the consolidated effective tax rate and implies variation between periods.

 

13.2 Deferred income tax and social contribution

 

The details of the amount of deferred income tax and social contribution by type of temporary difference are as follows:

 

             
  2023   2022
  Assets Liabilities Net   Assets Liabilities Net
Investment securities 8.2  -    8.2    7.5  -    7.5 
Intangible -    (1,369.7) (1,369.7)   -    (1,690.2) (1,690.2)
Employee benefits 856.5  -    856.5    951.2  -    951.2 
Trade payables 2,843.8  (3.3) 2,840.5    3,232.8  (2.9) 3,229.9 
Trade receivables 43.8  (7.0) 36.8    38.6  (3.8) 34.8 
Derivatives 31.1  (77.2) (46.1)   95.1  (44.8) 50.3 
Interest-Bearing Loans and Borrowings 7.5  -    7.5    0.5  (0.9) (0.4)
Inventories 268.6  (59.6) 209.0    413.9  (139.3) 274.6 
Property, plant and equipment 714.2  (1,837.2) (1,123.0)   899.5  (2,177.1) (1,277.6)
Withholding tax on undistributed profits and royalties -    (1,385.5) (1,385.5)   -    (1,877.6) (1,877.6)
Investments in joint ventures -    (383.7) (383.7)   -    (421.6) (421.6)
Losses carried forward 4,383.3  -    4,383.3    2,660.7  -    2,660.7 
Provisions 1,026.3  (4.6) 1,021.7    819.3  -    819.3 
Impact of the adoption of IFRS 16 (Leases) 14.5  (19.7) (5.2)   35.1  (11.4) 23.7 
ICMS on the assessment bases of PIS/COFINS -    (228.5) (228.5)   -    (168.2) (168.2)
Other items 266.5  (437.1) (170.6)   260.8  (164.1) 96.7 
Gross deferred tax assets/(liabilities) 10,464.3  (5,813.1) 4,651.2    9,415.0  (6,701.9) 2,713.1 
Netting by taxable entity (2,494.7) 2,494.7  -      (2,976.2) 2,976.2  -   
Net deferred tax assets/(liabilities) 7,969.6  (3,318.4) 4,651.2    6,438.8  (3,725.7) 2,713.1 

 

 

AMBEV S.A.

 

 

Most tax losses and negative social contribution bases on which deferred income tax and social contribution were calculated do not have a statute of limitations. The use of credits related to tax losses is based on the projected future existence of taxable profits, limited to 30% of taxable income for the year, according to the actual figures for prior years, and the projections of the Company's business in the economies in which they are located, and thus follows the applicable fiscal and accounting rules.

 

Among the deferred tax assets on tax losses carried forward, the tax authorities unilaterally offset in tax proceedings the total amount of R$268.6, which are equivalent to R$790.0 in tax losses basis. Such proceedings are classified as having a possible probability of loss.

 

The critical estimates of Ambev’s Management, as well the main contingent liabilities related to uncertainty about the tax treatment of income, are disclosed in Notes 27.2 - Contingencies

 

13.2.1 Realization of deferred taxes

 

As at December 31, 2023, the deferred tax assets and liabilities related to combined tax losses which are expected to be utilized/settled using temporary differences, as follows:

 

     
  2023
Deferred taxes not related to tax losses to be realized within 12 months to be realized after 12 months Total
       
Investment securities -    8.2  8.2 
Intangible (1.2) (1,368.5) (1,369.7)
Employee benefits 199.9  656.6  856.5 
Trade payables (220.6) 3,061.1  2,840.5 
Trade receivables 22.7  14.1  36.8 
Derivatives (49.8) 3.7  (46.1)
Interest-bearing loans and borrowings 0.1  7.4  7.5 
Inventories 252.7  (43.7) 209.0 
Property, plant and equipment (4.1) (1,118.9) (1,123.0)
Withholding tax on undistributed profits and royalties -    (1,385.5) (1,385.5)
Investments in joint ventures -    (383.7) (383.7)
Provisions 664.5  357.2  1,021.7 
Impact of the adoption of IFRS 16 (Leases) -    (5.2) (5.2)
ICMS on the assessment bases of PIS/COFINS -    (228.5) (228.5)
Other items 39.8  (210.4) (170.6)
Total 904.0  (636.1) 267.9 

 

 
Deferred tax related to tax losses 2023
2023 -   
2024 755.7 
2025 422.5 
2026 1,635.2 
2027 1,052.8 
2028 a 2030 170.3 
2031 em onward (i) 346.8 
Total 4,383.3 

 

(i)There is no expectation of realization beyond a term of ten years.

 

 

AMBEV S.A.

 

 

13.2.2 The net change of deferred taxes

 

The net change in deferred income tax and social contribution is as follows:

 

 
At December 31, 2021 1,513.7 
Recognition of actuarial gains/(losses) (146.9)
Investment hedge – put option granted on subsidiaries (105.0)
Cash flow hedge – gains/(losses) 41.3 
Gains/(losses) on translation of other foreign operations  (419.3)
Recognized in other comprehensive income (629.9)
Recognized in the income statement 2,374.5 
Changes directly in the balance sheet (545.2)
Recognized in deferred tax (595.5)
Effect of application of IAS 29 (hyperinflation) (595.5)
Recognized in other balance sheet group 50.3 
At December 31, 2022 2,713.1 
Recognition of actuarial gains/(losses) 24.4 
Investment hedge – put option granted on subsidiaries (155.9)
Cash flow hedge – gains/(losses) 83.2 
Gains/(losses) on translation of other foreign operations  553.9 
Recognized in other comprehensive income 505.6 
Recognized in the income statement 2,002.4 
Changes directly in the balance sheet (569.9)
Recognized in deferred tax (476.3)
Effect of application of IAS 29 (hyperinflation) (476.3)
Recognized in other balance sheet group (93.6)
At December 31, 2023 4,651.2 

 

13.2.3 Deferred tax asset related to tax losses

 

As at December 31, 2023, besides the tax credits related to tax losses effectively recognized in the amounts disclosed above, other tax credits related to accumulated tax losses in the amount of R$669.0 (R$875.3 in 2022) - which are equivalent, in value basis, to R$2,521.0 in 2023 (R$3,359.5 in 2022) - were not recorded, since their realization is not probable in currently Management evaluation.

 

Accounting Policies

 

Income tax and social contribution for the year comprises current tax and deferred tax. Income tax and social contribution are recognized in the income statement, unless they relate to items recognized directly in comprehensive income or in other equity accounts. In these cases, the tax effects are also recognized directly in comprehensive income or in equity accounts (except for interest on shareholders’ equity. See Note 22- Changes in equity).

 

Deferred income taxes are calculated on temporary differences between their calculation bases and the Company's accounting data. The deferred tax assets are recognized only to the extent that is probable that future taxable profits will be available. The deferred income tax assets are reduced to the extent that it is no longer probable that future taxable profits will occur. The existence of future taxable income is based on a technical study approved by the Company's management.

 

IAS 12 – “Income Taxes” prescribes that no deferred tax liability on goodwill recognition, and no deferred tax asset/liability is recorded: (1) at the initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss and (2) on differences related to investments in subsidiaries to the extent that they are not reversed in the foreseeable future. The amount of deferred tax provided is based on the expectation of the realization or settlement of the temporary difference, using currently or substantially enacted tax rates.

 

AMBEV S.A.

 

 

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and where these relate to income taxes levied by the same tax authority on the same taxable entity, or to different taxable entities which intend either to settle their current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously.

 

The company is subject to income tax in numerous jurisdictions and judgment is required to determine the Company’s worldwide provision for income tax. Some of the Company's subsidiaries are involved in tax audits, usually in relation to previous years. These audits are ongoing in various jurisdictions as at the balance sheet reporting date and, by their nature, can take a considerable time to be completed.

 

The Company applies the provisions of IFRIC 23 - Uncertainty on the Treatment of Income Taxes in relation to the treatments that affected the calculation of income taxes (uncertain tax treatments), as disclosed in note 27.2 – Contingencies – Uncertainties about treatment of IRPJ and CSLL.

 

14.PROPERTY, PLANT AND EQUIPMENT

 

   
  2023 2022
Property, plant and equipment 23,662.7  26,961.3 
Right of use assets 2,967.5  3,094.4 
  26,630.2  30,055.7 

 

 

 

AMBEV S.A.

 

 

14.1 Changes in the carrying amount of property, plant, and equipment

 

                     
                    Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  At December 31, 2022   Acquisition cost Depreciation
Land and buildings 9,090.2  (832.1) 712.7  11.2  (436.8) (20.1) 1,173.2  9,698.3    14,494.2  (4,795.9)
Plant and equipment 10,884.0  (1,067.3) 952.6  1,283.5  (3,564.6) (15.7) 3,116.6  11,589.1    39,818.3  (28,229.2)
Fixtures and fittings 1,285.1  (111.6) 96.7  87.3  (579.7) (14.6) 560.7  1,323.9    7,682.7  (6,358.8)
Under construction 5,404.7  (360.7) 252.7  4,923.7  -    -    (5,870.4) 4,350.0    4,350.0  -   
  26,664.0  (2,371.7) 2,014.7  6,305.7  (4,581.1) (50.4) (1,019.9) 26,961.3    66,345.2  (39,383.9)

 

                    Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  At December 31, 2023   Acquisition cost Depreciation
Land and buildings 9,698.3  (1,485.2) 663.1  44.7  (481.6) (3.7) 800.6  9,236.2    14,287.8  (5,051.6)
Plant and equipment 11,589.1  (1,726.7) 779.4  1,230.2  (3,533.4) (39.1) 2,488.8  10,788.3    39,509.2  (28,720.9)
Fixtures and fittings 1,323.9  (193.4) 86.5  56.4  (541.6) (13.5) 373.7  1,092.0    7,074.2  (5,982.2)
Under construction 4,350.0  (311.7) 120.2  3,283.9  -    (3.4) (4,892.8) 2,546.2    2,546.2  -   
  26,961.3  (3,717.0) 1,649.2  4,615.2  (4,556.6) (59.7) (1,229.7) 23,662.7    63,417.4  (39,754.7)

 

 

AMBEV S.A.

 

 

14.2 Changes in the carrying amount of right-of-use assets

 

                   
                  Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Additions Depreciation Disposals and write-offs Transfers  At December 31, 2022   Acquisition cost Depreciation
Buildings 1,206.0  (64.3) 628.0  (391.6) 9.7  (37.0) 1,350.8    2,698.3  (1,347.5)
Machinery, vehicles and others 1,354.3  (8.2) 1,009.7  (453.9) (194.5) 36.2  1,743.6    2,889.5  (1,145.9)
Total 2,560.3  (72.5) 1,637.7  (845.5) (184.8) (0.8) 3,094.4    5,587.8  (2,493.4)

 

                  Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Additions Depreciation Disposals and write-offs Transfers  At December 31, 2023   Acquisition cost Depreciation
Buildings 1,350.8  (49.5) 355.0  (451.8) (30.5) (1.8) 1,172.2    2,925.9  (1,753.7)
Machinery, vehicles and others 1,743.6  (32.7) 1,329.3  (773.9) (475.5) 4.5  1,795.3    3,534.4  (1,739.1)
Total 3,094.4  (82.2) 1,684.3  (1,225.7) (506.0) 2.7  2,967.5    6,460.3  (3,492.8)

 

 

 

 

 

 

AMBEV S.A.

 

 

Accounting Policies

 

Property, plant and equipment are measured at cost less accumulated depreciation and impairment losses. The cost includes the purchase price, borrowing costs incurred during the construction period and any other costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management (e.g., nonrefundable tax, transportation and the costs of dismantling, removal and site restoration, if applicable). The cost of a self-constructed asset is determined using the same principles as an acquired asset. The depreciation methods, residual value, as well as the useful lives are reassessed and adjusted if appropriate, on an annual basis. Property, plant and equipment, and depreciation include the effects of using the predecessor basis of accounting (Note 3.2.5.1).

 

a.1) Subsequent expenditure

 

The Company recognizes in the carrying amount of an item of property, plant and equipment the cost of replacing a component of such an item if it is probable that the future economic benefits of the component will flow to the Company and the cost of the component can be measured reliably. All other costs are expensed as incurred.

 

a.2) Depreciation

 

The depreciable amount is the cost of an asset less its residual value. Depreciation is calculated from the date on which the asset is available for use, using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the major classes of property, plant and equipment are as follows:

 

 
Buildings 25 years
Plant and equipment 15 years
Fixtures 10 years
Fittings 10 years
Assets for external use / commercial assets  2 - 5 years

 

Land is not depreciated since it is deemed to have an indefinite useful life.

 

The assets’ residual values and useful lives are reviewed when necessary.

 

a.3) Gains and losses on sale

 

Gains and losses on sales are determined by comparing the results with the carrying amounts and are recognized in Other operating income/(expenses) in the income statement.

 

b) Leases

 

With the adoption of IFRS 16 – Leasings, the Company begun to recognize a right-of-use asset and a liability at the date of the beginning of the lease term.

 

The Company recognizes the right-of-use asset and a corresponding lease liability related to all lease contracts which is the lessee, except for short-term leases (defined as leases with terms of 12-month or less) and leases of low value assets. To these leases, Company recognizes the lease payments as operating expense during the lease course.

The right-of-use asset is initially measured at cost, which includes the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date. The asset is subsequently depreciated on a straight-line basis over the lease term or until the end of the asset's useful life.

 

AMBEV S.A.

 

 

Currently, the main leases by the Company are related to trucks, forklifts, real estate, commercial vehicles and industrial equipment contracts.

 

The lease liability is initially measured at lease payments present value, discounted by using the rate implicit in the lease. If the rate cannot be promptly determined, Company uses its incremental loan rate specific for the country, term and currency of the contract or other local criteria.

 

Lease payments include fixed payments, less any lease incentives, variable lease payments that depend on an index or known rate at the commencement date, and purchase options or extension options payments if the Company is reasonably certain to exercise these options. In general, the contracts establish an annual readjustment of payments according to the rates established in the contract.

 

A lease liability is remeasured upon a change in the lease term, or on the future payments or alteration of an index or rate used to determine payments, the corresponding adjustment is made to the related right-of-use asset.

 

The Company applies IAS 36 - Impairment of Assets to determine if right-of-use asset is subject to impairment and to record eventual losses by impairment.

 

The lease liability is disclosed at “Interest-bearing loans and borrowing” line and the right-of-use assets are disclosed at “Property, plant and equipment” line of the balance sheet.

 

15.GOODWILL

 

   
  2023 2022
     
Balance at the end of the previous year 40,594.0  42,411.3 
Effects of movements in foreign exchange in the balance sheet (4,067.9) (3,510.6)
Effect of application of IAS 29 (hyperinflation) 1,481.1  1,709.9 
Acquisitions, (write-offs) and disposal through business combinations (3.6) (16.6)
Balance at the end of the year 38,003.6  40,594.0 

 

 

AMBEV S.A.

 

 

The carrying amount of goodwill was allocated to the different cash generating unit (“CGU”) as follows:

 

     
  Functional currency 2023 2022
       
Brazil BRL 17,698.8  17,702.4 
Goodwill   102,941.4  102,945.0 
 Non-controlling transactions (i)   (85,242.6) (85,242.6)
       
CAC:      
Dominican Republic DOP 3,805.5  4,231.6 
Panama PAB 1,682.9  1,813.8 
       
Latin America - South:      
Argentina ARS 2,183.8  3,463.0 
Bolivia BOB 1,712.5  1,845.6 
Chile CLP 47.9  53.1 
Paraguay PYG 888.2  953.8 
Uruguay UYU 184.0  193.1 
       
Canada CAD 9,800.0  10,337.6 
    38,003.6  40,594.0 

 

(i)This refers to the shareholding exchange transaction in 2013 as a result of the adoption of the predecessor basis of accounting.

 

The assets with indefinite useful life represent approximately 29% of the total consolidated assets at December 31, 2023 (29% at December 31, 2022).

Accounting policies

 

Goodwill arises on acquisitions of subsidiaries, associates, and joint arrangements and is determined as the excess between: the sum of (i) the consideration paid in exchange for control of the acquiree; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired and liabilities assumed, measured in accordance with IFRS 3 - Business Combination as at the date of acquisition.

 

Business combinations are recognized applying the investment cost allocation method. If the company's share of the net fair value of the recognized assets, liabilities, and contingent liabilities exceeds the cost of the business combination, such excess is immediately recognized in the income statement. In a business combination, the asset with indefinite useful life is allocated from the acquisition date to each CGU expected to benefit from the business combination synergies.

 

In compliance with IFRS 3, goodwill is carried at cost and not amortized, but is tested for impairment at least annually, or whenever there are indications that the CGU to which the goodwill has been allocated could be impaired. Impairment losses recognized on goodwill are not reversed. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

 

For associates and joint ventures, goodwill is included in the carrying amount of the investment in the associate/joint venture.

 

Goodwill is expressed in the functional currency of the CGU or joint operation to which it relates and translated into Reais using the year-end exchange rate.

 

AMBEV S.A.

 

 

Expenditure on internally generated goodwill is expensed as it is incurred.

 

Goodwill includes the effects of applying the predecessor basis of accounting (Note 3 (3.2.5.1)).

 

16.IMPAIRMENT OF NON-FINANCIAL ASSETS

 

The Company cannot predict whether an event that could triggers impairment will occur, when it will occur or how it will affect the value of the asset reported. The Company believes that all its estimates are reasonable, are consistent with the Company’s internal reporting and reflect Management’s best estimates. However, inherent uncertainty exists which Management is not able to control. While changes in estimates could have a material impact on the calculation of fair values, and trigger impairment, the Company, based on the sensitivity analysis performed, is not aware of any reasonably possible changes in key assumptions that would cause a business unit’s carrying amount to exceed its recoverable amount.

 

For the year ended December 31, 2023, the Company performed impairment testing of the non-current assets of the Group (property, plant and equipment, intangible assets, goodwill, and right-of-use assets) for CGUs that had goodwill and assets with indefinite useful life allocated, as well as for other CGUs that showed indicators of impairment. The Company assesses internal and external sources of information as indicators, in accordance with IAS 36 - Impairment of Assets.

 

As a result of the impairment tests conducted, the Company did not identify any impairment or reversal of impairment losses scenario for any asset or CGU.

 

16.1 Assets with definite useful life

The company did not identify impairment indicators in the assets with definite useful life.

 

16.2 Assets with indefinite useful life

16.2.1 Methodology

The methodology used by the Company to determine the recoverable value of all its CGUs is the net fair value of selling expenses, using multiples of the profit before financial result, income tax and depreciation and amortization expenses (“EBITDA”), observed in the market for previous comparable business transactions in the domestic and international brewing industry. The values used by the Company for this approach are based on external sources of information. This measurement is classified at Level 2 of the fair value hierarchy, since the main source of information used by the Company to determine the recoverable value was the EBITDA multiples of observable transactions involving comparable businesses. As part of this multiples analysis, the Company has established that CGUs with invested capital that exceeds seven times their EBITDA should have their recoverable value determined using the value-in-use approach, to determine whether the value-in-use exceeds the carrying amount of the CGU. Based on the most recent analysis carried out by the Company, for 2023, only Chile and Panama met this criterion. Additionally, Brasil CGU was also included in the scope of testing, as it is the most representative CGU of the Group.

 

 

AMBEV S.A.

 

Thus, for Brazil, Panama and Chile CGUs, the Company also used discounted cash flow projections to determine the CGUs’ recoverable amounts, to corroborate the conclusions reached by applying the fair value less disposal costs approach that the carrying amount of these CGUs does not exceed their recognized accounting values.

16.2.2 Key assumptions

 

The key judgments, estimates and key assumptions used for the discounted free cash flow calculations for these CGUs were as follow:

 

§The first year of the model is based on management's best estimate of the free cash flow outlook for the current year.

 

§To the second year of the model, the free cash flow is based on AB InBev's strategic plan, as approved by key management. AB InBev's strategic plan is prepared on a per country basis, and is based on external sources of macroeconomic assumptions, industry trends, inflation and foreign exchange rates, experience and identified initiatives in terms of market share, revenue, variable and fixed costs, capital expenditure and working capital assumptions.

 

§From the third to the tenth year of the model, the cash flow is extrapolated using the growth in volumes, price indexes, and expected market share for each CGU. For Chile, the best estimates from local Management were considered.

 

§Projections are made in the functional currency of the business unit and discounted at the unit's weighted average cost of capital (“WACC”), considering sensitivities of this metric.

 

Based on the cash flow analysis, the growth rates applied ranged from 1.2% to 8.1%.

 

The nominal WACC applied in the local currency for each CGU was as follows:

 

 
CGU 2023
Chile 9.83%
Panama 10.72%
Brazil 12.38%

 

Although Ambev believes that its judgments, assumptions and estimates are appropriate, actual results may differ from these estimates based on different assumptions or market or macroeconomic conditions.

 

16.2.3 Sensitivity analysis

Based on the probable scenario, a sensitivity analysis was carried out for a 0.5 percentage point increase / decrease in the discount rate and growth rate. In any combination, the value of the cash flow is higher than its book value. As a result of this analysis, there is no need to record any provision to impairment from these assets.

 

Accounting Polices

 

The carrying amounts of non-financial assets, such as property, plant and equipment, goodwill and intangible assets without defined useful lives are reviewed, at least, at each reporting date to determine the existence of any indication of impairment. If there is any indication, the asset’s recoverable amount is estimated, and the non-recoverable amount is recognized as an impairment in the income statement. This assessment is performed for assets individually or for the smallest identifiable groups of assets that generate cash inflows independent of the cash inflows from other assets or other groups of assets, also referred to as CGUs.

 

AMBEV S.A.

 

 

Goodwill, intangible assets not yet available for use, and intangibles with indefinite useful lives, are tested for impairment at the business unit level (one level below the reportable segment level) at least annually, or whenever there is any indication of impairment. An impairment loss is recognized whenever the carrying amount of an asset or the related CGU exceeds its recoverable amount. Impairment losses are recognized in the income statement.

 

An impairment loss is recognized whenever the carrying amount of an asset or the related CGU exceeds its recoverable amount. Impairment losses are recognized in the income statement. Intangible assets with an indefinite useful life are tested on a fair value approach applying multiples that reflect current market transactions to indicators that drive the profitability of the asset or the royalty stream that could be obtained from licensing the intangible asset to another party in an arm’s length transaction.

 

The recoverable amounts of other assets are determined as the higher of their fair value less costs to sell and their value in use. For an asset that does not generate substantially independent cash inflows, the recoverable amount is allocated to the CGU to which the asset belongs. The recoverable amounts of the CGU to which the goodwill and the intangible assets with indefinite useful lives belong are based on the fair value net of selling expenses, using EBITDA multiples observed in the market for previous business combinations involving comparable businesses in the brewing industry. For some CGUs, these calculations are corroborated using the fair-value less costs of disposal approach, where the free cash flow of these CGUs is discounted to fair value using a discount rate after tax that reflects current valuation models for the time value of money, and the risks specific to the asset.

 

Impairment losses recognized in CGUs carrying amount of goodwill allocated to the CGUs and subsequently impact the carrying amount of the assets within the unit. Reversals of previously recognized impairments may occur, except for impairment losses related to goodwill due to expected future profitability. Non-financial assets are reviewed for the possible reversal of the impairment at the reporting date. Impairment losses are reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization.

 

AMBEV S.A.

 

 

17.INTANGIBLES

 

                     
                    Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Additions Transfers  Disposal  Amortization At December 31, 2022   Acquisition cost Depreciation
Brands 6,329.0  (1,096.2) 930.3  -    -    -    -    6,163.1    6,163.1  -   
Intangibles 671.2  (44.7) 0.1  -    3.2  -    (58.1) 571.7    3,308.6  (2,736.9)
Software 1,129.7  (130.6) 126.9  6.9  1,402.3  -    (401.1) 2,134.1    4,353.9  (2,219.8)
Others 559.1  (96.0) 76.8  220.5  (364.1) -    (43.0) 353.3    1,218.8  (865.5)
Total 8,689.0  (1,367.5) 1,134.1  227.4  1,041.4  -    (502.2) 9,222.2    15,044.4  (5,822.2)

 

                    Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Additions Transfers  Disposal  Amortization At December 31, 2023   Acquisition cost Depreciation
Brands 6,163.1  (1,838.5) 808.6  73.9  -    -    -    5,207.1    5,207.1  -   
Intangibles 571.7  (33.5) -    869.3  -    -    (56.7) 1,350.8    4,087.0  (2,736.2)
Software 2,134.1  (344.6) 176.2  37.0  976.5  (0.9) (573.5) 2,404.8    4,954.2  (2,549.4)
Others 353.3  (32.9) 11.0  487.7  317.0  (0.7) (56.4) 1,079.0    1,837.9  (758.9)
Total 9,222.2  (2,249.5) 995.8  1,467.9  1,293.5  (1.6) (686.6) 10,041.7    16,086.2  (6,044.5)

 

 

AMBEV S.A.

 

Intangibles with indefinite useful life

 

The carrying value of intangible assets with indefinite useful lives classified as brands were allocated to the following CGUs:

   
  2023 2022
Argentina 1,303.7  2,019.2 
Bolivia 830.0  894.5 
Brazil 73.9  -   
Canada 195.7  206.4 
Chile 70.7  78.5 
Luxembourg 339.6  339.6 
Paraguay 504.7  542.7 
Dominican Republic 1,431.5  1,593.0 
Panama 333.0  358.8 
Uruguay 124.3  130.4 
  5,207.1  6,163.1 

 

Intangible assets with indefinite useful lives have been tested for impairment on a CGU level basis, which is consistent with the approach described in Note 16 – Impairment of Non-Financial assets.

 

The Company is implementing a new version of its principal enterprise resource planning (ERP) - S4/Hana, an SAP platform, whose capitalizable investments are recognized as intangible assets in the software line. The implementation is necessary to update and improve the company's technological environment. In the context of the implementation, several assessments were carried out by Management, including from the perspective of internal controls, to mitigate risks connected to this type of upgrade, such as operational risks, operational disruption, data integrity and regulatory compliance.

 

Accounting policies

 

The intangibles are recognized at cost of acquisition, net of accumulated amortization and impairment losses.

 

Intangible assets with definite useful lives are amortized on a straight-line basis over their estimated useful lives. Licenses, supply, and distribution rights are amortized over the period for which the rights exist, based on the contract terms, which vary, in general, from 1 to 8 years. Brands are considered to have indefinite lives, and therefore, are not amortized. Software and capitalized development costs related to technology are amortized over a period of 3 to 10 years. Items that are not amortized are tested for impairment on an annual basis

 

Net gains on sales of intangible assets are disclosed in the income statement as other operating income. Net losses on sales are included as other operating expenses. Net gains and losses are recorded in income statement when control is transferred to the buyer, the counterpart recovery is possible and associated costs can be reliably estimated

 

(a) Brands

The Company is the owner of some of the world’s leading brands in the beer industry. As a result, brands are expected to generate positive cash flow for as long as the Company owns the brands, and accordingly they have been assigned indefinite useful lives. The most representative brands that have been recorded as a result of the fair value determination of past acquisitions are Quilmes in Argentina, Pilsen in Paraguay, Paceña and Huari in Bolivia and Presidente and Presidente Light in the Dominican Republic.

 

AMBEV S.A.

 

 

When a portion of the consideration paid in a business combination relates to brands, this is recognized in a specific Intangible Assets account, and measured at fair values as at the acquisition date. Subsequently, the value of brands can be reduced in the case of impairment losses. Internally generated expenditure for brand development is recognized within expenses.

 

(b) Software

Purchased software is measured at cost less accumulated amortization. Amortization related to software is included in the cost of sales, commercial expenses or administrative expenses, based on the business activity which the software is intended to support.

 

The expenditures related to software maintenance are recognized as expense, as incurred. The expenditures with development, as the expenditures with employees allocated in software development, which are directly attributed to identifiable and exclusive software, controlled by the Company, are recognized as intangible assets.

 

(c) Commercial intangibles

The Company recognizes supply rights, which consists in the right that Company has to supply for a customer and the commitment from the customer to buy Company’s products. And distribution rights that are the rights of selling specific products in a given territory.

 

(d) Other intangible assets

Other intangible assets also include multi-year sponsorship rights acquired by the Company. These are initially recognized at the present value of the future payments and subsequently measured at cost less accumulated amortization and impairment losses.

 

18.RECOVERABLE TAXES

 

   
  2023 2022
PIS/COFINS exclusion of ICMS (i) 6,490.4  5,992.8 
ICMS 436.5  423.2 
Income tax and social contributions recoverable 4,087.0  4,607.5 
Other 311.2  292.8 
Non-current 11,325.1  11,316.3 
     
PIS/COFINS exclusion of ICMS (i) 219.0  73.5 
PIS/COFINS 170.4  242.7 
ICMS 426.9  542.2 
IPI 112.5  131.0 
Income tax and social contributions recoverable 2,436.6  1,808.7 
Other 70.3  55.4 
Current 3,435.7  2,853.5 
     
Total 14,760.8  14,169.8 

 

(i)As detailed in Note 27.2 - Contingencies, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS from the substitution of tax basis for contribution.

 

 

 

AMBEV S.A.

 

Accounting policies

 

Recognition of assets and liabilities relating to extemporaneous tax debits or credits

 

The accounting policy applied by the Company considers the extemporaneous tax credits and debits of any nature as determined by IAS 37 - Provisions, Contingent Liabilities and Contingent Assets, except for income taxes, for which the policy disclosed in note 13 – Income tax and social contribution is applied.

 

According to this policy, tax credits are recognized only when Management (i) has elements that guarantee that the credit is virtually certain; and (ii) the amount to be offset or refunded can be reliably measured. In cases where the recovery of the asset is probable, or the amount cannot be reliably measured, the amounts are not recognized in the account, but presented in Note 27 - Provisions, Contingent Liabilities and Contingent Assets related to contingent assets. Management understands that, in cases of lawsuits involving contingent assets, a final and unappealable decision on the specific lawsuit of the Company is required to confirm the existence of its rights, except where specific circumstances pertinent to the case allow the recognition of its rights with sufficient objectivity and reliability.

 

To measure the amounts of extemporaneous tax credits arising from lawsuits, the Company evaluates the documents for the period covered by the lawsuit, and applies the guidelines for the final decision, applicable legislation or other elements that enable the amount to be estimated with sufficient reliability.

 

Debts of the same nature are recognized if (i) they arise from a past event; (ii) there is a present obligation; (iii) the expected outflow of resources is probable and (iv) the amounts are reliably estimated. If the expectation of disbursement is possible or the amount cannot be reliably measured, the amounts are presented in Note 27.2 - Contingencies.

 

Both contingent assets and liabilities are assessed periodically to ensure that they are appropriately reflected and disclosed in the financial statements.

 

The accounting policy for the recognition of assets and liabilities of extemporaneous tax credits and debits of any nature are recorded as “Other operating income/(expenses)”, except for amnesty payments, which are recorded as exceptional items, given their one-off nature.

 

19.INVENTORY

 

   
  2023 2022
     
Finished goods  2,990.3  4,094.0 
Work in progress 826.5  845.7 
Raw materials and consumables 4,599.9  6,798.3 
Spare parts and others 806.9  986.9 
Prepayments 537.9  358.3 
Impairment losses (142.5) (160.2)
Total 9,619.0  12,923.0 

 

The changes in impairment losses on inventory, are as follows:

 

   
  2023 2022
Beginning balance (160.2) (157.8)
Effects of movements in foreign exchange in the balance sheet 12.9  17.8 
Provisions (262.9) (305.8)
Write-off 267.7  285.6 
Final balance (142.5) (160.2)

 

 

AMBEV S.A.

 

 

Accounting policies

 

Inventory is initially recorded at the acquisition cost and subsequent valued at the lower of their cost and net realizable value. Cost includes expenditure incurred to acquire the inventory, non-recoverable taxes, and the costs to bring it to the location and condition required for use. The weighted average method is used to determine the cost of inventory.

 

The cost of finished products and work in progress includes raw materials, other production materials, direct labor, other direct costs, gains and losses on derivative financial instruments, and an allocation of fixed and variable overheads based on the normal operating capacity. Fixed costs not allocated or idle costs not held in inventory, are recognized directly in the income statement, as determined by IAS 2- Inventories

.

 

The net realizable value is the estimated selling price in the ordinary course of business, less the costs of bringing the inventory to the condition required for sale, and the selling costs. The calculation of the net realizable value takes into consideration the specific characteristics of each category of inventory, such as the expiry date, the remaining shelf life, and any indicators of slow-moving inventory, amongst others.

 

Provisions for impairment losses are constituted, when necessary, in compliance with write-offs, slow moving and obsolete inventory of Company’s policies.

 

20.TRADE RECEIVABLES

 

   
  2023 2022
     
Trade receivables 6,225.8  5,737.5 
Bad debt provision (721.0) (679.1)
Net, trade receivables  5,504.8  5,058.4 
Related parties (Note 30) 236.7  290.7 
Total current trade receivables  5,741.5  5,349.1 

 

The details of the aging of the Company’s current trade receivables are as follows:

 

             
  2023   2022
  Trade receivables Bad debt provision Trade receivables, net   Trade receivables Bad debt provision Trade receivables, net
No past due 5,129.5  -    5,129.5    4,573.0  -    4,573.0 
Past due – within 30 days 283.4  -    283.4    343.8  -    343.8 
Past due – between 31 - 60 days  66.3  -    66.3    100.5  (0.3) 100.2 
Past due – between 61 - 90 days 33.2  (7.7) 25.5    49.4  (10.8) 38.6 
Past due – between 91 - 180 days 6.5  (6.4) 0.1    19.3  (16.5) 2.8 
Past due – between 181 - 360 days 46.6  (46.6) -      40.2  (40.2) -   
Past due over 360 days 660.3  (660.3) -      611.3  (611.3) -   
Net carrying amount as of December 31, 6,225.8  (721.0) 5,504.8    5,737.5  (679.1) 5,058.4 

 

 

AMBEV S.A.

 

 

The changes of the estimated loss for doubtful debts, are as follows:

 

   
  2023 2022
Beginning balance (679.1) (668.3)
Effects of movements in foreign exchange in the balance sheet 12.3  14.0 
Additions (103.6) (47.0)
Reversals 8.3  1.7 
Write-off 41.1  20.5 
Final balance (721.0) (679.1)

 

The Company’s exposure to credit risks, currency and interest rate risks is disclosed in Note 28 - Financial instruments and risks.

 

Accounting policies

 

Trade receivables are amounts due from customers for goods sold or services performed in the ordinary course of business. Trade receivables are recognized initially at the amount of the unconditional consideration, unless they contain significant financing components, in which case they are recognized at fair value.

 

The Company applies the IFRS 9 simplified approach to measuring expected credit losses whereby impairment allowances for trade receivables are measured upon initial recognition on the basis of the expected 12-month credit losses. This is primarily based on past experience of credit losses, current data on overdue receivables and credit score information. Prospective information (such as forecast economic performance indicators) is also taken into consideration if, based on past experience, such indicators show a strong correlation with actual credit losses. Typically trade receivables which are outstanding for more than 90 days are fully provisioned.

 

If security receiving deadline is equal or less than a year, trade receivables are categorized in current assets. Otherwise, its disclosed in non-current assets.

 

21.CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES

 

21.1 Cash and equivalents

 

   
  2023 2022
Short-term bank deposits (i) 8,973.6  8,655.2 
Current bank accounts 6,818.3  5,990.3 
Cash 267.1  280.9 
Cash and cash equivalents 16,059.0  14,926.4 
     
Bank overdrafts -    (74.3)
Cash and cash equivalents less bank overdraft 16,059.0  14,852.1 

 

(i)The balance refers mostly to Bank Deposit Certificates (“CDB”), with high liquidity, which are readily convertible into known amounts of cash, and which are subject to an insignificant risk of change in value.

 

The cash and cash equivalents balance include the amount to R$ 3,768 million in December 31, 2023 (R$3,083 million in December 31, 2022), which is not freely transferable to the parent company due to remittance restrictions in Cuba and Argentina, although available for use in the local operations of the subsidiaries in question.

 

 

AMBEV S.A.

 

 

21.2 Investment securities

 

   
Investment_securities 2023 2022
     
Investment on debt securities (i) 242.2  219.1 
Non-current investment securities 242.2  219.1 
     
Financial assets at fair value through profit or loss 277.2  454.5 
Current investment securities 277.2  454.5 
     
Total 519.4  673.6 

 

(i)The balance refers substantially to financial investments linked to tax incentives that do not have immediate convertibility into a known amount of cash.

 

Accounting policies

 

Cash and cash equivalents include all cash balances, bank deposits, and short-term highly with due date until 90 days, liquid investments with an insignificant risk of changes in value which are readily convertible into cash. They are stated at their face value, which approximates the fair value.

 

Other financial investments that do not satisfy the classification criteria as cash equivalents, for example, with maturities superior to 90 days from the date they were contracted, are presented as financial investments. These assets are initially measured at fair value and, depending on how these resources are managed and the characteristics of the contractual cash flows, their category may change:

 

·Amortized cost: "non-derivative" financial assets for which the purpose of the business model is to hold the assets in order to receive the contractual cash flows on specific dates (principal and interest).

 

·Fair value through profit or loss: financial assets for which the Company's objective is to receive a sale. They are presented in current assets based on their expected realization.

 

Cash and cash equivalents and short-term investments are held at financial institutions with low credit risk, based or domiciled in Brazil or abroad. For the cash flow statement, cash and cash equivalents are presented net of bank overdrafts, when applicable.

 

 

AMBEV S.A.

 

 

 

22.CHANGES IN EQUITY

 

22.1 Issued capital

 

At 31 December 2023, the authorized share capital, fully subscribed and paid-in, in the amount of R$58,177.9 (R$58,130.5 in 2022 and R$58,042.5 in 2021) in the amount of 15,753.8 common shares (15,750.2 in 2022 and 15,744.5 in 2021) book entry, nominative, without nominal value, thus distributed:

 

               
  2023   2022   2021
Shareholder Million common shares %   Million common shares %   Million common shares %
Interbrew International B.V. 8,441.7 53.6%   8,441.8 53.6%   8,441.9 53.6%
Ambrew S.A.R.L. 1,287.7 8.2%   1,287.7 8.2%   1,287.0 8.2%
Fundação Zerrenner 1,610.0 10.2%   1,610.0 10.2%   1,610.0 10.2%
Mercado 4,410.0 28.0%   4,402.2 27.9%   4,399.7 27.9%
Tesouraria 4.4 0.0%   8.5 0.1%   5.8 0.0%
  15,753.8 100.0%   15,750.2 100.0%   15,744.4 100.0%

 

    2023     2022     2021
  Million common shares Million Reais   Million common shares Million Reais   Million common shares Million Reais
                 
Beginning balance 15,750.2  58,130.5    15,744.4  58,042.5    15,735.1  57,899.1 
Capital increase (i) 3.6  47.4    5.8  88.0    9.3  143.4 
Final balance 15,753.8  58,177.9    15,750.2  58,130.5    15,744.4  58,042.5 

 

(i) Capital increase related to the issue of shares.

 

22.2 Capital reserves

 

         
  Capital Reserves   
  Treasury shares  Share Premium  Other capital reserves  Share-based Payments   Total 
           
At January 1, 2021 (941.7) 53,662.8  700.9  1,563.6  54,985.6 
Capital Increase (60.0) -    -    (74.4) (134.4)
Purchases of shares, results of treasury shares and share-based payments (36.1) -    -    372.1  336.0 
At December 31, 2021 (1,037.8) 53,662.8  700.9  1,861.3  55,187.2 
Capital Increase -    -    -    (64.2) (64.2)
Purchases of shares, results of treasury shares and share-based payments (35.6) -    -    252.4  216.8 
At December 31, 2022 (1,073.4) 53,662.8  700.9  2,049.5  55,339.8 
Capital Increase -    -    -    (32.9) (32.9)
Purchases of shares, results of treasury shares and share-based payments 61.6  -    -    111.2  172.8 
At December 31, 2023 (1,011.8) 53,662.8  700.9  2,127.8  55,479.7 

 

 

AMBEV S.A.

 

 

22.2.1 Purchase of shares and result of treasury shares

Treasury shares represent the Company’s own issued shares reacquired by the Company, and the results of treasury shares related to gains and losses on share-based payment transactions and others. The changes in treasury shares are as follow:

             
  Acquisition /realization of shares   Result of Treasury Shares   Total Treasury Shares
  Million shares   Million Brazilian Reais   Million shares   Million Brazilian Reais
At January 1, 2021 0.2    (3.2)   (938.5)   (941.7)
Changes during the year 5.6    (95.1)   (1.0)   (96.1)
At December 31, 2021 5.8    (98.3)   (939.5)   (1,037.8)
Changes during the year 2.7    (33.5)   (2.1)   (35.6)
At December 31, 2022 8.5    (131.8)   (941.6)   (1,073.4)
Changes during the year (4.1)   68.8    (7.2)   61.6 
At December 31, 2023 4.4    (63.0)   (948.8)   (1,011.8)

 

22.2.2 Share premium

 

The share premium refers to the difference between the subscription price that the shareholders paid for the shares and their nominal value. Since this is a capital reserve, it can only be used to increase capital, offset losses, or for the redemption, reimbursement or repurchase of shares.

22.2.3 Share-based payment

Different share-based payment programs and stock purchase option plans allow the senior management from Ambev’s economic group to acquire shares in the Company. The share-based payment reserve recorded a charge of R$331.6 in 2023 (R$313.9 and R$387.6 in 2022 and 2021, respectively) (Note 25 - Share-based payments).

 

22.3 Net income reserves

 

       
  Net income reserves
  Investments reserve  Legal reserve   Fiscal incentive  Total
At January 1, 2021 14,511.1  4.5  11,404.4  25,920.0 
Fiscal incentive reserve  -    -    1,423.5  1,423.5 
Investments reserve  3,848.1  -    -    3,848.1 
At December 31, 2021 18,359.2  4.5  12,827.9  31,191.6 
Fiscal incentive reserve  -    -    2,018.7  2,018.7 
Investments reserve  3,696.7  -    -    3,696.7 
At December 31, 2022 22,055.9  4.5  14,846.6  36,907.0 
Fiscal incentive reserve  -    -    2,552.7  2,552.7 
Investments reserve  3,730.2  -    -    3,730.2 
At December 31, 2023 25,786.1  4.5  17,399.3  43,189.9 

 

22.3.1 Investments reserve

From the net income after applicable deductions, there will be a target allocating of no more than 60% (sixty per cent) of the adjusted net profit to the investment reserve, to be used to support future investments.

 

AMBEV S.A.

 

 

22.3.2 Legal reserve

From the net income, 5% will be applied before any other allocation, to the legal reserve, which cannot exceed 20% of the issued capital. The Company is not required to supplement the legal reserve for the year when the balance of this reserve, plus the amount of the capital reserves, exceeds 30% of the issued capital.

22.3.3 Tax incentives

The Company recognizes annually in its equity, in the net income reserves line, the fiscal incentives regarding tax benefits at the government subsidies for the current year.

 

In general, these incentives are related to industrial development programs that aim to generate employment, promote regional decentralization, and complement and diversify the industrial base of the states. In these states, the grace periods and use and reductions are set out under the respective state normative acts, and when conditions for obtaining these grants exist, they are under Company’s control. The treatment of incentives complies with the provisions of current federal, state and municipal legislation, in particular set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. Due to change in article 30 of Federal Law 12,973/14 by Complementary Federal Law 160/2017, state fiscal incentives related to sales taxes are recognized as government subsidies for investments. in line with the interpretation of the Superior Court of Justice manifested mainly in the judgment of ERESP No. 1.517.492/PR, as well as in the judgment of Theme No. 1.182 and of the Federal Supreme Court, according to the manifestations expressed in the judgment of Theme 843.

 

22.3.4 Interest on shareholders’ equity / dividends

Brazilian companies are permitted to distribute the interest attributed to shareholders’ equity calculated based on the long-term interest rate (“TJLP”), with such interest being tax-deductible, in accordance with the applicable law and, when distributed, may be considered part of the minimum mandatory dividends.

As determined by its by-laws, the Company is required to distribute to its shareholders, as a minimum mandatory dividend in respect of each fiscal year ending December 31, an amount of not less than 40% of its net income determined under Brazilian law, adjusted in accordance with the applicable law, unless the payment of such amount would be incompatible with Ambev’s financial situation. The minimum mandatory dividend includes amounts paid as interest on shareholders’ equity.

Events during the year ended 2023:

 

             
Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/12/2023 Interest on shareholder´s equity 12/28/2023 2023 ON 0.7302 11,500.2 
              11,500.2 

 

Distribution of interest on shareholders’s equity. In accordance with Operations and Finance Committee recommendation at the meeting held on December 12, 2023, was approved the distribution of interest on shareholder’s equity in the amount of R$0.7302 per share, based on available balances, in the Company’s extraordinary balance sheet dated as of November 30, 2023, (the survey of which was approved by the Board of Directors at the meeting held on December 12, 2023) and in the Company’s investment reserve, pursuant to the balance sheet dated as of December 31, 2022, which were attributed to the minimum mandatory dividends of the same fiscal year. The interest on shareholder’s equity distribution was taxed pursuant to the applicable law, which resulted in a net interest on shareholder’s equity distribution of R$0.6207 per share of, except for shareholders that are corporate entities that are immune or exempted pursuant to article 5 of Law 11,053/04, as amended by Law 11,196/05.

 

AMBEV S.A.

 

 

The indicated payment was made on December 28, 2023, considering the shareholding position of December 19, 2022, with respect to B3, and December 26, 2023, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Events during the year ended 2022:

 

Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/06/2022 Interest on shareholder´s equity 12/29/2022 2022 ON 0.7623 11,999.8 
              11,999.8 

 

Distribution of Dividends in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 5, 2022, was approved the distribution of dividends of R$0.7623 per share, based on available balance and the Company’s extraordinary balance sheet dated as of October 31, 2022 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$0.6480 per share of the Company in 2022.

 

The indicated payment was made on December 29, 2022, considering the shareholding position of December 19, 2022, with respect to B3, and December 21, 2022, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Events during the year ended 2021:

 

Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/09/2021 Dividends 12/30/2021 2021 ON 0.1334 2,099.5 
Board of Directors Meeting 12/09/2021 Interest on shareholder´s equity 12/30/2021 2021 ON 0.4702 7,400.1 
              9,499.6 

 

Distribution of Dividends in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 07, 2021, was approved the distribution of dividends of R$0.1334 per share, based on available balance and the Company’s extraordinary balance sheet dated as of November 30, 2021 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation.

 

The indicated payment was made on December 30, 2021, considering the shareholding position of December 17, 2021, with respect to B3, and December 21, 2021, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Distribution of interest on shareholder’s equity in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 7, 2021, was approved the distribution of interest on shareholder’s equity of R$0.4702 per share, based on available balance and the Company’s extraordinary balance sheet dated as of November 30, 2021, and attributed to the minimum mandatory dividends for the same fiscal year. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$0.3996 per share.

 

AMBEV S.A.

 

 

The indicated payment was made on December 30, 2021, considering the shareholding position of December 17, 2020, with respect to B3, and December 21, 2021, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

22.3.5 Destinations

 

At December 31, 2023, the Company has made appropriations to retained earnings, in accordance with the Brazilian Corporate law and the Company’s bylaws. The dividends payments made up to December 31, 2023, were approved at the Board of Directors’ Meeting.

Regarding the basis for dividends, the Company believes that the predecessor basis of accounting, as well as its presentation for comparative purposes, will not affect the determination of the minimum mandatory dividend. Therefore, the Company intends to adjust the calculation basis of the minimum mandatory dividend to cancel out any current and future impacts on net income arising from the adoption of this accounting practice, related to the amortization/depreciation of surplus assets or even a possible impairment of goodwill, thus preserving the mandatory minimum dividends.

 

         
  2023   2022   2021
Net income, attributable to equity holders of Ambev 14,501.9    14,457.9    12,671.0 
Prescribed/(complementary) dividends -      20.9    24.7 
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting 11.8    11.8    11.8 
Effect of application of IAS 29 (hyperinflation) 3,269.4    3,224.4    2,063.7 
Retained earnings basis for dividends and destinations 17,783.1    17,715.0    14,771.2 
           
Dividends and interest on capital distributed and accrued for distribution based on the net income for the year          
Dividends and interest on capital paid based on profit 11,500.2    11,999.8    9,499.6 
Total of dividends and interest on capital  11,500.2    11,999.8    9,499.6 
Percentage of distributed profit 65%   68%   64%

 

 

AMBEV S.A.

 

22.5 Carrying value adjustments

 

               
  Carrying value adjustments  
  Translation reserves Cash flow hedge Actuarial gains/ (losses) Put option granted on subsidiary Gains/(losses) of non-controlling interest’s share Business combination Accounting adjustments for transactions between shareholders Total
                 
At January 1, 2021 11,076.5 744.5 (1,473.3) (4.8) (73.8) 156.1 (75,414.2) (64,989.0)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations 2,449.7 - - - - - - 2,449.7
Cash flow hedges - 480.8 - - - - - 480.8
Actuarial gains/(losses) - - 341.8 - - - - 341.8
Total Comprehensive income 2,449.7 480.8 341.8 - - - - 3,272.3
Options granted on subsidiaries - - - (1.9) - - - (1.9)
Gains/(losses) of controlling interest - - - - (46.2) - - (46.2)
Tax on deemed dividends - - - - (1.7) - - (1.7)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2021 13,526.2 1,225.3 (1,131.5) (6.7) (121.7) 156.1 (75,426.0) (61,778.3)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations (6,772.2) - - - - - - (6,772.2)
Cash flow hedges - (316.7) - - - - - (316.7)
Actuarial gains/(losses) - - 466.5 - - - - 466.5
Total Comprehensive income (6,772.2) (316.7) 466.5 - - - - (6,622.4)
Gains/(losses) of controlling interest - - - - (2.8) - - (2.8)
Tax on deemed dividends - - - - (6.2) - - (6.2)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2022 6,754.0 908.6 (665.0) (6.7) (130.7) 156.1 (75,437.8) (68,421.5)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations (9,212.4) - - - - - - (9,212.4)
Cash flow hedges - (210.8) - - - - - (210.8)
Actuarial gains/(losses) - - (13.2) - - - - (13.2)
Total Comprehensive income (9,212.4) (210.8) (13.2) - - - - (9,436.4)
Options granted on subsidiaries - - - 6.7 - - - 6.7
Gains/(losses) of controlling interest - - - - (2.6) - - (2.6)
Tax on deemed dividends - - - - (12.4) - - (12.4)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2023 (2,458.4) 697.8 (678.2) - (145.7) 156.1 (75,449.6) (77,878.0)

 

 

AMBEV S.A.

 

22.5.1 Translation reserves

 

The translation reserves comprise all foreign currency exchange differences arising from the translation of the financial statements with a functional currency different to the Real.

The translation reserves also comprise the portion of the gain or loss on the foreign currency liabilities and on the derivative financial instruments determined to be effective net investment hedges.

 

22.5.2 Cash flow hedge reserves

 

The hedging reserves represent the effective portion of the cumulative net change in the fair value of cash flow hedges to the extent that the hedged risk has not yet impacted profit or loss (for additional information, see Note 28 - Financial instruments and risks).

 

22.5.3 Actuarial gains and losses

Actuarial gains and losses include expectations regarding future pension plan obligations. Consequently, the results of actuarial gains and losses are recognized on a monthly considering the best estimates available to Management, reasoned on the expectations presented in the independent actuarial report. There was no actuarial gain or loss due to a surplus or deficit in 2023.

 

22.5.4 Accounting adjustments for transactions between shareholders

 

Transactions between shareholders of the same business, even when carried out between persons who are totally independent of each other, which have a valid economic rationale and reflect usual market conditions, will be consolidated by the applicable accounting standards as having taken place within the same accounting entity.

 

As determined by IFRS 10, any difference between the amount paid (fair value) for the acquisition of a non-controlling interest and the carrying amount of such non-controlling interest shall be recognized directly in the controlling shareholders’ equity. The acquisition of the non-controlling interest related to Former Ambev, and the abovementioned adjustment was recognized in Carrying value adjustments when applicable.

 

Accounting policies

 

Issued capital and treasury shares

 

The Company's issued capital consists only of common shares. The Company holds treasury shares for future disposal, cancellation or for the payment of its executives' share-based compensation programs. When the Company buyback its own shares, the amount paid, including directly attributable costs, are recognized in a specific account under treasury shares as a reduction of shareholders' equity.

 

Share issuance costs

 

Incremental costs directly attributable to the issuance of new shares or options are presented in equity as a deduction, net of tax, from the proceeds.

 

 

AMBEV S.A.

 

 

Dividends and interest on shareholder’s equity

 

Dividends and interest on shareholders’ equity are recognized in liabilities from the date on which they are approved by a Board of Directors’ Meeting, except for the minimum statutory dividends provided for under the Company’s bylaws, which are recognized as a liability, when applicable, at the end of each fiscal year.

 

The interest expense attributable to capital to shareholders is recognized in income for the purposes of the calculation of Brazilian income and social contribution tax and is subsequently reclassified from shareholders' equity for presentation purposes in the financial statements.

 

The projected effect of the deductibility of interest on shareholder´s equity is recognized in the interim financial statements in order to obtain the best estimate of the weighted average effective income tax rate expected for the full fiscal year, in accordance with IAS 34- Interim Financial Reporting.

 

23.INTEREST-BEARING LOANS AND BORROWING

 

   
  2023 2022
     
Secured bank loans 111.6  126.2 
Other secured loans (i) 279.4  328.1 
Lease liabilities 1,812.0  2,333.8 
Non-current liabilities 2,203.0  2,788.1 
     
Secured bank loans 14.9  54.5 
Other secured loans (i) 136.3  144.5 
Lease liabilities 1,146.9  783.6 
Current liabilities 1,298.1  982.6 
     
Total 3,501.1  3,770.7 

 

(i)Nomenclature modified to Other secured loans, including for comparative purposes.

 

Additional information regarding the exposure of the Company to interest rate, foreign currency risk and debt repayment schedule is disclosed in Note 28 - Financial instruments and risks.

 

 

AMBEV S.A.

 

 

At December 31, 2023, and 2022 the Company’s debts were exposed to the following interest rates:

 

             
    2023     2022
Debt instruments Average rate % Current Non-current   Average rate % Current Non-current
Debt denominated in US Dollars - fixed rate 14.00% 0.0  -      14.00% 6.2  -   
Other Latin American currencies - fixed rate 11.48% 124.6  281.0    10.39% 98.8  322.5 
Debt denominated in CAD Dollars - fixed rate 5.63% 130.1  350.2    5.32% 123.3  387.7 
Reais denominated floating rate (TJLP and TR) 9.47% 13.4  111.6    9.61% 12.3  125.1 
Reais debt - ICMS fixed rate 2.95% 103.2  194.3    2.95% 113.3  266.4 
Reais debt - ICMS floating rate 6.56% 33.0  85.1    6.97% 31.1  61.7 
Reais debt - fixed rate 11.17% 893.7  1,180.7    9.43% 597.6  1,624.7 
Total   1,298.1  2,203.0      982.6  2,788.1 

 

23.1 Changes in liabilities arising from financing activities

 

The tables below detail the changes in the Company’s liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flow was, or future cash flow will be classified in the company’s consolidated statement of cash flow from financing activities.

 

             
  2023   2022
  Non - current liabilities   Current liabilities   Non - current liabilities   Current liabilities
Beginning balance 2,788.1    982.6    2,253.5    847.1 
Proceeds 49.8    -      267.0    7.9 
Payments (0.8)   (226.6)   -      (230.2)
Foreign exchange (52.8)   (19.6)   (56.8)   (17.4)
Transfers between current and non-current (1,238.0)   1,238.0    (761.0)   761.0 
New lease agreements 629.5    524.4    905.3    469.2 
Interest on leases -      193.1    -      159.3 
Lease Payments -      (1,373.2)   -      (1,014.0)
Other movements 27.2    (20.6)   180.1    (0.3)
Final balance 2,203.0    1,298.1    2,788.1    982.6 

 

23.2 Maturity of contracts

 

The above amounts have the following expect payment flow:

 

             
            Balance as of December 31, 2023
  2024 2025 2026 2027 > 2028 2023 2022
Secured bank loans 14.9  14.7  16.1  36.8  44.0  126.5  180.7 
Other secured loans (i) 136.3  151.5  114.8  3.7  9.3  415.7  472.7 
Lease liabilities 1,146.9  481.8  472.4  385.0  472.8  2,958.9  3,117.3 
  1,298.1  648.0  603.3  425.5  526.1  3,501.1  3,770.7 

 

(i)Nomenclature modified to Other secured loans, including for comparative purposes.

 

 

AMBEV S.A.

 

 

23.3 Contractual clauses (Covenants)

 

As at December 31, 2023, as well as at December 31, 2022, the Company's loans had equal rights to payment without subordination clauses between them.

Most loan contracts contain contractual covenants, such as: actions that can reduce the ability to pay the loans; maintenance of the Company's assets, purposing to assure that all remain under usage condition; restrictions on acquisitions, mergers, sales or disposals of its assets; disclosure of financial statements and the balance sheet; no prohibitions related to new guarantees for loans contracted.

These clauses are applicable from the date of execution and effectiveness of each contract to the extent that the events mentioned in the contract occur. Depending on the materiality of each event and its potential adverse effects on the Company and /or its subsidiaries or the rights of its creditors, contractual penalties may be applied, including the early maturity of the respective contract.

 

In certain contracts, in the event of occurrence of any of the events set out in the restrictive clauses, the Company may be granted a grace period to resolve any contractual defaults, in order to avoid any penalties resulting from the breach of its obligations. As of December 31,2023, as well as at December 31, 2023, the Company followed all of its contractual obligations for its loans and financing.

 

23.4 Guarantees and contractual counterparts

 

The loans and financing contracted by the Company provide for the provision of various guarantees, such as sureties and real estate, or are unsecured, except in relation to the FINAME credit lines contracted by the Company with the National Bank for Economic and Social Development ("BNDES"), in which real guarantees were provided on the assets acquired with the credit granted. These loans contracted with BNDES are subject to certain “provisions applicable to agreements entered into with BNDES” (“Provisions”) and, according to these Provisions, the borrowers, such as the Company, may not, without the prior consent of BNDES, for instance: (i) raise new loans (except for the loans described in the Provisions); (ii) give preference and/or priority to other debts; and/or (iii) dispose of or encumber any items of their fixed assets (except as provided for within the Provisions).

 

In relation to regarding the tax incentives on financing or subsidized loans, these are subject to the fulfillment of several commitments according to the legislation or contracts upon which those incentives are based on, such as (i) maintaining or generating jobs in the long term; (ii) realization of investments; (iii) increase in production capacity; (iv) ICMS collection commitments; (v) maintaining tax compliance; among others, obligations that refer to facts under the Company’s control. These commitments are applicable as from the signature date of the respective contracts related to fiscal benefits.

 

23.5 Leasing contracts for term and discount rate

 

The average discount rate applied for IFRS 16, using the incremental rate was as follows:

 

 
  Rate %
Lease Term 2023
2023 - 2027 11.15%
2028 - 2035 11.48%

 

 

AMBEV S.A.

 

 

 

Accounting policies

 

Interest-bearing loans and borrowing are recognized initially at fair value less attributable transaction costs. Subsequent to their initial recognition, interest-bearing loans and borrowing are stated at amortized cost, with any differences between the initial and maturity amounts recognized in the income statement over the expected life of the instrument on an effective interest rate basis.

 

Borrowing costs directly related to the acquisition, construction or production of a qualifying asset which requires a substantial period to prepare for its intended use or sale, are capitalized as part of the cost of that asset when it is probable that the future economic benefits associated with the item will flow to the Company, and the costs can be measured reliably. Other borrowing costs are recognized as finance expenses in the period in which they are incurred.

 

The accounting policy applied to lease liabilities is disclosed in note 13 - Property, plant and equipment.

 

24.EMPLOYEE BENEFITS

The Company sponsors post-employment benefits, such as retirement plans, medical and dental care, among others for employees in Brazil and subsidiaries located in the Dominican Republic, Barbados, Panama, Uruguay, Bolivia, Argentina and Canada based on employees' salaries and length of service. The entities are governed by the local regulations and practices of each individual country as well as the relationship with the Company’s pension funds and their composition.

Post-employment benefits of retirement are managed through pension funds and are classified as either defined contribution or defined benefit plans.

Defined benefit plans and the other post-employment benefits are not granted to new retirees.

24.1 Defined contribution plans

 

These plans are funded by the participants and the sponsor and are managed by administered pension funds. During 2023, the Company contributed R$91.3 (R$82.0 and R$74.1 during 2022 and 2021) to these funds, which was recorded in expenses. Once the contributions have been paid, the Company has no further payment obligations.

 

AMBEV S.A.

 

 

24.2 Defined benefit plans

 

At December 31, 2023, 2022 and 2021 the net liability for defined benefit plans consists of the following:

     
  2023  2022  2021 
Present value of funded obligations (5,365.5) (5,476.5) (7,354.3)
Fair value of plan assets 4,604.6  4,543.3  5,638.0 
Present value of net obligations (760.9) (933.2) (1,716.3)
Present value of unfunded obligations (917.2) (921.0) (1,165.4)
Present value of net obligations  (1,678.1) (1,854.2) (2,881.7)
Asset ceiling (182.6) (163.3) (180.1)
Net liabilities (1,860.7) (2,017.5) (3,061.8)
Other long term employee benefits (93.9) (87.1) (104.3)
Total employee benefits (1,954.6) (2,104.6) (3,166.1)
Employee benefits amount in the balance sheet      
Liabilities  (2,011.9) (2,161.2) (3,194.0)
Assets  57.3  56.6  27.9 
Net liabilities (1,954.6) (2,104.6) (3,166.1)

 

The changes in the present value of the defined benefit obligations were as follow:

 

     
  2023  2022  2021 
Defined benefit obligation at January 1 (6,397.5) (8,519.7) (8,777.6)
Service costs (30.8) (47.0) (58.0)
Interest costs (413.2) (353.2) (324.3)
Gains and (losses) on settlements or reductions in benefits 9.2  3.8  3.6 
Contributions by plan participants (4.2) (5.6) (6.9)
Actuarial gains and (losses) - geographical assumptions 11.5  -    52.3 
Actuarial gains and (losses) - financial assumptions (297.0) 1,333.6  726.8 
Experience adjustments 91.2  (171.5) (213.0)
Reclassifications -    -    (1.0)
Effect of exchange rate fluctuations 216.7  787.7  (495.3)
Benefits paid 531.4  574.4  573.7 
Defined benefit obligation at December, 31 (6,282.7) (6,397.5) (8,519.7)

 

 

AMBEV S.A.

 

 

The changes in the fair value of plan assets are as follow:

 

     
  2023  2022  2021 
Fair value of plan assets at January 1 4,543.3  5,638.0  5,533.3 
Interest income 318.1  262.1  223.9 
Administrative costs (5.2) (5.2) (5.8)
Expected return, excluding interest income 101.7  (614.6) (148.3)
Contributions by employer 280.5  316.0  342.0 
Contributions by plan participants 4.6  5.8  7.1 
Exchange differences (102.0) (482.6) 263.1 
Curtailments, settlements and other (4.8) (1.8) (3.6)
Benefits paid, excluding administrative costs (531.6) (574.4) (573.7)
Fair value of plan assets at December, 31 4,604.6  4,543.3  5,638.0 

 

Fundação Zerrenner is a legally distinct entity whose main goal is to provide the Company’s current and retired employees and managers with health care and dental assistance, technical and higher education courses, and to maintain facilities for assisting and helping elderly people, among other matters, either through direct initiatives or through financial assistance agreements with other entities.

 

The present value of funded obligations includes R$633.3 at December 31, 2023 (R$665.4 at December 31, 2022, and R$603.9 at December 31, 2021) of two health care plans for which the benefits were provided directly by Fundação Zerrenner.

 

The real return on plan assets generated at December 31, 2023, was a gain of R$419.7 (a loss of R$(352.5) at December 31, 2022, and a gain of R$75.5 at December 31, 2021).

 

At December 31, 2023, the Company recorded R$57.3 (R$56.6 at December 31, 2022, and R$27.9 at December 31, 2021) up to the asset ceiling not exceeding the present value of future benefits.

 

The changes in the asset ceiling not exceeding the present value of future benefits are as follow:

 

     
  2023 2022 2021
Asset ceiling impact at January 1 56.6  27.9  33.6 
Interest income/(expenses) 4.9  -    1.3 
Change in asset ceiling excluding amounts included in interest income/(expenses) (0.1) 30.2  (9.0)
Effects of exchange rate fluctuations   (4.1) (1.5) 2.0 
Asset ceiling impact at December 31  57.3  56.6  27.9 

 

 

AMBEV S.A.

 

 

The income/(expense) recognized in the income statement with regard to defined benefit plans is detailed as follows:

 

     
  2023  2022  2021 
Current service costs (30.8) (47.0) (58.0)
Administrative costs (5.2) (5.2) (5.8)
(Gains) losses on settlement and curtailment 4.7  2.2  1.2 
Income from operations (31.3) (50.0) (62.6)
Financial costs (114.3) (107.8) (115.6)
Total employee benefit expenses (145.6) (157.8) (178.2)

 

The employee benefit revenue/(expenses) is included in the following line items in the income statement:

     
  2023  2022  2021 
Other operating income/(expenses) -    (0.1) (0.2)
Cost of sales (15.1) (26.4) (33.0)
Commercial expenses (7.3) (9.4) (11.7)
Administrative income/(expenses) (8.9) (14.1) (17.7)
Financial expense (114.3) (107.8) (115.6)
  (145.6) (157.8) (178.2)

 

The assumptions used in the calculation of the obligations are as follow:

 

     
  2023 (i) 2022 (i) 2021 (i)
Discount rate 4.6% to 11.7% 5.1% to 11.0% 2.4% to 10.0%
Inflation 2.0% to 3.5% 2.0% to 3.5% 2.0% to 3.5%
Future salary increases  1.0% to 7.1% 1.0% to 7.1% 1.0% to 7.1%
Future pension increases 2.7% to 3.8% 2.7% to 3.8% 2.5% to 3.8%
Medical cost trend rate  6.4% to 7.1% p.a. reducing to 7,1% 6.4% to 7.1% p.a. reducing to 7,1% 4.5% to 6.9% p.a. reducing to 6.9%
Dental claims trend rate  3.5% 3.5% 3.3%
       
Life expectancy for an over 65 years old male  84 to 87 84 to 87 85 to 87
Life expectancy for an over 65 years old female 86 to 89 86 to 89 87 to 89

 

(i)Includes assumptions in Brazil, Central America and Caribbean, Latin America - South and Canada.

 

24.3 Risk

 

Through its defined benefit pension plans and post-employment medical plans, the Company is exposed to a number of risks, the most significant of which are detailed below:

 

Asset volatility

 

The plan liabilities are calculated using a discount rate pegged to high-quality private securities; If plan assets underperform this yield, the Company’s net defined benefit obligation may increase. Most of the Company’s funded plans hold a significant proportion of equities, which are expected to outperform corporate bonds in the long-term while providing volatility and risk in the short-term. As the plans mature, the Company usually reduces the level of investment risk by investing more in assets that better match the liabilities.

 

 

AMBEV S.A.

 

Changes in bond yields

 

A decrease in corporate bond yields will increase plan liabilities, although this will be partially offset by an increase in the value of the plans’ bond holdings.

 

Inflation

 

Some of the Company’s pension obligations are linked to inflation, and higher inflation will lead to higher liabilities. The majority of the plan’s assets are either unaffected by or only loosely correlated with inflation, meaning that an increase in inflation could potentially increase the Company’s net benefit obligation.

 

Life expectancy

 

Most of the plans’ obligations are to provide benefits for the life of the member, so increases in life expectancy will result in an increase in the plans’ liabilities.

 

Investment strategy

 

In the case of funded plans, the Company ensures that the investment positions are managed within an asset-liability matching (“ALM”) framework to ensure long-term investments that are in line with the Company’s obligations under the pension schemes. Within this framework, the Company’s ALM objective is to match the assets to the pension obligations by investing in long-term fixed interest securities with maturities that match the benefit payments as they fall due and in the appropriate currency.

 

24.4 Sensitivity

 

The sensitivity of the defined benefit obligation to changes in the weighted principal assumptions is as follows:

 

                 
In millions of Brazilian Reais   2023   2022   2021
  Change in assumption Increase in assumption Decrease in assumption   Increase in assumption Decrease in assumption   Increase in assumption Decrease in assumption
Medical cost trend rate 100 bases points  (95.2) 82.2    (94.3) 81.8    (114.7) 98.6 
Discount rate 50 bases points  284.8  (302.4)   307.9  (328.0)   442.0  (470.3)
Future salary increases 50 bases points  (17.3) 14.7    (17.6) 16.5    (19.8) 18.6 
Longevity One year (201.0) 196.1    (221.5) 213.5    (287.6) 279.5 

 

The data presented in these tables are purely hypothetical and are based on changes in individual assumptions holding all other assumptions constant: economic conditions and changes therein always affect the other assumptions at the same time and their effects are not linear. Therefore, the above information is not necessarily a reasonable representation of future results.

 

 

AMBEV S.A.

 

 

24.5 Plans assets

 

The plans assets at December 31, 2023, 2022 and 2021 consist of the following:

                     
  2023   2022   2021
  Rated Unrated Total   Rated Unrated Total   Rated Unrated Total
Government bonds 43% -    43%   43% -    43%   43% -    43%
Corporate bonds 10% -    10%   10% -    10%   10% -    10%
Equity instruments 15% -    15%   15% -    15%   15% -    15%
Cash 6% -    6%   6% -    6%   6% -    6%
Others 26% -    26%   26% -    26%   26% -    26%

 

The overall expected rate of return is calculated by weighting the individual rates in accordance with Ambev’s expected share of the total investment portfolio.

 

Ambev expects to contribute approximately R$231.5 to its defined benefit plans in 2024.

 

Accounting policies

 

Post-employment benefits

 

Post-employment benefits include pensions managed in Brazil by Instituto Ambev de Previdência Privada (“IAPP”), post-employment dental benefits and post-employment medical benefits managed by Fundação Zerrenner. Usually, pension plans are funded by payments made by both the Company and its participants, considering the recommendations of independent actuaries. Post-employment dental benefits and post-employment medical benefit obligations are funded using the returns on the assets of the Fundação Zerrenner plan. If necessary, the Company may contribute some of its profits to Fundação Zerrenner. The Company maintains both funded and unfunded plans.

 

Defined contribution plans

 

A defined contribution plan is a pension plan under which the Company pays fixed contributions into a fund. The Company has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees for the benefits relating to their service in the current and prior periods. The contributions to these plans are recognized as expenses in the period during which they are incurred.

 

Defined benefit plans

 

Typically, defined benefit plans define an amount of pension benefit that an employee will receive upon retirement, usually dependent on one or more factors such as age, years of service and compensation level.

 

For defined benefit plans, expenses are assessed separately for each plan using the projected credit unit method. The projected credit unit method considers that each period of service gives rise to an additional unit of benefit and measures each such unit separately. Based on this method, the cost of providing pensions is charged to the income statement over the period of service of the employee and consist of current service costs, interest costs, past service costs and the effect of any agreements and settlements. The obligations of the plan recognized in the balance sheet are measured at the present value of the estimated future cash outflows using a discount rate equivalent to the government´s bond rates with maturity terms similar to those of the respective obligation and the fair values of the plan assets.

 

AMBEV S.A.

 

Past service costs arise from the introduction of a new plan or changes to an existing plan. They are recognized immediately in the income statement, at the earlier of: (i) when the settlement/curtailment occurs; or (ii) when the Company recognizes the related restructuring or termination costs, unless those changes are conditional upon the employee’s continued employment, for a specific period of time (the period in which the rights are acquired). In such cases, past services costs are amortized using the straight-line method over the period during which the rights were acquired.

 

Actuarial assumptions are established to anticipate future events and are used in the calculation of pensions and other long-term employee benefit expenses. These factors include assumptions regarding interest rates, health plan costs, discount rate, future salary increases and pensions, as well as life expectancy. Such estimates are reviewed annually by independent actuaries.

 

Actuarial gains and losses consist of the effects of differences between the previous actuarial assumptions and the actual results, and the effects of changes in actuarial assumptions. Actuarial gains and losses are fully recognized in Carrying value adjustments.

 

Remeasurements, representing actuarial gains and losses, the effect of the asset ceiling and the return on plan assets, both excluding net interest, are recognized in full in the period in which they occur in the statement of comprehensive income. Remeasurements are not reclassified to profit or loss in subsequent periods.

 

When the amount of the defined benefit obligation is negative (an asset), the Company recognizes those assets (prepaid expenses), to the extent of the value of the economic benefit available to the Company either from refunds or reductions in future contributions.

 

Other post-employment obligations

 

The Company and some of its subsidiaries provide post-employment medical benefits, the reimbursement of medication expenses and other benefits to certain retirees. These benefits are not granted to new retirees. The expected costs of these benefits are recognized over the period of employment, using an accounting methodology like that for defined benefit plans, including actuarial gains and losses.

 

Termination benefits

 

Termination benefits are recognized as expenses at the earlier of: (i) when the Company is demonstrably committed, without a realistic possibility of withdrawal, to a formal detailed plan to terminate employment before the normal retirement date; and (ii) when the Company recognizes costs related to restructuring.

 

Bonuses

 

Bonuses granted to employees and managers are based on pre-defined company and individual target achievement. The estimated amount of the bonus is recognized as an expense in the period during which the bonus is earned.

 

AMBEV S.A.

 

 

 

25.SHARE-BASED PAYMENTS

 

Currently the Company has two plans of share-based payment programs: (i) the Stock Option Plan, approved in Extraordinary General Meeting of July 30, 2013 (“Stock Option Plan”) and (ii) Share-based Plan, approved in Extraordinary General Meeting of April 29, 2016, as amended in Extraordinary General Meeting of April 24, 2020 (“Share-Based Plan”). Under each of these plans, the Company can periodically issue different stock option and restricted share units programs. These programs allow certain Group employees and members of the Management, indicated by the Board of Directors and People Committee, to either buy shares of the Company by exercising stock options or receive shares directly.

 

25.1 Share-Based Plan

 

In this plan, certain employees and members of the Management are eligible to receive Company shares, including in the form of ADRs. The shares subject to the Share-Based Plan are designated as "restricted shares" (RSUs) or “performance shares” (PSUs).

 

The delivery of restricted shares and performance shares are made without charge, and the vesting period may vary between three and five years from the corresponding grant date, depending on the share-based compensation program. Restricted shares and performance shares may entitle participates the right to receive additional shares with the same conditions, such as compensation dividends and interest on shareholder´s equity declared and paid by the Company during the vesting period. The right to receive restricted, performance and additional shares, can be partially or completely lost under certain circumstances, including in case of resignation or termination during the vesting period.

 

25.1.1 Other disclosures of the Share-Based plan

 

During the period, the Company granted 33,686 thousand restricted shares under the Share-Based Plan (49,328 thousand in 2022 and 20,629 thousand in 2021), representing a fair value of approximately R$463.5 in 2023 (R$766.6 in 2022 and R$325.7 in 2021).

The total number of shares granted to the Company’s executives under the Share-Based Plan, which will be delivered in the future under certain conditions, is shown below:

 

Restricted and performance shares

 

         
Thousand restricted shares 2023   2022   2021
           
Restricted and performance shares outstanding at January 108,854    62,545    43,458 
New restricted and performance shares during the period 33,686    49,328    20,629 
Restricted and performance shares granted during the period (18,309)   (12)   (22)
Restricted and performance shares forfeited during the period (5,235)   (3,007)   (1,520)
Restricted shares outstanding at the end of the year 118,996    108,854    62,545 

 

25.2 Option Plan

 

Since 2020, the Company no longer grants to your employees and executives stock options recognized in accordance with IFRS 2 - Share-Based Payment. However, there are stock options granted in previous periods that are not vested yet, as well as stock options that are already vested but not yet expired, which remain valid within the scope of the programs issued under the Option Plan and subject to the accounting treatment mentioned.

 

AMBEV S.A.

 

In addition, some employees of the Company and its subsidiaries, who receive their bonus in cash, have the option, according to their position, to choose to allocate part or all the amounts received as such to the acquisition of shares issued by Ambev, these shares are called "voluntary shares" and are granted under the Stock Option Plan. In general, voluntary shares are entitled to dividends from the date of grant and are subject to a vest period of three to five years (look-up). These shares are granted at market price with a discount applied up to 20%, the discount is delivered in the form of restricted shares. Executives who invest in voluntary shares also receive one and a half times the number of corresponding shares for each voluntary share acquired, up to a limited total percentage of each executive's variable remuneration. These matching shares are also delivered in the form of restricted shares.

 

As the voluntary shares, granted under the Stock Option Plan, are part of the profit share earned by eligible executives, they are recognized as an expense in the income statement against liabilities. Meanwhile, the mentioned restricted shares (discounted shares and matching shares) are granted under the Share-Based Plan, as per conditions outlined in item 25.1 above, and are recognized in accordance with the accounting treatment set out in this note, according to IFRS 2 - Share-based Payment.

 

25.2.1 Other disclosures of the Stock Options Plan

 

The Company have not granted stock options, neither there were options exercised during the year ended December 31, 2023, and 2022 (for options exercised in the year ended December 31, 2021, the weighted average share price on the exercise date was R$17.87). The total number of outstanding options developed was as follows:

 

         
Thousand options 2023   2022   2021
           
Options outstanding at January 99,717    113,760    127,265 
Options exercised during the period -      -      (5,247)
Options forfeited during the period (11,756)   (14,043)   (8,258)
Options outstanding at the end of the year 87,961    99,717    113,760 

 

The range of exercise prices of the outstanding options is from R$15.95 (R$15.95 in 2022 and R$15.95 in 2021) to R$32.81 (R$39.04 in 2022 and R$45.97 in 2021) and the weighted average remaining contractual life is approximately 3.60 years (4.29 years in 2022 and 6.70 years in 2021).

 

Of the 87,961 thousand outstanding options (99,717 thousand in 2022 and 113,760 thousand in 2022), 68,635 thousand options were vested in 2023 (63,850 thousand in 2022 and 59,250 thousand in 2021).

 

The weighted average exercise price of the options is as follows:

         
In R$ per share 2023   2022   2021
           
Options outstanding at January 1 19.39    19.92    19.81 
Options forfeited during the period 22.68    22.60    25.27 
Options exercised during the period -      -      13.16 
Options outstanding at the end of the period 18.86    19.39    19.92 
Options exercisable at the end of the period 19.08    20.12    21.14 

 

To settle the exercised stock options, the Company may use treasury shares. The current limit on the authorized capital is considered sufficient to meet the Company’s obligations under all stock option plans if the issue of new shares is required to meet the grants awarded under the programs.

 

AMBEV S.A.

 

During the period, the Company granted 47 thousand deferred shares under the stock option plan which are valued based on the share market price prior to the grant, which represented a fair value of R$0.6(at December 31, 2022, 44 thousand deferred shares under the stock option plan which are valued based on the share market price prior to the grant, which represented a fair value of R$0.6 and at December 31, 2021, 110 thousand deferred shares had been granted, which are valued based on the share market price prior to the grant, which represented a fair value of R$1.7). Such deferred shares are subject to a vesting period of five years from the grant date. The total number of shares purchased by employees, under the Stock Option Plan, which will be delivered in the future based on the fulfilment of certain conditions, is as set out below:

 

Deferred shares

 

         
Thousand deferred shares 2023   2022   2021
           
Deferred shares outstanding at January 1 889    1,168    6,065 
New deferred shares during the period 47    44    110 
Deferred shares granted during the period -      (214)   (4,964)
Deferred shares forfeited during the period -      (109)   (43)
Deferred shares outstanding at the end of the year 936    889    1,168 

 

25.3 Expenses related to share-based payments

 

The share-based payments transactions described above generated an expense of R$333.4 in 2023 (R$311.6 and R$391.5 in 2022 and 2021, respectively), recorded as administrative expenses.

 

Accounting policies

 

Under the Share-Based Plan, the reference price per restricted share is defined on the stock grant date based on the share price of the trading session on B3 immediately prior to the shares granting, except for the performance shares, which the fair value is defined at the grant date based on “Monte Carlo” pricing method. After defining the reference price, based on number of grant shares, the calculated amount is recorded as expense against equity. The shares are transferred to attendees according to the terms and periods by the respective programs.

Under the stock option programs, the fair value of the shares is estimated as at the option grant date, using the “Hull Binomial” pricing model, adjusted to reflect the IFRS 2 - Share-based Payment requirement that assumptions regarding forfeiture before the end of the vesting period cannot impact the fair value of the option. The fair value of the share options is estimated at the grant date, using an option pricing model. Based on the expected number of options that will be exercised, the fair value of the options granted is recognized as an expense over the vesting period with a corresponding credit to equity. When the options are exercised, the equity is increased by the amount of the proceeds received.

 

In addition, on some occasions, AB InBev employees and managers are expatriated to the Company. In these cases, the compensation cost related to options to acquire shares and restricted shares of AB InBev is recognized in the income statement against shareholders' equity, in proportion to the period of expatriation. When the equity instruments are delivered, this amount is reimbursed to AB InBev.

 

On the other hand, when employees and managers who have options to acquire shares and restricted shares of the Company are expatriated to AB InBev, the compensation cost is recognized by AB InBev in proportion to the period of expatriation, and the Company is reimbursed at the time of delivery of its equity instruments to AB InBev employees and managers.

 

AMBEV S.A.

 

 

The Company's share-based payment plans are settled in shares.

 

26.TRADE PAYABLES
   
  2023 2022
     
Trade payables 107.4  165.8 
Related parties (Note 30) 199.9  343.6 
Non-current 307.3  509.4 
     
Trade payables 21,278.6  23,498.1 
Related parties (Note 30) 1,916.5  830.4 
Current 23,195.1  24,328.5 
     
Total 23,502.4  24,837.9 

 

The present value adjustment recorded for trades payables, at December 31, 2023, is R$308 million (R$367 million at December 31,2022).

 

The subsidiaries in Argentina, Chile, Paraguay and Panama have discount transactions for duplicates with endorsement (trade payables securitization) with vendors in the amount of R$159.0 million at December 31, 2023 (R$219.3 million at December 31, 2022). In general, abovementioned discount transactions occur by legal impositions existing in these jurisdictions. These transactions maintain commercial characteristics since there are no change in previously established conditions and its vendor’s choice to carry out the anticipation of its receivables with the Company.

 

Accounting policies

 

Trade payables are recognized initially at their fair values and subsequently at amortized cost using the effective interest method. When relevant, trade payables values are adjusted by their present value, considering the following assumptions to calculation: (i) the amount to be discounted; (ii) the settlement dates; and (iii) the discount rate, in accordance with IFRS 13. The adjustment in the present value of installment purchases is record in trade payables and is offset by the cost of products sold account, due to the payment term.

 

Long-term intra-group loan agreements

 

The Company has long-term loan agreements, denominated in foreign currency, signed with wholly owned subsidiaries located abroad, whose amounts are recognized in the Company's accounts payable. As determined by IAS 21, considering that they are long-term loans, which settlement is not likely to occur in the foreseeable future, the exchange differences related to these instruments are recognized in other comprehensive income, following the accrual accounting concept.

 

The recognition of exchange rate variations in other comprehensive income does not affect the accounting classification assigned to the debt, which is recorded in a liability account and incurs interest, which is recognized as a financial expense in the income statement for the year.

 

The effects of exchange differences will only be reflected in profit or loss for the period if there is any change in the assumption related to the settlement of the loan, i.e., if it becomes foreseeable or probable. In the event of partial settlement, only the exchange differences corresponding to the settled portion or portion expected to be settled with probability or foreseeability will be reclassified to the profit or loss for the period.

 

AMBEV S.A.

 

 

 

27.PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS

The Company and its subsidiaries are involved in administrative and judicial proceedings and arbitrations arising from the normal course of business. Due to their nature, these processes involve inherent uncertainties, including, but not limited to, decisions by courts and tribunals, agreements between the parties involved and governmental actions and, as a result, management cannot, at this stage, estimate the exact time taken to resolve these issues.

 

27.1 Provision

 

The Company and some of its subsidiaries are involved in lawsuits, mainly of a tax, civil and labor nature, which are considered probable of loss, and which are fully provisioned, under the terms of IAS 37 - Provisions, Contingent Liabilities and Contingent Assets.

 

27.1.1 Main lawsuits with a probable likelihood of loss:

 

Sales taxes: in Brazil, the Company and its subsidiaries are parties to various administrative and judicial proceedings related to ICMS, IPI, PIS and COFINS taxes, considered as probable likelihood of loss. Such proceedings include, among others, tax offsetting, appropriation of tax credits and alleged insufficient payment of the respective taxes.

 

Labor: the Company and its subsidiaries are parties to labor proceedings with former employees or former employees of service providers. The main issues involve overtime and related effects and respective charges.

 

Civil: The Company and its subsidiaries are involved in civil lawsuits considered as representing a probable likelihood of loss. The most relevant portion of these lawsuits refers to former distributors, mainly in Brazil, mostly claiming damages resulting from the termination of their contracts.

 

 

27.1.2 Provision changes

 

           
  Taxes on sales Labor Civil Other taxes (i) Restructuring Total
             
At December 31, 2021 218.6  124.2  252.9  163.0  17.4  776.1 
Effect of changes in foreign exchange rates -    (4.6) (17.5) (8.1) (2.0) (32.2)
Additions 157.6  194.2  312.7  60.1  -    724.6 
Provisions used  (85.8) (162.0) (196.6) (7.2) (3.6) (455.2)
Provisions reversed (43.3) (19.7) (15.6) (15.0) -    (93.6)
At December 31, 2022 247.1  132.1  335.9  192.8  11.8  919.7 
Effect of changes in foreign exchange rates -    (2.8) (35.8) (6.3) (0.5) (45.4)
Additions 135.7  247.8  234.5  75.7  3.2  696.9 
Provisions used  (27.3) (181.7) (121.9) (40.8) (11.2) (382.9)
Provisions reversed (73.2) (45.5) (72.5) (19.1) -    (210.3)
At December 31, 2023 282.3  149.9  340.2  202.3  3.3  978.0 

 

(i)Other taxes refer to provisions for lawsuits concerning taxes unrelated to income taxation. The uncertain tax treatments related taxes on profits with a prognosis of probable loss have their value reported directly in the income tax and social contribution payable, as per IFRIC 23 - Uncertainty on the Treatment of Income Taxes.

 

 

AMBEV S.A.

 

 

27.1.3 Expected settlement of provision

 

               
  2023   2022
  Non-current Current Total   Non-current Current Total
               
Provision for disputes and litigation              
Taxes on sales 168.6  113.7  282.3    193.8  53.3  247.1 
Labor 82.7  67.2  149.9    104.9  27.2  132.1 
Civil 113.4  226.8  340.2    263.0  72.9  335.9 
Other taxes 194.9  7.4  202.3    170.1  22.7  192.8 
Total provision for disputes and litigation 559.6  415.1  974.7    731.8  176.1  907.9 
               
Restructuring -    3.3  3.3    7.2  4.6  11.8 
               
Total provisions 559.6  418.4  978.0    739.0  180.7  919.7 

 

The expected settlement of provisions was based on management’s best estimate at the balance sheet date.

27.2 Contingencies

 

The Company and its subsidiaries maintain administrative and judicial discussions with fiscal authorities in Brazil related to certain fiscal positions adopted when calculating the income tax and social contribution, which, based on Management’s current evaluation, probably are going to be accepted in superior court decisions of last instance, aligned with IFRIC 23. The Company also tax actions related to other taxes, which involve risk of a possible loss, according to management's assessment. To these uncertain tax treatments and possible contingencies there are no constituted provision, due to the assessment carried out as the following composition and estimates:

 

   
  2023 2022
     
Income tax and social contribution 63,621.0  60,453.5 
Value-added and excise taxes 26,761.0  25,904.6 
PIS and COFINS 3,496.2  3,293.5 
Others 1,679.4  1,909.1 
  95,557.6  91,560.7 

 

The Company and its subsidiaries have guarantee-insurance policies and letter of guarantee for some legal actions, disclosed as guarantee for civil, labor and tax execution or to enable resources of labor nature.

 

Contingencies with a remote risk of loss are not disclosed, as the possibility of any settlement is remote, in accordance with IAS 37 - Provisions, Contingent Liabilities and Contingent Assets.

 

27.2.1 Main contingencies with a possible risk of loss

 

On September 2023, Law 14,689 was enacted (“Law 14,689/2023”) in Brazil, which provides for the cancellation of fines imposed in tax administrative proceedings decided in favor of the Brazilian Federal Tax Authorities by a tie-breaking vote at the federal administrative level, including any such proceedings that were subsequently escalated to the judicial level and, as of the date of publication of Law 14,689/2023, were pending decision at the second level judicial courts. Following the enactment of Law 14,689/2023, Ambev reassessed the likelihood of success of fines imposed in proceedings decided by a tie-breaking vote, which resulted in the reclassification of the risk of loss from possible to remote in the approximate amount of R$ 6.9 billion as of December 31, 2023 In some cases of the discussions mentioned below, such as the deductibility of goodwill amortization expenses, foreign profits, the use of tax loss in mergers, and the Manaus Free Trade Zone - IPI.

 

AMBEV S.A.

 

 

The main processes classified with a possible loss probability are summarized in the tables below, along with their respective estimated values involved in the cases.

 

   
 

Uncertainty over the treatment of income taxes

In accordance with IFRIC 23 (Note13 - Income tax and social contribution)

Estimates

(in million of Brazilian Reais)

# Description of the main processes 2023 2022
1

Deductibility of IOC expenses

During the 2013 fiscal year, as approved in a General Meeting, the Company implemented a corporate restructuring aimed at simplifying its structure and unifying its share classes, among other objectives. One of the steps of this restructuring involved the exchange of shares and subsequent incorporation of the shares of its subsidiary Companhia de Bebidas das Américas into Ambev S.A. As a consequence of this operation, Ambev S.A. recognized in its accounting records the counterpart of the difference between the value of its shares issued for this exchange and the book value of the subsidiary's shares in equity, in accordance with IFRS 10, under the item "adjustments to equity".

In November 2019, Ambev received a tax assessment from the IRS regarding the deduction of Interest on Capital ("IOC") for the calendar year 2014. The queries primarily concern the accounting and corporate effects of the corporate restructuring carried out by the Company in 2013, and its impacts on increasing the calculation of the JCP deductibility limit. In August 2020, a partially favorable decision was issued to the Company by the first administrative instance, and in view of this decision, Ambev filed an appeal for the case to be reviewed by the CARF, which is awaiting judgment. The favorable portion of the first administrative instance decision will be subject to review by the CARF.

In December 2020, the Company received a tax assessment related to the deduction of IOC expenses for the calendar years 2015 and 2016. In June 2021, Ambev obtained a partially favorable decision in the first administrative instance and filed an appeal to the CARF, which is also awaiting judgment. Similarly, to the first tax assessment, the favorable portion of the first administrative instance decision will be subject to review by the CARF.

In December 2022, the Company received a tax assessment related to the deduction of IOC expenses for the calendar year 2017. In September 2023, Ambev obtained a partially favorable decision in the first administrative instance and filed an Appeal to the CARF, which is also awaiting judgment. Similarly, to the first tax assessment, the favorable portion of the first administrative instance decision will be subject to review by the CARF.

In November 2023, the Company received a new tax assessment related to the deduction of IOC expenses for the calendar years 2018 to 2021. The Company filed a defense and currently awaits a decision in the first administrative instance.

The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$27.4 billion as of December 31, 2023 (R$13.8 billion as of December 31, 2022). Due to the assessment of the likelihood of loss, no provision was made in the period.

This uncertain tax treatment, according to IFRIC 23, continued to be applied by Ambev and affected subsequent calendar years to those assessed (2022 and 2023), during which the Company also distributed IOC and deducted them from the taxable base of its Income Tax.

Therefore, if the deductibility of IOC is also questioned in the future, on the same bases and with the same grounds as the tax assessments mentioned, the Company estimates that the outcome of these potential new discussions would be consistent with the period already assessed.

In December 2023, Provisional Measure 1,185, of August 2023, was converted into a law (No. 14,789/2023), which changes the basis for calculating Interest on Capital as of January 1, 2024, making this uncertain tax treatment limited to Interest on Capital calculated in accordance with legislation in force before the aforementioned law effective date

27,439 13,846

 

 

AMBEV S.A.

 

 

 

2

Disallowance of tax paid abroad

Since 2014, the Company has been receiving tax assessments, relating to calendar years from 2007 onwards, which disallow the use of income tax credits paid abroad by its controlled companies. Considering these charges to be illegitimate, the Company is challenging these assessments in administrative and judicial courts. In November 2019, a final favorable decision was issued by the CARF canceling the assessment regarding one of the cases, covering the calendar year 2010.

For cases involving the calendar years 2015 and 2016, the Company received unfavorable decisions, in the administrative sphere, in three out of four processes. Ambev filed a lawsuit to discuss the matter and awaits a decision in first-instance judicial court. Still regarding the topic, new tax assessments were issued demanding isolated fines due to the alleged lack of monthly payment of IRPJ and CSLL due to the deduction of income tax paid by controlled companies abroad for the calendar years 2015 to 2018.

For cases involving the calendar years 2015 and 2016, an unfavorable decision was issued against the Company in the administrative first instance, against which Ambev filed voluntary appeals awaiting judgment by the CARF.

Regarding the tax assessments involving the collection of the isolated fine for the calendar years 2017 and 2018, received by the Company in October 2022 and December 2023 respectively, awaiting judgment in the administrative first instance.

With regard to other processes discussing this topic, the Company awaits decisions in the administrative and judicial spheres.

The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$14.3 billion as of December 31, 2023 (R$12.6 billion as of December 31, 2022), and, due to its loss classification, no provision was made in the period.

This uncertain tax treatment, according to IFRIC, regarding income tax credits paid abroad, continued to be applied by the Company and impacted subsequent calendar years to those assessed (2018-2023). If new questions arise in the future, on the same basis and with the same grounds as the tax assessments referred to, the Company estimates that the unfolding of these eventual new discussions will be consistent with the period already assessed.

14,302 12,596
3

Goodwill Inbev Holding

In December 2011, the Company received a first tax assessment issued by the Brazilian Federal Revenue Service ("RFB") mainly related to the disallowance of goodwill amortization expenses for the tax years 2005 to 2010, resulting from the incorporation of InBev Holding Brasil S.A. Partially favorable administrative decisions were rendered in this matter. In response to these decisions, the Company filed judicial measures to challenge the issues in which it was unsuccessful at the administrative level, which are awaiting first-instance judgment.

In June 2016, Ambev received a second tax assessment issued by the RFB regarding the disallowance of the remaining portion of the aforementioned goodwill amortization for the tax years 2011 to 2013. In April 2023, the Company obtained a partially favorable and final decision. For the portion of the dispute in which it was unsuccessful, the Company filed a judicial measure, which is awaiting judgment.

The updated value of this uncertain tax treatment, as per IFRIC 23, that has already been assessed, amounted to approximately R$6.5 billion as of December 31, 2023 (R$11.1 billion as of December 31, 2022), and, due to its classification as a loss, no provision was made in the period. Regarding this ongoing dispute, all periods affected by this uncertain tax treatment have already been subject to assessments by the Internal Revenue service (“IRS”). In the event that the Company is required to pay this amount, Anheuser-Busch InBev SA/NV will reimburse the proportional amount (70%) of its benefit from the goodwill amortization, as well as the respective costs, pursuant to the "Reimbursement Agreement" executed on December 21, 2011, between Companhia de Bebidas das Américas - Ambev and Anheuser-Busch InBev SA/NV.

6,505 11,122
4

Foreign Earnings

Since 2005, the Company and some of its subsidiaries have been subject to tax assessments by the IRS regarding the taxation of profits earned by subsidiaries domiciled abroad under various grounds. Deeming these charges illegitimate, the Company is challenging these assessments in administrative and judicial courts.

The cases pending in the administrative sphere have partially favorable decisions, still subject to review by the last administrative instance, the CSRF. In turn, in the cases pending in the judicial sphere, the Company has favorable decisions, subject to review by the higher instance.

In 2022 and 2023, the CARF issued favorable and partially favorable decisions for the Company. The decisions canceled part of the assessments, recognizing as partially correct the calculations made by the Company regarding the taxable income in Brazil of companies domiciled abroad, as well as the impossibility for the Brazilian tax authorities to disregard the goodwill amortization carried out by a subsidiary abroad. Part of these decisions represents a definitive success in the approximate amount of R$1 billion, while for the other decisions, appeals were filed by the IRS, which are awaiting judgment by the CSRF.

The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$6.1 billion as of December 31, 2023 (R$7.3 billion as of December 31, 2022).

This uncertain tax treatment, according to IFRIC 23, continued to be applied by the Company and impacted subsequent calendar years to those assessed (2019-2023). If new inquiries arise in the future, on the same basis and with the same grounds as the referred tax assessments, the Company estimates that the outcome of these eventual new discussions will be consistent with the periods already assessed.

6,075 7,280
5

Disallowance on Income Tax deduction

In January 2020, Arosuco (a subsidiary of Ambev) received a tax assessment from the IRS, relating to the calendar years 2015 to 2018, disallowing the tax reduction benefit provided for in “MP” No. 2,199-14/2001, based on Operating Profit, and filed an administrative challenge. In October 2020, Arosuco was notified of the unfavorable decision in the administrative first instance and filed an Appeal, which awaits judgment.

The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$2.6 billion as of December 31, 2023 (R$2.3 billion as of December 31, 2022). Due to the assessment of the likelihood of loss, no provision was made in the period.

This uncertain tax treatment, according to IFRIC 23, affected subsequent calendar years to those assessed (2019 to 2023), during which Arosuco similarly benefited from the tax reduction provided for in the aforementioned Provisional Measure 2,199-14/2001. If there are any new inquiries in the future on the same matter, on the same bases and with the same grounds as the tax assessments mentioned, Arosuco estimates that the outcome of these potential new discussions would be consistent with the period already assessed.

2,618 2,334
 

AMBEV S.A.

 

 

6

Goodwill BAH

In October 2013, Ambev received a tax assessment related to the goodwill amortized in the calendar years 2007 to 2012 concerning the incorporation of Beverage Associates Holding Limited ("BAH") into Ambev. In April and August 2018, Ambev received two new tax assessments related to the disallowance of the amortization of the remaining portion of the mentioned goodwill in the calendar years 2013 and 2014.

In the administrative sphere, partially favorable decisions were rendered in favor of the Company regarding the qualified fine and the statute of limitations for one of the periods under discussion. In response to these decisions, the Company filed judicial measures to challenge the matters in which it was unsuccessful in the administrative phase, obtaining decisions of total merit in the first judicial instance. The IRS filed appeals, which are awaiting judgment in the second judicial instance.

The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$1.4 billion as of December 31, 2023 (R$2.2 billion as of December 31, 2022). Due to its classification as a loss, no provision was made in the period. Regarding this discussion, all periods impacted by the aforementioned uncertain tax treatment have already been subject to tax assessments by the IRS.

1,412 2,218
7

Goodwill CND Holding

In November 2017, the Company received a tax assessment related to the amortization of goodwill for the calendar years 2012 to 2016 concerning the incorporation of CND Holdings into Ambev. In the administrative sphere, a partially favorable decision was rendered by CARF, which is subject to appeals filed by the Company and the IRS awaiting judgment by the Superior Chamber of Tax Appeals ("CSRF"), the last administrative instance.

In October 2022, Ambev received a new tax assessment related to the disallowance of the remaining portion of said goodwill for the calendar year 2017. The Company received a partially favorable decision, which is subject to appeals filed by the Company and IRS, awaiting judgment by CARF.

The updated value of the uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$1.4 billion as of December 31, 2023 (R$1.3 billion as of December 31, 2022). Due to its classification as a loss, no provision was made during the period. With regard to this discussion, all periods affected by the said uncertain tax treatment have already been subject to tax assessments by the IRS.

1,372 1,257
8

Presumed Profit

In April 2016, Arosuco (a subsidiary of Ambev) received an assessment related to the use of presumed profit for the calculation of IRPJ and CSLL instead of the actual profit method. In September 2017, Arosuco was notified of the unfavorable decision in the administrative first instance and filed a voluntary appeal. In 2019, a final favorable decision was issued by the CARF, canceling the assessment.

In March 2019, Arosuco received a new tax assessment on the same matter and filed a defense. In October 2019, the administrative first instance issued an unfavorable decision and Arosuco filed a voluntary appeal to the CARF, which awaits judgment.

Arosuco estimates that the updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$633.4 million as of December 31, 2023 (R$581.5 million as of December 31, 2022). Due to its loss classification, no provision was made in the period. With regard to this discussion, all periods affected by this uncertain tax treatment have already been subject to tax assessments by the IRS.

633.4 581.5
9

Disallowance of financial expenses

In 2015, 2016, and 2020, the Company received tax assessments issued by the IRS concerning the disallowance of expenses related to the results of financial instruments used to hedge risks inherent to price or rate fluctuations, as well as loans related to the Company's operational activities. In May and June 2023, Ambev was notified of final favorable administrative decisions for the assessments received in 2016 and 2020, which completely canceled the tax assessments issued by the tax authorities, in the approximate amount of R$5.1 billion. Regarding the assessment received in 2015, judgment is awaited from the CARF, both for the tax authority's automatic appeal regarding the portion of the first-instance decision favorable to the Company, and for the Company's appeal regarding the portion of the first-instance decision in which it was unsuccessful. The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$316 million as of December 31, 2023 (R$5.2 billion as of December 31, 2022). Due to its classification, no provision was made in the period. With regard to this discussion, all periods affected by this uncertain tax treatment have already been subject to assessments by the RFB.

316 5,200
10

Goodwill MAG

In December 2022, CRBS S.A. (a subsidiary of Ambev) received a tax assessment related to the goodwill amortized in the calendar years 2017 to 2020 concerning the acquisition and incorporation of RTD Barbados into CRBS. In the administrative sphere, CRBS received a partially favorable decision in the first administrative instance ("DRJ"), which is subject to appeals filed by the Company and the IRS pending judgment by CARF. The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$278 million as of December 31, 2023 (R$251 million as of December 31, 2022). Due to its classification as a loss, no provision was made in the period.

This uncertain tax treatment, according to IFRIC 23, continued to be applied by CRBS and impacted subsequent calendar years to those assessed (2021-2022). If new questions arise in the future, based on the same grounds and with the same fundamentals as the tax assessment mentioned, the Company estimates that the outcome of these potential new discussions will be consistent with the period already assessed.

278 251
 

AMBEV S.A.

 

 

11

Tax Loss Offset

Ambev and certain of its subsidiaries received a number of assessments from the Brazilian Federal Tax Authorities relating to the offset of tax losses carried forward in the context of business combinations.

Two main cases dealing with this matter are under judicial review. In one of the cases, Ambev received favorable decisions in 1st and 2nd instances of the judiciary, which prompted the National Treasury to file a Special Appeal, pending judgment by the Superior Court of Justice ("STJ"). In the second case, Ambev received an unfavorable decision in the 1st instance of the judiciary and filed an Appeal, awaiting judgment.

In December 2023, there was a third case under administrative review, which, in February 2023, was unfavorably decided against the Company by the the Upper Administrative Court  ("CSRF") by a casting vote. Due to the outcome of the judgment and considering the reductions provided for in Law No. 14,689/2023, after receiving notification of the decision, the Company opted to pay the case in December 2023, with the corresponding reductions.

The updated value of the uncertain tax treatment, according to ICPC 22/IFRIC 23, as of December 31, 2023, is approximately R$187 million (R$548 million on December 31, 2022), and therefore, no provision has been made for the matter. Regarding the present discussion, all periods affected by the uncertain tax treatment have already been subject to assessments by the RFB.

187 548
12

Isolet Fines

In March 2023, the Brazilian Supreme Federal Court (STF), in the trial of theme 736 (RE 796,939), established its understanding that the imposition of isolated fines due to the non-recognition of tax offsets is unconstitutional. Following this judgment, the Company reevaluated, together with its in-house lawyers and external advisors, the prognosis of the discussion and reclassified the risk of loss from possible to remote. The amount involved in the processes related to this issue, as of March 31, 2023, was R$1.6 billion (compared to R$1.7 billion on December 31, 2022). Due to the prognosis of remote loss, the processes related to this issue ceased to be reported as possible contingencies in the first quarter of 2023.

- 1,690

 

 

  Indirect taxes

Estimates

(in million of Brazilian Reais)

# Description of the main processes 2023 2022
1

ICMS-ST Trigger

Over the years, Ambev has received tax assessments to charge supposed ICMS differences considered due when the price of the products sold by Ambev is above the fixed price table basis established by the relevant states, cases in which the state tax authorities contend that the calculation basis should be based on a value-added percentage over the actual prices and not the fixed table price. Ambev is currently challenging those charges before the courts. The cases are being challenged at both the administrative and judicial levels.

A Company estimates that the total updated amount of possible risk involved in the processes related to this matter, as of December 31, 2023, is approximately R$10.7 billion (R$9.3 billion on December 31, 2022).

10,669 9,292
2

Manaus Free Trade Zone – IPI and PIS/COFINS

In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/ or zero-rated from excise tax (“IPI”) and social contributions (“PIS/COFINS”). With respect to IPI, Ambev’s subsidiaries have been registering IPI presumed tax credits upon the acquisition of exempted goods manufactured therein. Since 2009, Ambev has been receiving a number of tax assessments from the Brazilian Federal Tax Authorities relating to the disallowance of such credits.

Ambev and its subsidiaries have also been receiving charges from the Brazilian Federal Tax Authorities in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI excise tax credits that are under discussion in these proceedings and (ii) PIS/COFINS amounts allegedly due on Arosuco’s remittance to Ambev subsidiaries.

In April 2019, the Federal Supreme Court (“STF”) announced its judgment on Extraordinary Appeal No. 592.891/ /SP, with binding effect, deciding on the rights of taxpayers registering IPI excise tax presumed credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, Ambev reclassified part of the amounts related to the IPI cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF. The cases are being challenged at both the administrative and judicial levels.

The company estimates that the updated value classified as possible loss involved in these processes, as of December 31, 2023, is approximately R$6.3 billion (R$5.8 billion on December 31, 2022).

6,307 5,825
 

AMBEV S.A.

 

 

3

IPI Suspension

In 2014 and 2015, Ambev received tax assessments from the Brazilian Federal Tax Authorities relating to IPI allegedly due over remittances of manufactured goods to other related factories. The cases are being challenged at both the administrative and judicial levels. In July 2022, Ambev received the first judicial decision on this matter; the decision was unfavorable to Ambev, and it filed an appeal. In July 2023, the Federal Court rendered its decision on the appeal, annulling the first-level decision and ordering the production of technical evidence as requested by Ambev in order to demonstrate the proper collection of IPI. The federal government has filed motions for clarification against this decision, which are pending judgment by the Federal Court.

In October 2022, the Upper Administrative Court rendered a partially favorable decision to Ambev in one of the cases related to this matter, which ordered a tax audit to determine the amount of the tax already effectively paid. The results of the tax audit, which were notified in January 2024, were partially favorable to Ambev, reducing 98% of the amount alleged to be owed by Ambev in this case. Ambev will file an appeal at the judicial level against the unfavorable portion of the decision.

The Company estimates that the updated value classified as possible loss involved in these processes, as of December 31, 2023, is approximately R$1.8 billion (R$1.7 billion on December 31, 2022).

1,824 1,703
4

Social Contributions over products

Since 2015, Ambev has received tax assessments issued by the Brazilian Federal Tax Authorities relating to PIS/COFINS amounts allegedly due over bonus products granted to its customers. The cases are being challenged at both the administrative and judicial levels of the courts. In 2019, 2020 and 2023, Ambev received final favorable decisions at the administrative level in some of these cases. In 2023, the Lower Administrative Court rendered favorable decisions to Ambev in two other cases and Ambev is awaiting formal notification of these decisions, which are not final and remain subject to appeal. At the judicial level, one case is pending decision by the second level judicial court after the first-level judicial court rendered an unfavorable decision to Ambev.

The Ambev estimates that the amount involved in the proceedings as at December 31, 2023, classified as a possible loss, is approximately R$1.8 billion (R$1.6 billion as at December 31, 2022).

1,776 1,559
5

ICMS – ZFM

In 2018 and 2021, Ambev received infraction notices issued by the State Departments of Finance of Rio Grande do Sul and São Paulo for alleged differences in ICMS resulting from the disallowance of credits originating from operations with suppliers located in the Manaus Free Trade Zone (ZFM). Regarding the infraction notice issued by the state of Rio Grande do Sul, the outcome was unfavorable at the administrative level, and the Company awaits notification of the decision rendered by the Administrative Tribunal to assess, along with its external advisors, the presentation of a challenge in the judicial sphere.

Regarding the infractions issued by the state of São Paulo, all had unfavorable decisions at the first instance, and one of the cases is already in the final administrative instance, considering the special appeal filed by the Company. The other cases await judgment by the TIT.

The Company is litigating the matter in the administrative tribunals of the states. The Company estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$804.4 million (R$730.3 million on December 31, 2022).

804.4 730.3
6

ICMS - Prodepe

In 2015, Ambev received Infraction Notices issued by the State Treasury Department of Pernambuco for the collection of ICMS differences due to the alleged non-compliance with the rules of the Pernambuco Development Program - "PRODEPE," due to the rectification of its ancillary obligations.

In 2017, the Company obtained a final favorable decision recognizing the nullity of one of the infraction notices, due to formal errors. However, in September 2018, Ambev received a new infraction notice to discuss the same matter. In this new case, in June 2020, a first-instance decision partially favorable to the Company was rendered, recognizing errors by the tax auditor in the calculation of the incentive. The favorable portion of the decision is definitive, and for the unfavorable portion, the discussion will proceed to the judicial sphere. Additionally, there are other infraction notices related to PRODEPE, some of which are already being discussed in the judicial realm.

The Company estimates that the total updated value of possible risk involved in the processes related to this matter, as of December 31, 2023, is approximately R$739.4 million (R$663.9 million on December 31, 2022).

739.4 663.9
7

ICMS – FAIN

In recent years, Ambev has received infraction notices issued by the State Department of Finance of Paraíba for the collection of ICMS related to the Fund for Industrial Development Support of Paraíba (FAIN). The infractions stem from a controversy regarding the transfer of the tax incentive from the former Companhia de Bebidas das Américas to its successor Ambev S.A., as well as methodological issues regarding the calculation of the benefit. The Company is contesting these infractions in administrative and judicial courts. Ambev estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$647.4 million (R$591.4 million on December 31, 2022).

647.4 591.4
8

ICMS – AM

In 2016, Arosuco (a subsidiary of Ambev) received infraction notices issued by the State Department of Finance of Amazonas for alleged differences in ICMS due to questions about the calculation base applied in sales operations from Ambev to its subsidiaries. After unfavorable decisions at the first instance for Arosuco, appeals were filed, awaiting judgment in the state's administrative tribunal. Arosuco estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$605.8 million (R$561.5 million on December 31, 2022).

605.8 561.5
 

AMBEV S.A.

 

 

9

ICMS FISCAL WAR

The Company and its subsidiaries have received tax assessment notices from the states of São Paulo, Rio de Janeiro, Minas Gerais, among others, related to the legality of the appropriation of ICMS credits in transactions covered by tax incentives granted by other states. The Company is challenging these assessments in administrative and judicial courts.

In August 2020, the Brazilian Supreme Court (STF) ruled, under the system of general repercussion, on Case No. 628,075, recognizing the constitutionality of the unilateral disallowance, by destination states, of ICMS credits arising from tax incentives granted by other states. The decision also acknowledged that any collection of these credits should preserve the effects of the validation of tax incentives, as provided for in Complementary Law No. 160/2017. This decision does not change the likelihood of loss of the cases involving the Company and its subsidiaries.

Regarding assessments received from the state of São Paulo regarding credits originating from the state of Amazonas, there were unfavorable decisions at the second administrative level in the second quarter of 2022. In these cases, the Company filed appeals with the second administrative level in the same year. In December 2023, there was a favorable decision by the STF (Writ of Non-Compliance with a Fundamental Precept, ADPF No. 1004) to recognize the unconstitutionality of São Paulo's tax authorities' decisions questioning the validity of credits from the state of Amazonas. Thus, although the Company is not a party to this STF judgment, there was a favorable impact on the cases under discussion, resulting in a reassessment of the likelihood of success of the cases on this topic from possible to remote, reducing the reported contingency by approximately R$1 billion.

 

On the other hand, regarding other assessments received from the states of São Paulo and Minas Gerais, among others, there were other favorable decisions in 2023, impacting the total value of the reported possible contingency.

 

Ambev estimates that the updated amount involved in the cases, as of December 31, 2023, still classified as possible loss, is approximately R$530 million (R$1.7 billion on December 31, 2022).

530 1,690
10

ICMS – MIP

The company and its subsidiaries have been receiving assessments from State Tax Authorities over the years, disallowing ICMS credits and demanding payment of the Differential Tax Rate (DIFAL) on the acquisition of intermediate production materials. According to the tax authorities, such materials are not physically related to the productive activity of the companies and therefore should be considered as goods for consumption, which do not entitle the taxpayer to tax credits. Considering these allegations as illegitimate, the companies are challenging these assessments before administrative and judicial courts. Provisions have been made for cases related to this matter, with an updated value of approximately R$116 million as of December 31, 2023 (R$113.4 million in December 2022). The Company estimates the possible loss related to this matter to be, as of December 31, 2023, approximately R$447.5 million (R$388.7 million as of December 31, 2022).

447.5 388.7

 

 

  Other processes

Estimates

(in million of Brazilian Reais)

# Description of the main processes 2023 2022
1

Proposed class action in Quebec

Labatt and other, third-party defendants have been named in a proposed class action lawsuit in the Superior Court of Quebec seeking unquantified compensatory and punitive damages. The plaintiffs allege that the defendants failed to warn of certain specific health risks of consuming defendants’ alcoholic beverages. A sub-class of plaintiffs further alleges that their diseases were caused by the consumption of defendants’ products. The proposed class action has not yet been authorized by the Superior Court.

- -
       

 

27.2.2 Main active contingencies

 

The main contingent assets are summarized in the tables below.

 

  Contingent assets
# Description of the main processes
1

Exclusion of ICMS and ICMS-ST from the calculation bases of PIS and COFINS

In 2017, the Supreme Federal Court (STF) ruled that the inclusion of ICMS in the calculation bases of PIS and COFINS is unconstitutional (Theme 69 of general repercussion).

Recently, on December 13, 2023, the Superior Court of Justice (STJ) ruled favorably on Theme 1,125 for taxpayers, meaning the exclusion of ICMS-ST from the calculation bases of PIS and COFINS for substituted taxpayers, with the publication of the respective ruling pending. Regarding this matter, from 2017 to 2023, the Company and its subsidiaries recognized tax credits totaling R$10.5 billion.

The unredeemed amounts remain recorded as assets (see Note18 - Recoverable Taxes) and mainly refer to the tax credit from "REFRI" (period from 2009 to 2015), whose legal action is in the expert phase. The above-mentioned values were recognized in accordance with IAS 37 - Provisions, Contingent Liabilities, and Contingent Assets, considering: (i) the realization of the gain being practically certain, in accordance with the decisions rendered by the STF in Theme 69 and by the STJ in Theme 1,125, and the specific circumstances of each concrete case, as well as due to (ii) the value being able to be estimated with reasonable certainty, through the survey of the respective documents and quantification of the overpayment.

For additional matters related to this subject, the contingent asset capable of estimation corresponds to approximately R$0.2 billion. Additional amounts may eventually be disclosed and recognized.

2

Cerbuco Brewing Inc. arbitration

Cerbuco Brewing Inc., (“Cerbuco”) a Canadian subsidiary of Ambev, owns a 50% equity ownership in Cerveceria Bucanero S.A. (“Bucanero”), a joint venture in Cuba. In 2021, Cerbuco initiated an arbitration proceeding at the International Chamber of Commerce (“ICC”), relating to a potential breach of certain obligations relating to the joint venture, with the terms of reference being formally executed in 2022. Depending on the outcome of the arbitration proceedings, there may be an impact on Cerbuco's ability to influence the management of Bucanero's operations. As a result, Ambev’s ability to continue consolidating Bucanero into its financial statements may also be affected. Based on the opinion of Cerbuco’s Lawyers, the management estimate the chance of loss as possible. The amount involved has not yet been ascertained, as it depends on the outcome of the arbitration.

 

Accounting policies

 

Provisions are recognized when: (i) the Company has a present obligation (legal or constructive) as a result of past events; (ii) it is likely that a future disbursement will be required to settle the current obligation; and (iii) the amount of the obligation can be estimated reliably.

 

 

AMBEV S.A.

 

 

Provisions, except for those mentioned in the line item disputes and litigation, are determined by discounting the expected future cash flow, to a pre-tax rate, which reflects the current market assessments of the time value of money and, where appropriate, the risks specific to the liability.

 

Measuring the probability of loss includes evaluating the available evidence, the hierarchy of laws, the most recent court decisions, court precedents, their legal relevance, the history of occurrences and the amounts involved and the assessment of external lawyers.

 

a) Disputes and Litigations

A provision for disputes and litigation is recognized when it is more likely than not that the Company will be required to make future payments as a result of past events. Such items may include but are not limited to, claims, suits and actions filed by or against the Company relating to antitrust laws, violations of distribution and license agreements, environmental matters, employment-related disputes, claims from the tax authorities, and other matters.

 

b) Contingent liabilities

The Company and its subsidiaries have tax, civil and labor lawsuits defined as contingent liabilities, according to IAS 37, for which no provisions have been recorded, due to the prognosis assessment carried out by Management. Contingent liabilities are not recognized but are disclosed in this note.

 

c) Contingent Assets

Contingent assets are evaluated periodically to ensure that the stages of the claims are appropriately reflected in the financial statements. Contingent assets are not recognized, except when the Company's management believes that it is certain that an inflow of economic benefits will occur, in which case the asset and the corresponding gain are recognized in the financial statements for the period in which the change in estimate occurs. If the inflow of economic benefits becomes probable, the Company discloses the contingent asset.

 

d)Restructuring

A provision for restructuring is recognized when the Company has approved a detailed restructuring plan, and the restructuring has either commenced or been announced. Costs relating to the ongoing and future activities of the Company are not provided for but are recognized when expenses are incurred. The provision includes the benefit commitments in connection with early retirement and redundancy schemes.

 

From the fourth quarter of 2023 onwards, the nomenclature of the "provisions" accounting policy was changed to "provisions, contingent liabilities and contingent assets”.

 

28.FINANCIAL INSTRUMENTS AND RISKS

 

28.1Financial instruments categories

 

The financial instruments held by the Company are managed through operational strategies and internal controls to assure liquidity, profitability, and transaction security. Transactions involving financial instruments are regularly reviewed to assess the effectiveness of the risk exposure that management intends to cover (foreign exchange, and interest rate, among others).

 

 

AMBEV S.A.

 

 

The table below shows all of the consolidated financial instruments recognized in the financial statements, segregated by category:

 

   
  2023 2022
Assets    
Amortized cost    
Cash and cash equivalents less bank overdrafts (Note 21.1) 16,059.0  14,852.1 
Trade receivables excluding prepaid expenses  7,566.7  7,791.4 
Investment securities (Note 21.2) 242.2  219.1 
Subtotal 23,867.9  22,862.6 
Fair value through profit or loss    
Investment securities (Note 21.2) 277.2  454.5 
Derivatives hedges (Note 28) 379.7  273.8 
Subtotal 656.9  728.3 
Total assets 24,524.8  23,590.9 
     
Liabilities    
Amortized cost    
Trade payables (Note 26) 23,502.4  24,837.9 
Interest-bearing loans and borrowings (Note 23) 3,501.1  3,770.7 
Other liabilities 2,129.6  2,015.6 
Subtotal 29,133.1  30,624.2 
Fair value through profit or loss    
Put options granted on subsidiaries (i) 2,791.1  3,060.3 
Derivatives hedges (Note 28) 763.1  729.4 
Other liabilities 272.6  333.7 
Subtotal 3,826.8  4,123.4 
Total liabilities 32,959.9  34,747.6 

 

(i)Put options granted on subsidiaries: the Company constituted a liability related to the acquisition of a non-controlling interest of the operations in the Dominican Republic. This financial instrument is denominated in US Dollars (Tranche A) and Dominican Pesos (Tranche B) and is recorded by an entity, whose functional currency is the Real. The Company assigned this financial instrument as a hedging instrument for a portion of its net assets located in subsidiaries whose functional currency is the US Dollar and the Dominican Peso, in such a manner that the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.

 

28.2 Derivative financial instruments

 

The use of derivative financial instruments by the Company follow strictly the Financial Risk Management Policy (“Policy”) approved by Management. The instruments authorized by the Policy are Futures contracts traded on exchanges, full deliverable forwards, non-deliverable forwards, swaps, and options. The Policy excludes the use of derivatives when they are not related to the Company's business. At December 31, 2023, the Company and its subsidiaries had no target forwards, swaps with currency verification, or any other derivative transactions representing a risk level above the nominal value of the contracts. The derivative operations are managed on a consolidated basis and classified based on the strategy according to their purposes, as follows:

 

i) Cash flow hedge derivative instruments

ii) Fair value hedge derivative instruments.

iii) Net investment hedge derivative instruments.

 

In accordance with the hedge accounting, the effective hedge amount is recorded in equity and, in the event of an ineffective portion this result is recorded immediately in finance result during the period ineffectiveness was identified, for cash flow hedge and net investment hedge

 

The Company measures derivative financial instruments by calculating their fair value, using market curves that impact the value of the instrument as at the computation date. In the case of swaps, the asset and the liability positions are estimated independently and brought to their fair value, equivalent to the difference between the results of the asset and liability amounts, which generates the swap’s market value. For traded derivative financial instruments, the fair value is calculated based on the exchange-listed price. The following tables summarize the exposure identified and protected in accordance with the Company's Risk Policy.

 

 

 

AMBEV S.A.

 

Transactions protected by derivative financial instruments in accordance with the Financial Risk Management Policy

 

                   
2023 
          Fair Value   Gain / (Losses)
Hedge position   Risk Notional   Assets Liability   Finance Result Operational Result Equity
                     
Cost     17,374.2    379.5  (742.0)   (1,639.6) 34.6  (285.2)
    Commodities 4,025.7    198.3  (219.4)   (388.3) (336.2) (105.4)
    US Dollars 13,200.0    164.9  (522.4)   (1,250.7) 363.9  (182.1)
    Euros 37.4    0.1  (0.2)   (0.5) 2.6  0.5 
    Mexican Pesos 111.1    16.2  -      (0.1) 4.3  1.8 
                     
Importing of fixed assets     249.7    0.1  (14.6)   11.0  3.4  5.0 
    US Dollars 249.7    0.1  (14.6)   11.0  3.4  5.0 
                     
Expenses     64.7    0.1  (4.2)   (25.6) (0.1) 1.1 
    US Dollars 64.7    0.1  (4.2)   (25.6) (0.1) 1.1 
                     
Cash     (59.3)   -    (2.3)   13.7  -    -   
    US Dollars (59.3)   -    (2.3)   13.7  -    -   
At December 31, 2023     17,629.3    379.7  (763.1)   (1,640.5) 37.9  (279.1)

 

 

 

 

AMBEV S.A.

 

 

 

    2022 
          Fair Value   Gain / (Losses)
Hedge position   Risk Notional   Assets Liability   Finance Result Operational Result Equity
                     
Cost     19,853.3    271.8  (719.4)   (3,075.2) 452.7  134.3 
    Commodities 4,809.9    100.8  (376.0)   63.5  (32.3) (475.0)
    US Dollars 14,874.7    157.7  (342.9)   (3,139.2) 477.1  596.6 
    Euros 32.2    1.9  -      (0.7) (0.3) 1.2 
    Mexican Pesos 136.5    11.4  (0.5)   1.2  8.2  11.5 
                     
Fixed assets     226.8    1.5  (5.4)   (5.9) 4.9  (13.0)
    US Dollars 226.8    1.5  (5.4)   (5.9) 4.9  (13.0)
                     
Expenses     204.9    0.5  (4.6)   (42.5) 9.1  (14.8)
    US Dollars 204.9    0.5  (4.6)   (42.5) 9.1  (14.8)
                     
Cash     -      -    -      (17.1) -    -   
    American Dollar -      -    -      (17.1) -    -   
At December 31, 2022     20,285.0    273.8  (729.4)   (3,140.7) 466.7  106.5 

 

 

AMBEV S.A.

 

 

28.2.1 Instrument maturity

 

As of December 31, 2023, the Notional and Fair Value amounts per instrument and maturity were as follow:

 

             
    Notional Value
Exposure Risk 2024 2025 2026 2027 >2027 Total
               
Cost   16,763.3  610.9  -    -    -    17,374.2 
   Commodities  3,924.3  101.4  -    -    -    4,025.7 
   US Dollars  12,690.5  509.5  -    -    -    13,200.0 
   Euros 37.4  -    -    -    -    37.4 
   Mexican Pesos  111.1  -    -    -    -    111.1 
               
Importing of fixed assets   249.7  -    -    -    -    249.7 
  US Dollars  249.7  -    -    -    -    249.7 
               
Expenses   64.7  -    -    -    -    64.7 
  US Dollars  64.7  -    -    -    -    64.7 
               
Cash   (59.3) -    -    -    -    (59.3)
  US Dollars  (59.3) -    -    -    -    (59.3)
    17,018.4  610.9  -    -    -    17,629.3 

 

    Fair Value
Exposure Risk 2024 2025 2026 2027 >2027 Total
               
Costs   (352.5) (10.0) -    -    -    (362.5)
  Commodities (14.2) (6.9) -    -    -    (21.1)
  US Dollars (354.4) (3.1) -    -    -    (357.5)
  Euros (0.1) -    -    -    -    (0.1)
  Mexican Pesos 16.2  -    -    -    -    16.2 
               
Importing of fixed assets   (14.5) -    -    -    -    (14.5)
  US Dollars (14.5) -    -    -    -    (14.5)
               
Expenses   (4.1) -    -    -    -    (4.1)
  US Dollars (4.1) -    -    -    -    (4.1)
               
Cash   (2.3) -    -    -    -    (2.3)
  US Dollars (2.3) -    -    -    -    (2.3)
    (373.4) (10.0) -    -    -    (383.4)

 

Margins pledged as guarantees

 

In order to comply with the guarantee requirements regarding derivative exchanges and/or counterparties to certain operations with derivative financial instruments, as at December 31, 2023, the Company held R$197.7 in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (R$376.9 as at December 31, 2022).

 

 

AMBEV S.A.

 

 

28.3 Classification of financial instruments

 

 

                 
  2023   2022
                   
  Level 1 Level 2 Level 3  Total    Level 1 Level 2 Level 3 Total
Financial assets                  
Investment securities 277.2  -    -    277.2    454.5  -    -    454.5 
Derivatives – operational hedge 53.4  326.3  -    379.7    57.0  216.8  -    273.8 
 Total 330.6  326.3  -    656.9    511.5  216.8  -    728.3 
Financial liabilities                  
Put options granted on subsidiaries -    -    2,791.1  2,791.1    -    -    3,060.3  3,060.3 
Other liabilities -    -    272.6  272.6    -    -    333.7  333.7 
Derivatives liabilities at fair value through profit and loss 2.3  -    -    2.3    -    -    -    -   
Derivatives – operational hedge 70.0  690.8  -    760.8    76.1  653.3  -    729.4 
 Total 72.3  690.8  3,063.7  3,826.8    76.1  653.3  3,394.0  4,123.4 

 

28.3.1 Financial instruments level 3

 

As part of the negotiations regarding the acquisition of the shares of Tenedora, the Company signed at 2020 the second amendment to the Shareholders' Agreement extending the partnership between the Company and ELJ. As at December 2023, ELJ was the owner of 15% of the shares of Tenedora, and its put options was divided into two tranches: (i) Tranche A, corresponding to 12.11% of the shares, that was exercised at January 04, 2024; and (ii) Tranche B, corresponding to 2.89% of the shares, exercisable from 2026. The Company, on the other hand, has a call option over Tranche B shares, exercisable from 2029. On December 31, 2023, the sum of the two ELJ tranches is R$2,791.1 (R$3,053.7 on December 31, 2022).

 

The fair value of (i) Tranche A is calculated considering the interest under the contract, plus foreign exchange variations, less the dividends paid between the date of signature of the amendment and the exercise of the option. The fair value of (ii) Tranche B is calculated based on the EBITDA multiple defined in the contract, less the net debt, brought to its present value, calculated using standard valuation techniques (the present value of the principal amount and future interest, discounted by the local currency’s WACC rate as at the date of the calculation). The criteria used are based on market information from reliable sources and are categorized as “Level 3”.

 

28.3.2 Reconciliation of changes in the assets categorized at Level 3

 

 
Financial liabilities at December 31, 2022 3,394.0 
   Acquisition of investments (64.2)
Level reclassification (6.6)
Total gains and losses during the period (259.5)
   Losses/(gains) recognized in net income (269.9)
   Losses/(gains) recognized in equity 10.4 
Financial liabilities at December 31, 2023 3,063.7 

 

28.4 risk management

 

The Company is exposed to foreign currency, interest rate, commodity price, liquidity, and credit risk in the ordinary course of its business. The Company analyzes each of these risks both individually and on a consolidated basis, to define strategies to manage the economic impact on risk’s performance consistent with its Financial Risk Management Policy.

 

AMBEV S.A.

 

 

The objective of this policy is intended to provide guidelines for the management of the financial risks inherent to the capital markets in which Ambev operates. The policy includes four main aspects: (i) transactional risks related to the business; (ii) financial statement translation risk; (iii) credit risks of financial counterparties and (iv) capital structure; financing and liquidity.

 

The policy establishes that all the financial assets and liabilities in each country in which Ambev operates must be denominated in their respective local currencies. The policy also sets out the procedures and controls required to identify, measure, and minimize market risks, such as variations in foreign exchange rates, interest rates and commodities (mainly aluminum, sugar, wheat, corn and paraxylene) that may affect Ambev’s revenue, costs and/or investment amounts. The known risks (e.g., foreign currency and interest) shall be hedged by contracting derivative financial instruments. Existing risks which are not yet recorded (e.g., future contracts for the purchase of raw materials or property, plant and equipment) shall be mitigated using projections for the period required for the Company to adapt to the new costs’ scenario, which may vary from ten to fourteen months, also through the use of derivative financial instruments. Most translation risks are not hedged. The exceptions to the policy must be approved by the Operations and Finance Committee (“COF”)

 

28.4.1 Market risk

 

28.4.1.1 Interest rate risk: consists of the possibility that the Company may incur losses due to fluctuations in interest rates, which may increase the financial expenses of financial liabilities, and/or decrease the financial income of financial assets, as well as negatively impact the fair value of financial assets measured at fair value. To mitigate this risk the Company applies a dynamic interest rate hedging approach, whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of the Company’s policy is to achieve an optimal balance between the cost of funding and the volatility of financial results, considering market conditions. The Company’s overall business strategy, which is reviewed periodically.

 

The table below demonstrates the Company’s exposure related to debts. In 2023, the Company does not hold hedge positions to the exposure described below:

 

         
  2023   2022
  Risk   Risk
  Interest rate  Amount    Interest rate  Amount 
Brazilian Reais 8.1% 243.2    8.5% 230.1 
Post fixed interest rate    243.2      230.1 
           
           
Brazilian Reais 10.1% 2,372.0    8.5% 2,602.1 
Working Capital in Argentinean Peso  0.0% -      73.5% 74.3 
Other 11.5% 405.6    10.4% 421.3 
US Dollars 14.0% -      14.0% 6.2 
Canadian Dollars 5.6% 480.3    5.3% 511.0 
Pre-fixed interest rate    3,257.9      3,614.9 

 

Sensitivity analysis

 

The Company substantially mitigates the risks arising from non-derivative financial assets and liabilities, through the use of derivative financial instruments. In this context, the Company has identified the main risk factors that could generate losses from these derivative financial instruments, and has developed a sensitivity analysis based on three scenarios, which may impact the Company’s future results and/or cash flow, as described below:

 

AMBEV S.A.

 

 

1 - Probable scenario: Management’s expectations regarding the deterioration of each transaction’s main risk factor. To measure the possible effects on the results of derivative transactions, the Company uses the parametric Value at Risk (“VaR”), a statistical measure developed based on estimates of standard deviation and correlation between the returns of several risk factors. This model gives the loss limit expected for an asset over a certain time period and confidence interval. Under this methodology, the potential exposure of each financial instrument, a range of 95% and a horizon of 21 days from December 31, 2023, were used for the calculation, which are presented in the model.

 

2 - Adverse scenario: 25% deterioration in each transaction’s main risk factor compared to the level observed as at December 31, 2023.

 

3 - Remote scenario: 50% deterioration in each transaction’s main risk factor compared to the level observed as at December 31, 2023.

 

Sensitivity analysis of exchange rate variations and commodity price variations:

 

         
Transaction Risk Fair value Probable scenario Adverse scenario Remote
scenario
           
Commodities hedge Decrease in commodities price (21.1) 94.6  985.4  1,991.9 
Input purchases 21.1  (94.6) (985.4) (1,991.9)
Foreign exchange hedge Foreign currency decrease (341.4) (163.3) 2,995.8  6,333.0 
Input purchases 341.4  104.9  (3,336.8) (7,014.9)
Cost effects   -    (58.4) (341.0) (681.9)
           
Foreign exchange hedge Foreign currency decrease (14.5) (13.2) 47.9  110.3 
Capex Purchases 14.5  13.2  (47.9) (110.3)
Fixed asset effects   -    -    -    -   
           
Foreign exchange hedge Foreign currency decrease (4.1) (3.7) 12.0  28.2 
Expenses 4.1  (1.7) (44.0) (92.2)
Result of expense effects   -    (5.4) (32.0) (64.0)
           
Foreign exchange hedge Foreign currency decrease (2.3) (2.5) (17.1) (31.9)
Cash 2.3  2.5  17.1  31.9 
Cash effects   -    -    -    -   
    -    (63.8) (373.0) (745.9)

 

28.4.1.2 Foreign currency risk: the Company is exposed to foreign currency risk on borrowings, investments, purchases, dividends and/or interest expenses/income where these are denominated in a currency other than the functional currency of Group entity. The main derivative financial instruments used to manage foreign currency risk are futures contracts, swaps, options, non-deliverable forwards, and full deliverable forwards.

 

28.4.1.3 Commodity Risk: A significant portion of the Company’s inputs is made up of commodities, which have historically experienced substantial price fluctuations. The Company therefore uses both fixed prices purchasing contracts and derivative financial instruments to minimize its exposure to volatility in the commodity prices of aluminum, sugar, wheat, corn and paraxylene. These derivative financial instruments have been designated as cash flow hedges.

 

 

AMBEV S.A.

 

 

28.4.2 Credit Risk

 

A substantial portion of the Company’s sales is made to distributors, supermarkets, and retailers, through a broad distribution network. Credit risk is reduced due to the large number of customers and control procedures used to monitor risk. Historically, the Company has not incurred significant losses on receivables from customers.

In order to minimize the credit risk of its investments, the Company has adopted procedures for the allocation of cash and investments, taking into consideration the credit limits and credit analysis of financial institutions, avoiding credit concentration, i.e., the credit risk is monitored and minimized by restricting negotiations to a select group of highly rated counterparties.

 

The selection process for financial institutions authorized to operate as counterparties of the Company is set forth in the Credit Risk Policy, which also establishes exposure limits for each counterparty based on each counterparty's risk rating and capitalization.

 

Any deposits or cash available, must be kept in accounts with top tier banks, or banks with a high credit rating in the respective country. Any position of a short-term nature (less than six months) should be considered as a deposit or cash.

 

Counterparty risk must be managed by the Company globally, with product limits established by the treasury area, considering: (i) the counterparty’s credit rating (ii) the transaction term (iii) the amount; and (iv) the split between assets and liabilities, in the absence of a clearing clause in derivative contracts. The counterparty risk is reassessed on a quarterly basis.

 

The carrying amounts of cash and cash equivalents, investment securities, trade receivables excluding prepaid expenses, recoverable taxes and derivative financial instruments are disclosed net of provisions for impairment and represent the maximum exposure to credit risk as at December 31, 2023. As at December 31, 2023, there was no concentration of credit risk on any counterparties in excess of the limits established by the Company's Credit Risk Policy.

 

28.4.3Liquidity Risk

 

Historically, the Company’s primary sources of cash flow have been cash flow from operating activities, the issuance of debt, bank borrowings and equity securities. Ambev’s material cash requirements have included the following: debt servicing; capital expenditure; investments in companies; increases in the ownership of Ambev’s subsidiaries or companies in which it holds equity investments; share buyback programs; and payments of dividends and interest on shareholders’ equity.

 

AMBEV S.A.

 

 

The Company believes that cash flows from operating activities, cash and cash equivalents and short-term investments, together with derivatives and access to loan facilities are sufficient to finance capital expenditures, financial liabilities, and dividend payments in the future.

 

             
  2023
  Carrying amount Contractual cash flows Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
Trade and other payables (i) 36,817.8  38,453.7  35,522.5  439.9  10.6  808.6  1,672.1 
Secured bank loans 126.5  177.8  26.7  25.2  25.2  50.4  50.4 
Other secured loans (ii) 415.7  594.7  156.0  171.2  134.2  79.4  53.9 
Lease liabilities  2,958.9  3,473.0  1,344.0  608.3  552.6  452.6  515.5 
Total payables and liabilities  40,318.9  42,699.2  37,049.2  1,244.6  722.6  1,390.9  2,291.8 

 

               
  2022
  Carrying amount Contractual cash flows Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
Trade and other payables (i) 39,354.4  40,656.4  36,818.5  86.8  1,275.1  1,008.4  1,467.6 
Secured bank loans 180.8  245.7  68.2  26.4  25.2  50.4  75.5 
Other secured loans (ii) 472.5  759.1  169.9  156.7  151.6  165.4  115.5 
Lease liabilities  3,117.4  3,657.4  962.9  1,008.4  621.0  696.9  368.2 
Total payables and liabilities  43,125.1  45,318.6  38,019.5  1,278.3  2,072.9  1,921.1  2,026.8 

 

(i)Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends, and interest on equity payable, salaries and charges, put options related to the Company’s participation in subsidiaries and other liabilities, except for related parties, with payment term of less than one year.

 

(ii)Nomenclature modified to Other secured loans, including for comparative purposes.

 

28.4.4 Capital management

 

The Company is continuously optimizing its capital structure in order to maximize shareholder value while maintaining the desired financial flexibility to execute its strategic projects. Besides the statutory minimum equity funding requirements applicable to the Company’s subsidiaries in different countries, the Company is not subject to any externally imposed capital requirements. When analyzing the capital structure, the Company uses the same debt ratings and capital classifications applied to the financial statements.

 

The company evaluates its net debt in order to guarantee the continuity of its business in the long term.

 

     
    2023 2022
Assets      
Interest-bearing loans and borrowings current and non-current   3,501.1  3,770.7 
(-) Financial assets at fair value through profit or loss   (277.2) (454.5)
(-) Cash and cash equivalents less bank overdraft   (16,059.0) (14,852.1)
Net debt   (12,835.1) (11,535.9)

 

 

28.5 Offsetting financial assets and liabilities

 

For financial assets and liabilities subject to settlement agreements on a net basis or similar agreements, each agreement between the Company and the counterparty allows this type of settlement when both parties opt for this. In the absence of such a decision, the assets and liabilities will be settled at their gross amounts, but each party will have the option to settle on a net basis, in case of a default by the counterparty.

 

AMBEV S.A.

 

 

28.6 Risks management of climate change and the sustainability strategy

 

The Company’s operations, there is an inherent exposure to certain risks related to climate change, and relevant ESG (Environmental, Social and Governance) aspects. As the events mentioned in this section are highly uncertain, the Company cannot determine their financial impact at this moment. Any mentioned impacts may result in a material adverse effect on our business, liquidity, financial condition, and results of operations. The Company continues to manage liquidity and capital resources with discipline to meet the costs of the eventual materialization of such risks. In the period finished in December 31, 2023, the Management considered as main risks the points below.

28.6.1 Commodities prices

 

There is a growing concern that the currently level of carbon dioxide and other greenhouse gases in the atmosphere have adverse impacts on global temperatures, weather patterns and the frequency and severity of extreme weather and natural disasters, such as droughts, floods, unseasonal rains, tropical cyclones, among others. In the event the climate changes have a negative effect on agricultural productivity, the Company may be subject to decreased availability or less favorable pricing for certain agricultural commodities that are necessary for our products, such as barley, hops, sugar and corn. In addition, public expectations for reductions in greenhouse gas emissions could result in increased energy, transportation and raw material costs and may require us to make additional investments in facilities and equipment due to increased regulatory pressures. As a result, the effects of climate change could have a long-term, material adverse impact on our business and results of operations.

 

28.6.2 Water crisis

 

The Company also face water scarcity and quality risks. The availability of clean water is a limited resource in many parts of the world, facing unprecedented challenges from climate change and the resulting change in precipitation patterns and frequency of extreme weather, overexploitation, increasing pollution, and poor water management. The Company has implemented an internal strategy in order to considerably reduce the use of water in your operative plants. However, as demand for water continues to increase around the world, and as water becomes scarcer and the quality of available water deteriorates, we may be affected by increasing production costs or capacity constraints, which could adversely affect our business and results of operations.

 

Droughts can cause barley crop failures, especially in South America, where most barley is rain-fed. The meteorological droughts (short-term, precipitation-impacted droughts) can significantly affect barley crop performance. As a result, the effects of climate change could have a substantial long-term detrimental impact on the Company's business and operating results.

 

28.6.3 Environmental regulations

 

The Company’s operations are subject to a wide range of Brazilian federal, state and municipal safety and environmental laws and regulations related to licenses or authorizations necessary to our business, as well as use of water resources and management of solid waste and take-back scheme obligations.

 

 

AMBEV S.A.

 

The Company activities require the constant obtaining and renewal of environmental licenses, in which the production units operation depends. Technical difficulties or failure to meet license renewal terms and the requirements of environmental agencies may have adverse effects on our business, as we may be subject to (i) the imposition of several administrative penalties (such as fines, interruption or shutdown of activities, license cancellation, among others). (ii) payment of recovering costs to of degraded areas and (iii) accountability in the civil, administrative and criminal spheres, depending on the case.

 

There is no guarantee that the Company, even if it adopts adequate practices and processes, will not incur environmental liability or that these applicable environmental laws and regulations will not change or become stricter in the future. Accordingly, non-compliance with applicable laws and the technical conditions established in licenses and permits may harm the Company's reputation, results of operations and financial health.

 

28.6.4 Social

The Company is subject to obligations regarding the respect for human rights of all stakeholders, which may lead the Company to incur additional costs as well as significant contingencies relating to social issues. In general, social risks arise from the potential and actual adverse impacts of its business activities on the human rights of all stakeholders involved in its operation, including its own employees, consumers, suppliers, investors and the local community where the Company operates, whether directly or indirectly connected to its activities.

If the Company does not adopt well-structured and integrated long-term planning initiatives to promote diversity, equality and inclusion, both in its workforce and in the composition of statutory bodies and leadership, it may be challenged, including in court, about the absence of clear goals and effective actions in this area.

There is no guarantee that the Company will be able to adequately manage the social risks mentioned above in compliance with all national and international parameters and guidelines, which, consequently, may eventually harm the Company's operating results and reputation and expose it to legal and regulatory risks, which may materialize in different ways.

 

Accounting policies

 

Classification and measurement

 

Financial assets (except for accounts receivable without a significant financing component) or financial liabilities are initially measured at fair value, plus, for an item not measured at fair value through profit or loss, transaction costs directly attributable to their acquisition or issue.

 

Financial assets

 

The Company classifies its financial assets on initial recognition, depending on the business model used to manage the financial assets and the contractual terms of the cash flows, under the following measurement categories: (i) at amortized cost; (ii) at fair value through profit or loss; (iii) at fair value through other comprehensive income (“FVOCI”).

 

Financial assets are not reclassified subsequently to initial recognition, unless the Group changes the business model for the management of financial assets, in which case all impacted financial assets are reclassified on the first day of the post-change business model.

 

 

AMBEV S.A.

 

Financial assets are derecognized when the contractual rights to receive the cash flows from the asset has expired or are transferred in a transaction in which substantially all the risks and benefits of ownership of the financial asset are transferred by the Company.

 

On December 31, 2023, and 2022, the Company did not have any financial assets classified in the fair value through other comprehensive income category.

 

a) Amortized cost

The Company classifies financial assets as measured at amortized cost only when two criteria are satisfied:

 

i) The financial asset is held within a business model whose objective is to receive the contractual cash flows; and

ii) The contractual terms generate, on specific dates, cash flows that relate only to the payment of principal and interest on the principal amount outstanding.

 

b) Fair value through profit or loss

All financial assets not classified by the Company as measured at amortized cost or FVOCI and financial assets in which their cash flows do not represent exclusively payments of principal and interest, are classified at fair value through profit or loss. This category also includes debt instruments with cash flow characteristics which are not held within a business model with the objective either to collect contractual cash flow, or both to collect contractual cash flow and for sale.

 

c) Fair Value through Other Comprehensive Income

Debt instruments at FVOCI, with gains or losses recycled to profit or loss on derecognition. The financial assets in this category are the Company’s listed debt instruments thar are held within a business model either to collect cash flow or for sale.

 

Equity instruments designated at FVOCI, without remeasurement of gains or losses to the profit or loss upon derecognition. This category includes only equity instruments which the Company intends to hold for the foreseeable future, and which it has irrevocably elected to classify thus upon their initial recognition or transition. These instruments are not subject to impairment testing.

 

Financial liabilities

 

The Company classifies its financial liabilities, depending on the purpose for which the financial liabilities were entered into, in the following categories:

 

i) measured at amortized cost.

ii) measured at fair value through profit or loss.

 

Financial liabilities are derecognized when contractual obligations are removed, cancelled or expired. The difference between the written-off carrying amount and the consideration paid (including assets transferred or liabilities assumed) is recognized in profit or loss for the year.

 

 

AMBEV S.A.

 

All financial liabilities are initially measured at fair value, net of transaction costs incurred, and are subsequently measured at amortized cost and adjusted using the effective interest rate method. Derivative instruments, remain classified in the fair value through profit or loss category.

 

Hedge accounting

 

The company designates certain derivatives as hedging instruments to hedge the risk related to the variability of foreign exchange rates, interest rates and commodity prices and are not used for speculative purposes. Derivative financial instruments, that are contracted to protect against the exposure, but that do not meet all of the hedge accounting requirements, will be recognized at fair value through profit or loss.

 

Derivative financial instruments are initially recognized at fair value. The fair value of derivative financial instruments can be obtained from market prices or from pricing models that reflect current market rates, as well as the credit quality of the counterparty.

 

Subsequently to initial recognition, derivative financial instruments are remeasured to their fair value as at the date of the financial statements. Changes in the fair values of derivative financial instruments are recognized in current income, except when these instruments are cash flow hedges or net investment hedges, where portions of gains or losses on the hedge instrument defined as effective hedge are recognized in comprehensive income. The hedge designated instrument is the effective element present term contract, which only the present element value change is recognized in comprehensive income, The term element, which can be separated and excluded from the financial instrument designation as hedge instrument is recognized in financial result, in accordance with IFRS 9 - Financial Instruments.

 

The company contracts commodities derivatives which have similar terms to the hedged items and applies component hedging to its commodities. The hedged component is contractually specified and matches with what is defined in the derivative contract, and therefore the hedge ratio is always 1:1. At the beginning of the hedge operation, the Company prepares formal documentation for the operation including: (i) the objective of the hedge, (ii) the type of hedge, (iii) the risk management strategy, (iv) the nature of the risk to be hedged, (v) the identity of the hedged item, (vi) the identity of the hedging instrument, and (vii) the prospective demonstration of effectiveness.

 

Hedge effectiveness is measured on a qualitative basis. Whenever the terms do not match, the Company uses the hypothetical derivatives method to assess the hedge effectiveness. Therefore, usually causes of ineffectiveness include changes in the timing of forecast transactions, changes in the quantity of the commodity to be hedged, or changes in the credit risk of either party to the derivative contract.

 

a) Cash flow hedge

Cash flow hedges are used to protect the cash flow exposure of a recorded asset or liability, or the foreign currency risk or commodity price variations associated with a highly probable transaction. The effective portion of any (gain or loss) on the derivative financial instrument is recognized directly in the comprehensive income statement (cash flow hedge reserve) and will be reclassified from the cash flow hedge reserve to the same line item within which and the same period during which the cash flow futures were hedged impacted the result. The ineffective portion of any gain or loss is recognized immediately in the current income statement, in the financial result.

 

When a hedging instrument or a hedging relationship is terminated, but the hedged transaction is still expected to occur, the cumulative gains and losses (up to the date of termination) remain within comprehensive income, being reclassified in accordance with the above practice, when the transaction being protected occurs. If the hedged transaction is no longer probable, the accumulated gains and losses recognized in comprehensive income are reclassified immediately to the current income statement.

 

AMBEV S.A.

 

b) Fair value hedge

Fair value hedges are used to protect the Company's net debt from variations in exchange rates and interest rates. The Company's cash and debt positions in foreign currency are continually monitored to identify new exposures.

 

When a derivative is intended to hedge the variability in the fair value of a recognized asset or liability, or of a firm commitment, any resulting (gain or loss) on the hedging instrument is recognized in profit or loss. The carrying amount of the hedged item is also adjusted for changes in the fair value related to the risk being hedged, with any gain or loss being recognized in the income statement.

 

c) Net investment hedge

The net investment hedge is used to mitigate the exposure to exchange differences resulting from the conversion of the net investment, or part of it, in the Company's subsidiaries abroad, by balance sheet conversion quota.

 

When a non-derivative foreign currency liability hedges a net investment in a foreign operation, exchange differences arising on the translation of the liability into the functional currency are recognized directly in other comprehensive income (translation reserves). Any ineffectiveness is recognized immediately in profit or loss.

 

When a derivative financial instrument hedges a net investment in a foreign operation, the portion of the gain or loss on the hedging instrument that is determined to be effective is recognized directly in other comprehensive income (translation reserves), while the ineffective portion is reported in profit or loss.

 

28.8.4 Derivatives at fair value through profit or loss

 

Certain derivative financial instruments do not qualify for hedge accounting. Changes in the fair values of any of those derivative financial instruments are recognized immediately in profit or loss of exercise.

 

28.8.5 Impairment of financial assets

 

At the end of each reporting period basis, Management performs impairment testing for financial assets or groups of financial assets. If a trigger event occurs, a financial asset or group of financial assets will be deemed to be impaired. An asset or group of financial assets is deemed impaired, and impairment losses are recorded, only if there is evidence of impairment as a result of one or more events occurring after the initial recognition of the assets (a "loss event") and that event (or events) has an impact on the estimated future cash flow from the financial asset or group of financial assets and can be estimated reliably.

 

28.8.6 Classification of fair value

 

IFRS 13 defines the fair value as the price that would be received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

 

AMBEV S.A.

 

The definition of the fair value of financial instruments is based principally on market conditions existing at the date of each balance sheet. Pursuant to IFRS 13, financial instruments measured at fair value shall be classified within the following categories:

 

Level 1: quoted prices (unadjusted) in active markets available to the entity for identical assets or liabilities.

 

Level 2: fair value of financial instruments which are not traded in an active market, using other techniques for which all inputs that have a significant effect on the recorded fair value are observable, either directly or indirectly.

 

Level 3: if one or more of the significant data are not based on observed market data, the Company uses techniques that cover data that have a significant effect on the recorded fair value, which are not based on observed market data.

 

29.COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS

 

   
  2023 2022
     
Collateral given for the Company’s own liabilities 581.0  764.5 
Other commitments 1,146.8  1,368.1 
  1,727.8  2,132.6 
     
Commitments to suppliers - Property, plant and equipment and Intangible 1,000.8  276.7 
Commitments to suppliers - Inventories 38,391.0  50,088.6 
  39,391.8  50,365.3 

 

As at December 31, 2023, the Company had R$558.2 (R$744.0 as at December 31, 2022) of cash guarantees. The deposits in cash used as guarantees are presented as part of other assets. To provide the guarantees required for derivatives exchanges and/or counterparties contracted in certain derivative financial instrument transactions, as at December 31, 2023, Ambev maintained R$197.7 (R$376.9 as at December 31, 2022) in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (Note 28- Financial instruments and risks).

Most of the balance relates to commitments to suppliers of packaging. These commitments the main objective is to long-term supply security for the Company regarding strategic inputs, as well as offering greater assurance to suppliers for long-term investments. The balances of fixed assets provided as security are not material.

 

Future contractual commitments as at December 31, 2023, and December 31, 2022, are as follow:

 

   
  2023 2022
     
Less than 1 year 9,619.2  12,491.0 
Between 1 and 2 years 9,536.3  10,315.3 
More than 2 years 20,236.3  27,559.0 
  39,391.8  50,365.3 

 

 

 

AMBEV S.A.

 

 

30.RELATED PARTIES

 

The Company adopts the corporate governance practices recommended and/or required by the applicable laws. Under the Company’s by-laws, the Board of Directors is responsible for approving any transactions or agreements between the Company and/or any of its subsidiaries (except for full subsidiaries), its directors and/or shareholders (including direct or indirect shareholders of the Company). The Governance Committee of the Company is required to advise the Board of Directors on all transactions with related parties, among other subjects.

 

Management is prohibited from interfering in any transaction in which a conflict of interest exists, even in theory, with the Company’s interests. Management also is not permitted to interfere in decisions of any other members of management, and the minutes of meeting of the Board are required to document any decision to abstain from the respective deliberations.

 

30.1 Transactions with key management members

 

The key management includes the Statutory Executive Board and Board of Directors. In addition to short-term benefits (primarily salaries), management members are entitled to participate in the share-based payment, as in Note 25- Share-based payments).

 

Total expenses related to the Company’s management members are as follow:

 

       
  2023 2022 2021
       
Short-term benefits (i) 66.7  74.2  68.3 
Share-based payments (ii) 80.7  66.0  65.3 
Total key management remuneration  147.4  140.2  133.6 

 

(i)These mainly correspond to management’s salaries and profit sharing (including performance bonuses).

 

(ii)These correspond to compensation expenses of share options, restricted stocks and performance stocks granted to Management. In total amounts above exclude remuneration paid to members of the Fiscal Council and Committees.

 

Except the abovementioned remuneration, the Company has other types of transaction with the Management members or pending balances receivable or payable in its balance sheet.

 

In addition, on October 19th, 2023, the Company adopted a clawback policy that applies to incentive-based compensation received by certain executives (which currently comprise the members of the Executive Board of Officers). Under this policy, "incentive-based compensation" is defined broadly to include any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a financial reporting measure (e.g. variable performance-related compensation (bonus) and annual long-term incentive performance stock units (PSUs)). 

 

The policy provides that in the event the company is required to prepare an accounting restatement of its financial statements due to the company's material noncompliance with any financial reporting requirements under the applicable securities laws, the Company will recover (on a pre-tax basis) from the relevant executive officers any incentive-based compensation received by such executives on or after October 2nd, 2023 and during the three fiscal years preceding the date the restatement was required that exceeds the amount of incentive-based compensation that otherwise would have been received had such incentive-based compensation been determined according to the applicable accounting restatement, subject to limited exceptions. The recovery of such compensation applies regardless of whether any misconduct occurred and without regard to whether an executive officer engaged in misconduct or otherwise caused or contributed to the requirement for a restatement

 

AMBEV S.A.

 

 

 

30.2 Transactions with the Company's shareholders:

 

30.2.1 Medical, dental and other benefits

 

Fundação Zerrenner is one of Ambev’s shareholders, and at December 31, 2023, held 10.2% of its total share capital. Fundação Zerrenner is also an independent legal entity whose main goal is to provide Ambev’s employees, both active and retired, with health care and dental assistance, technical and higher education courses, facilities for assisting elderly people, either directly or through financial assistance agreements with other entities. As at December 31, 2023, and December 31, 2022, actuarial obligations related to the benefits provided directly by Fundação Zerrenner were fully funded by plan assets, held for that purpose, which significantly exceeded the liabilities at these dates.

 

Ambev recognizes the assets (prepaid expenses) of this plan to the extent of the economic benefits available to the Company, arising from reimbursements or from reductions in future contributions.

 

In December 31, 2023, the expenses incurred and recorded by Fundação Zerrenner with third parties, for providing these benefits totaled R$322.9 at December 31, 2023 (R$308.8 as at December 31, 2022), of which R$291.7 and R$31.2 were related to active employees and retirees respectively (R$270.7 and R$38.1 as at December 31, 2022, respectively).

 

30.2.2 Licensing agreement

 

The Company has a licensing agreement with Anheuser-Busch, Inc. (“AB Inbev”) to produce, bottle, sell and distribute Budweiser® products in Brazil, Canada and Argentina, and sales and distribution agreements for Budweiser® products in Guatemala, the Dominican Republic, Paraguay, El Salvador, Nicaragua, Uruguay, Chile, Panama, Costa Rica and Puerto Rico. In addition, the Company produces and distributes Stella Artois® products under a license to ABI in Brazil and Canada and, through a license granted to ABI, also distributes Brahma® products in the United States and several other countries such as the United Kingdom, Spain, Sweden, Finland and Greece.

The Company and its subsidiaries have licensing agreements with the Group Modelo, subsidiaries of AB Inbev to import, produce, promote and sell Corona® products in Brazil, Canada, Argentina e Chile, as well agreements to to import, promote and sell Corona® products in Latin America and with Spaten-Franziskaner-Bräu GmbH, a subsidiary of ABI, to produce, promote, advertise and sell Spaten® in Brazil.

 

In this context, at December 31, 2023, the Company recorded R$35.4 (R$22.6 as at December 31, 2022, and R$17.0 as at December 31, 2021) and R$888.6 (R$736.7 as at December 31, 2022, and R$819.0 as at December 31, 2021) as licensing income and expenses, respectively in its Consolidated results.

 

 

AMBEV S.A.

 

 

30.3 Transactions with related parties recognized in the income statement

 

           
  2023
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.1  97.2    (143.3) (0.5) 64.0 
AB Package -    -      (235.5) -    -   
AB Procurement  -    -      -    -    (0.5)
AB USA 35.3  -      (915.9) (3.1) (0.2)
Bavaria 72.3  -      (56.7) -    -   
Cervecería Modelo 0.9  -      (1,234.9) -    -   
Cervecerías Peruanas -    -      (7.8) -    -   
Inbev -    -      (41.9) -    -   
ITW International -    -      -    -    120.0 
Other 1.7  18.9    (32.6) (3.4) 1.0 
  110.3  116.1    (2,668.6) (7.0) 184.3 

 

  2022
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.1  5.2    (117.3) (8.5) 208.7 
AB Package -    -      (356.8) -    -   
AB Procurement  -    -      -    (18.1) -   
AB USA 25.5  -      (1,129.7) (3.2) -   
Ambev Peru 0.6  -      -    -    -   
Bavaria 32.0  -      (56.7) -    -   
Cervecería Modelo 124.4  -      (1,323.6) -    -   
Cervecerías Peruanas 1.7  -      (49.6) -    -   
Inbev -    -      (129.8) -    -   
ITW International -    -      -    -    37.3 
Other 84.8  9.6    (87.2) (7.1) 1.9 
  269.1  14.8    (3,250.7) (36.9) 247.9 

 

  2021
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.7  -      (180.3) (10.7) -   
AB Package -    -      (286.7) -    -   
AB Procurement  -    -      -    (16.1) -   
AB USA 32.1  -      (1,209.9) (3.9) 0.3 
Ambev Peru 3.2  -      -    -    -   
Bavaria 30.9  -      (57.0) -    -   
Cervecería Modelo 0.8  -      (1,708.2) -    -   
Cervecerías Peruanas 3.2  -      (32.9) -    -   
Inbev -    -      (107.9) -    -   
ITW International -    -      -    -    42.2 
Other 19.5  3.6    (143.0) (8.2) -   
  90.4  3.6    (3,725.9) (38.9) 42.5 

 

 

 

AMBEV S.A.

 

30.4 Open Balances with Related Parties

 

      2023     2022
  Current   Current
   Trade receivables (i)   Other trade receivables (i)   Dividends receivables     Trade receivables (i)   Other trade receivables (i) 
AB Africa 3.7  -    -      1.6  -   
AB InBev 139.2  -    -      142.7  -   
AB Services 17.2  -    -      23.7  -   
AB USA 27.1  -    -      71.1  -   
Bavaria 10.4  -    -      13.9  -   
Cervecería Modelo 11.2  -    -      12.0  -   
Cervecerías Peruanas -    -    -      0.9  -   
Inbev 1.4  19.0  -      1.0  23.9 
Panama Holding 4.0  -    1.0    3.9  -   
Other 22.5  -    -      19.9  0.9 
  236.7  19.0  1.0    290.7  24.8 

 

  2023   2022
  Non-current   Current   Non-current   Current
  Trade payables (i)   Trade payables (i)   Trade payables (i)   Trade payables (i)
AB InBev -      (21.5)   -      (82.0)
AB Package -      (110.2)   -      (79.3)
AB Services -      (2.4)   -      (5.7)
AB USA -      (209.6)   -      (237.7)
Bavaria -      (30.2)   -      (6.9)
Cervecería Modelo (ii) -      (1,497.9)   -      (345.5)
Cervecerías Peruanas -      (7.9)   -      (46.4)
Inbev -      (8.7)   -      (12.2)
ITW International (199.9)   -      (343.6)   -   
Other -      (28.1)   -      (14.7)
  (199.9)   (1,916.5)   (343.6)   (830.4)

 

(i)The amount represents trading operations (purchase and sale) and reimbursements between the companies of the group.

 

(ii)The outstanding balances with Cervecería Modelo are mainly made up of the accounts payable described in note 1.2.2, as well as amounts for product purchases and others.

 

List of companies included in the tables above:

 

AB InBev Procurement GmbH (“AB Procurement”)
Anheuser-Busch InBev N.V. (“AB InBev”)
Anheuser-Busch Inbev Services LLC (“AB Services”)
Arosuco Aromas e Sucos Ltda. (“Arosuco”)
Anheuser-Busch Packaging Group Inc. (“AB Package”)
Anheuser-Busch Inbev USA LLC (“AB USA”)
Cervecería Chile S.A. (“Cervecería Chile”)
Cervecería Modelo de Mexico S. de R.L. de C.V. (“Cervecería Modelo”)
Cervecería Nacional Dominicana, S.A. (“CND”)
Compañia Cervecera Ambev Peru S.A.C. (“Ambev Peru”)
Inbev Belgium N.V. (“Inbev”)
Interbrew International B.V. (“ITW International”)
Unión de Cervecerias Peruanas Backus Y Johnston S.A.A. (“Cervecerías Peruanas”)
 

AMBEV S.A.

 

 

Accounting Policies

 

Transactions between subsidiaries, including balances and unrealized gains and losses on these transactions, are eliminated. The accounting policies of the subsidiaries are consistent with those adopted by the parent company.

 

Royalties paid are classified as cost of goods sold.

 

It is the Company's rule that transactions with related parties follow reasonable and commutative conditions, in line with those applicable in the market or in which the Company would contract with third parties, are reflected clearly in the individual and consolidated financial statements and are formalized in written contracts.

 

31.EVENTS AFTER THE REPORTING PERIOD

 

31.1 Exercise PUT CND

 

As disclosed in Note 1 - Corporate Information, on January 31, 2024, ELJ exercised the put option to sell to Ambev a 12.11% stake in Tenedora's shares, corresponding to Tranche A, as set forth in the Shareholders' Agreement. The instrument was settled through: (i) a cash disbursement of R$1,704 million; and (ii) the offset of ELJ's debt held by the Group in the amount of R$335 million. As the transaction has been concluded, Ambev Group now holds a 97.11% stake in Tenedora, with the remaining 2.89% held by ELJ, corresponding to Tranche B, as disclosed in Note 28 - Financial Instruments and Risks.

 

31.2 IPI Excise Tax Suspension

 

As disclosed in explanatory note 27 - Provisions, Contingent Liabilities, and Contingent Assets, on December 31, 2023, the Company awaited notification of the decision rendered by the Superior Chamber of Tax Appeals (CSRF), which partially granted the Special Appeal filed by Ambev regarding the suspension of IPI. In January 2024, the Company was notified of the decision, resulting in a 98% reduction of the assessed amount, equivalent to approximately R$916 million. Regarding the remaining portion, the Company will pursue legal action seeking its full cancellation.

 

31.3 Presumed Profit

 

In February 2024, the ‘CARF’ rendered a unanimous favorable decision in the administrative process discussing Arosuco's (a subsidiary of Ambev) use of the presumptive profit method for calculating IRPJ and CSLL instead of actual profit. The amount classified as a possible contingency for the process was R$633.4 million on December 31, 2023 (R$581.5 million on December 31, 2022). The Company awaits formalization and notification of the decision to, together with its external advisors, assess any potential impacts on the risk classification of the contingency and take any necessary actions.

 

31.4 Disallowance on Income Tax deduction

 

In February 2024, CARF rendered a partially favorable, unanimous decision in the administrative process discussing the disallowance of the tax benefit reduction provided by Provisional Measure No. 2,199-14/2001, enjoyed by Arosuco, a subsidiary of the Company dedicated to the production of concentrates, located in the Manaus Free Trade Zone, during the years 2015 to 2018. The decision partially granting the appeal filed by Arosuco recognized the full enjoyment of the tax incentive, maintaining only a portion of the assessment related to the difference in calculation methodology between the tax authorities and the taxpayer. The portion related to the tax incentive amounts to approximately R$2.6 billion, and the portion related to the calculation difference amounts to approximately R$0.02 billion. The Company awaits the formalization and notification of the judgment to, together with its external advisors, assess any impact of the judgment on the contingency risk classification, as well as take any other necessary steps.

 

 

EX-2.2 2 ex02-2.htm EX-2.2

Exhibit 2.2

 

DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT

As of December 31, 2023, Ambev S.A. (“Ambev,” the “Company,” “we,” “us,” and “our”) had the following classes of securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

         
  Title of each class Trading symbol(s) Name of each exchange
on which registered
  Common shares without par value* ABEV New York Stock Exchange*
 

American Depositary Shares**,

each representing one common share

ABEV New York Stock Exchange**

 

*       Not for trading, but only in connection with the registration of the American depositary shares (the “ADSs”), representing such common shares, pursuant to the requirements of the SEC.

**       Evidenced by American depositary receipts (“ADRs”).

Capitalized terms used but not defined in this Exhibit 2.2 shall have the meaning given to such terms in the Ambev’s Annual Report on Form 20-F for the fiscal year ended December 31, 2023 (the “2023 Form 20-F”).

COMMON SHARES

The following description of Ambev’s common shares is a summary of the material provisions concerning our common shares, bylaws and the Brazilian Corporation Law. In Brazil, the principal governing document of a corporation is its bylaws (Estatuto Social). This description is qualified in its entirety by reference to the Brazilian Corporation Law and our bylaws. An English translation of the bylaws is incorporated by reference as Exhibit 1.1 to the 2023 Form 20-F. A copy of our bylaws (together with an English translation) is also available for inspection at the principal office of the depositary and at our website (www.ri.ambev.com.br).

General

Our common shares are listed and admitted to trade on the traditional segment of the B3 under the ticker symbol “ABEV”. Our common shares are listed on the New York Stock Exchange not for trading, but only in connection with the registration of the ADS representing such common shares, pursuant to the requirements of the SEC.

Our registered name is Ambev S.A., and our registered office is in the city of São Paulo, State of São Paulo, Brazil. Our registration number with the São Paulo Commercial Registry is 35,300,368,941. Our principal corporate purposes include the production and sale of beer, CSDs and other beverages. A more detailed description of our corporate purposes can be found in Chapter I, Article 3 of our bylaws.

Description of Capital Stock

As of December 31, 2023, our subscribed and paid-in capital stock consisted of 15,753,833,284 common shares, all of which have equal voting and equity rights, with no par value, of which 4,384,418 common shares were held in treasury.

Rights of the Ambev Common Shares

Each of our common shares is indivisible and entitles its holder to one vote at any shareholders’ meeting of Ambev. In accordance with our bylaws and the Brazilian Corporation Law, shareholders have the right to receive dividends or other distributions in proportion to their equity interest in our share capital. For additional information regarding the payment of dividends and other distributions relating to our common shares, see “Item 8. Financial Information—A. Consolidated Financial Statements and Other Financial Information—Dividend Policy.” In addition, our shareholders may freely transfer their shares and are entitled to be included in a statutory sale of control tender offer upon a disposition of our control (see item “Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council” for more information).

 

1 
 

Also, upon our liquidation, and after the discharge of all our liabilities, our common shares entitle its holders to a participation in our remaining assets as capital reimbursement in proportion to their equity interest in our share capital. Except under certain circumstances, holders of our common shares have the right, but not the obligation, to subscribe for our future capital increases (see “—Preemptive Rights”).

Moreover, pursuant to the Brazilian Corporation Law, neither our bylaws nor actions taken at a shareholders’ meeting may deprive a shareholder of the following rights:

·the right to participate in our profit distributions;
·the right to participate in our remaining assets in proportion to its equity interest in our share capital in the event of our liquidation;
·preemptive rights to subscribe for our common shares, convertible debentures and warrants, except in certain circumstances under the Brazilian Corporation Law, as described in “—Preemptive Rights”;
·the right to inspect and monitor our management, in accordance with the Brazilian Corporation Law; and
·the right to exercise appraisal rights and withdraw from the Company in the cases provided under the Brazilian Corporation Law, as described in “—Appraisal Rights.”

Shareholders’ Meetings

Pursuant to the Brazilian Corporation Law, shareholders, during shareholders’ meetings regularly called and convened, are generally empowered to pass resolutions relating to our corporate purpose as they may deem necessary. Shareholders’ meetings may be ordinary, such as the annual meeting, or extraordinary. Shareholders at the annual shareholders’ meeting (assembleia geral ordinária), which is required to be held within four months of the end of our fiscal year, have the exclusive power to approve our financial statements and to determine the allocation of our adjusted net income and the distribution of dividends with respect to the fiscal year ended immediately prior to the relevant annual meeting. Extraordinary shareholders’ meetings are convened to approve the remaining matters within their competency as provided by law and/or our bylaws. An extraordinary shareholders’ meeting may be held concurrently with an ordinary meeting.

A shareholders’ meeting is convened by publishing a meeting call notice no later than 21 days prior to the scheduled meeting date, on first call, and no later than eight days prior to the date of the meeting, on second call, and no fewer than three times, in a newspaper with general circulation in São Paulo, where we have our registered office. In certain circumstances, at the request of any shareholder (and as per additional regulations from CVM) and after hearing us, the CVM may (i) order, in a reasoned decision, that the meeting be postponed for up to 30 days, in case there is insufficient information for a vote to be held, which term will be counted as of the date on which complete information is delivered to shareholders; and (ii) stay call notices for up to 15 days in order to review the agenda and proposals subject to a shareholder vote at the meeting. At the shareholders’ meeting held on March 1, 2013, our shareholders designated Valor Econômico, a newspaper with general circulation in São Paulo for this purpose. The call notice must contain the date, time, place and agenda of the meeting, and in case of amendments to the bylaws, the indication of the relevant matters. CVM Resolution No. 81/22, also requires that additional information be disclosed in the meeting call notice for certain matters. For example, in the event of an election of all directors, the meeting call notice shall also disclose the minimum percentage of equity interest required from a shareholder to request the adoption of cumulative voting procedures. All documents in connection with the shareholders’ meeting’s agenda shall be made available to shareholders either within at least one month prior to the meeting or upon publication of the first meeting call notice, as the case may be, except if otherwise required by law or, as amended CVM regulations.

A shareholders’ meeting may be held on first call, if shareholders representing at least one quarter of the voting shares are present, except in some cases provided by law, such as in meetings seeking to amend the Company’s bylaws, which requires the presence, on first call of shareholders representing at least two-thirds of the voting shares. If no such quorum is present, an eight-day prior notice must be given in the same manner as described above, and a meeting may then be convened, on second call, without any specific quorum requirement, subject to the minimum quorum and voting requirements for specific matters, as discussed below.

 

2 
 

Except as otherwise provided by law, resolutions of a shareholders’ meeting are passed by a simple majority vote of the shares present or represented at the meeting, abstentions not being considered. Under the Brazilian Corporation Law, the approval of shareholders representing at least a majority of the votes granted by the issued and outstanding voting shares is required for the types of actions described below (among others):

·creating preferred shares or increasing disproportionately an existing class of preferred shares relative to the other classes of shares, unless such action is provided for or authorized by the bylaws;
·modifying a preference, privilege or condition of redemption or amortization conferred upon one or more classes of preferred shares, or creating a new class with greater privileges than those of the existing classes of preferred shares;
·reducing the minimum mandatory dividend;
·merging Ambev with another company or consolidating or executing a spin-off of Ambev;
·related party transactions, or the sale or contribution of assets to another company, in any case if the amount involved exceeds 50% of the amount of our assets indicated in the most recently approved balance sheet;
·changing our corporate purpose; and
·dissolving Ambev or ceasing its liquidation status.

Shareholders may not exercise voting rights with respect to the approval of the appraisal report of assets contributed by them in a capital increase paid in kind or with respect to the approval of their own accounts as managers of the company, as well as in those resolutions that may favor those shareholders specifically, or whenever there is a conflicting interest with the Company. Mergers between affiliated parties are subject to a special statutory valuation procedure intended to provide a parameter (based on the net equity at market prices of the companies involved) for comparing the proposed exchange ratio.

Shareholders’ meetings may be called by our Board of Directors. Under the Brazilian Corporation Law, meetings may also be convened by our shareholders as follows: (1) by any shareholder, if the directors take more than 60 days to convene a shareholders’ meeting after the date they were required to do so under applicable laws and our bylaws, (2) by shareholders holding at least 5% of our total capital stock, if our Board of Directors fails to call a meeting within eight days after receipt of a justified request to call a meeting by those shareholders indicating the proposed agenda, (3) by shareholders holding at least 5% of our voting capital stock, if the directors fail to call a general meeting within eight days after receipt of a request to call a shareholders’ meeting for purpose of assembling a Fiscal Council, and (4) by our Fiscal Council, if the Board of Directors fails to call an annual shareholders’ meeting within 30 days after the mandatory date for such call. The Fiscal Council may also call an extraordinary shareholders’ meeting if it believes that there are important or urgent matters to be addressed.

To attend a shareholders’ meeting, shareholders or their legal representatives willing to attend the meeting shall present proof of ownership of their Company shares, including identification and/or pertinent documentation that evidences their legal representation of such shareholder. A shareholder may be represented at a general meeting by an attorney-in-fact appointed no more than one year before the meeting, who must be another shareholder, a company officer, a lawyer or a financial institution. Notwithstanding the above, the CVM decided on November 4, 2014 that shareholders that are legal entities may be represented at general meetings by their legal representatives or by a duly appointed attorney-in-fact, pursuant to the bylaws and related corporate instruments of the legal entities and pursuant to the Brazilian Civil Code.

The participation and remote voting in general shareholders’ meetings of publicly-held companies are regulated by CVM Resolution No. 81/22, as amended, which aims to facilitate the participation of shareholders in general meetings either through the vote or through the submission of proposals, as well as to enhance the corporate governance instruments available in the Brazilian market. For this purpose, this regulation provided the following:

 

3 
 
·the creation of a remote voting bulletin through which shareholders may exercise their right to vote prior to the date the general meeting is held;
·the possibility of inclusion of candidates and proposals of deliberation of minority shareholders in that bulletin, with due observance of certain percentages of equity interest, in order to facilitate shareholders’ participation in general meetings; and
·the deadlines, procedures and ways of sending this bulletin, which may be forwarded by the shareholder: (a) to the custodian (if the shares held by the shareholder are kept at a centralized deposit) or; (b) to the book-entry agent of the shares issued by the company (if such shares are not kept at a centralized deposit); or (c) directly to the company.

CVM Resolution No. 81/22, also regulates the rules applicable to remote voting, including, but not limited to, (1) the deadlines for inclusion of candidates in the bulletin by request of minority shareholders and for the company to resend the bulletin in case of inclusion of candidates by minority shareholders and (2) the disclosure of the detailed final voting map of the shareholders’ meetings, including the partial disclosure of each shareholders taxpayer’s registry number and their respective votes on each matter.

Additionally, CVM Resolution No. 81/22, as amended, also regulates the possibility of publicly-held companies to hold virtual or hybrid (i.e. physical and virtual) shareholders’ meetings, including procedures that must be adopted by such companies when holding these types of meetings. The documents calling a shareholders’ meeting must indicate the format of the meeting and the arrangements that shareholders must take to participate remotely.

Board of Directors

In accordance with the Brazilian Corporation Law, as a general rule, any matters subject to the approval of our Board of Directors can be approved by the affirmative vote of a majority of our Board members present at the relevant meeting. Exceptions to this general rule are provided in the Shareholders’ Agreement.

Under our bylaws, (i) the majority of the members of our Board of Directors must be external directors (i.e. with no current employment or managerial relationship with the company) and (ii) at least two members or twenty percent (20%) of the total number of members of our Board of Directors, whichever is greater, shall be independent directors. According to our bylaws, for a director to be considered independent he or she may not: (1) be a controlling shareholder, or a spouse or relative to the second degree of a controlling shareholder, (2) have been, within the last three years, an employee or executive officer of (a) Ambev or of any of our controlled companies or (b) our controlling shareholder or entities under common control with Ambev, (3) have business relationships including directly or indirectly, supply to, or purchase from, us, our controlled companies, controlling shareholder, an associated company or entities under common control, any products or services, to such an extent as would cause that director to cease being independent, (4) be an employee or administrator of any corporation or entity that offers products or services to, or receives products or services from, us, our controlled companies, controlling shareholder or entities under common control, to such an extent as would cause that director to cease being independent, (5) be a spouse, partner or straight-line or collateral relative to the second degree of any member of management of Ambev, its controlled companies, controlling company, of management of ABI or entity under common control, (6) receive any other compensation from Ambev, its controlled companies, controlling shareholder, an associated company or entities under common control, aside from compensation for duties as a board member (gains arising from ownership of our stock are excluded from this restriction), (7) have voting exercise in the meetings of the Board of Directors bound by shareholder’s agreement whose purpose are matters related to Ambev or (8) founded the Company and has significant influence over it. Our bylaws also set forth that directors elected by a separate ballot vote of minority shareholders holding at least 10% of our capital stock, as provided in paragraphs 4 and 5 of Section 141 of the Brazilian Corporation Law, shall be deemed independent regardless of compliance with the abovementioned criteria. Furthermore, Brazilian law and CVM regulations requires that at least 20% of the members of the Board of Director shall be independent directors, who are qualified as such depending on certain criterion relating to the relationship between a director, and (i) Ambev, its controlling shareholder and their management; and (ii) companies controlled, affiliated or under common control.

 

4 
 

According to the general principles of the Brazilian Corporation Law, if a director or an executive officer has a conflict of interest with a company in connection with any proposed transaction, the director or executive officer may not intervene nor vote in any resolution of the Board of Directors or of the Board of Executive Officers regarding such transaction and must disclose the nature and extent of the conflicting interest for purposes of recording such information in the minutes of the meeting. In any case, a director or an executive officer may not transact any business with a company, including any borrowings, except on reasonable or fair terms and conditions that are identical to the terms and conditions prevailing in the market or offered by third parties. Any transaction in which a director or executive officer may have an interest can only be approved if carried out on an arm’s-length basis.

Election of Directors

Each Ambev common share represents one vote at any shareholders’ meeting in connection with the election of our Board of Directors.

Common shareholders holding at least 10% of our capital may elect one member and respective alternate to the Board of Directors without the participation of the controlling shareholders. To exercise these minority rights, shareholders must prove their continuous ownership of their Ambev common shares for at least three months prior to the shareholders’ meeting convened to elect board members. If that prerogative is exercised with the adoption of cumulative voting procedures, as described below, the controlling shareholder will always have the right to elect the same number of members appointed by minority shareholders plus one, regardless of the number of directors provided in our bylaws.

Shareholders holding shares representing at least 10% of our capital, or a smaller applicable percentage according to a sliding scale determined by the CVM and based on a company’s capital stock (currently 5% of the Ambev common shares, pursuant to the CVM’s sliding scale), have the right to request that cumulative voting procedures be adopted. Under such procedures, each of our common shares shall entitle as many votes as the number of director positions to be filled, and each shareholder may cast all of his or her votes for a single candidate or distribute them among various candidates.

Pursuant to CVM Resolution No. 81/22, publicly-held companies shall adopt the following measures regarding voting process: (1) inform the market of the adoption of cumulative voting process in applicable meetings immediately upon the receipt of the first valid requirement; (2) disclose the voting final summary statements, the voting final detailed statements, as well as any voting statement presented by shareholders at the relevant meeting; and (3) register in the minutes of the annual shareholders’ meeting the number of approving, rejecting or abstaining votes for each item of the agenda, including the votes received by each member of the Board of Directors and/or Fiscal Council elected in such shareholders’ meeting.

Under our bylaws and applicable law, the number of directors may be reduced to a minimum of five.

The current members of our Board of Directors were elected by our controlling shareholder. Board members, regardless of the shareholder they represent, owe fiduciary duties to the Company and all of our shareholders. At the same time, any director appointed by shareholders bound by a shareholders’ agreement is also bound by the terms of that agreement. For more information on our shareholders’ agreements, see “Item 7. Major Shareholders and Related Party Transactions—A. Major Shareholders—Ambev’s Major Shareholders.”

Dividends

The discussion below summarizes the main provisions of the Brazilian Corporation Law regarding the establishment of reserves by corporations and rules with respect to the distribution of dividends, including provisions regarding interest on shareholders’ equity.

 

5 
 

Calculation of Distributable Amounts

At each annual shareholders’ meeting, our Board of Directors is required to propose how Ambev’s net income for the preceding fiscal year is to be allocated. For purposes of the Brazilian Corporation Law, a company’s net income after income taxes and social contribution on profits for the immediately preceding fiscal year, net of any accumulated losses from prior fiscal years and amounts allocated to employees’ and management’s participation in earnings, represents its “adjusted net income” for such preceding fiscal year. In accordance with the Brazilian Corporation Law, an amount equal to such adjusted net income, which is also referred to in this section as the distributable amount, will be available for distribution to shareholders in any particular year. Such distributable amount is subject to:

·reductions that may be caused by amounts contributed for the purpose of meeting the charges of the assistance foundation for employees and management of the Company and its controlled companies, with due regard for the rules established by the Board of Directors to this effect; up to 10% of the distributable amount may be contributed under this concept;
·reductions caused by amounts allocated to the Legal Reserve or Contingency Reserves (see “—Reserves”); and
·increases caused by reversals of reserves constituted in prior years.

 

Minimum Mandatory Dividend

We are required by our bylaws to distribute to shareholders as dividends in respect to each fiscal year ending on December 31 a minimum mandatory dividend equivalent to no less than 40% of the distributable amount. In addition to the minimum mandatory dividend, the Board of Directors may recommend payment of additional dividends to shareholders. The limit for dividend payment is the distributable amount plus the balance available in certain profit reserves (including our statutory “Investment Reserve,” to which we allocate distributable amounts from previous fiscal years not paid as dividends. See “—Reserves.”) and retained profits. Furthermore, the Board of Directors may also resolve on the distribution of interim dividends and/or interest on shareholders’ equity based on the accrued profits or existing profits (retained profits or certain profits reserves) presented in the latest annual or six-month balance sheet. Interim dividends and interest on shareholders’ equity are always deemed as an advancement towards the minimum mandatory dividend.

In addition, the minimum mandatory dividend, whether the full amount or only a portion thereof, may not be distributed in any given year should the Board of Directors consider that such payment is incompatible with the Ambev’s financial situation, subject to shareholder approval. While the law does not establish the circumstances in which distribution of the minimum mandatory dividend is incompatible with a company’s financial situation, it is generally agreed that a company is allowed to refrain from paying the minimum mandatory dividend if such payment threatens its existence as a going concern or harms its normal course of operations. The Fiscal Council must opine on the nonpayment of minimum mandatory dividends, and management must submit to the CVM a report explaining the reasons considered by the Board of Directors to withhold the payment of the minimum mandatory dividend no later than five business days after the shareholders’ meeting that takes such decision.

Any postponed payment of minimum mandatory dividends must be allocated to a special reserve. Any remaining balance in such reserve not absorbed by losses in subsequent fiscal years must be paid to shareholders as soon as the Company’s financial situation allows.

Payment of Dividends

Under the Brazilian Corporation Law any holder of record of shares at the time of a dividend declaration is entitled to receive such dividends, which are generally required to be paid within 60 days following the date of such declaration, unless otherwise resolved by the shareholders’ meetings, which, in either case, must occur prior to the end of the fiscal year in which such dividends were declared. Our bylaws do not provide for a time frame for payment of dividends. The minimum mandatory dividend is satisfied through payments made both in the form of dividends and interest on shareholders’ equity (amount net of taxes), which, from an economic perspective, is equivalent to a dividend but represents a tax efficient alternative to distribute earnings to shareholders because it is deductible for income tax purposes up to a certain limit established by Brazilian tax laws (see “—Interest on Shareholders’ Equity”). Shareholders have a three-year period from the dividend payment date to claim the payment of dividends, after which we are no longer liable for such payment.

 

6 
 

Shareholders that do not reside in Brazil must register their investment with the Central Bank in order for gains, dividends, profits or other payments under Ambev’s shares to be eligible for remittance in foreign currency outside of Brazil. Our common shares underlying the Ambev ADSs will be deposited with the Brazilian custodian, Banco Bradesco S.A., which acts on behalf of and as agent for the Depositary, which is registered with the Central Bank as the fiduciary owner of those common shares underlying our ADSs. Payments of cash dividends and distributions on our common shares will be made in reais to the custodian on behalf of the Depositary. The custodian will then convert those proceeds into U.S. dollars and will deliver them to the Depositary for distribution to ADS holders. If the custodian is unable to immediately convert dividends in reais into U.S. dollars, ADS holders may be adversely affected by devaluations of the real or other exchange rate fluctuations before those dividends can be converted into U.S. dollars and remitted abroad. Fluctuations in the exchange rate between the real and the U.S. dollar may also affect the U.S. dollar equivalent of the trading price of our common shares in reais on the B3.

Interest on Shareholders’ Equity

Brazilian companies are permitted to distribute earnings to shareholders under the concept of an interest payment on shareholders’ equity, calculated based on specific Ambev’s shareholders’ equity accounts multiplied by the TJLP rate. The TJLP is the official interest rate defined by the Central Bank and used as reference in long-term loans provided by the BNDES.

Amounts distributed by Ambev to its shareholders as interest on shareholders’ equity is deductible for purposes of income tax and social contribution applicable to our profits. The amount of the deduction may not exceed the greater of:

·50% of net income (after the deduction of social contribution on net income but before taking into consideration the provision for corporate income tax and the amounts attributable to shareholders as interest on shareholders’ equity) for the period in respect of which the payment is made; or
·50% of the sum of retained profits and profit reserves as of the date of the beginning of the period in respect of which the payment is made.

Interest on shareholders’ equity is treated similarly to dividends for purposes of distribution of profits. The only significant difference is that a 15% withholding income tax is due by nonexempt shareholders, resident or not of Brazil, upon receipt of such interest payment, which tax must be withheld by us on behalf of our shareholders when the distribution is implemented. If the shareholder is not a Brazilian resident and is resident or domiciled in a tax-haven jurisdiction, withholding income tax is due at a 25% rate. The amount shareholders receive as interest on shareholders’ equity, net of taxes, is deducted from the minimum mandatory dividend owed to shareholders.

For further information on the taxation of interest on shareholders’ equity, including the concept of tax haven jurisdiction for such purposes, see “—E. Taxation—Brazilian Tax Considerations—Income Tax—Distributions of Interest on Shareholders’ Equity.”

Reserves

General

The Brazilian Corporation Law provides that all discretionary allocations of adjusted net income, including the Unrealized Income Reserve and the Investment Reserve, are subject to shareholder approval and may be added to capital (except for the amounts allocated to the Unrealized Income Reserve) or distributed as dividends in subsequent years. In the case of Tax Incentive Reserve and the Legal Reserve, they are also subject to shareholder approval; however, the use of their respective balances is limited to having those balances added to capital or used to absorb losses. They cannot be used as a source for income distribution to shareholders.

 

7 
 

Legal Reserve

Under the Brazilian Corporation Law, corporations are required to maintain a “Legal Reserve” to which they must allocate 5% of their adjusted net income for each fiscal year until the balance of the reserve equals 20% of their share capital. However, corporations are not required to make any allocations to their legal reserve in a fiscal year in which the Legal Reserve, when added to other established capital reserves, exceeds 30% of their share capital. Accumulated losses, if any, may be charged against the Legal Reserve. Other than that, the Legal Reserve can only be used to increase a company’s share capital.

Contingency Reserve

Under the Brazilian Corporation Law, a portion of a corporation’s adjusted net income may also be discretionally allocated to a “Contingency Reserve” for an anticipated loss that is deemed probable in future years and which amount can be estimated. Any amount so allocated in a prior year must be either reversed in the fiscal year in which the loss was anticipated if that loss does not in fact occur or is not charged off in the event that the anticipated loss occurs.

Investment Reserve

Under Brazilian Corporation Law, we are permitted to provide for the allocation of part of our net income to discretionary reserve accounts that may be established in accordance with our bylaws. The allocation of our net income to discretionary reserve accounts may not be made if it serves to prevent the distribution of the minimum mandatory distributable amount. According to our bylaws, a portion of up to 60% of our adjusted net income may be allocated to an “Investment Reserve” for the expansion of our activities, including to be capitalized by us or for our investment in new business ventures.

Pursuant to our bylaws, the Investment Reserve balance is not allowed to be greater than 80% of our share capital. In case such limit is reached, shareholders may resolve to use the exceeding amount for conversion into share capital or to be distributed as dividends.

Unrealized Income Reserve

Pursuant to the Brazilian Corporation Law, the amount by which the minimum mandatory dividend exceeds the “realized” portion of net income for any particular year may be allocated to the Unrealized Income Reserve. The realized portion of net income is the amount by which the adjusted net income exceeds the sum of:

·our net positive results, if any, from the equity method of accounting for earnings and losses of our subsidiaries and certain affiliates; and
·the net profits, net gains or net return obtained on transactions or on accounting of assets and liabilities based on their market value, to be completed after the end of the following fiscal year.

 

Tax Incentive Reserve

Under the Brazilian Corporation Law, a portion of the adjusted net income may also be allocated to a general “Tax Incentive Reserve” in amounts corresponding to reductions in a company’s income tax generated by credits for particular government-approved investments. This reserve is available only in connection with the acquisition of capital stock of companies undertaking specific government-approved projects.

 

8 
 

Goodwill Premium from Shares Issued

Pursuant to the Brazilian Corporation Law, the amount received from subscription of shares in excess of the par value of the shares or the portion of the issuance price allocated to capital stock, in case of shares without par value, must be allocated to this reserve. The amount can be used (i) to absorb losses that surpass accumulated profits and profit reserves, (ii) for future capital increases without the issuance of new shares, (iii) to redeem or reimburse shares (including founder’s shares, if applicable), (iv) for payment of dividends to preferred shares, if applicable, or (v) to support an approved share buyback program.

Fiscal Benefit of Goodwill Premium Amortization (CVM Resolution No. 78/22)

Pursuant to CVM Resolution No. 78/22, when a reporting company merges with its parent company, while remaining a reporting company, the goodwill previously paid by the parent company on its acquisition is deductible for purposes of income tax and social contribution on profits. This future tax benefit is recorded as a capital reserve by the reporting company. As this benefit is realized, the company increases its share capital proportionally to the benefit and is able to issue new shares to the parent company, pursuant to the terms of the merger agreement.

Appraisal Rights

Under the Brazilian Corporation Law, dissenting shareholders have appraisal rights that allow them to withdraw from the Company and be reimbursed for the value of their Ambev common shares, whenever, among other instances, a decision is taken at a shareholders’ meeting to:

·create preferred shares or increase disproportionately an existing class of preferred shares relative to the other classes of shares, unless such action is provided for or authorized by our bylaws;
·modify a preference, privilege or condition of redemption or amortization conferred upon one or more classes of preferred shares, or create a new class with greater privileges than the existing classes of preferred shares;
·reduce the minimum mandatory dividend;
·merge or consolidate us with another company;
·change our corporate purpose;
·conduct a spin-off of Ambev, if the new entities resulting from the spin-off have different primary corporate purposes or a lower minimum mandatory dividend or such spin-off causes us to join a group of companies (as defined in the Brazilian Corporation Law);
·transform us into another corporate type;
·conduct a stock swap merger of Ambev with another company, so that Ambev becomes a wholly-owned subsidiary of that company; or
·approve the acquisition of control of another company, the price of which exceeds the limits set forth in the Brazilian Corporation Law.

In cases where Ambev merges or is consolidated with another company, participates in a group of companies (as defined in the Brazilian Corporation Law), or is a party to a share merger, dissenting shareholders will not be entitled to exercise appraisal rights if their Ambev common shares are (1) liquid, defined as being part of the IBOVESPA Index and (2) widely-held such that the controlling shareholder or companies under its control holds less than 50% of the referred common shares.

Appraisal rights expire within 30 days after publication of the minutes of the relevant shareholders’ meeting that approved the transaction. We are entitled to reconsider any action triggering appraisal rights within 10 days following the expiration of the 30-day appraisal rights exercise period if the redemption of our common shares held by dissenting shareholders would jeopardize our financial stability.

Any shareholder that exercises appraisal rights is, in general, entitled to receive the amount equivalent to its shares’ book value as per the last balance sheet approved by our shareholders. If the resolution giving rise to appraisal rights is approved more than 60 days after the date of the last shareholder-approved balance sheet of Ambev, dissenting shareholders may require that the value of their shares be calculated on the basis of an updated balance sheet (balanço especial) dated no less than 60 days before the resolution date. In this case, we must (1) immediately advance 80% of the book value of the shares to be redeemed according to the most recent balance sheet approved by our shareholders and (2) pay the remaining balance within 120 days after the date of the resolution of the shareholders’ meeting. However, if the advanced payment of 80% of the book value of the shares to be redeemed is greater than the actual appraisal rights value per share determined by the updated balance sheet, then the amount in excess advanced by the Company shall be refunded to us by the dissenting shareholders who exercised appraisal rights.

 

9 
 

As a general rule, shareholders may not exercise appraisal rights with respect to shares acquired after the publishing of a first meeting call notice or the relevant press release concerning the matter giving rise to such appraisal rights.

Redemption

Under Brazilian Corporate Law, our shareholders may resolve in an extraordinary shareholders’ meeting to require us to redeem its outstanding shares. Share redemption may be paid for using our profits, profit reserves or capital reserves. If the share redemption is not applicable to all shares, the redemption will be made by lottery. If custody shares are picked in the lottery and there are no rules established in the custody agreement, the financial institution will specify the shares to be redeemed on a pro rata basis.

Registration of Shares

All of our shares are kept in book-entry form and held in a deposit account with a financial institution authorized by the CVM, in the name of their holders, without certificates issued. The transfer and record cost, as well as the cost of the services relating to our book-entry shares, may be charged directly to the shareholder by the bookkeeping institution.

Preemptive Rights

Each shareholder of Ambev generally has preemptive rights to subscribe for new shares of Ambev in our capital increases (including in the issuance of stock purchase warrants or convertible bonds) in proportion to its shareholdings. A minimum 30-day period following the publication of the capital increase notice is given for the exercise of preemptive rights. However, according to the Brazilian Corporate Law, our board of directors is authorized to exclude preemptive rights or reduce the exercise period with respect to the issuance of new shares, debentures convertible into shares and subscription warrants if the distribution of those shares is effected through sale in a stock exchange transaction, through a public offering or through an exchange of shares in a public offering the purpose of which is to acquire control of another company. Preemptive rights may be purchased and sold by shareholders. Our bylaws provide that if the Board of Directors decides to increase our share capital within the limit of the authorized capital through sales in stock exchanges, public offerings or public tender offers, no preemptive rights will apply. In addition, Brazilian law provides that the grant or the exercise of stock options pursuant to certain stock option plans, such as our Stock Option Plan, is not subject to preemptive rights.

Inspection of Corporate Records

Shareholders that own 1% or more of our outstanding share capital have the right to inspect our corporate records, including shareholders’ lists, corporate minutes, financial records and other documents, if (1) Ambev or any of its officers or directors have committed any act contrary to Brazilian law or our bylaws or (2) there are grounds to suspect that there are material irregularities in the Company. However, in either case, shareholders desiring to inspect our corporate records must obtain a court order authorizing the inspection.

 

10 
 

Form and Transfer

Brazilian law provides that ownership of shares issued by a Brazilian corporation shall generally be evidenced only by a record of ownership maintained by either the corporation or an accredited intermediary, such as a bank, acting as a registrar for the shares. Banco Bradesco S.A. currently maintains our share ownership records.

Because our common shares are in registered book-entry form, a transfer of those shares is made under the rules of the Brazilian Corporation Law, which provides that a transfer of shares is effected by an entry made by the registrar for our shares in its books, by debiting the share account of the transferor and crediting the share account of the transferee.

Transfers of shares by a foreign investor are made in the same way and executed by that investor’s local agent on the investor’s behalf, except that, if the original investment was registered with the Central Bank pursuant to foreign investment regulations, the foreign investor should also seek, through its local agent, an amendment of the corresponding electronic registration to reflect the new ownership, if necessary.

The B3 operates a central clearing system and a stock exchange. A holder of our common shares may choose, at its discretion, to participate in this system, and all shares elected to be transferred to B3’s market must be deposited in custody with the stock exchange through a Brazilian institution that is duly authorized to operate by the Central Bank and maintains a clearing account with the B3. Our common shares that are subject to custody with the stock exchange will be reflected in our registry of shareholders. Each participating shareholder will, in turn, be registered in our register of beneficial shareholders maintained by the stock exchange and will be treated in the same way as registered shareholders.

Disclosure of the Ownership and Trading of our Shares by Us, our Principal Shareholders, Directors and Officers or Members of our Fiscal Council

Pursuant to CVM rules, our directors and officers and members of our fiscal council or of any technical or advisory committee are required to disclose to us, to the CVM and to the B3 the number, type and manner of acquisition of any securities issued by us, or by our publicly held subsidiaries and held by them or any persons related to them (such as a spouse, companion or dependent). The information regarding the trade of any such securities (including the name and identification of the owner of the shares, amount and characteristics of the securities, form, price and date of the trade) must be provided to CVM within 10 days following the end of the month in which they were traded.

Such information must include:

•       name and qualification of the person providing the information;

•       amount, price, type, class and other characteristics of the shares or other securities transferred; and

•       form of transfer (private transaction, stock exchange transaction or otherwise).

Under Brazilian law, shareholders owning more than 5% of a company’s voting shares must publicly disclose their shareholder ownership to the CVM and to the Brazilian stock exchange. In addition, according to CVM Resolution No. 44, if any such principal shareholder or any shareholder electing members of the board of directors increases or decreases its participation in our capital stock directly or indirectly exceeding thresholds of 5% multiples (i.e. 5%, 10%, 15% etc.), this person or entity must disclose its shareholder ownership to CVM in the terms mentioned above, including the reasons for and purpose of the transaction and information on any agreement regarding the exercise of voting rights or the purchase and sale of the securities.

According to CVM Resolution No. 44, individual investment or disinvestment plans for direct or indirect controlling shareholders, members of any statutory governing bodies of a corporation, as well as any persons who, due to their responsibility, function or position in a listed company, its controlling company, subsidiaries or affiliates have potential access to insider information, are allowed, subject to certain requirements.

 

11 
 

Other Significant Provisions of the Brazilian Corporation Law

The Brazilian Corporation Law, as applicable to us, also requires the following:

·upon a sale of our control, the acquirer is required to launch a tender offer to purchase all minority voting shares at a price equal to at least 80% of the price per share paid for the controlling stake;
·our delisting is subject to an administrative proceeding before the CVM, having as a condition the launching of a tender offer by the controlling shareholder or us for the acquisition of all our outstanding shares (defined as those owned by shareholders other than the controlling shareholder, officers and directors) at their fair value, as determined by an independent appraiser. Shareholders holding more than two-thirds of the free float of shares must accept the tender offer or must expressly agree with the delisting (for this purpose, the free float of shares must be considered those held by shareholders that have either accepted the delisting or the offer);
·in addition, if a controlling shareholder or group of controlling shareholders acquires additional shares in excess of one-third of the free float of shares in any class (as calculated according to a formula created by CVM), a mandatory tender offer to ensure share dispersion is required for all the outstanding shares in that class. The same requirement applies whenever (1) a shareholder or group of shareholders representing the same interest and holding more than 50% of the shares in any class from March 7, 2002 (pursuant to CVM Resolution No. 85/22, except for public companies existing in September 5, 2000, in which case this date will prevail), acquires a further interest of 10% or more of that same class of shares within a 12-month period and (2) the CVM determines, within six months after being informed, that the acquisition restricts the liquidity of the shares;
·upon the occurrence of a tender offer aimed at delisting a company or through which the controlling shareholders will acquire more than one-third of the free float shares, the purchase price shall be equal to the fair value of the shares considering the total number of outstanding shares;
·members of our Board of Directors elected by noncontrolling shareholders (in a separate voting mechanism) have the right to veto the choice of the independent auditor by the Board;
·our controlling shareholder, the shareholders that elect members to our Board of Directors or Fiscal Council, the members of our Board of Directors and Fiscal Council, and our executive officers are required to disclose any purchase or sale of our shares to the CVM and to the B3; and
·the chairman of any shareholders’ meeting or directors shall disregard any vote that is rendered against provisions of any shareholders’ agreement if that shareholders’ agreement has been duly filed with us, as is the case with the Shareholders’ Agreement.

Restriction on Certain Transactions by Controlling Shareholders, Directors and Officers

We, our direct or indirect controlling shareholders, if any, members of our Board of Directors, Board of Executive Officers, members of our fiscal council, members of any technical or advisory body or whomever which, by virtue of its title, duty or position in us, or in our controlling shareholders, controlled companies or affiliates, have knowledge of a material fact, and any other person who has knowledge of material information and knows it has not been disclosed to the market (persons who have a business, professional or trust relationship with the Company, including auditors, analysts, underwriters and advisers), are considered insiders. Insiders may not trade our securities or derivatives of our securities prior to the disclosure of such material information to the market to obtain an advantage, for themselves or for others. In addition, former members of our Board of Directors or Board of Executive Officers who are in possession of material, as yet undisclosed information also may not use such information to trade in securities issued by the Company within three (3) months of their dismissal.

Such restriction will apply, without limitation, (i)  as from the moment when studies or analyses are initiated relating to operations of merger, total or partial spin-off, consolidation, transformation, or any form of corporate reorganization, business combination, change in the Company’s control (including by means of the execution, alteration or rescission of a shareholders' agreement), decision to promote the cancellation of the Company's registration as a publicly-held company, or change in the trading environment or segment of the shares issued by us; (ii)  during the 15-day period prior to the disclosure of our quarterly and annual financial statements required by CVM, regardless of whether such persons are aware of the contents of the Company’s quarterly financial information and annual financial statements; and (iii) to the controlling shareholders, if any, the officers, and members of the Board of Directors, whenever we, or any of our controlled companies, affiliates or companies subject to the same control, whenever an option or mandate is in course or has been granted for the purpose of acquisition or disposal of shares issued by us; and (iv) if we intend to request for judicial or extrajudicial reorganization and bankruptcy as from the moment when studies or analyses are started regarding such requests by us.

 

12 
 

Restriction on Certain Transactions outside Our Corporate Purposes

Brazilian Corporate Law prohibits us from undertaking any business practices inconsistent with our corporate purpose and core business.

Restrictions on Non-Brazilian Holders

There are no restrictions on ownership of our common shares by individuals or legal entities domiciled outside Brazil. Foreign investors may trade their shares through ADSs on the NYSE or directly on the B3.

However, the right to convert dividend payments and proceeds from the sale of common shares into foreign currency and to remit such amounts outside Brazil is subject to exchange control restrictions and foreign investment legislation, which generally require, among other things, obtaining an electronic registration with the Central Bank of Brazil. Nonetheless, any non-Brazilian holder who registers with the CVM may use the dividend payments and proceeds from the sale of shares to buy and sell securities directly on the B3.

AMERICAN DEPOSITARY SHARES

The following description of Ambev’s ADSs is a summary and does not purport to be complete. This description is subject to and qualified in its entirety by reference to the deposit agreement dated July 9, 2013, between Ambev, The Bank of New York Mellon, as depositary (the “depositary”) and all owners and beneficial owners from time to time of the American depositary shares (“ADSs”) issued thereunder (the “deposit agreement”), including the form of ADRs. For more complete information, you should read the entire deposit agreement and the form of ADR. The form of deposit agreement (including the form of ADR) is incorporated by reference as Exhibit 2.1 to the 2023 Form 20-F. As used in this section, “you” means an owner or beneficial owner of ADSs.

General

The ADRs are listed and traded on the New York Stock Exchange. Our common shares are listed on the New York Stock Exchange not for trading, but only in connection with the registration of the ADS representing such common shares, pursuant to the requirements of the SEC.

The depositary has executed and delivered, and may from time to time execute and deliver, ADRs. Each ADR is a certificate representing a specific number of ADSs. Each ADS represents one common share (or a right to receive one common share) deposited with the principal office of Banco Bradesco S.A., as agent for the depositary. Each ADS also represent any other securities, cash or other property, which may be held by the depositary. The depositary’s office at which the ADRs are administered, and its principal executive office is located at 240 Greenwich Street, New York, New York 10286.

You may hold ADSs either directly (by having an ADR registered in your name) or indirectly through your broker or other financial institution. If you hold ADSs directly, you are an ADR holder. This description assumes you hold your ADSs directly. If you hold the ADSs indirectly, you must rely on the procedures of your broker or other financial institution to assert the rights of ADR holders described in this section. You should consult with your broker or financial institution to find out what those procedures are.

 

13 
 

As an ADR holder, we will not treat you as one of our shareholders and you will not have shareholder rights, which are governed by Brazilian law. The depositary will be the holder of the shares underlying your ADSs. As a holder of ADRs, you will have ADR holder rights. The deposit agreement sets out the ADR holder rights as well as the rights and obligations of the depositary. New York law governs the deposit agreement and the ADRs.

Dividends and Other Distributions

How will you receive dividends and other distributions on the shares?

The depositary has agreed to pay you the cash dividends or other distributions it or the custodian receives on shares or other deposited securities, after deducting its fees and expenses. You will receive these distributions in proportion to the number of shares your ADSs represent.

 

    Cash. The depositary will convert any cash dividend or other cash distribution we pay on the shares into U.S. dollars, if it can do so on a reasonable basis and can transfer the U.S. dollars to the United States. If that is not possible, or if any government approval is needed and cannot be obtained, the deposit agreement allows the depositary to distribute the foreign currency only to those ADR holders to whom it is possible to do so. With respect to the foreign currency that is not distributed, the depositary may either (i) distribute such foreign currency to the ADR holder upon its request or (ii) hold the foreign currency for the account of the ADR holders who have not been paid. It will not invest the foreign currency and it will not be liable for any interest.

 

Before making a distribution, the depositary will deduct any withholding taxes that must be paid. It will distribute only whole U.S. dollars and cents and will round fractional cents to the nearest whole cent. If the exchange rates fluctuate during a time when the depositary cannot convert the foreign currency, you may lose some or all of the value of the distribution.

 

    Shares. The depositary, after consulting with us, may, and if we request, must, distribute additional ADSs representing any shares we distribute as a dividend or free distribution. The depositary will only distribute whole ADSs. It will try to sell shares which would require it to deliver a fractional ADS and distribute the net proceeds in the same way as it does with cash. The depositary may also sell a portion of the distributed shares to pay fees and expenses in connection with the distribution. If the depositary does not distribute additional ADRs, the outstanding ADSs will also represent the new shares.

 

    Rights to purchase additional shares. If we offer holders of our securities any rights to subscribe for additional shares, or any other rights, the depositary may, after consulting with us, make these rights available to you. If the depositary decides it is not legal and practical to make these rights available after consulting with us, it may sell the rights and distribute the proceeds in the same way it does with cash. The depositary will allow rights that are not distributed or sold to lapse. In that case, you will receive no value for them.

If the depositary makes rights available to you, it will exercise the rights and acquire the shares on your behalf. The depositary will then deposit the shares and deliver ADSs to you. It will only exercise these rights if you pay the exercise price and any other charges the rights require you to pay.

U.S. securities laws may restrict transfers and cancellation of the ADSs represented by shares purchased upon exercise of rights. For example, you may not be able to trade these ADSs freely in the United States. In this case, the depositary may deliver restricted depositary shares that have the same terms as the ADRs described in this section except for changes needed to put the necessary restrictions in place.

 

14 
 

 

    Other Distributions. The depositary will, after consulting with us, send you anything else we distribute on deposited securities by any means it believes is legal, fair and practical. If it cannot make the distribution in that way, the depositary has a choice. It may decide to sell what we distributed and distribute the net proceeds, in the same way as it does with cash. Alternatively, it may decide to hold what we distributed, in which case ADSs will also represent the newly distributed property. The depositary may sell a portion of the distributed property to pay fees and expenses in connection with the distribution.

The depositary is not responsible if it decides that it is unlawful or impractical to make a distribution available to any ADR holders. We have no obligation to register ADSs, shares, rights or other securities under the Securities Act. We also have no obligation to take any other action to permit the distribution of ADRs, shares, rights or anything else to ADR holders. This means that you may not receive the distributions we make on our shares or any value for them if it is illegal or impractical for us to make them available to you.

Deposit and Withdrawal

How are ADSs issued?

The depositary will deliver ADSs if you or your broker deposits shares or evidence of rights to receive shares with the custodian. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will register the appropriate number of ADSs in the names you request and will deliver the ADRs at its office to the persons you request.  

How do ADS holders cancel an ADR and obtain shares?

You may surrender your ADRs at the depositary’s office. Upon payment of its fees and expenses and of any taxes or charges, such as stamp taxes or stock transfer taxes or fees, the depositary will deliver the shares and any other deposited securities underlying the ADR to you or a person you designate at the office of the custodian. Alternatively, at your request, risk and expense, the depositary will deliver the deposited securities at its office, if feasible.

Voting Rights

How do you vote?

You may instruct the depositary to vote the number of shares your ADSs represent. The depositary will notify you of shareholders’ meetings and arrange to deliver our voting materials to you if we ask it to. Those materials will describe the matters to be voted on and explain how you may instruct the depositary how to vote. For instructions to be valid, they must reach the depositary by the date set by the depositary.

The depositary will try, as far as practical, subject to Brazilian law and the provisions of our organizational documents, to vote the number of shares, or other deposited securities represented by your ADSs, as you instruct. The depositary will only vote or attempt to vote as you instruct, or as described below.

We cannot ensure that you will receive voting materials or otherwise learn of an upcoming shareholders’ meeting in time to ensure that you can instruct the depositary to vote your shares. In addition, the depositary and its agents are not responsible for failing to carry out voting instructions or for the manner in which the voting instructions are carried out. This means that you may not be able to vote, and you may have no recourse if your shares are not voted as you requested.

If we asked the depositary to solicit your instructions and the depositary does not receive voting instructions from you by the specified date, it will consider you to have authorized and directed it to give a discretionary proxy to a person designated by us to vote the number of deposited securities represented by your ADSs. The depositary will give a discretionary proxy in those circumstances to vote on all questions to be voted upon.

 

15 
 

Fees and Expenses

The following table summarizes the fees and expenses payable by holders of ADSs:

   

Persons depositing or withdrawing shares must pay:

 

For

 
$5.00 (or less) per 100 ADSs (or portion of 100 ADSs)

(i) Issuance of ADSs, including issuances resulting from a distribution of shares or rights or other property; and

(ii) Cancellation of ADSs for the purpose of withdrawal, including if the Deposit Agreement terminates

$0.02 (or less) per ADSs Any cash distribution
A fee equivalent to the fee that would be payable if securities distributed to you had been shares and the shares had been deposited for issuance of ADSs Distribution of securities to holders of deposited securities which are distributed by the depositary to ADS holders
$0.02 (or less) per ADSs per calendar year Depositary services.
Registration or transfer fees Transfer and registration of shares on Ambev’s share registry to or from the name of the Depositary or its agent when you deposit or withdraw shares.
Expenses of the depositary

(i) Cable, telex and facsimile transmissions (when expressly provided in the deposit agreement); and

(ii) Converting foreign currency to U.S. dollars

Taxes and other governmental charges the depositary or the custodian have to pay on any ADS or share underlying an ADS, for example, stock transfer taxes, stamp duty (which currently are inapplicable in Brazil) or withholding taxes As necessary
Any charges incurred by the depositary or its agents for servicing the deposited securities As necessary

        The depositary collects its fees for delivery and surrender of ADSs directly from investors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting those fees from the amounts distributed or by selling a portion of distributable property to pay the fees. The depositary may collect its annual fee for depositary services through a deduction from cash distributions, by directly billing investors or by charging the book-entry system accounts of participants acting for them. The Depositary may collect any of its fees by deduction from any cash distribution payable to ADS holders that are obligated to pay those fees. The depositary may generally refuse to provide fee-attracting services until its fees for those services are paid.

Payment of Taxes

The depositary may deduct the amount of any taxes owed from any payments to you. It may also sell deposited securities, by public or private sale, to pay any taxes owed. You will remain liable if the proceeds of the sale are not sufficient to pay the taxes. If the depositary sells deposited securities, it will, if appropriate, reduce the number of ADSs to reflect the sale and pay to you any proceeds, or send you any property, remaining after it has paid the taxes.

 

16 
 

 

Reclassifications, Recapitalizations and Mergers

     
If we:   Then:

•      Change the par value of our shares

 

•      Reclassify, split up or consolidate any of the deposited securities

 

•      Distribute securities on the shares that are not distributed to you

 

•      Recapitalize, reorganize, merge, liquidate, sell all or substantially all of our assets, or take any similar action

 

The cash, shares or other securities received by the depositary will become deposited securities. Each ADS will automatically represent its equal share of the new deposited securities.

 

The depositary may distribute some or all of the cash, shares or other securities it received. It may also deliver new ADRs or ask you to surrender your outstanding ADRs in exchange for new ADRs identifying the new deposited securities.

 

Amendment and Termination

How may the deposit agreement be amended?

We may agree with the depositary to amend the deposit agreement and the ADRs without your consent for any reason. If an amendment adds or increases fees or charges, except for taxes and other governmental charges or expenses of the depositary for registration fees, facsimile costs, delivery charges or similar items, or prejudices a substantial right of ADR holders, it will not become effective for outstanding ADRs until 30 days after the depositary notifies ADR holders of the amendment. At the time an amendment becomes effective, you are considered, by continuing to hold your ADR, to agree to the amendment and to be bound by the ADRs and the deposit agreement as amended.

How may the deposit agreement be terminated?

The depositary will terminate the deposit agreement if we ask it to do so. The depositary may also terminate the deposit agreement if the depositary has told us that it would like to resign, and we have not appointed a new depositary bank within 60 days. In either case, the depositary must notify you at least 30 days before termination.

After termination, the depositary and its agents’ actions under the deposit agreement will be limited to the following: (1) advise you that the deposit agreement is terminated, (2) collect distributions on the deposited securities (3) sell rights and other property, and (4) deliver shares and other deposited securities upon cancellation of ADRs. One year or more after termination, the depositary may sell any remaining deposited securities by public or private sale. After that, the depositary will hold the money it received from the sale, as well as any other cash it is holding under the deposit agreement for the pro rata benefit of the ADR holders that have not surrendered their ADRs. It will not invest the money and has no liability for interest. The depositary’s only obligations will be to account for the money and other cash. After termination of the deposit agreement our only obligations will be to indemnify the depositary and to pay fees and expenses of the depositary that we agreed to pay.

Limitations on Obligations and Liability

The deposit agreement expressly limits our obligations and the obligations of the depositary. It also limits our liability and the liability of the depositary. We and the depositary:

 

    are only obligated to take the actions specifically set forth in the deposit agreement without negligence or bad faith;
    are not liable if either of us is prevented or delayed by law or circumstances beyond our control from performing our obligations under the deposit agreement;
    are not liable if either of us exercises discretion permitted under the deposit agreement;
    have no obligation to become involved in a lawsuit or other proceeding related to the ADRs or the deposit agreement on your behalf or on behalf of any other person unless it is indemnified on a basis satisfactory to it; and
    may rely upon any documents we believe in good faith to be genuine and to have been signed or presented by the proper party.

In the deposit agreement, we agree to indemnify the depositary for acting as depositary, except for losses caused by the depositary’s own negligence or bad faith, and the depositary agrees to indemnify us for losses resulting from its negligence or bad faith.

 

17 
 

Requirements for Depositary Actions

Before the depositary will deliver or register a transfer of an ADR, make a distribution on an ADR, or permit withdrawal of shares or other property, the depositary may require:

 

    payment of stock transfer or other taxes or other governmental charges and transfer or registration fees charged by third parties for the transfer of any shares or other deposited securities;
    satisfactory proof of the identity and authenticity of any signature or other information it deems necessary; and

 

    compliance with regulations it may establish, from time to time, consistent with the deposit agreement, including presentation of transfer documents.

The depositary may refuse to deliver ADRs or register transfers of ADRs generally when the transfer books of the depositary or our transfer books are closed or at any time if the depositary or we think it advisable to do so.

Your Right to Receive the Shares Underlying your ADRs

You have the right to cancel your ADRs and withdraw the underlying shares at any time except:

 

    When temporary delays arise because: (i) the depositary has closed its transfer books, or we have closed our transfer books; (ii) the transfer of shares is blocked to permit voting at a shareholders’ meeting; or (iii) we are paying a dividend on our shares.
    When you owe money to pay fees, taxes or similar charges.
    When it is necessary to prohibit withdrawals in order to comply with any laws or governmental regulations that apply to ADRs or to the withdrawal of shares or other deposited securities.

This right of withdrawal may not be limited by any other provision of the deposit agreement.

Pre-release of ADRs

The deposit agreement permits the depositary to deliver ADRs before deposit of the underlying shares, which is referred to as a pre-release of the ADR. The depositary may also deliver shares upon surrender of pre-released ADRs (even if the ADRs are surrendered before the pre-release transaction has been closed out). A pre-release is closed out as soon as the underlying shares are delivered to the depositary. The depositary may receive ADRs instead of shares to close out a pre-release. The depositary may pre-release ADRs only under the following conditions: (i) before or at the time of the pre-release, the person to whom the pre-release is being made represents to the depositary in writing that it or its customer owns the shares or ADRs to be deposited; (ii) the pre-release is fully collateralized with cash or other collateral that the depositary considers appropriate; (iii) the depositary must be able to close out the pre-release on not more than five business days’ notice; and (iv) any other indemnities and credit regulations are provided in which the depositary may deem necessary. In addition, the depositary will limit the number of ADSs that may be outstanding at any time as a result of pre-release, although the depositary may disregard the limit from time to time, if it thinks it is appropriate to do so.

Shareholder communications; inspection of register of holders of ADSs

The depositary will make available for your inspection at its office all communications that it receives from us as a holder of deposited securities that we make generally available to holders of deposited securities. The depositary will send you copies of those communications if we ask it to. You have a right to inspect the register of holders of ADSs, but not for the purpose of contacting those holders about a matter unrelated to our business or the ADSs.

***

 

18 

 

EX-8.1 3 ex08-1.htm EX-8.1

Exhibit 8.1. List of AMBEV’S Material Subsidiaries

Our operations are conducted principally by Ambev, and, in the case of our CAC, Latin America South and Canadian operations, by direct and indirect subsidiaries of Ambev. The following is a list of the significant companies that Ambev controlled, either directly or indirectly, as of December 31, 2023: 

1.The Company indirectly owns 99.78% of the economic and voting interests in Cerveceria Y Malteria Quilmes Saica Y G (incorporated in Argentina).
2.The Company directly owns 100% of the economic an economic and voting interests in Malteria Pampa S.A (incorporated in Argentina)
3.The Company indirectly owns 85.34% of the economic and voting interests in Cerveceria Boliviana Nacional S.A. (incorporated in Bolivia).
4.The Company, directly and indirectly, owns 100% of the economic and voting interests in Arosuco Aromas e Sucos Ltda. (incorporated in Brazil).
5.The Company, directly and indirectly, owns 100% of the economic and voting interests in CRBS S.A (incorporated in Brazil).
6.The Company indirectly owns 100% of Labatt Brewing Co. Ltd. (incorporated in Canada).
7.The Company indirectly owns 100% of the economic and voting interests in Cerveceria Chile S.A. (incorporated in Chile).
8.The Company directly owns 100% of the economic and voting interests in Jalua Spain S.L. (incorporated in Spain).
9.The Company directly owns 100% of the economic and voting interests in Ambev Luxembourg S.à R.L. (incorporated in Luxembourg).
10.The Company indirectly owns 87.36% of the economic and voting interests in Cerveceria Paraguaya S.A. (incorporated in Paraguay).
11.The Company indirectly owns 97.11% of the economic and voting interests in Cervecería Nacional Dominicana S.A. (incorporated in Dominican Republic).
12.The Company directly owns 100% of the economic an economic and voting interests in Maltería Uruguay S.A (incorporated in Uruguay)
13.The Company indirectly owns 100% of the economic and voting interests in Cerveceria Y Malteria Payssandú S.A. (incorporated in Uruguay).
14.The Company indirectly owns 100% of the economic and voting interests in Monthiers S.A. (incorporated in Uruguay).
15.The Company, directly and indirectly, owns 100% of the economic and voting interests in Cervecería Nacional S. de R.L. (incorporated in Panama).

 

 

***

EX-12.1 4 ex12-1.htm EX-12.1

Exhibit 12.1

PRINCIPAL EXECUTIVE OFFICER CERTIFICATION

I, Jean Jereissati Neto, certify that:

1.       I have reviewed this annual report on Form 20-F of Ambev S.A. (the “Company”);

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

4.       The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

5.       The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of Company’s Board of Directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

Date: March 11, 2024.

/s/ Jean Jereissati Neto

Name: Jean Jereissati Neto

Title: Chief Executive Officer

EX-12.2 5 ex12-2.htm EX-12.2

Exhibit 12.2

PRINCIPAL FINANCIAL OFFICER CERTIFICATION

I, Lucas Machado Lira, certify that:

1.       I have reviewed this annual report on Form 20-F of Ambev S.A. (the “Company”);

2.       Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.       Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

4.       The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

5.       The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of Company’s Board of Directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

Date: March 11, 2024.

/s/ Lucas Machado Lira

Name: Lucas Machado Lira

Title: Chief Financial Officer

EX-13.1 6 ex13-1.htm EX-13.1

Exhibit 13.1

Certification of the Principal Executive Officer
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the annual report of Ambev S.A. (the “Company”) on Form 20-F for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Jean Jereissati Neto, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 11, 2024.

/s/ Jean Jereissati Neto

Name: Jean Jereissati Neto

Title: Chief Executive Officer

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-13.2 7 ex13-2.htm EX-13.2

Exhibit 13.2

Certification of the Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes - Oxley Act of 2002

In connection with the annual report of Ambev S.A. (the Company) on Form 20–F for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Lucas Machado Lira, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes–Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 11, 2024.

/s/ Lucas Machado Lira

Name: Lucas Machado Lira

Title: Chief Financial Officer

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-97.1 8 ex97-1.htm EX-97.1

AMBEV S.A.

CLAWBACK POLICY REGARDING THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION

 

1.Background

Ambev S.A. (the “Company”) has adopted this policy (the “Policy”) to provide for the recovery or “clawback” of certain incentive compensation in the event of a Restatement (as defined below).

This Policy is intended to comply with, and will be interpreted to be consistent with, the requirements of Section 303A.14 of the New York Stock Exchange (“NYSE”) Listed Company Manual (the “Listing Standard”). This Policy has been approved by the Company’s Board of Directors (the “Board”) and will be administered by the People Committee of the Board (the “Committee”), who may consult with, and/or refer any decisions or determinations under this Policy to, the Board. All Committee and/or Board determinations under this Policy will be final, binding and conclusive on all interested parties, effective as of the Effective Date (as defined below).

2.Definitions

For purposes of this Policy, the following definitions shall apply:

a)Covered Compensation” means any Incentive-Based Compensation granted, vested or paid to a person who served as an Executive Officer at any time during the performance period for the Incentive-Based Compensation and that was received (i) on or after the effective date of the Listing Standard, (ii) after the person became an Executive Officer, and (iii) at a time that the Company had a class of securities listed on a national securities exchange or a national securities association.
b)Effective Date” means December 1, 2023.
c)Erroneously Awarded Compensation” means the amount of Covered Compensation granted, vested or paid to a person that exceeds the amount of Covered Compensation that otherwise would have been granted, vested or paid to the person had such amount been determined based on the applicable Restatement, computed without regard to any taxes paid. For Covered Compensation based on stock price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in a Restatement, the Committee will determine the amount of such Covered Compensation that constitutes Erroneously Awarded Compensation, if any, based on a reasonable estimate of the effect of the Restatement on the stock price or total shareholder return upon which the Covered Compensation was granted, vested or paid and the Committee shall maintain documentation of such determination and provide such documentation to the NYSE.
d)Exchange Act” means the Securities Exchange Act of 1934.
   
 1 
 
e)Executive Officer” means the Company’s president, principal financial officer, principal accounting officer (or if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer who performs a policy-making function, or any other person who performs similar policy-making functions for the Company. Executive officers of the Company’s parent(s) or subsidiaries are deemed executive officers of the Company if they perform such policy-making functions for the Company. “Policy-making function” does not include policy-making functions that are not significant. Identification of an Executive Officer for purposes of this Policy will include at a minimum executive officers identified pursuant to 17 CFR 229.401(b).
f)Financial Reporting Measure” means (i) any measure that is determined and presented in accordance with the accounting principles used in preparing the Company’s financial statements, and any measures derived wholly or in part from such measures, (ii) stock price or (iii) total shareholder return. Financial Reporting Measures need not be presented within the Company’s financial statements or included in a filing with the SEC.
g)Home Country” means Brazil, the Company’s jurisdiction of incorporation.
h)Incentive-Based Compensation” means any compensation that is granted, earned or vested based wholly or in part upon the attainment of a Financial Reporting Measure.
i)Lookback Period” means the three completed fiscal years (plus any transition period of less than nine months that is within or immediately following the three completed fiscal years and that results from a change in the Company’s fiscal year) immediately preceding the date on which the Company is required to prepare a Restatement for a given reporting period, with such date being the earlier of: (i) the date the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare a Restatement, or (ii) the date a court, regulator or other legally authorized body directs the Company to prepare a Restatement. Notwithstanding this lookback requirement, the Company is only required to apply this Policy to Incentive-Based Compensation received on or after October 2, 2023.
j)Received” Incentive-Based Compensation is deemed “received” in the Company’s fiscal period during which the Financial Reporting Measure specified in or otherwise relating to the Incentive-Based Compensation award is attained, even if the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.
k)Restatement” means a required accounting restatement of any Company financial statement due to the material noncompliance of the Company with any financial reporting requirement under the securities laws, including any required accounting restatement to correct an error in previously issued financial statements that is material to the previously issued financial statements, or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period.
   
 2 
 
l)SEC” means the United States Securities and Exchange Commission.
3.Clawback of Erroneously Awarded Compensation & Exceptions

In the event of a Restatement, any Erroneously Awarded Compensation received during the Lookback Period shall be subject to reasonably prompt repayment to the Company in accordance with Section 3 of this Policy. The Company, led by the Committee, must pursue the forfeiture and/or repayment of such Erroneously Awarded Compensation in accordance with Section 3 of this Policy, except as provided below.

Notwithstanding the foregoing, a majority of the independent directors serving on the Board may determine not to pursue the forfeiture and/or recovery of Erroneously Awarded Compensation from any person if the Committee determines that such recovery would be impracticable due to any of the following circumstances:

a)Direct Expense Exceeds Recoverable Amount. The direct expense paid to a third party to assist in enforcing the Policy would exceed the amount to be recovered (following reasonable attempts by the Company to recover such Erroneously Awarded Compensation, the documentation of such attempts, and the provision of such documentation to the NYSE); or
b)Violation of Home Country Law. Pursuing such recovery would violate the Company’s Home Country laws adopted prior to November 28, 2022 (provided that the Company obtains an opinion of Home Country counsel acceptable to the NYSE that recovery would result in such a violation and provides such opinion to the NYSE).
c)Recovery from Certain Tax-Qualified Retirement Plans. Recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and regulations thereunder.
4.Means of Repayment

In the event that the Committee determines that any person shall repay any Erroneously Awarded Compensation, the person shall reasonably promptly satisfy such repayment in a manner and on such terms as required by the Committee.

5.No Indemnification

The Company shall not indemnify any Executive Officer or former Executive Officer against the loss of erroneously awarded Incentive-Based Compensation. In the event of any conflict between the terms of this Policy and the Company’s rules, bylaws and other policies, the terms of this Policy shall control.

   
 3 
 
6.Miscellaneous

This Policy is intended to satisfy the requirements of Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as it may be amended from time to time, and any related rules or regulations promulgated by the SEC or the NYSE, including the Listing Standard and any additional or new requirements that become effective after the Effective Date which upon effectiveness shall be deemed to automatically amend this Policy to the extent necessary to comply with such additional or new requirements.

The provisions in this Policy are intended to be applied to the fullest extent of the law. To the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to applicable law. The invalidity or unenforceability of any provision of this Policy shall not affect the validity or enforceability of any other provision of this Policy. Recoupment of Erroneously Awarded Compensation under this Policy is not dependent upon the Company satisfying any conditions in this Policy, including any requirement to provide applicable documentation to the NYSE.

The rights of the Company under this Policy to seek forfeiture or reimbursement are in addition to, and not in lieu of, any rights of recoupment, or remedies or rights other than recoupment, that may be available to the Company pursuant to the terms of any law, government regulation or stock exchange listing requirement or any other policy, code of conduct, employee handbook, employment agreement, equity award agreement, or other plan or agreement.

7.Amendment and Termination

To the extent permitted by, and in a manner consistent with applicable law, including SEC and NYSE rules, the Committee may terminate, suspend or amend this Policy at any time in its discretion.

 

***

   
 4 

 

GRAPHIC 9 image_002.jpg GRAPHIC begin 644 image_002.jpg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end GRAPHIC 10 image_004.jpg GRAPHIC begin 644 image_004.jpg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end
EX-101.SCH 11 abev-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED INCOME STATEMENTS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - CORPORATE INFORMATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF MATERIAL ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - USE OF ESTIMATES AND JUDGMENTS link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - SEGMENT REPORTING link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - NET SALES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - EXCEPTIONAL ITEMS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - PAYROLL AND RELATED BENEFITS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - NET FINANCE RESULT link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - PROPERTY, PLANT AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - GOODWILL link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - INTANGIBLES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - RECOVERABLE TAXES link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - TRADE RECEIVABLES link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - CHANGES IN EQUITY link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - INTEREST-BEARING LOANS AND BORROWING link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - EMPLOYEE BENEFITS link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - SHARE-BASED PAYMENTS link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - TRADE PAYABLES link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - RELATED PARTIES link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - EVENTS AFTER THE REPORTING PERIOD link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - SUMMARY OF MATERIAL ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - SEGMENT REPORTING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - NET SALES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - EXCEPTIONAL ITEMS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - PAYROLL AND RELATED BENEFITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - NET FINANCE RESULT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - RECOVERABLE TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - TRADE RECEIVABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - CHANGES IN EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Tables) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - EMPLOYEE BENEFITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SHARE-BASED PAYMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - TRADE PAYABLES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - RELATED PARTIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - CORPORATE INFORMATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SEGMENT REPORTING - Reportable Segments (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - SEGMENT REPORTING - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SEGMENT REPORTING (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - NET SALES (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - NET SALES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - EXCEPTIONAL ITEMS (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - PAYROLL AND RELATED BENEFITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - PAYROLL AND RELATED BENEFITS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - NET FINANCE RESULT (Details) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - NET FINANCE RESULT (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - NET FINANCE RESULT (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000085 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000086 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000087 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000088 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 6) link:presentationLink link:calculationLink link:definitionLink 00000089 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000090 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000091 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000092 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000093 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000094 - Disclosure - GOODWILL (Details) link:presentationLink link:calculationLink link:definitionLink 00000095 - Disclosure - GOODWILL (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000096 - Disclosure - GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000097 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000098 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000099 - Disclosure - INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000100 - Disclosure - INTANGIBLES - Intangible Assets by Location (Details) link:presentationLink link:calculationLink link:definitionLink 00000101 - Disclosure - INTANGIBLES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000102 - Disclosure - RECOVERABLE TAXEs (Details) link:presentationLink link:calculationLink link:definitionLink 00000103 - Disclosure - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 00000104 - Disclosure - INVENTORY (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000105 - Disclosure - TRADE RECEIVABLES - Current Trade Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000106 - Disclosure - TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 00000107 - Disclosure - TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details) link:presentationLink link:calculationLink link:definitionLink 00000108 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 00000109 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details) link:presentationLink link:calculationLink link:definitionLink 00000110 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000111 - Disclosure - CHANGES IN EQUITY - Capital Stock (Details) link:presentationLink link:calculationLink link:definitionLink 00000112 - Disclosure - CHANGES IN EQUITY - Capital Reserves (Details) link:presentationLink link:calculationLink link:definitionLink 00000113 - Disclosure - CHANGES IN EQUITY - Treasury Shares (Details) link:presentationLink link:calculationLink link:definitionLink 00000114 - Disclosure - CHANGES IN EQUITY - Net Income Reserves (Details) link:presentationLink link:calculationLink link:definitionLink 00000115 - Disclosure - CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details) link:presentationLink link:calculationLink link:definitionLink 00000116 - Disclosure - CHANGES IN EQUITY - Basis for Dividends (Details) link:presentationLink link:calculationLink link:definitionLink 00000117 - Disclosure - CHANGES IN EQUITY - Carrying Value Adjustments (Details) link:presentationLink link:calculationLink link:definitionLink 00000118 - Disclosure - CHANGES IN EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000119 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details) link:presentationLink link:calculationLink link:definitionLink 00000120 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000121 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000122 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000123 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000124 - Disclosure - EMPLOYEE BENEFITS (Details) link:presentationLink link:calculationLink link:definitionLink 00000125 - Disclosure - EMPLOYEE BENEFITS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000126 - Disclosure - EMPLOYEE BENEFITS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000127 - Disclosure - EMPLOYEE BENEFITS (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000128 - Disclosure - EMPLOYEE BENEFITS (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000129 - Disclosure - EMPLOYEE BENEFITS (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000130 - Disclosure - EMPLOYEE BENEFITS (Details 6) link:presentationLink link:calculationLink link:definitionLink 00000131 - Disclosure - EMPLOYEE BENEFITS (Details 7) link:presentationLink link:calculationLink link:definitionLink 00000132 - Disclosure - EMPLOYEE BENEFITS (Details 8) link:presentationLink link:calculationLink link:definitionLink 00000133 - Disclosure - EMPLOYEE BENEFITS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000134 - Disclosure - SHARE-BASED PAYMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000135 - Disclosure - SHARE-BASED PAYMENTS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000136 - Disclosure - SHARE-BASED PAYMENTS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000137 - Disclosure - SHARE-BASED PAYMENTS (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000138 - Disclosure - SHARE-BASED PAYMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000139 - Disclosure - TRADE PAYABLES (Details) link:presentationLink link:calculationLink link:definitionLink 00000140 - Disclosure - TRADE PAYABLES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000141 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000142 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000143 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000144 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details) link:presentationLink link:calculationLink link:definitionLink 00000145 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000146 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000147 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000148 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000149 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 4) link:presentationLink link:calculationLink link:definitionLink 00000150 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 5) link:presentationLink link:calculationLink link:definitionLink 00000151 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 6) link:presentationLink link:calculationLink link:definitionLink 00000152 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 7) link:presentationLink link:calculationLink link:definitionLink 00000153 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 8) link:presentationLink link:calculationLink link:definitionLink 00000154 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000155 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 00000156 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 00000157 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000158 - Disclosure - RELATED PARTIES - Expenses Related to Management Members (Details) link:presentationLink link:calculationLink link:definitionLink 00000159 - Disclosure - RELATED PARTIES - Transactions With Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 00000160 - Disclosure - RELATED PARTIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000161 - Disclosure - EVENTS AFTER THE REPORTING PERIOD (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 abev-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 13 abev-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 14 abev-20231231_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Business Contact [Member] Components of equity [axis] Issued capital [member] Capital reserve [member] Net Income Reserves [Member] Retained earnings [member] Carrying Value Adjustments [Member] Equity attributable to owners of parent [member] Non-controlling interests [member] Counterparties [axis] Tenedora [Member] Legal Entity [Axis] ELJ [Member] Classes of ordinary shares [axis] Tranche A [Member] Tranche B [Member] Grupo Modelo [Member] Board Of Directors [Member] Segments [axis] Canadian Dollars Spent In Canada And Cuba [Member] Dominican Pesos Spent In The Dominican Republic [Member] U S Dollars Spent In Panama And Cuba [Member] Quetzal Spent In Guatemala [Member] Argentinean Peso Spent In Argentina [Member] Bolivian Peso Spent In Bolivia [Member] Guarani Spent In Paraguai [Member] Uruguayan Peso Spent In Uruguay [Member] Chilean Peso Spent In Chile [Member] Barbadian Dollar Spent In Barbados [Member] Brazil 1 [Member] CAC [member] South Latin America Segment [Member] Canada Segment [Member] Segment consolidation items [axis] Operating segments [member] Elimination of intersegment amounts [member] Unallocated amounts [member] BRAZIL CANADA ARGENTINA Products and services [axis] Beer [Member] N A B [Member] Central America And Caribbean [Member] Range [axis] Bottom of range [member] Top of range [member] Latin America South [Member] Country Of Canada [Member] Luxembourg [Member] Temporary difference, unused tax losses and unused tax credits [axis] Temporary Differences Investments In Securities [Member] Temporary Differences Intangibles [Member] Temporary Differences Employee Benefits [Member] Temporary Differences Trade Payables [Member] Temporary Differences Trade Receivable [Member] Temporary Differences Derivatives [Member] Temporary Differences Interestbearing Loans And Borrowings [Member] Temporary Differences Inventories [Member] Temporary Differences Property Plant And Equipment [Member] Temporary Differences Withholding Tax Over Undistributed Profits And Royalties [Member] Temporary Differences Investments In Joint Ventures [Member] Unused tax losses [member] Temporary Differences Provisions [Member] Impact Of Adoption Of I F R S Accounting Policy [Member] I C M S From The Assessment Bases Of P I S C O F I N S [Member] Temporary Differences Other Items [Member] Maturity [axis] Not later than one year [member] Later than one year [member] Deferred Taxes Not Related To Tax Losses [Member] Later than one year and not later than two years [member] Later than two years and not later than three years [member] Later Than Three Years And Not Later Than Fours Years [Member] Later than four years and not later than five years [member] Later Than Five Years And Not Later Than Eight Years [Member] Later Than Nine Years [Member] Classes of assets [axis] Property, plant and equipment [member] Right-of-use assets [member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Gross carrying amount [member] Classes of property, plant and equipment [axis] Land and buildings [member] Accumulated depreciation, amortisation and impairment [member] Plant And Equipment [Member] Fixtures and fittings [member] Construction in progress [member] Buildings [member] Machinery Vehicles And Others [Member] Fixtures [Member] Fittings [Member] External Use Assets Commercial Assets [Member] Individual assets or cash-generating units [axis] Country Of Brazil [Member] Dominican Republic [Member] Panama [Member] Argentina [Member] Bolivia [Member] Chile [Member] Paraguay [Member] Uruguay [Member] Unobservable inputs [axis] Weighted average cost of capital, measurement input [member] Classes of intangible assets and goodwill [axis] Brand names [member] Intangibles [Member] Computer software [member] Others [Member] Intangible assets with indefinite useful life [axis] Intangible Assets In Argentina [Member] Intangible Assets In Bolivia [Member] Intangible Assets In Brazil [Member] Intangible Assets In Canada [Member] Intangible Assets In Chile [Member] Intangible Assets In Luxembourg [Member] Intangible Assets In Paraguay [Member] Intangible Assets In The Dominican Republic [Member] Intangible Assets In Panama [Member] Intangible Assets In Uruaguay [Member] Statistical Measurement [Axis] PIS/COFINS exclusion of ICMS [member] ICMS [member] Income Tax And Social Contributions Recoverable [Member] Other temporary differences [member] Piscofins [Member] IPI [member] Classes of other provisions [axis] Inventory Provision [Member] Past due status [axis] Current [member] Less Than One Month [Member] Later than one month and not later than two months [member] Later than two months and not later than three months [member] Later Than Three Months And Less Than Six Months [Member] Later Than Six Months And Less Than 12 Months [Member] Later Than A Year [Member] Bad Debt Provision [Member] Authorized Share Capital [Member] Geographical areas [axis] Country of domicile [member] Subsidiaries [axis] Interbrew International B.V. [member] Ambrew S A R L [Member] Fundacao Zerrenner [member] Mercado [Member] Tesouraria [Member] Treasury shares [member] Share premium [member] Other reserves [member] Reserve of share-based payments [member] Net Income Reserves Investment Reserve [Member] Net Income Reserves Legal Reserve [Member] Net Income Reserves Fiscal Incentive [Member] Net Income Reserve [Member] Carrying Value Adjustments Translation Reserves [Member] Carrying Value Adjustments Cash Flow Hedge [Member] Carrying Value Adjustments Actuarial Gainslosses [Member] Carrying Value Adjustments Put Option Granted On Subsidiary [Member] Carrying Value Adjustments Gains Losses Of Noncontrolling Interests Share [Member] Carrying Value Adjustments Business Combination [Member] Carrying Value Adjustments Accounting Adjustments For Transactions Between Shareholders [Member] Carrying Value Adjustment [Member] Classes of liabilities [axis] Secured Bank Loans [Member] Other Secured Loans [Member] Lease liabilities [member] Total Liabilities [Member] Borrowings by name [axis] Debt Denominated In U S Dollars [Member] Weighted Average [Member] Types of interest rates [axis] Fixed interest rate [member] Debt Denominated In Other Latin American Currencies [Member] Debt Denominated In C A D Dollars [Member] Reais Debt [Member] Floating interest rate [member] Reais Debt Related To I C M S [Member] Non Current Liabilities [Member] Current Liabilities [Member] Secured Bank Loan [Member] Later than three years and not later than five years [member] Later Than Three Years And Not Later Than Six Years [Member] Other Secured Loan [Member] Lease Liability [Member] Maturity Total [Member] Lease Term 20232027 [Member] Lease Term 20282035 [Member] Defined benefit plans [axis] Two Health Care Plans From Fundacao Zerrenner [Member] Employee Benefit Liabilities [Member] Employee Benefits Assets [Member] Net defined benefit liability (asset) [axis] Present value of defined benefit obligation [member] Plan assets [member] Effect of asset ceiling [member] Employee Benefit Revenue Expenses Allocated To Other Operating Incomeexpenses Net [Member] Employee Benefit Revenueexpenses Allocated To Cost Of Sales [Member] Commercial Expenses [Member] Employee Benefit Revenue Expenses Allocated To Administrative Expenses [Member] Employee Benefit Revenue Expenses Allocated To Financial Expenses [Member] Actuarial assumptions [axis] Actuarial assumption of medical cost trend rates [member] Actuarial assumption of discount rates [member] Actuarial assumption of expected rates of salary increases [member] Actuarial assumption of life expectancy after retirement [member] Plan Assets Government Bonds [Member] Plan Assets Corporate Bonds [Member] Plan Assets Equity Instruments [Member] Plan Assets Cash [Member] Plan Assets Others [Member] Types of share-based payment arrangements [axis] Restricted Shares [Member] Deferred Stock Units Of Grant One [Member] Deferred Shares [Member] Trade payable [member] Provision for taxes other than income tax [member] Provisions For Labor [Member] Legal proceedings provision [member] Miscellaneous other provisions [member] Restructuring provision [member] Total Contingent Provisions [Member] Classes of contingent liabilities [axis] Income Tax And Social Contribution [Member] Value Added And Excise Taxes [Member] PIS and COFINS [member] Other contingent liabilities [member] Uncertainty Over The Treatment Of Income Taxes [Member] Icmsst Trigger [Member] Manaus Free Trade Zone [Member] I P I Suspension [Member] Social Contributions Over Products [Member] I C M S Z F M [Member] I C M S Prodepe [Member] I C M S F A I N [Member] I C M S A M [Member] I C M S Fiscal War [Member] I C M S M I P [Member] Proposed Class Action In Quebec [Member] Categories of financial assets [axis] Financial assets at amortised cost, category [member] Classes of financial assets [axis] Financial asset, cash and cash equivalents [member] Trade receivables [member] Financial asset, investment securities [member] Financial assets at fair value through profit or loss, category [member] Derivative hedge [member] Categories of financial liabilities [axis] Financial liabilities at amortised cost, category [member] Classes of financial liabilities [axis] Interest-bearing loans and borrowings [member] Other Liabilities 1 [Member] Financial liabilities at fair value through profit or loss, category [member] Put option granted on subsidiary [member] Types of risks [axis] Total cost exposure [member] Commodities risk portion of cost exposure [member] US Dollars risk portion of cost exposure [member] Euros risk portion of cost exposure [member] Mexican Pesos risk portion of cost exposure [member] Total fixed asset exposure [member] US Dollars risk portion of fixed assets exposure [member] Total expenses exposure [member] US Dollars risk portion of the expenses exposure [member] Total Cash Exposure [Member] Cash U [Member] U S Dollars Risk Portion Of The Cash Exposure [Member] U S Dollars Risk Portion Of Th Cash Exposure [Member] U S Dollars Cash [Member] Total financial risk exposure [member] Later than three years and not later than four years [member] Later than five years [member] Ownership [Axis] Levels of fair value hierarchy [axis] Level 1 of fair value hierarchy [member] Level 2 of fair value hierarchy [member] Level 3 of fair value hierarchy [member] Interest Rate Risk Brazilian Reais [Member] Interest rate risk [member] Interest rate risk, working capital in Argentinean Peso [member] Other currencies [member] Interest rate risk, US Dollars [member] Interest rate risk, Canadian Dollars [member] Types of hedges [axis] Commodities Hedge [Member] Input Purchases Affecting The Commodity Risk Portion Of Cost Exposure [Member] Foreign Currency Exchange Hedge [Member] Foreign Exchange Risk Portion Of Cost Exposure [Member] Commodities And Foreign Exchange Hedges [Member] Foreign Currency Risk Portion Of Fixed Assets Exposure [Member] Capex Purchases Affecting The Foreign Currency Exchange Risk Portion Of The Fixed Assets Exposure [Member] Expenses That Affect The Foreign Currency Exchange Risk Portion Of Expenses Exposure [Member] Foreign Currency Exchange Risk Portion Of Expenses Exposure [Member] Cash Effects Portion Of Expenses Exposure [Member] Foreign Currency Exchange Risk Portion Of Expenses Cash [Member] Total Cash Effects Exposure [Member] Carrying amount [member] Contractual Cash Flows [Member] Later than two years [member] Categories of related parties [axis] Active employees [member] Retirees [member] Anheuser-Busch, Inc [member] Anheuser-Busch InBev N.V. [member] Anheuser-Busch Package [member] Anheuser-Busch Procurement [member] Anheuser-Busch Inbev USA LLC [member] Bavaria S.A. [member] Cerveceria Modelo de Mexico S. de R.L. de C.V. [member] Cervecerias Peruanas [member] Inbev Belgium N.V. [member] Other related parties [member] Ambev Peru [member] Anheuser-Busch Africa [member] Anheuser-Busch Inbev Services LLC [member] Panam&amp;#63; Holding [member] Non-adjusting events after reporting period [axis] Exercise P U T C N D [Member] Nonadjusting Events [member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name ICFR Auditor Attestation Flag Document Financial Statement Error Correction Flag Auditor Firm Id Auditor Name Auditor Location Profit or loss [abstract] Net sales Cost of sales Gross profit Distribution expenses Commercial expenses Administrative expenses Other operating income/(expenses) Exceptional items Income from operations Finance expenses Finance income Net finance result Share of results of joint ventures Income before income tax Income tax expense Net income Attributable to: Equity holders of Ambev Non-controlling interest Basic earnings per share – common – R$ Diluted earnings per share – common – R$ Net income Items that may be subsequently reclassified to profit or loss: Exchange differences on the translation of foreign operations (gains/(losses)) Investment hedge – put option granted on subsidiaries Gains/losses on translation of other foreign operations  Gains/losses on translation of foreign operations  Cash flow hedge – gains/(losses) Recognized in Equity (Hedge reserve) Reclassified from Equity (Hedge reserve) and included in profit or loss Total cash flow hedge Items that will not be reclassified to profit or loss: Recognition of actuarial gains/(losses) Other comprehensive (loss)/income Total comprehensive (loss)/income Attributable to:    Equity holders of Ambev    Non-controlling interest Statement of financial position [abstract] Assets Property, plant and equipment Goodwill Intangible Investments in joint ventures Investment securities Deferred tax assets Employee benefits Derivative financial instruments Recoverable taxes Other assets Non-current assets Investment securities Inventories Trade receivables Derivative financial instruments Recoverable taxes Other assets Cash and cash equivalents Current assets Total assets Equity and liabilities Equity Issued capital Reserves Carrying value adjustments Equity attributable to the equity holders of Ambev Non-controlling interests Total Equity Interest-bearing loans and borrowings Employee benefits Derivative financial instruments Deferred tax assets Income tax and social contribution payable Taxes and contributions payable Trade payables Provisions Put option granted on subsidiaries and other liabilities Non-current liabilities Bank overdrafts Interest-bearing loans and borrowings Wages and salaries Dividends and interest on shareholders’ equity payable Derivative financial instruments Income tax and social contribution payable Taxes and contributions payable Trade payables Provisions Put option granted on subsidiaries and other liabilities Current liabilities Total liabilities Total equity and liabilities Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Beginning balance, value  Net Income  Gains/(losses) on the translation of foreign operations Cash flow hedges Actuarial gains/(losses) Total comprehensive income  Capital increase (Note 22) Effect of application of IAS 29 (hyperinflation) Options granted on subsidiaries Gains/(losses) of controlling interest Tax on deemed dividends Dividends paid Interest on shareholder´s equity Purchases of shares, results from treasury shares and share-based payments Prescribed/(complementary) dividends Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) Fiscal incentive reserve  Investments reserve  Ending balance, value Statement of cash flows [abstract] Depreciation, amortization and impairment Impairment losses on receivables and inventory Additions/(reversals) in provisions and employee benefits Net finance costs Losses/(gains) on sale of property, plant and equipment and intangible assets Share-based payment expenses Income tax expense Share of result of joint ventures Hedge operations results Other non-cash items included in profit Cash flow from operating activities before changes in working capital and use of provisions (Increase)/decrease in trade and other receivables (Increase)/decrease in inventories Increase/(decrease) in trade and other payables Cash generated from operations Interest paid Interest received Dividends received Income tax paid Cash flow from operating activities Proceeds from sales of property, plant and equipment and intangible assets Proceeds from sales of subsidiaries’ operations Acquisitions of property, plant and equipment and intangible assets Acquisitions of subsidiaries, net of cash acquired Acquisitions of other investments Investments in short-term debt securities and net proceeds/(acquisitions) of debt securities Net proceeds/(acquisitions) of other assets Cash flow from investing activities Capital increase Proceeds/(buyback) treasury shares Acquisitions of non-controlling interest Proceeds from borrowings Repayment of borrowings Cash net of finance costs other than interests Lease Payments Dividends and interest on shareholders’ equity paid Cash flow from financing activities Net increase/(decrease) in cash and cash equivalents Cash and cash equivalents less bank overdrafts at the beginning of the year Effect of exchange rate fluctuations on cash and cash equivalents Cash and cash equivalents less bank overdrafts at the end of the year Corporate Information CORPORATE INFORMATION Notes and other explanatory information [abstract] BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS Summary Of Material Accounting Policies SUMMARY OF MATERIAL ACCOUNTING POLICIES USE OF ESTIMATES AND JUDGMENTS SEGMENT REPORTING Net Sales NET SALES Other Operating Incomeexpenses OTHER OPERATING INCOME/(EXPENSES) Exceptional Items EXCEPTIONAL ITEMS Payroll And Related Benefits PAYROLL AND RELATED BENEFITS Additional Information On Cost Of Sales And Operating Expenses By Nature ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE NET FINANCE RESULT EARNINGS PER SHARE Income Tax And Social Contribution INCOME TAX AND SOCIAL CONTRIBUTION PROPERTY, PLANT AND EQUIPMENT GOODWILL Impairment Of Non-financial Assets IMPAIRMENT OF NON-FINANCIAL ASSETS INTANGIBLES Recoverable Taxes RECOVERABLE TAXES INVENTORY TRADE RECEIVABLES CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES Changes In Equity CHANGES IN EQUITY INTEREST-BEARING LOANS AND BORROWING EMPLOYEE BENEFITS SHARE-BASED PAYMENTS Trade Payables TRADE PAYABLES PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS FINANCIAL INSTRUMENTS AND RISKS Collateral And Contractual Commitments With Suppliers Advances From Customers And Others COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS RELATED PARTIES EVENTS AFTER THE REPORTING PERIOD Recently issued IFRS Consolidated financial statements Financial reporting in hyperinflationary economies Present value adjustment Tax incentives and subsidized loans Schedule of exchange rates Schedule of segment reporting Schedule of additional information Schedule of net sales Schedule of other operating income Schedule of exceptional items Schedule of payroll and related benefits Schedule of payroll expenses and related benefits Schedule of depreciation, amortization and impairment expenses Schedule of net finance result Schedule of interest expenses Schedule of interest income Schedule of earnings per share Schedule of income tax and social contribution by area Schedule of income taxes Schedule of reconciliation between the weighted nominal tax rate and the effective tax rate Schedule of deferred income tax Schedule of deferred tax assets and liabilities Schedule of deferred tax realization related to tax losses Schedule of net change in deferred income tax and social contribution Schedule of property, plant and equipment Schedule of changes in the carrying amount of property, plant and equipment Schedule of carrying amount of right-of-use assets Schedule of estimated useful lives of property, plant and equipment Schedule of goodwill Schedule of carrying amount of goodwill Schedule of local currency Schedule of intangible assets Schedule of carrying value of intangible assets with indefinite useful lives Schedule of Classifications of recoverable taxes Schedule of inventory components Schedule of changes in impairment losses on inventory Schedule of current trade receivables Schedule of maturity trade receivable Schedule of estimated loss for doubtful debts Schedule of components in cash and cash equivalents Schedule of investment securities Schedule of issued capital Schedule of capital reserves Schedule of treasury shares Schedule of net income reserves Schedule of interest on shareholders' equity and dividends Schedule of basis of dividends Schedule of Carrying value adjustments Schedule of total liabilities Schedule of debts Schedule of liabilities arising from financing activities Schedule of maturity of contracts Schedule of average discount rate applied for IFRS 16 Schedule of defined benefit plans Schedule of present value of defined benefit obligations Schedule of fair value of plan assets Schedule of asset ceiling Schedule of defined benefit plans recognized in income statement Schedule of employee benefit revenue/(expenses) Schedule of assumptions used Schedule of sensitivity of defined benefit obligation Schedule of plans assets Schedule of restricted and performance shares Schedule of outstanding options developed Schedule of weighted average exercise price Schedule of deferred shares Schedule of trade payable Schedule of provision changes Schedule of expected settlement of provision Schedule of contingencies Schedule of consolidated financial instruments Schedule of financial risk management Schedule of notional and fair value amounts per instrument and maturity Schedule of fair value measurement Schedule of reconciliation of changes in the assets Schedule of detailed information about hedging instruments Schedule of types of market risk Schedule of liquidity risk and payables Schedule of net debt of long term Schedule of commitments and contingent liabilities Schedule of future contractual commitments Schedule of key management remuneration Schedule of transactions with related parties Disclosure of offsetting of financial assets [table] Put options exercisable number of shares percent of outstanding stock Payment for license Tax credits Recognized tax credits Recognized tax credits Other operating income Finance expenses Stock repurchase program shares authorized Shares outstanding Disclosure of disaggregation of revenue from contracts with customers [table] Closing rate Average rate Gross profit Sales and marketing expenses Income from operations Net finance costs Income before income tax Income tax expense Acquisition of property, plant and equipment Total assets Total liabilities Non-current assets Net revenue Gross sales Excise duty Discounts Total Deduction of revenue Government grants/net present value of long-term fiscal incentives Extemporaneous credits/(debits) (i) (Additions)/reversals of provisions Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates Other operating income/(expenses), net Total Restructuring (i) COVID-19 impacts (ii) Legal fees (iii) Effect of application of IAS 29 (hyperinflation) Distribution agreement (iv) Write-off of investments (v) Total Wages and salaries Social security contributions Other personnel costs Increase in liabilities for defined benefit plans Share-based payments Contributions to defined contribution plans Total Cost of sales Distribution expenses Commercial expenses Administrative expenses Net finance costs Other operating (income)/expenses Exceptional items Cost of sales Amortization of intangible assets cost of sales Distribution expenses Amortization of intangible assets distribution expenses Commercial expenses Amortization of intangible assets commercial expenses Administrative expenses Amortization of intangible assets administrative expenses Total expenses Total amortisation expenses Payroll and related benefits Total payroll and related benefits Remaining amount of cost of sales Finance expenses Interest expense Net Interest on pension plans Losses on hedging instruments Interest on provision for disputes and litigation Exchange differences Tax on financial transactions Bank guarantee expenses Other financial results Total of finance expenses Finance income Interest income Interest and foreign exchange rate on loans to/from related parties Financial instruments at fair value through profit or loss Other financial results Total Effect of application of IAS 29 (hyperinflation) Total of finance income Net finance result Financial instruments measured at amortized cost Financial instruments at fair value through profit or loss (i) Total Accounts payable present value Cash and cash equivalents Investment on debt securities Other receivables (i) Total Numerator Income attributable to the Ambev equity holders Denominator  Weighted average number of shares (i) (non diluted)  Basic EPS  Weighted average numbers of shares (i) (diluted)   Diluted EPS Expected nominal rates Income tax expense – current Deferred tax expense on temporary differences Deferred tax on tax loss carryforward movements in the current period Total deferred tax (expense)/income Total income tax expenses Profit before tax Adjustment on a taxable basis Others non-taxable income Government grants related to sales taxes  Share of results of joint ventures Non-deductible expenses Worldwide taxation   Aggregated weighted nominal tax rate Taxes payable – nominal rate  Adjustment on tax expense Income tax Incentives Deductible interest on shareholders’ equity Tax savings from goodwill amortization Withholding income tax Recognition/(write-off) of deferred charges on tax losses Effect of application of IAS 29 (hyperinflation) Others with reduced taxation Income tax and social contribution expense Effective tax rate Disclosure of temporary difference, unused tax losses and unused tax credits [table] Gross deferred tax assets Gross deferred tax liabilities Gross deferred tax assets/(liabilities) Netting by taxable entity, deferred tax assets Netting by taxable entity, deferred tax liabilities Netting by taxable entity, deferred tax assets/(liabilities) Net deferred tax assets Net deferred tax liabilities Net deferred tax assets/(liabilities) Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Deferred taxes not related to tax losses Deferred tax related to tax losses Deferred income tax and social contribution at beginning Recognition of actuarial gains/(losses) Investment hedge - put option granted on subsidiaries Cash flow hedge - gains/(losses) Gains/(losses) on translation of other foreign operations Recognized in other comprehensive income Recognized in the income statement Changes directly in the balance sheet Recognized in deferred tax Effect of application of IAS 29 (hyperinflation) Recognized in other balance sheet group Deferred income tax and social contribution at ending Tax loses carried forward of unilaterally offset proceedings Tax loses carried forward of unilaterally offset Tax credit related to tax losses Tax loses carried forward in relation to credit Disclosure of fair value measurement of assets [table] Property, plant and equipment Disclosure of reconciliation of changes in goodwill [table] Property, plant and equipment at beginning Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Acquisition Depreciation Disposals and write-offs Transfers Property, plant and equipment at ending Property, plant and equipment Additions Disclosure of detailed information about property, plant and equipment [table] Estimated useful lives Balance at the end of the previous year Effects of movements in foreign exchange in the balance sheet Effect of application of IAS 29 (hyperinflation) Acquisitions, (write-offs) and disposal through business combinations Balance at the end of the year Disclosure of information for impairment loss recognised or reversed for individual asset or cash-generating unit [table] Goodwill Non-controlling transactions Goodwill percentage of total assets Weighted average cost of capital Disclosure of detailed information about borrowings [table] Growth rate Intangible assets, beginning balance Effects of movements in foreign exchange in the balance sheet Effect of application of IAS 29 (hyperinflation) Additions Transfers Disposal Amortization Intangible assets, final balance Acquisition cost Depreciation Amortization Disposal Disclosure of intangible assets with indefinite useful life [table] Intangible assets with indefinite useful life SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] Intangible assets useful lives Non-current Current Total Finished goods  Work in progress Raw materials and consumables Spare parts and others Prepayments Impairment losses Total Disclosure of other provisions [table] Beginning balance Effects of movements in foreign exchange in the balance sheet Provisions Write-off Final balance Trade receivables Bad debt provision Net, trade receivables  Related parties (Note 30) Total current trade receivables  Disclosure of provision matrix [table] Bad debt provision Trade receivables, net Effects of movements in foreign exchange in the balance sheet Additions Reversals Write-off Short-term bank deposits (i) Current bank accounts Cash Bank overdrafts Cash and cash equivalents less bank overdraft Investment on debt securities (i) Non-current investment securities Financial assets at fair value through profit or loss Current investment securities Total Short-term deposits, guarantee deposits Disclosure of subsidiaries [table] Number of shares outstanding Shareholder percentage Equity shares outstanding, Beginning balance Issue of equity shares Issue of equity Equity shares outstanding, Final balance Beginning balance, capital reserves Capital Increase Purchases of shares, results of treasury shares and share-based payments Final balance, capital reserves Changes In Equity - Treasury Shares Balance, treasury shares acquired/realized (in shares) Balance, treasury shares acquired/realized, amount Balance, treasury shares (in shares) Balance, treasury shares, amount Changes during the year, treasury shares acquired/realized (in shares) Changes during the year, treasury shares acquired/realized, amount Changes during the year, treasury shares (in shares) Changes during the year, treasury shares, amount Balance, treasury shares acquired/realized (in shares) Balance, treasury shares acquired/realized, amount Balance, treasury shares (in shares) Balance, treasury shares, amount Fiscal incentive reserve Investments reserve Changes In Equity - Interest On Shareholders Equity Dividends Amount per share, dividends (in BRL per share) Amount, distribution Total amount Amount per share, distribution (in BRL per share) Amount, dividends Net income, attributable to equity holders of Ambev Prescribed/(complementary) dividends Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting Effect of application of IAS 29 (hyperinflation) Retained earnings basis for dividends and destinations Dividends and interest on capital paid based on profit Total of dividends and interest on capital  Percentage of distributed profit Total comprehensive income Options granted on subsidiaries Gains/(losses) on controlling interest Tax on deemed dividends Authorized share capital Adjustments for share-based payments Investment reserve limit percentage of net income Statutory reserve limit percentage of net income Statutory reserve limit of capital stock Statutory reserve supplementation cutoff percentage related to capital stock Minimum mandatory dividend [custom:InterestOnShareholdersEquityDistributionAmountPerShare] Interest on shareholders equity distribution Interest on shareholders equity distribution of dividends Interest on shareholders equity distribution of dividends Disclosure of fair value measurement of liabilities [table] Interest-bearing loans and borrowings, noncurrent Interest-bearing loans and borrowings, current Average rate Interest-bearing loans and borrowings, current Balance, non current Balance, current Balance, non current Balance, current Proceeds, non-current Proceeds, current Payments, non-current Payments, current Foreign exchange, non-current Foreign exchange, current Transfers between current and non-current Transfers between current and non-current, current New lease agreements, non-current New lease agreements, current Interest on leases Payment of lease liabilities, current Other movements, non-current Other movements, current Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16 Present value of funded obligations Fair value of plan assets Present value of net obligations Present value of unfunded obligations Present value of net obligations  Asset ceiling Net liabilities Other long term employee benefits Total employee benefits Disclosure of net defined benefit liability (asset) [table] Defined benefit obligation at January 1 Service costs Interest costs Gains and (losses) on settlements or reductions in benefits Contributions by plan participants Actuarial gains and (losses) - geographical assumptions Actuarial gains and (losses) - financial assumptions Experience adjustments Reclassifications Effect of exchange rate fluctuations Benefits paid Defined benefit obligation at December, 31 Interest income Administrative costs Expected return, excluding interest income Contributions by employer Exchange differences Curtailments, settlements and other Benefits paid, excluding administrative costs Interest income/(expenses) Change in asset ceiling excluding amounts included in interest income/(expenses) Effects of exchange rate fluctuations   Current service costs Administrative costs (Gains) losses on settlement and curtailment Income from operations Financial costs Total employee benefit expenses employee benefit revenue/(expenses) Discount rate Inflation Future salary increases Future pension increases Medical cost trend rate Dental claims trend rate Life expectancy for an over 65 years old male Life expectancy for an over 65 years old female Disclosure of sensitivity analysis for actuarial assumptions [table] Increase in assumption Decrease in assumption Plan assets percentage, rated Plan assets percentage, unrated Plan assets percentage Disclosure of defined benefit plans [table] Post-employment benefit expense, defined contribution plans Defined benefit obligation, at present value Plan assets gain/(loss) Amount up to the asset ceiling not exceeding the present value of future benefits in a defined benefit plan Estimate Of Contributions Expected To Be Paid To Plan Disclosure of terms and conditions of share-based payment arrangement [table] Restricted shares outstanding at January New restricted and performance shares during the period Restricted and performance shares granted during the period Restricted and performance shares forfeited during the period Restricted shares outstanding at rhe end of the year Options outstanding at January 1 Options exercised during the period Options forfeited during the period Options outstanding at the end of the year Options outstanding at January 1, weighted average exercise price (in BRL per share) Options forfeited during the period, weighted average exercise price (in BRL per share) Options exercised during the period, weighted average exercise price (in BRL per share) Options outstanding at ended period, weighted average exercise price (in BRL per share) Options exercisable at ended period, weighted average exercise price (in BRL per share) New deferred shares during the period Deferred shares granted during the period Deferred shares forfeited during the period Restricted shares granted Fair value, granted Exercise prices of the outstanding options Weighted average remaining contractual life of outstanding share options (Year) Number of share options outstanding in share-based payment arrangement at end of period Number of share options vested in share-based payment arrangement Deferred shares Expense from share-based payment transactions with employees Trade payables Related parties (Note 30) Non-current Trade payables Related parties (Note 30) Current Total present value adjustment recorded for trades payables Trade payable Provision at beginning Effect of changes in foreign exchange rates Additions Provision used, other provisions Provisions reversed Provision at ending Non-current provisions Current provisions Total provisions Disclosure of contingent liabilities in business combination [table] Estimates of amounts of possible losses Disclosure of financial assets [table] Financial asset Financial liability Disclosure of risk management strategy related to hedge accounting [table] Notional Fair Value Assets Fair Value Liability Gain (loss) Finance Result Gain (loss) Operational Result Gain (loss) Equity Notional value Fair Value Reduction of issued capital Disallowance of tax paid abroad Disallowance of tax paid abroad Disallowance of tax paid abroad Disallowance of tax paid abroad Goodwill BAH Goodwill BAH Goodwill BAH Goodwill BAH Goodwill BAH Tax Loss Offset Tax Loss Offset Total updated amount of possible risk/loass Investment securities Derivatives – operational hedge  Total Put options granted on subsidiaries Other liabilities Derivatives liabilities at fair value through profit and loss Derivatives – operational hedge  Total Financial liabilities balance Acquisition of investments Level reclassification Total gains and losses during the period Losses/(gains) recognized in net income Losses/(gains) recognized in equity Financial liabilities balance Pre-hedge, post-fixed interest rate Pre-hedge, post-fixed interest rate, amount Pre-hedge, pre-fixed interest rate Pre-hedge, pre-fixed interest rate, amount Disclosure of detailed information about hedges [table] Fair value of hedging instruments Sensitivity value level, probable scenario Sensitivity value level, adverse scenario Sensitivity value level, remote scenario Sensitivity value level, probable scenario Sensitivity value level, adverse scenario Sensitivity value level, remote scenario Trade and other payables (i) Secured bank loans Other secured loans (ii) Lease liabilities  Total payables and liabilities  Interest-bearing loans and borrowings current and non-current (-) Financial assets at fair value through profit or loss (-) Cash and cash equivalents less bank overdraft Net debt Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table] Reserve Quantities [Line Items] Instruments sharing characteristic, highly liquid investments Put options, exercisable number of shares, percent of outstanding stock Put options, fair value Value at risk exposure, probable Value at risk, adverse scenario, deterioration percentage Value at risk, remote scenario, deterioration percentage Collateral And Contractual Commitments With Suppliers Advances From Customers And Others - Components Of Collateral And Commitments Collateral given for the Companys own liabilities Other commitments Total commitments Commitments to suppliers property, plant and equipment and Intangible Commitments to suppliers - Inventories Total commitments to suppliers Future contractual commitments Cash guarantees Guarantees held for derivative instruments Short-term benefits (i) Share-based payments (ii) Total key management remuneration  Disclosure of transactions between related parties [table] Sales and others, related parties Sales/service fees/reimbursement of expenses and others, related parties Buying and others, related parties Buying/service fees/reimbursement of expenses and others, related parties Net finance cost, related parties Trade receivables, related parties Other trade receivables, related parties Dividends receivables Noncurrent trade payables, related parties Current trade payables, related parties Current trade payables, related parties Percentage of ownership held by a related party Expenses incurred by a related party Transfers under licence agreements from entity, related party transactions Transfers under licence agreements to entity, related party transactions Disclosure of non-adjusting events after reporting period [table] Cash Disbursement Offset Of ELJ's Debt Held By The Group In The Amount Reduction of assessed amount Amount for possible contingency Tax incentive amounts Tax incentive difference amounts The percentage of ownership of the company that is held by a related party. Represents The Funda&amp;#63;&amp;#63;o Antonio e Helena Zerrenner Institui&amp;#63;&amp;#63;o Nacional de Benefici&amp;#63;ncia which is one of Ambev S.A.&amp;#8217;s shareholders. The amount of expenses incurred by a related party during the period. Employees who are still active with the company. Employees who are retired. The entity Anheuser-Busch, Inc. Refers to information regarding the entity Anheuser-Busch InBev N.V. Refers to information regarding the entity Anheuser-Busch Package. Refers to information regarding the entity Anheuser-Busch Procurement. The entity Anheuser-Busch Inbev USA LLC. The entity Bavaria S.A. The entity Cervecer&amp;#63;a Modelo de Mexico S. de R.L. de C.V. Information related to Cervecer&amp;#63;a Peruanas. The entity Inbev Belgium N.V. The entity Interbrew International B.V. The amount of sales, service fees, reimbursements of expenses and others resulting from related party transactions. The amount of service fees, reimbursement of expenses and others resulting from related party transactions. The amount of net finance cost resulting from related party transactions. This member stands for Ambev Peru. The amount of trade receivables resulting from related party transactions. Refers to information regarding the entity Anheuser-Busch Africa. The entity Anheuser-Busch Inbev Services LLC. Refers to information regarding the Panam&amp;#63; Holding. The amount of other trade receivables resulting from related party transactions. The amount of dividends receivables resulting from related party transactions. The amount of trade payables resulting from related party transactions. Other commitments held for a purpose restricting the use of cash. The amount recorded for collateral and other commitments outstanding. The amount of liabilities that the entity may have to pay due to exposure. The amount recorded for cash guarantees. The amount of guarantees held for derivative instrument requirements. Refers to information regarding the duration later than two years. The cash and cash equivalents portion of financial assets. The investment securities portion of financial assets. This member stands for derivative hedge. Represents the amount of trade payable. Refers to information regarding interest-bearing loans and borrowings. Information related to put option granted on subsidiary. Refers to information regarding total cost exposure. The commodities risk portion of cost exposure. The US Dollars risk portion of cost exposure. The Euros risk portion of cost exposure. The Mexican Pesos risk portion of cost exposure. Total total fixed asset exposure. Refers to information regarding the US Dollars risk portion of fixed assets exposure. Refers to information regarding the total expenses exposure. Refers to the US Dollars risk portion of the expenses exposure. Refers to information regarding the total financial risk exposure. The maximum exposure to the credit risk of financial liabilities designated as measured at fair value through profit or loss. The gains or losses recorded in financial results. The gains or losses recorded in operational results. The gains or losses recorded in equity. The amount of derivative financial assets held for hedging in operation hedges. The amount of derivative financial liabilities held for hedging in operational hedges. The amount of highly liquid investments of instruments sharing characteristics. The percent of outstanding stock that number of exercisable shares from put options will give the holder upon exercise. Related to Tenedora. Related to ELJ. RElated to tranche A. Related to Tranche B. The fair value of put options held. The gains (losses) recognised on the fair value measurement of liabilities. The gains (losses) recognised in equity on the fair value measurement of liabilities. The value of postfixed interest before it is hedged. The value of pre-set interest before it is hedged. Refers to information regarding the Canadian Dollar portion of interest rate risk. Refers to information regarding the US Dollars portion of interest rate risk. Related to other currencies. The Argentinean Peso portion of interest rate risk. The percentage range for potential exposure under a probable scenario using Value at Risk. The value at risk under an adverse scenario relating to the deterioration percentage. The value at risk under a remote scenario relating to the deterioration percentage. Cost of sales [Default Label] Distribution costs Sales and marketing expense General and administrative expense Finance costs IncomeTaxExpensesContinuingOperations Gains (losses) on exchange differences on translation of foreign operations, net of tax Amounts removed from equity and included in carrying amount of non-financial asset (liability) whose acquisition or incurrence was hedged highly probable forecast transaction, net of tax Other comprehensive income Current investments Current derivative financial assets Current receivables from taxes other than income tax Other current assets Current assets ReserveOfCarryingValueAdjustments Equity attributable to owners of parent Non-current provisions for employee benefits Non-current derivative financial liabilities Net deferred tax liabilities [Default Label] Non-current liabilities Current derivative financial liabilities IncomeTaxAndSocialContributionPayableCurrent TaxesAndContributionsPayableCurrent Trade and other current payables Current financial liabilities Current liabilities Liabilities Dividends recognised as distributions to owners Adjustments for finance income (cost) Adjustments for gain (loss) on disposals, property, plant and equipment HedgeOperationsResults Cash flows from (used in) operations before changes in working capital Cash flows from (used in) operations Interest paid, classified as operating activities Income taxes paid (refund), classified as operating activities Cash flows from (used in) operating activities Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities Cash flows from (used in) investing activities Payments to acquire or redeem entity's shares Repayments of borrowings, classified as financing activities PaymentsOnNetOfFinanceCostsOtherThanInterests PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities DividendsAndInterestPaidOnShareholdersEquity Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes CashAndCashEquivalentsAfterBankOverdrafts TaxEffectFromChangeInTaxRates Tax expense other than income tax expense SalesDiscounts Revenue Adjustments for provisions Expense of restructuring activities Covid19ImpactExpense LegalFee Gains (losses) on net monetary position DistributionAgreement WriteoffOfInvestmentsiv Wages and salaries [Default Label] EmployeeBenefitsExpenseNetFinanceCosts EmployeeBenefitsExpenseOtherOperatingIncomeExpense EmployeeBenefitsExpenseExceptionalItems DepreciationExpenseCostOfSales DepreciationOfDistributionExpenses DepreciationOfCommercialExpenses DepreciationOfAdministrativeExpenses Interest expense NetInterestOnPensionPlans InterestOnProvisionForContingencies Net foreign exchange loss Tax expense (income) at applicable tax rate Bank and similar charges Other finance cost FinanceCostsExcludingNonrecurringFinanceCosts FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems FinancialIncomeEffectOfAdoptionOfNewAccountingPolicies NetFinanceResult Interest expense on financial liabilities designated at fair value through profit or loss InterestExpenseOnInstrumentsAtFairValueThroughProfitOrLoss Interest income on cash and cash equivalents Deferred tax expense (income) IncomeTaxesExpenseContinuingOperations TaxEffectFromSharingResultsOfJointVentures Tax effect of foreign tax rates NetAccountingProfit TaxEffectOfAdoptionOfNewAccountingPolicy Income tax relating to changes in revaluation surplus of property, plant and equipment, right-of-use assets and intangible assets included in other comprehensive income ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet Other property, plant and equipment Depreciation, property, plant and equipment PropertyPlantAndEquipment1 Increase (decrease) through net exchange differences, goodwill GoodwillAdjustmentAdoptionOfNewAccountingAdjustment GoodwillGrossAmount Increase (decrease) through net exchange differences, intangible assets other than goodwill IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement Increase (decrease) through transfers, intangible assets other than goodwill InventoriesImpairmentLosses Other provisions IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2 New provisions, other provisions Current trade receivables BadDebtProvision IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1 AdditionalProvisionsOtherProvision ProvisionUsedOtherProvisions1 BankOverdraftsClassifiedAsCashEquivalent InvestmentSecurities EquitySharesOutstanding TreasurySharesAcquiredrealizedOutstanding TreasurySharesAcquiredrealizedOutstandingAmount TreasurySharesHeld Treasury shares PrescribedDividends IncreaseDecreaseThroughAdoptionOfNewAccountingPronouncement IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity InterestOnShareholderEquityDistributionAmountPerShare Borrowings, interest rate Current portion of non-current borrowings Repayments of non-current borrowings Repayments of current borrowings Payments of lease liabilities, classified as financing activities DefinedBenefitObligationFundedPortionAtPresentValue DefinedBenefitObligationUnfundedPortionAtPresentValue AssetCeiling Net defined benefit liability OtherLongTermEmployeeBenefitLiabilities Increase (decrease) in net defined benefit liability (asset) DefinedBenefitPlansRecognizedFinancialCosts NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1 Number of other equity instruments granted in share-based payment arrangement Number of other equity instruments forfeited in share-based payment arrangement NumberOfOutstandingShareOptions1 Weighted average exercise price of share options outstanding in share-based payment arrangement Non-current trade payables Current payables to related parties Current trade payables Non-current payables to related parties Additional provisions, other provisions Provision used, other provisions GoodwillForInbevHolding ForeignEarnings DisallowanceOnIncomeTaxDeduction GoodwillForCndHolding PresumedProfit DisallowanceOfFinancialExpenses GoodwillForMag IsoletFines FinancialAssetsInvestmentSecurities Derivatives liabilities - operational hedge Financial liabilities, at fair value Purchases, fair value measurement, liabilities FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenario FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenario FinancialAssetAtFairValueThroughProfitOrLoss Key management personnel compensation TradePayablesRelatedPartyTransactions1 EX-101.PRE 15 abev-20231231_pre.xml XBRL PRESENTATION FILE XML 16 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
12 Months Ended
Dec. 31, 2023
shares
Entity Addresses [Line Items]  
Document Type 20-F
Amendment Flag false
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Dec. 31, 2023
Document Fiscal Period Focus FY
Document Fiscal Year Focus 2023
Current Fiscal Year End Date --12-31
Entity File Number 001-36165
Entity Registrant Name AMBEV S.A.
Entity Central Index Key 0001565025
Entity Address, Address Line One Rua Dr. Renato Paes de Barros, 1017, 3rd floor
Entity Address, City or Town São Paulo
Entity Address, Country BR
Entity Address, Postal Zip Code 04530-001
Title of 12(b) Security American Depositary Shares,
Trading Symbol ABEV
Security Exchange Name NYSE
Entity Well-known Seasoned Issuer Yes
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Emerging Growth Company false
Document Accounting Standard International Financial Reporting Standards
Entity Shell Company false
Entity Common Stock, Shares Outstanding 15,753,833,284
ICFR Auditor Attestation Flag true
Document Financial Statement Error Correction Flag false
Auditor Firm Id 1351
Auditor Name PricewaterhouseCoopers Auditores Independentes Ltda.
Auditor Location São Paulo
Business Contact [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One Rua Dr. Renato Paes de Barros, 1017, 3rd floor
Entity Address, City or Town São Paulo
Entity Address, Country BR
Entity Address, Postal Zip Code 04530-001
City Area Code 55
Local Phone Number 2122-1200
Contact Personnel Name Lucas Machado Lira
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED INCOME STATEMENTS - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Profit or loss [abstract]      
Net sales R$ 79,736.9 R$ 79,708.8 R$ 72,854.3
Cost of sales (39,291.6) (40,422.1) (35,659.7)
Gross profit 40,445.3 39,286.7 37,194.6
Distribution expenses (10,750.6) (11,395.3) (9,932.7)
Commercial expenses (7,412.5) (7,337.4) (7,035.5)
Administrative expenses (5,273.7) (5,236.8) (4,877.4)
Other operating income/(expenses) 2,028.9 2,513.9 2,124.1
Exceptional items (206.4) (143.3) (392.8)
Income from operations 18,831.0 17,687.8 17,080.3
Finance expenses (6,280.1) (7,892.2) (5,427.8)
Finance income 2,670.3 4,469.1 2,222.4
Net finance result (3,609.8) (3,423.1) (3,205.4)
Share of results of joint ventures (185.3) (29.1) (115.7)
Income before income tax 15,035.9 14,235.6 13,759.2
Income tax expense (75.5) 655.6 (636.6)
Net income 14,960.4 14,891.2 13,122.6
Attributable to:      
Equity holders of Ambev 14,501.9 14,457.9 12,671.0
Non-controlling interest R$ 458.5 R$ 433.3 R$ 451.6
Basic earnings per share – common – R$ R$ 0.9211 R$ 0.9184 R$ 0.8052
Diluted earnings per share – common – R$ R$ 0.9156 R$ 0.9123 R$ 0.7991
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Profit or loss [abstract]      
Net income R$ 14,960.4 R$ 14,891.2 R$ 13,122.6
Exchange differences on the translation of foreign operations (gains/(losses))      
Investment hedge – put option granted on subsidiaries 302.6 203.8 193.6
Gains/losses on translation of other foreign operations  (9,637.0) (7,067.0) 2,364.4
Gains/losses on translation of foreign operations  (9,334.4) (6,863.2) 2,558.0
Cash flow hedge – gains/(losses)      
Recognized in Equity (Hedge reserve) (364.7) 38.0 2,311.2
Reclassified from Equity (Hedge reserve) and included in profit or loss 152.6 (356.7) (1,829.9)
Total cash flow hedge (212.1) (318.7) 481.3
Items that will not be reclassified to profit or loss:      
Recognition of actuarial gains/(losses) (12.5) 470.7 340.0
Other comprehensive (loss)/income (9,559.0) (6,711.2) 3,379.3
Total comprehensive (loss)/income 5,401.4 8,180.0 16,501.9
Attributable to:      
   Equity holders of Ambev 5,065.5 7,835.5 15,943.3
   Non-controlling interest R$ 335.9 R$ 344.5 R$ 558.6
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED BALANCE SHEETS - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Assets    
Property, plant and equipment R$ 26,630.2 R$ 30,055.7
Goodwill 38,003.6 40,594.0
Intangible 10,041.7 9,222.2
Investments in joint ventures 289.1 331.9
Investment securities 242.2 219.1
Deferred tax assets 7,969.6 6,438.8
Employee benefits 57.3 56.6
Derivative financial instruments 1.7 1.5
Recoverable taxes 11,325.1 11,316.3
Other assets 1,520.7 1,905.2
Non-current assets 96,081.2 100,141.3
Investment securities 277.2 454.5
Inventories 9,619.0 12,923.0
Trade receivables 5,741.5 5,349.1
Derivative financial instruments 378.0 272.3
Recoverable taxes 3,435.7 2,853.5
Other assets 1,052.7 1,037.9
Cash and cash equivalents 16,059.0 14,926.4
Current assets 36,563.1 37,816.7
Total assets 132,644.3 137,958.0
Equity    
Issued capital 58,177.9 58,130.5
Reserves 98,669.4 92,246.6
Carrying value adjustments (77,878.0) (68,421.5)
Equity attributable to the equity holders of Ambev 78,969.3 81,955.6
Non-controlling interests 1,174.5 1,372.2
Total Equity 80,143.8 83,327.8
Interest-bearing loans and borrowings 2,203.0 2,788.1
Employee benefits 2,011.8 2,161.1
Derivative financial instruments 11.7
Deferred tax assets 3,318.4 3,725.7
Income tax and social contribution payable 1,487.1 1,598.7
Taxes and contributions payable 513.3 671.0
Trade payables 307.3 509.4
Provisions 559.6 739.0
Put option granted on subsidiaries and other liabilities 1,083.2 1,896.8
Non-current liabilities 11,495.4 14,089.8
Bank overdrafts 74.3
Interest-bearing loans and borrowings 1,298.1 982.6
Wages and salaries 2,128.7 2,335.8
Dividends and interest on shareholders’ equity payable 1,526.2 1,464.8
Derivative financial instruments 751.4 729.4
Income tax and social contribution payable 1,340.5 1,118.6
Taxes and contributions payable 6,236.6 5,812.9
Trade payables 23,195.1 24,328.5
Provisions 418.4 180.7
Put option granted on subsidiaries and other liabilities 4,110.1 3,512.8
Current liabilities 41,005.1 40,540.4
Total liabilities 52,500.5 54,630.2
Total equity and liabilities R$ 132,644.3 R$ 137,958.0
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - BRL (R$)
R$ in Millions
Issued capital [member]
Capital reserve [member]
Net Income Reserves [Member]
Retained earnings [member]
Carrying Value Adjustments [Member]
Equity attributable to owners of parent [member]
Non-controlling interests [member]
Total
Beginning balance, value at Dec. 31, 2020 R$ 57,899.1 R$ 54,985.6 R$ 25,920.0 R$ (64,989.0) R$ 73,815.7 R$ 1,335.5 R$ 75,151.2
IfrsStatementLineItems [Line Items]                
 Net Income  12,671.0 12,671.0 451.6 13,122.6
Gains/(losses) on the translation of foreign operations 2,449.7 2,449.7 108.3 2,558.0
Cash flow hedges 480.8 480.8 0.5 481.3
Actuarial gains/(losses) 341.8 341.8 (1.8) 340.0
Total comprehensive income  12,671.0 3,272.3 15,943.3 558.6 16,501.9
Capital increase (Note 22) 143.4 (134.4) 9.0 9.0
Effect of application of IAS 29 (hyperinflation) 2,063.7 2,063.7 21.4 2,085.1
Options granted on subsidiaries (1.9) (1.9) (1.9)
Gains/(losses) of controlling interest (46.2) (46.2) 8.6 (37.6)
Tax on deemed dividends (1.7) (1.7) (1.7)
Dividends paid (2,099.5) (2,099.5) (549.5) (2,649.0)
Interest on shareholder´s equity (7,400.1) (7,400.1) (7,400.1)
Purchases of shares, results from treasury shares and share-based payments 336.0 336.0 336.0
Prescribed/(complementary) dividends 24.7 24.7 24.7
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) 11.8 (11.8)
Fiscal incentive reserve  1,423.5 (1,423.5)
Investments reserve  3,848.1 (3,848.1)
Ending balance, value at Dec. 31, 2021 58,042.5 55,187.2 31,191.6 (61,778.3) 82,643.0 1,374.6 84,017.6
IfrsStatementLineItems [Line Items]                
 Net Income  14,457.9 14,457.9 433.3 14,891.2
Gains/(losses) on the translation of foreign operations (6,772.2) (6,772.2) (91.0) (6,863.2)
Cash flow hedges (316.7) (316.7) (2.0) (318.7)
Actuarial gains/(losses) 466.5 466.5 4.2 470.7
Total comprehensive income  14,457.9 (6,622.4) 7,835.5 344.5 8,180.0
Capital increase (Note 22) 88.0 (64.3) 23.7 23.7
Effect of application of IAS 29 (hyperinflation) 3,224.5 3,224.5 9.2 3,233.7
Gains/(losses) of controlling interest (2.8) (2.8) (0.3) (3.1)
Tax on deemed dividends (6.2) (6.2) (6.2)
Dividends paid (357.4) (357.4)
Interest on shareholder´s equity (11,999.8) (11,999.8) (11,999.8)
Purchases of shares, results from treasury shares and share-based payments 216.8 216.8 1.6 218.4
Prescribed/(complementary) dividends 20.9 20.9 20.9
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) 11.8 (11.8)
Fiscal incentive reserve  2,018.6 (2,018.6)
Investments reserve  3,696.7 (3,696.7)
Ending balance, value at Dec. 31, 2022 58,130.5 55,339.7 36,906.9 (68,421.5) 81,955.6 1,372.2 83,327.8
IfrsStatementLineItems [Line Items]                
 Net Income  14,501.9 14,501.9 458.5 14,960.4
Gains/(losses) on the translation of foreign operations (9,212.4) (9,212.4) (122.0) (9,334.4)
Cash flow hedges (210.8) (210.8) (1.3) (212.1)
Actuarial gains/(losses) (13.2) (13.2) 0.7 (12.5)
Total comprehensive income  14,501.9 (9,436.4) 5,065.5 335.9 5,401.4
Capital increase (Note 22) 47.4 (32.9) 14.5 14.5
Effect of application of IAS 29 (hyperinflation) 3,269.4 3,269.4 8.5 3,277.9
Options granted on subsidiaries 6.7 6.7 6.7
Gains/(losses) of controlling interest (2.6) (2.6) (2.6)
Tax on deemed dividends (12.4) (12.4) (12.4)
Dividends paid (543.9) (543.9)
Interest on shareholder´s equity (11,500.2) (11,500.2) (11,500.2)
Purchases of shares, results from treasury shares and share-based payments 172.8 172.8 1.8 174.6
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22) 11.8 (11.8)
Fiscal incentive reserve  2,552.7 (2,552.7)
Investments reserve  3,730.2 (3,730.2)
Ending balance, value at Dec. 31, 2023 R$ 58,177.9 R$ 55,479.6 R$ 43,189.8 R$ (77,878.0) R$ 78,969.3 R$ 1,174.5 R$ 80,143.8
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Statement of cash flows [abstract]      
Net income R$ 14,960.4 R$ 14,891.2 R$ 13,122.6
Depreciation, amortization and impairment 6,417.9 5,956.3 5,396.7
Impairment losses on receivables and inventory 358.4 351.8 200.8
Additions/(reversals) in provisions and employee benefits 233.8 232.7 244.6
Net finance costs 3,609.8 3,423.1 3,205.4
Losses/(gains) on sale of property, plant and equipment and intangible assets (86.4) (88.8) (142.8)
Share-based payment expenses 331.6 313.9 387.6
Income tax expense 75.5 (655.6) 636.6
Share of result of joint ventures 185.3 29.1 115.7
Hedge operations results (37.9) (466.6) (1,852.2)
Other non-cash items included in profit (9.0) (17.4)
Cash flow from operating activities before changes in working capital and use of provisions 26,039.4 23,969.7 21,315.0
(Increase)/decrease in trade and other receivables (1,373.9) (322.5) 341.4
(Increase)/decrease in inventories 1,300.9 (3,088.0) (3,499.5)
Increase/(decrease) in trade and other payables (223.1) 726.6 6,157.5
Cash generated from operations 25,743.3 21,285.8 24,314.4
Interest paid (666.1) (826.3) (498.2)
Interest received 1,248.3 1,095.0 377.1
Dividends received 12.9 6.6 13.1
Income tax paid (1,627.0) (919.0) (1,305.1)
Cash flow from operating activities 24,711.4 20,642.1 22,901.3
Proceeds from sales of property, plant and equipment and intangible assets 154.1 133.9 301.7
Proceeds from sales of subsidiaries’ operations 0.5
Acquisitions of property, plant and equipment and intangible assets (6,004.1) (6,533.1) (7,677.1)
Acquisitions of subsidiaries, net of cash acquired (46.5) (3.0) (133.8)
Acquisitions of other investments (6.3) (30.0) (5.3)
Investments in short-term debt securities and net proceeds/(acquisitions) of debt securities 136.4 1,413.0 (236.0)
Net proceeds/(acquisitions) of other assets 0.4 15.0 15.0
Cash flow from investing activities (5,766.0) (5,004.2) (7,735.0)
Capital increase 14.5 23.8 9.1
Proceeds/(buyback) treasury shares (119.0) (54.1) (44.2)
Acquisitions of non-controlling interest (0.1)
Proceeds from borrowings 49.8 274.9 315.2
Repayment of borrowings (227.4) (230.2) (2,454.0)
Cash net of finance costs other than interests (2,731.1) (3,255.1) (2,089.6)
Lease Payments (1,180.1) (854.7) (663.2)
Dividends and interest on shareholders’ equity paid (11,921.9) (12,242.3) (11,115.3)
Cash flow from financing activities (16,115.2) (16,337.8) (16,042.0)
Net increase/(decrease) in cash and cash equivalents 2,830.2 (699.9) (875.7)
Cash and cash equivalents less bank overdrafts at the beginning of the year 14,852.1 16,597.2 17,090.3
Effect of exchange rate fluctuations on cash and cash equivalents (1,623.3) (1,045.2) 382.6
Cash and cash equivalents less bank overdrafts at the end of the year R$ 16,059.0 R$ 14,852.1 R$ 16,597.2
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CORPORATE INFORMATION
12 Months Ended
Dec. 31, 2023
Corporate Information  
CORPORATE INFORMATION

 

1.CORPORATE INFORMATION

 

1.1 Description of business

 

Ambev S.A. (referred to as the “Company” or “Ambev”) together with its subsidiaries (the “Group” or “Consolidated”), headquartered in São Paulo - SP, Brazil, has as its purpose, either directly or through participation in other companies, the production and sale of beer, draft beer, soft drinks, other non-alcoholic beverages, malt and food in general, as well as the advertising of its own and of third party products, the sale of promotional and advertising materials and the direct or indirect exploitation of bars, restaurants, snack bars and similar establishments, among others.

 

The Group portfolio includes several own brands, like Brahma®, Skol®, Antarctica®, Colorado®, Bohemia®, Serramalte®, Quilmes®, Patagonia®, Guaraná Antarctica®, Beats® among others, and licensed brands, like Budweiser®, Corona®, Stella Artois®, Spaten® Beck’s® and Mike’s®.

 

The Company’s shares and American Depositary Receipts (“ADRs”) are listed on the Brasil, Bolsa, Balcão S.A. (“B3”), under the ticker “ABEV3” and on the New York Stock Exchange (“NYSE”) under the ticker “ABEV”, respectively.

 

The Company’s direct controlling shareholders are Interbrew International B.V. (“ITW International”), AmBrew S.à.r.l (“Ambrew”), both of which are subsidiaries of Anheuser-Busch InBev N.V. (“AB InBev”) and Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência (“Fundação Zerrenner”).

 

1.2 Major corporate events in 2023, 2022 and 2021

 

1.2.1 Notification of ELJ to exercise the put option under the Tenedora Shareholders' Agreement

 

The Company and E. León Jimenes, S.A. (“ELJ”), as the shareholders of Tenedora CND, S.A. (“Tenedora”), a holding company headquartered in the Dominican Republic, the owner of almost the entire share capital of Cervecería Nacional Dominicana, S.A., on July 2, 2020, signed the second amendment to Tenedora’s Shareholders Agreement (the “Shareholders Agreement”), extending their partnership in the country and postponing the terms of the put and call options defined in the original Agreement. At December 31, 2023, ELJ was the owner of 15% of Tenedora’s shares, and its put option was divided into two tranches: (i) Tranche A, corresponding to 12.11% of the shares, as formalized in the Shareholders' Agreement and ratified by the notification received from ELJ on October 2023, Tranche A was exercised at January 31, 2024; and (ii) Tranche B, corresponding to 2.89% of the shares, exercisable starting in 2026. The Company, on the other hand, has a call option over Tranche B shares to be exercised starting in 2029. The details about the the exercise of the put option by ELJ are described in Note 31 - Events after the reporting period. The assumptions used for these options are described in Note 28 (Item 28.3.1).

 

1.2.2 New distribution agreement of Corona in Canada

 

As at December 2023, the Company renegotiated the licensing contract with Trademarks Grupo Modelo, S. de R.L. de C.V., subsidiary of the AB Inbev, to produce, promote, sell and distribute Corona products in Canada. As consideration for acquired rights, for a period of 100 years, automatically renewable for another 100, the Labatt Brewing Company Limited, subsidiary of the Company in Canada, shall pay the licensor a single payment of R$869 million. The amount relating to acquired right was recognized in 2023 as a commercial asset in intangible assets.

 

1.2.3 Tax Credits – 2022 and 2023

 

After the decision of the Supreme Federal Court ("STF") in the judgment of RE 574,706/PR, delivered in 2017 and ratified in May 2021, which declared unconstitutional the inclusion of ICMS in the calculation basis of PIS and COFINS, in September 2021 the National Treasury Attorney's Office ("PGFN") published Opinion PGFN 14,483/2021 in which it brought the agency's understanding about the procedures to be observed by the Tax Administration regarding the subject, especially regarding the impacts of said exclusion on the PIS and COFINS credits recorded by the acquirers in inbound operations. As a result of these events, the Company concluded in 2022 analyses that allowed the accounting recognition of R$1.2 billion, in the same period, as tax credits resulting from the exclusion of ICMS from the calculation basis of PIS and COFINS in operations with subsidiaries.

 

Furthermore, on December 13, 2023, the Superior Court of Justice ("STJ") concluded the judgment of Theme 1,125, confirming the understanding that ICMS collected under the substitution tax system should also be excluded from the calculation bases of PIS and COFINS of the taxpayer's substitutes. The judgment of this decision is still pending publication. Regarding this subject, from 2017 to 2023, the Company and its subsidiaries recognized tax credits in the amount of R$1.4 billion, having been approximately R$407.1 million recognized as extemporaneous credits in 2023 (R$218 million were recorded in other operating income and R$189.1 million in the finance result).

 

1.2.4 Share buyback program

 

The Board of Directors, in a meeting held on May 18, 2023, approved, pursuant to article 30, 1st Paragraph, “b”, of Law 6,404/76 and CVM Instruction 77/22, a share buyback program by the Company (“Program”) up to the limit of 13,000,000 common shares, with the primary purpose of covering any share delivery requirements contemplated in the Company's share-based compensation plans or to be held in treasury, canceled and/or subsequently transferred. The program must be concluded no later than November 18, 2024, as detailed together with other information about it in the Notice on Trading of Own Shares, prepared under the terms of Annex G to CVM Resolution 80/22 and disclosed to market on May 18, 2023. At the same date, the Company had 4,393,610,429 outstanding shares as defined in CVM Instruction 77/22. The acquisitions occurred as per a deduction of the capital reserve account recorded in the balance sheets dated as at March 31, 2023. The transaction was carried out through the following financial institution: UBS Brasil Corretora de Câmbio, Títulos e Valores Mobiliários S.A.

 

1.2.5 COVID-19 pandemic impacts

 

The impact of the pandemic on our operations and the restrictions imposed in response by national governments, especially since March 2020, have generated significant changes in market dynamics both in the off-trade sales channel, mainly comprised of supermarkets, and in the on-trade channel, which consists of bars and restaurants. In each case, the more severe the restrictions on the marketing and consumption of our products, the greater the reduction in volume, which is why Bolivia and Panama were the most affected countries, especially in fiscal year 2021. On the other hand, we observed an increase in sales related to e-commerce in all countries, although this channel represents a small portion of the Company’s total volume.

In early 2022, our operations, mainly in Brazil, were impacted by the wave of the Omicron variant of COVID-19, which, combined with factors such as unfavorable weather, negatively impacted our sales. From the second quarter on, with the progress of the vaccination programs and the greater control over the advance of the COVID-19 pandemic, there was a relaxation of the restrictions in the regions in which we operate, favoring the recovery of the on-trade channel.

In Brazil, the consistent implementation of the Company's strategy combined with the context of relaxed restrictions and the return of occasions for out-of-home consumption generated a positive volume trend, with growth in both volume and net revenue compared to the same 2021 period.

 

As required by IAS 1 - Presentation of Financial Statements, the Company updated the analysis of the impact of COVID-19, as at December 31,2022 – last year of the pandemic – which mainly involved, (i) a review of the assumptions of the annual impairment test, as described in Note 15 - Goodwill, (ii) an analysis of possible credit losses and inventory obsolescence, (iii) an analysis of the recoverability of deferred taxes, and (iv) the evaluation of the relevant estimates used for the preparation of the financial statements, among other analyses.

 

Any impacts arising from these analyses are reflected in the financial statements and disclosed in explanatory notes. In addition, due to the protective actions taken for its staff and the donations made by its community, the Company incurred exceptional expenses of R$16.7 at December 31, 2022 as reported in Note 8 - Exceptional items.

XML 23 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS

 

2.BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS

 

The consolidated financial statements have been prepared using the going concern basis of accounting and are being presented in accordance with the International Financial Reporting Standards (“IFRS®”) issued by the International Accounting Standards Board (“IASB®”), effective as at December 31, 2023 and disclose all (and only) the applicable significant information related to the financial statements, which is consistent with the information utilized by Management in the performance of its duties.

 

The measurement basis used in preparing the financial statements is the historical cost, net realizable value, fair value or recoverable amount.

 

In preparing the financial statements, management uses judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets, liabilities, income and expenses. The relevant estimates and judgments are disclosed in Note 4 - Use of estimates and judgments.

 

The financial statements were approved, in their final form, by the Board of Directors on March 11, 2024.

 

2.1 Functional and presentation currency

 

The functional and presentation currency of the Company financial statements is the Brazilian Real, which is the currency of its main economic operating environment. For presentation purposes, the financial statements are presented in millions of Brazilian Reais (“R$”), unless otherwise indicated, rounded to the nearest million.

 

Foreign currency transactions are accounted for at the exchange rates prevailing as at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies are translated using the balance sheet date rate. Non-monetary assets and liabilities denominated in foreign currencies are translated at the foreign exchange rate prevailing as at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies stated at fair value are translated at the exchange rate in force as at the date on which the fair value was determined. Gains and losses arising from the settlement of transactions in foreign currencies and resulting from the conversion of assets and liabilities denominated in foreign currencies are recognized in the income statement.

 

Assets and liabilities of subsidiaries located abroad are translated at the foreign exchange rates prevailing at the balance sheet date, while amounts from the income statement and cash flow are translated at the average exchange rate for the year, and changes in equity are translated at the historical exchange rate of each transaction. Translation adjustments arising from the difference between the average exchange rates and the historical rates are recorded directly in Carrying value adjustments.

 

In the consolidation process, exchange differences arising from the translation of equity in foreign operations and borrowing and other currency instruments designated as net investment hedges are recognized in Carrying value adjustments, an equity reserve, and included in Other comprehensive income.

 

Even when recorded in the acquiring entity, the goodwill and fair value adjustments arising from the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and are translated at the foreign exchange rate at the balance sheet date.

 

2.1.1 Exchange rates

 

The most significant exchange rates used for the preparation of the Company’s financial statements are as follow:

 

                 
      Closing rate   Average rate
Currency Name Country 2023 2022 2021   2023 2022 2021
                   
CAD Canadian Dollar Canada 3.6536  3.8540  4.3914    3.7048  3.9807  4.2960 
DOP Dominican Peso Dominican Republic 0.0831  0.0925  0.0970    0.0892  0.0937  0.0938 
USD US Dollar Panamá and Cuba 4.8413  5.2177  5.5805    5.0085  5.1644  5.3687 
GTQ Quetzal Guatemala 0.6189  0.6623  0.7201    0.6398  0.6649  0.6954 
ARS Argentinean Peso  Argentina 0.0060  0.0295  0.0543    0.0170  0.0403  0.0568 
BOB Bolivian Peso Bolivia 0.6956  0.7497  0.8018    0.7196  0.7420  0.7714 
PYG Guarani Paraguay 0.0007  0.0007  0.0008    0.0007  0.0007  0.0008 
UYU Uruguayan Peso Uruguay 0.1241  0.1302  0.1249    0.1291  0.1253  0.1236 
CLP Chilean Peso Chile 0.0055  0.0061  0.0066    0.0059  0.0059  0.0071 
BBD Barbadian Dollar Barbados 2.3866  2.5721  2.7510    2.4690  2.5458  2.6465 

 

XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF MATERIAL ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2023
Summary Of Material Accounting Policies  
SUMMARY OF MATERIAL ACCOUNTING POLICIES

 

3.SUMMARY OF MATERIAL ACCOUNTING POLICIES

 

The accounting practices adopted by the Company are consistent in all the years presented. There were no changes in accounting policies and in calculation methods used for the annual financial statements as at December 31, 2023, compared to those presented in the financial statements for the years ended December 31, 2022, and 2021.

 

For better understanding, the material accounting policies adopted by the Company and applied in the preparation of these financial statements have been included in the respective accompanying notes, except for the policies described below, which may permeate more than one subject of the financial statements and have therefore been summarized in this accompanying note.

 

3.1 Recently issued IFRS

 

The new standards, which became effective are not applicable or did not have any material impact for the Company for the preparation of these consolidated financial statements. Below are the main changes in accounting standards which, in management's opinion, could have an impact on the Company's subsequent disclosures:

 

(i)On May 25, 2023, the IASB® published amendments to IAS 7 – Statement of Cash Flows and IFRS 7 – Financial Instruments: Disclosures, which establish new disclosure requirements for financing transactions with suppliers, the so-called "drawn risk". These requirements must be adopted by companies that adhere to the IFRS® as of 2024. The Company is evaluating the impacts of these changes, for any additional corresponding disclosures in future individual and consolidated financial statements, even though these transactions are not material to the Group, as disclosed in note 26 – Trade payables.

 

(ii)In August 2023, the IASB® issued amendments to IAS 21 – The Effects of Changes in Foreign Exchange Rates. The modifications implemented will require the application of a consistent approach when assessing whether a currency can be exchanged for another currency and, when it cannot, determining the exchange rate to be used, and the related disclosures. The Company is evaluating the impacts of these standards, the adoption of which is required for fiscal years beginning on January 1, 2025.

 

(iii)In December 2021, the Organisation for Economic Cooperation and Development ("OECD"), as part of the Inclusive Framework on Base Erosion and Profit Shifting ("BEPS") project, released the Pillar Two model rules (or Global Anti-Base Erosion Model Rules - GloBE), aiming at a common approach to international corporate taxation, in order to ensure that multinational economic groups within the scope of these rules calculate taxes on profit at a minimum effective rate of 15% in each country where they operate. These rules will have to be approved locally in each country that adheres the proposal, via applicable legislation, some of which have already promulgated new laws or are in the process of discussing and approving them. In May 2023, the IASB® issued scope changes to IAS 12 – Income Taxes to allow a temporary exemption in accounting for deferred income taxes arising from promulgated or substantially promulgated legislation implementing OECD Pillar Two, an exemption which has been adopted by the Group. Considering the legislation already published in the countries in which the Company operates, the Company has estimated the impacts on the 2023 financial statements and the amount is not material.

 

In addition of these, the Company does not anticipate that there are any other standards or amendments to IFRS® standards or IFRIC interpretations that have not come into force yet and that could have a significant impact on the Group's individual and consolidated financial statements.

 

3.2 Consolidated financial statements

The financial statements of subsidiaries, joint arrangements and associates used in these consolidated financial statements are prepared for the same reporting period as Ambev, using a consistent accounting policy.

 

All intercompany transactions, balances and unrealized gains or losses on transactions between consolidated companies were integrally eliminated.

 

3.2.1 Subsidiaries

 

The Company controls an entity when it is exposed to or has rights to variable returns due to its involvement with the entity, and it can affect those returns through its power over the entity. When assessing control, potential voting rights are considered. Control is presumed to exist where the Company owns, directly or indirectly, more than half of the voting rights (which does not always equate to economic ownership), unless it can be demonstrated that such ownership does not confer control.

 

Subsidiaries are consolidated from the date on which control is obtained by the Company, except when the predecessor basis of accounting is applied to transactions of business combinations under common control. Consolidation is discontinued from the date on which control ceases.

 

3.2.2 Associates

 

Associates are companies which the Company has significant influence over the financial and operational policies but does not control.

 

3.2.3 Joint arrangements

 

Joint arrangements are all entities over which the Company shares control with one or more parties. Joint arrangements are classified either as joint operations or joint ventures depending on the contractual rights and obligations of each investor.

 

3.2.4 Business combination

 

Ambev uses the acquisition method to account its business combinations. The consideration transferred for the acquisition of a subsidiary represents the fair value of the assets transferred, the liabilities incurred, and the equity interest issued by Ambev. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration agreement, when applicable. Costs related to the acquisition are recognized in income as they are incurred. Assets, liabilities and contingent liabilities acquired/assumed in a business combination are recognized initially at their fair value as at the acquisition date. Ambev recognizes the non-controlling interest in the acquiree, either at its fair value or at the non-controlling interest’s proportional share of the net assets acquired. The measurement of the non-controlling interest to be recognized is determined for each acquisition.

 

The excess of: (i) the consideration paid; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired, at the date of acquisition, is recorded as goodwill. When the consideration transferred is less than the fair value of the net assets acquired, the difference is recognized directly in income.

 

3.2.5 Business combination between entities under common control

 

Business combinations between entities under common control have not been addressed under IFRS how they should be disclosed remains unclear. IFRS 3 - Business Combinations is the standard applicable to business combinations, but its scope explicitly excludes business combinations between entities under common control, thus, in evaluating transactions of this nature, Management’s judgment is required to adequately reflect the essence and economic reality of each transaction.

 

3.2.5.1 Predecessor basis of accounting

 

In accordance with IAS 8 – Accounting Policies, Changes in Accounting Estimates and Errors, Management has adopted the predecessor basis of accounting, which is consistent with United States Generally Accepted Accounting Principles (“USGAAP”) and United Kingdom Generally Accepted Accounting Principles (“UKGAAP”), to record the carrying amount of the asset received, as recorded by the parent company.

 

Under the predecessor basis of accounting, when accounting for a transfer of assets between entities under common control, the entity that receives the net assets or the equity interests (the acquirer) shall initially record the assets and liabilities transferred at their parent book value as at the transfer date. If the book value of the assets and liabilities transferred by the parent is different from the historical cost recorded by the controlling entity of the entities under common control (the ultimate parent), the financial statements of the acquirer shall reflect the assets and liabilities transferred at the same cost of the ultimate parent, as a counter-entry to shareholders' equity against the carrying value adjustments.

 

3.2.5.2 Assets Swap

 

For transactions between entities under common control that involve the disposal or transfer of assets from the subsidiary to its parent company (i.e., above the level of the consolidated financial statements), the Company assesses the existence of: (i) any conflicts of interest; and (ii) the economic substance and purpose of the transaction. Having fulfilled these assumptions, the Company adopted as a policy the concepts of IAS 16 – Property, Plant and Equipment in order to provide adequate visibility and a fair impact on the amount of distributable results to its shareholders, specially the non-controlling interest. This policy also includes assets acquired through the swapping of non-cash assets, or swaps with a combination of cash and non-cash assets. The assets swapped may be of the same or a different nature. The cost of such assets is measured at fair value, unless: (i) the swap transaction is not commercial in nature; or (ii) the fair value of the asset received (and the asset assigned) cannot be reliably measured. The acquired asset is measured in this way even if the assignor entity cannot immediately remove the asset from its books. If the acquired asset is not measurable at fair value, its cost is determined based on the book value of the assigned asset.

 

Whenever assets distributed are not recorded as cash, the asset, before distribution, is recorded at its fair value in the income account. This procedure is applicable to distributions where the assets are of the same nature and therefore can be treated equally. However, similarly to IFRIC 17 - Distributions of Non-cash Assets to Owners, in the absence of a specific accounting practice for transactions under common control, the Company applies these procedures as part of its accounting practices. We also apply the same procedures to sales (products, supplies, etc.) to its controlling entity, where the positive result of the sale is recognized in income.

 

3.3 Financial reporting in hyperinflationary economies

 

Under IAS 29 – Financial Reporting in Hyperinflationary Economies, the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in hyperinflationary economies are restated to reflect changes in the general purchasing power of the local currency by applying a general price index. On a monthly basis, the Company estimates the applicable general price index since the official release of the index takes place after the end of the accounting period. The financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether using the historical costs approach or the current costs approach, shall be stated in terms of the unit of measurement in force at the end of the reporting period, and translated into Reais at the closing rate for the period.

 

To determine if the economy of any of its operations is hyperinflationary, the Company assesses quantitative and qualitative aspects of the country's economic environment, such as the inflation rate recorded over the last three years. On July 1, 2018, the Argentine economy was considered by the Company to be hyperinflationary, under the terms of IAS 29, considering the increase in the official price indices accumulated in the period (National Consumer Price Index - "IPC"), measured by INDEC (National Institute of Statistics and Census). Since the company does not operate directly in a hyperinflationary economy, but one of its subsidiaries does, the restatement of comparative balances from previous years is not carried out, in accordance with IAS 21 - The Effects of Changes in Foreign Exchange Rates, however, the precepts of the standard are applied to the balances and transactions of the affected subsidiary.

 

3.4 Present value adjustment.

 

The elements of assets and liabilities, when relevant, are adjusted to their present value, considering the following assumptions for the calculation: i) the amount to be discounted; ii) the settlement dates; and iii) the discount rate, in accordance with IFRS 13 - Fair Value Measurement.

 

3.5 Tax incentives and subsidized loans

 

The Company and its subsidiaries enjoy state tax benefits in Brazil, provided by government grants. Referred grants may be as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credits, effective collection, payment deferral or partial reductions of state tax payable. The effective collection incentives are recorded in the operating net revenue, by its nature, as the others are recognized in other operating income.

 

Among the tax incentives granted to the Company, there are state tax incentive programs to promote industrial development either by financing or by deferring payment of taxes. These state programs are intended to promote long-term increases in employment and industrial decentralization, as well as to complement and diversify the industrial states.

 

In the case of these programs, the tax terms are set out in the respective state normative acts and, when conditions for obtaining these grants exist, they are under the Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. The benefits of the delayed payment of such taxes are recorded in the income statement, on an accrual basis.

Since it is benefits on financing category or tax payment deferring, as the interest rates and/or terms of these loans are advantageous compared to market conditions, these benefits are considered as subsidized loans as intended by IAS 20 - Accounting for Government Grants and Disclosure of Government Assistance. The respective subsidies consist of the gains identified by comparing the value of these operations under the market conditions to the value agreed in the contracts. Thereby, upon receipt of funding, the subsidy calculated is recorded in Other operating income, following the treatment for the other ICMS subsidies of similar nature. Management reviews the market conditions prevailing in the year to assess such subsidies on an annual basis.

 

Monthly, considering the value of the consideration, the period to maturity, the contract interest rate and the abovementioned discount rate, the reduction in present value adjustment is allocated to financial income, so as to bring the balance to zero by the time of settlement of each consideration.

 

Such financing is recognized as liability adjusted to its present value. When there is an intervening financial institution in the transaction, the financing is recorded at “Interest-bearing loans and borrowings”, otherwise, its recorded at “Trade payables”, because of the underlying economic essence and nature of the transaction.

XML 25 R10.htm IDEA: XBRL DOCUMENT v3.24.0.1
USE OF ESTIMATES AND JUDGMENTS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
USE OF ESTIMATES AND JUDGMENTS

 

4.USE OF ESTIMATES AND JUDGMENTS

 

The preparation of financial statements in compliance with IFRS requires Management to make use of judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and assumptions are based on experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for decision-making regarding judgments regarding the carrying amounts of assets and liabilities that are not readily evident from other sources. The actual results may differ from these estimates.

The estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the period during which they are realized, or future periods.

Although each significant accounting policy reflects judgments, assessments or estimates, the Company believes that the following accounting practices reflect the most critical judgments, estimates and assumptions that are important to its business operations and the understanding of its results:

 

Note Accounting policies that reflect significant estimates and judgments
3.2.3 Joint arrangements
3.2.4 Business combination
3.2.5 Business combination between entities under common control
3.3 Financial reporting in hyperinflationary economies
3.4 Present value adjustment
3.6 Tax incentives and subsidized loans
18 Recognition of assets and liabilities relating to extemporaneous tax debits or credits
13 Current and deferred tax
14 Leases
16 Impairment
24 Measurement of employee benefits
25 Share-based payments
27 Provisions and contingent liabilities, including tax contingencies
28 Measurement of financial instruments, including derivatives
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT REPORTING
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SEGMENT REPORTING

 

5.SEGMENT REPORTING

 

(a)Reportable segments - Years ended:

 

                             
  Brazil CAC Latin America - South  Canada Consolidated
  2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021
                               
Net sales 46,361.7  42,635.8  35,586.5  10,044.8  9,440.1  9,947.4  13,797.2  17,371.2  16,571.7  9,533.2  10,261.7  10,748.7  79,736.9  79,708.8  72,854.3 
Cost of sales (23,516.1) (22,736.8) (18,309.1) (5,035.1) (4,860.8) (4,727.9) (6,657.3) (8,553.1) (8,235.7) (4,083.1) (4,271.4) (4,387.0) (39,291.6) (40,422.1) (35,659.7)
Gross profit 22,845.6  19,899.0  17,277.4  5,009.7  4,579.3  5,219.5  7,139.9  8,818.1  8,336.0  5,450.1  5,990.3  6,361.7  40,445.3  39,286.7  37,194.6 
Distribution expenses (6,428.6) (6,111.1) (5,123.1) (853.1) (1,020.7) (872.7) (1,614.3) (2,159.5) (2,010.1) (1,854.6) (2,104.0) (1,926.8) (10,750.6) (11,395.3) (9,932.7)
Sales and marketing expenses (4,477.0) (4,065.0) (3,440.3) (665.1) (645.5) (693.3) (1,190.0) (1,426.9) (1,542.9) (1,080.4) (1,200.0) (1,359.0) (7,412.5) (7,337.4) (7,035.5)
Administrative expenses (3,563.2) (3,346.0) (3,006.2) (413.0) (333.6) (427.7) (659.5) (835.0) (832.0) (638.0) (722.2) (611.5) (5,273.7) (5,236.8) (4,877.4)
Other operating income/(expenses) 1,892.5  2,361.3  2,096.0  26.3  (52.9) 12.4  95.0  192.7  38.8  15.1  12.8  (23.1) 2,028.9  2,513.9  2,124.1 
Exceptional items (137.8) (34.5) (210.1) (17.9) (16.1) (46.7) (47.6) (60.5) (115.4) (3.1) (32.2) (20.6) (206.4) (143.3) (392.8)
Income from operations 10,131.5  8,703.7  7,593.7  3,086.9  2,510.5  3,191.5  3,723.5  4,528.9  3,874.4  1,889.1  1,944.7  2,420.7  18,831.0  17,687.8  17,080.3 
Net finance costs                         (3,609.8) (3,423.1) (3,205.4)
Share of results of joint ventures                         (185.3) (29.1) (115.7)
Income before income tax                         15,035.9  14,235.6  13,759.2 
Income tax expense                         (75.5) 655.6  (636.6)
Net income                         14,960.4  14,891.2  13,122.6 
                               
Acquisition of property, plant and equipment 3,365.5  4,062.9  4,645.1  593.4  968.4  801.6  782.2  1,112.8  1,665.4  1,263.0  389.0  565.0  6,004.1  6,533.1  7,677.1 

 

 

 

  Brazil CAC  Latin America - South  Canada Consolidated
  2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021
                               
Segment assets 56,974.2  57,353.8  54,609.4  13,692.3  15,385.6  15,351.9  16,085.1  22,044.5  21,583.0  15,856.9  16,093.3  18,016.6  102,608.5  110,877.2  109,560.9 
Intersegment elimination                         (2,162.1) (2,533.0) (2,868.5)
Non-segmented assets (i)                         32,197.9  29,613.8  31,910.1 
Total assets                         132,644.3  137,958.0  138,602.5 
                               
Segment liabilities 28,841.3  29,153.2  27,611.2  4,981.5  5,098.0  5,414.4  5,095.4  6,843.6  7,843.6  5,131.0  5,053.7  6,156.5  44,049.2  46,148.5  47,025.7 
Intersegment elimination                         (2,161.8) (2,534.2) (2,869.1)
Non-segmented liabilities (i)                         90,756.9  94,343.7  94,445.9 
Total liabilities                         132,644.3  137,958.0  138,602.5 

 

(i)The balance of non-segmented assets refers mainly to cash and cash equivalents, taxes and investments. The balance of non-segmented liabilities, in turn, refers mainly to equity values, taxes and derivatives.

 

 

Non-current assets attributed to Brazil (country of domicile of the company) and Canada amounted to R$45.1 billion and R$13.9 billion, respectively, in December 31, 2023 (R$44.6 billion and R$13.7 billion, respectively, in December 31, 2022, and R$42.6 billion and R$15.6 billion, respectively, in December 31, 2021). Furthermore, the net revenue attributable to the Company's operations in Argentina amounted to R$6.3 billion in December 31, 2023 (R$10.1 billion in December 31, 2022 and R$9.2 billion in December 31, 2021), and the segmented non-current assets attributed to the same country totaled R$5.9 billion for the year ended December 31, 2023 (R$9.7 billion in December 31, 2022 and R$9.1 billion in December 31, 2021).

 

(b)Additional information - by Business unit - Years ended:

 

                 
  Brazil
  Beer NAB Total 
  2023 2022 2021 2023 2022 2021 2023 2022 2021
                   
Net sales 38,985.9  35,857.9  30,537.1  7,375.8  6,777.9  5,049.4  46,361.7  42,635.8  35,586.5 
Cost of sales (19,377.7) (18,765.3) (15,382.0) (4,138.4) (3,971.5) (2,927.1) (23,516.1) (22,736.8) (18,309.1)
Gross profit 19,608.2  17,092.6  15,155.1  3,237.4  2,806.4  2,122.3  22,845.6  19,899.0  17,277.4 
Distribution expenses (5,171.9) (4,988.6) (4,263.1) (1,256.7) (1,122.5) (860.0) (6,428.6) (6,111.1) (5,123.1)
Sales and marketing expenses (3,969.4) (3,596.8) (3,096.2) (507.6) (468.2) (344.1) (4,477.0) (4,065.0) (3,440.3)
Administrative expenses (3,106.0) (2,928.8) (2,616.1) (457.2) (417.2) (390.1) (3,563.2) (3,346.0) (3,006.2)
Other operating income/(expenses) 1,474.1  1,884.5  1,711.3  418.4  476.8  384.7  1,892.5  2,361.3  2,096.0 
Exceptional items (137.8) (30.6) (202.0) -    (3.9) (8.1) (137.8) (34.5) (210.1)
Income from operations 8,697.2  7,432.3  6,689.0  1,434.3  1,271.4  904.7  10,131.5  8,703.7  7,593.7 
Net finance costs             (2,050.6) (1,110.3) (858.1)
Share of results of joint ventures             (179.0) (38.3) (11.7)
Income before income tax             7,901.9  7,555.1  6,723.9 
Income tax expense             2,214.9  2,787.7  1,953.2 
Net income             10,116.8  10,342.8  8,677.1 

 

Accounting policies

 

Reportable segments are consistently presented on the internal reporting regularly reviewed by the Company’s chief operating decision maker, the Chief Executive Officer, for the purpose of evaluating the performance of each segment and allocating resources to those segments. The information is prepared based on available financial data that is directly attributable to the segment or the information that can be allocated on a reasonable basis.

 

Therefore, the segment reporting is presented by geographical zone, since the risks and rates of return are predominantly affected by the fact that the company operates in different regions.

 

Performance information by business unit (Beer and Non-alcoholic beverages (“NAB”)), is also presented to the Company’s chief operating decision maker and is disclosed as additional information, even though it does not qualify as a segment.

 

The Company conducts its operations across four business segments, as follow:

 

▪ Brazil, where the Company operates two business subunits: (i) beer and (ii) non-alcoholic beverages (NAB).

 

▪ Central America and Caribbean (“CAC”), which includes direct operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala (which also serves El Salvador, Nicaragua and Honduras), Barbados and Panama.

 

▪ Latin America South (LAS), which includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay.

 

▪ Canada, represented by the operations of Labatt Brewing Company Ltd.

 

Our chief operating decision maker uses income from operations as the main measure of segment profitability.

 

In accordance with IFRS 8 - Segment Information, the Company does not disclose its revenues from external customers for each product or each group of similar products, since the necessary information is not available in a comparable form and the cost of preparing it would be excessive.

XML 27 R12.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET SALES
12 Months Ended
Dec. 31, 2023
Net Sales  
NET SALES

 

6.NET SALES

 

In compliance with the Brazilian Federal Law 6,404/76, Company discloses the reconciliation between gross and net sales presented in the consolidated income statement. The values by each operational segment are disclosed in note 5 – Segment reporting:

 

     
  2023 2022 2021
Gross sales 120,117.7  125,907.2  110,162.7 
Excise duty (25,227.5) (24,851.4) (22,052.6)
Discounts (15,153.3) (21,347.0) (15,255.8)
Total 79,736.9  79,708.8  72,854.3 

 

At December 31, 2023, the Company calculated R$1,467.2 million of fiscal incentives recognized as a deduction of revenue (R$1,245.8 million at December 31, 2022, and R$1,048.3 million at December 31, 2021).

 

Accounting Policies

The Company recognizes revenue when the performance obligations are satisfied, that is, when the Company or its subsidiaries transfer control of a product to a customer. Revenue represents the fair value of the amount received or receivable upon the sale of products or the rendering of services in the ordinary course of Group’s business. Revenue is presented net of taxes, returns, rebates and discounts, as well as net of the elimination of sales between the consolidated companies.

 

Revenue is measured based on the consideration, which the Company expect to have the right to receive in contracts with customers and excludes amounts collected on behalf of third parties.

 

Revenue recognition is based on the approach of IFRS 15 - Revenue from Contracts with Customers, from five-step:

 

·Identifying the contract with a customer.
·Identifying performance obligations in the contract.
·Determining the transaction price.
·Allocating the transaction price to performance obligations in the contracts.
·Revenue recognition when the performance obligations have been satisfied, meaning when the company transfers control of a product to a customer.

 

Contracts can include significant variable elements, such as discounts, rebates, refunds, credits, price concessions, incentives, performance bonuses and penalties. These trade incentives are treated as variable consideration. If the consideration includes a variable component, the company estimates the amount of consideration to which it will be entitled for transferring the promised goods or services to the customer. Variable consideration is only included in the transaction price if it is highly probable that the amount of revenue recognized would not be subject to significant future reversals when the respective uncertainty is resolved.

 

The gross sales obtained by the Company, in general, are subject to the incidence of certain taxes and contributions, which are calculated and paid to fiscal authorities in accordance with current municipal, state and federal legislation, and does not result in Group’s equity increase. These taxes and contributions are deducted from gross sales and relate substantially to tax on transactions concerning the circulation of goods (“ICMS”), social integration program (“PIS”), contribution to social security financing (“COFINS”) in Brazil.

XML 28 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER OPERATING INCOME/(EXPENSES)
12 Months Ended
Dec. 31, 2023
Other Operating Incomeexpenses  
OTHER OPERATING INCOME/(EXPENSES)

 

7.OTHER OPERATING INCOME/(EXPENSES)

 

     
  2023 2022 2021
Government grants/net present value of long-term fiscal incentives 1,573.2  1,289.3  853.2 
Extemporaneous credits/(debits) (i) 218.0  1,013.9  1,219.0 
(Additions)/reversals of provisions (77.7) (77.2) (71.4)
Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates 86.4  88.8  66.1 
Other operating income/(expenses), net 229.0  199.1  57.2 
Total 2,028.9  2,513.9  2,124.1 

 

(i)As detailed in Notes 1 – Corporate information and 27.2 – Contingencies, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS, including in the tax substitution form, from its calculation basis, in the item Other operating income/(expenses).

 

Accounting policies

 

The Company recognizes, in other operating income/(expenses) line, government incentives granted as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credit, deferred payment or partial reductions of due state tax payable.

 

Government grants are not recognized until there is reasonable assurance that the Company and subsidiaries will meet the respective conditions and obligations related to governmental terms.

XML 29 R14.htm IDEA: XBRL DOCUMENT v3.24.0.1
EXCEPTIONAL ITEMS
12 Months Ended
Dec. 31, 2023
Exceptional Items  
EXCEPTIONAL ITEMS

 

8.EXCEPTIONAL ITEMS

 

     
  2023 2022 2021
Restructuring (i) (109.4) (101.8) (165.4)
COVID-19 impacts (ii) -    (16.7) (134.3)
Legal fees (iii) (94.7) -    -   
Effect of application of IAS 29 (hyperinflation) (2.3) (8.2) (11.1)
Distribution agreement (iv) -    -    (82.0)
Write-off of investments (v) -    (16.6) -   
Total (206.4) (143.3) (392.8)

 

(i)The restructuring expenses primarily related to centralization projects and resizing in Brazil, Latin America CAC and Canada.
(ii)COVID-19 expenses refer to (a) additional administrative expenses to ensure the safety of the Company’s people (increased frequency of cleaning at the Company’s facilities, providing alcohol gel and masks for our employees); (b) donations; (c) Company initiatives providing support for some customer ecosystems, which were necessary due to the COVID-19 pandemic.
(iii)In 2003 some holders of warrants issued by Cervejaria Brahma filed lawsuits to discuss the criteria used in calculating the exercise price of such warrants. In 2023, the Company obtained some final favorable decisions on the matter, which was already classified as a remote loss. The amount recorded in this line refers to the provision for legal fees related to this matter.
(iv)Refers to distribution agreement with our strategic partner in Guatemala.
(v)Refers to an investment write-off of a business line in Canada

 

Accounting Policies

 

Exceptional items are those that, considering their peculiarities, in Management’s judgment need to be disclosed separately. In determining whether an event or transaction is exceptional, Management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence, and the potential impact on the variations in profit or loss. These items are disclosed in the income statement or separately disclosed in the notes to the financial statements. Transactions that may give rise to exceptional items are principally restructuring activities, amnesties, acquisitions of subsidiaries, impairment losses, and gains or losses on disposal of assets and investments.

XML 30 R15.htm IDEA: XBRL DOCUMENT v3.24.0.1
PAYROLL AND RELATED BENEFITS
12 Months Ended
Dec. 31, 2023
Payroll And Related Benefits  
PAYROLL AND RELATED BENEFITS

 

9.PAYROLL AND RELATED BENEFITS

 

     
  2023 2022 2021
Wages and salaries 4,550.2  4,496.1  4,162.6 
Social security contributions 1,322.3  1,239.7  1,016.0 
Other personnel costs 970.7  1,075.9  1,076.1 
Increase in liabilities for defined benefit plans 145.6  157.8  178.2 
Share-based payments 333.4  311.6  391.5 
Contributions to defined contribution plans 91.3  82.0  74.1 
Total 7,413.5  7,363.1  6,898.5 

 

The payroll expenses and related benefits are presented in the income statement as shown below:

 

     
  2023 2022 2021
Cost of sales 2,629.6  2,510.4  2,247.9 
Distribution expenses 1,289.9  1,396.3  1,286.8 
Commercial expenses 1,321.3  1,504.8  1,480.9 
Administrative expenses 1,907.6  1,798.7  1,699.1 
Net finance costs 114.3  107.8  115.6 
Other operating (income)/expenses (1.3) 1.5  -   
Exceptional items 152.1  43.6  68.2 
Total 7,413.5  7,363.1  6,898.5 

 

XML 31 R16.htm IDEA: XBRL DOCUMENT v3.24.0.1
ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE
12 Months Ended
Dec. 31, 2023
Additional Information On Cost Of Sales And Operating Expenses By Nature  
ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE

 

10.ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE

 

Depreciation, amortization and impairment expenses are included in the following income statement accounts for the years ended in December 31,2023, 2022 and 2021:

 

             
  Depreciation and impairment of property, plant and equipment   Amortization of intangible assets
  2023 2022 2021   2023 2022 2021
               
Cost of sales (i) 3,552.5  3,413.3  3,326.6    13.2  16.4  16.4 
Distribution expenses 1,098.3  893.5  654.1    -    -    -   
Commercial expenses 613.7  660.7  700.3    148.6  113.2  84.3 
Administrative expenses 464.1  474.4  331.4    524.8  372.6  304.2 
  5,728.6  5,441.9  5,012.4    686.6  502.2  404.9 

 

(i)These amounts added to R$2,629.6 (R$2,510.4 and R$2,247.9 as at December 31, 2022, and 2021, respectively) mentioned in Note 9 - Payroll and related benefits, total R$6,195.3 (R$5,940.1 and R$5,591.0 as at December 31, 2022, and 2021, respectively). The remaining amount of R$33,096.3 (R$34,482.0 and R$30,068.7 as at December 31, 2022, and 2021, respectively), recorded in the cost of sales, refers to other production costs.

 

XML 32 R17.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET FINANCE RESULT
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
NET FINANCE RESULT

 

11.NET FINANCE RESULT

 

     
  2023 2022 2021
Finance expenses      
Interest expense (2,432.2) (2,328.3) (1,431.8)
Net Interest on pension plans (114.3) (107.9) (115.6)
Losses on hedging instruments (1,675.1) (3,158.4) (2,540.2)
Interest on provision for disputes and litigation (269.2) (456.6) (290.0)
Exchange differences (1,154.0) (751.1) (453.9)
Tax on financial transactions (178.3) (339.6) (216.6)
Bank guarantee expenses (249.8) (176.1) (174.9)
Other financial results (207.2) (574.2) (204.8)
Total of finance expenses (6,280.1) (7,892.2) (5,427.8)
       
Finance income      
Interest income 2,085.6  2,167.7  1,101.6 
Interest and foreign exchange rate on loans to/from related parties 119.2  37.1  42.5 
Financial instruments at fair value through profit or loss -    95.5  77.0 
Other financial results 289.4  565.3  78.9 
Total 2,494.2  2,865.6  1,300.0 
       
Effect of application of IAS 29 (hyperinflation) 176.1  1,603.5  922.4 
Total of finance income 2,670.3  4,469.1  2,222.4 
       
Net finance result (3,609.8) (3,423.1) (3,205.4)

 

Interest expenses are presented net of the effects of interest rate derivative financial instruments which mitigate Ambev’s interest rate risk (Note 28 - Financial instruments and risks). The interest expenses are as follows:

 

     
  2023 2022 2021
Financial instruments measured at amortized cost (644.1) (764.0) (466.0)
Financial instruments at fair value through profit or loss (i) (1,788.1) (1,564.3) (965.8)
Total (2,432.2) (2,328.3) (1,431.8)

 

(i)Include R$1,231 million (R$654 million at December 31, 2022) as accounts payable present value adjustment.

 

Interest income arises from the following financial assets:

 

     
  2023 2022 2021
Cash and cash equivalents 1,072.2  791.6  329.5 
Investment on debt securities 49.2  175.9  84.7 
Other receivables (i) 964.2  1,200.2  687.4 
Total 2,085.6  2,167.7  1,101.6 

 

(i)Refers, mainly, to monetary adjustment of recoverable tax.

 

Accounting policies

 

a) Finance expenses

Finance expenses comprises, in general, of interest payable on loans and borrowing, calculated using the effective interest rate method, trade payables present value adjustment, expenses related to bank guarantees, monetary adjustments resulting from disputes and litigations, foreign exchange losses, losses on currency hedging instruments intended for the offsetting of currency gains, results on interest rate hedging instruments, losses on hedging instruments that are not part of a hedge accounting relationship, losses on financial assets classified as held for trading, impairment losses on financial assets classified as available for sale, and as any losses due to hedge ineffectiveness.

All interest costs incurred in connection with borrowing or financial transactions, including transaction costs, are expensed as incurred as part of finance expenses, except when capitalized. The interest expenses component of finance lease payments is also recognized in the income statement using the effective interest rate method.

 

b) Finance income

Finance income comprises, in general, of interest received or receivable on funds invested, monetary updates arising from legal disputes, foreign exchange gains, gains on currency hedging instruments intended for offsetting currency losses, gains on hedging instruments that are not part of a hedge accounting relationship, gains on financial assets classified as at fair value through profit or loss, and as any gains due to hedge ineffectiveness. Interest income is recognized on an accruals basis unless collectability is in doubt.

XML 33 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS PER SHARE
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
EARNINGS PER SHARE

 

12.EARNINGS PER SHARE

 

The tables below present the calculation of earnings per share (“EPS”) Basic and Diluted:

 

         
Basic 2023   2022   2021
Numerator          
Income attributable to the Ambev equity holders 14,501.9    14,457.9    12,671.0 
Denominator          
 Weighted average number of shares (i) (non diluted) 15,744.8    15,741.9    15,736.9 
 Basic EPS 0.9211    0.9184    0.8052 
           
           
Diluted 2023   2022   2021
Numerator          
Income attributable to the Ambev equity holders 14,501.9    14,457.9    12,671.0 
Denominator          
 Weighted average numbers of shares (i) (diluted)  15,838.6    15,848.6    15,857.5 
 Diluted EPS 0.9156    0.9123    0.7991 

 

(i)Million shares

 

Accounting Policies

 

The calculation of basic earnings per share is based on the net income attributable to Ambev equity holders and the weighted average number of shares outstanding during the year.

 

The diluted earnings per share of the stock option and deferred stock is based on the net income attributable to the equity holders of Ambev, adjusted by the weighted average number of shares outstanding during the year to assume the conversion of all potentially dilutive shares.

 

XML 34 R19.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION
12 Months Ended
Dec. 31, 2023
Income Tax And Social Contribution  
INCOME TAX AND SOCIAL CONTRIBUTION

 

13.INCOME TAX AND SOCIAL CONTRIBUTION

13.1 Income tax and social contribution

The income tax and social contribution taxes are based on tax rates for 25% for income tax and 9% for social contribution in Brazil. For other regions in which the Company operates, the expected nominal rates are as follows:

 

 
Central America and the Caribbean from 15% to 27%
Latin America - South (i) from 10% to 35%
Canada 26.5%
Luxembourg 24.94%

 

Income taxes reported in the income statement are analyzed as follow:

 

     
  2023 2022 2021
Income tax expense – current (2,077.9) (1,718.9) (1,268.6)
       
Deferred tax expense on temporary differences 279.8  1,012.6  1,072.9 
Deferred tax on tax loss carryforward movements in the current period 1,722.6  1,361.9  (440.9)
Total deferred tax (expense)/income 2,002.4  2,374.5  632.0 
       
Total income tax expenses (75.5) 655.6  (636.6)

 

The reconciliation between the weighted nominal tax rate and the effective tax rate is summarized as follows:

 

     
  2023 2022 2021
Profit before tax 15,035.9  14,235.6  13,759.2 
Adjustment on a taxable basis      
Others non-taxable income (919.0) (883.3) (611.0)
Government grants related to sales taxes  (3,011.7) (2,535.1) (1,883.1)
Share of results of joint ventures 185.3  29.1  115.7 
Non-deductible expenses 56.5  192.8  99.2 
Worldwide taxation 1,171.4  679.3  (360.0)
  12,518.4  11,718.4  11,120.0 
Aggregated weighted nominal tax rate 28.30% 29.47% 27.39%
Taxes payable – nominal rate  (3,542.3) (3,453.3) (3,045.3)
Adjustment on tax expense      
Income tax Incentives 120.4  234.0  213.2 
Deductible interest on shareholders’ equity 3,909.8  4,079.9  2,516.0 
Tax savings from goodwill amortization 17.2  27.2  77.5 
Withholding income tax (489.1) (164.5) (876.0)
Recognition/(write-off) of deferred charges on tax losses 100.9  (58.2) (1.5)
Effect of application of IAS 29 (hyperinflation) (382.3) (249.0) (123.3)
Others with reduced taxation 189.9  239.5  602.8 
Income tax and social contribution expense (75.5) 655.6  (636.6)
Effective tax rate 0.50% -4.61% 4.63%

 

 

The main events that impacted the effective tax rate for the period were:

 

·Government subsidy for sales taxes: for regional incentives and economic development policies, these are related primarily to local production, contributing to economic and social impact, and, when reinvested, are not subject to income tax and social contribution purposes, which explains the impact on the effective tax rate. The amount above is impacted by fluctuations in the volume, price and any eventual increases in state VAT (“ICMS”), reflected in other operating income or net sales depending on its nature. In addition, the above-mentioned amount is allocated to the profit reserve on an annual basis, according to item (2.3.3) “Tax incentives” on Note 22 - Changes in equity

 

·Complement of income tax on foreign subsidiaries due in Brazil: shows the result of the calculation of universal taxation of profits, according to the regulations of Law 12,973/14.

 

·Withholding income tax: The amount is mainly related to dividends already distributed and to be distributed by subsidiaries located outside of Brazil, applicable according to local tax legislation. The recorded values in 2023 are mainly related to withholding tax on dividends distributed in 2023 and the exchange rate variation of the deferred income tax related to subsidiary profits undistributed.

 

·Deductible interest on shareholders’ equity: under Brazilian law, companies have an option to remunerate their shareholders through the payment of Interest on shareholders’ equity, which amount is impacted by the taxable result, net income reserves of the Company and by the long-term interest rate (“TJLP”). These remunerations are deductible for income tax purposes.

 

·Effect of application of IAS 29 (hyperinflation): our subsidiary in Argentina, for operating in a hyperinflationary economy, is subject to monetary correction of non-financial assets and liabilities, equity and income statement, which, at times, reflects in the consolidated effective tax rate and implies variation between periods.

 

13.2 Deferred income tax and social contribution

 

The details of the amount of deferred income tax and social contribution by type of temporary difference are as follows:

 

             
  2023   2022
  Assets Liabilities Net   Assets Liabilities Net
Investment securities 8.2  -    8.2    7.5  -    7.5 
Intangible -    (1,369.7) (1,369.7)   -    (1,690.2) (1,690.2)
Employee benefits 856.5  -    856.5    951.2  -    951.2 
Trade payables 2,843.8  (3.3) 2,840.5    3,232.8  (2.9) 3,229.9 
Trade receivables 43.8  (7.0) 36.8    38.6  (3.8) 34.8 
Derivatives 31.1  (77.2) (46.1)   95.1  (44.8) 50.3 
Interest-Bearing Loans and Borrowings 7.5  -    7.5    0.5  (0.9) (0.4)
Inventories 268.6  (59.6) 209.0    413.9  (139.3) 274.6 
Property, plant and equipment 714.2  (1,837.2) (1,123.0)   899.5  (2,177.1) (1,277.6)
Withholding tax on undistributed profits and royalties -    (1,385.5) (1,385.5)   -    (1,877.6) (1,877.6)
Investments in joint ventures -    (383.7) (383.7)   -    (421.6) (421.6)
Losses carried forward 4,383.3  -    4,383.3    2,660.7  -    2,660.7 
Provisions 1,026.3  (4.6) 1,021.7    819.3  -    819.3 
Impact of the adoption of IFRS 16 (Leases) 14.5  (19.7) (5.2)   35.1  (11.4) 23.7 
ICMS on the assessment bases of PIS/COFINS -    (228.5) (228.5)   -    (168.2) (168.2)
Other items 266.5  (437.1) (170.6)   260.8  (164.1) 96.7 
Gross deferred tax assets/(liabilities) 10,464.3  (5,813.1) 4,651.2    9,415.0  (6,701.9) 2,713.1 
Netting by taxable entity (2,494.7) 2,494.7  -      (2,976.2) 2,976.2  -   
Net deferred tax assets/(liabilities) 7,969.6  (3,318.4) 4,651.2    6,438.8  (3,725.7) 2,713.1 

 

Most tax losses and negative social contribution bases on which deferred income tax and social contribution were calculated do not have a statute of limitations. The use of credits related to tax losses is based on the projected future existence of taxable profits, limited to 30% of taxable income for the year, according to the actual figures for prior years, and the projections of the Company's business in the economies in which they are located, and thus follows the applicable fiscal and accounting rules.

 

Among the deferred tax assets on tax losses carried forward, the tax authorities unilaterally offset in tax proceedings the total amount of R$268.6, which are equivalent to R$790.0 in tax losses basis. Such proceedings are classified as having a possible probability of loss.

 

The critical estimates of Ambev’s Management, as well the main contingent liabilities related to uncertainty about the tax treatment of income, are disclosed in Notes 27.2 - Contingencies

 

13.2.1 Realization of deferred taxes

 

As at December 31, 2023, the deferred tax assets and liabilities related to combined tax losses which are expected to be utilized/settled using temporary differences, as follows:

 

     
  2023
Deferred taxes not related to tax losses to be realized within 12 months to be realized after 12 months Total
       
Investment securities -    8.2  8.2 
Intangible (1.2) (1,368.5) (1,369.7)
Employee benefits 199.9  656.6  856.5 
Trade payables (220.6) 3,061.1  2,840.5 
Trade receivables 22.7  14.1  36.8 
Derivatives (49.8) 3.7  (46.1)
Interest-bearing loans and borrowings 0.1  7.4  7.5 
Inventories 252.7  (43.7) 209.0 
Property, plant and equipment (4.1) (1,118.9) (1,123.0)
Withholding tax on undistributed profits and royalties -    (1,385.5) (1,385.5)
Investments in joint ventures -    (383.7) (383.7)
Provisions 664.5  357.2  1,021.7 
Impact of the adoption of IFRS 16 (Leases) -    (5.2) (5.2)
ICMS on the assessment bases of PIS/COFINS -    (228.5) (228.5)
Other items 39.8  (210.4) (170.6)
Total 904.0  (636.1) 267.9 

 

 
Deferred tax related to tax losses 2023
2023 -   
2024 755.7 
2025 422.5 
2026 1,635.2 
2027 1,052.8 
2028 a 2030 170.3 
2031 em onward (i) 346.8 
Total 4,383.3 

 

(i)There is no expectation of realization beyond a term of ten years.

 

13.2.2 The net change of deferred taxes

 

The net change in deferred income tax and social contribution is as follows:

 

 
At December 31, 2021 1,513.7 
Recognition of actuarial gains/(losses) (146.9)
Investment hedge – put option granted on subsidiaries (105.0)
Cash flow hedge – gains/(losses) 41.3 
Gains/(losses) on translation of other foreign operations  (419.3)
Recognized in other comprehensive income (629.9)
Recognized in the income statement 2,374.5 
Changes directly in the balance sheet (545.2)
Recognized in deferred tax (595.5)
Effect of application of IAS 29 (hyperinflation) (595.5)
Recognized in other balance sheet group 50.3 
At December 31, 2022 2,713.1 
Recognition of actuarial gains/(losses) 24.4 
Investment hedge – put option granted on subsidiaries (155.9)
Cash flow hedge – gains/(losses) 83.2 
Gains/(losses) on translation of other foreign operations  553.9 
Recognized in other comprehensive income 505.6 
Recognized in the income statement 2,002.4 
Changes directly in the balance sheet (569.9)
Recognized in deferred tax (476.3)
Effect of application of IAS 29 (hyperinflation) (476.3)
Recognized in other balance sheet group (93.6)
At December 31, 2023 4,651.2 

 

13.2.3 Deferred tax asset related to tax losses

 

As at December 31, 2023, besides the tax credits related to tax losses effectively recognized in the amounts disclosed above, other tax credits related to accumulated tax losses in the amount of R$669.0 (R$875.3 in 2022) - which are equivalent, in value basis, to R$2,521.0 in 2023 (R$3,359.5 in 2022) - were not recorded, since their realization is not probable in currently Management evaluation.

 

Accounting Policies

 

Income tax and social contribution for the year comprises current tax and deferred tax. Income tax and social contribution are recognized in the income statement, unless they relate to items recognized directly in comprehensive income or in other equity accounts. In these cases, the tax effects are also recognized directly in comprehensive income or in equity accounts (except for interest on shareholders’ equity. See Note 22- Changes in equity).

 

Deferred income taxes are calculated on temporary differences between their calculation bases and the Company's accounting data. The deferred tax assets are recognized only to the extent that is probable that future taxable profits will be available. The deferred income tax assets are reduced to the extent that it is no longer probable that future taxable profits will occur. The existence of future taxable income is based on a technical study approved by the Company's management.

 

IAS 12 – “Income Taxes” prescribes that no deferred tax liability on goodwill recognition, and no deferred tax asset/liability is recorded: (1) at the initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss and (2) on differences related to investments in subsidiaries to the extent that they are not reversed in the foreseeable future. The amount of deferred tax provided is based on the expectation of the realization or settlement of the temporary difference, using currently or substantially enacted tax rates.

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and where these relate to income taxes levied by the same tax authority on the same taxable entity, or to different taxable entities which intend either to settle their current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously.

 

The company is subject to income tax in numerous jurisdictions and judgment is required to determine the Company’s worldwide provision for income tax. Some of the Company's subsidiaries are involved in tax audits, usually in relation to previous years. These audits are ongoing in various jurisdictions as at the balance sheet reporting date and, by their nature, can take a considerable time to be completed.

 

The Company applies the provisions of IFRIC 23 - Uncertainty on the Treatment of Income Taxes in relation to the treatments that affected the calculation of income taxes (uncertain tax treatments), as disclosed in note 27.2 – Contingencies – Uncertainties about treatment of IRPJ and CSLL.

XML 35 R20.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
PROPERTY, PLANT AND EQUIPMENT

 

14.PROPERTY, PLANT AND EQUIPMENT

 

   
  2023 2022
Property, plant and equipment 23,662.7  26,961.3 
Right of use assets 2,967.5  3,094.4 
  26,630.2  30,055.7 

 

14.1 Changes in the carrying amount of property, plant, and equipment

 

                     
                    Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  At December 31, 2022   Acquisition cost Depreciation
Land and buildings 9,090.2  (832.1) 712.7  11.2  (436.8) (20.1) 1,173.2  9,698.3    14,494.2  (4,795.9)
Plant and equipment 10,884.0  (1,067.3) 952.6  1,283.5  (3,564.6) (15.7) 3,116.6  11,589.1    39,818.3  (28,229.2)
Fixtures and fittings 1,285.1  (111.6) 96.7  87.3  (579.7) (14.6) 560.7  1,323.9    7,682.7  (6,358.8)
Under construction 5,404.7  (360.7) 252.7  4,923.7  -    -    (5,870.4) 4,350.0    4,350.0  -   
  26,664.0  (2,371.7) 2,014.7  6,305.7  (4,581.1) (50.4) (1,019.9) 26,961.3    66,345.2  (39,383.9)

 

                    Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  At December 31, 2023   Acquisition cost Depreciation
Land and buildings 9,698.3  (1,485.2) 663.1  44.7  (481.6) (3.7) 800.6  9,236.2    14,287.8  (5,051.6)
Plant and equipment 11,589.1  (1,726.7) 779.4  1,230.2  (3,533.4) (39.1) 2,488.8  10,788.3    39,509.2  (28,720.9)
Fixtures and fittings 1,323.9  (193.4) 86.5  56.4  (541.6) (13.5) 373.7  1,092.0    7,074.2  (5,982.2)
Under construction 4,350.0  (311.7) 120.2  3,283.9  -    (3.4) (4,892.8) 2,546.2    2,546.2  -   
  26,961.3  (3,717.0) 1,649.2  4,615.2  (4,556.6) (59.7) (1,229.7) 23,662.7    63,417.4  (39,754.7)

 

14.2 Changes in the carrying amount of right-of-use assets

 

                   
                  Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Additions Depreciation Disposals and write-offs Transfers  At December 31, 2022   Acquisition cost Depreciation
Buildings 1,206.0  (64.3) 628.0  (391.6) 9.7  (37.0) 1,350.8    2,698.3  (1,347.5)
Machinery, vehicles and others 1,354.3  (8.2) 1,009.7  (453.9) (194.5) 36.2  1,743.6    2,889.5  (1,145.9)
Total 2,560.3  (72.5) 1,637.7  (845.5) (184.8) (0.8) 3,094.4    5,587.8  (2,493.4)

 

                  Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Additions Depreciation Disposals and write-offs Transfers  At December 31, 2023   Acquisition cost Depreciation
Buildings 1,350.8  (49.5) 355.0  (451.8) (30.5) (1.8) 1,172.2    2,925.9  (1,753.7)
Machinery, vehicles and others 1,743.6  (32.7) 1,329.3  (773.9) (475.5) 4.5  1,795.3    3,534.4  (1,739.1)
Total 3,094.4  (82.2) 1,684.3  (1,225.7) (506.0) 2.7  2,967.5    6,460.3  (3,492.8)

 

 

 

Accounting Policies

 

Property, plant and equipment are measured at cost less accumulated depreciation and impairment losses. The cost includes the purchase price, borrowing costs incurred during the construction period and any other costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management (e.g., nonrefundable tax, transportation and the costs of dismantling, removal and site restoration, if applicable). The cost of a self-constructed asset is determined using the same principles as an acquired asset. The depreciation methods, residual value, as well as the useful lives are reassessed and adjusted if appropriate, on an annual basis. Property, plant and equipment, and depreciation include the effects of using the predecessor basis of accounting (Note 3.2.5.1).

 

a.1) Subsequent expenditure

 

The Company recognizes in the carrying amount of an item of property, plant and equipment the cost of replacing a component of such an item if it is probable that the future economic benefits of the component will flow to the Company and the cost of the component can be measured reliably. All other costs are expensed as incurred.

 

a.2) Depreciation

 

The depreciable amount is the cost of an asset less its residual value. Depreciation is calculated from the date on which the asset is available for use, using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the major classes of property, plant and equipment are as follows:

 

 
Buildings 25 years
Plant and equipment 15 years
Fixtures 10 years
Fittings 10 years
Assets for external use / commercial assets  2 - 5 years

 

Land is not depreciated since it is deemed to have an indefinite useful life.

 

The assets’ residual values and useful lives are reviewed when necessary.

 

a.3) Gains and losses on sale

 

Gains and losses on sales are determined by comparing the results with the carrying amounts and are recognized in Other operating income/(expenses) in the income statement.

 

b) Leases

 

With the adoption of IFRS 16 – Leasings, the Company begun to recognize a right-of-use asset and a liability at the date of the beginning of the lease term.

 

The Company recognizes the right-of-use asset and a corresponding lease liability related to all lease contracts which is the lessee, except for short-term leases (defined as leases with terms of 12-month or less) and leases of low value assets. To these leases, Company recognizes the lease payments as operating expense during the lease course.

The right-of-use asset is initially measured at cost, which includes the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date. The asset is subsequently depreciated on a straight-line basis over the lease term or until the end of the asset's useful life.

Currently, the main leases by the Company are related to trucks, forklifts, real estate, commercial vehicles and industrial equipment contracts.

 

The lease liability is initially measured at lease payments present value, discounted by using the rate implicit in the lease. If the rate cannot be promptly determined, Company uses its incremental loan rate specific for the country, term and currency of the contract or other local criteria.

 

Lease payments include fixed payments, less any lease incentives, variable lease payments that depend on an index or known rate at the commencement date, and purchase options or extension options payments if the Company is reasonably certain to exercise these options. In general, the contracts establish an annual readjustment of payments according to the rates established in the contract.

 

A lease liability is remeasured upon a change in the lease term, or on the future payments or alteration of an index or rate used to determine payments, the corresponding adjustment is made to the related right-of-use asset.

 

The Company applies IAS 36 - Impairment of Assets to determine if right-of-use asset is subject to impairment and to record eventual losses by impairment.

 

The lease liability is disclosed at “Interest-bearing loans and borrowing” line and the right-of-use assets are disclosed at “Property, plant and equipment” line of the balance sheet.

XML 36 R21.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
GOODWILL

 

15.GOODWILL

 

   
  2023 2022
     
Balance at the end of the previous year 40,594.0  42,411.3 
Effects of movements in foreign exchange in the balance sheet (4,067.9) (3,510.6)
Effect of application of IAS 29 (hyperinflation) 1,481.1  1,709.9 
Acquisitions, (write-offs) and disposal through business combinations (3.6) (16.6)
Balance at the end of the year 38,003.6  40,594.0 

 

The carrying amount of goodwill was allocated to the different cash generating unit (“CGU”) as follows:

 

     
  Functional currency 2023 2022
       
Brazil BRL 17,698.8  17,702.4 
Goodwill   102,941.4  102,945.0 
 Non-controlling transactions (i)   (85,242.6) (85,242.6)
       
CAC:      
Dominican Republic DOP 3,805.5  4,231.6 
Panama PAB 1,682.9  1,813.8 
       
Latin America - South:      
Argentina ARS 2,183.8  3,463.0 
Bolivia BOB 1,712.5  1,845.6 
Chile CLP 47.9  53.1 
Paraguay PYG 888.2  953.8 
Uruguay UYU 184.0  193.1 
       
Canada CAD 9,800.0  10,337.6 
    38,003.6  40,594.0 

 

(i)This refers to the shareholding exchange transaction in 2013 as a result of the adoption of the predecessor basis of accounting.

 

The assets with indefinite useful life represent approximately 29% of the total consolidated assets at December 31, 2023 (29% at December 31, 2022).

Accounting policies

 

Goodwill arises on acquisitions of subsidiaries, associates, and joint arrangements and is determined as the excess between: the sum of (i) the consideration paid in exchange for control of the acquiree; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired and liabilities assumed, measured in accordance with IFRS 3 - Business Combination as at the date of acquisition.

 

Business combinations are recognized applying the investment cost allocation method. If the company's share of the net fair value of the recognized assets, liabilities, and contingent liabilities exceeds the cost of the business combination, such excess is immediately recognized in the income statement. In a business combination, the asset with indefinite useful life is allocated from the acquisition date to each CGU expected to benefit from the business combination synergies.

 

In compliance with IFRS 3, goodwill is carried at cost and not amortized, but is tested for impairment at least annually, or whenever there are indications that the CGU to which the goodwill has been allocated could be impaired. Impairment losses recognized on goodwill are not reversed. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.

 

For associates and joint ventures, goodwill is included in the carrying amount of the investment in the associate/joint venture.

 

Goodwill is expressed in the functional currency of the CGU or joint operation to which it relates and translated into Reais using the year-end exchange rate.

Expenditure on internally generated goodwill is expensed as it is incurred.

 

Goodwill includes the effects of applying the predecessor basis of accounting (Note 3 (3.2.5.1)).

XML 37 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
IMPAIRMENT OF NON-FINANCIAL ASSETS
12 Months Ended
Dec. 31, 2023
Impairment Of Non-financial Assets  
IMPAIRMENT OF NON-FINANCIAL ASSETS

 

16.IMPAIRMENT OF NON-FINANCIAL ASSETS

 

The Company cannot predict whether an event that could triggers impairment will occur, when it will occur or how it will affect the value of the asset reported. The Company believes that all its estimates are reasonable, are consistent with the Company’s internal reporting and reflect Management’s best estimates. However, inherent uncertainty exists which Management is not able to control. While changes in estimates could have a material impact on the calculation of fair values, and trigger impairment, the Company, based on the sensitivity analysis performed, is not aware of any reasonably possible changes in key assumptions that would cause a business unit’s carrying amount to exceed its recoverable amount.

 

For the year ended December 31, 2023, the Company performed impairment testing of the non-current assets of the Group (property, plant and equipment, intangible assets, goodwill, and right-of-use assets) for CGUs that had goodwill and assets with indefinite useful life allocated, as well as for other CGUs that showed indicators of impairment. The Company assesses internal and external sources of information as indicators, in accordance with IAS 36 - Impairment of Assets.

 

As a result of the impairment tests conducted, the Company did not identify any impairment or reversal of impairment losses scenario for any asset or CGU.

 

16.1 Assets with definite useful life

The company did not identify impairment indicators in the assets with definite useful life.

 

16.2 Assets with indefinite useful life

16.2.1 Methodology

The methodology used by the Company to determine the recoverable value of all its CGUs is the net fair value of selling expenses, using multiples of the profit before financial result, income tax and depreciation and amortization expenses (“EBITDA”), observed in the market for previous comparable business transactions in the domestic and international brewing industry. The values used by the Company for this approach are based on external sources of information. This measurement is classified at Level 2 of the fair value hierarchy, since the main source of information used by the Company to determine the recoverable value was the EBITDA multiples of observable transactions involving comparable businesses. As part of this multiples analysis, the Company has established that CGUs with invested capital that exceeds seven times their EBITDA should have their recoverable value determined using the value-in-use approach, to determine whether the value-in-use exceeds the carrying amount of the CGU. Based on the most recent analysis carried out by the Company, for 2023, only Chile and Panama met this criterion. Additionally, Brasil CGU was also included in the scope of testing, as it is the most representative CGU of the Group.

 

Thus, for Brazil, Panama and Chile CGUs, the Company also used discounted cash flow projections to determine the CGUs’ recoverable amounts, to corroborate the conclusions reached by applying the fair value less disposal costs approach that the carrying amount of these CGUs does not exceed their recognized accounting values.

16.2.2 Key assumptions

 

The key judgments, estimates and key assumptions used for the discounted free cash flow calculations for these CGUs were as follow:

 

§The first year of the model is based on management's best estimate of the free cash flow outlook for the current year.

 

§To the second year of the model, the free cash flow is based on AB InBev's strategic plan, as approved by key management. AB InBev's strategic plan is prepared on a per country basis, and is based on external sources of macroeconomic assumptions, industry trends, inflation and foreign exchange rates, experience and identified initiatives in terms of market share, revenue, variable and fixed costs, capital expenditure and working capital assumptions.

 

§From the third to the tenth year of the model, the cash flow is extrapolated using the growth in volumes, price indexes, and expected market share for each CGU. For Chile, the best estimates from local Management were considered.

 

§Projections are made in the functional currency of the business unit and discounted at the unit's weighted average cost of capital (“WACC”), considering sensitivities of this metric.

 

Based on the cash flow analysis, the growth rates applied ranged from 1.2% to 8.1%.

 

The nominal WACC applied in the local currency for each CGU was as follows:

 

 
CGU 2023
Chile 9.83%
Panama 10.72%
Brazil 12.38%

 

Although Ambev believes that its judgments, assumptions and estimates are appropriate, actual results may differ from these estimates based on different assumptions or market or macroeconomic conditions.

 

16.2.3 Sensitivity analysis

Based on the probable scenario, a sensitivity analysis was carried out for a 0.5 percentage point increase / decrease in the discount rate and growth rate. In any combination, the value of the cash flow is higher than its book value. As a result of this analysis, there is no need to record any provision to impairment from these assets.

 

Accounting Polices

 

The carrying amounts of non-financial assets, such as property, plant and equipment, goodwill and intangible assets without defined useful lives are reviewed, at least, at each reporting date to determine the existence of any indication of impairment. If there is any indication, the asset’s recoverable amount is estimated, and the non-recoverable amount is recognized as an impairment in the income statement. This assessment is performed for assets individually or for the smallest identifiable groups of assets that generate cash inflows independent of the cash inflows from other assets or other groups of assets, also referred to as CGUs.

 

Goodwill, intangible assets not yet available for use, and intangibles with indefinite useful lives, are tested for impairment at the business unit level (one level below the reportable segment level) at least annually, or whenever there is any indication of impairment. An impairment loss is recognized whenever the carrying amount of an asset or the related CGU exceeds its recoverable amount. Impairment losses are recognized in the income statement.

 

An impairment loss is recognized whenever the carrying amount of an asset or the related CGU exceeds its recoverable amount. Impairment losses are recognized in the income statement. Intangible assets with an indefinite useful life are tested on a fair value approach applying multiples that reflect current market transactions to indicators that drive the profitability of the asset or the royalty stream that could be obtained from licensing the intangible asset to another party in an arm’s length transaction.

 

The recoverable amounts of other assets are determined as the higher of their fair value less costs to sell and their value in use. For an asset that does not generate substantially independent cash inflows, the recoverable amount is allocated to the CGU to which the asset belongs. The recoverable amounts of the CGU to which the goodwill and the intangible assets with indefinite useful lives belong are based on the fair value net of selling expenses, using EBITDA multiples observed in the market for previous business combinations involving comparable businesses in the brewing industry. For some CGUs, these calculations are corroborated using the fair-value less costs of disposal approach, where the free cash flow of these CGUs is discounted to fair value using a discount rate after tax that reflects current valuation models for the time value of money, and the risks specific to the asset.

 

Impairment losses recognized in CGUs carrying amount of goodwill allocated to the CGUs and subsequently impact the carrying amount of the assets within the unit. Reversals of previously recognized impairments may occur, except for impairment losses related to goodwill due to expected future profitability. Non-financial assets are reviewed for the possible reversal of the impairment at the reporting date. Impairment losses are reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization.

XML 38 R23.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
INTANGIBLES

 

17.INTANGIBLES

 

                     
                    Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Additions Transfers  Disposal  Amortization At December 31, 2022   Acquisition cost Depreciation
Brands 6,329.0  (1,096.2) 930.3  -    -    -    -    6,163.1    6,163.1  -   
Intangibles 671.2  (44.7) 0.1  -    3.2  -    (58.1) 571.7    3,308.6  (2,736.9)
Software 1,129.7  (130.6) 126.9  6.9  1,402.3  -    (401.1) 2,134.1    4,353.9  (2,219.8)
Others 559.1  (96.0) 76.8  220.5  (364.1) -    (43.0) 353.3    1,218.8  (865.5)
Total 8,689.0  (1,367.5) 1,134.1  227.4  1,041.4  -    (502.2) 9,222.2    15,044.4  (5,822.2)

 

                    Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Additions Transfers  Disposal  Amortization At December 31, 2023   Acquisition cost Depreciation
Brands 6,163.1  (1,838.5) 808.6  73.9  -    -    -    5,207.1    5,207.1  -   
Intangibles 571.7  (33.5) -    869.3  -    -    (56.7) 1,350.8    4,087.0  (2,736.2)
Software 2,134.1  (344.6) 176.2  37.0  976.5  (0.9) (573.5) 2,404.8    4,954.2  (2,549.4)
Others 353.3  (32.9) 11.0  487.7  317.0  (0.7) (56.4) 1,079.0    1,837.9  (758.9)
Total 9,222.2  (2,249.5) 995.8  1,467.9  1,293.5  (1.6) (686.6) 10,041.7    16,086.2  (6,044.5)

 

Intangibles with indefinite useful life

 

The carrying value of intangible assets with indefinite useful lives classified as brands were allocated to the following CGUs:

   
  2023 2022
Argentina 1,303.7  2,019.2 
Bolivia 830.0  894.5 
Brazil 73.9  -   
Canada 195.7  206.4 
Chile 70.7  78.5 
Luxembourg 339.6  339.6 
Paraguay 504.7  542.7 
Dominican Republic 1,431.5  1,593.0 
Panama 333.0  358.8 
Uruguay 124.3  130.4 
  5,207.1  6,163.1 

 

Intangible assets with indefinite useful lives have been tested for impairment on a CGU level basis, which is consistent with the approach described in Note 16 – Impairment of Non-Financial assets.

 

The Company is implementing a new version of its principal enterprise resource planning (ERP) - S4/Hana, an SAP platform, whose capitalizable investments are recognized as intangible assets in the software line. The implementation is necessary to update and improve the company's technological environment. In the context of the implementation, several assessments were carried out by Management, including from the perspective of internal controls, to mitigate risks connected to this type of upgrade, such as operational risks, operational disruption, data integrity and regulatory compliance.

 

Accounting policies

 

The intangibles are recognized at cost of acquisition, net of accumulated amortization and impairment losses.

 

Intangible assets with definite useful lives are amortized on a straight-line basis over their estimated useful lives. Licenses, supply, and distribution rights are amortized over the period for which the rights exist, based on the contract terms, which vary, in general, from 1 to 8 years. Brands are considered to have indefinite lives, and therefore, are not amortized. Software and capitalized development costs related to technology are amortized over a period of 3 to 10 years. Items that are not amortized are tested for impairment on an annual basis

 

Net gains on sales of intangible assets are disclosed in the income statement as other operating income. Net losses on sales are included as other operating expenses. Net gains and losses are recorded in income statement when control is transferred to the buyer, the counterpart recovery is possible and associated costs can be reliably estimated

 

(a) Brands

The Company is the owner of some of the world’s leading brands in the beer industry. As a result, brands are expected to generate positive cash flow for as long as the Company owns the brands, and accordingly they have been assigned indefinite useful lives. The most representative brands that have been recorded as a result of the fair value determination of past acquisitions are Quilmes in Argentina, Pilsen in Paraguay, Paceña and Huari in Bolivia and Presidente and Presidente Light in the Dominican Republic.

 

When a portion of the consideration paid in a business combination relates to brands, this is recognized in a specific Intangible Assets account, and measured at fair values as at the acquisition date. Subsequently, the value of brands can be reduced in the case of impairment losses. Internally generated expenditure for brand development is recognized within expenses.

 

(b) Software

Purchased software is measured at cost less accumulated amortization. Amortization related to software is included in the cost of sales, commercial expenses or administrative expenses, based on the business activity which the software is intended to support.

 

The expenditures related to software maintenance are recognized as expense, as incurred. The expenditures with development, as the expenditures with employees allocated in software development, which are directly attributed to identifiable and exclusive software, controlled by the Company, are recognized as intangible assets.

 

(c) Commercial intangibles

The Company recognizes supply rights, which consists in the right that Company has to supply for a customer and the commitment from the customer to buy Company’s products. And distribution rights that are the rights of selling specific products in a given territory.

 

(d) Other intangible assets

Other intangible assets also include multi-year sponsorship rights acquired by the Company. These are initially recognized at the present value of the future payments and subsequently measured at cost less accumulated amortization and impairment losses.

XML 39 R24.htm IDEA: XBRL DOCUMENT v3.24.0.1
RECOVERABLE TAXES
12 Months Ended
Dec. 31, 2023
Recoverable Taxes  
RECOVERABLE TAXES

 

18.RECOVERABLE TAXES

 

   
  2023 2022
PIS/COFINS exclusion of ICMS (i) 6,490.4  5,992.8 
ICMS 436.5  423.2 
Income tax and social contributions recoverable 4,087.0  4,607.5 
Other 311.2  292.8 
Non-current 11,325.1  11,316.3 
     
PIS/COFINS exclusion of ICMS (i) 219.0  73.5 
PIS/COFINS 170.4  242.7 
ICMS 426.9  542.2 
IPI 112.5  131.0 
Income tax and social contributions recoverable 2,436.6  1,808.7 
Other 70.3  55.4 
Current 3,435.7  2,853.5 
     
Total 14,760.8  14,169.8 

 

(i)As detailed in Note 27.2 - Contingencies, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS from the substitution of tax basis for contribution.

 

Accounting policies

 

Recognition of assets and liabilities relating to extemporaneous tax debits or credits

 

The accounting policy applied by the Company considers the extemporaneous tax credits and debits of any nature as determined by IAS 37 - Provisions, Contingent Liabilities and Contingent Assets, except for income taxes, for which the policy disclosed in note 13 – Income tax and social contribution is applied.

 

According to this policy, tax credits are recognized only when Management (i) has elements that guarantee that the credit is virtually certain; and (ii) the amount to be offset or refunded can be reliably measured. In cases where the recovery of the asset is probable, or the amount cannot be reliably measured, the amounts are not recognized in the account, but presented in Note 27 - Provisions, Contingent Liabilities and Contingent Assets related to contingent assets. Management understands that, in cases of lawsuits involving contingent assets, a final and unappealable decision on the specific lawsuit of the Company is required to confirm the existence of its rights, except where specific circumstances pertinent to the case allow the recognition of its rights with sufficient objectivity and reliability.

 

To measure the amounts of extemporaneous tax credits arising from lawsuits, the Company evaluates the documents for the period covered by the lawsuit, and applies the guidelines for the final decision, applicable legislation or other elements that enable the amount to be estimated with sufficient reliability.

 

Debts of the same nature are recognized if (i) they arise from a past event; (ii) there is a present obligation; (iii) the expected outflow of resources is probable and (iv) the amounts are reliably estimated. If the expectation of disbursement is possible or the amount cannot be reliably measured, the amounts are presented in Note 27.2 - Contingencies.

 

Both contingent assets and liabilities are assessed periodically to ensure that they are appropriately reflected and disclosed in the financial statements.

 

The accounting policy for the recognition of assets and liabilities of extemporaneous tax credits and debits of any nature are recorded as “Other operating income/(expenses)”, except for amnesty payments, which are recorded as exceptional items, given their one-off nature.

XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
INVENTORY

 

19.INVENTORY

 

   
  2023 2022
     
Finished goods  2,990.3  4,094.0 
Work in progress 826.5  845.7 
Raw materials and consumables 4,599.9  6,798.3 
Spare parts and others 806.9  986.9 
Prepayments 537.9  358.3 
Impairment losses (142.5) (160.2)
Total 9,619.0  12,923.0 

 

The changes in impairment losses on inventory, are as follows:

 

   
  2023 2022
Beginning balance (160.2) (157.8)
Effects of movements in foreign exchange in the balance sheet 12.9  17.8 
Provisions (262.9) (305.8)
Write-off 267.7  285.6 
Final balance (142.5) (160.2)

 

 

Accounting policies

 

Inventory is initially recorded at the acquisition cost and subsequent valued at the lower of their cost and net realizable value. Cost includes expenditure incurred to acquire the inventory, non-recoverable taxes, and the costs to bring it to the location and condition required for use. The weighted average method is used to determine the cost of inventory.

 

The cost of finished products and work in progress includes raw materials, other production materials, direct labor, other direct costs, gains and losses on derivative financial instruments, and an allocation of fixed and variable overheads based on the normal operating capacity. Fixed costs not allocated or idle costs not held in inventory, are recognized directly in the income statement, as determined by IAS 2- Inventories

.

 

The net realizable value is the estimated selling price in the ordinary course of business, less the costs of bringing the inventory to the condition required for sale, and the selling costs. The calculation of the net realizable value takes into consideration the specific characteristics of each category of inventory, such as the expiry date, the remaining shelf life, and any indicators of slow-moving inventory, amongst others.

 

Provisions for impairment losses are constituted, when necessary, in compliance with write-offs, slow moving and obsolete inventory of Company’s policies.

XML 41 R26.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE RECEIVABLES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
TRADE RECEIVABLES

 

20.TRADE RECEIVABLES

 

   
  2023 2022
     
Trade receivables 6,225.8  5,737.5 
Bad debt provision (721.0) (679.1)
Net, trade receivables  5,504.8  5,058.4 
Related parties (Note 30) 236.7  290.7 
Total current trade receivables  5,741.5  5,349.1 

 

The details of the aging of the Company’s current trade receivables are as follows:

 

             
  2023   2022
  Trade receivables Bad debt provision Trade receivables, net   Trade receivables Bad debt provision Trade receivables, net
No past due 5,129.5  -    5,129.5    4,573.0  -    4,573.0 
Past due – within 30 days 283.4  -    283.4    343.8  -    343.8 
Past due – between 31 - 60 days  66.3  -    66.3    100.5  (0.3) 100.2 
Past due – between 61 - 90 days 33.2  (7.7) 25.5    49.4  (10.8) 38.6 
Past due – between 91 - 180 days 6.5  (6.4) 0.1    19.3  (16.5) 2.8 
Past due – between 181 - 360 days 46.6  (46.6) -      40.2  (40.2) -   
Past due over 360 days 660.3  (660.3) -      611.3  (611.3) -   
Net carrying amount as of December 31, 6,225.8  (721.0) 5,504.8    5,737.5  (679.1) 5,058.4 

 

 

The changes of the estimated loss for doubtful debts, are as follows:

 

   
  2023 2022
Beginning balance (679.1) (668.3)
Effects of movements in foreign exchange in the balance sheet 12.3  14.0 
Additions (103.6) (47.0)
Reversals 8.3  1.7 
Write-off 41.1  20.5 
Final balance (721.0) (679.1)

 

The Company’s exposure to credit risks, currency and interest rate risks is disclosed in Note 28 - Financial instruments and risks.

 

Accounting policies

 

Trade receivables are amounts due from customers for goods sold or services performed in the ordinary course of business. Trade receivables are recognized initially at the amount of the unconditional consideration, unless they contain significant financing components, in which case they are recognized at fair value.

 

The Company applies the IFRS 9 simplified approach to measuring expected credit losses whereby impairment allowances for trade receivables are measured upon initial recognition on the basis of the expected 12-month credit losses. This is primarily based on past experience of credit losses, current data on overdue receivables and credit score information. Prospective information (such as forecast economic performance indicators) is also taken into consideration if, based on past experience, such indicators show a strong correlation with actual credit losses. Typically trade receivables which are outstanding for more than 90 days are fully provisioned.

 

If security receiving deadline is equal or less than a year, trade receivables are categorized in current assets. Otherwise, its disclosed in non-current assets.

XML 42 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES

 

21.CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES

 

21.1 Cash and equivalents

 

   
  2023 2022
Short-term bank deposits (i) 8,973.6  8,655.2 
Current bank accounts 6,818.3  5,990.3 
Cash 267.1  280.9 
Cash and cash equivalents 16,059.0  14,926.4 
     
Bank overdrafts -    (74.3)
Cash and cash equivalents less bank overdraft 16,059.0  14,852.1 

 

(i)The balance refers mostly to Bank Deposit Certificates (“CDB”), with high liquidity, which are readily convertible into known amounts of cash, and which are subject to an insignificant risk of change in value.

 

The cash and cash equivalents balance include the amount to R$ 3,768 million in December 31, 2023 (R$3,083 million in December 31, 2022), which is not freely transferable to the parent company due to remittance restrictions in Cuba and Argentina, although available for use in the local operations of the subsidiaries in question.

 

 

21.2 Investment securities

 

   
Investment_securities 2023 2022
     
Investment on debt securities (i) 242.2  219.1 
Non-current investment securities 242.2  219.1 
     
Financial assets at fair value through profit or loss 277.2  454.5 
Current investment securities 277.2  454.5 
     
Total 519.4  673.6 

 

(i)The balance refers substantially to financial investments linked to tax incentives that do not have immediate convertibility into a known amount of cash.

 

Accounting policies

 

Cash and cash equivalents include all cash balances, bank deposits, and short-term highly with due date until 90 days, liquid investments with an insignificant risk of changes in value which are readily convertible into cash. They are stated at their face value, which approximates the fair value.

 

Other financial investments that do not satisfy the classification criteria as cash equivalents, for example, with maturities superior to 90 days from the date they were contracted, are presented as financial investments. These assets are initially measured at fair value and, depending on how these resources are managed and the characteristics of the contractual cash flows, their category may change:

 

·Amortized cost: "non-derivative" financial assets for which the purpose of the business model is to hold the assets in order to receive the contractual cash flows on specific dates (principal and interest).

 

·Fair value through profit or loss: financial assets for which the Company's objective is to receive a sale. They are presented in current assets based on their expected realization.

 

Cash and cash equivalents and short-term investments are held at financial institutions with low credit risk, based or domiciled in Brazil or abroad. For the cash flow statement, cash and cash equivalents are presented net of bank overdrafts, when applicable.

 

XML 43 R28.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY
12 Months Ended
Dec. 31, 2023
Changes In Equity  
CHANGES IN EQUITY

 

22.CHANGES IN EQUITY

 

22.1 Issued capital

 

At 31 December 2023, the authorized share capital, fully subscribed and paid-in, in the amount of R$58,177.9 (R$58,130.5 in 2022 and R$58,042.5 in 2021) in the amount of 15,753.8 common shares (15,750.2 in 2022 and 15,744.5 in 2021) book entry, nominative, without nominal value, thus distributed:

 

               
  2023   2022   2021
Shareholder Million common shares %   Million common shares %   Million common shares %
Interbrew International B.V. 8,441.7 53.6%   8,441.8 53.6%   8,441.9 53.6%
Ambrew S.A.R.L. 1,287.7 8.2%   1,287.7 8.2%   1,287.0 8.2%
Fundação Zerrenner 1,610.0 10.2%   1,610.0 10.2%   1,610.0 10.2%
Mercado 4,410.0 28.0%   4,402.2 27.9%   4,399.7 27.9%
Tesouraria 4.4 0.0%   8.5 0.1%   5.8 0.0%
  15,753.8 100.0%   15,750.2 100.0%   15,744.4 100.0%

 

    2023     2022     2021
  Million common shares Million Reais   Million common shares Million Reais   Million common shares Million Reais
                 
Beginning balance 15,750.2  58,130.5    15,744.4  58,042.5    15,735.1  57,899.1 
Capital increase (i) 3.6  47.4    5.8  88.0    9.3  143.4 
Final balance 15,753.8  58,177.9    15,750.2  58,130.5    15,744.4  58,042.5 

 

(i) Capital increase related to the issue of shares.

 

22.2 Capital reserves

 

         
  Capital Reserves   
  Treasury shares  Share Premium  Other capital reserves  Share-based Payments   Total 
           
At January 1, 2021 (941.7) 53,662.8  700.9  1,563.6  54,985.6 
Capital Increase (60.0) -    -    (74.4) (134.4)
Purchases of shares, results of treasury shares and share-based payments (36.1) -    -    372.1  336.0 
At December 31, 2021 (1,037.8) 53,662.8  700.9  1,861.3  55,187.2 
Capital Increase -    -    -    (64.2) (64.2)
Purchases of shares, results of treasury shares and share-based payments (35.6) -    -    252.4  216.8 
At December 31, 2022 (1,073.4) 53,662.8  700.9  2,049.5  55,339.8 
Capital Increase -    -    -    (32.9) (32.9)
Purchases of shares, results of treasury shares and share-based payments 61.6  -    -    111.2  172.8 
At December 31, 2023 (1,011.8) 53,662.8  700.9  2,127.8  55,479.7 

 

 

22.2.1 Purchase of shares and result of treasury shares

Treasury shares represent the Company’s own issued shares reacquired by the Company, and the results of treasury shares related to gains and losses on share-based payment transactions and others. The changes in treasury shares are as follow:

             
  Acquisition /realization of shares   Result of Treasury Shares   Total Treasury Shares
  Million shares   Million Brazilian Reais   Million shares   Million Brazilian Reais
At January 1, 2021 0.2    (3.2)   (938.5)   (941.7)
Changes during the year 5.6    (95.1)   (1.0)   (96.1)
At December 31, 2021 5.8    (98.3)   (939.5)   (1,037.8)
Changes during the year 2.7    (33.5)   (2.1)   (35.6)
At December 31, 2022 8.5    (131.8)   (941.6)   (1,073.4)
Changes during the year (4.1)   68.8    (7.2)   61.6 
At December 31, 2023 4.4    (63.0)   (948.8)   (1,011.8)

 

22.2.2 Share premium

 

The share premium refers to the difference between the subscription price that the shareholders paid for the shares and their nominal value. Since this is a capital reserve, it can only be used to increase capital, offset losses, or for the redemption, reimbursement or repurchase of shares.

22.2.3 Share-based payment

Different share-based payment programs and stock purchase option plans allow the senior management from Ambev’s economic group to acquire shares in the Company. The share-based payment reserve recorded a charge of R$331.6 in 2023 (R$313.9 and R$387.6 in 2022 and 2021, respectively) (Note 25 - Share-based payments).

 

22.3 Net income reserves

 

       
  Net income reserves
  Investments reserve  Legal reserve   Fiscal incentive  Total
At January 1, 2021 14,511.1  4.5  11,404.4  25,920.0 
Fiscal incentive reserve  -    -    1,423.5  1,423.5 
Investments reserve  3,848.1  -    -    3,848.1 
At December 31, 2021 18,359.2  4.5  12,827.9  31,191.6 
Fiscal incentive reserve  -    -    2,018.7  2,018.7 
Investments reserve  3,696.7  -    -    3,696.7 
At December 31, 2022 22,055.9  4.5  14,846.6  36,907.0 
Fiscal incentive reserve  -    -    2,552.7  2,552.7 
Investments reserve  3,730.2  -    -    3,730.2 
At December 31, 2023 25,786.1  4.5  17,399.3  43,189.9 

 

22.3.1 Investments reserve

From the net income after applicable deductions, there will be a target allocating of no more than 60% (sixty per cent) of the adjusted net profit to the investment reserve, to be used to support future investments.

 

22.3.2 Legal reserve

From the net income, 5% will be applied before any other allocation, to the legal reserve, which cannot exceed 20% of the issued capital. The Company is not required to supplement the legal reserve for the year when the balance of this reserve, plus the amount of the capital reserves, exceeds 30% of the issued capital.

22.3.3 Tax incentives

The Company recognizes annually in its equity, in the net income reserves line, the fiscal incentives regarding tax benefits at the government subsidies for the current year.

 

In general, these incentives are related to industrial development programs that aim to generate employment, promote regional decentralization, and complement and diversify the industrial base of the states. In these states, the grace periods and use and reductions are set out under the respective state normative acts, and when conditions for obtaining these grants exist, they are under Company’s control. The treatment of incentives complies with the provisions of current federal, state and municipal legislation, in particular set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. Due to change in article 30 of Federal Law 12,973/14 by Complementary Federal Law 160/2017, state fiscal incentives related to sales taxes are recognized as government subsidies for investments. in line with the interpretation of the Superior Court of Justice manifested mainly in the judgment of ERESP No. 1.517.492/PR, as well as in the judgment of Theme No. 1.182 and of the Federal Supreme Court, according to the manifestations expressed in the judgment of Theme 843.

 

22.3.4 Interest on shareholders’ equity / dividends

Brazilian companies are permitted to distribute the interest attributed to shareholders’ equity calculated based on the long-term interest rate (“TJLP”), with such interest being tax-deductible, in accordance with the applicable law and, when distributed, may be considered part of the minimum mandatory dividends.

As determined by its by-laws, the Company is required to distribute to its shareholders, as a minimum mandatory dividend in respect of each fiscal year ending December 31, an amount of not less than 40% of its net income determined under Brazilian law, adjusted in accordance with the applicable law, unless the payment of such amount would be incompatible with Ambev’s financial situation. The minimum mandatory dividend includes amounts paid as interest on shareholders’ equity.

Events during the year ended 2023:

 

             
Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/12/2023 Interest on shareholder´s equity 12/28/2023 2023 ON 0.7302 11,500.2 
              11,500.2 

 

Distribution of interest on shareholders’s equity. In accordance with Operations and Finance Committee recommendation at the meeting held on December 12, 2023, was approved the distribution of interest on shareholder’s equity in the amount of R$0.7302 per share, based on available balances, in the Company’s extraordinary balance sheet dated as of November 30, 2023, (the survey of which was approved by the Board of Directors at the meeting held on December 12, 2023) and in the Company’s investment reserve, pursuant to the balance sheet dated as of December 31, 2022, which were attributed to the minimum mandatory dividends of the same fiscal year. The interest on shareholder’s equity distribution was taxed pursuant to the applicable law, which resulted in a net interest on shareholder’s equity distribution of R$0.6207 per share of, except for shareholders that are corporate entities that are immune or exempted pursuant to article 5 of Law 11,053/04, as amended by Law 11,196/05.

 

The indicated payment was made on December 28, 2023, considering the shareholding position of December 19, 2022, with respect to B3, and December 26, 2023, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Events during the year ended 2022:

 

Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/06/2022 Interest on shareholder´s equity 12/29/2022 2022 ON 0.7623 11,999.8 
              11,999.8 

 

Distribution of Dividends in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 5, 2022, was approved the distribution of dividends of R$0.7623 per share, based on available balance and the Company’s extraordinary balance sheet dated as of October 31, 2022 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$0.6480 per share of the Company in 2022.

 

The indicated payment was made on December 29, 2022, considering the shareholding position of December 19, 2022, with respect to B3, and December 21, 2022, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Events during the year ended 2021:

 

Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/09/2021 Dividends 12/30/2021 2021 ON 0.1334 2,099.5 
Board of Directors Meeting 12/09/2021 Interest on shareholder´s equity 12/30/2021 2021 ON 0.4702 7,400.1 
              9,499.6 

 

Distribution of Dividends in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 07, 2021, was approved the distribution of dividends of R$0.1334 per share, based on available balance and the Company’s extraordinary balance sheet dated as of November 30, 2021 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation.

 

The indicated payment was made on December 30, 2021, considering the shareholding position of December 17, 2021, with respect to B3, and December 21, 2021, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Distribution of interest on shareholder’s equity in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 7, 2021, was approved the distribution of interest on shareholder’s equity of R$0.4702 per share, based on available balance and the Company’s extraordinary balance sheet dated as of November 30, 2021, and attributed to the minimum mandatory dividends for the same fiscal year. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$0.3996 per share.

 

The indicated payment was made on December 30, 2021, considering the shareholding position of December 17, 2020, with respect to B3, and December 21, 2021, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

22.3.5 Destinations

 

At December 31, 2023, the Company has made appropriations to retained earnings, in accordance with the Brazilian Corporate law and the Company’s bylaws. The dividends payments made up to December 31, 2023, were approved at the Board of Directors’ Meeting.

Regarding the basis for dividends, the Company believes that the predecessor basis of accounting, as well as its presentation for comparative purposes, will not affect the determination of the minimum mandatory dividend. Therefore, the Company intends to adjust the calculation basis of the minimum mandatory dividend to cancel out any current and future impacts on net income arising from the adoption of this accounting practice, related to the amortization/depreciation of surplus assets or even a possible impairment of goodwill, thus preserving the mandatory minimum dividends.

 

         
  2023   2022   2021
Net income, attributable to equity holders of Ambev 14,501.9    14,457.9    12,671.0 
Prescribed/(complementary) dividends -      20.9    24.7 
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting 11.8    11.8    11.8 
Effect of application of IAS 29 (hyperinflation) 3,269.4    3,224.4    2,063.7 
Retained earnings basis for dividends and destinations 17,783.1    17,715.0    14,771.2 
           
Dividends and interest on capital distributed and accrued for distribution based on the net income for the year          
Dividends and interest on capital paid based on profit 11,500.2    11,999.8    9,499.6 
Total of dividends and interest on capital  11,500.2    11,999.8    9,499.6 
Percentage of distributed profit 65%   68%   64%

 

22.5 Carrying value adjustments

 

               
  Carrying value adjustments  
  Translation reserves Cash flow hedge Actuarial gains/ (losses) Put option granted on subsidiary Gains/(losses) of non-controlling interest’s share Business combination Accounting adjustments for transactions between shareholders Total
                 
At January 1, 2021 11,076.5 744.5 (1,473.3) (4.8) (73.8) 156.1 (75,414.2) (64,989.0)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations 2,449.7 - - - - - - 2,449.7
Cash flow hedges - 480.8 - - - - - 480.8
Actuarial gains/(losses) - - 341.8 - - - - 341.8
Total Comprehensive income 2,449.7 480.8 341.8 - - - - 3,272.3
Options granted on subsidiaries - - - (1.9) - - - (1.9)
Gains/(losses) of controlling interest - - - - (46.2) - - (46.2)
Tax on deemed dividends - - - - (1.7) - - (1.7)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2021 13,526.2 1,225.3 (1,131.5) (6.7) (121.7) 156.1 (75,426.0) (61,778.3)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations (6,772.2) - - - - - - (6,772.2)
Cash flow hedges - (316.7) - - - - - (316.7)
Actuarial gains/(losses) - - 466.5 - - - - 466.5
Total Comprehensive income (6,772.2) (316.7) 466.5 - - - - (6,622.4)
Gains/(losses) of controlling interest - - - - (2.8) - - (2.8)
Tax on deemed dividends - - - - (6.2) - - (6.2)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2022 6,754.0 908.6 (665.0) (6.7) (130.7) 156.1 (75,437.8) (68,421.5)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations (9,212.4) - - - - - - (9,212.4)
Cash flow hedges - (210.8) - - - - - (210.8)
Actuarial gains/(losses) - - (13.2) - - - - (13.2)
Total Comprehensive income (9,212.4) (210.8) (13.2) - - - - (9,436.4)
Options granted on subsidiaries - - - 6.7 - - - 6.7
Gains/(losses) of controlling interest - - - - (2.6) - - (2.6)
Tax on deemed dividends - - - - (12.4) - - (12.4)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2023 (2,458.4) 697.8 (678.2) - (145.7) 156.1 (75,449.6) (77,878.0)

 

22.5.1 Translation reserves

 

The translation reserves comprise all foreign currency exchange differences arising from the translation of the financial statements with a functional currency different to the Real.

The translation reserves also comprise the portion of the gain or loss on the foreign currency liabilities and on the derivative financial instruments determined to be effective net investment hedges.

 

22.5.2 Cash flow hedge reserves

 

The hedging reserves represent the effective portion of the cumulative net change in the fair value of cash flow hedges to the extent that the hedged risk has not yet impacted profit or loss (for additional information, see Note 28 - Financial instruments and risks).

 

22.5.3 Actuarial gains and losses

Actuarial gains and losses include expectations regarding future pension plan obligations. Consequently, the results of actuarial gains and losses are recognized on a monthly considering the best estimates available to Management, reasoned on the expectations presented in the independent actuarial report. There was no actuarial gain or loss due to a surplus or deficit in 2023.

 

22.5.4 Accounting adjustments for transactions between shareholders

 

Transactions between shareholders of the same business, even when carried out between persons who are totally independent of each other, which have a valid economic rationale and reflect usual market conditions, will be consolidated by the applicable accounting standards as having taken place within the same accounting entity.

 

As determined by IFRS 10, any difference between the amount paid (fair value) for the acquisition of a non-controlling interest and the carrying amount of such non-controlling interest shall be recognized directly in the controlling shareholders’ equity. The acquisition of the non-controlling interest related to Former Ambev, and the abovementioned adjustment was recognized in Carrying value adjustments when applicable.

 

Accounting policies

 

Issued capital and treasury shares

 

The Company's issued capital consists only of common shares. The Company holds treasury shares for future disposal, cancellation or for the payment of its executives' share-based compensation programs. When the Company buyback its own shares, the amount paid, including directly attributable costs, are recognized in a specific account under treasury shares as a reduction of shareholders' equity.

 

Share issuance costs

 

Incremental costs directly attributable to the issuance of new shares or options are presented in equity as a deduction, net of tax, from the proceeds.

 

Dividends and interest on shareholder’s equity

 

Dividends and interest on shareholders’ equity are recognized in liabilities from the date on which they are approved by a Board of Directors’ Meeting, except for the minimum statutory dividends provided for under the Company’s bylaws, which are recognized as a liability, when applicable, at the end of each fiscal year.

 

The interest expense attributable to capital to shareholders is recognized in income for the purposes of the calculation of Brazilian income and social contribution tax and is subsequently reclassified from shareholders' equity for presentation purposes in the financial statements.

 

The projected effect of the deductibility of interest on shareholder´s equity is recognized in the interim financial statements in order to obtain the best estimate of the weighted average effective income tax rate expected for the full fiscal year, in accordance with IAS 34- Interim Financial Reporting.

XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTEREST-BEARING LOANS AND BORROWING
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
INTEREST-BEARING LOANS AND BORROWING

 

23.INTEREST-BEARING LOANS AND BORROWING

 

   
  2023 2022
     
Secured bank loans 111.6  126.2 
Other secured loans (i) 279.4  328.1 
Lease liabilities 1,812.0  2,333.8 
Non-current liabilities 2,203.0  2,788.1 
     
Secured bank loans 14.9  54.5 
Other secured loans (i) 136.3  144.5 
Lease liabilities 1,146.9  783.6 
Current liabilities 1,298.1  982.6 
     
Total 3,501.1  3,770.7 

 

(i)Nomenclature modified to Other secured loans, including for comparative purposes.

 

Additional information regarding the exposure of the Company to interest rate, foreign currency risk and debt repayment schedule is disclosed in Note 28 - Financial instruments and risks.

 

At December 31, 2023, and 2022 the Company’s debts were exposed to the following interest rates:

 

             
    2023     2022
Debt instruments Average rate % Current Non-current   Average rate % Current Non-current
Debt denominated in US Dollars - fixed rate 14.00% 0.0  -      14.00% 6.2  -   
Other Latin American currencies - fixed rate 11.48% 124.6  281.0    10.39% 98.8  322.5 
Debt denominated in CAD Dollars - fixed rate 5.63% 130.1  350.2    5.32% 123.3  387.7 
Reais denominated floating rate (TJLP and TR) 9.47% 13.4  111.6    9.61% 12.3  125.1 
Reais debt - ICMS fixed rate 2.95% 103.2  194.3    2.95% 113.3  266.4 
Reais debt - ICMS floating rate 6.56% 33.0  85.1    6.97% 31.1  61.7 
Reais debt - fixed rate 11.17% 893.7  1,180.7    9.43% 597.6  1,624.7 
Total   1,298.1  2,203.0      982.6  2,788.1 

 

23.1 Changes in liabilities arising from financing activities

 

The tables below detail the changes in the Company’s liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flow was, or future cash flow will be classified in the company’s consolidated statement of cash flow from financing activities.

 

             
  2023   2022
  Non - current liabilities   Current liabilities   Non - current liabilities   Current liabilities
Beginning balance 2,788.1    982.6    2,253.5    847.1 
Proceeds 49.8    -      267.0    7.9 
Payments (0.8)   (226.6)   -      (230.2)
Foreign exchange (52.8)   (19.6)   (56.8)   (17.4)
Transfers between current and non-current (1,238.0)   1,238.0    (761.0)   761.0 
New lease agreements 629.5    524.4    905.3    469.2 
Interest on leases -      193.1    -      159.3 
Lease Payments -      (1,373.2)   -      (1,014.0)
Other movements 27.2    (20.6)   180.1    (0.3)
Final balance 2,203.0    1,298.1    2,788.1    982.6 

 

23.2 Maturity of contracts

 

The above amounts have the following expect payment flow:

 

             
            Balance as of December 31, 2023
  2024 2025 2026 2027 > 2028 2023 2022
Secured bank loans 14.9  14.7  16.1  36.8  44.0  126.5  180.7 
Other secured loans (i) 136.3  151.5  114.8  3.7  9.3  415.7  472.7 
Lease liabilities 1,146.9  481.8  472.4  385.0  472.8  2,958.9  3,117.3 
  1,298.1  648.0  603.3  425.5  526.1  3,501.1  3,770.7 

 

(i)Nomenclature modified to Other secured loans, including for comparative purposes.

 

23.3 Contractual clauses (Covenants)

 

As at December 31, 2023, as well as at December 31, 2022, the Company's loans had equal rights to payment without subordination clauses between them.

Most loan contracts contain contractual covenants, such as: actions that can reduce the ability to pay the loans; maintenance of the Company's assets, purposing to assure that all remain under usage condition; restrictions on acquisitions, mergers, sales or disposals of its assets; disclosure of financial statements and the balance sheet; no prohibitions related to new guarantees for loans contracted.

These clauses are applicable from the date of execution and effectiveness of each contract to the extent that the events mentioned in the contract occur. Depending on the materiality of each event and its potential adverse effects on the Company and /or its subsidiaries or the rights of its creditors, contractual penalties may be applied, including the early maturity of the respective contract.

 

In certain contracts, in the event of occurrence of any of the events set out in the restrictive clauses, the Company may be granted a grace period to resolve any contractual defaults, in order to avoid any penalties resulting from the breach of its obligations. As of December 31,2023, as well as at December 31, 2023, the Company followed all of its contractual obligations for its loans and financing.

 

23.4 Guarantees and contractual counterparts

 

The loans and financing contracted by the Company provide for the provision of various guarantees, such as sureties and real estate, or are unsecured, except in relation to the FINAME credit lines contracted by the Company with the National Bank for Economic and Social Development ("BNDES"), in which real guarantees were provided on the assets acquired with the credit granted. These loans contracted with BNDES are subject to certain “provisions applicable to agreements entered into with BNDES” (“Provisions”) and, according to these Provisions, the borrowers, such as the Company, may not, without the prior consent of BNDES, for instance: (i) raise new loans (except for the loans described in the Provisions); (ii) give preference and/or priority to other debts; and/or (iii) dispose of or encumber any items of their fixed assets (except as provided for within the Provisions).

 

In relation to regarding the tax incentives on financing or subsidized loans, these are subject to the fulfillment of several commitments according to the legislation or contracts upon which those incentives are based on, such as (i) maintaining or generating jobs in the long term; (ii) realization of investments; (iii) increase in production capacity; (iv) ICMS collection commitments; (v) maintaining tax compliance; among others, obligations that refer to facts under the Company’s control. These commitments are applicable as from the signature date of the respective contracts related to fiscal benefits.

 

23.5 Leasing contracts for term and discount rate

 

The average discount rate applied for IFRS 16, using the incremental rate was as follows:

 

 
  Rate %
Lease Term 2023
2023 - 2027 11.15%
2028 - 2035 11.48%

 

 

 

Accounting policies

 

Interest-bearing loans and borrowing are recognized initially at fair value less attributable transaction costs. Subsequent to their initial recognition, interest-bearing loans and borrowing are stated at amortized cost, with any differences between the initial and maturity amounts recognized in the income statement over the expected life of the instrument on an effective interest rate basis.

 

Borrowing costs directly related to the acquisition, construction or production of a qualifying asset which requires a substantial period to prepare for its intended use or sale, are capitalized as part of the cost of that asset when it is probable that the future economic benefits associated with the item will flow to the Company, and the costs can be measured reliably. Other borrowing costs are recognized as finance expenses in the period in which they are incurred.

 

The accounting policy applied to lease liabilities is disclosed in note 13 - Property, plant and equipment.

XML 45 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
EMPLOYEE BENEFITS

 

24.EMPLOYEE BENEFITS

The Company sponsors post-employment benefits, such as retirement plans, medical and dental care, among others for employees in Brazil and subsidiaries located in the Dominican Republic, Barbados, Panama, Uruguay, Bolivia, Argentina and Canada based on employees' salaries and length of service. The entities are governed by the local regulations and practices of each individual country as well as the relationship with the Company’s pension funds and their composition.

Post-employment benefits of retirement are managed through pension funds and are classified as either defined contribution or defined benefit plans.

Defined benefit plans and the other post-employment benefits are not granted to new retirees.

24.1 Defined contribution plans

 

These plans are funded by the participants and the sponsor and are managed by administered pension funds. During 2023, the Company contributed R$91.3 (R$82.0 and R$74.1 during 2022 and 2021) to these funds, which was recorded in expenses. Once the contributions have been paid, the Company has no further payment obligations.

24.2 Defined benefit plans

 

At December 31, 2023, 2022 and 2021 the net liability for defined benefit plans consists of the following:

     
  2023  2022  2021 
Present value of funded obligations (5,365.5) (5,476.5) (7,354.3)
Fair value of plan assets 4,604.6  4,543.3  5,638.0 
Present value of net obligations (760.9) (933.2) (1,716.3)
Present value of unfunded obligations (917.2) (921.0) (1,165.4)
Present value of net obligations  (1,678.1) (1,854.2) (2,881.7)
Asset ceiling (182.6) (163.3) (180.1)
Net liabilities (1,860.7) (2,017.5) (3,061.8)
Other long term employee benefits (93.9) (87.1) (104.3)
Total employee benefits (1,954.6) (2,104.6) (3,166.1)
Employee benefits amount in the balance sheet      
Liabilities  (2,011.9) (2,161.2) (3,194.0)
Assets  57.3  56.6  27.9 
Net liabilities (1,954.6) (2,104.6) (3,166.1)

 

The changes in the present value of the defined benefit obligations were as follow:

 

     
  2023  2022  2021 
Defined benefit obligation at January 1 (6,397.5) (8,519.7) (8,777.6)
Service costs (30.8) (47.0) (58.0)
Interest costs (413.2) (353.2) (324.3)
Gains and (losses) on settlements or reductions in benefits 9.2  3.8  3.6 
Contributions by plan participants (4.2) (5.6) (6.9)
Actuarial gains and (losses) - geographical assumptions 11.5  -    52.3 
Actuarial gains and (losses) - financial assumptions (297.0) 1,333.6  726.8 
Experience adjustments 91.2  (171.5) (213.0)
Reclassifications -    -    (1.0)
Effect of exchange rate fluctuations 216.7  787.7  (495.3)
Benefits paid 531.4  574.4  573.7 
Defined benefit obligation at December, 31 (6,282.7) (6,397.5) (8,519.7)

 

 

The changes in the fair value of plan assets are as follow:

 

     
  2023  2022  2021 
Fair value of plan assets at January 1 4,543.3  5,638.0  5,533.3 
Interest income 318.1  262.1  223.9 
Administrative costs (5.2) (5.2) (5.8)
Expected return, excluding interest income 101.7  (614.6) (148.3)
Contributions by employer 280.5  316.0  342.0 
Contributions by plan participants 4.6  5.8  7.1 
Exchange differences (102.0) (482.6) 263.1 
Curtailments, settlements and other (4.8) (1.8) (3.6)
Benefits paid, excluding administrative costs (531.6) (574.4) (573.7)
Fair value of plan assets at December, 31 4,604.6  4,543.3  5,638.0 

 

Fundação Zerrenner is a legally distinct entity whose main goal is to provide the Company’s current and retired employees and managers with health care and dental assistance, technical and higher education courses, and to maintain facilities for assisting and helping elderly people, among other matters, either through direct initiatives or through financial assistance agreements with other entities.

 

The present value of funded obligations includes R$633.3 at December 31, 2023 (R$665.4 at December 31, 2022, and R$603.9 at December 31, 2021) of two health care plans for which the benefits were provided directly by Fundação Zerrenner.

 

The real return on plan assets generated at December 31, 2023, was a gain of R$419.7 (a loss of R$(352.5) at December 31, 2022, and a gain of R$75.5 at December 31, 2021).

 

At December 31, 2023, the Company recorded R$57.3 (R$56.6 at December 31, 2022, and R$27.9 at December 31, 2021) up to the asset ceiling not exceeding the present value of future benefits.

 

The changes in the asset ceiling not exceeding the present value of future benefits are as follow:

 

     
  2023 2022 2021
Asset ceiling impact at January 1 56.6  27.9  33.6 
Interest income/(expenses) 4.9  -    1.3 
Change in asset ceiling excluding amounts included in interest income/(expenses) (0.1) 30.2  (9.0)
Effects of exchange rate fluctuations   (4.1) (1.5) 2.0 
Asset ceiling impact at December 31  57.3  56.6  27.9 

 

 

The income/(expense) recognized in the income statement with regard to defined benefit plans is detailed as follows:

 

     
  2023  2022  2021 
Current service costs (30.8) (47.0) (58.0)
Administrative costs (5.2) (5.2) (5.8)
(Gains) losses on settlement and curtailment 4.7  2.2  1.2 
Income from operations (31.3) (50.0) (62.6)
Financial costs (114.3) (107.8) (115.6)
Total employee benefit expenses (145.6) (157.8) (178.2)

 

The employee benefit revenue/(expenses) is included in the following line items in the income statement:

     
  2023  2022  2021 
Other operating income/(expenses) -    (0.1) (0.2)
Cost of sales (15.1) (26.4) (33.0)
Commercial expenses (7.3) (9.4) (11.7)
Administrative income/(expenses) (8.9) (14.1) (17.7)
Financial expense (114.3) (107.8) (115.6)
  (145.6) (157.8) (178.2)

 

The assumptions used in the calculation of the obligations are as follow:

 

     
  2023 (i) 2022 (i) 2021 (i)
Discount rate 4.6% to 11.7% 5.1% to 11.0% 2.4% to 10.0%
Inflation 2.0% to 3.5% 2.0% to 3.5% 2.0% to 3.5%
Future salary increases  1.0% to 7.1% 1.0% to 7.1% 1.0% to 7.1%
Future pension increases 2.7% to 3.8% 2.7% to 3.8% 2.5% to 3.8%
Medical cost trend rate  6.4% to 7.1% p.a. reducing to 7,1% 6.4% to 7.1% p.a. reducing to 7,1% 4.5% to 6.9% p.a. reducing to 6.9%
Dental claims trend rate  3.5% 3.5% 3.3%
       
Life expectancy for an over 65 years old male  84 to 87 84 to 87 85 to 87
Life expectancy for an over 65 years old female 86 to 89 86 to 89 87 to 89

 

(i)Includes assumptions in Brazil, Central America and Caribbean, Latin America - South and Canada.

 

24.3 Risk

 

Through its defined benefit pension plans and post-employment medical plans, the Company is exposed to a number of risks, the most significant of which are detailed below:

 

Asset volatility

 

The plan liabilities are calculated using a discount rate pegged to high-quality private securities; If plan assets underperform this yield, the Company’s net defined benefit obligation may increase. Most of the Company’s funded plans hold a significant proportion of equities, which are expected to outperform corporate bonds in the long-term while providing volatility and risk in the short-term. As the plans mature, the Company usually reduces the level of investment risk by investing more in assets that better match the liabilities.

 

Changes in bond yields

 

A decrease in corporate bond yields will increase plan liabilities, although this will be partially offset by an increase in the value of the plans’ bond holdings.

 

Inflation

 

Some of the Company’s pension obligations are linked to inflation, and higher inflation will lead to higher liabilities. The majority of the plan’s assets are either unaffected by or only loosely correlated with inflation, meaning that an increase in inflation could potentially increase the Company’s net benefit obligation.

 

Life expectancy

 

Most of the plans’ obligations are to provide benefits for the life of the member, so increases in life expectancy will result in an increase in the plans’ liabilities.

 

Investment strategy

 

In the case of funded plans, the Company ensures that the investment positions are managed within an asset-liability matching (“ALM”) framework to ensure long-term investments that are in line with the Company’s obligations under the pension schemes. Within this framework, the Company’s ALM objective is to match the assets to the pension obligations by investing in long-term fixed interest securities with maturities that match the benefit payments as they fall due and in the appropriate currency.

 

24.4 Sensitivity

 

The sensitivity of the defined benefit obligation to changes in the weighted principal assumptions is as follows:

 

                 
In millions of Brazilian Reais   2023   2022   2021
  Change in assumption Increase in assumption Decrease in assumption   Increase in assumption Decrease in assumption   Increase in assumption Decrease in assumption
Medical cost trend rate 100 bases points  (95.2) 82.2    (94.3) 81.8    (114.7) 98.6 
Discount rate 50 bases points  284.8  (302.4)   307.9  (328.0)   442.0  (470.3)
Future salary increases 50 bases points  (17.3) 14.7    (17.6) 16.5    (19.8) 18.6 
Longevity One year (201.0) 196.1    (221.5) 213.5    (287.6) 279.5 

 

The data presented in these tables are purely hypothetical and are based on changes in individual assumptions holding all other assumptions constant: economic conditions and changes therein always affect the other assumptions at the same time and their effects are not linear. Therefore, the above information is not necessarily a reasonable representation of future results.

 

24.5 Plans assets

 

The plans assets at December 31, 2023, 2022 and 2021 consist of the following:

                     
  2023   2022   2021
  Rated Unrated Total   Rated Unrated Total   Rated Unrated Total
Government bonds 43% -    43%   43% -    43%   43% -    43%
Corporate bonds 10% -    10%   10% -    10%   10% -    10%
Equity instruments 15% -    15%   15% -    15%   15% -    15%
Cash 6% -    6%   6% -    6%   6% -    6%
Others 26% -    26%   26% -    26%   26% -    26%

 

The overall expected rate of return is calculated by weighting the individual rates in accordance with Ambev’s expected share of the total investment portfolio.

 

Ambev expects to contribute approximately R$231.5 to its defined benefit plans in 2024.

 

Accounting policies

 

Post-employment benefits

 

Post-employment benefits include pensions managed in Brazil by Instituto Ambev de Previdência Privada (“IAPP”), post-employment dental benefits and post-employment medical benefits managed by Fundação Zerrenner. Usually, pension plans are funded by payments made by both the Company and its participants, considering the recommendations of independent actuaries. Post-employment dental benefits and post-employment medical benefit obligations are funded using the returns on the assets of the Fundação Zerrenner plan. If necessary, the Company may contribute some of its profits to Fundação Zerrenner. The Company maintains both funded and unfunded plans.

 

Defined contribution plans

 

A defined contribution plan is a pension plan under which the Company pays fixed contributions into a fund. The Company has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees for the benefits relating to their service in the current and prior periods. The contributions to these plans are recognized as expenses in the period during which they are incurred.

 

Defined benefit plans

 

Typically, defined benefit plans define an amount of pension benefit that an employee will receive upon retirement, usually dependent on one or more factors such as age, years of service and compensation level.

 

For defined benefit plans, expenses are assessed separately for each plan using the projected credit unit method. The projected credit unit method considers that each period of service gives rise to an additional unit of benefit and measures each such unit separately. Based on this method, the cost of providing pensions is charged to the income statement over the period of service of the employee and consist of current service costs, interest costs, past service costs and the effect of any agreements and settlements. The obligations of the plan recognized in the balance sheet are measured at the present value of the estimated future cash outflows using a discount rate equivalent to the government´s bond rates with maturity terms similar to those of the respective obligation and the fair values of the plan assets.

Past service costs arise from the introduction of a new plan or changes to an existing plan. They are recognized immediately in the income statement, at the earlier of: (i) when the settlement/curtailment occurs; or (ii) when the Company recognizes the related restructuring or termination costs, unless those changes are conditional upon the employee’s continued employment, for a specific period of time (the period in which the rights are acquired). In such cases, past services costs are amortized using the straight-line method over the period during which the rights were acquired.

 

Actuarial assumptions are established to anticipate future events and are used in the calculation of pensions and other long-term employee benefit expenses. These factors include assumptions regarding interest rates, health plan costs, discount rate, future salary increases and pensions, as well as life expectancy. Such estimates are reviewed annually by independent actuaries.

 

Actuarial gains and losses consist of the effects of differences between the previous actuarial assumptions and the actual results, and the effects of changes in actuarial assumptions. Actuarial gains and losses are fully recognized in Carrying value adjustments.

 

Remeasurements, representing actuarial gains and losses, the effect of the asset ceiling and the return on plan assets, both excluding net interest, are recognized in full in the period in which they occur in the statement of comprehensive income. Remeasurements are not reclassified to profit or loss in subsequent periods.

 

When the amount of the defined benefit obligation is negative (an asset), the Company recognizes those assets (prepaid expenses), to the extent of the value of the economic benefit available to the Company either from refunds or reductions in future contributions.

 

Other post-employment obligations

 

The Company and some of its subsidiaries provide post-employment medical benefits, the reimbursement of medication expenses and other benefits to certain retirees. These benefits are not granted to new retirees. The expected costs of these benefits are recognized over the period of employment, using an accounting methodology like that for defined benefit plans, including actuarial gains and losses.

 

Termination benefits

 

Termination benefits are recognized as expenses at the earlier of: (i) when the Company is demonstrably committed, without a realistic possibility of withdrawal, to a formal detailed plan to terminate employment before the normal retirement date; and (ii) when the Company recognizes costs related to restructuring.

 

Bonuses

 

Bonuses granted to employees and managers are based on pre-defined company and individual target achievement. The estimated amount of the bonus is recognized as an expense in the period during which the bonus is earned.

 

XML 46 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED PAYMENTS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
SHARE-BASED PAYMENTS

 

25.SHARE-BASED PAYMENTS

 

Currently the Company has two plans of share-based payment programs: (i) the Stock Option Plan, approved in Extraordinary General Meeting of July 30, 2013 (“Stock Option Plan”) and (ii) Share-based Plan, approved in Extraordinary General Meeting of April 29, 2016, as amended in Extraordinary General Meeting of April 24, 2020 (“Share-Based Plan”). Under each of these plans, the Company can periodically issue different stock option and restricted share units programs. These programs allow certain Group employees and members of the Management, indicated by the Board of Directors and People Committee, to either buy shares of the Company by exercising stock options or receive shares directly.

 

25.1 Share-Based Plan

 

In this plan, certain employees and members of the Management are eligible to receive Company shares, including in the form of ADRs. The shares subject to the Share-Based Plan are designated as "restricted shares" (RSUs) or “performance shares” (PSUs).

 

The delivery of restricted shares and performance shares are made without charge, and the vesting period may vary between three and five years from the corresponding grant date, depending on the share-based compensation program. Restricted shares and performance shares may entitle participates the right to receive additional shares with the same conditions, such as compensation dividends and interest on shareholder´s equity declared and paid by the Company during the vesting period. The right to receive restricted, performance and additional shares, can be partially or completely lost under certain circumstances, including in case of resignation or termination during the vesting period.

 

25.1.1 Other disclosures of the Share-Based plan

 

During the period, the Company granted 33,686 thousand restricted shares under the Share-Based Plan (49,328 thousand in 2022 and 20,629 thousand in 2021), representing a fair value of approximately R$463.5 in 2023 (R$766.6 in 2022 and R$325.7 in 2021).

The total number of shares granted to the Company’s executives under the Share-Based Plan, which will be delivered in the future under certain conditions, is shown below:

 

Restricted and performance shares

 

         
Thousand restricted shares 2023   2022   2021
           
Restricted and performance shares outstanding at January 108,854    62,545    43,458 
New restricted and performance shares during the period 33,686    49,328    20,629 
Restricted and performance shares granted during the period (18,309)   (12)   (22)
Restricted and performance shares forfeited during the period (5,235)   (3,007)   (1,520)
Restricted shares outstanding at the end of the year 118,996    108,854    62,545 

 

25.2 Option Plan

 

Since 2020, the Company no longer grants to your employees and executives stock options recognized in accordance with IFRS 2 - Share-Based Payment. However, there are stock options granted in previous periods that are not vested yet, as well as stock options that are already vested but not yet expired, which remain valid within the scope of the programs issued under the Option Plan and subject to the accounting treatment mentioned.

In addition, some employees of the Company and its subsidiaries, who receive their bonus in cash, have the option, according to their position, to choose to allocate part or all the amounts received as such to the acquisition of shares issued by Ambev, these shares are called "voluntary shares" and are granted under the Stock Option Plan. In general, voluntary shares are entitled to dividends from the date of grant and are subject to a vest period of three to five years (look-up). These shares are granted at market price with a discount applied up to 20%, the discount is delivered in the form of restricted shares. Executives who invest in voluntary shares also receive one and a half times the number of corresponding shares for each voluntary share acquired, up to a limited total percentage of each executive's variable remuneration. These matching shares are also delivered in the form of restricted shares.

 

As the voluntary shares, granted under the Stock Option Plan, are part of the profit share earned by eligible executives, they are recognized as an expense in the income statement against liabilities. Meanwhile, the mentioned restricted shares (discounted shares and matching shares) are granted under the Share-Based Plan, as per conditions outlined in item 25.1 above, and are recognized in accordance with the accounting treatment set out in this note, according to IFRS 2 - Share-based Payment.

 

25.2.1 Other disclosures of the Stock Options Plan

 

The Company have not granted stock options, neither there were options exercised during the year ended December 31, 2023, and 2022 (for options exercised in the year ended December 31, 2021, the weighted average share price on the exercise date was R$17.87). The total number of outstanding options developed was as follows:

 

         
Thousand options 2023   2022   2021
           
Options outstanding at January 99,717    113,760    127,265 
Options exercised during the period -      -      (5,247)
Options forfeited during the period (11,756)   (14,043)   (8,258)
Options outstanding at the end of the year 87,961    99,717    113,760 

 

The range of exercise prices of the outstanding options is from R$15.95 (R$15.95 in 2022 and R$15.95 in 2021) to R$32.81 (R$39.04 in 2022 and R$45.97 in 2021) and the weighted average remaining contractual life is approximately 3.60 years (4.29 years in 2022 and 6.70 years in 2021).

 

Of the 87,961 thousand outstanding options (99,717 thousand in 2022 and 113,760 thousand in 2022), 68,635 thousand options were vested in 2023 (63,850 thousand in 2022 and 59,250 thousand in 2021).

 

The weighted average exercise price of the options is as follows:

         
In R$ per share 2023   2022   2021
           
Options outstanding at January 1 19.39    19.92    19.81 
Options forfeited during the period 22.68    22.60    25.27 
Options exercised during the period -      -      13.16 
Options outstanding at the end of the period 18.86    19.39    19.92 
Options exercisable at the end of the period 19.08    20.12    21.14 

 

To settle the exercised stock options, the Company may use treasury shares. The current limit on the authorized capital is considered sufficient to meet the Company’s obligations under all stock option plans if the issue of new shares is required to meet the grants awarded under the programs.

During the period, the Company granted 47 thousand deferred shares under the stock option plan which are valued based on the share market price prior to the grant, which represented a fair value of R$0.6(at December 31, 2022, 44 thousand deferred shares under the stock option plan which are valued based on the share market price prior to the grant, which represented a fair value of R$0.6 and at December 31, 2021, 110 thousand deferred shares had been granted, which are valued based on the share market price prior to the grant, which represented a fair value of R$1.7). Such deferred shares are subject to a vesting period of five years from the grant date. The total number of shares purchased by employees, under the Stock Option Plan, which will be delivered in the future based on the fulfilment of certain conditions, is as set out below:

 

Deferred shares

 

         
Thousand deferred shares 2023   2022   2021
           
Deferred shares outstanding at January 1 889    1,168    6,065 
New deferred shares during the period 47    44    110 
Deferred shares granted during the period -      (214)   (4,964)
Deferred shares forfeited during the period -      (109)   (43)
Deferred shares outstanding at the end of the year 936    889    1,168 

 

25.3 Expenses related to share-based payments

 

The share-based payments transactions described above generated an expense of R$333.4 in 2023 (R$311.6 and R$391.5 in 2022 and 2021, respectively), recorded as administrative expenses.

 

Accounting policies

 

Under the Share-Based Plan, the reference price per restricted share is defined on the stock grant date based on the share price of the trading session on B3 immediately prior to the shares granting, except for the performance shares, which the fair value is defined at the grant date based on “Monte Carlo” pricing method. After defining the reference price, based on number of grant shares, the calculated amount is recorded as expense against equity. The shares are transferred to attendees according to the terms and periods by the respective programs.

Under the stock option programs, the fair value of the shares is estimated as at the option grant date, using the “Hull Binomial” pricing model, adjusted to reflect the IFRS 2 - Share-based Payment requirement that assumptions regarding forfeiture before the end of the vesting period cannot impact the fair value of the option. The fair value of the share options is estimated at the grant date, using an option pricing model. Based on the expected number of options that will be exercised, the fair value of the options granted is recognized as an expense over the vesting period with a corresponding credit to equity. When the options are exercised, the equity is increased by the amount of the proceeds received.

 

In addition, on some occasions, AB InBev employees and managers are expatriated to the Company. In these cases, the compensation cost related to options to acquire shares and restricted shares of AB InBev is recognized in the income statement against shareholders' equity, in proportion to the period of expatriation. When the equity instruments are delivered, this amount is reimbursed to AB InBev.

 

On the other hand, when employees and managers who have options to acquire shares and restricted shares of the Company are expatriated to AB InBev, the compensation cost is recognized by AB InBev in proportion to the period of expatriation, and the Company is reimbursed at the time of delivery of its equity instruments to AB InBev employees and managers.

 

The Company's share-based payment plans are settled in shares.

XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE PAYABLES
12 Months Ended
Dec. 31, 2023
Trade Payables  
TRADE PAYABLES

 

26.TRADE PAYABLES
   
  2023 2022
     
Trade payables 107.4  165.8 
Related parties (Note 30) 199.9  343.6 
Non-current 307.3  509.4 
     
Trade payables 21,278.6  23,498.1 
Related parties (Note 30) 1,916.5  830.4 
Current 23,195.1  24,328.5 
     
Total 23,502.4  24,837.9 

 

The present value adjustment recorded for trades payables, at December 31, 2023, is R$308 million (R$367 million at December 31,2022).

 

The subsidiaries in Argentina, Chile, Paraguay and Panama have discount transactions for duplicates with endorsement (trade payables securitization) with vendors in the amount of R$159.0 million at December 31, 2023 (R$219.3 million at December 31, 2022). In general, abovementioned discount transactions occur by legal impositions existing in these jurisdictions. These transactions maintain commercial characteristics since there are no change in previously established conditions and its vendor’s choice to carry out the anticipation of its receivables with the Company.

 

Accounting policies

 

Trade payables are recognized initially at their fair values and subsequently at amortized cost using the effective interest method. When relevant, trade payables values are adjusted by their present value, considering the following assumptions to calculation: (i) the amount to be discounted; (ii) the settlement dates; and (iii) the discount rate, in accordance with IFRS 13. The adjustment in the present value of installment purchases is record in trade payables and is offset by the cost of products sold account, due to the payment term.

 

Long-term intra-group loan agreements

 

The Company has long-term loan agreements, denominated in foreign currency, signed with wholly owned subsidiaries located abroad, whose amounts are recognized in the Company's accounts payable. As determined by IAS 21, considering that they are long-term loans, which settlement is not likely to occur in the foreseeable future, the exchange differences related to these instruments are recognized in other comprehensive income, following the accrual accounting concept.

 

The recognition of exchange rate variations in other comprehensive income does not affect the accounting classification assigned to the debt, which is recorded in a liability account and incurs interest, which is recognized as a financial expense in the income statement for the year.

 

The effects of exchange differences will only be reflected in profit or loss for the period if there is any change in the assumption related to the settlement of the loan, i.e., if it becomes foreseeable or probable. In the event of partial settlement, only the exchange differences corresponding to the settled portion or portion expected to be settled with probability or foreseeability will be reclassified to the profit or loss for the period.

XML 48 R33.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS

 

27.PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS

The Company and its subsidiaries are involved in administrative and judicial proceedings and arbitrations arising from the normal course of business. Due to their nature, these processes involve inherent uncertainties, including, but not limited to, decisions by courts and tribunals, agreements between the parties involved and governmental actions and, as a result, management cannot, at this stage, estimate the exact time taken to resolve these issues.

 

27.1 Provision

 

The Company and some of its subsidiaries are involved in lawsuits, mainly of a tax, civil and labor nature, which are considered probable of loss, and which are fully provisioned, under the terms of IAS 37 - Provisions, Contingent Liabilities and Contingent Assets.

 

27.1.1 Main lawsuits with a probable likelihood of loss:

 

Sales taxes: in Brazil, the Company and its subsidiaries are parties to various administrative and judicial proceedings related to ICMS, IPI, PIS and COFINS taxes, considered as probable likelihood of loss. Such proceedings include, among others, tax offsetting, appropriation of tax credits and alleged insufficient payment of the respective taxes.

 

Labor: the Company and its subsidiaries are parties to labor proceedings with former employees or former employees of service providers. The main issues involve overtime and related effects and respective charges.

 

Civil: The Company and its subsidiaries are involved in civil lawsuits considered as representing a probable likelihood of loss. The most relevant portion of these lawsuits refers to former distributors, mainly in Brazil, mostly claiming damages resulting from the termination of their contracts.

 

 

27.1.2 Provision changes

 

           
  Taxes on sales Labor Civil Other taxes (i) Restructuring Total
             
At December 31, 2021 218.6  124.2  252.9  163.0  17.4  776.1 
Effect of changes in foreign exchange rates -    (4.6) (17.5) (8.1) (2.0) (32.2)
Additions 157.6  194.2  312.7  60.1  -    724.6 
Provisions used  (85.8) (162.0) (196.6) (7.2) (3.6) (455.2)
Provisions reversed (43.3) (19.7) (15.6) (15.0) -    (93.6)
At December 31, 2022 247.1  132.1  335.9  192.8  11.8  919.7 
Effect of changes in foreign exchange rates -    (2.8) (35.8) (6.3) (0.5) (45.4)
Additions 135.7  247.8  234.5  75.7  3.2  696.9 
Provisions used  (27.3) (181.7) (121.9) (40.8) (11.2) (382.9)
Provisions reversed (73.2) (45.5) (72.5) (19.1) -    (210.3)
At December 31, 2023 282.3  149.9  340.2  202.3  3.3  978.0 

 

(i)Other taxes refer to provisions for lawsuits concerning taxes unrelated to income taxation. The uncertain tax treatments related taxes on profits with a prognosis of probable loss have their value reported directly in the income tax and social contribution payable, as per IFRIC 23 - Uncertainty on the Treatment of Income Taxes.

 

27.1.3 Expected settlement of provision

 

               
  2023   2022
  Non-current Current Total   Non-current Current Total
               
Provision for disputes and litigation              
Taxes on sales 168.6  113.7  282.3    193.8  53.3  247.1 
Labor 82.7  67.2  149.9    104.9  27.2  132.1 
Civil 113.4  226.8  340.2    263.0  72.9  335.9 
Other taxes 194.9  7.4  202.3    170.1  22.7  192.8 
Total provision for disputes and litigation 559.6  415.1  974.7    731.8  176.1  907.9 
               
Restructuring -    3.3  3.3    7.2  4.6  11.8 
               
Total provisions 559.6  418.4  978.0    739.0  180.7  919.7 

 

The expected settlement of provisions was based on management’s best estimate at the balance sheet date.

27.2 Contingencies

 

The Company and its subsidiaries maintain administrative and judicial discussions with fiscal authorities in Brazil related to certain fiscal positions adopted when calculating the income tax and social contribution, which, based on Management’s current evaluation, probably are going to be accepted in superior court decisions of last instance, aligned with IFRIC 23. The Company also tax actions related to other taxes, which involve risk of a possible loss, according to management's assessment. To these uncertain tax treatments and possible contingencies there are no constituted provision, due to the assessment carried out as the following composition and estimates:

 

   
  2023 2022
     
Income tax and social contribution 63,621.0  60,453.5 
Value-added and excise taxes 26,761.0  25,904.6 
PIS and COFINS 3,496.2  3,293.5 
Others 1,679.4  1,909.1 
  95,557.6  91,560.7 

 

The Company and its subsidiaries have guarantee-insurance policies and letter of guarantee for some legal actions, disclosed as guarantee for civil, labor and tax execution or to enable resources of labor nature.

 

Contingencies with a remote risk of loss are not disclosed, as the possibility of any settlement is remote, in accordance with IAS 37 - Provisions, Contingent Liabilities and Contingent Assets.

 

27.2.1 Main contingencies with a possible risk of loss

 

On September 2023, Law 14,689 was enacted (“Law 14,689/2023”) in Brazil, which provides for the cancellation of fines imposed in tax administrative proceedings decided in favor of the Brazilian Federal Tax Authorities by a tie-breaking vote at the federal administrative level, including any such proceedings that were subsequently escalated to the judicial level and, as of the date of publication of Law 14,689/2023, were pending decision at the second level judicial courts. Following the enactment of Law 14,689/2023, Ambev reassessed the likelihood of success of fines imposed in proceedings decided by a tie-breaking vote, which resulted in the reclassification of the risk of loss from possible to remote in the approximate amount of R$ 6.9 billion as of December 31, 2023 In some cases of the discussions mentioned below, such as the deductibility of goodwill amortization expenses, foreign profits, the use of tax loss in mergers, and the Manaus Free Trade Zone - IPI.

The main processes classified with a possible loss probability are summarized in the tables below, along with their respective estimated values involved in the cases.

 

   
 

Uncertainty over the treatment of income taxes

In accordance with IFRIC 23 (Note13 - Income tax and social contribution)

Estimates

(in million of Brazilian Reais)

# Description of the main processes 2023 2022
1

Deductibility of IOC expenses

During the 2013 fiscal year, as approved in a General Meeting, the Company implemented a corporate restructuring aimed at simplifying its structure and unifying its share classes, among other objectives. One of the steps of this restructuring involved the exchange of shares and subsequent incorporation of the shares of its subsidiary Companhia de Bebidas das Américas into Ambev S.A. As a consequence of this operation, Ambev S.A. recognized in its accounting records the counterpart of the difference between the value of its shares issued for this exchange and the book value of the subsidiary's shares in equity, in accordance with IFRS 10, under the item "adjustments to equity".

In November 2019, Ambev received a tax assessment from the IRS regarding the deduction of Interest on Capital ("IOC") for the calendar year 2014. The queries primarily concern the accounting and corporate effects of the corporate restructuring carried out by the Company in 2013, and its impacts on increasing the calculation of the JCP deductibility limit. In August 2020, a partially favorable decision was issued to the Company by the first administrative instance, and in view of this decision, Ambev filed an appeal for the case to be reviewed by the CARF, which is awaiting judgment. The favorable portion of the first administrative instance decision will be subject to review by the CARF.

In December 2020, the Company received a tax assessment related to the deduction of IOC expenses for the calendar years 2015 and 2016. In June 2021, Ambev obtained a partially favorable decision in the first administrative instance and filed an appeal to the CARF, which is also awaiting judgment. Similarly, to the first tax assessment, the favorable portion of the first administrative instance decision will be subject to review by the CARF.

In December 2022, the Company received a tax assessment related to the deduction of IOC expenses for the calendar year 2017. In September 2023, Ambev obtained a partially favorable decision in the first administrative instance and filed an Appeal to the CARF, which is also awaiting judgment. Similarly, to the first tax assessment, the favorable portion of the first administrative instance decision will be subject to review by the CARF.

In November 2023, the Company received a new tax assessment related to the deduction of IOC expenses for the calendar years 2018 to 2021. The Company filed a defense and currently awaits a decision in the first administrative instance.

The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$27.4 billion as of December 31, 2023 (R$13.8 billion as of December 31, 2022). Due to the assessment of the likelihood of loss, no provision was made in the period.

This uncertain tax treatment, according to IFRIC 23, continued to be applied by Ambev and affected subsequent calendar years to those assessed (2022 and 2023), during which the Company also distributed IOC and deducted them from the taxable base of its Income Tax.

Therefore, if the deductibility of IOC is also questioned in the future, on the same bases and with the same grounds as the tax assessments mentioned, the Company estimates that the outcome of these potential new discussions would be consistent with the period already assessed.

In December 2023, Provisional Measure 1,185, of August 2023, was converted into a law (No. 14,789/2023), which changes the basis for calculating Interest on Capital as of January 1, 2024, making this uncertain tax treatment limited to Interest on Capital calculated in accordance with legislation in force before the aforementioned law effective date

27,439 13,846
2

Disallowance of tax paid abroad

Since 2014, the Company has been receiving tax assessments, relating to calendar years from 2007 onwards, which disallow the use of income tax credits paid abroad by its controlled companies. Considering these charges to be illegitimate, the Company is challenging these assessments in administrative and judicial courts. In November 2019, a final favorable decision was issued by the CARF canceling the assessment regarding one of the cases, covering the calendar year 2010.

For cases involving the calendar years 2015 and 2016, the Company received unfavorable decisions, in the administrative sphere, in three out of four processes. Ambev filed a lawsuit to discuss the matter and awaits a decision in first-instance judicial court. Still regarding the topic, new tax assessments were issued demanding isolated fines due to the alleged lack of monthly payment of IRPJ and CSLL due to the deduction of income tax paid by controlled companies abroad for the calendar years 2015 to 2018.

For cases involving the calendar years 2015 and 2016, an unfavorable decision was issued against the Company in the administrative first instance, against which Ambev filed voluntary appeals awaiting judgment by the CARF.

Regarding the tax assessments involving the collection of the isolated fine for the calendar years 2017 and 2018, received by the Company in October 2022 and December 2023 respectively, awaiting judgment in the administrative first instance.

With regard to other processes discussing this topic, the Company awaits decisions in the administrative and judicial spheres.

The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$14.3 billion as of December 31, 2023 (R$12.6 billion as of December 31, 2022), and, due to its loss classification, no provision was made in the period.

This uncertain tax treatment, according to IFRIC, regarding income tax credits paid abroad, continued to be applied by the Company and impacted subsequent calendar years to those assessed (2018-2023). If new questions arise in the future, on the same basis and with the same grounds as the tax assessments referred to, the Company estimates that the unfolding of these eventual new discussions will be consistent with the period already assessed.

14,302 12,596
3

Goodwill Inbev Holding

In December 2011, the Company received a first tax assessment issued by the Brazilian Federal Revenue Service ("RFB") mainly related to the disallowance of goodwill amortization expenses for the tax years 2005 to 2010, resulting from the incorporation of InBev Holding Brasil S.A. Partially favorable administrative decisions were rendered in this matter. In response to these decisions, the Company filed judicial measures to challenge the issues in which it was unsuccessful at the administrative level, which are awaiting first-instance judgment.

In June 2016, Ambev received a second tax assessment issued by the RFB regarding the disallowance of the remaining portion of the aforementioned goodwill amortization for the tax years 2011 to 2013. In April 2023, the Company obtained a partially favorable and final decision. For the portion of the dispute in which it was unsuccessful, the Company filed a judicial measure, which is awaiting judgment.

The updated value of this uncertain tax treatment, as per IFRIC 23, that has already been assessed, amounted to approximately R$6.5 billion as of December 31, 2023 (R$11.1 billion as of December 31, 2022), and, due to its classification as a loss, no provision was made in the period. Regarding this ongoing dispute, all periods affected by this uncertain tax treatment have already been subject to assessments by the Internal Revenue service (“IRS”). In the event that the Company is required to pay this amount, Anheuser-Busch InBev SA/NV will reimburse the proportional amount (70%) of its benefit from the goodwill amortization, as well as the respective costs, pursuant to the "Reimbursement Agreement" executed on December 21, 2011, between Companhia de Bebidas das Américas - Ambev and Anheuser-Busch InBev SA/NV.

6,505 11,122
4

Foreign Earnings

Since 2005, the Company and some of its subsidiaries have been subject to tax assessments by the IRS regarding the taxation of profits earned by subsidiaries domiciled abroad under various grounds. Deeming these charges illegitimate, the Company is challenging these assessments in administrative and judicial courts.

The cases pending in the administrative sphere have partially favorable decisions, still subject to review by the last administrative instance, the CSRF. In turn, in the cases pending in the judicial sphere, the Company has favorable decisions, subject to review by the higher instance.

In 2022 and 2023, the CARF issued favorable and partially favorable decisions for the Company. The decisions canceled part of the assessments, recognizing as partially correct the calculations made by the Company regarding the taxable income in Brazil of companies domiciled abroad, as well as the impossibility for the Brazilian tax authorities to disregard the goodwill amortization carried out by a subsidiary abroad. Part of these decisions represents a definitive success in the approximate amount of R$1 billion, while for the other decisions, appeals were filed by the IRS, which are awaiting judgment by the CSRF.

The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$6.1 billion as of December 31, 2023 (R$7.3 billion as of December 31, 2022).

This uncertain tax treatment, according to IFRIC 23, continued to be applied by the Company and impacted subsequent calendar years to those assessed (2019-2023). If new inquiries arise in the future, on the same basis and with the same grounds as the referred tax assessments, the Company estimates that the outcome of these eventual new discussions will be consistent with the periods already assessed.

6,075 7,280
5

Disallowance on Income Tax deduction

In January 2020, Arosuco (a subsidiary of Ambev) received a tax assessment from the IRS, relating to the calendar years 2015 to 2018, disallowing the tax reduction benefit provided for in “MP” No. 2,199-14/2001, based on Operating Profit, and filed an administrative challenge. In October 2020, Arosuco was notified of the unfavorable decision in the administrative first instance and filed an Appeal, which awaits judgment.

The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$2.6 billion as of December 31, 2023 (R$2.3 billion as of December 31, 2022). Due to the assessment of the likelihood of loss, no provision was made in the period.

This uncertain tax treatment, according to IFRIC 23, affected subsequent calendar years to those assessed (2019 to 2023), during which Arosuco similarly benefited from the tax reduction provided for in the aforementioned Provisional Measure 2,199-14/2001. If there are any new inquiries in the future on the same matter, on the same bases and with the same grounds as the tax assessments mentioned, Arosuco estimates that the outcome of these potential new discussions would be consistent with the period already assessed.

2,618 2,334
6

Goodwill BAH

In October 2013, Ambev received a tax assessment related to the goodwill amortized in the calendar years 2007 to 2012 concerning the incorporation of Beverage Associates Holding Limited ("BAH") into Ambev. In April and August 2018, Ambev received two new tax assessments related to the disallowance of the amortization of the remaining portion of the mentioned goodwill in the calendar years 2013 and 2014.

In the administrative sphere, partially favorable decisions were rendered in favor of the Company regarding the qualified fine and the statute of limitations for one of the periods under discussion. In response to these decisions, the Company filed judicial measures to challenge the matters in which it was unsuccessful in the administrative phase, obtaining decisions of total merit in the first judicial instance. The IRS filed appeals, which are awaiting judgment in the second judicial instance.

The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$1.4 billion as of December 31, 2023 (R$2.2 billion as of December 31, 2022). Due to its classification as a loss, no provision was made in the period. Regarding this discussion, all periods impacted by the aforementioned uncertain tax treatment have already been subject to tax assessments by the IRS.

1,412 2,218
7

Goodwill CND Holding

In November 2017, the Company received a tax assessment related to the amortization of goodwill for the calendar years 2012 to 2016 concerning the incorporation of CND Holdings into Ambev. In the administrative sphere, a partially favorable decision was rendered by CARF, which is subject to appeals filed by the Company and the IRS awaiting judgment by the Superior Chamber of Tax Appeals ("CSRF"), the last administrative instance.

In October 2022, Ambev received a new tax assessment related to the disallowance of the remaining portion of said goodwill for the calendar year 2017. The Company received a partially favorable decision, which is subject to appeals filed by the Company and IRS, awaiting judgment by CARF.

The updated value of the uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$1.4 billion as of December 31, 2023 (R$1.3 billion as of December 31, 2022). Due to its classification as a loss, no provision was made during the period. With regard to this discussion, all periods affected by the said uncertain tax treatment have already been subject to tax assessments by the IRS.

1,372 1,257
8

Presumed Profit

In April 2016, Arosuco (a subsidiary of Ambev) received an assessment related to the use of presumed profit for the calculation of IRPJ and CSLL instead of the actual profit method. In September 2017, Arosuco was notified of the unfavorable decision in the administrative first instance and filed a voluntary appeal. In 2019, a final favorable decision was issued by the CARF, canceling the assessment.

In March 2019, Arosuco received a new tax assessment on the same matter and filed a defense. In October 2019, the administrative first instance issued an unfavorable decision and Arosuco filed a voluntary appeal to the CARF, which awaits judgment.

Arosuco estimates that the updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$633.4 million as of December 31, 2023 (R$581.5 million as of December 31, 2022). Due to its loss classification, no provision was made in the period. With regard to this discussion, all periods affected by this uncertain tax treatment have already been subject to tax assessments by the IRS.

633.4 581.5
9

Disallowance of financial expenses

In 2015, 2016, and 2020, the Company received tax assessments issued by the IRS concerning the disallowance of expenses related to the results of financial instruments used to hedge risks inherent to price or rate fluctuations, as well as loans related to the Company's operational activities. In May and June 2023, Ambev was notified of final favorable administrative decisions for the assessments received in 2016 and 2020, which completely canceled the tax assessments issued by the tax authorities, in the approximate amount of R$5.1 billion. Regarding the assessment received in 2015, judgment is awaited from the CARF, both for the tax authority's automatic appeal regarding the portion of the first-instance decision favorable to the Company, and for the Company's appeal regarding the portion of the first-instance decision in which it was unsuccessful. The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$316 million as of December 31, 2023 (R$5.2 billion as of December 31, 2022). Due to its classification, no provision was made in the period. With regard to this discussion, all periods affected by this uncertain tax treatment have already been subject to assessments by the RFB.

316 5,200
10

Goodwill MAG

In December 2022, CRBS S.A. (a subsidiary of Ambev) received a tax assessment related to the goodwill amortized in the calendar years 2017 to 2020 concerning the acquisition and incorporation of RTD Barbados into CRBS. In the administrative sphere, CRBS received a partially favorable decision in the first administrative instance ("DRJ"), which is subject to appeals filed by the Company and the IRS pending judgment by CARF. The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$278 million as of December 31, 2023 (R$251 million as of December 31, 2022). Due to its classification as a loss, no provision was made in the period.

This uncertain tax treatment, according to IFRIC 23, continued to be applied by CRBS and impacted subsequent calendar years to those assessed (2021-2022). If new questions arise in the future, based on the same grounds and with the same fundamentals as the tax assessment mentioned, the Company estimates that the outcome of these potential new discussions will be consistent with the period already assessed.

278 251
11

Tax Loss Offset

Ambev and certain of its subsidiaries received a number of assessments from the Brazilian Federal Tax Authorities relating to the offset of tax losses carried forward in the context of business combinations.

Two main cases dealing with this matter are under judicial review. In one of the cases, Ambev received favorable decisions in 1st and 2nd instances of the judiciary, which prompted the National Treasury to file a Special Appeal, pending judgment by the Superior Court of Justice ("STJ"). In the second case, Ambev received an unfavorable decision in the 1st instance of the judiciary and filed an Appeal, awaiting judgment.

In December 2023, there was a third case under administrative review, which, in February 2023, was unfavorably decided against the Company by the the Upper Administrative Court  ("CSRF") by a casting vote. Due to the outcome of the judgment and considering the reductions provided for in Law No. 14,689/2023, after receiving notification of the decision, the Company opted to pay the case in December 2023, with the corresponding reductions.

The updated value of the uncertain tax treatment, according to ICPC 22/IFRIC 23, as of December 31, 2023, is approximately R$187 million (R$548 million on December 31, 2022), and therefore, no provision has been made for the matter. Regarding the present discussion, all periods affected by the uncertain tax treatment have already been subject to assessments by the RFB.

187 548
12

Isolet Fines

In March 2023, the Brazilian Supreme Federal Court (STF), in the trial of theme 736 (RE 796,939), established its understanding that the imposition of isolated fines due to the non-recognition of tax offsets is unconstitutional. Following this judgment, the Company reevaluated, together with its in-house lawyers and external advisors, the prognosis of the discussion and reclassified the risk of loss from possible to remote. The amount involved in the processes related to this issue, as of March 31, 2023, was R$1.6 billion (compared to R$1.7 billion on December 31, 2022). Due to the prognosis of remote loss, the processes related to this issue ceased to be reported as possible contingencies in the first quarter of 2023.

- 1,690

 

 

  Indirect taxes

Estimates

(in million of Brazilian Reais)

# Description of the main processes 2023 2022
1

ICMS-ST Trigger

Over the years, Ambev has received tax assessments to charge supposed ICMS differences considered due when the price of the products sold by Ambev is above the fixed price table basis established by the relevant states, cases in which the state tax authorities contend that the calculation basis should be based on a value-added percentage over the actual prices and not the fixed table price. Ambev is currently challenging those charges before the courts. The cases are being challenged at both the administrative and judicial levels.

A Company estimates that the total updated amount of possible risk involved in the processes related to this matter, as of December 31, 2023, is approximately R$10.7 billion (R$9.3 billion on December 31, 2022).

10,669 9,292
2

Manaus Free Trade Zone – IPI and PIS/COFINS

In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/ or zero-rated from excise tax (“IPI”) and social contributions (“PIS/COFINS”). With respect to IPI, Ambev’s subsidiaries have been registering IPI presumed tax credits upon the acquisition of exempted goods manufactured therein. Since 2009, Ambev has been receiving a number of tax assessments from the Brazilian Federal Tax Authorities relating to the disallowance of such credits.

Ambev and its subsidiaries have also been receiving charges from the Brazilian Federal Tax Authorities in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI excise tax credits that are under discussion in these proceedings and (ii) PIS/COFINS amounts allegedly due on Arosuco’s remittance to Ambev subsidiaries.

In April 2019, the Federal Supreme Court (“STF”) announced its judgment on Extraordinary Appeal No. 592.891/ /SP, with binding effect, deciding on the rights of taxpayers registering IPI excise tax presumed credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, Ambev reclassified part of the amounts related to the IPI cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF. The cases are being challenged at both the administrative and judicial levels.

The company estimates that the updated value classified as possible loss involved in these processes, as of December 31, 2023, is approximately R$6.3 billion (R$5.8 billion on December 31, 2022).

6,307 5,825
3

IPI Suspension

In 2014 and 2015, Ambev received tax assessments from the Brazilian Federal Tax Authorities relating to IPI allegedly due over remittances of manufactured goods to other related factories. The cases are being challenged at both the administrative and judicial levels. In July 2022, Ambev received the first judicial decision on this matter; the decision was unfavorable to Ambev, and it filed an appeal. In July 2023, the Federal Court rendered its decision on the appeal, annulling the first-level decision and ordering the production of technical evidence as requested by Ambev in order to demonstrate the proper collection of IPI. The federal government has filed motions for clarification against this decision, which are pending judgment by the Federal Court.

In October 2022, the Upper Administrative Court rendered a partially favorable decision to Ambev in one of the cases related to this matter, which ordered a tax audit to determine the amount of the tax already effectively paid. The results of the tax audit, which were notified in January 2024, were partially favorable to Ambev, reducing 98% of the amount alleged to be owed by Ambev in this case. Ambev will file an appeal at the judicial level against the unfavorable portion of the decision.

The Company estimates that the updated value classified as possible loss involved in these processes, as of December 31, 2023, is approximately R$1.8 billion (R$1.7 billion on December 31, 2022).

1,824 1,703
4

Social Contributions over products

Since 2015, Ambev has received tax assessments issued by the Brazilian Federal Tax Authorities relating to PIS/COFINS amounts allegedly due over bonus products granted to its customers. The cases are being challenged at both the administrative and judicial levels of the courts. In 2019, 2020 and 2023, Ambev received final favorable decisions at the administrative level in some of these cases. In 2023, the Lower Administrative Court rendered favorable decisions to Ambev in two other cases and Ambev is awaiting formal notification of these decisions, which are not final and remain subject to appeal. At the judicial level, one case is pending decision by the second level judicial court after the first-level judicial court rendered an unfavorable decision to Ambev.

The Ambev estimates that the amount involved in the proceedings as at December 31, 2023, classified as a possible loss, is approximately R$1.8 billion (R$1.6 billion as at December 31, 2022).

1,776 1,559
5

ICMS – ZFM

In 2018 and 2021, Ambev received infraction notices issued by the State Departments of Finance of Rio Grande do Sul and São Paulo for alleged differences in ICMS resulting from the disallowance of credits originating from operations with suppliers located in the Manaus Free Trade Zone (ZFM). Regarding the infraction notice issued by the state of Rio Grande do Sul, the outcome was unfavorable at the administrative level, and the Company awaits notification of the decision rendered by the Administrative Tribunal to assess, along with its external advisors, the presentation of a challenge in the judicial sphere.

Regarding the infractions issued by the state of São Paulo, all had unfavorable decisions at the first instance, and one of the cases is already in the final administrative instance, considering the special appeal filed by the Company. The other cases await judgment by the TIT.

The Company is litigating the matter in the administrative tribunals of the states. The Company estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$804.4 million (R$730.3 million on December 31, 2022).

804.4 730.3
6

ICMS - Prodepe

In 2015, Ambev received Infraction Notices issued by the State Treasury Department of Pernambuco for the collection of ICMS differences due to the alleged non-compliance with the rules of the Pernambuco Development Program - "PRODEPE," due to the rectification of its ancillary obligations.

In 2017, the Company obtained a final favorable decision recognizing the nullity of one of the infraction notices, due to formal errors. However, in September 2018, Ambev received a new infraction notice to discuss the same matter. In this new case, in June 2020, a first-instance decision partially favorable to the Company was rendered, recognizing errors by the tax auditor in the calculation of the incentive. The favorable portion of the decision is definitive, and for the unfavorable portion, the discussion will proceed to the judicial sphere. Additionally, there are other infraction notices related to PRODEPE, some of which are already being discussed in the judicial realm.

The Company estimates that the total updated value of possible risk involved in the processes related to this matter, as of December 31, 2023, is approximately R$739.4 million (R$663.9 million on December 31, 2022).

739.4 663.9
7

ICMS – FAIN

In recent years, Ambev has received infraction notices issued by the State Department of Finance of Paraíba for the collection of ICMS related to the Fund for Industrial Development Support of Paraíba (FAIN). The infractions stem from a controversy regarding the transfer of the tax incentive from the former Companhia de Bebidas das Américas to its successor Ambev S.A., as well as methodological issues regarding the calculation of the benefit. The Company is contesting these infractions in administrative and judicial courts. Ambev estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$647.4 million (R$591.4 million on December 31, 2022).

647.4 591.4
8

ICMS – AM

In 2016, Arosuco (a subsidiary of Ambev) received infraction notices issued by the State Department of Finance of Amazonas for alleged differences in ICMS due to questions about the calculation base applied in sales operations from Ambev to its subsidiaries. After unfavorable decisions at the first instance for Arosuco, appeals were filed, awaiting judgment in the state's administrative tribunal. Arosuco estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$605.8 million (R$561.5 million on December 31, 2022).

605.8 561.5
9

ICMS FISCAL WAR

The Company and its subsidiaries have received tax assessment notices from the states of São Paulo, Rio de Janeiro, Minas Gerais, among others, related to the legality of the appropriation of ICMS credits in transactions covered by tax incentives granted by other states. The Company is challenging these assessments in administrative and judicial courts.

In August 2020, the Brazilian Supreme Court (STF) ruled, under the system of general repercussion, on Case No. 628,075, recognizing the constitutionality of the unilateral disallowance, by destination states, of ICMS credits arising from tax incentives granted by other states. The decision also acknowledged that any collection of these credits should preserve the effects of the validation of tax incentives, as provided for in Complementary Law No. 160/2017. This decision does not change the likelihood of loss of the cases involving the Company and its subsidiaries.

Regarding assessments received from the state of São Paulo regarding credits originating from the state of Amazonas, there were unfavorable decisions at the second administrative level in the second quarter of 2022. In these cases, the Company filed appeals with the second administrative level in the same year. In December 2023, there was a favorable decision by the STF (Writ of Non-Compliance with a Fundamental Precept, ADPF No. 1004) to recognize the unconstitutionality of São Paulo's tax authorities' decisions questioning the validity of credits from the state of Amazonas. Thus, although the Company is not a party to this STF judgment, there was a favorable impact on the cases under discussion, resulting in a reassessment of the likelihood of success of the cases on this topic from possible to remote, reducing the reported contingency by approximately R$1 billion.

 

On the other hand, regarding other assessments received from the states of São Paulo and Minas Gerais, among others, there were other favorable decisions in 2023, impacting the total value of the reported possible contingency.

 

Ambev estimates that the updated amount involved in the cases, as of December 31, 2023, still classified as possible loss, is approximately R$530 million (R$1.7 billion on December 31, 2022).

530 1,690
10

ICMS – MIP

The company and its subsidiaries have been receiving assessments from State Tax Authorities over the years, disallowing ICMS credits and demanding payment of the Differential Tax Rate (DIFAL) on the acquisition of intermediate production materials. According to the tax authorities, such materials are not physically related to the productive activity of the companies and therefore should be considered as goods for consumption, which do not entitle the taxpayer to tax credits. Considering these allegations as illegitimate, the companies are challenging these assessments before administrative and judicial courts. Provisions have been made for cases related to this matter, with an updated value of approximately R$116 million as of December 31, 2023 (R$113.4 million in December 2022). The Company estimates the possible loss related to this matter to be, as of December 31, 2023, approximately R$447.5 million (R$388.7 million as of December 31, 2022).

447.5 388.7

 

 

  Other processes

Estimates

(in million of Brazilian Reais)

# Description of the main processes 2023 2022
1

Proposed class action in Quebec

Labatt and other, third-party defendants have been named in a proposed class action lawsuit in the Superior Court of Quebec seeking unquantified compensatory and punitive damages. The plaintiffs allege that the defendants failed to warn of certain specific health risks of consuming defendants’ alcoholic beverages. A sub-class of plaintiffs further alleges that their diseases were caused by the consumption of defendants’ products. The proposed class action has not yet been authorized by the Superior Court.

- -
       

 

27.2.2 Main active contingencies

 

The main contingent assets are summarized in the tables below.

 

  Contingent assets
# Description of the main processes
1

Exclusion of ICMS and ICMS-ST from the calculation bases of PIS and COFINS

In 2017, the Supreme Federal Court (STF) ruled that the inclusion of ICMS in the calculation bases of PIS and COFINS is unconstitutional (Theme 69 of general repercussion).

Recently, on December 13, 2023, the Superior Court of Justice (STJ) ruled favorably on Theme 1,125 for taxpayers, meaning the exclusion of ICMS-ST from the calculation bases of PIS and COFINS for substituted taxpayers, with the publication of the respective ruling pending. Regarding this matter, from 2017 to 2023, the Company and its subsidiaries recognized tax credits totaling R$10.5 billion.

The unredeemed amounts remain recorded as assets (see Note18 - Recoverable Taxes) and mainly refer to the tax credit from "REFRI" (period from 2009 to 2015), whose legal action is in the expert phase. The above-mentioned values were recognized in accordance with IAS 37 - Provisions, Contingent Liabilities, and Contingent Assets, considering: (i) the realization of the gain being practically certain, in accordance with the decisions rendered by the STF in Theme 69 and by the STJ in Theme 1,125, and the specific circumstances of each concrete case, as well as due to (ii) the value being able to be estimated with reasonable certainty, through the survey of the respective documents and quantification of the overpayment.

For additional matters related to this subject, the contingent asset capable of estimation corresponds to approximately R$0.2 billion. Additional amounts may eventually be disclosed and recognized.

2

Cerbuco Brewing Inc. arbitration

Cerbuco Brewing Inc., (“Cerbuco”) a Canadian subsidiary of Ambev, owns a 50% equity ownership in Cerveceria Bucanero S.A. (“Bucanero”), a joint venture in Cuba. In 2021, Cerbuco initiated an arbitration proceeding at the International Chamber of Commerce (“ICC”), relating to a potential breach of certain obligations relating to the joint venture, with the terms of reference being formally executed in 2022. Depending on the outcome of the arbitration proceedings, there may be an impact on Cerbuco's ability to influence the management of Bucanero's operations. As a result, Ambev’s ability to continue consolidating Bucanero into its financial statements may also be affected. Based on the opinion of Cerbuco’s Lawyers, the management estimate the chance of loss as possible. The amount involved has not yet been ascertained, as it depends on the outcome of the arbitration.

 

Accounting policies

 

Provisions are recognized when: (i) the Company has a present obligation (legal or constructive) as a result of past events; (ii) it is likely that a future disbursement will be required to settle the current obligation; and (iii) the amount of the obligation can be estimated reliably.

 

Provisions, except for those mentioned in the line item disputes and litigation, are determined by discounting the expected future cash flow, to a pre-tax rate, which reflects the current market assessments of the time value of money and, where appropriate, the risks specific to the liability.

 

Measuring the probability of loss includes evaluating the available evidence, the hierarchy of laws, the most recent court decisions, court precedents, their legal relevance, the history of occurrences and the amounts involved and the assessment of external lawyers.

 

a) Disputes and Litigations

A provision for disputes and litigation is recognized when it is more likely than not that the Company will be required to make future payments as a result of past events. Such items may include but are not limited to, claims, suits and actions filed by or against the Company relating to antitrust laws, violations of distribution and license agreements, environmental matters, employment-related disputes, claims from the tax authorities, and other matters.

 

b) Contingent liabilities

The Company and its subsidiaries have tax, civil and labor lawsuits defined as contingent liabilities, according to IAS 37, for which no provisions have been recorded, due to the prognosis assessment carried out by Management. Contingent liabilities are not recognized but are disclosed in this note.

 

c) Contingent Assets

Contingent assets are evaluated periodically to ensure that the stages of the claims are appropriately reflected in the financial statements. Contingent assets are not recognized, except when the Company's management believes that it is certain that an inflow of economic benefits will occur, in which case the asset and the corresponding gain are recognized in the financial statements for the period in which the change in estimate occurs. If the inflow of economic benefits becomes probable, the Company discloses the contingent asset.

 

d)Restructuring

A provision for restructuring is recognized when the Company has approved a detailed restructuring plan, and the restructuring has either commenced or been announced. Costs relating to the ongoing and future activities of the Company are not provided for but are recognized when expenses are incurred. The provision includes the benefit commitments in connection with early retirement and redundancy schemes.

 

From the fourth quarter of 2023 onwards, the nomenclature of the "provisions" accounting policy was changed to "provisions, contingent liabilities and contingent assets”.

XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
FINANCIAL INSTRUMENTS AND RISKS

 

28.FINANCIAL INSTRUMENTS AND RISKS

 

28.1Financial instruments categories

 

The financial instruments held by the Company are managed through operational strategies and internal controls to assure liquidity, profitability, and transaction security. Transactions involving financial instruments are regularly reviewed to assess the effectiveness of the risk exposure that management intends to cover (foreign exchange, and interest rate, among others).

 

 

The table below shows all of the consolidated financial instruments recognized in the financial statements, segregated by category:

 

   
  2023 2022
Assets    
Amortized cost    
Cash and cash equivalents less bank overdrafts (Note 21.1) 16,059.0  14,852.1 
Trade receivables excluding prepaid expenses  7,566.7  7,791.4 
Investment securities (Note 21.2) 242.2  219.1 
Subtotal 23,867.9  22,862.6 
Fair value through profit or loss    
Investment securities (Note 21.2) 277.2  454.5 
Derivatives hedges (Note 28) 379.7  273.8 
Subtotal 656.9  728.3 
Total assets 24,524.8  23,590.9 
     
Liabilities    
Amortized cost    
Trade payables (Note 26) 23,502.4  24,837.9 
Interest-bearing loans and borrowings (Note 23) 3,501.1  3,770.7 
Other liabilities 2,129.6  2,015.6 
Subtotal 29,133.1  30,624.2 
Fair value through profit or loss    
Put options granted on subsidiaries (i) 2,791.1  3,060.3 
Derivatives hedges (Note 28) 763.1  729.4 
Other liabilities 272.6  333.7 
Subtotal 3,826.8  4,123.4 
Total liabilities 32,959.9  34,747.6 

 

(i)Put options granted on subsidiaries: the Company constituted a liability related to the acquisition of a non-controlling interest of the operations in the Dominican Republic. This financial instrument is denominated in US Dollars (Tranche A) and Dominican Pesos (Tranche B) and is recorded by an entity, whose functional currency is the Real. The Company assigned this financial instrument as a hedging instrument for a portion of its net assets located in subsidiaries whose functional currency is the US Dollar and the Dominican Peso, in such a manner that the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.

 

28.2 Derivative financial instruments

 

The use of derivative financial instruments by the Company follow strictly the Financial Risk Management Policy (“Policy”) approved by Management. The instruments authorized by the Policy are Futures contracts traded on exchanges, full deliverable forwards, non-deliverable forwards, swaps, and options. The Policy excludes the use of derivatives when they are not related to the Company's business. At December 31, 2023, the Company and its subsidiaries had no target forwards, swaps with currency verification, or any other derivative transactions representing a risk level above the nominal value of the contracts. The derivative operations are managed on a consolidated basis and classified based on the strategy according to their purposes, as follows:

 

i) Cash flow hedge derivative instruments

ii) Fair value hedge derivative instruments.

iii) Net investment hedge derivative instruments.

 

In accordance with the hedge accounting, the effective hedge amount is recorded in equity and, in the event of an ineffective portion this result is recorded immediately in finance result during the period ineffectiveness was identified, for cash flow hedge and net investment hedge

 

The Company measures derivative financial instruments by calculating their fair value, using market curves that impact the value of the instrument as at the computation date. In the case of swaps, the asset and the liability positions are estimated independently and brought to their fair value, equivalent to the difference between the results of the asset and liability amounts, which generates the swap’s market value. For traded derivative financial instruments, the fair value is calculated based on the exchange-listed price. The following tables summarize the exposure identified and protected in accordance with the Company's Risk Policy.

 

Transactions protected by derivative financial instruments in accordance with the Financial Risk Management Policy

 

                   
2023 
          Fair Value   Gain / (Losses)
Hedge position   Risk Notional   Assets Liability   Finance Result Operational Result Equity
                     
Cost     17,374.2    379.5  (742.0)   (1,639.6) 34.6  (285.2)
    Commodities 4,025.7    198.3  (219.4)   (388.3) (336.2) (105.4)
    US Dollars 13,200.0    164.9  (522.4)   (1,250.7) 363.9  (182.1)
    Euros 37.4    0.1  (0.2)   (0.5) 2.6  0.5 
    Mexican Pesos 111.1    16.2  -      (0.1) 4.3  1.8 
                     
Importing of fixed assets     249.7    0.1  (14.6)   11.0  3.4  5.0 
    US Dollars 249.7    0.1  (14.6)   11.0  3.4  5.0 
                     
Expenses     64.7    0.1  (4.2)   (25.6) (0.1) 1.1 
    US Dollars 64.7    0.1  (4.2)   (25.6) (0.1) 1.1 
                     
Cash     (59.3)   -    (2.3)   13.7  -    -   
    US Dollars (59.3)   -    (2.3)   13.7  -    -   
At December 31, 2023     17,629.3    379.7  (763.1)   (1,640.5) 37.9  (279.1)

 

    2022 
          Fair Value   Gain / (Losses)
Hedge position   Risk Notional   Assets Liability   Finance Result Operational Result Equity
                     
Cost     19,853.3    271.8  (719.4)   (3,075.2) 452.7  134.3 
    Commodities 4,809.9    100.8  (376.0)   63.5  (32.3) (475.0)
    US Dollars 14,874.7    157.7  (342.9)   (3,139.2) 477.1  596.6 
    Euros 32.2    1.9  -      (0.7) (0.3) 1.2 
    Mexican Pesos 136.5    11.4  (0.5)   1.2  8.2  11.5 
                     
Fixed assets     226.8    1.5  (5.4)   (5.9) 4.9  (13.0)
    US Dollars 226.8    1.5  (5.4)   (5.9) 4.9  (13.0)
                     
Expenses     204.9    0.5  (4.6)   (42.5) 9.1  (14.8)
    US Dollars 204.9    0.5  (4.6)   (42.5) 9.1  (14.8)
                     
Cash     -      -    -      (17.1) -    -   
    American Dollar -      -    -      (17.1) -    -   
At December 31, 2022     20,285.0    273.8  (729.4)   (3,140.7) 466.7  106.5 

 

28.2.1 Instrument maturity

 

As of December 31, 2023, the Notional and Fair Value amounts per instrument and maturity were as follow:

 

             
    Notional Value
Exposure Risk 2024 2025 2026 2027 >2027 Total
               
Cost   16,763.3  610.9  -    -    -    17,374.2 
   Commodities  3,924.3  101.4  -    -    -    4,025.7 
   US Dollars  12,690.5  509.5  -    -    -    13,200.0 
   Euros 37.4  -    -    -    -    37.4 
   Mexican Pesos  111.1  -    -    -    -    111.1 
               
Importing of fixed assets   249.7  -    -    -    -    249.7 
  US Dollars  249.7  -    -    -    -    249.7 
               
Expenses   64.7  -    -    -    -    64.7 
  US Dollars  64.7  -    -    -    -    64.7 
               
Cash   (59.3) -    -    -    -    (59.3)
  US Dollars  (59.3) -    -    -    -    (59.3)
    17,018.4  610.9  -    -    -    17,629.3 

 

    Fair Value
Exposure Risk 2024 2025 2026 2027 >2027 Total
               
Costs   (352.5) (10.0) -    -    -    (362.5)
  Commodities (14.2) (6.9) -    -    -    (21.1)
  US Dollars (354.4) (3.1) -    -    -    (357.5)
  Euros (0.1) -    -    -    -    (0.1)
  Mexican Pesos 16.2  -    -    -    -    16.2 
               
Importing of fixed assets   (14.5) -    -    -    -    (14.5)
  US Dollars (14.5) -    -    -    -    (14.5)
               
Expenses   (4.1) -    -    -    -    (4.1)
  US Dollars (4.1) -    -    -    -    (4.1)
               
Cash   (2.3) -    -    -    -    (2.3)
  US Dollars (2.3) -    -    -    -    (2.3)
    (373.4) (10.0) -    -    -    (383.4)

 

Margins pledged as guarantees

 

In order to comply with the guarantee requirements regarding derivative exchanges and/or counterparties to certain operations with derivative financial instruments, as at December 31, 2023, the Company held R$197.7 in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (R$376.9 as at December 31, 2022).

 

28.3 Classification of financial instruments

 

 

                 
  2023   2022
                   
  Level 1 Level 2 Level 3  Total    Level 1 Level 2 Level 3 Total
Financial assets                  
Investment securities 277.2  -    -    277.2    454.5  -    -    454.5 
Derivatives – operational hedge 53.4  326.3  -    379.7    57.0  216.8  -    273.8 
 Total 330.6  326.3  -    656.9    511.5  216.8  -    728.3 
Financial liabilities                  
Put options granted on subsidiaries -    -    2,791.1  2,791.1    -    -    3,060.3  3,060.3 
Other liabilities -    -    272.6  272.6    -    -    333.7  333.7 
Derivatives liabilities at fair value through profit and loss 2.3  -    -    2.3    -    -    -    -   
Derivatives – operational hedge 70.0  690.8  -    760.8    76.1  653.3  -    729.4 
 Total 72.3  690.8  3,063.7  3,826.8    76.1  653.3  3,394.0  4,123.4 

 

28.3.1 Financial instruments level 3

 

As part of the negotiations regarding the acquisition of the shares of Tenedora, the Company signed at 2020 the second amendment to the Shareholders' Agreement extending the partnership between the Company and ELJ. As at December 2023, ELJ was the owner of 15% of the shares of Tenedora, and its put options was divided into two tranches: (i) Tranche A, corresponding to 12.11% of the shares, that was exercised at January 04, 2024; and (ii) Tranche B, corresponding to 2.89% of the shares, exercisable from 2026. The Company, on the other hand, has a call option over Tranche B shares, exercisable from 2029. On December 31, 2023, the sum of the two ELJ tranches is R$2,791.1 (R$3,053.7 on December 31, 2022).

 

The fair value of (i) Tranche A is calculated considering the interest under the contract, plus foreign exchange variations, less the dividends paid between the date of signature of the amendment and the exercise of the option. The fair value of (ii) Tranche B is calculated based on the EBITDA multiple defined in the contract, less the net debt, brought to its present value, calculated using standard valuation techniques (the present value of the principal amount and future interest, discounted by the local currency’s WACC rate as at the date of the calculation). The criteria used are based on market information from reliable sources and are categorized as “Level 3”.

 

28.3.2 Reconciliation of changes in the assets categorized at Level 3

 

 
Financial liabilities at December 31, 2022 3,394.0 
   Acquisition of investments (64.2)
Level reclassification (6.6)
Total gains and losses during the period (259.5)
   Losses/(gains) recognized in net income (269.9)
   Losses/(gains) recognized in equity 10.4 
Financial liabilities at December 31, 2023 3,063.7 

 

28.4 risk management

 

The Company is exposed to foreign currency, interest rate, commodity price, liquidity, and credit risk in the ordinary course of its business. The Company analyzes each of these risks both individually and on a consolidated basis, to define strategies to manage the economic impact on risk’s performance consistent with its Financial Risk Management Policy.

 

The objective of this policy is intended to provide guidelines for the management of the financial risks inherent to the capital markets in which Ambev operates. The policy includes four main aspects: (i) transactional risks related to the business; (ii) financial statement translation risk; (iii) credit risks of financial counterparties and (iv) capital structure; financing and liquidity.

 

The policy establishes that all the financial assets and liabilities in each country in which Ambev operates must be denominated in their respective local currencies. The policy also sets out the procedures and controls required to identify, measure, and minimize market risks, such as variations in foreign exchange rates, interest rates and commodities (mainly aluminum, sugar, wheat, corn and paraxylene) that may affect Ambev’s revenue, costs and/or investment amounts. The known risks (e.g., foreign currency and interest) shall be hedged by contracting derivative financial instruments. Existing risks which are not yet recorded (e.g., future contracts for the purchase of raw materials or property, plant and equipment) shall be mitigated using projections for the period required for the Company to adapt to the new costs’ scenario, which may vary from ten to fourteen months, also through the use of derivative financial instruments. Most translation risks are not hedged. The exceptions to the policy must be approved by the Operations and Finance Committee (“COF”)

 

28.4.1 Market risk

 

28.4.1.1 Interest rate risk: consists of the possibility that the Company may incur losses due to fluctuations in interest rates, which may increase the financial expenses of financial liabilities, and/or decrease the financial income of financial assets, as well as negatively impact the fair value of financial assets measured at fair value. To mitigate this risk the Company applies a dynamic interest rate hedging approach, whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of the Company’s policy is to achieve an optimal balance between the cost of funding and the volatility of financial results, considering market conditions. The Company’s overall business strategy, which is reviewed periodically.

 

The table below demonstrates the Company’s exposure related to debts. In 2023, the Company does not hold hedge positions to the exposure described below:

 

         
  2023   2022
  Risk   Risk
  Interest rate  Amount    Interest rate  Amount 
Brazilian Reais 8.1% 243.2    8.5% 230.1 
Post fixed interest rate    243.2      230.1 
           
           
Brazilian Reais 10.1% 2,372.0    8.5% 2,602.1 
Working Capital in Argentinean Peso  0.0% -      73.5% 74.3 
Other 11.5% 405.6    10.4% 421.3 
US Dollars 14.0% -      14.0% 6.2 
Canadian Dollars 5.6% 480.3    5.3% 511.0 
Pre-fixed interest rate    3,257.9      3,614.9 

 

Sensitivity analysis

 

The Company substantially mitigates the risks arising from non-derivative financial assets and liabilities, through the use of derivative financial instruments. In this context, the Company has identified the main risk factors that could generate losses from these derivative financial instruments, and has developed a sensitivity analysis based on three scenarios, which may impact the Company’s future results and/or cash flow, as described below:

1 - Probable scenario: Management’s expectations regarding the deterioration of each transaction’s main risk factor. To measure the possible effects on the results of derivative transactions, the Company uses the parametric Value at Risk (“VaR”), a statistical measure developed based on estimates of standard deviation and correlation between the returns of several risk factors. This model gives the loss limit expected for an asset over a certain time period and confidence interval. Under this methodology, the potential exposure of each financial instrument, a range of 95% and a horizon of 21 days from December 31, 2023, were used for the calculation, which are presented in the model.

 

2 - Adverse scenario: 25% deterioration in each transaction’s main risk factor compared to the level observed as at December 31, 2023.

 

3 - Remote scenario: 50% deterioration in each transaction’s main risk factor compared to the level observed as at December 31, 2023.

 

Sensitivity analysis of exchange rate variations and commodity price variations:

 

         
Transaction Risk Fair value Probable scenario Adverse scenario Remote
scenario
           
Commodities hedge Decrease in commodities price (21.1) 94.6  985.4  1,991.9 
Input purchases 21.1  (94.6) (985.4) (1,991.9)
Foreign exchange hedge Foreign currency decrease (341.4) (163.3) 2,995.8  6,333.0 
Input purchases 341.4  104.9  (3,336.8) (7,014.9)
Cost effects   -    (58.4) (341.0) (681.9)
           
Foreign exchange hedge Foreign currency decrease (14.5) (13.2) 47.9  110.3 
Capex Purchases 14.5  13.2  (47.9) (110.3)
Fixed asset effects   -    -    -    -   
           
Foreign exchange hedge Foreign currency decrease (4.1) (3.7) 12.0  28.2 
Expenses 4.1  (1.7) (44.0) (92.2)
Result of expense effects   -    (5.4) (32.0) (64.0)
           
Foreign exchange hedge Foreign currency decrease (2.3) (2.5) (17.1) (31.9)
Cash 2.3  2.5  17.1  31.9 
Cash effects   -    -    -    -   
    -    (63.8) (373.0) (745.9)

 

28.4.1.2 Foreign currency risk: the Company is exposed to foreign currency risk on borrowings, investments, purchases, dividends and/or interest expenses/income where these are denominated in a currency other than the functional currency of Group entity. The main derivative financial instruments used to manage foreign currency risk are futures contracts, swaps, options, non-deliverable forwards, and full deliverable forwards.

 

28.4.1.3 Commodity Risk: A significant portion of the Company’s inputs is made up of commodities, which have historically experienced substantial price fluctuations. The Company therefore uses both fixed prices purchasing contracts and derivative financial instruments to minimize its exposure to volatility in the commodity prices of aluminum, sugar, wheat, corn and paraxylene. These derivative financial instruments have been designated as cash flow hedges.

 

28.4.2 Credit Risk

 

A substantial portion of the Company’s sales is made to distributors, supermarkets, and retailers, through a broad distribution network. Credit risk is reduced due to the large number of customers and control procedures used to monitor risk. Historically, the Company has not incurred significant losses on receivables from customers.

In order to minimize the credit risk of its investments, the Company has adopted procedures for the allocation of cash and investments, taking into consideration the credit limits and credit analysis of financial institutions, avoiding credit concentration, i.e., the credit risk is monitored and minimized by restricting negotiations to a select group of highly rated counterparties.

 

The selection process for financial institutions authorized to operate as counterparties of the Company is set forth in the Credit Risk Policy, which also establishes exposure limits for each counterparty based on each counterparty's risk rating and capitalization.

 

Any deposits or cash available, must be kept in accounts with top tier banks, or banks with a high credit rating in the respective country. Any position of a short-term nature (less than six months) should be considered as a deposit or cash.

 

Counterparty risk must be managed by the Company globally, with product limits established by the treasury area, considering: (i) the counterparty’s credit rating (ii) the transaction term (iii) the amount; and (iv) the split between assets and liabilities, in the absence of a clearing clause in derivative contracts. The counterparty risk is reassessed on a quarterly basis.

 

The carrying amounts of cash and cash equivalents, investment securities, trade receivables excluding prepaid expenses, recoverable taxes and derivative financial instruments are disclosed net of provisions for impairment and represent the maximum exposure to credit risk as at December 31, 2023. As at December 31, 2023, there was no concentration of credit risk on any counterparties in excess of the limits established by the Company's Credit Risk Policy.

 

28.4.3Liquidity Risk

 

Historically, the Company’s primary sources of cash flow have been cash flow from operating activities, the issuance of debt, bank borrowings and equity securities. Ambev’s material cash requirements have included the following: debt servicing; capital expenditure; investments in companies; increases in the ownership of Ambev’s subsidiaries or companies in which it holds equity investments; share buyback programs; and payments of dividends and interest on shareholders’ equity.

The Company believes that cash flows from operating activities, cash and cash equivalents and short-term investments, together with derivatives and access to loan facilities are sufficient to finance capital expenditures, financial liabilities, and dividend payments in the future.

 

             
  2023
  Carrying amount Contractual cash flows Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
Trade and other payables (i) 36,817.8  38,453.7  35,522.5  439.9  10.6  808.6  1,672.1 
Secured bank loans 126.5  177.8  26.7  25.2  25.2  50.4  50.4 
Other secured loans (ii) 415.7  594.7  156.0  171.2  134.2  79.4  53.9 
Lease liabilities  2,958.9  3,473.0  1,344.0  608.3  552.6  452.6  515.5 
Total payables and liabilities  40,318.9  42,699.2  37,049.2  1,244.6  722.6  1,390.9  2,291.8 

 

               
  2022
  Carrying amount Contractual cash flows Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
Trade and other payables (i) 39,354.4  40,656.4  36,818.5  86.8  1,275.1  1,008.4  1,467.6 
Secured bank loans 180.8  245.7  68.2  26.4  25.2  50.4  75.5 
Other secured loans (ii) 472.5  759.1  169.9  156.7  151.6  165.4  115.5 
Lease liabilities  3,117.4  3,657.4  962.9  1,008.4  621.0  696.9  368.2 
Total payables and liabilities  43,125.1  45,318.6  38,019.5  1,278.3  2,072.9  1,921.1  2,026.8 

 

(i)Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends, and interest on equity payable, salaries and charges, put options related to the Company’s participation in subsidiaries and other liabilities, except for related parties, with payment term of less than one year.

 

(ii)Nomenclature modified to Other secured loans, including for comparative purposes.

 

28.4.4 Capital management

 

The Company is continuously optimizing its capital structure in order to maximize shareholder value while maintaining the desired financial flexibility to execute its strategic projects. Besides the statutory minimum equity funding requirements applicable to the Company’s subsidiaries in different countries, the Company is not subject to any externally imposed capital requirements. When analyzing the capital structure, the Company uses the same debt ratings and capital classifications applied to the financial statements.

 

The company evaluates its net debt in order to guarantee the continuity of its business in the long term.

 

     
    2023 2022
Assets      
Interest-bearing loans and borrowings current and non-current   3,501.1  3,770.7 
(-) Financial assets at fair value through profit or loss   (277.2) (454.5)
(-) Cash and cash equivalents less bank overdraft   (16,059.0) (14,852.1)
Net debt   (12,835.1) (11,535.9)

 

 

28.5 Offsetting financial assets and liabilities

 

For financial assets and liabilities subject to settlement agreements on a net basis or similar agreements, each agreement between the Company and the counterparty allows this type of settlement when both parties opt for this. In the absence of such a decision, the assets and liabilities will be settled at their gross amounts, but each party will have the option to settle on a net basis, in case of a default by the counterparty.

28.6 Risks management of climate change and the sustainability strategy

 

The Company’s operations, there is an inherent exposure to certain risks related to climate change, and relevant ESG (Environmental, Social and Governance) aspects. As the events mentioned in this section are highly uncertain, the Company cannot determine their financial impact at this moment. Any mentioned impacts may result in a material adverse effect on our business, liquidity, financial condition, and results of operations. The Company continues to manage liquidity and capital resources with discipline to meet the costs of the eventual materialization of such risks. In the period finished in December 31, 2023, the Management considered as main risks the points below.

28.6.1 Commodities prices

 

There is a growing concern that the currently level of carbon dioxide and other greenhouse gases in the atmosphere have adverse impacts on global temperatures, weather patterns and the frequency and severity of extreme weather and natural disasters, such as droughts, floods, unseasonal rains, tropical cyclones, among others. In the event the climate changes have a negative effect on agricultural productivity, the Company may be subject to decreased availability or less favorable pricing for certain agricultural commodities that are necessary for our products, such as barley, hops, sugar and corn. In addition, public expectations for reductions in greenhouse gas emissions could result in increased energy, transportation and raw material costs and may require us to make additional investments in facilities and equipment due to increased regulatory pressures. As a result, the effects of climate change could have a long-term, material adverse impact on our business and results of operations.

 

28.6.2 Water crisis

 

The Company also face water scarcity and quality risks. The availability of clean water is a limited resource in many parts of the world, facing unprecedented challenges from climate change and the resulting change in precipitation patterns and frequency of extreme weather, overexploitation, increasing pollution, and poor water management. The Company has implemented an internal strategy in order to considerably reduce the use of water in your operative plants. However, as demand for water continues to increase around the world, and as water becomes scarcer and the quality of available water deteriorates, we may be affected by increasing production costs or capacity constraints, which could adversely affect our business and results of operations.

 

Droughts can cause barley crop failures, especially in South America, where most barley is rain-fed. The meteorological droughts (short-term, precipitation-impacted droughts) can significantly affect barley crop performance. As a result, the effects of climate change could have a substantial long-term detrimental impact on the Company's business and operating results.

 

28.6.3 Environmental regulations

 

The Company’s operations are subject to a wide range of Brazilian federal, state and municipal safety and environmental laws and regulations related to licenses or authorizations necessary to our business, as well as use of water resources and management of solid waste and take-back scheme obligations.

 

The Company activities require the constant obtaining and renewal of environmental licenses, in which the production units operation depends. Technical difficulties or failure to meet license renewal terms and the requirements of environmental agencies may have adverse effects on our business, as we may be subject to (i) the imposition of several administrative penalties (such as fines, interruption or shutdown of activities, license cancellation, among others). (ii) payment of recovering costs to of degraded areas and (iii) accountability in the civil, administrative and criminal spheres, depending on the case.

 

There is no guarantee that the Company, even if it adopts adequate practices and processes, will not incur environmental liability or that these applicable environmental laws and regulations will not change or become stricter in the future. Accordingly, non-compliance with applicable laws and the technical conditions established in licenses and permits may harm the Company's reputation, results of operations and financial health.

 

28.6.4 Social

The Company is subject to obligations regarding the respect for human rights of all stakeholders, which may lead the Company to incur additional costs as well as significant contingencies relating to social issues. In general, social risks arise from the potential and actual adverse impacts of its business activities on the human rights of all stakeholders involved in its operation, including its own employees, consumers, suppliers, investors and the local community where the Company operates, whether directly or indirectly connected to its activities.

If the Company does not adopt well-structured and integrated long-term planning initiatives to promote diversity, equality and inclusion, both in its workforce and in the composition of statutory bodies and leadership, it may be challenged, including in court, about the absence of clear goals and effective actions in this area.

There is no guarantee that the Company will be able to adequately manage the social risks mentioned above in compliance with all national and international parameters and guidelines, which, consequently, may eventually harm the Company's operating results and reputation and expose it to legal and regulatory risks, which may materialize in different ways.

 

Accounting policies

 

Classification and measurement

 

Financial assets (except for accounts receivable without a significant financing component) or financial liabilities are initially measured at fair value, plus, for an item not measured at fair value through profit or loss, transaction costs directly attributable to their acquisition or issue.

 

Financial assets

 

The Company classifies its financial assets on initial recognition, depending on the business model used to manage the financial assets and the contractual terms of the cash flows, under the following measurement categories: (i) at amortized cost; (ii) at fair value through profit or loss; (iii) at fair value through other comprehensive income (“FVOCI”).

 

Financial assets are not reclassified subsequently to initial recognition, unless the Group changes the business model for the management of financial assets, in which case all impacted financial assets are reclassified on the first day of the post-change business model.

 

Financial assets are derecognized when the contractual rights to receive the cash flows from the asset has expired or are transferred in a transaction in which substantially all the risks and benefits of ownership of the financial asset are transferred by the Company.

 

On December 31, 2023, and 2022, the Company did not have any financial assets classified in the fair value through other comprehensive income category.

 

a) Amortized cost

The Company classifies financial assets as measured at amortized cost only when two criteria are satisfied:

 

i) The financial asset is held within a business model whose objective is to receive the contractual cash flows; and

ii) The contractual terms generate, on specific dates, cash flows that relate only to the payment of principal and interest on the principal amount outstanding.

 

b) Fair value through profit or loss

All financial assets not classified by the Company as measured at amortized cost or FVOCI and financial assets in which their cash flows do not represent exclusively payments of principal and interest, are classified at fair value through profit or loss. This category also includes debt instruments with cash flow characteristics which are not held within a business model with the objective either to collect contractual cash flow, or both to collect contractual cash flow and for sale.

 

c) Fair Value through Other Comprehensive Income

Debt instruments at FVOCI, with gains or losses recycled to profit or loss on derecognition. The financial assets in this category are the Company’s listed debt instruments thar are held within a business model either to collect cash flow or for sale.

 

Equity instruments designated at FVOCI, without remeasurement of gains or losses to the profit or loss upon derecognition. This category includes only equity instruments which the Company intends to hold for the foreseeable future, and which it has irrevocably elected to classify thus upon their initial recognition or transition. These instruments are not subject to impairment testing.

 

Financial liabilities

 

The Company classifies its financial liabilities, depending on the purpose for which the financial liabilities were entered into, in the following categories:

 

i) measured at amortized cost.

ii) measured at fair value through profit or loss.

 

Financial liabilities are derecognized when contractual obligations are removed, cancelled or expired. The difference between the written-off carrying amount and the consideration paid (including assets transferred or liabilities assumed) is recognized in profit or loss for the year.

 

All financial liabilities are initially measured at fair value, net of transaction costs incurred, and are subsequently measured at amortized cost and adjusted using the effective interest rate method. Derivative instruments, remain classified in the fair value through profit or loss category.

 

Hedge accounting

 

The company designates certain derivatives as hedging instruments to hedge the risk related to the variability of foreign exchange rates, interest rates and commodity prices and are not used for speculative purposes. Derivative financial instruments, that are contracted to protect against the exposure, but that do not meet all of the hedge accounting requirements, will be recognized at fair value through profit or loss.

 

Derivative financial instruments are initially recognized at fair value. The fair value of derivative financial instruments can be obtained from market prices or from pricing models that reflect current market rates, as well as the credit quality of the counterparty.

 

Subsequently to initial recognition, derivative financial instruments are remeasured to their fair value as at the date of the financial statements. Changes in the fair values of derivative financial instruments are recognized in current income, except when these instruments are cash flow hedges or net investment hedges, where portions of gains or losses on the hedge instrument defined as effective hedge are recognized in comprehensive income. The hedge designated instrument is the effective element present term contract, which only the present element value change is recognized in comprehensive income, The term element, which can be separated and excluded from the financial instrument designation as hedge instrument is recognized in financial result, in accordance with IFRS 9 - Financial Instruments.

 

The company contracts commodities derivatives which have similar terms to the hedged items and applies component hedging to its commodities. The hedged component is contractually specified and matches with what is defined in the derivative contract, and therefore the hedge ratio is always 1:1. At the beginning of the hedge operation, the Company prepares formal documentation for the operation including: (i) the objective of the hedge, (ii) the type of hedge, (iii) the risk management strategy, (iv) the nature of the risk to be hedged, (v) the identity of the hedged item, (vi) the identity of the hedging instrument, and (vii) the prospective demonstration of effectiveness.

 

Hedge effectiveness is measured on a qualitative basis. Whenever the terms do not match, the Company uses the hypothetical derivatives method to assess the hedge effectiveness. Therefore, usually causes of ineffectiveness include changes in the timing of forecast transactions, changes in the quantity of the commodity to be hedged, or changes in the credit risk of either party to the derivative contract.

 

a) Cash flow hedge

Cash flow hedges are used to protect the cash flow exposure of a recorded asset or liability, or the foreign currency risk or commodity price variations associated with a highly probable transaction. The effective portion of any (gain or loss) on the derivative financial instrument is recognized directly in the comprehensive income statement (cash flow hedge reserve) and will be reclassified from the cash flow hedge reserve to the same line item within which and the same period during which the cash flow futures were hedged impacted the result. The ineffective portion of any gain or loss is recognized immediately in the current income statement, in the financial result.

 

When a hedging instrument or a hedging relationship is terminated, but the hedged transaction is still expected to occur, the cumulative gains and losses (up to the date of termination) remain within comprehensive income, being reclassified in accordance with the above practice, when the transaction being protected occurs. If the hedged transaction is no longer probable, the accumulated gains and losses recognized in comprehensive income are reclassified immediately to the current income statement.

b) Fair value hedge

Fair value hedges are used to protect the Company's net debt from variations in exchange rates and interest rates. The Company's cash and debt positions in foreign currency are continually monitored to identify new exposures.

 

When a derivative is intended to hedge the variability in the fair value of a recognized asset or liability, or of a firm commitment, any resulting (gain or loss) on the hedging instrument is recognized in profit or loss. The carrying amount of the hedged item is also adjusted for changes in the fair value related to the risk being hedged, with any gain or loss being recognized in the income statement.

 

c) Net investment hedge

The net investment hedge is used to mitigate the exposure to exchange differences resulting from the conversion of the net investment, or part of it, in the Company's subsidiaries abroad, by balance sheet conversion quota.

 

When a non-derivative foreign currency liability hedges a net investment in a foreign operation, exchange differences arising on the translation of the liability into the functional currency are recognized directly in other comprehensive income (translation reserves). Any ineffectiveness is recognized immediately in profit or loss.

 

When a derivative financial instrument hedges a net investment in a foreign operation, the portion of the gain or loss on the hedging instrument that is determined to be effective is recognized directly in other comprehensive income (translation reserves), while the ineffective portion is reported in profit or loss.

 

28.8.4 Derivatives at fair value through profit or loss

 

Certain derivative financial instruments do not qualify for hedge accounting. Changes in the fair values of any of those derivative financial instruments are recognized immediately in profit or loss of exercise.

 

28.8.5 Impairment of financial assets

 

At the end of each reporting period basis, Management performs impairment testing for financial assets or groups of financial assets. If a trigger event occurs, a financial asset or group of financial assets will be deemed to be impaired. An asset or group of financial assets is deemed impaired, and impairment losses are recorded, only if there is evidence of impairment as a result of one or more events occurring after the initial recognition of the assets (a "loss event") and that event (or events) has an impact on the estimated future cash flow from the financial asset or group of financial assets and can be estimated reliably.

 

28.8.6 Classification of fair value

 

IFRS 13 defines the fair value as the price that would be received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

 

The definition of the fair value of financial instruments is based principally on market conditions existing at the date of each balance sheet. Pursuant to IFRS 13, financial instruments measured at fair value shall be classified within the following categories:

 

Level 1: quoted prices (unadjusted) in active markets available to the entity for identical assets or liabilities.

 

Level 2: fair value of financial instruments which are not traded in an active market, using other techniques for which all inputs that have a significant effect on the recorded fair value are observable, either directly or indirectly.

 

Level 3: if one or more of the significant data are not based on observed market data, the Company uses techniques that cover data that have a significant effect on the recorded fair value, which are not based on observed market data.

XML 50 R35.htm IDEA: XBRL DOCUMENT v3.24.0.1
COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS
12 Months Ended
Dec. 31, 2023
Collateral And Contractual Commitments With Suppliers Advances From Customers And Others  
COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS

 

29.COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS

 

   
  2023 2022
     
Collateral given for the Company’s own liabilities 581.0  764.5 
Other commitments 1,146.8  1,368.1 
  1,727.8  2,132.6 
     
Commitments to suppliers - Property, plant and equipment and Intangible 1,000.8  276.7 
Commitments to suppliers - Inventories 38,391.0  50,088.6 
  39,391.8  50,365.3 

 

As at December 31, 2023, the Company had R$558.2 (R$744.0 as at December 31, 2022) of cash guarantees. The deposits in cash used as guarantees are presented as part of other assets. To provide the guarantees required for derivatives exchanges and/or counterparties contracted in certain derivative financial instrument transactions, as at December 31, 2023, Ambev maintained R$197.7 (R$376.9 as at December 31, 2022) in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (Note 28- Financial instruments and risks).

Most of the balance relates to commitments to suppliers of packaging. These commitments the main objective is to long-term supply security for the Company regarding strategic inputs, as well as offering greater assurance to suppliers for long-term investments. The balances of fixed assets provided as security are not material.

 

Future contractual commitments as at December 31, 2023, and December 31, 2022, are as follow:

 

   
  2023 2022
     
Less than 1 year 9,619.2  12,491.0 
Between 1 and 2 years 9,536.3  10,315.3 
More than 2 years 20,236.3  27,559.0 
  39,391.8  50,365.3 

 

XML 51 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTIES
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
RELATED PARTIES

 

30.RELATED PARTIES

 

The Company adopts the corporate governance practices recommended and/or required by the applicable laws. Under the Company’s by-laws, the Board of Directors is responsible for approving any transactions or agreements between the Company and/or any of its subsidiaries (except for full subsidiaries), its directors and/or shareholders (including direct or indirect shareholders of the Company). The Governance Committee of the Company is required to advise the Board of Directors on all transactions with related parties, among other subjects.

 

Management is prohibited from interfering in any transaction in which a conflict of interest exists, even in theory, with the Company’s interests. Management also is not permitted to interfere in decisions of any other members of management, and the minutes of meeting of the Board are required to document any decision to abstain from the respective deliberations.

 

30.1 Transactions with key management members

 

The key management includes the Statutory Executive Board and Board of Directors. In addition to short-term benefits (primarily salaries), management members are entitled to participate in the share-based payment, as in Note 25- Share-based payments).

 

Total expenses related to the Company’s management members are as follow:

 

       
  2023 2022 2021
       
Short-term benefits (i) 66.7  74.2  68.3 
Share-based payments (ii) 80.7  66.0  65.3 
Total key management remuneration  147.4  140.2  133.6 

 

(i)These mainly correspond to management’s salaries and profit sharing (including performance bonuses).

 

(ii)These correspond to compensation expenses of share options, restricted stocks and performance stocks granted to Management. In total amounts above exclude remuneration paid to members of the Fiscal Council and Committees.

 

Except the abovementioned remuneration, the Company has other types of transaction with the Management members or pending balances receivable or payable in its balance sheet.

 

In addition, on October 19th, 2023, the Company adopted a clawback policy that applies to incentive-based compensation received by certain executives (which currently comprise the members of the Executive Board of Officers). Under this policy, "incentive-based compensation" is defined broadly to include any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a financial reporting measure (e.g. variable performance-related compensation (bonus) and annual long-term incentive performance stock units (PSUs)). 

 

The policy provides that in the event the company is required to prepare an accounting restatement of its financial statements due to the company's material noncompliance with any financial reporting requirements under the applicable securities laws, the Company will recover (on a pre-tax basis) from the relevant executive officers any incentive-based compensation received by such executives on or after October 2nd, 2023 and during the three fiscal years preceding the date the restatement was required that exceeds the amount of incentive-based compensation that otherwise would have been received had such incentive-based compensation been determined according to the applicable accounting restatement, subject to limited exceptions. The recovery of such compensation applies regardless of whether any misconduct occurred and without regard to whether an executive officer engaged in misconduct or otherwise caused or contributed to the requirement for a restatement

30.2 Transactions with the Company's shareholders:

 

30.2.1 Medical, dental and other benefits

 

Fundação Zerrenner is one of Ambev’s shareholders, and at December 31, 2023, held 10.2% of its total share capital. Fundação Zerrenner is also an independent legal entity whose main goal is to provide Ambev’s employees, both active and retired, with health care and dental assistance, technical and higher education courses, facilities for assisting elderly people, either directly or through financial assistance agreements with other entities. As at December 31, 2023, and December 31, 2022, actuarial obligations related to the benefits provided directly by Fundação Zerrenner were fully funded by plan assets, held for that purpose, which significantly exceeded the liabilities at these dates.

 

Ambev recognizes the assets (prepaid expenses) of this plan to the extent of the economic benefits available to the Company, arising from reimbursements or from reductions in future contributions.

 

In December 31, 2023, the expenses incurred and recorded by Fundação Zerrenner with third parties, for providing these benefits totaled R$322.9 at December 31, 2023 (R$308.8 as at December 31, 2022), of which R$291.7 and R$31.2 were related to active employees and retirees respectively (R$270.7 and R$38.1 as at December 31, 2022, respectively).

 

30.2.2 Licensing agreement

 

The Company has a licensing agreement with Anheuser-Busch, Inc. (“AB Inbev”) to produce, bottle, sell and distribute Budweiser® products in Brazil, Canada and Argentina, and sales and distribution agreements for Budweiser® products in Guatemala, the Dominican Republic, Paraguay, El Salvador, Nicaragua, Uruguay, Chile, Panama, Costa Rica and Puerto Rico. In addition, the Company produces and distributes Stella Artois® products under a license to ABI in Brazil and Canada and, through a license granted to ABI, also distributes Brahma® products in the United States and several other countries such as the United Kingdom, Spain, Sweden, Finland and Greece.

The Company and its subsidiaries have licensing agreements with the Group Modelo, subsidiaries of AB Inbev to import, produce, promote and sell Corona® products in Brazil, Canada, Argentina e Chile, as well agreements to to import, promote and sell Corona® products in Latin America and with Spaten-Franziskaner-Bräu GmbH, a subsidiary of ABI, to produce, promote, advertise and sell Spaten® in Brazil.

 

In this context, at December 31, 2023, the Company recorded R$35.4 (R$22.6 as at December 31, 2022, and R$17.0 as at December 31, 2021) and R$888.6 (R$736.7 as at December 31, 2022, and R$819.0 as at December 31, 2021) as licensing income and expenses, respectively in its Consolidated results.

 

30.3 Transactions with related parties recognized in the income statement

 

           
  2023
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.1  97.2    (143.3) (0.5) 64.0 
AB Package -    -      (235.5) -    -   
AB Procurement  -    -      -    -    (0.5)
AB USA 35.3  -      (915.9) (3.1) (0.2)
Bavaria 72.3  -      (56.7) -    -   
Cervecería Modelo 0.9  -      (1,234.9) -    -   
Cervecerías Peruanas -    -      (7.8) -    -   
Inbev -    -      (41.9) -    -   
ITW International -    -      -    -    120.0 
Other 1.7  18.9    (32.6) (3.4) 1.0 
  110.3  116.1    (2,668.6) (7.0) 184.3 

 

  2022
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.1  5.2    (117.3) (8.5) 208.7 
AB Package -    -      (356.8) -    -   
AB Procurement  -    -      -    (18.1) -   
AB USA 25.5  -      (1,129.7) (3.2) -   
Ambev Peru 0.6  -      -    -    -   
Bavaria 32.0  -      (56.7) -    -   
Cervecería Modelo 124.4  -      (1,323.6) -    -   
Cervecerías Peruanas 1.7  -      (49.6) -    -   
Inbev -    -      (129.8) -    -   
ITW International -    -      -    -    37.3 
Other 84.8  9.6    (87.2) (7.1) 1.9 
  269.1  14.8    (3,250.7) (36.9) 247.9 

 

  2021
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.7  -      (180.3) (10.7) -   
AB Package -    -      (286.7) -    -   
AB Procurement  -    -      -    (16.1) -   
AB USA 32.1  -      (1,209.9) (3.9) 0.3 
Ambev Peru 3.2  -      -    -    -   
Bavaria 30.9  -      (57.0) -    -   
Cervecería Modelo 0.8  -      (1,708.2) -    -   
Cervecerías Peruanas 3.2  -      (32.9) -    -   
Inbev -    -      (107.9) -    -   
ITW International -    -      -    -    42.2 
Other 19.5  3.6    (143.0) (8.2) -   
  90.4  3.6    (3,725.9) (38.9) 42.5 

 

30.4 Open Balances with Related Parties

 

      2023     2022
  Current   Current
   Trade receivables (i)   Other trade receivables (i)   Dividends receivables     Trade receivables (i)   Other trade receivables (i) 
AB Africa 3.7  -    -      1.6  -   
AB InBev 139.2  -    -      142.7  -   
AB Services 17.2  -    -      23.7  -   
AB USA 27.1  -    -      71.1  -   
Bavaria 10.4  -    -      13.9  -   
Cervecería Modelo 11.2  -    -      12.0  -   
Cervecerías Peruanas -    -    -      0.9  -   
Inbev 1.4  19.0  -      1.0  23.9 
Panama Holding 4.0  -    1.0    3.9  -   
Other 22.5  -    -      19.9  0.9 
  236.7  19.0  1.0    290.7  24.8 

 

  2023   2022
  Non-current   Current   Non-current   Current
  Trade payables (i)   Trade payables (i)   Trade payables (i)   Trade payables (i)
AB InBev -      (21.5)   -      (82.0)
AB Package -      (110.2)   -      (79.3)
AB Services -      (2.4)   -      (5.7)
AB USA -      (209.6)   -      (237.7)
Bavaria -      (30.2)   -      (6.9)
Cervecería Modelo (ii) -      (1,497.9)   -      (345.5)
Cervecerías Peruanas -      (7.9)   -      (46.4)
Inbev -      (8.7)   -      (12.2)
ITW International (199.9)   -      (343.6)   -   
Other -      (28.1)   -      (14.7)
  (199.9)   (1,916.5)   (343.6)   (830.4)

 

(i)The amount represents trading operations (purchase and sale) and reimbursements between the companies of the group.

 

(ii)The outstanding balances with Cervecería Modelo are mainly made up of the accounts payable described in note 1.2.2, as well as amounts for product purchases and others.

 

List of companies included in the tables above:

 

AB InBev Procurement GmbH (“AB Procurement”)
Anheuser-Busch InBev N.V. (“AB InBev”)
Anheuser-Busch Inbev Services LLC (“AB Services”)
Arosuco Aromas e Sucos Ltda. (“Arosuco”)
Anheuser-Busch Packaging Group Inc. (“AB Package”)
Anheuser-Busch Inbev USA LLC (“AB USA”)
Cervecería Chile S.A. (“Cervecería Chile”)
Cervecería Modelo de Mexico S. de R.L. de C.V. (“Cervecería Modelo”)
Cervecería Nacional Dominicana, S.A. (“CND”)
Compañia Cervecera Ambev Peru S.A.C. (“Ambev Peru”)
Inbev Belgium N.V. (“Inbev”)
Interbrew International B.V. (“ITW International”)
Unión de Cervecerias Peruanas Backus Y Johnston S.A.A. (“Cervecerías Peruanas”)

Accounting Policies

 

Transactions between subsidiaries, including balances and unrealized gains and losses on these transactions, are eliminated. The accounting policies of the subsidiaries are consistent with those adopted by the parent company.

 

Royalties paid are classified as cost of goods sold.

 

It is the Company's rule that transactions with related parties follow reasonable and commutative conditions, in line with those applicable in the market or in which the Company would contract with third parties, are reflected clearly in the individual and consolidated financial statements and are formalized in written contracts.

XML 52 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
EVENTS AFTER THE REPORTING PERIOD
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
EVENTS AFTER THE REPORTING PERIOD

 

31.EVENTS AFTER THE REPORTING PERIOD

 

31.1 Exercise PUT CND

 

As disclosed in Note 1 - Corporate Information, on January 31, 2024, ELJ exercised the put option to sell to Ambev a 12.11% stake in Tenedora's shares, corresponding to Tranche A, as set forth in the Shareholders' Agreement. The instrument was settled through: (i) a cash disbursement of R$1,704 million; and (ii) the offset of ELJ's debt held by the Group in the amount of R$335 million. As the transaction has been concluded, Ambev Group now holds a 97.11% stake in Tenedora, with the remaining 2.89% held by ELJ, corresponding to Tranche B, as disclosed in Note 28 - Financial Instruments and Risks.

 

31.2 IPI Excise Tax Suspension

 

As disclosed in explanatory note 27 - Provisions, Contingent Liabilities, and Contingent Assets, on December 31, 2023, the Company awaited notification of the decision rendered by the Superior Chamber of Tax Appeals (CSRF), which partially granted the Special Appeal filed by Ambev regarding the suspension of IPI. In January 2024, the Company was notified of the decision, resulting in a 98% reduction of the assessed amount, equivalent to approximately R$916 million. Regarding the remaining portion, the Company will pursue legal action seeking its full cancellation.

 

31.3 Presumed Profit

 

In February 2024, the ‘CARF’ rendered a unanimous favorable decision in the administrative process discussing Arosuco's (a subsidiary of Ambev) use of the presumptive profit method for calculating IRPJ and CSLL instead of actual profit. The amount classified as a possible contingency for the process was R$633.4 million on December 31, 2023 (R$581.5 million on December 31, 2022). The Company awaits formalization and notification of the decision to, together with its external advisors, assess any potential impacts on the risk classification of the contingency and take any necessary actions.

 

31.4 Disallowance on Income Tax deduction

 

In February 2024, CARF rendered a partially favorable, unanimous decision in the administrative process discussing the disallowance of the tax benefit reduction provided by Provisional Measure No. 2,199-14/2001, enjoyed by Arosuco, a subsidiary of the Company dedicated to the production of concentrates, located in the Manaus Free Trade Zone, during the years 2015 to 2018. The decision partially granting the appeal filed by Arosuco recognized the full enjoyment of the tax incentive, maintaining only a portion of the assessment related to the difference in calculation methodology between the tax authorities and the taxpayer. The portion related to the tax incentive amounts to approximately R$2.6 billion, and the portion related to the calculation difference amounts to approximately R$0.02 billion. The Company awaits the formalization and notification of the judgment to, together with its external advisors, assess any impact of the judgment on the contingency risk classification, as well as take any other necessary steps.

 

XML 53 R38.htm IDEA: XBRL DOCUMENT v3.24.0.1
SUMMARY OF MATERIAL ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2023
Summary Of Material Accounting Policies  
Recently issued IFRS

3.1 Recently issued IFRS

 

The new standards, which became effective are not applicable or did not have any material impact for the Company for the preparation of these consolidated financial statements. Below are the main changes in accounting standards which, in management's opinion, could have an impact on the Company's subsequent disclosures:

 

(i)On May 25, 2023, the IASB® published amendments to IAS 7 – Statement of Cash Flows and IFRS 7 – Financial Instruments: Disclosures, which establish new disclosure requirements for financing transactions with suppliers, the so-called "drawn risk". These requirements must be adopted by companies that adhere to the IFRS® as of 2024. The Company is evaluating the impacts of these changes, for any additional corresponding disclosures in future individual and consolidated financial statements, even though these transactions are not material to the Group, as disclosed in note 26 – Trade payables.

 

(ii)In August 2023, the IASB® issued amendments to IAS 21 – The Effects of Changes in Foreign Exchange Rates. The modifications implemented will require the application of a consistent approach when assessing whether a currency can be exchanged for another currency and, when it cannot, determining the exchange rate to be used, and the related disclosures. The Company is evaluating the impacts of these standards, the adoption of which is required for fiscal years beginning on January 1, 2025.

 

(iii)In December 2021, the Organisation for Economic Cooperation and Development ("OECD"), as part of the Inclusive Framework on Base Erosion and Profit Shifting ("BEPS") project, released the Pillar Two model rules (or Global Anti-Base Erosion Model Rules - GloBE), aiming at a common approach to international corporate taxation, in order to ensure that multinational economic groups within the scope of these rules calculate taxes on profit at a minimum effective rate of 15% in each country where they operate. These rules will have to be approved locally in each country that adheres the proposal, via applicable legislation, some of which have already promulgated new laws or are in the process of discussing and approving them. In May 2023, the IASB® issued scope changes to IAS 12 – Income Taxes to allow a temporary exemption in accounting for deferred income taxes arising from promulgated or substantially promulgated legislation implementing OECD Pillar Two, an exemption which has been adopted by the Group. Considering the legislation already published in the countries in which the Company operates, the Company has estimated the impacts on the 2023 financial statements and the amount is not material.

 

In addition of these, the Company does not anticipate that there are any other standards or amendments to IFRS® standards or IFRIC interpretations that have not come into force yet and that could have a significant impact on the Group's individual and consolidated financial statements.

 

Consolidated financial statements

3.2 Consolidated financial statements

The financial statements of subsidiaries, joint arrangements and associates used in these consolidated financial statements are prepared for the same reporting period as Ambev, using a consistent accounting policy.

 

All intercompany transactions, balances and unrealized gains or losses on transactions between consolidated companies were integrally eliminated.

 

3.2.1 Subsidiaries

 

The Company controls an entity when it is exposed to or has rights to variable returns due to its involvement with the entity, and it can affect those returns through its power over the entity. When assessing control, potential voting rights are considered. Control is presumed to exist where the Company owns, directly or indirectly, more than half of the voting rights (which does not always equate to economic ownership), unless it can be demonstrated that such ownership does not confer control.

 

Subsidiaries are consolidated from the date on which control is obtained by the Company, except when the predecessor basis of accounting is applied to transactions of business combinations under common control. Consolidation is discontinued from the date on which control ceases.

 

3.2.2 Associates

 

Associates are companies which the Company has significant influence over the financial and operational policies but does not control.

 

3.2.3 Joint arrangements

 

Joint arrangements are all entities over which the Company shares control with one or more parties. Joint arrangements are classified either as joint operations or joint ventures depending on the contractual rights and obligations of each investor.

 

3.2.4 Business combination

 

Ambev uses the acquisition method to account its business combinations. The consideration transferred for the acquisition of a subsidiary represents the fair value of the assets transferred, the liabilities incurred, and the equity interest issued by Ambev. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration agreement, when applicable. Costs related to the acquisition are recognized in income as they are incurred. Assets, liabilities and contingent liabilities acquired/assumed in a business combination are recognized initially at their fair value as at the acquisition date. Ambev recognizes the non-controlling interest in the acquiree, either at its fair value or at the non-controlling interest’s proportional share of the net assets acquired. The measurement of the non-controlling interest to be recognized is determined for each acquisition.

 

The excess of: (i) the consideration paid; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired, at the date of acquisition, is recorded as goodwill. When the consideration transferred is less than the fair value of the net assets acquired, the difference is recognized directly in income.

 

3.2.5 Business combination between entities under common control

 

Business combinations between entities under common control have not been addressed under IFRS how they should be disclosed remains unclear. IFRS 3 - Business Combinations is the standard applicable to business combinations, but its scope explicitly excludes business combinations between entities under common control, thus, in evaluating transactions of this nature, Management’s judgment is required to adequately reflect the essence and economic reality of each transaction.

 

3.2.5.1 Predecessor basis of accounting

 

In accordance with IAS 8 – Accounting Policies, Changes in Accounting Estimates and Errors, Management has adopted the predecessor basis of accounting, which is consistent with United States Generally Accepted Accounting Principles (“USGAAP”) and United Kingdom Generally Accepted Accounting Principles (“UKGAAP”), to record the carrying amount of the asset received, as recorded by the parent company.

 

Under the predecessor basis of accounting, when accounting for a transfer of assets between entities under common control, the entity that receives the net assets or the equity interests (the acquirer) shall initially record the assets and liabilities transferred at their parent book value as at the transfer date. If the book value of the assets and liabilities transferred by the parent is different from the historical cost recorded by the controlling entity of the entities under common control (the ultimate parent), the financial statements of the acquirer shall reflect the assets and liabilities transferred at the same cost of the ultimate parent, as a counter-entry to shareholders' equity against the carrying value adjustments.

 

3.2.5.2 Assets Swap

 

For transactions between entities under common control that involve the disposal or transfer of assets from the subsidiary to its parent company (i.e., above the level of the consolidated financial statements), the Company assesses the existence of: (i) any conflicts of interest; and (ii) the economic substance and purpose of the transaction. Having fulfilled these assumptions, the Company adopted as a policy the concepts of IAS 16 – Property, Plant and Equipment in order to provide adequate visibility and a fair impact on the amount of distributable results to its shareholders, specially the non-controlling interest. This policy also includes assets acquired through the swapping of non-cash assets, or swaps with a combination of cash and non-cash assets. The assets swapped may be of the same or a different nature. The cost of such assets is measured at fair value, unless: (i) the swap transaction is not commercial in nature; or (ii) the fair value of the asset received (and the asset assigned) cannot be reliably measured. The acquired asset is measured in this way even if the assignor entity cannot immediately remove the asset from its books. If the acquired asset is not measurable at fair value, its cost is determined based on the book value of the assigned asset.

 

Whenever assets distributed are not recorded as cash, the asset, before distribution, is recorded at its fair value in the income account. This procedure is applicable to distributions where the assets are of the same nature and therefore can be treated equally. However, similarly to IFRIC 17 - Distributions of Non-cash Assets to Owners, in the absence of a specific accounting practice for transactions under common control, the Company applies these procedures as part of its accounting practices. We also apply the same procedures to sales (products, supplies, etc.) to its controlling entity, where the positive result of the sale is recognized in income.

 

Financial reporting in hyperinflationary economies

3.3 Financial reporting in hyperinflationary economies

 

Under IAS 29 – Financial Reporting in Hyperinflationary Economies, the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in hyperinflationary economies are restated to reflect changes in the general purchasing power of the local currency by applying a general price index. On a monthly basis, the Company estimates the applicable general price index since the official release of the index takes place after the end of the accounting period. The financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether using the historical costs approach or the current costs approach, shall be stated in terms of the unit of measurement in force at the end of the reporting period, and translated into Reais at the closing rate for the period.

 

To determine if the economy of any of its operations is hyperinflationary, the Company assesses quantitative and qualitative aspects of the country's economic environment, such as the inflation rate recorded over the last three years. On July 1, 2018, the Argentine economy was considered by the Company to be hyperinflationary, under the terms of IAS 29, considering the increase in the official price indices accumulated in the period (National Consumer Price Index - "IPC"), measured by INDEC (National Institute of Statistics and Census). Since the company does not operate directly in a hyperinflationary economy, but one of its subsidiaries does, the restatement of comparative balances from previous years is not carried out, in accordance with IAS 21 - The Effects of Changes in Foreign Exchange Rates, however, the precepts of the standard are applied to the balances and transactions of the affected subsidiary.

 

Present value adjustment

3.4 Present value adjustment.

 

The elements of assets and liabilities, when relevant, are adjusted to their present value, considering the following assumptions for the calculation: i) the amount to be discounted; ii) the settlement dates; and iii) the discount rate, in accordance with IFRS 13 - Fair Value Measurement.

 

Tax incentives and subsidized loans

3.5 Tax incentives and subsidized loans

 

The Company and its subsidiaries enjoy state tax benefits in Brazil, provided by government grants. Referred grants may be as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credits, effective collection, payment deferral or partial reductions of state tax payable. The effective collection incentives are recorded in the operating net revenue, by its nature, as the others are recognized in other operating income.

 

Among the tax incentives granted to the Company, there are state tax incentive programs to promote industrial development either by financing or by deferring payment of taxes. These state programs are intended to promote long-term increases in employment and industrial decentralization, as well as to complement and diversify the industrial states.

 

In the case of these programs, the tax terms are set out in the respective state normative acts and, when conditions for obtaining these grants exist, they are under the Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. The benefits of the delayed payment of such taxes are recorded in the income statement, on an accrual basis.

Since it is benefits on financing category or tax payment deferring, as the interest rates and/or terms of these loans are advantageous compared to market conditions, these benefits are considered as subsidized loans as intended by IAS 20 - Accounting for Government Grants and Disclosure of Government Assistance. The respective subsidies consist of the gains identified by comparing the value of these operations under the market conditions to the value agreed in the contracts. Thereby, upon receipt of funding, the subsidy calculated is recorded in Other operating income, following the treatment for the other ICMS subsidies of similar nature. Management reviews the market conditions prevailing in the year to assess such subsidies on an annual basis.

 

Monthly, considering the value of the consideration, the period to maturity, the contract interest rate and the abovementioned discount rate, the reduction in present value adjustment is allocated to financial income, so as to bring the balance to zero by the time of settlement of each consideration.

 

Such financing is recognized as liability adjusted to its present value. When there is an intervening financial institution in the transaction, the financing is recorded at “Interest-bearing loans and borrowings”, otherwise, its recorded at “Trade payables”, because of the underlying economic essence and nature of the transaction.

XML 54 R39.htm IDEA: XBRL DOCUMENT v3.24.0.1
BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of exchange rates
                 
      Closing rate   Average rate
Currency Name Country 2023 2022 2021   2023 2022 2021
                   
CAD Canadian Dollar Canada 3.6536  3.8540  4.3914    3.7048  3.9807  4.2960 
DOP Dominican Peso Dominican Republic 0.0831  0.0925  0.0970    0.0892  0.0937  0.0938 
USD US Dollar Panamá and Cuba 4.8413  5.2177  5.5805    5.0085  5.1644  5.3687 
GTQ Quetzal Guatemala 0.6189  0.6623  0.7201    0.6398  0.6649  0.6954 
ARS Argentinean Peso  Argentina 0.0060  0.0295  0.0543    0.0170  0.0403  0.0568 
BOB Bolivian Peso Bolivia 0.6956  0.7497  0.8018    0.7196  0.7420  0.7714 
PYG Guarani Paraguay 0.0007  0.0007  0.0008    0.0007  0.0007  0.0008 
UYU Uruguayan Peso Uruguay 0.1241  0.1302  0.1249    0.1291  0.1253  0.1236 
CLP Chilean Peso Chile 0.0055  0.0061  0.0066    0.0059  0.0059  0.0071 
BBD Barbadian Dollar Barbados 2.3866  2.5721  2.7510    2.4690  2.5458  2.6465 
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of segment reporting
                             
  Brazil CAC Latin America - South  Canada Consolidated
  2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021
                               
Net sales 46,361.7  42,635.8  35,586.5  10,044.8  9,440.1  9,947.4  13,797.2  17,371.2  16,571.7  9,533.2  10,261.7  10,748.7  79,736.9  79,708.8  72,854.3 
Cost of sales (23,516.1) (22,736.8) (18,309.1) (5,035.1) (4,860.8) (4,727.9) (6,657.3) (8,553.1) (8,235.7) (4,083.1) (4,271.4) (4,387.0) (39,291.6) (40,422.1) (35,659.7)
Gross profit 22,845.6  19,899.0  17,277.4  5,009.7  4,579.3  5,219.5  7,139.9  8,818.1  8,336.0  5,450.1  5,990.3  6,361.7  40,445.3  39,286.7  37,194.6 
Distribution expenses (6,428.6) (6,111.1) (5,123.1) (853.1) (1,020.7) (872.7) (1,614.3) (2,159.5) (2,010.1) (1,854.6) (2,104.0) (1,926.8) (10,750.6) (11,395.3) (9,932.7)
Sales and marketing expenses (4,477.0) (4,065.0) (3,440.3) (665.1) (645.5) (693.3) (1,190.0) (1,426.9) (1,542.9) (1,080.4) (1,200.0) (1,359.0) (7,412.5) (7,337.4) (7,035.5)
Administrative expenses (3,563.2) (3,346.0) (3,006.2) (413.0) (333.6) (427.7) (659.5) (835.0) (832.0) (638.0) (722.2) (611.5) (5,273.7) (5,236.8) (4,877.4)
Other operating income/(expenses) 1,892.5  2,361.3  2,096.0  26.3  (52.9) 12.4  95.0  192.7  38.8  15.1  12.8  (23.1) 2,028.9  2,513.9  2,124.1 
Exceptional items (137.8) (34.5) (210.1) (17.9) (16.1) (46.7) (47.6) (60.5) (115.4) (3.1) (32.2) (20.6) (206.4) (143.3) (392.8)
Income from operations 10,131.5  8,703.7  7,593.7  3,086.9  2,510.5  3,191.5  3,723.5  4,528.9  3,874.4  1,889.1  1,944.7  2,420.7  18,831.0  17,687.8  17,080.3 
Net finance costs                         (3,609.8) (3,423.1) (3,205.4)
Share of results of joint ventures                         (185.3) (29.1) (115.7)
Income before income tax                         15,035.9  14,235.6  13,759.2 
Income tax expense                         (75.5) 655.6  (636.6)
Net income                         14,960.4  14,891.2  13,122.6 
                               
Acquisition of property, plant and equipment 3,365.5  4,062.9  4,645.1  593.4  968.4  801.6  782.2  1,112.8  1,665.4  1,263.0  389.0  565.0  6,004.1  6,533.1  7,677.1 

 

 

 

  Brazil CAC  Latin America - South  Canada Consolidated
  2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021 2023 2022 2021
                               
Segment assets 56,974.2  57,353.8  54,609.4  13,692.3  15,385.6  15,351.9  16,085.1  22,044.5  21,583.0  15,856.9  16,093.3  18,016.6  102,608.5  110,877.2  109,560.9 
Intersegment elimination                         (2,162.1) (2,533.0) (2,868.5)
Non-segmented assets (i)                         32,197.9  29,613.8  31,910.1 
Total assets                         132,644.3  137,958.0  138,602.5 
                               
Segment liabilities 28,841.3  29,153.2  27,611.2  4,981.5  5,098.0  5,414.4  5,095.4  6,843.6  7,843.6  5,131.0  5,053.7  6,156.5  44,049.2  46,148.5  47,025.7 
Intersegment elimination                         (2,161.8) (2,534.2) (2,869.1)
Non-segmented liabilities (i)                         90,756.9  94,343.7  94,445.9 
Total liabilities                         132,644.3  137,958.0  138,602.5 

 

(i)The balance of non-segmented assets refers mainly to cash and cash equivalents, taxes and investments. The balance of non-segmented liabilities, in turn, refers mainly to equity values, taxes and derivatives.
Schedule of additional information
                 
  Brazil
  Beer NAB Total 
  2023 2022 2021 2023 2022 2021 2023 2022 2021
                   
Net sales 38,985.9  35,857.9  30,537.1  7,375.8  6,777.9  5,049.4  46,361.7  42,635.8  35,586.5 
Cost of sales (19,377.7) (18,765.3) (15,382.0) (4,138.4) (3,971.5) (2,927.1) (23,516.1) (22,736.8) (18,309.1)
Gross profit 19,608.2  17,092.6  15,155.1  3,237.4  2,806.4  2,122.3  22,845.6  19,899.0  17,277.4 
Distribution expenses (5,171.9) (4,988.6) (4,263.1) (1,256.7) (1,122.5) (860.0) (6,428.6) (6,111.1) (5,123.1)
Sales and marketing expenses (3,969.4) (3,596.8) (3,096.2) (507.6) (468.2) (344.1) (4,477.0) (4,065.0) (3,440.3)
Administrative expenses (3,106.0) (2,928.8) (2,616.1) (457.2) (417.2) (390.1) (3,563.2) (3,346.0) (3,006.2)
Other operating income/(expenses) 1,474.1  1,884.5  1,711.3  418.4  476.8  384.7  1,892.5  2,361.3  2,096.0 
Exceptional items (137.8) (30.6) (202.0) -    (3.9) (8.1) (137.8) (34.5) (210.1)
Income from operations 8,697.2  7,432.3  6,689.0  1,434.3  1,271.4  904.7  10,131.5  8,703.7  7,593.7 
Net finance costs             (2,050.6) (1,110.3) (858.1)
Share of results of joint ventures             (179.0) (38.3) (11.7)
Income before income tax             7,901.9  7,555.1  6,723.9 
Income tax expense             2,214.9  2,787.7  1,953.2 
Net income             10,116.8  10,342.8  8,677.1 
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET SALES (Tables)
12 Months Ended
Dec. 31, 2023
Net Sales  
Schedule of net sales
     
  2023 2022 2021
Gross sales 120,117.7  125,907.2  110,162.7 
Excise duty (25,227.5) (24,851.4) (22,052.6)
Discounts (15,153.3) (21,347.0) (15,255.8)
Total 79,736.9  79,708.8  72,854.3 
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER OPERATING INCOME/(EXPENSES) (Tables)
12 Months Ended
Dec. 31, 2023
Other Operating Incomeexpenses  
Schedule of other operating income
     
  2023 2022 2021
Government grants/net present value of long-term fiscal incentives 1,573.2  1,289.3  853.2 
Extemporaneous credits/(debits) (i) 218.0  1,013.9  1,219.0 
(Additions)/reversals of provisions (77.7) (77.2) (71.4)
Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates 86.4  88.8  66.1 
Other operating income/(expenses), net 229.0  199.1  57.2 
Total 2,028.9  2,513.9  2,124.1 

 

(i)As detailed in Notes 1 – Corporate information and 27.2 – Contingencies, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS, including in the tax substitution form, from its calculation basis, in the item Other operating income/(expenses).
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.24.0.1
EXCEPTIONAL ITEMS (Tables)
12 Months Ended
Dec. 31, 2023
Exceptional Items  
Schedule of exceptional items
     
  2023 2022 2021
Restructuring (i) (109.4) (101.8) (165.4)
COVID-19 impacts (ii) -    (16.7) (134.3)
Legal fees (iii) (94.7) -    -   
Effect of application of IAS 29 (hyperinflation) (2.3) (8.2) (11.1)
Distribution agreement (iv) -    -    (82.0)
Write-off of investments (v) -    (16.6) -   
Total (206.4) (143.3) (392.8)

 

(i)The restructuring expenses primarily related to centralization projects and resizing in Brazil, Latin America CAC and Canada.
(ii)COVID-19 expenses refer to (a) additional administrative expenses to ensure the safety of the Company’s people (increased frequency of cleaning at the Company’s facilities, providing alcohol gel and masks for our employees); (b) donations; (c) Company initiatives providing support for some customer ecosystems, which were necessary due to the COVID-19 pandemic.
(iii)In 2003 some holders of warrants issued by Cervejaria Brahma filed lawsuits to discuss the criteria used in calculating the exercise price of such warrants. In 2023, the Company obtained some final favorable decisions on the matter, which was already classified as a remote loss. The amount recorded in this line refers to the provision for legal fees related to this matter.
(iv)Refers to distribution agreement with our strategic partner in Guatemala.
(v)Refers to an investment write-off of a business line in Canada
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1
PAYROLL AND RELATED BENEFITS (Tables)
12 Months Ended
Dec. 31, 2023
Payroll And Related Benefits  
Schedule of payroll and related benefits
     
  2023 2022 2021
Wages and salaries 4,550.2  4,496.1  4,162.6 
Social security contributions 1,322.3  1,239.7  1,016.0 
Other personnel costs 970.7  1,075.9  1,076.1 
Increase in liabilities for defined benefit plans 145.6  157.8  178.2 
Share-based payments 333.4  311.6  391.5 
Contributions to defined contribution plans 91.3  82.0  74.1 
Total 7,413.5  7,363.1  6,898.5 
Schedule of payroll expenses and related benefits
     
  2023 2022 2021
Cost of sales 2,629.6  2,510.4  2,247.9 
Distribution expenses 1,289.9  1,396.3  1,286.8 
Commercial expenses 1,321.3  1,504.8  1,480.9 
Administrative expenses 1,907.6  1,798.7  1,699.1 
Net finance costs 114.3  107.8  115.6 
Other operating (income)/expenses (1.3) 1.5  -   
Exceptional items 152.1  43.6  68.2 
Total 7,413.5  7,363.1  6,898.5 
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Tables)
12 Months Ended
Dec. 31, 2023
Additional Information On Cost Of Sales And Operating Expenses By Nature  
Schedule of depreciation, amortization and impairment expenses
             
  Depreciation and impairment of property, plant and equipment   Amortization of intangible assets
  2023 2022 2021   2023 2022 2021
               
Cost of sales (i) 3,552.5  3,413.3  3,326.6    13.2  16.4  16.4 
Distribution expenses 1,098.3  893.5  654.1    -    -    -   
Commercial expenses 613.7  660.7  700.3    148.6  113.2  84.3 
Administrative expenses 464.1  474.4  331.4    524.8  372.6  304.2 
  5,728.6  5,441.9  5,012.4    686.6  502.2  404.9 

 

(i)These amounts added to R$2,629.6 (R$2,510.4 and R$2,247.9 as at December 31, 2022, and 2021, respectively) mentioned in Note 9 - Payroll and related benefits, total R$6,195.3 (R$5,940.1 and R$5,591.0 as at December 31, 2022, and 2021, respectively). The remaining amount of R$33,096.3 (R$34,482.0 and R$30,068.7 as at December 31, 2022, and 2021, respectively), recorded in the cost of sales, refers to other production costs.
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET FINANCE RESULT (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of net finance result
     
  2023 2022 2021
Finance expenses      
Interest expense (2,432.2) (2,328.3) (1,431.8)
Net Interest on pension plans (114.3) (107.9) (115.6)
Losses on hedging instruments (1,675.1) (3,158.4) (2,540.2)
Interest on provision for disputes and litigation (269.2) (456.6) (290.0)
Exchange differences (1,154.0) (751.1) (453.9)
Tax on financial transactions (178.3) (339.6) (216.6)
Bank guarantee expenses (249.8) (176.1) (174.9)
Other financial results (207.2) (574.2) (204.8)
Total of finance expenses (6,280.1) (7,892.2) (5,427.8)
       
Finance income      
Interest income 2,085.6  2,167.7  1,101.6 
Interest and foreign exchange rate on loans to/from related parties 119.2  37.1  42.5 
Financial instruments at fair value through profit or loss -    95.5  77.0 
Other financial results 289.4  565.3  78.9 
Total 2,494.2  2,865.6  1,300.0 
       
Effect of application of IAS 29 (hyperinflation) 176.1  1,603.5  922.4 
Total of finance income 2,670.3  4,469.1  2,222.4 
       
Net finance result (3,609.8) (3,423.1) (3,205.4)
Schedule of interest expenses
     
  2023 2022 2021
Financial instruments measured at amortized cost (644.1) (764.0) (466.0)
Financial instruments at fair value through profit or loss (i) (1,788.1) (1,564.3) (965.8)
Total (2,432.2) (2,328.3) (1,431.8)

 

(i)Include R$1,231 million (R$654 million at December 31, 2022) as accounts payable present value adjustment.
Schedule of interest income
     
  2023 2022 2021
Cash and cash equivalents 1,072.2  791.6  329.5 
Investment on debt securities 49.2  175.9  84.7 
Other receivables (i) 964.2  1,200.2  687.4 
Total 2,085.6  2,167.7  1,101.6 

 

(i)Refers, mainly, to monetary adjustment of recoverable tax.
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS PER SHARE (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of earnings per share
         
Basic 2023   2022   2021
Numerator          
Income attributable to the Ambev equity holders 14,501.9    14,457.9    12,671.0 
Denominator          
 Weighted average number of shares (i) (non diluted) 15,744.8    15,741.9    15,736.9 
 Basic EPS 0.9211    0.9184    0.8052 
           
           
Diluted 2023   2022   2021
Numerator          
Income attributable to the Ambev equity holders 14,501.9    14,457.9    12,671.0 
Denominator          
 Weighted average numbers of shares (i) (diluted)  15,838.6    15,848.6    15,857.5 
 Diluted EPS 0.9156    0.9123    0.7991 

 

(i)Million shares
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax And Social Contribution  
Schedule of income tax and social contribution by area
 
Central America and the Caribbean from 15% to 27%
Latin America - South (i) from 10% to 35%
Canada 26.5%
Luxembourg 24.94%
Schedule of income taxes
     
  2023 2022 2021
Income tax expense – current (2,077.9) (1,718.9) (1,268.6)
       
Deferred tax expense on temporary differences 279.8  1,012.6  1,072.9 
Deferred tax on tax loss carryforward movements in the current period 1,722.6  1,361.9  (440.9)
Total deferred tax (expense)/income 2,002.4  2,374.5  632.0 
       
Total income tax expenses (75.5) 655.6  (636.6)
Schedule of reconciliation between the weighted nominal tax rate and the effective tax rate
     
  2023 2022 2021
Profit before tax 15,035.9  14,235.6  13,759.2 
Adjustment on a taxable basis      
Others non-taxable income (919.0) (883.3) (611.0)
Government grants related to sales taxes  (3,011.7) (2,535.1) (1,883.1)
Share of results of joint ventures 185.3  29.1  115.7 
Non-deductible expenses 56.5  192.8  99.2 
Worldwide taxation 1,171.4  679.3  (360.0)
  12,518.4  11,718.4  11,120.0 
Aggregated weighted nominal tax rate 28.30% 29.47% 27.39%
Taxes payable – nominal rate  (3,542.3) (3,453.3) (3,045.3)
Adjustment on tax expense      
Income tax Incentives 120.4  234.0  213.2 
Deductible interest on shareholders’ equity 3,909.8  4,079.9  2,516.0 
Tax savings from goodwill amortization 17.2  27.2  77.5 
Withholding income tax (489.1) (164.5) (876.0)
Recognition/(write-off) of deferred charges on tax losses 100.9  (58.2) (1.5)
Effect of application of IAS 29 (hyperinflation) (382.3) (249.0) (123.3)
Others with reduced taxation 189.9  239.5  602.8 
Income tax and social contribution expense (75.5) 655.6  (636.6)
Effective tax rate 0.50% -4.61% 4.63%
Schedule of deferred income tax
             
  2023   2022
  Assets Liabilities Net   Assets Liabilities Net
Investment securities 8.2  -    8.2    7.5  -    7.5 
Intangible -    (1,369.7) (1,369.7)   -    (1,690.2) (1,690.2)
Employee benefits 856.5  -    856.5    951.2  -    951.2 
Trade payables 2,843.8  (3.3) 2,840.5    3,232.8  (2.9) 3,229.9 
Trade receivables 43.8  (7.0) 36.8    38.6  (3.8) 34.8 
Derivatives 31.1  (77.2) (46.1)   95.1  (44.8) 50.3 
Interest-Bearing Loans and Borrowings 7.5  -    7.5    0.5  (0.9) (0.4)
Inventories 268.6  (59.6) 209.0    413.9  (139.3) 274.6 
Property, plant and equipment 714.2  (1,837.2) (1,123.0)   899.5  (2,177.1) (1,277.6)
Withholding tax on undistributed profits and royalties -    (1,385.5) (1,385.5)   -    (1,877.6) (1,877.6)
Investments in joint ventures -    (383.7) (383.7)   -    (421.6) (421.6)
Losses carried forward 4,383.3  -    4,383.3    2,660.7  -    2,660.7 
Provisions 1,026.3  (4.6) 1,021.7    819.3  -    819.3 
Impact of the adoption of IFRS 16 (Leases) 14.5  (19.7) (5.2)   35.1  (11.4) 23.7 
ICMS on the assessment bases of PIS/COFINS -    (228.5) (228.5)   -    (168.2) (168.2)
Other items 266.5  (437.1) (170.6)   260.8  (164.1) 96.7 
Gross deferred tax assets/(liabilities) 10,464.3  (5,813.1) 4,651.2    9,415.0  (6,701.9) 2,713.1 
Netting by taxable entity (2,494.7) 2,494.7  -      (2,976.2) 2,976.2  -   
Net deferred tax assets/(liabilities) 7,969.6  (3,318.4) 4,651.2    6,438.8  (3,725.7) 2,713.1 
Schedule of deferred tax assets and liabilities
     
  2023
Deferred taxes not related to tax losses to be realized within 12 months to be realized after 12 months Total
       
Investment securities -    8.2  8.2 
Intangible (1.2) (1,368.5) (1,369.7)
Employee benefits 199.9  656.6  856.5 
Trade payables (220.6) 3,061.1  2,840.5 
Trade receivables 22.7  14.1  36.8 
Derivatives (49.8) 3.7  (46.1)
Interest-bearing loans and borrowings 0.1  7.4  7.5 
Inventories 252.7  (43.7) 209.0 
Property, plant and equipment (4.1) (1,118.9) (1,123.0)
Withholding tax on undistributed profits and royalties -    (1,385.5) (1,385.5)
Investments in joint ventures -    (383.7) (383.7)
Provisions 664.5  357.2  1,021.7 
Impact of the adoption of IFRS 16 (Leases) -    (5.2) (5.2)
ICMS on the assessment bases of PIS/COFINS -    (228.5) (228.5)
Other items 39.8  (210.4) (170.6)
Total 904.0  (636.1) 267.9 
Schedule of deferred tax realization related to tax losses
 
Deferred tax related to tax losses 2023
2023 -   
2024 755.7 
2025 422.5 
2026 1,635.2 
2027 1,052.8 
2028 a 2030 170.3 
2031 em onward (i) 346.8 
Total 4,383.3 

 

(i)There is no expectation of realization beyond a term of ten years.
Schedule of net change in deferred income tax and social contribution
 
At December 31, 2021 1,513.7 
Recognition of actuarial gains/(losses) (146.9)
Investment hedge – put option granted on subsidiaries (105.0)
Cash flow hedge – gains/(losses) 41.3 
Gains/(losses) on translation of other foreign operations  (419.3)
Recognized in other comprehensive income (629.9)
Recognized in the income statement 2,374.5 
Changes directly in the balance sheet (545.2)
Recognized in deferred tax (595.5)
Effect of application of IAS 29 (hyperinflation) (595.5)
Recognized in other balance sheet group 50.3 
At December 31, 2022 2,713.1 
Recognition of actuarial gains/(losses) 24.4 
Investment hedge – put option granted on subsidiaries (155.9)
Cash flow hedge – gains/(losses) 83.2 
Gains/(losses) on translation of other foreign operations  553.9 
Recognized in other comprehensive income 505.6 
Recognized in the income statement 2,002.4 
Changes directly in the balance sheet (569.9)
Recognized in deferred tax (476.3)
Effect of application of IAS 29 (hyperinflation) (476.3)
Recognized in other balance sheet group (93.6)
At December 31, 2023 4,651.2 
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of property, plant and equipment
   
  2023 2022
Property, plant and equipment 23,662.7  26,961.3 
Right of use assets 2,967.5  3,094.4 
  26,630.2  30,055.7 
Schedule of changes in the carrying amount of property, plant and equipment
                     
                    Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  At December 31, 2022   Acquisition cost Depreciation
Land and buildings 9,090.2  (832.1) 712.7  11.2  (436.8) (20.1) 1,173.2  9,698.3    14,494.2  (4,795.9)
Plant and equipment 10,884.0  (1,067.3) 952.6  1,283.5  (3,564.6) (15.7) 3,116.6  11,589.1    39,818.3  (28,229.2)
Fixtures and fittings 1,285.1  (111.6) 96.7  87.3  (579.7) (14.6) 560.7  1,323.9    7,682.7  (6,358.8)
Under construction 5,404.7  (360.7) 252.7  4,923.7  -    -    (5,870.4) 4,350.0    4,350.0  -   
  26,664.0  (2,371.7) 2,014.7  6,305.7  (4,581.1) (50.4) (1,019.9) 26,961.3    66,345.2  (39,383.9)

 

                    Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Acquisitions  Depreciation Disposals and write-offs Transfers  At December 31, 2023   Acquisition cost Depreciation
Land and buildings 9,698.3  (1,485.2) 663.1  44.7  (481.6) (3.7) 800.6  9,236.2    14,287.8  (5,051.6)
Plant and equipment 11,589.1  (1,726.7) 779.4  1,230.2  (3,533.4) (39.1) 2,488.8  10,788.3    39,509.2  (28,720.9)
Fixtures and fittings 1,323.9  (193.4) 86.5  56.4  (541.6) (13.5) 373.7  1,092.0    7,074.2  (5,982.2)
Under construction 4,350.0  (311.7) 120.2  3,283.9  -    (3.4) (4,892.8) 2,546.2    2,546.2  -   
  26,961.3  (3,717.0) 1,649.2  4,615.2  (4,556.6) (59.7) (1,229.7) 23,662.7    63,417.4  (39,754.7)
Schedule of carrying amount of right-of-use assets
                   
                  Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Additions Depreciation Disposals and write-offs Transfers  At December 31, 2022   Acquisition cost Depreciation
Buildings 1,206.0  (64.3) 628.0  (391.6) 9.7  (37.0) 1,350.8    2,698.3  (1,347.5)
Machinery, vehicles and others 1,354.3  (8.2) 1,009.7  (453.9) (194.5) 36.2  1,743.6    2,889.5  (1,145.9)
Total 2,560.3  (72.5) 1,637.7  (845.5) (184.8) (0.8) 3,094.4    5,587.8  (2,493.4)

 

                  Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Additions Depreciation Disposals and write-offs Transfers  At December 31, 2023   Acquisition cost Depreciation
Buildings 1,350.8  (49.5) 355.0  (451.8) (30.5) (1.8) 1,172.2    2,925.9  (1,753.7)
Machinery, vehicles and others 1,743.6  (32.7) 1,329.3  (773.9) (475.5) 4.5  1,795.3    3,534.4  (1,739.1)
Total 3,094.4  (82.2) 1,684.3  (1,225.7) (506.0) 2.7  2,967.5    6,460.3  (3,492.8)

 

 

Schedule of estimated useful lives of property, plant and equipment
 
Buildings 25 years
Plant and equipment 15 years
Fixtures 10 years
Fittings 10 years
Assets for external use / commercial assets  2 - 5 years
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of goodwill
   
  2023 2022
     
Balance at the end of the previous year 40,594.0  42,411.3 
Effects of movements in foreign exchange in the balance sheet (4,067.9) (3,510.6)
Effect of application of IAS 29 (hyperinflation) 1,481.1  1,709.9 
Acquisitions, (write-offs) and disposal through business combinations (3.6) (16.6)
Balance at the end of the year 38,003.6  40,594.0 
Schedule of carrying amount of goodwill
     
  Functional currency 2023 2022
       
Brazil BRL 17,698.8  17,702.4 
Goodwill   102,941.4  102,945.0 
 Non-controlling transactions (i)   (85,242.6) (85,242.6)
       
CAC:      
Dominican Republic DOP 3,805.5  4,231.6 
Panama PAB 1,682.9  1,813.8 
       
Latin America - South:      
Argentina ARS 2,183.8  3,463.0 
Bolivia BOB 1,712.5  1,845.6 
Chile CLP 47.9  53.1 
Paraguay PYG 888.2  953.8 
Uruguay UYU 184.0  193.1 
       
Canada CAD 9,800.0  10,337.6 
    38,003.6  40,594.0 

 

(i)This refers to the shareholding exchange transaction in 2013 as a result of the adoption of the predecessor basis of accounting.
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
IMPAIRMENT OF NON-FINANCIAL ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
Impairment Of Non-financial Assets  
Schedule of local currency
 
CGU 2023
Chile 9.83%
Panama 10.72%
Brazil 12.38%
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of intangible assets
                     
                    Carrying amount
  At December 31, 2021 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Additions Transfers  Disposal  Amortization At December 31, 2022   Acquisition cost Depreciation
Brands 6,329.0  (1,096.2) 930.3  -    -    -    -    6,163.1    6,163.1  -   
Intangibles 671.2  (44.7) 0.1  -    3.2  -    (58.1) 571.7    3,308.6  (2,736.9)
Software 1,129.7  (130.6) 126.9  6.9  1,402.3  -    (401.1) 2,134.1    4,353.9  (2,219.8)
Others 559.1  (96.0) 76.8  220.5  (364.1) -    (43.0) 353.3    1,218.8  (865.5)
Total 8,689.0  (1,367.5) 1,134.1  227.4  1,041.4  -    (502.2) 9,222.2    15,044.4  (5,822.2)

 

                    Carrying amount
  At December 31, 2022 Effects of movements in foreign exchange in the balance sheet Effects of application of IAS 29 (hyperinflation) Additions Transfers  Disposal  Amortization At December 31, 2023   Acquisition cost Depreciation
Brands 6,163.1  (1,838.5) 808.6  73.9  -    -    -    5,207.1    5,207.1  -   
Intangibles 571.7  (33.5) -    869.3  -    -    (56.7) 1,350.8    4,087.0  (2,736.2)
Software 2,134.1  (344.6) 176.2  37.0  976.5  (0.9) (573.5) 2,404.8    4,954.2  (2,549.4)
Others 353.3  (32.9) 11.0  487.7  317.0  (0.7) (56.4) 1,079.0    1,837.9  (758.9)
Total 9,222.2  (2,249.5) 995.8  1,467.9  1,293.5  (1.6) (686.6) 10,041.7    16,086.2  (6,044.5)
Schedule of carrying value of intangible assets with indefinite useful lives
   
  2023 2022
Argentina 1,303.7  2,019.2 
Bolivia 830.0  894.5 
Brazil 73.9  -   
Canada 195.7  206.4 
Chile 70.7  78.5 
Luxembourg 339.6  339.6 
Paraguay 504.7  542.7 
Dominican Republic 1,431.5  1,593.0 
Panama 333.0  358.8 
Uruguay 124.3  130.4 
  5,207.1  6,163.1 
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.24.0.1
RECOVERABLE TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Recoverable Taxes  
Schedule of Classifications of recoverable taxes
   
  2023 2022
PIS/COFINS exclusion of ICMS (i) 6,490.4  5,992.8 
ICMS 436.5  423.2 
Income tax and social contributions recoverable 4,087.0  4,607.5 
Other 311.2  292.8 
Non-current 11,325.1  11,316.3 
     
PIS/COFINS exclusion of ICMS (i) 219.0  73.5 
PIS/COFINS 170.4  242.7 
ICMS 426.9  542.2 
IPI 112.5  131.0 
Income tax and social contributions recoverable 2,436.6  1,808.7 
Other 70.3  55.4 
Current 3,435.7  2,853.5 
     
Total 14,760.8  14,169.8 

 

(i)As detailed in Note 27.2 - Contingencies, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS from the substitution of tax basis for contribution.
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of inventory components
   
  2023 2022
     
Finished goods  2,990.3  4,094.0 
Work in progress 826.5  845.7 
Raw materials and consumables 4,599.9  6,798.3 
Spare parts and others 806.9  986.9 
Prepayments 537.9  358.3 
Impairment losses (142.5) (160.2)
Total 9,619.0  12,923.0 
Schedule of changes in impairment losses on inventory
   
  2023 2022
Beginning balance (160.2) (157.8)
Effects of movements in foreign exchange in the balance sheet 12.9  17.8 
Provisions (262.9) (305.8)
Write-off 267.7  285.6 
Final balance (142.5) (160.2)
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE RECEIVABLES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of current trade receivables
   
  2023 2022
     
Trade receivables 6,225.8  5,737.5 
Bad debt provision (721.0) (679.1)
Net, trade receivables  5,504.8  5,058.4 
Related parties (Note 30) 236.7  290.7 
Total current trade receivables  5,741.5  5,349.1 
Schedule of maturity trade receivable
             
  2023   2022
  Trade receivables Bad debt provision Trade receivables, net   Trade receivables Bad debt provision Trade receivables, net
No past due 5,129.5  -    5,129.5    4,573.0  -    4,573.0 
Past due – within 30 days 283.4  -    283.4    343.8  -    343.8 
Past due – between 31 - 60 days  66.3  -    66.3    100.5  (0.3) 100.2 
Past due – between 61 - 90 days 33.2  (7.7) 25.5    49.4  (10.8) 38.6 
Past due – between 91 - 180 days 6.5  (6.4) 0.1    19.3  (16.5) 2.8 
Past due – between 181 - 360 days 46.6  (46.6) -      40.2  (40.2) -   
Past due over 360 days 660.3  (660.3) -      611.3  (611.3) -   
Net carrying amount as of December 31, 6,225.8  (721.0) 5,504.8    5,737.5  (679.1) 5,058.4 
Schedule of estimated loss for doubtful debts
   
  2023 2022
Beginning balance (679.1) (668.3)
Effects of movements in foreign exchange in the balance sheet 12.3  14.0 
Additions (103.6) (47.0)
Reversals 8.3  1.7 
Write-off 41.1  20.5 
Final balance (721.0) (679.1)
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of components in cash and cash equivalents
   
  2023 2022
Short-term bank deposits (i) 8,973.6  8,655.2 
Current bank accounts 6,818.3  5,990.3 
Cash 267.1  280.9 
Cash and cash equivalents 16,059.0  14,926.4 
     
Bank overdrafts -    (74.3)
Cash and cash equivalents less bank overdraft 16,059.0  14,852.1 

 

(i)The balance refers mostly to Bank Deposit Certificates (“CDB”), with high liquidity, which are readily convertible into known amounts of cash, and which are subject to an insignificant risk of change in value.
Schedule of investment securities
   
Investment_securities 2023 2022
     
Investment on debt securities (i) 242.2  219.1 
Non-current investment securities 242.2  219.1 
     
Financial assets at fair value through profit or loss 277.2  454.5 
Current investment securities 277.2  454.5 
     
Total 519.4  673.6 

 

(i)The balance refers substantially to financial investments linked to tax incentives that do not have immediate convertibility into a known amount of cash.
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY (Tables)
12 Months Ended
Dec. 31, 2023
Changes In Equity  
Schedule of issued capital
               
  2023   2022   2021
Shareholder Million common shares %   Million common shares %   Million common shares %
Interbrew International B.V. 8,441.7 53.6%   8,441.8 53.6%   8,441.9 53.6%
Ambrew S.A.R.L. 1,287.7 8.2%   1,287.7 8.2%   1,287.0 8.2%
Fundação Zerrenner 1,610.0 10.2%   1,610.0 10.2%   1,610.0 10.2%
Mercado 4,410.0 28.0%   4,402.2 27.9%   4,399.7 27.9%
Tesouraria 4.4 0.0%   8.5 0.1%   5.8 0.0%
  15,753.8 100.0%   15,750.2 100.0%   15,744.4 100.0%

 

    2023     2022     2021
  Million common shares Million Reais   Million common shares Million Reais   Million common shares Million Reais
                 
Beginning balance 15,750.2  58,130.5    15,744.4  58,042.5    15,735.1  57,899.1 
Capital increase (i) 3.6  47.4    5.8  88.0    9.3  143.4 
Final balance 15,753.8  58,177.9    15,750.2  58,130.5    15,744.4  58,042.5 

 

(i) Capital increase related to the issue of shares.

Schedule of capital reserves
         
  Capital Reserves   
  Treasury shares  Share Premium  Other capital reserves  Share-based Payments   Total 
           
At January 1, 2021 (941.7) 53,662.8  700.9  1,563.6  54,985.6 
Capital Increase (60.0) -    -    (74.4) (134.4)
Purchases of shares, results of treasury shares and share-based payments (36.1) -    -    372.1  336.0 
At December 31, 2021 (1,037.8) 53,662.8  700.9  1,861.3  55,187.2 
Capital Increase -    -    -    (64.2) (64.2)
Purchases of shares, results of treasury shares and share-based payments (35.6) -    -    252.4  216.8 
At December 31, 2022 (1,073.4) 53,662.8  700.9  2,049.5  55,339.8 
Capital Increase -    -    -    (32.9) (32.9)
Purchases of shares, results of treasury shares and share-based payments 61.6  -    -    111.2  172.8 
At December 31, 2023 (1,011.8) 53,662.8  700.9  2,127.8  55,479.7 
Schedule of treasury shares
             
  Acquisition /realization of shares   Result of Treasury Shares   Total Treasury Shares
  Million shares   Million Brazilian Reais   Million shares   Million Brazilian Reais
At January 1, 2021 0.2    (3.2)   (938.5)   (941.7)
Changes during the year 5.6    (95.1)   (1.0)   (96.1)
At December 31, 2021 5.8    (98.3)   (939.5)   (1,037.8)
Changes during the year 2.7    (33.5)   (2.1)   (35.6)
At December 31, 2022 8.5    (131.8)   (941.6)   (1,073.4)
Changes during the year (4.1)   68.8    (7.2)   61.6 
At December 31, 2023 4.4    (63.0)   (948.8)   (1,011.8)
Schedule of net income reserves
       
  Net income reserves
  Investments reserve  Legal reserve   Fiscal incentive  Total
At January 1, 2021 14,511.1  4.5  11,404.4  25,920.0 
Fiscal incentive reserve  -    -    1,423.5  1,423.5 
Investments reserve  3,848.1  -    -    3,848.1 
At December 31, 2021 18,359.2  4.5  12,827.9  31,191.6 
Fiscal incentive reserve  -    -    2,018.7  2,018.7 
Investments reserve  3,696.7  -    -    3,696.7 
At December 31, 2022 22,055.9  4.5  14,846.6  36,907.0 
Fiscal incentive reserve  -    -    2,552.7  2,552.7 
Investments reserve  3,730.2  -    -    3,730.2 
At December 31, 2023 25,786.1  4.5  17,399.3  43,189.9 
Schedule of interest on shareholders' equity and dividends
             
Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/12/2023 Interest on shareholder´s equity 12/28/2023 2023 ON 0.7302 11,500.2 
              11,500.2 

 

Distribution of interest on shareholders’s equity. In accordance with Operations and Finance Committee recommendation at the meeting held on December 12, 2023, was approved the distribution of interest on shareholder’s equity in the amount of R$0.7302 per share, based on available balances, in the Company’s extraordinary balance sheet dated as of November 30, 2023, (the survey of which was approved by the Board of Directors at the meeting held on December 12, 2023) and in the Company’s investment reserve, pursuant to the balance sheet dated as of December 31, 2022, which were attributed to the minimum mandatory dividends of the same fiscal year. The interest on shareholder’s equity distribution was taxed pursuant to the applicable law, which resulted in a net interest on shareholder’s equity distribution of R$0.6207 per share of, except for shareholders that are corporate entities that are immune or exempted pursuant to article 5 of Law 11,053/04, as amended by Law 11,196/05.

 

The indicated payment was made on December 28, 2023, considering the shareholding position of December 19, 2022, with respect to B3, and December 26, 2023, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Events during the year ended 2022:

 

Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/06/2022 Interest on shareholder´s equity 12/29/2022 2022 ON 0.7623 11,999.8 
              11,999.8 

 

Distribution of Dividends in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 5, 2022, was approved the distribution of dividends of R$0.7623 per share, based on available balance and the Company’s extraordinary balance sheet dated as of October 31, 2022 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$0.6480 per share of the Company in 2022.

 

The indicated payment was made on December 29, 2022, considering the shareholding position of December 19, 2022, with respect to B3, and December 21, 2022, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.

 

Events during the year ended 2021:

 

Event Approval Type Date of payment Year Type of share Amount per share Total amount
Board of Directors Meeting 12/09/2021 Dividends 12/30/2021 2021 ON 0.1334 2,099.5 
Board of Directors Meeting 12/09/2021 Interest on shareholder´s equity 12/30/2021 2021 ON 0.4702 7,400.1 
              9,499.6 
Schedule of basis of dividends
         
  2023   2022   2021
Net income, attributable to equity holders of Ambev 14,501.9    14,457.9    12,671.0 
Prescribed/(complementary) dividends -      20.9    24.7 
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting 11.8    11.8    11.8 
Effect of application of IAS 29 (hyperinflation) 3,269.4    3,224.4    2,063.7 
Retained earnings basis for dividends and destinations 17,783.1    17,715.0    14,771.2 
           
Dividends and interest on capital distributed and accrued for distribution based on the net income for the year          
Dividends and interest on capital paid based on profit 11,500.2    11,999.8    9,499.6 
Total of dividends and interest on capital  11,500.2    11,999.8    9,499.6 
Percentage of distributed profit 65%   68%   64%
Schedule of Carrying value adjustments
               
  Carrying value adjustments  
  Translation reserves Cash flow hedge Actuarial gains/ (losses) Put option granted on subsidiary Gains/(losses) of non-controlling interest’s share Business combination Accounting adjustments for transactions between shareholders Total
                 
At January 1, 2021 11,076.5 744.5 (1,473.3) (4.8) (73.8) 156.1 (75,414.2) (64,989.0)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations 2,449.7 - - - - - - 2,449.7
Cash flow hedges - 480.8 - - - - - 480.8
Actuarial gains/(losses) - - 341.8 - - - - 341.8
Total Comprehensive income 2,449.7 480.8 341.8 - - - - 3,272.3
Options granted on subsidiaries - - - (1.9) - - - (1.9)
Gains/(losses) of controlling interest - - - - (46.2) - - (46.2)
Tax on deemed dividends - - - - (1.7) - - (1.7)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2021 13,526.2 1,225.3 (1,131.5) (6.7) (121.7) 156.1 (75,426.0) (61,778.3)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations (6,772.2) - - - - - - (6,772.2)
Cash flow hedges - (316.7) - - - - - (316.7)
Actuarial gains/(losses) - - 466.5 - - - - 466.5
Total Comprehensive income (6,772.2) (316.7) 466.5 - - - - (6,622.4)
Gains/(losses) of controlling interest - - - - (2.8) - - (2.8)
Tax on deemed dividends - - - - (6.2) - - (6.2)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2022 6,754.0 908.6 (665.0) (6.7) (130.7) 156.1 (75,437.8) (68,421.5)
Comprehensive income:                
Gains/(losses) on the translation of foreign operations (9,212.4) - - - - - - (9,212.4)
Cash flow hedges - (210.8) - - - - - (210.8)
Actuarial gains/(losses) - - (13.2) - - - - (13.2)
Total Comprehensive income (9,212.4) (210.8) (13.2) - - - - (9,436.4)
Options granted on subsidiaries - - - 6.7 - - - 6.7
Gains/(losses) of controlling interest - - - - (2.6) - - (2.6)
Tax on deemed dividends - - - - (12.4) - - (12.4)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting - - - - - - (11.8) (11.8)
At December 31, 2023 (2,458.4) 697.8 (678.2) - (145.7) 156.1 (75,449.6) (77,878.0)
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTEREST-BEARING LOANS AND BORROWING (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of total liabilities
   
  2023 2022
     
Secured bank loans 111.6  126.2 
Other secured loans (i) 279.4  328.1 
Lease liabilities 1,812.0  2,333.8 
Non-current liabilities 2,203.0  2,788.1 
     
Secured bank loans 14.9  54.5 
Other secured loans (i) 136.3  144.5 
Lease liabilities 1,146.9  783.6 
Current liabilities 1,298.1  982.6 
     
Total 3,501.1  3,770.7 

 

(i)Nomenclature modified to Other secured loans, including for comparative purposes.
Schedule of debts
             
    2023     2022
Debt instruments Average rate % Current Non-current   Average rate % Current Non-current
Debt denominated in US Dollars - fixed rate 14.00% 0.0  -      14.00% 6.2  -   
Other Latin American currencies - fixed rate 11.48% 124.6  281.0    10.39% 98.8  322.5 
Debt denominated in CAD Dollars - fixed rate 5.63% 130.1  350.2    5.32% 123.3  387.7 
Reais denominated floating rate (TJLP and TR) 9.47% 13.4  111.6    9.61% 12.3  125.1 
Reais debt - ICMS fixed rate 2.95% 103.2  194.3    2.95% 113.3  266.4 
Reais debt - ICMS floating rate 6.56% 33.0  85.1    6.97% 31.1  61.7 
Reais debt - fixed rate 11.17% 893.7  1,180.7    9.43% 597.6  1,624.7 
Total   1,298.1  2,203.0      982.6  2,788.1 
Schedule of liabilities arising from financing activities
             
  2023   2022
  Non - current liabilities   Current liabilities   Non - current liabilities   Current liabilities
Beginning balance 2,788.1    982.6    2,253.5    847.1 
Proceeds 49.8    -      267.0    7.9 
Payments (0.8)   (226.6)   -      (230.2)
Foreign exchange (52.8)   (19.6)   (56.8)   (17.4)
Transfers between current and non-current (1,238.0)   1,238.0    (761.0)   761.0 
New lease agreements 629.5    524.4    905.3    469.2 
Interest on leases -      193.1    -      159.3 
Lease Payments -      (1,373.2)   -      (1,014.0)
Other movements 27.2    (20.6)   180.1    (0.3)
Final balance 2,203.0    1,298.1    2,788.1    982.6 
Schedule of maturity of contracts
             
            Balance as of December 31, 2023
  2024 2025 2026 2027 > 2028 2023 2022
Secured bank loans 14.9  14.7  16.1  36.8  44.0  126.5  180.7 
Other secured loans (i) 136.3  151.5  114.8  3.7  9.3  415.7  472.7 
Lease liabilities 1,146.9  481.8  472.4  385.0  472.8  2,958.9  3,117.3 
  1,298.1  648.0  603.3  425.5  526.1  3,501.1  3,770.7 

 

(i)Nomenclature modified to Other secured loans, including for comparative purposes.
Schedule of average discount rate applied for IFRS 16
 
  Rate %
Lease Term 2023
2023 - 2027 11.15%
2028 - 2035 11.48%
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of defined benefit plans
     
  2023  2022  2021 
Present value of funded obligations (5,365.5) (5,476.5) (7,354.3)
Fair value of plan assets 4,604.6  4,543.3  5,638.0 
Present value of net obligations (760.9) (933.2) (1,716.3)
Present value of unfunded obligations (917.2) (921.0) (1,165.4)
Present value of net obligations  (1,678.1) (1,854.2) (2,881.7)
Asset ceiling (182.6) (163.3) (180.1)
Net liabilities (1,860.7) (2,017.5) (3,061.8)
Other long term employee benefits (93.9) (87.1) (104.3)
Total employee benefits (1,954.6) (2,104.6) (3,166.1)
Employee benefits amount in the balance sheet      
Liabilities  (2,011.9) (2,161.2) (3,194.0)
Assets  57.3  56.6  27.9 
Net liabilities (1,954.6) (2,104.6) (3,166.1)
Schedule of present value of defined benefit obligations
     
  2023  2022  2021 
Defined benefit obligation at January 1 (6,397.5) (8,519.7) (8,777.6)
Service costs (30.8) (47.0) (58.0)
Interest costs (413.2) (353.2) (324.3)
Gains and (losses) on settlements or reductions in benefits 9.2  3.8  3.6 
Contributions by plan participants (4.2) (5.6) (6.9)
Actuarial gains and (losses) - geographical assumptions 11.5  -    52.3 
Actuarial gains and (losses) - financial assumptions (297.0) 1,333.6  726.8 
Experience adjustments 91.2  (171.5) (213.0)
Reclassifications -    -    (1.0)
Effect of exchange rate fluctuations 216.7  787.7  (495.3)
Benefits paid 531.4  574.4  573.7 
Defined benefit obligation at December, 31 (6,282.7) (6,397.5) (8,519.7)
Schedule of fair value of plan assets
     
  2023  2022  2021 
Fair value of plan assets at January 1 4,543.3  5,638.0  5,533.3 
Interest income 318.1  262.1  223.9 
Administrative costs (5.2) (5.2) (5.8)
Expected return, excluding interest income 101.7  (614.6) (148.3)
Contributions by employer 280.5  316.0  342.0 
Contributions by plan participants 4.6  5.8  7.1 
Exchange differences (102.0) (482.6) 263.1 
Curtailments, settlements and other (4.8) (1.8) (3.6)
Benefits paid, excluding administrative costs (531.6) (574.4) (573.7)
Fair value of plan assets at December, 31 4,604.6  4,543.3  5,638.0 
Schedule of asset ceiling
     
  2023 2022 2021
Asset ceiling impact at January 1 56.6  27.9  33.6 
Interest income/(expenses) 4.9  -    1.3 
Change in asset ceiling excluding amounts included in interest income/(expenses) (0.1) 30.2  (9.0)
Effects of exchange rate fluctuations   (4.1) (1.5) 2.0 
Asset ceiling impact at December 31  57.3  56.6  27.9 
Schedule of defined benefit plans recognized in income statement
     
  2023  2022  2021 
Current service costs (30.8) (47.0) (58.0)
Administrative costs (5.2) (5.2) (5.8)
(Gains) losses on settlement and curtailment 4.7  2.2  1.2 
Income from operations (31.3) (50.0) (62.6)
Financial costs (114.3) (107.8) (115.6)
Total employee benefit expenses (145.6) (157.8) (178.2)
Schedule of employee benefit revenue/(expenses)
     
  2023  2022  2021 
Other operating income/(expenses) -    (0.1) (0.2)
Cost of sales (15.1) (26.4) (33.0)
Commercial expenses (7.3) (9.4) (11.7)
Administrative income/(expenses) (8.9) (14.1) (17.7)
Financial expense (114.3) (107.8) (115.6)
  (145.6) (157.8) (178.2)
Schedule of assumptions used
     
  2023 (i) 2022 (i) 2021 (i)
Discount rate 4.6% to 11.7% 5.1% to 11.0% 2.4% to 10.0%
Inflation 2.0% to 3.5% 2.0% to 3.5% 2.0% to 3.5%
Future salary increases  1.0% to 7.1% 1.0% to 7.1% 1.0% to 7.1%
Future pension increases 2.7% to 3.8% 2.7% to 3.8% 2.5% to 3.8%
Medical cost trend rate  6.4% to 7.1% p.a. reducing to 7,1% 6.4% to 7.1% p.a. reducing to 7,1% 4.5% to 6.9% p.a. reducing to 6.9%
Dental claims trend rate  3.5% 3.5% 3.3%
       
Life expectancy for an over 65 years old male  84 to 87 84 to 87 85 to 87
Life expectancy for an over 65 years old female 86 to 89 86 to 89 87 to 89

 

(i)Includes assumptions in Brazil, Central America and Caribbean, Latin America - South and Canada.
Schedule of sensitivity of defined benefit obligation
                 
In millions of Brazilian Reais   2023   2022   2021
  Change in assumption Increase in assumption Decrease in assumption   Increase in assumption Decrease in assumption   Increase in assumption Decrease in assumption
Medical cost trend rate 100 bases points  (95.2) 82.2    (94.3) 81.8    (114.7) 98.6 
Discount rate 50 bases points  284.8  (302.4)   307.9  (328.0)   442.0  (470.3)
Future salary increases 50 bases points  (17.3) 14.7    (17.6) 16.5    (19.8) 18.6 
Longevity One year (201.0) 196.1    (221.5) 213.5    (287.6) 279.5 
Schedule of plans assets
                     
  2023   2022   2021
  Rated Unrated Total   Rated Unrated Total   Rated Unrated Total
Government bonds 43% -    43%   43% -    43%   43% -    43%
Corporate bonds 10% -    10%   10% -    10%   10% -    10%
Equity instruments 15% -    15%   15% -    15%   15% -    15%
Cash 6% -    6%   6% -    6%   6% -    6%
Others 26% -    26%   26% -    26%   26% -    26%
XML 75 R60.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED PAYMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of restricted and performance shares
         
Thousand restricted shares 2023   2022   2021
           
Restricted and performance shares outstanding at January 108,854    62,545    43,458 
New restricted and performance shares during the period 33,686    49,328    20,629 
Restricted and performance shares granted during the period (18,309)   (12)   (22)
Restricted and performance shares forfeited during the period (5,235)   (3,007)   (1,520)
Restricted shares outstanding at the end of the year 118,996    108,854    62,545 
Schedule of outstanding options developed
         
Thousand options 2023   2022   2021
           
Options outstanding at January 99,717    113,760    127,265 
Options exercised during the period -      -      (5,247)
Options forfeited during the period (11,756)   (14,043)   (8,258)
Options outstanding at the end of the year 87,961    99,717    113,760 
Schedule of weighted average exercise price
         
In R$ per share 2023   2022   2021
           
Options outstanding at January 1 19.39    19.92    19.81 
Options forfeited during the period 22.68    22.60    25.27 
Options exercised during the period -      -      13.16 
Options outstanding at the end of the period 18.86    19.39    19.92 
Options exercisable at the end of the period 19.08    20.12    21.14 
Schedule of deferred shares
         
Thousand deferred shares 2023   2022   2021
           
Deferred shares outstanding at January 1 889    1,168    6,065 
New deferred shares during the period 47    44    110 
Deferred shares granted during the period -      (214)   (4,964)
Deferred shares forfeited during the period -      (109)   (43)
Deferred shares outstanding at the end of the year 936    889    1,168 
XML 76 R61.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE PAYABLES (Tables)
12 Months Ended
Dec. 31, 2023
Trade Payables  
Schedule of trade payable
   
  2023 2022
     
Trade payables 107.4  165.8 
Related parties (Note 30) 199.9  343.6 
Non-current 307.3  509.4 
     
Trade payables 21,278.6  23,498.1 
Related parties (Note 30) 1,916.5  830.4 
Current 23,195.1  24,328.5 
     
Total 23,502.4  24,837.9 
XML 77 R62.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of provision changes
           
  Taxes on sales Labor Civil Other taxes (i) Restructuring Total
             
At December 31, 2021 218.6  124.2  252.9  163.0  17.4  776.1 
Effect of changes in foreign exchange rates -    (4.6) (17.5) (8.1) (2.0) (32.2)
Additions 157.6  194.2  312.7  60.1  -    724.6 
Provisions used  (85.8) (162.0) (196.6) (7.2) (3.6) (455.2)
Provisions reversed (43.3) (19.7) (15.6) (15.0) -    (93.6)
At December 31, 2022 247.1  132.1  335.9  192.8  11.8  919.7 
Effect of changes in foreign exchange rates -    (2.8) (35.8) (6.3) (0.5) (45.4)
Additions 135.7  247.8  234.5  75.7  3.2  696.9 
Provisions used  (27.3) (181.7) (121.9) (40.8) (11.2) (382.9)
Provisions reversed (73.2) (45.5) (72.5) (19.1) -    (210.3)
At December 31, 2023 282.3  149.9  340.2  202.3  3.3  978.0 

 

(i)Other taxes refer to provisions for lawsuits concerning taxes unrelated to income taxation. The uncertain tax treatments related taxes on profits with a prognosis of probable loss have their value reported directly in the income tax and social contribution payable, as per IFRIC 23 - Uncertainty on the Treatment of Income Taxes.
Schedule of expected settlement of provision
               
  2023   2022
  Non-current Current Total   Non-current Current Total
               
Provision for disputes and litigation              
Taxes on sales 168.6  113.7  282.3    193.8  53.3  247.1 
Labor 82.7  67.2  149.9    104.9  27.2  132.1 
Civil 113.4  226.8  340.2    263.0  72.9  335.9 
Other taxes 194.9  7.4  202.3    170.1  22.7  192.8 
Total provision for disputes and litigation 559.6  415.1  974.7    731.8  176.1  907.9 
               
Restructuring -    3.3  3.3    7.2  4.6  11.8 
               
Total provisions 559.6  418.4  978.0    739.0  180.7  919.7 
Schedule of contingencies
   
  2023 2022
     
Income tax and social contribution 63,621.0  60,453.5 
Value-added and excise taxes 26,761.0  25,904.6 
PIS and COFINS 3,496.2  3,293.5 
Others 1,679.4  1,909.1 
  95,557.6  91,560.7 
XML 78 R63.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of consolidated financial instruments
   
  2023 2022
Assets    
Amortized cost    
Cash and cash equivalents less bank overdrafts (Note 21.1) 16,059.0  14,852.1 
Trade receivables excluding prepaid expenses  7,566.7  7,791.4 
Investment securities (Note 21.2) 242.2  219.1 
Subtotal 23,867.9  22,862.6 
Fair value through profit or loss    
Investment securities (Note 21.2) 277.2  454.5 
Derivatives hedges (Note 28) 379.7  273.8 
Subtotal 656.9  728.3 
Total assets 24,524.8  23,590.9 
     
Liabilities    
Amortized cost    
Trade payables (Note 26) 23,502.4  24,837.9 
Interest-bearing loans and borrowings (Note 23) 3,501.1  3,770.7 
Other liabilities 2,129.6  2,015.6 
Subtotal 29,133.1  30,624.2 
Fair value through profit or loss    
Put options granted on subsidiaries (i) 2,791.1  3,060.3 
Derivatives hedges (Note 28) 763.1  729.4 
Other liabilities 272.6  333.7 
Subtotal 3,826.8  4,123.4 
Total liabilities 32,959.9  34,747.6 

 

(i)Put options granted on subsidiaries: the Company constituted a liability related to the acquisition of a non-controlling interest of the operations in the Dominican Republic. This financial instrument is denominated in US Dollars (Tranche A) and Dominican Pesos (Tranche B) and is recorded by an entity, whose functional currency is the Real. The Company assigned this financial instrument as a hedging instrument for a portion of its net assets located in subsidiaries whose functional currency is the US Dollar and the Dominican Peso, in such a manner that the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.
Schedule of financial risk management
                   
2023 
          Fair Value   Gain / (Losses)
Hedge position   Risk Notional   Assets Liability   Finance Result Operational Result Equity
                     
Cost     17,374.2    379.5  (742.0)   (1,639.6) 34.6  (285.2)
    Commodities 4,025.7    198.3  (219.4)   (388.3) (336.2) (105.4)
    US Dollars 13,200.0    164.9  (522.4)   (1,250.7) 363.9  (182.1)
    Euros 37.4    0.1  (0.2)   (0.5) 2.6  0.5 
    Mexican Pesos 111.1    16.2  -      (0.1) 4.3  1.8 
                     
Importing of fixed assets     249.7    0.1  (14.6)   11.0  3.4  5.0 
    US Dollars 249.7    0.1  (14.6)   11.0  3.4  5.0 
                     
Expenses     64.7    0.1  (4.2)   (25.6) (0.1) 1.1 
    US Dollars 64.7    0.1  (4.2)   (25.6) (0.1) 1.1 
                     
Cash     (59.3)   -    (2.3)   13.7  -    -   
    US Dollars (59.3)   -    (2.3)   13.7  -    -   
At December 31, 2023     17,629.3    379.7  (763.1)   (1,640.5) 37.9  (279.1)

 

    2022 
          Fair Value   Gain / (Losses)
Hedge position   Risk Notional   Assets Liability   Finance Result Operational Result Equity
                     
Cost     19,853.3    271.8  (719.4)   (3,075.2) 452.7  134.3 
    Commodities 4,809.9    100.8  (376.0)   63.5  (32.3) (475.0)
    US Dollars 14,874.7    157.7  (342.9)   (3,139.2) 477.1  596.6 
    Euros 32.2    1.9  -      (0.7) (0.3) 1.2 
    Mexican Pesos 136.5    11.4  (0.5)   1.2  8.2  11.5 
                     
Fixed assets     226.8    1.5  (5.4)   (5.9) 4.9  (13.0)
    US Dollars 226.8    1.5  (5.4)   (5.9) 4.9  (13.0)
                     
Expenses     204.9    0.5  (4.6)   (42.5) 9.1  (14.8)
    US Dollars 204.9    0.5  (4.6)   (42.5) 9.1  (14.8)
                     
Cash     -      -    -      (17.1) -    -   
    American Dollar -      -    -      (17.1) -    -   
At December 31, 2022     20,285.0    273.8  (729.4)   (3,140.7) 466.7  106.5 
Schedule of notional and fair value amounts per instrument and maturity
             
    Notional Value
Exposure Risk 2024 2025 2026 2027 >2027 Total
               
Cost   16,763.3  610.9  -    -    -    17,374.2 
   Commodities  3,924.3  101.4  -    -    -    4,025.7 
   US Dollars  12,690.5  509.5  -    -    -    13,200.0 
   Euros 37.4  -    -    -    -    37.4 
   Mexican Pesos  111.1  -    -    -    -    111.1 
               
Importing of fixed assets   249.7  -    -    -    -    249.7 
  US Dollars  249.7  -    -    -    -    249.7 
               
Expenses   64.7  -    -    -    -    64.7 
  US Dollars  64.7  -    -    -    -    64.7 
               
Cash   (59.3) -    -    -    -    (59.3)
  US Dollars  (59.3) -    -    -    -    (59.3)
    17,018.4  610.9  -    -    -    17,629.3 

 

    Fair Value
Exposure Risk 2024 2025 2026 2027 >2027 Total
               
Costs   (352.5) (10.0) -    -    -    (362.5)
  Commodities (14.2) (6.9) -    -    -    (21.1)
  US Dollars (354.4) (3.1) -    -    -    (357.5)
  Euros (0.1) -    -    -    -    (0.1)
  Mexican Pesos 16.2  -    -    -    -    16.2 
               
Importing of fixed assets   (14.5) -    -    -    -    (14.5)
  US Dollars (14.5) -    -    -    -    (14.5)
               
Expenses   (4.1) -    -    -    -    (4.1)
  US Dollars (4.1) -    -    -    -    (4.1)
               
Cash   (2.3) -    -    -    -    (2.3)
  US Dollars (2.3) -    -    -    -    (2.3)
    (373.4) (10.0) -    -    -    (383.4)
Schedule of fair value measurement
                 
  2023   2022
                   
  Level 1 Level 2 Level 3  Total    Level 1 Level 2 Level 3 Total
Financial assets                  
Investment securities 277.2  -    -    277.2    454.5  -    -    454.5 
Derivatives – operational hedge 53.4  326.3  -    379.7    57.0  216.8  -    273.8 
 Total 330.6  326.3  -    656.9    511.5  216.8  -    728.3 
Financial liabilities                  
Put options granted on subsidiaries -    -    2,791.1  2,791.1    -    -    3,060.3  3,060.3 
Other liabilities -    -    272.6  272.6    -    -    333.7  333.7 
Derivatives liabilities at fair value through profit and loss 2.3  -    -    2.3    -    -    -    -   
Derivatives – operational hedge 70.0  690.8  -    760.8    76.1  653.3  -    729.4 
 Total 72.3  690.8  3,063.7  3,826.8    76.1  653.3  3,394.0  4,123.4 
Schedule of reconciliation of changes in the assets
 
Financial liabilities at December 31, 2022 3,394.0 
   Acquisition of investments (64.2)
Level reclassification (6.6)
Total gains and losses during the period (259.5)
   Losses/(gains) recognized in net income (269.9)
   Losses/(gains) recognized in equity 10.4 
Financial liabilities at December 31, 2023 3,063.7 
Schedule of detailed information about hedging instruments
         
  2023   2022
  Risk   Risk
  Interest rate  Amount    Interest rate  Amount 
Brazilian Reais 8.1% 243.2    8.5% 230.1 
Post fixed interest rate    243.2      230.1 
           
           
Brazilian Reais 10.1% 2,372.0    8.5% 2,602.1 
Working Capital in Argentinean Peso  0.0% -      73.5% 74.3 
Other 11.5% 405.6    10.4% 421.3 
US Dollars 14.0% -      14.0% 6.2 
Canadian Dollars 5.6% 480.3    5.3% 511.0 
Pre-fixed interest rate    3,257.9      3,614.9 
Schedule of types of market risk
         
Transaction Risk Fair value Probable scenario Adverse scenario Remote
scenario
           
Commodities hedge Decrease in commodities price (21.1) 94.6  985.4  1,991.9 
Input purchases 21.1  (94.6) (985.4) (1,991.9)
Foreign exchange hedge Foreign currency decrease (341.4) (163.3) 2,995.8  6,333.0 
Input purchases 341.4  104.9  (3,336.8) (7,014.9)
Cost effects   -    (58.4) (341.0) (681.9)
           
Foreign exchange hedge Foreign currency decrease (14.5) (13.2) 47.9  110.3 
Capex Purchases 14.5  13.2  (47.9) (110.3)
Fixed asset effects   -    -    -    -   
           
Foreign exchange hedge Foreign currency decrease (4.1) (3.7) 12.0  28.2 
Expenses 4.1  (1.7) (44.0) (92.2)
Result of expense effects   -    (5.4) (32.0) (64.0)
           
Foreign exchange hedge Foreign currency decrease (2.3) (2.5) (17.1) (31.9)
Cash 2.3  2.5  17.1  31.9 
Cash effects   -    -    -    -   
    -    (63.8) (373.0) (745.9)
Schedule of liquidity risk and payables
             
  2023
  Carrying amount Contractual cash flows Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
Trade and other payables (i) 36,817.8  38,453.7  35,522.5  439.9  10.6  808.6  1,672.1 
Secured bank loans 126.5  177.8  26.7  25.2  25.2  50.4  50.4 
Other secured loans (ii) 415.7  594.7  156.0  171.2  134.2  79.4  53.9 
Lease liabilities  2,958.9  3,473.0  1,344.0  608.3  552.6  452.6  515.5 
Total payables and liabilities  40,318.9  42,699.2  37,049.2  1,244.6  722.6  1,390.9  2,291.8 

 

               
  2022
  Carrying amount Contractual cash flows Less than 1 year 1-2 years 2-3 years 3-5 years More than 5 years
Trade and other payables (i) 39,354.4  40,656.4  36,818.5  86.8  1,275.1  1,008.4  1,467.6 
Secured bank loans 180.8  245.7  68.2  26.4  25.2  50.4  75.5 
Other secured loans (ii) 472.5  759.1  169.9  156.7  151.6  165.4  115.5 
Lease liabilities  3,117.4  3,657.4  962.9  1,008.4  621.0  696.9  368.2 
Total payables and liabilities  43,125.1  45,318.6  38,019.5  1,278.3  2,072.9  1,921.1  2,026.8 

 

(i)Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends, and interest on equity payable, salaries and charges, put options related to the Company’s participation in subsidiaries and other liabilities, except for related parties, with payment term of less than one year.

 

(ii)Nomenclature modified to Other secured loans, including for comparative purposes.
Schedule of net debt of long term
     
    2023 2022
Assets      
Interest-bearing loans and borrowings current and non-current   3,501.1  3,770.7 
(-) Financial assets at fair value through profit or loss   (277.2) (454.5)
(-) Cash and cash equivalents less bank overdraft   (16,059.0) (14,852.1)
Net debt   (12,835.1) (11,535.9)
XML 79 R64.htm IDEA: XBRL DOCUMENT v3.24.0.1
COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Tables)
12 Months Ended
Dec. 31, 2023
Collateral And Contractual Commitments With Suppliers Advances From Customers And Others  
Schedule of commitments and contingent liabilities
   
  2023 2022
     
Collateral given for the Company’s own liabilities 581.0  764.5 
Other commitments 1,146.8  1,368.1 
  1,727.8  2,132.6 
     
Commitments to suppliers - Property, plant and equipment and Intangible 1,000.8  276.7 
Commitments to suppliers - Inventories 38,391.0  50,088.6 
  39,391.8  50,365.3 
Schedule of future contractual commitments
   
  2023 2022
     
Less than 1 year 9,619.2  12,491.0 
Between 1 and 2 years 9,536.3  10,315.3 
More than 2 years 20,236.3  27,559.0 
  39,391.8  50,365.3 
XML 80 R65.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTIES (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of key management remuneration
       
  2023 2022 2021
       
Short-term benefits (i) 66.7  74.2  68.3 
Share-based payments (ii) 80.7  66.0  65.3 
Total key management remuneration  147.4  140.2  133.6 

 

(i)These mainly correspond to management’s salaries and profit sharing (including performance bonuses).

 

(ii)These correspond to compensation expenses of share options, restricted stocks and performance stocks granted to Management. In total amounts above exclude remuneration paid to members of the Fiscal Council and Committees.
Schedule of transactions with related parties
           
  2023
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.1  97.2    (143.3) (0.5) 64.0 
AB Package -    -      (235.5) -    -   
AB Procurement  -    -      -    -    (0.5)
AB USA 35.3  -      (915.9) (3.1) (0.2)
Bavaria 72.3  -      (56.7) -    -   
Cervecería Modelo 0.9  -      (1,234.9) -    -   
Cervecerías Peruanas -    -      (7.8) -    -   
Inbev -    -      (41.9) -    -   
ITW International -    -      -    -    120.0 
Other 1.7  18.9    (32.6) (3.4) 1.0 
  110.3  116.1    (2,668.6) (7.0) 184.3 

 

  2022
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.1  5.2    (117.3) (8.5) 208.7 
AB Package -    -      (356.8) -    -   
AB Procurement  -    -      -    (18.1) -   
AB USA 25.5  -      (1,129.7) (3.2) -   
Ambev Peru 0.6  -      -    -    -   
Bavaria 32.0  -      (56.7) -    -   
Cervecería Modelo 124.4  -      (1,323.6) -    -   
Cervecerías Peruanas 1.7  -      (49.6) -    -   
Inbev -    -      (129.8) -    -   
ITW International -    -      -    -    37.3 
Other 84.8  9.6    (87.2) (7.1) 1.9 
  269.1  14.8    (3,250.7) (36.9) 247.9 

 

  2021
  Sales and other Service fees / reimbursement of expenses and other receivables   Product purchases and other Service fees / reimbursement of expenses and other payables Net finance cost
AB InBev 0.7  -      (180.3) (10.7) -   
AB Package -    -      (286.7) -    -   
AB Procurement  -    -      -    (16.1) -   
AB USA 32.1  -      (1,209.9) (3.9) 0.3 
Ambev Peru 3.2  -      -    -    -   
Bavaria 30.9  -      (57.0) -    -   
Cervecería Modelo 0.8  -      (1,708.2) -    -   
Cervecerías Peruanas 3.2  -      (32.9) -    -   
Inbev -    -      (107.9) -    -   
ITW International -    -      -    -    42.2 
Other 19.5  3.6    (143.0) (8.2) -   
  90.4  3.6    (3,725.9) (38.9) 42.5 

 

30.4 Open Balances with Related Parties

 

      2023     2022
  Current   Current
   Trade receivables (i)   Other trade receivables (i)   Dividends receivables     Trade receivables (i)   Other trade receivables (i) 
AB Africa 3.7  -    -      1.6  -   
AB InBev 139.2  -    -      142.7  -   
AB Services 17.2  -    -      23.7  -   
AB USA 27.1  -    -      71.1  -   
Bavaria 10.4  -    -      13.9  -   
Cervecería Modelo 11.2  -    -      12.0  -   
Cervecerías Peruanas -    -    -      0.9  -   
Inbev 1.4  19.0  -      1.0  23.9 
Panama Holding 4.0  -    1.0    3.9  -   
Other 22.5  -    -      19.9  0.9 
  236.7  19.0  1.0    290.7  24.8 

 

  2023   2022
  Non-current   Current   Non-current   Current
  Trade payables (i)   Trade payables (i)   Trade payables (i)   Trade payables (i)
AB InBev -      (21.5)   -      (82.0)
AB Package -      (110.2)   -      (79.3)
AB Services -      (2.4)   -      (5.7)
AB USA -      (209.6)   -      (237.7)
Bavaria -      (30.2)   -      (6.9)
Cervecería Modelo (ii) -      (1,497.9)   -      (345.5)
Cervecerías Peruanas -      (7.9)   -      (46.4)
Inbev -      (8.7)   -      (12.2)
ITW International (199.9)   -      (343.6)   -   
Other -      (28.1)   -      (14.7)
  (199.9)   (1,916.5)   (343.6)   (830.4)

 

(i)The amount represents trading operations (purchase and sale) and reimbursements between the companies of the group.

 

(ii)The outstanding balances with Cervecería Modelo are mainly made up of the accounts payable described in note 1.2.2, as well as amounts for product purchases and others.
XML 81 R66.htm IDEA: XBRL DOCUMENT v3.24.0.1
CORPORATE INFORMATION (Details Narrative) - BRL (R$)
R$ in Millions
1 Months Ended 12 Months Ended
May 18, 2023
May 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]          
Payment for license     R$ 7,413.5 R$ 7,363.1 R$ 6,898.5
Tax credits   R$ 1,200.0      
Recognized tax credits     1,400.0    
Recognized tax credits     407.1    
Other operating income     218.0    
Finance expenses     189.1    
Grupo Modelo [Member]          
IfrsStatementLineItems [Line Items]          
Payment for license     R$ 869.0    
Tenedora [Member] | ELJ [Member]          
IfrsStatementLineItems [Line Items]          
Put options exercisable number of shares percent of outstanding stock     15.00%    
Tenedora [Member] | ELJ [Member] | Tranche A [Member]          
IfrsStatementLineItems [Line Items]          
Put options exercisable number of shares percent of outstanding stock     12.11%    
Tenedora [Member] | ELJ [Member] | Tranche B [Member]          
IfrsStatementLineItems [Line Items]          
Put options exercisable number of shares percent of outstanding stock     2.89%    
Board Of Directors [Member]          
IfrsStatementLineItems [Line Items]          
Stock repurchase program shares authorized 13,000,000        
Shares outstanding 4,393,610,429        
XML 82 R67.htm IDEA: XBRL DOCUMENT v3.24.0.1
BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Canadian Dollars Spent In Canada And Cuba [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 3.6536 3.8540 4.3914
Average rate 3.7048 3.9807 4.2960
Dominican Pesos Spent In The Dominican Republic [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 0.0831 0.0925 0.0970
Average rate 0.0892 0.0937 0.0938
U S Dollars Spent In Panama And Cuba [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 4.8413 5.2177 5.5805
Average rate 5.0085 5.1644 5.3687
Quetzal Spent In Guatemala [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 0.6189 0.6623 0.7201
Average rate 0.6398 0.6649 0.6954
Argentinean Peso Spent In Argentina [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 0.0060 0.0295 0.0543
Average rate 0.0170 0.0403 0.0568
Bolivian Peso Spent In Bolivia [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 0.6956 0.7497 0.8018
Average rate 0.7196 0.7420 0.7714
Guarani Spent In Paraguai [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 0.0007 0.0007 0.0008
Average rate 0.0007 0.0007 0.0008
Uruguayan Peso Spent In Uruguay [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 0.1241 0.1302 0.1249
Average rate 0.1291 0.1253 0.1236
Chilean Peso Spent In Chile [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 0.0055 0.0061 0.0066
Average rate 0.0059 0.0059 0.0071
Barbadian Dollar Spent In Barbados [Member]      
IfrsStatementLineItems [Line Items]      
Closing rate 2.3866 2.5721 2.7510
Average rate 2.4690 2.5458 2.6465
XML 83 R68.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT REPORTING - Reportable Segments (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Net sales R$ 79,736.9 R$ 79,708.8 R$ 72,854.3
Cost of sales (39,291.6) (40,422.1) (35,659.7)
Gross profit 40,445.3 39,286.7 37,194.6
Distribution expenses (10,750.6) (11,395.3) (9,932.7)
Sales and marketing expenses (7,412.5) (7,337.4) (7,035.5)
Administrative expenses (5,273.7) (5,236.8) (4,877.4)
Other operating income/(expenses) 2,028.9 2,513.9 2,124.1
Exceptional items (206.4) (143.3) (392.8)
Income from operations 18,831.0 17,687.8 17,080.3
Net finance costs (3,609.8) (3,423.1) (3,205.4)
Share of results of joint ventures (185.3) (29.1) (115.7)
Income before income tax 15,035.9 14,235.6 13,759.2
Income tax expense (75.5) 655.6 (636.6)
Net income 14,960.4 14,891.2 13,122.6
Acquisition of property, plant and equipment 6,004.1 6,533.1 7,677.1
Total assets 132,644.3 137,958.0 138,602.5
Total liabilities 132,644.3 137,958.0 138,602.5
Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total assets 102,608.5 110,877.2 109,560.9
Total liabilities 44,049.2 46,148.5 47,025.7
Elimination of intersegment amounts [member]      
IfrsStatementLineItems [Line Items]      
Total assets (2,162.1) (2,533.0) (2,868.5)
Total liabilities (2,161.8) (2,534.2) (2,869.1)
Unallocated amounts [member]      
IfrsStatementLineItems [Line Items]      
Total assets 32,197.9 29,613.8 31,910.1
Total liabilities 90,756.9 94,343.7 94,445.9
Brazil 1 [Member]      
IfrsStatementLineItems [Line Items]      
Net sales 46,361.7 42,635.8 35,586.5
Cost of sales (23,516.1) (22,736.8) (18,309.1)
Gross profit 22,845.6 19,899.0 17,277.4
Distribution expenses (6,428.6) (6,111.1) (5,123.1)
Sales and marketing expenses (4,477.0) (4,065.0) (3,440.3)
Administrative expenses (3,563.2) (3,346.0) (3,006.2)
Other operating income/(expenses) 1,892.5 2,361.3 2,096.0
Exceptional items (137.8) (34.5) (210.1)
Income from operations 10,131.5 8,703.7 7,593.7
Net finance costs (2,050.6) (1,110.3) (858.1)
Share of results of joint ventures (179.0) (38.3) (11.7)
Income before income tax 7,901.9 7,555.1 6,723.9
Income tax expense 2,214.9 2,787.7 1,953.2
Net income 10,116.8 10,342.8 8,677.1
Acquisition of property, plant and equipment 3,365.5 4,062.9 4,645.1
Brazil 1 [Member] | Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total assets 56,974.2 57,353.8 54,609.4
Total liabilities 28,841.3 29,153.2 27,611.2
CAC [member]      
IfrsStatementLineItems [Line Items]      
Net sales 10,044.8 9,440.1 9,947.4
Cost of sales (5,035.1) (4,860.8) (4,727.9)
Gross profit 5,009.7 4,579.3 5,219.5
Distribution expenses (853.1) (1,020.7) (872.7)
Sales and marketing expenses (665.1) (645.5) (693.3)
Administrative expenses (413.0) (333.6) (427.7)
Other operating income/(expenses) 26.3 (52.9) 12.4
Exceptional items (17.9) (16.1) (46.7)
Income from operations 3,086.9 2,510.5 3,191.5
Acquisition of property, plant and equipment 593.4 968.4 801.6
CAC [member] | Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total assets 13,692.3 15,385.6 15,351.9
Total liabilities 4,981.5 5,098.0 5,414.4
South Latin America Segment [Member]      
IfrsStatementLineItems [Line Items]      
Net sales 13,797.2 17,371.2 16,571.7
Cost of sales (6,657.3) (8,553.1) (8,235.7)
Gross profit 7,139.9 8,818.1 8,336.0
Distribution expenses (1,614.3) (2,159.5) (2,010.1)
Sales and marketing expenses (1,190.0) (1,426.9) (1,542.9)
Administrative expenses (659.5) (835.0) (832.0)
Other operating income/(expenses) 95.0 192.7 38.8
Exceptional items (47.6) (60.5) (115.4)
Income from operations 3,723.5 4,528.9 3,874.4
Acquisition of property, plant and equipment 782.2 1,112.8 1,665.4
South Latin America Segment [Member] | Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total assets 16,085.1 22,044.5 21,583.0
Total liabilities 5,095.4 6,843.6 7,843.6
Canada Segment [Member]      
IfrsStatementLineItems [Line Items]      
Net sales 9,533.2 10,261.7 10,748.7
Cost of sales (4,083.1) (4,271.4) (4,387.0)
Gross profit 5,450.1 5,990.3 6,361.7
Distribution expenses (1,854.6) (2,104.0) (1,926.8)
Sales and marketing expenses (1,080.4) (1,200.0) (1,359.0)
Administrative expenses (638.0) (722.2) (611.5)
Other operating income/(expenses) 15.1 12.8 (23.1)
Exceptional items (3.1) (32.2) (20.6)
Income from operations 1,889.1 1,944.7 2,420.7
Acquisition of property, plant and equipment 1,263.0 389.0 565.0
Canada Segment [Member] | Operating segments [member]      
IfrsStatementLineItems [Line Items]      
Total assets 15,856.9 16,093.3 18,016.6
Total liabilities R$ 5,131.0 R$ 5,053.7 R$ 6,156.5
XML 84 R69.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT REPORTING - Additional information (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Net sales R$ 79,736.9 R$ 79,708.8 R$ 72,854.3
Cost of sales (39,291.6) (40,422.1) (35,659.7)
Gross profit 40,445.3 39,286.7 37,194.6
Distribution expenses (10,750.6) (11,395.3) (9,932.7)
Sales and marketing expenses (7,412.5) (7,337.4) (7,035.5)
Administrative expenses (5,273.7) (5,236.8) (4,877.4)
Other operating income/(expenses) 2,028.9 2,513.9 2,124.1
Exceptional items (206.4) (143.3) (392.8)
Income from operations 18,831.0 17,687.8 17,080.3
Net finance costs (3,609.8) (3,423.1) (3,205.4)
Share of results of joint ventures (185.3) (29.1) (115.7)
Income before income tax 15,035.9 14,235.6 13,759.2
Income tax expense (75.5) 655.6 (636.6)
Net income 14,960.4 14,891.2 13,122.6
Brazil 1 [Member]      
IfrsStatementLineItems [Line Items]      
Net sales 46,361.7 42,635.8 35,586.5
Cost of sales (23,516.1) (22,736.8) (18,309.1)
Gross profit 22,845.6 19,899.0 17,277.4
Distribution expenses (6,428.6) (6,111.1) (5,123.1)
Sales and marketing expenses (4,477.0) (4,065.0) (3,440.3)
Administrative expenses (3,563.2) (3,346.0) (3,006.2)
Other operating income/(expenses) 1,892.5 2,361.3 2,096.0
Exceptional items (137.8) (34.5) (210.1)
Income from operations 10,131.5 8,703.7 7,593.7
Net finance costs (2,050.6) (1,110.3) (858.1)
Share of results of joint ventures (179.0) (38.3) (11.7)
Income before income tax 7,901.9 7,555.1 6,723.9
Income tax expense 2,214.9 2,787.7 1,953.2
Net income 10,116.8 10,342.8 8,677.1
Beer [Member] | Brazil 1 [Member]      
IfrsStatementLineItems [Line Items]      
Net sales 38,985.9 35,857.9 30,537.1
Cost of sales (19,377.7) (18,765.3) (15,382.0)
Gross profit 19,608.2 17,092.6 15,155.1
Distribution expenses (5,171.9) (4,988.6) (4,263.1)
Sales and marketing expenses (3,969.4) (3,596.8) (3,096.2)
Administrative expenses (3,106.0) (2,928.8) (2,616.1)
Other operating income/(expenses) 1,474.1 1,884.5 1,711.3
Exceptional items (137.8) (30.6) (202.0)
Income from operations 8,697.2 7,432.3 6,689.0
N A B [Member] | Brazil 1 [Member]      
IfrsStatementLineItems [Line Items]      
Net sales 7,375.8 6,777.9 5,049.4
Cost of sales (4,138.4) (3,971.5) (2,927.1)
Gross profit 3,237.4 2,806.4 2,122.3
Distribution expenses (1,256.7) (1,122.5) (860.0)
Sales and marketing expenses (507.6) (468.2) (344.1)
Administrative expenses (457.2) (417.2) (390.1)
Other operating income/(expenses) 418.4 476.8 384.7
Exceptional items (3.9) (8.1)
Income from operations R$ 1,434.3 R$ 1,271.4 R$ 904.7
XML 85 R70.htm IDEA: XBRL DOCUMENT v3.24.0.1
SEGMENT REPORTING (Details Narrative) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Non-current assets R$ 96,081.2 R$ 100,141.3  
BRAZIL      
IfrsStatementLineItems [Line Items]      
Non-current assets 45,100.0 44,600.0 R$ 42,600.0
CANADA      
IfrsStatementLineItems [Line Items]      
Non-current assets 13,900.0 13,700.0 15,600.0
ARGENTINA      
IfrsStatementLineItems [Line Items]      
Non-current assets 5,900.0 9,700.0 9,100.0
Net revenue R$ 6,300.0 R$ 10,100.0 R$ 9,200.0
XML 86 R71.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET SALES (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Sales      
Gross sales R$ 120,117.7 R$ 125,907.2 R$ 110,162.7
Excise duty (25,227.5) (24,851.4) (22,052.6)
Discounts (15,153.3) (21,347.0) (15,255.8)
Total R$ 79,736.9 R$ 79,708.8 R$ 72,854.3
XML 87 R72.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET SALES (Details Narrative) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Net Sales      
Deduction of revenue R$ 1,467.2 R$ 1,245.8 R$ 1,048.3
XML 88 R73.htm IDEA: XBRL DOCUMENT v3.24.0.1
OTHER OPERATING INCOME/(EXPENSES) (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Other Operating Incomeexpenses      
Government grants/net present value of long-term fiscal incentives R$ 1,573.2 R$ 1,289.3 R$ 853.2
Extemporaneous credits/(debits) (i) 218.0 1,013.9 1,219.0
(Additions)/reversals of provisions (77.7) (77.2) (71.4)
Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates 86.4 88.8 66.1
Other operating income/(expenses), net 229.0 199.1 57.2
Total R$ 2,028.9 R$ 2,513.9 R$ 2,124.1
XML 89 R74.htm IDEA: XBRL DOCUMENT v3.24.0.1
EXCEPTIONAL ITEMS (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Exceptional Items      
Restructuring (i) R$ (109.4) R$ (101.8) R$ (165.4)
COVID-19 impacts (ii) (16.7) (134.3)
Legal fees (iii) (94.7)
Effect of application of IAS 29 (hyperinflation) (2.3) (8.2) (11.1)
Distribution agreement (iv) (82.0)
Write-off of investments (v) (16.6)
Total R$ (206.4) R$ (143.3) R$ (392.8)
XML 90 R75.htm IDEA: XBRL DOCUMENT v3.24.0.1
PAYROLL AND RELATED BENEFITS (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Payroll And Related Benefits      
Wages and salaries R$ 4,550.2 R$ 4,496.1 R$ 4,162.6
Social security contributions 1,322.3 1,239.7 1,016.0
Other personnel costs 970.7 1,075.9 1,076.1
Increase in liabilities for defined benefit plans 145.6 157.8 178.2
Share-based payments 333.4 311.6 391.5
Contributions to defined contribution plans 91.3 82.0 74.1
Total R$ 7,413.5 R$ 7,363.1 R$ 6,898.5
XML 91 R76.htm IDEA: XBRL DOCUMENT v3.24.0.1
PAYROLL AND RELATED BENEFITS (Details 1) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Payroll And Related Benefits      
Cost of sales R$ 2,629.6 R$ 2,510.4 R$ 2,247.9
Distribution expenses 1,289.9 1,396.3 1,286.8
Commercial expenses 1,321.3 1,504.8 1,480.9
Administrative expenses 1,907.6 1,798.7 1,699.1
Net finance costs 114.3 107.8 115.6
Other operating (income)/expenses (1.3) 1.5
Exceptional items 152.1 43.6 68.2
Total R$ 7,413.5 R$ 7,363.1 R$ 6,898.5
XML 92 R77.htm IDEA: XBRL DOCUMENT v3.24.0.1
ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Additional Information On Cost Of Sales And Operating Expenses By Nature      
Cost of sales R$ 3,552.5 R$ 3,413.3 R$ 3,326.6
Amortization of intangible assets cost of sales 13.2 16.4 16.4
Distribution expenses 1,098.3 893.5 654.1
Amortization of intangible assets distribution expenses
Commercial expenses 613.7 660.7 700.3
Amortization of intangible assets commercial expenses 148.6 113.2 84.3
Administrative expenses 464.1 474.4 331.4
Amortization of intangible assets administrative expenses 524.8 372.6 304.2
Total expenses 5,728.6 5,441.9 5,012.4
Total amortisation expenses 686.6 502.2 404.9
Payroll and related benefits 2,629.6 2,510.4 2,247.9
Total payroll and related benefits 6,195.3 5,940.1 5,591.0
Remaining amount of cost of sales R$ 33,096.3 R$ 34,482.0 R$ 30,068.7
XML 93 R78.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET FINANCE RESULT (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Finance expenses      
Interest expense R$ (2,432.2) R$ (2,328.3) R$ (1,431.8)
Net Interest on pension plans (114.3) (107.9) (115.6)
Losses on hedging instruments (1,675.1) (3,158.4) (2,540.2)
Interest on provision for disputes and litigation (269.2) (456.6) (290.0)
Exchange differences (1,154.0) (751.1) (453.9)
Tax on financial transactions (178.3) (339.6) (216.6)
Bank guarantee expenses (249.8) (176.1) (174.9)
Other financial results (207.2) (574.2) (204.8)
Total of finance expenses (6,280.1) (7,892.2) (5,427.8)
Finance income      
Interest income 2,085.6 2,167.7 1,101.6
Interest and foreign exchange rate on loans to/from related parties 119.2 37.1 42.5
Financial instruments at fair value through profit or loss 95.5 77.0
Other financial results 289.4 565.3 78.9
Total 2,494.2 2,865.6 1,300.0
Effect of application of IAS 29 (hyperinflation) 176.1 1,603.5 922.4
Total of finance income 2,670.3 4,469.1 2,222.4
Net finance result R$ (3,609.8) R$ (3,423.1) R$ (3,205.4)
XML 94 R79.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET FINANCE RESULT (Details 1) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Financial instruments measured at amortized cost R$ (644.1) R$ (764.0) R$ (466.0)
Financial instruments at fair value through profit or loss (i) (1,788.1) (1,564.3) (965.8)
Total (2,432.2) (2,328.3) R$ (1,431.8)
Accounts payable present value R$ 1,231.0 R$ 654.0  
XML 95 R80.htm IDEA: XBRL DOCUMENT v3.24.0.1
NET FINANCE RESULT (Details 2) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Cash and cash equivalents R$ 1,072.2 R$ 791.6 R$ 329.5
Investment on debt securities 49.2 175.9 84.7
Other receivables (i) 964.2 1,200.2 687.4
Total R$ 2,085.6 R$ 2,167.7 R$ 1,101.6
XML 96 R81.htm IDEA: XBRL DOCUMENT v3.24.0.1
EARNINGS PER SHARE (Details) - BRL (R$)
R$ / shares in Units, shares in Millions, R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Numerator      
Income attributable to the Ambev equity holders R$ 14,501.9 R$ 14,457.9 R$ 12,671.0
Denominator      
 Weighted average number of shares (i) (non diluted) 15,744.8 15,741.9 15,736.9
 Basic EPS R$ 0.9211 R$ 0.9184 R$ 0.8052
 Weighted average numbers of shares (i) (diluted)  15,838.6 15,848.6 15,857.5
 Diluted EPS R$ 0.9156 R$ 0.9123 R$ 0.7991
XML 97 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details)
12 Months Ended
Dec. 31, 2023
Central America And Caribbean [Member] | Bottom of range [member]  
IfrsStatementLineItems [Line Items]  
Expected nominal rates 15.00%
Central America And Caribbean [Member] | Top of range [member]  
IfrsStatementLineItems [Line Items]  
Expected nominal rates 27.00%
Latin America South [Member] | Bottom of range [member]  
IfrsStatementLineItems [Line Items]  
Expected nominal rates 10.00%
Latin America South [Member] | Top of range [member]  
IfrsStatementLineItems [Line Items]  
Expected nominal rates 35.00%
Country Of Canada [Member]  
IfrsStatementLineItems [Line Items]  
Expected nominal rates 26.50%
Luxembourg [Member]  
IfrsStatementLineItems [Line Items]  
Expected nominal rates 24.94%
XML 98 R83.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details 1) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax And Social Contribution      
Income tax expense – current R$ (2,077.9) R$ (1,718.9) R$ (1,268.6)
Deferred tax expense on temporary differences 279.8 1,012.6 1,072.9
Deferred tax on tax loss carryforward movements in the current period 1,722.6 1,361.9 (440.9)
Total deferred tax (expense)/income 2,002.4 2,374.5 632.0
Total income tax expenses R$ (75.5) R$ 655.6 R$ (636.6)
XML 99 R84.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details 2) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Tax And Social Contribution      
Profit before tax R$ 15,035.9 R$ 14,235.6 R$ 13,759.2
Adjustment on a taxable basis      
Others non-taxable income (919.0) (883.3) (611.0)
Government grants related to sales taxes  (3,011.7) (2,535.1) (1,883.1)
Share of results of joint ventures 185.3 29.1 115.7
Non-deductible expenses 56.5 192.8 99.2
Worldwide taxation 1,171.4 679.3 (360.0)
  R$ 12,518.4 R$ 11,718.4 R$ 11,120.0
Aggregated weighted nominal tax rate 28.30% 29.47% 27.39%
Taxes payable – nominal rate  R$ (3,542.3) R$ (3,453.3) R$ (3,045.3)
Adjustment on tax expense      
Income tax Incentives 120.4 234.0 213.2
Deductible interest on shareholders’ equity 3,909.8 4,079.9 2,516.0
Tax savings from goodwill amortization 17.2 27.2 77.5
Withholding income tax (489.1) (164.5) (876.0)
Recognition/(write-off) of deferred charges on tax losses 100.9 (58.2) (1.5)
Effect of application of IAS 29 (hyperinflation) (382.3) (249.0) (123.3)
Others with reduced taxation 189.9 239.5 602.8
Income tax and social contribution expense R$ (75.5) R$ 655.6 R$ (636.6)
Effective tax rate 0.50% (4.61%) 4.63%
XML 100 R85.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details 3) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets R$ 10,464.3 R$ 9,415.0  
Gross deferred tax liabilities (5,813.1) (6,701.9)  
Gross deferred tax assets/(liabilities) 4,651.2 2,713.1 R$ 1,513.7
Netting by taxable entity, deferred tax assets (2,494.7) (2,976.2)  
Netting by taxable entity, deferred tax liabilities 2,494.7 2,976.2  
Netting by taxable entity, deferred tax assets/(liabilities)  
Net deferred tax assets 7,969.6 6,438.8  
Net deferred tax liabilities (3,318.4) (3,725.7)  
Net deferred tax assets/(liabilities) 4,651.2 2,713.1  
Temporary Differences Investments In Securities [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 8.2 7.5  
Gross deferred tax liabilities  
Gross deferred tax assets/(liabilities) 8.2 7.5  
Temporary Differences Intangibles [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets  
Gross deferred tax liabilities (1,369.7) (1,690.2)  
Gross deferred tax assets/(liabilities) (1,369.7) (1,690.2)  
Temporary Differences Employee Benefits [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 856.5 951.2  
Gross deferred tax liabilities  
Gross deferred tax assets/(liabilities) 856.5 951.2  
Temporary Differences Trade Payables [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 2,843.8 3,232.8  
Gross deferred tax liabilities (3.3) (2.9)  
Gross deferred tax assets/(liabilities) 2,840.5 3,229.9  
Temporary Differences Trade Receivable [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 43.8 38.6  
Gross deferred tax liabilities (7.0) (3.8)  
Gross deferred tax assets/(liabilities) 36.8 34.8  
Temporary Differences Derivatives [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 31.1 95.1  
Gross deferred tax liabilities (77.2) (44.8)  
Gross deferred tax assets/(liabilities) (46.1) 50.3  
Temporary Differences Interestbearing Loans And Borrowings [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 7.5 0.5  
Gross deferred tax liabilities (0.9)  
Gross deferred tax assets/(liabilities) 7.5 (0.4)  
Temporary Differences Inventories [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 268.6 413.9  
Gross deferred tax liabilities (59.6) (139.3)  
Gross deferred tax assets/(liabilities) 209.0 274.6  
Temporary Differences Property Plant And Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 714.2 899.5  
Gross deferred tax liabilities (1,837.2) (2,177.1)  
Gross deferred tax assets/(liabilities) (1,123.0) (1,277.6)  
Temporary Differences Withholding Tax Over Undistributed Profits And Royalties [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets  
Gross deferred tax liabilities (1,385.5) (1,877.6)  
Gross deferred tax assets/(liabilities) (1,385.5) (1,877.6)  
Temporary Differences Investments In Joint Ventures [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets  
Gross deferred tax liabilities (383.7) (421.6)  
Gross deferred tax assets/(liabilities) (383.7) (421.6)  
Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 4,383.3 2,660.7  
Gross deferred tax liabilities  
Gross deferred tax assets/(liabilities) 4,383.3 2,660.7  
Temporary Differences Provisions [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 1,026.3 819.3  
Gross deferred tax liabilities (4.6)  
Gross deferred tax assets/(liabilities) 1,021.7 819.3  
Impact Of Adoption Of I F R S Accounting Policy [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 14.5 35.1  
Gross deferred tax liabilities (19.7) (11.4)  
Gross deferred tax assets/(liabilities) (5.2) 23.7  
I C M S From The Assessment Bases Of P I S C O F I N S [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets  
Gross deferred tax liabilities (228.5) (168.2)  
Gross deferred tax assets/(liabilities) (228.5) (168.2)  
Temporary Differences Other Items [Member]      
IfrsStatementLineItems [Line Items]      
Gross deferred tax assets 266.5 260.8  
Gross deferred tax liabilities (437.1) (164.1)  
Gross deferred tax assets/(liabilities) R$ (170.6) R$ 96.7  
XML 101 R86.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details 4) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses R$ 4,651.2 R$ 2,713.1 R$ 1,513.7
Temporary Differences Investments In Securities [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 8.2 7.5  
Temporary Differences Intangibles [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (1,369.7) (1,690.2)  
Temporary Differences Employee Benefits [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 856.5 951.2  
Temporary Differences Trade Payables [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 2,840.5 3,229.9  
Temporary Differences Trade Receivable [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 36.8 34.8  
Temporary Differences Derivatives [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (46.1) 50.3  
Temporary Differences Interestbearing Loans And Borrowings [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 7.5 (0.4)  
Temporary Differences Inventories [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 209.0 274.6  
Temporary Differences Property Plant And Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (1,123.0) (1,277.6)  
Temporary Differences Withholding Tax Over Undistributed Profits And Royalties [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (1,385.5) (1,877.6)  
Temporary Differences Investments In Joint Ventures [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (383.7) (421.6)  
Temporary Differences Provisions [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 1,021.7 819.3  
Impact Of Adoption Of I F R S Accounting Policy [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (5.2) 23.7  
I C M S From The Assessment Bases Of P I S C O F I N S [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (228.5) (168.2)  
Temporary Differences Other Items [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (170.6) R$ 96.7  
Deferred Taxes Not Related To Tax Losses [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 267.9    
Not later than one year [member] | Temporary Differences Investments In Securities [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses    
Not later than one year [member] | Temporary Differences Intangibles [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (1.2)    
Not later than one year [member] | Temporary Differences Employee Benefits [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 199.9    
Not later than one year [member] | Temporary Differences Trade Payables [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (220.6)    
Not later than one year [member] | Temporary Differences Trade Receivable [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 22.7    
Not later than one year [member] | Temporary Differences Derivatives [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (49.8)    
Not later than one year [member] | Temporary Differences Interestbearing Loans And Borrowings [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 0.1    
Not later than one year [member] | Temporary Differences Inventories [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 252.7    
Not later than one year [member] | Temporary Differences Property Plant And Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (4.1)    
Not later than one year [member] | Temporary Differences Withholding Tax Over Undistributed Profits And Royalties [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses    
Not later than one year [member] | Temporary Differences Investments In Joint Ventures [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses    
Not later than one year [member] | Temporary Differences Provisions [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 664.5    
Not later than one year [member] | Impact Of Adoption Of I F R S Accounting Policy [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses    
Not later than one year [member] | I C M S From The Assessment Bases Of P I S C O F I N S [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses    
Not later than one year [member] | Temporary Differences Other Items [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 39.8    
Not later than one year [member] | Deferred Taxes Not Related To Tax Losses [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 904.0    
Later than one year [member] | Temporary Differences Investments In Securities [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 8.2    
Later than one year [member] | Temporary Differences Intangibles [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (1,368.5)    
Later than one year [member] | Temporary Differences Employee Benefits [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 656.6    
Later than one year [member] | Temporary Differences Trade Payables [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 3,061.1    
Later than one year [member] | Temporary Differences Trade Receivable [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 14.1    
Later than one year [member] | Temporary Differences Derivatives [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 3.7    
Later than one year [member] | Temporary Differences Interestbearing Loans And Borrowings [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 7.4    
Later than one year [member] | Temporary Differences Inventories [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (43.7)    
Later than one year [member] | Temporary Differences Property Plant And Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (1,118.9)    
Later than one year [member] | Temporary Differences Withholding Tax Over Undistributed Profits And Royalties [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (1,385.5)    
Later than one year [member] | Temporary Differences Investments In Joint Ventures [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (383.7)    
Later than one year [member] | Temporary Differences Provisions [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses 357.2    
Later than one year [member] | Impact Of Adoption Of I F R S Accounting Policy [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (5.2)    
Later than one year [member] | I C M S From The Assessment Bases Of P I S C O F I N S [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (228.5)    
Later than one year [member] | Temporary Differences Other Items [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses (210.4)    
Later than one year [member] | Deferred Taxes Not Related To Tax Losses [Member]      
IfrsStatementLineItems [Line Items]      
Deferred taxes not related to tax losses R$ (636.1)    
XML 102 R87.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details 5) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses R$ 4,651.2 R$ 2,713.1 R$ 1,513.7
Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses 4,383.3 R$ 2,660.7  
Not later than one year [member] | Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses    
Later than one year and not later than two years [member] | Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses 755.7    
Later than two years and not later than three years [member] | Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses 422.5    
Later Than Three Years And Not Later Than Fours Years [Member] | Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses 1,635.2    
Later than four years and not later than five years [member] | Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses 1,052.8    
Later Than Five Years And Not Later Than Eight Years [Member] | Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses 170.3    
Later Than Nine Years [Member] | Unused tax losses [member]      
IfrsStatementLineItems [Line Items]      
Deferred tax related to tax losses R$ 346.8    
XML 103 R88.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details 6) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Tax And Social Contribution    
Deferred income tax and social contribution at beginning R$ 2,713.1 R$ 1,513.7
Recognition of actuarial gains/(losses) 24.4 (146.9)
Investment hedge - put option granted on subsidiaries (155.9) (105.0)
Cash flow hedge - gains/(losses) 83.2 41.3
Gains/(losses) on translation of other foreign operations 553.9 (419.3)
Recognized in other comprehensive income 505.6 (629.9)
Recognized in the income statement 2,002.4 2,374.5
Changes directly in the balance sheet (569.9) (545.2)
Recognized in deferred tax (476.3) (595.5)
Effect of application of IAS 29 (hyperinflation) (476.3) (595.5)
Recognized in other balance sheet group (93.6) 50.3
Deferred income tax and social contribution at ending R$ 4,651.2 R$ 2,713.1
XML 104 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
INCOME TAX AND SOCIAL CONTRIBUTION (Details Narrative) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Income Tax And Social Contribution    
Tax loses carried forward of unilaterally offset proceedings R$ 268.6  
Tax loses carried forward of unilaterally offset 790.0  
Tax credit related to tax losses 669.0 R$ 875.3
Tax loses carried forward in relation to credit R$ 2,521.0 R$ 3,359.5
XML 105 R90.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Property, plant and equipment R$ 26,630.2 R$ 30,055.7
Property, plant and equipment [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment 23,662.7 26,961.3
Right-of-use assets [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment R$ 2,967.5 R$ 3,094.4
XML 106 R91.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT (Details 1) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning R$ 30,055.7  
Property, plant and equipment at ending 26,630.2 R$ 30,055.7
Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 26,961.3 26,664.0
Effects of movements in foreign exchange in the balance sheet (3,717.0) (2,371.7)
Effects of application of IAS 29 (hyperinflation) 1,649.2 2,014.7
Acquisition 4,615.2 6,305.7
Depreciation (4,556.6) (4,581.1)
Disposals and write-offs (59.7) (50.4)
Transfers (1,229.7) (1,019.9)
Property, plant and equipment at ending 23,662.7 26,961.3
Property, plant and equipment 63,417.4 66,345.2
Gross carrying amount [member] | Land and buildings [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 9,698.3 9,090.2
Effects of movements in foreign exchange in the balance sheet (1,485.2) (832.1)
Effects of application of IAS 29 (hyperinflation) 663.1 712.7
Acquisition 44.7 11.2
Depreciation (481.6) (436.8)
Disposals and write-offs (3.7) (20.1)
Transfers 800.6 1,173.2
Property, plant and equipment at ending 9,236.2 9,698.3
Property, plant and equipment 14,287.8 14,494.2
Gross carrying amount [member] | Plant And Equipment [Member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 11,589.1 10,884.0
Effects of movements in foreign exchange in the balance sheet (1,726.7) (1,067.3)
Effects of application of IAS 29 (hyperinflation) 779.4 952.6
Acquisition 1,230.2 1,283.5
Depreciation (3,533.4) (3,564.6)
Disposals and write-offs (39.1) (15.7)
Transfers 2,488.8 3,116.6
Property, plant and equipment at ending 10,788.3 11,589.1
Property, plant and equipment 39,509.2 39,818.3
Gross carrying amount [member] | Fixtures and fittings [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 1,323.9 1,285.1
Effects of movements in foreign exchange in the balance sheet (193.4) (111.6)
Effects of application of IAS 29 (hyperinflation) 86.5 96.7
Acquisition 56.4 87.3
Depreciation (541.6) (579.7)
Disposals and write-offs (13.5) (14.6)
Transfers 373.7 560.7
Property, plant and equipment at ending 1,092.0 1,323.9
Property, plant and equipment 7,074.2 7,682.7
Gross carrying amount [member] | Construction in progress [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 4,350.0 5,404.7
Effects of movements in foreign exchange in the balance sheet (311.7) (360.7)
Effects of application of IAS 29 (hyperinflation) 120.2 252.7
Acquisition 3,283.9 4,923.7
Depreciation
Disposals and write-offs (3.4)
Transfers (4,892.8) (5,870.4)
Property, plant and equipment at ending 2,546.2 4,350.0
Property, plant and equipment 2,546.2 4,350.0
Accumulated depreciation, amortisation and impairment [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment (39,754.7) (39,383.9)
Accumulated depreciation, amortisation and impairment [member] | Land and buildings [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment (5,051.6) (4,795.9)
Accumulated depreciation, amortisation and impairment [member] | Plant And Equipment [Member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment (28,720.9) (28,229.2)
Accumulated depreciation, amortisation and impairment [member] | Fixtures and fittings [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment (5,982.2) (6,358.8)
Accumulated depreciation, amortisation and impairment [member] | Construction in progress [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment
XML 107 R92.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT (Details 2) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning R$ 30,055.7  
Property, plant and equipment at ending 26,630.2 R$ 30,055.7
Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 26,961.3 26,664.0
Effects of movements in foreign exchange in the balance sheet (3,717.0) (2,371.7)
Additions 4,615.2 6,305.7
Depreciation (4,556.6) (4,581.1)
Disposals and write-offs (59.7) (50.4)
Transfers (1,229.7) (1,019.9)
Property, plant and equipment at ending 23,662.7 26,961.3
Property, plant and equipment 63,417.4 66,345.2
Gross carrying amount [member] | Right-of-use assets [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 3,094.4 2,560.3
Effects of movements in foreign exchange in the balance sheet (82.2) (72.5)
Additions 1,684.3 1,637.7
Depreciation (1,225.7) (845.5)
Disposals and write-offs (506.0) (184.8)
Transfers 2.7 (0.8)
Property, plant and equipment at ending 2,967.5 3,094.4
Property, plant and equipment 6,460.3 5,587.8
Gross carrying amount [member] | Buildings [member] | Right-of-use assets [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 1,350.8 1,206.0
Effects of movements in foreign exchange in the balance sheet (49.5) (64.3)
Additions 355.0 628.0
Depreciation (451.8) (391.6)
Disposals and write-offs (30.5) 9.7
Transfers (1.8) (37.0)
Property, plant and equipment at ending 1,172.2 1,350.8
Property, plant and equipment 2,925.9 2,698.3
Gross carrying amount [member] | Machinery Vehicles And Others [Member] | Right-of-use assets [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment at beginning 1,743.6 1,354.3
Effects of movements in foreign exchange in the balance sheet (32.7) (8.2)
Additions 1,329.3 1,009.7
Depreciation (773.9) (453.9)
Disposals and write-offs (475.5) (194.5)
Transfers 4.5 36.2
Property, plant and equipment at ending 1,795.3 1,743.6
Property, plant and equipment 3,534.4 2,889.5
Accumulated depreciation, amortisation and impairment [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment (39,754.7) (39,383.9)
Accumulated depreciation, amortisation and impairment [member] | Right-of-use assets [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment (3,492.8) (2,493.4)
Accumulated depreciation, amortisation and impairment [member] | Buildings [member] | Right-of-use assets [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment (1,753.7) (1,347.5)
Accumulated depreciation, amortisation and impairment [member] | Machinery Vehicles And Others [Member] | Right-of-use assets [member]    
IfrsStatementLineItems [Line Items]    
Property, plant and equipment R$ (1,739.1) R$ (1,145.9)
XML 108 R93.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROPERTY, PLANT AND EQUIPMENT (Details 3)
12 Months Ended
Dec. 31, 2023
Buildings [member]  
IfrsStatementLineItems [Line Items]  
Estimated useful lives 25 years
Plant And Equipment [Member]  
IfrsStatementLineItems [Line Items]  
Estimated useful lives 15 years
Fixtures [Member]  
IfrsStatementLineItems [Line Items]  
Estimated useful lives 10 years
Fittings [Member]  
IfrsStatementLineItems [Line Items]  
Estimated useful lives 10 years
External Use Assets Commercial Assets [Member] | Bottom of range [member]  
IfrsStatementLineItems [Line Items]  
Estimated useful lives 2 years
External Use Assets Commercial Assets [Member] | Top of range [member]  
IfrsStatementLineItems [Line Items]  
Estimated useful lives 5 years
XML 109 R94.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Balance at the end of the previous year R$ 40,594.0 R$ 42,411.3
Effects of movements in foreign exchange in the balance sheet (4,067.9) (3,510.6)
Effect of application of IAS 29 (hyperinflation) 1,481.1 1,709.9
Acquisitions, (write-offs) and disposal through business combinations (3.6) (16.6)
Balance at the end of the year R$ 38,003.6 R$ 40,594.0
XML 110 R95.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL (Details 1) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Goodwill R$ 38,003.6 R$ 40,594.0 R$ 42,411.3
Goodwill 102,941.4 102,945.0  
Non-controlling transactions (85,242.6) (85,242.6)  
Country Of Brazil [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 17,698.8 17,702.4  
CAC [member] | Dominican Republic [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 3,805.5 4,231.6  
CAC [member] | Panama [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 1,682.9 1,813.8  
Latin America South [Member] | Argentina [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 2,183.8 3,463.0  
Latin America South [Member] | Bolivia [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 1,712.5 1,845.6  
Latin America South [Member] | Chile [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 47.9 53.1  
Latin America South [Member] | Paraguay [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 888.2 953.8  
Latin America South [Member] | Uruguay [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill 184.0 193.1  
Country Of Canada [Member]      
IfrsStatementLineItems [Line Items]      
Goodwill R$ 9,800.0 R$ 10,337.6  
XML 111 R96.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL (Details Narrative)
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Goodwill percentage of total assets 29.00% 29.00%
XML 112 R97.htm IDEA: XBRL DOCUMENT v3.24.0.1
IMPAIRMENT OF NON-FINANCIAL ASSETS (Details) - Weighted average cost of capital, measurement input [member]
Dec. 31, 2023
Chile [Member]  
IfrsStatementLineItems [Line Items]  
Weighted average cost of capital 9.83%
Panama [Member]  
IfrsStatementLineItems [Line Items]  
Weighted average cost of capital 10.72%
Country Of Brazil [Member]  
IfrsStatementLineItems [Line Items]  
Weighted average cost of capital 12.38%
XML 113 R98.htm IDEA: XBRL DOCUMENT v3.24.0.1
IMPAIRMENT OF NON-FINANCIAL ASSETS (Details Narrative)
12 Months Ended
Dec. 31, 2023
Bottom of range [member]  
IfrsStatementLineItems [Line Items]  
Growth rate 1.20%
Top of range [member]  
IfrsStatementLineItems [Line Items]  
Growth rate 8.10%
XML 114 R99.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Intangible assets, beginning balance R$ 9,222.2  
Intangible assets, final balance 10,041.7 R$ 9,222.2
Gross carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets, beginning balance 9,222.2 8,689.0
Effects of movements in foreign exchange in the balance sheet (2,249.5) (1,367.5)
Effect of application of IAS 29 (hyperinflation) 995.8 1,134.1
Additions 1,467.9 227.4
Transfers 1,293.5 1,041.4
Disposal 1.6
Amortization 686.6 502.2
Intangible assets, final balance 10,041.7 9,222.2
Acquisition cost 16,086.2 15,044.4
Depreciation (6,044.5) (5,822.2)
Amortization (686.6) (502.2)
Disposal (1.6)
Gross carrying amount [member] | Brand names [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets, beginning balance 6,163.1 6,329.0
Effects of movements in foreign exchange in the balance sheet (1,838.5) (1,096.2)
Effect of application of IAS 29 (hyperinflation) 808.6 930.3
Additions 73.9
Transfers
Disposal
Amortization
Intangible assets, final balance 5,207.1 6,163.1
Acquisition cost 5,207.1 6,163.1
Depreciation
Amortization
Disposal
Gross carrying amount [member] | Intangibles [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets, beginning balance 571.7 671.2
Effects of movements in foreign exchange in the balance sheet (33.5) (44.7)
Effect of application of IAS 29 (hyperinflation) 0.1
Additions 869.3
Transfers 3.2
Disposal
Amortization 56.7 58.1
Intangible assets, final balance 1,350.8 571.7
Acquisition cost 4,087.0 3,308.6
Depreciation (2,736.2) (2,736.9)
Amortization (56.7) (58.1)
Disposal
Gross carrying amount [member] | Computer software [member]    
IfrsStatementLineItems [Line Items]    
Intangible assets, beginning balance 2,134.1 1,129.7
Effects of movements in foreign exchange in the balance sheet (344.6) (130.6)
Effect of application of IAS 29 (hyperinflation) 176.2 126.9
Additions 37.0 6.9
Transfers 976.5 1,402.3
Disposal 0.9
Amortization 573.5 401.1
Intangible assets, final balance 2,404.8 2,134.1
Acquisition cost 4,954.2 4,353.9
Depreciation (2,549.4) (2,219.8)
Amortization (573.5) (401.1)
Disposal (0.9)
Gross carrying amount [member] | Others [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets, beginning balance 353.3 559.1
Effects of movements in foreign exchange in the balance sheet (32.9) (96.0)
Effect of application of IAS 29 (hyperinflation) 11.0 76.8
Additions 487.7 220.5
Transfers 317.0 (364.1)
Disposal 0.7
Amortization 56.4 43.0
Intangible assets, final balance 1,079.0 353.3
Acquisition cost 1,837.9 1,218.8
Depreciation (758.9) (865.5)
Amortization (56.4) (43.0)
Disposal R$ (0.7)
XML 115 R100.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLES - Intangible Assets by Location (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life R$ 5,207.1 R$ 6,163.1
Intangible Assets In Argentina [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 1,303.7 2,019.2
Intangible Assets In Bolivia [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 830.0 894.5
Intangible Assets In Brazil [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 73.9
Intangible Assets In Canada [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 195.7 206.4
Intangible Assets In Chile [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 70.7 78.5
Intangible Assets In Luxembourg [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 339.6 339.6
Intangible Assets In Paraguay [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 504.7 542.7
Intangible Assets In The Dominican Republic [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 1,431.5 1,593.0
Intangible Assets In Panama [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life 333.0 358.8
Intangible Assets In Uruaguay [Member]    
IfrsStatementLineItems [Line Items]    
Intangible assets with indefinite useful life R$ 124.3 R$ 130.4
XML 116 R101.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTANGIBLES (Details Narrative)
12 Months Ended
Dec. 31, 2023
Bottom of range [member]  
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]  
Intangible assets useful lives 1 year
Bottom of range [member] | Computer software [member]  
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]  
Intangible assets useful lives 3 years
Top of range [member]  
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]  
Intangible assets useful lives 8 years
Top of range [member] | Computer software [member]  
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]  
Intangible assets useful lives 10 years
XML 117 R102.htm IDEA: XBRL DOCUMENT v3.24.0.1
RECOVERABLE TAXEs (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Non-current R$ 11,325.1 R$ 11,316.3
Current 3,435.7 2,853.5
Total 14,760.8 14,169.8
PIS/COFINS exclusion of ICMS [member]    
IfrsStatementLineItems [Line Items]    
Non-current 6,490.4 5,992.8
Current 219.0 73.5
ICMS [member]    
IfrsStatementLineItems [Line Items]    
Non-current 436.5 423.2
Current 426.9 542.2
Income Tax And Social Contributions Recoverable [Member]    
IfrsStatementLineItems [Line Items]    
Non-current 4,087.0 4,607.5
Current 2,436.6 1,808.7
Other temporary differences [member]    
IfrsStatementLineItems [Line Items]    
Non-current 311.2 292.8
Current 70.3 55.4
Piscofins [Member]    
IfrsStatementLineItems [Line Items]    
Current 170.4 242.7
IPI [member]    
IfrsStatementLineItems [Line Items]    
Current R$ 112.5 R$ 131.0
XML 118 R103.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Finished goods  R$ 2,990.3 R$ 4,094.0
Work in progress 826.5 845.7
Raw materials and consumables 4,599.9 6,798.3
Spare parts and others 806.9 986.9
Prepayments 537.9 358.3
Impairment losses (142.5) (160.2)
Total R$ 9,619.0 R$ 12,923.0
XML 119 R104.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVENTORY (Details 1) - Inventory Provision [Member] - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Beginning balance R$ (160.2) R$ (157.8)
Effects of movements in foreign exchange in the balance sheet 12.9 17.8
Provisions (262.9) (305.8)
Write-off 267.7 285.6
Final balance R$ (142.5) R$ (160.2)
XML 120 R105.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE RECEIVABLES - Current Trade Receivables (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Trade receivables R$ 6,225.8 R$ 5,737.5
Bad debt provision (721.0) (679.1)
Net, trade receivables  5,504.8 5,058.4
Related parties (Note 30) 236.7 290.7
Total current trade receivables  R$ 5,741.5 R$ 5,349.1
XML 121 R106.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Trade receivables R$ 6,225.8 R$ 5,737.5
Bad debt provision (721.0) (679.1)
Trade receivables, net 5,504.8 5,058.4
Current [member]    
IfrsStatementLineItems [Line Items]    
Trade receivables 5,129.5 4,573.0
Bad debt provision
Trade receivables, net 5,129.5 4,573.0
Less Than One Month [Member]    
IfrsStatementLineItems [Line Items]    
Trade receivables 283.4 343.8
Bad debt provision
Trade receivables, net 283.4 343.8
Later than one month and not later than two months [member]    
IfrsStatementLineItems [Line Items]    
Trade receivables 66.3 100.5
Bad debt provision (0.3)
Trade receivables, net 66.3 100.2
Later than two months and not later than three months [member]    
IfrsStatementLineItems [Line Items]    
Trade receivables 33.2 49.4
Bad debt provision (7.7) (10.8)
Trade receivables, net 25.5 38.6
Later Than Three Months And Less Than Six Months [Member]    
IfrsStatementLineItems [Line Items]    
Trade receivables 6.5 19.3
Bad debt provision (6.4) (16.5)
Trade receivables, net 0.1 2.8
Later Than Six Months And Less Than 12 Months [Member]    
IfrsStatementLineItems [Line Items]    
Trade receivables 46.6 40.2
Bad debt provision (46.6) (40.2)
Trade receivables, net
Later Than A Year [Member]    
IfrsStatementLineItems [Line Items]    
Trade receivables 660.3 611.3
Bad debt provision (660.3) (611.3)
Trade receivables, net
XML 122 R107.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details) - Bad Debt Provision [Member] - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Beginning balance R$ (679.1) R$ (668.3)
Effects of movements in foreign exchange in the balance sheet 12.3 14.0
Additions (103.6) (47.0)
Reversals 8.3 1.7
Write-off 41.1 20.5
Final balance R$ (721.0) R$ (679.1)
XML 123 R108.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Short-term bank deposits (i) R$ 8,973.6 R$ 8,655.2
Current bank accounts 6,818.3 5,990.3
Cash 267.1 280.9
Cash and cash equivalents 16,059.0 14,926.4
Bank overdrafts (74.3)
Cash and cash equivalents less bank overdraft R$ 16,059.0 R$ 14,852.1
XML 124 R109.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Investment on debt securities (i) R$ 242.2 R$ 219.1
Non-current investment securities 242.2 219.1
Financial assets at fair value through profit or loss 277.2 454.5
Current investment securities 277.2 454.5
Total R$ 519.4 R$ 673.6
XML 125 R110.htm IDEA: XBRL DOCUMENT v3.24.0.1
CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Details Narrative) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Short-term deposits, guarantee deposits R$ 3,768 R$ 3,083
XML 126 R111.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY - Capital Stock (Details) - BRL (R$)
shares in Millions, R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Number of shares outstanding 15,753.8 15,750.2 15,744.4
Shareholder percentage 100.00% 100.00% 100.00%
Beginning balance, value R$ 83,327.8 R$ 84,017.6 R$ 75,151.2
Issue of equity 14.5 23.7 9.0
Ending balance, value R$ 80,143.8 R$ 83,327.8 R$ 84,017.6
Issued capital [member]      
IfrsStatementLineItems [Line Items]      
Equity shares outstanding, Beginning balance 15,750.2 15,744.4 15,735.1
Beginning balance, value R$ 58,130.5 R$ 58,042.5 R$ 57,899.1
Issue of equity shares 3.6 5.8 9.3
Issue of equity R$ 47.4 R$ 88.0 R$ 143.4
Equity shares outstanding, Final balance 15,753.8 15,750.2 15,744.4
Ending balance, value R$ 58,177.9 R$ 58,130.5 R$ 58,042.5
Interbrew International B.V. [member]      
IfrsStatementLineItems [Line Items]      
Number of shares outstanding 8,441.7 8,441.8 8,441.9
Shareholder percentage 53.60% 53.60% 53.60%
Ambrew S A R L [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares outstanding 1,287.7 1,287.7 1,287.0
Shareholder percentage 8.20% 8.20% 8.20%
Fundacao Zerrenner [member]      
IfrsStatementLineItems [Line Items]      
Number of shares outstanding 1,610.0 1,610.0 1,610.0
Shareholder percentage 10.20% 10.20% 10.20%
Mercado [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares outstanding 4,410.0 4,402.2 4,399.7
Shareholder percentage 28.00% 27.90% 27.90%
Tesouraria [Member]      
IfrsStatementLineItems [Line Items]      
Number of shares outstanding 4.4 8.5 5.8
Shareholder percentage 0.00% 0.10% 0.00%
XML 127 R112.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY - Capital Reserves (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Beginning balance, capital reserves R$ 92,246.6    
Final balance, capital reserves 98,669.4 R$ 92,246.6  
Treasury shares [member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, capital reserves (1,073.4) (1,037.8) R$ (941.7)
Capital Increase (60.0)
Purchases of shares, results of treasury shares and share-based payments 61.6 (35.6) (36.1)
Final balance, capital reserves (1,011.8) (1,073.4) (1,037.8)
Share premium [member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, capital reserves 53,662.8 53,662.8 53,662.8
Capital Increase
Purchases of shares, results of treasury shares and share-based payments
Final balance, capital reserves 53,662.8 53,662.8 53,662.8
Other reserves [member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, capital reserves 700.9 700.9 700.9
Capital Increase
Purchases of shares, results of treasury shares and share-based payments
Final balance, capital reserves 700.9 700.9 700.9
Reserve of share-based payments [member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, capital reserves 2,049.5 1,861.3 1,563.6
Capital Increase (32.9) (64.2) (74.4)
Purchases of shares, results of treasury shares and share-based payments 111.2 252.4 372.1
Final balance, capital reserves 2,127.8 2,049.5 1,861.3
Capital reserve [member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, capital reserves 55,339.8 55,187.2 54,985.6
Capital Increase (32.9) (64.2) (134.4)
Purchases of shares, results of treasury shares and share-based payments 172.8 216.8 336.0
Final balance, capital reserves R$ 55,479.7 R$ 55,339.8 R$ 55,187.2
XML 128 R113.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY - Treasury Shares (Details) - BRL (R$)
shares in Millions, R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Changes In Equity      
Balance, treasury shares acquired/realized (in shares) 8.5 5.8 0.2
Balance, treasury shares acquired/realized, amount R$ (131.8) R$ (98.3) R$ (3.2)
Balance, treasury shares (in shares) (941.6) (939.5) (938.5)
Balance, treasury shares, amount R$ (1,073.4) R$ (1,037.8) R$ (941.7)
Changes during the year, treasury shares acquired/realized (in shares) (4.1) 2.7 5.6
Changes during the year, treasury shares acquired/realized, amount R$ 68.8 R$ (33.5) R$ (95.1)
Changes during the year, treasury shares (in shares) (7.2) (2.1) (1.0)
Changes during the year, treasury shares, amount R$ 61.6 R$ (35.6) R$ (96.1)
Balance, treasury shares acquired/realized (in shares) 4.4 8.5 5.8
Balance, treasury shares acquired/realized, amount R$ (63.0) R$ (131.8) R$ (98.3)
Balance, treasury shares (in shares) (948.8) (941.6) (939.5)
Balance, treasury shares, amount R$ (1,011.8) R$ (1,073.4) R$ (1,037.8)
XML 129 R114.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY - Net Income Reserves (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Beginning balance, value R$ 83,327.8 R$ 84,017.6 R$ 75,151.2
Fiscal incentive reserve
Investments reserve
Ending balance, value 80,143.8 83,327.8 84,017.6
Net Income Reserves Investment Reserve [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value 22,055.9 18,359.2 14,511.1
Fiscal incentive reserve
Investments reserve 3,730.2 3,696.7 3,848.1
Ending balance, value 25,786.1 22,055.9 18,359.2
Net Income Reserves Legal Reserve [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value 4.5 4.5 4.5
Fiscal incentive reserve
Investments reserve  
Ending balance, value 4.5 4.5 4.5
Net Income Reserves Fiscal Incentive [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value 14,846.6 12,827.9 11,404.4
Fiscal incentive reserve 2,552.7 2,018.7 1,423.5
Investments reserve
Ending balance, value 17,399.3 14,846.6 12,827.9
Net Income Reserve [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value 36,907.0 31,191.6 25,920.0
Fiscal incentive reserve 2,552.7 2,018.7 1,423.5
Investments reserve 3,730.2 3,696.7 3,848.1
Ending balance, value R$ 43,189.9 R$ 36,907.0 R$ 31,191.6
XML 130 R115.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details) - BRL (R$)
R$ / shares in Units, R$ in Millions
1 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Changes In Equity                
Amount per share, dividends (in BRL per share) R$ 0.7302   R$ 0.1334          
Amount, distribution           R$ 11,500.2 R$ 11,999.8 R$ 7,400.1
Total amount           R$ 11,500.2 R$ 11,999.8 9,499.6
Amount per share, distribution (in BRL per share)   R$ 0.7623 R$ 0.4702 R$ 0.7302 R$ 0.7623      
Amount, dividends               R$ 2,099.5
XML 131 R116.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY - Basis for Dividends (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Net income, attributable to equity holders of Ambev R$ 14,501.9 R$ 14,457.9 R$ 12,671.0
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Retained earnings [member]      
IfrsStatementLineItems [Line Items]      
Net income, attributable to equity holders of Ambev 14,501.9 14,457.9 12,671.0
Prescribed/(complementary) dividends 20.9 24.7
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting 11.8 11.8 11.8
Effect of application of IAS 29 (hyperinflation) 3,269.4 3,224.4 2,063.7
Retained earnings basis for dividends and destinations 17,783.1 17,715.0 14,771.2
Dividends and interest on capital paid based on profit 11,500.2 11,999.8 9,499.6
Total of dividends and interest on capital  R$ 11,500.2 R$ 11,999.8 R$ 9,499.6
Percentage of distributed profit 65.00% 68.00% 64.00%
XML 132 R117.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY - Carrying Value Adjustments (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Beginning balance, value R$ 83,327.8 R$ 84,017.6 R$ 75,151.2
Gains/(losses) on the translation of foreign operations (9,334.4) (6,863.2) 2,558.0
Cash flow hedges (212.1) (318.7) 481.3
Actuarial gains/(losses) (12.5) 470.7 340.0
Total comprehensive income 5,401.4 8,180.0 16,501.9
Gains/(losses) on controlling interest (2.6) (3.1) (37.6)
Tax on deemed dividends 12.4 6.2 1.7
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Ending balance, value 80,143.8 83,327.8 84,017.6
Carrying Value Adjustments Translation Reserves [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value 6,754.0 13,526.2 11,076.5
Gains/(losses) on the translation of foreign operations (9,212.4) (6,772.2) 2,449.7
Cash flow hedges
Actuarial gains/(losses)
Total comprehensive income (9,212.4) (6,772.2) 2,449.7
Options granted on subsidiaries  
Gains/(losses) on controlling interest
Tax on deemed dividends
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Ending balance, value (2,458.4) 6,754.0 13,526.2
Carrying Value Adjustments Cash Flow Hedge [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value 908.6 1,225.3 744.5
Gains/(losses) on the translation of foreign operations
Cash flow hedges (210.8) (316.7) 480.8
Actuarial gains/(losses)
Total comprehensive income (210.8) (316.7) 480.8
Options granted on subsidiaries  
Gains/(losses) on controlling interest
Tax on deemed dividends
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Ending balance, value 697.8 908.6 1,225.3
Carrying Value Adjustments Actuarial Gainslosses [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value (665.0) (1,131.5) (1,473.3)
Gains/(losses) on the translation of foreign operations
Cash flow hedges
Actuarial gains/(losses) (13.2) 466.5 341.8
Total comprehensive income (13.2) 466.5 341.8
Options granted on subsidiaries  
Gains/(losses) on controlling interest
Tax on deemed dividends
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Ending balance, value (678.2) (665.0) (1,131.5)
Carrying Value Adjustments Put Option Granted On Subsidiary [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value (6.7) (6.7) (4.8)
Gains/(losses) on the translation of foreign operations
Cash flow hedges
Actuarial gains/(losses)
Total comprehensive income
Options granted on subsidiaries 6.7   (1.9)
Gains/(losses) on controlling interest
Tax on deemed dividends
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Ending balance, value (6.7) (6.7)
Carrying Value Adjustments Gains Losses Of Noncontrolling Interests Share [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value (130.7) (121.7) (73.8)
Gains/(losses) on the translation of foreign operations
Cash flow hedges
Actuarial gains/(losses)
Total comprehensive income
Options granted on subsidiaries  
Gains/(losses) on controlling interest (2.6) (2.8) (46.2)
Tax on deemed dividends (12.4) (6.2) (1.7)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Ending balance, value (145.7) (130.7) (121.7)
Carrying Value Adjustments Business Combination [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value 156.1 156.1 156.1
Gains/(losses) on the translation of foreign operations
Cash flow hedges
Actuarial gains/(losses)
Total comprehensive income
Options granted on subsidiaries  
Gains/(losses) on controlling interest
Tax on deemed dividends
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting
Ending balance, value 156.1 156.1 156.1
Carrying Value Adjustments Accounting Adjustments For Transactions Between Shareholders [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value (75,437.8) (75,426.0) (75,414.2)
Gains/(losses) on the translation of foreign operations
Cash flow hedges
Actuarial gains/(losses)
Total comprehensive income
Options granted on subsidiaries  
Gains/(losses) on controlling interest
Tax on deemed dividends
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (118.0) (11.8) (11.8)
Ending balance, value (75,449.6) (75,437.8) (75,426.0)
Carrying Value Adjustments [Member]      
IfrsStatementLineItems [Line Items]      
Beginning balance, value (68,421.5) (61,778.3) (64,989.0)
Gains/(losses) on the translation of foreign operations (9,212.4) (6,772.2) 2,449.7
Cash flow hedges (210.8) (316.7) 480.8
Actuarial gains/(losses) (13.2) 466.5 341.8
Total comprehensive income (9,436.4) (6,622.4) 3,272.3
Gains/(losses) on controlling interest (2.6) (2.8) (46.2)
Tax on deemed dividends 12.4 6.2 1.7
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (11.8) (11.8) (11.8)
Ending balance, value (77,878.0) (68,421.5) (61,778.3)
Carrying Value Adjustment [Member]      
IfrsStatementLineItems [Line Items]      
Gains/(losses) on the translation of foreign operations (9,212.4) (6,772.2) 2,449.7
Cash flow hedges (210.8) (316.7) 480.8
Actuarial gains/(losses) (13.2) 466.5 341.8
Total comprehensive income (9,436.4) (6,622.4) 3,272.3
Options granted on subsidiaries 6.7   (1.9)
Gains/(losses) on controlling interest (2.6) (2.8) (46.2)
Tax on deemed dividends (12.4) (6.2) (1.7)
Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting R$ (11.8) R$ (11.8) R$ (11.8)
XML 133 R118.htm IDEA: XBRL DOCUMENT v3.24.0.1
CHANGES IN EQUITY (Details Narrative) - BRL (R$)
R$ / shares in Units, shares in Millions, R$ in Millions
1 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Nov. 30, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
IfrsStatementLineItems [Line Items]                    
Authorized share capital R$ 83,327.8 R$ 84,017.6 R$ 80,143.8 R$ 83,327.8 R$ 84,017.6   R$ 80,143.8 R$ 83,327.8 R$ 84,017.6 R$ 75,151.2
Number of shares outstanding 15,750.2 15,744.4 15,753.8 15,750.2 15,744.4   15,753.8 15,750.2 15,744.4  
Adjustments for share-based payments             R$ 331.6 R$ 313.9 R$ 387.6  
Investment reserve limit percentage of net income             60.00%      
Statutory reserve limit percentage of net income             5.00%      
Statutory reserve limit of capital stock             20.00%      
Statutory reserve supplementation cutoff percentage related to capital stock             30.00%      
[custom:InterestOnShareholdersEquityDistributionAmountPerShare] R$ 0.7623 R$ 0.4702 R$ 0.7302 R$ 0.7623            
Interest on shareholders equity distribution           R$ 0.3996 R$ 0.6207 R$ 0.6480    
Interest on shareholders equity distribution of dividends         R$ 0.1334          
Interest on shareholders equity distribution of dividends         R$ 0.4702          
Country of domicile [member] | Top of range [member]                    
IfrsStatementLineItems [Line Items]                    
Minimum mandatory dividend             40.00%      
Authorized Share Capital [Member]                    
IfrsStatementLineItems [Line Items]                    
Authorized share capital R$ 58,130.5 R$ 58,042.5 R$ 58,177.9 R$ 58,130.5 R$ 58,042.5   R$ 58,177.9 R$ 58,130.5 R$ 58,042.5  
Number of shares outstanding 15,750.2 15,744.5 15,753.8 15,750.2 15,744.5   15,753.8 15,750.2 15,744.5  
XML 134 R119.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTEREST-BEARING LOANS AND BORROWING (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent R$ 2,203.0 R$ 2,788.1
Interest-bearing loans and borrowings, current 1,298.1 982.6
Secured Bank Loans [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 111.6 126.2
Interest-bearing loans and borrowings, current 14.9 54.5
Other Secured Loans [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 279.4 328.1
Interest-bearing loans and borrowings, current 136.3 144.5
Lease liabilities [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 1,812.0 2,333.8
Interest-bearing loans and borrowings, current 1,146.9 783.6
Total Liabilities [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current R$ 3,501.1 R$ 3,770.7
XML 135 R120.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTEREST-BEARING LOANS AND BORROWING (Details 1) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current R$ 1,298.1 R$ 982.6
Interest-bearing loans and borrowings, noncurrent 2,203.0 2,788.1
Debt Denominated In U S Dollars [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current 0.0 6.2
Interest-bearing loans and borrowings, noncurrent
Debt Denominated In U S Dollars [Member] | Weighted Average [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Average rate 14.00% 14.00%
Debt Denominated In Other Latin American Currencies [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current R$ 124.6 R$ 98.8
Interest-bearing loans and borrowings, noncurrent R$ 281.0 R$ 322.5
Debt Denominated In Other Latin American Currencies [Member] | Weighted Average [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Average rate 11.48% 10.39%
Debt Denominated In C A D Dollars [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current R$ 130.1 R$ 123.3
Interest-bearing loans and borrowings, noncurrent R$ 350.2 R$ 387.7
Debt Denominated In C A D Dollars [Member] | Weighted Average [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Average rate 5.63% 5.32%
Reais Debt [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current R$ 893.7 R$ 597.6
Interest-bearing loans and borrowings, noncurrent 1,180.7 1,624.7
Reais Debt [Member] | Floating interest rate [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current 13.4 12.3
Interest-bearing loans and borrowings, noncurrent R$ 111.6 R$ 125.1
Reais Debt [Member] | Weighted Average [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Average rate 11.17% 9.43%
Reais Debt [Member] | Weighted Average [Member] | Floating interest rate [member]    
IfrsStatementLineItems [Line Items]    
Average rate 9.47% 9.61%
Reais Debt Related To I C M S [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current R$ 103.2 R$ 113.3
Interest-bearing loans and borrowings, noncurrent 194.3 266.4
Reais Debt Related To I C M S [Member] | Floating interest rate [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, current 33.0 31.1
Interest-bearing loans and borrowings, noncurrent R$ 85.1 R$ 61.7
Reais Debt Related To I C M S [Member] | Weighted Average [Member] | Fixed interest rate [member]    
IfrsStatementLineItems [Line Items]    
Average rate 2.95% 2.95%
Reais Debt Related To I C M S [Member] | Weighted Average [Member] | Floating interest rate [member]    
IfrsStatementLineItems [Line Items]    
Average rate 6.56% 6.97%
XML 136 R121.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTEREST-BEARING LOANS AND BORROWING (Details 2) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Balance, non current R$ 2,203.0 R$ 2,788.1
Balance, current 1,298.1 982.6
Balance, non current 2,788.1  
Balance, current 982.6  
Proceeds, non-current 49.8 267.0
Proceeds, current 7.9
Payments, non-current (0.8)
Payments, current (226.6) (230.2)
Foreign exchange, non-current (52.8) (56.8)
Foreign exchange, current (19.6) (17.4)
Transfers between current and non-current (1,238.0) (761.0)
Transfers between current and non-current, current 1,238.0 761.0
New lease agreements, non-current 629.5 905.3
New lease agreements, current 524.4 469.2
Interest on leases 193.1 159.3
Payment of lease liabilities, current (1,373.2) (1,014.0)
Other movements, non-current 27.2 180.1
Other movements, current (20.6) (0.3)
Non Current Liabilities [Member]    
IfrsStatementLineItems [Line Items]    
Balance, non current 2,203.0 2,788.1
Balance, non current 2,788.1 2,253.5
Current Liabilities [Member]    
IfrsStatementLineItems [Line Items]    
Balance, current 1,298.1 982.6
Balance, current R$ 982.6 R$ 847.1
XML 137 R122.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTEREST-BEARING LOANS AND BORROWING (Details 3) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent R$ 2,203.0 R$ 2,788.1
Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 1,298.1  
Later than one year and not later than two years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 648.0  
Later than two years and not later than three years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 603.3  
Later than three years and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 425.5  
Later Than Three Years And Not Later Than Six Years [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 526.1  
Maturity Total [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 3,501.1 3,770.7
Secured Bank Loan [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 126.5 180.7
Secured Bank Loan [Member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 14.9  
Secured Bank Loan [Member] | Later than one year and not later than two years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 14.7  
Secured Bank Loan [Member] | Later than two years and not later than three years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 16.1  
Secured Bank Loan [Member] | Later than three years and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 36.8  
Secured Bank Loan [Member] | Later Than Three Years And Not Later Than Six Years [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 44.0  
Other Secured Loan [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 415.7 472.7
Other Secured Loan [Member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 136.3  
Other Secured Loan [Member] | Later than one year and not later than two years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 151.5  
Other Secured Loan [Member] | Later than two years and not later than three years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 114.8  
Other Secured Loan [Member] | Later than three years and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 3.7  
Other Secured Loan [Member] | Later Than Three Years And Not Later Than Six Years [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 9.3  
Lease Liability [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 2,958.9 R$ 3,117.3
Lease Liability [Member] | Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 1,146.9  
Lease Liability [Member] | Later than one year and not later than two years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 481.8  
Lease Liability [Member] | Later than two years and not later than three years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 472.4  
Lease Liability [Member] | Later than three years and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent 385.0  
Lease Liability [Member] | Later Than Three Years And Not Later Than Six Years [Member]    
IfrsStatementLineItems [Line Items]    
Interest-bearing loans and borrowings, noncurrent R$ 472.8  
XML 138 R123.htm IDEA: XBRL DOCUMENT v3.24.0.1
INTEREST-BEARING LOANS AND BORROWING (Details 4)
Dec. 31, 2023
Lease Term 20232027 [Member]  
IfrsStatementLineItems [Line Items]  
Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16 11.15%
Lease Term 20282035 [Member]  
IfrsStatementLineItems [Line Items]  
Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16 11.48%
XML 139 R124.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Present value of funded obligations R$ (5,365.5) R$ (5,476.5) R$ (7,354.3)
Fair value of plan assets 4,604.6 4,543.3 5,638.0
Present value of net obligations (760.9) (933.2) (1,716.3)
Present value of unfunded obligations (917.2) (921.0) (1,165.4)
Present value of net obligations  (1,678.1) (1,854.2) (2,881.7)
Asset ceiling (182.6) (163.3) (180.1)
Net liabilities (1,860.7) (2,017.5) (3,061.8)
Other long term employee benefits (93.9) (87.1) (104.3)
Total employee benefits (1,954.6) (2,104.6) (3,166.1)
Employee Benefits Assets [Member]      
IfrsStatementLineItems [Line Items]      
Total employee benefits 57.3 56.6 27.9
Employee Benefit Liabilities [Member]      
IfrsStatementLineItems [Line Items]      
Total employee benefits R$ (2,011.9) R$ (2,161.2) R$ (3,194.0)
XML 140 R125.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 1) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Defined benefit obligation at January 1 R$ (2,104.6) R$ (3,166.1)  
Service costs 30.8 47.0 R$ 58.0
Defined benefit obligation at December, 31 (1,954.6) (2,104.6) (3,166.1)
Present value of defined benefit obligation [member]      
IfrsStatementLineItems [Line Items]      
Defined benefit obligation at January 1 (6,397.5) (8,519.7) (8,777.6)
Service costs (30.8) (47.0) (58.0)
Interest costs (413.2) (353.2) (324.3)
Gains and (losses) on settlements or reductions in benefits 9.2 3.8 3.6
Contributions by plan participants (4.2) (5.6) (6.9)
Actuarial gains and (losses) - geographical assumptions 11.5 52.3
Actuarial gains and (losses) - financial assumptions (297.0) 1,333.6 726.8
Experience adjustments 91.2 (171.5) (213.0)
Reclassifications (1.0)
Effect of exchange rate fluctuations 216.7 787.7 (495.3)
Benefits paid 531.4 574.4 573.7
Defined benefit obligation at December, 31 R$ (6,282.7) R$ (6,397.5) R$ (8,519.7)
XML 141 R126.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 2) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Defined benefit obligation at January 1 R$ (2,104.6) R$ (3,166.1)  
Administrative costs 5.2 5.2 R$ 5.8
Defined benefit obligation at December, 31 (1,954.6) (2,104.6) (3,166.1)
Plan assets [member]      
IfrsStatementLineItems [Line Items]      
Defined benefit obligation at January 1 4,543.3 5,638.0 5,533.3
Interest income 318.1 262.1 223.9
Administrative costs (5.2) (5.2) (5.8)
Expected return, excluding interest income 101.7 (614.6) (148.3)
Contributions by employer 280.5 316.0 342.0
Contributions by plan participants 4.6 5.8 7.1
Exchange differences (102.0) (482.6) 263.1
Curtailments, settlements and other (4.8) (1.8) (3.6)
Benefits paid, excluding administrative costs (531.6) (574.4) (573.7)
Defined benefit obligation at December, 31 R$ 4,604.6 R$ 4,543.3 R$ 5,638.0
XML 142 R127.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 3) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Defined benefit obligation at January 1 R$ (2,104.6) R$ (3,166.1)  
Defined benefit obligation at December, 31 (1,954.6) (2,104.6) R$ (3,166.1)
Effect of asset ceiling [member]      
IfrsStatementLineItems [Line Items]      
Defined benefit obligation at January 1 56.6 27.9 33.6
Interest income/(expenses) 4.9 1.3
Change in asset ceiling excluding amounts included in interest income/(expenses) (0.1) 30.2 (9.0)
Effects of exchange rate fluctuations   (4.1) (1.5) 2.0
Defined benefit obligation at December, 31 R$ 57.3 R$ 56.6 R$ 27.9
XML 143 R128.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 4) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Current service costs R$ (30.8) R$ (47.0) R$ (58.0)
Administrative costs (5.2) (5.2) (5.8)
(Gains) losses on settlement and curtailment 4.7 2.2 1.2
Income from operations (31.3) (50.0) (62.6)
Financial costs (114.3) (107.8) (115.6)
Total employee benefit expenses R$ (145.6) R$ (157.8) R$ (178.2)
XML 144 R129.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 5) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
employee benefit revenue/(expenses) R$ (145.6) R$ (157.8) R$ (178.2)
Employee Benefit Revenue Expenses Allocated To Other Operating Incomeexpenses Net [Member]      
IfrsStatementLineItems [Line Items]      
employee benefit revenue/(expenses) (0.1) (0.2)
Employee Benefit Revenueexpenses Allocated To Cost Of Sales [Member]      
IfrsStatementLineItems [Line Items]      
employee benefit revenue/(expenses) (15.1) (26.4) (33.0)
Commercial Expenses [Member]      
IfrsStatementLineItems [Line Items]      
employee benefit revenue/(expenses) (7.3) (9.4) (11.7)
Employee Benefit Revenue Expenses Allocated To Administrative Expenses [Member]      
IfrsStatementLineItems [Line Items]      
employee benefit revenue/(expenses) (8.9) (14.1) (17.7)
Employee Benefit Revenue Expenses Allocated To Financial Expenses [Member]      
IfrsStatementLineItems [Line Items]      
employee benefit revenue/(expenses) R$ (114.3) R$ (107.8) R$ (115.6)
XML 145 R130.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 6)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Discount rate 4.60% 5.10% 2.40%
Inflation 2.00% 2.00% 2.00%
Future salary increases 1.00% 1.00% 1.00%
Future pension increases 2.70% 2.70% 2.50%
Medical cost trend rate 6.40% 6.40% 4.50%
Life expectancy for an over 65 years old male 84 years 84 years 85 years
Life expectancy for an over 65 years old female 86 years 86 years 87 years
Top of range [member]      
IfrsStatementLineItems [Line Items]      
Discount rate 11.70% 11.00% 10.00%
Inflation 3.50% 3.50% 3.50%
Future salary increases 7.10% 7.10% 7.10%
Future pension increases 3.80% 3.80% 3.80%
Medical cost trend rate 7.10% 7.10% 6.90%
Life expectancy for an over 65 years old male 87 years 87 years 87 years
Life expectancy for an over 65 years old female 89 years 89 years 89 years
Weighted Average [Member]      
IfrsStatementLineItems [Line Items]      
Dental claims trend rate 3.50% 3.50% 3.30%
XML 146 R131.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 7) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Actuarial assumption of medical cost trend rates [member]      
IfrsStatementLineItems [Line Items]      
Increase in assumption R$ (95.2) R$ (94.3) R$ (114.7)
Decrease in assumption 82.2 81.8 98.6
Actuarial assumption of discount rates [member]      
IfrsStatementLineItems [Line Items]      
Increase in assumption 284.8 307.9 442.0
Decrease in assumption (302.4) (328.0) (470.3)
Actuarial assumption of expected rates of salary increases [member]      
IfrsStatementLineItems [Line Items]      
Increase in assumption (17.3) (17.6) (19.8)
Decrease in assumption 14.7 16.5 18.6
Actuarial assumption of life expectancy after retirement [member]      
IfrsStatementLineItems [Line Items]      
Increase in assumption (201.0) (221.5) (287.6)
Decrease in assumption R$ 196.1 R$ 213.5 R$ 279.5
XML 147 R132.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details 8)
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Plan Assets Government Bonds [Member]      
IfrsStatementLineItems [Line Items]      
Plan assets percentage, rated 43.00% 43.00% 43.00%
Plan assets percentage, unrated
Plan assets percentage 43.00% 43.00% 43.00%
Plan Assets Corporate Bonds [Member]      
IfrsStatementLineItems [Line Items]      
Plan assets percentage, rated 10.00% 10.00% 10.00%
Plan assets percentage, unrated
Plan assets percentage 10.00% 10.00% 10.00%
Plan Assets Equity Instruments [Member]      
IfrsStatementLineItems [Line Items]      
Plan assets percentage, rated 15.00% 15.00% 15.00%
Plan assets percentage, unrated
Plan assets percentage 15.00% 15.00% 15.00%
Plan Assets Cash [Member]      
IfrsStatementLineItems [Line Items]      
Plan assets percentage, rated 6.00% 6.00% 6.00%
Plan assets percentage, unrated
Plan assets percentage 6.00% 6.00% 6.00%
Plan Assets Others [Member]      
IfrsStatementLineItems [Line Items]      
Plan assets percentage, rated 26.00% 26.00% 26.00%
Plan assets percentage, unrated
Plan assets percentage 26.00% 26.00% 26.00%
XML 148 R133.htm IDEA: XBRL DOCUMENT v3.24.0.1
EMPLOYEE BENEFITS (Details Narrative) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Post-employment benefit expense, defined contribution plans R$ 91.3 R$ 82.0 R$ 74.1
Defined benefit obligation, at present value 1,678.1 1,854.2 2,881.7
Plan assets gain/(loss) 419.7 (352.5) 75.5
Amount up to the asset ceiling not exceeding the present value of future benefits in a defined benefit plan 57.3 56.6 27.9
Estimate Of Contributions Expected To Be Paid To Plan 231.5    
Two Health Care Plans From Fundacao Zerrenner [Member]      
IfrsStatementLineItems [Line Items]      
Defined benefit obligation, at present value R$ 633.3 R$ 665.4 R$ 603.9
XML 149 R134.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED PAYMENTS (Details) - Restricted Shares [Member]
shares in Thousands, Pure in Thousands
12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2022
shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]      
Restricted shares outstanding at January 108,854 62,545 43,458
New restricted and performance shares during the period 33,686 49,328 20,629
Restricted and performance shares granted during the period (18,309) (12) (22)
Restricted and performance shares forfeited during the period (5,235) (3,007) (1,520)
Restricted shares outstanding at rhe end of the year 118,996 108,854 62,545
XML 150 R135.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED PAYMENTS (Details 1) - shares
shares in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Options outstanding at January 1 99,717 113,760 127,265
Options exercised during the period     (5,247)
Options forfeited during the period (11,756) (14,043) (8,258)
Options outstanding at the end of the year 87,961 99,717 113,760
XML 151 R136.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED PAYMENTS (Details 2) - R$ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Options outstanding at January 1, weighted average exercise price (in BRL per share) R$ 19.39 R$ 19.92 R$ 19.81
Options forfeited during the period, weighted average exercise price (in BRL per share) 22.68 22.60 25.27
Options exercised during the period, weighted average exercise price (in BRL per share)     13.16
Options outstanding at ended period, weighted average exercise price (in BRL per share) 18.86 19.39 19.92
Options exercisable at ended period, weighted average exercise price (in BRL per share) R$ 19.08 R$ 20.12 R$ 21.14
XML 152 R137.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED PAYMENTS (Details 3) - Deferred Shares [Member]
shares in Thousands, Pure in Thousands
12 Months Ended
Dec. 31, 2023
shares
Dec. 31, 2022
shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]      
Restricted shares outstanding at January 889 1,168 6,065
New deferred shares during the period 47 44 110
Deferred shares granted during the period   (214) (4,964)
Deferred shares forfeited during the period   (109) (43)
Restricted shares outstanding at rhe end of the year 936 889 1,168
XML 153 R138.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED PAYMENTS (Details Narrative)
R$ / shares in Units, shares in Thousands, Pure in Thousands, R$ in Millions
12 Months Ended
Dec. 31, 2023
BRL (R$)
shares
R$ / shares
Dec. 31, 2022
BRL (R$)
shares
R$ / shares
Dec. 31, 2021
BRL (R$)
shares
R$ / shares
IfrsStatementLineItems [Line Items]      
Weighted average remaining contractual life of outstanding share options (Year) 3 years 7 months 6 days 4 years 3 months 14 days 6 years 8 months 12 days
Number of share options outstanding in share-based payment arrangement at end of period | shares 87,961 99,717 113,760
Number of share options vested in share-based payment arrangement | shares 68,635 63,850 59,250
Expense from share-based payment transactions with employees R$ 333.4 R$ 311.6 R$ 391.5
Bottom of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise prices of the outstanding options | R$ / shares R$ 15.95 R$ 15.95 R$ 15.95
Top of range [member]      
IfrsStatementLineItems [Line Items]      
Exercise prices of the outstanding options | R$ / shares R$ 32.81 R$ 39.04 R$ 45.97
Restricted Shares [Member]      
IfrsStatementLineItems [Line Items]      
Restricted shares granted 33,686 49,328 20,629
Fair value, granted R$ 463.5 R$ 766.6 R$ 325.7
Deferred Stock Units Of Grant One [Member]      
IfrsStatementLineItems [Line Items]      
Fair value, granted R$ 0.6 R$ 0.6 R$ 1.7
Deferred shares 47 44 110
XML 154 R139.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE PAYABLES (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Trade Payables    
Trade payables R$ 107.4 R$ 165.8
Related parties (Note 30) 199.9 343.6
Non-current 307.3 509.4
Trade payables 21,278.6 23,498.1
Related parties (Note 30) 1,916.5 830.4
Current 23,195.1 24,328.5
Total R$ 23,502.4 R$ 24,837.9
XML 155 R140.htm IDEA: XBRL DOCUMENT v3.24.0.1
TRADE PAYABLES (Details Narrative) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Trade payable R$ 159.0 R$ 219.3
Trade payable [member]    
IfrsStatementLineItems [Line Items]    
present value adjustment recorded for trades payables R$ 308.0 R$ 367.0
XML 156 R141.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Provision at beginning R$ 919.7 R$ 776.1
Effect of changes in foreign exchange rates (45.4) (32.2)
Additions 696.9 724.6
Provision used, other provisions (382.9) (455.2)
Provisions reversed (210.3) (93.6)
Provision at ending 978.0 919.7
Provision for taxes other than income tax [member]    
IfrsStatementLineItems [Line Items]    
Provision at beginning 247.1 218.6
Effect of changes in foreign exchange rates
Additions 135.7 157.6
Provision used, other provisions (27.3) (85.8)
Provisions reversed (73.2) (43.3)
Provision at ending 282.3 247.1
Provisions For Labor [Member]    
IfrsStatementLineItems [Line Items]    
Provision at beginning 132.1 124.2
Effect of changes in foreign exchange rates (2.8) (4.6)
Additions 247.8 194.2
Provision used, other provisions (181.7) (162.0)
Provisions reversed (45.5) (19.7)
Provision at ending 149.9 132.1
Legal proceedings provision [member]    
IfrsStatementLineItems [Line Items]    
Provision at beginning 335.9 252.9
Effect of changes in foreign exchange rates (35.8) (17.5)
Additions 234.5 312.7
Provision used, other provisions (121.9) (196.6)
Provisions reversed (72.5) (15.6)
Provision at ending 340.2 335.9
Miscellaneous other provisions [member]    
IfrsStatementLineItems [Line Items]    
Provision at beginning 192.8 163.0
Effect of changes in foreign exchange rates (6.3) (8.1)
Additions 75.7 60.1
Provision used, other provisions (40.8) (7.2)
Provisions reversed (19.1) (15.0)
Provision at ending 202.3 192.8
Restructuring provision [member]    
IfrsStatementLineItems [Line Items]    
Provision at beginning 11.8 17.4
Effect of changes in foreign exchange rates (0.5) (2.0)
Additions 3.2
Provision used, other provisions (11.2) (3.6)
Provisions reversed
Provision at ending R$ 3.3 R$ 11.8
XML 157 R142.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Non-current provisions R$ 559.6 R$ 739.0  
Current provisions 418.4 180.7  
Total provisions 978.0 919.7 R$ 776.1
Provision for taxes other than income tax [member]      
IfrsStatementLineItems [Line Items]      
Non-current provisions 168.6 193.8  
Current provisions 113.7 53.3  
Total provisions 282.3 247.1 218.6
Provisions For Labor [Member]      
IfrsStatementLineItems [Line Items]      
Non-current provisions 82.7 104.9  
Current provisions 67.2 27.2  
Total provisions 149.9 132.1 124.2
Legal proceedings provision [member]      
IfrsStatementLineItems [Line Items]      
Non-current provisions 113.4 263.0  
Current provisions 226.8 72.9  
Total provisions 340.2 335.9 252.9
Miscellaneous other provisions [member]      
IfrsStatementLineItems [Line Items]      
Non-current provisions 194.9 170.1  
Current provisions 7.4 22.7  
Total provisions 202.3 192.8 163.0
Total Contingent Provisions [Member]      
IfrsStatementLineItems [Line Items]      
Non-current provisions 559.6 731.8  
Current provisions 415.1 176.1  
Total provisions 974.7 907.9  
Restructuring provision [member]      
IfrsStatementLineItems [Line Items]      
Non-current provisions 7.2  
Current provisions 3.3 4.6  
Total provisions R$ 3.3 R$ 11.8 R$ 17.4
XML 158 R143.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Estimates of amounts of possible losses R$ 95,557.6 R$ 91,560.7
Income Tax And Social Contribution [Member]    
IfrsStatementLineItems [Line Items]    
Estimates of amounts of possible losses 63,621.0 60,453.5
Value Added And Excise Taxes [Member]    
IfrsStatementLineItems [Line Items]    
Estimates of amounts of possible losses 26,761.0 25,904.6
PIS and COFINS [member]    
IfrsStatementLineItems [Line Items]    
Estimates of amounts of possible losses 3,496.2 3,293.5
Other contingent liabilities [member]    
IfrsStatementLineItems [Line Items]    
Estimates of amounts of possible losses R$ 1,679.4 R$ 1,909.1
XML 159 R144.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Financial asset R$ 24,524.8 R$ 23,590.9
Financial liability 32,959.9 34,747.6
Financial liabilities at amortised cost, category [member]    
IfrsStatementLineItems [Line Items]    
Financial liability 29,133.1 30,624.2
Financial liabilities at amortised cost, category [member] | Trade payable [member]    
IfrsStatementLineItems [Line Items]    
Financial liability 23,502.4 24,837.9
Financial liabilities at amortised cost, category [member] | Interest-bearing loans and borrowings [member]    
IfrsStatementLineItems [Line Items]    
Financial liability 3,501.1 3,770.7
Financial liabilities at amortised cost, category [member] | Other Liabilities 1 [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability 2,129.6 2,015.6
Financial liabilities at fair value through profit or loss, category [member]    
IfrsStatementLineItems [Line Items]    
Financial liability 3,826.8 4,123.4
Financial liabilities at fair value through profit or loss, category [member] | Other Liabilities 1 [Member]    
IfrsStatementLineItems [Line Items]    
Financial liability 272.6 333.7
Financial liabilities at fair value through profit or loss, category [member] | Put option granted on subsidiary [member]    
IfrsStatementLineItems [Line Items]    
Financial liability 2,791.1 3,060.3
Financial liabilities at fair value through profit or loss, category [member] | Derivative hedge [member]    
IfrsStatementLineItems [Line Items]    
Financial liability 763.1 729.4
Financial assets at amortised cost, category [member]    
IfrsStatementLineItems [Line Items]    
Financial asset 23,867.9 22,862.6
Financial assets at amortised cost, category [member] | Financial asset, cash and cash equivalents [member]    
IfrsStatementLineItems [Line Items]    
Financial asset 16,059.0 14,852.1
Financial assets at amortised cost, category [member] | Trade receivables [member]    
IfrsStatementLineItems [Line Items]    
Financial asset 7,566.7 7,791.4
Financial assets at amortised cost, category [member] | Financial asset, investment securities [member]    
IfrsStatementLineItems [Line Items]    
Financial asset 242.2 219.1
Financial assets at fair value through profit or loss, category [member]    
IfrsStatementLineItems [Line Items]    
Financial asset 656.9 728.3
Financial assets at fair value through profit or loss, category [member] | Financial asset, investment securities [member]    
IfrsStatementLineItems [Line Items]    
Financial asset 277.2 454.5
Financial assets at fair value through profit or loss, category [member] | Derivative hedge [member]    
IfrsStatementLineItems [Line Items]    
Financial asset R$ 379.7 R$ 273.8
XML 160 R145.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 1) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Total cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional R$ 17,374.2 R$ 19,853.3
Fair Value Assets 379.5 271.8
Fair Value Liability (742.0) (719.4)
Gain (loss) Finance Result (1,639.6) (3,075.2)
Gain (loss) Operational Result 34.6 452.7
Gain (loss) Equity (285.2) 134.3
Commodities risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 4,025.7 4,809.9
Fair Value Assets 198.3 100.8
Fair Value Liability (219.4) (376.0)
Gain (loss) Finance Result (388.3) 63.5
Gain (loss) Operational Result (336.2) (32.3)
Gain (loss) Equity (105.4) (475.0)
US Dollars risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 13,200.0 14,874.7
Fair Value Assets 164.9 157.7
Fair Value Liability (522.4) (342.9)
Gain (loss) Finance Result (1,250.7) (3,139.2)
Gain (loss) Operational Result 363.9 477.1
Gain (loss) Equity (182.1) 596.6
Euros risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 37.4 32.2
Fair Value Assets 0.1 1.9
Fair Value Liability (0.2)
Gain (loss) Finance Result (0.5) (0.7)
Gain (loss) Operational Result 2.6 (0.3)
Gain (loss) Equity 0.5 1.2
Mexican Pesos risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 111.1 136.5
Fair Value Assets 16.2 11.4
Fair Value Liability (0.5)
Gain (loss) Finance Result (0.1) 1.2
Gain (loss) Operational Result 4.3 8.2
Gain (loss) Equity 1.8 11.5
Total fixed asset exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 249.7 226.8
Fair Value Assets 0.1 1.5
Fair Value Liability (14.6) (5.4)
Gain (loss) Finance Result 11.0 (5.9)
Gain (loss) Operational Result 3.4 4.9
Gain (loss) Equity 5.0 (13.0)
US Dollars risk portion of fixed assets exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 249.7 226.8
Fair Value Assets 0.1 1.5
Fair Value Liability (14.6) (5.4)
Gain (loss) Finance Result 11.0 (5.9)
Gain (loss) Operational Result 3.4 4.9
Gain (loss) Equity 5.0 (13.0)
Total expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 64.7 204.9
Fair Value Assets 0.1 0.5
Fair Value Liability (4.2) (4.6)
Gain (loss) Finance Result (25.6) (42.5)
Gain (loss) Operational Result (0.1) 9.1
Gain (loss) Equity 1.1 (14.8)
US Dollars risk portion of the expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 64.7 204.9
Fair Value Assets 0.1 0.5
Fair Value Liability (4.2) (4.6)
Gain (loss) Finance Result (25.6) (42.5)
Gain (loss) Operational Result (0.1) 9.1
Gain (loss) Equity 1.1 (14.8)
Total Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional (59.3)
Fair Value Assets
Fair Value Liability (2.3)
Gain (loss) Operational Result
Gain (loss) Equity
Cash U [Member]    
IfrsStatementLineItems [Line Items]    
Gain (loss) Finance Result 13.7 (17.1)
U S Dollars Risk Portion Of The Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional (59.3)
Fair Value Assets
Gain (loss) Operational Result
Gain (loss) Equity
U S Dollars Risk Portion Of Th Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Fair Value Liability (2.3)
U S Dollars Cash [Member]    
IfrsStatementLineItems [Line Items]    
Gain (loss) Finance Result 13.7 (17.1)
Total financial risk exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional 17,629.3 20,285.0
Fair Value Assets 379.7 273.8
Fair Value Liability (763.1) (729.4)
Gain (loss) Finance Result (1,640.5) (3,140.7)
Gain (loss) Operational Result 37.9 466.7
Gain (loss) Equity R$ (279.1) R$ 106.5
XML 161 R146.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 2) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Fair Value R$ 656.9 R$ 728.3
Total cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 17,374.2  
Fair Value (362.5)  
Commodities risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 4,025.7  
Fair Value (21.1)  
US Dollars risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 13,200.0  
Fair Value (357.5)  
Euros risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 37.4  
Fair Value (0.1)  
Mexican Pesos risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 111.1  
Fair Value 16.2  
Total fixed asset exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 249.7  
Fair Value (14.5)  
US Dollars risk portion of fixed assets exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 249.7  
Fair Value (14.5)  
Total expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 64.7  
Fair Value (4.1)  
US Dollars risk portion of the expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 64.7  
Fair Value (4.1)  
Total Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value (59.3)  
Fair Value (2.3)  
U S Dollars Risk Portion Of The Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value (59.3)  
Fair Value (2.3)  
Total financial risk exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 17,629.3  
Fair Value (383.4)  
Later than one year and not later than two years [member] | Total cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 16,763.3  
Fair Value (352.5)  
Later than one year and not later than two years [member] | Commodities risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 3,924.3  
Fair Value (14.2)  
Later than one year and not later than two years [member] | US Dollars risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 12,690.5  
Fair Value (354.4)  
Later than one year and not later than two years [member] | Euros risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 37.4  
Fair Value (0.1)  
Later than one year and not later than two years [member] | Mexican Pesos risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 111.1  
Fair Value 16.2  
Later than one year and not later than two years [member] | Total fixed asset exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 249.7  
Fair Value (14.5)  
Later than one year and not later than two years [member] | US Dollars risk portion of fixed assets exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 249.7  
Fair Value (14.5)  
Later than one year and not later than two years [member] | Total expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 64.7  
Fair Value (4.1)  
Later than one year and not later than two years [member] | US Dollars risk portion of the expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 64.7  
Fair Value (4.1)  
Later than one year and not later than two years [member] | Total Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value (59.3)  
Fair Value (2.3)  
Later than one year and not later than two years [member] | U S Dollars Risk Portion Of The Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value (59.3)  
Fair Value (2.3)  
Later than one year and not later than two years [member] | Total financial risk exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 17,018.4  
Fair Value (373.4)  
Later than two years and not later than three years [member] | Total cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 610.9  
Fair Value (10.0)  
Later than two years and not later than three years [member] | Commodities risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 101.4  
Fair Value (6.9)  
Later than two years and not later than three years [member] | US Dollars risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 509.5  
Fair Value (3.1)  
Later than two years and not later than three years [member] | Euros risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | Mexican Pesos risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | Total fixed asset exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | US Dollars risk portion of fixed assets exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | Total expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | US Dollars risk portion of the expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | Total Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | U S Dollars Risk Portion Of The Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than two years and not later than three years [member] | Total financial risk exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value 610.9  
Fair Value (10.0)  
Later than three years and not later than four years [member] | Total cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | Commodities risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | US Dollars risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | Euros risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | Mexican Pesos risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | Total fixed asset exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | US Dollars risk portion of fixed assets exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | Total expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | US Dollars risk portion of the expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | Total Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | U S Dollars Risk Portion Of The Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than three years and not later than four years [member] | Total financial risk exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Total cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Commodities risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | US Dollars risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Euros risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Mexican Pesos risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Total fixed asset exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | US Dollars risk portion of fixed assets exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Total expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | US Dollars risk portion of the expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Total Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | U S Dollars Risk Portion Of The Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than four years and not later than five years [member] | Total financial risk exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Total cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Commodities risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | US Dollars risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Euros risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Mexican Pesos risk portion of cost exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Total fixed asset exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | US Dollars risk portion of fixed assets exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Total expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | US Dollars risk portion of the expenses exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Total Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | U S Dollars Risk Portion Of The Cash Exposure [Member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
Later than five years [member] | Total financial risk exposure [member]    
IfrsStatementLineItems [Line Items]    
Notional value  
Fair Value  
XML 162 R147.htm IDEA: XBRL DOCUMENT v3.24.0.1
PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details Narrative) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Uncertainty Over The Treatment Of Income Taxes [Member]    
IfrsStatementLineItems [Line Items]    
Reduction of issued capital R$ 27,439.0 R$ 13,846.0
Disallowance of tax paid abroad 14,302.0 12,596.0
Disallowance of tax paid abroad 6,505.0 11,122.0
Disallowance of tax paid abroad 6,075.0 7,280.0
Disallowance of tax paid abroad 2,618.0 2,334.0
Goodwill BAH 1,412.0 2,218.0
Goodwill BAH 1,372.0 1,257.0
Goodwill BAH 633.4 581.5
Goodwill BAH 316.0 5,200.0
Goodwill BAH 278.0 251.0
Tax Loss Offset 187.0 548.0
Tax Loss Offset 1,690.0
Icmsst Trigger [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 10,669.0 9,292.0
Manaus Free Trade Zone [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 6,307.0 5,825.0
I P I Suspension [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 1,824.0 1,703.0
Social Contributions Over Products [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 1,776.0 1,559.0
I C M S Z F M [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 804.4 730.3
I C M S Prodepe [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 739.4 663.9
I C M S F A I N [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 647.4 591.4
I C M S A M [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 605.8 561.5
I C M S Fiscal War [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 530.0 1,690.0
I C M S M I P [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass 447.5 388.7
Proposed Class Action In Quebec [Member]    
IfrsStatementLineItems [Line Items]    
Total updated amount of possible risk/loass
XML 163 R148.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 3) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Investment securities R$ 277.2 R$ 454.5
Derivatives – operational hedge 379.7 273.8
 Total 656.9 728.3
Put options granted on subsidiaries 2,791.1 3,060.3
Other liabilities 272.6 333.7
Derivatives liabilities at fair value through profit and loss 2.3
Derivatives – operational hedge 760.8 729.4
 Total 3,826.8 4,123.4
Level 1 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Investment securities 277.2 454.5
Derivatives – operational hedge 53.4 57.0
 Total 330.6 511.5
Put options granted on subsidiaries
Other liabilities
Derivatives liabilities at fair value through profit and loss 2.3
Derivatives – operational hedge 70.0 76.1
 Total 72.3 76.1
Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Investment securities
Derivatives – operational hedge 326.3 216.8
 Total 326.3 216.8
Put options granted on subsidiaries
Other liabilities
Derivatives liabilities at fair value through profit and loss
Derivatives – operational hedge 690.8 653.3
 Total 690.8 653.3
Level 3 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Investment securities
Derivatives – operational hedge
 Total
Put options granted on subsidiaries 2,791.1 3,060.3
Other liabilities 272.6 333.7
Derivatives liabilities at fair value through profit and loss
Derivatives – operational hedge
 Total R$ 3,063.7 R$ 3,394.0
XML 164 R149.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 4)
R$ in Millions
12 Months Ended
Dec. 31, 2023
BRL (R$)
IfrsStatementLineItems [Line Items]  
Financial liabilities balance R$ 34,747.6
Financial liabilities balance 32,959.9
Level 3 of fair value hierarchy [member]  
IfrsStatementLineItems [Line Items]  
Financial liabilities balance 3,394.0
Acquisition of investments (64.2)
Level reclassification (6.6)
Total gains and losses during the period (259.5)
Losses/(gains) recognized in net income (269.9)
Losses/(gains) recognized in equity 10.4
Financial liabilities balance R$ 3,063.7
XML 165 R150.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 5) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Interest Rate Risk Brazilian Reais [Member]    
IfrsStatementLineItems [Line Items]    
Pre-hedge, post-fixed interest rate 8.10% 8.50%
Pre-hedge, post-fixed interest rate, amount R$ 243.2 R$ 230.1
Pre-hedge, pre-fixed interest rate 10.10% 8.50%
Pre-hedge, pre-fixed interest rate, amount R$ 2,372.0 R$ 2,602.1
Interest rate risk [member]    
IfrsStatementLineItems [Line Items]    
Pre-hedge, post-fixed interest rate, amount 243.2 230.1
Pre-hedge, pre-fixed interest rate, amount R$ 3,257.9 R$ 3,614.9
Interest rate risk, working capital in Argentinean Peso [member]    
IfrsStatementLineItems [Line Items]    
Pre-hedge, pre-fixed interest rate 0.00% 73.50%
Pre-hedge, pre-fixed interest rate, amount R$ 74.3
Other currencies [member]    
IfrsStatementLineItems [Line Items]    
Pre-hedge, pre-fixed interest rate 11.50% 10.40%
Pre-hedge, pre-fixed interest rate, amount R$ 405.6 R$ 421.3
Interest rate risk, US Dollars [member]    
IfrsStatementLineItems [Line Items]    
Pre-hedge, pre-fixed interest rate 14.00% 14.00%
Pre-hedge, pre-fixed interest rate, amount R$ 6.2
Interest rate risk, Canadian Dollars [member]    
IfrsStatementLineItems [Line Items]    
Pre-hedge, pre-fixed interest rate 5.60% 5.30%
Pre-hedge, pre-fixed interest rate, amount R$ 480.3 R$ 511.0
XML 166 R151.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 6)
R$ in Millions
12 Months Ended
Dec. 31, 2023
BRL (R$)
IfrsStatementLineItems [Line Items]  
Sensitivity value level, probable scenario R$ (63.8)
Sensitivity value level, adverse scenario (373.0)
Sensitivity value level, remote scenario (745.9)
Commodities Hedge [Member] | Commodities risk portion of cost exposure [member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments (21.1)
Sensitivity value level, probable scenario 94.6
Sensitivity value level, adverse scenario 985.4
Sensitivity value level, remote scenario 1,991.9
Commodities Hedge [Member] | Input Purchases Affecting The Commodity Risk Portion Of Cost Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments 21.1
Sensitivity value level, probable scenario (94.6)
Sensitivity value level, adverse scenario (985.4)
Sensitivity value level, remote scenario (1,991.9)
Foreign Currency Exchange Hedge [Member] | Input Purchases Affecting The Commodity Risk Portion Of Cost Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments 341.4
Sensitivity value level, probable scenario 104.9
Sensitivity value level, adverse scenario (3,336.8)
Sensitivity value level, remote scenario (7,014.9)
Foreign Currency Exchange Hedge [Member] | Foreign Exchange Risk Portion Of Cost Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments (341.4)
Sensitivity value level, probable scenario (163.3)
Sensitivity value level, adverse scenario 2,995.8
Sensitivity value level, remote scenario 6,333.0
Foreign Currency Exchange Hedge [Member] | Foreign Currency Risk Portion Of Fixed Assets Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments (14.5)
Sensitivity value level, probable scenario (13.2)
Sensitivity value level, adverse scenario 47.9
Sensitivity value level, remote scenario 110.3
Foreign Currency Exchange Hedge [Member] | Capex Purchases Affecting The Foreign Currency Exchange Risk Portion Of The Fixed Assets Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments 14.5
Sensitivity value level, probable scenario 13.2
Sensitivity value level, adverse scenario (47.9)
Sensitivity value level, remote scenario (110.3)
Foreign Currency Exchange Hedge [Member] | Total fixed asset exposure [member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments
Sensitivity value level, probable scenario
Sensitivity value level, adverse scenario
Sensitivity value level, remote scenario
Foreign Currency Exchange Hedge [Member] | Expenses That Affect The Foreign Currency Exchange Risk Portion Of Expenses Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments (4.1)
Sensitivity value level, probable scenario (3.7)
Sensitivity value level, adverse scenario 12.0
Sensitivity value level, remote scenario 28.2
Foreign Currency Exchange Hedge [Member] | Foreign Currency Exchange Risk Portion Of Expenses Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments 4.1
Sensitivity value level, probable scenario (1.7)
Sensitivity value level, adverse scenario (44.0)
Sensitivity value level, remote scenario (92.2)
Foreign Currency Exchange Hedge [Member] | Total expenses exposure [member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments
Sensitivity value level, probable scenario (5.4)
Sensitivity value level, adverse scenario (32.0)
Sensitivity value level, remote scenario (64.0)
Foreign Currency Exchange Hedge [Member] | Cash Effects Portion Of Expenses Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments (2.3)
Sensitivity value level, probable scenario (2.5)
Sensitivity value level, adverse scenario (17.1)
Sensitivity value level, remote scenario (31.9)
Foreign Currency Exchange Hedge [Member] | Foreign Currency Exchange Risk Portion Of Expenses Cash [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments 2.3
Sensitivity value level, probable scenario 2.5
Sensitivity value level, adverse scenario 17.1
Sensitivity value level, remote scenario 31.9
Foreign Currency Exchange Hedge [Member] | Total Cash Effects Exposure [Member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments
Sensitivity value level, probable scenario
Sensitivity value level, adverse scenario
Sensitivity value level, remote scenario
Commodities And Foreign Exchange Hedges [Member] | Total cost exposure [member]  
IfrsStatementLineItems [Line Items]  
Fair value of hedging instruments
Sensitivity value level, probable scenario (58.4)
Sensitivity value level, adverse scenario (341.0)
Sensitivity value level, remote scenario R$ (681.9)
XML 167 R152.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 7) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) R$ 23,502.4 R$ 24,837.9
Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) 35,522.5 36,818.5
Secured bank loans 26.7 68.2
Other secured loans (ii) 156.0 169.9
Lease liabilities  1,344.0 962.9
Total payables and liabilities  37,049.2 38,019.5
Later than one year and not later than two years [member]    
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) 439.9 86.8
Secured bank loans 25.2 26.4
Other secured loans (ii) 171.2 156.7
Lease liabilities  608.3 1,008.4
Total payables and liabilities  1,244.6 1,278.3
Later than two years and not later than three years [member]    
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) 10.6 1,275.1
Secured bank loans 25.2 25.2
Other secured loans (ii) 134.2 151.6
Lease liabilities  552.6 621.0
Total payables and liabilities  722.6 2,072.9
Later than three years and not later than five years [member]    
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) 808.6 1,008.4
Secured bank loans 50.4 50.4
Other secured loans (ii) 79.4 165.4
Lease liabilities  452.6 696.9
Total payables and liabilities  1,390.9 1,921.1
Later than five years [member]    
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) 1,672.1 1,467.6
Secured bank loans 50.4 75.5
Other secured loans (ii) 53.9 115.5
Lease liabilities  515.5 368.2
Total payables and liabilities  2,291.8 2,026.8
Carrying amount [member]    
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) 36,817.8 39,354.4
Secured bank loans 126.5 180.8
Other secured loans (ii) 415.7 472.5
Lease liabilities  2,958.9 3,117.4
Total payables and liabilities  40,318.9 43,125.1
Contractual Cash Flows [Member]    
IfrsStatementLineItems [Line Items]    
Trade and other payables (i) 38,453.7 40,656.4
Secured bank loans 177.8 245.7
Other secured loans (ii) 594.7 759.1
Lease liabilities  3,473.0 3,657.4
Total payables and liabilities  R$ 42,699.2 R$ 45,318.6
XML 168 R153.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details 8) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Notes and other explanatory information [abstract]    
Interest-bearing loans and borrowings current and non-current R$ 3,501.1 R$ 3,770.7
(-) Financial assets at fair value through profit or loss (277.2) (454.5)
(-) Cash and cash equivalents less bank overdraft (16,059.0) (14,852.1)
Net debt R$ (12,835.1) R$ (11,535.9)
XML 169 R154.htm IDEA: XBRL DOCUMENT v3.24.0.1
FINANCIAL INSTRUMENTS AND RISKS (Details Narrative) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Reserve Quantities [Line Items]    
Instruments sharing characteristic, highly liquid investments R$ 197.7 R$ 376.9
Value at risk exposure, probable 95.00%  
Value at risk, adverse scenario, deterioration percentage 25.00%  
Value at risk, remote scenario, deterioration percentage 50.00%  
Tenedora [Member] | ELJ [Member]    
Reserve Quantities [Line Items]    
Put options, exercisable number of shares, percent of outstanding stock 15.00%  
Put options, fair value R$ 2,791.1 R$ 3,053.7
Tenedora [Member] | ELJ [Member] | Tranche A [Member]    
Reserve Quantities [Line Items]    
Put options, exercisable number of shares, percent of outstanding stock 12.11%  
Tenedora [Member] | ELJ [Member] | Tranche B [Member]    
Reserve Quantities [Line Items]    
Put options, exercisable number of shares, percent of outstanding stock 2.89%  
XML 170 R155.htm IDEA: XBRL DOCUMENT v3.24.0.1
COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Collateral And Contractual Commitments With Suppliers Advances From Customers And Others    
Collateral given for the Companys own liabilities R$ 581.0 R$ 764.5
Other commitments 1,146.8 1,368.1
Total commitments 1,727.8 2,132.6
Commitments to suppliers property, plant and equipment and Intangible 1,000.8 276.7
Commitments to suppliers - Inventories 38,391.0 50,088.6
Total commitments to suppliers R$ 39,391.8 R$ 50,365.3
XML 171 R156.htm IDEA: XBRL DOCUMENT v3.24.0.1
COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Future contractual commitments R$ 39,391.8 R$ 50,365.3
Not later than one year [member]    
IfrsStatementLineItems [Line Items]    
Future contractual commitments 9,619.2 12,491.0
Later than one year and not later than two years [member]    
IfrsStatementLineItems [Line Items]    
Future contractual commitments 9,536.3 10,315.3
Later than two years [member]    
IfrsStatementLineItems [Line Items]    
Future contractual commitments R$ 20,236.3 R$ 27,559.0
XML 172 R157.htm IDEA: XBRL DOCUMENT v3.24.0.1
COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Details Narrative) - BRL (R$)
R$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Collateral And Contractual Commitments With Suppliers Advances From Customers And Others    
Cash guarantees R$ 558.2 R$ 744.0
Guarantees held for derivative instruments R$ 197.7 R$ 376.9
XML 173 R158.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTIES - Expenses Related to Management Members (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Short-term benefits (i) R$ 66.7 R$ 74.2 R$ 68.3
Share-based payments (ii) 80.7 66.0 65.3
Total key management remuneration  R$ 147.4 R$ 140.2 R$ 133.6
XML 174 R159.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTIES - Transactions With Related Parties (Details) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Sales and others, related parties R$ 110.3 R$ 269.1 R$ 90.4
Sales/service fees/reimbursement of expenses and others, related parties 116.1 14.8 3.6
Buying and others, related parties (2,668.6) (3,250.7) (3,725.9)
Buying/service fees/reimbursement of expenses and others, related parties (7.0) (36.9) (38.9)
Net finance cost, related parties 184.3 247.9 42.5
Trade receivables, related parties 236.7 290.7  
Other trade receivables, related parties 19.0 24.8  
Dividends receivables 1.0    
Noncurrent trade payables, related parties (199.9) (343.6)  
Current trade payables, related parties (1,916.5) (830.4)  
Anheuser-Busch InBev N.V. [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties 0.1 0.1 0.7
Sales/service fees/reimbursement of expenses and others, related parties 97.2 5.2
Buying and others, related parties (143.3) (117.3) (180.3)
Buying/service fees/reimbursement of expenses and others, related parties (0.5) (8.5) (10.7)
Net finance cost, related parties 64.0 208.7
Trade receivables, related parties 139.2 142.7  
Other trade receivables, related parties  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (21.5) (82.0)  
Anheuser-Busch Package [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties (235.5) (356.8) (286.7)
Buying/service fees/reimbursement of expenses and others, related parties
Net finance cost, related parties
Noncurrent trade payables, related parties  
Current trade payables, related parties (110.2) (79.3)  
Anheuser-Busch Procurement [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties
Buying/service fees/reimbursement of expenses and others, related parties (18.1) (16.1)
Net finance cost, related parties (0.5)
Anheuser-Busch Inbev USA LLC [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties 35.3 25.5 32.1
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties (915.9) (1,129.7) (1,209.9)
Buying/service fees/reimbursement of expenses and others, related parties (3.1) (3.2) (3.9)
Net finance cost, related parties (0.2) 0.3
Trade receivables, related parties 27.1 71.1  
Other trade receivables, related parties  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (209.6) (237.7)  
Bavaria S.A. [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties 72.3 32.0 30.9
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties (56.7) (56.7) (57.0)
Buying/service fees/reimbursement of expenses and others, related parties
Net finance cost, related parties
Trade receivables, related parties 10.4 13.9  
Other trade receivables, related parties  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (30.2) (6.9)  
Cerveceria Modelo de Mexico S. de R.L. de C.V. [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties 0.9 124.4 0.8
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties (1,234.9) (1,323.6) (1,708.2)
Buying/service fees/reimbursement of expenses and others, related parties
Net finance cost, related parties
Trade receivables, related parties 11.2 12.0  
Other trade receivables, related parties  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (1,497.9) (345.5)  
Cervecerias Peruanas [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties 1.7 3.2
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties (7.8) (49.6) (32.9)
Buying/service fees/reimbursement of expenses and others, related parties
Net finance cost, related parties
Trade receivables, related parties 0.9  
Other trade receivables, related parties  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (7.9) (46.4)  
Inbev Belgium N.V. [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties (41.9) (129.8) (107.9)
Buying/service fees/reimbursement of expenses and others, related parties
Net finance cost, related parties
Trade receivables, related parties 1.4 1.0  
Other trade receivables, related parties 19.0 23.9  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (8.7) (12.2)  
Interbrew International B.V. [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties
Sales/service fees/reimbursement of expenses and others, related parties
Buying and others, related parties
Buying/service fees/reimbursement of expenses and others, related parties
Net finance cost, related parties 120.0 37.3 42.2
Noncurrent trade payables, related parties (199.9) (343.6)  
Current trade payables, related parties  
Other related parties [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties 1.7 84.8 19.5
Sales/service fees/reimbursement of expenses and others, related parties 18.9 9.6 3.6
Buying and others, related parties (32.6) (87.2) (143.0)
Buying/service fees/reimbursement of expenses and others, related parties (3.4) (7.1) (8.2)
Net finance cost, related parties 1.0 1.9
Trade receivables, related parties 22.5 19.9  
Other trade receivables, related parties 0.9  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (28.1) (14.7)  
Ambev Peru [member]      
IfrsStatementLineItems [Line Items]      
Sales and others, related parties   0.6 3.2
Sales/service fees/reimbursement of expenses and others, related parties  
Buying and others, related parties  
Buying/service fees/reimbursement of expenses and others, related parties  
Net finance cost, related parties  
Anheuser-Busch Africa [member]      
IfrsStatementLineItems [Line Items]      
Trade receivables, related parties 3.7 1.6  
Other trade receivables, related parties  
Dividends receivables    
Anheuser-Busch Inbev Services LLC [member]      
IfrsStatementLineItems [Line Items]      
Trade receivables, related parties 17.2 23.7  
Other trade receivables, related parties  
Dividends receivables    
Noncurrent trade payables, related parties  
Current trade payables, related parties (2.4) (5.7)  
Panam&amp;#63; Holding [member]      
IfrsStatementLineItems [Line Items]      
Trade receivables, related parties 4.0 3.9  
Other trade receivables, related parties  
Dividends receivables R$ 1.0    
XML 175 R160.htm IDEA: XBRL DOCUMENT v3.24.0.1
RELATED PARTIES (Details Narrative) - BRL (R$)
R$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Fundacao Zerrenner [member]      
IfrsStatementLineItems [Line Items]      
Percentage of ownership held by a related party 10.20%    
Expenses incurred by a related party R$ 322.9 R$ 308.8  
Fundacao Zerrenner [member] | Active employees [member]      
IfrsStatementLineItems [Line Items]      
Expenses incurred by a related party 291.7 270.7  
Fundacao Zerrenner [member] | Retirees [member]      
IfrsStatementLineItems [Line Items]      
Expenses incurred by a related party 31.2 38.1  
Anheuser-Busch, Inc [member]      
IfrsStatementLineItems [Line Items]      
Transfers under licence agreements from entity, related party transactions 35.4 22.6 R$ 17.0
Transfers under licence agreements to entity, related party transactions R$ 888.6 R$ 736.7 R$ 819.0
XML 176 R161.htm IDEA: XBRL DOCUMENT v3.24.0.1
EVENTS AFTER THE REPORTING PERIOD (Details Narrative) - BRL (R$)
R$ in Thousands
12 Months Ended
Feb. 29, 2024
Dec. 31, 2023
Dec. 31, 2022
Jan. 31, 2024
IfrsStatementLineItems [Line Items]        
Reduction of assessed amount       R$ 916,000
Amount for possible contingency   R$ 633,400 R$ 581,500  
Exercise P U T C N D [Member]        
IfrsStatementLineItems [Line Items]        
Cash Disbursement   1,704,000    
Offset Of ELJ's Debt Held By The Group In The Amount   R$ 335,000    
Nonadjusting Events [member]        
IfrsStatementLineItems [Line Items]        
Tax incentive amounts R$ 2,600,000      
Tax incentive difference amounts R$ 20,000      
EXCEL 178 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 179 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 180 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 182 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1082 685 1 false 290 0 false 6 false false R1.htm 00000001 - Document - Cover Sheet http://ambev.com.br/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED INCOME STATEMENTS Sheet http://ambev.com.br/role/ConsolidatedIncomeStatements CONSOLIDATED INCOME STATEMENTS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://ambev.com.br/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Sheet http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Disclosure - CORPORATE INFORMATION Sheet http://ambev.com.br/role/CorporateInformation CORPORATE INFORMATION Notes 7 false false R8.htm 00000008 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS Sheet http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatements BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF MATERIAL ACCOUNTING POLICIES Sheet http://ambev.com.br/role/SummaryOfMaterialAccountingPolicies SUMMARY OF MATERIAL ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - USE OF ESTIMATES AND JUDGMENTS Sheet http://ambev.com.br/role/UseOfEstimatesAndJudgments USE OF ESTIMATES AND JUDGMENTS Notes 10 false false R11.htm 00000011 - Disclosure - SEGMENT REPORTING Sheet http://ambev.com.br/role/SegmentReporting SEGMENT REPORTING Notes 11 false false R12.htm 00000012 - Disclosure - NET SALES Sheet http://ambev.com.br/role/NetSales NET SALES Notes 12 false false R13.htm 00000013 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) Sheet http://ambev.com.br/role/OtherOperatingIncomeexpenses OTHER OPERATING INCOME/(EXPENSES) Notes 13 false false R14.htm 00000014 - Disclosure - EXCEPTIONAL ITEMS Sheet http://ambev.com.br/role/ExceptionalItems EXCEPTIONAL ITEMS Notes 14 false false R15.htm 00000015 - Disclosure - PAYROLL AND RELATED BENEFITS Sheet http://ambev.com.br/role/PayrollAndRelatedBenefits PAYROLL AND RELATED BENEFITS Notes 15 false false R16.htm 00000016 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE Sheet http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNature ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE Notes 16 false false R17.htm 00000017 - Disclosure - NET FINANCE RESULT Sheet http://ambev.com.br/role/NetFinanceResult NET FINANCE RESULT Notes 17 false false R18.htm 00000018 - Disclosure - EARNINGS PER SHARE Sheet http://ambev.com.br/role/EarningsPerShare EARNINGS PER SHARE Notes 18 false false R19.htm 00000019 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION Sheet http://ambev.com.br/role/IncomeTaxAndSocialContribution INCOME TAX AND SOCIAL CONTRIBUTION Notes 19 false false R20.htm 00000020 - Disclosure - PROPERTY, PLANT AND EQUIPMENT Sheet http://ambev.com.br/role/PropertyPlantAndEquipment PROPERTY, PLANT AND EQUIPMENT Notes 20 false false R21.htm 00000021 - Disclosure - GOODWILL Sheet http://ambev.com.br/role/Goodwill GOODWILL Notes 21 false false R22.htm 00000022 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS Sheet http://ambev.com.br/role/ImpairmentOfNon-financialAssets IMPAIRMENT OF NON-FINANCIAL ASSETS Notes 22 false false R23.htm 00000023 - Disclosure - INTANGIBLES Sheet http://ambev.com.br/role/Intangibles INTANGIBLES Notes 23 false false R24.htm 00000024 - Disclosure - RECOVERABLE TAXES Sheet http://ambev.com.br/role/RecoverableTaxes RECOVERABLE TAXES Notes 24 false false R25.htm 00000025 - Disclosure - INVENTORY Sheet http://ambev.com.br/role/Inventory INVENTORY Notes 25 false false R26.htm 00000026 - Disclosure - TRADE RECEIVABLES Sheet http://ambev.com.br/role/TradeReceivables TRADE RECEIVABLES Notes 26 false false R27.htm 00000027 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES Sheet http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES Notes 27 false false R28.htm 00000028 - Disclosure - CHANGES IN EQUITY Sheet http://ambev.com.br/role/ChangesInEquity CHANGES IN EQUITY Notes 28 false false R29.htm 00000029 - Disclosure - INTEREST-BEARING LOANS AND BORROWING Sheet http://ambev.com.br/role/Interest-bearingLoansAndBorrowing INTEREST-BEARING LOANS AND BORROWING Notes 29 false false R30.htm 00000030 - Disclosure - EMPLOYEE BENEFITS Sheet http://ambev.com.br/role/EmployeeBenefits EMPLOYEE BENEFITS Notes 30 false false R31.htm 00000031 - Disclosure - SHARE-BASED PAYMENTS Sheet http://ambev.com.br/role/Share-basedPayments SHARE-BASED PAYMENTS Notes 31 false false R32.htm 00000032 - Disclosure - TRADE PAYABLES Sheet http://ambev.com.br/role/TradePayables TRADE PAYABLES Notes 32 false false R33.htm 00000033 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS Sheet http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssets PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS Notes 33 false false R34.htm 00000034 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisks FINANCIAL INSTRUMENTS AND RISKS Notes 34 false false R35.htm 00000035 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS Sheet http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS Notes 35 false false R36.htm 00000036 - Disclosure - RELATED PARTIES Sheet http://ambev.com.br/role/RelatedParties RELATED PARTIES Notes 36 false false R37.htm 00000037 - Disclosure - EVENTS AFTER THE REPORTING PERIOD Sheet http://ambev.com.br/role/EventsAfterReportingPeriod EVENTS AFTER THE REPORTING PERIOD Notes 37 false false R38.htm 00000038 - Disclosure - SUMMARY OF MATERIAL ACCOUNTING POLICIES (Policies) Sheet http://ambev.com.br/role/SummaryOfMaterialAccountingPoliciesPolicies SUMMARY OF MATERIAL ACCOUNTING POLICIES (Policies) Policies 38 false false R39.htm 00000039 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Tables) Sheet http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsTables BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Tables) Tables http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatements 39 false false R40.htm 00000040 - Disclosure - SEGMENT REPORTING (Tables) Sheet http://ambev.com.br/role/SegmentReportingTables SEGMENT REPORTING (Tables) Tables http://ambev.com.br/role/SegmentReporting 40 false false R41.htm 00000041 - Disclosure - NET SALES (Tables) Sheet http://ambev.com.br/role/NetSalesTables NET SALES (Tables) Tables http://ambev.com.br/role/NetSales 41 false false R42.htm 00000042 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Tables) Sheet http://ambev.com.br/role/OtherOperatingIncomeexpensesTables OTHER OPERATING INCOME/(EXPENSES) (Tables) Tables http://ambev.com.br/role/OtherOperatingIncomeexpenses 42 false false R43.htm 00000043 - Disclosure - EXCEPTIONAL ITEMS (Tables) Sheet http://ambev.com.br/role/ExceptionalItemsTables EXCEPTIONAL ITEMS (Tables) Tables http://ambev.com.br/role/ExceptionalItems 43 false false R44.htm 00000044 - Disclosure - PAYROLL AND RELATED BENEFITS (Tables) Sheet http://ambev.com.br/role/PayrollAndRelatedBenefitsTables PAYROLL AND RELATED BENEFITS (Tables) Tables http://ambev.com.br/role/PayrollAndRelatedBenefits 44 false false R45.htm 00000045 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Tables) Sheet http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureTables ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Tables) Tables http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNature 45 false false R46.htm 00000046 - Disclosure - NET FINANCE RESULT (Tables) Sheet http://ambev.com.br/role/NetFinanceResultTables NET FINANCE RESULT (Tables) Tables http://ambev.com.br/role/NetFinanceResult 46 false false R47.htm 00000047 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://ambev.com.br/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://ambev.com.br/role/EarningsPerShare 47 false false R48.htm 00000048 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Tables) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionTables INCOME TAX AND SOCIAL CONTRIBUTION (Tables) Tables http://ambev.com.br/role/IncomeTaxAndSocialContribution 48 false false R49.htm 00000049 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables) Sheet http://ambev.com.br/role/PropertyPlantAndEquipmentTables PROPERTY, PLANT AND EQUIPMENT (Tables) Tables http://ambev.com.br/role/PropertyPlantAndEquipment 49 false false R50.htm 00000050 - Disclosure - GOODWILL (Tables) Sheet http://ambev.com.br/role/GoodwillTables GOODWILL (Tables) Tables http://ambev.com.br/role/Goodwill 50 false false R51.htm 00000051 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Tables) Sheet http://ambev.com.br/role/ImpairmentOfNon-financialAssetsTables IMPAIRMENT OF NON-FINANCIAL ASSETS (Tables) Tables http://ambev.com.br/role/ImpairmentOfNon-financialAssets 51 false false R52.htm 00000052 - Disclosure - INTANGIBLES (Tables) Sheet http://ambev.com.br/role/IntangiblesTables INTANGIBLES (Tables) Tables http://ambev.com.br/role/Intangibles 52 false false R53.htm 00000053 - Disclosure - RECOVERABLE TAXES (Tables) Sheet http://ambev.com.br/role/RecoverableTaxesTables RECOVERABLE TAXES (Tables) Tables http://ambev.com.br/role/RecoverableTaxes 53 false false R54.htm 00000054 - Disclosure - INVENTORY (Tables) Sheet http://ambev.com.br/role/InventoryTables INVENTORY (Tables) Tables http://ambev.com.br/role/Inventory 54 false false R55.htm 00000055 - Disclosure - TRADE RECEIVABLES (Tables) Sheet http://ambev.com.br/role/TradeReceivablesTables TRADE RECEIVABLES (Tables) Tables http://ambev.com.br/role/TradeReceivables 55 false false R56.htm 00000056 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Tables) Sheet http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesTables CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Tables) Tables http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities 56 false false R57.htm 00000057 - Disclosure - CHANGES IN EQUITY (Tables) Sheet http://ambev.com.br/role/ChangesInEquityTables CHANGES IN EQUITY (Tables) Tables http://ambev.com.br/role/ChangesInEquity 57 false false R58.htm 00000058 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Tables) Sheet http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables INTEREST-BEARING LOANS AND BORROWING (Tables) Tables http://ambev.com.br/role/Interest-bearingLoansAndBorrowing 58 false false R59.htm 00000059 - Disclosure - EMPLOYEE BENEFITS (Tables) Sheet http://ambev.com.br/role/EmployeeBenefitsTables EMPLOYEE BENEFITS (Tables) Tables http://ambev.com.br/role/EmployeeBenefits 59 false false R60.htm 00000060 - Disclosure - SHARE-BASED PAYMENTS (Tables) Sheet http://ambev.com.br/role/Share-basedPaymentsTables SHARE-BASED PAYMENTS (Tables) Tables http://ambev.com.br/role/Share-basedPayments 60 false false R61.htm 00000061 - Disclosure - TRADE PAYABLES (Tables) Sheet http://ambev.com.br/role/TradePayablesTables TRADE PAYABLES (Tables) Tables http://ambev.com.br/role/TradePayables 61 false false R62.htm 00000062 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Tables) Sheet http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Tables) Tables http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssets 62 false false R63.htm 00000063 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Tables) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksTables FINANCIAL INSTRUMENTS AND RISKS (Tables) Tables http://ambev.com.br/role/FinancialInstrumentsAndRisks 63 false false R64.htm 00000064 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Tables) Sheet http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersTables COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Tables) Tables http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers 64 false false R65.htm 00000065 - Disclosure - RELATED PARTIES (Tables) Sheet http://ambev.com.br/role/RelatedPartiesTables RELATED PARTIES (Tables) Tables http://ambev.com.br/role/RelatedParties 65 false false R66.htm 00000066 - Disclosure - CORPORATE INFORMATION (Details Narrative) Sheet http://ambev.com.br/role/CorporateInformationDetailsNarrative CORPORATE INFORMATION (Details Narrative) Details http://ambev.com.br/role/CorporateInformation 66 false false R67.htm 00000067 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details) Sheet http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details) Details http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsTables 67 false false R68.htm 00000068 - Disclosure - SEGMENT REPORTING - Reportable Segments (Details) Sheet http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails SEGMENT REPORTING - Reportable Segments (Details) Details 68 false false R69.htm 00000069 - Disclosure - SEGMENT REPORTING - Additional information (Details) Sheet http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails SEGMENT REPORTING - Additional information (Details) Details 69 false false R70.htm 00000070 - Disclosure - SEGMENT REPORTING (Details Narrative) Sheet http://ambev.com.br/role/SegmentReportingDetailsNarrative SEGMENT REPORTING (Details Narrative) Details http://ambev.com.br/role/SegmentReportingTables 70 false false R71.htm 00000071 - Disclosure - NET SALES (Details) Sheet http://ambev.com.br/role/NetSalesDetails NET SALES (Details) Details http://ambev.com.br/role/NetSalesTables 71 false false R72.htm 00000072 - Disclosure - NET SALES (Details Narrative) Sheet http://ambev.com.br/role/NetSalesDetailsNarrative NET SALES (Details Narrative) Details http://ambev.com.br/role/NetSalesTables 72 false false R73.htm 00000073 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Details) Sheet http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails OTHER OPERATING INCOME/(EXPENSES) (Details) Details http://ambev.com.br/role/OtherOperatingIncomeexpensesTables 73 false false R74.htm 00000074 - Disclosure - EXCEPTIONAL ITEMS (Details) Sheet http://ambev.com.br/role/ExceptionalItemsDetails EXCEPTIONAL ITEMS (Details) Details http://ambev.com.br/role/ExceptionalItemsTables 74 false false R75.htm 00000075 - Disclosure - PAYROLL AND RELATED BENEFITS (Details) Sheet http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails PAYROLL AND RELATED BENEFITS (Details) Details http://ambev.com.br/role/PayrollAndRelatedBenefitsTables 75 false false R76.htm 00000076 - Disclosure - PAYROLL AND RELATED BENEFITS (Details 1) Sheet http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1 PAYROLL AND RELATED BENEFITS (Details 1) Details http://ambev.com.br/role/PayrollAndRelatedBenefitsTables 76 false false R77.htm 00000077 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details) Sheet http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details) Details http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureTables 77 false false R78.htm 00000078 - Disclosure - NET FINANCE RESULT (Details) Sheet http://ambev.com.br/role/NetFinanceResultDetails NET FINANCE RESULT (Details) Details http://ambev.com.br/role/NetFinanceResultTables 78 false false R79.htm 00000079 - Disclosure - NET FINANCE RESULT (Details 1) Sheet http://ambev.com.br/role/NetFinanceResultDetails1 NET FINANCE RESULT (Details 1) Details http://ambev.com.br/role/NetFinanceResultTables 79 false false R80.htm 00000080 - Disclosure - NET FINANCE RESULT (Details 2) Sheet http://ambev.com.br/role/NetFinanceResultDetails2 NET FINANCE RESULT (Details 2) Details http://ambev.com.br/role/NetFinanceResultTables 80 false false R81.htm 00000081 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://ambev.com.br/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://ambev.com.br/role/EarningsPerShareTables 81 false false R82.htm 00000082 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails INCOME TAX AND SOCIAL CONTRIBUTION (Details) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 82 false false R83.htm 00000083 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 1) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1 INCOME TAX AND SOCIAL CONTRIBUTION (Details 1) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 83 false false R84.htm 00000084 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 2) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2 INCOME TAX AND SOCIAL CONTRIBUTION (Details 2) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 84 false false R85.htm 00000085 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 3) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3 INCOME TAX AND SOCIAL CONTRIBUTION (Details 3) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 85 false false R86.htm 00000086 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 4) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4 INCOME TAX AND SOCIAL CONTRIBUTION (Details 4) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 86 false false R87.htm 00000087 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 5) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5 INCOME TAX AND SOCIAL CONTRIBUTION (Details 5) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 87 false false R88.htm 00000088 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 6) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6 INCOME TAX AND SOCIAL CONTRIBUTION (Details 6) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 88 false false R89.htm 00000089 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details Narrative) Sheet http://ambev.com.br/role/IncomeTaxAndSocialContributionDetailsNarrative INCOME TAX AND SOCIAL CONTRIBUTION (Details Narrative) Details http://ambev.com.br/role/IncomeTaxAndSocialContributionTables 89 false false R90.htm 00000090 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details) Sheet http://ambev.com.br/role/PropertyPlantAndEquipmentDetails PROPERTY, PLANT AND EQUIPMENT (Details) Details http://ambev.com.br/role/PropertyPlantAndEquipmentTables 90 false false R91.htm 00000091 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 1) Sheet http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1 PROPERTY, PLANT AND EQUIPMENT (Details 1) Details http://ambev.com.br/role/PropertyPlantAndEquipmentTables 91 false false R92.htm 00000092 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 2) Sheet http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2 PROPERTY, PLANT AND EQUIPMENT (Details 2) Details http://ambev.com.br/role/PropertyPlantAndEquipmentTables 92 false false R93.htm 00000093 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 3) Sheet http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3 PROPERTY, PLANT AND EQUIPMENT (Details 3) Details http://ambev.com.br/role/PropertyPlantAndEquipmentTables 93 false false R94.htm 00000094 - Disclosure - GOODWILL (Details) Sheet http://ambev.com.br/role/GoodwillDetails GOODWILL (Details) Details http://ambev.com.br/role/GoodwillTables 94 false false R95.htm 00000095 - Disclosure - GOODWILL (Details 1) Sheet http://ambev.com.br/role/GoodwillDetails1 GOODWILL (Details 1) Details http://ambev.com.br/role/GoodwillTables 95 false false R96.htm 00000096 - Disclosure - GOODWILL (Details Narrative) Sheet http://ambev.com.br/role/GoodwillDetailsNarrative GOODWILL (Details Narrative) Details http://ambev.com.br/role/GoodwillTables 96 false false R97.htm 00000097 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details) Sheet http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails IMPAIRMENT OF NON-FINANCIAL ASSETS (Details) Details http://ambev.com.br/role/ImpairmentOfNon-financialAssetsTables 97 false false R98.htm 00000098 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details Narrative) Sheet http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative IMPAIRMENT OF NON-FINANCIAL ASSETS (Details Narrative) Details http://ambev.com.br/role/ImpairmentOfNon-financialAssetsTables 98 false false R99.htm 00000099 - Disclosure - INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details) Sheet http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details) Details 99 false false R100.htm 00000100 - Disclosure - INTANGIBLES - Intangible Assets by Location (Details) Sheet http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails INTANGIBLES - Intangible Assets by Location (Details) Details 100 false false R101.htm 00000101 - Disclosure - INTANGIBLES (Details Narrative) Sheet http://ambev.com.br/role/IntangiblesDetailsNarrative INTANGIBLES (Details Narrative) Details http://ambev.com.br/role/IntangiblesTables 101 false false R102.htm 00000102 - Disclosure - RECOVERABLE TAXEs (Details) Sheet http://ambev.com.br/role/RecoverableTaxesDetails RECOVERABLE TAXEs (Details) Details http://ambev.com.br/role/RecoverableTaxesTables 102 false false R103.htm 00000103 - Disclosure - INVENTORY (Details) Sheet http://ambev.com.br/role/InventoryDetails INVENTORY (Details) Details http://ambev.com.br/role/InventoryTables 103 false false R104.htm 00000104 - Disclosure - INVENTORY (Details 1) Sheet http://ambev.com.br/role/InventoryDetails1 INVENTORY (Details 1) Details http://ambev.com.br/role/InventoryTables 104 false false R105.htm 00000105 - Disclosure - TRADE RECEIVABLES - Current Trade Receivables (Details) Sheet http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails TRADE RECEIVABLES - Current Trade Receivables (Details) Details 105 false false R106.htm 00000106 - Disclosure - TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details) Sheet http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details) Details 106 false false R107.htm 00000107 - Disclosure - TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details) Sheet http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details) Details 107 false false R108.htm 00000108 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details) Sheet http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details) Details 108 false false R109.htm 00000109 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details) Sheet http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details) Details 109 false false R110.htm 00000110 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Details Narrative) Sheet http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesDetailsNarrative CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Details Narrative) Details http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesTables 110 false false R111.htm 00000111 - Disclosure - CHANGES IN EQUITY - Capital Stock (Details) Sheet http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails CHANGES IN EQUITY - Capital Stock (Details) Details 111 false false R112.htm 00000112 - Disclosure - CHANGES IN EQUITY - Capital Reserves (Details) Sheet http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails CHANGES IN EQUITY - Capital Reserves (Details) Details 112 false false R113.htm 00000113 - Disclosure - CHANGES IN EQUITY - Treasury Shares (Details) Sheet http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails CHANGES IN EQUITY - Treasury Shares (Details) Details 113 false false R114.htm 00000114 - Disclosure - CHANGES IN EQUITY - Net Income Reserves (Details) Sheet http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails CHANGES IN EQUITY - Net Income Reserves (Details) Details 114 false false R115.htm 00000115 - Disclosure - CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details) Sheet http://ambev.com.br/role/ChangesInEquity-InterestOnShareholdersEquityDividendsDetails CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details) Details 115 false false R116.htm 00000116 - Disclosure - CHANGES IN EQUITY - Basis for Dividends (Details) Sheet http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails CHANGES IN EQUITY - Basis for Dividends (Details) Details 116 false false R117.htm 00000117 - Disclosure - CHANGES IN EQUITY - Carrying Value Adjustments (Details) Sheet http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails CHANGES IN EQUITY - Carrying Value Adjustments (Details) Details 117 false false R118.htm 00000118 - Disclosure - CHANGES IN EQUITY (Details Narrative) Sheet http://ambev.com.br/role/ChangesInEquityDetailsNarrative CHANGES IN EQUITY (Details Narrative) Details http://ambev.com.br/role/ChangesInEquityTables 118 false false R119.htm 00000119 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details) Sheet http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails INTEREST-BEARING LOANS AND BORROWING (Details) Details http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables 119 false false R120.htm 00000120 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 1) Sheet http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1 INTEREST-BEARING LOANS AND BORROWING (Details 1) Details http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables 120 false false R121.htm 00000121 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 2) Sheet http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2 INTEREST-BEARING LOANS AND BORROWING (Details 2) Details http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables 121 false false R122.htm 00000122 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 3) Sheet http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3 INTEREST-BEARING LOANS AND BORROWING (Details 3) Details http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables 122 false false R123.htm 00000123 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 4) Sheet http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4 INTEREST-BEARING LOANS AND BORROWING (Details 4) Details http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables 123 false false R124.htm 00000124 - Disclosure - EMPLOYEE BENEFITS (Details) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails EMPLOYEE BENEFITS (Details) Details http://ambev.com.br/role/EmployeeBenefitsTables 124 false false R125.htm 00000125 - Disclosure - EMPLOYEE BENEFITS (Details 1) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails1 EMPLOYEE BENEFITS (Details 1) Details http://ambev.com.br/role/EmployeeBenefitsTables 125 false false R126.htm 00000126 - Disclosure - EMPLOYEE BENEFITS (Details 2) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails2 EMPLOYEE BENEFITS (Details 2) Details http://ambev.com.br/role/EmployeeBenefitsTables 126 false false R127.htm 00000127 - Disclosure - EMPLOYEE BENEFITS (Details 3) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails3 EMPLOYEE BENEFITS (Details 3) Details http://ambev.com.br/role/EmployeeBenefitsTables 127 false false R128.htm 00000128 - Disclosure - EMPLOYEE BENEFITS (Details 4) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails4 EMPLOYEE BENEFITS (Details 4) Details http://ambev.com.br/role/EmployeeBenefitsTables 128 false false R129.htm 00000129 - Disclosure - EMPLOYEE BENEFITS (Details 5) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails5 EMPLOYEE BENEFITS (Details 5) Details http://ambev.com.br/role/EmployeeBenefitsTables 129 false false R130.htm 00000130 - Disclosure - EMPLOYEE BENEFITS (Details 6) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails6 EMPLOYEE BENEFITS (Details 6) Details http://ambev.com.br/role/EmployeeBenefitsTables 130 false false R131.htm 00000131 - Disclosure - EMPLOYEE BENEFITS (Details 7) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails7 EMPLOYEE BENEFITS (Details 7) Details http://ambev.com.br/role/EmployeeBenefitsTables 131 false false R132.htm 00000132 - Disclosure - EMPLOYEE BENEFITS (Details 8) Sheet http://ambev.com.br/role/EmployeeBenefitsDetails8 EMPLOYEE BENEFITS (Details 8) Details http://ambev.com.br/role/EmployeeBenefitsTables 132 false false R133.htm 00000133 - Disclosure - EMPLOYEE BENEFITS (Details Narrative) Sheet http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative EMPLOYEE BENEFITS (Details Narrative) Details http://ambev.com.br/role/EmployeeBenefitsTables 133 false false R134.htm 00000134 - Disclosure - SHARE-BASED PAYMENTS (Details) Sheet http://ambev.com.br/role/Share-basedPaymentsDetails SHARE-BASED PAYMENTS (Details) Details http://ambev.com.br/role/Share-basedPaymentsTables 134 false false R135.htm 00000135 - Disclosure - SHARE-BASED PAYMENTS (Details 1) Sheet http://ambev.com.br/role/Share-basedPaymentsDetails1 SHARE-BASED PAYMENTS (Details 1) Details http://ambev.com.br/role/Share-basedPaymentsTables 135 false false R136.htm 00000136 - Disclosure - SHARE-BASED PAYMENTS (Details 2) Sheet http://ambev.com.br/role/Share-basedPaymentsDetails2 SHARE-BASED PAYMENTS (Details 2) Details http://ambev.com.br/role/Share-basedPaymentsTables 136 false false R137.htm 00000137 - Disclosure - SHARE-BASED PAYMENTS (Details 3) Sheet http://ambev.com.br/role/Share-basedPaymentsDetails3 SHARE-BASED PAYMENTS (Details 3) Details http://ambev.com.br/role/Share-basedPaymentsTables 137 false false R138.htm 00000138 - Disclosure - SHARE-BASED PAYMENTS (Details Narrative) Sheet http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative SHARE-BASED PAYMENTS (Details Narrative) Details http://ambev.com.br/role/Share-basedPaymentsTables 138 false false R139.htm 00000139 - Disclosure - TRADE PAYABLES (Details) Sheet http://ambev.com.br/role/TradePayablesDetails TRADE PAYABLES (Details) Details http://ambev.com.br/role/TradePayablesTables 139 false false R140.htm 00000140 - Disclosure - TRADE PAYABLES (Details Narrative) Sheet http://ambev.com.br/role/TradePayablesDetailsNarrative TRADE PAYABLES (Details Narrative) Details http://ambev.com.br/role/TradePayablesTables 140 false false R141.htm 00000141 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details) Sheet http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details) Details http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables 141 false false R142.htm 00000142 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1) Sheet http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1 PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1) Details http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables 142 false false R143.htm 00000143 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2) Sheet http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2 PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2) Details http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables 143 false false R144.htm 00000144 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails FINANCIAL INSTRUMENTS AND RISKS (Details) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 144 false false R145.htm 00000145 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 1) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1 FINANCIAL INSTRUMENTS AND RISKS (Details 1) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 145 false false R146.htm 00000146 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 2) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2 FINANCIAL INSTRUMENTS AND RISKS (Details 2) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 146 false false R147.htm 00000147 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details Narrative) Sheet http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details Narrative) Details http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables 147 false false R148.htm 00000148 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 3) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3 FINANCIAL INSTRUMENTS AND RISKS (Details 3) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 148 false false R149.htm 00000149 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 4) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4 FINANCIAL INSTRUMENTS AND RISKS (Details 4) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 149 false false R150.htm 00000150 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 5) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5 FINANCIAL INSTRUMENTS AND RISKS (Details 5) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 150 false false R151.htm 00000151 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 6) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6 FINANCIAL INSTRUMENTS AND RISKS (Details 6) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 151 false false R152.htm 00000152 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 7) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7 FINANCIAL INSTRUMENTS AND RISKS (Details 7) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 152 false false R153.htm 00000153 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 8) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails8 FINANCIAL INSTRUMENTS AND RISKS (Details 8) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 153 false false R154.htm 00000154 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details Narrative) Sheet http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative FINANCIAL INSTRUMENTS AND RISKS (Details Narrative) Details http://ambev.com.br/role/FinancialInstrumentsAndRisksTables 154 false false R155.htm 00000155 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details) Sheet http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details) Details 155 false false R156.htm 00000156 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details) Sheet http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details) Details 156 false false R157.htm 00000157 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Details Narrative) Sheet http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersDetailsNarrative COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Details Narrative) Details http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersTables 157 false false R158.htm 00000158 - Disclosure - RELATED PARTIES - Expenses Related to Management Members (Details) Sheet http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails RELATED PARTIES - Expenses Related to Management Members (Details) Details 158 false false R159.htm 00000159 - Disclosure - RELATED PARTIES - Transactions With Related Parties (Details) Sheet http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails RELATED PARTIES - Transactions With Related Parties (Details) Details 159 false false R160.htm 00000160 - Disclosure - RELATED PARTIES (Details Narrative) Sheet http://ambev.com.br/role/RelatedPartiesDetailsNarrative RELATED PARTIES (Details Narrative) Details http://ambev.com.br/role/RelatedPartiesTables 160 false false R161.htm 00000161 - Disclosure - EVENTS AFTER THE REPORTING PERIOD (Details Narrative) Sheet http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative EVENTS AFTER THE REPORTING PERIOD (Details Narrative) Details http://ambev.com.br/role/EventsAfterReportingPeriod 161 false false All Reports Book All Reports abev-20231231.xsd abev-20231231_cal.xml abev-20231231_def.xml abev-20231231_lab.xml abev-20231231_pre.xml abevform20f_2023.htm image_002.jpg image_004.jpg http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 185 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "abevform20f_2023.htm": { "nsprefix": "abev", "nsuri": "http://ambev.com.br/20231231", "dts": { "schema": { "local": [ "abev-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "abev-20231231_cal.xml" ] }, "definitionLink": { "local": [ "abev-20231231_def.xml" ] }, "labelLink": { "local": [ "abev-20231231_lab.xml" ] }, "presentationLink": { "local": [ "abev-20231231_pre.xml" ] }, "inline": { "local": [ "abevform20f_2023.htm" ] } }, "keyStandard": 361, "keyCustom": 324, "axisStandard": 41, "axisCustom": 0, "memberStandard": 70, "memberCustom": 209, "hidden": { "total": 793, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 341, "http://ambev.com.br/20231231": 448, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 1082, "entityCount": 1, "segmentCount": 290, "elementCount": 1137, "unitCount": 6, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 2542, "http://xbrl.sec.gov/dei/2023": 41 }, "report": { "R1": { "role": "http://ambev.com.br/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R2": { "role": "http://ambev.com.br/role/ConsolidatedIncomeStatements", "longName": "00000002 - Statement - CONSOLIDATED INCOME STATEMENTS", "shortName": "CONSOLIDATED INCOME STATEMENTS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:FinanceCosts", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R3": { "role": "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome", "longName": "00000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfitLoss", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R4": { "role": "http://ambev.com.br/role/ConsolidatedBalanceSheets", "longName": "00000004 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:InvestmentsInAssociates", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R5": { "role": "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "ifrs-full:Equity", "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_CapitalReserveMember", "name": "ifrs-full:Equity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R6": { "role": "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfitLoss", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R7": { "role": "http://ambev.com.br/role/CorporateInformation", "longName": "00000007 - Disclosure - CORPORATE INFORMATION", "shortName": "CORPORATE INFORMATION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DescriptionOfCorporateInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DescriptionOfCorporateInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R8": { "role": "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatements", "longName": "00000008 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS", "shortName": "BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R9": { "role": "http://ambev.com.br/role/SummaryOfMaterialAccountingPolicies", "longName": "00000009 - Disclosure - SUMMARY OF MATERIAL ACCOUNTING POLICIES", "shortName": "SUMMARY OF MATERIAL ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosuresOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosuresOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R10": { "role": "http://ambev.com.br/role/UseOfEstimatesAndJudgments", "longName": "00000010 - Disclosure - USE OF ESTIMATES AND JUDGMENTS", "shortName": "USE OF ESTIMATES AND JUDGMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R11": { "role": "http://ambev.com.br/role/SegmentReporting", "longName": "00000011 - Disclosure - SEGMENT REPORTING", "shortName": "SEGMENT REPORTING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R12": { "role": "http://ambev.com.br/role/NetSales", "longName": "00000012 - Disclosure - NET SALES", "shortName": "NET SALES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosuresOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosuresOfRevenueExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R13": { "role": "http://ambev.com.br/role/OtherOperatingIncomeexpenses", "longName": "00000013 - Disclosure - OTHER OPERATING INCOME/(EXPENSES)", "shortName": "OTHER OPERATING INCOME/(EXPENSES)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R14": { "role": "http://ambev.com.br/role/ExceptionalItems", "longName": "00000014 - Disclosure - EXCEPTIONAL ITEMS", "shortName": "EXCEPTIONAL ITEMS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfExceptionalItemsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfExceptionalItemsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R15": { "role": "http://ambev.com.br/role/PayrollAndRelatedBenefits", "longName": "00000015 - Disclosure - PAYROLL AND RELATED BENEFITS", "shortName": "PAYROLL AND RELATED BENEFITS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R16": { "role": "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNature", "longName": "00000016 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE", "shortName": "ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfAdditionalInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfAdditionalInformationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R17": { "role": "http://ambev.com.br/role/NetFinanceResult", "longName": "00000017 - Disclosure - NET FINANCE RESULT", "shortName": "NET FINANCE RESULT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R18": { "role": "http://ambev.com.br/role/EarningsPerShare", "longName": "00000018 - Disclosure - EARNINGS PER SHARE", "shortName": "EARNINGS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R19": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContribution", "longName": "00000019 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R20": { "role": "http://ambev.com.br/role/PropertyPlantAndEquipment", "longName": "00000020 - Disclosure - PROPERTY, PLANT AND EQUIPMENT", "shortName": "PROPERTY, PLANT AND EQUIPMENT", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R21": { "role": "http://ambev.com.br/role/Goodwill", "longName": "00000021 - Disclosure - GOODWILL", "shortName": "GOODWILL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R22": { "role": "http://ambev.com.br/role/ImpairmentOfNon-financialAssets", "longName": "00000022 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS", "shortName": "IMPAIRMENT OF NON-FINANCIAL ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R23": { "role": "http://ambev.com.br/role/Intangibles", "longName": "00000023 - Disclosure - INTANGIBLES", "shortName": "INTANGIBLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R24": { "role": "http://ambev.com.br/role/RecoverableTaxes", "longName": "00000024 - Disclosure - RECOVERABLE TAXES", "shortName": "RECOVERABLE TAXES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:RecoverableTaxesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:RecoverableTaxesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R25": { "role": "http://ambev.com.br/role/Inventory", "longName": "00000025 - Disclosure - INVENTORY", "shortName": "INVENTORY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfInventoriesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R26": { "role": "http://ambev.com.br/role/TradeReceivables", "longName": "00000026 - Disclosure - TRADE RECEIVABLES", "shortName": "TRADE RECEIVABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R27": { "role": "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities", "longName": "00000027 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES", "shortName": "CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R28": { "role": "http://ambev.com.br/role/ChangesInEquity", "longName": "00000028 - Disclosure - CHANGES IN EQUITY", "shortName": "CHANGES IN EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfChangesInEquityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfChangesInEquityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R29": { "role": "http://ambev.com.br/role/Interest-bearingLoansAndBorrowing", "longName": "00000029 - Disclosure - INTEREST-BEARING LOANS AND BORROWING", "shortName": "INTEREST-BEARING LOANS AND BORROWING", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R30": { "role": "http://ambev.com.br/role/EmployeeBenefits", "longName": "00000030 - Disclosure - EMPLOYEE BENEFITS", "shortName": "EMPLOYEE BENEFITS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R31": { "role": "http://ambev.com.br/role/Share-basedPayments", "longName": "00000031 - Disclosure - SHARE-BASED PAYMENTS", "shortName": "SHARE-BASED PAYMENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R32": { "role": "http://ambev.com.br/role/TradePayables", "longName": "00000032 - Disclosure - TRADE PAYABLES", "shortName": "TRADE PAYABLES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R33": { "role": "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssets", "longName": "00000033 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS", "shortName": "PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R34": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisks", "longName": "00000034 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS", "shortName": "FINANCIAL INSTRUMENTS AND RISKS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R35": { "role": "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers", "longName": "00000035 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS", "shortName": "COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R36": { "role": "http://ambev.com.br/role/RelatedParties", "longName": "00000036 - Disclosure - RELATED PARTIES", "shortName": "RELATED PARTIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R37": { "role": "http://ambev.com.br/role/EventsAfterReportingPeriod", "longName": "00000037 - Disclosure - EVENTS AFTER THE REPORTING PERIOD", "shortName": "EVENTS AFTER THE REPORTING PERIOD", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R38": { "role": "http://ambev.com.br/role/SummaryOfMaterialAccountingPoliciesPolicies", "longName": "00000038 - Disclosure - SUMMARY OF MATERIAL ACCOUNTING POLICIES (Policies)", "shortName": "SUMMARY OF MATERIAL ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "38", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DescriptionOfAccountingPolicyForNewIFRSRelasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosuresOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DescriptionOfAccountingPolicyForNewIFRSRelasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosuresOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R39": { "role": "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsTables", "longName": "00000039 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Tables)", "shortName": "BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R40": { "role": "http://ambev.com.br/role/SegmentReportingTables", "longName": "00000040 - Disclosure - SEGMENT REPORTING (Tables)", "shortName": "SEGMENT REPORTING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfReportableSegmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfReportableSegmentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R41": { "role": "http://ambev.com.br/role/NetSalesTables", "longName": "00000041 - Disclosure - NET SALES (Tables)", "shortName": "NET SALES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosuresOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosuresOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R42": { "role": "http://ambev.com.br/role/OtherOperatingIncomeexpensesTables", "longName": "00000042 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Tables)", "shortName": "OTHER OPERATING INCOME/(EXPENSES) (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R43": { "role": "http://ambev.com.br/role/ExceptionalItemsTables", "longName": "00000043 - Disclosure - EXCEPTIONAL ITEMS (Tables)", "shortName": "EXCEPTIONAL ITEMS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfExceptionalItemsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfExceptionalItemsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R44": { "role": "http://ambev.com.br/role/PayrollAndRelatedBenefitsTables", "longName": "00000044 - Disclosure - PAYROLL AND RELATED BENEFITS (Tables)", "shortName": "PAYROLL AND RELATED BENEFITS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "44", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfPayrollAndRelatedBenefitsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfPayrollAndRelatedBenefitsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R45": { "role": "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureTables", "longName": "00000045 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Tables)", "shortName": "ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "45", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfAdditionalInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfAdditionalInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R46": { "role": "http://ambev.com.br/role/NetFinanceResultTables", "longName": "00000046 - Disclosure - NET FINANCE RESULT (Tables)", "shortName": "NET FINANCE RESULT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinanceCostExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinanceCostExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R47": { "role": "http://ambev.com.br/role/EarningsPerShareTables", "longName": "00000047 - Disclosure - EARNINGS PER SHARE (Tables)", "shortName": "EARNINGS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "47", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R48": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables", "longName": "00000048 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Tables)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "48", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R49": { "role": "http://ambev.com.br/role/PropertyPlantAndEquipmentTables", "longName": "00000049 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "49", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R50": { "role": "http://ambev.com.br/role/GoodwillTables", "longName": "00000050 - Disclosure - GOODWILL (Tables)", "shortName": "GOODWILL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "50", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R51": { "role": "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsTables", "longName": "00000051 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Tables)", "shortName": "IMPAIRMENT OF NON-FINANCIAL ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "51", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R52": { "role": "http://ambev.com.br/role/IntangiblesTables", "longName": "00000052 - Disclosure - INTANGIBLES (Tables)", "shortName": "INTANGIBLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "52", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R53": { "role": "http://ambev.com.br/role/RecoverableTaxesTables", "longName": "00000053 - Disclosure - RECOVERABLE TAXES (Tables)", "shortName": "RECOVERABLE TAXES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "53", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:RecoverableTaxesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:RecoverableTaxesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R54": { "role": "http://ambev.com.br/role/InventoryTables", "longName": "00000054 - Disclosure - INVENTORY (Tables)", "shortName": "INVENTORY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "54", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfInventoryComponentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfInventoryComponentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R55": { "role": "http://ambev.com.br/role/TradeReceivablesTables", "longName": "00000055 - Disclosure - TRADE RECEIVABLES (Tables)", "shortName": "TRADE RECEIVABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "55", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfCurrentTradeReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfCurrentTradeReceivablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R56": { "role": "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesTables", "longName": "00000056 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Tables)", "shortName": "CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "56", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfComponentsInCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfComponentsInCashAndCashEquivalentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R57": { "role": "http://ambev.com.br/role/ChangesInEquityTables", "longName": "00000057 - Disclosure - CHANGES IN EQUITY (Tables)", "shortName": "CHANGES IN EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "57", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R58": { "role": "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables", "longName": "00000058 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Tables)", "shortName": "INTEREST-BEARING LOANS AND BORROWING (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "58", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfTotalLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfTotalLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R59": { "role": "http://ambev.com.br/role/EmployeeBenefitsTables", "longName": "00000059 - Disclosure - EMPLOYEE BENEFITS (Tables)", "shortName": "EMPLOYEE BENEFITS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "59", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R60": { "role": "http://ambev.com.br/role/Share-basedPaymentsTables", "longName": "00000060 - Disclosure - SHARE-BASED PAYMENTS (Tables)", "shortName": "SHARE-BASED PAYMENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "60", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R61": { "role": "http://ambev.com.br/role/TradePayablesTables", "longName": "00000061 - Disclosure - TRADE PAYABLES (Tables)", "shortName": "TRADE PAYABLES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "61", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfTheComponentsOfTradePayablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfTheComponentsOfTradePayablesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R62": { "role": "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables", "longName": "00000062 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Tables)", "shortName": "PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "62", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfOtherProvisionsChangesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfOtherProvisionsChangesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R63": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables", "longName": "00000063 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Tables)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "63", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R64": { "role": "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersTables", "longName": "00000064 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Tables)", "shortName": "COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "64", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R65": { "role": "http://ambev.com.br/role/RelatedPartiesTables", "longName": "00000065 - Disclosure - RELATED PARTIES (Tables)", "shortName": "RELATED PARTIES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "65", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfKeyManagementPersonnelCompensationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DisclosureOfKeyManagementPersonnelCompensationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R66": { "role": "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "longName": "00000066 - Disclosure - CORPORATE INFORMATION (Details Narrative)", "shortName": "CORPORATE INFORMATION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:EmployeeBenefitsExpense", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfPayrollAndRelatedBenefitsTextBlock", "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2021-05-012021-05-31", "name": "abev:TaxEffectOfTaxLoss", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "p", "abev:DescriptionOfCorporateInformationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R67": { "role": "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails", "longName": "00000067 - Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details)", "shortName": "BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_CanadianDollarsSpentInCanadaAndCubaMember", "name": "ifrs-full:ClosingForeignExchangeRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_CanadianDollarsSpentInCanadaAndCubaMember", "name": "ifrs-full:ClosingForeignExchangeRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R68": { "role": "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails", "longName": "00000068 - Disclosure - SEGMENT REPORTING - Reportable Segments (Details)", "shortName": "SEGMENT REPORTING - Reportable Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfReportableSegmentsTextBlock", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R69": { "role": "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "longName": "00000069 - Disclosure - SEGMENT REPORTING - Additional information (Details)", "shortName": "SEGMENT REPORTING - Additional information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_BeerMember_custom_Brazil1Member", "name": "ifrs-full:RevenueFromContractsWithCustomers", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:ScheduleOfAdditionalInformationByBusinessUnitTableTextBlock", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R70": { "role": "http://ambev.com.br/role/SegmentReportingDetailsNarrative", "longName": "00000070 - Disclosure - SEGMENT REPORTING (Details Narrative)", "shortName": "SEGMENT REPORTING (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NoncurrentAssets", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_country_BR", "name": "ifrs-full:NoncurrentAssets", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-8", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R71": { "role": "http://ambev.com.br/role/NetSalesDetails", "longName": "00000071 - Disclosure - NET SALES (Details)", "shortName": "NET SALES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock", "abev:DisclosuresOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromSaleOfGoods", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock", "abev:DisclosuresOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R72": { "role": "http://ambev.com.br/role/NetSalesDetailsNarrative", "longName": "00000072 - Disclosure - NET SALES (Details Narrative)", "shortName": "NET SALES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DeductionOfRevenue", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosuresOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DeductionOfRevenue", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosuresOfRevenueExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R73": { "role": "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails", "longName": "00000073 - Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Details)", "shortName": "OTHER OPERATING INCOME/(EXPENSES) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromGovernmentGrants", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromGovernmentGrants", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock", "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R74": { "role": "http://ambev.com.br/role/ExceptionalItemsDetails", "longName": "00000074 - Disclosure - EXCEPTIONAL ITEMS (Details)", "shortName": "EXCEPTIONAL ITEMS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ExpenseOfRestructuringActivities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock", "abev:DisclosureOfExceptionalItemsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ExpenseOfRestructuringActivities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock", "abev:DisclosureOfExceptionalItemsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R75": { "role": "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails", "longName": "00000075 - Disclosure - PAYROLL AND RELATED BENEFITS (Details)", "shortName": "PAYROLL AND RELATED BENEFITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:WagesAndSalaries", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfPayrollAndRelatedBenefitsTextBlock", "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:WagesAndSalaries", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfPayrollAndRelatedBenefitsTextBlock", "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R76": { "role": "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1", "longName": "00000076 - Disclosure - PAYROLL AND RELATED BENEFITS (Details 1)", "shortName": "PAYROLL AND RELATED BENEFITS (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:EmployeeBenefitsExpenseCostOfSales", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfPayrollAndRelatedBenefitsAffectingTheIncomeStatementTextBlock", "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:EmployeeBenefitsExpenseDistributionExpenses", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfPayrollAndRelatedBenefitsAffectingTheIncomeStatementTextBlock", "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R77": { "role": "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails", "longName": "00000077 - Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details)", "shortName": "ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DepreciationExpenseCostOfSales", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "ifrs-full:DisclosureOfAdditionalInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:DepreciationExpenseCostOfSales", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "ifrs-full:DisclosureOfAdditionalInformationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R78": { "role": "http://ambev.com.br/role/NetFinanceResultDetails", "longName": "00000078 - Disclosure - NET FINANCE RESULT (Details)", "shortName": "NET FINANCE RESULT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestExpense", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceCostExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:NetInterestOnPensionPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinanceCostExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R79": { "role": "http://ambev.com.br/role/NetFinanceResultDetails1", "longName": "00000079 - Disclosure - NET FINANCE RESULT (Details 1)", "shortName": "NET FINANCE RESULT (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInterestExpenseExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInterestExpenseExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R80": { "role": "http://ambev.com.br/role/NetFinanceResultDetails2", "longName": "00000080 - Disclosure - NET FINANCE RESULT (Details 2)", "shortName": "NET FINANCE RESULT (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestIncomeOnCashAndCashEquivalents", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInterestIncomeExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:InterestIncomeOnCashAndCashEquivalents", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInterestIncomeExplanatory", "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R81": { "role": "http://ambev.com.br/role/EarningsPerShareDetails", "longName": "00000081 - Disclosure - EARNINGS PER SHARE (Details)", "shortName": "EARNINGS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:ProfitLossAttributableToOrdinaryEquityHoldersParentEntity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:ProfitLossAttributableToOrdinaryEquityHoldersParentEntity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:EarningsPerShareExplanatory", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R82": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "longName": "00000082 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_CentralAmericaAndCaribbeanMember_ifrs-full_BottomOfRangeMember", "name": "ifrs-full:TaxRateEffectOfForeignTaxRates", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "abev:ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_CentralAmericaAndCaribbeanMember_ifrs-full_BottomOfRangeMember", "name": "ifrs-full:TaxRateEffectOfForeignTaxRates", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "abev:ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R83": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1", "longName": "00000083 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 1)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:CurrentTaxExpenseIncome", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIncomeTaxExplanatory", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R84": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2", "longName": "00000084 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 2)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AccountingProfit", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfReconciliationFromTheWeightedNominalToTheEffectiveTaxRateTextBlock", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AccountingProfit", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfReconciliationFromTheWeightedNominalToTheEffectiveTaxRateTextBlock", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R85": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "longName": "00000085 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 3)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DeferredTaxAssets", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DeferredTaxAssets", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R86": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "longName": "00000086 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 4)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_DeferredTaxesNotRelatedToTaxLossesMember", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfTheRealizationOfDeferredTaxAssetsAndLiabilitiesTextBlock", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R87": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "longName": "00000087 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 5)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details 5)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_ifrs-full_UnusedTaxLossesMember", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfDeferredTaxRealizationRelatedToTaxLossesTextBlock", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R88": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6", "longName": "00000088 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 6)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details 6)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:DeferredTaxLiabilityAsset", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfTheReconciliationOfChangesInDeferredTaxLiabilityAssetTextBlock", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R89": { "role": "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetailsNarrative", "longName": "00000089 - Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details Narrative)", "shortName": "INCOME TAX AND SOCIAL CONTRIBUTION (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:TaxLosesCarriedForwardOfUnilaterallyOffsetProceedings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:TaxLosesCarriedForwardOfUnilaterallyOffsetProceedings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosureOfIncomeTaxAndSocialContributionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R90": { "role": "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails", "longName": "00000090 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:OtherPropertyPlantAndEquipment", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:OtherPropertyPlantAndEquipment", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R91": { "role": "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "longName": "00000091 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 1)", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember", "name": "abev:PropertyPlantAndEquipmentEffectOfAccountingPolicy", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:ReconciliationOfChangesInPropertyPlantAndEquipmentTextBlock", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R92": { "role": "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2", "longName": "00000092 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 2)", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_RightofuseAssetsMember", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfChangesInCarryingAmountOfRightofuseAssetsExplanatory", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R93": { "role": "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3", "longName": "00000093 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 3)", "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_BuildingsMember", "name": "abev:PropertyPlantAndEquipmentUsefulLifes", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "abev:DisclosureOfEstimatedUsefulLivesOfMajorPropertyPlantAndEquipmentClassesTextBlock", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_BuildingsMember", "name": "abev:PropertyPlantAndEquipmentUsefulLifes", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "abev:DisclosureOfEstimatedUsefulLivesOfMajorPropertyPlantAndEquipmentClassesTextBlock", "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R94": { "role": "http://ambev.com.br/role/GoodwillDetails", "longName": "00000094 - Disclosure - GOODWILL (Details)", "shortName": "GOODWILL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:Goodwill", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesGoodwill", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "ifrs-full:DisclosureOfGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R95": { "role": "http://ambev.com.br/role/GoodwillDetails1", "longName": "00000095 - Disclosure - GOODWILL (Details 1)", "shortName": "GOODWILL (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:Goodwill", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:GoodwillGrossAmount", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory", "ifrs-full:DisclosureOfGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R96": { "role": "http://ambev.com.br/role/GoodwillDetailsNarrative", "longName": "00000096 - Disclosure - GOODWILL (Details Narrative)", "shortName": "GOODWILL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:GoodwillPercentageOfTotalAssets", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:GoodwillPercentageOfTotalAssets", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfGoodwillExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R97": { "role": "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails", "longName": "00000097 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details)", "shortName": "IMPAIRMENT OF NON-FINANCIAL ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_ChileMember_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember", "name": "ifrs-full:EquityInstrumentsPercentageContributedToFairValueOfPlanAssets", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_ChileMember_ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember", "name": "ifrs-full:EquityInstrumentsPercentageContributedToFairValueOfPlanAssets", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R98": { "role": "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative", "longName": "00000098 - Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details Narrative)", "shortName": "IMPAIRMENT OF NON-FINANCIAL ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember", "name": "abev:GrowthRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember", "name": "abev:GrowthRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R99": { "role": "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "longName": "00000099 - Disclosure - INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details)", "shortName": "INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember", "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R100": { "role": "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails", "longName": "00000100 - Disclosure - INTANGIBLES - Intangible Assets by Location (Details)", "shortName": "INTANGIBLES - Intangible Assets by Location (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R101": { "role": "http://ambev.com.br/role/IntangiblesDetailsNarrative", "longName": "00000101 - Disclosure - INTANGIBLES (Details Narrative)", "shortName": "INTANGIBLES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember-2112976031", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_BottomOfRangeMember-2112976031", "name": "ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ifrs-full:DisclosureOfIntangibleAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R102": { "role": "http://ambev.com.br/role/RecoverableTaxesDetails", "longName": "00000102 - Disclosure - RECOVERABLE TAXEs (Details)", "shortName": "RECOVERABLE TAXEs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "102", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:RecoverableTaxCreditAssetsNoncurrent", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock", "abev:RecoverableTaxesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:RecoverableTaxCreditAssetsNoncurrent", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock", "abev:RecoverableTaxesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R103": { "role": "http://ambev.com.br/role/InventoryDetails", "longName": "00000103 - Disclosure - INVENTORY (Details)", "shortName": "INVENTORY (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "103", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinishedGoods", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfInventoryComponentsTextBlock", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinishedGoods", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfInventoryComponentsTextBlock", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R104": { "role": "http://ambev.com.br/role/InventoryDetails1", "longName": "00000104 - Disclosure - INVENTORY (Details 1)", "shortName": "INVENTORY (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "104", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_InventoryProvisionMember", "name": "ifrs-full:OtherProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_custom_InventoryProvisionMember", "name": "ifrs-full:OtherProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfOtherProvisionsExplanatory", "ifrs-full:DisclosureOfInventoriesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R105": { "role": "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails", "longName": "00000105 - Disclosure - TRADE RECEIVABLES - Current Trade Receivables (Details)", "shortName": "TRADE RECEIVABLES - Current Trade Receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "105", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfCurrentTradeReceivablesTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:BadDebtProvision", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfCurrentTradeReceivablesTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R106": { "role": "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails", "longName": "00000106 - Disclosure - TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details)", "shortName": "TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "106", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfCurrentTradeReceivablesTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:BadDebtProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfMaturityOfTheCurrentTradeReceivablesTextBlock", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R107": { "role": "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails", "longName": "00000107 - Disclosure - TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details)", "shortName": "TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "107", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_BadDebtProvisionMember", "name": "ifrs-full:OtherProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfOtherProvisionExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_custom_BadDebtProvisionMember", "name": "ifrs-full:OtherProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfOtherProvisionExplanatory", "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R108": { "role": "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails", "longName": "00000108 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details)", "shortName": "CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "108", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfComponentsInCashAndCashEquivalentsTextBlock", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfComponentsInCashAndCashEquivalentsTextBlock", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R109": { "role": "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails", "longName": "00000109 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details)", "shortName": "CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "109", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DebtInstrumentsHeld", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfInvestmentSecuritiesTextBlock", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DebtInstrumentsHeld", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfInvestmentSecuritiesTextBlock", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R110": { "role": "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesDetailsNarrative", "longName": "00000110 - Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Details Narrative)", "shortName": "CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "110", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:ShorttermDepositsGuaranteeDeposits", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:ShorttermDepositsGuaranteeDeposits", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R111": { "role": "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "longName": "00000111 - Disclosure - CHANGES IN EQUITY - Capital Stock (Details)", "shortName": "CHANGES IN EQUITY - Capital Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "111", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NumberOfSharesOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:ShareholderPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfIssuedCapitalExplanatory", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R112": { "role": "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails", "longName": "00000112 - Disclosure - CHANGES IN EQUITY - Capital Reserves (Details)", "shortName": "CHANGES IN EQUITY - Capital Reserves (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "112", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:CapitalReserve", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_TreasurySharesMember", "name": "ifrs-full:CapitalReserve", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfClassesOfCapitalReservesTextBlock", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R113": { "role": "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails", "longName": "00000113 - Disclosure - CHANGES IN EQUITY - Treasury Shares (Details)", "shortName": "CHANGES IN EQUITY - Treasury Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "113", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "abev:TreasurySharesAcquiredrealizedOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTreasurySharesExplanatory", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31", "name": "abev:TreasurySharesAcquiredrealizedOutstanding", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTreasurySharesExplanatory", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R114": { "role": "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "longName": "00000114 - Disclosure - CHANGES IN EQUITY - Net Income Reserves (Details)", "shortName": "CHANGES IN EQUITY - Net Income Reserves (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "114", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:Equity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_custom_NetIncomeReservesInvestmentReserveMember", "name": "ifrs-full:Equity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfNetIncomeReservesTextBlock", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R115": { "role": "http://ambev.com.br/role/ChangesInEquity-InterestOnShareholdersEquityDividendsDetails", "longName": "00000115 - Disclosure - CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details)", "shortName": "CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "115", "firstAnchor": { "contextRef": "From2023-12-282023-12-31", "name": "abev:InterestOnShareholdersEquityDividendsAmountPerShare", "unitRef": "BRLPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfInterestOnShareholdersEquityAndDividendsTextBlock", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-12-282023-12-31", "name": "abev:InterestOnShareholdersEquityDividendsAmountPerShare", "unitRef": "BRLPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfInterestOnShareholdersEquityAndDividendsTextBlock", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R116": { "role": "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "longName": "00000116 - Disclosure - CHANGES IN EQUITY - Basis for Dividends (Details)", "shortName": "CHANGES IN EQUITY - Basis for Dividends (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "116", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_RetainedEarningsMember", "name": "ifrs-full:ProfitLossAttributableToOwnersOfParent", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureForTheBasisOfDividendsTextBlock", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R117": { "role": "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "longName": "00000117 - Disclosure - CHANGES IN EQUITY - Carrying Value Adjustments (Details)", "shortName": "CHANGES IN EQUITY - Carrying Value Adjustments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "117", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:Equity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_custom_CarryingValueAdjustmentsTranslationReservesMember", "name": "ifrs-full:Equity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfChangesInCarryingValueOfEquityTextBlock", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R118": { "role": "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "longName": "00000118 - Disclosure - CHANGES IN EQUITY (Details Narrative)", "shortName": "CHANGES IN EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "118", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:Equity", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:InvestmentReserveLimitPercentageOfNetIncome", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "abev:DisclosureOfChangesInEquityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R119": { "role": "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails", "longName": "00000119 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details)", "shortName": "INTEREST-BEARING LOANS AND BORROWING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "119", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:LongtermBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_SecuredBankLoansMember", "name": "ifrs-full:LongtermBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfTotalLiabilitiesTextBlock", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R120": { "role": "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1", "longName": "00000120 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 1)", "shortName": "INTEREST-BEARING LOANS AND BORROWING (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "120", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentPortionOfLongtermBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentPortionOfLongtermBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R121": { "role": "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2", "longName": "00000121 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 2)", "shortName": "INTEREST-BEARING LOANS AND BORROWING (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "121", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:LongtermBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProceedsFromNoncurrentBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTextBlock", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R122": { "role": "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3", "longName": "00000122 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 3)", "shortName": "INTEREST-BEARING LOANS AND BORROWING (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "122", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:LongtermBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_NotLaterThanOneYearMember", "name": "ifrs-full:LongtermBorrowings", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:ScheduleOfMaturityOfContractsTableTextBlock", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R123": { "role": "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4", "longName": "00000123 - Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 4)", "shortName": "INTEREST-BEARING LOANS AND BORROWING (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "123", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_LeaseTerm20232027Member", "name": "ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_LeaseTerm20232027Member", "name": "ifrs-full:WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R124": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails", "longName": "00000124 - Disclosure - EMPLOYEE BENEFITS (Details)", "shortName": "EMPLOYEE BENEFITS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "124", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:DefinedBenefitObligationFundedPortionAtPresentValue", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:DefinedBenefitObligationFundedPortionAtPresentValue", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R125": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails1", "longName": "00000125 - Disclosure - EMPLOYEE BENEFITS (Details 1)", "shortName": "EMPLOYEE BENEFITS (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "125", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_PresentValueOfDefinedBenefitObligationMember", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfDefinedBenefitObligationTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R126": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails2", "longName": "00000126 - Disclosure - EMPLOYEE BENEFITS (Details 2)", "shortName": "EMPLOYEE BENEFITS (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "126", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_PlanAssetsMember", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfTheChangeInFairValueOfThePlanAssetsTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R127": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails3", "longName": "00000127 - Disclosure - EMPLOYEE BENEFITS (Details 3)", "shortName": "EMPLOYEE BENEFITS (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "127", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_EffectOfAssetCeilingMember", "name": "ifrs-full:LiabilityAssetOfDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfAssetCeilingTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R128": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails4", "longName": "00000128 - Disclosure - EMPLOYEE BENEFITS (Details 4)", "shortName": "EMPLOYEE BENEFITS (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "128", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfDefinedBenefitPlansRecognizedInTheIncomeStatementTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAssets", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfDefinedBenefitPlansRecognizedInTheIncomeStatementTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R129": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails5", "longName": "00000129 - Disclosure - EMPLOYEE BENEFITS (Details 5)", "shortName": "EMPLOYEE BENEFITS (Details 5)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "129", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:PostemploymentBenefitIncomeExpenseDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfEmployeeBenefitRevenueExpensesAllocationInIncomeStatementTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:PostemploymentBenefitIncomeExpenseDefinedBenefitPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfEmployeeBenefitRevenueExpensesAllocationInIncomeStatementTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R130": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails6", "longName": "00000130 - Disclosure - EMPLOYEE BENEFITS (Details 6)", "shortName": "EMPLOYEE BENEFITS (Details 6)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "130", "firstAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_BottomOfRangeMember", "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "abev:DisclosureOfActuarialAssumptionsOfTheEntityTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_BottomOfRangeMember", "name": "ifrs-full:ActuarialAssumptionOfDiscountRates", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "abev:DisclosureOfActuarialAssumptionsOfTheEntityTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R131": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails7", "longName": "00000131 - Disclosure - EMPLOYEE BENEFITS (Details 7)", "shortName": "EMPLOYEE BENEFITS (Details 7)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "131", "firstAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember", "name": "ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember", "name": "ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R132": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetails8", "longName": "00000132 - Disclosure - EMPLOYEE BENEFITS (Details 8)", "shortName": "EMPLOYEE BENEFITS (Details 8)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "132", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_PlanAssetsGovernmentBondsMember", "name": "abev:RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "abev:DisclosureOfPlanAssetsComponentsTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_PlanAssetsGovernmentBondsMember", "name": "abev:RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "abev:DisclosureOfPlanAssetsComponentsTextBlock", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R133": { "role": "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative", "longName": "00000133 - Disclosure - EMPLOYEE BENEFITS (Details Narrative)", "shortName": "EMPLOYEE BENEFITS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "133", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfPayrollAndRelatedBenefitsTextBlock", "abev:DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfEmployeeBenefitsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R134": { "role": "http://ambev.com.br/role/Share-basedPaymentsDetails", "longName": "00000134 - Disclosure - SHARE-BASED PAYMENTS (Details)", "shortName": "SHARE-BASED PAYMENTS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "134", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_RestrictedSharesMember", "name": "abev:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_custom_RestrictedSharesMember", "name": "abev:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R135": { "role": "http://ambev.com.br/role/Share-basedPaymentsDetails1", "longName": "00000135 - Disclosure - SHARE-BASED PAYMENTS (Details 1)", "shortName": "SHARE-BASED PAYMENTS (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "135", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "abev:NumberOfOutstandingShareOptions1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "span", "td", "tr", "table", "abev:ScheduleOfOutstandingOptionsTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31", "name": "abev:NumberOfOutstandingShareOptions1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "span", "td", "tr", "table", "abev:ScheduleOfOutstandingOptionsTableTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R136": { "role": "http://ambev.com.br/role/Share-basedPaymentsDetails2", "longName": "00000136 - Disclosure - SHARE-BASED PAYMENTS (Details 2)", "shortName": "SHARE-BASED PAYMENTS (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "136", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "unitRef": "BRLPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfWeightedAverageExercisePricesOfShareOptionsTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "unitRef": "BRLPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfWeightedAverageExercisePricesOfShareOptionsTextBlock", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R137": { "role": "http://ambev.com.br/role/Share-basedPaymentsDetails3", "longName": "00000137 - Disclosure - SHARE-BASED PAYMENTS (Details 3)", "shortName": "SHARE-BASED PAYMENTS (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "137", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_DeferredSharesMember", "name": "abev:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfNumbersAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_custom_DeferredSharesMember", "name": "abev:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfNumbersAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R138": { "role": "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative", "longName": "00000138 - Disclosure - SHARE-BASED PAYMENTS (Details Narrative)", "shortName": "SHARE-BASED PAYMENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "138", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R139": { "role": "http://ambev.com.br/role/TradePayablesDetails", "longName": "00000139 - Disclosure - TRADE PAYABLES (Details)", "shortName": "TRADE PAYABLES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "139", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NoncurrentPayablesToTradeSuppliers", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfTheComponentsOfTradePayablesTextBlock", "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NoncurrentPayablesToTradeSuppliers", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfTheComponentsOfTradePayablesTextBlock", "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R140": { "role": "http://ambev.com.br/role/TradePayablesDetailsNarrative", "longName": "00000140 - Disclosure - TRADE PAYABLES (Details Narrative)", "shortName": "TRADE PAYABLES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "140", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:TradeAndOtherPayables1", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:TradeAndOtherPayables1", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R141": { "role": "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "longName": "00000141 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details)", "shortName": "PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "141", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:Provisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfOtherProvisionsChangesExplanatory", "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfOtherProvisionsChangesExplanatory", "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R142": { "role": "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1", "longName": "00000142 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1)", "shortName": "PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "142", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NoncurrentProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember", "name": "ifrs-full:NoncurrentProvisions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfTheDisbursementExpectativeOfTheProvisionsTextBlock", "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R143": { "role": "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2", "longName": "00000143 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2)", "shortName": "PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "143", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:EstimatedFinancialEffectOfContingentLiabilities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfEstimatesOfPossibleLossesTextBlock", "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:EstimatedFinancialEffectOfContingentLiabilities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfEstimatesOfPossibleLossesTextBlock", "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R144": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails", "longName": "00000144 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "144", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialAssets", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialAssets", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R145": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "longName": "00000145 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 1)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "145", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_TotalCostExposureMember", "name": "abev:NotionalAmount1", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_TotalCostExposureMember", "name": "abev:NotionalAmount1", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfFinancialRiskManagementExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R146": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "longName": "00000146 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 2)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "146", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:FinancialAssetsAtFairValue", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfFinancialInstrumentsFairValueHierarchyTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_TotalCostExposureMember", "name": "abev:NotionalAmountOne", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfNotionalAndFairValueAmountsPerFinancialInstrumentAndMaturityTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R147": { "role": "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative", "longName": "00000147 - Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details Narrative)", "shortName": "PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "147", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_UncertaintyOverTheTreatmentOfIncomeTaxesMember", "name": "ifrs-full:ReductionOfIssuedCapital", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_UncertaintyOverTheTreatmentOfIncomeTaxesMember", "name": "ifrs-full:ReductionOfIssuedCapital", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R148": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3", "longName": "00000148 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 3)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "148", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:FinancialAssetsInvestmentSecurities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfFinancialInstrumentsFairValueHierarchyTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:FinancialAssetsInvestmentSecurities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfFinancialInstrumentsFairValueHierarchyTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R149": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4", "longName": "00000149 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 4)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 4)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "149", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:FinancialLiabilities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31_ifrs-full_Level3OfFairValueHierarchyMember", "name": "ifrs-full:FinancialLiabilities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R150": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5", "longName": "00000150 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 5)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 5)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "150", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_InterestRateRiskBrazilianReaisMember", "name": "abev:PostfixedInterestRatePrehedged", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutHedgingInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_InterestRateRiskBrazilianReaisMember", "name": "abev:PostfixedInterestRatePrehedged", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutHedgingInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R151": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6", "longName": "00000151 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 6)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 6)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "151", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "abev:FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:SensitivityAnalysisForEachTypeOfMarketRisk", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R152": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "longName": "00000152 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 7)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 7)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "152", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:TradeAndOtherPayables", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "abev:DisclosureOfTheComponentsOfTradePayablesTextBlock", "abev:DisclosuresOfTradeAndOtherPayablesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_NotLaterThanOneYearMember", "name": "ifrs-full:TradeAndOtherPayables", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:ScheduleOfDisclosureOfTermsAndDebtRepaymentsTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R153": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails8", "longName": "00000153 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 8)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details 8)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "153", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:InterestbearingLoansAndBorrowingsCurrentAndNoncurrent", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:ScheduleOfNetDebtOfContinuityInTheLongTerm", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:InterestbearingLoansAndBorrowingsCurrentAndNoncurrent", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:ScheduleOfNetDebtOfContinuityInTheLongTerm", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R154": { "role": "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative", "longName": "00000154 - Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details Narrative)", "shortName": "FINANCIAL INSTRUMENTS AND RISKS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "154", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:InstrumentsSharingCharacteristicHighlyLiquidInvestments", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:InstrumentsSharingCharacteristicHighlyLiquidInvestments", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R155": { "role": "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails", "longName": "00000155 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details)", "shortName": "COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "155", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R156": { "role": "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails", "longName": "00000156 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details)", "shortName": "COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "156", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:TotalExposureLiabilities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_NotLaterThanOneYearMember", "name": "abev:TotalExposureLiabilities", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfFutureContractualCommitmentsTextBlock", "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "unique": true } }, "R157": { "role": "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersDetailsNarrative", "longName": "00000157 - Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Details Narrative)", "shortName": "COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "157", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:CashGuarantees", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "abev:CashGuarantees", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "abev:DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R158": { "role": "http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails", "longName": "00000158 - Disclosure - RELATED PARTIES - Expenses Related to Management Members (Details)", "shortName": "RELATED PARTIES - Expenses Related to Management Members (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "158", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfKeyManagementPersonnelCompensationTextBlock", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "td", "tr", "table", "abev:DisclosureOfKeyManagementPersonnelCompensationTextBlock", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R159": { "role": "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails", "longName": "00000159 - Disclosure - RELATED PARTIES - Transactions With Related Parties (Details)", "shortName": "RELATED PARTIES - Transactions With Related Parties (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "159", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "b", "span", "td", "tr", "table", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R160": { "role": "http://ambev.com.br/role/RelatedPartiesDetailsNarrative", "longName": "00000160 - Disclosure - RELATED PARTIES (Details Narrative)", "shortName": "RELATED PARTIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "160", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_FundacaoZerrennerMember-2112933515", "name": "abev:PercentageOfOwnershipHeldByARelatedParty", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_FundacaoZerrennerMember-2112933515", "name": "abev:PercentageOfOwnershipHeldByARelatedParty", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfRelatedPartyExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } }, "R161": { "role": "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative", "longName": "00000161 - Disclosure - EVENTS AFTER THE REPORTING PERIOD (Details Narrative)", "shortName": "EVENTS AFTER THE REPORTING PERIOD (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "161", "firstAnchor": { "contextRef": "AsOf2024-01-31", "name": "abev:ReductionOfAssessedAmount", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-31", "name": "abev:ReductionOfAssessedAmount", "unitRef": "BRL", "xsiNil": "false", "lang": null, "decimals": "-6", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "abevform20f_2023.htm", "first": true, "unique": true } } }, "tag": { "country_AR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "AR", "presentation": [ "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ARGENTINA" } } }, "auth_ref": [] }, "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2": { "parentTag": "abev_NetAccountingProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Profit before tax" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r53", "r54" ] }, "abev_AccountsPayablePresentValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AccountsPayablePresentValue", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails1" ], "lang": { "en-us": { "role": { "label": "Accounts payable present value" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation, amortisation and impairment [member]" } }, "en": { "role": { "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]" } } }, "auth_ref": [ "r59", "r66", "r131", "r141", "r144" ] }, "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Acquisition", "verboseLabel": "Additions" } }, "en": { "role": { "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r60" ] }, "abev_ActiveEmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ActiveEmployeesMember", "presentation": [ "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Active employees [member]", "documentation": "Employees who are still active with the company." } } }, "auth_ref": [] }, "abev_ActuarialAssumptionOfDentalClaimsCostTrendRates": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ActuarialAssumptionOfDentalClaimsCostTrendRates", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Dental claims trend rate" } } }, "auth_ref": [] }, "ifrs-full_ActuarialAssumptionOfDiscountRates": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfDiscountRates", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Discount rate" } }, "en": { "role": { "documentation": "The discount rate used as the significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfDiscountRatesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Actuarial assumption of discount rates [member]" } }, "en": { "role": { "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } } }, "auth_ref": [ "r377" ] }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflation": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfExpectedRatesOfInflation", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Inflation" } }, "en": { "role": { "documentation": "The expected rate of inflation that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfPensionIncreases": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfExpectedRatesOfPensionIncreases", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Future pension increases" } }, "en": { "role": { "documentation": "The expected rate of increases in pension that is used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreases": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreases", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Future salary increases" } }, "en": { "role": { "documentation": "The expected rate of salary increases used as a significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit plans [member]; Defined benefit obligation, at present value; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Actuarial assumption of expected rates of salary increases [member]" } }, "en": { "role": { "documentation": "This member stands for the expected rates of salary increases used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } } }, "auth_ref": [ "r377" ] }, "ifrs-full_ActuarialAssumptionOfLifeExpectancyAfterRetirementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfLifeExpectancyAfterRetirementMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Actuarial assumption of life expectancy after retirement [member]" } }, "en": { "role": { "documentation": "This member stands for the life expectancy after retirement used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } } }, "auth_ref": [ "r377" ] }, "abev_ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge": { "xbrltype": "durationItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Life expectancy for an over 65 years old female" } } }, "auth_ref": [] }, "abev_ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge": { "xbrltype": "durationItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Life expectancy for an over 65 years old male" } } }, "auth_ref": [] }, "ifrs-full_ActuarialAssumptionOfMedicalCostTrendRates": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfMedicalCostTrendRates", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6" ], "lang": { "en-us": { "role": { "label": "Medical cost trend rate" } }, "en": { "role": { "documentation": "Medical cost trend rate used as significant actuarial assumption to determine the present value of a defined benefit obligation. [Refer: Defined benefit obligation, at present value; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r376" ] }, "ifrs-full_ActuarialAssumptionOfMedicalCostTrendRatesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionOfMedicalCostTrendRatesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Actuarial assumption of medical cost trend rates [member]" } }, "en": { "role": { "documentation": "This member stands for the medical cost trend rates used as actuarial assumptions. [Refer: Actuarial assumptions [member]]" } } }, "auth_ref": [ "r377" ] }, "ifrs-full_ActuarialAssumptionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionsAxis", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Actuarial assumptions [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r87" ] }, "ifrs-full_ActuarialAssumptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialAssumptionsMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en": { "role": { "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used." } } }, "auth_ref": [ "r87" ] }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Actuarial gains and (losses) - geographical assumptions" } }, "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in demographic assumptions that result in remeasurements of the net defined benefit liability (asset). Demographic assumptions deal with matters such as: (a) mortality; (b) rates of employee turnover, disability and early retirement; (c) the proportion of plan members with dependants who will be eligible for benefits; (d) the proportion of plan members who will select each form of payment option available under the plan terms; and (e) claim rates under medical plans. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r76" ] }, "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Actuarial gains and (losses) - financial assumptions" } }, "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r77" ] }, "ifrs-full_ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Experience adjustments" } }, "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from experience adjustments that result in remeasurements of the net defined benefit liability (asset). Experience adjustments deal with the effects of differences between the previous actuarial assumptions and what has actually occurred. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r373" ] }, "abev_AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureAbstract", "lang": { "en-us": { "role": { "label": "Additional Information On Cost Of Sales And Operating Expenses By Nature" } } }, "auth_ref": [] }, "abev_AdditionalProvisionsOtherProvision": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdditionalProvisionsOtherProvision", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Additions", "label": "AdditionalProvisionsOtherProvision" } } }, "auth_ref": [] }, "ifrs-full_AdditionalProvisionsOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionalProvisionsOtherProvisions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Additions", "label": "Additional provisions, other provisions" } }, "en": { "role": { "documentation": "The amount of additional other provisions made. [Refer: Other provisions]" } } }, "auth_ref": [ "r122" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions" } }, "en": { "role": { "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r132" ] }, "abev_AdditionsToLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdditionsToLeaseLiabilityCurrent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "New lease agreements, current" } } }, "auth_ref": [] }, "abev_AdditionsToLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdditionsToLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "New lease agreements, non-current" } } }, "auth_ref": [] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "abev_AdiministrativeCostsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdiministrativeCostsNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails4" ], "lang": { "en-us": { "role": { "negatedLabel": "Administrative costs", "label": "Administrative costs" } } }, "auth_ref": [] }, "ifrs-full_AdjustedWeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustedWeightedAverageShares", "presentation": [ "http://ambev.com.br/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average numbers of shares\u00a0(i)\u00a0(diluted)" } }, "en": { "role": { "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r111" ] }, "abev_AdjustmentOnTaxExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdjustmentOnTaxExpenseAbstract", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Adjustment on tax expense" } } }, "auth_ref": [] }, "abev_AdjustmentOnTaxableBasisAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdjustmentOnTaxableBasisAbstract", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Adjustment on a taxable basis" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForAmountsTransferredToInitialCarryingAmountOfHedgedItems": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForAmountsTransferredToInitialCarryingAmountOfHedgedItems", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "negatedLabel": "Reclassified from Equity (Hedge reserve) and included in profit or loss", "label": "Amounts removed from equity and included in carrying amount of non-financial asset (liability) whose acquisition or incurrence was hedged highly probable forecast transaction, net of tax" } }, "en": { "role": { "documentation": "The amounts removed from equity and included in the initial cost or other carrying amount of a non-financial asset (liability) whose acquisition or incurrence was a hedged, highly probable forecast transaction, net of tax. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r273" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInInventories", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "(Increase)/decrease in inventories" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]" } } }, "auth_ref": [ "r390" ] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "(Increase)/decrease in trade and other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in trade and other receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other receivables; Profit (loss)]" } } }, "auth_ref": [ "r392" ] }, "ifrs-full_AdjustmentsForDeferredTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDeferredTaxExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1" ], "lang": { "en-us": { "role": { "label": "Deferred tax on tax loss carryforward movements in the current period" } }, "en": { "role": { "documentation": "Adjustments for deferred tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Deferred tax expense (income); Profit (loss)]" } } }, "auth_ref": [ "r392" ] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation, amortization and impairment" } }, "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Impairment loss; Depreciation and amortisation expense; Impairment loss (reversal of impairment loss) recognised in profit or loss; Profit (loss)]" } } }, "auth_ref": [ "r392" ] }, "ifrs-full_AdjustmentsForFinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForFinanceIncomeCost", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Net finance costs", "label": "Adjustments for finance income (cost)" } }, "en": { "role": { "documentation": "Adjustments for net finance income or cost to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance income (cost); Profit (loss)]" } } }, "auth_ref": [ "r392" ] }, "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Losses/(gains) on sale of property, plant and equipment and intangible assets", "label": "Adjustments for gain (loss) on disposals, property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]" } } }, "auth_ref": [ "r392" ] }, "abev_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossReceivablesAndInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossReceivablesAndInventories", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Impairment losses on receivables and inventory" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncomeTaxExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Income tax expense" } }, "en": { "role": { "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r150" ] }, "abev_AdjustmentsForIncreaseDecreaseInProvisionsAndEmployeeBenefitLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdjustmentsForIncreaseDecreaseInProvisionsAndEmployeeBenefitLiabilities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Additions/(reversals) in provisions and employee benefits" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase/(decrease) in trade and other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r392" ] }, "ifrs-full_AdjustmentsForProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForProvisions", "crdr": "debit", "calculation": { "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "(Additions)/reversals of provisions", "label": "Adjustments for provisions" } }, "en": { "role": { "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]" } } }, "auth_ref": [ "r391" ] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Share-based payment expenses", "verboseLabel": "Adjustments for share-based payments" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r391" ] }, "abev_AdjustmentsToEquityOptionsGrantedOnSubsidiary": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AdjustmentsToEquityOptionsGrantedOnSubsidiary", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Options granted on subsidiaries" } } }, "auth_ref": [] }, "ifrs-full_AggregatedTimeBandsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedTimeBandsMember", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r25", "r184", "r189", "r190", "r193", "r194", "r196", "r202", "r222", "r292", "r325", "r328" ] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r85", "r174" ] }, "abev_AmbevPeruMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmbevPeruMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Ambev Peru [member]", "documentation": "This member stands for Ambev Peru." } } }, "auth_ref": [] }, "abev_AmbrewSARLMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmbrewSARLMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Ambrew S A R L [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_AmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationExpense", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Total amortisation expenses" } }, "en": { "role": { "documentation": "The amount of amortisation expense. Amortisation is the systematic allocation of depreciable amounts of intangible assets over their useful lives." } } }, "auth_ref": [ "r359" ] }, "abev_AmortisationExpenseCostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmortisationExpenseCostOfSales", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets cost of sales" } } }, "auth_ref": [] }, "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmortisationIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Amortization", "negatedLabel": "Amortization" } }, "en": { "role": { "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r134" ] }, "abev_AmortisationOfAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmortisationOfAdministrativeExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets administrative expenses" } } }, "auth_ref": [] }, "abev_AmortisationOfCommercialExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmortisationOfCommercialExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets commercial expenses" } } }, "auth_ref": [] }, "abev_AmortisationOfDistributionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmortisationOfDistributionExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Amortization of intangible assets distribution expenses" } } }, "auth_ref": [] }, "abev_AmountForPossibleContingency": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmountForPossibleContingency", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amount for possible contingency" } } }, "auth_ref": [] }, "abev_AmountUpToTheAssetCeilingNotExceedingThePresentValueOfFutureBenefitsInADefinedBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AmountUpToTheAssetCeilingNotExceedingThePresentValueOfFutureBenefitsInADefinedBenefitPlan", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amount up to the asset ceiling not exceeding the present value of future benefits in a defined benefit plan" } } }, "auth_ref": [] }, "abev_AnheuserBuschAfricaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AnheuserBuschAfricaMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Anheuser-Busch Africa [member]", "documentation": "Refers to information regarding the entity Anheuser-Busch Africa." } } }, "auth_ref": [] }, "abev_AnheuserBuschInBevNvMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AnheuserBuschInBevNvMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Anheuser-Busch InBev N.V. [member]", "documentation": "Refers to information regarding the entity Anheuser-Busch InBev N.V." } } }, "auth_ref": [] }, "abev_AnheuserBuschInbevServicesLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AnheuserBuschInbevServicesLlcMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Anheuser-Busch Inbev Services LLC [member]", "documentation": "The entity Anheuser-Busch Inbev Services LLC." } } }, "auth_ref": [] }, "abev_AnheuserBuschInbevUsaLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AnheuserBuschInbevUsaLlcMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Anheuser-Busch Inbev USA LLC [member]", "documentation": "The entity Anheuser-Busch Inbev USA LLC." } } }, "auth_ref": [] }, "abev_AnheuserBuschIncMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AnheuserBuschIncMember", "presentation": [ "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Anheuser-Busch, Inc [member]", "documentation": "The entity Anheuser-Busch, Inc." } } }, "auth_ref": [] }, "abev_AnheuserBuschPackageMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AnheuserBuschPackageMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Anheuser-Busch Package [member]", "documentation": "Refers to information regarding the entity Anheuser-Busch Package." } } }, "auth_ref": [] }, "abev_AnheuserBuschProcurementMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AnheuserBuschProcurementMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Anheuser-Busch Procurement [member]", "documentation": "Refers to information regarding the entity Anheuser-Busch Procurement." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r349" ] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Aggregated weighted nominal tax rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r54" ] }, "abev_ArgentinaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ArgentinaMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Argentina [Member]" } } }, "auth_ref": [] }, "abev_ArgentineanPesoSpentInArgentinaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ArgentineanPesoSpentInArgentinaMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Argentinean Peso Spent In Argentina [Member]" } } }, "auth_ref": [] }, "abev_AssetCeiling": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AssetCeiling", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Asset ceiling", "label": "AssetCeiling" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Total assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r21", "r173", "r174", "r178", "r256", "r259" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Assets" } } }, "auth_ref": [] }, "ifrs-full_AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Collateral given for the Companys own liabilities" } }, "en": { "role": { "documentation": "The fair value of collateral held that is permitted to be sold or repledged in the absence of default by the owner of the collateral. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r219" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r349" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm Id", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r346", "r348", "r349" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r346", "r348", "r349" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r346", "r348", "r349" ] }, "abev_AuthorizedShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "AuthorizedShareCapitalMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Authorized Share Capital [Member]" } } }, "auth_ref": [] }, "ifrs-full_AverageEffectiveTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AverageEffectiveTaxRate", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Effective tax rate" } }, "en": { "role": { "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]" } } }, "auth_ref": [ "r54" ] }, "ifrs-full_AverageForeignExchangeRate": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AverageForeignExchangeRate", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Average rate" } }, "en": { "role": { "documentation": "The average exchange rate used by the entity. Exchange rate is the ratio of exchange for two currencies." } } }, "auth_ref": [ "r359" ] }, "country_BR": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "BR", "presentation": [ "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "BRAZIL" } } }, "auth_ref": [] }, "abev_BadDebtProvision": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BadDebtProvision", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails": { "parentTag": "abev_CurrentTradeReceivablesNetOfBadDebtProvisions", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Bad debt provision", "label": "BadDebtProvision" } } }, "auth_ref": [] }, "abev_BadDebtProvisionMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BadDebtProvisionMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "label": "Bad Debt Provision [Member]" } } }, "auth_ref": [] }, "abev_BadDebtProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BadDebtProvisions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Bad debt provision" } } }, "auth_ref": [] }, "ifrs-full_BalancesWithBanks": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BalancesWithBanks", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Current bank accounts" } }, "en": { "role": { "documentation": "The amount of cash balances held at banks." } } }, "auth_ref": [ "r393" ] }, "ifrs-full_BankAndSimilarCharges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BankAndSimilarCharges", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Bank guarantee expenses", "label": "Bank and similar charges" } }, "en": { "role": { "documentation": "The amount of bank and similar charges recognised by the entity as an expense." } } }, "auth_ref": [ "r359" ] }, "abev_BankOverdraftsClassifiedAsCashEquivalent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BankOverdraftsClassifiedAsCashEquivalent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Bank overdrafts", "label": "BankOverdraftsClassifiedAsCashEquivalent" } } }, "auth_ref": [] }, "ifrs-full_BankOverdraftsClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BankOverdraftsClassifiedAsCashEquivalents", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Bank overdrafts" } }, "en": { "role": { "documentation": "The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r393" ] }, "abev_BarbadianDollarSpentInBarbadosMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BarbadianDollarSpentInBarbadosMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Barbadian Dollar Spent In Barbados [Member]" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic earnings per share \u2013 common \u2013 R$", "verboseLabel": "Basic EPS" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r109", "r110" ] }, "abev_BavariaSaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BavariaSaMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Bavaria S.A. [member]", "documentation": "The entity Bavaria S.A." } } }, "auth_ref": [] }, "abev_BeerMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BeerMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Beer [Member]" } } }, "auth_ref": [] }, "abev_BoardOfDirectorsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BoardOfDirectorsMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Board Of Directors [Member]" } } }, "auth_ref": [] }, "abev_BoliviaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BoliviaMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Bolivia [Member]" } } }, "auth_ref": [] }, "abev_BolivianPesoSpentInBoliviaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "BolivianPesoSpentInBoliviaMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Bolivian Peso Spent In Bolivia [Member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r397" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r397" ] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Average rate", "label": "Borrowings, interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r397" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/IntangiblesDetailsNarrative", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r180", "r196", "r210", "r316", "r317", "r397" ] }, "ifrs-full_BrandNamesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BrandNamesMember", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Brand names [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r301" ] }, "abev_Brazil1Member": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "Brazil1Member", "presentation": [ "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Brazil 1 [Member]" } } }, "auth_ref": [] }, "ifrs-full_BuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BuildingsMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Buildings [member]" } }, "en": { "role": { "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r370" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r348", "r349" ] }, "country_CA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2023", "localname": "CA", "presentation": [ "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "CANADA" } } }, "auth_ref": [] }, "abev_CACMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CACMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "CAC [member]" } } }, "auth_ref": [] }, "abev_CanadaSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CanadaSegmentMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Canada Segment [Member]" } } }, "auth_ref": [] }, "abev_CanadianDollarsSpentInCanadaAndCubaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CanadianDollarsSpentInCanadaAndCubaMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Canadian Dollars Spent In Canada And Cuba [Member]" } } }, "auth_ref": [] }, "abev_CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Capex Purchases Affecting The Foreign Currency Exchange Risk Portion Of The Fixed Assets Exposure [Member]" } } }, "auth_ref": [] }, "ifrs-full_CapitalReserve": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CapitalReserve", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails", "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Reserves", "periodStartLabel": "Beginning balance, capital reserves", "periodEndLabel": "Final balance, capital reserves" } }, "en": { "role": { "documentation": "A component of equity representing the capital reserves." } } }, "auth_ref": [ "r362" ] }, "ifrs-full_CapitalReserveMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CapitalReserveMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Capital reserve [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing capital reserves." } } }, "auth_ref": [ "r358" ] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r59", "r63", "r131", "r136", "r140", "r141", "r142", "r143", "r144", "r216", "r233", "r234" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r63", "r136", "r140", "r142", "r143", "r216", "r233", "r234" ] }, "abev_CarryingValueAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustment [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments Accounting Adjustments For Transactions Between Shareholders [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsActuarialGainslossesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsActuarialGainslossesMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments Actuarial Gainslosses [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsBusinessCombinationMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsBusinessCombinationMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments Business Combination [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsCashFlowHedgeMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsCashFlowHedgeMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments Cash Flow Hedge [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments Gains Losses Of Noncontrolling Interests Share [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments Put Option Granted On Subsidiary [Member]" } } }, "auth_ref": [] }, "abev_CarryingValueAdjustmentsTranslationReservesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CarryingValueAdjustmentsTranslationReservesMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "label": "Carrying Value Adjustments Translation Reserves [Member]" } } }, "auth_ref": [] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails", "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r14", "r152", "r168" ] }, "abev_CashAndCashEquivalentsAfterBankOverdrafts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CashAndCashEquivalentsAfterBankOverdrafts", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash and cash equivalents less bank overdrafts at the beginning of the year", "periodEndLabel": "Cash and cash equivalents less bank overdrafts at the end of the year", "label": "CashAndCashEquivalentsAfterBankOverdrafts" } } }, "auth_ref": [] }, "ifrs-full_CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents less bank overdraft" } }, "en": { "role": { "documentation": "The amount of cash and cash equivalents in the statement of cash flows when different from the amount of cash and cash equivalents in the statement of financial position. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r393" ] }, "abev_CashAndCashEquivalentsLessBankOverdraft": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CashAndCashEquivalentsLessBankOverdraft", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails8" ], "lang": { "en-us": { "role": { "label": "(-) Cash and cash equivalents less bank overdraft" } } }, "auth_ref": [] }, "abev_CashDisbursement": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CashDisbursement", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash Disbursement" } } }, "auth_ref": [] }, "abev_CashEffectsPortionOfExpensesExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CashEffectsPortionOfExpensesExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Cash Effects Portion Of Expenses Exposure [Member]" } } }, "auth_ref": [] }, "ifrs-full_CashFlowHedgesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowHedgesAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Cash flow hedge \u2013 gains/(losses)" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash flow from financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r145", "r153" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash flow from investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r145", "r153" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash flow from operating activities", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r145", "r153" ] }, "ifrs-full_CashFlowsFromUsedInOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperations", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash generated from operations", "label": "Cash flows from (used in) operations" } }, "en": { "role": { "documentation": "The cash from (used in) the entity's operations." } } }, "auth_ref": [ "r310", "r312" ] }, "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Cash flow from operating activities before changes in working capital and use of provisions", "label": "Cash flows from (used in) operations before changes in working capital" } }, "en": { "role": { "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital." } } }, "auth_ref": [ "r312", "r392" ] }, "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions of subsidiaries, net of cash acquired", "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities" } }, "en": { "role": { "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r151" ] }, "abev_CashGuarantees": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CashGuarantees", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash guarantees", "documentation": "The amount recorded for cash guarantees." } } }, "auth_ref": [] }, "ifrs-full_CashOnHand": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashOnHand", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Cash" } }, "en": { "role": { "documentation": "The amount of cash held by the entity. This does not include demand deposits." } } }, "auth_ref": [ "r393" ] }, "abev_CashUMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CashUMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "Cash U [Member]" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfFinancialAssetsAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Categories of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r247" ] }, "ifrs-full_CategoriesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfFinancialLiabilitiesAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Categories of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r247" ] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails", "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r101" ] }, "abev_CentralAmericaAndCaribbeanMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CentralAmericaAndCaribbeanMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails" ], "lang": { "en-us": { "role": { "label": "Central America And Caribbean [Member]" } } }, "auth_ref": [] }, "abev_CerveceriaModeloDeMexicoSDeRlDeCvMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CerveceriaModeloDeMexicoSDeRlDeCvMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Cerveceria Modelo de Mexico S. de R.L. de C.V. [member]", "documentation": "The entity Cervecer&amp;#63;a Modelo de Mexico S. de R.L. de C.V." } } }, "auth_ref": [] }, "abev_CerveceriaPeruanasMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CerveceriaPeruanasMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Cervecerias Peruanas [member]", "documentation": "Information related to Cervecer&amp;#63;a Peruanas." } } }, "auth_ref": [] }, "abev_ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "verboseLabel": "Effect of application of IAS 29 (hyperinflation)", "label": "ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet" } } }, "auth_ref": [] }, "ifrs-full_ChangesInOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ChangesInOtherProvisions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/InventoryDetails1" ], "lang": { "en-us": { "role": { "label": "Write-off" } }, "en": { "role": { "documentation": "The increase (decrease) in other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r125" ] }, "abev_ChangesRelatedToDeferredTaxRecognizedInOtherInTheBalanceSheet": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ChangesRelatedToDeferredTaxRecognizedInOtherInTheBalanceSheet", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Recognized in other balance sheet group" } } }, "auth_ref": [] }, "abev_ChileMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ChileMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Chile [Member]" } } }, "auth_ref": [] }, "abev_ChileanPesoSpentInChileMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ChileanPesoSpentInChileMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Chilean Peso Spent In Chile [Member]" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsAxis", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Classes of assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r113", "r114", "r179", "r188" ] }, "ifrs-full_ClassesOfAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfAssetsMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en": { "role": { "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used." } } }, "auth_ref": [ "r113", "r179", "r188" ] }, "ifrs-full_ClassesOfContingentLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfContingentLiabilitiesAxis", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of contingent liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r127", "r214" ] }, "ifrs-full_ClassesOfFinancialAssetsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialAssetsAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial assets [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r203", "r240", "r241", "r269", "r270" ] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r240", "r241", "r269", "r270" ] }, "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets and goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r387" ] }, "ifrs-full_ClassesOfLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfLiabilitiesAxis", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3", "http://ambev.com.br/role/TradePayablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r179" ] }, "ifrs-full_ClassesOfOrdinarySharesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfOrdinarySharesAxis", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of ordinary shares [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r109" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r64" ] }, "ifrs-full_ClassesOfProvisionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfProvisionsAxis", "presentation": [ "http://ambev.com.br/role/InventoryDetails1", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1", "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "label": "Classes of other provisions [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r125" ] }, "ifrs-full_ClosingForeignExchangeRate": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClosingForeignExchangeRate", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Closing rate" } }, "en": { "role": { "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery." } } }, "auth_ref": [ "r359" ] }, "abev_CollateralAndOtherCommitments": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CollateralAndOtherCommitments", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Total commitments", "documentation": "The amount recorded for collateral and other commitments outstanding." } } }, "auth_ref": [] }, "abev_CommercialExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CommercialExpensesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails5" ], "lang": { "en-us": { "role": { "label": "Commercial Expenses [Member]" } } }, "auth_ref": [] }, "abev_CommitmentsToSuppliersInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CommitmentsToSuppliersInventories", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Commitments to suppliers - Inventories" } } }, "auth_ref": [] }, "abev_CommitmentsToSuppliersPropertyPlantAndEquipmentAndIntangible": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CommitmentsToSuppliersPropertyPlantAndEquipmentAndIntangible", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Commitments to suppliers property, plant and equipment and Intangible" } } }, "auth_ref": [] }, "abev_CommoditiesAndForeignExchangeHedgesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CommoditiesAndForeignExchangeHedgesMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Commodities And Foreign Exchange Hedges [Member]" } } }, "auth_ref": [] }, "abev_CommoditiesHedgeMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CommoditiesHedgeMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Commodities Hedge [Member]" } } }, "auth_ref": [] }, "abev_CommoditiesRiskPortionOfCostExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CommoditiesRiskPortionOfCostExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Commodities risk portion of cost exposure [member]", "documentation": "The commodities risk portion of cost exposure." } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails", "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Items that will not be reclassified to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity", "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive (loss)/income", "label": "Total comprehensive income", "verboseLabel": "Total comprehensive income" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r2", "r36", "r155", "r157", "r165", "r314" ] }, "ifrs-full_ComprehensiveIncomeAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "verboseLabel": "Attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Non-controlling interest" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]" } } }, "auth_ref": [ "r2", "r39" ] }, "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncomeAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Equity holders of Ambev" } }, "en": { "role": { "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]" } } }, "auth_ref": [ "r2", "r40" ] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Computer software [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r302" ] }, "ifrs-full_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConstructionInProgressMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1" ], "lang": { "en-us": { "role": { "label": "Construction in progress [member]" } }, "en": { "role": { "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r370" ] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "ifrs-full_ContingentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContingentLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used." } } }, "auth_ref": [ "r128", "r214" ] }, "abev_ContractualCashFlowsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ContractualCashFlowsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7" ], "lang": { "en-us": { "role": { "label": "Contractual Cash Flows [Member]" } } }, "auth_ref": [] }, "ifrs-full_ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails2" ], "lang": { "en-us": { "role": { "label": "Contributions by employer" } }, "en": { "role": { "documentation": "The decrease (increase) in net defined benefit liability (asset) resulting from contributions to a defined benefit plan by the employer. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]" } } }, "auth_ref": [ "r82" ] }, "ifrs-full_ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2" ], "lang": { "en-us": { "role": { "label": "Contributions by plan participants" } }, "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan by plan participants. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]" } } }, "auth_ref": [ "r82" ] }, "ifrs-full_CostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CostOfSales", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of sales", "label": "Cost of sales [Default Label]" } }, "en": { "role": { "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories." } } }, "auth_ref": [ "r0", "r48" ] }, "abev_CostOfSalesProductionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CostOfSalesProductionCosts", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Remaining amount of cost of sales" } } }, "auth_ref": [] }, "ifrs-full_CounterpartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesAxis", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Counterparties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r249" ] }, "ifrs-full_CounterpartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CounterpartiesMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used." } } }, "auth_ref": [ "r249" ] }, "abev_CountryOfBrazilMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CountryOfBrazilMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Country Of Brazil [Member]" } } }, "auth_ref": [] }, "abev_CountryOfCanadaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CountryOfCanadaMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails" ], "lang": { "en-us": { "role": { "label": "Country Of Canada [Member]" } } }, "auth_ref": [] }, "ifrs-full_CountryOfDomicileMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfDomicileMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Country of domicile [member]" } }, "en": { "role": { "documentation": "This member stands for the country in which the entity is registered and where it has its legal address or registered office." } } }, "auth_ref": [ "r264", "r265" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "abev_Covid19ImpactExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "Covid19ImpactExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ExceptionalItemsDetails": { "parentTag": "abev_ExceptionalItems", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ExceptionalItemsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "COVID-19 impacts\u00a0(ii)", "label": "Covid19ImpactExpense" } } }, "auth_ref": [] }, "abev_CumulativeEffectOfInflationAccountingAndFinancialReportingInHyperinflationaryEconomies": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CumulativeEffectOfInflationAccountingAndFinancialReportingInHyperinflationaryEconomies", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Effect of application of IAS 29 (hyperinflation)" } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Current assets", "label": "Current assets" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r26", "r161", "r314" ] }, "ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest-bearing loans and borrowings", "label": "Interest-bearing loans and borrowings, current", "periodEndLabel": "Balance, current", "periodStartLabel": "Balance, current" } }, "en": { "role": { "documentation": "The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_CurrentDerivativeFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDerivativeFinancialAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative financial instruments", "label": "Current derivative financial assets" } }, "en": { "role": { "documentation": "The amount of current derivative financial assets. [Refer: Derivative financial assets]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_CurrentDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative financial instruments", "label": "Current derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of current derivative financial liabilities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r362" ] }, "abev_CurrentDividendAndInterestPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CurrentDividendAndInterestPayables", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Dividends and interest on shareholders\u2019 equity payable" } } }, "auth_ref": [] }, "ifrs-full_CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading", "crdr": "debit", "calculation": { "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails": { "parentTag": "ifrs-full_CurrentInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at fair value through profit or loss" } }, "en": { "role": { "documentation": "The amount of current financial assets measured at fair value through profit or loss classified as held for trading. [Refer: Financial assets at fair value through profit or loss, classified as held for trading]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_CurrentFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentFinancialLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Put option granted on subsidiaries and other liabilities", "label": "Current financial liabilities" } }, "en": { "role": { "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r228" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentInvestments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentInvestments", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 }, "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails": { "parentTag": "abev_InvestmentSecurities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails", "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Investment securities", "totalLabel": "Current investment securities", "label": "Current investments" } }, "en": { "role": { "documentation": "The amount of current investments." } } }, "auth_ref": [ "r362" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Current liabilities", "label": "Current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r27", "r163", "r314" ] }, "abev_CurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CurrentLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Current Liabilities [Member]" } } }, "auth_ref": [] }, "ifrs-full_CurrentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Current [member]" } }, "en": { "role": { "documentation": "This member stands for a current time band." } } }, "auth_ref": [ "r324", "r329" ] }, "ifrs-full_CurrentPortionOfLongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPortionOfLongtermBorrowings", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest-bearing loans and borrowings, current", "label": "Current portion of non-current borrowings" } }, "en": { "role": { "documentation": "The current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_CurrentPrepayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepayments", "crdr": "debit", "calculation": { "http://ambev.com.br/role/InventoryDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Prepayments" } }, "en": { "role": { "documentation": "The amount of current prepayments. [Refer: Prepayments]" } } }, "auth_ref": [ "r281" ] }, "ifrs-full_CurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentProvisions", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Provisions", "label": "Current provisions" } }, "en": { "role": { "documentation": "The amount of current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r16" ] }, "ifrs-full_CurrentReceivablesFromTaxesOtherThanIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentReceivablesFromTaxesOtherThanIncomeTax", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Recoverable taxes", "label": "Current receivables from taxes other than income tax" } }, "en": { "role": { "documentation": "The amount of current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } } }, "auth_ref": [ "r363" ] }, "ifrs-full_CurrentServiceCostNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentServiceCostNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails4" ], "lang": { "en-us": { "role": { "label": "Service costs", "negatedLabel": "Current service costs" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from employee service in the current period. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r73" ] }, "ifrs-full_CurrentTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTaxExpenseIncome", "crdr": "debit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1": { "parentTag": "abev_IncomeTaxesExpenseContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1" ], "lang": { "en-us": { "role": { "label": "Income tax expense \u2013 current" } }, "en": { "role": { "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period." } } }, "auth_ref": [ "r286" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails": { "parentTag": "abev_CurrentTradeReceivablesNetOfBadDebtProvisions", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails", "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade receivables", "label": "Current trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r279", "r281" ] }, "abev_CurrentTradeReceivablesNetOfBadDebtProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "CurrentTradeReceivablesNetOfBadDebtProvisions", "crdr": "debit", "calculation": { "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails", "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net, trade receivables", "label": "Trade receivables, net" } } }, "auth_ref": [] }, "abev_DebtDenominatedInCADDollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DebtDenominatedInCADDollarsMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Debt Denominated In C A D Dollars [Member]" } } }, "auth_ref": [] }, "abev_DebtDenominatedInOtherLatinAmericanCurrenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DebtDenominatedInOtherLatinAmericanCurrenciesMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Debt Denominated In Other Latin American Currencies [Member]" } } }, "auth_ref": [] }, "abev_DebtDenominatedInUSDollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DebtDenominatedInUSDollarsMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Debt Denominated In U S Dollars [Member]" } } }, "auth_ref": [] }, "ifrs-full_DebtInstrumentsHeld": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DebtInstrumentsHeld", "crdr": "debit", "calculation": { "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails": { "parentTag": "ifrs-full_NoncurrentHeldtomaturityInvestments", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails" ], "lang": { "en-us": { "role": { "label": "Investment on debt securities\u00a0(i)" } }, "en": { "role": { "documentation": "The amount of instruments representing indebtedness held by the entity." } } }, "auth_ref": [ "r362" ] }, "abev_DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax on deemed dividends", "label": "Tax on deemed dividends" } } }, "auth_ref": [] }, "abev_DeductionOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeductionOfRevenue", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/NetSalesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deduction of revenue" } } }, "auth_ref": [] }, "abev_DeferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredSharesMember", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails3" ], "lang": { "en-us": { "role": { "label": "Deferred Shares [Member]" } } }, "auth_ref": [] }, "abev_DeferredStockUnitsOfGrantOneMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredStockUnitsOfGrantOneMember", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred Stock Units Of Grant One [Member]" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Gross deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r18", "r22", "r55" ] }, "abev_DeferredTaxAssetsNettingByTaxableEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredTaxAssetsNettingByTaxableEntity", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Netting by taxable entity, deferred tax assets" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncome", "crdr": "debit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1": { "parentTag": "abev_IncomeTaxesExpenseContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax (expense)/income", "label": "Deferred tax expense (income)" } }, "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences", "crdr": "debit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1" ], "lang": { "en-us": { "role": { "label": "Deferred tax expense on temporary differences" } }, "en": { "role": { "documentation": "The amount of deferred tax expense or income relating to the creation or reversal of temporary differences. [Refer: Temporary differences [member]; Deferred tax expense (income)]" } } }, "auth_ref": [ "r287" ] }, "abev_DeferredTaxExpenseIncomes": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredTaxExpenseIncomes", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Recognized in the income statement" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilityAsset", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Gross deferred tax assets/(liabilities)", "verboseLabel": "Deferred taxes not related to tax losses", "terseLabel": "Deferred tax related to tax losses", "periodStartLabel": "Deferred income tax and social contribution at beginning", "periodEndLabel": "Deferred income tax and social contribution at ending" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r55" ] }, "abev_DeferredTaxLiabilityAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredTaxLiabilityAssetNet", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Net deferred tax assets/(liabilities)" } } }, "auth_ref": [] }, "abev_DeferredTaxLiabilityAssetNettingByTaxableEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredTaxLiabilityAssetNettingByTaxableEntity", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Netting by taxable entity, deferred tax assets/(liabilities)" } } }, "auth_ref": [] }, "abev_DeferredTaxesNotRelatedToTaxLossesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredTaxesNotRelatedToTaxLossesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Deferred Taxes Not Related To Tax Losses [Member]" } } }, "auth_ref": [] }, "abev_DeferredTaxsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredTaxsLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Gross deferred tax liabilities" } } }, "auth_ref": [] }, "abev_DeferredTaxsLiabilitiesNettingByTaxableEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DeferredTaxsLiabilitiesNettingByTaxableEntity", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Netting by taxable entity, deferred tax liabilities" } } }, "auth_ref": [] }, "abev_DefinedBenefitObligationAtPresentValues": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DefinedBenefitObligationAtPresentValues", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Present value of net obligations", "label": "Defined benefit obligation, at present value" } } }, "auth_ref": [] }, "abev_DefinedBenefitObligationFundedPortionAtPresentValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DefinedBenefitObligationFundedPortionAtPresentValue", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Present value of funded obligations", "label": "DefinedBenefitObligationFundedPortionAtPresentValue" } } }, "auth_ref": [] }, "abev_DefinedBenefitObligationUnfundedPortionAtPresentValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DefinedBenefitObligationUnfundedPortionAtPresentValue", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Present value of unfunded obligations", "label": "DefinedBenefitObligationUnfundedPortionAtPresentValue" } } }, "auth_ref": [] }, "ifrs-full_DefinedBenefitPlansAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DefinedBenefitPlansAxis", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Defined benefit plans [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r68" ] }, "ifrs-full_DefinedBenefitPlansMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DefinedBenefitPlansMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used." } } }, "auth_ref": [ "r68" ] }, "abev_DefinedBenefitPlansRecognizedFinancialCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DefinedBenefitPlansRecognizedFinancialCosts", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails4" ], "lang": { "en-us": { "role": { "negatedLabel": "Financial costs", "label": "DefinedBenefitPlansRecognizedFinancialCosts" } } }, "auth_ref": [] }, "abev_DenominatorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DenominatorAbstract", "presentation": [ "http://ambev.com.br/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Denominator" } } }, "auth_ref": [] }, "ifrs-full_DepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationExpense", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Total expenses" } }, "en": { "role": { "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives." } } }, "auth_ref": [ "r359" ] }, "abev_DepreciationExpenseCostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DepreciationExpenseCostOfSales", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cost of sales", "label": "DepreciationExpenseCostOfSales" } } }, "auth_ref": [] }, "abev_DepreciationExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DepreciationExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Depreciation" } } }, "auth_ref": [] }, "abev_DepreciationOfAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DepreciationOfAdministrativeExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Administrative expenses", "label": "DepreciationOfAdministrativeExpenses" } } }, "auth_ref": [] }, "abev_DepreciationOfCommercialExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DepreciationOfCommercialExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Commercial expenses", "label": "DepreciationOfCommercialExpenses" } } }, "auth_ref": [] }, "abev_DepreciationOfDistributionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DepreciationOfDistributionExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Distribution expenses", "label": "DepreciationOfDistributionExpenses" } } }, "auth_ref": [] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation", "label": "Depreciation, property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } } }, "auth_ref": [ "r61", "r65" ] }, "abev_DerivativeFinancialAssetsHeldForHedgingOperationalHedges": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DerivativeFinancialAssetsHeldForHedgingOperationalHedges", "crdr": "debit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": "ifrs-full_FinancialAssetsAtFairValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "label": "Derivatives \u2013 operational hedge", "documentation": "The amount of derivative financial assets held for hedging in operation hedges." } } }, "auth_ref": [] }, "abev_DerivativeFinancialLiabilitiesHeldForHedgingOperationalHedge": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DerivativeFinancialLiabilitiesHeldForHedgingOperationalHedge", "crdr": "credit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": "ifrs-full_FinancialLiabilitiesAtFairValue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivatives \u2013 operational hedge", "documentation": "The amount of derivative financial liabilities held for hedging in operational hedges.", "label": "Derivatives liabilities - operational hedge" } } }, "auth_ref": [] }, "abev_DerivativeHedgeMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DerivativeHedgeMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Derivative hedge [member]", "documentation": "This member stands for derivative hedge." } } }, "auth_ref": [] }, "abev_DerivativesLiabilitiesAtFairValueThroughProfitAndLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DerivativesLiabilitiesAtFairValueThroughProfitAndLoss", "crdr": "credit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": "ifrs-full_FinancialLiabilitiesAtFairValue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "label": "Derivatives liabilities at fair value through profit and loss" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://ambev.com.br/role/SummaryOfMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Financial reporting in hyperinflationary economies" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r360" ] }, "ifrs-full_DescriptionOfAccountingPolicyForGovernmentGrants": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForGovernmentGrants", "presentation": [ "http://ambev.com.br/role/SummaryOfMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Tax incentives and subsidized loans" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for government grants, including the methods of presentation adopted in the financial statements. [Refer: Government [member]; Government grants]" } } }, "auth_ref": [ "r94" ] }, "abev_DescriptionOfAccountingPolicyForNewIFRSRelasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DescriptionOfAccountingPolicyForNewIFRSRelasesTextBlock", "presentation": [ "http://ambev.com.br/role/SummaryOfMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recently issued IFRS" } } }, "auth_ref": [] }, "abev_DescriptionOfAccountingPolicyForTheBasisOfConsolidationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DescriptionOfAccountingPolicyForTheBasisOfConsolidationTextBlock", "presentation": [ "http://ambev.com.br/role/SummaryOfMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Consolidated financial statements" } } }, "auth_ref": [] }, "abev_DescriptionOfCorporateInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DescriptionOfCorporateInformationTextBlock", "presentation": [ "http://ambev.com.br/role/CorporateInformation" ], "lang": { "en-us": { "role": { "label": "CORPORATE INFORMATION" } } }, "auth_ref": [] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Diluted earnings per share \u2013 common \u2013 R$", "verboseLabel": "Diluted EPS" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r109", "r110" ] }, "abev_DirectChangesToDeferredTaxAndLiabilitiesInTheBalanceSheet": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DirectChangesToDeferredTaxAndLiabilitiesInTheBalanceSheet", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Recognized in deferred tax" } } }, "auth_ref": [] }, "abev_DisallowanceOfFinancialExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisallowanceOfFinancialExpenses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill BAH", "label": "DisallowanceOfFinancialExpenses" } } }, "auth_ref": [] }, "abev_DisallowanceOfTaxPaidAbroad": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisallowanceOfTaxPaidAbroad", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disallowance of tax paid abroad" } } }, "auth_ref": [] }, "abev_DisallowanceOnIncomeTaxDeduction": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisallowanceOnIncomeTaxDeduction", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Disallowance of tax paid abroad", "label": "DisallowanceOnIncomeTaxDeduction" } } }, "auth_ref": [] }, "abev_DisclosureChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureChangesInEquityAbstract", "lang": { "en-us": { "role": { "label": "Changes In Equity", "verboseLabel": "Changes In Equity - Treasury Shares", "terseLabel": "Changes In Equity - Interest On Shareholders Equity Dividends" } } }, "auth_ref": [] }, "abev_DisclosureCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersAbstract", "lang": { "en-us": { "role": { "label": "Collateral And Contractual Commitments With Suppliers Advances From Customers And Others", "verboseLabel": "Collateral And Contractual Commitments With Suppliers Advances From Customers And Others - Components Of Collateral And Commitments" } } }, "auth_ref": [] }, "abev_DisclosureCorporateInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureCorporateInformationAbstract", "lang": { "en-us": { "role": { "label": "Corporate Information" } } }, "auth_ref": [] }, "abev_DisclosureExceptionalItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureExceptionalItemsAbstract", "lang": { "en-us": { "role": { "label": "Exceptional Items" } } }, "auth_ref": [] }, "abev_DisclosureForTheBasisOfDividendsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureForTheBasisOfDividendsTextBlock", "presentation": [ "http://ambev.com.br/role/ChangesInEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of basis of dividends" } } }, "auth_ref": [] }, "abev_DisclosureIncomeTaxAndSocialContributionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureIncomeTaxAndSocialContributionAbstract", "lang": { "en-us": { "role": { "label": "Income Tax And Social Contribution" } } }, "auth_ref": [] }, "abev_DisclosureNetSalesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureNetSalesAbstract", "lang": { "en-us": { "role": { "label": "Net Sales" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory", "presentation": [ "http://ambev.com.br/role/UseOfEstimatesAndJudgments" ], "lang": { "en-us": { "role": { "label": "USE OF ESTIMATES AND JUDGMENTS" } }, "en": { "role": { "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]" } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfActuarialAssumptionsOfTheEntityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfActuarialAssumptionsOfTheEntityTextBlock", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of assumptions used" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAdditionalInformationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAdditionalInformationExplanatory", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNature" ], "lang": { "en-us": { "role": { "label": "ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE" } }, "en": { "role": { "documentation": "The disclosure of additional information that is not presented elsewhere in the financial statements, but that is relevant to an understanding of them." } } }, "auth_ref": [ "r9" ] }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4" ], "lang": { "en-us": { "role": { "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } } }, "auth_ref": [ "r25" ] }, "abev_DisclosureOfAssetCeilingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfAssetCeilingTextBlock", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of asset ceiling" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatements" ], "lang": { "en-us": { "role": { "label": "BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS" } }, "en": { "role": { "documentation": "The disclosure of the basis used for the preparation of the financial statements." } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBorrowingsExplanatory", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowing" ], "lang": { "en-us": { "role": { "label": "INTEREST-BEARING LOANS AND BORROWING" } }, "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCashAndCashEquivalentsExplanatory", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities" ], "lang": { "en-us": { "role": { "label": "CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES" } }, "en": { "role": { "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfChangesInCarryingAmountOfRightofuseAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfChangesInCarryingAmountOfRightofuseAssetsExplanatory", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of carrying amount of right-of-use assets" } } }, "auth_ref": [] }, "abev_DisclosureOfChangesInCarryingValueOfEquityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfChangesInCarryingValueOfEquityTextBlock", "presentation": [ "http://ambev.com.br/role/ChangesInEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Carrying value adjustments" } } }, "auth_ref": [] }, "abev_DisclosureOfChangesInEquityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfChangesInEquityTextBlock", "presentation": [ "http://ambev.com.br/role/ChangesInEquity" ], "lang": { "en-us": { "role": { "label": "CHANGES IN EQUITY" } } }, "auth_ref": [] }, "abev_DisclosureOfClassesOfCapitalReservesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfClassesOfCapitalReservesTextBlock", "presentation": [ "http://ambev.com.br/role/ChangesInEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of capital reserves" } } }, "auth_ref": [] }, "abev_DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers" ], "lang": { "en-us": { "role": { "label": "COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersTables" ], "lang": { "en-us": { "role": { "label": "Schedule of commitments and contingent liabilities" } }, "en": { "role": { "documentation": "The disclosure of commitments and contingent liabilities. [Refer: Contingent liabilities [member]]" } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfComponentsInCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfComponentsInCashAndCashEquivalentsTextBlock", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of components in cash and cash equivalents" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationTable", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of contingent liabilities in business combination [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to contingent liabilities in business combinations." } } }, "auth_ref": [ "r213", "r214" ] }, "abev_DisclosureOfCurrentTradeReceivablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfCurrentTradeReceivablesTextBlock", "presentation": [ "http://ambev.com.br/role/TradeReceivablesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of current trade receivables" } } }, "auth_ref": [] }, "abev_DisclosureOfDeferredTaxRealizationRelatedToTaxLossesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfDeferredTaxRealizationRelatedToTaxLossesTextBlock", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred tax realization related to tax losses" } } }, "auth_ref": [] }, "abev_DisclosureOfDefinedBenefitObligationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfDefinedBenefitObligationTextBlock", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of present value of defined benefit obligations" } } }, "auth_ref": [] }, "abev_DisclosureOfDefinedBenefitPlansRecognizedInTheIncomeStatementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfDefinedBenefitPlansRecognizedInTheIncomeStatementTextBlock", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of defined benefit plans recognized in income statement" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDefinedBenefitPlansTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDefinedBenefitPlansTable", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of defined benefit plans [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to defined benefit plans." } } }, "auth_ref": [ "r68" ] }, "ifrs-full_DisclosureOfDepreciationAndAmortisationExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDepreciationAndAmortisationExpenseExplanatory", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureTables" ], "lang": { "en-us": { "role": { "label": "Schedule of depreciation, amortization and impairment expenses" } }, "en": { "role": { "documentation": "The disclosure of depreciation and amortisation expense. [Refer: Depreciation and amortisation expense]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of debts" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r397" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r397" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of consolidated financial instruments" } }, "en": { "role": { "documentation": "The disclosure of detailed information about financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r229", "r235", "r242" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutHedgingInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutHedgingInstrumentsExplanatory", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of detailed information about hedging instruments" } }, "en": { "role": { "documentation": "The disclosure of detailed information about hedging instruments. [Refer: Hedging instruments [member]]" } } }, "auth_ref": [ "r223" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory", "presentation": [ "http://ambev.com.br/role/IntangiblesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of intangible assets" } }, "en": { "role": { "documentation": "The disclosure of detailed information about intangible assets. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r137" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property, plant and equipment" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r64" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails", "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r182" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://ambev.com.br/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "label": "EARNINGS PER SHARE" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r112" ] }, "ifrs-full_DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of exchange rates" } }, "en": { "role": { "documentation": "The entire disclosure for the effect of changes in foreign exchange rates." } } }, "auth_ref": [ "r95" ] }, "abev_DisclosureOfEmployeeBenefitRevenueExpensesAllocationInIncomeStatementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfEmployeeBenefitRevenueExpensesAllocationInIncomeStatementTextBlock", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of employee benefit revenue/(expenses)" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfEmployeeBenefitsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEmployeeBenefitsExplanatory", "presentation": [ "http://ambev.com.br/role/EmployeeBenefits" ], "lang": { "en-us": { "role": { "label": "EMPLOYEE BENEFITS" } }, "en": { "role": { "documentation": "The entire disclosure for employee benefits." } } }, "auth_ref": [ "r91" ] }, "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEntitysReportableSegmentsExplanatory", "presentation": [ "http://ambev.com.br/role/SegmentReporting" ], "lang": { "en-us": { "role": { "label": "SEGMENT REPORTING" } }, "en": { "role": { "documentation": "The entire disclosure for operating segments." } } }, "auth_ref": [ "r268" ] }, "abev_DisclosureOfEstimatedUsefulLivesOfMajorPropertyPlantAndEquipmentClassesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfEstimatedUsefulLivesOfMajorPropertyPlantAndEquipmentClassesTextBlock", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of estimated useful lives of property, plant and equipment" } } }, "auth_ref": [] }, "abev_DisclosureOfEstimatesOfPossibleLossesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfEstimatesOfPossibleLossesTextBlock", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of contingencies" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriod" ], "lang": { "en-us": { "role": { "label": "EVENTS AFTER THE REPORTING PERIOD" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r50" ] }, "abev_DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock", "presentation": [ "http://ambev.com.br/role/ExceptionalItemsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of exceptional items" } } }, "auth_ref": [] }, "abev_DisclosureOfExceptionalItemsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfExceptionalItemsTextBlock", "presentation": [ "http://ambev.com.br/role/ExceptionalItems" ], "lang": { "en-us": { "role": { "label": "EXCEPTIONAL ITEMS" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r179" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation of changes in the assets" } }, "en": { "role": { "documentation": "The disclosure of the fair value measurement of liabilities." } } }, "auth_ref": [ "r179" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfLiabilitiesTable", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3", "http://ambev.com.br/role/TradePayablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of liabilities [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of liabilities." } } }, "auth_ref": [ "r179" ] }, "ifrs-full_DisclosureOfFinanceCostExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinanceCostExplanatory", "presentation": [ "http://ambev.com.br/role/NetFinanceResultTables" ], "lang": { "en-us": { "role": { "label": "Schedule of net finance result" } }, "en": { "role": { "documentation": "The disclosure of finance cost. [Refer: Finance costs]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinanceIncomeExpenseExplanatory", "presentation": [ "http://ambev.com.br/role/NetFinanceResult" ], "lang": { "en-us": { "role": { "label": "NET FINANCE RESULT" } }, "en": { "role": { "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialAssetsTable", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to financial assets." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisks" ], "lang": { "en-us": { "role": { "label": "FINANCIAL INSTRUMENTS AND RISKS" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r251" ] }, "abev_DisclosureOfFinancialInstrumentsFairValueHierarchyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfFinancialInstrumentsFairValueHierarchyTextBlock", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of fair value measurement" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialRiskManagementExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialRiskManagementExplanatory", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of financial risk management" } }, "en": { "role": { "documentation": "The disclosure of the entity's financial risk management practices and policies." } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfFutureContractualCommitmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfFutureContractualCommitmentsTextBlock", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersTables" ], "lang": { "en-us": { "role": { "label": "Schedule of future contractual commitments" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGoodwillExplanatory", "presentation": [ "http://ambev.com.br/role/Goodwill" ], "lang": { "en-us": { "role": { "label": "GOODWILL" } }, "en": { "role": { "documentation": "The disclosure of goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfHedgeAccountingTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfHedgeAccountingTable", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about hedges [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of hedges." } } }, "auth_ref": [ "r272" ] }, "ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory", "presentation": [ "http://ambev.com.br/role/ImpairmentOfNon-financialAssets" ], "lang": { "en-us": { "role": { "label": "IMPAIRMENT OF NON-FINANCIAL ASSETS" } }, "en": { "role": { "documentation": "The disclosure of impairment loss and the reversal of impairment loss. [Refer: Impairment loss; Reversal of impairment loss]" } } }, "auth_ref": [ "r113" ] }, "abev_DisclosureOfIncomeTaxAndSocialContributionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfIncomeTaxAndSocialContributionTextBlock", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContribution" ], "lang": { "en-us": { "role": { "label": "INCOME TAX AND SOCIAL CONTRIBUTION" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIncomeTaxExplanatory", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of income taxes" } }, "en": { "role": { "documentation": "The entire disclosure for income taxes." } } }, "auth_ref": [ "r58" ] }, "ifrs-full_DisclosureOfInformationForEachMaterialImpairmentLossRecognisedOrReversedForIndividualAssetOrCashgeneratingUnitTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationForEachMaterialImpairmentLossRecognisedOrReversedForIndividualAssetOrCashgeneratingUnitTable", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of information for impairment loss recognised or reversed for individual asset or cash-generating unit [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to an individual asset or a cash-generating unit, for which an impairment loss has been recognised or reversed." } } }, "auth_ref": [ "r115" ] }, "ifrs-full_DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory", "presentation": [ "http://ambev.com.br/role/GoodwillTables" ], "lang": { "en-us": { "role": { "label": "Schedule of carrying amount of goodwill" } }, "en": { "role": { "documentation": "The disclosure of information for cash-generating units. [Refer: Cash-generating units [member]]" } } }, "auth_ref": [ "r118" ] }, "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsExplanatory", "presentation": [ "http://ambev.com.br/role/Intangibles" ], "lang": { "en-us": { "role": { "label": "INTANGIBLES" } }, "en": { "role": { "documentation": "The entire disclosure for intangible assets." } } }, "auth_ref": [ "r139" ] }, "ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory", "presentation": [ "http://ambev.com.br/role/IntangiblesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of carrying value of intangible assets with indefinite useful lives" } }, "en": { "role": { "documentation": "The disclosure of intangible assets with an indefinite useful life. [Refer: Intangible assets with indefinite useful life]" } } }, "auth_ref": [ "r138" ] }, "ifrs-full_DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeTable", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of intangible assets with indefinite useful life [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to intangible assets with an indefinite useful life." } } }, "auth_ref": [ "r138" ] }, "ifrs-full_DisclosureOfInterestExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInterestExpenseExplanatory", "presentation": [ "http://ambev.com.br/role/NetFinanceResultTables" ], "lang": { "en-us": { "role": { "label": "Schedule of interest expenses" } }, "en": { "role": { "documentation": "The disclosure of interest expense. [Refer: Interest expense]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfInterestIncomeExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInterestIncomeExplanatory", "presentation": [ "http://ambev.com.br/role/NetFinanceResultTables" ], "lang": { "en-us": { "role": { "label": "Schedule of interest income" } }, "en": { "role": { "documentation": "The disclosure of interest income. [Refer: Interest income]" } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfInterestOnShareholdersEquityAndDividendsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfInterestOnShareholdersEquityAndDividendsTextBlock", "presentation": [ "http://ambev.com.br/role/ChangesInEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of interest on shareholders' equity and dividends" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfInventoriesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInventoriesExplanatory", "presentation": [ "http://ambev.com.br/role/Inventory" ], "lang": { "en-us": { "role": { "label": "INVENTORY" } }, "en": { "role": { "documentation": "The entire disclosure for inventories." } } }, "auth_ref": [ "r93" ] }, "abev_DisclosureOfInventoryComponentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfInventoryComponentsTextBlock", "presentation": [ "http://ambev.com.br/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Schedule of inventory components" } } }, "auth_ref": [] }, "abev_DisclosureOfInvestmentSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfInvestmentSecuritiesTextBlock", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of investment securities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIssuedCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIssuedCapitalExplanatory", "presentation": [ "http://ambev.com.br/role/ChangesInEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of issued capital" } }, "en": { "role": { "documentation": "The disclosure of issued capital. [Refer: Issued capital]" } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfKeyManagementPersonnelCompensationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfKeyManagementPersonnelCompensationTextBlock", "presentation": [ "http://ambev.com.br/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of key management remuneration" } } }, "auth_ref": [] }, "abev_DisclosureOfMaturityOfTheCurrentTradeReceivablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfMaturityOfTheCurrentTradeReceivablesTextBlock", "presentation": [ "http://ambev.com.br/role/TradeReceivablesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of maturity trade receivable" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of defined benefit plans" } }, "en": { "role": { "documentation": "The disclosure of a net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r72" ] }, "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails3", "http://ambev.com.br/role/EmployeeBenefitsDetails5", "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Disclosure of net defined benefit liability (asset) [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)." } } }, "auth_ref": [ "r72" ] }, "abev_DisclosureOfNetIncomeReservesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfNetIncomeReservesTextBlock", "presentation": [ "http://ambev.com.br/role/ChangesInEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of net income reserves" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } } }, "auth_ref": [ "r49" ] }, "abev_DisclosureOfNotionalAndFairValueAmountsPerFinancialInstrumentAndMaturityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfNotionalAndFairValueAmountsPerFinancialInstrumentAndMaturityTextBlock", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of notional and fair value amounts per instrument and maturity" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of restricted and performance shares" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } } }, "auth_ref": [ "r395" ] }, "abev_DisclosureOfNumbersAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfNumbersAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred shares" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOffsettingOfFinancialAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOffsettingOfFinancialAssetsTable", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of offsetting of financial assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the offsetting of financial assets." } } }, "auth_ref": [ "r218" ] }, "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory", "presentation": [ "http://ambev.com.br/role/OtherOperatingIncomeexpenses" ], "lang": { "en-us": { "role": { "label": "OTHER OPERATING INCOME/(EXPENSES)" } }, "en": { "role": { "documentation": "The disclosure of other operating income or expense. [Refer: Other operating income (expense)]" } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock", "presentation": [ "http://ambev.com.br/role/OtherOperatingIncomeexpensesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of other operating income" } } }, "auth_ref": [] }, "abev_DisclosureOfOtherProvisionExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfOtherProvisionExplanatory", "presentation": [ "http://ambev.com.br/role/TradeReceivablesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of estimated loss for doubtful debts" } } }, "auth_ref": [] }, "abev_DisclosureOfOtherProvisionsChangesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfOtherProvisionsChangesExplanatory", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of provision changes" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssets" ], "lang": { "en-us": { "role": { "label": "PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS" } }, "en": { "role": { "documentation": "The entire disclosure for other provisions, contingent liabilities and contingent assets." } } }, "auth_ref": [ "r129" ] }, "ifrs-full_DisclosureOfOtherProvisionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsExplanatory", "presentation": [ "http://ambev.com.br/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Schedule of changes in impairment losses on inventory" } }, "en": { "role": { "documentation": "The disclosure of other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r125" ] }, "ifrs-full_DisclosureOfOtherProvisionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOtherProvisionsTable", "presentation": [ "http://ambev.com.br/role/InventoryDetails1", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1", "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of other provisions [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to other provisions." } } }, "auth_ref": [ "r125" ] }, "abev_DisclosureOfPayrollAndRelatedBenefitsAffectingTheIncomeStatementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfPayrollAndRelatedBenefitsAffectingTheIncomeStatementTextBlock", "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of payroll expenses and related benefits" } } }, "auth_ref": [] }, "abev_DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock", "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefits" ], "lang": { "en-us": { "role": { "label": "PAYROLL AND RELATED BENEFITS" } } }, "auth_ref": [] }, "abev_DisclosureOfPayrollAndRelatedBenefitsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfPayrollAndRelatedBenefitsTextBlock", "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of payroll and related benefits" } } }, "auth_ref": [] }, "abev_DisclosureOfPlanAssetsComponentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfPlanAssetsComponentsTextBlock", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of plans assets" } } }, "auth_ref": [] }, "abev_DisclosureOfPresentValueAdjustmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfPresentValueAdjustmentExplanatory", "presentation": [ "http://ambev.com.br/role/SummaryOfMaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Present value adjustment" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipment" ], "lang": { "en-us": { "role": { "label": "PROPERTY, PLANT AND EQUIPMENT" } }, "en": { "role": { "documentation": "The entire disclosure for property, plant and equipment." } } }, "auth_ref": [ "r67" ] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r64" ] }, "ifrs-full_DisclosureOfProvisionMatrixTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfProvisionMatrixTable", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of provision matrix [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the provision matrix." } } }, "auth_ref": [ "r324" ] }, "abev_DisclosureOfReconciliationFromTheWeightedNominalToTheEffectiveTaxRateTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfReconciliationFromTheWeightedNominalToTheEffectiveTaxRateTextBlock", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of reconciliation between the weighted nominal tax rate and the effective tax rate" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillExplanatory", "presentation": [ "http://ambev.com.br/role/GoodwillTables" ], "lang": { "en-us": { "role": { "label": "Schedule of goodwill" } }, "en": { "role": { "documentation": "The disclosure of the reconciliation of changes in goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r216" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r216" ] }, "ifrs-full_DisclosureOfRelatedPartyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRelatedPartyExplanatory", "presentation": [ "http://ambev.com.br/role/RelatedParties" ], "lang": { "en-us": { "role": { "label": "RELATED PARTIES" } }, "en": { "role": { "documentation": "The entire disclosure for related parties." } } }, "auth_ref": [ "r102" ] }, "abev_DisclosureOfReportableSegmentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfReportableSegmentsTextBlock", "presentation": [ "http://ambev.com.br/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of segment reporting" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Disclosure of risk management strategy related to hedge accounting [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the risk management strategy in relation to hedge accounting." } } }, "auth_ref": [ "r221", "r272" ] }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of sensitivity of defined benefit obligation" } }, "en": { "role": { "documentation": "The disclosure of a sensitivity analysis for significant actuarial assumptions used to determine the present value of a defined benefit obligation. [Refer: Actuarial assumptions [member]; Defined benefit obligation, at present value]" } } }, "auth_ref": [ "r87" ] }, "ifrs-full_DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Disclosure of sensitivity analysis for actuarial assumptions [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the sensitivity analysis for actuarial assumptions." } } }, "auth_ref": [ "r87" ] }, "ifrs-full_DisclosureOfSharebasedPaymentArrangementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSharebasedPaymentArrangementsExplanatory", "presentation": [ "http://ambev.com.br/role/Share-basedPayments" ], "lang": { "en-us": { "role": { "label": "SHARE-BASED PAYMENTS" } }, "en": { "role": { "documentation": "The entire disclosure for share-based payment arrangements." } } }, "auth_ref": [ "r204" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } } }, "auth_ref": [ "r105", "r106", "r172" ] }, "ifrs-full_DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory", "presentation": [ "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of local currency" } }, "en": { "role": { "documentation": "The disclosure of significant inputs for which market data are not available and that are developed using the best information available about the assumptions that market participants would use when measuring the fair value of assets." } } }, "auth_ref": [ "r175" ] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred income tax" } }, "en": { "role": { "documentation": "The disclosure of types of temporary differences, unused tax losses and unused tax credits. [Refer: Unused tax credits [member]; Unused tax losses [member]; Temporary differences [member]]" } } }, "auth_ref": [ "r57" ] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } } }, "auth_ref": [ "r57" ] }, "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of terms and conditions of share-based payment arrangement [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements." } } }, "auth_ref": [ "r211" ] }, "abev_DisclosureOfTheChangeInFairValueOfThePlanAssetsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfTheChangeInFairValueOfThePlanAssetsTextBlock", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of fair value of plan assets" } } }, "auth_ref": [] }, "abev_DisclosureOfTheComponentsOfTradePayablesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfTheComponentsOfTradePayablesTextBlock", "presentation": [ "http://ambev.com.br/role/TradePayablesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of trade payable" } } }, "auth_ref": [] }, "abev_DisclosureOfTheDisbursementExpectativeOfTheProvisionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfTheDisbursementExpectativeOfTheProvisionsTextBlock", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of expected settlement of provision" } } }, "auth_ref": [] }, "abev_DisclosureOfTheRealizationOfDeferredTaxAssetsAndLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfTheRealizationOfDeferredTaxAssetsAndLiabilitiesTextBlock", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred tax assets and liabilities" } } }, "auth_ref": [] }, "abev_DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock", "presentation": [ "http://ambev.com.br/role/NetSalesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of net sales" } } }, "auth_ref": [] }, "abev_DisclosureOfTheReconciliationOfChangesInDeferredTaxLiabilityAssetTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfTheReconciliationOfChangesInDeferredTaxLiabilityAssetTextBlock", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of net change in deferred income tax and social contribution" } } }, "auth_ref": [] }, "abev_DisclosureOfTotalLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfTotalLiabilitiesTextBlock", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of total liabilities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory", "presentation": [ "http://ambev.com.br/role/TradeReceivables" ], "lang": { "en-us": { "role": { "label": "TRADE RECEIVABLES" } }, "en": { "role": { "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]" } } }, "auth_ref": [ "r356" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://ambev.com.br/role/RelatedPartiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of transactions with related parties" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r99" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails", "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r101" ] }, "ifrs-full_DisclosureOfTreasurySharesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTreasurySharesExplanatory", "presentation": [ "http://ambev.com.br/role/ChangesInEquityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of treasury shares" } }, "en": { "role": { "documentation": "The disclosure of treasury shares. [Refer: Treasury shares]" } } }, "auth_ref": [ "r356" ] }, "abev_DisclosureOfWeightedAverageExercisePricesOfShareOptionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureOfWeightedAverageExercisePricesOfShareOptionsTextBlock", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of weighted average exercise price" } } }, "auth_ref": [] }, "abev_DisclosurePayrollAndRelatedBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosurePayrollAndRelatedBenefitsAbstract", "lang": { "en-us": { "role": { "label": "Payroll And Related Benefits" } } }, "auth_ref": [] }, "abev_DisclosureRecoverableTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureRecoverableTaxesAbstract", "lang": { "en-us": { "role": { "label": "Recoverable Taxes" } } }, "auth_ref": [] }, "abev_DisclosureSummaryOfMaterialAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureSummaryOfMaterialAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Summary Of Material Accounting Policies" } } }, "auth_ref": [] }, "abev_DisclosureTradePayablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosureTradePayablesAbstract", "lang": { "en-us": { "role": { "label": "Trade Payables" } } }, "auth_ref": [] }, "abev_DisclosuresOfRevenueExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosuresOfRevenueExplanatory", "presentation": [ "http://ambev.com.br/role/NetSales" ], "lang": { "en-us": { "role": { "label": "NET SALES" } } }, "auth_ref": [] }, "abev_DisclosuresOfSummaryOfSignificantAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosuresOfSummaryOfSignificantAccountingPoliciesExplanatory", "presentation": [ "http://ambev.com.br/role/SummaryOfMaterialAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SUMMARY OF MATERIAL ACCOUNTING POLICIES" } } }, "auth_ref": [] }, "abev_DisclosuresOfTradeAndOtherPayablesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisclosuresOfTradeAndOtherPayablesExplanatory", "presentation": [ "http://ambev.com.br/role/TradePayables" ], "lang": { "en-us": { "role": { "label": "TRADE PAYABLES" } } }, "auth_ref": [] }, "abev_DisposalsAndWriteoffsOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DisposalsAndWriteoffsOfPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Disposals and write-offs" } } }, "auth_ref": [] }, "ifrs-full_DisposalsIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisposalsIntangibleAssetsOtherThanGoodwill", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Disposal", "negatedLabel": "Disposal" } }, "en": { "role": { "documentation": "The decrease in intangible assets other than goodwill resulting from disposals. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r133" ] }, "abev_DistributionAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DistributionAgreement", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ExceptionalItemsDetails": { "parentTag": "abev_ExceptionalItems", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ExceptionalItemsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Distribution agreement\u00a0(iv)", "label": "DistributionAgreement" } } }, "auth_ref": [] }, "ifrs-full_DistributionCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DistributionCosts", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Distribution expenses", "label": "Distribution costs" } }, "en": { "role": { "documentation": "The amount of costs relating to the distribution of goods and services." } } }, "auth_ref": [ "r48", "r277" ] }, "abev_DividendPercentageOfNetIncome": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DividendPercentageOfNetIncome", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Percentage of distributed profit" } } }, "auth_ref": [] }, "abev_DividendsAndInterestOnCapitalPaidBasedOnProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DividendsAndInterestOnCapitalPaidBasedOnProfit", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Dividends and interest on capital paid based on profit" } } }, "auth_ref": [] }, "abev_DividendsAndInterestPaidOnShareholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DividendsAndInterestPaidOnShareholdersEquity", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends and interest on shareholders\u2019 equity paid", "label": "DividendsAndInterestPaidOnShareholdersEquity" } } }, "auth_ref": [] }, "ifrs-full_DividendsPaid": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsPaid", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Dividends paid", "label": "Dividends recognised as distributions to owners" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners." } } }, "auth_ref": [ "r8" ] }, "abev_DividendsReceivablesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DividendsReceivablesRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Dividends receivables", "documentation": "The amount of dividends receivables resulting from related party transactions." } } }, "auth_ref": [] }, "ifrs-full_DividendsReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Dividends received" } }, "en": { "role": { "documentation": "The cash inflow from dividends received, classified as operating activities. [Refer: Dividends received]" } } }, "auth_ref": [ "r149" ] }, "ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DividendsRecognisedAsDistributionsToOwnersOfParent", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Prescribed/(complementary) dividends" } }, "en": { "role": { "documentation": "The amount of dividends recognised as distributions to owners of the parent. [Refer: Parent [member]]" } } }, "auth_ref": [ "r357" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r348" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r346", "r348", "r349" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction Flag", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r346", "r348", "r349", "r351" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r347" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r335" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r348" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r348" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r350" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r338" ] }, "abev_DominicanPesosSpentInTheDominicanRepublicMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DominicanPesosSpentInTheDominicanRepublicMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Dominican Pesos Spent In The Dominican Republic [Member]" } } }, "auth_ref": [] }, "abev_DominicanRepublicMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "DominicanRepublicMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Dominican Republic [Member]" } } }, "auth_ref": [] }, "abev_ELJMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ELJMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "ELJ [Member]", "documentation": "Related to ELJ." } } }, "auth_ref": [] }, "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://ambev.com.br/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "label": "Schedule of earnings per share" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r109" ] }, "ifrs-full_EffectOfAssetCeilingMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfAssetCeilingMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails3" ], "lang": { "en-us": { "role": { "label": "Effect of asset ceiling [member]" } }, "en": { "role": { "documentation": "This member stands for the effect of asset ceiling in a defined benefit plan. Asset ceiling is the present value of any economic benefits available in the form of refunds from the defined benefit plan or reductions in future contributions to the defined benefit plan. [Refer: Defined benefit plans [member]]" } } }, "auth_ref": [ "r71" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate fluctuations on cash and cash equivalents" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r147", "r148" ] }, "ifrs-full_EliminationOfIntersegmentAmountsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EliminationOfIntersegmentAmountsMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Elimination of intersegment amounts [member]" } }, "en": { "role": { "documentation": "This member stands for the elimination of intersegment amounts in the reconciliations of total segment amounts to amounts recognised in the entity's financial statements." } } }, "auth_ref": [ "r333", "r334" ] }, "abev_EmployeeBenefitLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Benefit Liabilities [Member]" } } }, "auth_ref": [] }, "abev_EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails5" ], "lang": { "en-us": { "role": { "label": "Employee Benefit Revenue Expenses Allocated To Administrative Expenses [Member]" } } }, "auth_ref": [] }, "abev_EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails5" ], "lang": { "en-us": { "role": { "label": "Employee Benefit Revenue Expenses Allocated To Financial Expenses [Member]" } } }, "auth_ref": [] }, "abev_EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails5" ], "lang": { "en-us": { "role": { "label": "Employee Benefit Revenue Expenses Allocated To Other Operating Incomeexpenses Net [Member]" } } }, "auth_ref": [] }, "abev_EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails5" ], "lang": { "en-us": { "role": { "label": "Employee Benefit Revenueexpenses Allocated To Cost Of Sales [Member]" } } }, "auth_ref": [] }, "abev_EmployeeBenefitsAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsAssetsMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Employee Benefits Assets [Member]" } } }, "auth_ref": [] }, "ifrs-full_EmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails", "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Payment for license", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r1", "r48", "r276" ] }, "abev_EmployeeBenefitsExpenseAdministrativeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsExpenseAdministrativeExpenses", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Administrative expenses" } } }, "auth_ref": [] }, "abev_EmployeeBenefitsExpenseCommercialExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsExpenseCommercialExpenses", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Commercial expenses" } } }, "auth_ref": [] }, "abev_EmployeeBenefitsExpenseCostOfSales": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsExpenseCostOfSales", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails", "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Cost of sales", "verboseLabel": "Payroll and related benefits" } } }, "auth_ref": [] }, "abev_EmployeeBenefitsExpenseDistributionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsExpenseDistributionExpenses", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Distribution expenses" } } }, "auth_ref": [] }, "abev_EmployeeBenefitsExpenseExceptionalItems": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsExpenseExceptionalItems", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Exceptional items", "label": "EmployeeBenefitsExpenseExceptionalItems" } } }, "auth_ref": [] }, "abev_EmployeeBenefitsExpenseNetFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsExpenseNetFinanceCosts", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Net finance costs", "label": "EmployeeBenefitsExpenseNetFinanceCosts" } } }, "auth_ref": [] }, "abev_EmployeeBenefitsExpenseOtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EmployeeBenefitsExpenseOtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Other operating (income)/expenses", "label": "EmployeeBenefitsExpenseOtherOperatingIncomeExpense" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesLineItems", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesTable", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r337" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r341" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r337" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r337" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r355" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r337" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r352" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r349" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r337" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r337" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r337" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r337" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r353" ] }, "ifrs-full_EntitysTotalForIndividualAssetsOrCashgeneratingUnitsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForIndividualAssetsOrCashgeneratingUnitsMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Individual assets or cash-generating units' axis if no other member is used." } } }, "auth_ref": [ "r115" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails", "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r101" ] }, "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSegmentConsolidationItemsMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used." } } }, "auth_ref": [ "r262" ] }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSubsidiariesMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r105", "r106", "r172" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Authorized share capital" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r21", "r31", "r154", "r156", "r173", "r174", "r178" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity and liabilities", "label": "Total liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r21" ] }, "ifrs-full_EquityAndLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilitiesAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Equity and liabilities" } } }, "auth_ref": [] }, "ifrs-full_EquityAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParent", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Equity attributable to the equity holders of Ambev", "label": "Equity attributable to owners of parent" } }, "en": { "role": { "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest." } } }, "auth_ref": [ "r20" ] }, "ifrs-full_EquityAttributableToOwnersOfParentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAttributableToOwnersOfParentMember", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Equity attributable to owners of parent [member]" } }, "en": { "role": { "documentation": "This member stands for equity attributable to the owners of the parent." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_EquityInstrumentsPercentageContributedToFairValueOfPlanAssets": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityInstrumentsPercentageContributedToFairValueOfPlanAssets", "presentation": [ "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average cost of capital" } }, "en": { "role": { "documentation": "The percentage equity instruments contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]] [Contrast: Equity instruments, amount contributed to fair value of plan assets]" } } }, "auth_ref": [ "r375" ] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails", "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r7" ] }, "abev_EquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EquitySharesOutstanding", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Equity shares outstanding, Beginning balance", "periodEndLabel": "Equity shares outstanding, Final balance", "label": "EquitySharesOutstanding" } } }, "auth_ref": [] }, "ifrs-full_EstimateOfContributionsExpectedToBePaidToPlan": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EstimateOfContributionsExpectedToBePaidToPlan", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Estimate Of Contributions Expected To Be Paid To Plan" } }, "en": { "role": { "documentation": "The estimate of the expected contributions to be made to a defined benefit plan for the next annual reporting period. [Refer: Defined benefit plans [member]]" } } }, "auth_ref": [ "r88", "r89" ] }, "ifrs-full_EstimatedFinancialEffectOfContingentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EstimatedFinancialEffectOfContingentLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "Estimates of amounts of possible losses" } }, "en": { "role": { "documentation": "The amount of the estimated financial effect of contingent liabilities. [Refer: Contingent liabilities [member]]" } } }, "auth_ref": [ "r126" ] }, "abev_EurosRiskPortionOfCostExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "EurosRiskPortionOfCostExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "Euros risk portion of cost exposure [member]", "documentation": "The Euros risk portion of cost exposure." } } }, "auth_ref": [] }, "abev_ExceptionalItems": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ExceptionalItems", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 6.0 }, "http://ambev.com.br/role/ExceptionalItemsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/ExceptionalItemsDetails", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Exceptional items", "totalLabel": "Total" } } }, "auth_ref": [] }, "ifrs-full_ExchangeDifferencesOnTranslationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExchangeDifferencesOnTranslationAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Exchange differences on the translation of foreign operations (gains/(losses))" } } }, "auth_ref": [] }, "abev_ExercisePUTCNDMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ExercisePUTCNDMember", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise P U T C N D [Member]" } } }, "auth_ref": [] }, "abev_ExercisePricesOfTheOutstandingOptions": { "xbrltype": "perShareItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ExercisePricesOfTheOutstandingOptions", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise prices of the outstanding options" } } }, "auth_ref": [] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share-based payments", "verboseLabel": "Expense from share-based payment transactions with employees" } }, "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_ExpenseOfRestructuringActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseOfRestructuringActivities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ExceptionalItemsDetails": { "parentTag": "abev_ExceptionalItems", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ExceptionalItemsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Restructuring\u00a0(i)", "label": "Expense of restructuring activities" } }, "en": { "role": { "documentation": "The amount of expense relating to restructuring. Restructuring is a programme that is planned and controlled by management and materially changes either the scope of a business undertaken by an entity or the manner in which that business is conducted. Such programmes include: (a) the sale or termination of a line of business; (b) closure of business locations in a country or region or the relocation of activities from one country or region to another; (c) changes in management structure; and (d) fundamental reorganisations that have a material effect on the nature and focus of the entity's operations." } } }, "auth_ref": [ "r46" ] }, "abev_ExpensesIncurredByARelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ExpensesIncurredByARelatedParty", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expenses incurred by a related party", "documentation": "The amount of expenses incurred by a related party during the period." } } }, "auth_ref": [] }, "abev_ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Expenses That Affect The Foreign Currency Exchange Risk Portion Of Expenses Exposure [Member]" } } }, "auth_ref": [] }, "ifrs-full_ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of average discount rate applied for IFRS 16" } }, "en": { "role": { "documentation": "The explanation of the difference between: (a) operating lease commitments disclosed applying IAS 17 at the end of the annual reporting period immediately preceding the date of initial application of IFRS 16, discounted using the incremental borrowing rate at the date of initial application; and (b) lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment." } } }, "auth_ref": [ "r192" ] }, "abev_ExtemporaneousCreditsDebits": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ExtemporaneousCreditsDebits", "crdr": "credit", "calculation": { "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails" ], "lang": { "en-us": { "role": { "label": "Extemporaneous credits/(debits)\u00a0(i)" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "abev_ExternalUseAssetsCommercialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ExternalUseAssetsCommercialAssetsMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "External Use Assets Commercial Assets [Member]" } } }, "auth_ref": [] }, "abev_FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value, granted" } } }, "auth_ref": [] }, "abev_FairValueOfPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FairValueOfPlanAssets", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of plan assets" } } }, "auth_ref": [] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements" ], "lang": { "en-us": { "role": { "negatedLabel": "Finance expenses", "label": "Finance costs" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r42" ] }, "abev_FinanceCostsExcludingNonrecurringFinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinanceCostsExcludingNonrecurringFinanceCosts", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_NetFinanceResult", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total of finance expenses", "label": "FinanceCostsExcludingNonrecurringFinanceCosts" } } }, "auth_ref": [] }, "abev_FinanceExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinanceExpensesAbstract", "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Finance expenses" } } }, "auth_ref": [] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_FinanceIncomeCost", "weight": 1.0, "order": 2.0 }, "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_NetFinanceResult", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "label": "Finance income", "totalLabel": "Total of finance income" } }, "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r366" ] }, "abev_FinanceIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinanceIncomeAbstract", "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Finance income" } } }, "auth_ref": [] }, "abev_FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems" } } }, "auth_ref": [] }, "ifrs-full_FinanceIncomeCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncomeCost", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net finance result", "label": "Net finance costs" } }, "en": { "role": { "documentation": "The amount of income or cost associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r366" ] }, "abev_FinancialAssetAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialAssetAtFairValueThroughProfitOrLoss", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails8" ], "lang": { "en-us": { "role": { "negatedLabel": "(-) Financial assets at fair value through profit or loss", "label": "FinancialAssetAtFairValueThroughProfitOrLoss" } } }, "auth_ref": [] }, "abev_FinancialAssetCashAndCashEquivalentsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialAssetCashAndCashEquivalentsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Financial asset, cash and cash equivalents [member]", "documentation": "The cash and cash equivalents portion of financial assets." } } }, "auth_ref": [] }, "abev_FinancialAssetInvestmentSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialAssetInvestmentSecuritiesMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Financial asset, investment securities [member]", "documentation": "The investment securities portion of financial assets." } } }, "auth_ref": [] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Financial asset" } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } } }, "auth_ref": [ "r228", "r233", "r234", "r237", "r324" ] }, "ifrs-full_FinancialAssetsAtAmortisedCostCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtAmortisedCostCategoryMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at amortised cost, category [member]" } }, "en": { "role": { "documentation": "This member stands for the financial assets at amortised cost category. [Refer: Financial assets at amortised cost]" } } }, "auth_ref": [ "r245" ] }, "ifrs-full_FinancialAssetsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtFairValue", "crdr": "debit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "label": "Fair Value", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Financial assets at fair value through profit or loss, category [member]" } }, "en": { "role": { "documentation": "This member stands for the financial assets at fair value through profit or loss category. [Refer: Financial assets at fair value through profit or loss]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_FinancialAssetsCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsCategoryMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial assets. It also represents the standard value for the 'Categories of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r247" ] }, "abev_FinancialAssetsInvestmentSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialAssetsInvestmentSecurities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": "ifrs-full_FinancialAssetsAtFairValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "verboseLabel": "Investment securities", "label": "FinancialAssetsInvestmentSecurities" } } }, "auth_ref": [] }, "ifrs-full_FinancialAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssetsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r203", "r240", "r241", "r269", "r270" ] }, "abev_FinancialIncomeEffectOfAdoptionOfNewAccountingPolicies": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialIncomeEffectOfAdoptionOfNewAccountingPolicies", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "ifrs-full_FinanceIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effect of application of IAS 29 (hyperinflation)", "label": "FinancialIncomeEffectOfAdoptionOfNewAccountingPolicies" } } }, "auth_ref": [] }, "ifrs-full_FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Fair value of hedging instruments" } }, "en": { "role": { "documentation": "The fair value of financial instruments designated as hedging instruments. Hedging instruments are designated derivatives or (for a hedge of the risk of changes in foreign currency exchange rates only) designated non-derivative financial assets or non-derivative financial liabilities whose fair value or cash flows are expected to offset changes in the fair value or cash flows of a designated hedged item. [Refer: At fair value [member]; Derivatives [member]; Derivative financial assets; Derivative financial liabilities; Financial instruments, class [member]; Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r271" ] }, "abev_FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenario": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenario", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "verboseLabel": "Sensitivity value level, adverse scenario", "label": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenario" } } }, "auth_ref": [] }, "abev_FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Sensitivity value level, adverse scenario" } } }, "auth_ref": [] }, "abev_FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "verboseLabel": "Sensitivity value level, probable scenario", "label": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario" } } }, "auth_ref": [] }, "abev_FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Sensitivity value level, probable scenario" } } }, "auth_ref": [] }, "abev_FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenario": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenario", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "verboseLabel": "Sensitivity value level, remote scenario", "label": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenario" } } }, "auth_ref": [] }, "abev_FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Sensitivity value level, remote scenario" } } }, "auth_ref": [] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "label": "Financial liability", "periodStartLabel": "Financial liabilities balance", "periodEndLabel": "Financial liabilities balance" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_FinancialLiabilitiesAtAmortisedCostCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtAmortisedCostCategoryMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at amortised cost, category [member]" } }, "en": { "role": { "documentation": "This member stands for the financial liabilities at amortised cost category. [Refer: Financial liabilities at amortised cost]" } } }, "auth_ref": [ "r246" ] }, "ifrs-full_FinancialLiabilitiesAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValue", "crdr": "credit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Financial liabilities, at fair value" } }, "en": { "role": { "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Financial liabilities at fair value through profit or loss, category [member]" } }, "en": { "role": { "documentation": "This member stands for the financial liabilities at fair value through profit or loss category. [Refer: Financial liabilities at fair value through profit or loss]" } } }, "auth_ref": [ "r244" ] }, "ifrs-full_FinancialLiabilitiesCategoryMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesCategoryMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated categories of financial liabilities. It also represents the standard value for the 'Categories of financial liabilities' axis if no other member is used. [Refer: Financial assets]" } } }, "auth_ref": [ "r247" ] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r240", "r241", "r269", "r270" ] }, "ifrs-full_FinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinishedGoods", "crdr": "debit", "calculation": { "http://ambev.com.br/role/InventoryDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished goods" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of goods that have completed the production process and are held for sale in the ordinary course of business. [Refer: Inventories]" } } }, "auth_ref": [ "r282", "r381" ] }, "abev_FittingsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FittingsMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Fittings [Member]" } } }, "auth_ref": [] }, "ifrs-full_FixedInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FixedInterestRateMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Fixed interest rate [member]" } }, "en": { "role": { "documentation": "This member stands for a fixed interest rate. [Refer: Interest rate risk [member]]" } } }, "auth_ref": [ "r396" ] }, "ifrs-full_FixturesAndFittingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FixturesAndFittingsMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1" ], "lang": { "en-us": { "role": { "label": "Fixtures and fittings [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r289" ] }, "abev_FixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FixturesMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Fixtures [Member]" } } }, "auth_ref": [] }, "ifrs-full_FloatingInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FloatingInterestRateMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Floating interest rate [member]" } }, "en": { "role": { "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]" } } }, "auth_ref": [ "r396" ] }, "abev_ForeignCurrencyExchangeHedgeMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignCurrencyExchangeHedgeMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Exchange Hedge [Member]" } } }, "auth_ref": [] }, "abev_ForeignCurrencyExchangeRiskPortionOfExpensesCashMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignCurrencyExchangeRiskPortionOfExpensesCashMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Exchange Risk Portion Of Expenses Cash [Member]" } } }, "auth_ref": [] }, "abev_ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Exchange Risk Portion Of Expenses Exposure [Member]" } } }, "auth_ref": [] }, "abev_ForeignCurrencyRiskPortionOfFixedAssetsExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignCurrencyRiskPortionOfFixedAssetsExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Risk Portion Of Fixed Assets Exposure [Member]" } } }, "auth_ref": [] }, "abev_ForeignEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignEarnings", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Disallowance of tax paid abroad", "label": "ForeignEarnings" } } }, "auth_ref": [] }, "abev_ForeignExchangeEffectOnCurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignExchangeEffectOnCurrentBorrowings", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Foreign exchange, current" } } }, "auth_ref": [] }, "abev_ForeignExchangeEffectOnNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignExchangeEffectOnNoncurrentBorrowings", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Foreign exchange, non-current" } } }, "auth_ref": [] }, "abev_ForeignExchangeRiskPortionOfCostExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ForeignExchangeRiskPortionOfCostExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Foreign Exchange Risk Portion Of Cost Exposure [Member]" } } }, "auth_ref": [] }, "abev_FundacaoZerrennerMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "FundacaoZerrennerMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fundacao Zerrenner [member]", "documentation": "Represents The Funda&amp;#63;&amp;#63;o Antonio e Helena Zerrenner Institui&amp;#63;&amp;#63;o Nacional de Benefici&amp;#63;ncia which is one of Ambev S.A.&amp;#8217;s shareholders." } } }, "auth_ref": [] }, "ifrs-full_GainLossOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeiling": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainLossOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeiling", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails3" ], "lang": { "en-us": { "role": { "label": "Change in asset ceiling excluding amounts included in interest income/(expenses)" } }, "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the gain (loss) on changes in the effect of limiting a net defined benefit asset to the asset ceiling, excluding amounts included in interest income or expense. [Refer: Interest income (expense); Net defined benefit liability (asset); Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]" } } }, "auth_ref": [ "r78" ] }, "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails2" ], "lang": { "en-us": { "role": { "label": "Expected return, excluding interest income" } }, "en": { "role": { "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r79" ] }, "ifrs-full_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails2" ], "lang": { "en-us": { "role": { "label": "Curtailments, settlements and other" } }, "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from settlements. Settlements are transactions that eliminate all further legal or constructive obligations for part or all of the benefits provided under a defined benefit plan, other than a payment of benefits to, or on behalf of, employees that is set out in the terms of the plan and included in the actuarial assumptions. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]; Actuarial assumptions [member]]" } } }, "auth_ref": [ "r80" ] }, "abev_GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAssets", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails4" ], "lang": { "en-us": { "role": { "label": "(Gains) losses on settlement and curtailment" } } }, "auth_ref": [] }, "abev_GainsLossesFromOperationalResults": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GainsLossesFromOperationalResults", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "Gain (loss) Operational Result", "documentation": "The gains or losses recorded in operational results." } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnCashFlowHedgesNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnCashFlowHedgesNetOfTax", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Recognized in Equity (Hedge reserve)" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on cash flow hedges, net of tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]" } } }, "auth_ref": [ "r45", "r225", "r227" ] }, "ifrs-full_GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnChangeInValueOfTimeValueOfOptionsNetOfTax", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Investment hedge \u2013 put option granted on subsidiaries" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on change in value of time value of options, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r45" ] }, "ifrs-full_GainsLossesOnDisposalsOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnDisposalsOfPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails" ], "lang": { "en-us": { "role": { "label": "Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates" } }, "en": { "role": { "documentation": "The gains (losses) on disposals of property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r47" ] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Gains/losses on translation of foreign operations", "label": "Gains (losses) on exchange differences on translation of foreign operations, net of tax" } }, "en": { "role": { "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r45" ] }, "ifrs-full_GainsLossesOnHedgingInstrument": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnHedgingInstrument", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "label": "Losses on hedging instruments" } }, "en": { "role": { "documentation": "The gains (losses) on hedging instruments in fair value hedges. [Refer: Fair value hedges [member]]" } } }, "auth_ref": [ "r274" ] }, "ifrs-full_GainsLossesOnNetMonetaryPosition": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnNetMonetaryPosition", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ExceptionalItemsDetails": { "parentTag": "abev_ExceptionalItems", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ExceptionalItemsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effect of application of IAS 29 (hyperinflation)", "label": "Gains (losses) on net monetary position" } }, "en": { "role": { "documentation": "The gains (losses) representing the difference resulting from the restatement of non-monetary assets, owners' equity and items in the statement of comprehensive income and the adjustment of index linked assets and liabilities in hyperinflationary reporting." } } }, "auth_ref": [ "r107" ] }, "abev_GainsLossesOnOtherExchangeDifferencesOnTranslationNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GainsLossesOnOtherExchangeDifferencesOnTranslationNetOfTax", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Gains/losses on translation of other foreign operations" } } }, "auth_ref": [] }, "abev_GainsLossesOnSettlementAndCurtailment": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GainsLossesOnSettlementAndCurtailment", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Gains and (losses) on settlements or reductions in benefits" } } }, "auth_ref": [] }, "abev_GainsLossesRecognisedEquityFairValueMeasurementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GainsLossesRecognisedEquityFairValueMeasurementLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "label": "Losses/(gains) recognized in equity", "documentation": "The gains (losses) recognised in equity on the fair value measurement of liabilities." } } }, "auth_ref": [] }, "ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "label": "Losses/(gains) recognized in net income" } }, "en": { "role": { "documentation": "The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r176" ] }, "abev_GainsLossesRecordedInEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GainsLossesRecordedInEquity", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "Gain (loss) Equity", "documentation": "The gains or losses recorded in equity." } } }, "auth_ref": [] }, "abev_GainsLossesRecordedInFinancialResults": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GainsLossesRecordedInFinancialResults", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "Gain (loss) Finance Result", "documentation": "The gains or losses recorded in financial results." } } }, "auth_ref": [] }, "ifrs-full_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Administrative expenses", "label": "General and administrative expense" } }, "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } } }, "auth_ref": [ "r359" ] }, "ifrs-full_GeographicalAreasAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasAxis", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Geographical areas [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r266", "r290", "r319", "r322" ] }, "ifrs-full_GeographicalAreasMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeographicalAreasMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used." } } }, "auth_ref": [ "r266", "r290", "r319", "r322" ] }, "ifrs-full_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/GoodwillDetails", "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Goodwill", "periodStartLabel": "Balance at the end of the previous year", "periodEndLabel": "Balance at the end of the year" } }, "en": { "role": { "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]" } } }, "auth_ref": [ "r11", "r116", "r119", "r216" ] }, "abev_GoodwillAdjustmentAdoptionOfNewAccountingAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillAdjustmentAdoptionOfNewAccountingAdjustment", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effect of application of IAS 29 (hyperinflation)", "label": "GoodwillAdjustmentAdoptionOfNewAccountingAdjustment" } } }, "auth_ref": [] }, "abev_GoodwillForBah": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillForBah", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Goodwill BAH" } } }, "auth_ref": [] }, "abev_GoodwillForCndHolding": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillForCndHolding", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill BAH", "label": "GoodwillForCndHolding" } } }, "auth_ref": [] }, "abev_GoodwillForInbevHolding": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillForInbevHolding", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Disallowance of tax paid abroad", "label": "GoodwillForInbevHolding" } } }, "auth_ref": [] }, "abev_GoodwillForMag": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillForMag", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill BAH", "label": "GoodwillForMag" } } }, "auth_ref": [] }, "abev_GoodwillGrossAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillGrossAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "label": "GoodwillGrossAmount" } } }, "auth_ref": [] }, "abev_GoodwillNoncontrollingTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillNoncontrollingTransactions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Non-controlling transactions" } } }, "auth_ref": [] }, "abev_GoodwillPercentageOfTotalAssets": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GoodwillPercentageOfTotalAssets", "presentation": [ "http://ambev.com.br/role/GoodwillDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Goodwill percentage of total assets" } } }, "auth_ref": [] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r59", "r131", "r141", "r144", "r216", "r234", "r237", "r324" ] }, "ifrs-full_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross profit" } }, "en": { "role": { "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]" } } }, "auth_ref": [ "r277" ] }, "abev_GrowthRate": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GrowthRate", "presentation": [ "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Growth rate" } } }, "auth_ref": [] }, "abev_GrupoModeloMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GrupoModeloMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Grupo Modelo [Member]" } } }, "auth_ref": [] }, "abev_GuaraniSpentInParaguaiMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GuaraniSpentInParaguaiMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Guarani Spent In Paraguai [Member]" } } }, "auth_ref": [] }, "abev_GuaranteesHeldForDerivativeInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "GuaranteesHeldForDerivativeInstruments", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthersDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Guarantees held for derivative instruments", "documentation": "The amount of guarantees held for derivative instrument requirements." } } }, "auth_ref": [] }, "abev_HedgeOperationsResults": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "HedgeOperationsResults", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Hedge operations results", "label": "HedgeOperationsResults" } } }, "auth_ref": [] }, "abev_ICMSAMMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSAMMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I C M S A M [Member]" } } }, "auth_ref": [] }, "abev_ICMSFAINMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSFAINMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I C M S F A I N [Member]" } } }, "auth_ref": [] }, "abev_ICMSFiscalWarMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSFiscalWarMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I C M S Fiscal War [Member]" } } }, "auth_ref": [] }, "abev_ICMSFromTheAssessmentBasesOfPISCOFINSMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSFromTheAssessmentBasesOfPISCOFINSMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "I C M S From The Assessment Bases Of P I S C O F I N S [Member]" } } }, "auth_ref": [] }, "abev_ICMSMIPMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSMIPMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I C M S M I P [Member]" } } }, "auth_ref": [] }, "abev_ICMSMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSMember", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "ICMS [member]" } } }, "auth_ref": [] }, "abev_ICMSProdepeMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSProdepeMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I C M S Prodepe [Member]" } } }, "auth_ref": [] }, "abev_ICMSZFMMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ICMSZFMMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I C M S Z F M [Member]" } } }, "auth_ref": [] }, "abev_IPIMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IPIMember", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "IPI [member]" } } }, "auth_ref": [] }, "abev_IPISuspensionMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IPISuspensionMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "I P I Suspension [Member]" } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r346", "r348", "r349" ] }, "abev_IcmsstTriggerMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IcmsstTriggerMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Icmsst Trigger [Member]" } } }, "auth_ref": [] }, "abev_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IfrsStatementLineItems", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails", "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails", "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity", "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails3", "http://ambev.com.br/role/EmployeeBenefitsDetails5", "http://ambev.com.br/role/EmployeeBenefitsDetails6", "http://ambev.com.br/role/EmployeeBenefitsDetails7", "http://ambev.com.br/role/EmployeeBenefitsDetails8", "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative", "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails", "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4", "http://ambev.com.br/role/InventoryDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative", "http://ambev.com.br/role/RecoverableTaxesDetails", "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails", "http://ambev.com.br/role/RelatedPartiesDetailsNarrative", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails", "http://ambev.com.br/role/SegmentReportingDetailsNarrative", "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative", "http://ambev.com.br/role/TradePayablesDetailsNarrative", "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails", "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "abev_ImpactOfAdoptionOfIFRSAccountingPolicyMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ImpactOfAdoptionOfIFRSAccountingPolicyMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Impact Of Adoption Of I F R S Accounting Policy [Member]" } } }, "auth_ref": [] }, "abev_ImpairmentOfNonFinancialAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ImpairmentOfNonFinancialAssetsAbstract", "lang": { "en-us": { "role": { "label": "Impairment Of Non-financial Assets" } } }, "auth_ref": [] }, "abev_InbevBelgiumNvMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InbevBelgiumNvMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Inbev Belgium N.V. [member]", "documentation": "The entity Inbev Belgium N.V." } } }, "auth_ref": [] }, "abev_IncomeFromInterestAndForeignExchangeRateOnLoansWithRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeFromInterestAndForeignExchangeRateOnLoansWithRelatedParties", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "label": "Interest and foreign exchange rate on loans to/from related parties" } } }, "auth_ref": [] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "abev_IncomeTaxAndSocialContributionMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeTaxAndSocialContributionMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "Income Tax And Social Contribution [Member]" } } }, "auth_ref": [] }, "abev_IncomeTaxAndSocialContributionPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeTaxAndSocialContributionPayableCurrent", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Income tax and social contribution payable", "label": "IncomeTaxAndSocialContributionPayableCurrent" } } }, "auth_ref": [] }, "abev_IncomeTaxAndSocialContributionPayableNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeTaxAndSocialContributionPayableNonCurrent", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Income tax and social contribution payable" } } }, "auth_ref": [] }, "abev_IncomeTaxAndSocialContributionsRecoverableMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeTaxAndSocialContributionsRecoverableMember", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax And Social Contributions Recoverable [Member]" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Income tax expense", "label": "Income tax and social contribution expense" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r43", "r51", "r53", "r54", "r103", "r171", "r255" ] }, "abev_IncomeTaxExpensesContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeTaxExpensesContinuingOperations", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax expense", "label": "IncomeTaxExpensesContinuingOperations" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Cash flow hedge - gains/(losses)" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]" } } }, "auth_ref": [ "r44", "r52" ] }, "ifrs-full_IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "verboseLabel": "Recognition of actuarial gains/(losses)", "label": "Income tax relating to changes in revaluation surplus of property, plant and equipment, right-of-use assets and intangible assets included in other comprehensive income" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to changes in a revaluation surplus of property, plant and equipment, right-of-use assets and intangible assets. [Refer: Revaluation surplus; Other comprehensive income]" } } }, "auth_ref": [ "r44", "r52" ] }, "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Recognized in other comprehensive income" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r44", "r52" ] }, "ifrs-full_IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Gains/(losses) on translation of other foreign operations" } }, "en": { "role": { "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to exchange differences on the translation of financial statements of foreign operations. [Refer: Other comprehensive income; Reserve of exchange differences on translation]" } } }, "auth_ref": [ "r44", "r52" ] }, "abev_IncomeTaxRelatingToHedgesOfInvestmentsRegardingPutOptionsOfASubsidiaryInterestInEquityInstrumentsOfOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeTaxRelatingToHedgesOfInvestmentsRegardingPutOptionsOfASubsidiaryInterestInEquityInstrumentsOfOtherComprehensiveIncome", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Investment hedge - put option granted on subsidiaries" } } }, "auth_ref": [] }, "abev_IncomeTaxesExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncomeTaxesExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails1" ], "lang": { "en-us": { "role": { "totalLabel": "Total income tax expenses", "label": "IncomeTaxesExpenseContinuingOperations" } } }, "auth_ref": [] }, "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax paid", "label": "Income taxes paid (refund), classified as operating activities" } }, "en": { "role": { "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]" } } }, "auth_ref": [ "r150", "r303" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase/(decrease) in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r152" ] }, "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Decrease in assumption" } }, "en": { "role": { "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by a decrease in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]" } } }, "auth_ref": [ "r86" ] }, "ifrs-full_IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails7" ], "lang": { "en-us": { "role": { "label": "Increase in assumption" } }, "en": { "role": { "documentation": "The increase (decrease) in a defined benefit obligation that would have been caused by an increase in a significant actuarial assumption that was reasonably possible at the end of the reporting period. [Refer: Actuarial assumptions [member]]" } } }, "auth_ref": [ "r86" ] }, "abev_IncreaseDecreaseInFiscalIncentiveReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseInFiscalIncentiveReserve", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Fiscal incentive reserve", "verboseLabel": "Fiscal incentive reserve" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseInNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails4" ], "lang": { "en-us": { "role": { "negatedLabel": "Income from operations", "label": "Increase (decrease) in net defined benefit liability (asset)" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r84" ] }, "ifrs-full_IncreaseDecreaseInNumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInNumberOfSharesOutstanding", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Shares outstanding" } }, "en": { "role": { "documentation": "The increase (decrease) in the number of shares outstanding. [Refer: Number of shares outstanding]" } } }, "auth_ref": [ "r32" ] }, "abev_IncreaseDecreaseInvestmentsReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseInvestmentsReserve", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Investments reserve", "verboseLabel": "Investments reserve" } } }, "auth_ref": [] }, "abev_IncreaseDecreaseThroughAdoptionOfNewAccountingPronouncement": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughAdoptionOfNewAccountingPronouncement", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effect of application of IAS 29 (hyperinflation)", "label": "IncreaseDecreaseThroughAdoptionOfNewAccountingPronouncement" } } }, "auth_ref": [] }, "abev_IncreaseDecreaseThroughBusinessCombinationsGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughBusinessCombinationsGoodwill", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "label": "Acquisitions, (write-offs) and disposal through business combinations" } } }, "auth_ref": [] }, "abev_IncreaseDecreaseThroughChangeInShareholdersEquityEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughChangeInShareholdersEquityEquity", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Interest on shareholder\u00b4s equity" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails3" ], "lang": { "en-us": { "role": { "label": "Effect of exchange rate fluctuations", "verboseLabel": "Exchange differences", "terseLabel": "Effects of exchange rate fluctuations" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes in foreign exchange rates. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r81" ] }, "abev_IncreaseDecreaseThroughEquityIncrease": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughEquityIncrease", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails" ], "lang": { "en-us": { "role": { "label": "Capital Increase" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesGoodwill", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/GoodwillDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effects of movements in foreign exchange in the balance sheet", "label": "Increase (decrease) through net exchange differences, goodwill" } }, "en": { "role": { "documentation": "The increase (decrease) in goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Goodwill]" } } }, "auth_ref": [ "r215" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effects of movements in foreign exchange in the balance sheet", "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r135" ] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Effect of changes in foreign exchange rates" } }, "en": { "role": { "documentation": "The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]" } } }, "auth_ref": [ "r385" ] }, "abev_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effects of movements in foreign exchange in the balance sheet", "label": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1" } } }, "auth_ref": [] }, "abev_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/InventoryDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Effects of movements in foreign exchange in the balance sheet", "label": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Effects of movements in foreign exchange in the balance sheet" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r62" ] }, "abev_IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Options granted on subsidiaries", "label": "IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughOtherChangesNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughOtherChangesNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Reclassifications" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r374" ] }, "ifrs-full_IncreaseDecreaseThroughTransactionsWithOwners": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTransactionsWithOwners", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Gains/(losses) of controlling interest", "verboseLabel": "Gains/(losses) on controlling interest" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from transactions with owners." } } }, "auth_ref": [ "r357" ] }, "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Transfers", "label": "Increase (decrease) through transfers, intangible assets other than goodwill" } }, "en": { "role": { "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r386" ] }, "ifrs-full_IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Transfers" } }, "en": { "role": { "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r371" ] }, "ifrs-full_IncreaseDecreaseThroughTreasuryShareTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughTreasuryShareTransactions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Purchases of shares, results from treasury shares and share-based payments" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares]" } } }, "auth_ref": [ "r6" ] }, "abev_IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails" ], "lang": { "en-us": { "role": { "label": "Purchases of shares, results of treasury shares and share-based payments" } } }, "auth_ref": [] }, "ifrs-full_IndividualAssetsOrCashgeneratingUnitsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IndividualAssetsOrCashgeneratingUnitsAxis", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Individual assets or cash-generating units [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r115" ] }, "abev_InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Input Purchases Affecting The Commodity Risk Portion Of Cost Exposure [Member]" } } }, "auth_ref": [] }, "abev_InstrumentsSharingCharacteristicHighlyLiquidInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InstrumentsSharingCharacteristicHighlyLiquidInvestments", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Instruments sharing characteristic, highly liquid investments", "documentation": "The amount of highly liquid investments of instruments sharing characteristics." } } }, "auth_ref": [] }, "ifrs-full_InsuranceFinanceIncomeExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceFinanceIncomeExpenses", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Finance expenses" } }, "en": { "role": { "documentation": "The amount that comprises the change in the carrying amount of the group of insurance contracts arising from: (a) the effect of the time value of money and changes in the time value of money; and (b) the effect of financial risk and changes in financial risk; but (c) excluding any such changes for groups of insurance contracts with direct participation features that would adjust the contractual service margin but do not do so when applying paragraphs 45(b)(ii), 45(b)(iii), 45(c)(ii) or 45(c)(iii) of IFRS 17." } } }, "auth_ref": [ "r195" ] }, "ifrs-full_IntangibleAssetsAndGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsAndGoodwillMember", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails", "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]" } } }, "auth_ref": [ "r387" ] }, "abev_IntangibleAssetsInArgentinaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInArgentinaMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Argentina [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInBoliviaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInBoliviaMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Bolivia [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInBrazilMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInBrazilMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Brazil [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInCanadaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInCanadaMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Canada [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInChileMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInChileMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Chile [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInLuxembourgMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInLuxembourgMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Luxembourg [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInPanamaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInPanamaMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Panama [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInParaguayMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInParaguayMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Paraguay [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInTheDominicanRepublicMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInTheDominicanRepublicMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In The Dominican Republic [Member]" } } }, "auth_ref": [] }, "abev_IntangibleAssetsInUruaguayMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsInUruaguayMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible Assets In Uruaguay [Member]" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangible", "periodStartLabel": "Intangible assets, beginning balance", "periodEndLabel": "Intangible assets, final balance" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r11", "r136" ] }, "abev_IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Effect of application of IAS 29 (hyperinflation)", "label": "IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement" } } }, "auth_ref": [] }, "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsWithIndefiniteUsefulLife", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets with indefinite useful life" } }, "en": { "role": { "documentation": "The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r117", "r120", "r138" ] }, "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsWithIndefiniteUsefulLifeAxis", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en-us": { "role": { "label": "Intangible assets with indefinite useful life [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r138" ] }, "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLifeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsWithIndefiniteUsefulLifeMember", "presentation": [ "http://ambev.com.br/role/Intangibles-IntangibleAssetsByLocationDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets with an indefinite useful life. It also represents the standard value for the 'Intangible assets with indefinite useful life' axis if no other member is used. [Refer: Intangible assets with indefinite useful life]" } } }, "auth_ref": [ "r138" ] }, "abev_IntangiblesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IntangiblesMember", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Intangibles [Member]" } } }, "auth_ref": [] }, "abev_InterbrewInternationalBvMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterbrewInternationalBvMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Interbrew International B.V. [member]", "documentation": "The entity Interbrew International B.V." } } }, "auth_ref": [] }, "ifrs-full_InterestCostsCapitalised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestCostsCapitalised", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Acquisition cost" } }, "en": { "role": { "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset." } } }, "auth_ref": [ "r359" ] }, "ifrs-full_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": 1.0, "order": 1.0 }, "http://ambev.com.br/role/NetFinanceResultDetails1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails", "http://ambev.com.br/role/NetFinanceResultDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "negatedTotalLabel": "Total", "label": "Interest expense" } }, "en": { "role": { "documentation": "The amount of expense arising from interest." } } }, "auth_ref": [ "r170", "r254", "r261" ] }, "ifrs-full_InterestExpenseIncomeNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseIncomeNetDefinedBenefitLiabilityAsset", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails3" ], "lang": { "en-us": { "role": { "label": "Interest costs", "negatedLabel": "Interest income", "negatedTerseLabel": "Interest income/(expenses)" } }, "en": { "role": { "documentation": "The increase (decrease) in the net defined benefit liability (asset) resulting from the passage of time. [Refer: Interest expense; Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r74" ] }, "ifrs-full_InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails1": { "parentTag": "ifrs-full_InterestExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Financial instruments measured at amortized cost", "label": "Interest expense on financial liabilities designated at fair value through profit or loss" } }, "en": { "role": { "documentation": "The amount of interest expense on financial liabilities designated at fair value through profit or loss. [Refer: Interest expense; Financial liabilities at fair value through profit or loss, designated upon initial recognition or subsequently]" } } }, "auth_ref": [ "r359" ] }, "abev_InterestExpenseOnInstrumentsAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestExpenseOnInstrumentsAtFairValueThroughProfitOrLoss", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails1": { "parentTag": "ifrs-full_InterestExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Financial instruments at fair value through profit or loss\u00a0(i)", "label": "InterestExpenseOnInstrumentsAtFairValueThroughProfitOrLoss" } } }, "auth_ref": [] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Interest on leases" } }, "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r187" ] }, "ifrs-full_InterestIncomeOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestIncomeOnCashAndCashEquivalents", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails2": { "parentTag": "ifrs-full_RevenueFromInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash and cash equivalents", "label": "Interest income on cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of interest income on cash and cash equivalents. [Refer: Interest income; Cash and cash equivalents]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_InterestIncomeOnFinancialAssetsHeldForTrading": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestIncomeOnFinancialAssetsHeldForTrading", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails2": { "parentTag": "ifrs-full_RevenueFromInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails2" ], "lang": { "en-us": { "role": { "label": "Investment on debt securities" } }, "en": { "role": { "documentation": "The amount of interest income on financial assets held for trading. [Refer: Interest income; Financial assets at fair value through profit or loss, classified as held for trading]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_InterestIncomeOnOtherFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestIncomeOnOtherFinancialAssets", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails2": { "parentTag": "ifrs-full_RevenueFromInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails2" ], "lang": { "en-us": { "role": { "label": "Other receivables\u00a0(i)" } }, "en": { "role": { "documentation": "The amount of interest income on other financial assets. [Refer: Interest income; Other financial assets]" } } }, "auth_ref": [ "r359" ] }, "abev_InterestOnProvisionForContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnProvisionForContingencies", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest on provision for disputes and litigation", "label": "InterestOnProvisionForContingencies" } } }, "auth_ref": [] }, "abev_InterestOnShareholderEquityDistributionAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholderEquityDistributionAmountPerShare", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Interest on shareholders equity distribution of dividends", "label": "InterestOnShareholderEquityDistributionAmountPerShare" } } }, "auth_ref": [] }, "abev_InterestOnShareholderEquityDividendsAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholderEquityDividendsAmountPerShare", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest on shareholders equity distribution of dividends" } } }, "auth_ref": [] }, "abev_InterestOnShareholdersEquityDistribution": { "xbrltype": "perShareItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholdersEquityDistribution", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest on shareholders equity distribution" } } }, "auth_ref": [] }, "abev_InterestOnShareholdersEquityDistributionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholdersEquityDistributionAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-InterestOnShareholdersEquityDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Amount, distribution" } } }, "auth_ref": [] }, "abev_InterestOnShareholdersEquityDistributionAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholdersEquityDistributionAmountPerShare", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-InterestOnShareholdersEquityDividendsDetails", "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amount per share, distribution (in BRL per share)", "verboseLabel": "[custom:InterestOnShareholdersEquityDistributionAmountPerShare]" } } }, "auth_ref": [] }, "abev_InterestOnShareholdersEquityDistributionAndDividendAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholdersEquityDistributionAndDividendAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-InterestOnShareholdersEquityDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Total amount" } } }, "auth_ref": [] }, "abev_InterestOnShareholdersEquityDividendsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholdersEquityDividendsAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-InterestOnShareholdersEquityDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Amount, dividends" } } }, "auth_ref": [] }, "abev_InterestOnShareholdersEquityDividendsAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestOnShareholdersEquityDividendsAmountPerShare", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-InterestOnShareholdersEquityDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Amount per share, dividends (in BRL per share)" } } }, "auth_ref": [] }, "ifrs-full_InterestPaidClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestPaidClassifiedAsOperatingActivities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest paid", "label": "Interest paid, classified as operating activities" } }, "en": { "role": { "documentation": "The cash outflow for interest paid, classified as operating activities." } } }, "auth_ref": [ "r149" ] }, "abev_InterestRateRiskBrazilianReaisMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestRateRiskBrazilianReaisMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Interest Rate Risk Brazilian Reais [Member]" } } }, "auth_ref": [] }, "abev_InterestRateRiskCanadianDollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestRateRiskCanadianDollarsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Interest rate risk, Canadian Dollars [member]", "documentation": "Refers to information regarding the Canadian Dollar portion of interest rate risk." } } }, "auth_ref": [] }, "ifrs-full_InterestRateRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestRateRiskMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Interest rate risk [member]" } }, "en": { "role": { "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r197", "r198", "r199", "r200", "r250" ] }, "abev_InterestRateRiskUSDollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestRateRiskUSDollarsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Interest rate risk, US Dollars [member]", "documentation": "Refers to information regarding the US Dollars portion of interest rate risk." } } }, "auth_ref": [] }, "abev_InterestRateRiskWorkingCapitalinArgentineanPesoMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestRateRiskWorkingCapitalinArgentineanPesoMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Interest rate risk, working capital in Argentinean Peso [member]", "documentation": "The Argentinean Peso portion of interest rate risk." } } }, "auth_ref": [] }, "ifrs-full_InterestRateTypesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestRateTypesMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]" } } }, "auth_ref": [ "r396" ] }, "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestReceivedClassifiedAsOperatingActivities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Interest received" } }, "en": { "role": { "documentation": "The cash inflow from interest received, classified as operating activities." } } }, "auth_ref": [ "r149" ] }, "abev_InterestbearingLoansAndBorrowingsCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestbearingLoansAndBorrowingsCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails8" ], "lang": { "en-us": { "role": { "label": "Interest-bearing loans and borrowings current and non-current" } } }, "auth_ref": [] }, "abev_InterestbearingLoansAndBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InterestbearingLoansAndBorrowingsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Interest-bearing loans and borrowings [member]", "documentation": "Refers to information regarding interest-bearing loans and borrowings." } } }, "auth_ref": [] }, "ifrs-full_Inventories": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Inventories", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 }, "http://ambev.com.br/role/InventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Inventories", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of current inventories. [Refer: Inventories]" } } }, "auth_ref": [ "r12", "r92", "r279" ] }, "abev_InventoriesImpairmentLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InventoriesImpairmentLosses", "crdr": "credit", "calculation": { "http://ambev.com.br/role/InventoryDetails": { "parentTag": "ifrs-full_Inventories", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/InventoryDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment losses", "label": "InventoriesImpairmentLosses" } } }, "auth_ref": [] }, "abev_InventoryProvisionMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InventoryProvisionMember", "presentation": [ "http://ambev.com.br/role/InventoryDetails1" ], "lang": { "en-us": { "role": { "label": "Inventory Provision [Member]" } } }, "auth_ref": [] }, "abev_InvestmentReserveLimitPercentageOfNetIncome": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InvestmentReserveLimitPercentageOfNetIncome", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investment reserve limit percentage of net income" } } }, "auth_ref": [] }, "abev_InvestmentSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InvestmentSecurities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "InvestmentSecurities" } } }, "auth_ref": [] }, "ifrs-full_InvestmentsInAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsInAssociates", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Investments in joint ventures" } }, "en": { "role": { "documentation": "The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]" } } }, "auth_ref": [ "r104" ] }, "abev_InvestmentsInShorttermDebtSecuritiesAndNetProceedsacquisitionsOfDebtSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "InvestmentsInShorttermDebtSecuritiesAndNetProceedsacquisitionsOfDebtSecurities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investments in short-term debt securities and net proceeds/(acquisitions) of debt securities" } } }, "auth_ref": [] }, "abev_IsoletFines": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IsoletFines", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Tax Loss Offset", "label": "IsoletFines" } } }, "auth_ref": [] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Capital increase (Note 22)", "verboseLabel": "Issue of equity" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r5" ] }, "abev_IssueOfEquityShares": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "IssueOfEquityShares", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Issue of equity shares" } } }, "auth_ref": [] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Issued capital" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r283" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r7" ] }, "abev_ItemsThatMayBeSubsequentlyReclassifiedToProfitOrLoss": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ItemsThatMayBeSubsequentlyReclassifiedToProfitOrLoss", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Items that may be subsequently reclassified to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_KeyManagementPersonnelCompensation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensation", "crdr": "debit", "calculation": { "http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total key management remuneration", "label": "Key management personnel compensation" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r98" ] }, "ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationSharebasedPayment", "crdr": "debit", "calculation": { "http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails" ], "lang": { "en-us": { "role": { "label": "Share-based payments\u00a0(ii)" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of share-based payments. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r97" ] }, "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits", "crdr": "debit", "calculation": { "http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails": { "parentTag": "ifrs-full_KeyManagementPersonnelCompensation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/RelatedParties-ExpensesRelatedToManagementMembersDetails" ], "lang": { "en-us": { "role": { "label": "Short-term benefits\u00a0(i)" } }, "en": { "role": { "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]" } } }, "auth_ref": [ "r96" ] }, "ifrs-full_LandAndBuildingsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LandAndBuildingsMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1" ], "lang": { "en-us": { "role": { "label": "Land and buildings [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing land and depreciable buildings and similar structures for use in operations. [Refer: Buildings; Land; Property, plant and equipment]" } } }, "auth_ref": [ "r288" ] }, "abev_LaterThanAYearMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanAYearMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later Than A Year [Member]" } } }, "auth_ref": [] }, "abev_LaterThanFiveYearsAndNotLaterThanEightYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanFiveYearsAndNotLaterThanEightYearsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5" ], "lang": { "en-us": { "role": { "label": "Later Than Five Years And Not Later Than Eight Years [Member]" } } }, "auth_ref": [] }, "ifrs-full_LaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFiveYearsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7" ], "lang": { "en-us": { "role": { "label": "Later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than five years." } } }, "auth_ref": [ "r189", "r190", "r202", "r325", "r327", "r330" ] }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5" ], "lang": { "en-us": { "role": { "label": "Later than four years and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } } }, "auth_ref": [ "r189", "r190", "r202", "r325", "r330", "r359" ] }, "abev_LaterThanNineYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanNineYearsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5" ], "lang": { "en-us": { "role": { "label": "Later Than Nine Years [Member]" } } }, "auth_ref": [] }, "ifrs-full_LaterThanOneMonthAndNotLaterThanTwoMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneMonthAndNotLaterThanTwoMonthsMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later than one month and not later than two months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one month and not later than two months." } } }, "auth_ref": [ "r324", "r329", "r359" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than two years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } } }, "auth_ref": [ "r189", "r190", "r202", "r325", "r330", "r359" ] }, "ifrs-full_LaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year." } } }, "auth_ref": [ "r24" ] }, "abev_LaterThanSixMonthsAndLessThan12MonthsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanSixMonthsAndLessThan12MonthsMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later Than Six Months And Less Than 12 Months [Member]" } } }, "auth_ref": [] }, "abev_LaterThanThreeMonthsAndLessThanSixMonthsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanThreeMonthsAndLessThanSixMonthsMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later Than Three Months And Less Than Six Months [Member]" } } }, "auth_ref": [] }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Later than three years and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than five years." } } }, "auth_ref": [ "r325", "r326", "r330" ] }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "Later than three years and not later than four years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than four years." } } }, "auth_ref": [ "r189", "r190", "r202", "r325", "r330", "r359" ] }, "abev_LaterThanThreeYearsAndNotLaterThanFoursYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanThreeYearsAndNotLaterThanFoursYearsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5" ], "lang": { "en-us": { "role": { "label": "Later Than Three Years And Not Later Than Fours Years [Member]" } } }, "auth_ref": [] }, "abev_LaterThanThreeYearsAndNotLaterThanSixYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanThreeYearsAndNotLaterThanSixYearsMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Later Than Three Years And Not Later Than Six Years [Member]" } } }, "auth_ref": [] }, "ifrs-full_LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Later than two months and not later than three months [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than two months and not later than three months." } } }, "auth_ref": [ "r324", "r329", "r359" ] }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Later than two years and not later than three years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than three years." } } }, "auth_ref": [ "r189", "r190", "r202", "r325", "r330", "r359" ] }, "abev_LaterThanTwoYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LaterThanTwoYearsMember", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Later than two years [member]", "documentation": "Refers to information regarding the duration later than two years." } } }, "auth_ref": [] }, "abev_LatinAmericaSouthMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LatinAmericaSouthMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails" ], "lang": { "en-us": { "role": { "label": "Latin America South [Member]" } } }, "auth_ref": [] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7" ], "lang": { "en-us": { "role": { "label": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r186" ] }, "ifrs-full_LeaseLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r311", "r313" ] }, "abev_LeaseLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LeaseLiabilityMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Lease Liability [Member]" } } }, "auth_ref": [] }, "abev_LeaseTerm20232027Member": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LeaseTerm20232027Member", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4" ], "lang": { "en-us": { "role": { "label": "Lease Term 20232027 [Member]" } } }, "auth_ref": [] }, "abev_LeaseTerm20282035Member": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LeaseTerm20282035Member", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4" ], "lang": { "en-us": { "role": { "label": "Lease Term 20282035 [Member]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "abev_LegalFee": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LegalFee", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ExceptionalItemsDetails": { "parentTag": "abev_ExceptionalItems", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ExceptionalItemsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Legal fees\u00a0(iii)", "label": "LegalFee" } } }, "auth_ref": [] }, "ifrs-full_LegalProceedingsProvisionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LegalProceedingsProvisionMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Legal proceedings provision [member]" } }, "en": { "role": { "documentation": "This member stands for a provision for legal proceedings. [Refer: Other provisions [member]]" } } }, "auth_ref": [ "r298", "r300" ] }, "abev_LessThanOneMonthMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LessThanOneMonthMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Less Than One Month [Member]" } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r85", "r174" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r174" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r174" ] }, "abev_LevelReclassification": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LevelReclassification", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "label": "Level reclassification" } } }, "auth_ref": [] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r85", "r174" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r21", "r173", "r174", "r178", "r256", "r260" ] }, "ifrs-full_LiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3", "http://ambev.com.br/role/TradePayablesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of liabilities' axis if no other member is used. [Refer: Liabilities]" } } }, "auth_ref": [ "r179" ] }, "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilityAssetOfDefinedBenefitPlans", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails", "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails3" ], "lang": { "en-us": { "role": { "label": "Total employee benefits", "periodStartLabel": "Defined benefit obligation at January 1", "periodEndLabel": "Defined benefit obligation at December, 31" } }, "en": { "role": { "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [member]]" } } }, "auth_ref": [ "r72" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ifrs-full_LongtermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LongtermBorrowings", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Interest-bearing loans and borrowings", "verboseLabel": "Interest-bearing loans and borrowings, noncurrent", "periodEndLabel": "Balance, non current", "periodStartLabel": "Balance, non current" } }, "en": { "role": { "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r362" ] }, "abev_LossesGainsRecognizedInTheYearFairValueMeasurementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LossesGainsRecognizedInTheYearFairValueMeasurementLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "label": "Total gains and losses during the period", "documentation": "The gains (losses) recognised on the fair value measurement of liabilities." } } }, "auth_ref": [] }, "abev_LuxembourgMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "LuxembourgMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails" ], "lang": { "en-us": { "role": { "label": "Luxembourg [Member]" } } }, "auth_ref": [] }, "abev_MachineryVehiclesAndOthersMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "MachineryVehiclesAndOthersMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Machinery Vehicles And Others [Member]" } } }, "auth_ref": [] }, "abev_ManausFreeTradeZoneMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ManausFreeTradeZoneMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Manaus Free Trade Zone [Member]" } } }, "auth_ref": [] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r25", "r184", "r189", "r190", "r193", "r194", "r196", "r202", "r222", "r239", "r292", "r325" ] }, "abev_MaturityTotalMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "MaturityTotalMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Maturity Total [Member]" } } }, "auth_ref": [] }, "ifrs-full_MaximumExposureToCreditRiskOfFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaximumExposureToCreditRiskOfFinancialAssets", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "Fair Value Assets" } }, "en": { "role": { "documentation": "The maximum exposure to the credit risk of financial assets designated as measured at fair value through profit or loss. [Refer: Credit risk [member]; Maximum exposure to credit risk]" } } }, "auth_ref": [ "r248" ] }, "abev_MaximumExposureToCreditRiskOfFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "MaximumExposureToCreditRiskOfFinancialLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "Fair Value Liability", "documentation": "The maximum exposure to the credit risk of financial liabilities designated as measured at fair value through profit or loss." } } }, "auth_ref": [] }, "abev_MercadoMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "MercadoMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Mercado [Member]" } } }, "auth_ref": [] }, "abev_MexicanPesosRiskPortionOfCostExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "MexicanPesosRiskPortionOfCostExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "Mexican Pesos risk portion of cost exposure [member]", "documentation": "The Mexican Pesos risk portion of cost exposure." } } }, "auth_ref": [] }, "abev_MinimumMandatoryDividend": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "MinimumMandatoryDividend", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Minimum mandatory dividend" } } }, "auth_ref": [] }, "ifrs-full_MiscellaneousOtherProvisionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MiscellaneousOtherProvisionsMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Miscellaneous other provisions [member]" } }, "en": { "role": { "documentation": "This member stands for miscellaneous other provisions. [Refer: Other provisions [member]]" } } }, "auth_ref": [ "r125" ] }, "srt_MortgageLoansOnRealEstateLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateLineItems", "presentation": [ "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]" } } }, "auth_ref": [] }, "srt_MortgageLoansOnRealEstateScheduleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MortgageLoansOnRealEstateScheduleTable", "presentation": [ "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Schedule [Table]" } } }, "auth_ref": [] }, "abev_NABMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NABMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "N A B [Member]" } } }, "auth_ref": [] }, "abev_NetAccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetAccountingProfit", "crdr": "credit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "totalLabel": "", "label": "NetAccountingProfit" } } }, "auth_ref": [] }, "ifrs-full_NetDebt": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDebt", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails8" ], "lang": { "en-us": { "role": { "label": "Net debt" } }, "en": { "role": { "documentation": "The amount of net debt of the entity." } } }, "auth_ref": [ "r359" ] }, "ifrs-full_NetDeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDeferredTaxAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets", "verboseLabel": "Net deferred tax assets" } }, "en": { "role": { "documentation": "The amount of deferred tax assets net of deferred tax liabilities, when the absolute amount of deferred tax assets is greater than the absolute amount of deferred tax liabilities. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r368" ] }, "ifrs-full_NetDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred tax assets", "label": "Net deferred tax liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r368" ] }, "abev_NetDeferredTaxLiabilities1": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetDeferredTaxLiabilities1", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3" ], "lang": { "en-us": { "role": { "label": "Net deferred tax liabilities" } } }, "auth_ref": [] }, "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDefinedBenefitLiabilityAssetAxis", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails3", "http://ambev.com.br/role/EmployeeBenefitsDetails5", "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Net defined benefit liability (asset) [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r72" ] }, "ifrs-full_NetDefinedBenefitLiabilityAssetMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDefinedBenefitLiabilityAssetMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2", "http://ambev.com.br/role/EmployeeBenefitsDetails3", "http://ambev.com.br/role/EmployeeBenefitsDetails5", "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en": { "role": { "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r72" ] }, "abev_NetFinanceCostRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetFinanceCostRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Net finance cost, related parties", "documentation": "The amount of net finance cost resulting from related party transactions." } } }, "auth_ref": [] }, "abev_NetFinanceResult": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetFinanceResult", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net finance result", "label": "NetFinanceResult" } } }, "auth_ref": [] }, "ifrs-full_NetForeignExchangeLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetForeignExchangeLoss", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exchange differences", "label": "Net foreign exchange loss" } }, "en": { "role": { "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]" } } }, "auth_ref": [ "r361", "r383" ] }, "abev_NetIncomeReserveMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetIncomeReserveMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails" ], "lang": { "en-us": { "role": { "label": "Net Income Reserve [Member]" } } }, "auth_ref": [] }, "abev_NetIncomeReservesFiscalIncentiveMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetIncomeReservesFiscalIncentiveMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails" ], "lang": { "en-us": { "role": { "label": "Net Income Reserves Fiscal Incentive [Member]" } } }, "auth_ref": [] }, "abev_NetIncomeReservesInvestmentReserveMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetIncomeReservesInvestmentReserveMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails" ], "lang": { "en-us": { "role": { "label": "Net Income Reserves Investment Reserve [Member]" } } }, "auth_ref": [] }, "abev_NetIncomeReservesLegalReserveMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetIncomeReservesLegalReserveMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails" ], "lang": { "en-us": { "role": { "label": "Net Income Reserves Legal Reserve [Member]" } } }, "auth_ref": [] }, "abev_NetIncomeReservesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetIncomeReservesMember", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Net Income Reserves [Member]" } } }, "auth_ref": [] }, "abev_NetInterestOnPensionPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetInterestOnPensionPlans", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net Interest on pension plans", "label": "NetInterestOnPensionPlans" } } }, "auth_ref": [] }, "abev_NetProceedsAcquisitionOfOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NetProceedsAcquisitionOfOtherAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Net proceeds/(acquisitions) of other assets" } } }, "auth_ref": [] }, "ifrs-full_NewProvisionsOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NewProvisionsOtherProvisions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/InventoryDetails1" ], "lang": { "en-us": { "role": { "negatedLabel": "Provisions", "label": "New provisions, other provisions" } }, "en": { "role": { "documentation": "The amount recognised for new other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r384" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "abev_NominalContractualAmountsIncludingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NominalContractualAmountsIncludingInterest", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/TradePayablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "present value adjustment recorded for trades payables" } } }, "auth_ref": [] }, "abev_NonCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NonCurrentLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Non Current Liabilities [Member]" } } }, "auth_ref": [] }, "abev_NonadjustingEventMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NonadjustingEventMember", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Nonadjusting Events [member]" } } }, "auth_ref": [] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r49" ] }, "ifrs-full_NonadjustingEventsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsMember", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r49" ] }, "ifrs-full_NoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterests", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests" } }, "en": { "role": { "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r19", "r158", "r160" ] }, "ifrs-full_NoncontrollingInterestsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncontrollingInterestsMember", "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Non-controlling interests [member]" } }, "en": { "role": { "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "totalLabel": "Non-current assets", "label": "Non-current assets" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r26", "r162", "r314" ] }, "ifrs-full_NoncurrentDerivativeFinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentDerivativeFinancialAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Derivative financial instruments" } }, "en": { "role": { "documentation": "The amount of non-current derivative financial assets. [Refer: Derivative financial assets]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_NoncurrentDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative financial instruments", "label": "Non-current derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_NoncurrentFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentFinancialLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Put option granted on subsidiaries and other liabilities" } }, "en": { "role": { "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r228" ] }, "ifrs-full_NoncurrentHeldtomaturityInvestments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentHeldtomaturityInvestments", "crdr": "debit", "calculation": { "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails": { "parentTag": "abev_InvestmentSecurities", "weight": 1.0, "order": 1.0 }, "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-InvestmentSecuritiesDetails", "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Investment securities", "totalLabel": "Non-current investment securities" } }, "en": { "role": { "documentation": "The amount of non-current held-to-maturity investments. [Refer: Held-to-maturity investments]" } } }, "auth_ref": [ "r275" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Non-current liabilities", "label": "Non-current liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r27", "r164", "r314" ] }, "ifrs-full_NoncurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPayables", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradePayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherPayables", "weight": 1.0, "order": 1.0 }, "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/TradePayablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade payables", "totalLabel": "Non-current" } }, "en": { "role": { "documentation": "The amount of non-current trade payables and non-current other payables. [Refer: Other non-current payables; Non-current trade payables]" } } }, "auth_ref": [ "r15" ] }, "ifrs-full_NoncurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPayablesToRelatedParties", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradePayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/TradePayablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Related parties (Note 30)", "label": "Non-current payables to related parties" } }, "en": { "role": { "documentation": "The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r364" ] }, "ifrs-full_NoncurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradePayablesDetails": { "parentTag": "ifrs-full_NoncurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/TradePayablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade payables", "label": "Non-current trade payables" } }, "en": { "role": { "documentation": "The non-current amount of payment due to suppliers for goods and services used in the entity's business. [Refer: Trade payables]" } } }, "auth_ref": [ "r364" ] }, "ifrs-full_NoncurrentProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentProvisions", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Provisions", "verboseLabel": "Non-current provisions" } }, "en": { "role": { "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r16" ] }, "ifrs-full_NoncurrentProvisionsForEmployeeBenefits": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentProvisionsForEmployeeBenefits", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee benefits", "label": "Non-current provisions for employee benefits" } }, "en": { "role": { "documentation": "The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits]" } } }, "auth_ref": [ "r30" ] }, "ifrs-full_NoncurrentReceivablesFromTaxesOtherThanIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentReceivablesFromTaxesOtherThanIncomeTax", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Recoverable taxes" } }, "en": { "role": { "documentation": "The amount of non-current receivables from taxes other than income tax. [Refer: Receivables from taxes other than income tax]" } } }, "auth_ref": [ "r363" ] }, "ifrs-full_NoncurrentRecognisedAssetsDefinedBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentRecognisedAssetsDefinedBenefitPlan", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Employee benefits" } }, "en": { "role": { "documentation": "The amount of non-current net defined benefit asset. [Refer: Net defined benefit asset]" } } }, "auth_ref": [ "r362" ] }, "abev_NoncurrentTradePayablesRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NoncurrentTradePayablesRelatedParties", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Noncurrent trade payables, related parties" } } }, "auth_ref": [] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r23", "r189", "r190", "r202", "r325", "r330" ] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "abev_NotionalAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NotionalAmount1", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "Notional" } } }, "auth_ref": [] }, "abev_NotionalAmountOne": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NotionalAmountOne", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "Notional value" } } }, "auth_ref": [] }, "abev_NumberOfInstrumentsOtherEquityInstrumentGranted": { "xbrltype": "decimalItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfInstrumentsOtherEquityInstrumentGranted", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted shares granted" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3" ], "lang": { "en-us": { "role": { "negatedLabel": "Restricted and performance shares granted during the period", "negatedTerseLabel": "Deferred shares granted during the period", "label": "Number of other equity instruments granted in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r212", "r395" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3" ], "lang": { "en-us": { "role": { "negatedLabel": "Restricted and performance shares forfeited during the period", "negatedTerseLabel": "Deferred shares forfeited during the period", "label": "Number of other equity instruments forfeited in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement." } } }, "auth_ref": [ "r395" ] }, "abev_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3" ], "lang": { "en-us": { "role": { "periodStartLabel": "Restricted shares outstanding at January", "periodEndLabel": "Restricted shares outstanding at rhe end of the year", "label": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1" } } }, "auth_ref": [] }, "abev_NumberOfOtherNewEquityInstrumentIntroducedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfOtherNewEquityInstrumentIntroducedInSharebasedPaymentArrangement", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deferred shares" } } }, "auth_ref": [] }, "abev_NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3" ], "lang": { "en-us": { "role": { "label": "New restricted and performance shares during the period", "verboseLabel": "New deferred shares during the period" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of share options outstanding in share-based payment arrangement at end of period" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r205", "r208", "r210" ] }, "abev_NumberOfOutstandingShareOptions1": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfOutstandingShareOptions1", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options outstanding at January 1", "periodEndLabel": "Options outstanding at the end of the year", "label": "NumberOfOutstandingShareOptions1" } } }, "auth_ref": [] }, "abev_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement1": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement1", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails1" ], "lang": { "en-us": { "role": { "label": "Options exercised during the period" } } }, "auth_ref": [] }, "abev_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails1" ], "lang": { "en-us": { "role": { "label": "Options forfeited during the period" } } }, "auth_ref": [] }, "abev_NumberOfShareOptionsVestedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumberOfShareOptionsVestedInSharebasedPaymentArrangement", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of share options vested in share-based payment arrangement" } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesOutstanding", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails", "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares outstanding" } }, "en": { "role": { "documentation": "The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares]" } } }, "auth_ref": [ "r32" ] }, "abev_NumeratorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "NumeratorAbstract", "presentation": [ "http://ambev.com.br/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Numerator" } } }, "auth_ref": [] }, "abev_OffsetOfELJsDebtHeldByTheGroupInTheAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OffsetOfELJsDebtHeldByTheGroupInTheAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Offset Of ELJ's Debt Held By The Group In The Amount" } } }, "auth_ref": [] }, "ifrs-full_OperatingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OperatingExpense", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Other operating income" } }, "en": { "role": { "documentation": "The amount of all operating expenses." } } }, "auth_ref": [ "r366" ] }, "ifrs-full_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OperatingSegmentsMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Operating segments [member]" } }, "en": { "role": { "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]" } } }, "auth_ref": [ "r262" ] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r109", "r365" ] }, "ifrs-full_OtherAdjustmentsForNoncashItems": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherAdjustmentsForNoncashItems", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Other non-cash items included in profit" } }, "en": { "role": { "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r391" ] }, "ifrs-full_OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions of other investments", "label": "Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow to acquire equity or debt instruments of other entities (other than payments for those instruments considered to be cash equivalents or those held for dealing or trading purposes), classified as investing activities." } } }, "auth_ref": [ "r305" ] }, "abev_OtherCommitmentsHeld": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherCommitmentsHeld", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Other commitments", "documentation": "Other commitments held for a purpose restricting the use of cash." } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive (loss)/income", "label": "Other comprehensive income" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r4", "r35", "r45", "r167" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxCashFlowHedges": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxCashFlowHedges", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity", "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash flow hedge", "label": "Cash flow hedges" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]" } } }, "auth_ref": [ "r28", "r45" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Gains/(losses) on the translation of foreign operations" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r28", "r45" ] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Actuarial gains/(losses)" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to gains (losses) in relation to changes in the revaluation surplus of property, plant and equipment, right-of-use assets and intangible assets. [Refer: Other comprehensive income; Revaluation surplus]" } } }, "auth_ref": [ "r28", "r45" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_OtherComprehensiveIncome", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome" ], "lang": { "en-us": { "role": { "label": "Recognition of actuarial gains/(losses)" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r284", "r285" ] }, "ifrs-full_OtherContingentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherContingentLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "Other contingent liabilities [member]" } }, "en": { "role": { "documentation": "This member stands for contingent liabilities that the entity does not separately disclose in the same statement or note. [Refer: Contingent liabilities [member]]" } } }, "auth_ref": [ "r299" ] }, "abev_OtherCurrenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherCurrenciesMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Other currencies [member]", "documentation": "Related to other currencies." } } }, "auth_ref": [] }, "ifrs-full_OtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Other assets", "label": "Other current assets" } }, "en": { "role": { "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_OtherEmployeeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherEmployeeExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Other personnel costs" } }, "en": { "role": { "documentation": "The amount of employee expenses that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r378" ] }, "ifrs-full_OtherExpenseByNature": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherExpenseByNature", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Total updated amount of possible risk/loass" } }, "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]" } } }, "auth_ref": [ "r48", "r276" ] }, "ifrs-full_OtherFinanceCost": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherFinanceCost", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other financial results", "label": "Other finance cost" } }, "en": { "role": { "documentation": "The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_OtherFinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherFinanceIncome", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "label": "Other financial results" } }, "en": { "role": { "documentation": "The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_OtherFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherFinancialLiabilities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": "ifrs-full_FinancialLiabilitiesAtFairValue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "label": "Other liabilities" } }, "en": { "role": { "documentation": "The amount of financial liabilities that the entity does not separately disclose in the same statement or note. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r17" ] }, "abev_OtherLiabilities1Member": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherLiabilities1Member", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Other Liabilities 1 [Member]" } } }, "auth_ref": [] }, "abev_OtherLongTermEmployeeBenefitLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherLongTermEmployeeBenefitLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Other long term employee benefits", "label": "OtherLongTermEmployeeBenefitLiabilities" } } }, "auth_ref": [] }, "abev_OtherMovementsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherMovementsCurrent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Other movements, current" } } }, "auth_ref": [] }, "abev_OtherMovementsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherMovementsNoncurrent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Other movements, non-current" } } }, "auth_ref": [] }, "ifrs-full_OtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other assets" } }, "en": { "role": { "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]" } } }, "auth_ref": [ "r362" ] }, "ifrs-full_OtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": 1.0, "order": 5.0 }, "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Other operating income/(expenses)", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of operating income (expense) that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r366" ] }, "abev_OtherOperatingIncomeExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherOperatingIncomeExpensesAbstract", "lang": { "en-us": { "role": { "label": "Other Operating Incomeexpenses" } } }, "auth_ref": [] }, "abev_OtherPortionsOfOtherOperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherPortionsOfOtherOperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails" ], "lang": { "en-us": { "role": { "label": "Other operating income/(expenses), net" } } }, "auth_ref": [] }, "ifrs-full_OtherPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, plant and equipment", "label": "Other property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r370" ] }, "ifrs-full_OtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherProvisions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/InventoryDetails1", "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "negatedPeriodStartLabel": "Beginning balance", "negatedPeriodEndLabel": "Final balance", "label": "Other provisions" } }, "en": { "role": { "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]" } } }, "auth_ref": [ "r30", "r121" ] }, "ifrs-full_OtherProvisionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherProvisionsMember", "presentation": [ "http://ambev.com.br/role/InventoryDetails1", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1", "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]" } } }, "auth_ref": [ "r125" ] }, "ifrs-full_OtherRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherRelatedPartiesMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Other related parties [member]" } }, "en": { "role": { "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r100" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r348" ] }, "ifrs-full_OtherReservesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherReservesMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails" ], "lang": { "en-us": { "role": { "label": "Other reserves [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. It also represents the standard value for the 'Reserves within equity' axis if no other member is used. [Refer: Retained earnings]" } } }, "auth_ref": [ "r7", "r33" ] }, "ifrs-full_OtherRevenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherRevenue", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net revenue" } }, "en": { "role": { "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]" } } }, "auth_ref": [ "r359" ] }, "abev_OtherSecuredLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherSecuredLoanMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Other Secured Loan [Member]" } } }, "auth_ref": [] }, "abev_OtherSecuredLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherSecuredLoans", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7" ], "lang": { "en-us": { "role": { "label": "Other secured loans\u00a0(ii)" } } }, "auth_ref": [] }, "abev_OtherSecuredLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherSecuredLoansMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails" ], "lang": { "en-us": { "role": { "label": "Other Secured Loans [Member]" } } }, "auth_ref": [] }, "ifrs-full_OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Others with reduced taxation" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that the entity does not separately disclose in the same statement or note. [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r53" ] }, "ifrs-full_OtherTemporaryDifferencesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherTemporaryDifferencesMember", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Other temporary differences [member]" } }, "en": { "role": { "documentation": "This member stands for temporary differences that the entity does not separately disclose in the same statement or note. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r369" ] }, "abev_OtherTradeReceivablesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OtherTradeReceivablesRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Other trade receivables, related parties", "documentation": "The amount of other trade receivables resulting from related party transactions." } } }, "auth_ref": [] }, "abev_OthersMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "OthersMember", "presentation": [ "http://ambev.com.br/role/Intangibles-ReconciliationOfChangesInIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Others [Member]" } } }, "auth_ref": [] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "auth_ref": [] }, "abev_PISAndCOFINSTaxContingentLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PISAndCOFINSTaxContingentLiabilityMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "PIS and COFINS [member]" } } }, "auth_ref": [] }, "abev_PISCOFINSExclusionOfICMSMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PISCOFINSExclusionOfICMSMember", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "PIS/COFINS exclusion of ICMS [member]" } } }, "auth_ref": [] }, "abev_PanamaHoldingMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PanamaHoldingMember", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Panam&amp;#63; Holding [member]", "documentation": "Refers to information regarding the Panam&amp;#63; Holding." } } }, "auth_ref": [] }, "abev_PanamaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PanamaMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Panama [Member]" } } }, "auth_ref": [] }, "abev_ParaguayMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ParaguayMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Paraguay [Member]" } } }, "auth_ref": [] }, "ifrs-full_PastDueStatusAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PastDueStatusAxis", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Past due status [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r324" ] }, "ifrs-full_PastDueStatusMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PastDueStatusMember", "presentation": [ "http://ambev.com.br/role/TradeReceivables-AgingOfOurCurrentTradeReceivablesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used." } } }, "auth_ref": [ "r324" ] }, "ifrs-full_PaymentsFromPlanNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsFromPlanNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1", "http://ambev.com.br/role/EmployeeBenefitsDetails2" ], "lang": { "en-us": { "role": { "label": "Benefits paid", "verboseLabel": "Benefits paid, excluding administrative costs" } }, "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from payments from the plan. [Refer: Net defined benefit liability (asset)]" } } }, "auth_ref": [ "r83" ] }, "abev_PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Lease Payments", "label": "PaymentsOfFinanceLeaseLiabilitiesClassifiedAsFinancingActivities" } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of lease liabilities, current", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r309" ] }, "abev_PaymentsOnNetOfFinanceCostsOtherThanInterests": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PaymentsOnNetOfFinanceCostsOtherThanInterests", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash net of finance costs other than interests", "label": "PaymentsOnNetOfFinanceCostsOtherThanInterests" } } }, "auth_ref": [] }, "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsToAcquireOrRedeemEntitysShares", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions of non-controlling interest", "label": "Payments to acquire or redeem entity's shares" } }, "en": { "role": { "documentation": "The cash outflow to acquire or redeem entity's shares." } } }, "auth_ref": [ "r306" ] }, "abev_PercentageOfOwnershipHeldByARelatedParty": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PercentageOfOwnershipHeldByARelatedParty", "presentation": [ "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of ownership held by a related party", "documentation": "The percentage of ownership of the company that is held by a related party." } } }, "auth_ref": [] }, "abev_PiscofinsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PiscofinsMember", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Piscofins [Member]" } } }, "auth_ref": [] }, "abev_PlanAssetsCashMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PlanAssetsCashMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan Assets Cash [Member]" } } }, "auth_ref": [] }, "abev_PlanAssetsCorporateBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PlanAssetsCorporateBondsMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan Assets Corporate Bonds [Member]" } } }, "auth_ref": [] }, "abev_PlanAssetsEquityInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PlanAssetsEquityInstrumentsMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan Assets Equity Instruments [Member]" } } }, "auth_ref": [] }, "abev_PlanAssetsGovernmentBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PlanAssetsGovernmentBondsMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan Assets Government Bonds [Member]" } } }, "auth_ref": [] }, "ifrs-full_PlanAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PlanAssetsMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails2" ], "lang": { "en-us": { "role": { "label": "Plan assets [member]" } }, "en": { "role": { "documentation": "This member stands for defined benefit plan assets. Plan assets comprise: (a) assets held by a long-term employee benefit fund; and (b) qualifying insurance policies." } } }, "auth_ref": [ "r69" ] }, "abev_PlanAssetsOfDefinedBenefitPlanComponentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PlanAssetsOfDefinedBenefitPlanComponentPercentage", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan assets percentage" } } }, "auth_ref": [] }, "abev_PlanAssetsOthersMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PlanAssetsOthersMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan Assets Others [Member]" } } }, "auth_ref": [] }, "abev_PlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PlantAndEquipmentMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Plant And Equipment [Member]" } } }, "auth_ref": [] }, "ifrs-full_PostemploymentBenefitExpenseDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PostemploymentBenefitExpenseDefinedBenefitPlans", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails4", "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Increase in liabilities for defined benefit plans", "negatedLabel": "Total employee benefit expenses" } }, "en": { "role": { "documentation": "The amount of post-employment benefit expense included in profit or loss relating to defined benefit plans. [Refer: Profit (loss); Defined benefit plans [member]] [Contrast: Increase (decrease) in net defined benefit liability (asset) resulting from expense (income) in profit or loss]" } } }, "auth_ref": [ "r372", "r378" ] }, "ifrs-full_PostemploymentBenefitExpenseDefinedContributionPlans": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PostemploymentBenefitExpenseDefinedContributionPlans", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative", "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Contributions to defined contribution plans", "verboseLabel": "Post-employment benefit expense, defined contribution plans" } }, "en": { "role": { "documentation": "The amount of post-employment benefit expense relating to defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods." } } }, "auth_ref": [ "r90" ] }, "abev_PostemploymentBenefitIncomeExpenseDefinedBenefitPlans": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PostemploymentBenefitIncomeExpenseDefinedBenefitPlans", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails5" ], "lang": { "en-us": { "role": { "label": "employee benefit revenue/(expenses)" } } }, "auth_ref": [] }, "abev_PostfixedInterestPrehedgedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PostfixedInterestPrehedgedValue", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Pre-hedge, post-fixed interest rate, amount", "documentation": "The value of postfixed interest before it is hedged." } } }, "auth_ref": [] }, "abev_PostfixedInterestRatePrehedged": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PostfixedInterestRatePrehedged", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Pre-hedge, post-fixed interest rate" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r342" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r343" ] }, "abev_PrescribedDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PrescribedDividends", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Prescribed/(complementary) dividends", "label": "PrescribedDividends" } } }, "auth_ref": [] }, "ifrs-full_PresentValueOfDefinedBenefitObligationMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PresentValueOfDefinedBenefitObligationMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails1" ], "lang": { "en-us": { "role": { "label": "Present value of defined benefit obligation [member]" } }, "en": { "role": { "documentation": "This member stands for the present value of a defined benefit obligation. The present value of a defined benefit obligation is the present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods." } } }, "auth_ref": [ "r70" ] }, "abev_PresetInterestPrehedgedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PresetInterestPrehedgedValue", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Pre-hedge, pre-fixed interest rate, amount", "documentation": "The value of pre-set interest before it is hedged." } } }, "auth_ref": [] }, "abev_PresetInterestRatePrehedged": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PresetInterestRatePrehedged", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5" ], "lang": { "en-us": { "role": { "label": "Pre-hedge, pre-fixed interest rate" } } }, "auth_ref": [] }, "abev_PresumedProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PresumedProfit", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill BAH", "label": "PresumedProfit" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from borrowings" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r307" ] }, "ifrs-full_ProceedsFromCurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromCurrentBorrowings", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Proceeds, current" } }, "en": { "role": { "documentation": "The cash inflow from current borrowings obtained. [Refer: Current borrowings]" } } }, "auth_ref": [ "r389" ] }, "ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of property, plant and equipment and intangible assets" } }, "en": { "role": { "documentation": "The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Capital increase" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r389" ] }, "ifrs-full_ProceedsFromNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromNoncurrentBorrowings", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Proceeds, non-current" } }, "en": { "role": { "documentation": "The cash inflow from non-current borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r389" ] }, "ifrs-full_ProceedsFromSalesOfInterestsInAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromSalesOfInterestsInAssociates", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from sales of subsidiaries\u2019 operations" } }, "en": { "role": { "documentation": "The cash inflow from sales of interests in associates. [Refer: Associates [member]]" } } }, "auth_ref": [ "r388" ] }, "abev_ProceedsbuybackTreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ProceedsbuybackTreasuryShares", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds/(buyback) treasury shares" } } }, "auth_ref": [] }, "ifrs-full_ProductsAndServicesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesAxis", "presentation": [ "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails" ], "lang": { "en-us": { "role": { "label": "Products and services [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r263", "r318" ] }, "ifrs-full_ProductsAndServicesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProductsAndServicesMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used." } } }, "auth_ref": [ "r263", "r318" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": 1.0, "order": 1.0 }, "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity", "http://ambev.com.br/role/ConsolidatedStatementsOfComprehensiveIncome", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "label": "Net income", "verboseLabel": "Net Income" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r3", "r34", "r146", "r155", "r157", "r256", "r258", "r314", "r321" ] }, "ifrs-full_ProfitLossAttributableToAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToAbstract", "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements" ], "lang": { "en-us": { "role": { "label": "Attributable to:" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToNoncontrollingInterests", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements" ], "lang": { "en-us": { "role": { "label": "Non-controlling interest" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]" } } }, "auth_ref": [ "r37", "r159" ] }, "abev_ProfitLossAttributableToOrdinaryEquityHoldersParentEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ProfitLossAttributableToOrdinaryEquityHoldersParentEntity", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Income attributable to the Ambev equity holders" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossAttributableToOwnersOfParent": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossAttributableToOwnersOfParent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "http://ambev.com.br/role/ConsolidatedIncomeStatements" ], "lang": { "en-us": { "role": { "label": "Equity holders of Ambev", "verboseLabel": "Net income, attributable to equity holders of Ambev" } }, "en": { "role": { "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r38" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income tax", "label": "Income before income tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r217", "r276", "r277", "r331", "r332" ] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income from operations", "label": "Income from operations" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r295", "r366" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment", "periodStartLabel": "Property, plant and equipment at beginning", "periodEndLabel": "Property, plant and equipment at ending" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r10", "r63" ] }, "abev_PropertyPlantAndEquipment1": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PropertyPlantAndEquipment1", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, plant and equipment", "label": "PropertyPlantAndEquipment1" } } }, "auth_ref": [] }, "abev_PropertyPlantAndEquipmentEffectOfAccountingPolicy": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PropertyPlantAndEquipmentEffectOfAccountingPolicy", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1" ], "lang": { "en-us": { "role": { "label": "Effects of application of IAS 29 (hyperinflation)" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment [member]" } }, "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r64", "r296", "r320" ] }, "abev_PropertyPlantAndEquipmentUsefulLifes": { "xbrltype": "durationItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PropertyPlantAndEquipmentUsefulLifes", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3" ], "lang": { "en-us": { "role": { "label": "Estimated useful lives" } } }, "auth_ref": [] }, "abev_ProposedClassActionInQuebecMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ProposedClassActionInQuebecMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proposed Class Action In Quebec [Member]" } } }, "auth_ref": [] }, "srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table]" } } }, "auth_ref": [] }, "ifrs-full_ProvisionForTaxesOtherThanIncomeTaxMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProvisionForTaxesOtherThanIncomeTaxMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Provision for taxes other than income tax [member]" } }, "en": { "role": { "documentation": "This member stands for a provision for taxes other than income tax. Income taxes include all domestic and foreign taxes which are based on taxable profits. Income taxes also include taxes, such as withholding taxes, which are payable by a subsidiary, associate or joint arrangement on distributions to the reporting entity. [Refer: Other provisions [member]]" } } }, "auth_ref": [ "r385" ] }, "abev_ProvisionReversedOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ProvisionReversedOtherProvisions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Provisions reversed" } } }, "auth_ref": [] }, "ifrs-full_ProvisionUsedOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProvisionUsedOtherProvisions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Provision used, other provisions", "label": "Provision used, other provisions" } }, "en": { "role": { "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r123" ] }, "abev_ProvisionUsedOtherProvisions1": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ProvisionUsedOtherProvisions1", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Write-off", "label": "ProvisionUsedOtherProvisions1" } } }, "auth_ref": [] }, "ifrs-full_Provisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Provisions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "periodStartLabel": "Provision at beginning", "periodEndLabel": "Provision at ending", "label": "Total provisions" } }, "en": { "role": { "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits." } } }, "auth_ref": [ "r16" ] }, "abev_ProvisionsForLaborMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ProvisionsForLaborMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Provisions For Labor [Member]" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Acquisition of property, plant and equipment" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r304" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisitions of property, plant and equipment and intangible assets", "label": "Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]" } } }, "auth_ref": [ "r388" ] }, "ifrs-full_PurchasesFairValueMeasurementLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchasesFairValueMeasurementLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails4" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisition of investments", "label": "Purchases, fair value measurement, liabilities" } }, "en": { "role": { "documentation": "The increase in the fair value measurement of liabilities resulting from purchases of those liabilities. [Refer: At fair value [member]]" } } }, "auth_ref": [ "r177" ] }, "abev_PurchasesOfGoodsRelatedPartyTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PurchasesOfGoodsRelatedPartyTransaction", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Buying and others, related parties" } } }, "auth_ref": [] }, "abev_PutOptionGrantedOnSubsidiaryMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PutOptionGrantedOnSubsidiaryMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Put option granted on subsidiary [member]", "documentation": "Information related to put option granted on subsidiary." } } }, "auth_ref": [] }, "abev_PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Put options exercisable number of shares percent of outstanding stock", "verboseLabel": "Put options, exercisable number of shares, percent of outstanding stock", "documentation": "The percent of outstanding stock that number of exercisable shares from put options will give the holder upon exercise." } } }, "auth_ref": [] }, "abev_PutOptionsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PutOptionsFairValue", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Put options, fair value", "documentation": "The fair value of put options held." } } }, "auth_ref": [] }, "abev_PutOptionsGrantedOnSubsidiaries": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "PutOptionsGrantedOnSubsidiaries", "crdr": "credit", "calculation": { "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3": { "parentTag": "ifrs-full_FinancialLiabilitiesAtFairValue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails3" ], "lang": { "en-us": { "role": { "label": "Put options granted on subsidiaries" } } }, "auth_ref": [] }, "abev_QuetzalSpentInGuatemalaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "QuetzalSpentInGuatemalaMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Quetzal Spent In Guatemala [Member]" } } }, "auth_ref": [] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/EmployeeBenefitsDetails6", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r180", "r196", "r210", "r316", "r317", "r397" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "auth_ref": [] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/EmployeeBenefitsDetails6", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r180", "r196", "r210", "r316", "r317", "r397" ] }, "abev_RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan assets percentage, rated" } } }, "auth_ref": [] }, "ifrs-full_RawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RawMaterials", "crdr": "debit", "calculation": { "http://ambev.com.br/role/InventoryDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw materials and consumables" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets to be consumed in the production process or in the rendering of services. [Refer: Inventories]" } } }, "auth_ref": [ "r282", "r381" ] }, "abev_ReaisDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ReaisDebtMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Reais Debt [Member]" } } }, "auth_ref": [] }, "abev_ReaisDebtRelatedToICMSMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ReaisDebtRelatedToICMSMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Reais Debt Related To I C M S [Member]" } } }, "auth_ref": [] }, "ifrs-full_RecognisedLiabilitiesDefinedBenefitPlan": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RecognisedLiabilitiesDefinedBenefitPlan", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Net liabilities", "label": "Net defined benefit liability" } }, "en": { "role": { "documentation": "The amount of deficit in a defined benefit plan. [Refer: Defined benefit plans [member]]" } } }, "auth_ref": [ "r362" ] }, "abev_ReconciliationOfChangesInPropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ReconciliationOfChangesInPropertyPlantAndEquipmentTextBlock", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "label": "Schedule of changes in the carrying amount of property, plant and equipment" } } }, "auth_ref": [] }, "abev_ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTextBlock", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of liabilities arising from financing activities" } } }, "auth_ref": [] }, "abev_RecoverableTaxCreditAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RecoverableTaxCreditAssets", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Total" } } }, "auth_ref": [] }, "abev_RecoverableTaxCreditAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RecoverableTaxCreditAssetsCurrent", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Current" } } }, "auth_ref": [] }, "abev_RecoverableTaxCreditAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RecoverableTaxCreditAssetsNoncurrent", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Non-current" } } }, "auth_ref": [] }, "abev_RecoverableTaxesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RecoverableTaxesTextBlock", "presentation": [ "http://ambev.com.br/role/RecoverableTaxes" ], "lang": { "en-us": { "role": { "label": "RECOVERABLE TAXES" } } }, "auth_ref": [] }, "abev_ReductionOfAssessedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ReductionOfAssessedAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reduction of assessed amount" } } }, "auth_ref": [] }, "ifrs-full_ReductionOfIssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReductionOfIssuedCapital", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reduction of issued capital" } }, "en": { "role": { "documentation": "The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]" } } }, "auth_ref": [ "r357" ] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of borrowings", "label": "Repayments of borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r308" ] }, "ifrs-full_RepaymentsOfCurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfCurrentBorrowings", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments, current", "label": "Repayments of current borrowings" } }, "en": { "role": { "documentation": "The cash outflow for repayments of current borrowings. [Refer: Current borrowings]" } } }, "auth_ref": [ "r389" ] }, "ifrs-full_RepaymentsOfNoncurrentBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfNoncurrentBorrowings", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments, non-current", "label": "Repayments of non-current borrowings" } }, "en": { "role": { "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r389" ] }, "abev_ReserveOfCarryingValueAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ReserveOfCarryingValueAdjustments", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Carrying value adjustments", "label": "ReserveOfCarryingValueAdjustments" } } }, "auth_ref": [] }, "ifrs-full_ReserveOfSharebasedPaymentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfSharebasedPaymentsMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails" ], "lang": { "en-us": { "role": { "label": "Reserve of share-based payments [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity resulting from share-based payments." } } }, "auth_ref": [ "r278" ] }, "srt_ReserveQuantitiesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ReserveQuantitiesLineItems", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Reserve Quantities [Line Items]" } } }, "auth_ref": [] }, "abev_RestrictedSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RestrictedSharesMember", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Restricted Shares [Member]" } } }, "auth_ref": [] }, "ifrs-full_RestructuringProvisionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestructuringProvisionMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails", "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Restructuring provision [member]" } }, "en": { "role": { "documentation": "This member stands for a provision for restructuring, such as the sale or termination of a line of business; closure of business locations in a country or region or relocation of activities from one country or region to another; changes in management structure; and fundamental reorganisations that have a material effect on the nature and focus of the entity's operations. [Refer: Other provisions [member]]" } } }, "auth_ref": [ "r297" ] }, "abev_RetainedEarningsBasisForDividendsAndDestinations": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RetainedEarningsBasisForDividendsAndDestinations", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Retained earnings basis for dividends and destinations" } } }, "auth_ref": [] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r7", "r278" ] }, "abev_RetireesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RetireesMember", "presentation": [ "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Retirees [member]", "documentation": "Employees who are retired." } } }, "auth_ref": [] }, "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Plan assets gain/(loss)" } }, "en": { "role": { "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [member]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]" } } }, "auth_ref": [ "r75" ] }, "ifrs-full_Revenue": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Revenue", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetSalesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/NetSalesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Revenue" } }, "en": { "role": { "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims." } } }, "auth_ref": [ "r41", "r166", "r217", "r252", "r257", "r263", "r264", "r267", "r276", "r277", "r314" ] }, "ifrs-full_RevenueFromContractsWithCustomers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromContractsWithCustomers", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Net sales" } }, "en": { "role": { "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration." } } }, "auth_ref": [ "r181", "r182" ] }, "abev_RevenueFromFinancialInstrumentsAtFairValueThroughProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "RevenueFromFinancialInstrumentsAtFairValueThroughProfitOrLoss", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "label": "Financial instruments at fair value through profit or loss" } } }, "auth_ref": [] }, "ifrs-full_RevenueFromGovernmentGrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromGovernmentGrants", "crdr": "credit", "calculation": { "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails": { "parentTag": "ifrs-full_OtherOperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/OtherOperatingIncomeexpensesDetails" ], "lang": { "en-us": { "role": { "label": "Government grants/net present value of long-term fiscal incentives" } }, "en": { "role": { "documentation": "The amount of income recognised in relation to government grants. [Refer: Government grants]" } } }, "auth_ref": [ "r382" ] }, "ifrs-full_RevenueFromInterest": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromInterest", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems", "weight": 1.0, "order": 1.0 }, "http://ambev.com.br/role/NetFinanceResultDetails2": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails", "http://ambev.com.br/role/NetFinanceResultDetails2" ], "lang": { "en-us": { "role": { "label": "Interest income", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of income arising from interest." } } }, "auth_ref": [ "r169", "r253", "r261", "r359" ] }, "ifrs-full_RevenueFromSaleOfGoods": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromSaleOfGoods", "crdr": "credit", "calculation": { "http://ambev.com.br/role/NetSalesDetails": { "parentTag": "ifrs-full_Revenue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/NetSalesDetails" ], "lang": { "en-us": { "role": { "label": "Gross sales" } }, "en": { "role": { "documentation": "The amount of revenue arising from the sale of goods. [Refer: Revenue]" } } }, "auth_ref": [ "r359" ] }, "ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RevenueFromSaleOfGoodsRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Sales and others, related parties" } }, "en": { "role": { "documentation": "The amount of revenue arising from the sale of goods in related party transactions. [Refer: Revenue; Related parties [member]]" } } }, "auth_ref": [ "r293" ] }, "abev_ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting (Note 22)", "verboseLabel": "Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting" } } }, "auth_ref": [] }, "ifrs-full_RightofuseAssetsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssetsMember", "presentation": [ "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails2" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets [member]" } }, "en": { "role": { "documentation": "This member stands for right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r185" ] }, "ifrs-full_SalesAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SalesAndMarketingExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Commercial expenses", "negatedTerseLabel": "Sales and marketing expenses", "label": "Sales and marketing expense" } }, "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } } }, "auth_ref": [ "r366" ] }, "abev_SalesDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "SalesDiscounts", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetSalesDetails": { "parentTag": "ifrs-full_Revenue", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/NetSalesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Discounts", "label": "SalesDiscounts" } } }, "auth_ref": [] }, "abev_SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Sales/service fees/reimbursement of expenses and others, related parties", "documentation": "The amount of sales, service fees, reimbursements of expenses and others resulting from related party transactions." } } }, "auth_ref": [] }, "abev_ScheduleOfAdditionalInformationByBusinessUnitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ScheduleOfAdditionalInformationByBusinessUnitTableTextBlock", "presentation": [ "http://ambev.com.br/role/SegmentReportingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of additional information" } } }, "auth_ref": [] }, "abev_ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock", "presentation": [ "http://ambev.com.br/role/RecoverableTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Classifications of recoverable taxes" } } }, "auth_ref": [] }, "abev_ScheduleOfDisclosureOfTermsAndDebtRepaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ScheduleOfDisclosureOfTermsAndDebtRepaymentsTextBlock", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of liquidity risk and payables" } } }, "auth_ref": [] }, "abev_ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionTables" ], "lang": { "en-us": { "role": { "label": "Schedule of income tax and social contribution by area" } } }, "auth_ref": [] }, "abev_ScheduleOfMaturityOfContractsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ScheduleOfMaturityOfContractsTableTextBlock", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingTables" ], "lang": { "en-us": { "role": { "label": "Schedule of maturity of contracts" } } }, "auth_ref": [] }, "abev_ScheduleOfNetDebtOfContinuityInTheLongTerm": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ScheduleOfNetDebtOfContinuityInTheLongTerm", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of net debt of long term" } } }, "auth_ref": [] }, "abev_ScheduleOfOutstandingOptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ScheduleOfOutstandingOptionsTableTextBlock", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of outstanding options developed" } } }, "auth_ref": [] }, "abev_SecuredBankLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "SecuredBankLoanMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails3" ], "lang": { "en-us": { "role": { "label": "Secured Bank Loan [Member]" } } }, "auth_ref": [] }, "abev_SecuredBankLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "SecuredBankLoans", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7" ], "lang": { "en-us": { "role": { "label": "Secured bank loans" } } }, "auth_ref": [] }, "abev_SecuredBankLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "SecuredBankLoansMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails" ], "lang": { "en-us": { "role": { "label": "Secured Bank Loans [Member]" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r336" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r340" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r339" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r344" ] }, "ifrs-full_SegmentConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentConsolidationItemsAxis", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Segment consolidation items [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r256" ] }, "ifrs-full_SegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsAxis", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails", "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails", "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Segments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r114", "r183", "r256", "r291", "r323" ] }, "ifrs-full_SegmentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SegmentsMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails", "http://ambev.com.br/role/GoodwillDetails1", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails", "http://ambev.com.br/role/SegmentReportingDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used." } } }, "auth_ref": [ "r114", "r183", "r262", "r291", "r323" ] }, "ifrs-full_SensitivityAnalysisForEachTypeOfMarketRisk": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SensitivityAnalysisForEachTypeOfMarketRisk", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksTables" ], "lang": { "en-us": { "role": { "label": "Schedule of types of market risk" } }, "en": { "role": { "documentation": "The disclosure of the sensitivity analysis for types of market risk to which the entity is exposed, showing how profit or loss and equity would have been affected by changes in the relevant risk variable that were reasonably possible at that date. [Refer: Market risk [member]]" } } }, "auth_ref": [ "r238" ] }, "abev_ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Buying/service fees/reimbursement of expenses and others, related parties", "documentation": "The amount of service fees, reimbursement of expenses and others resulting from related party transactions." } } }, "auth_ref": [] }, "ifrs-full_ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedIncomeStatements": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 3.0 }, "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedIncomeStatements", "http://ambev.com.br/role/ConsolidatedStatementsOfCashFlows", "http://ambev.com.br/role/SegmentReporting-AdditionalInformationDetails", "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Share of results of joint ventures", "negatedLabel": "Share of result of joint ventures" } }, "en": { "role": { "documentation": "The entity's share of the profit (loss) of joint ventures accounted for using the equity method. [Refer: Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]" } } }, "auth_ref": [ "r366" ] }, "ifrs-full_SharePremiumMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharePremiumMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails" ], "lang": { "en-us": { "role": { "label": "Share premium [member]" } }, "en": { "role": { "documentation": "This member stands for the amount received or receivable from issuance of the entity's shares in excess of nominal value." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_SharebasedPaymentArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SharebasedPaymentArrangementsMember", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used." } } }, "auth_ref": [ "r211" ] }, "abev_ShareholderPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ShareholderPercentage", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Shareholder percentage" } } }, "auth_ref": [] }, "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermDepositsClassifiedAsCashEquivalents", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecurities-ComponentsOfCashAndCashEquivalentsDetails" ], "lang": { "en-us": { "role": { "label": "Short-term bank deposits\u00a0(i)" } }, "en": { "role": { "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r393" ] }, "abev_ShorttermDepositsGuaranteeDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ShorttermDepositsGuaranteeDeposits", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CashAndCashEquivalentsAndInvestmentSecuritiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Short-term deposits, guarantee deposits" } } }, "auth_ref": [] }, "ifrs-full_ShorttermEmployeeBenefitsAccruals": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermEmployeeBenefitsAccruals", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Wages and salaries" } }, "en": { "role": { "documentation": "The amount of accruals for employee benefits (other than termination benefits) that are expected to be settled wholly within twelve months after the end of the annual reporting period in which the employees render the related services. [Refer: Accruals classified as current]" } } }, "auth_ref": [ "r364" ] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r105", "r106", "r172" ] }, "abev_SocialContributionsOverProductsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "SocialContributionsOverProductsMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Social Contributions Over Products [Member]" } } }, "auth_ref": [] }, "ifrs-full_SocialSecurityContributions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SocialSecurityContributions", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Social security contributions" } }, "en": { "role": { "documentation": "A class of employee benefits expense that represents social security contributions. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r380" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r345" ] }, "abev_SouthLatinAmericaSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "SouthLatinAmericaSegmentMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "South Latin America Segment [Member]" } } }, "auth_ref": [] }, "ifrs-full_SpareParts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SpareParts", "crdr": "debit", "calculation": { "http://ambev.com.br/role/InventoryDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Spare parts and others" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of interchangeable parts that are kept in an inventory and are used for the repair or replacement of failed parts. [Refer: Inventories]" } } }, "auth_ref": [ "r381" ] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails", "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails", "http://ambev.com.br/role/ChangesInEquity-CarryingValueAdjustmentsDetails", "http://ambev.com.br/role/ChangesInEquity-NetIncomeReservesDetails", "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r7" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "abev_StatutoryReserveLimitOfCapitalStock": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "StatutoryReserveLimitOfCapitalStock", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statutory reserve limit of capital stock" } } }, "auth_ref": [] }, "abev_StatutoryReserveLimitPercentageOfNetIncome": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "StatutoryReserveLimitPercentageOfNetIncome", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statutory reserve limit percentage of net income" } } }, "auth_ref": [] }, "abev_StatutoryReserveSupplementationCutoffPercentageRelatedToCapitalStock": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "StatutoryReserveSupplementationCutoffPercentageRelatedToCapitalStock", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statutory reserve supplementation cutoff percentage related to capital stock" } } }, "auth_ref": [] }, "abev_StockRepurchaseProgramSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "StockRepurchaseProgramSharesAuthorized", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock repurchase program shares authorized" } } }, "auth_ref": [] }, "ifrs-full_SurplusDeficitInPlan": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SurplusDeficitInPlan", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails" ], "lang": { "en-us": { "role": { "label": "Present value of net obligations" } }, "en": { "role": { "documentation": "The fair value of any plan assets, less the present value of the defined benefit obligation. [Refer: Plan assets [member]]" } } }, "auth_ref": [ "r379" ] }, "abev_TaxCreditRelatedToTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxCreditRelatedToTaxLosses", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax credit related to tax losses" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectFromChangeInTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectFromChangeInTaxRate", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Recognized tax credits" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to changes in the tax rate. [Refer: Accounting profit]" } } }, "auth_ref": [ "r53" ] }, "abev_TaxEffectFromChangeInTaxRates": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectFromChangeInTaxRates", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Recognized tax credits", "label": "TaxEffectFromChangeInTaxRates" } } }, "auth_ref": [] }, "abev_TaxEffectFromSharingResultsOfJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectFromSharingResultsOfJointVentures", "crdr": "credit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2": { "parentTag": "abev_NetAccountingProfit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Share of results of joint ventures", "label": "TaxEffectFromSharingResultsOfJointVentures" } } }, "auth_ref": [] }, "abev_TaxEffectOfAdoptionOfNewAccountingPolicy": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfAdoptionOfNewAccountingPolicy", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Effect of application of IAS 29 (hyperinflation)", "label": "TaxEffectOfAdoptionOfNewAccountingPolicy" } } }, "auth_ref": [] }, "abev_TaxEffectOfDeductibleInterestOfShareholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfDeductibleInterestOfShareholdersEquity", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Deductible interest on shareholders\u2019 equity" } } }, "auth_ref": [] }, "abev_TaxEffectOfExpenseNotDeductible": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfExpenseNotDeductible", "crdr": "credit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2": { "parentTag": "abev_NetAccountingProfit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Non-deductible expenses" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfForeignTaxRates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfForeignTaxRates", "crdr": "debit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2": { "parentTag": "abev_NetAccountingProfit", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Worldwide taxation", "label": "Tax effect of foreign tax rates" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } } }, "auth_ref": [ "r53" ] }, "abev_TaxEffectOfGovernmentGrantsRelatedToSalesTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfGovernmentGrantsRelatedToSalesTaxes", "crdr": "credit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2": { "parentTag": "abev_NetAccountingProfit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Government grants related to sales taxes" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfImpairmentOfGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfImpairmentOfGoodwill", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Tax savings from goodwill amortization" } }, "en": { "role": { "documentation": "The amount representing the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to impairment of goodwill. [Refer: Accounting profit; Goodwill]" } } }, "auth_ref": [ "r367" ] }, "abev_TaxEffectOfOthersNontaxableIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfOthersNontaxableIncome", "crdr": "credit", "calculation": { "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2": { "parentTag": "abev_NetAccountingProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Others non-taxable income" } } }, "auth_ref": [] }, "abev_TaxEffectOfRegionalIncentives": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfRegionalIncentives", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Income tax Incentives" } } }, "auth_ref": [] }, "abev_TaxEffectOfTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfTaxLoss", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax credits" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfTaxLosses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfTaxLosses", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Recognition/(write-off) of deferred charges on tax losses" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to tax losses. [Refer: Accounting profit]" } } }, "auth_ref": [ "r53" ] }, "abev_TaxEffectOfWithholdingTaxOverUndistributedProfits": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxEffectOfWithholdingTaxOverUndistributedProfits", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Withholding income tax" } } }, "auth_ref": [] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetFinanceResultDetails": { "parentTag": "abev_FinanceCostsExcludingNonrecurringFinanceCosts", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/NetFinanceResultDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax on financial transactions", "label": "Tax expense (income) at applicable tax rate" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r53" ] }, "ifrs-full_TaxExpenseOtherThanIncomeTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseOtherThanIncomeTaxExpense", "crdr": "debit", "calculation": { "http://ambev.com.br/role/NetSalesDetails": { "parentTag": "ifrs-full_Revenue", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/NetSalesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Excise duty", "label": "Tax expense other than income tax expense" } }, "en": { "role": { "documentation": "The amount of tax expense exclusive of income tax expense." } } }, "auth_ref": [ "r366" ] }, "abev_TaxIncentiveAmounts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxIncentiveAmounts", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax incentive amounts" } } }, "auth_ref": [] }, "abev_TaxIncentiveDifferenceAmounts": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxIncentiveDifferenceAmounts", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/EventsAfterReportingPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax incentive difference amounts" } } }, "auth_ref": [] }, "abev_TaxLosesCarriedForwardOfUnilaterallyOffset": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxLosesCarriedForwardOfUnilaterallyOffset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax loses carried forward of unilaterally offset" } } }, "auth_ref": [] }, "abev_TaxLosesCarriedForwardOfUnilaterallyOffsetProceedings": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxLosesCarriedForwardOfUnilaterallyOffsetProceedings", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax loses carried forward of unilaterally offset proceedings" } } }, "auth_ref": [] }, "abev_TaxLossOffset": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxLossOffset", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax Loss Offset" } } }, "auth_ref": [] }, "abev_TaxLossesCarriedForwardInRelationToCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxLossesCarriedForwardInRelationToCredit", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tax loses carried forward in relation to credit" } } }, "auth_ref": [] }, "ifrs-full_TaxRateEffectOfForeignTaxRates": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxRateEffectOfForeignTaxRates", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails" ], "lang": { "en-us": { "role": { "label": "Expected nominal rates" } }, "en": { "role": { "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]" } } }, "auth_ref": [ "r54" ] }, "abev_TaxesAndContributionsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxesAndContributionsPayableCurrent", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Taxes and contributions payable", "label": "TaxesAndContributionsPayableCurrent" } } }, "auth_ref": [] }, "abev_TaxesAndContributionsPayableNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxesAndContributionsPayableNonCurrent", "crdr": "credit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Taxes and contributions payable" } } }, "auth_ref": [] }, "abev_TaxesPayableNominalRate": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TaxesPayableNominalRate", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails2" ], "lang": { "en-us": { "role": { "label": "Taxes payable \u2013 nominal rate" } } }, "auth_ref": [] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r57" ] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5", "http://ambev.com.br/role/RecoverableTaxesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r57" ] }, "abev_TemporaryDifferencesDerivativesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesDerivativesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Derivatives [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesEmployeeBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesEmployeeBenefitsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Employee Benefits [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesIntangiblesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesIntangiblesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Intangibles [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesInterestbearingLoansAndBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesInterestbearingLoansAndBorrowingsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Interestbearing Loans And Borrowings [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesInventoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesInventoriesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Inventories [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesInvestmentsInJointVenturesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesInvestmentsInJointVenturesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Investments In Joint Ventures [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesInvestmentsInSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesInvestmentsInSecuritiesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Investments In Securities [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesOtherItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesOtherItemsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Other Items [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesPropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesPropertyPlantAndEquipmentMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Property Plant And Equipment [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesProvisionsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesProvisionsMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Provisions [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesTradePayablesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesTradePayablesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Trade Payables [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesTradeReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesTradeReceivableMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Trade Receivable [Member]" } } }, "auth_ref": [] }, "abev_TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails4" ], "lang": { "en-us": { "role": { "label": "Temporary Differences Withholding Tax Over Undistributed Profits And Royalties [Member]" } } }, "auth_ref": [] }, "abev_TenedoraMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TenedoraMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tenedora [Member]", "documentation": "Related to Tenedora." } } }, "auth_ref": [] }, "abev_TesourariaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TesourariaMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalStockDetails" ], "lang": { "en-us": { "role": { "label": "Tesouraria [Member]" } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquityDetailsNarrative", "http://ambev.com.br/role/EmployeeBenefitsDetails6", "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetailsNarrative", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails", "http://ambev.com.br/role/IntangiblesDetailsNarrative", "http://ambev.com.br/role/PropertyPlantAndEquipmentDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r180", "r196", "r210", "r316", "r317", "r397" ] }, "abev_TotalCashEffectsExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalCashEffectsExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Total Cash Effects Exposure [Member]" } } }, "auth_ref": [] }, "abev_TotalCashExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalCashExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "Total Cash Exposure [Member]" } } }, "auth_ref": [] }, "abev_TotalChangesRelatedToDeferredIncomeTaxAndSocialContributionsAffectingTheBalanceSheet": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalChangesRelatedToDeferredIncomeTaxAndSocialContributionsAffectingTheBalanceSheet", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails6" ], "lang": { "en-us": { "role": { "label": "Changes directly in the balance sheet" } } }, "auth_ref": [] }, "abev_TotalContingentProvisionsMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalContingentProvisionsMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails1" ], "lang": { "en-us": { "role": { "label": "Total Contingent Provisions [Member]" } } }, "auth_ref": [] }, "abev_TotalCostExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalCostExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Total cost exposure [member]", "documentation": "Refers to information regarding total cost exposure." } } }, "auth_ref": [] }, "abev_TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/AdditionalInformationOnCostOfSalesAndOperatingExpensesByNatureDetails" ], "lang": { "en-us": { "role": { "label": "Total payroll and related benefits" } } }, "auth_ref": [] }, "abev_TotalExpensesExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalExpensesExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Total expenses exposure [member]", "documentation": "Refers to information regarding the total expenses exposure." } } }, "auth_ref": [] }, "abev_TotalExposureLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalExposureLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-ComponentsOfCollateralAndCommitmentsDetails", "http://ambev.com.br/role/CollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOthers-FutureContractualCommitmentsDetails" ], "lang": { "en-us": { "role": { "label": "Total commitments to suppliers", "verboseLabel": "Future contractual commitments", "documentation": "The amount of liabilities that the entity may have to pay due to exposure." } } }, "auth_ref": [] }, "abev_TotalFinancialRiskExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalFinancialRiskExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "Total financial risk exposure [member]", "documentation": "Refers to information regarding the total financial risk exposure." } } }, "auth_ref": [] }, "abev_TotalFixedAssetExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalFixedAssetExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Total fixed asset exposure [member]", "documentation": "Total total fixed asset exposure." } } }, "auth_ref": [] }, "abev_TotalLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalLiabilitiesMember", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails" ], "lang": { "en-us": { "role": { "label": "Total Liabilities [Member]" } } }, "auth_ref": [] }, "abev_TotalOfDividendsAndInterestOnCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalOfDividendsAndInterestOnCapital", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-BasisForDividendsDetails" ], "lang": { "en-us": { "role": { "label": "Total of dividends and interest on capital" } } }, "auth_ref": [] }, "abev_TotalPayablesAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TotalPayablesAndLiabilities", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7" ], "lang": { "en-us": { "role": { "label": "Total payables and liabilities" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradePayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherPayables", "weight": 1.0, "order": 2.0 }, "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/TradePayablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade payables", "totalLabel": "Current", "label": "Trade and other current payables" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r15" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToRelatedParties", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradePayablesDetails": { "parentTag": "ifrs-full_NoncurrentPayables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/TradePayablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Related parties (Note 30)", "label": "Current payables to related parties" } }, "en": { "role": { "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]" } } }, "auth_ref": [ "r364" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradePayablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentPayables", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/TradePayablesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade payables", "label": "Current trade payables" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r280", "r364" ] }, "ifrs-full_TradeAndOtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivables", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ConsolidatedBalanceSheets": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 }, "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/ConsolidatedBalanceSheets", "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivables", "totalLabel": "Total current trade receivables" } }, "en": { "role": { "documentation": "The amount of current trade receivables and current other receivables. [Refer: Current trade receivables; Other current receivables]" } } }, "auth_ref": [ "r13", "r29" ] }, "ifrs-full_TradeAndOtherCurrentReceivablesDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentReceivablesDueFromRelatedParties", "crdr": "debit", "calculation": { "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails": { "parentTag": "ifrs-full_TradeAndOtherCurrentReceivables", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/TradeReceivables-CurrentTradeReceivablesDetails" ], "lang": { "en-us": { "role": { "label": "Related parties (Note 30)" } }, "en": { "role": { "documentation": "The amount of current receivables due from related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r281" ] }, "ifrs-full_TradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayables", "crdr": "credit", "calculation": { "http://ambev.com.br/role/TradePayablesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails7", "http://ambev.com.br/role/TradePayablesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Trade and other payables\u00a0(i)" } }, "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } } }, "auth_ref": [ "r15" ] }, "abev_TradeAndOtherPayables1": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TradeAndOtherPayables1", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/TradePayablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trade payable" } } }, "auth_ref": [] }, "abev_TradePayableMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TradePayableMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails", "http://ambev.com.br/role/TradePayablesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trade payable [member]", "documentation": "Represents the amount of trade payable." } } }, "auth_ref": [] }, "abev_TradePayablesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TradePayablesRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Current trade payables, related parties", "documentation": "The amount of trade payables resulting from related party transactions." } } }, "auth_ref": [] }, "abev_TradePayablesRelatedPartyTransactions1": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TradePayablesRelatedPartyTransactions1", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Current trade payables, related parties", "label": "TradePayablesRelatedPartyTransactions1" } } }, "auth_ref": [] }, "ifrs-full_TradeReceivablesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeReceivablesMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivables [member]" } }, "en": { "role": { "documentation": "This member stands for trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r232", "r236", "r324", "r359" ] }, "abev_TradeReceivablesRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TradeReceivablesRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/RelatedParties-TransactionsWithRelatedPartiesDetails" ], "lang": { "en-us": { "role": { "label": "Trade receivables, related parties", "documentation": "The amount of trade receivables resulting from related party transactions." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "abev_TrancheAMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TrancheAMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tranche A [Member]", "documentation": "RElated to tranche A." } } }, "auth_ref": [] }, "abev_TrancheBMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TrancheBMember", "presentation": [ "http://ambev.com.br/role/CorporateInformationDetailsNarrative", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tranche B [Member]", "documentation": "Related to Tranche B." } } }, "auth_ref": [] }, "abev_TransferBetweenCurrentAndNoncurrentCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TransferBetweenCurrentAndNoncurrentCurrent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Transfers between current and non-current, current" } } }, "auth_ref": [] }, "abev_TransferBetweenCurrentAndNoncurrentNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TransferBetweenCurrentAndNoncurrentNoncurrent", "crdr": "credit", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails2" ], "lang": { "en-us": { "role": { "label": "Transfers between current and non-current" } } }, "auth_ref": [] }, "ifrs-full_TransfersUnderLicenseAgreementsFromEntityRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TransfersUnderLicenseAgreementsFromEntityRelatedPartyTransactions", "presentation": [ "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transfers under licence agreements from entity, related party transactions" } }, "en": { "role": { "documentation": "The amount of transfers under licence agreements from the entity in related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r294" ] }, "ifrs-full_TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions", "presentation": [ "http://ambev.com.br/role/RelatedPartiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Transfers under licence agreements to entity, related party transactions" } }, "en": { "role": { "documentation": "The amount of transfers under licence agreements to the entity in related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r294" ] }, "ifrs-full_TreasuryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TreasuryShares", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "negatedPeriodStartLabel": "Balance, treasury shares, amount", "negatedPeriodEndLabel": "Balance, treasury shares, amount", "label": "Treasury shares" } }, "en": { "role": { "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r108", "r283" ] }, "abev_TreasurySharesAcquiredRealizedDuringThePeriod": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TreasurySharesAcquiredRealizedDuringThePeriod", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "label": "Changes during the year, treasury shares acquired/realized (in shares)" } } }, "auth_ref": [] }, "abev_TreasurySharesAcquiredrealizedDuringThePeriodAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TreasurySharesAcquiredrealizedDuringThePeriodAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "label": "Changes during the year, treasury shares acquired/realized, amount" } } }, "auth_ref": [] }, "abev_TreasurySharesAcquiredrealizedOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TreasurySharesAcquiredrealizedOutstanding", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, treasury shares acquired/realized (in shares)", "periodEndLabel": "Balance, treasury shares acquired/realized (in shares)", "label": "TreasurySharesAcquiredrealizedOutstanding" } } }, "auth_ref": [] }, "abev_TreasurySharesAcquiredrealizedOutstandingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TreasurySharesAcquiredrealizedOutstandingAmount", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, treasury shares acquired/realized, amount", "periodEndLabel": "Balance, treasury shares acquired/realized, amount", "label": "TreasurySharesAcquiredrealizedOutstandingAmount" } } }, "auth_ref": [] }, "abev_TreasurySharesChangeDuringThePeriod": { "xbrltype": "sharesItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TreasurySharesChangeDuringThePeriod", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "label": "Changes during the year, treasury shares (in shares)" } } }, "auth_ref": [] }, "abev_TreasurySharesChangeDuringThePeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TreasurySharesChangeDuringThePeriodValue", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "label": "Changes during the year, treasury shares, amount" } } }, "auth_ref": [] }, "abev_TreasurySharesHeld": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TreasurySharesHeld", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-TreasurySharesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, treasury shares (in shares)", "periodEndLabel": "Balance, treasury shares (in shares)", "label": "TreasurySharesHeld" } } }, "auth_ref": [] }, "ifrs-full_TreasurySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TreasurySharesMember", "presentation": [ "http://ambev.com.br/role/ChangesInEquity-CapitalReservesDetails" ], "lang": { "en-us": { "role": { "label": "Treasury shares [member]" } }, "en": { "role": { "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group." } } }, "auth_ref": [ "r7" ] }, "abev_TwoHealthCarePlansFromFundacaoZerrennerMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "TwoHealthCarePlansFromFundacaoZerrennerMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Two Health Care Plans From Fundacao Zerrenner [Member]" } } }, "auth_ref": [] }, "ifrs-full_TypesOfHedgesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfHedgesAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Types of hedges [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r223", "r224", "r226" ] }, "ifrs-full_TypesOfHedgesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfHedgesMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used." } } }, "auth_ref": [ "r223", "r224", "r226" ] }, "ifrs-full_TypesOfInterestRatesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfInterestRatesAxis", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Types of interest rates [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r396" ] }, "ifrs-full_TypesOfRisksAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksAxis", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en-us": { "role": { "label": "Types of risks [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r197", "r198", "r199", "r201", "r220", "r230", "r231" ] }, "ifrs-full_TypesOfRisksMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfRisksMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails5", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails6" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used." } } }, "auth_ref": [ "r197", "r198", "r199", "r201", "r220", "r230", "r231" ] }, "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfSharebasedPaymentArrangementsAxis", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails", "http://ambev.com.br/role/Share-basedPaymentsDetails3", "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of share-based payment arrangements [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r211" ] }, "abev_USDollarsCashMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "USDollarsCashMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "U S Dollars Cash [Member]" } } }, "auth_ref": [] }, "abev_USDollarsRiskPortionOfCostExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "USDollarsRiskPortionOfCostExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "US Dollars risk portion of cost exposure [member]", "documentation": "The US Dollars risk portion of cost exposure." } } }, "auth_ref": [] }, "abev_USDollarsRiskPortionOfFixedAssetsExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "USDollarsRiskPortionOfFixedAssetsExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "US Dollars risk portion of fixed assets exposure [member]", "documentation": "Refers to information regarding the US Dollars risk portion of fixed assets exposure." } } }, "auth_ref": [] }, "abev_USDollarsRiskPortionOfThCashExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "USDollarsRiskPortionOfThCashExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1" ], "lang": { "en-us": { "role": { "label": "U S Dollars Risk Portion Of Th Cash Exposure [Member]" } } }, "auth_ref": [] }, "abev_USDollarsRiskPortionOfTheCashExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "USDollarsRiskPortionOfTheCashExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "U S Dollars Risk Portion Of The Cash Exposure [Member]" } } }, "auth_ref": [] }, "abev_USDollarsRiskPortionOfTheExpensesExposureMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "USDollarsRiskPortionOfTheExpensesExposureMember", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails1", "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetails2" ], "lang": { "en-us": { "role": { "label": "US Dollars risk portion of the expenses exposure [member]", "documentation": "Refers to the US Dollars risk portion of the expenses exposure." } } }, "auth_ref": [] }, "abev_USDollarsSpentInPanamaAndCubaMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "USDollarsSpentInPanamaAndCubaMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "U S Dollars Spent In Panama And Cuba [Member]" } } }, "auth_ref": [] }, "ifrs-full_UnallocatedAmountsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnallocatedAmountsMember", "presentation": [ "http://ambev.com.br/role/SegmentReporting-ReportableSegmentsDetails" ], "lang": { "en-us": { "role": { "label": "Unallocated amounts [member]" } }, "en": { "role": { "documentation": "This member stands for items that have not been allocated to operating segments." } } }, "auth_ref": [ "r333", "r334" ] }, "abev_UncertaintyOverTheTreatmentOfIncomeTaxesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "UncertaintyOverTheTreatmentOfIncomeTaxesMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Uncertainty Over The Treatment Of Income Taxes [Member]" } } }, "auth_ref": [] }, "ifrs-full_UnobservableInputsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnobservableInputsAxis", "presentation": [ "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Unobservable inputs [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r175", "r394" ] }, "ifrs-full_UnobservableInputsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnobservableInputsMember", "presentation": [ "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for all the unobservable inputs. It also represents the standard value for the 'Unobservable inputs' axis if no other member is used." } } }, "auth_ref": [ "r175", "r394" ] }, "abev_UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails8" ], "lang": { "en-us": { "role": { "label": "Plan assets percentage, unrated" } } }, "auth_ref": [] }, "ifrs-full_UnusedProvisionReversedOtherProvisions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedProvisionReversedOtherProvisions", "crdr": "debit", "presentation": [ "http://ambev.com.br/role/TradeReceivables-EstimatedLossForDoubtfulDebtsDetails" ], "lang": { "en-us": { "role": { "label": "Reversals" } }, "en": { "role": { "documentation": "The amount reversed for unused other provisions. [Refer: Other provisions]" } } }, "auth_ref": [ "r124" ] }, "ifrs-full_UnusedTaxLossesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UnusedTaxLossesMember", "presentation": [ "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails3", "http://ambev.com.br/role/IncomeTaxAndSocialContributionDetails5" ], "lang": { "en-us": { "role": { "label": "Unused tax losses [member]" } }, "en": { "role": { "documentation": "This member stands for tax losses that have been incurred and are carried forward for use against future taxable profit." } } }, "auth_ref": [ "r57" ] }, "abev_UruguayMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "UruguayMember", "presentation": [ "http://ambev.com.br/role/GoodwillDetails1" ], "lang": { "en-us": { "role": { "label": "Uruguay [Member]" } } }, "auth_ref": [] }, "abev_UruguayanPesoSpentInUruguayMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "UruguayanPesoSpentInUruguayMember", "presentation": [ "http://ambev.com.br/role/BasisOfPreparationAndPresentationOfFinancialStatementsDetails" ], "lang": { "en-us": { "role": { "label": "Uruguayan Peso Spent In Uruguay [Member]" } } }, "auth_ref": [] }, "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill", "presentation": [ "http://ambev.com.br/role/IntangiblesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Intangible assets useful lives" } }, "en": { "role": { "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r130" ] }, "abev_ValueAddedAndExciseTaxesMember": { "xbrltype": "domainItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ValueAddedAndExciseTaxesMember", "presentation": [ "http://ambev.com.br/role/ProvisionsContingentLiabilitiesAndContingentAssetsDetails2" ], "lang": { "en-us": { "role": { "label": "Value Added And Excise Taxes [Member]" } } }, "auth_ref": [] }, "abev_ValueAtRiskAdverseScenarioDeteriorationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ValueAtRiskAdverseScenarioDeteriorationPercentage", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Value at risk, adverse scenario, deterioration percentage", "documentation": "The value at risk under an adverse scenario relating to the deterioration percentage." } } }, "auth_ref": [] }, "abev_ValueAtRiskExposureProbable": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ValueAtRiskExposureProbable", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Value at risk exposure, probable", "documentation": "The percentage range for potential exposure under a probable scenario using Value at Risk." } } }, "auth_ref": [] }, "abev_ValueAtRiskRemoteScenarioDeteriorationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "ValueAtRiskRemoteScenarioDeteriorationPercentage", "presentation": [ "http://ambev.com.br/role/FinancialInstrumentsAndRisksDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Value at risk, remote scenario, deterioration percentage", "documentation": "The value at risk under a remote scenario relating to the deterioration percentage." } } }, "auth_ref": [] }, "ifrs-full_WagesAndSalaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WagesAndSalaries", "crdr": "debit", "calculation": { "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails": { "parentTag": "ifrs-full_EmployeeBenefitsExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ambev.com.br/role/PayrollAndRelatedBenefitsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Wages and salaries", "label": "Wages and salaries [Default Label]" } }, "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r380" ] }, "ifrs-full_WeightedAverageCostOfCapitalMeasurementInputMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageCostOfCapitalMeasurementInputMember", "presentation": [ "http://ambev.com.br/role/ImpairmentOfNon-financialAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average cost of capital, measurement input [member]" } }, "en": { "role": { "documentation": "This member stands for the weighted average cost of capital used as a measurement input." } } }, "auth_ref": [ "r315", "r317" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails2" ], "lang": { "en-us": { "role": { "label": "Options exercisable at ended period, weighted average exercise price (in BRL per share)" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r209" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails2" ], "lang": { "en-us": { "role": { "label": "Options exercised during the period, weighted average exercise price (in BRL per share)" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r207" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails2" ], "lang": { "en-us": { "role": { "label": "Options forfeited during the period, weighted average exercise price (in BRL per share)" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r206" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Options outstanding at January 1, weighted average exercise price (in BRL per share)", "periodEndLabel": "Options outstanding at ended period, weighted average exercise price (in BRL per share)", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r205", "r208" ] }, "ifrs-full_WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16", "presentation": [ "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails4" ], "lang": { "en-us": { "role": { "label": "Weighted average lessee's incremental borrowing rate applied to lease liabilities recognised at date of initial application of IFRS 16" } }, "en": { "role": { "documentation": "The weighted average lessee's incremental borrowing rate applied to lease liabilities recognised in the statement of financial position at the date of initial application of IFRS 16. The incremental borrowing rate is the rate of interest that a lessee would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment." } } }, "auth_ref": [ "r191" ] }, "srt_WeightedAverageMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "WeightedAverageMember", "presentation": [ "http://ambev.com.br/role/EmployeeBenefitsDetails6", "http://ambev.com.br/role/Interest-bearingLoansAndBorrowingDetails1" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://ambev.com.br/role/Share-basedPaymentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options (Year)" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r210" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://ambev.com.br/role/EarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of shares\u00a0(i)\u00a0(non diluted)" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r111" ] }, "ifrs-full_WorkInProgress": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WorkInProgress", "crdr": "debit", "calculation": { "http://ambev.com.br/role/InventoryDetails": { "parentTag": "ifrs-full_Inventories", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ambev.com.br/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Work in progress" } }, "en": { "role": { "documentation": "A classification of current inventory representing the amount of assets currently in production, which require further processes to be converted into finished goods or services. [Refer: Current finished goods; Inventories]" } } }, "auth_ref": [ "r282", "r381" ] }, "abev_WriteoffOfInvestmentsiv": { "xbrltype": "monetaryItemType", "nsuri": "http://ambev.com.br/20231231", "localname": "WriteoffOfInvestmentsiv", "crdr": "debit", "calculation": { "http://ambev.com.br/role/ExceptionalItemsDetails": { "parentTag": "abev_ExceptionalItems", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://ambev.com.br/role/ExceptionalItemsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Write-off of investments\u00a0(v)", "label": "WriteoffOfInvestmentsiv" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://ambev.com.br/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r354" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "107", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_107&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_g&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_h&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "l", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_l&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "m", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_m&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "q", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_q&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "r", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_r&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_b&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_d&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_b&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81B", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81B_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_a&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "90", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_90&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "98", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_98_b&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "98", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_98_c&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "ab", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_ab&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "140", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "140", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "140", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "140", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_140_a&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_a&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_b&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "c", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "c", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_d&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_e&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_f&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_g&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "145", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_145_a&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "145", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_145&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_b&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "148", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_148_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS19_g2-7_TI", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "36", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_36_b&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS02_g36-39_TI", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_a&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS21_g51-57_TI", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19_g&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Section": "Disclosures", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "29", "IssueDate": "2023-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=29&code=ifrs-tx-2023-en-r&anchor=para_9&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "130", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "130", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_130&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_a&doctype=Standard", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134_b&doctype=Standard", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "134", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_134&doctype=Standard", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_a&doctype=Standard", "URIDate": "2023-03-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2023-03-23" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_a&doctype=Standard", "URIDate": "2023-03-23" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_b&doctype=Standard", "URIDate": "2023-03-23" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_c&doctype=Standard", "URIDate": "2023-03-23" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_d&doctype=Standard", "URIDate": "2023-03-23" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard", "URIDate": "2023-03-23" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "86", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_86_a&doctype=Standard", "URIDate": "2023-03-23" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "86", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_86&doctype=Standard", "URIDate": "2023-03-23" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "88", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_88&doctype=Standard", "URIDate": "2023-03-23" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS37_g84-92_TI", "URIDate": "2023-03-23" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_a&doctype=Standard", "URIDate": "2023-03-23" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "122", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_122_a&doctype=Standard", "URIDate": "2023-03-23" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI", "URIDate": "2023-03-23" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39&doctype=Standard", "URIDate": "2023-03-23" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard", "URIDate": "2023-03-23" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_e&doctype=Standard", "URIDate": "2023-03-23" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_f&doctype=Standard", "URIDate": "2023-03-23" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_d&doctype=Standard", "URIDate": "2023-03-23" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_113_a&doctype=Standard", "URIDate": "2023-03-23" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "115", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_115&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "C12", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_C12_a&doctype=Appendix&subtype=C", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "C12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_C12_b&doctype=Appendix&subtype=C", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "110", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_110&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "124", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_124&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "125", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_125&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "128", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_128_a&doctype=Standard", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "C32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_C32&doctype=Appendix&subtype=C", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "44", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_44&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d_vi&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "13C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_13C&doctype=Standard", "URIDate": "2023-03-23" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "15", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_15_a&doctype=Standard", "URIDate": "2023-03-23" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "21C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_21C&doctype=Standard", "URIDate": "2023-03-23" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "22A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_22A&doctype=Standard", "URIDate": "2023-03-23" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24A&doctype=Standard", "URIDate": "2023-03-23" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24B", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24B&doctype=Standard", "URIDate": "2023-03-23" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24C&doctype=Standard", "URIDate": "2023-03-23" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24E", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24E_a&doctype=Standard", "URIDate": "2023-03-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_a&doctype=Standard", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_e&doctype=Standard", "URIDate": "2023-03-23" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_f&doctype=Standard", "URIDate": "2023-03-23" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8_g&doctype=Standard", "URIDate": "2023-03-23" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_8&doctype=Standard", "URIDate": "2023-03-23" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "9", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_9_a&doctype=Standard", "URIDate": "2023-03-23" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B52", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B52&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Defined terms", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI", "URIDate": "2023-03-23" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_a&doctype=Standard", "URIDate": "2023-03-23" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_c&doctype=Standard", "URIDate": "2023-03-23" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_d&doctype=Standard", "URIDate": "2023-03-23" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_a&doctype=Standard", "URIDate": "2023-03-23" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "32", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_32&doctype=Standard", "URIDate": "2023-03-23" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_a&doctype=Standard", "URIDate": "2023-03-23" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33&doctype=Standard", "URIDate": "2023-03-23" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_34&doctype=Standard", "URIDate": "2023-03-23" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI", "URIDate": "2023-03-23" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "22", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_22_b&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "22", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_22&doctype=Standard", "URIDate": "2023-03-23" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_23_e&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_24_a_i&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Note": "Expired 2023-01-01", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "8", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_8_b&doctype=Standard&book=b", "URIDate": "2023-03-23" }, "r276": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r277": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r278": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r279": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r280": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r281": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r282": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_c&doctype=Standard", "URIDate": "2023-03-23" }, "r283": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r284": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r285": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r286": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_a&doctype=Standard", "URIDate": "2023-03-23" }, "r287": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "80", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_80_c&doctype=Standard", "URIDate": "2023-03-23" }, "r288": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_b&doctype=Standard", "URIDate": "2023-03-23" }, "r289": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37_g&doctype=Standard", "URIDate": "2023-03-23" }, "r290": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_a&doctype=Standard", "URIDate": "2023-03-23" }, "r291": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_d&doctype=Standard", "URIDate": "2023-03-23" }, "r292": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2023-03-23" }, "r293": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "21", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_21_a&doctype=Standard", "URIDate": "2023-03-23" }, "r294": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "21", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_21_f&doctype=Standard", "URIDate": "2023-03-23" }, "r295": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r296": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r297": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r298": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "87", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_87&doctype=Standard", "URIDate": "2023-03-23" }, "r299": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "88", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_88&doctype=Standard", "URIDate": "2023-03-23" }, "r300": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Section": "Example 10 A court case", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10_TI", "URIDate": "2023-03-23" }, "r301": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_a&doctype=Standard", "URIDate": "2023-03-23" }, "r302": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2023-03-23" }, "r303": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "14", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_14_f&doctype=Standard", "URIDate": "2023-03-23" }, "r304": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r305": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_c&doctype=Standard", "URIDate": "2023-03-23" }, "r306": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r307": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r308": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2023-03-23" }, "r309": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r310": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r311": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "44C", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_44C&doctype=Standard", "URIDate": "2023-03-23" }, "r312": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "A Statement of cash flows for an entity other than a financial institution", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI", "URIDate": "2023-03-23" }, "r313": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Section": "C Reconciliation of liabilities arising from financing activities", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C_TI", "URIDate": "2023-03-23" }, "r314": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r315": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_d&doctype=Standard", "URIDate": "2023-03-23" }, "r316": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r317": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r318": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r319": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r320": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r321": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r322": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_b&doctype=Standard", "URIDate": "2023-03-23" }, "r323": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_c&doctype=Standard", "URIDate": "2023-03-23" }, "r324": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r325": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r326": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r327": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r328": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r329": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG20D", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r330": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r331": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r332": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r333": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r334": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "IG4", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_IG4&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r335": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r336": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r337": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r339": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r341": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r342": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r343": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r344": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r345": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r346": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r347": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r348": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r349": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r350": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r352": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r353": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r354": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r355": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2023-03-23" }, "r370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "135", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_135_b&doctype=Standard", "URIDate": "2023-03-23" }, "r373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141_c&doctype=Standard", "URIDate": "2023-03-23" }, "r374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "141", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_141&doctype=Standard", "URIDate": "2023-03-23" }, "r375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142_b&doctype=Standard", "URIDate": "2023-03-23" }, "r376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "144", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_144&doctype=Standard", "URIDate": "2023-03-23" }, "r377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "145", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_145&doctype=Standard", "URIDate": "2023-03-23" }, "r378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "5", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_5&doctype=Standard", "URIDate": "2023-03-23" }, "r379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "57", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_57_a&doctype=Standard", "URIDate": "2023-03-23" }, "r380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_9&doctype=Standard", "URIDate": "2023-03-23" }, "r381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "20", "IssueDate": "2023-01-01", "Paragraph": "39", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=20&code=ifrs-tx-2023-en-r&anchor=para_39_b&doctype=Standard", "URIDate": "2023-03-23" }, "r383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2023-03-23" }, "r384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84_b&doctype=Standard", "URIDate": "2023-03-23" }, "r385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "37", "IssueDate": "2023-01-01", "Paragraph": "84", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2023-en-r&anchor=para_84&doctype=Standard", "URIDate": "2023-03-23" }, "r386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_h&doctype=Standard", "URIDate": "2023-03-23" }, "r395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "39", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_39&doctype=Standard", "URIDate": "2023-03-23" }, "r397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" } } } ZIP 186 0001292814-24-000771-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001292814-24-000771-xbrl.zip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�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�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�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abevform20f_2023_htm.xml IDEA: XBRL DOCUMENT 0001565025 2023-01-01 2023-12-31 0001565025 dei:BusinessContactMember 2023-01-01 2023-12-31 0001565025 2023-12-31 0001565025 2022-01-01 2022-12-31 0001565025 2021-01-01 2021-12-31 0001565025 2022-12-31 0001565025 ifrs-full:IssuedCapitalMember 2020-12-31 0001565025 ifrs-full:CapitalReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesMember 2020-12-31 0001565025 ifrs-full:RetainedEarningsMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2020-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2020-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2020-12-31 0001565025 2020-12-31 0001565025 ifrs-full:IssuedCapitalMember 2021-12-31 0001565025 ifrs-full:CapitalReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesMember 2021-12-31 0001565025 ifrs-full:RetainedEarningsMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2021-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2021-12-31 0001565025 2021-12-31 0001565025 ifrs-full:IssuedCapitalMember 2022-12-31 0001565025 ifrs-full:CapitalReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesMember 2022-12-31 0001565025 ifrs-full:RetainedEarningsMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2022-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2022-12-31 0001565025 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001565025 ifrs-full:CapitalReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:RetainedEarningsMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2021-01-01 2021-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001565025 ifrs-full:CapitalReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:RetainedEarningsMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2022-01-01 2022-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:IssuedCapitalMember 2023-01-01 2023-12-31 0001565025 ifrs-full:CapitalReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:RetainedEarningsMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-01-01 2023-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:IssuedCapitalMember 2023-12-31 0001565025 ifrs-full:CapitalReserveMember 2023-12-31 0001565025 abev:NetIncomeReservesMember 2023-12-31 0001565025 ifrs-full:RetainedEarningsMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsMember 2023-12-31 0001565025 ifrs-full:EquityAttributableToOwnersOfParentMember 2023-12-31 0001565025 ifrs-full:NoncontrollingInterestsMember 2023-12-31 0001565025 abev:ELJMember abev:TenedoraMember 2023-12-31 0001565025 abev:ELJMember abev:TrancheAMember abev:TenedoraMember 2023-12-31 0001565025 abev:ELJMember abev:TrancheBMember abev:TenedoraMember 2023-12-31 0001565025 abev:GrupoModeloMember 2023-01-01 2023-12-31 0001565025 2021-05-01 2021-05-31 0001565025 abev:BoardOfDirectorsMember 2023-05-18 0001565025 abev:BoardOfDirectorsMember 2023-05-17 2023-05-18 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2023-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2022-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2021-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2023-01-01 2023-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2022-01-01 2022-12-31 0001565025 abev:CanadianDollarsSpentInCanadaAndCubaMember 2021-01-01 2021-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2023-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2022-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2021-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2023-01-01 2023-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2022-01-01 2022-12-31 0001565025 abev:DominicanPesosSpentInTheDominicanRepublicMember 2021-01-01 2021-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2023-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2022-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2021-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsSpentInPanamaAndCubaMember 2021-01-01 2021-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2023-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2022-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2021-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2023-01-01 2023-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2022-01-01 2022-12-31 0001565025 abev:QuetzalSpentInGuatemalaMember 2021-01-01 2021-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2023-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2022-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2021-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2023-01-01 2023-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2022-01-01 2022-12-31 0001565025 abev:ArgentineanPesoSpentInArgentinaMember 2021-01-01 2021-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2023-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2022-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2021-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2023-01-01 2023-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2022-01-01 2022-12-31 0001565025 abev:BolivianPesoSpentInBoliviaMember 2021-01-01 2021-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2023-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2022-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2021-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2023-01-01 2023-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2022-01-01 2022-12-31 0001565025 abev:GuaraniSpentInParaguaiMember 2021-01-01 2021-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2023-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2022-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2021-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2023-01-01 2023-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2022-01-01 2022-12-31 0001565025 abev:UruguayanPesoSpentInUruguayMember 2021-01-01 2021-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2023-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2022-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2021-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2023-01-01 2023-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2022-01-01 2022-12-31 0001565025 abev:ChileanPesoSpentInChileMember 2021-01-01 2021-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2023-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2022-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2021-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2023-01-01 2023-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2022-01-01 2022-12-31 0001565025 abev:BarbadianDollarSpentInBarbadosMember 2021-01-01 2021-12-31 0001565025 abev:Brazil1Member 2023-01-01 2023-12-31 0001565025 abev:Brazil1Member 2022-01-01 2022-12-31 0001565025 abev:Brazil1Member 2021-01-01 2021-12-31 0001565025 abev:CACMember 2023-01-01 2023-12-31 0001565025 abev:CACMember 2022-01-01 2022-12-31 0001565025 abev:CACMember 2021-01-01 2021-12-31 0001565025 abev:SouthLatinAmericaSegmentMember 2023-01-01 2023-12-31 0001565025 abev:SouthLatinAmericaSegmentMember 2022-01-01 2022-12-31 0001565025 abev:SouthLatinAmericaSegmentMember 2021-01-01 2021-12-31 0001565025 abev:CanadaSegmentMember 2023-01-01 2023-12-31 0001565025 abev:CanadaSegmentMember 2022-01-01 2022-12-31 0001565025 abev:CanadaSegmentMember 2021-01-01 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:Brazil1Member 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:Brazil1Member 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:Brazil1Member 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CACMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CACMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CACMember 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:SouthLatinAmericaSegmentMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:SouthLatinAmericaSegmentMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:SouthLatinAmericaSegmentMember 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CanadaSegmentMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CanadaSegmentMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember abev:CanadaSegmentMember 2021-12-31 0001565025 ifrs-full:OperatingSegmentsMember 2023-12-31 0001565025 ifrs-full:OperatingSegmentsMember 2022-12-31 0001565025 ifrs-full:OperatingSegmentsMember 2021-12-31 0001565025 ifrs-full:EliminationOfIntersegmentAmountsMember 2023-12-31 0001565025 ifrs-full:EliminationOfIntersegmentAmountsMember 2022-12-31 0001565025 ifrs-full:EliminationOfIntersegmentAmountsMember 2021-12-31 0001565025 ifrs-full:UnallocatedAmountsMember 2023-12-31 0001565025 ifrs-full:UnallocatedAmountsMember 2022-12-31 0001565025 ifrs-full:UnallocatedAmountsMember 2021-12-31 0001565025 country:BR 2023-12-31 0001565025 country:CA 2023-12-31 0001565025 country:BR 2022-12-31 0001565025 country:CA 2022-12-31 0001565025 country:BR 2021-12-31 0001565025 country:CA 2021-12-31 0001565025 country:AR 2023-01-01 2023-12-31 0001565025 country:AR 2022-01-01 2022-12-31 0001565025 country:AR 2021-01-01 2021-12-31 0001565025 country:AR 2023-12-31 0001565025 country:AR 2022-12-31 0001565025 country:AR 2021-12-31 0001565025 abev:BeerMember abev:Brazil1Member 2023-01-01 2023-12-31 0001565025 abev:BeerMember abev:Brazil1Member 2022-01-01 2022-12-31 0001565025 abev:BeerMember abev:Brazil1Member 2021-01-01 2021-12-31 0001565025 abev:NABMember abev:Brazil1Member 2023-01-01 2023-12-31 0001565025 abev:NABMember abev:Brazil1Member 2022-01-01 2022-12-31 0001565025 abev:NABMember abev:Brazil1Member 2021-01-01 2021-12-31 0001565025 ifrs-full:BottomOfRangeMember abev:CentralAmericaAndCaribbeanMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember abev:CentralAmericaAndCaribbeanMember 2023-01-01 2023-12-31 0001565025 ifrs-full:BottomOfRangeMember abev:LatinAmericaSouthMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember abev:LatinAmericaSouthMember 2023-01-01 2023-12-31 0001565025 abev:CountryOfCanadaMember 2023-01-01 2023-12-31 0001565025 abev:LuxembourgMember 2023-01-01 2023-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2023-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2022-12-31 0001565025 abev:TemporaryDifferencesIntangiblesMember 2023-12-31 0001565025 abev:TemporaryDifferencesIntangiblesMember 2022-12-31 0001565025 abev:TemporaryDifferencesEmployeeBenefitsMember 2023-12-31 0001565025 abev:TemporaryDifferencesEmployeeBenefitsMember 2022-12-31 0001565025 abev:TemporaryDifferencesTradePayablesMember 2023-12-31 0001565025 abev:TemporaryDifferencesTradePayablesMember 2022-12-31 0001565025 abev:TemporaryDifferencesTradeReceivableMember 2023-12-31 0001565025 abev:TemporaryDifferencesTradeReceivableMember 2022-12-31 0001565025 abev:TemporaryDifferencesDerivativesMember 2023-12-31 0001565025 abev:TemporaryDifferencesDerivativesMember 2022-12-31 0001565025 abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2022-12-31 0001565025 abev:TemporaryDifferencesInventoriesMember 2023-12-31 0001565025 abev:TemporaryDifferencesInventoriesMember 2022-12-31 0001565025 abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2023-12-31 0001565025 abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2022-12-31 0001565025 abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2023-12-31 0001565025 abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2022-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2023-12-31 0001565025 abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2022-12-31 0001565025 ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:UnusedTaxLossesMember 2022-12-31 0001565025 abev:TemporaryDifferencesProvisionsMember 2023-12-31 0001565025 abev:TemporaryDifferencesProvisionsMember 2022-12-31 0001565025 abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2023-12-31 0001565025 abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2022-12-31 0001565025 abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2023-12-31 0001565025 abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2022-12-31 0001565025 abev:TemporaryDifferencesOtherItemsMember 2023-12-31 0001565025 abev:TemporaryDifferencesOtherItemsMember 2022-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInSecuritiesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesIntangiblesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesIntangiblesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesEmployeeBenefitsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesEmployeeBenefitsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesTradePayablesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesTradePayablesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesTradeReceivableMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesTradeReceivableMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesDerivativesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesDerivativesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInventoriesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInventoriesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesPropertyPlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesInvestmentsInJointVenturesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesProvisionsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesProvisionsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:ImpactOfAdoptionOfIFRSAccountingPolicyMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:ICMSFromTheAssessmentBasesOfPISCOFINSMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:TemporaryDifferencesOtherItemsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:TemporaryDifferencesOtherItemsMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember abev:DeferredTaxesNotRelatedToTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearMember abev:DeferredTaxesNotRelatedToTaxLossesMember 2023-12-31 0001565025 abev:DeferredTaxesNotRelatedToTaxLossesMember 2023-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 abev:LaterThanThreeYearsAndNotLaterThanFoursYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 abev:LaterThanFiveYearsAndNotLaterThanEightYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 abev:LaterThanNineYearsMember ifrs-full:UnusedTaxLossesMember 2023-12-31 0001565025 ifrs-full:PropertyPlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:PropertyPlantAndEquipmentMember 2022-12-31 0001565025 ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LandAndBuildingsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember abev:PlantAndEquipmentMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:FixturesAndFittingsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ConstructionInProgressMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:LandAndBuildingsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:LandAndBuildingsMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:PlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember abev:PlantAndEquipmentMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:FixturesAndFittingsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:FixturesAndFittingsMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ConstructionInProgressMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ConstructionInProgressMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember ifrs-full:BuildingsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember ifrs-full:BuildingsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember ifrs-full:BuildingsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember ifrs-full:BuildingsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember abev:MachineryVehiclesAndOthersMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember abev:MachineryVehiclesAndOthersMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember abev:MachineryVehiclesAndOthersMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember abev:MachineryVehiclesAndOthersMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember ifrs-full:BuildingsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember ifrs-full:BuildingsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember ifrs-full:BuildingsMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember abev:MachineryVehiclesAndOthersMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember abev:MachineryVehiclesAndOthersMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember abev:MachineryVehiclesAndOthersMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:RightofuseAssetsMember 2023-12-31 0001565025 ifrs-full:BuildingsMember 2023-01-01 2023-12-31 0001565025 abev:PlantAndEquipmentMember 2023-01-01 2023-12-31 0001565025 abev:FixturesMember 2023-01-01 2023-12-31 0001565025 abev:FittingsMember 2023-01-01 2023-12-31 0001565025 abev:ExternalUseAssetsCommercialAssetsMember ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:ExternalUseAssetsCommercialAssetsMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:CountryOfBrazilMember 2023-12-31 0001565025 abev:CountryOfBrazilMember 2022-12-31 0001565025 abev:CACMember abev:DominicanRepublicMember 2023-12-31 0001565025 abev:CACMember abev:DominicanRepublicMember 2022-12-31 0001565025 abev:CACMember abev:PanamaMember 2023-12-31 0001565025 abev:CACMember abev:PanamaMember 2022-12-31 0001565025 abev:LatinAmericaSouthMember abev:ArgentinaMember 2023-12-31 0001565025 abev:LatinAmericaSouthMember abev:ArgentinaMember 2022-12-31 0001565025 abev:LatinAmericaSouthMember abev:BoliviaMember 2023-12-31 0001565025 abev:LatinAmericaSouthMember abev:BoliviaMember 2022-12-31 0001565025 abev:LatinAmericaSouthMember abev:ChileMember 2023-12-31 0001565025 abev:LatinAmericaSouthMember abev:ChileMember 2022-12-31 0001565025 abev:LatinAmericaSouthMember abev:ParaguayMember 2023-12-31 0001565025 abev:LatinAmericaSouthMember abev:ParaguayMember 2022-12-31 0001565025 abev:LatinAmericaSouthMember abev:UruguayMember 2023-12-31 0001565025 abev:LatinAmericaSouthMember abev:UruguayMember 2022-12-31 0001565025 abev:CountryOfCanadaMember 2023-12-31 0001565025 abev:CountryOfCanadaMember 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 abev:ChileMember ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2023-12-31 0001565025 abev:PanamaMember ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2023-12-31 0001565025 abev:CountryOfBrazilMember ifrs-full:WeightedAverageCostOfCapitalMeasurementInputMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2021-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2022-01-01 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2022-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:BrandNamesMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:IntangiblesMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2023-01-01 2023-12-31 0001565025 ifrs-full:GrossCarryingAmountMember abev:OthersMember 2023-12-31 0001565025 abev:IntangibleAssetsInArgentinaMember 2023-12-31 0001565025 abev:IntangibleAssetsInArgentinaMember 2022-12-31 0001565025 abev:IntangibleAssetsInBoliviaMember 2023-12-31 0001565025 abev:IntangibleAssetsInBoliviaMember 2022-12-31 0001565025 abev:IntangibleAssetsInBrazilMember 2023-12-31 0001565025 abev:IntangibleAssetsInBrazilMember 2022-12-31 0001565025 abev:IntangibleAssetsInCanadaMember 2023-12-31 0001565025 abev:IntangibleAssetsInCanadaMember 2022-12-31 0001565025 abev:IntangibleAssetsInChileMember 2023-12-31 0001565025 abev:IntangibleAssetsInChileMember 2022-12-31 0001565025 abev:IntangibleAssetsInLuxembourgMember 2023-12-31 0001565025 abev:IntangibleAssetsInLuxembourgMember 2022-12-31 0001565025 abev:IntangibleAssetsInParaguayMember 2023-12-31 0001565025 abev:IntangibleAssetsInParaguayMember 2022-12-31 0001565025 abev:IntangibleAssetsInTheDominicanRepublicMember 2023-12-31 0001565025 abev:IntangibleAssetsInTheDominicanRepublicMember 2022-12-31 0001565025 abev:IntangibleAssetsInPanamaMember 2023-12-31 0001565025 abev:IntangibleAssetsInPanamaMember 2022-12-31 0001565025 abev:IntangibleAssetsInUruaguayMember 2023-12-31 0001565025 abev:IntangibleAssetsInUruaguayMember 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 ifrs-full:BottomOfRangeMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TopOfRangeMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001565025 abev:PISCOFINSExclusionOfICMSMember 2023-12-31 0001565025 abev:PISCOFINSExclusionOfICMSMember 2022-12-31 0001565025 abev:ICMSMember 2023-12-31 0001565025 abev:ICMSMember 2022-12-31 0001565025 abev:IncomeTaxAndSocialContributionsRecoverableMember 2023-12-31 0001565025 abev:IncomeTaxAndSocialContributionsRecoverableMember 2022-12-31 0001565025 ifrs-full:OtherTemporaryDifferencesMember 2023-12-31 0001565025 ifrs-full:OtherTemporaryDifferencesMember 2022-12-31 0001565025 abev:PiscofinsMember 2023-12-31 0001565025 abev:PiscofinsMember 2022-12-31 0001565025 abev:IPIMember 2023-12-31 0001565025 abev:IPIMember 2022-12-31 0001565025 abev:InventoryProvisionMember 2022-12-31 0001565025 abev:InventoryProvisionMember 2021-12-31 0001565025 abev:InventoryProvisionMember 2023-01-01 2023-12-31 0001565025 abev:InventoryProvisionMember 2022-01-01 2022-12-31 0001565025 abev:InventoryProvisionMember 2023-12-31 0001565025 ifrs-full:CurrentMember 2023-12-31 0001565025 ifrs-full:CurrentMember 2022-12-31 0001565025 abev:LessThanOneMonthMember 2023-12-31 0001565025 abev:LessThanOneMonthMember 2022-12-31 0001565025 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2023-12-31 0001565025 ifrs-full:LaterThanOneMonthAndNotLaterThanTwoMonthsMember 2022-12-31 0001565025 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember 2022-12-31 0001565025 abev:LaterThanThreeMonthsAndLessThanSixMonthsMember 2023-12-31 0001565025 abev:LaterThanThreeMonthsAndLessThanSixMonthsMember 2022-12-31 0001565025 abev:LaterThanSixMonthsAndLessThan12MonthsMember 2023-12-31 0001565025 abev:LaterThanSixMonthsAndLessThan12MonthsMember 2022-12-31 0001565025 abev:LaterThanAYearMember 2023-12-31 0001565025 abev:LaterThanAYearMember 2022-12-31 0001565025 abev:BadDebtProvisionMember 2022-12-31 0001565025 abev:BadDebtProvisionMember 2021-12-31 0001565025 abev:BadDebtProvisionMember 2023-01-01 2023-12-31 0001565025 abev:BadDebtProvisionMember 2022-01-01 2022-12-31 0001565025 abev:BadDebtProvisionMember 2023-12-31 0001565025 abev:AuthorizedShareCapitalMember 2023-12-31 0001565025 abev:AuthorizedShareCapitalMember 2022-12-31 0001565025 abev:AuthorizedShareCapitalMember 2021-12-31 0001565025 ifrs-full:CountryOfDomicileMember ifrs-full:TopOfRangeMember 2023-01-01 2023-12-31 0001565025 2023-12-12 2023-12-31 0001565025 2022-12-05 2022-12-31 0001565025 2021-12-07 2021-12-31 0001565025 2021-11-01 2021-11-30 0001565025 abev:InterbrewInternationalBvMember 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2023-01-01 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-01-01 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2021-12-31 0001565025 abev:InterbrewInternationalBvMember 2021-01-01 2021-12-31 0001565025 abev:AmbrewSARLMember 2023-12-31 0001565025 abev:AmbrewSARLMember 2023-01-01 2023-12-31 0001565025 abev:AmbrewSARLMember 2022-12-31 0001565025 abev:AmbrewSARLMember 2022-01-01 2022-12-31 0001565025 abev:AmbrewSARLMember 2021-12-31 0001565025 abev:AmbrewSARLMember 2021-01-01 2021-12-31 0001565025 abev:FundacaoZerrennerMember 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2022-12-31 0001565025 abev:FundacaoZerrennerMember 2022-01-01 2022-12-31 0001565025 abev:FundacaoZerrennerMember 2021-12-31 0001565025 abev:FundacaoZerrennerMember 2021-01-01 2021-12-31 0001565025 abev:MercadoMember 2023-12-31 0001565025 abev:MercadoMember 2023-01-01 2023-12-31 0001565025 abev:MercadoMember 2022-12-31 0001565025 abev:MercadoMember 2022-01-01 2022-12-31 0001565025 abev:MercadoMember 2021-12-31 0001565025 abev:MercadoMember 2021-01-01 2021-12-31 0001565025 abev:TesourariaMember 2023-12-31 0001565025 abev:TesourariaMember 2023-01-01 2023-12-31 0001565025 abev:TesourariaMember 2022-12-31 0001565025 abev:TesourariaMember 2022-01-01 2022-12-31 0001565025 abev:TesourariaMember 2021-12-31 0001565025 abev:TesourariaMember 2021-01-01 2021-12-31 0001565025 ifrs-full:TreasurySharesMember 2020-12-31 0001565025 ifrs-full:SharePremiumMember 2020-12-31 0001565025 ifrs-full:OtherReservesMember 2020-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2020-12-31 0001565025 ifrs-full:TreasurySharesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:SharePremiumMember 2021-01-01 2021-12-31 0001565025 ifrs-full:OtherReservesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:TreasurySharesMember 2021-12-31 0001565025 ifrs-full:SharePremiumMember 2021-12-31 0001565025 ifrs-full:OtherReservesMember 2021-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-12-31 0001565025 ifrs-full:TreasurySharesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:SharePremiumMember 2022-01-01 2022-12-31 0001565025 ifrs-full:OtherReservesMember 2022-01-01 2022-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:TreasurySharesMember 2022-12-31 0001565025 ifrs-full:SharePremiumMember 2022-12-31 0001565025 ifrs-full:OtherReservesMember 2022-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001565025 ifrs-full:TreasurySharesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:SharePremiumMember 2023-01-01 2023-12-31 0001565025 ifrs-full:OtherReservesMember 2023-01-01 2023-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:TreasurySharesMember 2023-12-31 0001565025 ifrs-full:SharePremiumMember 2023-12-31 0001565025 ifrs-full:OtherReservesMember 2023-12-31 0001565025 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2020-12-31 0001565025 abev:NetIncomeReserveMember 2020-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReserveMember 2021-01-01 2021-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2021-12-31 0001565025 abev:NetIncomeReserveMember 2021-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReserveMember 2022-01-01 2022-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2022-12-31 0001565025 abev:NetIncomeReserveMember 2022-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReserveMember 2023-01-01 2023-12-31 0001565025 abev:NetIncomeReservesInvestmentReserveMember 2023-12-31 0001565025 abev:NetIncomeReservesLegalReserveMember 2023-12-31 0001565025 abev:NetIncomeReservesFiscalIncentiveMember 2023-12-31 0001565025 abev:NetIncomeReserveMember 2023-12-31 0001565025 2023-12-28 2023-12-31 0001565025 2022-12-29 2022-12-31 0001565025 2021-12-30 2021-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2020-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentMember 2021-01-01 2021-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2021-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentMember 2022-01-01 2022-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2022-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentMember 2023-01-01 2023-12-31 0001565025 abev:CarryingValueAdjustmentsTranslationReservesMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsCashFlowHedgeMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsActuarialGainslossesMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsBusinessCombinationMember 2023-12-31 0001565025 abev:CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember 2023-12-31 0001565025 abev:SecuredBankLoansMember 2023-12-31 0001565025 abev:SecuredBankLoansMember 2022-12-31 0001565025 abev:OtherSecuredLoansMember 2023-12-31 0001565025 abev:OtherSecuredLoansMember 2022-12-31 0001565025 ifrs-full:LeaseLiabilitiesMember 2023-12-31 0001565025 ifrs-full:LeaseLiabilitiesMember 2022-12-31 0001565025 abev:TotalLiabilitiesMember 2023-12-31 0001565025 abev:TotalLiabilitiesMember 2022-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInUSDollarsMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInOtherLatinAmericanCurrenciesMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:DebtDenominatedInCADDollarsMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FloatingInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember srt:WeightedAverageMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtRelatedToICMSMember ifrs-full:FloatingInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FixedInterestRateMember 2023-12-31 0001565025 abev:ReaisDebtMember srt:WeightedAverageMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:ReaisDebtMember ifrs-full:FixedInterestRateMember 2022-12-31 0001565025 abev:NonCurrentLiabilitiesMember 2022-12-31 0001565025 abev:CurrentLiabilitiesMember 2022-12-31 0001565025 abev:NonCurrentLiabilitiesMember 2021-12-31 0001565025 abev:CurrentLiabilitiesMember 2021-12-31 0001565025 abev:NonCurrentLiabilitiesMember 2023-12-31 0001565025 abev:CurrentLiabilitiesMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:SecuredBankLoanMember 2023-12-31 0001565025 abev:SecuredBankLoanMember 2022-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember 2023-12-31 0001565025 abev:OtherSecuredLoanMember 2022-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:LeaseLiabilityMember 2023-12-31 0001565025 abev:LeaseLiabilityMember 2022-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001565025 abev:LaterThanThreeYearsAndNotLaterThanSixYearsMember 2023-12-31 0001565025 abev:MaturityTotalMember 2023-12-31 0001565025 abev:MaturityTotalMember 2022-12-31 0001565025 abev:LeaseTerm20232027Member 2023-12-31 0001565025 abev:LeaseTerm20282035Member 2023-12-31 0001565025 abev:TwoHealthCarePlansFromFundacaoZerrennerMember 2023-12-31 0001565025 abev:TwoHealthCarePlansFromFundacaoZerrennerMember 2022-12-31 0001565025 abev:TwoHealthCarePlansFromFundacaoZerrennerMember 2021-12-31 0001565025 abev:EmployeeBenefitLiabilitiesMember 2023-12-31 0001565025 abev:EmployeeBenefitLiabilitiesMember 2022-12-31 0001565025 abev:EmployeeBenefitLiabilitiesMember 2021-12-31 0001565025 abev:EmployeeBenefitsAssetsMember 2023-12-31 0001565025 abev:EmployeeBenefitsAssetsMember 2022-12-31 0001565025 abev:EmployeeBenefitsAssetsMember 2021-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2022-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2021-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2020-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2023-01-01 2023-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2022-01-01 2022-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2021-01-01 2021-12-31 0001565025 ifrs-full:PresentValueOfDefinedBenefitObligationMember 2023-12-31 0001565025 ifrs-full:PlanAssetsMember 2022-12-31 0001565025 ifrs-full:PlanAssetsMember 2021-12-31 0001565025 ifrs-full:PlanAssetsMember 2020-12-31 0001565025 ifrs-full:PlanAssetsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:PlanAssetsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:PlanAssetsMember 2021-01-01 2021-12-31 0001565025 ifrs-full:PlanAssetsMember 2023-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2022-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2021-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2020-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2023-01-01 2023-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2022-01-01 2022-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2021-01-01 2021-12-31 0001565025 ifrs-full:EffectOfAssetCeilingMember 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember 2021-01-01 2021-12-31 0001565025 abev:EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember 2021-01-01 2021-12-31 0001565025 abev:CommercialExpensesMember 2023-01-01 2023-12-31 0001565025 abev:CommercialExpensesMember 2022-01-01 2022-12-31 0001565025 abev:CommercialExpensesMember 2021-01-01 2021-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember 2021-01-01 2021-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember 2023-01-01 2023-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember 2022-01-01 2022-12-31 0001565025 abev:EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember 2021-01-01 2021-12-31 0001565025 ifrs-full:BottomOfRangeMember 2023-12-31 0001565025 ifrs-full:TopOfRangeMember 2023-12-31 0001565025 ifrs-full:BottomOfRangeMember 2022-12-31 0001565025 ifrs-full:TopOfRangeMember 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2021-12-31 0001565025 ifrs-full:TopOfRangeMember 2021-12-31 0001565025 srt:WeightedAverageMember 2023-12-31 0001565025 srt:WeightedAverageMember 2022-12-31 0001565025 srt:WeightedAverageMember 2021-12-31 0001565025 ifrs-full:BottomOfRangeMember 2022-01-01 2022-12-31 0001565025 ifrs-full:TopOfRangeMember 2022-01-01 2022-12-31 0001565025 ifrs-full:BottomOfRangeMember 2021-01-01 2021-12-31 0001565025 ifrs-full:TopOfRangeMember 2021-01-01 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfDiscountRatesMember 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember 2021-12-31 0001565025 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2023-12-31 0001565025 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2022-12-31 0001565025 ifrs-full:ActuarialAssumptionOfLifeExpectancyAfterRetirementMember 2021-12-31 0001565025 abev:PlanAssetsGovernmentBondsMember 2023-12-31 0001565025 abev:PlanAssetsGovernmentBondsMember 2022-12-31 0001565025 abev:PlanAssetsGovernmentBondsMember 2021-12-31 0001565025 abev:PlanAssetsCorporateBondsMember 2023-12-31 0001565025 abev:PlanAssetsCorporateBondsMember 2022-12-31 0001565025 abev:PlanAssetsCorporateBondsMember 2021-12-31 0001565025 abev:PlanAssetsEquityInstrumentsMember 2023-12-31 0001565025 abev:PlanAssetsEquityInstrumentsMember 2022-12-31 0001565025 abev:PlanAssetsEquityInstrumentsMember 2021-12-31 0001565025 abev:PlanAssetsCashMember 2023-12-31 0001565025 abev:PlanAssetsCashMember 2022-12-31 0001565025 abev:PlanAssetsCashMember 2021-12-31 0001565025 abev:PlanAssetsOthersMember 2023-12-31 0001565025 abev:PlanAssetsOthersMember 2022-12-31 0001565025 abev:PlanAssetsOthersMember 2021-12-31 0001565025 abev:RestrictedSharesMember 2023-01-01 2023-12-31 0001565025 abev:RestrictedSharesMember 2022-01-01 2022-12-31 0001565025 abev:RestrictedSharesMember 2021-01-01 2021-12-31 0001565025 abev:DeferredStockUnitsOfGrantOneMember 2023-01-01 2023-12-31 0001565025 abev:DeferredStockUnitsOfGrantOneMember 2022-01-01 2022-12-31 0001565025 abev:DeferredStockUnitsOfGrantOneMember 2021-01-01 2021-12-31 0001565025 abev:RestrictedSharesMember 2022-12-31 0001565025 abev:RestrictedSharesMember 2021-12-31 0001565025 abev:RestrictedSharesMember 2020-12-31 0001565025 abev:RestrictedSharesMember 2023-12-31 0001565025 abev:DeferredSharesMember 2022-12-31 0001565025 abev:DeferredSharesMember 2021-12-31 0001565025 abev:DeferredSharesMember 2020-12-31 0001565025 abev:DeferredSharesMember 2023-01-01 2023-12-31 0001565025 abev:DeferredSharesMember 2022-01-01 2022-12-31 0001565025 abev:DeferredSharesMember 2021-01-01 2021-12-31 0001565025 abev:DeferredSharesMember 2023-12-31 0001565025 abev:TradePayableMember 2023-12-31 0001565025 abev:TradePayableMember 2022-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2021-12-31 0001565025 abev:ProvisionsForLaborMember 2021-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2021-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2021-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2021-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2022-01-01 2022-12-31 0001565025 abev:ProvisionsForLaborMember 2022-01-01 2022-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2022-01-01 2022-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2022-01-01 2022-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2022-01-01 2022-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2022-12-31 0001565025 abev:ProvisionsForLaborMember 2022-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2022-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2022-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2022-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2023-01-01 2023-12-31 0001565025 abev:ProvisionsForLaborMember 2023-01-01 2023-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2023-01-01 2023-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2023-01-01 2023-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2023-01-01 2023-12-31 0001565025 ifrs-full:ProvisionForTaxesOtherThanIncomeTaxMember 2023-12-31 0001565025 abev:ProvisionsForLaborMember 2023-12-31 0001565025 ifrs-full:LegalProceedingsProvisionMember 2023-12-31 0001565025 ifrs-full:MiscellaneousOtherProvisionsMember 2023-12-31 0001565025 ifrs-full:RestructuringProvisionMember 2023-12-31 0001565025 abev:TotalContingentProvisionsMember 2023-12-31 0001565025 abev:TotalContingentProvisionsMember 2022-12-31 0001565025 abev:IncomeTaxAndSocialContributionMember 2023-12-31 0001565025 abev:IncomeTaxAndSocialContributionMember 2022-12-31 0001565025 abev:ValueAddedAndExciseTaxesMember 2023-12-31 0001565025 abev:ValueAddedAndExciseTaxesMember 2022-12-31 0001565025 abev:PISAndCOFINSTaxContingentLiabilityMember 2023-12-31 0001565025 abev:PISAndCOFINSTaxContingentLiabilityMember 2022-12-31 0001565025 ifrs-full:OtherContingentLiabilitiesMember 2023-12-31 0001565025 ifrs-full:OtherContingentLiabilitiesMember 2022-12-31 0001565025 abev:UncertaintyOverTheTreatmentOfIncomeTaxesMember 2023-01-01 2023-12-31 0001565025 abev:UncertaintyOverTheTreatmentOfIncomeTaxesMember 2022-01-01 2022-12-31 0001565025 abev:IcmsstTriggerMember 2023-01-01 2023-12-31 0001565025 abev:IcmsstTriggerMember 2022-01-01 2022-12-31 0001565025 abev:ManausFreeTradeZoneMember 2023-01-01 2023-12-31 0001565025 abev:ManausFreeTradeZoneMember 2022-01-01 2022-12-31 0001565025 abev:IPISuspensionMember 2023-01-01 2023-12-31 0001565025 abev:IPISuspensionMember 2022-01-01 2022-12-31 0001565025 abev:SocialContributionsOverProductsMember 2023-01-01 2023-12-31 0001565025 abev:SocialContributionsOverProductsMember 2022-01-01 2022-12-31 0001565025 abev:ICMSZFMMember 2023-01-01 2023-12-31 0001565025 abev:ICMSZFMMember 2022-01-01 2022-12-31 0001565025 abev:ICMSProdepeMember 2023-01-01 2023-12-31 0001565025 abev:ICMSProdepeMember 2022-01-01 2022-12-31 0001565025 abev:ICMSFAINMember 2023-01-01 2023-12-31 0001565025 abev:ICMSFAINMember 2022-01-01 2022-12-31 0001565025 abev:ICMSAMMember 2023-01-01 2023-12-31 0001565025 abev:ICMSAMMember 2022-01-01 2022-12-31 0001565025 abev:ICMSFiscalWarMember 2023-01-01 2023-12-31 0001565025 abev:ICMSFiscalWarMember 2022-01-01 2022-12-31 0001565025 abev:ICMSMIPMember 2023-01-01 2023-12-31 0001565025 abev:ICMSMIPMember 2022-01-01 2022-12-31 0001565025 abev:ProposedClassActionInQuebecMember 2023-01-01 2023-12-31 0001565025 abev:ProposedClassActionInQuebecMember 2022-01-01 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetCashAndCashEquivalentsMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetCashAndCashEquivalentsMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember ifrs-full:TradeReceivablesMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember ifrs-full:TradeReceivablesMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtAmortisedCostCategoryMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:FinancialAssetInvestmentSecuritiesMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2022-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:TradePayableMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:TradePayableMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:InterestbearingLoansAndBorrowingsMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:InterestbearingLoansAndBorrowingsMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:OtherLiabilities1Member 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember abev:OtherLiabilities1Member 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtAmortisedCostCategoryMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:PutOptionGrantedOnSubsidiaryMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:PutOptionGrantedOnSubsidiaryMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:DerivativeHedgeMember 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:OtherLiabilities1Member 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember abev:OtherLiabilities1Member 2022-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember 2023-12-31 0001565025 ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember 2022-12-31 0001565025 abev:TotalCostExposureMember 2023-12-31 0001565025 abev:TotalCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 abev:TotalFixedAssetExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalExpensesExposureMember 2023-12-31 0001565025 abev:TotalExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalCashExposureMember 2023-12-31 0001565025 abev:CashUMember 2023-01-01 2023-12-31 0001565025 abev:TotalCashExposureMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 abev:USDollarsRiskPortionOfThCashExposureMember 2023-12-31 0001565025 abev:USDollarsCashMember 2023-01-01 2023-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2023-01-01 2023-12-31 0001565025 abev:TotalCostExposureMember 2022-12-31 0001565025 abev:TotalCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:CommoditiesRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:EurosRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2022-12-31 0001565025 abev:MexicanPesosRiskPortionOfCostExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalFixedAssetExposureMember 2022-12-31 0001565025 abev:TotalFixedAssetExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalExpensesExposureMember 2022-12-31 0001565025 abev:TotalExpensesExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheExpensesExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalCashExposureMember 2022-12-31 0001565025 abev:CashUMember 2022-01-01 2022-12-31 0001565025 abev:TotalCashExposureMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2022-12-31 0001565025 abev:USDollarsRiskPortionOfThCashExposureMember 2022-12-31 0001565025 abev:USDollarsCashMember 2022-01-01 2022-12-31 0001565025 abev:USDollarsRiskPortionOfTheCashExposureMember 2022-01-01 2022-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2022-12-31 0001565025 abev:TotalFinancialRiskExposureMember 2022-01-01 2022-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:EurosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:MexicanPesosRiskPortionOfCostExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheExpensesExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:USDollarsRiskPortionOfTheCashExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember abev:TotalFinancialRiskExposureMember 2023-12-31 0001565025 abev:TenedoraMember abev:ELJMember 2023-12-31 0001565025 abev:TenedoraMember abev:ELJMember abev:TrancheAMember 2023-12-31 0001565025 abev:TenedoraMember abev:ELJMember abev:TrancheBMember 2023-12-31 0001565025 abev:TenedoraMember abev:ELJMember 2022-12-31 0001565025 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001565025 ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001565025 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001565025 ifrs-full:Level1OfFairValueHierarchyMember 2022-12-31 0001565025 ifrs-full:Level2OfFairValueHierarchyMember 2022-12-31 0001565025 ifrs-full:Level3OfFairValueHierarchyMember 2022-12-31 0001565025 ifrs-full:Level3OfFairValueHierarchyMember 2023-01-01 2023-12-31 0001565025 abev:InterestRateRiskBrazilianReaisMember 2023-12-31 0001565025 abev:InterestRateRiskBrazilianReaisMember 2022-12-31 0001565025 ifrs-full:InterestRateRiskMember 2023-12-31 0001565025 ifrs-full:InterestRateRiskMember 2022-12-31 0001565025 abev:InterestRateRiskWorkingCapitalinArgentineanPesoMember 2023-12-31 0001565025 abev:InterestRateRiskWorkingCapitalinArgentineanPesoMember 2022-12-31 0001565025 abev:OtherCurrenciesMember 2023-12-31 0001565025 abev:OtherCurrenciesMember 2022-12-31 0001565025 abev:InterestRateRiskUSDollarsMember 2023-12-31 0001565025 abev:InterestRateRiskUSDollarsMember 2022-12-31 0001565025 abev:InterestRateRiskCanadianDollarsMember 2023-12-31 0001565025 abev:InterestRateRiskCanadianDollarsMember 2022-12-31 0001565025 abev:CommoditiesHedgeMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:CommoditiesHedgeMember abev:CommoditiesRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:CommoditiesHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:CommoditiesHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignExchangeRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignExchangeRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:CommoditiesAndForeignExchangeHedgesMember abev:TotalCostExposureMember 2023-12-31 0001565025 abev:CommoditiesAndForeignExchangeHedgesMember abev:TotalCostExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyRiskPortionOfFixedAssetsExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyRiskPortionOfFixedAssetsExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalFixedAssetExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalFixedAssetExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CashEffectsPortionOfExpensesExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:CashEffectsPortionOfExpensesExposureMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesCashMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:ForeignCurrencyExchangeRiskPortionOfExpensesCashMember 2023-01-01 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalCashEffectsExposureMember 2023-12-31 0001565025 abev:ForeignCurrencyExchangeHedgeMember abev:TotalCashEffectsExposureMember 2023-01-01 2023-12-31 0001565025 ifrs-full:CarryingAmountMember 2023-12-31 0001565025 abev:ContractualCashFlowsMember 2023-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember 2023-12-31 0001565025 ifrs-full:CarryingAmountMember 2022-12-31 0001565025 abev:ContractualCashFlowsMember 2022-12-31 0001565025 ifrs-full:NotLaterThanOneYearMember 2022-12-31 0001565025 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2022-12-31 0001565025 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2022-12-31 0001565025 ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember 2022-12-31 0001565025 ifrs-full:LaterThanFiveYearsMember 2022-12-31 0001565025 abev:LaterThanTwoYearsMember 2023-12-31 0001565025 abev:LaterThanTwoYearsMember 2022-12-31 0001565025 abev:FundacaoZerrennerMember 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember 2022-01-01 2022-12-31 0001565025 abev:FundacaoZerrennerMember abev:ActiveEmployeesMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember abev:RetireesMember 2023-01-01 2023-12-31 0001565025 abev:FundacaoZerrennerMember abev:ActiveEmployeesMember 2022-01-01 2022-12-31 0001565025 abev:FundacaoZerrennerMember abev:RetireesMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschIncMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschIncMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschIncMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschPackageMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschProcurementMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2023-01-01 2023-12-31 0001565025 abev:BavariaSaMember 2023-01-01 2023-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2023-01-01 2023-12-31 0001565025 abev:CerveceriaPeruanasMember 2023-01-01 2023-12-31 0001565025 abev:InbevBelgiumNvMember 2023-01-01 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2023-01-01 2023-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2023-01-01 2023-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschPackageMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschProcurementMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2022-01-01 2022-12-31 0001565025 abev:AmbevPeruMember 2022-01-01 2022-12-31 0001565025 abev:BavariaSaMember 2022-01-01 2022-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2022-01-01 2022-12-31 0001565025 abev:CerveceriaPeruanasMember 2022-01-01 2022-12-31 0001565025 abev:InbevBelgiumNvMember 2022-01-01 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-01-01 2022-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2022-01-01 2022-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschPackageMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschProcurementMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2021-01-01 2021-12-31 0001565025 abev:AmbevPeruMember 2021-01-01 2021-12-31 0001565025 abev:BavariaSaMember 2021-01-01 2021-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2021-01-01 2021-12-31 0001565025 abev:CerveceriaPeruanasMember 2021-01-01 2021-12-31 0001565025 abev:InbevBelgiumNvMember 2021-01-01 2021-12-31 0001565025 abev:InterbrewInternationalBvMember 2021-01-01 2021-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2021-01-01 2021-12-31 0001565025 abev:AnheuserBuschAfricaMember 2023-12-31 0001565025 abev:AnheuserBuschAfricaMember 2022-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2023-12-31 0001565025 abev:AnheuserBuschInBevNvMember 2022-12-31 0001565025 abev:AnheuserBuschInbevServicesLlcMember 2023-12-31 0001565025 abev:AnheuserBuschInbevServicesLlcMember 2022-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2023-12-31 0001565025 abev:AnheuserBuschInbevUsaLlcMember 2022-12-31 0001565025 abev:BavariaSaMember 2023-12-31 0001565025 abev:BavariaSaMember 2022-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2023-12-31 0001565025 abev:CerveceriaModeloDeMexicoSDeRlDeCvMember 2022-12-31 0001565025 abev:CerveceriaPeruanasMember 2023-12-31 0001565025 abev:CerveceriaPeruanasMember 2022-12-31 0001565025 abev:InbevBelgiumNvMember 2023-12-31 0001565025 abev:InbevBelgiumNvMember 2022-12-31 0001565025 abev:PanamaHoldingMember 2023-12-31 0001565025 abev:PanamaHoldingMember 2022-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2023-12-31 0001565025 ifrs-full:OtherRelatedPartiesMember 2022-12-31 0001565025 abev:AnheuserBuschPackageMember 2023-12-31 0001565025 abev:AnheuserBuschPackageMember 2022-12-31 0001565025 abev:InterbrewInternationalBvMember 2023-12-31 0001565025 abev:InterbrewInternationalBvMember 2022-12-31 0001565025 abev:ExercisePUTCNDMember 2023-01-01 2023-12-31 0001565025 2024-01-31 0001565025 abev:NonadjustingEventMember 2024-02-28 2024-02-29 iso4217:BRL shares iso4217:BRL shares pure iso4217:USD utr:D false 2023 FY 0001565025 20-F false true 2023-12-31 --12-31 false false 001-36165 AMBEV S.A. Rua Dr. Renato Paes de Barros, 1017, 3rd floor 04530-001 São Paulo BR Lucas Machado Lira Rua Dr. Renato Paes de Barros, 1017, 3rd floor 04530-001 São Paulo BR 55 2122-1200 American Depositary Shares, NYSE ABEV 15753833284 Yes No Yes Yes Large Accelerated Filer false true false International Financial Reporting Standards false 1351 PricewaterhouseCoopers Auditores Independentes Ltda. São Paulo 79736900000 79708800000 72854300000 39291600000 40422100000 35659700000 40445300000 39286700000 37194600000 10750600000 11395300000 9932700000 7412500000 7337400000 7035500000 5273700000 5236800000 4877400000 2028900000 2513900000 2124100000 -206400000 -143300000 -392800000 18831000000.0 17687800000 17080300000 6280100000 7892200000 5427800000 2670300000 4469100000 2222400000 -3609800000 -3423100000 -3205400000 -185300000 -29100000 -115700000 15035900000 14235600000 13759200000 75500000 -655600000 636600000 14960400000 14891200000 13122600000 14501900000 14457900000 12671000000.0 458500000 433300000 451600000 0.9211 0.9184 0.8052 0.9156 0.9123 0.7991 14960400000 14891200000 13122600000 302600000 203800000 193600000 -9637000000.0 -7067000000.0 2364400000 -9334400000 -6863200000 2558000000.0 -364700000 38000000.0 2311200000 -152600000 356700000 1829900000 -212100000 -318700000 481300000 -12500000 470700000 340000000.0 -9559000000.0 -6711200000 3379300000 5401400000 8180000000.0 16501900000 5065500000 7835500000 15943300000 335900000 344500000 558600000 26630200000 30055700000 38003600000 40594000000.0 10041700000 9222200000 289100000 331900000 242200000 219100000 7969600000 6438800000 57300000 56600000 1700000 1500000 11325100000 11316300000 1520700000 1905200000 96081200000 100141300000 277200000 454500000 9619000000.0 12923000000.0 5741500000 5349100000 378000000.0 272300000 3435700000 2853500000 1052700000 1037900000 16059000000.0 14926400000 36563100000 37816700000 132644300000 137958000000.0 58177900000 58130500000 98669400000 92246600000 77878000000.0 68421500000 78969300000 81955600000 1174500000 1372200000 80143800000 83327800000 2203000000.0 2788100000 2011800000 2161100000 11700000 3318400000 3725700000 1487100000 1598700000 513300000 671000000.0 307300000 509400000 559600000 739000000.0 1083200000 1896800000 11495400000 14089800000 74300000 1298100000 982600000 2128700000 2335800000 1526200000 1464800000 751400000 729400000 1340500000 1118600000 6236600000 5812900000 23195100000 24328500000 418400000 180700000 4110100000 3512800000 41005100000 40540400000 52500500000 54630200000 132644300000 137958000000.0 57899100000 57899100000 54985600000 54985600000 25920000000.0 25920000000.0 -64989000000.0 -64989000000.0 73815700000 73815700000 1335500000 1335500000 75151200000 75151200000 12671000000.0 12671000000.0 451600000 13122600000 2449700000 2449700000 108300000 2558000000.0 480800000 480800000 500000 481300000 341800000 341800000 -1800000 340000000.0 12671000000.0 3272300000 15943300000 558600000 16501900000 143400000 -134400000 9000000.0 9000000.0 2063700000 2063700000 21400000 2085100000 -1900000 -1900000 -1900000 -46200000 -46200000 8600000 -37600000 1700000 1700000 1700000 2099500000 2099500000 549500000 2649000000.0 -7400100000 -7400100000 -7400100000 336000000.0 336000000.0 336000000.0 24700000 24700000 24700000 11800000 -11800000 1423500000 -1423500000 3848100000 -3848100000 58042500000 58042500000 55187200000 55187200000 31191600000 31191600000 -61778300000 -61778300000 82643000000.0 82643000000.0 1374600000 1374600000 84017600000 84017600000 58042500000 58042500000 55187200000 55187200000 31191600000 31191600000 -61778300000 -61778300000 82643000000.0 82643000000.0 1374600000 1374600000 84017600000 84017600000 14457900000 14457900000 433300000 14891200000 -6772200000 -6772200000 -91000000.0 -6863200000 -316700000 -316700000 -2000000.0 -318700000 466500000 466500000 4200000 470700000 14457900000 -6622400000 7835500000 344500000 8180000000.0 88000000.0 -64300000 23700000 23700000 3224500000 3224500000 9200000 3233700000 -2800000 -2800000 -300000 -3100000 6200000 6200000 6200000 357400000 357400000 -11999800000 -11999800000 -11999800000 216800000 216800000 1600000 218400000 20900000 20900000 20900000 11800000 -11800000 2018600000 -2018600000 3696700000 -3696700000 58130500000 58130500000 55339700000 55339700000 36906900000 36906900000 -68421500000 -68421500000 81955600000 81955600000 1372200000 1372200000 83327800000 83327800000 58130500000 58130500000 55339700000 55339700000 36906900000 36906900000 -68421500000 -68421500000 81955600000 81955600000 1372200000 1372200000 83327800000 83327800000 14501900000 14501900000 458500000 14960400000 -9212400000 -9212400000 -122000000.0 -9334400000 -210800000 -210800000 -1300000 -212100000 -13200000 -13200000 700000 -12500000 14501900000 -9436400000 5065500000 335900000 5401400000 47400000 -32900000 14500000 14500000 3269400000 3269400000 8500000 3277900000 6700000 6700000 6700000 -2600000 -2600000 -2600000 12400000 12400000 12400000 543900000 543900000 -11500200000 -11500200000 -11500200000 172800000 172800000 1800000 174600000 11800000 -11800000 2552700000 -2552700000 3730200000 -3730200000 58177900000 58177900000 55479600000 55479600000 43189800000 43189800000 -77878000000.0 -77878000000.0 78969300000 78969300000 1174500000 1174500000 80143800000 80143800000 14960400000 14891200000 13122600000 6417900000 5956300000 5396700000 358400000 351800000 200800000 233800000 232700000 244600000 -3609800000 -3423100000 -3205400000 86400000 88800000 142800000 331600000 313900000 387600000 75500000 -655600000 636600000 -185300000 -29100000 -115700000 37900000 466600000 1852200000 -9000000.0 -17400000 26039400000 23969700000 21315000000.0 -1373900000 -322500000 341400000 1300900000 -3088000000.0 -3499500000 -223100000 726600000 6157500000 25743300000 21285800000 24314400000 666100000 826300000 498200000 1248300000 1095000000.0 377100000 12900000 6600000 13100000 1627000000.0 919000000.0 1305100000 24711400000 20642100000 22901300000 154100000 133900000 301700000 500000 6004100000 6533100000 7677100000 46500000 3000000.0 133800000 6300000 30000000.0 5300000 136400000 1413000000.0 -236000000.0 400000 15000000.0 15000000.0 -5766000000.0 -5004200000 -7735000000.0 14500000 23800000 9100000 -119000000.0 -54100000 -44200000 100000 49800000 274900000 315200000 227400000 230200000 2454000000.0 2731100000 3255100000 2089600000 1180100000 854700000 663200000 11921900000 12242300000 11115300000 -16115200000 -16337800000 -16042000000.0 2830200000 -699900000 -875700000 14852100000 16597200000 17090300000 -1623300000 -1045200000 382600000 16059000000.0 14852100000 16597200000 <p id="xdx_805_ecustom--DescriptionOfCorporateInformationTextBlock_zhztycduFKql" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span id="a_006"></span><b>1.</b></td><td style="text-align: justify"><b><span id="xdx_828_zfYAgWp00dU6">CORPORATE INFORMATION</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1.1 Description of business</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ambev S.A. (referred to as the “Company” or “Ambev”) together with its subsidiaries (the “Group” or “Consolidated”), headquartered in São Paulo - SP, Brazil, has as its purpose, either directly or through participation in other companies, the production and sale of beer, draft beer, soft drinks, other non-alcoholic beverages, malt and food in general, as well as the advertising of its own and of third party products, the sale of promotional and advertising materials and the direct or indirect exploitation of bars, restaurants, snack bars and similar establishments, among others.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Group portfolio includes several own brands, like Brahma®, Skol®, Antarctica®, Colorado®, Bohemia®, Serramalte®, Quilmes®, Patagonia®, Guaraná Antarctica®, Beats® among others, and licensed brands, like Budweiser®, Corona®, Stella Artois®, Spaten® Beck’s® and Mike’s®.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s shares and American Depositary Receipts (“ADRs”) are listed on the Brasil, Bolsa, Balcão S.A. (“B3”), under the ticker “ABEV3” and on the New York Stock Exchange (“NYSE”) under the ticker “ABEV”, respectively.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s direct controlling shareholders are Interbrew International B.V. (“ITW International”), AmBrew S.à.r.l (“Ambrew”), both of which are subsidiaries of Anheuser-Busch InBev N.V. (“AB InBev”) and Fundação Antonio e Helena Zerrenner Instituição Nacional de Beneficência (“Fundação Zerrenner”).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1.2 Major corporate events in 2023, 2022 and 2021</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>1.2.1 Notification of ELJ to exercise the put option under the Tenedora Shareholders' Agreement</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and E. León Jimenes, S.A. (“ELJ”), as the shareholders of Tenedora CND, S.A. (“Tenedora”), a holding company headquartered in the Dominican Republic, the owner of almost the entire share capital of Cervecería Nacional Dominicana, S.A., on July 2, 2020, signed the second amendment to Tenedora’s Shareholders Agreement (the “Shareholders Agreement”), extending their partnership in the country and postponing the terms of the put and call options defined in the original Agreement. At December 31, 2023, ELJ was the owner of <span id="xdx_90A_ecustom--PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock_iI_pip0_dp_c20231231__ifrs-full--CounterpartiesAxis__custom--TenedoraMember__dei--LegalEntityAxis__custom--ELJMember_z2WAbL80fLgb" title="Put options exercisable number of shares percent of outstanding stock">15</span>% of Tenedora’s shares, and its put option was divided into two tranches: (i) Tranche A, corresponding to <span id="xdx_90D_ecustom--PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock_iI_pip0_dp_c20231231__ifrs-full--CounterpartiesAxis__custom--TenedoraMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--TrancheAMember__dei--LegalEntityAxis__custom--ELJMember_zXvlFwpKRlHi" title="Put options exercisable number of shares percent of outstanding stock">12.11</span>% of the shares, as formalized in the Shareholders' Agreement and ratified by the notification received from ELJ on October 2023, Tranche A was exercised at January 31, 2024; and (ii) Tranche B, corresponding to <span id="xdx_90A_ecustom--PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock_iI_pip0_dp_c20231231__ifrs-full--CounterpartiesAxis__custom--TenedoraMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--TrancheBMember__dei--LegalEntityAxis__custom--ELJMember_zBoabM8fnjM6" title="Put options exercisable number of shares percent of outstanding stock">2.89</span>% of the shares, exercisable starting in 2026. The Company, on the other hand, has a call option over Tranche B shares to be exercised starting in 2029. The details about the the exercise of the put option by ELJ are described in Note 31 - <i>Events after the reporting period</i>. The assumptions used for these options are described in Note 28 (Item 28.3.1).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1.2.2 New distribution agreement of Corona in Canada</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As at December 2023, the Company renegotiated the licensing contract with Trademarks Grupo Modelo, S. de R.L. de C.V., <span style="color: black">subsidiary of the AB Inbev, </span>to produce, promote, sell and distribute Corona products in Canada. As consideration for acquired rights, for a period of 100 years, automatically renewable for another 100, the Labatt Brewing Company Limited, <span style="color: black">subsidiary of the Company in Canada, shall pay the licensor a single payment of R$<span id="xdx_90D_eifrs-full--EmployeeBenefitsExpense_pn6n6_c20230101__20231231__dei--LegalEntityAxis__custom--GrupoModeloMember_z77KwxP7chSh" title="Payment for license">869</span> million. The amount relating to acquired right was recognized in 2023 as a commercial asset in intangible assets.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1.2.3 Tax Credits – 2022 and 2023</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">After the decision of the Supreme Federal Court ("STF") in the judgment of RE 574,706/PR, delivered in 2017 and ratified in May 2021, which declared unconstitutional the inclusion of ICMS in the calculation basis of PIS and COFINS, in September 2021 the National Treasury Attorney's Office ("PGFN") published Opinion PGFN 14,483/2021 in which it brought the agency's understanding about the procedures to be observed by the Tax Administration regarding the subject, especially regarding the impacts of said exclusion on the PIS and COFINS credits recorded by the acquirers in inbound operations. As a result of these events, the Company concluded in 2022 analyses that allowed the accounting recognition of R$<span id="xdx_905_ecustom--TaxEffectOfTaxLoss_pn8n9_c20210501__20210531_ztsONS97Gq65" title="Tax credits">1.2</span> billion, in the same period, as tax credits resulting from the exclusion of ICMS from the calculation basis of PIS and COFINS in operations with subsidiaries.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Furthermore, on December 13, 2023, the Superior Court of Justice ("STJ") concluded the judgment of Theme 1,125, confirming the understanding that ICMS collected under the substitution tax system should also be excluded from the calculation bases of PIS and COFINS of the taxpayer's substitutes. The judgment of this decision is still pending publication. Regarding this subject, from 2017 to 2023, the Company and its subsidiaries recognized tax credits in the amount of R$<span id="xdx_906_eifrs-full--TaxEffectFromChangeInTaxRate_pn8n9_c20230101__20231231_z8aS8hxi8lsb" title="Recognized tax credits">1.4</span> billion, having been approximately R$<span id="xdx_909_ecustom--TaxEffectFromChangeInTaxRates_pn5n6_c20230101__20231231_zw93SlZERsGk" title="Recognized tax credits">407.1</span> million recognized as extemporaneous credits in 2023 (R$<span id="xdx_902_eifrs-full--OperatingExpense_pn6n6_c20230101__20231231_zQzNkL9suq3e" title="Other operating income">218</span> million were recorded in other operating income and R$<span id="xdx_901_eifrs-full--InsuranceFinanceIncomeExpenses_pn5n6_c20230101__20231231_z5p4SmG6EVOi" title="Finance expenses">189.1</span> million in the finance result).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>1.2.4 Share buyback program</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Board of Directors, in a meeting held on May 18, 2023, approved, pursuant to article 30, 1<sup>st</sup> Paragraph, “b”, of Law 6,404/76 and CVM Instruction 77/22, a share buyback program by the Company (“Program”) up to the limit of <span id="xdx_908_ecustom--StockRepurchaseProgramSharesAuthorized_iI_pip0_c20230518__ifrs-full--CounterpartiesAxis__custom--BoardOfDirectorsMember_zwN624FRV62d" title="Stock repurchase program shares authorized">13,000,000</span> common shares, with the primary purpose of covering any share delivery requirements contemplated in the Company's share-based compensation plans or to be held in treasury, canceled and/or subsequently transferred. The program must be concluded no later than November 18, 2024, as detailed together with other information about it in the Notice on Trading of Own Shares, prepared under the terms of Annex G to CVM Resolution 80/22 and disclosed to market on May 18, 2023. At the same date, the Company had <span id="xdx_909_eifrs-full--IncreaseDecreaseInNumberOfSharesOutstanding_pip0_c20230517__20230518__ifrs-full--CounterpartiesAxis__custom--BoardOfDirectorsMember_zFNgXyyFY4Gi" title="Shares outstanding">4,393,610,429</span> outstanding shares as defined in CVM Instruction 77/22. The acquisitions occurred as per a deduction of the capital reserve account recorded in the balance sheets dated as at March 31, 2023. The transaction was carried out through the following financial institution: <i>UBS Brasil Corretora de Câmbio, Títulos e Valores Mobiliários S.A.</i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>1.2.5 COVID-19 pandemic impacts</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-right: 0; margin-left: 0">The impact of the pandemic on our operations and the restrictions imposed in response by national governments, especially since March 2020, have generated significant changes in market dynamics both in the off-trade sales channel, mainly comprised of supermarkets, and in the on-trade channel, which consists of bars and restaurants. In each case, the more severe the restrictions on the marketing and consumption of our products, the greater the reduction in volume, which is why Bolivia and Panama were the most affected countries, especially in fiscal year 2021. On the other hand, we observed an increase in sales related to e-commerce in all countries, although this channel represents a small portion of the Company’s total volume.</p> <p style="font: 11pt Times New Roman, Times, Serif; text-align: justify; margin-right: 0; margin-left: 0">In early 2022, our operations, mainly in Brazil, were impacted by the wave of the Omicron variant of COVID-19, which, combined with factors such as unfavorable weather, negatively impacted our sales. From the second quarter on, with the progress of the vaccination programs and the greater control over the advance of the COVID-19 pandemic, there was a relaxation of the restrictions in the regions in which we operate, favoring the recovery of the on-trade channel.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In Brazil, the consistent implementation of the Company's strategy combined with the context of relaxed restrictions and the return of occasions for out-of-home consumption generated a positive volume trend, with growth in both volume and net revenue compared to the same 2021 period.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As required by IAS 1 - <i>Presentation of Financial Statements</i>, the Company updated the analysis of the impact of COVID-19, as at December 31,2022 – last year of the pandemic – which mainly involved, (i) a review of the assumptions of the annual impairment test, as described in Note 15 - <i>Goodwill</i>, (ii) an analysis of possible credit losses and inventory obsolescence, (iii) an analysis of the recoverability of deferred taxes, and (iv) the evaluation of the relevant estimates used for the preparation of the financial statements, among other analyses.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any impacts arising from these analyses are reflected in the financial statements and disclosed in explanatory notes. In addition, due to the protective actions taken for its staff and the donations made by its community, the Company incurred exceptional expenses of R$16.7 at December 31, 2022 as reported in Note 8 - <i>Exceptional items</i>.</p> 0.15 0.1211 0.0289 869000000 1200000000 1400000000 407100000 218000000 189100000 13000000 4393610429 <p id="xdx_802_eifrs-full--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_zlPchJJ9VsXk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span id="a_007"></span><b>2.</b></td><td style="text-align: justify"><b><span id="xdx_822_zl16Bw545o3">BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements have been prepared using the going concern basis of accounting and are being presented in accordance with the International Financial Reporting Standards (“IFRS®”) issued by the International Accounting Standards Board (“IASB®”), effective as at December 31, 2023 and disclose all (and only) the applicable significant information related to the financial statements, which is consistent with the information utilized by Management in the performance of its duties.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The measurement basis used in preparing the financial statements is the historical cost, net realizable value, fair value or recoverable amount.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the financial statements, management uses judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets, liabilities, income and expenses. The relevant estimates and judgments are disclosed in Note 4 - <i>Use of estimates and judgments</i>.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements were approved, in their final form, by the Board of Directors on March 11, 2024.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>2.1 Functional and presentation currency</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The functional and presentation currency of the Company financial statements is the Brazilian Real, which is the currency of its main economic operating environment. For presentation purposes, the financial statements are presented in millions of Brazilian Reais (“R$”), unless otherwise indicated, rounded to the nearest million.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Foreign currency transactions are accounted for at the exchange rates prevailing as at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies are translated using the balance sheet date rate. Non-monetary assets and liabilities denominated in foreign currencies are translated at the foreign exchange rate prevailing as at the date of the transaction. Non-monetary assets and liabilities denominated in foreign currencies stated at fair value are translated at the exchange rate in force as at the date on which the fair value was determined. Gains and losses arising from the settlement of transactions in foreign currencies and resulting from the conversion of assets and liabilities denominated in foreign currencies are recognized in the income statement.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Assets and liabilities of subsidiaries located abroad are translated at the foreign exchange rates prevailing at the balance sheet date, while amounts from the income statement and cash flow are translated at the average exchange rate for the year, and changes in equity are translated at the historical exchange rate of each transaction. Translation adjustments arising from the difference between the average exchange rates and the historical rates are recorded directly in Carrying value adjustments.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the consolidation process, exchange differences arising from the translation of equity in foreign operations and borrowing and other currency instruments designated as net investment hedges are recognized in Carrying value adjustments, an equity reserve, and included in Other comprehensive income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Even when recorded in the acquiring entity, the goodwill and fair value adjustments arising from the acquisition of a foreign entity are treated as assets and liabilities of the foreign entity and are translated at the foreign exchange rate at the balance sheet date.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>2.1.1 Exchange rates</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The most significant exchange rates used for the preparation of the Company’s financial statements are as follow:</p> <p style="font: 11pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eifrs-full--DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_pn5n6_zbniUnwopgAj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zY67v2isZ1D8" style="display: none">Schedule of exchange rates</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Closing rate</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Average rate</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Currency</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Name</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Country</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2021</b></span></td></tr> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">CAD</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Canadian Dollar</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Canada</span></td> <td id="xdx_981_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_z3n0mkAk57Bj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.6536 </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_zahsKRX4Rc83" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.8540 </span></td> <td id="xdx_98E_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_z7VZrSc8cRtl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">4.3914 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_zPK6tAapn54d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.7048 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_zq6j3rsSkkVa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.9807 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_z0zFF8ewFOr6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">4.2960 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">DOP</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Dominican Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Dominican Republic</span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_z55j8kQDirhk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0831 </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zPiawrgh3X6h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0925 </span></td> <td id="xdx_983_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zqYQjVTujuL6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0970 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zGsGqdwyqBn1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0892 </span></td> <td id="xdx_989_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zxEi8L1KwsAc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0937 </span></td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zz9vVisfejS3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0938 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">USD</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">US Dollar</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Panamá and Cuba</span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_z6wB3unHigii" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">4.8413 </span></td> <td id="xdx_989_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zirqq6HDO9r7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.2177 </span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zOp0Jjsg3pnk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.5805 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zz6ppAeOqcHc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.0085 </span></td> <td id="xdx_988_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zvdLiHePcOQf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.1644 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_z0lZU9kO89Yk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.3687 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">GTQ</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Quetzal</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Guatemala</span></td> <td id="xdx_98B_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zvt9XekVahNf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6189 </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zP3BvYB7s9Q3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6623 </span></td> <td id="xdx_986_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zymQRGAQRutf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7201 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zzDP1TmmWFuk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6398 </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zKjWROneTAX6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6649 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zkAW9g8nLykd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6954 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ARS</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Argentinean Peso </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Argentina</span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zydxSKRGPz36" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0060 </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zTpVBVZUAC6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0295 </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zycwZ5m515ya" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0543 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zaaWz7qkwqkh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0170 </span></td> <td id="xdx_983_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zuQkB7DlzwV3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0403 </span></td> <td id="xdx_986_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zuvVkeOWFble" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0568 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">BOB</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Bolivian Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Bolivia</span></td> <td id="xdx_986_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_zV6pklwMtARb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6956 </span></td> <td id="xdx_989_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_zlgWPIoo99Ke" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7497 </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_zMWDpEJoNree" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.8018 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_ziu35jzKL23c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7196 </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_ze71KlHGT4la" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7420 </span></td> <td id="xdx_987_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_ziLh6nd9RZt7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7714 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">PYG</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Guarani</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Paraguay</span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_z8iAywk7kd1i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zEAIOgLONHtj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_98E_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zdXJb1sC7eBi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0008 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zxvqTCWfD6uj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zMZhadg4Iz68" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zLoaWjWFa87c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0008 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">UYU</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Uruguayan Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Uruguay</span></td> <td id="xdx_982_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zRtcCK7Avdn9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1241 </span></td> <td id="xdx_98C_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zXLnv5EItVic" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1302 </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zsxzrePjyrOf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1249 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zn94m3GWdQc9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1291 </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zz30XPfnZHb7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1253 </span></td> <td id="xdx_98A_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zMN6JznQnue7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1236 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">CLP</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Chilean Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Chile</span></td> <td id="xdx_98D_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_z9rc6C9qH8nc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0055 </span></td> <td id="xdx_98B_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zrX2yruplkn4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0061 </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zf6b208LYwH1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0066 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zjP2u9aIjXY4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0059 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zai3uue77Epj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0059 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_z8v2TXdYYemj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0071 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">BBD</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Barbadian Dollar</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Barbados</span></td> <td id="xdx_988_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zN6vgOSDb6Dh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.3866 </span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zeel9EBsPSG3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.5721 </span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_ziXmOHFyUvpi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.7510 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_z8gNZcKeGiw5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.4690 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zRajvLrxvTWh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.5458 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zAwR3WMgEuJ9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.6465 </span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eifrs-full--DisclosureOfEffectOfChangesInForeignExchangeRatesExplanatory_pn5n6_zbniUnwopgAj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - BASIS OF PREPARATION AND PRESENTATION OF THE FINANCIAL STATEMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zY67v2isZ1D8" style="display: none">Schedule of exchange rates</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Closing rate</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Average rate</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Currency</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Name</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Country</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2021</b></span></td></tr> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">CAD</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Canadian Dollar</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Canada</span></td> <td id="xdx_981_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_z3n0mkAk57Bj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.6536 </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_zahsKRX4Rc83" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.8540 </span></td> <td id="xdx_98E_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_z7VZrSc8cRtl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">4.3914 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_zPK6tAapn54d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.7048 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_zq6j3rsSkkVa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.9807 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--CanadianDollarsSpentInCanadaAndCubaMember_z0zFF8ewFOr6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">4.2960 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">DOP</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Dominican Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Dominican Republic</span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_z55j8kQDirhk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0831 </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zPiawrgh3X6h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0925 </span></td> <td id="xdx_983_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zqYQjVTujuL6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0970 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zGsGqdwyqBn1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0892 </span></td> <td id="xdx_989_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zxEi8L1KwsAc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0937 </span></td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DominicanPesosSpentInTheDominicanRepublicMember_zz9vVisfejS3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0938 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">USD</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">US Dollar</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Panamá and Cuba</span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_z6wB3unHigii" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">4.8413 </span></td> <td id="xdx_989_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zirqq6HDO9r7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.2177 </span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zOp0Jjsg3pnk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.5805 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zz6ppAeOqcHc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.0085 </span></td> <td id="xdx_988_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_zvdLiHePcOQf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.1644 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--USDollarsSpentInPanamaAndCubaMember_z0lZU9kO89Yk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.3687 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">GTQ</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Quetzal</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Guatemala</span></td> <td id="xdx_98B_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zvt9XekVahNf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6189 </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zP3BvYB7s9Q3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6623 </span></td> <td id="xdx_986_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zymQRGAQRutf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7201 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zzDP1TmmWFuk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6398 </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zKjWROneTAX6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6649 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--QuetzalSpentInGuatemalaMember_zkAW9g8nLykd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6954 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ARS</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Argentinean Peso </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Argentina</span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zydxSKRGPz36" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0060 </span></td> <td id="xdx_984_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zTpVBVZUAC6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0295 </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zycwZ5m515ya" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0543 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zaaWz7qkwqkh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0170 </span></td> <td id="xdx_983_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zuQkB7DlzwV3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0403 </span></td> <td id="xdx_986_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ArgentineanPesoSpentInArgentinaMember_zuvVkeOWFble" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0568 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">BOB</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Bolivian Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Bolivia</span></td> <td id="xdx_986_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_zV6pklwMtARb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.6956 </span></td> <td id="xdx_989_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_zlgWPIoo99Ke" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7497 </span></td> <td id="xdx_987_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_zMWDpEJoNree" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.8018 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_ziu35jzKL23c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7196 </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_ze71KlHGT4la" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7420 </span></td> <td id="xdx_987_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--BolivianPesoSpentInBoliviaMember_ziLh6nd9RZt7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7714 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">PYG</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Guarani</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Paraguay</span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_z8iAywk7kd1i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zEAIOgLONHtj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_98E_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zdXJb1sC7eBi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0008 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zxvqTCWfD6uj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zMZhadg4Iz68" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0007 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--GuaraniSpentInParaguaiMember_zLoaWjWFa87c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0008 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">UYU</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Uruguayan Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Uruguay</span></td> <td id="xdx_982_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zRtcCK7Avdn9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1241 </span></td> <td id="xdx_98C_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zXLnv5EItVic" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1302 </span></td> <td id="xdx_985_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zsxzrePjyrOf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1249 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zn94m3GWdQc9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1291 </span></td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zz30XPfnZHb7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1253 </span></td> <td id="xdx_98A_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UruguayanPesoSpentInUruguayMember_zMN6JznQnue7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1236 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">CLP</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Chilean Peso</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Chile</span></td> <td id="xdx_98D_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_z9rc6C9qH8nc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0055 </span></td> <td id="xdx_98B_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zrX2yruplkn4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0061 </span></td> <td id="xdx_98F_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zf6b208LYwH1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0066 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zjP2u9aIjXY4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0059 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_zai3uue77Epj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0059 </span></td> <td id="xdx_982_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ChileanPesoSpentInChileMember_z8v2TXdYYemj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.0071 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">BBD</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Barbadian Dollar</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Barbados</span></td> <td id="xdx_988_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20231231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zN6vgOSDb6Dh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.3866 </span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20221231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zeel9EBsPSG3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.5721 </span></td> <td id="xdx_980_eifrs-full--ClosingForeignExchangeRate_iI_pip0_uPure_c20211231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_ziXmOHFyUvpi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Closing rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.7510 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20230101__20231231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_z8gNZcKeGiw5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.4690 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20220101__20221231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zRajvLrxvTWh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.5458 </span></td> <td id="xdx_98B_eifrs-full--AverageForeignExchangeRate_pip0_uPure_c20210101__20211231__ifrs-full--SegmentsAxis__custom--BarbadianDollarSpentInBarbadosMember_zAwR3WMgEuJ9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Average rate"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2.6465 </span></td></tr> </table> 3.6536 3.8540 4.3914 3.7048 3.9807 4.2960 0.0831 0.0925 0.0970 0.0892 0.0937 0.0938 4.8413 5.2177 5.5805 5.0085 5.1644 5.3687 0.6189 0.6623 0.7201 0.6398 0.6649 0.6954 0.0060 0.0295 0.0543 0.0170 0.0403 0.0568 0.6956 0.7497 0.8018 0.7196 0.7420 0.7714 0.0007 0.0007 0.0008 0.0007 0.0007 0.0008 0.1241 0.1302 0.1249 0.1291 0.1253 0.1236 0.0055 0.0061 0.0066 0.0059 0.0059 0.0071 2.3866 2.5721 2.7510 2.4690 2.5458 2.6465 <p id="xdx_80E_ecustom--DisclosuresOfSummaryOfSignificantAccountingPoliciesExplanatory_zrjErq1cLd3d" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><b><span id="a_008"></span>3.</b></td><td><b><span id="xdx_82A_zrvevSoYJBY4">SUMMARY OF MATERIAL ACCOUNTING POLICIES</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting practices adopted by the Company are consistent in all the years presented. There were no changes in accounting policies and in calculation methods used for the annual financial statements as at December 31, 2023, compared to those presented in the financial statements for the years ended December 31, 2022, and 2021.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For better understanding, the material accounting policies adopted by the Company and applied in the preparation of these financial statements have been included in the respective accompanying notes, except for the policies described below, which may permeate more than one subject of the financial statements and have therefore been summarized in this accompanying note.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_846_ecustom--DescriptionOfAccountingPolicyForNewIFRSRelasesTextBlock_zq6dABfDH0O1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.1 <span id="xdx_863_zD8LPKTaT4od">Recently issued IFRS</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The new standards, which became effective are not applicable or did not have any material impact for the Company for the preparation of these consolidated financial statements. Below are the main changes in accounting standards which, in management's opinion, could have an impact on the Company's subsequent disclosures:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-size: 11pt">(i)</span></td><td style="text-align: justify"><span style="font-size: 11pt">On May 25, 2023, the IASB® published amendments to IAS 7 – <i>Statement of Cash Flows</i> and IFRS 7 – <i>Financial Instruments: Disclosures</i>, which establish new disclosure requirements for financing transactions with suppliers, the so-called "drawn risk". These requirements must be adopted by companies that adhere to the IFRS® as of 2024. The Company is evaluating the impacts of these changes, for any additional corresponding disclosures in future individual and consolidated financial statements, even though these transactions are not material to the Group, as disclosed in note 26 – <i>Trade payables</i>.</span></td></tr></table> <p style="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-size: 11pt">(ii)</span></td><td style="text-align: justify"><span style="font-size: 11pt">In August 2023, the IASB® issued amendments to IAS 21 – <span style="color: black"><i>The Effects of Changes in Foreign Exchange Rates</i>. </span>The modifications implemented will require the application of a consistent approach when assessing whether a currency can be exchanged for another currency and, when it cannot, determining the exchange rate to be used, and the related disclosures. The Company is evaluating the impacts of these standards, the adoption of which is required for fiscal years beginning on January 1, 2025.</span></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-size: 11pt">(iii)</span></td><td style="text-align: justify"><span style="font-size: 11pt">In December 2021, the Organisation for Economic Cooperation and Development ("OECD"), as part of the Inclusive Framework on Base Erosion and Profit Shifting ("BEPS") project, released the Pillar Two model rules (or Global Anti-Base Erosion Model Rules - GloBE), aiming at a common approach to international corporate taxation, in order to ensure that multinational economic groups within the scope of these rules calculate taxes on profit at a minimum effective rate of 15% in each country where they operate. These rules will have to be approved locally in each country that adheres the proposal, via applicable legislation, some of which have already promulgated new laws or are in the process of discussing and approving them. In May 2023, the IASB® issued scope changes to IAS 12 – <i>Income Taxes</i> to allow a temporary exemption in accounting for deferred income taxes arising from promulgated or substantially promulgated legislation implementing OECD Pillar Two, an exemption which has been adopted by the Group. Considering the legislation already published in the countries in which the Company operates, the Company has estimated the impacts on the 2023 financial statements and the amount is not material.</span></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition of these, the Company does not anticipate that there are any other standards or amendments to IFRS® standards or IFRIC interpretations that have not come into force yet and that could have a significant impact on the Group's individual and consolidated financial statements.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForTheBasisOfConsolidationTextBlock_zXnxTlEPuBtb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>3.2 <span id="xdx_868_z9L8HV7VuSah">Consolidated financial statements</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements of subsidiaries, joint arrangements and associates used in these consolidated financial statements are prepared for the same reporting period as Ambev, using a consistent accounting policy.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany transactions, balances and unrealized gains or losses on transactions between consolidated companies were integrally eliminated.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.1 Subsidiaries</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls an entity when it is exposed to or has rights to variable returns due to its involvement with the entity, and it can affect those returns through its power over the entity. When assessing control, potential voting rights are considered. Control is presumed to exist where the Company owns, directly or indirectly, more than half of the voting rights (which does not always equate to economic ownership), unless it can be demonstrated that such ownership does not confer control.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsidiaries are consolidated from the date on which control is obtained by the Company, except when the predecessor basis of accounting is applied to transactions of business combinations under common control. Consolidation is discontinued from the date on which control ceases.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.2 Associates</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Associates are companies which the Company has significant influence over the financial and operational policies but does not control.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.3 Joint arrangements</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Joint arrangements are all entities over which the Company shares control with one or more parties. Joint arrangements are classified either as joint operations or joint ventures depending on the contractual rights and obligations of each investor.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.4 Business combination</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ambev uses the acquisition method to account its business combinations. The consideration transferred for the acquisition of a subsidiary represents the fair value of the assets transferred, the liabilities incurred, and the equity interest issued by Ambev. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration agreement, when applicable. Costs related to the acquisition are recognized in income as they are incurred. Assets, liabilities and contingent liabilities acquired/assumed in a business combination are recognized initially at their fair value as at the acquisition date. Ambev recognizes the non-controlling interest in the acquiree, either at its fair value or at the non-controlling interest’s proportional share of the net assets acquired. The measurement of the non-controlling interest to be recognized is determined for each acquisition.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The excess of: (i) the consideration paid; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired, at the date of acquisition, is recorded as goodwill. When the consideration transferred is less than the fair value of the net assets acquired, the difference is recognized directly in income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.5 Business combination between entities under common control</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Business combinations between entities under common control have not been addressed under IFRS how they should be disclosed remains unclear. IFRS 3 - <i>Business Combinations</i> is the standard applicable to business combinations, but its scope explicitly excludes business combinations between entities under common control, thus, in evaluating transactions of this nature, Management’s judgment is required to adequately reflect the essence and economic reality of each transaction.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><b>3.2.5.1 Predecessor basis of accounting</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">In accordance with IAS 8 – <i>Accounting Policies, Changes in Accounting Estimates and Errors</i>, Management has adopted the predecessor basis of accounting, which is consistent with United States Generally Accepted Accounting Principles (“USGAAP”) and United Kingdom Generally Accepted Accounting Principles (“UKGAAP”), to record the carrying amount of the asset received, as recorded by the parent company.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the predecessor basis of accounting, when accounting for a transfer of assets between entities under common control, the entity that receives the net assets or the equity interests (the acquirer) shall initially record the assets and liabilities transferred at their parent book value as at the transfer date. If the book value of the assets and liabilities transferred by the parent is different from the historical cost recorded by the controlling entity of the entities under common control (the ultimate parent), the financial statements of the acquirer shall reflect the assets and liabilities transferred at the same cost of the ultimate parent, as a counter-entry to shareholders' equity against the carrying value adjustments.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.2.5.2 Assets Swap</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For transactions between entities under common control that involve the disposal or transfer of assets from the subsidiary to its parent company (i.e., above the level of the consolidated financial statements), the Company assesses the existence of: (i) any conflicts of interest; and (ii) the economic substance and purpose of the transaction. Having fulfilled these assumptions, the Company adopted as a policy the concepts of IAS 16 – <span style="color: windowtext"><i>Property, Plant and Equipment</i></span> in order to provide adequate visibility and a fair impact on the amount of distributable results to its shareholders, specially the non-controlling interest. This policy also includes assets acquired through the swapping of non-cash assets, or swaps with a combination of cash and non-cash assets. The assets swapped may be of the same or a different nature. The cost of such assets is measured at fair value, unless: (i) the swap transaction is not commercial in nature; or (ii) the fair value of the asset received (and the asset assigned) cannot be reliably measured. The acquired asset is measured in this way even if the assignor entity cannot immediately remove the asset from its books. If the acquired asset is not measurable at fair value, its cost is determined based on the book value of the assigned asset.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Whenever assets distributed are not recorded as cash, the asset, before distribution, is recorded at its fair value in the income account. This procedure is applicable to distributions where the assets are of the same nature and therefore can be treated equally. However, similarly to IFRIC 17 - <i>Distributions of Non-cash Assets to Owners</i>, in the absence of a specific accounting practice for transactions under common control, the Company applies these procedures as part of its accounting practices. We also apply the same procedures to sales (products, supplies, etc.) to its controlling entity, where the positive result of the sale is recognized in income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zVKxlSNJYvd8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.3 <span id="xdx_86E_zCs6LFcpMA7i">Financial reporting in hyperinflationary economies</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under IAS 29 – <span style="color: black"><i>Financial Reporting in Hyperinflationary Economies</i></span>, the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in hyperinflationary economies are restated to reflect changes in the general purchasing power of the local currency by applying a general price index. On a monthly basis, the Company estimates the applicable general price index since the official release of the index takes place after the end of the accounting period. The financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether using the historical costs approach or the current costs approach, shall be stated in terms of the unit of measurement in force at the end of the reporting period, and translated into Reais at the closing rate for the period.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: black">To determine if the economy of any of its operations is </span>hyperinflationary<span style="color: black">, the Company assesses quantitative and qualitative aspects of the country's economic environment, such as the inflation rate recorded over the last three years. On July 1, 2018, the Argentine economy was considered by the Company to be </span>hyperinflationary<span style="color: black">, under the terms of IAS 29, considering the increase in the official price indices accumulated in the period (National Consumer Price Index - "IPC"), measured by INDEC (National Institute of Statistics and Census). Since the company does not operate directly in a </span>hyperinflationary <span style="color: black">economy, but one of its subsidiaries does, the restatement of comparative balances from previous years is not carried out, in accordance with IAS 21 - <i>The Effects of Changes in Foreign Exchange Rates</i>, however, the precepts of the standard are applied to the balances and transactions of the affected subsidiary.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_847_ecustom--DisclosureOfPresentValueAdjustmentExplanatory_zFE50ATDPJie" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.4 <span id="xdx_86C_zkhzazAH6c9c">Present value adjustment</span>.</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The elements of assets and liabilities, when relevant, are adjusted to their present value, considering the following assumptions for the calculation: i) the amount to be discounted; ii) the settlement dates; and iii) the discount rate, in accordance with IFRS 13 - <i>Fair Value Measurement</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zQah3TLqXRA4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.5 <span id="xdx_86E_zOSKoth8MxU8">Tax incentives and subsidized loans</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries enjoy state tax benefits in Brazil, provided by government grants. Referred grants may be as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credits, effective collection, payment deferral or partial reductions of state tax payable. The effective collection incentives are recorded in the operating net revenue, by its nature, as the others are recognized in other operating income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Among the tax incentives granted to the Company, there are state tax incentive programs to promote industrial development either by financing or by deferring payment of taxes. These state programs are intended to promote long-term increases in employment and industrial decentralization, as well as to complement and diversify the industrial states.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the case of these programs, the tax terms are set out in the respective state normative acts and, when conditions for obtaining these grants exist, they are under the Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. The benefits of the delayed payment of such taxes are recorded in the income statement, on an accrual basis.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Since it is benefits on financing category or tax payment deferring, as the interest rates and/or terms of these loans are advantageous compared to market conditions, these benefits are considered as subsidized loans as intended by IAS 20 <i>- </i></span><i><span style="color: black">Accounting for Government Grants and Disclosure of Government Assistance</span></i><span style="background-color: white">. The respective subsidies consist of the gains identified by comparing the value of these operations under the market conditions to the value agreed in the contracts. Thereby, upon receipt of funding, the subsidy calculated is recorded in Other operating income, following the treatment for the other ICMS subsidies of similar nature. Management reviews the market conditions prevailing in the year to assess such subsidies on an annual basis.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Monthly, considering the value of the consideration, the period to maturity, the contract interest rate and the abovementioned discount rate, the reduction in present value adjustment is allocated to financial income, so as to bring the balance to zero by the time of settlement of each consideration.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Such financing is recognized as liability adjusted to its present value. When there is an intervening financial institution in the transaction, the financing is recorded at “Interest-bearing loans and borrowings”, otherwise, its recorded at “Trade payables”, because of the underlying economic essence and nature of the transaction.</span></p> <p id="xdx_846_ecustom--DescriptionOfAccountingPolicyForNewIFRSRelasesTextBlock_zq6dABfDH0O1" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.1 <span id="xdx_863_zD8LPKTaT4od">Recently issued IFRS</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The new standards, which became effective are not applicable or did not have any material impact for the Company for the preparation of these consolidated financial statements. Below are the main changes in accounting standards which, in management's opinion, could have an impact on the Company's subsequent disclosures:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-size: 11pt">(i)</span></td><td style="text-align: justify"><span style="font-size: 11pt">On May 25, 2023, the IASB® published amendments to IAS 7 – <i>Statement of Cash Flows</i> and IFRS 7 – <i>Financial Instruments: Disclosures</i>, which establish new disclosure requirements for financing transactions with suppliers, the so-called "drawn risk". These requirements must be adopted by companies that adhere to the IFRS® as of 2024. The Company is evaluating the impacts of these changes, for any additional corresponding disclosures in future individual and consolidated financial statements, even though these transactions are not material to the Group, as disclosed in note 26 – <i>Trade payables</i>.</span></td></tr></table> <p style="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-size: 11pt">(ii)</span></td><td style="text-align: justify"><span style="font-size: 11pt">In August 2023, the IASB® issued amendments to IAS 21 – <span style="color: black"><i>The Effects of Changes in Foreign Exchange Rates</i>. </span>The modifications implemented will require the application of a consistent approach when assessing whether a currency can be exchanged for another currency and, when it cannot, determining the exchange rate to be used, and the related disclosures. The Company is evaluating the impacts of these standards, the adoption of which is required for fiscal years beginning on January 1, 2025.</span></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-size: 11pt">(iii)</span></td><td style="text-align: justify"><span style="font-size: 11pt">In December 2021, the Organisation for Economic Cooperation and Development ("OECD"), as part of the Inclusive Framework on Base Erosion and Profit Shifting ("BEPS") project, released the Pillar Two model rules (or Global Anti-Base Erosion Model Rules - GloBE), aiming at a common approach to international corporate taxation, in order to ensure that multinational economic groups within the scope of these rules calculate taxes on profit at a minimum effective rate of 15% in each country where they operate. These rules will have to be approved locally in each country that adheres the proposal, via applicable legislation, some of which have already promulgated new laws or are in the process of discussing and approving them. In May 2023, the IASB® issued scope changes to IAS 12 – <i>Income Taxes</i> to allow a temporary exemption in accounting for deferred income taxes arising from promulgated or substantially promulgated legislation implementing OECD Pillar Two, an exemption which has been adopted by the Group. Considering the legislation already published in the countries in which the Company operates, the Company has estimated the impacts on the 2023 financial statements and the amount is not material.</span></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.75in; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition of these, the Company does not anticipate that there are any other standards or amendments to IFRS® standards or IFRIC interpretations that have not come into force yet and that could have a significant impact on the Group's individual and consolidated financial statements.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForTheBasisOfConsolidationTextBlock_zXnxTlEPuBtb" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>3.2 <span id="xdx_868_z9L8HV7VuSah">Consolidated financial statements</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial statements of subsidiaries, joint arrangements and associates used in these consolidated financial statements are prepared for the same reporting period as Ambev, using a consistent accounting policy.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All intercompany transactions, balances and unrealized gains or losses on transactions between consolidated companies were integrally eliminated.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.1 Subsidiaries</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company controls an entity when it is exposed to or has rights to variable returns due to its involvement with the entity, and it can affect those returns through its power over the entity. When assessing control, potential voting rights are considered. Control is presumed to exist where the Company owns, directly or indirectly, more than half of the voting rights (which does not always equate to economic ownership), unless it can be demonstrated that such ownership does not confer control.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsidiaries are consolidated from the date on which control is obtained by the Company, except when the predecessor basis of accounting is applied to transactions of business combinations under common control. Consolidation is discontinued from the date on which control ceases.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.2 Associates</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Associates are companies which the Company has significant influence over the financial and operational policies but does not control.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.3 Joint arrangements</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Joint arrangements are all entities over which the Company shares control with one or more parties. Joint arrangements are classified either as joint operations or joint ventures depending on the contractual rights and obligations of each investor.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.4 Business combination</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ambev uses the acquisition method to account its business combinations. The consideration transferred for the acquisition of a subsidiary represents the fair value of the assets transferred, the liabilities incurred, and the equity interest issued by Ambev. The consideration transferred includes the fair value of any asset or liability resulting from a contingent consideration agreement, when applicable. Costs related to the acquisition are recognized in income as they are incurred. Assets, liabilities and contingent liabilities acquired/assumed in a business combination are recognized initially at their fair value as at the acquisition date. Ambev recognizes the non-controlling interest in the acquiree, either at its fair value or at the non-controlling interest’s proportional share of the net assets acquired. The measurement of the non-controlling interest to be recognized is determined for each acquisition.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The excess of: (i) the consideration paid; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired, at the date of acquisition, is recorded as goodwill. When the consideration transferred is less than the fair value of the net assets acquired, the difference is recognized directly in income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.2.5 Business combination between entities under common control</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">Business combinations between entities under common control have not been addressed under IFRS how they should be disclosed remains unclear. IFRS 3 - <i>Business Combinations</i> is the standard applicable to business combinations, but its scope explicitly excludes business combinations between entities under common control, thus, in evaluating transactions of this nature, Management’s judgment is required to adequately reflect the essence and economic reality of each transaction.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"><b>3.2.5.1 Predecessor basis of accounting</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in">In accordance with IAS 8 – <i>Accounting Policies, Changes in Accounting Estimates and Errors</i>, Management has adopted the predecessor basis of accounting, which is consistent with United States Generally Accepted Accounting Principles (“USGAAP”) and United Kingdom Generally Accepted Accounting Principles (“UKGAAP”), to record the carrying amount of the asset received, as recorded by the parent company.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the predecessor basis of accounting, when accounting for a transfer of assets between entities under common control, the entity that receives the net assets or the equity interests (the acquirer) shall initially record the assets and liabilities transferred at their parent book value as at the transfer date. If the book value of the assets and liabilities transferred by the parent is different from the historical cost recorded by the controlling entity of the entities under common control (the ultimate parent), the financial statements of the acquirer shall reflect the assets and liabilities transferred at the same cost of the ultimate parent, as a counter-entry to shareholders' equity against the carrying value adjustments.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.2.5.2 Assets Swap</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For transactions between entities under common control that involve the disposal or transfer of assets from the subsidiary to its parent company (i.e., above the level of the consolidated financial statements), the Company assesses the existence of: (i) any conflicts of interest; and (ii) the economic substance and purpose of the transaction. Having fulfilled these assumptions, the Company adopted as a policy the concepts of IAS 16 – <span style="color: windowtext"><i>Property, Plant and Equipment</i></span> in order to provide adequate visibility and a fair impact on the amount of distributable results to its shareholders, specially the non-controlling interest. This policy also includes assets acquired through the swapping of non-cash assets, or swaps with a combination of cash and non-cash assets. The assets swapped may be of the same or a different nature. The cost of such assets is measured at fair value, unless: (i) the swap transaction is not commercial in nature; or (ii) the fair value of the asset received (and the asset assigned) cannot be reliably measured. The acquired asset is measured in this way even if the assignor entity cannot immediately remove the asset from its books. If the acquired asset is not measurable at fair value, its cost is determined based on the book value of the assigned asset.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Whenever assets distributed are not recorded as cash, the asset, before distribution, is recorded at its fair value in the income account. This procedure is applicable to distributions where the assets are of the same nature and therefore can be treated equally. However, similarly to IFRIC 17 - <i>Distributions of Non-cash Assets to Owners</i>, in the absence of a specific accounting practice for transactions under common control, the Company applies these procedures as part of its accounting practices. We also apply the same procedures to sales (products, supplies, etc.) to its controlling entity, where the positive result of the sale is recognized in income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zVKxlSNJYvd8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.3 <span id="xdx_86E_zCs6LFcpMA7i">Financial reporting in hyperinflationary economies</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under IAS 29 – <span style="color: black"><i>Financial Reporting in Hyperinflationary Economies</i></span>, the non-monetary assets and liabilities, the equity and the income statement of subsidiaries operating in hyperinflationary economies are restated to reflect changes in the general purchasing power of the local currency by applying a general price index. On a monthly basis, the Company estimates the applicable general price index since the official release of the index takes place after the end of the accounting period. The financial statements of an entity whose functional currency is the currency of a hyperinflationary economy, whether using the historical costs approach or the current costs approach, shall be stated in terms of the unit of measurement in force at the end of the reporting period, and translated into Reais at the closing rate for the period.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: black">To determine if the economy of any of its operations is </span>hyperinflationary<span style="color: black">, the Company assesses quantitative and qualitative aspects of the country's economic environment, such as the inflation rate recorded over the last three years. On July 1, 2018, the Argentine economy was considered by the Company to be </span>hyperinflationary<span style="color: black">, under the terms of IAS 29, considering the increase in the official price indices accumulated in the period (National Consumer Price Index - "IPC"), measured by INDEC (National Institute of Statistics and Census). Since the company does not operate directly in a </span>hyperinflationary <span style="color: black">economy, but one of its subsidiaries does, the restatement of comparative balances from previous years is not carried out, in accordance with IAS 21 - <i>The Effects of Changes in Foreign Exchange Rates</i>, however, the precepts of the standard are applied to the balances and transactions of the affected subsidiary.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p id="xdx_847_ecustom--DisclosureOfPresentValueAdjustmentExplanatory_zFE50ATDPJie" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>3.4 <span id="xdx_86C_zkhzazAH6c9c">Present value adjustment</span>.</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The elements of assets and liabilities, when relevant, are adjusted to their present value, considering the following assumptions for the calculation: i) the amount to be discounted; ii) the settlement dates; and iii) the discount rate, in accordance with IFRS 13 - <i>Fair Value Measurement</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForGovernmentGrants_zQah3TLqXRA4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>3.5 <span id="xdx_86E_zOSKoth8MxU8">Tax incentives and subsidized loans</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries enjoy state tax benefits in Brazil, provided by government grants. Referred grants may be as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credits, effective collection, payment deferral or partial reductions of state tax payable. The effective collection incentives are recorded in the operating net revenue, by its nature, as the others are recognized in other operating income.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Among the tax incentives granted to the Company, there are state tax incentive programs to promote industrial development either by financing or by deferring payment of taxes. These state programs are intended to promote long-term increases in employment and industrial decentralization, as well as to complement and diversify the industrial states.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the case of these programs, the tax terms are set out in the respective state normative acts and, when conditions for obtaining these grants exist, they are under the Company's control. Such benefits comply with the systematic set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. The benefits of the delayed payment of such taxes are recorded in the income statement, on an accrual basis.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Since it is benefits on financing category or tax payment deferring, as the interest rates and/or terms of these loans are advantageous compared to market conditions, these benefits are considered as subsidized loans as intended by IAS 20 <i>- </i></span><i><span style="color: black">Accounting for Government Grants and Disclosure of Government Assistance</span></i><span style="background-color: white">. The respective subsidies consist of the gains identified by comparing the value of these operations under the market conditions to the value agreed in the contracts. Thereby, upon receipt of funding, the subsidy calculated is recorded in Other operating income, following the treatment for the other ICMS subsidies of similar nature. Management reviews the market conditions prevailing in the year to assess such subsidies on an annual basis.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Monthly, considering the value of the consideration, the period to maturity, the contract interest rate and the abovementioned discount rate, the reduction in present value adjustment is allocated to financial income, so as to bring the balance to zero by the time of settlement of each consideration.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Such financing is recognized as liability adjusted to its present value. When there is an intervening financial institution in the transaction, the financing is recorded at “Interest-bearing loans and borrowings”, otherwise, its recorded at “Trade payables”, because of the underlying economic essence and nature of the transaction.</span></p> <p id="xdx_80C_eifrs-full--DisclosureOfAccountingJudgementsAndEstimatesExplanatory_z0dfPwisXa44" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt/110% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"><span id="a_009"></span></td><td style="width: 14.2pt"><b>4.</b></td><td style="text-align: justify"><b><span id="xdx_82A_zNaOHDm88Hb2">USE OF ESTIMATES AND JUDGMENTS</span></b></td></tr></table> <p style="font: 11pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The preparation of financial statements in compliance with IFRS requires Management to make use of judgments, estimates and assumptions that affect the application of accounting practices and the reported amounts of assets and liabilities, income and expenses. The estimates and assumptions are based on experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for decision-making regarding judgments regarding the carrying amounts of assets and liabilities that are not readily evident from other sources. The actual results may differ from these estimates.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The estimates and assumptions are reviewed on a regular basis. Changes in accounting estimates may affect the period during which they are realized, or future periods.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although each significant accounting policy reflects judgments, assessments or estimates, the Company believes that the following accounting practices reflect the most critical judgments, estimates and assumptions that are important to its business operations and the understanding of its results:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; white-space: nowrap; vertical-align: bottom; width: 12%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>Note</b></span></td> <td style="border-bottom: Black 1pt solid; padding: 0.75pt 5.4pt; white-space: nowrap; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><b>Accounting policies that reflect significant estimates and judgments</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.2.3</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Joint arrangements</span></td></tr> <tr style="background-color: White"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.2.4</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Business combination</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.2.5</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Business combination between entities under common control</span></td></tr> <tr style="background-color: White"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.3</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Financial reporting in hyperinflationary economies</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.4</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Present value adjustment</span></td></tr> <tr style="background-color: White"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">3.6</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Tax incentives and subsidized loans</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">18</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify; line-height: 110%"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt; line-height: 110%">Recognition of assets and liabilities relating to extemporaneous tax debits or credits</span></td></tr> <tr style="background-color: White"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">13</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Current and deferred tax</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">14</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Leases</span></td></tr> <tr style="background-color: White"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">16</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Impairment</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">24</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Measurement of employee benefits</span></td></tr> <tr style="background-color: White"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">25</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Share-based payments</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">27</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Provisions and contingent liabilities, including tax contingencies</span></td></tr> <tr> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">28</span></td> <td style="padding: 0.75pt 5.4pt; white-space: nowrap; width: 88%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Measurement of financial instruments, including derivatives</span></td></tr> </table> <p id="xdx_807_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_zxfNspjZDkN" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span id="a_010"></span><b>5.</b></td><td><b><span id="xdx_825_zrLrChNc2si8">SEGMENT REPORTING</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt">(a)</td><td>Reportable segments - Years ended:</td></tr></table> <p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfReportableSegmentsTextBlock_pn5n6_zMqXLHNLl1A3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT REPORTING - Reportable Segments (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zil8oqV38dnc" style="display: none">Schedule of segment reporting</span></td> <td id="xdx_499_20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zhUA59DuBtPf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zrod5Le1o9T8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zhmDDXMicQS5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20230101__20231231__ifrs-full--SegmentsAxis__custom--CACMember_ziF4RNs5Bvl4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20220101__20221231__ifrs-full--SegmentsAxis__custom--CACMember_zpZVk97GeaGg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20210101__20211231__ifrs-full--SegmentsAxis__custom--CACMember_znoqcAIXwL42" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20230101__20231231__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zwYoao0hqkg3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20220101__20221231__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zP4QQb5nrBCe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20210101__20211231__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zYI9BVqrpBrk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20230101__20231231__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_z6ue2WNdVQvh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20220101__20221231__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_z8iviwB6BJtg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20210101__20211231__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zbKCiPCgDAR3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20230101__20231231_zLsymrTftFFk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_499_20220101__20221231_zH7915ZjJ7V8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20210101__20211231_zZ29619u9U3l" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Brazil</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>CAC</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 6.5pt Times New Roman, Times, Serif"><b>Latin America - South</b></span><b><span style="font: normal 8pt Times New Roman, Times, Serif"><sup> </sup></span></b></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Canada</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Consolidated</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_409_eifrs-full--RevenueFromContractsWithCustomers_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Net sales</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">46,361.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">42,635.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">35,586.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">10,044.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">9,440.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">9,947.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">13,797.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">17,371.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">16,571.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">9,533.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">10,261.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">10,748.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">79,736.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">79,708.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">72,854.3 </span></td></tr> <tr id="xdx_405_eifrs-full--CostOfSales_iN_di_zqLiI3IHr2r3" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Cost of sales</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(23,516.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(22,736.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(18,309.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,035.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,860.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,727.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(6,657.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(8,553.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(8,235.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,083.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,271.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,387.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(39,291.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(40,422.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(35,659.7)</span></td></tr> <tr id="xdx_403_eifrs-full--GrossProfit_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Gross profit</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>22,845.6 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>19,899.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>17,277.4 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,009.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>4,579.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,219.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>7,139.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>8,818.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>8,336.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,450.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,990.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>6,361.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>40,445.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>39,286.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>37,194.6 </b></span></td></tr> <tr id="xdx_406_eifrs-full--DistributionCosts_iN_di_zk4kqJ5FQw08" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Distribution expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(6,428.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(6,111.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,123.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(853.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,020.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(872.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,614.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,159.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,010.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,854.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,104.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,926.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(10,750.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(11,395.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(9,932.7)</span></td></tr> <tr id="xdx_405_eifrs-full--SalesAndMarketingExpense_iN_di_zHIhBu5Yxpjg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Sales and marketing expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,477.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,065.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,440.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(665.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(645.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(693.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,190.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,426.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,542.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,080.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,200.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,359.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(7,412.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(7,337.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(7,035.5)</span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zhqkEYCkYAl8" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Administrative expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,563.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,346.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,006.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(413.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(333.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(427.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(659.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(835.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(832.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(638.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(722.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(611.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,273.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,236.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,877.4)</span></td></tr> <tr id="xdx_407_eifrs-full--OtherOperatingIncomeExpense_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Other operating income/(expenses)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,892.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,361.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,096.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">26.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(52.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">12.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">95.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">192.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">38.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">12.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(23.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,028.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,513.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,124.1 </span></td></tr> <tr id="xdx_40F_ecustom--ExceptionalItems_i_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Exceptional items</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(137.8)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(34.5)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(210.1)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(17.9)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(16.1)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(46.7)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(47.6)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(60.5)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(115.4)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3.1)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(32.2)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(20.6)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(206.4)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(143.3)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(392.8)</span></td></tr> <tr id="xdx_402_eifrs-full--ProfitLossFromOperatingActivities_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Income from operations</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>10,131.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>8,703.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>7,593.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,086.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2,510.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,191.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,723.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>4,528.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,874.4 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>1,889.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>1,944.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2,420.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>18,831.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>17,687.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>17,080.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Net finance costs</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td id="xdx_983_eifrs-full--FinanceIncomeCost_pn5n6_c20230101__20231231_zrg9VVeccPL1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,609.8)</span></td> <td id="xdx_989_eifrs-full--FinanceIncomeCost_pn5n6_c20220101__20221231_zm6M88z0kdRe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,423.1)</span></td> <td id="xdx_98C_eifrs-full--FinanceIncomeCost_pn5n6_c20210101__20211231_z1RBiS0l5D" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,205.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Share of results of joint ventures</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20230101__20231231_zEqgJaVfxiaf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(185.3)</span></td> <td id="xdx_98D_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20220101__20221231_zKrNBhkQhGMj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(29.1)</span></td> <td id="xdx_98D_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20210101__20211231_zbgfjLMv12n4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(115.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Income before income tax</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_pn5n6_c20230101__20231231_zdfUHT58ag11" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>15,035.9 </b></span></td> <td id="xdx_987_eifrs-full--ProfitLossBeforeTax_pn5n6_c20220101__20221231_zD14yRE4akM2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>14,235.6 </b></span></td> <td id="xdx_980_eifrs-full--ProfitLossBeforeTax_pn5n6_c20210101__20211231_zv8ZQNzZatc1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>13,759.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Income tax expense</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td id="xdx_980_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20230101__20231231_zR5kMezUmZi7" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(75.5)</span></td> <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20220101__20221231_zZ0YR99jQYp6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">655.6 </span></td> <td id="xdx_989_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20210101__20211231_zXYpZHcEc6G1" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(636.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Net income</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td id="xdx_986_eifrs-full--ProfitLoss_pn5n6_c20230101__20231231_zuuqxhh6d9dj" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>14,960.4 </b></span></td> <td id="xdx_989_eifrs-full--ProfitLoss_pn5n6_c20220101__20221231_zS8W3YH1pzud" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>14,891.2 </b></span></td> <td id="xdx_987_eifrs-full--ProfitLoss_pn5n6_c20210101__20211231_zcM6QF5Conth" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>13,122.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Acquisition of property, plant and equipment</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">3,365.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">4,062.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">4,645.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">593.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">968.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">801.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">782.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,112.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,665.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,263.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">389.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">565.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,004.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,533.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">7,677.1 </span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 6pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Brazil</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>CAC </b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 6.5pt Times New Roman, Times, Serif"><b>Latin America - South</b></span><b><span style="font: normal 8pt Times New Roman, Times, Serif"><sup> </sup></span></b></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Canada</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Consolidated</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Segment assets</span></td> <td id="xdx_988_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_z0wbLqvBwkL6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">56,974.2 </span></td> <td id="xdx_980_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zj1Nk7eSl5Q2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">57,353.8 </span></td> <td id="xdx_98B_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zINhXNo28Sn8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">54,609.4 </span></td> <td id="xdx_98A_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zkN2vPQqbir9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">13,692.3 </span></td> <td id="xdx_987_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_z33Vaoyx1Ia3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15,385.6 </span></td> <td id="xdx_980_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zwJ3eA74vQP7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15,351.9 </span></td> <td id="xdx_985_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zRvD0uGiPxnk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">16,085.1 </span></td> <td id="xdx_981_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zD1fZLa4Q9D9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">22,044.5 </span></td> <td id="xdx_98A_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_ziY3BvuM13Wb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">21,583.0 </span></td> <td id="xdx_980_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zMjKpM9oft76" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15,856.9 </span></td> <td id="xdx_984_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_z0Oc9TqcPNJg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">16,093.3 </span></td> <td id="xdx_98C_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zeTiyoO960id" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">18,016.6 </span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zjvjshHKtWel" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">102,608.5 </span></td> <td id="xdx_98A_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZMwwaxaxMoi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">110,877.2 </span></td> <td id="xdx_988_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLnamQ7uwSKc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">109,560.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Intersegment elimination</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zlm8UezkMwJ1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,162.1)</span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zzOX7gqmwDja" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,533.0)</span></td> <td id="xdx_981_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zVmerwrPCC4c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,868.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 6.5pt Times New Roman, Times, Serif">Non-segmented assets </span><span style="font: normal 8pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_zQHojmfSIny3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">32,197.9 </span></td> <td id="xdx_982_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_zh5OJlZEVKpd" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">29,613.8 </span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_z4tm8CcBQW1d" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">31,910.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Total assets</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--Assets_iI_c20231231_zkGME8AD96t3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>132,644.3 </b></span></td> <td id="xdx_98C_eifrs-full--Assets_iI_c20221231_zxsETkqUshaa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>137,958.0 </b></span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20211231_zfCmfHPYiZAb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>138,602.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Segment liabilities</span></td> <td id="xdx_98C_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zBBVqbOUdN59" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">28,841.3 </span></td> <td id="xdx_984_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zmvaI4g2MO8f" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">29,153.2 </span></td> <td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zljAZNrU2AF2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">27,611.2 </span></td> <td id="xdx_984_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_ztQrW1WYEQI2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">4,981.5 </span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zRXa7XLCBZZa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,098.0 </span></td> <td id="xdx_98F_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zit77PO4uQE3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,414.4 </span></td> <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_za2Aiw3wlDAd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,095.4 </span></td> <td id="xdx_980_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_z6Oy09c63xRk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,843.6 </span></td> <td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_z6vjztkTQiz" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">7,843.6 </span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zsTU55kzBT55" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,131.0 </span></td> <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zayzaaFhbds7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,053.7 </span></td> <td id="xdx_985_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zhI29FJIksG5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,156.5 </span></td> <td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfkLi7NNj1h6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">44,049.2 </span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrDQdHc7KtJe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">46,148.5 </span></td> <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKSww68bPExh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">47,025.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Intersegment elimination</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zKhheJ68Ow38" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,161.8)</span></td> <td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z3lpTtGAcRFd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,534.2)</span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zHcyZSJES4yi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,869.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 6.5pt Times New Roman, Times, Serif">Non-segmented liabilities </span><span style="font: normal 8pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_z8LCSRr9Hrkb" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">90,756.9 </span></td> <td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_z3SNHuW1Qhse" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">94,343.7 </span></td> <td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_zHlY9gYbD3F5" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">94,445.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Total liabilities</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20231231_z0z7v3nEbYE" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>132,644.3 </b></span></td> <td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20221231_zTXsM6OMrd81" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>137,958.0 </b></span></td> <td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231_zX1MKKQ4cxzg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>138,602.5 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 55.3pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The balance of non-segmented assets refers mainly to cash and cash equivalents, taxes and investments. The balance of non-segmented liabilities, in turn, refers mainly to equity values, taxes and derivatives.</td> </tr></table> <p id="xdx_8A3_z4JmF2Hcmuhe" style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Non-current assets attributed to Brazil (country of domicile of the company) and Canada amounted to R$<span id="xdx_90B_eifrs-full--NoncurrentAssets_iI_pn8n9_c20231231__ifrs-full--SegmentsAxis__country--BR_zTnjzKPkP85g" title="Non-current assets">45.1</span> billion and R$<span id="xdx_903_eifrs-full--NoncurrentAssets_iI_pn8n9_c20231231__ifrs-full--SegmentsAxis__country--CA_z7niAXhHrYnf" title="Non-current assets">13.9</span> billion, respectively, in December 31, 2023 (R$<span id="xdx_908_eifrs-full--NoncurrentAssets_iI_pn8n9_c20221231__ifrs-full--SegmentsAxis__country--BR_zxwLUxNYqUM9" title="Non-current assets">44.6</span> billion and R$<span id="xdx_908_eifrs-full--NoncurrentAssets_iI_pn8n9_c20221231__ifrs-full--SegmentsAxis__country--CA_zpyUMTUBr6c4" title="Non-current assets">13.7</span> billion, respectively, in December 31, 2022, and R$<span id="xdx_90F_eifrs-full--NoncurrentAssets_iI_pn8n9_c20211231__ifrs-full--SegmentsAxis__country--BR_zGezIZaeQvqa" title="Non-current assets">42.6</span> billion and R$<span id="xdx_90C_eifrs-full--NoncurrentAssets_iI_pn8n9_c20211231__ifrs-full--SegmentsAxis__country--CA_z1bYGfGCr6Gj" title="Non-current assets">15.6</span> billion, respectively, in December 31, 2021). Furthermore, the net revenue attributable to the Company's operations in Argentina amounted to R$<span id="xdx_904_eifrs-full--OtherRevenue_pn8n9_c20230101__20231231__ifrs-full--SegmentsAxis__country--AR_zNurhbPVPRF1" title="Net revenue">6.3</span> billion in December 31, 2023 (R$<span id="xdx_90D_eifrs-full--OtherRevenue_pn8n9_c20220101__20221231__ifrs-full--SegmentsAxis__country--AR_zrnPsLBmF1ni" title="Net revenue">10.1</span> billion in December 31, 2022 and R$<span id="xdx_903_eifrs-full--OtherRevenue_pn8n9_c20210101__20211231__ifrs-full--SegmentsAxis__country--AR_za5vRo4rfmTk" title="Net revenue">9.2</span> billion in December 31, 2021), and the segmented non-current assets attributed to the same country totaled R$<span id="xdx_90E_eifrs-full--NoncurrentAssets_iI_pn8n9_c20231231__ifrs-full--SegmentsAxis__country--AR_z7wM6hI26ZQ4" title="Non-current assets">5.9</span> billion for the year ended December 31, 2023 (R$<span id="xdx_905_eifrs-full--NoncurrentAssets_iI_pn8n9_c20221231__ifrs-full--SegmentsAxis__country--AR_zA8IWXiCNh7k" title="Non-current assets">9.7</span> billion in December 31, 2022 and R$<span id="xdx_908_eifrs-full--NoncurrentAssets_iI_pn8n9_c20211231__ifrs-full--SegmentsAxis__country--AR_zZ21A4ElsRO6" title="Non-current assets">9.1</span> billion in December 31, 2021).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt">(b)</td><td>Additional information - by Business unit - Years ended:</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfAdditionalInformationByBusinessUnitTableTextBlock_pn5n6_zzch8O6lKc85" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT REPORTING - Additional information (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zjw2hVprrkx2" style="display: none">Schedule of additional information</span></td> <td id="xdx_499_20230101__20231231__ifrs-full--ProductsAndServicesAxis__custom--BeerMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_z4aEV57inP0h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_490_20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--BeerMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_ztZNOenlUZPg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--BeerMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_z2RsmMV6BYIa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20230101__20231231__ifrs-full--ProductsAndServicesAxis__custom--NABMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zfuXohcVb6a6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--NABMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zQpfXDD942lc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--NABMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zbG0YCBl4Qi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_496_20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zbcy6wqP4Lz9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_z8Kz9Akqkbu5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49D_20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zid5VtVducOa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Brazil</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Beer</b></span></td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>NAB</b></span></td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Total </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 29%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2021</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2021</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40A_eifrs-full--RevenueFromContractsWithCustomers_zT32ksBlSvfa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net sales</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">38,985.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">35,857.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">30,537.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,375.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">6,777.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">5,049.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">46,361.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">42,635.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">35,586.5 </span></td></tr> <tr id="xdx_40E_eifrs-full--CostOfSales_iN_di_zqZGwQVdjsrg" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Cost of sales</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(19,377.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(18,765.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(15,382.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,138.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,971.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,927.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(23,516.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(22,736.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(18,309.1)</span></td></tr> <tr id="xdx_40D_eifrs-full--GrossProfit_zLNA6kz1B3Z6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Gross profit</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>19,608.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>17,092.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>15,155.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>3,237.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2,806.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2,122.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>22,845.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>19,899.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>17,277.4 </b></span></td></tr> <tr id="xdx_40A_eifrs-full--DistributionCosts_iN_di_ziQedEjXC1gj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Distribution expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,171.9)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,988.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,263.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,256.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,122.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(860.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(6,428.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(6,111.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,123.1)</span></td></tr> <tr id="xdx_404_eifrs-full--SalesAndMarketingExpense_iN_di_znIbCbIVKacf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Sales and marketing expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,969.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,596.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,096.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(507.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(468.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(344.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,477.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,065.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,440.3)</span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zdI05gqHYE2f" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Administrative expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,106.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,928.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,616.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(457.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(417.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(390.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,563.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,346.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,006.2)</span></td></tr> <tr id="xdx_405_eifrs-full--OtherOperatingIncomeExpense_zki8Glg3lJZg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Other operating income/(expenses)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,474.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,884.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,711.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">418.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">476.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">384.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,892.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,361.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,096.0 </span></td></tr> <tr id="xdx_408_ecustom--ExceptionalItems_zn4cUvMYxbHe" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Exceptional items</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(137.8)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(30.6)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(202.0)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1696">-</span>   </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3.9)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(8.1)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(137.8)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(34.5)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(210.1)</span></td></tr> <tr id="xdx_405_eifrs-full--ProfitLossFromOperatingActivities_zEwWj9q1Cpte" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Income from operations</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>8,697.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,432.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>6,689.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>1,434.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>1,271.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>904.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>10,131.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>8,703.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,593.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net finance costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--FinanceIncomeCost_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zkusIcULGuwl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,050.6)</span></td> <td id="xdx_98F_eifrs-full--FinanceIncomeCost_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zcnXkYvBAdqh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,110.3)</span></td> <td id="xdx_98E_eifrs-full--FinanceIncomeCost_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zvlWJicdAeRl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(858.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Share of results of joint ventures</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zDx46OnRcZ36" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(179.0)</span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zYO0WlLUOtv1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(38.3)</span></td> <td id="xdx_98C_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zu31T3KXNR7j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(11.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Income before income tax</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_z2n7FCriMnAc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,901.9 </b></span></td> <td id="xdx_982_eifrs-full--ProfitLossBeforeTax_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zBDleDSR1Bx5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,555.1 </b></span></td> <td id="xdx_983_eifrs-full--ProfitLossBeforeTax_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zzJeP4gpTGSg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>6,723.9 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Income tax expense</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td id="xdx_985_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zIPc1SKcTMLi" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,214.9 </span></td> <td id="xdx_981_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_z6GrO149h8Uk" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,787.7 </span></td> <td id="xdx_988_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zyWUNqXp5621" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,953.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Net income</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td id="xdx_988_eifrs-full--ProfitLoss_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>10,116.8 </b></span></td> <td id="xdx_98E_eifrs-full--ProfitLoss_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>10,342.8 </b></span></td> <td id="xdx_98C_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>8,677.1 </b></span></td></tr> </table> <p id="xdx_8A5_z74wLT0powQj" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Reportable segments are consistently presented on the internal reporting regularly reviewed by the Company’s chief operating decision maker, the Chief Executive Officer, for the purpose of evaluating the performance of each segment and allocating resources to those segments. The information is prepared based on available financial data that is directly attributable to the segment or the information that can be allocated on a reasonable basis.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Therefore, the segment reporting is presented by geographical zone, since the risks and rates of return are predominantly affected by the fact that the company operates in different regions.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Performance information by business unit (Beer and Non-alcoholic beverages (“NAB”)), is also presented to the Company’s chief operating decision maker and is disclosed as additional information, even though it does not qualify as a segment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company conducts its operations across four business segments, as follow:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">▪ Brazil, where the Company operates two business subunits: (i) beer and (ii) non-alcoholic beverages (NAB).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">▪ Central America and Caribbean (“CAC”), which includes direct operations in the Dominican Republic, Saint Vincent, Antigua, Dominica, Cuba, Guatemala (which also serves El Salvador, Nicaragua and Honduras), Barbados and Panama.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">▪ Latin America South (LAS), which includes operations in Argentina, Bolivia, Chile, Paraguay and Uruguay.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">▪ Canada, represented by the operations of Labatt Brewing Company Ltd.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Our chief operating decision maker uses income from operations as the main measure of segment profitability.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with IFRS 8 - <i>Segment Information</i>, the Company does not disclose its revenues from external customers for each product or each group of similar products, since the necessary information is not available in a comparable form and the cost of preparing it would be excessive.</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_ecustom--DisclosureOfReportableSegmentsTextBlock_pn5n6_zMqXLHNLl1A3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT REPORTING - Reportable Segments (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zil8oqV38dnc" style="display: none">Schedule of segment reporting</span></td> <td id="xdx_499_20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zhUA59DuBtPf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zrod5Le1o9T8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zhmDDXMicQS5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20230101__20231231__ifrs-full--SegmentsAxis__custom--CACMember_ziF4RNs5Bvl4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20220101__20221231__ifrs-full--SegmentsAxis__custom--CACMember_zpZVk97GeaGg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20210101__20211231__ifrs-full--SegmentsAxis__custom--CACMember_znoqcAIXwL42" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20230101__20231231__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zwYoao0hqkg3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20220101__20221231__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zP4QQb5nrBCe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20210101__20211231__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zYI9BVqrpBrk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20230101__20231231__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_z6ue2WNdVQvh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20220101__20221231__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_z8iviwB6BJtg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20210101__20211231__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zbKCiPCgDAR3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20230101__20231231_zLsymrTftFFk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_499_20220101__20221231_zH7915ZjJ7V8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20210101__20211231_zZ29619u9U3l" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Brazil</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>CAC</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 6.5pt Times New Roman, Times, Serif"><b>Latin America - South</b></span><b><span style="font: normal 8pt Times New Roman, Times, Serif"><sup> </sup></span></b></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Canada</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Consolidated</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_409_eifrs-full--RevenueFromContractsWithCustomers_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Net sales</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">46,361.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">42,635.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">35,586.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">10,044.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">9,440.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">9,947.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">13,797.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">17,371.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">16,571.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">9,533.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">10,261.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">10,748.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">79,736.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">79,708.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">72,854.3 </span></td></tr> <tr id="xdx_405_eifrs-full--CostOfSales_iN_di_zqLiI3IHr2r3" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Cost of sales</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(23,516.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(22,736.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(18,309.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,035.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,860.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,727.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(6,657.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(8,553.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(8,235.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,083.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,271.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,387.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(39,291.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(40,422.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(35,659.7)</span></td></tr> <tr id="xdx_403_eifrs-full--GrossProfit_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Gross profit</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>22,845.6 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>19,899.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>17,277.4 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,009.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>4,579.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,219.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>7,139.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>8,818.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>8,336.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,450.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>5,990.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>6,361.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>40,445.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>39,286.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>37,194.6 </b></span></td></tr> <tr id="xdx_406_eifrs-full--DistributionCosts_iN_di_zk4kqJ5FQw08" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Distribution expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(6,428.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(6,111.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,123.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(853.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,020.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(872.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,614.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,159.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,010.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,854.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,104.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,926.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(10,750.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(11,395.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(9,932.7)</span></td></tr> <tr id="xdx_405_eifrs-full--SalesAndMarketingExpense_iN_di_zHIhBu5Yxpjg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Sales and marketing expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,477.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,065.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,440.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(665.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(645.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(693.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,190.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,426.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,542.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,080.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,200.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(1,359.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(7,412.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(7,337.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(7,035.5)</span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zhqkEYCkYAl8" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Administrative expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,563.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,346.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,006.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(413.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(333.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(427.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(659.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(835.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(832.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(638.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(722.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(611.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,273.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(5,236.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(4,877.4)</span></td></tr> <tr id="xdx_407_eifrs-full--OtherOperatingIncomeExpense_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Other operating income/(expenses)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,892.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,361.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,096.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">26.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(52.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">12.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">95.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">192.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">38.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">12.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(23.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,028.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,513.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">2,124.1 </span></td></tr> <tr id="xdx_40F_ecustom--ExceptionalItems_i_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Exceptional items</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(137.8)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(34.5)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(210.1)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(17.9)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(16.1)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(46.7)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(47.6)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(60.5)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(115.4)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3.1)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(32.2)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(20.6)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(206.4)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(143.3)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(392.8)</span></td></tr> <tr id="xdx_402_eifrs-full--ProfitLossFromOperatingActivities_i_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Income from operations</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>10,131.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>8,703.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>7,593.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,086.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2,510.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,191.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,723.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>4,528.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>3,874.4 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>1,889.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>1,944.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2,420.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>18,831.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>17,687.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>17,080.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Net finance costs</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td id="xdx_983_eifrs-full--FinanceIncomeCost_pn5n6_c20230101__20231231_zrg9VVeccPL1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,609.8)</span></td> <td id="xdx_989_eifrs-full--FinanceIncomeCost_pn5n6_c20220101__20221231_zm6M88z0kdRe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,423.1)</span></td> <td id="xdx_98C_eifrs-full--FinanceIncomeCost_pn5n6_c20210101__20211231_z1RBiS0l5D" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(3,205.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Share of results of joint ventures</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20230101__20231231_zEqgJaVfxiaf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(185.3)</span></td> <td id="xdx_98D_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20220101__20221231_zKrNBhkQhGMj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(29.1)</span></td> <td id="xdx_98D_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20210101__20211231_zbgfjLMv12n4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(115.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Income before income tax</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_pn5n6_c20230101__20231231_zdfUHT58ag11" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>15,035.9 </b></span></td> <td id="xdx_987_eifrs-full--ProfitLossBeforeTax_pn5n6_c20220101__20221231_zD14yRE4akM2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>14,235.6 </b></span></td> <td id="xdx_980_eifrs-full--ProfitLossBeforeTax_pn5n6_c20210101__20211231_zv8ZQNzZatc1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>13,759.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Income tax expense</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"> </span></td> <td id="xdx_980_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20230101__20231231_zR5kMezUmZi7" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(75.5)</span></td> <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20220101__20221231_zZ0YR99jQYp6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">655.6 </span></td> <td id="xdx_989_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20210101__20211231_zXYpZHcEc6G1" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(636.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Net income</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b> </b></span></td> <td id="xdx_986_eifrs-full--ProfitLoss_pn5n6_c20230101__20231231_zuuqxhh6d9dj" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>14,960.4 </b></span></td> <td id="xdx_989_eifrs-full--ProfitLoss_pn5n6_c20220101__20221231_zS8W3YH1pzud" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>14,891.2 </b></span></td> <td id="xdx_987_eifrs-full--ProfitLoss_pn5n6_c20210101__20211231_zcM6QF5Conth" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>13,122.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Acquisition of property, plant and equipment</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">3,365.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">4,062.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">4,645.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">593.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">968.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">801.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">782.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,112.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,665.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">1,263.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">389.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">565.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,004.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,533.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">7,677.1 </span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 6pt/115% Arial, Helvetica, Sans-Serif; margin: 0 0 10pt"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Brazil</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>CAC </b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 6.5pt Times New Roman, Times, Serif"><b>Latin America - South</b></span><b><span style="font: normal 8pt Times New Roman, Times, Serif"><sup> </sup></span></b></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Canada</b></span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Consolidated</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 5%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Segment assets</span></td> <td id="xdx_988_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_z0wbLqvBwkL6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">56,974.2 </span></td> <td id="xdx_980_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zj1Nk7eSl5Q2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">57,353.8 </span></td> <td id="xdx_98B_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zINhXNo28Sn8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">54,609.4 </span></td> <td id="xdx_98A_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zkN2vPQqbir9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">13,692.3 </span></td> <td id="xdx_987_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_z33Vaoyx1Ia3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15,385.6 </span></td> <td id="xdx_980_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zwJ3eA74vQP7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15,351.9 </span></td> <td id="xdx_985_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zRvD0uGiPxnk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">16,085.1 </span></td> <td id="xdx_981_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_zD1fZLa4Q9D9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">22,044.5 </span></td> <td id="xdx_98A_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_ziY3BvuM13Wb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">21,583.0 </span></td> <td id="xdx_980_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zMjKpM9oft76" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">15,856.9 </span></td> <td id="xdx_984_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_z0Oc9TqcPNJg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">16,093.3 </span></td> <td id="xdx_98C_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zeTiyoO960id" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">18,016.6 </span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zjvjshHKtWel" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">102,608.5 </span></td> <td id="xdx_98A_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zZMwwaxaxMoi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">110,877.2 </span></td> <td id="xdx_988_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLnamQ7uwSKc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">109,560.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Intersegment elimination</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zlm8UezkMwJ1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,162.1)</span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zzOX7gqmwDja" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,533.0)</span></td> <td id="xdx_981_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zVmerwrPCC4c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,868.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 6.5pt Times New Roman, Times, Serif">Non-segmented assets </span><span style="font: normal 8pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--Assets_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_zQHojmfSIny3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">32,197.9 </span></td> <td id="xdx_982_eifrs-full--Assets_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_zh5OJlZEVKpd" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">29,613.8 </span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_z4tm8CcBQW1d" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">31,910.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Total assets</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--Assets_iI_c20231231_zkGME8AD96t3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>132,644.3 </b></span></td> <td id="xdx_98C_eifrs-full--Assets_iI_c20221231_zxsETkqUshaa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>137,958.0 </b></span></td> <td id="xdx_989_eifrs-full--Assets_iI_c20211231_zfCmfHPYiZAb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>138,602.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Segment liabilities</span></td> <td id="xdx_98C_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zBBVqbOUdN59" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">28,841.3 </span></td> <td id="xdx_984_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zmvaI4g2MO8f" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">29,153.2 </span></td> <td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zljAZNrU2AF2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">27,611.2 </span></td> <td id="xdx_984_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_ztQrW1WYEQI2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">4,981.5 </span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zRXa7XLCBZZa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,098.0 </span></td> <td id="xdx_98F_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CACMember_zit77PO4uQE3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,414.4 </span></td> <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_za2Aiw3wlDAd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,095.4 </span></td> <td id="xdx_980_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_z6Oy09c63xRk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,843.6 </span></td> <td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--SouthLatinAmericaSegmentMember_z6vjztkTQiz" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">7,843.6 </span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zsTU55kzBT55" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,131.0 </span></td> <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zayzaaFhbds7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">5,053.7 </span></td> <td id="xdx_985_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--CanadaSegmentMember_zhI29FJIksG5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">6,156.5 </span></td> <td id="xdx_98B_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfkLi7NNj1h6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">44,049.2 </span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrDQdHc7KtJe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">46,148.5 </span></td> <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKSww68bPExh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">47,025.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">Intersegment elimination</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zKhheJ68Ow38" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,161.8)</span></td> <td id="xdx_987_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z3lpTtGAcRFd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,534.2)</span></td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zHcyZSJES4yi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">(2,869.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 6.5pt Times New Roman, Times, Serif">Non-segmented liabilities </span><span style="font: normal 8pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_c20231231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_z8LCSRr9Hrkb" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">90,756.9 </span></td> <td id="xdx_981_eifrs-full--EquityAndLiabilities_iI_c20221231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_z3SNHuW1Qhse" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">94,343.7 </span></td> <td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--UnallocatedAmountsMember_zHlY9gYbD3F5" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt">94,445.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>Total liabilities</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20231231_z0z7v3nEbYE" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>132,644.3 </b></span></td> <td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20221231_zTXsM6OMrd81" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>137,958.0 </b></span></td> <td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231_zX1MKKQ4cxzg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 6.5pt"><b>138,602.5 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 55.3pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The balance of non-segmented assets refers mainly to cash and cash equivalents, taxes and investments. The balance of non-segmented liabilities, in turn, refers mainly to equity values, taxes and derivatives.</td> </tr></table> 46361700000 42635800000 35586500000 10044800000 9440100000 9947400000 13797200000 17371200000 16571700000 9533200000 10261700000 10748700000 79736900000 79708800000 72854300000 23516100000 22736800000 18309100000 5035100000 4860800000 4727900000 6657300000 8553100000 8235700000 4083100000 4271400000 4387000000.0 39291600000 40422100000 35659700000 22845600000 19899000000.0 17277400000 5009700000 4579300000 5219500000 7139900000 8818100000 8336000000.0 5450100000 5990300000 6361700000 40445300000 39286700000 37194600000 6428600000 6111100000 5123100000 853100000 1020700000 872700000 1614300000 2159500000 2010100000 1854600000 2104000000.0 1926800000 10750600000 11395300000 9932700000 4477000000.0 4065000000.0 3440300000 665100000 645500000 693300000 1190000000.0 1426900000 1542900000 1080400000 1200000000.0 1359000000.0 7412500000 7337400000 7035500000 3563200000 3346000000.0 3006200000 413000000.0 333600000 427700000 659500000 835000000.0 832000000.0 638000000.0 722200000 611500000 5273700000 5236800000 4877400000 1892500000 2361300000 2096000000.0 26300000 -52900000 12400000 95000000.0 192700000 38800000 15100000 12800000 -23100000 2028900000 2513900000 2124100000 -137800000 -34500000 -210100000 -17900000 -16100000 -46700000 -47600000 -60500000 -115400000 -3100000 -32200000 -20600000 -206400000 -143300000 -392800000 10131500000 8703700000 7593700000 3086900000 2510500000 3191500000 3723500000 4528900000 3874400000 1889100000 1944700000 2420700000 18831000000.0 17687800000 17080300000 -3609800000 -3423100000 -3205400000 -185300000 -29100000 -115700000 15035900000 14235600000 13759200000 -75500000 655600000 -636600000 14960400000 14891200000 13122600000 3365500000 4062900000 4645100000 593400000 968400000 801600000 782200000 1112800000 1665400000 1263000000.0 389000000.0 565000000.0 6004100000 6533100000 7677100000 56974200000 57353800000 54609400000 13692300000 15385600000 15351900000 16085100000 22044500000 21583000000.0 15856900000 16093300000 18016600000 102608500000 110877200000 109560900000 -2162100000 -2533000000.0 -2868500000 32197900000 29613800000 31910100000 132644300000 137958000000.0 138602500000 28841300000 29153200000 27611200000 4981500000 5098000000.0 5414400000 5095400000 6843600000 7843600000 5131000000.0 5053700000 6156500000 44049200000 46148500000 47025700000 -2161800000 -2534200000 -2869100000 90756900000 94343700000 94445900000 132644300000 137958000000.0 138602500000 45100000000 13900000000 44600000000 13700000000 42600000000 15600000000 6300000000 10100000000 9200000000 5900000000 9700000000 9100000000 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfAdditionalInformationByBusinessUnitTableTextBlock_pn5n6_zzch8O6lKc85" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT REPORTING - Additional information (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zjw2hVprrkx2" style="display: none">Schedule of additional information</span></td> <td id="xdx_499_20230101__20231231__ifrs-full--ProductsAndServicesAxis__custom--BeerMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_z4aEV57inP0h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_490_20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--BeerMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_ztZNOenlUZPg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--BeerMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_z2RsmMV6BYIa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20230101__20231231__ifrs-full--ProductsAndServicesAxis__custom--NABMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zfuXohcVb6a6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231__ifrs-full--ProductsAndServicesAxis__custom--NABMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zQpfXDD942lc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20210101__20211231__ifrs-full--ProductsAndServicesAxis__custom--NABMember__ifrs-full--SegmentsAxis__custom--Brazil1Member_zbG0YCBl4Qi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_496_20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zbcy6wqP4Lz9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_z8Kz9Akqkbu5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49D_20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zid5VtVducOa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Brazil</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Beer</b></span></td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>NAB</b></span></td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Total </b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 29%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2021</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2021</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40A_eifrs-full--RevenueFromContractsWithCustomers_zT32ksBlSvfa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net sales</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">38,985.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">35,857.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">30,537.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">7,375.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">6,777.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">5,049.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">46,361.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">42,635.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">35,586.5 </span></td></tr> <tr id="xdx_40E_eifrs-full--CostOfSales_iN_di_zqZGwQVdjsrg" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Cost of sales</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(19,377.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(18,765.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(15,382.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,138.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,971.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,927.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(23,516.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(22,736.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(18,309.1)</span></td></tr> <tr id="xdx_40D_eifrs-full--GrossProfit_zLNA6kz1B3Z6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Gross profit</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>19,608.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>17,092.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>15,155.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>3,237.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2,806.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>2,122.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>22,845.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>19,899.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>17,277.4 </b></span></td></tr> <tr id="xdx_40A_eifrs-full--DistributionCosts_iN_di_ziQedEjXC1gj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Distribution expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,171.9)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,988.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,263.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,256.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,122.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(860.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(6,428.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(6,111.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(5,123.1)</span></td></tr> <tr id="xdx_404_eifrs-full--SalesAndMarketingExpense_iN_di_znIbCbIVKacf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Sales and marketing expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,969.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,596.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,096.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(507.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(468.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(344.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,477.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(4,065.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,440.3)</span></td></tr> <tr id="xdx_40F_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zdI05gqHYE2f" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Administrative expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,106.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,928.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,616.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(457.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(417.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(390.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,563.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,346.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3,006.2)</span></td></tr> <tr id="xdx_405_eifrs-full--OtherOperatingIncomeExpense_zki8Glg3lJZg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Other operating income/(expenses)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,474.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,884.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,711.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">418.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">476.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">384.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,892.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,361.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,096.0 </span></td></tr> <tr id="xdx_408_ecustom--ExceptionalItems_zn4cUvMYxbHe" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Exceptional items</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(137.8)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(30.6)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(202.0)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1696">-</span>   </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(3.9)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(8.1)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(137.8)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(34.5)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(210.1)</span></td></tr> <tr id="xdx_405_eifrs-full--ProfitLossFromOperatingActivities_zEwWj9q1Cpte" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Income from operations</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>8,697.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,432.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>6,689.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>1,434.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>1,271.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>904.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>10,131.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>8,703.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,593.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Net finance costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--FinanceIncomeCost_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zkusIcULGuwl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(2,050.6)</span></td> <td id="xdx_98F_eifrs-full--FinanceIncomeCost_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zcnXkYvBAdqh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(1,110.3)</span></td> <td id="xdx_98E_eifrs-full--FinanceIncomeCost_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zvlWJicdAeRl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance costs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(858.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Share of results of joint ventures</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td id="xdx_981_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zDx46OnRcZ36" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(179.0)</span></td> <td id="xdx_983_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zYO0WlLUOtv1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(38.3)</span></td> <td id="xdx_98C_eifrs-full--ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zu31T3KXNR7j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Share of results of joint ventures"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">(11.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Income before income tax</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_z2n7FCriMnAc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,901.9 </b></span></td> <td id="xdx_982_eifrs-full--ProfitLossBeforeTax_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zBDleDSR1Bx5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>7,555.1 </b></span></td> <td id="xdx_983_eifrs-full--ProfitLossBeforeTax_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zzJeP4gpTGSg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income before income tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>6,723.9 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">Income tax expense</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"> </span></td> <td id="xdx_985_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zIPc1SKcTMLi" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,214.9 </span></td> <td id="xdx_981_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_z6GrO149h8Uk" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">2,787.7 </span></td> <td id="xdx_988_eifrs-full--IncomeTaxExpenseContinuingOperations_pn5n6_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_zyWUNqXp5621" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Income tax expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">1,953.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>Net income</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b> </b></span></td> <td id="xdx_988_eifrs-full--ProfitLoss_c20230101__20231231__ifrs-full--SegmentsAxis__custom--Brazil1Member_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>10,116.8 </b></span></td> <td id="xdx_98E_eifrs-full--ProfitLoss_c20220101__20221231__ifrs-full--SegmentsAxis__custom--Brazil1Member_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>10,342.8 </b></span></td> <td id="xdx_98C_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentsAxis__custom--Brazil1Member_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt"><b>8,677.1 </b></span></td></tr> </table> 38985900000 35857900000 30537100000 7375800000 6777900000 5049400000 46361700000 42635800000 35586500000 19377700000 18765300000 15382000000.0 4138400000 3971500000 2927100000 23516100000 22736800000 18309100000 19608200000 17092600000 15155100000 3237400000 2806400000 2122300000 22845600000 19899000000.0 17277400000 5171900000 4988600000 4263100000 1256700000 1122500000 860000000.0 6428600000 6111100000 5123100000 3969400000 3596800000 3096200000 507600000 468200000 344100000 4477000000.0 4065000000.0 3440300000 3106000000.0 2928800000 2616100000 457200000 417200000 390100000 3563200000 3346000000.0 3006200000 1474100000 1884500000 1711300000 418400000 476800000 384700000 1892500000 2361300000 2096000000.0 -137800000 -30600000 -202000000.0 -3900000 -8100000 -137800000 -34500000 -210100000 8697200000 7432300000 6689000000.0 1434300000 1271400000 904700000 10131500000 8703700000 7593700000 -2050600000 -1110300000 -858100000 -179000000.0 -38300000 -11700000 7901900000 7555100000 6723900000 2214900000 2787700000 1953200000 10116800000 10342800000 8677100000 <p id="xdx_805_ecustom--DisclosuresOfRevenueExplanatory_z6Ao0kO9Pnz4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span id="a_011"></span><b>6.</b></td><td><b><span id="xdx_82E_zZArGPDpccee">NET SALES</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In compliance with the Brazilian Federal Law 6,404/76, Company discloses the reconciliation between gross and net sales presented in the consolidated income statement. The values by each operational segment are disclosed in note 5 – <i>Segment reporting</i>:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock_pn5n6_zPyuzti80T22" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET SALES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zuKYczv8j3m3" style="display: none">Schedule of net sales</span></td> <td id="xdx_497_20230101__20231231_zNq1eWwWGx1j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231_zPKwNUZCBKqf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_z2wQb2YDYyl2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 39%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40E_eifrs-full--RevenueFromSaleOfGoods_maRzPZ3_z7qg3efHjBKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gross sales</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">120,117.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">125,907.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110,162.7 </span></td></tr> <tr id="xdx_401_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_iN_di_msRzPZ3_zx7MmvVgEW9e" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Excise duty</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(25,227.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(24,851.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(22,052.6)</span></td></tr> <tr id="xdx_40C_ecustom--SalesDiscounts_iN_di_msRzPZ3_zLK0ze78t1Z3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discounts</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15,153.3)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(21,347.0)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15,255.8)</span></td></tr> <tr id="xdx_404_eifrs-full--Revenue_iT_mtRzPZ3_zEqNFMbcH4Oi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>79,736.9 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>79,708.8 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>72,854.3 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2023, the Company calculated R$<span id="xdx_905_ecustom--DeductionOfRevenue_pn5n6_c20230101__20231231_zZKcaxh3kHFf" title="Deduction of revenue">1,467.2</span> million of fiscal incentives recognized as a deduction of revenue (R$<span id="xdx_908_ecustom--DeductionOfRevenue_pn5n6_c20220101__20221231_zBx6wiF0pXDc" title="Deduction of revenue">1,245.8</span> million at December 31, 2022, and R$<span id="xdx_903_ecustom--DeductionOfRevenue_pn5n6_c20210101__20211231_zqT3xHlqGaQ5" title="Deduction of revenue">1,048.3</span> million at December 31, 2021).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><b>Accounting Policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue when the performance obligations are satisfied, that is, when the Company or its subsidiaries transfer control of a product to a customer. Revenue represents the fair value of the amount received or receivable upon the sale of products or the rendering of services in the ordinary course of Group’s business. Revenue is presented net of taxes, returns, rebates and discounts, as well as net of the elimination of sales between the consolidated companies.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue <span style="color: black">is measured based on the consideration, which the Company expect to have</span> the <span style="color: black">right</span> to receive <span style="color: black">in contracts with customers and </span>excludes amounts <span style="color: black">collected on behalf of third parties.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue recognition is based on the approach of IFRS 15 - <span style="color: windowtext"><i>Revenue from Contracts with Customers</i></span>, from five-step:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 3.3pt"></td><td style="width: 18pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identifying the contract with a customer.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 3.3pt"></td><td style="width: 18pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identifying performance obligations in the contract.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 3.3pt"></td><td style="width: 18pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Determining the transaction price.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 3.3pt"></td><td style="width: 18pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Allocating the transaction price to performance obligations in the contracts.</td></tr></table> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 3.3pt"></td><td style="width: 18pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Revenue recognition when the performance obligations have been satisfied, meaning when the company transfers control of a product to a customer.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Contracts can include significant variable elements, such as discounts, rebates, refunds, credits, price concessions, incentives, performance bonuses and penalties. These trade incentives are treated as variable consideration. If the consideration includes a variable component, the company estimates the amount of consideration to which it will be entitled for transferring the promised goods or services to the customer. Variable consideration is only included in the transaction price if it is highly probable that the amount of revenue recognized would not be subject to significant future reversals when the respective uncertainty is resolved.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The gross sales obtained by the Company, in general, are subject to the incidence of certain taxes and contributions, which are calculated and paid to fiscal authorities in accordance with current municipal, state and federal legislation, and does not result in Group’s equity increase. These taxes and contributions are deducted from gross sales and relate substantially to tax on transactions concerning the circulation of goods (“ICMS”), social integration program (“PIS”), contribution to social security financing (“COFINS”) in Brazil.</p> <table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureOfTheReconciliationBetweenGrossSalesAndNetSalesTextBlock_pn5n6_zPyuzti80T22" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET SALES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zuKYczv8j3m3" style="display: none">Schedule of net sales</span></td> <td id="xdx_497_20230101__20231231_zNq1eWwWGx1j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231_zPKwNUZCBKqf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_z2wQb2YDYyl2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 39%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40E_eifrs-full--RevenueFromSaleOfGoods_maRzPZ3_z7qg3efHjBKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gross sales</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">120,117.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">125,907.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110,162.7 </span></td></tr> <tr id="xdx_401_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_iN_di_msRzPZ3_zx7MmvVgEW9e" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Excise duty</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(25,227.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(24,851.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(22,052.6)</span></td></tr> <tr id="xdx_40C_ecustom--SalesDiscounts_iN_di_msRzPZ3_zLK0ze78t1Z3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discounts</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15,153.3)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(21,347.0)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15,255.8)</span></td></tr> <tr id="xdx_404_eifrs-full--Revenue_iT_mtRzPZ3_zEqNFMbcH4Oi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>79,736.9 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>79,708.8 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>72,854.3 </b></span></td></tr> </table> 120117700000 125907200000 110162700000 25227500000 24851400000 22052600000 15153300000 21347000000.0 15255800000 79736900000 79708800000 72854300000 1467200000 1245800000 1048300000 <p id="xdx_800_eifrs-full--DisclosureOfOtherOperatingIncomeExpenseExplanatory_zCqkR8PAfrn5" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><b><span id="a_012"></span>7.</b></td><td><b><span><span id="xdx_820_zIiYOQLrnnC8">OTHER OPERATING INCOME/(EXPENSES)</span></span></b></td></tr></table> <p style="font: 12pt/13pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock_pn5n6_zpIATmHCcG" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zwJIOACYAz7h" style="display: none">Schedule of other operating income</span></td> <td id="xdx_49D_20230101__20231231_zYGbsKE7Zhm2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20220101__20221231_zXm1JJJ4qSn3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20210101__20211231_zpFZttOcZTXk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 70%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_403_eifrs-full--RevenueFromGovernmentGrants_maOOIEz3DT_zjjpU4Ej75sh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Government grants/net present value of long-term fiscal incentives</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,573.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,289.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">853.2 </span></td></tr> <tr id="xdx_40A_ecustom--ExtemporaneousCreditsDebits_maOOIEz3DT_zBwuz5BzDqJi" style="vertical-align: bottom; background-color: White"> <td style="font-size: 9pt; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Extemporaneous credits/(debits) </span><span style="font: normal 9pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">218.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,013.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,219.0 </span></td></tr> <tr id="xdx_401_eifrs-full--AdjustmentsForProvisions_iN_di_msOOIEz3DT_zfHVWHP8Wzrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Additions)/reversals of provisions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(77.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(77.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(71.4)</span></td></tr> <tr id="xdx_409_eifrs-full--GainsLossesOnDisposalsOfPropertyPlantAndEquipment_maOOIEz3DT_zxj8ET9ygiG2" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">86.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">88.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">66.1 </span></td></tr> <tr id="xdx_400_ecustom--OtherPortionsOfOtherOperatingIncomeExpense_maOOIEz3DT_z6fEDsm0TwP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other operating income/(expenses), net</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">229.0 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">199.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">57.2 </span></td></tr> <tr id="xdx_409_eifrs-full--OtherOperatingIncomeExpense_iT_mtOOIEz3DT_z13TGVuxpCq4" style="background-color: White"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,028.9 </b></span></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,513.9 </b></span></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,124.1 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">As detailed in Notes 1 – <i>Corporate information</i> and 27.2 – <i>Contingencies</i>, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS, including in the tax substitution form, from its calculation basis, in the item Other operating income/(expenses). </td> </tr></table> <p id="xdx_8AA_zdrapisUYcF7" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes, in other operating income/(expenses) line, government incentives granted as rate reduction, calculation basis reduction, financing or subsidized loans, assumed credit, deferred payment or partial reductions of due state tax payable.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Government grants are not recognized until there is reasonable assurance that the Company and subsidiaries will meet the respective conditions and obligations related to governmental terms.</p> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfOtherOperatingIncomeExpensePortionsTextBlock_pn5n6_zpIATmHCcG" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER OPERATING INCOME/(EXPENSES) (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zwJIOACYAz7h" style="display: none">Schedule of other operating income</span></td> <td id="xdx_49D_20230101__20231231_zYGbsKE7Zhm2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20220101__20221231_zXm1JJJ4qSn3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20210101__20211231_zpFZttOcZTXk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 70%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_403_eifrs-full--RevenueFromGovernmentGrants_maOOIEz3DT_zjjpU4Ej75sh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Government grants/net present value of long-term fiscal incentives</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,573.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,289.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">853.2 </span></td></tr> <tr id="xdx_40A_ecustom--ExtemporaneousCreditsDebits_maOOIEz3DT_zBwuz5BzDqJi" style="vertical-align: bottom; background-color: White"> <td style="font-size: 9pt; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Extemporaneous credits/(debits) </span><span style="font: normal 9pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">218.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,013.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,219.0 </span></td></tr> <tr id="xdx_401_eifrs-full--AdjustmentsForProvisions_iN_di_msOOIEz3DT_zfHVWHP8Wzrg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Additions)/reversals of provisions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(77.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(77.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(71.4)</span></td></tr> <tr id="xdx_409_eifrs-full--GainsLossesOnDisposalsOfPropertyPlantAndEquipment_maOOIEz3DT_zxj8ET9ygiG2" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains/(losses) on disposals of property, plant and equipment, intangible assets and the operations of associates</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">86.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">88.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">66.1 </span></td></tr> <tr id="xdx_400_ecustom--OtherPortionsOfOtherOperatingIncomeExpense_maOOIEz3DT_z6fEDsm0TwP5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other operating income/(expenses), net</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">229.0 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">199.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">57.2 </span></td></tr> <tr id="xdx_409_eifrs-full--OtherOperatingIncomeExpense_iT_mtOOIEz3DT_z13TGVuxpCq4" style="background-color: White"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,028.9 </b></span></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,513.9 </b></span></td> <td style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,124.1 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">As detailed in Notes 1 – <i>Corporate information</i> and 27.2 – <i>Contingencies</i>, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS, including in the tax substitution form, from its calculation basis, in the item Other operating income/(expenses). </td> </tr></table> 1573200000 1289300000 853200000 218000000.0 1013900000 1219000000.0 77700000 77200000 71400000 86400000 88800000 66100000 229000000.0 199100000 57200000 2028900000 2513900000 2124100000 <p id="xdx_806_ecustom--DisclosureOfExceptionalItemsTextBlock_ztjwVLRtyMx8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt/13pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"><span id="a_013"></span></td><td style="width: 14.2pt"><b>8.</b></td><td><b><span id="xdx_824_zs9UVMJYrFw7">EXCEPTIONAL ITEMS</span></b></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock_zGdp4wVpRr14" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EXCEPTIONAL ITEMS (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_zy4zQYfFKA0k" style="display: none">Schedule of exceptional items</span></td> <td id="xdx_49C_20230101__20231231_zD84TsaBgZX3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20220101__20221231_zHzt0m63NCk2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20210101__20211231_zUA5gCj0cyZ3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40D_eifrs-full--ExpenseOfRestructuringActivities_iN_di_msEIzMUm_zfMxM8QdXR58" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Restructuring </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(109.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(101.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(165.4)</span></td></tr> <tr id="xdx_403_ecustom--Covid19ImpactExpense_iN_di_msEIzMUm_zG6ELK1mC3Y6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">COVID-19 impacts </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1807">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(134.3)</span></td></tr> <tr id="xdx_401_ecustom--LegalFee_iN_di_msEIzMUm_zMfUhBRlNk0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Legal fees </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(iii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(94.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1813">-</span>   </span></td></tr> <tr id="xdx_402_eifrs-full--GainsLossesOnNetMonetaryPosition_maEIzMUm_zg4MPzySAOva" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.1)</span></td></tr> <tr id="xdx_40D_ecustom--DistributionAgreement_iN_di_msEIzMUm_zevVBjOntgL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Distribution agreement </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(iv)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(82.0)</span></td></tr> <tr id="xdx_40C_ecustom--WriteoffOfInvestmentsiv_iN_di_msEIzMUm_zdY8VVsCHzhk" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Write-off of investments</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (v)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span>   </span></td></tr> <tr id="xdx_405_ecustom--ExceptionalItems_iT_mtEIzMUm_zOa5ZCAZm6J4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(206.4)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(143.3)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(392.8)</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The restructuring expenses primarily related to centralization projects and resizing in Brazil, Latin America CAC and Canada.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">COVID-19 expenses refer to (a) additional administrative expenses to ensure the safety of the Company’s people (increased frequency of cleaning at the Company’s facilities, providing alcohol gel and masks for our employees); (b) donations; (c) Company initiatives providing support for some customer ecosystems, which were necessary due to the COVID-19 pandemic.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">In 2003 some holders of warrants issued by Cervejaria Brahma filed lawsuits to discuss the criteria used in calculating the exercise price of such warrants. In 2023, the Company obtained some final favorable decisions on the matter, which was already classified as a remote loss. The amount recorded in this line refers to the provision for legal fees related to this matter.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to distribution agreement with our strategic partner in Guatemala.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to an investment write-off of a business line in Canada</td> </tr></table> <p id="xdx_8A9_zZgaSUdjpOf9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Accounting Policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Exceptional items are those that, considering their peculiarities, in Management’s judgment need to be disclosed separately. In determining whether an event or transaction is exceptional, Management considers quantitative as well as qualitative factors such as the frequency or predictability of occurrence, and the potential impact on the variations in profit or loss. These items are disclosed in the income statement or separately disclosed in the notes to the financial statements. Transactions that may give rise to exceptional items are principally restructuring activities, amnesties, acquisitions of subsidiaries, impairment losses, and gains or losses on disposal of assets and investments.</p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfExceptionalItemsIncludedInTheIncomeStatementTextBlock_zGdp4wVpRr14" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EXCEPTIONAL ITEMS (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_zy4zQYfFKA0k" style="display: none">Schedule of exceptional items</span></td> <td id="xdx_49C_20230101__20231231_zD84TsaBgZX3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20220101__20221231_zHzt0m63NCk2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20210101__20211231_zUA5gCj0cyZ3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40D_eifrs-full--ExpenseOfRestructuringActivities_iN_di_msEIzMUm_zfMxM8QdXR58" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Restructuring </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(109.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(101.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(165.4)</span></td></tr> <tr id="xdx_403_ecustom--Covid19ImpactExpense_iN_di_msEIzMUm_zG6ELK1mC3Y6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">COVID-19 impacts </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1807">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(134.3)</span></td></tr> <tr id="xdx_401_ecustom--LegalFee_iN_di_msEIzMUm_zMfUhBRlNk0g" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Legal fees </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(iii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(94.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1813">-</span>   </span></td></tr> <tr id="xdx_402_eifrs-full--GainsLossesOnNetMonetaryPosition_maEIzMUm_zg4MPzySAOva" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.1)</span></td></tr> <tr id="xdx_40D_ecustom--DistributionAgreement_iN_di_msEIzMUm_zevVBjOntgL8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Distribution agreement </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(iv)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1820">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(82.0)</span></td></tr> <tr id="xdx_40C_ecustom--WriteoffOfInvestmentsiv_iN_di_msEIzMUm_zdY8VVsCHzhk" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Write-off of investments</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (v)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1825">-</span>   </span></td></tr> <tr id="xdx_405_ecustom--ExceptionalItems_iT_mtEIzMUm_zOa5ZCAZm6J4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(206.4)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(143.3)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(392.8)</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The restructuring expenses primarily related to centralization projects and resizing in Brazil, Latin America CAC and Canada.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">COVID-19 expenses refer to (a) additional administrative expenses to ensure the safety of the Company’s people (increased frequency of cleaning at the Company’s facilities, providing alcohol gel and masks for our employees); (b) donations; (c) Company initiatives providing support for some customer ecosystems, which were necessary due to the COVID-19 pandemic.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(iii)</td><td style="width: 5pt"></td><td style="text-align: justify">In 2003 some holders of warrants issued by Cervejaria Brahma filed lawsuits to discuss the criteria used in calculating the exercise price of such warrants. In 2023, the Company obtained some final favorable decisions on the matter, which was already classified as a remote loss. The amount recorded in this line refers to the provision for legal fees related to this matter.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(iv)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to distribution agreement with our strategic partner in Guatemala.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(v)</td><td style="width: 5pt"></td><td style="text-align: justify">Refers to an investment write-off of a business line in Canada</td> </tr></table> 109400000 101800000 165400000 16700000 134300000 94700000 -2300000 -8200000 -11100000 82000000.0 16600000 -206400000 -143300000 -392800000 <p id="xdx_802_ecustom--DisclosureOfPayrollAndRelatedBenefitsOfTheEntityTextBlock_z9VjYAe6cDQg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt/110% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"><span id="a_015"></span></td><td style="width: 14.2pt"><b>9.</b></td><td style="text-align: justify"><b><span id="xdx_82E_zmWfZcOVQMw8">PAYROLL AND RELATED BENEFITS</span></b></td></tr></table> <p style="font: 8pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfPayrollAndRelatedBenefitsTextBlock_pn5n6_z9HS2pxerbVj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PAYROLL AND RELATED BENEFITS (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_ztcrXEXUt0X4" style="display: none">Schedule of payroll and related benefits</span></td> <td id="xdx_496_20230101__20231231_zsOljV864Xvh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231_zzHOWl1TWh03" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_zQzUS91lrdj6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_400_eifrs-full--WagesAndSalaries_pn5n6_maEBEzkEh_zzy5x8O8FvL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Wages and salaries</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,550.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,496.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,162.6 </span></td></tr> <tr id="xdx_40F_eifrs-full--SocialSecurityContributions_pn5n6_maEBEzkEh_zmpYaqUQCcYi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Social security contributions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,322.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,239.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,016.0 </span></td></tr> <tr id="xdx_40D_eifrs-full--OtherEmployeeExpense_pn5n6_maEBEzkEh_ziCKMdP8r6Ke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other personnel costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">970.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,075.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,076.1 </span></td></tr> <tr id="xdx_40E_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_pn5n6_maEBEzkEh_zurAOW5Ehrx5" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Increase in liabilities for defined benefit plans</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">145.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">157.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">178.2 </span></td></tr> <tr id="xdx_40D_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn5n6_maEBEzkEh_zqHWMWA7y1q9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Share-based payments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">333.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">311.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">391.5 </span></td></tr> <tr id="xdx_408_eifrs-full--PostemploymentBenefitExpenseDefinedContributionPlans_pn5n6_maEBEzkEh_zHHt534O6eF" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions to defined contribution plans</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">91.3 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">82.0 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74.1 </span></td></tr> <tr id="xdx_40C_eifrs-full--EmployeeBenefitsExpense_iT_pn5n6_mtEBEzkEh_zn2jM4Ui5MT7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,413.5 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,363.1 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,898.5 </b></span></td></tr> </table> <p id="xdx_8A1_zSVrbEi5XCu1" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The payroll expenses and related benefits are presented in the income statement as shown below:</p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfPayrollAndRelatedBenefitsAffectingTheIncomeStatementTextBlock_zI6gBsL7neYd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PAYROLL AND RELATED BENEFITS (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zEshqxPdvMVd" style="display: none">Schedule of payroll expenses and related benefits</span></td> <td id="xdx_49D_20230101__20231231_zV78hoSOXT9j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_491_20220101__20221231_zZ7O1ASKK54k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_496_20210101__20211231_zLNdGb3zOhA7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40E_ecustom--EmployeeBenefitsExpenseCostOfSales_maEBEzCdK_zktAJBP3UbVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cost of sales</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,629.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,510.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,247.9 </span></td></tr> <tr id="xdx_40B_ecustom--EmployeeBenefitsExpenseDistributionExpenses_maEBEzCdK_zfjATiW9vXNa" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Distribution expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,289.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,396.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,286.8 </span></td></tr> <tr id="xdx_402_ecustom--EmployeeBenefitsExpenseCommercialExpenses_maEBEzCdK_zeQdyGHyS2Bf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commercial expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,321.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,504.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,480.9 </span></td></tr> <tr id="xdx_406_ecustom--EmployeeBenefitsExpenseAdministrativeExpenses_maEBEzCdK_zVQn3vzGIky9" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,907.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,798.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,699.1 </span></td></tr> <tr id="xdx_406_ecustom--EmployeeBenefitsExpenseNetFinanceCosts_maEBEzCdK_z9o6JTFTJShc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net finance costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">114.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">107.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">115.6 </span></td></tr> <tr id="xdx_409_ecustom--EmployeeBenefitsExpenseOtherOperatingIncomeExpense_iN_di_msEBEzCdK_zkjmjeljYK1j" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other operating (income)/expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span>   </span></td></tr> <tr id="xdx_406_ecustom--EmployeeBenefitsExpenseExceptionalItems_maEBEzCdK_zrliWMa3aXl5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Exceptional items</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">152.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">43.6 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">68.2 </span></td></tr> <tr id="xdx_40A_eifrs-full--EmployeeBenefitsExpense_iT_mtEBEzCdK_zyUwCBW4oFi9" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,413.5 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,363.1 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,898.5 </b></span></td></tr> </table> <p id="xdx_8AD_z5ylTvhycgn1" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfPayrollAndRelatedBenefitsTextBlock_pn5n6_z9HS2pxerbVj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PAYROLL AND RELATED BENEFITS (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_ztcrXEXUt0X4" style="display: none">Schedule of payroll and related benefits</span></td> <td id="xdx_496_20230101__20231231_zsOljV864Xvh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231_zzHOWl1TWh03" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_zQzUS91lrdj6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_400_eifrs-full--WagesAndSalaries_pn5n6_maEBEzkEh_zzy5x8O8FvL9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Wages and salaries</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,550.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,496.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,162.6 </span></td></tr> <tr id="xdx_40F_eifrs-full--SocialSecurityContributions_pn5n6_maEBEzkEh_zmpYaqUQCcYi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Social security contributions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,322.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,239.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,016.0 </span></td></tr> <tr id="xdx_40D_eifrs-full--OtherEmployeeExpense_pn5n6_maEBEzkEh_ziCKMdP8r6Ke" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other personnel costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">970.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,075.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,076.1 </span></td></tr> <tr id="xdx_40E_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_pn5n6_maEBEzkEh_zurAOW5Ehrx5" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Increase in liabilities for defined benefit plans</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">145.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">157.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">178.2 </span></td></tr> <tr id="xdx_40D_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn5n6_maEBEzkEh_zqHWMWA7y1q9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Share-based payments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">333.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">311.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">391.5 </span></td></tr> <tr id="xdx_408_eifrs-full--PostemploymentBenefitExpenseDefinedContributionPlans_pn5n6_maEBEzkEh_zHHt534O6eF" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions to defined contribution plans</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">91.3 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">82.0 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74.1 </span></td></tr> <tr id="xdx_40C_eifrs-full--EmployeeBenefitsExpense_iT_pn5n6_mtEBEzkEh_zn2jM4Ui5MT7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,413.5 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,363.1 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,898.5 </b></span></td></tr> </table> 4550200000 4496100000 4162600000 1322300000 1239700000 1016000000.0 970700000 1075900000 1076100000 145600000 157800000 178200000 333400000 311600000 391500000 91300000 82000000.0 74100000 7413500000 7363100000 6898500000 <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfPayrollAndRelatedBenefitsAffectingTheIncomeStatementTextBlock_zI6gBsL7neYd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PAYROLL AND RELATED BENEFITS (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zEshqxPdvMVd" style="display: none">Schedule of payroll expenses and related benefits</span></td> <td id="xdx_49D_20230101__20231231_zV78hoSOXT9j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_491_20220101__20221231_zZ7O1ASKK54k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_496_20210101__20211231_zLNdGb3zOhA7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 59%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40E_ecustom--EmployeeBenefitsExpenseCostOfSales_maEBEzCdK_zktAJBP3UbVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cost of sales</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,629.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,510.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,247.9 </span></td></tr> <tr id="xdx_40B_ecustom--EmployeeBenefitsExpenseDistributionExpenses_maEBEzCdK_zfjATiW9vXNa" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Distribution expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,289.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,396.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,286.8 </span></td></tr> <tr id="xdx_402_ecustom--EmployeeBenefitsExpenseCommercialExpenses_maEBEzCdK_zeQdyGHyS2Bf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commercial expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,321.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,504.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,480.9 </span></td></tr> <tr id="xdx_406_ecustom--EmployeeBenefitsExpenseAdministrativeExpenses_maEBEzCdK_zVQn3vzGIky9" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,907.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,798.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,699.1 </span></td></tr> <tr id="xdx_406_ecustom--EmployeeBenefitsExpenseNetFinanceCosts_maEBEzCdK_z9o6JTFTJShc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net finance costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">114.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">107.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">115.6 </span></td></tr> <tr id="xdx_409_ecustom--EmployeeBenefitsExpenseOtherOperatingIncomeExpense_iN_di_msEBEzCdK_zkjmjeljYK1j" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other operating (income)/expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1888">-</span>   </span></td></tr> <tr id="xdx_406_ecustom--EmployeeBenefitsExpenseExceptionalItems_maEBEzCdK_zrliWMa3aXl5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Exceptional items</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">152.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">43.6 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">68.2 </span></td></tr> <tr id="xdx_40A_eifrs-full--EmployeeBenefitsExpense_iT_mtEBEzCdK_zyUwCBW4oFi9" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,413.5 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>7,363.1 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,898.5 </b></span></td></tr> </table> 2629600000 2510400000 2247900000 1289900000 1396300000 1286800000 1321300000 1504800000 1480900000 1907600000 1798700000 1699100000 114300000 107800000 115600000 1300000 -1500000 152100000 43600000 68200000 7413500000 7363100000 6898500000 <p id="xdx_805_eifrs-full--DisclosureOfAdditionalInformationExplanatory_zkyCcZxmq3E8" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_016"></span>10.</b></td><td><b><span id="xdx_821_zmFCSgyzLodi">ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation, amortization and impairment expenses are included in the following income statement accounts for the years ended in December 31,2023, 2022 and 2021:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eifrs-full--DisclosureOfDepreciationAndAmortisationExpenseExplanatory_pn5n6_z5HCKTbE8azj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zDoE9GXiO8n8" style="display: none">Schedule of depreciation, amortization and impairment expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Depreciation and impairment of property, plant and equipment</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Amortization of intangible assets</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 27%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Cost of sales </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(i)</sup></span></td> <td id="xdx_987_ecustom--DepreciationExpenseCostOfSales_pn5n6_c20230101__20231231_zTDcS8SojZh9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,552.5 </span></td> <td id="xdx_987_ecustom--DepreciationExpenseCostOfSales_pn5n6_c20220101__20221231_zyXWZ9rOdBgj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,413.3 </span></td> <td id="xdx_98C_ecustom--DepreciationExpenseCostOfSales_pn5n6_c20210101__20211231_zd38Dg0N10Y6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,326.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--AmortisationExpenseCostOfSales_pn5n6_c20230101__20231231_zPNLqT1zSdGc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.2 </span></td> <td id="xdx_98F_ecustom--AmortisationExpenseCostOfSales_pn5n6_c20220101__20221231_zSYtJqmlw5th" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.4 </span></td> <td id="xdx_980_ecustom--AmortisationExpenseCostOfSales_pn5n6_c20210101__20211231_zDi4UU770XPh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Distribution expenses</span></td> <td id="xdx_986_ecustom--DepreciationOfDistributionExpenses_pn5n6_c20230101__20231231_z3D7ja2zcgJl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,098.3 </span></td> <td id="xdx_98D_ecustom--DepreciationOfDistributionExpenses_pn5n6_c20220101__20221231_zTSXOLLTr713" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">893.5 </span></td> <td id="xdx_98B_ecustom--DepreciationOfDistributionExpenses_pn5n6_c20210101__20211231_zLwPsk3TMdEk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">654.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--AmortisationOfDistributionExpenses_pn5n6_c20230101__20231231_zE4Eo7AOiLUa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1920">-</span>   </span></td> <td id="xdx_983_ecustom--AmortisationOfDistributionExpenses_pn5n6_c20220101__20221231_zmsuIStbj7Wi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1922">-</span>   </span></td> <td id="xdx_98F_ecustom--AmortisationOfDistributionExpenses_pn5n6_c20210101__20211231_zUyl9ZCw3WF9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1924">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commercial expenses</span></td> <td id="xdx_984_ecustom--DepreciationOfCommercialExpenses_pn5n6_c20230101__20231231_zy6ROvdUeIje" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">613.7 </span></td> <td id="xdx_98F_ecustom--DepreciationOfCommercialExpenses_pn5n6_c20220101__20221231_zfpKMWHCoiUj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">660.7 </span></td> <td id="xdx_98A_ecustom--DepreciationOfCommercialExpenses_pn5n6_c20210101__20211231_zE3WWhpGpUQg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">700.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--AmortisationOfCommercialExpenses_pn5n6_c20230101__20231231_zkyitreWiQN" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">148.6 </span></td> <td id="xdx_985_ecustom--AmortisationOfCommercialExpenses_pn5n6_c20220101__20221231_zstf8fMxHRmi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">113.2 </span></td> <td id="xdx_985_ecustom--AmortisationOfCommercialExpenses_pn5n6_c20210101__20211231_zbUhh71YsOab" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">84.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative expenses</span></td> <td id="xdx_986_ecustom--DepreciationOfAdministrativeExpenses_pn5n6_c20230101__20231231_zlwa0fRom7N7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">464.1 </span></td> <td id="xdx_984_ecustom--DepreciationOfAdministrativeExpenses_pn5n6_c20220101__20221231_z1DpnBww2sM5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">474.4 </span></td> <td id="xdx_982_ecustom--DepreciationOfAdministrativeExpenses_pn5n6_c20210101__20211231_zqC6HxSyOl53" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">331.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--AmortisationOfAdministrativeExpenses_pn5n6_c20230101__20231231_z0xDRyRhGqGf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">524.8 </span></td> <td id="xdx_983_ecustom--AmortisationOfAdministrativeExpenses_pn5n6_c20220101__20221231_zwf2axhWaHC7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">372.6 </span></td> <td id="xdx_987_ecustom--AmortisationOfAdministrativeExpenses_pn5n6_c20210101__20211231_zunIgORFQBY5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">304.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--DepreciationExpense_pn5n6_c20230101__20231231_zIPcB5Tv4Waf" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,728.6 </b></span></td> <td id="xdx_982_eifrs-full--DepreciationExpense_pn5n6_c20220101__20221231_zQogAK3AHijb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,441.9 </b></span></td> <td id="xdx_989_eifrs-full--DepreciationExpense_pn5n6_c20210101__20211231_zETcTPdI1sw3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,012.4 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--AmortisationExpense_pn5n6_c20230101__20231231_z6hw7oOWeRb3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amortisation expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>686.6 </b></span></td> <td id="xdx_98D_eifrs-full--AmortisationExpense_pn5n6_c20220101__20221231_zR8V60lVAe9i" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amortisation expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>502.2 </b></span></td> <td id="xdx_98E_eifrs-full--AmortisationExpense_pn5n6_c20210101__20211231_zK1VQIB8lfo6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amortisation expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>404.9 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">These amounts added to R$<span id="xdx_90F_ecustom--EmployeeBenefitsExpenseCostOfSales_pn5n6_c20230101__20231231_zV3pLQioqy3i" title="Payroll and related benefits">2,629.6</span> (R$<span id="xdx_909_ecustom--EmployeeBenefitsExpenseCostOfSales_pn5n6_c20220101__20221231_zTIJUAred2Cc" title="Payroll and related benefits">2,510.4</span> and R$<span id="xdx_905_ecustom--EmployeeBenefitsExpenseCostOfSales_pn5n6_c20210101__20211231_zteUiZrCHFAf" title="Payroll and related benefits">2,247.9</span> as at December 31, 2022, and 2021, respectively) mentioned in Note 9 - <i>Payroll and related benefits</i>, total R$<span id="xdx_903_ecustom--TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment_iI_pn5n6_c20231231_zlro1w0NgsWc" title="Total payroll and related benefits">6,195.3</span> (R$<span id="xdx_90A_ecustom--TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment_iI_pn5n6_c20221231_zX0fTuEHwdR5" title="Total payroll and related benefits">5,940.1</span> and R$<span id="xdx_900_ecustom--TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment_iI_pn5n6_c20211231_z9aFx6c4Zmra" title="Total payroll and related benefits">5,591</span>.0 as at December 31, 2022, and 2021, respectively). The remaining amount of R$<span id="xdx_902_ecustom--CostOfSalesProductionCosts_pn5n6_c20230101__20231231_zW6CfS9O4cS3" title="Remaining amount of cost of sales">33,096.3</span> (R$<span id="xdx_906_ecustom--CostOfSalesProductionCosts_pn6n6_c20220101__20221231_zsiOjKF1yjf8" title="Remaining amount of cost of sales">34,482</span>.0 and R$<span id="xdx_90D_ecustom--CostOfSalesProductionCosts_pn5n6_c20210101__20211231_zkes8Zpi9Cpj" title="Remaining amount of cost of sales">30,068.7</span> as at December 31, 2022, and 2021, respectively), recorded in the cost of sales, refers to other production costs.</td> </tr></table> <p id="xdx_8A6_zsBF7d7UukC9" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_893_eifrs-full--DisclosureOfDepreciationAndAmortisationExpenseExplanatory_pn5n6_z5HCKTbE8azj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - ADDITIONAL INFORMATION ON COST OF SALES AND OPERATING EXPENSES BY NATURE (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zDoE9GXiO8n8" style="display: none">Schedule of depreciation, amortization and impairment expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Depreciation and impairment of property, plant and equipment</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Amortization of intangible assets</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 27%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Cost of sales </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(i)</sup></span></td> <td id="xdx_987_ecustom--DepreciationExpenseCostOfSales_pn5n6_c20230101__20231231_zTDcS8SojZh9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,552.5 </span></td> <td id="xdx_987_ecustom--DepreciationExpenseCostOfSales_pn5n6_c20220101__20221231_zyXWZ9rOdBgj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,413.3 </span></td> <td id="xdx_98C_ecustom--DepreciationExpenseCostOfSales_pn5n6_c20210101__20211231_zd38Dg0N10Y6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,326.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--AmortisationExpenseCostOfSales_pn5n6_c20230101__20231231_zPNLqT1zSdGc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.2 </span></td> <td id="xdx_98F_ecustom--AmortisationExpenseCostOfSales_pn5n6_c20220101__20221231_zSYtJqmlw5th" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.4 </span></td> <td id="xdx_980_ecustom--AmortisationExpenseCostOfSales_pn5n6_c20210101__20211231_zDi4UU770XPh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets cost of sales"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Distribution expenses</span></td> <td id="xdx_986_ecustom--DepreciationOfDistributionExpenses_pn5n6_c20230101__20231231_z3D7ja2zcgJl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,098.3 </span></td> <td id="xdx_98D_ecustom--DepreciationOfDistributionExpenses_pn5n6_c20220101__20221231_zTSXOLLTr713" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">893.5 </span></td> <td id="xdx_98B_ecustom--DepreciationOfDistributionExpenses_pn5n6_c20210101__20211231_zLwPsk3TMdEk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">654.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--AmortisationOfDistributionExpenses_pn5n6_c20230101__20231231_zE4Eo7AOiLUa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1920">-</span>   </span></td> <td id="xdx_983_ecustom--AmortisationOfDistributionExpenses_pn5n6_c20220101__20221231_zmsuIStbj7Wi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1922">-</span>   </span></td> <td id="xdx_98F_ecustom--AmortisationOfDistributionExpenses_pn5n6_c20210101__20211231_zUyl9ZCw3WF9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets distribution expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl1924">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commercial expenses</span></td> <td id="xdx_984_ecustom--DepreciationOfCommercialExpenses_pn5n6_c20230101__20231231_zy6ROvdUeIje" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">613.7 </span></td> <td id="xdx_98F_ecustom--DepreciationOfCommercialExpenses_pn5n6_c20220101__20221231_zfpKMWHCoiUj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">660.7 </span></td> <td id="xdx_98A_ecustom--DepreciationOfCommercialExpenses_pn5n6_c20210101__20211231_zE3WWhpGpUQg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">700.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--AmortisationOfCommercialExpenses_pn5n6_c20230101__20231231_zkyitreWiQN" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">148.6 </span></td> <td id="xdx_985_ecustom--AmortisationOfCommercialExpenses_pn5n6_c20220101__20221231_zstf8fMxHRmi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">113.2 </span></td> <td id="xdx_985_ecustom--AmortisationOfCommercialExpenses_pn5n6_c20210101__20211231_zbUhh71YsOab" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets commercial expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">84.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative expenses</span></td> <td id="xdx_986_ecustom--DepreciationOfAdministrativeExpenses_pn5n6_c20230101__20231231_zlwa0fRom7N7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">464.1 </span></td> <td id="xdx_984_ecustom--DepreciationOfAdministrativeExpenses_pn5n6_c20220101__20221231_z1DpnBww2sM5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">474.4 </span></td> <td id="xdx_982_ecustom--DepreciationOfAdministrativeExpenses_pn5n6_c20210101__20211231_zqC6HxSyOl53" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">331.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--AmortisationOfAdministrativeExpenses_pn5n6_c20230101__20231231_z0xDRyRhGqGf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">524.8 </span></td> <td id="xdx_983_ecustom--AmortisationOfAdministrativeExpenses_pn5n6_c20220101__20221231_zwf2axhWaHC7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">372.6 </span></td> <td id="xdx_987_ecustom--AmortisationOfAdministrativeExpenses_pn5n6_c20210101__20211231_zunIgORFQBY5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization of intangible assets administrative expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">304.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--DepreciationExpense_pn5n6_c20230101__20231231_zIPcB5Tv4Waf" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,728.6 </b></span></td> <td id="xdx_982_eifrs-full--DepreciationExpense_pn5n6_c20220101__20221231_zQogAK3AHijb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,441.9 </b></span></td> <td id="xdx_989_eifrs-full--DepreciationExpense_pn5n6_c20210101__20211231_zETcTPdI1sw3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,012.4 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--AmortisationExpense_pn5n6_c20230101__20231231_z6hw7oOWeRb3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amortisation expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>686.6 </b></span></td> <td id="xdx_98D_eifrs-full--AmortisationExpense_pn5n6_c20220101__20221231_zR8V60lVAe9i" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amortisation expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>502.2 </b></span></td> <td id="xdx_98E_eifrs-full--AmortisationExpense_pn5n6_c20210101__20211231_zK1VQIB8lfo6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amortisation expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>404.9 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">These amounts added to R$<span id="xdx_90F_ecustom--EmployeeBenefitsExpenseCostOfSales_pn5n6_c20230101__20231231_zV3pLQioqy3i" title="Payroll and related benefits">2,629.6</span> (R$<span id="xdx_909_ecustom--EmployeeBenefitsExpenseCostOfSales_pn5n6_c20220101__20221231_zTIJUAred2Cc" title="Payroll and related benefits">2,510.4</span> and R$<span id="xdx_905_ecustom--EmployeeBenefitsExpenseCostOfSales_pn5n6_c20210101__20211231_zteUiZrCHFAf" title="Payroll and related benefits">2,247.9</span> as at December 31, 2022, and 2021, respectively) mentioned in Note 9 - <i>Payroll and related benefits</i>, total R$<span id="xdx_903_ecustom--TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment_iI_pn5n6_c20231231_zlro1w0NgsWc" title="Total payroll and related benefits">6,195.3</span> (R$<span id="xdx_90A_ecustom--TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment_iI_pn5n6_c20221231_zX0fTuEHwdR5" title="Total payroll and related benefits">5,940.1</span> and R$<span id="xdx_900_ecustom--TotalCostOfSalesEmployeeBenefitExpensesDepreciationAmortizationAndImpairment_iI_pn5n6_c20211231_z9aFx6c4Zmra" title="Total payroll and related benefits">5,591</span>.0 as at December 31, 2022, and 2021, respectively). The remaining amount of R$<span id="xdx_902_ecustom--CostOfSalesProductionCosts_pn5n6_c20230101__20231231_zW6CfS9O4cS3" title="Remaining amount of cost of sales">33,096.3</span> (R$<span id="xdx_906_ecustom--CostOfSalesProductionCosts_pn6n6_c20220101__20221231_zsiOjKF1yjf8" title="Remaining amount of cost of sales">34,482</span>.0 and R$<span id="xdx_90D_ecustom--CostOfSalesProductionCosts_pn5n6_c20210101__20211231_zkes8Zpi9Cpj" title="Remaining amount of cost of sales">30,068.7</span> as at December 31, 2022, and 2021, respectively), recorded in the cost of sales, refers to other production costs.</td> </tr></table> 3552500000 3413300000 3326600000 13200000 16400000 16400000 1098300000 893500000 654100000 613700000 660700000 700300000 148600000 113200000 84300000 464100000 474400000 331400000 524800000 372600000 304200000 5728600000 5441900000 5012400000 686600000 502200000 404900000 2629600000 2510400000 2247900000 6195300000 5940100000 5591000000 33096300000 34482000000 30068700000 <p id="xdx_808_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zPeDh10fCBLk" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_017"></span>11.</b></td><td><b><span id="xdx_821_z81OCJ1WinM9">NET FINANCE RESULT</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfFinanceCostExplanatory_pn5n6_zYWfELqyRLy5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET FINANCE RESULT (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zchPmpQ4gn4f" style="display: none">Schedule of net finance result</span></td> <td id="xdx_498_20230101__20231231_zMLnowkGXAT" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231_zgAlQ8SnImy3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20210101__20211231_zVCvwB3XBqZ2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40E_ecustom--FinanceExpensesAbstract_iB_zswvsoH8Kjkk" style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Finance expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_403_eifrs-full--InterestExpense_iN_di_maFCENFzTbH_zpLBXli7yTZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest expense</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,432.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,328.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,431.8)</span></td></tr> <tr id="xdx_408_ecustom--NetInterestOnPensionPlans_iN_di_maFCENFzTbH_zBc9jk4Q2bAd" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Interest on pension plans</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(107.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(115.6)</span></td></tr> <tr id="xdx_40A_eifrs-full--GainsLossesOnHedgingInstrument_msFCENFzTbH_zrEGn0BfLM3b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Losses on hedging instruments</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,675.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,158.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,540.2)</span></td></tr> <tr id="xdx_40F_ecustom--InterestOnProvisionForContingencies_iN_di_maFCENFzTbH_zx7QUwpRJ2dg" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest on provision for disputes and litigation</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(269.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(456.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(290.0)</span></td></tr> <tr id="xdx_40E_eifrs-full--NetForeignExchangeLoss_iN_di_maFCENFzTbH_zgHS6KTb1LT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Exchange differences</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,154.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(751.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(453.9)</span></td></tr> <tr id="xdx_400_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_iN_di_maFCENFzTbH_zURd7e1MBN77" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Tax on financial transactions</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(178.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(339.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(216.6)</span></td></tr> <tr id="xdx_406_eifrs-full--BankAndSimilarCharges_iN_di_maFCENFzTbH_zPPUyDSwExO5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bank guarantee expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(249.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(176.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(174.9)</span></td></tr> <tr id="xdx_404_eifrs-full--OtherFinanceCost_iN_di_maFCENFzTbH_zZAWr45hjXbj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other financial results</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(207.2)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(574.2)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(204.8)</span></td></tr> <tr id="xdx_400_ecustom--FinanceCostsExcludingNonrecurringFinanceCosts_iNT_di_mtFCENFzTbH_msNFRzLXu_zn7WAUYpOdO6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total of finance expenses</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,280.1)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(7,892.2)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(5,427.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--FinanceIncomeAbstract_iB_zf4JOPBPVK01" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Finance income</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40C_eifrs-full--RevenueFromInterest_maFIBAOzuCZ_zq1pNx9QPbD4" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest income</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,085.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,167.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,101.6 </span></td></tr> <tr id="xdx_40B_ecustom--IncomeFromInterestAndForeignExchangeRateOnLoansWithRelatedParties_maFIBAOzuCZ_zBdVRS9OlIg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest and foreign exchange rate on loans to/from related parties</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">119.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">37.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">42.5 </span></td></tr> <tr id="xdx_40E_ecustom--RevenueFromFinancialInstrumentsAtFairValueThroughProfitOrLoss_maFIBAOzuCZ_zhR7TvQBfBX6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial instruments at fair value through profit or loss</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2037">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">95.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">77.0 </span></td></tr> <tr id="xdx_401_eifrs-full--OtherFinanceIncome_maFIBAOzuCZ_zmMfkfXTChq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other financial results</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">289.4 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">565.3 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">78.9 </span></td></tr> <tr id="xdx_403_ecustom--FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems_iT_mtFIBAOzuCZ_maFIzz0V_zrBaQABeUtV9" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,494.2 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,865.6 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,300.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40B_ecustom--FinancialIncomeEffectOfAdoptionOfNewAccountingPolicies_maFIzz0V_zSRjOxqsrp7e" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">176.1 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,603.5 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">922.4 </span></td></tr> <tr id="xdx_40A_eifrs-full--FinanceIncome_iT_mtFIzz0V_maNFRzLXu_z1dAlmSmNP98" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total of finance income</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,670.3 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,469.1 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,222.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--NetFinanceResult_iT_mtNFRzLXu_zB2znMNQEwu7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net finance result</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,609.8)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,423.1)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,205.4)</b></span></td></tr> </table> <p id="xdx_8AC_zVSyvIa28XQ3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest expenses are presented net of the effects of interest rate derivative financial instruments which mitigate Ambev’s interest rate risk (Note 28 - <i>Financial instruments and risks</i>). The interest expenses are as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eifrs-full--DisclosureOfInterestExpenseExplanatory_pn5n6_zKGUQr3YwN0b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET FINANCE RESULT (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_zl7Acj1hNTx7" style="display: none">Schedule of interest expenses</span></td> <td id="xdx_493_20230101__20231231_zlBVbalRFrsb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20220101__20221231_zscG6t1MFzI2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20210101__20211231_zDdUlSKQo7Ok" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_408_eifrs-full--InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss_iN_di_maIEzJSo_zaee9fRc642j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial instruments measured at amortized cost</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(644.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(764.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(466.0)</span></td></tr> <tr id="xdx_407_ecustom--InterestExpenseOnInstrumentsAtFairValueThroughProfitOrLoss_iN_di_maIEzJSo_z9b9HhQCDjkd" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Financial instruments at fair value through profit or loss</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,788.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,564.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(965.8)</span></td></tr> <tr id="xdx_404_eifrs-full--InterestExpense_iNT_di_mtIEzJSo_zqsctawoj2hi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,432.2)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,328.3)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,431.8)</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Include R$<span id="xdx_904_ecustom--AccountsPayablePresentValue_iI_pn6n6_c20231231_zjD8sL8C4yvi" title="Accounts payable present value">1,231</span> million (R$<span id="xdx_90A_ecustom--AccountsPayablePresentValue_iI_pn6n6_c20221231_zjo8Wg8nrsx7" title="Accounts payable present value">654</span> million at December 31, 2022) as accounts payable present value adjustment.</td> </tr></table> <p id="xdx_8AF_z5XbSDQ31PO3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Interest income arises from the following financial assets:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_eifrs-full--DisclosureOfInterestIncomeExplanatory_pn5n6_zyt38WKlWYPj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET FINANCE RESULT (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zyskpq4qHaPk" style="display: none">Schedule of interest income</span></td> <td id="xdx_49C_20230101__20231231_zzv9qN7jG4si" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20220101__20221231_znD2qqM5uqP5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20210101__20211231_zDEThkG3c06" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_400_eifrs-full--InterestIncomeOnCashAndCashEquivalents_maRFIzT61_zHNCbnIwfD72" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash and cash equivalents</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,072.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">791.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">329.5 </span></td></tr> <tr id="xdx_404_eifrs-full--InterestIncomeOnFinancialAssetsHeldForTrading_maRFIzT61_zg61O7mO2cdd" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment on debt securities</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">175.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">84.7 </span></td></tr> <tr id="xdx_406_eifrs-full--InterestIncomeOnOtherFinancialAssets_maRFIzT61_z7qn213RVaSf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Other receivables</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">964.2 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,200.2 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">687.4 </span></td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromInterest_iT_mtRFIzT61_zLtERY2T2Tjc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,085.6 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,167.7 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,101.6 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(i)</span></td><td style="width: 5pt"></td><td style="text-align: justify">Refers, mainly, to monetary adjustment of recoverable tax.</td> </tr></table> <p id="xdx_8A3_zWFkYIvBAs65" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>a) Finance expenses</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Finance expenses comprises, in general, of interest payable on loans and borrowing, calculated using the effective interest rate method, trade payables present value adjustment, expenses related to bank guarantees, monetary adjustments resulting from disputes and litigations, foreign exchange losses, losses on currency hedging instruments intended for the offsetting of currency gains, results on interest rate hedging instruments, losses on hedging instruments that are not part of a hedge accounting relationship, losses on financial assets classified as held for trading, impairment losses on financial assets classified as available for sale, and as any losses due to hedge ineffectiveness.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All interest costs incurred in connection with borrowing or financial transactions, including transaction costs, are expensed as incurred as part of finance expenses, except when capitalized. The interest expenses component of finance lease payments is also recognized in the income statement using the effective interest rate method.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>b) Finance income</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Finance income comprises, in general, of interest received or receivable on funds invested, monetary updates arising from legal disputes, foreign exchange gains, gains on currency hedging instruments intended for offsetting currency losses, gains on hedging instruments that are not part of a hedge accounting relationship, gains on financial assets classified as at fair value through profit or loss, and as any gains due to hedge ineffectiveness. Interest income is recognized on an accruals basis unless collectability is in doubt.</p> <table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfFinanceCostExplanatory_pn5n6_zYWfELqyRLy5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET FINANCE RESULT (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zchPmpQ4gn4f" style="display: none">Schedule of net finance result</span></td> <td id="xdx_498_20230101__20231231_zMLnowkGXAT" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231_zgAlQ8SnImy3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49F_20210101__20211231_zVCvwB3XBqZ2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40E_ecustom--FinanceExpensesAbstract_iB_zswvsoH8Kjkk" style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Finance expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_403_eifrs-full--InterestExpense_iN_di_maFCENFzTbH_zpLBXli7yTZ6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest expense</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,432.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,328.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,431.8)</span></td></tr> <tr id="xdx_408_ecustom--NetInterestOnPensionPlans_iN_di_maFCENFzTbH_zBc9jk4Q2bAd" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Net Interest on pension plans</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(107.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(115.6)</span></td></tr> <tr id="xdx_40A_eifrs-full--GainsLossesOnHedgingInstrument_msFCENFzTbH_zrEGn0BfLM3b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Losses on hedging instruments</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,675.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,158.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,540.2)</span></td></tr> <tr id="xdx_40F_ecustom--InterestOnProvisionForContingencies_iN_di_maFCENFzTbH_zx7QUwpRJ2dg" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest on provision for disputes and litigation</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(269.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(456.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(290.0)</span></td></tr> <tr id="xdx_40E_eifrs-full--NetForeignExchangeLoss_iN_di_maFCENFzTbH_zgHS6KTb1LT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Exchange differences</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,154.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(751.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(453.9)</span></td></tr> <tr id="xdx_400_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_iN_di_maFCENFzTbH_zURd7e1MBN77" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Tax on financial transactions</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(178.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(339.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(216.6)</span></td></tr> <tr id="xdx_406_eifrs-full--BankAndSimilarCharges_iN_di_maFCENFzTbH_zPPUyDSwExO5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bank guarantee expenses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(249.8)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(176.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(174.9)</span></td></tr> <tr id="xdx_404_eifrs-full--OtherFinanceCost_iN_di_maFCENFzTbH_zZAWr45hjXbj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other financial results</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(207.2)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(574.2)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(204.8)</span></td></tr> <tr id="xdx_400_ecustom--FinanceCostsExcludingNonrecurringFinanceCosts_iNT_di_mtFCENFzTbH_msNFRzLXu_zn7WAUYpOdO6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total of finance expenses</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,280.1)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(7,892.2)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(5,427.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--FinanceIncomeAbstract_iB_zf4JOPBPVK01" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Finance income</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40C_eifrs-full--RevenueFromInterest_maFIBAOzuCZ_zq1pNx9QPbD4" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest income</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,085.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,167.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,101.6 </span></td></tr> <tr id="xdx_40B_ecustom--IncomeFromInterestAndForeignExchangeRateOnLoansWithRelatedParties_maFIBAOzuCZ_zBdVRS9OlIg8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest and foreign exchange rate on loans to/from related parties</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">119.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">37.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">42.5 </span></td></tr> <tr id="xdx_40E_ecustom--RevenueFromFinancialInstrumentsAtFairValueThroughProfitOrLoss_maFIBAOzuCZ_zhR7TvQBfBX6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial instruments at fair value through profit or loss</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2037">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">95.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">77.0 </span></td></tr> <tr id="xdx_401_eifrs-full--OtherFinanceIncome_maFIBAOzuCZ_zmMfkfXTChq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other financial results</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">289.4 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">565.3 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">78.9 </span></td></tr> <tr id="xdx_403_ecustom--FinanceIncomeBeforeAdoptionOfNewAccountingPoliciesAndNonrecurringItems_iT_mtFIBAOzuCZ_maFIzz0V_zrBaQABeUtV9" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,494.2 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,865.6 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,300.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40B_ecustom--FinancialIncomeEffectOfAdoptionOfNewAccountingPolicies_maFIzz0V_zSRjOxqsrp7e" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">176.1 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,603.5 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">922.4 </span></td></tr> <tr id="xdx_40A_eifrs-full--FinanceIncome_iT_mtFIzz0V_maNFRzLXu_z1dAlmSmNP98" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total of finance income</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,670.3 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,469.1 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,222.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--NetFinanceResult_iT_mtNFRzLXu_zB2znMNQEwu7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net finance result</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,609.8)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,423.1)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,205.4)</b></span></td></tr> </table> 2432200000 2328300000 1431800000 114300000 107900000 115600000 -1675100000 -3158400000 -2540200000 269200000 456600000 290000000.0 1154000000.0 751100000 453900000 178300000 339600000 216600000 249800000 176100000 174900000 207200000 574200000 204800000 6280100000 7892200000 5427800000 2085600000 2167700000 1101600000 119200000 37100000 42500000 95500000 77000000.0 289400000 565300000 78900000 2494200000 2865600000 1300000000.0 176100000 1603500000 922400000 2670300000 4469100000 2222400000 -3609800000 -3423100000 -3205400000 <table cellpadding="0" cellspacing="0" id="xdx_896_eifrs-full--DisclosureOfInterestExpenseExplanatory_pn5n6_zKGUQr3YwN0b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET FINANCE RESULT (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_zl7Acj1hNTx7" style="display: none">Schedule of interest expenses</span></td> <td id="xdx_493_20230101__20231231_zlBVbalRFrsb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20220101__20221231_zscG6t1MFzI2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20210101__20211231_zDdUlSKQo7Ok" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_408_eifrs-full--InterestExpenseOnFinancialLiabilitiesDesignatedAtFairValueThroughProfitOrLoss_iN_di_maIEzJSo_zaee9fRc642j" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial instruments measured at amortized cost</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(644.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(764.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(466.0)</span></td></tr> <tr id="xdx_407_ecustom--InterestExpenseOnInstrumentsAtFairValueThroughProfitOrLoss_iN_di_maIEzJSo_z9b9HhQCDjkd" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Financial instruments at fair value through profit or loss</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,788.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,564.3)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(965.8)</span></td></tr> <tr id="xdx_404_eifrs-full--InterestExpense_iNT_di_mtIEzJSo_zqsctawoj2hi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,432.2)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,328.3)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,431.8)</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Include R$<span id="xdx_904_ecustom--AccountsPayablePresentValue_iI_pn6n6_c20231231_zjD8sL8C4yvi" title="Accounts payable present value">1,231</span> million (R$<span id="xdx_90A_ecustom--AccountsPayablePresentValue_iI_pn6n6_c20221231_zjo8Wg8nrsx7" title="Accounts payable present value">654</span> million at December 31, 2022) as accounts payable present value adjustment.</td> </tr></table> 644100000 764000000.0 466000000.0 1788100000 1564300000 965800000 2432200000 2328300000 1431800000 1231000000 654000000 <table cellpadding="0" cellspacing="0" id="xdx_89B_eifrs-full--DisclosureOfInterestIncomeExplanatory_pn5n6_zyt38WKlWYPj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - NET FINANCE RESULT (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zyskpq4qHaPk" style="display: none">Schedule of interest income</span></td> <td id="xdx_49C_20230101__20231231_zzv9qN7jG4si" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20220101__20221231_znD2qqM5uqP5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20210101__20211231_zDEThkG3c06" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_400_eifrs-full--InterestIncomeOnCashAndCashEquivalents_maRFIzT61_zHNCbnIwfD72" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash and cash equivalents</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,072.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">791.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">329.5 </span></td></tr> <tr id="xdx_404_eifrs-full--InterestIncomeOnFinancialAssetsHeldForTrading_maRFIzT61_zg61O7mO2cdd" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment on debt securities</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">175.9 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">84.7 </span></td></tr> <tr id="xdx_406_eifrs-full--InterestIncomeOnOtherFinancialAssets_maRFIzT61_z7qn213RVaSf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Other receivables</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">964.2 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,200.2 </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">687.4 </span></td></tr> <tr id="xdx_40F_eifrs-full--RevenueFromInterest_iT_mtRFIzT61_zLtERY2T2Tjc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,085.6 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,167.7 </b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,101.6 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(i)</span></td><td style="width: 5pt"></td><td style="text-align: justify">Refers, mainly, to monetary adjustment of recoverable tax.</td> </tr></table> 1072200000 791600000 329500000 49200000 175900000 84700000 964200000 1200200000 687400000 2085600000 2167700000 1101600000 <p id="xdx_80C_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zfkc04QlsESa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_018"></span>12.</b></td><td><b><span id="xdx_826_zn3OWwbynIoe">EARNINGS PER SHARE</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The tables below present the calculation of earnings per share (“EPS”) Basic and Diluted:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--EarningsPerShareExplanatory_pn5n6_zWDcagK6XLEd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_z6oFlxi7LOlg" style="display: none">Schedule of earnings per share</span></td> <td id="xdx_498_20230101__20231231_zKHmUkYSTXA4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_494_20220101__20221231_zNMe8msqVqo3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_497_20210101__20211231_zqph3BRJqddb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 48%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Basic</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40A_ecustom--NumeratorAbstract_iB_zRlYJ1Lv32H9"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Numerator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40E_ecustom--ProfitLossAttributableToOrdinaryEquityHoldersParentEntity_pn5n6_zRM56M72czL4" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income attributable to the Ambev equity holders</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,501.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,457.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,671.0 </span></td></tr> <tr id="xdx_408_ecustom--DenominatorAbstract_iB_zilNPoAxS9td" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Denominator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_409_eifrs-full--WeightedAverageShares_pn5n6_zfPI0DRQtwj9" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif"> Weighted average number of shares </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span><span style="font: normal 9pt Times New Roman, Times, Serif"> (non diluted)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,744.8 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,741.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,736.9 </span></td></tr> <tr id="xdx_400_eifrs-full--BasicEarningsLossPerShare_pip0_uBRLPerShare_ze3Qsa6i3gU7" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b> Basic EPS</b></span></td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9211 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9184 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.8052 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Diluted</b></span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40F_ecustom--NumeratorAbstract_iB_zC5EkzDbBO84" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Numerator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_ecustom--ProfitLossAttributableToOrdinaryEquityHoldersParentEntity_pn5n6_zbu24xfRnHSf" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income attributable to the Ambev equity holders</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,501.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,457.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,671.0 </span></td></tr> <tr id="xdx_406_ecustom--DenominatorAbstract_iB_z4Iay2o2xoe5" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Denominator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40E_eifrs-full--AdjustedWeightedAverageShares_pn5n6_zNsWo0PkwK3k" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif"> Weighted average numbers of shares </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span><span style="font: normal 9pt Times New Roman, Times, Serif"> (diluted) </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,838.6 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,848.6 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,857.5 </span></td></tr> <tr id="xdx_407_eifrs-full--DilutedEarningsLossPerShare_pip0_uBRLPerShare_zok72RbIxYC4" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b> Diluted EPS</b></span></td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9156 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9123 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.7991 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify"><span style="color: black">Million shares</span></td> </tr></table> <p id="xdx_8AE_zaT0rmZ02x2k" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Accounting Policies</b></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The calculation of basic earnings per share is based on the net income attributable to Ambev equity holders and the weighted average number of shares outstanding during the year.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The diluted earnings per share of the stock option and deferred stock is based on the net income attributable to the equity holders of Ambev, adjusted by the weighted average number of shares outstanding during the year to assume the conversion of all potentially dilutive shares.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_eifrs-full--EarningsPerShareExplanatory_pn5n6_zWDcagK6XLEd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EARNINGS PER SHARE (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_z6oFlxi7LOlg" style="display: none">Schedule of earnings per share</span></td> <td id="xdx_498_20230101__20231231_zKHmUkYSTXA4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_494_20220101__20221231_zNMe8msqVqo3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_497_20210101__20211231_zqph3BRJqddb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 48%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Basic</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40A_ecustom--NumeratorAbstract_iB_zRlYJ1Lv32H9"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Numerator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40E_ecustom--ProfitLossAttributableToOrdinaryEquityHoldersParentEntity_pn5n6_zRM56M72czL4" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income attributable to the Ambev equity holders</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,501.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,457.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,671.0 </span></td></tr> <tr id="xdx_408_ecustom--DenominatorAbstract_iB_zilNPoAxS9td" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Denominator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_409_eifrs-full--WeightedAverageShares_pn5n6_zfPI0DRQtwj9" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif"> Weighted average number of shares </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span><span style="font: normal 9pt Times New Roman, Times, Serif"> (non diluted)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,744.8 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,741.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,736.9 </span></td></tr> <tr id="xdx_400_eifrs-full--BasicEarningsLossPerShare_pip0_uBRLPerShare_ze3Qsa6i3gU7" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b> Basic EPS</b></span></td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9211 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9184 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.8052 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Diluted</b></span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_40F_ecustom--NumeratorAbstract_iB_zC5EkzDbBO84" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Numerator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_ecustom--ProfitLossAttributableToOrdinaryEquityHoldersParentEntity_pn5n6_zbu24xfRnHSf" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income attributable to the Ambev equity holders</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,501.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,457.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,671.0 </span></td></tr> <tr id="xdx_406_ecustom--DenominatorAbstract_iB_z4Iay2o2xoe5" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Denominator</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40E_eifrs-full--AdjustedWeightedAverageShares_pn5n6_zNsWo0PkwK3k" style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif"> Weighted average numbers of shares </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span><span style="font: normal 9pt Times New Roman, Times, Serif"> (diluted) </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,838.6 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,848.6 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">15,857.5 </span></td></tr> <tr id="xdx_407_eifrs-full--DilutedEarningsLossPerShare_pip0_uBRLPerShare_zok72RbIxYC4" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b> Diluted EPS</b></span></td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9156 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.9123 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>0.7991 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify"><span style="color: black">Million shares</span></td> </tr></table> 14501900000 14457900000 12671000000.0 15744800000 15741900000 15736900000 0.9211 0.9184 0.8052 14501900000 14457900000 12671000000.0 15838600000 15848600000 15857500000 0.9156 0.9123 0.7991 <p id="xdx_80D_ecustom--DisclosureOfIncomeTaxAndSocialContributionTextBlock_zyelfFkBnIQ7" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_019"></span><b>13.</b></td><td><b><span id="xdx_82C_zkaNEVrE1Gjg">INCOME TAX AND SOCIAL CONTRIBUTION</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>13.1 Income tax and social contribution</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The income tax and social contribution taxes are based on tax rates for 25% for income tax and 9% for social contribution in Brazil. For other regions in which the Company operates, the expected nominal rates are as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock_z7NiE7fMYzs7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BC_zgIwHSxtfnj1" style="display: none">Schedule of income tax and social contribution by area</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Central America and the Caribbean</span></td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">from <span id="xdx_900_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CentralAmericaAndCaribbeanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zkli4mLf9UL2" title="Expected nominal rates">15</span>% to <span id="xdx_90A_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CentralAmericaAndCaribbeanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zhDa58lWoxnk" title="Expected nominal rates">27</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Latin America - South <sup>(i)</sup></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">from <span id="xdx_904_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--LatinAmericaSouthMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcZoJgsmgfk4" title="Expected nominal rates">10</span>% to <span id="xdx_908_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--LatinAmericaSouthMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFOH59or7jo6" title="Expected nominal rates">35</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Canada</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90C_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CountryOfCanadaMember_zufM1nUgoNag" title="Expected nominal rates">26.5</span>% </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luxembourg</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--LuxembourgMember_zm6R8DhNDaTi" title="Expected nominal rates">24.94</span>%</span></td></tr> </table> <p id="xdx_8AA_zB3oQ1RmyX63" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Income taxes reported in the income statement are analyzed as follow:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfIncomeTaxExplanatory_pn5n6_zpsbpwx6ARWk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_ztxtmMpy9Lz5" style="display: none">Schedule of income taxes</span></td> <td id="xdx_493_20230101__20231231_zKY9b9rIE6E5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49D_20220101__20221231_zf7R9pmOqTAe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20210101__20211231_zjxFpge4lp4h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_408_eifrs-full--CurrentTaxExpenseIncome_maITECOzyJ5_zC4GKeOS2zhd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Income tax expense – current</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,077.9)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,718.9)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,268.6)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_maDTEIzXSe_z3No4q8FqsP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred tax expense on temporary differences</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">279.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,012.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,072.9 </span></td></tr> <tr id="xdx_40E_eifrs-full--AdjustmentsForDeferredTaxExpense_maDTEIzXSe_zhFr4TaGg6nc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred tax on tax loss carryforward movements in the current period</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,722.6 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,361.9 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(440.9)</span></td></tr> <tr id="xdx_401_eifrs-full--DeferredTaxExpenseIncome_iT_mtDTEIzXSe_maITECOzyJ5_zTkxrTeOyYza" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total deferred tax (expense)/income</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,002.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,374.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>632.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_ecustom--IncomeTaxesExpenseContinuingOperations_iT_mtITECOzyJ5_zOhbtMNILXd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total income tax expenses</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(75.5)</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>655.6 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(636.6)</b></span></td></tr> </table> <p id="xdx_8A4_zm5M8PvRGWX4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The reconciliation between the weighted nominal tax rate and the effective tax rate is summarized as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfReconciliationFromTheWeightedNominalToTheEffectiveTaxRateTextBlock_z1SPyOwyToDc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zABeP0PwVq6f" style="display: none">Schedule of reconciliation between the weighted nominal tax rate and the effective tax rate</span></td> <td id="xdx_49F_20230101__20231231_zng7f8zdbExk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231_zfC5deAJAY4g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_z1e0o4kvWts9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>2021</b></span></td></tr> <tr id="xdx_40F_eifrs-full--AccountingProfit_maNAPzlZV_zmgXaUmJZM26" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Profit before tax</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>15,035.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>14,235.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>13,759.2 </b></span></td></tr> <tr id="xdx_401_ecustom--AdjustmentOnTaxableBasisAbstract_iB_zcFgNWWzxVdl" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Adjustment on a taxable basis</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_408_ecustom--TaxEffectOfOthersNontaxableIncome_i01_maNAPzlZV_zw5F7foKcYfa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Others non-taxable income</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(919.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(883.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(611.0)</span></td></tr> <tr id="xdx_402_ecustom--TaxEffectOfGovernmentGrantsRelatedToSalesTaxes_i01_maNAPzlZV_zQGfBsSJfw4k" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Government grants related to sales taxes </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(3,011.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(2,535.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(1,883.1)</span></td></tr> <tr id="xdx_40A_ecustom--TaxEffectFromSharingResultsOfJointVentures_i01_maNAPzlZV_zzigr4IYzKGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Share of results of joint ventures</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">185.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">29.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">115.7 </span></td></tr> <tr id="xdx_40B_ecustom--TaxEffectOfExpenseNotDeductible_i01_maNAPzlZV_zJUa0xVp7Jl1" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Non-deductible expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">56.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">192.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">99.2 </span></td></tr> <tr id="xdx_403_eifrs-full--TaxEffectOfForeignTaxRates_i01N_di_msNAPzlZV_zXp1pZImQh69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Worldwide taxation</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">1,171.4 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">679.3 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(360.0)</span></td></tr> <tr id="xdx_40F_ecustom--NetAccountingProfit_i01T_mtNAPzlZV_zKDa2ctaOnF4" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>12,518.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>11,718.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>11,120.0 </b></span></td></tr> <tr id="xdx_404_eifrs-full--ApplicableTaxRate_i01_pip0_dp_zzyDcx6Ujd4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Aggregated weighted nominal tax rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">28.30%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">29.47%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.39%</span></td></tr> <tr id="xdx_40B_ecustom--TaxesPayableNominalRate_zEt2zZhAQ3Oh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Taxes payable – nominal rate </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(3,542.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(3,453.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(3,045.3)</b></span></td></tr> <tr id="xdx_400_ecustom--AdjustmentOnTaxExpenseAbstract_iB_zUTX3otC5JYc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Adjustment on tax expense</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40C_ecustom--TaxEffectOfRegionalIncentives_i01_zYm4tJnvNNni" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Income tax Incentives</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">120.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">234.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">213.2 </span></td></tr> <tr id="xdx_40E_ecustom--TaxEffectOfDeductibleInterestOfShareholdersEquity_i01_zrclW5BpC5ae" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Deductible interest on shareholders’ equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">3,909.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">4,079.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">2,516.0 </span></td></tr> <tr id="xdx_40B_eifrs-full--TaxEffectOfImpairmentOfGoodwill_i01_zyrZdzDmoyF1" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Tax savings from goodwill amortization</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">17.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">27.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">77.5 </span></td></tr> <tr id="xdx_40E_ecustom--TaxEffectOfWithholdingTaxOverUndistributedProfits_i01_z6yKJraD3oAg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Withholding income tax</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(489.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(164.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(876.0)</span></td></tr> <tr id="xdx_402_eifrs-full--TaxEffectOfTaxLosses_i01_z9wskj6juwij" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Recognition/(write-off) of deferred charges on tax losses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">100.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(58.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(1.5)</span></td></tr> <tr id="xdx_406_ecustom--TaxEffectOfAdoptionOfNewAccountingPolicy_i01N_di_zVl9JSAyP757" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(382.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(249.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(123.3)</span></td></tr> <tr id="xdx_405_eifrs-full--OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_i01_zwAnSi6Pc9Q1" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Others with reduced taxation</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">189.9 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">239.5 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">602.8 </span></td></tr> <tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_i01_zjUji83uYOB8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Income tax and social contribution expense</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(75.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>655.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(636.6)</b></span></td></tr> <tr id="xdx_40F_eifrs-full--AverageEffectiveTaxRate_i01_pip0_dp_z1iARdPc6zTf" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Effective tax rate</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>0.50%</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>-4.61%</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>4.63%</b></span></td></tr> </table> <p id="xdx_8A1_z5SkeCp0GWZ3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The main events that impacted the effective tax rate for the period were:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 14.2pt; text-align: justify; text-indent: 0in"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Government subsidy for sales taxes: for regional incentives and economic development policies, these are related primarily to local production, contributing to economic and social impact, and, when reinvested, are not subject to income tax and social contribution purposes, which explains the impact on the effective tax rate. The amount above is impacted by fluctuations in the volume, price and any eventual increases in state VAT (“ICMS”), reflected in other operating income or net sales depending on its nature. In addition, the above-mentioned amount is allocated to the profit reserve on an annual basis, according to item (2.3.3) “Tax incentives” on Note 22 - <i>Changes in equity</i></td></tr></table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 14.2pt; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Complement of income tax on foreign subsidiaries due in Brazil: shows the result of the calculation of universal taxation of profits, according to the regulations of Law 12,973/14.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Withholding income tax: The amount is mainly related to dividends already distributed and to be distributed by subsidiaries located outside of Brazil, applicable according to local tax legislation. The recorded values in 2023 are mainly related to withholding tax on dividends distributed in 2023 and the exchange rate variation of the deferred income tax related to subsidiary profits undistributed.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0pt"></td><td style="width: 14.2pt"><span style="font-family: Symbol; color: black">·</span></td><td style="text-align: justify">Deductible interest on shareholders’ equity: under Brazilian law, companies have an option to remunerate their shareholders through the payment of Interest on shareholders’ equity, which amount is impacted by the taxable result, net income reserves of the Company and by the long-term interest rate (“TJLP”). These remunerations are deductible for income tax purposes.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 14.2pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0pt"></td><td style="width: 14.2pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Effect of application of IAS 29 (hyperinflation): our subsidiary in Argentina, for operating in a hyperinflationary economy, is subject to monetary correction of non-financial assets and liabilities, equity and income statement, which, at times, reflects in the consolidated effective tax rate and implies variation between periods.</td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>13.2 Deferred income tax and social contribution</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The details of the amount of deferred income tax and social contribution by type of temporary difference are as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_pn5n6_zYc1IpZcRZQj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_zOliFNfl0Syc" style="display: none">Schedule of deferred income tax</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liabilities</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liabilities</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investment securities</span></td> <td id="xdx_981_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zVh4Ub2YENC" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zY4T3Of6PJyd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2268">-</span>   </span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zQMuu69WHWk8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zVEcLP5rOX4k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td> <td id="xdx_98A_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zAZxpFyNb2F8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2274">-</span>   </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_z00IHKtEK836" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangible</span></td> <td id="xdx_988_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_z6zsvcCvij09" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span>   </span></td> <td id="xdx_983_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zTsx7tXmgkh7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,369.7)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zHKIbfGffk14" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,369.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zK6e7OCACRmi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2284">-</span>   </span></td> <td id="xdx_986_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_z9M9u88S8Zo9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,690.2)</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_ztdhCkuQXrN3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,690.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Employee benefits</span></td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zD0ItU7d1Ag" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">856.5 </span></td> <td id="xdx_98D_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zldW6dKufUa1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span>   </span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zA1vfpL04Uj3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">856.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zHpbGDcp54z6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">951.2 </span></td> <td id="xdx_98D_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zGgHgX8uqlqa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2298">-</span>   </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zlbgVSKzx7Tk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">951.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_986_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_z2CQezzxyuv2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,843.8 </span></td> <td id="xdx_987_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zZ9Ua1fAh1X1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.3)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zJERJ9hPDr8l" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,840.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_z9NWLb6sVTb7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,232.8 </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zbonq1cJf5nk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.9)</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_ziu6wOnAKbma" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,229.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade receivables</span></td> <td id="xdx_986_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zszXvzry4Bq1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">43.8 </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zZAybmpmpqK3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.0)</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zRVWTzGzLnM8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zJ0oFF7DJ7m4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38.6 </span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zxbEWh4O4kpg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.8)</span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zBew3QqzXTIi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">34.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives</span></td> <td id="xdx_984_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zZTCvZOs7pT9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">31.1 </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zHP9BwPdp56j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(77.2)</span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_z8pX7t0HU1Ih" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zaGWtATEPk8g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">95.1 </span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zbYiii8fKfvb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(44.8)</span></td> <td id="xdx_98E_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zxpidRbfs7Q5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interest-Bearing Loans and Borrowings</span></td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zCXnz87QIQh3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td> <td id="xdx_98C_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z2Jy0b7pTIC9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2340">-</span>   </span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zjSrXJ0SrzJ1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zsyHXPRFCZKl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.5 </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z5wGWnDImCr6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.9)</span></td> <td id="xdx_98C_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z8Aoa2lXe6Rj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inventories</span></td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zzTnudX7rKA" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">268.6 </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zhhd0valUWn7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.6)</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zbUDOr8rr2B5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">209.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_z615MmxljWPd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">413.9 </span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zb39H8NIkJV5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(139.3)</span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zk4dFNY7379k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">274.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Property, plant and equipment</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zqdXvGn4Jivl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">714.2 </span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zuMsnEUGFxtg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,837.2)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zckL9XR2C0ca" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,123.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zP3MA6Cpf5a8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">899.5 </span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zEdEP7CEbgha" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,177.1)</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zr3G2LL2cgA" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,277.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Withholding tax on undistributed profits and royalties</span></td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zSrcX6aBRb56" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2374">-</span>   </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zfsUWXzHii5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zY7RMPZfl609" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_z8dqEkXJiLu6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2380">-</span>   </span></td> <td id="xdx_987_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zVV4zmlz1Gm2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,877.6)</span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_z35a1Mx5Ovml" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,877.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investments in joint ventures</span></td> <td id="xdx_982_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_z5YRlxvzvk96" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2386">-</span>   </span></td> <td id="xdx_983_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_z3JsjaYMAx5k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zlYkymDxVn2a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zbnlQvb13vpa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2392">-</span>   </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zp4pqUa8SgA5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(421.6)</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zWMlPeLOxjnj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(421.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Losses carried forward</span></td> <td id="xdx_987_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zbBjQmBphQUg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,383.3 </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zmOjiIakeM8f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span>   </span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_z8mtAIvLAKe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,383.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zSIk0155ah4i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,660.7 </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zygw2IHuKoSe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2406">-</span>   </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zDa3mOolTWQ5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,660.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Provisions</span></td> <td id="xdx_988_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zW4QJknDM9e6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,026.3 </span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zrRDhBkHWyTd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.6)</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zBNRiR0Jp4Dd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,021.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_z5en1lrfqEVe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">819.3 </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_z5ZpT3A9pYpb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2418">-</span>   </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zd8355fASSE3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">819.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Impact of the adoption of IFRS 16 (Leases)</span></td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zH4zaaOmPaLc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.5 </span></td> <td id="xdx_986_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zRNHSl8eMySi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19.7)</span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zjrGUBiZIhBk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zpsxZvnwWqS7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">35.1 </span></td> <td id="xdx_988_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zJWeKwj233M6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.4)</span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zDjtivVrwNZ1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ICMS on the assessment bases of PIS/COFINS</span></td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zMoUTHHQI4s7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2434">-</span>   </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_z64irvKLDpx8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td> <td id="xdx_98C_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_z55dBU0ECyUi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zjTDUDKUwEO9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2440">-</span>   </span></td> <td id="xdx_982_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zmaibY6fXjfe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(168.2)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zv1D7rqYu1ah" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(168.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other items</span></td> <td id="xdx_988_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zRVJ7l60ivvj" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">266.5 </span></td> <td id="xdx_98B_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zoRqTV6wqhl4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(437.1)</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zzIdMYUAkY88" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(170.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zMhQoE1jYST7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">260.8 </span></td> <td id="xdx_98C_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zChFkqisaJRb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(164.1)</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zIghVpaahvBh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">96.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Gross deferred tax assets/(liabilities)</b></span></td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231_z9KwFA1JOGHe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>10,464.3 </b></span></td> <td id="xdx_987_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231_zNa8N6y9V9q3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5,813.1)</b></span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231_zSy5Lto07Kwc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,651.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231_zghHvzIgHieb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,415.0 </b></span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231_ztDUNt5yc89i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,701.9)</b></span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231_zKV4HjcH2bZ6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,713.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Netting by taxable entity</span></td> <td id="xdx_988_ecustom--DeferredTaxAssetsNettingByTaxableEntity_iI_pn5n6_c20231231_zjVFEOgRTsdl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,494.7)</span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilitiesNettingByTaxableEntity_iI_pn5n6_c20231231_zBczMKrRVCdf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,494.7 </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAssetNettingByTaxableEntity_iI_pn5n6_c20231231_zR2MXCLaiupf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2474">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--DeferredTaxAssetsNettingByTaxableEntity_iI_pn5n6_c20221231_zKREUKLY3Fnc" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,976.2)</span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilitiesNettingByTaxableEntity_iI_pn5n6_c20221231_zTXbZVB9EnD8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,976.2 </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAssetNettingByTaxableEntity_iI_pn5n6_c20221231_zyEWylP4Fo8k" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2480">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Net deferred tax assets/(liabilities)</b></span></td> <td id="xdx_98A_eifrs-full--NetDeferredTaxAssets_iI_pn5n6_c20231231_zZKOQSyYnuA8" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>7,969.6 </b></span></td> <td id="xdx_986_ecustom--NetDeferredTaxLiabilities1_iI_pn5n6_c20231231_zgkAfO4Juq01" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,318.4)</b></span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAssetNet_iI_pn5n6_c20231231_zNhzMQjcxGR1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,651.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NetDeferredTaxAssets_iI_pn5n6_c20221231_zP7xMzAleYte" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,438.8 </b></span></td> <td id="xdx_982_ecustom--NetDeferredTaxLiabilities1_iI_pn5n6_c20221231_z1aTESTTK2F3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,725.7)</b></span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAssetNet_iI_pn5n6_c20221231_za89ikCuVUU7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,713.1 </b></span></td></tr> </table> <p id="xdx_8A9_zbhxG0HvSyY" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most tax losses and negative social contribution bases on which deferred income tax and social contribution were calculated do not have a statute of limitations. The use of credits related to tax losses is based on the projected future existence of taxable profits, limited to 30% of taxable income for the year, according to the actual figures for prior years, and the projections of the Company's business in the economies in which they are located, and thus follows the applicable fiscal and accounting rules.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Among the deferred tax assets on tax losses carried forward, the tax authorities unilaterally offset in tax proceedings the total amount of R$<span id="xdx_90B_ecustom--TaxLosesCarriedForwardOfUnilaterallyOffsetProceedings_iI_pn5n6_c20231231_zQfCDieuLGs5" title="Tax loses carried forward of unilaterally offset proceedings">268.6</span>, which are equivalent to R$<span id="xdx_90C_ecustom--TaxLosesCarriedForwardOfUnilaterallyOffset_iI_pn6n6_c20231231_zbVaMGAKj995" title="Tax loses carried forward of unilaterally offset">790</span>.0 in tax losses basis. Such proceedings are classified as having a possible probability of loss.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The critical estimates of Ambev’s Management, as well the main contingent liabilities related to uncertainty about the tax treatment of income, are disclosed in Notes 27.2 - <i>Contingencies</i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13.2.1 Realization of deferred taxes</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As at December 31, 2023, the deferred tax assets and liabilities related to combined tax losses which are expected to be utilized/settled using temporary differences, as follows:</p> <p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfTheRealizationOfDeferredTaxAssetsAndLiabilitiesTextBlock_zVki2GZIdpt1" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 4)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_z65lbEULJvqb" style="display: none">Schedule of deferred tax assets and liabilities</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 50%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Deferred taxes not related to tax losses</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>to be realized within 12 months</b></span></td> <td style="width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>to be realized after 12 months</b></span></td> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investment securities</span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zqdPFF2eF3fl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span>   </span></td> <td id="xdx_984_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zOxDp3fbQWuk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zMqSBDYHAIV" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangible</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zymOtaUKVYv6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.2)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zjlqBWWCP0W7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,368.5)</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zJc8Aj061qr2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,369.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Employee benefits</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zPjt27zAHZ58" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">199.9 </span></td> <td id="xdx_980_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zwxr2J83JBUj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">656.6 </span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zFrra1N1ENUj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">856.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zkYdE3rnG8Oe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(220.6)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zfGDdcO1Ufrd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,061.1 </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zULpUPbQzl0b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,840.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade receivables</span></td> <td id="xdx_984_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zITSepmcDr9c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">22.7 </span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zeLRi6SLVzqd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.1 </span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zHX6Bb7n9vCh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zKBRqSXxFTH1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(49.8)</span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zg87Db8uW5G6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.7 </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zqLFVHokKsB8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interest-bearing loans and borrowings</span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z6ssHwa6E7G7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zpk1wSAW8Aqh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.4 </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zdCC5Lfh6qUf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inventories</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zzmZg1CnHdHh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">252.7 </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zbp9LJHo3sp8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(43.7)</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zCGpx675sTh9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">209.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Property, plant and equipment</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zdZemGEob8u8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td id="xdx_980_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_z3mrixsNOxig" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,118.9)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_z76DNHLzPMM" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,123.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Withholding tax on undistributed profits and royalties</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zE6LNVOi3Rkg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2555">-</span>   </span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zyDXlFXX3NK6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zqm8BytHIFC7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investments in joint ventures</span></td> <td id="xdx_984_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zPWYWTimpaB6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2561">-</span>   </span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_z7KyySgpNY04" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zAVjgZUSGEn5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Provisions</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zO7hhMwWWPn2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">664.5 </span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zUDPeLCrl9S3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">357.2 </span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zsxd8oN6mlLk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,021.7 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Impact of the adoption of IFRS 16 (Leases)</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zxDxt3avnqEd" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2573">-</span>   </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zKpC6KY5NJac" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.2)</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zdiLmN2Za5Na" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.2)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ICMS on the assessment bases of PIS/COFINS</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zQyJg2S2SvJl" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2579">-</span>   </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zRgPrFEQ3d4h" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zshDGyIVB0Mi" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other items</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zGqY02Ssrc94" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">39.8 </span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zU3W6tRFpE96" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(210.4)</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_z2M20zv4RY3j" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(170.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxesNotRelatedToTaxLossesMember_z1QAX417KY3k" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>904.0 </b></span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxesNotRelatedToTaxLossesMember_zjtsslkdfSgg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(636.1)</b></span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxesNotRelatedToTaxLossesMember_zCfsqCL0Bfx7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>267.9 </b></span></td></tr> </table> <p id="xdx_8A3_zCHb27oAnYqe" style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfDeferredTaxRealizationRelatedToTaxLossesTextBlock_zfAtOJXJFIU9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 5)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zibOEvvXLFhl" style="display: none">Schedule of deferred tax realization related to tax losses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 75%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Deferred tax related to tax losses</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2023</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zk6xPqVxAf6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2599">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2024</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zuT0oXNdYDFe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">755.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2025</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_z3I2scQu4L2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">422.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2026</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanFoursYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zgwb377yjUB" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,635.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2027</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zlqfitwvXLac" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,052.8 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2028 a 2030</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanFiveYearsAndNotLaterThanEightYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zaj6fcFrYwEj" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">170.3 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">2031 em onward</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (i)</sup></span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanNineYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_fKGkp_zboUJtOdfsz9" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">346.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zb31jK8Jnb14" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,383.3 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">There is no expectation of realization beyond a term of ten years.</td> </tr></table> <p id="xdx_8A7_zFWSkr7fyFN9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13.2.2 The net change of deferred taxes</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net change in deferred income tax and social contribution is as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfTheReconciliationOfChangesInDeferredTaxLiabilityAssetTextBlock_zX30kOHV8CR9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 6)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_zG2meMdIy5a3" style="display: none">Schedule of net change in deferred income tax and social contribution</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iS_pn5n6_c20220101__20221231_zpDxzW9bWmzh" style="width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred income tax and social contribution at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,513.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognition of actuarial gains/(losses)</span></td> <td id="xdx_984_eifrs-full--IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_z8GkOjN3Tnwi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognition of actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(146.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment hedge – put option granted on subsidiaries</span></td> <td id="xdx_985_ecustom--IncomeTaxRelatingToHedgesOfInvestmentsRegardingPutOptionsOfASubsidiaryInterestInEquityInstrumentsOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zC30brer13Ve" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investment hedge - put option granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(105.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash flow hedge – gains/(losses)</span></td> <td id="xdx_98D_eifrs-full--IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zlajrlHY2sY6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedge - gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">41.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains/(losses) on translation of other foreign operations </span></td> <td id="xdx_987_eifrs-full--IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zLQ6m7eYvCab" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on translation of other foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(419.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in other comprehensive income</b></span></td> <td id="xdx_985_eifrs-full--IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zU2tmVyGcM7f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(629.9)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in the income statement</b></span></td> <td id="xdx_981_ecustom--DeferredTaxExpenseIncomes_pn5n6_c20220101__20221231_zmqWWAZPMXqg" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in the income statement"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,374.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Changes directly in the balance sheet</b></span></td> <td id="xdx_98F_ecustom--TotalChangesRelatedToDeferredIncomeTaxAndSocialContributionsAffectingTheBalanceSheet_pn5n6_c20220101__20221231_zpStXnvQ51U4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes directly in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(545.2)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in deferred tax</span></td> <td id="xdx_987_ecustom--DirectChangesToDeferredTaxAndLiabilitiesInTheBalanceSheet_pn5n6_c20220101__20221231_zyPnSVKRNZT6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in deferred tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(595.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td id="xdx_98A_ecustom--ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet_pn5n6_c20220101__20221231_zDLKNkvAb9c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(595.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in other balance sheet group</span></td> <td id="xdx_986_ecustom--ChangesRelatedToDeferredTaxRecognizedInOtherInTheBalanceSheet_pn5n6_c20220101__20221231_zw1Ok6aBvRD1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other balance sheet group"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98C_eifrs-full--DeferredTaxLiabilityAsset_iS_pn5n6_c20230101__20231231_zSnPboOxKoph" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred income tax and social contribution at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,713.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognition of actuarial gains/(losses)</span></td> <td id="xdx_98F_eifrs-full--IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zo50hQHrM372" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognition of actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">24.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment hedge – put option granted on subsidiaries</span></td> <td id="xdx_98B_ecustom--IncomeTaxRelatingToHedgesOfInvestmentsRegardingPutOptionsOfASubsidiaryInterestInEquityInstrumentsOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zAjio8w1bq06" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investment hedge - put option granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(155.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash flow hedge – gains/(losses)</span></td> <td id="xdx_988_eifrs-full--IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zoccoUBe2ja7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedge - gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">83.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains/(losses) on translation of other foreign operations </span></td> <td id="xdx_988_eifrs-full--IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zcNCCLl7kI82" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on translation of other foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">553.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in other comprehensive income</b></span></td> <td id="xdx_986_eifrs-full--IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zeSXEuRcO2jb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>505.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in the income statement</b></span></td> <td id="xdx_982_ecustom--DeferredTaxExpenseIncomes_pn5n6_c20230101__20231231_zxFf1mlVOkW8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in the income statement"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,002.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Changes directly in the balance sheet</b></span></td> <td id="xdx_986_ecustom--TotalChangesRelatedToDeferredIncomeTaxAndSocialContributionsAffectingTheBalanceSheet_pn5n6_c20230101__20231231_z1faFhuQC8ac" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes directly in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(569.9)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in deferred tax</span></td> <td id="xdx_98B_ecustom--DirectChangesToDeferredTaxAndLiabilitiesInTheBalanceSheet_pn5n6_c20230101__20231231_zvKhDRzw2fSk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in deferred tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(476.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td id="xdx_981_ecustom--ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet_pn5n6_c20230101__20231231_zi7YdHvX5nRb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(476.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in other balance sheet group</span></td> <td id="xdx_982_ecustom--ChangesRelatedToDeferredTaxRecognizedInOtherInTheBalanceSheet_pn5n6_c20230101__20231231_zRENE8C3nyr2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other balance sheet group"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(93.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2023</b></span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iE_pn5n6_c20230101__20231231_z8vGROGYnMLa" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred income tax and social contribution at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,651.2 </b></span></td></tr> </table> <p id="xdx_8AD_zs8eBqwDryPd" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>13.2.3 Deferred tax asset related to tax losses</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As at December 31, 2023, besides the tax credits related to tax losses effectively recognized in the amounts disclosed above, other tax credits related to accumulated tax losses in the amount of R$<span id="xdx_903_ecustom--TaxCreditRelatedToTaxLosses_iI_pn6n6_c20231231_zO0wwccf9RYg" title="Tax credit related to tax losses">669</span>.0 (R$<span id="xdx_905_ecustom--TaxCreditRelatedToTaxLosses_iI_pn5n6_c20221231_zQ7XdamlYj81" title="Tax credit related to tax losses">875.3</span> in 2022) - which are equivalent, in value basis, to R$<span id="xdx_90B_ecustom--TaxLossesCarriedForwardInRelationToCredit_iI_pn6n6_c20231231_zr7m2uKzCkSe" title="Tax loses carried forward in relation to credit">2,521</span>.0 in 2023 (R$<span id="xdx_901_ecustom--TaxLossesCarriedForwardInRelationToCredit_iI_pn5n6_c20221231_zBt7c6FEBvza" title="Tax loses carried forward in relation to credit">3,359.5</span> in 2022) - were not recorded, since their realization is not probable in currently Management evaluation.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting Policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income tax and social contribution for the year comprises current tax and deferred tax. Income tax and social contribution are recognized in the income statement, unless they relate to items recognized directly in comprehensive income or in other equity accounts. In these cases, the tax effects are also recognized directly in comprehensive income or in equity accounts (except for interest on shareholders’ equity. See Note 22- <i>Changes in equity</i>).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred income taxes are calculated on temporary differences between their calculation bases and the Company's accounting data. The deferred tax assets are recognized only to the extent that is probable that future taxable profits will be available. The deferred income tax assets are reduced to the extent that it is no longer probable that future taxable profits will occur. The existence of future taxable income is based on a technical study approved by the Company's management.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">IAS 12 – “Income Taxes” prescribes that no deferred tax liability on goodwill recognition, and no deferred tax asset/liability is recorded: (1) at the initial recognition of an asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss and (2) on differences related to investments in subsidiaries to the extent that they are not reversed in the foreseeable future. The amount of deferred tax provided is based on the expectation of the realization or settlement of the temporary difference, using currently or substantially enacted tax rates.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and where these relate to income taxes levied by the same tax authority on the same taxable entity, or to different taxable entities which intend either to settle their current tax liabilities and assets on a net basis, or to realize the assets and settle the liabilities simultaneously.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company is subject to income tax in numerous jurisdictions and judgment is required to determine the Company’s worldwide provision for income tax. Some of the Company's subsidiaries are involved in tax audits, usually in relation to previous years. These audits are ongoing in various jurisdictions as at the balance sheet reporting date and, by their nature, can take a considerable time to be completed.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the provisions of IFRIC 23 - <i>Uncertainty on the Treatment of Income Taxes</i> in relation to the treatments that affected the calculation of income taxes (uncertain tax treatments), as disclosed in note 27.2 – <i>Contingencies</i> – Uncertainties about treatment of IRPJ and CSLL.</p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfIncomeTaxAndSocialContributionByAreaTableTextBlock_z7NiE7fMYzs7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8BC_zgIwHSxtfnj1" style="display: none">Schedule of income tax and social contribution by area</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 68%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Central America and the Caribbean</span></td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">from <span id="xdx_900_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CentralAmericaAndCaribbeanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zkli4mLf9UL2" title="Expected nominal rates">15</span>% to <span id="xdx_90A_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CentralAmericaAndCaribbeanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zhDa58lWoxnk" title="Expected nominal rates">27</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Latin America - South <sup>(i)</sup></span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">from <span id="xdx_904_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--LatinAmericaSouthMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcZoJgsmgfk4" title="Expected nominal rates">10</span>% to <span id="xdx_908_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--LatinAmericaSouthMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFOH59or7jo6" title="Expected nominal rates">35</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Canada</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90C_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--CountryOfCanadaMember_zufM1nUgoNag" title="Expected nominal rates">26.5</span>% </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Luxembourg</span></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_907_eifrs-full--TaxRateEffectOfForeignTaxRates_pip0_dp_c20230101__20231231__ifrs-full--SegmentsAxis__custom--LuxembourgMember_zm6R8DhNDaTi" title="Expected nominal rates">24.94</span>%</span></td></tr> </table> 0.15 0.27 0.10 0.35 0.265 0.2494 <table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfIncomeTaxExplanatory_pn5n6_zpsbpwx6ARWk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_ztxtmMpy9Lz5" style="display: none">Schedule of income taxes</span></td> <td id="xdx_493_20230101__20231231_zKY9b9rIE6E5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49D_20220101__20221231_zf7R9pmOqTAe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20210101__20211231_zjxFpge4lp4h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_408_eifrs-full--CurrentTaxExpenseIncome_maITECOzyJ5_zC4GKeOS2zhd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Income tax expense – current</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,077.9)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,718.9)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,268.6)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_eifrs-full--DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences_maDTEIzXSe_z3No4q8FqsP9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred tax expense on temporary differences</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">279.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,012.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,072.9 </span></td></tr> <tr id="xdx_40E_eifrs-full--AdjustmentsForDeferredTaxExpense_maDTEIzXSe_zhFr4TaGg6nc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred tax on tax loss carryforward movements in the current period</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,722.6 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,361.9 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(440.9)</span></td></tr> <tr id="xdx_401_eifrs-full--DeferredTaxExpenseIncome_iT_mtDTEIzXSe_maITECOzyJ5_zTkxrTeOyYza" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total deferred tax (expense)/income</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,002.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,374.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>632.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_ecustom--IncomeTaxesExpenseContinuingOperations_iT_mtITECOzyJ5_zOhbtMNILXd5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total income tax expenses</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(75.5)</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>655.6 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(636.6)</b></span></td></tr> </table> -2077900000 -1718900000 -1268600000 279800000 1012600000 1072900000 1722600000 1361900000 -440900000 2002400000 2374500000 632000000.0 -75500000 655600000 -636600000 <table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfReconciliationFromTheWeightedNominalToTheEffectiveTaxRateTextBlock_z1SPyOwyToDc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 2)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zABeP0PwVq6f" style="display: none">Schedule of reconciliation between the weighted nominal tax rate and the effective tax rate</span></td> <td id="xdx_49F_20230101__20231231_zng7f8zdbExk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231_zfC5deAJAY4g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_z1e0o4kvWts9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>2021</b></span></td></tr> <tr id="xdx_40F_eifrs-full--AccountingProfit_maNAPzlZV_zmgXaUmJZM26" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Profit before tax</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>15,035.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>14,235.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>13,759.2 </b></span></td></tr> <tr id="xdx_401_ecustom--AdjustmentOnTaxableBasisAbstract_iB_zcFgNWWzxVdl" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Adjustment on a taxable basis</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_408_ecustom--TaxEffectOfOthersNontaxableIncome_i01_maNAPzlZV_zw5F7foKcYfa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Others non-taxable income</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(919.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(883.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(611.0)</span></td></tr> <tr id="xdx_402_ecustom--TaxEffectOfGovernmentGrantsRelatedToSalesTaxes_i01_maNAPzlZV_zQGfBsSJfw4k" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Government grants related to sales taxes </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(3,011.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(2,535.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(1,883.1)</span></td></tr> <tr id="xdx_40A_ecustom--TaxEffectFromSharingResultsOfJointVentures_i01_maNAPzlZV_zzigr4IYzKGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Share of results of joint ventures</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">185.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">29.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">115.7 </span></td></tr> <tr id="xdx_40B_ecustom--TaxEffectOfExpenseNotDeductible_i01_maNAPzlZV_zJUa0xVp7Jl1" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Non-deductible expenses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">56.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">192.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">99.2 </span></td></tr> <tr id="xdx_403_eifrs-full--TaxEffectOfForeignTaxRates_i01N_di_msNAPzlZV_zXp1pZImQh69" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Worldwide taxation</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">1,171.4 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">679.3 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(360.0)</span></td></tr> <tr id="xdx_40F_ecustom--NetAccountingProfit_i01T_mtNAPzlZV_zKDa2ctaOnF4" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>12,518.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>11,718.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>11,120.0 </b></span></td></tr> <tr id="xdx_404_eifrs-full--ApplicableTaxRate_i01_pip0_dp_zzyDcx6Ujd4i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Aggregated weighted nominal tax rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">28.30%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">29.47%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.39%</span></td></tr> <tr id="xdx_40B_ecustom--TaxesPayableNominalRate_zEt2zZhAQ3Oh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Taxes payable – nominal rate </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(3,542.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(3,453.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(3,045.3)</b></span></td></tr> <tr id="xdx_400_ecustom--AdjustmentOnTaxExpenseAbstract_iB_zUTX3otC5JYc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Adjustment on tax expense</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40C_ecustom--TaxEffectOfRegionalIncentives_i01_zYm4tJnvNNni" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Income tax Incentives</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">120.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">234.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">213.2 </span></td></tr> <tr id="xdx_40E_ecustom--TaxEffectOfDeductibleInterestOfShareholdersEquity_i01_zrclW5BpC5ae" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Deductible interest on shareholders’ equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">3,909.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">4,079.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">2,516.0 </span></td></tr> <tr id="xdx_40B_eifrs-full--TaxEffectOfImpairmentOfGoodwill_i01_zyrZdzDmoyF1" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Tax savings from goodwill amortization</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">17.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">27.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">77.5 </span></td></tr> <tr id="xdx_40E_ecustom--TaxEffectOfWithholdingTaxOverUndistributedProfits_i01_z6yKJraD3oAg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Withholding income tax</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(489.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(164.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(876.0)</span></td></tr> <tr id="xdx_402_eifrs-full--TaxEffectOfTaxLosses_i01_z9wskj6juwij" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Recognition/(write-off) of deferred charges on tax losses</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">100.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(58.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(1.5)</span></td></tr> <tr id="xdx_406_ecustom--TaxEffectOfAdoptionOfNewAccountingPolicy_i01N_di_zVl9JSAyP757" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(382.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(249.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">(123.3)</span></td></tr> <tr id="xdx_405_eifrs-full--OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_i01_zwAnSi6Pc9Q1" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">Others with reduced taxation</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">189.9 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">239.5 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt">602.8 </span></td></tr> <tr id="xdx_402_eifrs-full--IncomeTaxExpenseContinuingOperations_i01_zjUji83uYOB8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Income tax and social contribution expense</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(75.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>655.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>(636.6)</b></span></td></tr> <tr id="xdx_40F_eifrs-full--AverageEffectiveTaxRate_i01_pip0_dp_z1iARdPc6zTf" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>Effective tax rate</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>0.50%</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>-4.61%</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8.5pt"><b>4.63%</b></span></td></tr> </table> 15035900000 14235600000 13759200000 -919000000.0 -883300000 -611000000.0 -3011700000 -2535100000 -1883100000 185300000 29100000 115700000 56500000 192800000 99200000 -1171400000 -679300000 360000000.0 12518400000 11718400000 11120000000.0 0.2830 0.2947 0.2739 -3542300000 -3453300000 -3045300000 120400000 234000000.0 213200000 3909800000 4079900000 2516000000.0 17200000 27200000 77500000 -489100000 -164500000 -876000000.0 100900000 -58200000 -1500000 382300000 249000000.0 123300000 189900000 239500000 602800000 -75500000 655600000 -636600000 0.0050 -0.0461 0.0463 <table cellpadding="0" cellspacing="0" id="xdx_892_eifrs-full--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory_pn5n6_zYc1IpZcRZQj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_zOliFNfl0Syc" style="display: none">Schedule of deferred income tax</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liabilities</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liabilities</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investment securities</span></td> <td id="xdx_981_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zVh4Ub2YENC" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zY4T3Of6PJyd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2268">-</span>   </span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zQMuu69WHWk8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zVEcLP5rOX4k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td> <td id="xdx_98A_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zAZxpFyNb2F8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2274">-</span>   </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_z00IHKtEK836" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangible</span></td> <td id="xdx_988_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_z6zsvcCvij09" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span>   </span></td> <td id="xdx_983_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zTsx7tXmgkh7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,369.7)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zHKIbfGffk14" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,369.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zK6e7OCACRmi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2284">-</span>   </span></td> <td id="xdx_986_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_z9M9u88S8Zo9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,690.2)</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_ztdhCkuQXrN3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,690.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Employee benefits</span></td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zD0ItU7d1Ag" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">856.5 </span></td> <td id="xdx_98D_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zldW6dKufUa1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2292">-</span>   </span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zA1vfpL04Uj3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">856.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zHpbGDcp54z6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">951.2 </span></td> <td id="xdx_98D_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zGgHgX8uqlqa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2298">-</span>   </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zlbgVSKzx7Tk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">951.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_986_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_z2CQezzxyuv2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,843.8 </span></td> <td id="xdx_987_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zZ9Ua1fAh1X1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.3)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zJERJ9hPDr8l" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,840.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_z9NWLb6sVTb7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,232.8 </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zbonq1cJf5nk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.9)</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_ziu6wOnAKbma" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,229.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade receivables</span></td> <td id="xdx_986_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zszXvzry4Bq1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">43.8 </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zZAybmpmpqK3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.0)</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zRVWTzGzLnM8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zJ0oFF7DJ7m4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38.6 </span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zxbEWh4O4kpg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.8)</span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zBew3QqzXTIi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">34.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives</span></td> <td id="xdx_984_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zZTCvZOs7pT9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">31.1 </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zHP9BwPdp56j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(77.2)</span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_z8pX7t0HU1Ih" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zaGWtATEPk8g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">95.1 </span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zbYiii8fKfvb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(44.8)</span></td> <td id="xdx_98E_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zxpidRbfs7Q5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interest-Bearing Loans and Borrowings</span></td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zCXnz87QIQh3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td> <td id="xdx_98C_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z2Jy0b7pTIC9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2340">-</span>   </span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zjSrXJ0SrzJ1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zsyHXPRFCZKl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.5 </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z5wGWnDImCr6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.9)</span></td> <td id="xdx_98C_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z8Aoa2lXe6Rj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inventories</span></td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zzTnudX7rKA" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">268.6 </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zhhd0valUWn7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.6)</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zbUDOr8rr2B5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">209.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_z615MmxljWPd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">413.9 </span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zb39H8NIkJV5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(139.3)</span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zk4dFNY7379k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">274.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Property, plant and equipment</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zqdXvGn4Jivl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">714.2 </span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zuMsnEUGFxtg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,837.2)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zckL9XR2C0ca" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,123.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zP3MA6Cpf5a8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">899.5 </span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zEdEP7CEbgha" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,177.1)</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zr3G2LL2cgA" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,277.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Withholding tax on undistributed profits and royalties</span></td> <td id="xdx_985_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zSrcX6aBRb56" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2374">-</span>   </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zfsUWXzHii5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zY7RMPZfl609" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_z8dqEkXJiLu6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2380">-</span>   </span></td> <td id="xdx_987_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zVV4zmlz1Gm2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,877.6)</span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_z35a1Mx5Ovml" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,877.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investments in joint ventures</span></td> <td id="xdx_982_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_z5YRlxvzvk96" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2386">-</span>   </span></td> <td id="xdx_983_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_z3JsjaYMAx5k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zlYkymDxVn2a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zbnlQvb13vpa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2392">-</span>   </span></td> <td id="xdx_984_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zp4pqUa8SgA5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(421.6)</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zWMlPeLOxjnj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(421.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Losses carried forward</span></td> <td id="xdx_987_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zbBjQmBphQUg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,383.3 </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zmOjiIakeM8f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span>   </span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_z8mtAIvLAKe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,383.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zSIk0155ah4i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,660.7 </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zygw2IHuKoSe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2406">-</span>   </span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zDa3mOolTWQ5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,660.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Provisions</span></td> <td id="xdx_988_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zW4QJknDM9e6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,026.3 </span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zrRDhBkHWyTd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.6)</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zBNRiR0Jp4Dd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,021.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_z5en1lrfqEVe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">819.3 </span></td> <td id="xdx_98E_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_z5ZpT3A9pYpb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2418">-</span>   </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zd8355fASSE3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">819.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Impact of the adoption of IFRS 16 (Leases)</span></td> <td id="xdx_983_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zH4zaaOmPaLc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.5 </span></td> <td id="xdx_986_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zRNHSl8eMySi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19.7)</span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zjrGUBiZIhBk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zpsxZvnwWqS7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">35.1 </span></td> <td id="xdx_988_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zJWeKwj233M6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.4)</span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zDjtivVrwNZ1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ICMS on the assessment bases of PIS/COFINS</span></td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zMoUTHHQI4s7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2434">-</span>   </span></td> <td id="xdx_985_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_z64irvKLDpx8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td> <td id="xdx_98C_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_z55dBU0ECyUi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zjTDUDKUwEO9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2440">-</span>   </span></td> <td id="xdx_982_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zmaibY6fXjfe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(168.2)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zv1D7rqYu1ah" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(168.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other items</span></td> <td id="xdx_988_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zRVJ7l60ivvj" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">266.5 </span></td> <td id="xdx_98B_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zoRqTV6wqhl4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(437.1)</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zzIdMYUAkY88" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(170.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zMhQoE1jYST7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">260.8 </span></td> <td id="xdx_98C_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zChFkqisaJRb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(164.1)</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zIghVpaahvBh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets / (liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">96.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Gross deferred tax assets/(liabilities)</b></span></td> <td id="xdx_98E_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20231231_z9KwFA1JOGHe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>10,464.3 </b></span></td> <td id="xdx_987_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20231231_zNa8N6y9V9q3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5,813.1)</b></span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231_zSy5Lto07Kwc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,651.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--DeferredTaxAssets_iI_pn5n6_c20221231_zghHvzIgHieb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,415.0 </b></span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilities_iI_pn5n6_c20221231_ztDUNt5yc89i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,701.9)</b></span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20221231_zKV4HjcH2bZ6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gross deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,713.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Netting by taxable entity</span></td> <td id="xdx_988_ecustom--DeferredTaxAssetsNettingByTaxableEntity_iI_pn5n6_c20231231_zjVFEOgRTsdl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,494.7)</span></td> <td id="xdx_98F_ecustom--DeferredTaxsLiabilitiesNettingByTaxableEntity_iI_pn5n6_c20231231_zBczMKrRVCdf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,494.7 </span></td> <td id="xdx_989_ecustom--DeferredTaxLiabilityAssetNettingByTaxableEntity_iI_pn5n6_c20231231_zR2MXCLaiupf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2474">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--DeferredTaxAssetsNettingByTaxableEntity_iI_pn5n6_c20221231_zKREUKLY3Fnc" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,976.2)</span></td> <td id="xdx_981_ecustom--DeferredTaxsLiabilitiesNettingByTaxableEntity_iI_pn5n6_c20221231_zTXbZVB9EnD8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,976.2 </span></td> <td id="xdx_986_ecustom--DeferredTaxLiabilityAssetNettingByTaxableEntity_iI_pn5n6_c20221231_zyEWylP4Fo8k" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Netting by taxable entity, deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2480">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Net deferred tax assets/(liabilities)</b></span></td> <td id="xdx_98A_eifrs-full--NetDeferredTaxAssets_iI_pn5n6_c20231231_zZKOQSyYnuA8" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>7,969.6 </b></span></td> <td id="xdx_986_ecustom--NetDeferredTaxLiabilities1_iI_pn5n6_c20231231_zgkAfO4Juq01" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,318.4)</b></span></td> <td id="xdx_980_ecustom--DeferredTaxLiabilityAssetNet_iI_pn5n6_c20231231_zNhzMQjcxGR1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,651.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NetDeferredTaxAssets_iI_pn5n6_c20221231_zP7xMzAleYte" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,438.8 </b></span></td> <td id="xdx_982_ecustom--NetDeferredTaxLiabilities1_iI_pn5n6_c20221231_z1aTESTTK2F3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,725.7)</b></span></td> <td id="xdx_988_ecustom--DeferredTaxLiabilityAssetNet_iI_pn5n6_c20221231_za89ikCuVUU7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net deferred tax assets/(liabilities)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,713.1 </b></span></td></tr> </table> 8200000 8200000 7500000 7500000 -1369700000 -1369700000 -1690200000 -1690200000 856500000 856500000 951200000 951200000 2843800000 -3300000 2840500000 3232800000 -2900000 3229900000 43800000 -7000000.0 36800000 38600000 -3800000 34800000 31100000 -77200000 -46100000 95100000 -44800000 50300000 7500000 7500000 500000 -900000 -400000 268600000 -59600000 209000000.0 413900000 -139300000 274600000 714200000 -1837200000 -1123000000.0 899500000 -2177100000 -1277600000 -1385500000 -1385500000 -1877600000 -1877600000 -383700000 -383700000 -421600000 -421600000 4383300000 4383300000 2660700000 2660700000 1026300000 -4600000 1021700000 819300000 819300000 14500000 -19700000 -5200000 35100000 -11400000 23700000 -228500000 -228500000 -168200000 -168200000 266500000 -437100000 -170600000 260800000 -164100000 96700000 10464300000 -5813100000 4651200000 9415000000.0 -6701900000 2713100000 -2494700000 2494700000 -2976200000 2976200000 7969600000 -3318400000 4651200000 6438800000 -3725700000 2713100000 268600000 790000000 <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfTheRealizationOfDeferredTaxAssetsAndLiabilitiesTextBlock_zVki2GZIdpt1" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 4)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_z65lbEULJvqb" style="display: none">Schedule of deferred tax assets and liabilities</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 50%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Deferred taxes not related to tax losses</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>to be realized within 12 months</b></span></td> <td style="width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>to be realized after 12 months</b></span></td> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investment securities</span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zqdPFF2eF3fl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2501">-</span>   </span></td> <td id="xdx_984_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zOxDp3fbQWuk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInSecuritiesMember_zMqSBDYHAIV" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangible</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zymOtaUKVYv6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.2)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zjlqBWWCP0W7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,368.5)</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesIntangiblesMember_zJc8Aj061qr2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,369.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Employee benefits</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zPjt27zAHZ58" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">199.9 </span></td> <td id="xdx_980_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zwxr2J83JBUj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">656.6 </span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesEmployeeBenefitsMember_zFrra1N1ENUj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">856.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade payables</span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zkYdE3rnG8Oe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(220.6)</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zfGDdcO1Ufrd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,061.1 </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradePayablesMember_zULpUPbQzl0b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,840.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade receivables</span></td> <td id="xdx_984_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zITSepmcDr9c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">22.7 </span></td> <td id="xdx_987_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zeLRi6SLVzqd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.1 </span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesTradeReceivableMember_zHX6Bb7n9vCh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zKBRqSXxFTH1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(49.8)</span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zg87Db8uW5G6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.7 </span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesDerivativesMember_zqLFVHokKsB8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interest-bearing loans and borrowings</span></td> <td id="xdx_98B_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_z6ssHwa6E7G7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_981_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zpk1wSAW8Aqh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.4 </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInterestbearingLoansAndBorrowingsMember_zdCC5Lfh6qUf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inventories</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zzmZg1CnHdHh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">252.7 </span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zbp9LJHo3sp8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(43.7)</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInventoriesMember_zCGpx675sTh9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">209.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Property, plant and equipment</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_zdZemGEob8u8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td id="xdx_980_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_z3mrixsNOxig" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,118.9)</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesPropertyPlantAndEquipmentMember_z76DNHLzPMM" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,123.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Withholding tax on undistributed profits and royalties</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zE6LNVOi3Rkg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2555">-</span>   </span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zyDXlFXX3NK6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesWithholdingTaxOverUndistributedProfitsAndRoyaltiesMember_zqm8BytHIFC7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,385.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investments in joint ventures</span></td> <td id="xdx_984_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zPWYWTimpaB6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2561">-</span>   </span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_z7KyySgpNY04" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesInvestmentsInJointVenturesMember_zAVjgZUSGEn5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(383.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Provisions</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zO7hhMwWWPn2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">664.5 </span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zUDPeLCrl9S3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">357.2 </span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesProvisionsMember_zsxd8oN6mlLk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,021.7 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Impact of the adoption of IFRS 16 (Leases)</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zxDxt3avnqEd" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2573">-</span>   </span></td> <td id="xdx_98E_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zKpC6KY5NJac" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.2)</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ImpactOfAdoptionOfIFRSAccountingPolicyMember_zdiLmN2Za5Na" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.2)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ICMS on the assessment bases of PIS/COFINS</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zQyJg2S2SvJl" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2579">-</span>   </span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zRgPrFEQ3d4h" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSFromTheAssessmentBasesOfPISCOFINSMember_zshDGyIVB0Mi" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(228.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other items</span></td> <td id="xdx_989_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zGqY02Ssrc94" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">39.8 </span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_zU3W6tRFpE96" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(210.4)</span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--TemporaryDifferencesOtherItemsMember_z2M20zv4RY3j" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(170.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_988_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxesNotRelatedToTaxLossesMember_z1QAX417KY3k" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>904.0 </b></span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxesNotRelatedToTaxLossesMember_zjtsslkdfSgg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(636.1)</b></span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DeferredTaxesNotRelatedToTaxLossesMember_zCfsqCL0Bfx7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred taxes not related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>267.9 </b></span></td></tr> </table> 8200000 8200000 -1200000 -1368500000 -1369700000 199900000 656600000 856500000 -220600000 3061100000 2840500000 22700000 14100000 36800000 -49800000 3700000 -46100000 100000 7400000 7500000 252700000 -43700000 209000000.0 -4100000 -1118900000 -1123000000.0 -1385500000 -1385500000 -383700000 -383700000 664500000 357200000 1021700000 -5200000 -5200000 -228500000 -228500000 39800000 -210400000 -170600000 904000000.0 -636100000 267900000 <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfDeferredTaxRealizationRelatedToTaxLossesTextBlock_zfAtOJXJFIU9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 5)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zibOEvvXLFhl" style="display: none">Schedule of deferred tax realization related to tax losses</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 75%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Deferred tax related to tax losses</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2023</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zk6xPqVxAf6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2599">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2024</span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zuT0oXNdYDFe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">755.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2025</span></td> <td id="xdx_982_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_z3I2scQu4L2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">422.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2026</span></td> <td id="xdx_98A_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanFoursYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zgwb377yjUB" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,635.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2027</span></td> <td id="xdx_986_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zlqfitwvXLac" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,052.8 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2028 a 2030</span></td> <td id="xdx_985_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanFiveYearsAndNotLaterThanEightYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zaj6fcFrYwEj" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">170.3 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">2031 em onward</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (i)</sup></span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanNineYearsMember__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_fKGkp_zboUJtOdfsz9" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">346.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_983_eifrs-full--DeferredTaxLiabilityAsset_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--UnusedTaxLossesMember_zb31jK8Jnb14" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred tax related to tax losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,383.3 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">There is no expectation of realization beyond a term of ten years.</td> </tr></table> 755700000 422500000 1635200000 1052800000 170300000 346800000 4383300000 <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfTheReconciliationOfChangesInDeferredTaxLiabilityAssetTextBlock_zX30kOHV8CR9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INCOME TAX AND SOCIAL CONTRIBUTION (Details 6)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_zG2meMdIy5a3" style="display: none">Schedule of net change in deferred income tax and social contribution</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98F_eifrs-full--DeferredTaxLiabilityAsset_iS_pn5n6_c20220101__20221231_zpDxzW9bWmzh" style="width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred income tax and social contribution at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,513.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognition of actuarial gains/(losses)</span></td> <td id="xdx_984_eifrs-full--IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_z8GkOjN3Tnwi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognition of actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(146.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment hedge – put option granted on subsidiaries</span></td> <td id="xdx_985_ecustom--IncomeTaxRelatingToHedgesOfInvestmentsRegardingPutOptionsOfASubsidiaryInterestInEquityInstrumentsOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zC30brer13Ve" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investment hedge - put option granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(105.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash flow hedge – gains/(losses)</span></td> <td id="xdx_98D_eifrs-full--IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zlajrlHY2sY6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedge - gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">41.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains/(losses) on translation of other foreign operations </span></td> <td id="xdx_987_eifrs-full--IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zLQ6m7eYvCab" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on translation of other foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(419.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in other comprehensive income</b></span></td> <td id="xdx_985_eifrs-full--IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_pn5n6_c20220101__20221231_zU2tmVyGcM7f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(629.9)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in the income statement</b></span></td> <td id="xdx_981_ecustom--DeferredTaxExpenseIncomes_pn5n6_c20220101__20221231_zmqWWAZPMXqg" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in the income statement"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,374.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Changes directly in the balance sheet</b></span></td> <td id="xdx_98F_ecustom--TotalChangesRelatedToDeferredIncomeTaxAndSocialContributionsAffectingTheBalanceSheet_pn5n6_c20220101__20221231_zpStXnvQ51U4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes directly in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(545.2)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in deferred tax</span></td> <td id="xdx_987_ecustom--DirectChangesToDeferredTaxAndLiabilitiesInTheBalanceSheet_pn5n6_c20220101__20221231_zyPnSVKRNZT6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in deferred tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(595.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td id="xdx_98A_ecustom--ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet_pn5n6_c20220101__20221231_zDLKNkvAb9c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(595.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in other balance sheet group</span></td> <td id="xdx_986_ecustom--ChangesRelatedToDeferredTaxRecognizedInOtherInTheBalanceSheet_pn5n6_c20220101__20221231_zw1Ok6aBvRD1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other balance sheet group"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98C_eifrs-full--DeferredTaxLiabilityAsset_iS_pn5n6_c20230101__20231231_zSnPboOxKoph" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred income tax and social contribution at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,713.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognition of actuarial gains/(losses)</span></td> <td id="xdx_98F_eifrs-full--IncomeTaxRelatingToChangesInRevaluationSurplusOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zo50hQHrM372" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognition of actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">24.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment hedge – put option granted on subsidiaries</span></td> <td id="xdx_98B_ecustom--IncomeTaxRelatingToHedgesOfInvestmentsRegardingPutOptionsOfASubsidiaryInterestInEquityInstrumentsOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zAjio8w1bq06" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investment hedge - put option granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(155.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash flow hedge – gains/(losses)</span></td> <td id="xdx_988_eifrs-full--IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zoccoUBe2ja7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedge - gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">83.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains/(losses) on translation of other foreign operations </span></td> <td id="xdx_988_eifrs-full--IncomeTaxRelatingToExchangeDifferencesOnTranslationOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zcNCCLl7kI82" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on translation of other foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">553.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in other comprehensive income</b></span></td> <td id="xdx_986_eifrs-full--IncomeTaxRelatingToComponentsOfOtherComprehensiveIncome_pn5n6_c20230101__20231231_zeSXEuRcO2jb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>505.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Recognized in the income statement</b></span></td> <td id="xdx_982_ecustom--DeferredTaxExpenseIncomes_pn5n6_c20230101__20231231_zxFf1mlVOkW8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in the income statement"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,002.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Changes directly in the balance sheet</b></span></td> <td id="xdx_986_ecustom--TotalChangesRelatedToDeferredIncomeTaxAndSocialContributionsAffectingTheBalanceSheet_pn5n6_c20230101__20231231_z1faFhuQC8ac" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes directly in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(569.9)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in deferred tax</span></td> <td id="xdx_98B_ecustom--DirectChangesToDeferredTaxAndLiabilitiesInTheBalanceSheet_pn5n6_c20230101__20231231_zvKhDRzw2fSk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in deferred tax"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(476.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td id="xdx_981_ecustom--ChangesInDeferredTaxRelatedToAdoptionOfNewAccountingPolicyRecognisedInTheBalanceSheet_pn5n6_c20230101__20231231_zi7YdHvX5nRb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(476.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Recognized in other balance sheet group</span></td> <td id="xdx_982_ecustom--ChangesRelatedToDeferredTaxRecognizedInOtherInTheBalanceSheet_pn5n6_c20230101__20231231_zRENE8C3nyr2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Recognized in other balance sheet group"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(93.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2023</b></span></td> <td id="xdx_98D_eifrs-full--DeferredTaxLiabilityAsset_iE_pn5n6_c20230101__20231231_z8vGROGYnMLa" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred income tax and social contribution at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,651.2 </b></span></td></tr> </table> 1513700000 -146900000 -105000000.0 41300000 -419300000 -629900000 2374500000 -545200000 -595500000 -595500000 50300000 2713100000 24400000 -155900000 83200000 553900000 505600000 2002400000 -569900000 -476300000 -476300000 -93600000 4651200000 669000000 875300000 2521000000 3359500000 <p id="xdx_80E_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zJ9I6xjRawje" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_020"></span><b>14.</b></td><td><b><span id="xdx_82D_z3dIOzHlmFyb">PROPERTY, PLANT AND EQUIPMENT</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn5n6_zDS5GBHm6Ak5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BA_zohFEtIneYP9" style="display: none">Schedule of property, plant and equipment</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 52%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Property, plant and equipment</span></td> <td id="xdx_984_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--PropertyPlantAndEquipmentMember_zSqA0FWFde14" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,662.7 </span></td> <td id="xdx_988_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--PropertyPlantAndEquipmentMember_z0xcbF0CFzp9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26,961.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Right of use assets</span></td> <td id="xdx_98C_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zwXO6LcyMbKf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,967.5 </span></td> <td id="xdx_989_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zpI3TJaiSdw4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,094.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20231231_zHyytgBWfddh" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>26,630.2 </b></span></td> <td id="xdx_98E_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20221231_zK5uq3M9xh6a" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>30,055.7 </b></span></td></tr> </table> <p id="xdx_8AA_zEA163VT05I3" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>14.1 <span style="color: #0D0D0D; background-color: white">Changes in the carrying amount of property, plant, and equipment</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0D0D0D"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ReconciliationOfChangesInPropertyPlantAndEquipmentTextBlock_zlscBNe4eCv7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 1)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zJbsMt1MBLmk" style="display: none">Schedule of changes in the carrying amount of property, plant and equipment</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Carrying amount</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2021</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisitions </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Disposals and write-offs</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Transfers </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2022</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Land and buildings</span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_z8xlx77NPb1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,090.2 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zYAYVyPTpax6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(832.1)</span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_z5IT4b2dl8Te" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">712.7 </span></td> <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqaPROgYp5pd" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">11.2 </span></td> <td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAXlk7OTB5Ak" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(436.8)</span></td> <td id="xdx_98F_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zNryr9IJDzy9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(20.1)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zaJ82jy0Yiq2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">1,173.2 </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zODtZz90GkY5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,698.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zYikptyJJ276" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">14,494.2 </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zNR3UZvXsj44" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(4,795.9)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Plant and equipment</span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zEKoyxOmOZE6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>10,884.0 </b></span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zvgN5otvy4Ag" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(1,067.3)</span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zr3BknSwKmO2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">952.6 </span></td> <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyzcMLCGYxH4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">1,283.5 </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwqq8NGjL8m8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3,564.6)</span></td> <td id="xdx_989_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_z4P5r1BHiz3c" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(15.7)</span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zsjHSzZ33r54" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">3,116.6 </span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zxuZZWurwcp" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>11,589.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zXYItkfTElgi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">39,818.3 </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zJTqlriNi1a8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(28,229.2)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Fixtures and fittings</span></td> <td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zpbtPMRHjaMi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,285.1 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zOGDRfF1hb4a" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(111.6)</span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_z4NuqqoLN98j" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">96.7 </span></td> <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0dMmAsLW9R3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">87.3 </span></td> <td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zw5WnIoZfgdh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(579.7)</span></td> <td id="xdx_981_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_z6Ak0zxNqwGg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(14.6)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zr4Q8YryBMKg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">560.7 </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zRPmRGYBWqj7" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,323.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zDYZM2I8D2rg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">7,682.7 </span></td> <td id="xdx_987_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zeRJK5MFrFNc" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(6,358.8)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Under construction</span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zhigPLxwEPa8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>5,404.7 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zNN6CgklBUlj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(360.7)</span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zsQs54rOlUCa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">252.7 </span></td> <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWYitLl6XwJe" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">4,923.7 </span></td> <td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdqbBEDkkeZ3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2761">-</span>   </span></td> <td id="xdx_982_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zWWCiMAdgFY6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2763">-</span>   </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zr3ZrExMyvAa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(5,870.4)</span></td> <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zmUF6Lk14vHb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>4,350.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zCa6ExjV9KSg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">4,350.0 </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zOxO7Myaw9Y4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2771">-</span>   </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrLlTDPzoa37" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>26,664.0 </b></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjvCTzOb1r0a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(2,371.7)</b></span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6VxmDDrVc4a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>2,014.7 </b></span></td> <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8SGQdkUZZR6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>6,305.7 </b></span></td> <td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcg1Xgql6lkc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(4,581.1)</b></span></td> <td id="xdx_989_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkt0UJQVJiLe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(50.4)</b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRLJ69aG160b" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(1,019.9)</b></span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrLOSu7bGr4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>26,961.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMzd3TN0MIgj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>66,345.2 </b></span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zQUDWIAfeBC4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(39,383.9)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0D0D0D"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Carrying amount</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2022</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisitions </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Disposals and write-offs</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Transfers </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2023</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Land and buildings</span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zMJ329CswrIb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,698.3 </b></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zRjeBf1jDVB1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(1,485.2)</span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zst1gZU7Ru25" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">663.1 </span></td> <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zB1xzUu9IfQa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">44.7 </span></td> <td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zS8IfWRjk9v5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(481.6)</span></td> <td id="xdx_988_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zWouoTg6dTEc" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3.7)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zNH5ZNi4qaQi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">800.6 </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zKLjtIbngRj8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,236.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zFXZQ6bsSLGa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">14,287.8 </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zJiKSs01ZErb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(5,051.6)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Plant and equipment</span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zNnIUp9yqR0h" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>11,589.1 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_z2CNWKGP5RP1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(1,726.7)</span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zyhd4WKj57H6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">779.4 </span></td> <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqjCTKncNzk9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">1,230.2 </span></td> <td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zV0ei0Y5qel3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3,533.4)</span></td> <td id="xdx_98C_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_ziMcUs7yLit5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(39.1)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_z0cqBLOeKAj9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">2,488.8 </span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zDZTSlifcV62" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>10,788.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zUL3d66Wy3Df" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">39,509.2 </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zLoOGaIlrE64" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(28,720.9)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Fixtures and fittings</span></td> <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zpweW1i3Tzw2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,323.9 </b></span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGDG206yXgq6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(193.4)</span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zJ0A5pfqT7ra" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">86.5 </span></td> <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziTnxY7ZUXs8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">56.4 </span></td> <td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYhLRHMiePlg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(541.6)</span></td> <td id="xdx_980_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zi71EYeUNbP3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(13.5)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_z7j7f4Ub0Iua" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">373.7 </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zKuVHz277J01" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,092.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zihNfu0zxxf3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">7,074.2 </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zr5OUdqM7ZDk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(5,982.2)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Under construction</span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zVsUkYFXAOy" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>4,350.0 </b></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zl5LJKoGxRI6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(311.7)</span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zDX9G6lKtf82" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">120.2 </span></td> <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5c4ot4fuT07" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">3,283.9 </span></td> <td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyfj5CW5h273" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2861">-</span>   </span></td> <td id="xdx_981_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_znRY0qNZ4lHl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3.4)</span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zWdospWonsre" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(4,892.8)</span></td> <td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zZ9j906LF9Mb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>2,546.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zMPHaHpVDUHf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">2,546.2 </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zYeO41nfUzKh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2871">-</span>   </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxFNKjDG7Tg5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>26,961.3 </b></span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTtk6Hfrtrl6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(3,717.0)</b></span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zP1YmKighhdh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,649.2 </b></span></td> <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zI9hVcr71Sa" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>4,615.2 </b></span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR4t7LvHkBW2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(4,556.6)</b></span></td> <td id="xdx_983_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRkM2x4a9eC8" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(59.7)</b></span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXmWOU3k7G8l" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(1,229.7)</b></span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzECjwpUw655" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>23,662.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc6sofnam3l4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>63,417.4 </b></span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zFh6xPFgyTa5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(39,754.7)</b></span></td></tr> </table> <p id="xdx_8A0_zcu7iIo5gNn8" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"><b>14.2 <span style="color: #0D0D0D; background-color: white">Changes in the carrying amount of right-of-use assets</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfChangesInCarryingAmountOfRightofuseAssetsExplanatory_zXvLW54q2wih" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zGHZ0zSRo9Vi" style="display: none">Schedule of carrying amount of right-of-use assets</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td style="border-top: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposals and write-offs</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="border-top: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Buildings</span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_ztFILacQPRz7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,206.0 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z74qsli2jEpl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(64.3)</span></td> <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zsA0CO1JXHEf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">628.0 </span></td> <td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zqJc4PkrnVab" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(391.6)</span></td> <td id="xdx_981_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zBQPMyTx3jyc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.7 </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zfpDiP3iPb8i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(37.0)</span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z3tzsuFMMiL1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,350.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zocNySwmi3Wh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,698.3 </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zWvy4ic80jMk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,347.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Machinery, vehicles and others</span></td> <td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zUcTMv6j0VQh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,354.3 </b></span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zvPrXc7rI7H8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.2)</span></td> <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zfAESfcVMOF7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,009.7 </span></td> <td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z1yPF0f3P7ye" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(453.9)</span></td> <td id="xdx_985_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zF0QOw28Vaca" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(194.5)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zzvFvgUZVU7h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.2 </span></td> <td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zbu5vRbT9tQ5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,743.6 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zp2S12Z7Vvhf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,889.5 </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zegSDuIwKNi1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,145.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z7y2vVhGd7R3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,560.3 </b></span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zuqQY9LUAhH4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(72.5)</b></span></td> <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zS06Wo424Uy7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,637.7 </b></span></td> <td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zMUFb4U1ose5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(845.5)</b></span></td> <td id="xdx_98F_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zwR83JaU34I" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(184.8)</b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zSioMb2MAzef" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(0.8)</b></span></td> <td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zasJB2PktsD3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,094.4 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zjWuJaU7dPbc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,587.8 </b></span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zxNINWB9WhXc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,493.4)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="border-top: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposals and write-offs</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td style="border-top: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Buildings</span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zLQFvYZZBtGc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,350.8 </b></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z3fm9NyJy2Qg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(49.5)</span></td> <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zAhGs00uhpq6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">355.0 </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zJCrrLYJ8Jhl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(451.8)</span></td> <td id="xdx_984_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zquiTc7T1ZA6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(30.5)</span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zQfkFjA6hrKl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.8)</span></td> <td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zif5uckyjTE7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,172.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zR4cXGlXFA" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,925.9 </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zA5solwd0FEb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,753.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Machinery, vehicles and others</span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zTEOX34r9Dq" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,743.6 </b></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zxPnWHXfouRf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.7)</span></td> <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zRnChUrZyVw1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,329.3 </span></td> <td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zPSjhuD2t3G3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(773.9)</span></td> <td id="xdx_98E_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zIi7Vti8xG8i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(475.5)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zzIKrb9q9137" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.5 </span></td> <td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zGQwQnvSzQ9h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,795.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zqa5nRfsxlt3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,534.4 </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zVa55XyoU2nc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,739.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zLLTlSVUPUIi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,094.4 </b></span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zzpFHjMSHPHd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(82.2)</b></span></td> <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zT8MEHdGl8i2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,684.3 </b></span></td> <td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zxGuigD98Xlc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,225.7)</b></span></td> <td id="xdx_984_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zji7t7tKIu3e" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(506.0)</b></span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zmLKXIzTvq26" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2.7 </b></span></td> <td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z6UzfX2dGOOg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,967.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zJQud4vhZjj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,460.3 </b></span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z2iWKXSHYNHh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,492.8)</b></span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p id="xdx_8A5_zMQsyvULr24h" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting Policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, plant and equipment are measured at cost less accumulated depreciation and impairment losses. The cost includes the purchase price, borrowing costs incurred during the construction period and any other costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management (e.g., nonrefundable tax, transportation and the costs of dismantling, removal and site restoration, if applicable). The cost of a self-constructed asset is determined using the same principles as an acquired asset. The depreciation methods, residual value, as well as the useful lives are reassessed and adjusted if appropriate, on an annual basis. Property, plant and equipment, and depreciation include the effects of using the predecessor basis of accounting (Note 3.2.5.1).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>a.1) Subsequent expenditure</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes in the carrying amount of an item of property, plant and equipment the cost of replacing a component of such an item if it is probable that the future economic benefits of the component will flow to the Company and the cost of the component can be measured reliably. All other costs are expensed as incurred.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>a.2) Depreciation</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The depreciable amount is the cost of an asset less its residual value. Depreciation is calculated from the date on which the asset is available for use, using the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the major classes of property, plant and equipment are as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfEstimatedUsefulLivesOfMajorPropertyPlantAndEquipmentClassesTextBlock_zukS7TX4It98" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zhJ4MDqeTZQ5" style="display: none">Schedule of estimated useful lives of property, plant and equipment</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 73%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Buildings</span></td> <td style="white-space: nowrap; width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_903_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z539hn5h8ENc" title="Estimated useful lives">25</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Plant and equipment</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zW5DFrJz6hQ6" title="Estimated useful lives">15</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Fixtures </span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90B_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FixturesMember_zurtUqjyTNi8" title="Estimated useful lives">10</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Fittings</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90E_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FittingsMember_zQlDAjLibTq8" title="Estimated useful lives">10</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Assets for external use / commercial assets</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"> <span id="xdx_90A_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ExternalUseAssetsCommercialAssetsMember_zs1gmO8Ycf75" title="Estimated useful lives">2</span> - <span id="xdx_905_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ExternalUseAssetsCommercialAssetsMember_znXQpamgpFR5" title="Estimated useful lives">5</span> years</span></td></tr> </table> <p id="xdx_8AE_z136wZ9SFL02" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Land is not depreciated since it is deemed to have an indefinite useful life.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The assets’ residual values and useful lives are reviewed when necessary.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>a.3) Gains and losses on sale</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Gains and losses on sales are determined by comparing the results with the carrying amounts and are recognized in Other operating income/(expenses) in the income statement.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>b) Leases</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With the adoption of IFRS 16 – <i>Leasings</i>, the Company begun to recognize a right-of-use asset and a liability at the date of the beginning of the lease term.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes the right-of-use asset and a corresponding lease liability related to all lease contracts which is the lessee, except for short-term leases (defined as leases with terms of 12-month or less) and leases of low value assets. To these leases, Company recognizes the lease payments as operating expense during the lease course.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The right-of-use asset is initially measured at cost, which includes the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date. The asset is subsequently depreciated on a straight-line basis over the lease term or until the end of the asset's useful life.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Currently, the main leases by the Company are related to trucks, forklifts, real estate, commercial vehicles and industrial equipment contracts.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The lease liability is initially measured at lease payments present value, discounted by using the rate implicit in the lease. If the rate cannot be promptly determined, Company uses its incremental loan rate specific for the country, term and currency of the contract or other local criteria.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lease payments include fixed payments, less any lease incentives, variable lease payments that depend on an index or known rate at the commencement date, and purchase options or extension options payments if the Company is reasonably certain to exercise these options. In general, the contracts establish an annual readjustment of payments according to the rates established in the contract.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A lease liability is remeasured upon a change in the lease term, or on the future payments or alteration of an index or rate used to determine payments<span style="color: #0D0D0D; background-color: white">, t</span>he corresponding adjustment is made to the related right-of-use asset.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0D0D0D; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies IAS 36 - <i>Impairment of Assets to determine if right-of-use asse</i>t is subject to impairment and to record eventual losses by impairment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The lease liability is disclosed at “Interest-bearing loans and borrowing” line and the right-of-use assets are disclosed at “Property, plant and equipment” line of the balance sheet.</p> <table cellpadding="0" cellspacing="0" id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_pn5n6_zDS5GBHm6Ak5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BA_zohFEtIneYP9" style="display: none">Schedule of property, plant and equipment</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 52%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Property, plant and equipment</span></td> <td id="xdx_984_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--PropertyPlantAndEquipmentMember_zSqA0FWFde14" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,662.7 </span></td> <td id="xdx_988_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--PropertyPlantAndEquipmentMember_z0xcbF0CFzp9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26,961.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Right of use assets</span></td> <td id="xdx_98C_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20231231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zwXO6LcyMbKf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,967.5 </span></td> <td id="xdx_989_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20221231__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zpI3TJaiSdw4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,094.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20231231_zHyytgBWfddh" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>26,630.2 </b></span></td> <td id="xdx_98E_eifrs-full--OtherPropertyPlantAndEquipment_iI_pn5n6_c20221231_zK5uq3M9xh6a" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>30,055.7 </b></span></td></tr> </table> 23662700000 26961300000 2967500000 3094400000 26630200000 30055700000 <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--ReconciliationOfChangesInPropertyPlantAndEquipmentTextBlock_zlscBNe4eCv7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 1)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zJbsMt1MBLmk" style="display: none">Schedule of changes in the carrying amount of property, plant and equipment</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Carrying amount</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2021</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisitions </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Disposals and write-offs</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Transfers </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2022</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Land and buildings</span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_z8xlx77NPb1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,090.2 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zYAYVyPTpax6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(832.1)</span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_z5IT4b2dl8Te" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">712.7 </span></td> <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqaPROgYp5pd" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">11.2 </span></td> <td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAXlk7OTB5Ak" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(436.8)</span></td> <td id="xdx_98F_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zNryr9IJDzy9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(20.1)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zaJ82jy0Yiq2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">1,173.2 </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zODtZz90GkY5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,698.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zYikptyJJ276" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">14,494.2 </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zNR3UZvXsj44" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(4,795.9)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Plant and equipment</span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zEKoyxOmOZE6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>10,884.0 </b></span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zvgN5otvy4Ag" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(1,067.3)</span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zr3BknSwKmO2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">952.6 </span></td> <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyzcMLCGYxH4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">1,283.5 </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zwqq8NGjL8m8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3,564.6)</span></td> <td id="xdx_989_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_z4P5r1BHiz3c" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(15.7)</span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zsjHSzZ33r54" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">3,116.6 </span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zxuZZWurwcp" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>11,589.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zXYItkfTElgi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">39,818.3 </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zJTqlriNi1a8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(28,229.2)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Fixtures and fittings</span></td> <td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zpbtPMRHjaMi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,285.1 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zOGDRfF1hb4a" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(111.6)</span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_z4NuqqoLN98j" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">96.7 </span></td> <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z0dMmAsLW9R3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">87.3 </span></td> <td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zw5WnIoZfgdh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(579.7)</span></td> <td id="xdx_981_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_z6Ak0zxNqwGg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(14.6)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zr4Q8YryBMKg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">560.7 </span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zRPmRGYBWqj7" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,323.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zDYZM2I8D2rg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">7,682.7 </span></td> <td id="xdx_987_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zeRJK5MFrFNc" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(6,358.8)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Under construction</span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zhigPLxwEPa8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>5,404.7 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zNN6CgklBUlj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(360.7)</span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zsQs54rOlUCa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">252.7 </span></td> <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWYitLl6XwJe" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">4,923.7 </span></td> <td id="xdx_980_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zdqbBEDkkeZ3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2761">-</span>   </span></td> <td id="xdx_982_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zWWCiMAdgFY6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2763">-</span>   </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zr3ZrExMyvAa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(5,870.4)</span></td> <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zmUF6Lk14vHb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>4,350.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zCa6ExjV9KSg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">4,350.0 </span></td> <td id="xdx_985_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zOxO7Myaw9Y4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2771">-</span>   </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrLlTDPzoa37" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>26,664.0 </b></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjvCTzOb1r0a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(2,371.7)</b></span></td> <td id="xdx_989_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z6VxmDDrVc4a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>2,014.7 </b></span></td> <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z8SGQdkUZZR6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>6,305.7 </b></span></td> <td id="xdx_989_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcg1Xgql6lkc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(4,581.1)</b></span></td> <td id="xdx_989_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkt0UJQVJiLe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(50.4)</b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRLJ69aG160b" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(1,019.9)</b></span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrLOSu7bGr4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>26,961.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zMzd3TN0MIgj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>66,345.2 </b></span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zQUDWIAfeBC4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(39,383.9)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0D0D0D"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Carrying amount</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2022</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisitions </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Disposals and write-offs</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Transfers </b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>At December 31, 2023</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>Depreciation</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Land and buildings</span></td> <td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zMJ329CswrIb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,698.3 </b></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zRjeBf1jDVB1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(1,485.2)</span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zst1gZU7Ru25" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">663.1 </span></td> <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zB1xzUu9IfQa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">44.7 </span></td> <td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zS8IfWRjk9v5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(481.6)</span></td> <td id="xdx_988_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zWouoTg6dTEc" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3.7)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zNH5ZNi4qaQi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">800.6 </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zKLjtIbngRj8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>9,236.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zFXZQ6bsSLGa" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">14,287.8 </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LandAndBuildingsMember_zJiKSs01ZErb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(5,051.6)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Plant and equipment</span></td> <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zNnIUp9yqR0h" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>11,589.1 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_z2CNWKGP5RP1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(1,726.7)</span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zyhd4WKj57H6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">779.4 </span></td> <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqjCTKncNzk9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">1,230.2 </span></td> <td id="xdx_98A_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zV0ei0Y5qel3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3,533.4)</span></td> <td id="xdx_98C_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_ziMcUs7yLit5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(39.1)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_z0cqBLOeKAj9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">2,488.8 </span></td> <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zDZTSlifcV62" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>10,788.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_987_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zUL3d66Wy3Df" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">39,509.2 </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zLoOGaIlrE64" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(28,720.9)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Fixtures and fittings</span></td> <td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zpweW1i3Tzw2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,323.9 </b></span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGDG206yXgq6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(193.4)</span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zJ0A5pfqT7ra" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">86.5 </span></td> <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_ziTnxY7ZUXs8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">56.4 </span></td> <td id="xdx_982_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zYhLRHMiePlg" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(541.6)</span></td> <td id="xdx_980_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zi71EYeUNbP3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(13.5)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_z7j7f4Ub0Iua" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">373.7 </span></td> <td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zKuVHz277J01" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,092.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98D_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zihNfu0zxxf3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">7,074.2 </span></td> <td id="xdx_983_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zr5OUdqM7ZDk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(5,982.2)</span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">Under construction</span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zVsUkYFXAOy" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>4,350.0 </b></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zl5LJKoGxRI6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(311.7)</span></td> <td id="xdx_982_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zDX9G6lKtf82" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">120.2 </span></td> <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5c4ot4fuT07" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">3,283.9 </span></td> <td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyfj5CW5h273" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2861">-</span>   </span></td> <td id="xdx_981_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_znRY0qNZ4lHl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(3.4)</span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zWdospWonsre" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">(4,892.8)</span></td> <td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zZ9j906LF9Mb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>2,546.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98B_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zMPHaHpVDUHf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black">2,546.2 </span></td> <td id="xdx_98F_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ConstructionInProgressMember_zYeO41nfUzKh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><span style="-sec-ix-hidden: xdx2ixbrl2871">-</span>   </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zxFNKjDG7Tg5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>26,961.3 </b></span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTtk6Hfrtrl6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(3,717.0)</b></span></td> <td id="xdx_984_ecustom--PropertyPlantAndEquipmentEffectOfAccountingPolicy_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zP1YmKighhdh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>1,649.2 </b></span></td> <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zI9hVcr71Sa" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>4,615.2 </b></span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR4t7LvHkBW2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(4,556.6)</b></span></td> <td id="xdx_983_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zRkM2x4a9eC8" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(59.7)</b></span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXmWOU3k7G8l" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(1,229.7)</b></span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzECjwpUw655" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>23,662.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-size: 7pt"> </span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zc6sofnam3l4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>63,417.4 </b></span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zFh6xPFgyTa5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt; color: black"><b>(39,754.7)</b></span></td></tr> </table> 9090200000 -832100000 712700000 11200000 436800000 -20100000 1173200000 9698300000 14494200000 -4795900000 10884000000.0 -1067300000 952600000 1283500000 3564600000 -15700000 3116600000 11589100000 39818300000 -28229200000 1285100000 -111600000 96700000 87300000 579700000 -14600000 560700000 1323900000 7682700000 -6358800000 5404700000 -360700000 252700000 4923700000 -5870400000 4350000000.0 4350000000.0 26664000000.0 -2371700000 2014700000 6305700000 4581100000 -50400000 -1019900000 26961300000 66345200000 -39383900000 9698300000 -1485200000 663100000 44700000 481600000 -3700000 800600000 9236200000 14287800000 -5051600000 11589100000 -1726700000 779400000 1230200000 3533400000 -39100000 2488800000 10788300000 39509200000 -28720900000 1323900000 -193400000 86500000 56400000 541600000 -13500000 373700000 1092000000.0 7074200000 -5982200000 4350000000.0 -311700000 120200000 3283900000 -3400000 -4892800000 2546200000 2546200000 26961300000 -3717000000.0 1649200000 4615200000 4556600000 -59700000 -1229700000 23662700000 63417400000 -39754700000 <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--DisclosureOfChangesInCarryingAmountOfRightofuseAssetsExplanatory_zXvLW54q2wih" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zGHZ0zSRo9Vi" style="display: none">Schedule of carrying amount of right-of-use assets</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td style="border-top: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposals and write-offs</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="border-top: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Buildings</span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_ztFILacQPRz7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,206.0 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z74qsli2jEpl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(64.3)</span></td> <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zsA0CO1JXHEf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">628.0 </span></td> <td id="xdx_986_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zqJc4PkrnVab" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(391.6)</span></td> <td id="xdx_981_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zBQPMyTx3jyc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.7 </span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zfpDiP3iPb8i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(37.0)</span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z3tzsuFMMiL1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,350.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zocNySwmi3Wh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,698.3 </span></td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zWvy4ic80jMk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,347.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Machinery, vehicles and others</span></td> <td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zUcTMv6j0VQh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,354.3 </b></span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zvPrXc7rI7H8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.2)</span></td> <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zfAESfcVMOF7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,009.7 </span></td> <td id="xdx_98F_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z1yPF0f3P7ye" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(453.9)</span></td> <td id="xdx_985_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zF0QOw28Vaca" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(194.5)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zzvFvgUZVU7h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.2 </span></td> <td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zbu5vRbT9tQ5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,743.6 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zp2S12Z7Vvhf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,889.5 </span></td> <td id="xdx_986_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zegSDuIwKNi1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,145.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_981_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z7y2vVhGd7R3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,560.3 </b></span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zuqQY9LUAhH4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(72.5)</b></span></td> <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zS06Wo424Uy7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,637.7 </b></span></td> <td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zMUFb4U1ose5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(845.5)</b></span></td> <td id="xdx_98F_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zwR83JaU34I" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(184.8)</b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zSioMb2MAzef" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(0.8)</b></span></td> <td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zasJB2PktsD3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,094.4 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zjWuJaU7dPbc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,587.8 </b></span></td> <td id="xdx_980_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zxNINWB9WhXc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,493.4)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="width: 24%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="border-top: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td> <td style="border-top: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposals and write-offs</b></span></td> <td style="border-top: black 1.5pt solid; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="border-top: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td style="border-top: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Buildings</span></td> <td id="xdx_989_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zLQFvYZZBtGc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,350.8 </b></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z3fm9NyJy2Qg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(49.5)</span></td> <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zAhGs00uhpq6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">355.0 </span></td> <td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zJCrrLYJ8Jhl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(451.8)</span></td> <td id="xdx_984_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zquiTc7T1ZA6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(30.5)</span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zQfkFjA6hrKl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.8)</span></td> <td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zif5uckyjTE7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,172.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zR4cXGlXFA" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,925.9 </span></td> <td id="xdx_98A_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zA5solwd0FEb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,753.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Machinery, vehicles and others</span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zTEOX34r9Dq" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,743.6 </b></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zxPnWHXfouRf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.7)</span></td> <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zRnChUrZyVw1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,329.3 </span></td> <td id="xdx_983_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zPSjhuD2t3G3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(773.9)</span></td> <td id="xdx_98E_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zIi7Vti8xG8i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(475.5)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zzIKrb9q9137" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.5 </span></td> <td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zGQwQnvSzQ9h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,795.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zqa5nRfsxlt3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,534.4 </span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryVehiclesAndOthersMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zVa55XyoU2nc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,739.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zLLTlSVUPUIi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,094.4 </b></span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zzpFHjMSHPHd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(82.2)</b></span></td> <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zT8MEHdGl8i2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,684.3 </b></span></td> <td id="xdx_987_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zxGuigD98Xlc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,225.7)</b></span></td> <td id="xdx_984_ecustom--DisposalsAndWriteoffsOfPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zji7t7tKIu3e" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposals and write-offs"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(506.0)</b></span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zmLKXIzTvq26" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2.7 </b></span></td> <td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z6UzfX2dGOOg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,967.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_zJQud4vhZjj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,460.3 </b></span></td> <td id="xdx_98E_ecustom--PropertyPlantAndEquipment1_iI_pn5n6_c20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfAssetsAxis__ifrs-full--RightofuseAssetsMember_z2iWKXSHYNHh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Property, plant and equipment"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,492.8)</b></span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> 1206000000.0 -64300000 628000000.0 391600000 9700000 -37000000.0 1350800000 2698300000 -1347500000 1354300000 -8200000 1009700000 453900000 -194500000 36200000 1743600000 2889500000 -1145900000 2560300000 -72500000 1637700000 845500000 -184800000 -800000 3094400000 5587800000 -2493400000 1350800000 -49500000 355000000.0 451800000 -30500000 -1800000 1172200000 2925900000 -1753700000 1743600000 -32700000 1329300000 773900000 -475500000 4500000 1795300000 3534400000 -1739100000 3094400000 -82200000 1684300000 1225700000 -506000000.0 2700000 2967500000 6460300000 -3492800000 <table cellpadding="0" cellspacing="0" id="xdx_895_ecustom--DisclosureOfEstimatedUsefulLivesOfMajorPropertyPlantAndEquipmentClassesTextBlock_zukS7TX4It98" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span id="xdx_8B2_zhJ4MDqeTZQ5" style="display: none">Schedule of estimated useful lives of property, plant and equipment</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; width: 73%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Buildings</span></td> <td style="white-space: nowrap; width: 27%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_903_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_z539hn5h8ENc" title="Estimated useful lives">25</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Plant and equipment</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_900_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--PlantAndEquipmentMember_zW5DFrJz6hQ6" title="Estimated useful lives">15</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Fixtures </span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90B_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FixturesMember_zurtUqjyTNi8" title="Estimated useful lives">10</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Fittings</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"><span id="xdx_90E_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FittingsMember_zQlDAjLibTq8" title="Estimated useful lives">10</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">Assets for external use / commercial assets</span></td> <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 11pt"> <span id="xdx_90A_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ExternalUseAssetsCommercialAssetsMember_zs1gmO8Ycf75" title="Estimated useful lives">2</span> - <span id="xdx_905_ecustom--PropertyPlantAndEquipmentUsefulLifes_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ExternalUseAssetsCommercialAssetsMember_znXQpamgpFR5" title="Estimated useful lives">5</span> years</span></td></tr> </table> P25Y P15Y P10Y P10Y P2Y P5Y <p id="xdx_800_eifrs-full--DisclosureOfGoodwillExplanatory_zQVlZ6zBVtC" style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0 0 0 0.25in"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_021"></span><b>15.</b></td><td><b><span id="xdx_823_zGjNmDdXG5h6">GOODWILL</span></b></td></tr></table> <p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfReconciliationOfChangesInGoodwillExplanatory_pn5n6_zczhmxUTjdZ3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - GOODWILL (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_zS7Cn6Yhgwhc" style="display: none">Schedule of goodwill</span></td> <td id="xdx_495_20230101__20231231_zXkcT52VQ4Hl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20220101__20221231_zYRk6xprPxI8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 66%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_eifrs-full--Goodwill_iS_pn5n6_z7ccxj4YlRvj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Balance at the end of the previous year</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>40,594.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>42,411.3 </b></span></td></tr> <tr id="xdx_403_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesGoodwill_pn5n6_zWzkTImQEUWc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effects of movements in foreign exchange in the balance sheet</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,067.9)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,510.6)</span></td></tr> <tr id="xdx_405_ecustom--GoodwillAdjustmentAdoptionOfNewAccountingAdjustment_pn5n6_z1SsqjfOXjr" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,481.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,709.9 </span></td></tr> <tr id="xdx_405_ecustom--IncreaseDecreaseThroughBusinessCombinationsGoodwill_pn5n6_z7H7Gjhe7F2j" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Acquisitions, (write-offs) and disposal through business combinations</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16.6)</span></td></tr> <tr id="xdx_402_eifrs-full--Goodwill_iE_pn5n6_zo5me6OS8UJg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Balance at the end of the year</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>38,003.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>40,594.0 </b></span></td></tr> </table> <p id="xdx_8A2_z2WI6FAe9Uc5" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amount of goodwill was allocated to the different cash generating unit (“CGU”) as follows:</p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory_pn5n6_zyNjPaB2igu2" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - GOODWILL (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_z5pIK68kylWf" style="display: none">Schedule of carrying amount of goodwill</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Functional currency</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Brazil</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">BRL</span></td> <td id="xdx_982_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfBrazilMember_zhneBS1NhRN3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,698.8 </span></td> <td id="xdx_980_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfBrazilMember_zVtIndkyOjNc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,702.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Goodwill</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--GoodwillGrossAmount_iI_pn5n6_c20231231_zWohUjFUvECe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">102,941.4 </span></td> <td id="xdx_984_ecustom--GoodwillGrossAmount_iI_pn5n6_c20221231_zPTmNnbuIzGj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">102,945.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif"> Non-controlling transactions </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--GoodwillNoncontrollingTransactions_iI_pn5n6_c20231231_zdkhduadylte" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-controlling transactions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(85,242.6)</span></td> <td id="xdx_982_ecustom--GoodwillNoncontrollingTransactions_iI_pn5n6_c20221231_zuIfFmFXSzFe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-controlling transactions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(85,242.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>CAC:</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Dominican Republic</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">DOP</span></td> <td id="xdx_982_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--DominicanRepublicMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_z6tA17PZSxGg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,805.5 </span></td> <td id="xdx_983_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--DominicanRepublicMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_zbBv1y1eVet3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,231.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Panama</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PAB</span></td> <td id="xdx_983_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--PanamaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_z8C0L19ibZnh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,682.9 </span></td> <td id="xdx_980_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--PanamaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_zDW2uqWfdxhj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,813.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Latin America - South:</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Argentina</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">ARS</span></td> <td id="xdx_984_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--ArgentinaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zSDWFkkNss2k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,183.8 </span></td> <td id="xdx_98B_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--ArgentinaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zAGFdhrcKLv6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,463.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bolivia</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">BOB</span></td> <td id="xdx_989_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--BoliviaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zs8oo4fkUCwj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,712.5 </span></td> <td id="xdx_988_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--BoliviaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zlf8p9PIaJge" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,845.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chile</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">CLP</span></td> <td id="xdx_98C_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--ChileMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zxUmBWcTVW8l" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">47.9 </span></td> <td id="xdx_98E_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--ChileMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zPMU4xpgF1l4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">53.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Paraguay</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PYG</span></td> <td id="xdx_98C_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--ParaguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_z9SJkOAIst2e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">888.2 </span></td> <td id="xdx_986_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--ParaguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zk1EUWRZmKH5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">953.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Uruguay</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">UYU</span></td> <td id="xdx_989_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--UruguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zpg7S0PW0xP4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">184.0 </span></td> <td id="xdx_988_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--UruguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zYp25p7jxdCc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">193.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Canada</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">CAD</span></td> <td id="xdx_985_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfCanadaMember_zja67PwmtFL6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,800.0 </span></td> <td id="xdx_988_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfCanadaMember_zJIEjBuPvYMk" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,337.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--Goodwill_iI_pn5n6_c20231231_zd5gA0XePTAi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>38,003.6 </b></span></td> <td id="xdx_989_eifrs-full--Goodwill_iI_pn5n6_c20221231_zd66z0YcDfRe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>40,594.0 </b></span></td></tr> </table> <p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">This refers to the shareholding exchange transaction in 2013 as a result of the adoption of the predecessor basis of accounting.</td> </tr></table> <p id="xdx_8A0_zIxFeEJ231v3" style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The assets with indefinite useful life represent approximately <span id="xdx_905_ecustom--GoodwillPercentageOfTotalAssets_iI_pip0_dp_c20231231_z9fUlU9ZHywk" title="Goodwill percentage of total assets">29</span>% of the total consolidated assets at December 31, 2023 (<span id="xdx_908_ecustom--GoodwillPercentageOfTotalAssets_iI_pip0_dp_c20221231_zXHUoniw43t9" title="Goodwill percentage of total assets">29</span>% at December 31, 2022).</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill arises on acquisitions of subsidiaries, associates, and joint arrangements and is determined as the excess between: the sum of (i) the consideration paid in exchange for control of the acquiree; plus (ii) the amount of any non-controlling interests in the acquiree (when applicable); and (iii) the fair value, at the acquisition date, of any previous equity interest in the acquiree, over the fair value of the net identifiable assets acquired and liabilities assumed, measured in accordance with IFRS 3 - <i>Business Combination</i> as at the date of acquisition.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Business combinations are recognized applying the investment cost allocation method. If the company's share of the net fair value of the recognized assets, liabilities, and contingent liabilities exceeds the cost of the business combination, such excess is immediately recognized in the income statement. In a business combination, the asset with indefinite useful life is allocated from the acquisition date to each CGU expected to benefit from the business combination synergies.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In compliance with IFRS 3, goodwill is <span style="color: windowtext">carried at cost and not amortized, but is tested for impairment at least annually, or whenever there are indications that the CGU to which the goodwill has been allocated could be impaired. Impairment losses recognized on goodwill are not reversed. Gains and losses on the disposal of an entity include the carrying amount of goodwill relating to the entity sold.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For associates and joint ventures, goodwill is included in the carrying amount of the investment in the associate/joint venture.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill is expressed in the functional currency of the CGU or joint operation to which it relates and translated into Reais using the year-end exchange rate.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Expenditure on internally generated goodwill is expensed as it is incurred.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Goodwill includes the effects of applying the predecessor basis of accounting (Note 3 (3.2.5.1)).</p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfReconciliationOfChangesInGoodwillExplanatory_pn5n6_zczhmxUTjdZ3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - GOODWILL (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_zS7Cn6Yhgwhc" style="display: none">Schedule of goodwill</span></td> <td id="xdx_495_20230101__20231231_zXkcT52VQ4Hl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_492_20220101__20221231_zYRk6xprPxI8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 66%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_eifrs-full--Goodwill_iS_pn5n6_z7ccxj4YlRvj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Balance at the end of the previous year</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>40,594.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>42,411.3 </b></span></td></tr> <tr id="xdx_403_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesGoodwill_pn5n6_zWzkTImQEUWc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effects of movements in foreign exchange in the balance sheet</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,067.9)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,510.6)</span></td></tr> <tr id="xdx_405_ecustom--GoodwillAdjustmentAdoptionOfNewAccountingAdjustment_pn5n6_z1SsqjfOXjr" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,481.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,709.9 </span></td></tr> <tr id="xdx_405_ecustom--IncreaseDecreaseThroughBusinessCombinationsGoodwill_pn5n6_z7H7Gjhe7F2j" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Acquisitions, (write-offs) and disposal through business combinations</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16.6)</span></td></tr> <tr id="xdx_402_eifrs-full--Goodwill_iE_pn5n6_zo5me6OS8UJg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Balance at the end of the year</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>38,003.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>40,594.0 </b></span></td></tr> </table> 40594000000.0 42411300000 -4067900000 -3510600000 1481100000 1709900000 -3600000 -16600000 38003600000 40594000000.0 <table cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfInformationForIndividualAssetOrCashgeneratingUnitWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesExplanatory_pn5n6_zyNjPaB2igu2" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - GOODWILL (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_z5pIK68kylWf" style="display: none">Schedule of carrying amount of goodwill</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Functional currency</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Brazil</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">BRL</span></td> <td id="xdx_982_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfBrazilMember_zhneBS1NhRN3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,698.8 </span></td> <td id="xdx_980_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfBrazilMember_zVtIndkyOjNc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17,702.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Goodwill</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--GoodwillGrossAmount_iI_pn5n6_c20231231_zWohUjFUvECe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">102,941.4 </span></td> <td id="xdx_984_ecustom--GoodwillGrossAmount_iI_pn5n6_c20221231_zPTmNnbuIzGj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">102,945.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif"> Non-controlling transactions </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--GoodwillNoncontrollingTransactions_iI_pn5n6_c20231231_zdkhduadylte" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-controlling transactions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(85,242.6)</span></td> <td id="xdx_982_ecustom--GoodwillNoncontrollingTransactions_iI_pn5n6_c20221231_zuIfFmFXSzFe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-controlling transactions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(85,242.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>CAC:</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Dominican Republic</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">DOP</span></td> <td id="xdx_982_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--DominicanRepublicMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_z6tA17PZSxGg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,805.5 </span></td> <td id="xdx_983_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--DominicanRepublicMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_zbBv1y1eVet3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,231.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Panama</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PAB</span></td> <td id="xdx_983_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--PanamaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_z8C0L19ibZnh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,682.9 </span></td> <td id="xdx_980_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--PanamaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CACMember_zDW2uqWfdxhj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,813.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Latin America - South:</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Argentina</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">ARS</span></td> <td id="xdx_984_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--ArgentinaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zSDWFkkNss2k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,183.8 </span></td> <td id="xdx_98B_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--ArgentinaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zAGFdhrcKLv6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,463.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bolivia</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">BOB</span></td> <td id="xdx_989_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--BoliviaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zs8oo4fkUCwj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,712.5 </span></td> <td id="xdx_988_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--BoliviaMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zlf8p9PIaJge" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,845.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chile</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">CLP</span></td> <td id="xdx_98C_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--ChileMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zxUmBWcTVW8l" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">47.9 </span></td> <td id="xdx_98E_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--ChileMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zPMU4xpgF1l4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">53.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Paraguay</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PYG</span></td> <td id="xdx_98C_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--ParaguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_z9SJkOAIst2e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">888.2 </span></td> <td id="xdx_986_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--ParaguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zk1EUWRZmKH5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">953.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Uruguay</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">UYU</span></td> <td id="xdx_989_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--SegmentsAxis__custom--UruguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zpg7S0PW0xP4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">184.0 </span></td> <td id="xdx_988_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--SegmentsAxis__custom--UruguayMember__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--LatinAmericaSouthMember_zYp25p7jxdCc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">193.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Canada</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">CAD</span></td> <td id="xdx_985_eifrs-full--Goodwill_iI_pn5n6_c20231231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfCanadaMember_zja67PwmtFL6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,800.0 </span></td> <td id="xdx_988_eifrs-full--Goodwill_iI_pn5n6_c20221231__ifrs-full--IndividualAssetsOrCashgeneratingUnitsAxis__custom--CountryOfCanadaMember_zJIEjBuPvYMk" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,337.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--Goodwill_iI_pn5n6_c20231231_zd5gA0XePTAi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>38,003.6 </b></span></td> <td id="xdx_989_eifrs-full--Goodwill_iI_pn5n6_c20221231_zd66z0YcDfRe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Goodwill"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>40,594.0 </b></span></td></tr> </table> <p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">This refers to the shareholding exchange transaction in 2013 as a result of the adoption of the predecessor basis of accounting.</td> </tr></table> 17698800000 17702400000 102941400000 102945000000.0 -85242600000 -85242600000 3805500000 4231600000 1682900000 1813800000 2183800000 3463000000.0 1712500000 1845600000 47900000 53100000 888200000 953800000 184000000.0 193100000 9800000000.0 10337600000 38003600000 40594000000.0 0.29 0.29 <p id="xdx_801_eifrs-full--DisclosureOfImpairmentLossAndReversalOfImpairmentLossExplanatory_zLC4kiQ5z6l1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_022"></span><b>16.</b></td><td><b><span id="xdx_825_zczRy3O4nX4e">IMPAIRMENT OF NON-FINANCIAL ASSETS</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company cannot predict whether an event that could triggers impairment will occur, when it will occur or how it will affect the value of the asset reported. The Company believes that all its estimates are reasonable, are consistent with the Company’s internal reporting and reflect Management’s best estimates. However, inherent uncertainty exists which Management is not able to control. While changes in estimates could have a material impact on the calculation of fair values, and trigger impairment, the Company, based on the sensitivity analysis performed, is not aware of any reasonably possible changes in key assumptions that would cause a business unit’s carrying amount to exceed its recoverable amount.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended December 31, 2023, the Company performed impairment testing of the non-current assets of the Group (property, plant and equipment, intangible assets, goodwill, and right-of-use assets) for CGUs that had goodwill and assets with indefinite useful life allocated, as well as for other CGUs that showed indicators of impairment. The Company assesses internal and external sources of information as indicators, in accordance with IAS 36 - Impairment of Assets.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the impairment tests conducted, the Company did not identify any impairment or reversal of impairment losses scenario for any asset or CGU.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>16.1 Assets with definite useful life</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company did not identify impairment indicators in the assets with definite useful life.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>16.2 Assets with indefinite useful life</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>16.2.1 Methodology</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The methodology used by the Company to determine the recoverable value of all its CGUs is the net fair value of selling expenses, using multiples of the profit before financial result, income tax and depreciation and amortization expenses (“EBITDA”), observed in the market for previous comparable business transactions in the domestic and international brewing industry. The values used by the Company for this approach are based on external sources of information. This measurement is classified at Level 2 of the fair value hierarchy, since the main source of information used by the Company to determine the recoverable value was the EBITDA multiples of observable transactions involving comparable businesses. As part of this multiples analysis, the Company has established that CGUs with invested capital that exceeds seven times their EBITDA should have their recoverable value determined using the value-in-use approach, to determine whether the value-in-use exceeds the carrying amount of the CGU. Based on the most recent analysis carried out by the Company, for 2023, only Chile and Panama met this criterion. Additionally, Brasil CGU was also included in the scope of testing, as it is the most representative CGU of the Group.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Thus, for Brazil, Panama and Chile CGUs, the Company also used discounted cash flow projections to determine the CGUs’ recoverable amounts, to corroborate the conclusions reached by applying the fair value less disposal costs approach that the carrying amount of these CGUs does not exceed their recognized accounting values.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>16.2.2 Key assumptions</b></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The key judgments, estimates and key assumptions used for the discounted free cash flow calculations for these CGUs were as follow:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Wingdings">§</span></td><td>The first year of the model is based on management's best estimate of the free cash flow outlook for the current year.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 1.85pt 0 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Wingdings">§</span></td><td style="text-align: justify; padding-right: 1.85pt">To the second year of the model, the free cash flow is based on AB InBev's strategic plan, as approved by key management. AB InBev's strategic plan is prepared on a per country basis, and is based on external sources of macroeconomic assumptions, industry trends, inflation and foreign exchange rates, experience and identified initiatives in terms of market share, revenue, variable and fixed costs, capital expenditure and working capital assumptions.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 1.85pt 0 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Wingdings">§</span></td><td style="text-align: justify; padding-right: 1.85pt">From the third to the tenth year of the model, the cash flow is extrapolated using the growth in volumes, price indexes, and expected market share for each CGU. For Chile, the best estimates from local Management were considered.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 1.85pt 0 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Wingdings">§</span></td><td style="text-align: justify; padding-right: 1.85pt">Projections are made in the functional currency of the business unit and discounted at the unit's weighted average cost of capital (“WACC”), considering sensitivities of this metric.</td></tr></table> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 1.85pt 0 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Based on the cash flow analysis, the growth rates applied ranged from <span id="xdx_905_ecustom--GrowthRate_pip0_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zu5qA5WLwaY3" title="Growth rate">1.2</span>% to <span id="xdx_904_ecustom--GrowthRate_pip0_dp_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0zd1qWOPrjh" title="Growth rate">8.1</span>%.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The nominal WACC applied in the local currency for each CGU was as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_888_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory_zFvo0jauDdzd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span><span id="xdx_8BE_zvxzZuFmKHK5" style="display: none">Schedule of local currency</span></span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"> </td></tr> <tr> <td style="border-bottom: Black 1pt solid; width: 79%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>CGU</b></span></td> <td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Chile</span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--EquityInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pip0_dp_uPure_c20231231__srt--SegmentsAxis__custom--ChileMember__ifrs-full--UnobservableInputsAxis__ifrs-full--WeightedAverageCostOfCapitalMeasurementInputMember_zqIv2kyl70n2" title="Weighted average cost of capital">9.83</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Panama</span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--EquityInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pip0_dp_uPure_c20231231__srt--SegmentsAxis__custom--PanamaMember__ifrs-full--UnobservableInputsAxis__ifrs-full--WeightedAverageCostOfCapitalMeasurementInputMember_zTu79thI5QO5" title="Weighted average cost of capital">10.72</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Brazil</span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--EquityInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pip0_dp_uPure_c20231231__srt--SegmentsAxis__custom--CountryOfBrazilMember__ifrs-full--UnobservableInputsAxis__ifrs-full--WeightedAverageCostOfCapitalMeasurementInputMember_z89Hu0a74xdl" title="Weighted average cost of capital">12.38</span>%</span></td></tr> </table> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Although Ambev believes that its judgments, assumptions and estimates are appropriate, actual results may differ from these estimates based on different assumptions or market or macroeconomic conditions.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>16.2.3 Sensitivity analysis </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Based on the probable scenario, a sensitivity analysis was carried out for a 0.5 percentage point increase / decrease in the discount rate and growth rate. In any combination, the value of the cash flow is higher than its book value. As a result of this analysis, there is no need to record any provision to impairment from these assets.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b>Accounting Polices</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of non-financial assets, such as property, plant and equipment, goodwill and intangible assets without defined useful lives are reviewed, at least, at each reporting date to determine the existence of any indication of impairment. If there is any indication, the asset’s recoverable amount is estimated, and the non-recoverable amount is recognized as an impairment in the income statement. This assessment is performed for assets individually or for the smallest identifiable groups of assets that generate cash inflows independent of the cash inflows from other assets or other groups of assets, also referred to as CGUs.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill, intangible assets not yet available for use, and intangibles with indefinite useful lives, are tested for impairment at the business unit level (one level below the reportable segment level) at least annually, or whenever there is any indication of impairment. An impairment loss is recognized whenever the carrying amount of an asset or the related CGU exceeds its recoverable amount. Impairment losses are recognized in the income statement.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An impairment loss is recognized whenever the carrying amount of an asset or the related CGU exceeds its recoverable amount. Impairment losses are recognized in the income statement. Intangible assets with an indefinite useful life are tested on a fair value approach applying multiples that reflect current market transactions to indicators that drive the profitability of the asset or the royalty stream that could be obtained from licensing the intangible asset to another party in an arm’s length transaction.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The recoverable amounts of other assets are determined as the higher of their fair value less costs to sell and their value in use. For an asset that does not generate substantially independent cash inflows, the recoverable amount is allocated to the CGU to which the asset belongs. The recoverable amounts of the CGU to which the goodwill and the intangible assets with indefinite useful lives belong are based on the fair value net of selling expenses, using EBITDA multiples observed in the market for previous business combinations involving comparable businesses in the brewing industry. For some CGUs, these calculations are corroborated using the fair-value less costs of disposal approach, where the free cash flow of these CGUs is discounted to fair value using a discount rate after tax that reflects current valuation models for the time value of money, and the risks specific to the asset.</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Impairment losses recognized in CGUs carrying amount of goodwill allocated to the CGUs and subsequently impact the carrying amount of the assets within the unit. Reversals of previously recognized impairments may occur, except for impairment losses related to goodwill due to expected future profitability. Non-financial assets are reviewed for the possible reversal of the impairment at the reporting date. Impairment losses are reversed only to the extent that the asset’s carrying amount does not exceed the carrying amount that would have been determined, net of depreciation or amortization.</p> 0.012 0.081 <table cellpadding="0" cellspacing="0" id="xdx_888_eifrs-full--DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfAssetsExplanatory_zFvo0jauDdzd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - IMPAIRMENT OF NON-FINANCIAL ASSETS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span><span id="xdx_8BE_zvxzZuFmKHK5" style="display: none">Schedule of local currency</span></span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"> </td></tr> <tr> <td style="border-bottom: Black 1pt solid; width: 79%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>CGU</b></span></td> <td style="border-bottom: Black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Chile</span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--EquityInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pip0_dp_uPure_c20231231__srt--SegmentsAxis__custom--ChileMember__ifrs-full--UnobservableInputsAxis__ifrs-full--WeightedAverageCostOfCapitalMeasurementInputMember_zqIv2kyl70n2" title="Weighted average cost of capital">9.83</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Panama</span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_905_eifrs-full--EquityInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pip0_dp_uPure_c20231231__srt--SegmentsAxis__custom--PanamaMember__ifrs-full--UnobservableInputsAxis__ifrs-full--WeightedAverageCostOfCapitalMeasurementInputMember_zTu79thI5QO5" title="Weighted average cost of capital">10.72</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif">Brazil</span></td> <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--EquityInstrumentsPercentageContributedToFairValueOfPlanAssets_iI_pip0_dp_uPure_c20231231__srt--SegmentsAxis__custom--CountryOfBrazilMember__ifrs-full--UnobservableInputsAxis__ifrs-full--WeightedAverageCostOfCapitalMeasurementInputMember_z89Hu0a74xdl" title="Weighted average cost of capital">12.38</span>%</span></td></tr> </table> 0.0983 0.1072 0.1238 <p id="xdx_809_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_ze1dDu6ATJbd" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt/115% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"><span id="a_023"></span></td><td style="width: 21.3pt"><b>17.</b></td><td><b><span id="xdx_822_z0YcsCi0MUc6">INTANGIBLES</span></b></td></tr></table> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_pn5n6_z7BATwKTLJAg" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B1_zojxjk7ISGee" style="display: none">Schedule of intangible assets</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposal </b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Amortization</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brands</span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zNUyWl2VCK25" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,329.0 </b></span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,096.2)</span></td> <td id="xdx_98F_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_znVans5T3R44" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">930.3 </span></td> <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3121">-</span>   </span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zztO5k2kqPf7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3123">-</span>   </span></td> <td id="xdx_983_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3125">-</span>   </span></td> <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3127">-</span>   </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvu8ztWTot5d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,163.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvbGfkWO8zAh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,163.1 </span></td> <td id="xdx_985_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zEw5OGF8Xft2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3133">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangibles</span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zZZX91lbiZhj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>671.2 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(44.7)</span></td> <td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3141">-</span>   </span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.2 </span></td> <td id="xdx_98C_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3145">-</span>   </span></td> <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zaUcgPRHpleg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(58.1)</span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z97B3iS7Yxdl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>571.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z0AGvNs871Hg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,308.6 </span></td> <td id="xdx_989_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zXCkux3DhPn8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,736.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Software</span></td> <td id="xdx_98E_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zmRkS68lPiUg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,129.7 </b></span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(130.6)</span></td> <td id="xdx_986_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">126.9 </span></td> <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.9 </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,402.3 </span></td> <td id="xdx_98B_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3165">-</span>   </span></td> <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zi7ai46tCttb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(401.1)</span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zEsTixAJQllg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,134.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zJF1IJzFN65" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,353.9 </span></td> <td id="xdx_98A_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zP4O7nSUYZfe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,219.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Others</span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zBak9JcfSLWa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>559.1 </b></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(96.0)</span></td> <td id="xdx_985_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">76.8 </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">220.5 </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(364.1)</span></td> <td id="xdx_98D_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span>   </span></td> <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zRGUwx4mMrT8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(43.0)</span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zcti0uwEQL32" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>353.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_z1ezK7wUb4Ug" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,218.8 </span></td> <td id="xdx_98C_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zoZKCnVvlAZh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(865.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zy1KLU55vDJh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>8,689.0 </b></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,367.5)</b></span></td> <td id="xdx_985_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,134.1 </b></span></td> <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>227.4 </b></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,041.4 </b></span></td> <td id="xdx_983_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3205">-</span>   </b></span></td> <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf01oZe1617d" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(502.2)</b></span></td> <td id="xdx_988_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zynS5Be1Emd1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,222.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSVazFqHyfN4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,044.4 </b></span></td> <td id="xdx_98D_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhLoCv2lArv1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5,822.2)</b></span></td></tr> </table> <p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposal </b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Amortization</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brands</span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zB017qmSYgok" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,163.1 </b></span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,838.5)</span></td> <td id="xdx_98B_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">808.6 </span></td> <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">73.9 </span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3223">-</span>   </span></td> <td id="xdx_981_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3225">-</span>   </span></td> <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3227">-</span>   </span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zCBxzT5dEVyg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,207.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zCwa6rWrFeQ2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,207.1 </span></td> <td id="xdx_982_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zLiRhe5muqqg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3233">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangibles</span></td> <td id="xdx_980_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zHAAc6bahIG3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>571.7 </b></span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zc0Qo1Cnncrk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(33.5)</span></td> <td id="xdx_98E_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z5aE1fzSY6Pd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3239">-</span>   </span></td> <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zIaMTiyKlzRk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">869.3 </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z4cruxN7iLQ4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3243">-</span>   </span></td> <td id="xdx_989_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zurXdoCgYw8i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3245">-</span>   </span></td> <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z4tOuJOhgesi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.7)</span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zEwEkinCyGL7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,350.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zJvpMNXJzLKc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,087.0 </span></td> <td id="xdx_985_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z55nBUQun95d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,736.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Software</span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zlYGLhYviOya" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,134.1 </b></span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(344.6)</span></td> <td id="xdx_984_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">176.2 </span></td> <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.0 </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">976.5 </span></td> <td id="xdx_982_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zn4qHm44bvEh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.9)</span></td> <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zZV6csDLqBC6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(573.5)</span></td> <td id="xdx_984_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z1YLsp4KwNvk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,404.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zR2JHcGvW0Dj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,954.2 </span></td> <td id="xdx_98A_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zqSNbkMtELd4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,549.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Others</span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zBkpdr6hq3f2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>353.3 </b></span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td> <td id="xdx_98B_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.0 </span></td> <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">487.7 </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">317.0 </span></td> <td id="xdx_98A_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zdv4Qof4ZHD" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.7)</span></td> <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zFwWNHX4c6Tl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.4)</span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zNzcVf2j33Nf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,079.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zlJcovZ34Tn6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,837.9 </span></td> <td id="xdx_98F_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zwOBzkdNUmz2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(758.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlOf87u0gHNk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,222.2 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,249.5)</b></span></td> <td id="xdx_988_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>995.8 </b></span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,467.9 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,293.5 </b></span></td> <td id="xdx_986_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuMVU4Cvj75k" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1.6)</b></span></td> <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z23HZ6Vhd925" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(686.6)</b></span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVOuX1V51VV3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>10,041.7 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAYF27EAPLh4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>16,086.2 </b></span></td> <td id="xdx_98B_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIxfYnfFR0Mg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,044.5)</b></span></td></tr> </table> <p id="xdx_8AE_zkYKyL63Lmrb" style="font: 8pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0D0D0D"><span style="background-color: white"><b>Intangibles with indefinite useful life</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The carrying value of intangible assets with indefinite useful lives classified as brands were allocated to the following CGUs:</p> <table cellpadding="0" cellspacing="0" id="xdx_894_eifrs-full--DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory_pn5n6_zSu1CxPsZeT2" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTANGIBLES - Intangible Assets by Location (Details)"> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span id="xdx_8BD_zkuqZ805Ast4" style="display: none">Schedule of carrying value of intangible assets with indefinite useful lives</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 42%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 29%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 29%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Argentina</span></td> <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInArgentinaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,303.7 </span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInArgentinaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,019.2 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bolivia</span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBoliviaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">830.0 </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBoliviaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">894.5 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Brazil</span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn5n6_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBrazilMember_zAj8bCo57x0f" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73.9 </span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn5n6_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBrazilMember_zsGK5R6U9TOa" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3327">-</span>   </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Canada</span></td> <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInCanadaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">195.7 </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInCanadaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">206.4 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chile</span></td> <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInChileMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">70.7 </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInChileMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">78.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Luxembourg</span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInLuxembourgMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">339.6 </span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInLuxembourgMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">339.6 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Paraguay</span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInParaguayMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">504.7 </span></td> <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInParaguayMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">542.7 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Dominican Republic</span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInTheDominicanRepublicMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,431.5 </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInTheDominicanRepublicMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,593.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Panama</span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInPanamaMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">333.0 </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInPanamaMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">358.8 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Uruguay</span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInUruaguayMember_pn5n6" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">124.3 </span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInUruaguayMember_pn5n6" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">130.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,207.1 </b></span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,163.1 </b></span></td></tr> </table> <p id="xdx_8A5_zYW3T62FiNz6" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets with indefinite useful lives have been tested for impairment on a CGU level basis, which is consistent with the approach described in <i>Note </i>16 <i>– Impairment of Non-Financial assets.</i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is implementing a new version of its principal enterprise resource planning (ERP) - S4/Hana, an SAP platform, whose capitalizable investments are recognized as intangible assets in the software line. The implementation is necessary to update and improve the company's technological environment. In the context of the implementation, several assessments were carried out by Management, including from the perspective of internal controls, to mitigate risks connected to this type of upgrade, such as operational risks, operational disruption, data integrity and regulatory compliance.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; color: #0D0D0D"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The intangibles are recognized at cost of acquisition, net of accumulated amortization and impairment losses.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Intangible assets with definite useful lives are amortized on a straight-line basis over their estimated useful lives. Licenses, supply, and distribution rights are amortized over the period for which the rights exist, based on the contract terms, which vary, in general, from <span id="xdx_90C_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__srt--RangeAxis__ifrs-full--BottomOfRangeMember_zqzoai0oQFC2" title="Intangible assets useful lives">1</span> to <span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__srt--RangeAxis__ifrs-full--TopOfRangeMember_zEG2JYJbcV2j" title="Intangible assets useful lives">8</span> years. Brands are considered to have indefinite lives, and therefore, are not amortized. Software and capitalized development costs related to technology are amortized over a period of <span id="xdx_905_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__srt--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zNIXR3xZk8Mh" title="Intangible assets useful lives">3</span> to <span id="xdx_90E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dtY_c20230101__20231231__srt--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zcxkZcWYUjD4" title="Intangible assets useful lives">10</span> years. Items that are not amortized are tested for impairment on an annual basis</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net gains on sales of intangible assets are disclosed in the income statement as other operating income. Net losses on sales are included as other operating expenses. Net gains and losses are recorded in income statement when control is transferred to the buyer, the counterpart recovery is possible and associated costs can be reliably estimated</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>(a) Brands</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is the owner of some of the world’s leading brands in the beer industry. As a result, brands are expected to generate positive cash flow for as long as the Company owns the brands, and accordingly they have been assigned indefinite useful lives. The most representative brands that have been recorded as a result of the fair value determination of past acquisitions are Quilmes in Argentina, Pilsen in Paraguay, Paceña and Huari in Bolivia and Presidente and Presidente Light in the Dominican Republic.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When a portion of the consideration paid in a business combination relates to brands, this is recognized in a specific Intangible Assets account, and measured at fair values as at the acquisition date. Subsequently, the value of brands can be reduced in the case of impairment losses. Internally generated expenditure for brand development is recognized within expenses.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>(b) Software</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Purchased software is measured at cost less accumulated amortization. Amortization related to software is included in the cost of sales, commercial expenses or administrative expenses, based on the business activity which the software is intended to support.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The expenditures related to software maintenance are recognized as expense, as incurred. The expenditures with development, as the expenditures with employees allocated in software development, which are directly attributed to identifiable and exclusive software, controlled by the Company, are recognized as intangible assets.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>(c) Commercial intangibles</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes supply rights, which consists in the right that Company has to supply for a customer and the commitment from the customer to buy Company’s products. And distribution rights that are the rights of selling specific products in a given territory.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>(d) Other intangible assets</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other intangible assets also include multi-year sponsorship rights acquired by the Company. These are initially recognized at the present value of the future payments and subsequently measured at cost less accumulated amortization and impairment losses.</p> <table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfDetailedInformationAboutIntangibleAssetsExplanatory_pn5n6_z7BATwKTLJAg" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTANGIBLES - Reconciliation of Changes in Intangible Assets (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B1_zojxjk7ISGee" style="display: none">Schedule of intangible assets</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposal </b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Amortization</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brands</span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zNUyWl2VCK25" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,329.0 </b></span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,096.2)</span></td> <td id="xdx_98F_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_znVans5T3R44" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">930.3 </span></td> <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3121">-</span>   </span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zztO5k2kqPf7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3123">-</span>   </span></td> <td id="xdx_983_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3125">-</span>   </span></td> <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3127">-</span>   </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvu8ztWTot5d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,163.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zvbGfkWO8zAh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,163.1 </span></td> <td id="xdx_985_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zEw5OGF8Xft2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3133">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangibles</span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zZZX91lbiZhj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>671.2 </b></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(44.7)</span></td> <td id="xdx_980_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3141">-</span>   </span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.2 </span></td> <td id="xdx_98C_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3145">-</span>   </span></td> <td id="xdx_989_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zaUcgPRHpleg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(58.1)</span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z97B3iS7Yxdl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>571.7 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z0AGvNs871Hg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,308.6 </span></td> <td id="xdx_989_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zXCkux3DhPn8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,736.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Software</span></td> <td id="xdx_98E_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zmRkS68lPiUg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,129.7 </b></span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(130.6)</span></td> <td id="xdx_986_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">126.9 </span></td> <td id="xdx_986_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.9 </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,402.3 </span></td> <td id="xdx_98B_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3165">-</span>   </span></td> <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zi7ai46tCttb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(401.1)</span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zEsTixAJQllg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,134.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zJF1IJzFN65" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,353.9 </span></td> <td id="xdx_98A_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zP4O7nSUYZfe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,219.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Others</span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zBak9JcfSLWa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>559.1 </b></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(96.0)</span></td> <td id="xdx_985_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">76.8 </span></td> <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">220.5 </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(364.1)</span></td> <td id="xdx_98D_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span>   </span></td> <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zRGUwx4mMrT8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(43.0)</span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zcti0uwEQL32" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>353.3 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_z1ezK7wUb4Ug" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,218.8 </span></td> <td id="xdx_98C_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zoZKCnVvlAZh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(865.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zy1KLU55vDJh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>8,689.0 </b></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,367.5)</b></span></td> <td id="xdx_985_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,134.1 </b></span></td> <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>227.4 </b></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,041.4 </b></span></td> <td id="xdx_983_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3205">-</span>   </b></span></td> <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf01oZe1617d" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(502.2)</b></span></td> <td id="xdx_988_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zynS5Be1Emd1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,222.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestCostsCapitalised_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zSVazFqHyfN4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,044.4 </b></span></td> <td id="xdx_98D_ecustom--DepreciationExpenses_pn5n6_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhLoCv2lArv1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5,822.2)</b></span></td></tr> </table> <p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td></tr> <tr> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of movements in foreign exchange in the balance sheet</b></span></td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Effects of application of IAS 29 (hyperinflation)</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Additions</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transfers </b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Disposal </b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Amortization</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition cost</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Depreciation</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brands</span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zB017qmSYgok" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,163.1 </b></span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,838.5)</span></td> <td id="xdx_98B_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">808.6 </span></td> <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">73.9 </span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3223">-</span>   </span></td> <td id="xdx_981_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3225">-</span>   </span></td> <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3227">-</span>   </span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zCBxzT5dEVyg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,207.1 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zCwa6rWrFeQ2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,207.1 </span></td> <td id="xdx_982_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zLiRhe5muqqg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3233">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Intangibles</span></td> <td id="xdx_980_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zHAAc6bahIG3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>571.7 </b></span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zc0Qo1Cnncrk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(33.5)</span></td> <td id="xdx_98E_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z5aE1fzSY6Pd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3239">-</span>   </span></td> <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zIaMTiyKlzRk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">869.3 </span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z4cruxN7iLQ4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3243">-</span>   </span></td> <td id="xdx_989_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zurXdoCgYw8i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3245">-</span>   </span></td> <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z4tOuJOhgesi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.7)</span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zEwEkinCyGL7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,350.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_zJvpMNXJzLKc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,087.0 </span></td> <td id="xdx_985_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--IntangiblesMember_z55nBUQun95d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,736.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Software</span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zlYGLhYviOya" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,134.1 </b></span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(344.6)</span></td> <td id="xdx_984_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">176.2 </span></td> <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.0 </span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">976.5 </span></td> <td id="xdx_982_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zn4qHm44bvEh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.9)</span></td> <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zZV6csDLqBC6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(573.5)</span></td> <td id="xdx_984_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_z1YLsp4KwNvk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,404.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zR2JHcGvW0Dj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,954.2 </span></td> <td id="xdx_98A_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zqSNbkMtELd4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2,549.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Others</span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zBkpdr6hq3f2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>353.3 </b></span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td> <td id="xdx_98B_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.0 </span></td> <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">487.7 </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">317.0 </span></td> <td id="xdx_98A_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zdv4Qof4ZHD" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.7)</span></td> <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zFwWNHX4c6Tl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.4)</span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zNzcVf2j33Nf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,079.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zlJcovZ34Tn6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,837.9 </span></td> <td id="xdx_98F_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--OthersMember_zwOBzkdNUmz2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(758.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsOtherThanGoodwill_iS_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlOf87u0gHNk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,222.2 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,249.5)</b></span></td> <td id="xdx_988_ecustom--IntangibleAssetsOtherThanGoodwillAdjustmentDueToAdoptionOfAccountingPronouncement_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of application of IAS 29 (hyperinflation)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>995.8 </b></span></td> <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,467.9 </b></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,293.5 </b></span></td> <td id="xdx_986_eifrs-full--DisposalsIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zuMVU4Cvj75k" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Disposal"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1.6)</b></span></td> <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_iN_pn5n6_di_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z23HZ6Vhd925" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(686.6)</b></span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsOtherThanGoodwill_iE_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVOuX1V51VV3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets, final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>10,041.7 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--InterestCostsCapitalised_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAYF27EAPLh4" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition cost"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>16,086.2 </b></span></td> <td id="xdx_98B_ecustom--DepreciationExpenses_pn5n6_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zIxfYnfFR0Mg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,044.5)</b></span></td></tr> </table> 6329000000.0 -1096200000 930300000 6163100000 6163100000 671200000 -44700000 100000 3200000 58100000 571700000 3308600000 -2736900000 1129700000 -130600000 126900000 6900000 1402300000 401100000 2134100000 4353900000 -2219800000 559100000 -96000000.0 76800000 220500000 -364100000 43000000.0 353300000 1218800000 -865500000 8689000000.0 -1367500000 1134100000 227400000 1041400000 502200000 9222200000 15044400000 -5822200000 6163100000 -1838500000 808600000 73900000 5207100000 5207100000 571700000 -33500000 869300000 56700000 1350800000 4087000000.0 -2736200000 2134100000 -344600000 176200000 37000000.0 976500000 900000 573500000 2404800000 4954200000 -2549400000 353300000 -32900000 11000000.0 487700000 317000000.0 700000 56400000 1079000000.0 1837900000 -758900000 9222200000 -2249500000 995800000 1467900000 1293500000 1600000 686600000 10041700000 16086200000 -6044500000 <table cellpadding="0" cellspacing="0" id="xdx_894_eifrs-full--DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory_pn5n6_zSu1CxPsZeT2" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTANGIBLES - Intangible Assets by Location (Details)"> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span id="xdx_8BD_zkuqZ805Ast4" style="display: none">Schedule of carrying value of intangible assets with indefinite useful lives</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 42%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 29%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 29%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Argentina</span></td> <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInArgentinaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,303.7 </span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInArgentinaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,019.2 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bolivia</span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBoliviaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">830.0 </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBoliviaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">894.5 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Brazil</span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn5n6_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBrazilMember_zAj8bCo57x0f" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73.9 </span></td> <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_pn5n6_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInBrazilMember_zsGK5R6U9TOa" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3327">-</span>   </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Canada</span></td> <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInCanadaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">195.7 </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInCanadaMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">206.4 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Chile</span></td> <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInChileMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">70.7 </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInChileMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">78.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Luxembourg</span></td> <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInLuxembourgMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">339.6 </span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInLuxembourgMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">339.6 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Paraguay</span></td> <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInParaguayMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">504.7 </span></td> <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInParaguayMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">542.7 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Dominican Republic</span></td> <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInTheDominicanRepublicMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,431.5 </span></td> <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInTheDominicanRepublicMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,593.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Panama</span></td> <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInPanamaMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">333.0 </span></td> <td id="xdx_98A_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInPanamaMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">358.8 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Uruguay</span></td> <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInUruaguayMember_pn5n6" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">124.3 </span></td> <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231__ifrs-full--IntangibleAssetsWithIndefiniteUsefulLifeAxis__custom--IntangibleAssetsInUruaguayMember_pn5n6" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">130.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20231231_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,207.1 </b></span></td> <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_c20221231_pn5n6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Intangible assets with indefinite useful life"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,163.1 </b></span></td></tr> </table> 1303700000 2019200000 830000000.0 894500000 73900000 195700000 206400000 70700000 78500000 339600000 339600000 504700000 542700000 1431500000 1593000000.0 333000000.0 358800000 124300000 130400000 5207100000 6163100000 P1Y P8Y P3Y P10Y <p id="xdx_802_ecustom--RecoverableTaxesTextBlock_zALPCQclv8Kh" style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_024"></span>18.</b></td><td style="text-align: justify"><b><span id="xdx_82E_zp5sb7Yljxub">RECOVERABLE TAXES</span></b></td></tr></table> <p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock_pn5n6_zpMGQN0RKhyg" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - RECOVERABLE TAXEs (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zl4ls2TCL5q4" style="display: none">Schedule of Classifications of recoverable taxes</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 52%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">PIS/COFINS exclusion of ICMS <sup>(i)</sup></span></td> <td id="xdx_98D_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_zT8SKpyNUV87" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,490.4 </span></td> <td id="xdx_988_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_zRk1gpZHPlb8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,992.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">ICMS</span></td> <td id="xdx_982_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_zO9rqG0luc2d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">436.5 </span></td> <td id="xdx_98B_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">423.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income tax and social contributions recoverable</span></td> <td id="xdx_984_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zlCnYoonDOG4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,087.0 </span></td> <td id="xdx_985_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zE1FnsJTw2ql" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,607.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other</span></td> <td id="xdx_984_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">311.2 </span></td> <td id="xdx_987_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">292.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td id="xdx_989_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20231231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11,325.1 </b></span></td> <td id="xdx_98E_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20221231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11,316.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">PIS/COFINS exclusion of ICMS <sup>(i)</sup></span></td> <td id="xdx_985_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_zU2PJivRnnGe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219.0 </span></td> <td id="xdx_98C_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PIS/COFINS</span></td> <td id="xdx_98E_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PiscofinsMember_zgDP2po342N2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">170.4 </span></td> <td id="xdx_982_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PiscofinsMember_zDcwQ0JqXev8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">242.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">ICMS</span></td> <td id="xdx_98E_ecustom--RecoverableTaxCreditAssetsCurrent_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">426.9 </span></td> <td id="xdx_98F_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">542.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">IPI</span></td> <td id="xdx_985_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IPIMember_zG6HjawjXcv8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">112.5 </span></td> <td id="xdx_981_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IPIMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">131.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income tax and social contributions recoverable</span></td> <td id="xdx_986_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zpN3gpnTrTr8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,436.6 </span></td> <td id="xdx_987_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zHsANddIQHOd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,808.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other</span></td> <td id="xdx_980_ecustom--RecoverableTaxCreditAssetsCurrent_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">70.3 </span></td> <td id="xdx_981_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">55.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td id="xdx_980_ecustom--RecoverableTaxCreditAssetsCurrent_c20231231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,435.7 </b></span></td> <td id="xdx_981_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,853.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td id="xdx_986_ecustom--RecoverableTaxCreditAssets_iI_pn5n6_c20231231_zL9Yxejoid4g" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,760.8 </b></span></td> <td id="xdx_983_ecustom--RecoverableTaxCreditAssets_c20221231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,169.8 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">As detailed in Note 27.2 - <i>Contingencies</i>, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS from the substitution of tax basis for contribution.</td> </tr></table> <p id="xdx_8A3_zmngQkL2Ntwe" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Recognition of assets and liabilities relating to extemporaneous tax debits or credits</i></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting policy applied by the Company considers the extemporaneous tax credits and debits of any nature as determined by IAS 37 - <i>Provisions, Contingent Liabilities and Contingent Assets</i>, except for income taxes, for which the policy disclosed in note 13 – <i>Income tax and social contribution </i>is applied.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">According to this policy, tax credits are recognized only when Management (i) has elements that guarantee that the credit is virtually certain; and (ii) the amount to be offset or refunded can be reliably measured. In cases where the recovery of the asset is probable, or the amount cannot be reliably measured, the amounts are not recognized in the account, but presented in Note 27 - <i>Provisions, Contingent Liabilities and Contingent Assets</i> related to contingent assets. Management understands that, in cases of lawsuits involving contingent assets, a final and unappealable decision on the specific lawsuit of the Company is required to confirm the existence of its rights, except where specific circumstances pertinent to the case allow the recognition of its rights with sufficient objectivity and reliability.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">To measure the amounts of extemporaneous tax credits arising from lawsuits, the Company evaluates the documents for the period covered by the lawsuit, and applies the guidelines for the final decision, applicable legislation or other elements that enable the amount to be estimated with sufficient reliability.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Debts of the same nature are recognized if (i) they arise from a past event; (ii) there is a present obligation; (iii) the expected outflow of resources is probable and (iv) the amounts are reliably estimated. If the expectation of disbursement is possible or the amount cannot be reliably measured, the amounts are presented in Note 27.2 - <i>Contingencies</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Both contingent assets and liabilities are assessed periodically to ensure that they are appropriately reflected and disclosed in the financial statements.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accounting policy for the recognition of assets and liabilities of <span style="color: black">extemporaneous</span> tax credits and debits of any nature are recorded as “Other operating income/(expenses)”, except for amnesty payments, which are recorded as exceptional items, given their one-off nature.</p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfClassificationsOfRecoverableTaxesTableTextBlock_pn5n6_zpMGQN0RKhyg" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - RECOVERABLE TAXEs (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zl4ls2TCL5q4" style="display: none">Schedule of Classifications of recoverable taxes</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 52%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 24%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">PIS/COFINS exclusion of ICMS <sup>(i)</sup></span></td> <td id="xdx_98D_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_zT8SKpyNUV87" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,490.4 </span></td> <td id="xdx_988_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_zRk1gpZHPlb8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,992.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">ICMS</span></td> <td id="xdx_982_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_zO9rqG0luc2d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">436.5 </span></td> <td id="xdx_98B_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">423.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income tax and social contributions recoverable</span></td> <td id="xdx_984_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zlCnYoonDOG4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,087.0 </span></td> <td id="xdx_985_ecustom--RecoverableTaxCreditAssetsNoncurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zE1FnsJTw2ql" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,607.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other</span></td> <td id="xdx_984_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">311.2 </span></td> <td id="xdx_987_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">292.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td id="xdx_989_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20231231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11,325.1 </b></span></td> <td id="xdx_98E_ecustom--RecoverableTaxCreditAssetsNoncurrent_c20221231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11,316.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">PIS/COFINS exclusion of ICMS <sup>(i)</sup></span></td> <td id="xdx_985_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_zU2PJivRnnGe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219.0 </span></td> <td id="xdx_98C_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PISCOFINSExclusionOfICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">73.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PIS/COFINS</span></td> <td id="xdx_98E_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PiscofinsMember_zgDP2po342N2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">170.4 </span></td> <td id="xdx_982_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PiscofinsMember_zDcwQ0JqXev8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">242.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">ICMS</span></td> <td id="xdx_98E_ecustom--RecoverableTaxCreditAssetsCurrent_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">426.9 </span></td> <td id="xdx_98F_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ICMSMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">542.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">IPI</span></td> <td id="xdx_985_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IPIMember_zG6HjawjXcv8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">112.5 </span></td> <td id="xdx_981_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IPIMember_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">131.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income tax and social contributions recoverable</span></td> <td id="xdx_986_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zpN3gpnTrTr8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,436.6 </span></td> <td id="xdx_987_ecustom--RecoverableTaxCreditAssetsCurrent_iI_pn5n6_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--IncomeTaxAndSocialContributionsRecoverableMember_zHsANddIQHOd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,808.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other</span></td> <td id="xdx_980_ecustom--RecoverableTaxCreditAssetsCurrent_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">70.3 </span></td> <td id="xdx_981_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__ifrs-full--OtherTemporaryDifferencesMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">55.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td id="xdx_980_ecustom--RecoverableTaxCreditAssetsCurrent_c20231231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,435.7 </b></span></td> <td id="xdx_981_ecustom--RecoverableTaxCreditAssetsCurrent_c20221231_pn5n6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,853.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td id="xdx_986_ecustom--RecoverableTaxCreditAssets_iI_pn5n6_c20231231_zL9Yxejoid4g" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,760.8 </b></span></td> <td id="xdx_983_ecustom--RecoverableTaxCreditAssets_c20221231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,169.8 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">As detailed in Note 27.2 - <i>Contingencies</i>, the Company recognized PIS and COFINS credits arising from the exclusion of ICMS from the substitution of tax basis for contribution.</td> </tr></table> 6490400000 5992800000 436500000 423200000 4087000000.0 4607500000 311200000 292800000 11325100000 11316300000 219000000.0 73500000 170400000 242700000 426900000 542200000 112500000 131000000.0 2436600000 1808700000 70300000 55400000 3435700000 2853500000 14760800000 14169800000 <p id="xdx_804_eifrs-full--DisclosureOfInventoriesExplanatory_z27UJF29Zdz4" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_025"></span>19.</b></td><td><b><span id="xdx_82A_zh1B2jHRD0Wg">INVENTORY</span></b></td></tr></table> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfInventoryComponentsTextBlock_pn5n6_zt82WqP4uVL4" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INVENTORY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_z9LjTOrAFuZ8" style="display: none">Schedule of inventory components</span></td> <td id="xdx_497_20231231" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_496_20221231" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_eifrs-full--FinishedGoods_iI_pn5n6_maIzEBC_znkz8axz9wrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Finished goods </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,990.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,094.0 </span></td></tr> <tr id="xdx_406_eifrs-full--WorkInProgress_iI_pn5n6_maIzEBC_zejhruuAeEf8" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Work in progress</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">826.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">845.7 </span></td></tr> <tr id="xdx_404_eifrs-full--RawMaterials_iI_pn5n6_maIzEBC_zXa7SKxMer95" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Raw materials and consumables</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,599.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,798.3 </span></td></tr> <tr id="xdx_40A_eifrs-full--SpareParts_iI_pn5n6_maIzEBC_zUkJuHGQ7js" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Spare parts and others</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">806.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">986.9 </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentPrepayments_iI_pn5n6_maIzEBC_zdQle1koZWm6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Prepayments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">537.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">358.3 </span></td></tr> <tr id="xdx_408_ecustom--InventoriesImpairmentLosses_iNI_pn5n6_di_msIzEBC_znCTECiKcUOa" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Impairment losses</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(142.5)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(160.2)</span></td></tr> <tr id="xdx_40D_eifrs-full--Inventories_iTI_pn5n6_mtIzEBC_zDPF6c3hkeGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>9,619.0 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>12,923.0 </b></span></td></tr> </table> <p id="xdx_8AE_zoqMT4LAyn84" style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The changes in impairment losses on inventory, are as follows:</p> <p style="font: 11pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfOtherProvisionsExplanatory_pn5n6_zneXxyGlCH99" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INVENTORY (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_z6JCPwTJ6THf" style="display: none">Schedule of changes in impairment losses on inventory</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Beginning balance</b></span></td> <td id="xdx_983_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zo9R0qucRnz8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(160.2)</b></span></td> <td id="xdx_982_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zMuLERB3dQNa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(157.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effects of movements in foreign exchange in the balance sheet</span></td> <td id="xdx_988_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_z5bvFi6u17Bg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.9 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zmr8uIeMLmmf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions</span></td> <td id="xdx_986_eifrs-full--NewProvisionsOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zNouDB0PHvji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(262.9)</span></td> <td id="xdx_98D_eifrs-full--NewProvisionsOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zfwpyO2YNOQ2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(305.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Write-off</span></td> <td id="xdx_980_eifrs-full--ChangesInOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zn4Vb9p8lxX8" style="width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">267.7 </span></td> <td id="xdx_980_eifrs-full--ChangesInOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zNolworC8PT" style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">285.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Final balance</b></span></td> <td id="xdx_98A_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zaL5rEUNXNY8" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(142.5)</b></span></td> <td id="xdx_984_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zwUmHsKXiXwi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(160.2)</b></span></td></tr> </table> <p id="xdx_8A8_zwEdIsZTlqhb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory is initially recorded at the acquisition cost and subsequent valued at the lower of their cost and net realizable value. Cost includes expenditure incurred to acquire the inventory, non-recoverable taxes, and the costs to bring it to the location and condition required for use. The weighted average method is used to determine the cost of inventory.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 11pt">The cost of finished products and work in progress includes raw materials, other production materials, direct labor, other direct costs, gains and losses on derivative financial instruments, and an allocation of fixed and variable overheads based on the normal operating capacity. Fixed costs not allocated or idle costs not held in inventory, are recognized directly in the income statement, as determined by <i>IAS 2- </i></span><i><span style="font-size: 12pt">Inventories</span></i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net realizable value is the estimated selling price in the ordinary course of business, less the costs of bringing the inventory to the condition required for sale, and the selling costs. The calculation of the net realizable value takes into consideration the specific characteristics of each category of inventory, such as the expiry date, the remaining shelf life, and any indicators of slow-moving inventory, amongst others.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Provisions for impairment losses are constituted, when necessary, in compliance with write-offs, slow moving and obsolete inventory of Company’s policies.</p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfInventoryComponentsTextBlock_pn5n6_zt82WqP4uVL4" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INVENTORY (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_z9LjTOrAFuZ8" style="display: none">Schedule of inventory components</span></td> <td id="xdx_497_20231231" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_496_20221231" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_eifrs-full--FinishedGoods_iI_pn5n6_maIzEBC_znkz8axz9wrh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Finished goods </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,990.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,094.0 </span></td></tr> <tr id="xdx_406_eifrs-full--WorkInProgress_iI_pn5n6_maIzEBC_zejhruuAeEf8" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Work in progress</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">826.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">845.7 </span></td></tr> <tr id="xdx_404_eifrs-full--RawMaterials_iI_pn5n6_maIzEBC_zXa7SKxMer95" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Raw materials and consumables</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,599.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,798.3 </span></td></tr> <tr id="xdx_40A_eifrs-full--SpareParts_iI_pn5n6_maIzEBC_zUkJuHGQ7js" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Spare parts and others</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">806.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">986.9 </span></td></tr> <tr id="xdx_40F_eifrs-full--CurrentPrepayments_iI_pn5n6_maIzEBC_zdQle1koZWm6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Prepayments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">537.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">358.3 </span></td></tr> <tr id="xdx_408_ecustom--InventoriesImpairmentLosses_iNI_pn5n6_di_msIzEBC_znCTECiKcUOa" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Impairment losses</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(142.5)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(160.2)</span></td></tr> <tr id="xdx_40D_eifrs-full--Inventories_iTI_pn5n6_mtIzEBC_zDPF6c3hkeGj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total</b></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>9,619.0 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>12,923.0 </b></span></td></tr> </table> 2990300000 4094000000.0 826500000 845700000 4599900000 6798300000 806900000 986900000 537900000 358300000 142500000 160200000 9619000000.0 12923000000.0 <table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfOtherProvisionsExplanatory_pn5n6_zneXxyGlCH99" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INVENTORY (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_z6JCPwTJ6THf" style="display: none">Schedule of changes in impairment losses on inventory</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Beginning balance</b></span></td> <td id="xdx_983_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zo9R0qucRnz8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(160.2)</b></span></td> <td id="xdx_982_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zMuLERB3dQNa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(157.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effects of movements in foreign exchange in the balance sheet</span></td> <td id="xdx_988_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_z5bvFi6u17Bg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12.9 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions2_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zmr8uIeMLmmf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">17.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions</span></td> <td id="xdx_986_eifrs-full--NewProvisionsOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zNouDB0PHvji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(262.9)</span></td> <td id="xdx_98D_eifrs-full--NewProvisionsOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zfwpyO2YNOQ2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(305.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Write-off</span></td> <td id="xdx_980_eifrs-full--ChangesInOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zn4Vb9p8lxX8" style="width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">267.7 </span></td> <td id="xdx_980_eifrs-full--ChangesInOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zNolworC8PT" style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">285.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Final balance</b></span></td> <td id="xdx_98A_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zaL5rEUNXNY8" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(142.5)</b></span></td> <td id="xdx_984_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--InventoryProvisionMember_zwUmHsKXiXwi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(160.2)</b></span></td></tr> </table> 160200000 157800000 12900000 17800000 262900000 305800000 267700000 285600000 142500000 160200000 <p id="xdx_808_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_z5x2Gsonz7hc" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_026"></span><b>20.</b></td><td><b><span id="xdx_824_zzKa3coLAfJ6">TRADE RECEIVABLES</span></b></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfCurrentTradeReceivablesTextBlock_zNb50wJYcOyj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE RECEIVABLES - Current Trade Receivables (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zMhupyFxKGpc" style="display: none">Schedule of current trade receivables</span></td> <td id="xdx_494_20231231_zmVGcNnvhl2b" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20221231_zZh5flKuoO5h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 66%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_407_eifrs-full--CurrentTradeReceivables_iI_pn5n6_maCTRNOz569_z5WBBPoVXkii" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade receivables</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,225.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,737.5 </span></td></tr> <tr id="xdx_404_ecustom--BadDebtProvision_iNI_pn5n6_di_msCTRNOz569_zv6jspZgJvqf" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bad debt provision</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(721.0)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(679.1)</span></td></tr> <tr id="xdx_405_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iTI_pn5n6_mtCTRNOz569_maTAOCRzrd6_zlrqpJOEWHQc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net, trade receivables </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,504.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,058.4 </b></span></td></tr> <tr id="xdx_402_eifrs-full--TradeAndOtherCurrentReceivablesDueFromRelatedParties_iI_pn5n6_maTAOCRzrd6_z3k4cwgq6wRj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Related parties (Note 30)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">236.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">290.7 </span></td></tr> <tr id="xdx_404_eifrs-full--TradeAndOtherCurrentReceivables_iTI_pn5n6_mtTAOCRzrd6_zxElGEW8CPqh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total current trade receivables </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,741.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,349.1 </b></span></td></tr> </table> <p id="xdx_8AD_zET7Nhdgg9K5" style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The details of the aging of the Company’s current trade receivables are as follows:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfMaturityOfTheCurrentTradeReceivablesTextBlock_z8sdpynEWgya" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_ziSjw1evI0q7" style="display: none">Schedule of maturity trade receivable</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 34%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Bad debt provision</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables, net</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Bad debt provision</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables, net</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">No past due</span></td> <td id="xdx_989_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,129.5 </span></td> <td id="xdx_98F_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3496">-</span>   </span></td> <td id="xdx_98D_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iI_pn5n6_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zW6ZztNfaz56" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,129.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,573.0 </span></td> <td id="xdx_98E_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3502">-</span>   </span></td> <td id="xdx_985_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,573.0 </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – within 30 days</span></td> <td id="xdx_980_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">283.4 </span></td> <td id="xdx_98D_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3508">-</span>   </span></td> <td id="xdx_986_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">283.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">343.8 </span></td> <td id="xdx_98C_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3514">-</span>   </span></td> <td id="xdx_987_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">343.8 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 31 - 60 days </span></td> <td id="xdx_98B_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">66.3 </span></td> <td id="xdx_982_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3520">-</span>   </span></td> <td id="xdx_984_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">66.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.5 </span></td> <td id="xdx_983_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.3)</span></td> <td id="xdx_985_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.2 </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 61 - 90 days</span></td> <td id="xdx_989_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.2 </span></td> <td id="xdx_981_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.7)</span></td> <td id="xdx_988_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">49.4 </span></td> <td id="xdx_98F_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10.8)</span></td> <td id="xdx_98F_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38.6 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 91 - 180 days</span></td> <td id="xdx_98F_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.5 </span></td> <td id="xdx_983_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.4)</span></td> <td id="xdx_983_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iI_pn5n6_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_zH1vpUFnIXW6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.3 </span></td> <td id="xdx_982_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(16.5)</span></td> <td id="xdx_983_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.8 </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 181 - 360 days</span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">46.6 </span></td> <td id="xdx_98C_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.6)</span></td> <td id="xdx_984_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3558">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">40.2 </span></td> <td id="xdx_98F_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(40.2)</span></td> <td id="xdx_987_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3564">-</span>   </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due over 360 days</span></td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">660.3 </span></td> <td id="xdx_981_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(660.3)</span></td> <td id="xdx_985_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3570">-</span>   </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">611.3 </span></td> <td id="xdx_982_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(611.3)</span></td> <td id="xdx_986_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="border-bottom: #BA0C2F 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3576">-</span>   </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net carrying amount as of December 31,</b></span></td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20231231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,225.8 </b></span></td> <td id="xdx_98B_ecustom--BadDebtProvisions_c20231231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(721.0)</b></span></td> <td id="xdx_983_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,504.8 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--CurrentTradeReceivables_c20221231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,737.5 </b></span></td> <td id="xdx_98A_ecustom--BadDebtProvisions_c20221231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(679.1)</b></span></td> <td id="xdx_98D_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iI_pn5n6_c20221231_zhTVNksijPS7" style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,058.4 </b></span></td></tr> </table> <p id="xdx_8A7_z3ryCRWglV84" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The changes of the estimated loss for doubtful debts, are as follows:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfOtherProvisionExplanatory_zxOVg0XBxmSa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B3_zSBO5wQSlNck"><span id="xdx_8BD_zoDS4Cccpqca" style="display: none">Schedule of estimated loss for doubtful debts</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 67%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Beginning balance</b></span></td> <td id="xdx_989_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zf1xdf87L4u4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(679.1)</b></span></td> <td id="xdx_984_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zY3hBNuip1tc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(668.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Effects of movements in foreign exchange in the balance sheet</span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zwMyCuGOe8wd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.3 </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Additions</span></td> <td id="xdx_981_ecustom--AdditionalProvisionsOtherProvision_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_z4x6CcKyetR8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(103.6)</span></td> <td id="xdx_982_ecustom--AdditionalProvisionsOtherProvision_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zfiV9f1zS9Bd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(47.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversals</span></td> <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversals"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.3 </span></td> <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversals"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Write-off</span></td> <td id="xdx_983_ecustom--ProvisionUsedOtherProvisions1_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zdcY8OcImUmc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">41.1 </span></td> <td id="xdx_98B_ecustom--ProvisionUsedOtherProvisions1_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Final balance</b></span></td> <td id="xdx_985_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_z4NC2DdivXe1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(721.0)</b></span></td> <td id="xdx_982_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_ztXfulSBtq15" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(679.1)</b></span></td></tr> </table> <p id="xdx_8A7_zdhO1PyuG1A8" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s exposure to credit risks, currency and interest rate risks is disclosed in Note 28 - <i>Financial instruments and risks</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Trade receivables are amounts due from customers for goods sold or services performed in the ordinary course of business. Trade receivables are recognized initially at the amount of the unconditional consideration, unless they contain significant financing components, in which case they are recognized at fair value.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company applies the <i>IFRS 9</i> simplified approach to measuring expected credit losses whereby impairment allowances for trade receivables are measured upon initial recognition on the basis of the expected 12-month credit losses. This is primarily based on past experience of credit losses, current data on overdue receivables and credit score information. Prospective information (such as forecast economic performance indicators) is also taken into consideration if, based on past experience, such indicators show a strong correlation with actual credit losses. Typically trade receivables which are outstanding for more than 90 days are fully provisioned.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If security receiving deadline is equal or less than a year, trade receivables are categorized in current assets. Otherwise, its disclosed in non-current assets.</p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfCurrentTradeReceivablesTextBlock_zNb50wJYcOyj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE RECEIVABLES - Current Trade Receivables (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zMhupyFxKGpc" style="display: none">Schedule of current trade receivables</span></td> <td id="xdx_494_20231231_zmVGcNnvhl2b" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20221231_zZh5flKuoO5h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 66%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_407_eifrs-full--CurrentTradeReceivables_iI_pn5n6_maCTRNOz569_z5WBBPoVXkii" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Trade receivables</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,225.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,737.5 </span></td></tr> <tr id="xdx_404_ecustom--BadDebtProvision_iNI_pn5n6_di_msCTRNOz569_zv6jspZgJvqf" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bad debt provision</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(721.0)</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(679.1)</span></td></tr> <tr id="xdx_405_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iTI_pn5n6_mtCTRNOz569_maTAOCRzrd6_zlrqpJOEWHQc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net, trade receivables </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,504.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,058.4 </b></span></td></tr> <tr id="xdx_402_eifrs-full--TradeAndOtherCurrentReceivablesDueFromRelatedParties_iI_pn5n6_maTAOCRzrd6_z3k4cwgq6wRj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Related parties (Note 30)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">236.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">290.7 </span></td></tr> <tr id="xdx_404_eifrs-full--TradeAndOtherCurrentReceivables_iTI_pn5n6_mtTAOCRzrd6_zxElGEW8CPqh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total current trade receivables </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,741.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,349.1 </b></span></td></tr> </table> 6225800000 5737500000 721000000.0 679100000 5504800000 5058400000 236700000 290700000 5741500000 5349100000 <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfMaturityOfTheCurrentTradeReceivablesTextBlock_z8sdpynEWgya" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE RECEIVABLES - Aging of Our Current Trade Receivables (Details)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_ziSjw1evI0q7" style="display: none">Schedule of maturity trade receivable</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 34%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Bad debt provision</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables, net</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Bad debt provision</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade receivables, net</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">No past due</span></td> <td id="xdx_989_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,129.5 </span></td> <td id="xdx_98F_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3496">-</span>   </span></td> <td id="xdx_98D_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iI_pn5n6_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zW6ZztNfaz56" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,129.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,573.0 </span></td> <td id="xdx_98E_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3502">-</span>   </span></td> <td id="xdx_985_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,573.0 </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – within 30 days</span></td> <td id="xdx_980_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">283.4 </span></td> <td id="xdx_98D_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3508">-</span>   </span></td> <td id="xdx_986_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">283.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">343.8 </span></td> <td id="xdx_98C_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3514">-</span>   </span></td> <td id="xdx_987_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LessThanOneMonthMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">343.8 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 31 - 60 days </span></td> <td id="xdx_98B_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">66.3 </span></td> <td id="xdx_982_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3520">-</span>   </span></td> <td id="xdx_984_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">66.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.5 </span></td> <td id="xdx_983_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.3)</span></td> <td id="xdx_985_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanOneMonthAndNotLaterThanTwoMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.2 </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 61 - 90 days</span></td> <td id="xdx_989_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.2 </span></td> <td id="xdx_981_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.7)</span></td> <td id="xdx_988_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">49.4 </span></td> <td id="xdx_98F_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10.8)</span></td> <td id="xdx_98F_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanTwoMonthsAndNotLaterThanThreeMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38.6 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 91 - 180 days</span></td> <td id="xdx_98F_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.5 </span></td> <td id="xdx_983_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.4)</span></td> <td id="xdx_983_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iI_pn5n6_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_zH1vpUFnIXW6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.3 </span></td> <td id="xdx_982_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(16.5)</span></td> <td id="xdx_983_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanThreeMonthsAndLessThanSixMonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.8 </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due – between 181 - 360 days</span></td> <td id="xdx_985_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">46.6 </span></td> <td id="xdx_98C_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.6)</span></td> <td id="xdx_984_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3558">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">40.2 </span></td> <td id="xdx_98F_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(40.2)</span></td> <td id="xdx_987_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanSixMonthsAndLessThan12MonthsMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3564">-</span>   </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Past due over 360 days</span></td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">660.3 </span></td> <td id="xdx_981_ecustom--BadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(660.3)</span></td> <td id="xdx_985_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3570">-</span>   </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--CurrentTradeReceivables_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">611.3 </span></td> <td id="xdx_982_ecustom--BadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(611.3)</span></td> <td id="xdx_986_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20221231__ifrs-full--PastDueStatusAxis__custom--LaterThanAYearMember_pn5n6" style="border-bottom: #BA0C2F 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3576">-</span>   </span></td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net carrying amount as of December 31,</b></span></td> <td id="xdx_988_eifrs-full--CurrentTradeReceivables_c20231231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,225.8 </b></span></td> <td id="xdx_98B_ecustom--BadDebtProvisions_c20231231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(721.0)</b></span></td> <td id="xdx_983_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_c20231231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,504.8 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--CurrentTradeReceivables_c20221231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,737.5 </b></span></td> <td id="xdx_98A_ecustom--BadDebtProvisions_c20221231_pn5n6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Bad debt provision"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(679.1)</b></span></td> <td id="xdx_98D_ecustom--CurrentTradeReceivablesNetOfBadDebtProvisions_iI_pn5n6_c20221231_zhTVNksijPS7" style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5,058.4 </b></span></td></tr> </table> 5129500000 5129500000 4573000000.0 4573000000.0 283400000 283400000 343800000 343800000 66300000 66300000 100500000 -300000 100200000 33200000 -7700000 25500000 49400000 -10800000 38600000 6500000 -6400000 100000 19300000 -16500000 2800000 46600000 -46600000 40200000 -40200000 660300000 -660300000 611300000 -611300000 6225800000 -721000000.0 5504800000 5737500000 -679100000 5058400000 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfOtherProvisionExplanatory_zxOVg0XBxmSa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE RECEIVABLES - Estimated Loss For Doubtful Debts (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B3_zSBO5wQSlNck"><span id="xdx_8BD_zoDS4Cccpqca" style="display: none">Schedule of estimated loss for doubtful debts</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 67%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Beginning balance</b></span></td> <td id="xdx_989_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zf1xdf87L4u4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(679.1)</b></span></td> <td id="xdx_984_eifrs-full--OtherProvisions_iNS_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zY3hBNuip1tc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(668.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Effects of movements in foreign exchange in the balance sheet</span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zwMyCuGOe8wd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.3 </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions1_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effects of movements in foreign exchange in the balance sheet"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Additions</span></td> <td id="xdx_981_ecustom--AdditionalProvisionsOtherProvision_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_z4x6CcKyetR8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(103.6)</span></td> <td id="xdx_982_ecustom--AdditionalProvisionsOtherProvision_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zfiV9f1zS9Bd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(47.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversals</span></td> <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversals"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.3 </span></td> <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversals"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Write-off</span></td> <td id="xdx_983_ecustom--ProvisionUsedOtherProvisions1_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_zdcY8OcImUmc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">41.1 </span></td> <td id="xdx_98B_ecustom--ProvisionUsedOtherProvisions1_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_pn5n6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Write-off"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Final balance</b></span></td> <td id="xdx_985_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_z4NC2DdivXe1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(721.0)</b></span></td> <td id="xdx_982_eifrs-full--OtherProvisions_iNE_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--BadDebtProvisionMember_ztXfulSBtq15" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(679.1)</b></span></td></tr> </table> 679100000 668300000 12300000 14000000.0 103600000 47000000.0 8300000 1700000 41100000 20500000 721000000.0 679100000 <p id="xdx_802_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zOdwQDT6Yree" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_027"></span>21.</b></td><td><b><span id="xdx_824_zsLJsFbTzuql">CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES</span></b></td></tr></table> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>21.1 Cash and equivalents</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfComponentsInCashAndCashEquivalentsTextBlock_zwLl4RnuD0Qa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zUc5IAbxlGVc" style="display: none">Schedule of components in cash and cash equivalents</span></td> <td id="xdx_493_20231231_zkrduVZXoW5e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20221231_zz30KWXeAAD5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 60%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr id="xdx_402_eifrs-full--ShorttermDepositsClassifiedAsCashEquivalents_iI_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Short-term bank deposits</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,973.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,655.2 </span></td></tr> <tr id="xdx_403_eifrs-full--BalancesWithBanks_iI_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Current bank accounts</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,818.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,990.3 </span></td></tr> <tr id="xdx_409_eifrs-full--CashOnHand_iI_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">267.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">280.9 </span></td></tr> <tr id="xdx_403_eifrs-full--CashAndCashEquivalents_iI_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Cash and cash equivalents</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>16,059.0 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,926.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40D_ecustom--BankOverdraftsClassifiedAsCashEquivalent_iI_pn5n6_zbZdUekDZREg" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bank overdrafts</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3632">-</span>   </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(74.3)</span></td></tr> <tr id="xdx_40A_eifrs-full--CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_iI_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Cash and cash equivalents less bank overdraft</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>16,059.0 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,852.1 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The balance refers mostly to Bank Deposit Certificates (“CDB”), with high liquidity, which are readily convertible into known amounts of cash, and which are subject to an insignificant risk of change in value.</td> </tr></table> <p id="xdx_8AC_zciRVEH5livi" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cash and cash equivalents balance include the amount to R$ <span id="xdx_90E_ecustom--ShorttermDepositsGuaranteeDeposits_iI_pn6n6_c20231231_zbcsmq4W3xF7" title="Short-term deposits, guarantee deposits">3,768</span> million in December 31, 2023 (R$<span id="xdx_907_ecustom--ShorttermDepositsGuaranteeDeposits_iI_pn6n6_c20221231_zY6jDsvYtiQi" title="Short-term deposits, guarantee deposits">3,083</span> million in December 31, 2022), which is not freely transferable to the parent company due to remittance restrictions in Cuba and Argentina, although available for use in the local operations of the subsidiaries in question.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>21.2 Investment securities</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfInvestmentSecuritiesTextBlock_zkd1EaPJW9al" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details)"> <tr> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span><span id="xdx_8BA_z6ymAOXWyGza" style="display: none">Schedule of investment securities</span></span></td> <td id="xdx_494_20231231_zOmQLuax9G5" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_493_20221231_zHo3rku3xzQh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 62%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Investment_securities</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40B_eifrs-full--DebtInstrumentsHeld_iI_pn5n6_maNHIzdXe_zYsYMF4zcbeb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Investment on debt securities <sup>(i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">242.2 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219.1 </span></td></tr> <tr id="xdx_401_eifrs-full--NoncurrentHeldtomaturityInvestments_iTI_pn5n6_mtNHIzdXe_maISz1Vq_zffOvWxek6dj" style="background-color: White"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current investment securities</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>242.2 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>219.1 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40A_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_iI_pn5n6_maCIzlNw_zT98QxwLpqkk" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial assets at fair value through profit or loss</span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">277.2 </span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">454.5 </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentInvestments_iTI_pn5n6_mtCIzlNw_maISz1Vq_zFPtmMcfsnL2" style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current investment securities</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>277.2 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>454.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_403_ecustom--InvestmentSecurities_iTI_pn5n6_mtISz1Vq_zmHOzZ0zLEq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>519.4 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>673.6 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The balance refers substantially to financial investments linked to tax incentives that do not have immediate convertibility into a known amount of cash.</td> </tr></table> <p id="xdx_8AF_zIWyPdQBDF4g" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents include all cash balances, bank deposits, and short-term highly with due date until 90 days, liquid investments with an insignificant risk of changes in value which are readily convertible into cash. They are stated at their face value, which approximates the fair value.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other financial investments that do not satisfy the classification criteria as cash equivalents, for example, with maturities superior to 90 days from the date they were contracted, are presented as financial investments. These assets are initially measured at fair value and, depending on how these resources are managed and the characteristics of the contractual cash flows, their category may change:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt/13pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 3.3pt"></td><td style="width: 18pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Amortized cost: "non-derivative" financial assets for which the purpose of the business model is to hold the assets in order to receive the contractual cash flows on specific dates (principal and interest).</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt/13pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 3.3pt"></td><td style="width: 18pt"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Fair value through profit or loss: financial assets for which the Company's objective is to receive a sale. They are presented in current assets based on their expected realization.</td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and cash equivalents and short-term investments are held at financial institutions with low credit risk, based or domiciled in Brazil or abroad. For the cash flow statement, cash and cash equivalents are presented net of bank overdrafts, when applicable.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89C_ecustom--DisclosureOfComponentsInCashAndCashEquivalentsTextBlock_zwLl4RnuD0Qa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Components of Cash and Cash Equivalents (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zUc5IAbxlGVc" style="display: none">Schedule of components in cash and cash equivalents</span></td> <td id="xdx_493_20231231_zkrduVZXoW5e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20221231_zz30KWXeAAD5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 60%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr id="xdx_402_eifrs-full--ShorttermDepositsClassifiedAsCashEquivalents_iI_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Short-term bank deposits</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,973.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">8,655.2 </span></td></tr> <tr id="xdx_403_eifrs-full--BalancesWithBanks_iI_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Current bank accounts</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">6,818.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,990.3 </span></td></tr> <tr id="xdx_409_eifrs-full--CashOnHand_iI_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">267.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">280.9 </span></td></tr> <tr id="xdx_403_eifrs-full--CashAndCashEquivalents_iI_pn5n6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Cash and cash equivalents</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>16,059.0 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,926.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40D_ecustom--BankOverdraftsClassifiedAsCashEquivalent_iI_pn5n6_zbZdUekDZREg" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Bank overdrafts</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3632">-</span>   </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(74.3)</span></td></tr> <tr id="xdx_40A_eifrs-full--CashAndCashEquivalentsIfDifferentFromStatementOfFinancialPosition_iI_pn5n6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Cash and cash equivalents less bank overdraft</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>16,059.0 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,852.1 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The balance refers mostly to Bank Deposit Certificates (“CDB”), with high liquidity, which are readily convertible into known amounts of cash, and which are subject to an insignificant risk of change in value.</td> </tr></table> 8973600000 8655200000 6818300000 5990300000 267100000 280900000 16059000000.0 14926400000 -74300000 16059000000.0 14852100000 3768000000 3083000000 <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfInvestmentSecuritiesTextBlock_zkd1EaPJW9al" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CASH AND CASH EQUIVALENTS AND INVESTMENT SECURITIES - Investment Securities (Details)"> <tr> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span><span id="xdx_8BA_z6ymAOXWyGza" style="display: none">Schedule of investment securities</span></span></td> <td id="xdx_494_20231231_zOmQLuax9G5" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_493_20221231_zHo3rku3xzQh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 62%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Investment_securities</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40B_eifrs-full--DebtInstrumentsHeld_iI_pn5n6_maNHIzdXe_zYsYMF4zcbeb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Investment on debt securities <sup>(i)</sup></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">242.2 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219.1 </span></td></tr> <tr id="xdx_401_eifrs-full--NoncurrentHeldtomaturityInvestments_iTI_pn5n6_mtNHIzdXe_maISz1Vq_zffOvWxek6dj" style="background-color: White"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current investment securities</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>242.2 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>219.1 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_40A_eifrs-full--CurrentFinancialAssetsAtFairValueThroughProfitOrLossClassifiedAsHeldForTrading_iI_pn5n6_maCIzlNw_zT98QxwLpqkk" style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial assets at fair value through profit or loss</span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">277.2 </span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">454.5 </span></td></tr> <tr id="xdx_40B_eifrs-full--CurrentInvestments_iTI_pn5n6_mtCIzlNw_maISz1Vq_zFPtmMcfsnL2" style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current investment securities</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>277.2 </b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>454.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_403_ecustom--InvestmentSecurities_iTI_pn5n6_mtISz1Vq_zmHOzZ0zLEq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>519.4 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>673.6 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The balance refers substantially to financial investments linked to tax incentives that do not have immediate convertibility into a known amount of cash.</td> </tr></table> 242200000 219100000 242200000 219100000 277200000 454500000 277200000 454500000 519400000 673600000 <p id="xdx_804_ecustom--DisclosureOfChangesInEquityTextBlock_zjdxoFbm4Zxi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_028"></span><b>22.</b></td><td><b><span id="xdx_824_z7iLfKXRjbCf">CHANGES IN EQUITY</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>22.1 Issued capital</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At 31 December 2023, the authorized share capital, fully subscribed and paid-in, in the amount of R$<span id="xdx_907_eifrs-full--Equity_iI_pn5n6_c20231231__ifrs-full--ComponentsOfEquityAxis__custom--AuthorizedShareCapitalMember_zYmTOph9GJi7" title="Authorized share capital">58,177.9</span> (R$<span id="xdx_90E_eifrs-full--Equity_iI_pn5n6_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--AuthorizedShareCapitalMember_zft5I1RZ2nP4" title="Authorized share capital">58,130.5</span> in 2022 and R$<span id="xdx_90C_eifrs-full--Equity_iI_pn5n6_c20211231__ifrs-full--ComponentsOfEquityAxis__custom--AuthorizedShareCapitalMember_zAwsE0TA7Zyj" title="Authorized share capital">58,042.5</span> in 2021) in the amount of <span id="xdx_90D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_uShares_c20231231__ifrs-full--ComponentsOfEquityAxis__custom--AuthorizedShareCapitalMember_zh1QdNrC9qI3" title="Number of shares outstanding">15,753.8</span> common shares (<span id="xdx_907_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_uShares_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--AuthorizedShareCapitalMember_z8eTVX8NGYCj" title="Number of shares outstanding">15,750.2</span> in 2022 and <span id="xdx_90F_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_uShares_c20211231__ifrs-full--ComponentsOfEquityAxis__custom--AuthorizedShareCapitalMember_z9hnaQ0Ow9Tc" title="Number of shares outstanding">15,744.5</span> in 2021) book entry, nominative, without nominal value, thus distributed:</p> <p style="font: 11pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--DisclosureOfIssuedCapitalExplanatory_pin6_zEywOImOH00b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Capital Stock (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_z6UNIjWDgT4i" style="display: none">Schedule of issued capital</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 29%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Shareholder</b></span></td> <td style="white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million common shares</b></span></td> <td style="white-space: nowrap; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>%</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million common shares</b></span></td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>%</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million common shares</b></span></td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>%</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interbrew International B.V.</span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zM0g8AcJc39j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,441.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zPtRRIB6Bro" title="Shareholder percentage">53.6</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zwMOUnUPSSp3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,441.8</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zFWauxEMSCCb" title="Shareholder percentage">53.6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zI3leOmFzwy6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,441.9</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_z3RF1Wcdd7Be" title="Shareholder percentage">53.6</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ambrew S.A.R.L.</span></td> <td id="xdx_98D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_z3iW8stDhJn2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,287.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_909_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_z8GeCuLfvAf4" title="Shareholder percentage">8.2</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zx49t4dPZnV3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,287.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zci3kH5uBHI8" title="Shareholder percentage">8.2</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zJsGdcXW7co9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,287.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zYHnU9EHyTqk" title="Shareholder percentage">8.2</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fundação Zerrenner</span></td> <td id="xdx_98D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zt50DhYnMoYh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,610.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_z9w6qMY1kvak" title="Shareholder percentage">10.2</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zF95HUK9Rcg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,610.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_z4MnKPD84eh1" title="Shareholder percentage">10.2</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zKgLJ9vMPWg2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,610.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zMbsM4Dupkne" title="Shareholder percentage">10.2</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mercado</span></td> <td id="xdx_98D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_z133Ti2fxS3g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,410.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zzJNofRLDzbb" title="Shareholder percentage">28.0</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zTN95Frj6Xfg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,402.2</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90D_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zojFAofXRaBj" title="Shareholder percentage">27.9</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zJKEOmmYRIAg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,399.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zwiu6Em700Ui" title="Shareholder percentage">27.9</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tesouraria</span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zF1DNQsGVsa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.4</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zTfLu2AJ2dz7" title="Shareholder percentage">0.0</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zxSxprxsT2wd" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.5</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zcOBsjCcumS3" title="Shareholder percentage">0.1</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_z7IOCipPo2Ed" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.8</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zo89NsUzv6Bc" title="Shareholder percentage">0.0</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231_zvOKWmugz1Aa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,753.8</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span id="xdx_905_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231_zC4MG7hs1Aef" title="Shareholder percentage">100.0</span>%</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231_zumWtmegtlO2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,750.2</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span id="xdx_906_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231_zZtVAvjffFG3" title="Shareholder percentage">100.0</span>%</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231_zwdM23G6BYa2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,744.4</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span id="xdx_90C_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231_zzqOlgZlvXB7" title="Shareholder percentage">100.0</span>%</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2021</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million common shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million Reais</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million common shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million Reais</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million common shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million Reais</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Beginning balance</span></td> <td id="xdx_98A_ecustom--EquitySharesOutstanding_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zxxB8T9hG26j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">15,750.2 </span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zaxEy7blDHE" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">58,130.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--EquitySharesOutstanding_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z9kuXZfQ9To3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">15,744.4 </span></td> <td id="xdx_98C_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_ztKH6zJT19Wd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">58,042.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--EquitySharesOutstanding_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zpCSCQyg8C3k" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">15,735.1 </span></td> <td id="xdx_98A_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zaMi93dgzPNe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">57,899.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 7.5pt Times New Roman, Times, Serif">Capital increase<sup> (i)</sup></span></td> <td id="xdx_987_ecustom--IssueOfEquityShares_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zztwia5J9aWa" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.6 </span></td> <td id="xdx_983_eifrs-full--IssueOfEquity_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">47.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--IssueOfEquityShares_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zWUYPxuGQnza" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.8 </span></td> <td id="xdx_985_eifrs-full--IssueOfEquity_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">88.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--IssueOfEquityShares_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zcZhmvxP5tge" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">9.3 </span></td> <td id="xdx_987_eifrs-full--IssueOfEquity_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">143.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Final balance</b></span></td> <td id="xdx_987_ecustom--EquitySharesOutstanding_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z9R9cVIiWrMf" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>15,753.8 </b></span></td> <td id="xdx_986_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zFFsVe0lZH8c" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>58,177.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--EquitySharesOutstanding_iE_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zpuoQgWK6Mh5" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>15,750.2 </b></span></td> <td id="xdx_98F_eifrs-full--Equity_iE_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zhIVnkjzpy45" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>58,130.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--EquitySharesOutstanding_iE_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zn5gnfr76XX5" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>15,744.4 </b></span></td> <td id="xdx_984_eifrs-full--Equity_iE_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zj9EN74AahN3" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>58,042.5 </b></span></td></tr> </table> <p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0">(i) Capital increase related to the issue of shares.</p> <p id="xdx_8A9_z6AZXvuSdsq6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>22.2 Capital reserves</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfClassesOfCapitalReservesTextBlock_z6kwolobmbll" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Capital Reserves (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_zpDPkPbFnBv3" style="display: none">Schedule of capital reserves</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Capital Reserves </b></span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="vertical-align: bottom; width: 35%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Treasury shares </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Share Premium </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Other capital reserves </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Share-based Payments </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Total </b></span></td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At January 1, 2021</b></span></td> <td id="xdx_984_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zS5auM9PGEoa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(941.7)</b></span></td> <td id="xdx_98B_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zktaIM9rAyP2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_981_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zzh0iyAT25ua" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_985_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zOls1UJgeg2g" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,563.6 </b></span></td> <td id="xdx_986_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zyFYZD5F0Iwe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>54,985.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital Increase</span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_znXiv6DIxOBk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(60.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90D_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_z3vJVpL0UzL4" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3798">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_905_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zuqN6dyYGL2l" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3800">-</span></span>   </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zFhLB3qizHGf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(74.4)</span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zXCvb54kYJQa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(134.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchases of shares, results of treasury shares and share-based payments</span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zro4iLq7tbnf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(36.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zOGEmDldt6ba" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3808">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zgbPFu1VsXOh" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3810">-</span></span>   </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zEiK4KIB6TSj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">372.1 </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zxPuqoFlL22g" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">336.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98E_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zBGKiiXzbw61" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,037.8)</b></span></td> <td id="xdx_988_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zwF0UsoWH67a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_987_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_ztJXCMhTpXNb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_98F_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zUxyPJGWjKn7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,861.3 </b></span></td> <td id="xdx_986_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zRKbJQwaQBsj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>55,187.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital Increase</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zxyISQ7S0v6f" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3826">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_z6cSCFTTHwcb" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3828">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zT4kOaZsUKQk" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3830">-</span></span>   </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_z4025sYWAep8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(64.2)</span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zXe0hiVyfxt3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(64.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchases of shares, results of treasury shares and share-based payments</span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zy2yvpj0fKXf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(35.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zdPoP0u4sEvk" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3838">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zAcen1PLMYV7" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3840">-</span></span>   </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zJmfK3veom9i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">252.4 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zwddPxyXm784" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">216.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98A_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zIIIwNeTlCFe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,073.4)</b></span></td> <td id="xdx_980_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zVa1QBMF4R37" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_983_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_z75Qec0yrX4g" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_986_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zoteUjHDLpu7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,049.5 </b></span></td> <td id="xdx_981_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zeVCoFqhEINh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>55,339.8 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital Increase</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zYyvHy6nMBI9" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3856">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zg6GmCTi6kn4" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3858">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zG5XD3MFq0dc" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3860">-</span></span>   </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_z4jQCFPU3zJ1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_z3kX4NWd9oY2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchases of shares, results of treasury shares and share-based payments</span></td> <td id="xdx_988_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z39lXcTzRA5j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">61.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zIctffzkeYMb" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3868">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_904_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zZRDtEVIh4hi" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3870">-</span></span>   </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zpTkyYn2HFHh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.2 </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zmcTGAq7tqX4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">172.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td id="xdx_988_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zwpyMbVd6Sxe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,011.8)</b></span></td> <td id="xdx_989_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zeA1KpUmcM2d" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_98F_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zRTP5iuAPgZ" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_98C_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zxaD770h8ysk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,127.8 </b></span></td> <td id="xdx_983_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zAi4UYEpabka" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>55,479.7 </b></span></td></tr> </table> <p id="xdx_8A4_zMf4rqs9xyJ1" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>22.2.1 Purchase of shares and result of treasury shares</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Treasury shares represent the Company’s own issued shares reacquired by the Company, and the results of treasury shares related to gains and losses on share-based payment transactions and others. The changes in treasury shares are as follow:</p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--DisclosureOfTreasurySharesExplanatory_pn5n6_zbpfD6TpTovj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Treasury Shares (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zjEtcesTwW9f" style="display: none">Schedule of treasury shares</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition /realization of shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Result of Treasury Shares</b></span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Treasury Shares</b></span></td></tr> <tr> <td style="vertical-align: top; width: 27%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million shares</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million Brazilian Reais</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million shares</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million Brazilian Reais</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At January 1, 2021</b></span></td> <td id="xdx_987_ecustom--TreasurySharesAcquiredrealizedOutstanding_iS_pn5n6_c20210101__20211231_zCkG98oBSqhc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iS_pn5n6_c20210101__20211231_zICBPwPm0Vz" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TreasurySharesHeld_iS_pn5n6_c20210101__20211231_zowVtwOO6986" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(938.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--TreasuryShares_iNS_pn5n6_di_c20210101__20211231_zFKXugwX6khl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(941.7)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Changes during the year</span></td> <td id="xdx_98A_ecustom--TreasurySharesAcquiredRealizedDuringThePeriod_pn5n6_c20210101__20211231_zSHJZoRoyHBh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--TreasurySharesAcquiredrealizedDuringThePeriodAmount_pn5n6_c20210101__20211231_zMBUnjdyLyhe" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(95.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TreasurySharesChangeDuringThePeriod_pn5n6_c20210101__20211231_zYJN4w6RMS5h" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--TreasurySharesChangeDuringThePeriodValue_pn5n6_c20210101__20211231_zPQxzP3pZvl1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(96.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98F_ecustom--TreasurySharesAcquiredrealizedOutstanding_iS_pn5n6_c20220101__20221231_zcjzgmlrcYBi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5.8 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iS_pn5n6_c20220101__20221231_zqr2KWy27Akc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(98.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TreasurySharesHeld_iS_pn5n6_c20220101__20221231_zSUD7NA2gTA1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(939.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--TreasuryShares_iNS_pn5n6_di_c20220101__20221231_zRI6YdvkBXq2" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,037.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Changes during the year</span></td> <td id="xdx_98E_ecustom--TreasurySharesAcquiredRealizedDuringThePeriod_pn5n6_c20220101__20221231_zVsqBaoTYt7i" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--TreasurySharesAcquiredrealizedDuringThePeriodAmount_pn5n6_c20220101__20221231_zihmyF0ptJL3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(33.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--TreasurySharesChangeDuringThePeriod_pn5n6_c20220101__20221231_zhJNdrke84Xd" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TreasurySharesChangeDuringThePeriodValue_pn5n6_c20220101__20221231_z2keoKwkP7pe" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(35.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td id="xdx_987_ecustom--TreasurySharesAcquiredrealizedOutstanding_iS_pn5n6_c20230101__20231231_zfxhJ9A2CCga" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>8.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iS_pn5n6_c20230101__20231231_z9wePg79Uyra" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(131.8)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TreasurySharesHeld_iS_pn5n6_c20230101__20231231_z2EK6KqjN34b" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(941.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--TreasuryShares_iNS_pn5n6_di_c20230101__20231231_zlQ1qiCipPxb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,073.4)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Changes during the year</span></td> <td id="xdx_98C_ecustom--TreasurySharesAcquiredRealizedDuringThePeriod_pn5n6_c20230101__20231231_zYajbi1ZoBwb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--TreasurySharesAcquiredrealizedDuringThePeriodAmount_pn5n6_c20230101__20231231_zpd7tCjfSCl8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">68.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TreasurySharesChangeDuringThePeriod_pn5n6_c20230101__20231231_z8TFssgf9KZh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TreasurySharesChangeDuringThePeriodValue_pn5n6_c20230101__20231231_zZm0SqqEhLLa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">61.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td id="xdx_984_ecustom--TreasurySharesAcquiredrealizedOutstanding_iE_pn5n6_c20230101__20231231_z3IT19D5dwlg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iE_pn5n6_c20230101__20231231_zN2tWaHP2rA" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(63.0)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TreasurySharesHeld_iE_pn5n6_c20230101__20231231_zrJoLRy64T1j" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(948.8)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--TreasuryShares_iNE_pn5n6_di_c20230101__20231231_ziewhsmnqY1i" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,011.8)</b></span></td></tr> </table> <p id="xdx_8A6_zSlbCCjD6Nj9" style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>22.2.2 Share premium</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The share premium refers to the difference between the subscription price that the shareholders paid for the shares and their nominal value. Since this is a capital reserve, it can only be used to increase capital, offset losses, or for the redemption, reimbursement or repurchase of shares.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>22.2.3 Share-based payment</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Different share-based payment programs and stock purchase option plans allow the senior management from Ambev’s economic group to acquire shares in the Company. The share-based payment reserve recorded a charge of R$<span id="xdx_90D_eifrs-full--AdjustmentsForSharebasedPayments_pn5n6_c20230101__20231231_zI1kzV3tStje" title="Adjustments for share-based payments">331.6</span> in 2023 (R$<span id="xdx_905_eifrs-full--AdjustmentsForSharebasedPayments_pn5n6_c20220101__20221231_zSYwbYTWqfC5" title="Adjustments for share-based payments">313.9</span> and R$<span id="xdx_902_eifrs-full--AdjustmentsForSharebasedPayments_pn5n6_c20210101__20211231_zyC9olZw3QZ8" title="Adjustments for share-based payments">387.6</span> in 2022 and 2021, respectively) (Note 25 - <i>Share-based payments</i>).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>22.3 Net income reserves</b></p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfNetIncomeReservesTextBlock_ztSNd5GVSS51" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Net Income Reserves (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B3_zhsGjGPZZwUe" style="display: none">Schedule of net income reserves</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: top"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net income reserves</b></span></td></tr> <tr> <td style="vertical-align: top; width: 38%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Investments reserve </b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Legal reserve </b></span></td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b> Fiscal incentive </b></span></td> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At January 1, 2021</b></span></td> <td id="xdx_981_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zhXBYgyxZzZd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,511.1 </b></span></td> <td id="xdx_983_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_z63UkhAIKcyb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_98B_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zOkn4mFrxKja" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11,404.4 </b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zdCw01puUe23" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>25,920.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fiscal incentive reserve </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_z9NYCJamCvc8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3960">-</span>   </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zSNQY43x5FKe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3962">-</span>   </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_z9R4deRHBxYi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,423.5 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_z8LcnoEnhZDf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,423.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investments reserve </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zMWjtJLvOdo1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,848.1 </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zIY2b9q8Iwc3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3970">-</span>   </span></td> <td id="xdx_988_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zqpQnPphGX5k" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span>   </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zkdI27qEaw9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,848.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2021</b></span></td> <td id="xdx_985_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zfvGp78awRdi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>18,359.2 </b></span></td> <td id="xdx_98B_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zDVhLiuFM6Pe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_98F_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zdqKvSBA3lZh" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>12,827.9 </b></span></td> <td id="xdx_982_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zw8V8TpC51Kc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>31,191.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fiscal incentive reserve </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zsz1wFBWbukf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3984">-</span>   </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zIiL2cveGkji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3986">-</span>   </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_z5bskZo7uYRd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,018.7 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_z45J2q2Untej" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,018.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investments reserve </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zfH9VMRO7DJf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,696.7 </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_znMcqcIQIEoc" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3994">-</span>   </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zrSRbQc2Nkc8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3996">-</span>   </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zzQQSBjEORjg" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,696.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_z2nVrSdJxkQb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>22,055.9 </b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zUK789yfyUF3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_98E_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zW6gg4FcVda4" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,846.6 </b></span></td> <td id="xdx_98B_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zGivNBrJLxDg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>36,907.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fiscal incentive reserve </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zaezvKXu5N4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4008">-</span>   </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zYZdpx46Bp52" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4010">-</span>   </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zGKq7uItnwLk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,552.7 </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zNITyuctyuef" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,552.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investments reserve </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_z8FcGv7QaVt2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,730.2 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_z0XIGuvoBS84" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4018">-</span>   </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zlu8NC6VmxPf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4020">-</span>   </span></td> <td id="xdx_988_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zbgpeZnRqWwh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,730.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2023</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zjbmtWSmTXU7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>25,786.1 </b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zGbBi9lOwhPd" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_986_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_ziYeuQRynwFe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>17,399.3 </b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zPbWpfqn79z5" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>43,189.9 </b></span></td></tr> </table> <p id="xdx_8A6_ztg4Vr3MWUY1" style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><b>22.3.1 Investments reserve</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">From the net income after applicable deductions, there will be a target allocating of no more than <span id="xdx_901_ecustom--InvestmentReserveLimitPercentageOfNetIncome_pip0_dp_c20230101__20231231_zqcuhMzJMKlc" title="Investment reserve limit percentage of net income">60</span>% (sixty per cent) of the adjusted net profit to the investment reserve, to be used to support future investments.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>22.3.2 Legal reserve</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">From the net income, <span id="xdx_901_ecustom--StatutoryReserveLimitPercentageOfNetIncome_pip0_dp_c20230101__20231231_zDXYizPpcUf7" title="Statutory reserve limit percentage of net income">5</span>% will be applied before any other allocation, to the legal reserve, which cannot exceed <span id="xdx_905_ecustom--StatutoryReserveLimitOfCapitalStock_pip0_dp_c20230101__20231231_z2o9YGQDcjd1" title="Statutory reserve limit of capital stock">20</span>% of the issued capital. The Company is not required to supplement the legal reserve for the year when the balance of this reserve, plus the amount of the capital reserves, exceeds <span id="xdx_906_ecustom--StatutoryReserveSupplementationCutoffPercentageRelatedToCapitalStock_pip0_dp_c20230101__20231231_zMkL7szlxsQ1" title="Statutory reserve supplementation cutoff percentage related to capital stock">30</span>% of the issued capital. </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt"><b>22.3.3 Tax incentives</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes annually in its equity, in the net income reserves line, the fiscal incentives regarding tax benefits at the government subsidies for the current year.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In general, these incentives are related to industrial development programs that aim to generate employment, promote regional decentralization, and complement and diversify the industrial base of the states. In these states, the grace periods and use and reductions are set out under the respective state normative acts, and when conditions for obtaining these grants exist, they are under Company’s control. The treatment of incentives complies with the provisions of current federal, state and municipal legislation, in particular set by Complementary Federal Law 160/2017 and by Convênio CONFAZ 190/2017. Due to change in article 30 of Federal Law 12,973/14 by Complementary Federal Law 160/2017, state fiscal incentives related to sales taxes are recognized as government subsidies for investments. in line with the interpretation of the Superior Court of Justice manifested mainly in the judgment of ERESP No. 1.517.492/PR, as well as in the judgment of Theme No. 1.182 and of the Federal Supreme Court, according to the manifestations expressed in the judgment of Theme 843.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>22.3.4 Interest on shareholders’ equity / dividends</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Brazilian companies are permitted to distribute the interest attributed to shareholders’ equity calculated based on the long-term interest rate (“TJLP”), with such interest being tax-deductible, in accordance with the applicable law and, when distributed, may be considered part of the minimum mandatory dividends.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">As determined by its by-laws, the Company is required to distribute to its shareholders, as a minimum mandatory dividend in respect of each fiscal year ending December 31, an amount of not less than <span id="xdx_901_ecustom--MinimumMandatoryDividend_pip0_dp_c20230101__20231231__ifrs-full--GeographicalAreasAxis__ifrs-full--CountryOfDomicileMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8ttBFZWMhP7" title="Minimum mandatory dividend">40</span>% of its net income determined under Brazilian law, adjusted in accordance with the applicable law, unless the payment of such amount would be incompatible with Ambev’s financial situation. The minimum mandatory dividend includes amounts paid as interest on shareholders’ equity.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Events during the year ended 2023:</i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfInterestOnShareholdersEquityAndDividendsTextBlock_zGHVRtjPk5m5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zhfwizs5BYp6" style="display: none">Schedule of interest on shareholders' equity and dividends</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Event</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Approval</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Date of payment</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Year</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type of share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Amount per share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Total amount</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/12/2023</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Interest on shareholder´s equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/28/2023</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2023</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_98C_ecustom--InterestOnShareholdersEquityDividendsAmountPerShare_pip0_c20231228__20231231_zvuL7tJnl5qk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, dividends (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7302</span></td> <td id="xdx_98C_ecustom--InterestOnShareholdersEquityDistributionAmount_pn5n6_c20230101__20231231_zEkclNlyNax9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, distribution"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">11,500.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--InterestOnShareholdersEquityDistributionAndDividendAmount_pn5n6_c20230101__20231231_zISTUoUCj6ga" style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>11,500.2 </b></span></td></tr> </table> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Distribution of interest on shareholders’s equity</span>. In accordance with Operations and Finance Committee recommendation at the meeting held on December 12, 2023, was approved the distribution of interest on shareholder’s equity in the amount of R$<span id="xdx_90E_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_c20231212__20231231_zDQvH8E8s7I7">0.7302</span> per share, based on available balances, in the Company’s extraordinary balance sheet dated as of November 30, 2023, (the survey of which was approved by the Board of Directors at the meeting held on December 12, 2023) and in the Company’s investment reserve, pursuant to the balance sheet dated as of December 31, 2022, which were attributed to the minimum mandatory dividends of the same fiscal year. The interest on shareholder’s equity distribution was taxed pursuant to the applicable law, which resulted in a net interest on shareholder’s equity distribution of R$<span id="xdx_90B_ecustom--InterestOnShareholdersEquityDistribution_pip0_c20230101__20231231_zjQBDnUOGcf" title="Interest on shareholders equity distribution">0.6207</span> per share of, except for shareholders that are corporate entities that are immune or exempted pursuant to article 5 of Law 11,053/04, as amended by Law 11,196/05.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The indicated payment was made on December 28, 2023, considering the shareholding position of December 19, 2022, with respect to B3, and December 26, 2023, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Events during the year ended 2022:</i></p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Event</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Approval</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Date of payment</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Year</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type of share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Amount per share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Total amount</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/06/2022</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Interest on shareholder´s equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/29/2022</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2022</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_pip0_c20221229__20221231_zeswsfNedih2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, distribution (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7623</span></td> <td id="xdx_98B_ecustom--InterestOnShareholdersEquityDistributionAmount_pn5n6_c20220101__20221231_z8fK4CgEDFHl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, distribution"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">11,999.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--InterestOnShareholdersEquityDistributionAndDividendAmount_pn5n6_c20220101__20221231_zHsniJJjGsxc" style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>11,999.8 </b></span></td></tr> </table> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Distribution of Dividends</span> in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 5, 2022, was approved the distribution of dividends of R$<span id="xdx_904_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_c20221205__20221231_zNAuDoWIZLA">0.7623</span> per share, based on available balance and the Company’s extraordinary balance sheet dated as of October 31, 2022 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$<span id="xdx_909_ecustom--InterestOnShareholdersEquityDistribution_pip0_c20220101__20221231_zaV8QQ6KwpZj" title="Interest on shareholders equity distribution">0.6480</span> per share of the Company in 2022.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The indicated payment was made on December 29, 2022, considering the shareholding position of December 19, 2022, with respect to B3, and December 21, 2022, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Events during the year ended 2021:</i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Event</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Approval</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Date of payment</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Year</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type of share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Amount per share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Total amount</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/09/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Dividends</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/30/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDividendsAmountPerShare_pip0_c20211230__20211231_zOrQycbww9b2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, dividends (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1334</span></td> <td id="xdx_987_ecustom--InterestOnShareholdersEquityDividendsAmount_pn5n6_c20210101__20211231_zTtssmMErVwf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2,099.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/09/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Interest on shareholder´s equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/30/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_984_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_pip0_c20211230__20211231_zbFpJrGzEbv6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, distribution (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.4702</span></td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDistributionAmount_pn5n6_c20210101__20211231_zkuXOajP9CWc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, distribution"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">7,400.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDistributionAndDividendAmount_pn5n6_c20210101__20211231_zxi3UJFXFr9i" style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>9,499.6 </b></span></td></tr> </table> <p id="xdx_8AF_ztQ1nyMRnBnc" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Distribution of Dividends</span> in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 07, 2021, was approved the distribution of dividends of R$<span id="xdx_900_ecustom--InterestOnShareholderEquityDividendsAmountPerShare_pip0_c20211207__20211231_z1v0lsr2RgF5" title="Interest on shareholders equity distribution of dividends">0.1334</span> per share, based on available balance and the Company’s extraordinary balance sheet dated as of November 30, 2021 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The indicated payment was made on December 30, 2021, considering the shareholding position of December 17, 2021, with respect to B3, and December 21, 2021, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Distribution of interest on shareholder’s equity</span> in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 7, 2021, was approved the distribution of interest on shareholder’s equity of R$<span id="xdx_901_ecustom--InterestOnShareholderEquityDistributionAmountPerShare_pip0_c20211207__20211231_zvRCGBnmXRt4" title="Interest on shareholders equity distribution of dividends">0.4702</span> per share, based on available balance and the Company’s extraordinary balance sheet dated as of November 30, 2021, and attributed to the minimum mandatory dividends for the same fiscal year. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$<span id="xdx_906_ecustom--InterestOnShareholdersEquityDistribution_pip0_c20211101__20211130_ztVl1Undfccd" title="Interest on shareholders equity distribution">0.3996</span> per share.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The indicated payment was made on December 30, 2021, considering the shareholding position of December 17, 2020, with respect to B3, and December 21, 2021, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>22.3.5 Destinations</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">At December 31, 2023, the Company has made appropriations to retained earnings, in accordance with the Brazilian Corporate law and the Company’s bylaws. The dividends payments made up to December 31, 2023, were approved at the Board of Directors’ Meeting.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Regarding the basis for dividends, the Company believes that the predecessor basis of accounting, as well as its presentation for comparative purposes, will not affect the determination of the minimum mandatory dividend. Therefore, the Company intends to adjust the calculation basis of the minimum mandatory dividend to cancel out any current and future impacts on net income arising from the adoption of this accounting practice, related to the amortization/depreciation of surplus assets or even a possible impairment of goodwill, thus preserving the mandatory minimum dividends.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureForTheBasisOfDividendsTextBlock_zu6Sn0nzs5w6" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Basis for Dividends (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_z2nuifu7YMr5" style="display: none">Schedule of basis of dividends</span></td> <td id="xdx_490_20230101_20231231_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49E_20220101_20221231_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49C_20210101_20211231_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2021</b></span></td></tr> <tr id="xdx_40B_eifrs-full--ProfitLossAttributableToOwnersOfParent_pn5n6_zw2Z2SY99khb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net income, attributable to equity holders of Ambev</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14,501.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14,457.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>12,671.0 </b></span></td></tr> <tr id="xdx_408_ecustom--PrescribedDividends_pn5n6_zqWxUk649Jvj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Prescribed/(complementary) dividends</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4084">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24.7 </span></td></tr> <tr id="xdx_40A_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_zqaNUZfslEZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.8 </span></td></tr> <tr id="xdx_401_ecustom--IncreaseDecreaseThroughAdoptionOfNewAccountingPronouncement_pn5n6_zFb6x5tLM7Ce" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,269.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,224.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,063.7 </span></td></tr> <tr id="xdx_40C_ecustom--RetainedEarningsBasisForDividendsAndDestinations_pn5n6_zMsiYzMQwgQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Retained earnings basis for dividends and destinations</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,783.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,715.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14,771.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Dividends and interest on capital distributed and accrued for distribution based on the net income for the year</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--DividendsAndInterestOnCapitalPaidBasedOnProfit_pn5n6_zPS9wlQVb87h" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Dividends and interest on capital paid based on profit</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,500.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,999.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,499.6 </span></td></tr> <tr id="xdx_409_ecustom--TotalOfDividendsAndInterestOnCapital_pn5n6_zDjF4DDaIR8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total of dividends and interest on capital </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11,500.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11,999.8 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,499.6 </b></span></td></tr> <tr id="xdx_401_ecustom--DividendPercentageOfNetIncome_pip0_dp_z1g8etOixW67" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Percentage of distributed profit</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">65%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">68%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64%</span></td></tr> </table> <p id="xdx_8A4_zp322DqOrBjf" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>22.5 Carrying value adjustments</b></p> <p style="font: 6pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfChangesInCarryingValueOfEquityTextBlock_ze0452fSklbi" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Carrying Value Adjustments (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zhtAjFHfSrbi" style="display: none">Schedule of Carrying value adjustments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying value adjustments</b></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="vertical-align: bottom; width: 36%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Translation reserves</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>Cash flow hedge</i></b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Actuarial gains/ (losses)</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Put option granted on subsidiary</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Gains/(losses) of non-controlling interest’s share</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Business combination</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Accounting adjustments for transactions between shareholders</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At January 1, 2021</b></span></td> <td id="xdx_986_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zJ8ffs5CuV7d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11,076.5</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zmoNSDShyENg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>744.5</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zRLU5BaKDCNj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,473.3)</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zjGSUdnB8fu8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.8)</b></span></td> <td id="xdx_983_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zDqff6fmPgma" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(73.8)</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zmG6kkfN9671" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_98A_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zPfdseqFmqt1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,414.2)</b></span></td> <td id="xdx_98E_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zc7MNOGJXUm9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(64,989.0)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive income:</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) on the translation of foreign operations</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zQBZfVWWkwr7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,449.7</span></td> <td id="xdx_98A_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zDVjDASjHef1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4132">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zvh5rH3eTcQh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4134">-</span></span></td> <td id="xdx_98F_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zmbrF47MKcCh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4136">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zUJ82nb66HC1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4138">-</span></span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zsXuTXUkK2ei" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4140">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zymRqpFlyu6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4142">-</span></span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zmY6l0QZLSJ5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,449.7</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash flow hedges</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z3Wzaz73Ccl8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4146">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zOLtDE6QNsS" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">480.8</span></td> <td id="xdx_987_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zpuZr6YMVq6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4150">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z1ukFeyi0Hwc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4152">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zWAGbdKKKkjh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4154">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zAuNOlKOsizi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4156">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zZmUQp5o8UTc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4158">-</span></span></td> <td id="xdx_98C_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zbMlSY45k6se" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">480.8</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Actuarial gains/(losses)</span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_ztMtHNNgDUB" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4162">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zdPR3OJQuye9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4164">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_z4zF9NLlMy7c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">341.8</span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z4OCCZgwZ5U6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4168">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zRpCrvg7y8Pg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4170">-</span></span></td> <td id="xdx_98D_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zBJjSjqjsI69" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4172">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z14xPvu6Ic8c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4174">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zlynI9ciJAm2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">341.8</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Comprehensive income </b></span></td> <td id="xdx_980_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zFV82oYkluu4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,449.7</b></span></td> <td id="xdx_98D_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zLXE0QrodPr3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>480.8</b></span></td> <td id="xdx_980_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zAu4ERnpeDva" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>341.8</b></span></td> <td id="xdx_980_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z3b7eKYNpM2f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4184">-</span></b></span></td> <td id="xdx_987_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zGnvt5pDjKj3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4186">-</span></b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z7osc3ZTYjY9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4188">-</span></b></span></td> <td id="xdx_98F_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zJM5OYzEfka6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4190">-</span></b></span></td> <td id="xdx_987_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zVtzEnUTjAK3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,272.3</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Options granted on subsidiaries</span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zl8heClOHVtj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4194">-</span></span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z52VviM1rdll" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4196">-</span></span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zzxyfO0rRZW1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4198">-</span></span></td> <td id="xdx_986_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zL7dXFUgK41f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.9)</span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zOYjKCZ5Jow2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4202">-</span></span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zv0wr1HNLsqh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4204">-</span></span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_znVv2inynoXl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4206">-</span></span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zcm36apIgiY3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) of controlling interest</span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zeU7ufYZ6bZc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4210">-</span></span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zmgaBACWP45d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4212">-</span></span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zXoDoOMLWRKb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4214">-</span></span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zpcOKwkvNp3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4216">-</span></span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zTIuUY6DlEt8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.2)</span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zoMfMZBYh1Qc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4220">-</span></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_znMEa396CYx1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4222">-</span></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zj3v9VdWM9Rg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tax on deemed dividends</span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zMqjNHshoxoa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4226">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zZwc943sVG82" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4228">-</span></span></td> <td id="xdx_980_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zo5unmExFWca" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4230">-</span></span></td> <td id="xdx_989_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zF2UYFRHiml8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4232">-</span></span></td> <td id="xdx_982_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zuIOSG5Uorda" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.7)</span></td> <td id="xdx_98E_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zjSySfXvb8Ec" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4236">-</span></span></td> <td id="xdx_984_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zBwNSHpJAwbb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4238">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zsgThwpE0zl4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td id="xdx_98D_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zigtPxLvh9Cl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4242">-</span></span></td> <td id="xdx_98A_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zlguYrfvj7d4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4244">-</span></span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zTpZXZA50tVk" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4246">-</span></span></td> <td id="xdx_987_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z5fc7pCPs0Ka" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4248">-</span></span></td> <td id="xdx_989_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zRIEUvsyMJ9g" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4250">-</span></span></td> <td id="xdx_98D_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zcbLE8aENau5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4252">-</span></span></td> <td id="xdx_982_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zVdGTmwAJLrb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td> <td id="xdx_98C_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zotNbyLN6Zpl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td id="xdx_983_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zqBYmGhjOph8" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>13,526.2</b></span></td> <td id="xdx_98F_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z2fEpvdYM4a1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,225.3</b></span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zTqtoEUDMkz7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,131.5)</b></span></td> <td id="xdx_982_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zWG62HXFwzRa" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6.7)</b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zciQ9duiRD3e" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(121.7)</b></span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zBB4ifJfYpwk" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_984_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zNzAv75zHhl9" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,426.0)</b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zdu40Mop76Pc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(61,778.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive income:</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) on the translation of foreign operations</span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z9MgQ2uK0Dal" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6,772.2)</span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zq2ZOiE5Cju6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4276">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zSOM4ieOnS13" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4278">-</span></span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z3rXOm09Bp51" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4280">-</span></span></td> <td id="xdx_98C_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zZcLpvNGVmZg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4282">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zLM9c7yUbAX4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4284">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zzsay2IFScZd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4286">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zeZnFEXUtXE4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6,772.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash flow hedges</span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zxjM3vukEGV" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4290">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zz9WsaumF5Vd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(316.7)</span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zNfHC6uJjjjb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4294">-</span></span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zFeExVL2ibvh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zyqovz5MDEk8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4298">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z8s6NCuJ7Byc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4300">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zY4jCd1C8cra" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4302">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zjGgVtQMhTq2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(316.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Actuarial gains/(losses)</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z8jMOYfwDZie" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4306">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zGTArIYdRMS5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4308">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_z0NcH0R6vyOb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">466.5</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z2IWvA3dGME7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4312">-</span></span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zLwSVxJv66tb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4314">-</span></span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zNb0sP2EAnXc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4316">-</span></span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z63oXvE9f8u3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4318">-</span></span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zpk2l6VFq8J9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">466.5</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Comprehensive income </b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zjsBoKXqDG0c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,772.2)</b></span></td> <td id="xdx_98E_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zXpWEVBnfz44" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(316.7)</b></span></td> <td id="xdx_985_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zPmDeftXcVib" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>466.5</b></span></td> <td id="xdx_98E_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zameF7NdyNyf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4328">-</span></b></span></td> <td id="xdx_982_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zTst4h8bdAa9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4330">-</span></b></span></td> <td id="xdx_987_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_ziPLsgWMtySb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4332">-</span></b></span></td> <td id="xdx_985_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zEqEqp7rjEha" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4334">-</span></b></span></td> <td id="xdx_98C_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_za68SlNQnoF9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,622.4)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) of controlling interest</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zkJZOEDpexc6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4338">-</span></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zjltLRHXbfYl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4340">-</span></span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zXlPlvXqcA7f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4342">-</span></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_ziRJqL04dVtk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4344">-</span></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zmgfo3Vvucg5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.8)</span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zEte52AdWRh7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4348">-</span></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z0Lp6KfBO106" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4350">-</span></span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_z2Ev69E7ACD7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tax on deemed dividends</span></td> <td id="xdx_983_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z37FtErVFED5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4354">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zVn1rmlWUs16" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4356">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_z5o3x4FEf8Bl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4358">-</span></span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zBUm7xx2YLk3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4360">-</span></span></td> <td id="xdx_98E_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zk6TrPZ0YbWl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.2)</span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z8AGHsaVQRU9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4364">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zjitMylb8SBb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4366">-</span></span></td> <td id="xdx_980_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zEpQOLVpC26i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td id="xdx_98D_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zz6TzGUc5da8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4370">-</span></span></td> <td id="xdx_986_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z5jnkClNzWs2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4372">-</span></span></td> <td id="xdx_980_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zOTPHYdnA0Gh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4374">-</span></span></td> <td id="xdx_984_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zP8r8uF9XNT5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4376">-</span></span></td> <td id="xdx_987_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_ze024heLqJJ9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4378">-</span></span></td> <td id="xdx_98E_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z6gpT7VOsB" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4380">-</span></span></td> <td id="xdx_982_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zaJ4r1z51UIl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zI030BH8gsb6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98A_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zzF5S0tPP3pg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,754.0</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zl0aEFcW0e6k" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>908.6</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zxzrmg4GdNKd" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(665.0)</b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zBLwTbiBVtRb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6.7)</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zgehjQjo89Pd" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(130.7)</b></span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zci5YNlmIXcf" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zOvxQZLyq8cc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,437.8)</b></span></td> <td id="xdx_98F_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zRx121XMN8b5" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(68,421.5)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive income:</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) on the translation of foreign operations</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_ze4AQRobVqQh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,212.4)</span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zRSbCRBXKtUe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4404">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zHj1XLC3PFm5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4406">-</span></span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zmPcqGcvTtse" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4408">-</span></span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zJtBIntwXNSl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4410">-</span></span></td> <td id="xdx_98D_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z4oDrF8Mpjlk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4412">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z8YSPytEfwMe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4414">-</span></span></td> <td id="xdx_98C_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zNfB0JWKW8F8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,212.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash flow hedges</span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zHfTXXqiIKLi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4418">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zYSK4qYZm8R8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(210.8)</span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zVyYNHyWJS3g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4422">-</span></span></td> <td id="xdx_987_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zQpgQqr9GRW9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4424">-</span></span></td> <td id="xdx_987_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_z01PIaLwPOAk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4426">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z0SRay4gb0Q5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4428">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zzu9m9CUyNuc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4430">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zDwnPcxfz2f4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(210.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Actuarial gains/(losses)</span></td> <td id="xdx_98A_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_ztk4VFqZlQG9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4434">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z5EAy3V0XIl4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4436">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zF88Z6K7hkWh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.2)</span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zZJkLP4znkf6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4440">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zzWmBiSWSv95" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4442">-</span></span></td> <td id="xdx_98D_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zJ7yV7HfBnC2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4444">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zKECrnY9WcRi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4446">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zjc7jsa79st6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Comprehensive income </b></span></td> <td id="xdx_984_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zB7V0yv4rJwd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(9,212.4)</b></span></td> <td id="xdx_98F_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zYrpEj9AqSOk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(210.8)</b></span></td> <td id="xdx_98A_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zVnUNwbP2lde" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(13.2)</b></span></td> <td id="xdx_98C_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zxJzXscJGIne" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4456">-</span></b></span></td> <td id="xdx_98D_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zLtyMxOyODL7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4458">-</span></b></span></td> <td id="xdx_98C_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zk8Hvcb6W9N7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4460">-</span></b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zIqfDxbbLe1d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4462">-</span></b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zmqRd0DrQbM6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(9,436.4)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Options granted on subsidiaries</span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zcppM0bNlsr4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4466">-</span></span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zOrXa26ndjvf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4468">-</span></span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zflQsTnfO681" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4470">-</span></span></td> <td id="xdx_989_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_ze4CRWHqNFF7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.7</span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zQ8SsdYsS1a6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4474">-</span></span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zuAxSY2qdz9d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4476">-</span></span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zgCdKbmk4Ig9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4478">-</span></span></td> <td id="xdx_984_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zCYWnykdGyWh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.7</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) of controlling interest</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zDXvDlkhxH0j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4482">-</span></span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z5IPh4zAbcr8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4484">-</span></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zqocOSraGXOf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4486">-</span></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z3bZP74gXWWi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4488">-</span></span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_z5mgB74kLjn" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.6)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z35XdMgXYwoi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4492">-</span></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zDQY6JKBcHn3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4494">-</span></span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zduGM1bq6ypg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tax on deemed dividends</span></td> <td id="xdx_982_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zTgRcBVNBIs2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4498">-</span></span></td> <td id="xdx_984_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zNEyae1ULXwb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4500">-</span></span></td> <td id="xdx_980_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zCaFwNJq4Z74" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4502">-</span></span></td> <td id="xdx_983_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zq3j0Z3DcINl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4504">-</span></span></td> <td id="xdx_98C_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zW3k95qwbwB3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12.4)</span></td> <td id="xdx_98A_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zDZbHPR9WGpd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4508">-</span></span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z2NBLr2qcIU7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4510">-</span></span></td> <td id="xdx_98F_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zBwMwKsSvWKe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td id="xdx_983_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zanYWJPkljOg" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4514">-</span></span></td> <td id="xdx_982_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zkIzDQdlpqOf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4516">-</span></span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zFSzN1hN8Hx2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4518">-</span></span></td> <td id="xdx_98A_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_znXW0L2OOSRa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4520">-</span></span></td> <td id="xdx_981_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zFpEbBEuYide" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4522">-</span></span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zL03F56Qi33" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4524">-</span></span></td> <td id="xdx_989_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n7_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zXg9IeoutAm5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td> <td id="xdx_986_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zL1G84Ybjnd8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zPwBX0EBt6B" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,458.4)</b></span></td> <td id="xdx_983_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zrrVIFwqZgNi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>697.8</b></span></td> <td id="xdx_980_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zr0b0D8hYNZh" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(678.2)</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zB5Zb5Jqmgnb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4536">-</span></b></span></td> <td id="xdx_981_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zM1nrNcDQgA1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(145.7)</b></span></td> <td id="xdx_981_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zUhdVyM4DOBk" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_986_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_znSf4RVZ9jU3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,449.6)</b></span></td> <td id="xdx_988_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zoB36kxOat99" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(77,878.0)</b></span></td></tr> </table> <p id="xdx_8A7_zmy9AxyatUHd" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>22.5.1 Translation reserves</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The translation reserves comprise all foreign currency exchange differences arising from the translation of the financial statements with a functional currency different to the Real.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The translation reserves also comprise the portion of the gain or loss on the foreign currency liabilities and on the derivative financial instruments determined to be effective net investment hedges.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>22.5.2 Cash flow hedge reserves</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The hedging reserves represent the effective portion of the cumulative net change in the fair value of cash flow hedges to the extent that the hedged risk has not yet impacted profit or loss (for additional information, see Note 28 - <i>Financial instruments and risks)</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><b>22.5.3 Actuarial gains and losses</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Actuarial gains and losses include expectations regarding future pension plan obligations. Consequently, the results of actuarial gains and losses are recognized on a monthly considering the best estimates available to Management, reasoned on the expectations presented in the independent actuarial report. There was no actuarial gain or loss due to a surplus or deficit in 2023.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>22.5.4 <span style="color: black">Accounting adjustments for transactions between shareholders</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions between shareholders of the same business, even when carried out between persons who are totally independent of each other, which have a valid economic rationale and reflect usual market conditions, will be consolidated by the applicable accounting standards as having taken place within the same accounting entity.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As determined by IFRS 10, any difference between the amount paid (fair value) for the acquisition of a non-controlling interest and the carrying amount of such non-controlling interest shall be recognized directly in the controlling shareholders’ equity. The acquisition of the non-controlling interest related to Former Ambev, and the abovementioned adjustment was recognized in Carrying value adjustments when applicable.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Issued capital and treasury shares</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's issued capital consists only of common shares. The Company holds treasury shares for future disposal, cancellation or for the payment of its executives' share-based compensation programs. When the Company buyback its own shares, the amount paid, including directly attributable costs, are recognized in a specific account under treasury shares as a reduction of shareholders' equity.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Share issuance costs</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Incremental costs directly attributable to the issuance of new shares or options are presented in equity as a deduction, net of tax, from the proceeds.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Dividends and interest on shareholder’s equity</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Dividends and interest on shareholders’ equity are recognized in liabilities from the date on which they are approved by a Board of Directors’ Meeting, except for the minimum statutory dividends provided for under the Company’s bylaws, which are recognized as a liability, when applicable, at the end of each fiscal year.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The interest expense attributable to capital to shareholders is recognized in income for the purposes of the calculation of Brazilian income and social contribution tax and is subsequently reclassified from shareholders' equity for presentation purposes in the financial statements.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The projected effect of the deductibility of interest on shareholder´s equity is recognized in the interim financial statements in order to obtain the best estimate of the weighted average effective income tax rate expected for the full fiscal year, in accordance with IAS 34- <span style="background-color: white">Interim Financial Reporting</span>.</p> 58177900000 58130500000 58042500000 15753800000 15750200000 15744500000 <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--DisclosureOfIssuedCapitalExplanatory_pin6_zEywOImOH00b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Capital Stock (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_z6UNIjWDgT4i" style="display: none">Schedule of issued capital</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 29%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Shareholder</b></span></td> <td style="white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million common shares</b></span></td> <td style="white-space: nowrap; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>%</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million common shares</b></span></td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>%</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million common shares</b></span></td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>%</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interbrew International B.V.</span></td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zM0g8AcJc39j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,441.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zPtRRIB6Bro" title="Shareholder percentage">53.6</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zwMOUnUPSSp3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,441.8</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zFWauxEMSCCb" title="Shareholder percentage">53.6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_zI3leOmFzwy6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8,441.9</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InterbrewInternationalBVMember_z3RF1Wcdd7Be" title="Shareholder percentage">53.6</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ambrew S.A.R.L.</span></td> <td id="xdx_98D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_z3iW8stDhJn2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,287.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_909_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_z8GeCuLfvAf4" title="Shareholder percentage">8.2</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zx49t4dPZnV3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,287.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zci3kH5uBHI8" title="Shareholder percentage">8.2</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zJsGdcXW7co9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,287.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AmbrewSARLMember_zYHnU9EHyTqk" title="Shareholder percentage">8.2</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Fundação Zerrenner</span></td> <td id="xdx_98D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zt50DhYnMoYh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,610.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_z9w6qMY1kvak" title="Shareholder percentage">10.2</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zF95HUK9Rcg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,610.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_z4MnKPD84eh1" title="Shareholder percentage">10.2</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zKgLJ9vMPWg2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,610.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FundacaoZerrennerMember_zMbsM4Dupkne" title="Shareholder percentage">10.2</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mercado</span></td> <td id="xdx_98D_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_z133Ti2fxS3g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,410.0</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zzJNofRLDzbb" title="Shareholder percentage">28.0</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zTN95Frj6Xfg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,402.2</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90D_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zojFAofXRaBj" title="Shareholder percentage">27.9</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zJKEOmmYRIAg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,399.7</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MercadoMember_zwiu6Em700Ui" title="Shareholder percentage">27.9</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tesouraria</span></td> <td id="xdx_987_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zF1DNQsGVsa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.4</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zTfLu2AJ2dz7" title="Shareholder percentage">0.0</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zxSxprxsT2wd" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.5</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zcOBsjCcumS3" title="Shareholder percentage">0.1</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_z7IOCipPo2Ed" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.8</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TesourariaMember_zo89NsUzv6Bc" title="Shareholder percentage">0.0</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20231231_zvOKWmugz1Aa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,753.8</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span id="xdx_905_ecustom--ShareholderPercentage_pip0_dp_c20230101__20231231_zC4MG7hs1Aef" title="Shareholder percentage">100.0</span>%</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20221231_zumWtmegtlO2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,750.2</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span id="xdx_906_ecustom--ShareholderPercentage_pip0_dp_c20220101__20221231_zZtVAvjffFG3" title="Shareholder percentage">100.0</span>%</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--NumberOfSharesOutstanding_iI_pn5n6_c20211231_zwdM23G6BYa2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Number of shares outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>15,744.4</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span id="xdx_90C_ecustom--ShareholderPercentage_pip0_dp_c20210101__20211231_zzqOlgZlvXB7" title="Shareholder percentage">100.0</span>%</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2021</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million common shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million Reais</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million common shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million Reais</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million common shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Million Reais</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Beginning balance</span></td> <td id="xdx_98A_ecustom--EquitySharesOutstanding_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zxxB8T9hG26j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">15,750.2 </span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zaxEy7blDHE" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">58,130.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--EquitySharesOutstanding_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z9kuXZfQ9To3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">15,744.4 </span></td> <td id="xdx_98C_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_ztKH6zJT19Wd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">58,042.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--EquitySharesOutstanding_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zpCSCQyg8C3k" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">15,735.1 </span></td> <td id="xdx_98A_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zaMi93dgzPNe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">57,899.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 7.5pt Times New Roman, Times, Serif">Capital increase<sup> (i)</sup></span></td> <td id="xdx_987_ecustom--IssueOfEquityShares_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zztwia5J9aWa" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">3.6 </span></td> <td id="xdx_983_eifrs-full--IssueOfEquity_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">47.4 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--IssueOfEquityShares_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zWUYPxuGQnza" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">5.8 </span></td> <td id="xdx_985_eifrs-full--IssueOfEquity_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">88.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--IssueOfEquityShares_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zcZhmvxP5tge" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">9.3 </span></td> <td id="xdx_987_eifrs-full--IssueOfEquity_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_pn5n6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Issue of equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">143.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Final balance</b></span></td> <td id="xdx_987_ecustom--EquitySharesOutstanding_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_z9R9cVIiWrMf" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>15,753.8 </b></span></td> <td id="xdx_986_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zFFsVe0lZH8c" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>58,177.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--EquitySharesOutstanding_iE_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zpuoQgWK6Mh5" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>15,750.2 </b></span></td> <td id="xdx_98F_eifrs-full--Equity_iE_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zhIVnkjzpy45" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>58,130.5 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--EquitySharesOutstanding_iE_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zn5gnfr76XX5" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity shares outstanding, Final balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>15,744.4 </b></span></td> <td id="xdx_984_eifrs-full--Equity_iE_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--IssuedCapitalMember_zj9EN74AahN3" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>58,042.5 </b></span></td></tr> </table> <p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0">(i) Capital increase related to the issue of shares.</p> 8441700000 0.536 8441800000 0.536 8441900000 0.536 1287700000 0.082 1287700000 0.082 1287000000.0 0.082 1610000000.0 0.102 1610000000.0 0.102 1610000000.0 0.102 4410000000.0 0.280 4402200000 0.279 4399700000 0.279 4400000 0.000 8500000 0.001 5800000 0.000 15753800000 1.000 15750200000 1.000 15744400000 1.000 15750200000 58130500000 15744400000 58042500000 15735100000 57899100000 3600000 47400000 5800000 88000000.0 9300000 143400000 15753800000 58177900000 15750200000 58130500000 15744400000 58042500000 <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--DisclosureOfClassesOfCapitalReservesTextBlock_z6kwolobmbll" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Capital Reserves (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_zpDPkPbFnBv3" style="display: none">Schedule of capital reserves</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Capital Reserves </b></span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="vertical-align: bottom; width: 35%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Treasury shares </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Share Premium </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Other capital reserves </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Share-based Payments </b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Total </b></span></td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At January 1, 2021</b></span></td> <td id="xdx_984_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zS5auM9PGEoa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(941.7)</b></span></td> <td id="xdx_98B_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zktaIM9rAyP2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_981_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zzh0iyAT25ua" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_985_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zOls1UJgeg2g" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,563.6 </b></span></td> <td id="xdx_986_eifrs-full--CapitalReserve_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zyFYZD5F0Iwe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>54,985.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital Increase</span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_znXiv6DIxOBk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(60.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90D_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_z3vJVpL0UzL4" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3798">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_905_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zuqN6dyYGL2l" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3800">-</span></span>   </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zFhLB3qizHGf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(74.4)</span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zXCvb54kYJQa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(134.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchases of shares, results of treasury shares and share-based payments</span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zro4iLq7tbnf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(36.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zOGEmDldt6ba" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3808">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zgbPFu1VsXOh" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3810">-</span></span>   </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zEiK4KIB6TSj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">372.1 </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zxPuqoFlL22g" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">336.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98E_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zBGKiiXzbw61" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,037.8)</b></span></td> <td id="xdx_988_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zwF0UsoWH67a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_987_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_ztJXCMhTpXNb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_98F_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zUxyPJGWjKn7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,861.3 </b></span></td> <td id="xdx_986_eifrs-full--CapitalReserve_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zRKbJQwaQBsj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>55,187.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital Increase</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zxyISQ7S0v6f" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3826">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_z6cSCFTTHwcb" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3828">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zT4kOaZsUKQk" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3830">-</span></span>   </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_z4025sYWAep8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(64.2)</span></td> <td id="xdx_981_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zXe0hiVyfxt3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(64.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchases of shares, results of treasury shares and share-based payments</span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zy2yvpj0fKXf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(35.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zdPoP0u4sEvk" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3838">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zAcen1PLMYV7" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3840">-</span></span>   </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zJmfK3veom9i" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">252.4 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zwddPxyXm784" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">216.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98A_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zIIIwNeTlCFe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,073.4)</b></span></td> <td id="xdx_980_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zVa1QBMF4R37" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_983_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_z75Qec0yrX4g" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_986_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zoteUjHDLpu7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,049.5 </b></span></td> <td id="xdx_981_eifrs-full--CapitalReserve_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zeVCoFqhEINh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Beginning balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>55,339.8 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital Increase</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zYyvHy6nMBI9" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3856">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zg6GmCTi6kn4" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3858">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zG5XD3MFq0dc" title="Capital Increase"><span style="-sec-ix-hidden: xdx2ixbrl3860">-</span></span>   </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_z4jQCFPU3zJ1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughEquityIncrease_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_z3kX4NWd9oY2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Capital Increase"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Purchases of shares, results of treasury shares and share-based payments</span></td> <td id="xdx_988_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_z39lXcTzRA5j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">61.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zIctffzkeYMb" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3868">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_904_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zZRDtEVIh4hi" title="Purchases of shares, results of treasury shares and share-based payments"><span style="-sec-ix-hidden: xdx2ixbrl3870">-</span></span>   </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zpTkyYn2HFHh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.2 </span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughTreasuryShareTransactionsCapitalReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zmcTGAq7tqX4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Purchases of shares, results of treasury shares and share-based payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">172.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td id="xdx_988_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--TreasurySharesMember_zwpyMbVd6Sxe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,011.8)</b></span></td> <td id="xdx_989_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--SharePremiumMember_zeA1KpUmcM2d" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>53,662.8 </b></span></td> <td id="xdx_98F_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--OtherReservesMember_zRTP5iuAPgZ" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>700.9 </b></span></td> <td id="xdx_98C_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--ReserveOfSharebasedPaymentsMember_zxaD770h8ysk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,127.8 </b></span></td> <td id="xdx_983_eifrs-full--CapitalReserve_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__ifrs-full--CapitalReserveMember_zAi4UYEpabka" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Final balance, capital reserves"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>55,479.7 </b></span></td></tr> </table> -941700000 53662800000 700900000 1563600000 54985600000 -60000000.0 -74400000 -134400000 -36100000 372100000 336000000.0 -1037800000 53662800000 700900000 1861300000 55187200000 -64200000 -64200000 -35600000 252400000 216800000 -1073400000 53662800000 700900000 2049500000 55339800000 -32900000 -32900000 61600000 111200000 172800000 -1011800000 53662800000 700900000 2127800000 55479700000 <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--DisclosureOfTreasurySharesExplanatory_pn5n6_zbpfD6TpTovj" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Treasury Shares (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zjEtcesTwW9f" style="display: none">Schedule of treasury shares</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Acquisition /realization of shares</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Result of Treasury Shares</b></span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Treasury Shares</b></span></td></tr> <tr> <td style="vertical-align: top; width: 27%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million shares</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million Brazilian Reais</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million shares</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Million Brazilian Reais</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At January 1, 2021</b></span></td> <td id="xdx_987_ecustom--TreasurySharesAcquiredrealizedOutstanding_iS_pn5n6_c20210101__20211231_zCkG98oBSqhc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iS_pn5n6_c20210101__20211231_zICBPwPm0Vz" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TreasurySharesHeld_iS_pn5n6_c20210101__20211231_zowVtwOO6986" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(938.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--TreasuryShares_iNS_pn5n6_di_c20210101__20211231_zFKXugwX6khl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(941.7)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Changes during the year</span></td> <td id="xdx_98A_ecustom--TreasurySharesAcquiredRealizedDuringThePeriod_pn5n6_c20210101__20211231_zSHJZoRoyHBh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--TreasurySharesAcquiredrealizedDuringThePeriodAmount_pn5n6_c20210101__20211231_zMBUnjdyLyhe" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(95.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TreasurySharesChangeDuringThePeriod_pn5n6_c20210101__20211231_zYJN4w6RMS5h" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--TreasurySharesChangeDuringThePeriodValue_pn5n6_c20210101__20211231_zPQxzP3pZvl1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(96.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98F_ecustom--TreasurySharesAcquiredrealizedOutstanding_iS_pn5n6_c20220101__20221231_zcjzgmlrcYBi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5.8 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iS_pn5n6_c20220101__20221231_zqr2KWy27Akc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(98.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TreasurySharesHeld_iS_pn5n6_c20220101__20221231_zSUD7NA2gTA1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(939.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--TreasuryShares_iNS_pn5n6_di_c20220101__20221231_zRI6YdvkBXq2" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,037.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Changes during the year</span></td> <td id="xdx_98E_ecustom--TreasurySharesAcquiredRealizedDuringThePeriod_pn5n6_c20220101__20221231_zVsqBaoTYt7i" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--TreasurySharesAcquiredrealizedDuringThePeriodAmount_pn5n6_c20220101__20221231_zihmyF0ptJL3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(33.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--TreasurySharesChangeDuringThePeriod_pn5n6_c20220101__20221231_zhJNdrke84Xd" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TreasurySharesChangeDuringThePeriodValue_pn5n6_c20220101__20221231_z2keoKwkP7pe" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(35.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td id="xdx_987_ecustom--TreasurySharesAcquiredrealizedOutstanding_iS_pn5n6_c20230101__20231231_zfxhJ9A2CCga" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>8.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iS_pn5n6_c20230101__20231231_z9wePg79Uyra" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(131.8)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TreasurySharesHeld_iS_pn5n6_c20230101__20231231_z2EK6KqjN34b" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(941.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--TreasuryShares_iNS_pn5n6_di_c20230101__20231231_zlQ1qiCipPxb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,073.4)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Changes during the year</span></td> <td id="xdx_98C_ecustom--TreasurySharesAcquiredRealizedDuringThePeriod_pn5n6_c20230101__20231231_zYajbi1ZoBwb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--TreasurySharesAcquiredrealizedDuringThePeriodAmount_pn5n6_c20230101__20231231_zpd7tCjfSCl8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">68.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TreasurySharesChangeDuringThePeriod_pn5n6_c20230101__20231231_z8TFssgf9KZh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TreasurySharesChangeDuringThePeriodValue_pn5n6_c20230101__20231231_zZm0SqqEhLLa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Changes during the year, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">61.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td id="xdx_984_ecustom--TreasurySharesAcquiredrealizedOutstanding_iE_pn5n6_c20230101__20231231_z3IT19D5dwlg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4.4 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--TreasurySharesAcquiredrealizedOutstandingAmount_iE_pn5n6_c20230101__20231231_zN2tWaHP2rA" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares acquired/realized, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(63.0)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TreasurySharesHeld_iE_pn5n6_c20230101__20231231_zrJoLRy64T1j" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares (in shares)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(948.8)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--TreasuryShares_iNE_pn5n6_di_c20230101__20231231_ziewhsmnqY1i" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, treasury shares, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,011.8)</b></span></td></tr> </table> 200000 -3200000 -938500000 941700000 5600000 -95100000 -1000000.0 -96100000 5800000 -98300000 -939500000 1037800000 2700000 -33500000 -2100000 -35600000 8500000 -131800000 -941600000 1073400000 -4100000 68800000 -7200000 61600000 4400000 -63000000.0 -948800000 1011800000 331600000 313900000 387600000 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfNetIncomeReservesTextBlock_ztSNd5GVSS51" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Net Income Reserves (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B3_zhsGjGPZZwUe" style="display: none">Schedule of net income reserves</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: top"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net income reserves</b></span></td></tr> <tr> <td style="vertical-align: top; width: 38%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Investments reserve </b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Legal reserve </b></span></td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b> Fiscal incentive </b></span></td> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At January 1, 2021</b></span></td> <td id="xdx_981_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zhXBYgyxZzZd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,511.1 </b></span></td> <td id="xdx_983_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_z63UkhAIKcyb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_98B_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zOkn4mFrxKja" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11,404.4 </b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zdCw01puUe23" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>25,920.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fiscal incentive reserve </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_z9NYCJamCvc8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3960">-</span>   </span></td> <td id="xdx_98B_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zSNQY43x5FKe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3962">-</span>   </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_z9R4deRHBxYi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,423.5 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_z8LcnoEnhZDf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,423.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investments reserve </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zMWjtJLvOdo1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,848.1 </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zIY2b9q8Iwc3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3970">-</span>   </span></td> <td id="xdx_988_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zqpQnPphGX5k" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3972">-</span>   </span></td> <td id="xdx_987_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zkdI27qEaw9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,848.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2021</b></span></td> <td id="xdx_985_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zfvGp78awRdi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>18,359.2 </b></span></td> <td id="xdx_98B_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zDVhLiuFM6Pe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_98F_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zdqKvSBA3lZh" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>12,827.9 </b></span></td> <td id="xdx_982_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zw8V8TpC51Kc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>31,191.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fiscal incentive reserve </span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zsz1wFBWbukf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3984">-</span>   </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zIiL2cveGkji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3986">-</span>   </span></td> <td id="xdx_982_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_z5bskZo7uYRd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,018.7 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_z45J2q2Untej" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,018.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investments reserve </span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zfH9VMRO7DJf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,696.7 </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_znMcqcIQIEoc" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3994">-</span>   </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zrSRbQc2Nkc8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3996">-</span>   </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zzQQSBjEORjg" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,696.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_z2nVrSdJxkQb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>22,055.9 </b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zUK789yfyUF3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_98E_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zW6gg4FcVda4" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>14,846.6 </b></span></td> <td id="xdx_98B_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zGivNBrJLxDg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>36,907.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fiscal incentive reserve </span></td> <td id="xdx_985_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zaezvKXu5N4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4008">-</span>   </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zYZdpx46Bp52" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4010">-</span>   </span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zGKq7uItnwLk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,552.7 </span></td> <td id="xdx_984_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zNITyuctyuef" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,552.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investments reserve </span></td> <td id="xdx_980_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_z8FcGv7QaVt2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,730.2 </span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseInFiscalIncentiveReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_z0XIGuvoBS84" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fiscal incentive reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4018">-</span>   </span></td> <td id="xdx_986_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_zlu8NC6VmxPf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4020">-</span>   </span></td> <td id="xdx_988_ecustom--IncreaseDecreaseInvestmentsReserve_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zbgpeZnRqWwh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Investments reserve"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,730.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2023</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesInvestmentReserveMember_zjbmtWSmTXU7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>25,786.1 </b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesLegalReserveMember_zGbBi9lOwhPd" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4.5 </b></span></td> <td id="xdx_986_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReservesFiscalIncentiveMember_ziYeuQRynwFe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>17,399.3 </b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--NetIncomeReserveMember_zPbWpfqn79z5" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>43,189.9 </b></span></td></tr> </table> 14511100000 4500000 11404400000 25920000000.0 1423500000 1423500000 3848100000 3848100000 18359200000 4500000 12827900000 31191600000 2018700000 2018700000 3696700000 3696700000 22055900000 4500000 14846600000 36907000000.0 2552700000 2552700000 3730200000 3730200000 25786100000 4500000 17399300000 43189900000 0.60 0.05 0.20 0.30 0.40 <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfInterestOnShareholdersEquityAndDividendsTextBlock_zGHVRtjPk5m5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Interest on Shareholders' Equity Dividends (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zhfwizs5BYp6" style="display: none">Schedule of interest on shareholders' equity and dividends</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Event</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Approval</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Date of payment</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Year</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type of share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Amount per share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Total amount</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/12/2023</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Interest on shareholder´s equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/28/2023</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2023</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_98C_ecustom--InterestOnShareholdersEquityDividendsAmountPerShare_pip0_c20231228__20231231_zvuL7tJnl5qk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, dividends (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7302</span></td> <td id="xdx_98C_ecustom--InterestOnShareholdersEquityDistributionAmount_pn5n6_c20230101__20231231_zEkclNlyNax9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, distribution"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">11,500.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--InterestOnShareholdersEquityDistributionAndDividendAmount_pn5n6_c20230101__20231231_zISTUoUCj6ga" style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>11,500.2 </b></span></td></tr> </table> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Distribution of interest on shareholders’s equity</span>. In accordance with Operations and Finance Committee recommendation at the meeting held on December 12, 2023, was approved the distribution of interest on shareholder’s equity in the amount of R$<span id="xdx_90E_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_c20231212__20231231_zDQvH8E8s7I7">0.7302</span> per share, based on available balances, in the Company’s extraordinary balance sheet dated as of November 30, 2023, (the survey of which was approved by the Board of Directors at the meeting held on December 12, 2023) and in the Company’s investment reserve, pursuant to the balance sheet dated as of December 31, 2022, which were attributed to the minimum mandatory dividends of the same fiscal year. The interest on shareholder’s equity distribution was taxed pursuant to the applicable law, which resulted in a net interest on shareholder’s equity distribution of R$<span id="xdx_90B_ecustom--InterestOnShareholdersEquityDistribution_pip0_c20230101__20231231_zjQBDnUOGcf" title="Interest on shareholders equity distribution">0.6207</span> per share of, except for shareholders that are corporate entities that are immune or exempted pursuant to article 5 of Law 11,053/04, as amended by Law 11,196/05.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The indicated payment was made on December 28, 2023, considering the shareholding position of December 19, 2022, with respect to B3, and December 26, 2023, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Events during the year ended 2022:</i></p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Event</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Approval</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Date of payment</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Year</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type of share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Amount per share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Total amount</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/06/2022</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Interest on shareholder´s equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/29/2022</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2022</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_pip0_c20221229__20221231_zeswsfNedih2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, distribution (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.7623</span></td> <td id="xdx_98B_ecustom--InterestOnShareholdersEquityDistributionAmount_pn5n6_c20220101__20221231_z8fK4CgEDFHl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, distribution"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">11,999.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--InterestOnShareholdersEquityDistributionAndDividendAmount_pn5n6_c20220101__20221231_zHsniJJjGsxc" style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>11,999.8 </b></span></td></tr> </table> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="text-decoration: underline">Distribution of Dividends</span> in accordance with the recommendation of the Operations, Finance and Compensation Committee at a meeting of the Board of Directors held on December 5, 2022, was approved the distribution of dividends of R$<span id="xdx_904_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_c20221205__20221231_zNAuDoWIZLA">0.7623</span> per share, based on available balance and the Company’s extraordinary balance sheet dated as of October 31, 2022 and attributed to the minimum mandatory dividends for the same fiscal year, without income tax withholding in accordance with current legislation. The distribution of interest on shareholder’s equity was taxed pursuant to applicable law, which resulted in a net distribution of interest on shareholder’s equity of R$<span id="xdx_909_ecustom--InterestOnShareholdersEquityDistribution_pip0_c20220101__20221231_zaV8QQ6KwpZj" title="Interest on shareholders equity distribution">0.6480</span> per share of the Company in 2022.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The indicated payment was made on December 29, 2022, considering the shareholding position of December 19, 2022, with respect to B3, and December 21, 2022, with respect to the New York Stock Exchange - NYSE, without any monetary adjustment.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Events during the year ended 2021:</i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Event</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Approval</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Date of payment</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Year</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Type of share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Amount per share</b></span></td> <td style="border-right: white 1.5pt solid; border-bottom: black 1.5pt solid; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Total amount</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/09/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Dividends</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/30/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDividendsAmountPerShare_pip0_c20211230__20211231_zOrQycbww9b2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, dividends (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.1334</span></td> <td id="xdx_987_ecustom--InterestOnShareholdersEquityDividendsAmount_pn5n6_c20210101__20211231_zTtssmMErVwf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2,099.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Board of Directors Meeting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/09/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">Interest on shareholder´s equity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">12/30/2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">2021</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">ON</span></td> <td id="xdx_984_ecustom--InterestOnShareholdersEquityDistributionAmountPerShare_pip0_c20211230__20211231_zbFpJrGzEbv6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount per share, distribution (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">0.4702</span></td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDistributionAmount_pn5n6_c20210101__20211231_zkuXOajP9CWc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Amount, distribution"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt">7,400.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--InterestOnShareholdersEquityDistributionAndDividendAmount_pn5n6_c20210101__20211231_zxi3UJFXFr9i" style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>9,499.6 </b></span></td></tr> </table> 0.7302 11500200000 11500200000 0.7302 0.6207 0.7623 11999800000 11999800000 0.7623 0.6480 0.1334 2099500000 0.4702 7400100000 9499600000 0.1334 0.4702 0.3996 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureForTheBasisOfDividendsTextBlock_zu6Sn0nzs5w6" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Basis for Dividends (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_z2nuifu7YMr5" style="display: none">Schedule of basis of dividends</span></td> <td id="xdx_490_20230101_20231231_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49E_20220101_20221231_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49C_20210101_20211231_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2021</b></span></td></tr> <tr id="xdx_40B_eifrs-full--ProfitLossAttributableToOwnersOfParent_pn5n6_zw2Z2SY99khb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net income, attributable to equity holders of Ambev</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14,501.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14,457.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>12,671.0 </b></span></td></tr> <tr id="xdx_408_ecustom--PrescribedDividends_pn5n6_zqWxUk649Jvj" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Prescribed/(complementary) dividends</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4084">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">20.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24.7 </span></td></tr> <tr id="xdx_40A_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_zqaNUZfslEZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.8 </span></td></tr> <tr id="xdx_401_ecustom--IncreaseDecreaseThroughAdoptionOfNewAccountingPronouncement_pn5n6_zFb6x5tLM7Ce" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Effect of application of IAS 29 (hyperinflation)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,269.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,224.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,063.7 </span></td></tr> <tr id="xdx_40C_ecustom--RetainedEarningsBasisForDividendsAndDestinations_pn5n6_zMsiYzMQwgQ7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Retained earnings basis for dividends and destinations</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,783.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,715.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14,771.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Dividends and interest on capital distributed and accrued for distribution based on the net income for the year</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--DividendsAndInterestOnCapitalPaidBasedOnProfit_pn5n6_zPS9wlQVb87h" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Dividends and interest on capital paid based on profit</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,500.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,999.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9,499.6 </span></td></tr> <tr id="xdx_409_ecustom--TotalOfDividendsAndInterestOnCapital_pn5n6_zDjF4DDaIR8i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total of dividends and interest on capital </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11,500.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11,999.8 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9,499.6 </b></span></td></tr> <tr id="xdx_401_ecustom--DividendPercentageOfNetIncome_pip0_dp_z1g8etOixW67" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Percentage of distributed profit</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">65%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">68%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64%</span></td></tr> </table> 14501900000 14457900000 12671000000.0 20900000 24700000 11800000 11800000 11800000 3269400000 3224400000 2063700000 17783100000 17715000000.0 14771200000 11500200000 11999800000 9499600000 11500200000 11999800000 9499600000 0.65 0.68 0.64 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfChangesInCarryingValueOfEquityTextBlock_ze0452fSklbi" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - CHANGES IN EQUITY - Carrying Value Adjustments (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zhtAjFHfSrbi" style="display: none">Schedule of Carrying value adjustments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying value adjustments</b></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="vertical-align: bottom; width: 36%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Translation reserves</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><i>Cash flow hedge</i></b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Actuarial gains/ (losses)</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Put option granted on subsidiary</b></span></td> <td style="width: 8%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Gains/(losses) of non-controlling interest’s share</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Business combination</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Accounting adjustments for transactions between shareholders</b></span></td> <td style="width: 7%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At January 1, 2021</b></span></td> <td id="xdx_986_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zJ8ffs5CuV7d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11,076.5</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zmoNSDShyENg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>744.5</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zRLU5BaKDCNj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,473.3)</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zjGSUdnB8fu8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.8)</b></span></td> <td id="xdx_983_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zDqff6fmPgma" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(73.8)</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zmG6kkfN9671" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_98A_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zPfdseqFmqt1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,414.2)</b></span></td> <td id="xdx_98E_eifrs-full--Equity_iS_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zc7MNOGJXUm9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(64,989.0)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive income:</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) on the translation of foreign operations</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zQBZfVWWkwr7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,449.7</span></td> <td id="xdx_98A_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zDVjDASjHef1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4132">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zvh5rH3eTcQh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4134">-</span></span></td> <td id="xdx_98F_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zmbrF47MKcCh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4136">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zUJ82nb66HC1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4138">-</span></span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zsXuTXUkK2ei" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4140">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zymRqpFlyu6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4142">-</span></span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zmY6l0QZLSJ5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,449.7</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash flow hedges</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z3Wzaz73Ccl8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4146">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zOLtDE6QNsS" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">480.8</span></td> <td id="xdx_987_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zpuZr6YMVq6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4150">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z1ukFeyi0Hwc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4152">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zWAGbdKKKkjh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4154">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zAuNOlKOsizi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4156">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zZmUQp5o8UTc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4158">-</span></span></td> <td id="xdx_98C_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zbMlSY45k6se" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">480.8</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Actuarial gains/(losses)</span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_ztMtHNNgDUB" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4162">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zdPR3OJQuye9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4164">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_z4zF9NLlMy7c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">341.8</span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z4OCCZgwZ5U6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4168">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zRpCrvg7y8Pg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4170">-</span></span></td> <td id="xdx_98D_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zBJjSjqjsI69" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4172">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z14xPvu6Ic8c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4174">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zlynI9ciJAm2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">341.8</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Comprehensive income </b></span></td> <td id="xdx_980_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zFV82oYkluu4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,449.7</b></span></td> <td id="xdx_98D_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zLXE0QrodPr3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>480.8</b></span></td> <td id="xdx_980_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zAu4ERnpeDva" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>341.8</b></span></td> <td id="xdx_980_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z3b7eKYNpM2f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4184">-</span></b></span></td> <td id="xdx_987_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zGnvt5pDjKj3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4186">-</span></b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z7osc3ZTYjY9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4188">-</span></b></span></td> <td id="xdx_98F_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zJM5OYzEfka6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4190">-</span></b></span></td> <td id="xdx_987_eifrs-full--ComprehensiveIncome_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zVtzEnUTjAK3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,272.3</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Options granted on subsidiaries</span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zl8heClOHVtj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4194">-</span></span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z52VviM1rdll" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4196">-</span></span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zzxyfO0rRZW1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4198">-</span></span></td> <td id="xdx_986_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zL7dXFUgK41f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.9)</span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zOYjKCZ5Jow2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4202">-</span></span></td> <td id="xdx_98F_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zv0wr1HNLsqh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4204">-</span></span></td> <td id="xdx_98C_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_znVv2inynoXl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4206">-</span></span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zcm36apIgiY3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) of controlling interest</span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zeU7ufYZ6bZc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4210">-</span></span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zmgaBACWP45d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4212">-</span></span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zXoDoOMLWRKb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4214">-</span></span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zpcOKwkvNp3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4216">-</span></span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zTIuUY6DlEt8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.2)</span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zoMfMZBYh1Qc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4220">-</span></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_znMEa396CYx1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4222">-</span></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zj3v9VdWM9Rg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tax on deemed dividends</span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zMqjNHshoxoa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4226">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zZwc943sVG82" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4228">-</span></span></td> <td id="xdx_980_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zo5unmExFWca" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4230">-</span></span></td> <td id="xdx_989_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zF2UYFRHiml8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4232">-</span></span></td> <td id="xdx_982_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zuIOSG5Uorda" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.7)</span></td> <td id="xdx_98E_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zjSySfXvb8Ec" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4236">-</span></span></td> <td id="xdx_984_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zBwNSHpJAwbb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4238">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zsgThwpE0zl4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td id="xdx_98D_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zigtPxLvh9Cl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4242">-</span></span></td> <td id="xdx_98A_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zlguYrfvj7d4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4244">-</span></span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zTpZXZA50tVk" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4246">-</span></span></td> <td id="xdx_987_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z5fc7pCPs0Ka" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4248">-</span></span></td> <td id="xdx_989_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zRIEUvsyMJ9g" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4250">-</span></span></td> <td id="xdx_98D_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zcbLE8aENau5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4252">-</span></span></td> <td id="xdx_982_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zVdGTmwAJLrb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td> <td id="xdx_98C_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20210101__20211231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zotNbyLN6Zpl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2021</b></span></td> <td id="xdx_983_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zqBYmGhjOph8" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>13,526.2</b></span></td> <td id="xdx_98F_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z2fEpvdYM4a1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,225.3</b></span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zTqtoEUDMkz7" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,131.5)</b></span></td> <td id="xdx_982_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zWG62HXFwzRa" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6.7)</b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zciQ9duiRD3e" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(121.7)</b></span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zBB4ifJfYpwk" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_984_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zNzAv75zHhl9" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,426.0)</b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zdu40Mop76Pc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(61,778.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive income:</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) on the translation of foreign operations</span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z9MgQ2uK0Dal" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6,772.2)</span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zq2ZOiE5Cju6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4276">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zSOM4ieOnS13" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4278">-</span></span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z3rXOm09Bp51" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4280">-</span></span></td> <td id="xdx_98C_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zZcLpvNGVmZg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4282">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zLM9c7yUbAX4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4284">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zzsay2IFScZd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4286">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zeZnFEXUtXE4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6,772.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash flow hedges</span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zxjM3vukEGV" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4290">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zz9WsaumF5Vd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(316.7)</span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zNfHC6uJjjjb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4294">-</span></span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zFeExVL2ibvh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zyqovz5MDEk8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4298">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z8s6NCuJ7Byc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4300">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zY4jCd1C8cra" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4302">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zjGgVtQMhTq2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(316.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Actuarial gains/(losses)</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z8jMOYfwDZie" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4306">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zGTArIYdRMS5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4308">-</span></span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_z0NcH0R6vyOb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">466.5</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z2IWvA3dGME7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4312">-</span></span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zLwSVxJv66tb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4314">-</span></span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zNb0sP2EAnXc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4316">-</span></span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z63oXvE9f8u3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4318">-</span></span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zpk2l6VFq8J9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">466.5</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Comprehensive income </b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zjsBoKXqDG0c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,772.2)</b></span></td> <td id="xdx_98E_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zXpWEVBnfz44" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(316.7)</b></span></td> <td id="xdx_985_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zPmDeftXcVib" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>466.5</b></span></td> <td id="xdx_98E_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zameF7NdyNyf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4328">-</span></b></span></td> <td id="xdx_982_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zTst4h8bdAa9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4330">-</span></b></span></td> <td id="xdx_987_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_ziPLsgWMtySb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4332">-</span></b></span></td> <td id="xdx_985_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zEqEqp7rjEha" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4334">-</span></b></span></td> <td id="xdx_98C_eifrs-full--ComprehensiveIncome_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_za68SlNQnoF9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6,622.4)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) of controlling interest</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zkJZOEDpexc6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4338">-</span></span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zjltLRHXbfYl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4340">-</span></span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zXlPlvXqcA7f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4342">-</span></span></td> <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_ziRJqL04dVtk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4344">-</span></span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zmgfo3Vvucg5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.8)</span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zEte52AdWRh7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4348">-</span></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z0Lp6KfBO106" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4350">-</span></span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_z2Ev69E7ACD7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tax on deemed dividends</span></td> <td id="xdx_983_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_z37FtErVFED5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4354">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zVn1rmlWUs16" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4356">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_z5o3x4FEf8Bl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4358">-</span></span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zBUm7xx2YLk3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4360">-</span></span></td> <td id="xdx_98E_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zk6TrPZ0YbWl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.2)</span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z8AGHsaVQRU9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4364">-</span></span></td> <td id="xdx_986_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zjitMylb8SBb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4366">-</span></span></td> <td id="xdx_980_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zEpQOLVpC26i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td id="xdx_98D_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zz6TzGUc5da8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4370">-</span></span></td> <td id="xdx_986_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z5jnkClNzWs2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4372">-</span></span></td> <td id="xdx_980_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zOTPHYdnA0Gh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4374">-</span></span></td> <td id="xdx_984_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zP8r8uF9XNT5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4376">-</span></span></td> <td id="xdx_987_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_ze024heLqJJ9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4378">-</span></span></td> <td id="xdx_98E_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z6gpT7VOsB" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4380">-</span></span></td> <td id="xdx_982_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zaJ4r1z51UIl" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20220101__20221231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zI030BH8gsb6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td id="xdx_98A_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zzF5S0tPP3pg" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>6,754.0</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zl0aEFcW0e6k" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>908.6</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zxzrmg4GdNKd" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(665.0)</b></span></td> <td id="xdx_989_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zBLwTbiBVtRb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(6.7)</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zgehjQjo89Pd" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(130.7)</b></span></td> <td id="xdx_988_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zci5YNlmIXcf" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_987_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zOvxQZLyq8cc" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,437.8)</b></span></td> <td id="xdx_98F_eifrs-full--Equity_iS_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zRx121XMN8b5" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Beginning balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(68,421.5)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Comprehensive income:</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) on the translation of foreign operations</span></td> <td id="xdx_981_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_ze4AQRobVqQh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,212.4)</span></td> <td id="xdx_983_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zRSbCRBXKtUe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4404">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zHj1XLC3PFm5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4406">-</span></span></td> <td id="xdx_988_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zmPcqGcvTtse" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4408">-</span></span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zJtBIntwXNSl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4410">-</span></span></td> <td id="xdx_98D_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z4oDrF8Mpjlk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4412">-</span></span></td> <td id="xdx_98E_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z8YSPytEfwMe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4414">-</span></span></td> <td id="xdx_98C_eifrs-full--OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zNfB0JWKW8F8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on the translation of foreign operations"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(9,212.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash flow hedges</span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zHfTXXqiIKLi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4418">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zYSK4qYZm8R8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(210.8)</span></td> <td id="xdx_980_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zVyYNHyWJS3g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4422">-</span></span></td> <td id="xdx_987_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zQpgQqr9GRW9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4424">-</span></span></td> <td id="xdx_987_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_z01PIaLwPOAk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4426">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z0SRay4gb0Q5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4428">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zzu9m9CUyNuc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4430">-</span></span></td> <td id="xdx_984_eifrs-full--OtherComprehensiveIncomeNetOfTaxCashFlowHedges_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zDwnPcxfz2f4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Cash flow hedges"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(210.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Actuarial gains/(losses)</span></td> <td id="xdx_98A_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_ztk4VFqZlQG9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4434">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z5EAy3V0XIl4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4436">-</span></span></td> <td id="xdx_986_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zF88Z6K7hkWh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.2)</span></td> <td id="xdx_98B_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zZJkLP4znkf6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4440">-</span></span></td> <td id="xdx_985_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zzWmBiSWSv95" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4442">-</span></span></td> <td id="xdx_98D_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zJ7yV7HfBnC2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4444">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zKECrnY9WcRi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4446">-</span></span></td> <td id="xdx_982_eifrs-full--OtherComprehensiveIncomeNetOfTaxGainsLossesOnRevaluation_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zjc7jsa79st6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Actuarial gains/(losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total Comprehensive income </b></span></td> <td id="xdx_984_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zB7V0yv4rJwd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(9,212.4)</b></span></td> <td id="xdx_98F_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zYrpEj9AqSOk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(210.8)</b></span></td> <td id="xdx_98A_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zVnUNwbP2lde" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(13.2)</b></span></td> <td id="xdx_98C_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zxJzXscJGIne" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4456">-</span></b></span></td> <td id="xdx_98D_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zLtyMxOyODL7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4458">-</span></b></span></td> <td id="xdx_98C_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zk8Hvcb6W9N7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4460">-</span></b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zIqfDxbbLe1d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4462">-</span></b></span></td> <td id="xdx_98B_eifrs-full--ComprehensiveIncome_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zmqRd0DrQbM6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total comprehensive income"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(9,436.4)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Options granted on subsidiaries</span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zcppM0bNlsr4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4466">-</span></span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zOrXa26ndjvf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4468">-</span></span></td> <td id="xdx_985_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zflQsTnfO681" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4470">-</span></span></td> <td id="xdx_989_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_ze4CRWHqNFF7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.7</span></td> <td id="xdx_98D_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zQ8SsdYsS1a6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4474">-</span></span></td> <td id="xdx_98E_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zuAxSY2qdz9d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4476">-</span></span></td> <td id="xdx_983_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zgCdKbmk4Ig9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4478">-</span></span></td> <td id="xdx_984_ecustom--IncreaseDecreaseThroughOptionsGrantedOnSubsidiaryEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zCYWnykdGyWh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options granted on subsidiaries"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.7</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Gains/(losses) of controlling interest</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zDXvDlkhxH0j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4482">-</span></span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_z5IPh4zAbcr8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4484">-</span></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zqocOSraGXOf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4486">-</span></span></td> <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_z3bZP74gXWWi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4488">-</span></span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_z5mgB74kLjn" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.6)</span></td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_z35XdMgXYwoi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4492">-</span></span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zDQY6JKBcHn3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4494">-</span></span></td> <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughTransactionsWithOwners_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zduGM1bq6ypg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gains/(losses) on controlling interest"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Tax on deemed dividends</span></td> <td id="xdx_982_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zTgRcBVNBIs2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4498">-</span></span></td> <td id="xdx_984_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zNEyae1ULXwb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4500">-</span></span></td> <td id="xdx_980_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zCaFwNJq4Z74" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4502">-</span></span></td> <td id="xdx_983_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zq3j0Z3DcINl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4504">-</span></span></td> <td id="xdx_98C_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zW3k95qwbwB3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12.4)</span></td> <td id="xdx_98A_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zDZbHPR9WGpd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4508">-</span></span></td> <td id="xdx_985_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_z2NBLr2qcIU7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4510">-</span></span></td> <td id="xdx_98F_ecustom--DecreaseIncreaseThroughTaxOnFictitiousDividendsEquity_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zBwMwKsSvWKe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Tax on deemed dividends"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting</span></td> <td id="xdx_983_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zanYWJPkljOg" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4514">-</span></span></td> <td id="xdx_982_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zkIzDQdlpqOf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4516">-</span></span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zFSzN1hN8Hx2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4518">-</span></span></td> <td id="xdx_98A_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_znXW0L2OOSRa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4520">-</span></span></td> <td id="xdx_981_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zFpEbBEuYide" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4522">-</span></span></td> <td id="xdx_985_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zL03F56Qi33" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4524">-</span></span></td> <td id="xdx_989_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n7_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_zXg9IeoutAm5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td> <td id="xdx_986_ecustom--ReversalEffectRevaluationOfFixedAssetsUnderThePredecessorBasisAccounting_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentMember_zL1G84Ybjnd8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Reversal of effects of the revaluation of property, plant and equipment based on the predecessor basis of accounting"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(11.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td id="xdx_98D_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsTranslationReservesMember_zPwBX0EBt6B" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,458.4)</b></span></td> <td id="xdx_983_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsCashFlowHedgeMember_zrrVIFwqZgNi" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>697.8</b></span></td> <td id="xdx_980_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsActuarialGainslossesMember_zr0b0D8hYNZh" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(678.2)</b></span></td> <td id="xdx_98C_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsPutOptionGrantedOnSubsidiaryMember_zB5Zb5Jqmgnb" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4536">-</span></b></span></td> <td id="xdx_981_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsGainsLossesOfNoncontrollingInterestsShareMember_zM1nrNcDQgA1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(145.7)</b></span></td> <td id="xdx_981_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsBusinessCombinationMember_zUhdVyM4DOBk" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>156.1</b></span></td> <td id="xdx_986_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsAccountingAdjustmentsForTransactionsBetweenShareholdersMember_znSf4RVZ9jU3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(75,449.6)</b></span></td> <td id="xdx_988_eifrs-full--Equity_iE_pn5n6_c20230101__20231231__ifrs-full--ComponentsOfEquityAxis__custom--CarryingValueAdjustmentsMember_zoB36kxOat99" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Equity, Ending balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(77,878.0)</b></span></td></tr> </table> 11076500000 744500000 -1473300000 -4800000 -73800000 156100000 -75414200000 -64989000000.0 2449700000 2449700000 480800000 480800000 341800000 341800000 2449700000 480800000 341800000 3272300000 -1900000 -1900000 -46200000 -46200000 -1700000 -1700000 -11800000 -11800000 13526200000 1225300000 -1131500000 -6700000 -121700000 156100000 -75426000000.0 -61778300000 -6772200000 -6772200000 -316700000 -316700000 466500000 466500000 -6772200000 -316700000 466500000 -6622400000 -2800000 -2800000 -6200000 -6200000 -11800000 -11800000 6754000000.0 908600000 -665000000.0 -6700000 -130700000 156100000 -75437800000 -68421500000 -9212400000 -9212400000 -210800000 -210800000 -13200000 -13200000 -9212400000 -210800000 -13200000 -9436400000 6700000 6700000 -2600000 -2600000 -12400000 -12400000 -118000000 -11800000 -2458400000 697800000 -678200000 -145700000 156100000 -75449600000 -77878000000.0 <p id="xdx_807_eifrs-full--DisclosureOfBorrowingsExplanatory_zcsOdEYMXMu1" style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_029"></span><b>23.</b></td><td style="text-align: justify"><b><span id="xdx_824_zznoyPue1vM8">INTEREST-BEARING LOANS AND BORROWING</span></b></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTotalLiabilitiesTextBlock_zh9PN2Y58x8b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_zmNLIPIW6Dka" style="display: none">Schedule of total liabilities</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 54%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Secured bank loans</span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_zNJPzRNv39Yb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">111.6 </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_zPDRaX94NRae" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">126.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Other secured loans </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_zEMQou9b0qq3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">279.4 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_z7PXMOwcAkAk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">328.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Lease liabilities</span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zHh00psg1151" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,812.0 </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z4Dxe7JT4A9a" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,333.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current liabilities</b></span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231_z3ey6y2N5978" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,203.0 </b></span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231_zt6eNWbDXGf6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,788.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Secured bank loans</span></td> <td id="xdx_986_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_znPFmp9ejEL1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14.9 </span></td> <td id="xdx_98D_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_zlECO6n4TXv4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">54.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Other secured loans </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td id="xdx_981_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_z79VaQBMXsU8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">136.3 </span></td> <td id="xdx_987_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_ziPaw34Fygo3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">144.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Lease liabilities</span></td> <td id="xdx_98B_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zuWaXaQ2tq9h" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,146.9 </span></td> <td id="xdx_986_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zSB2VrXFRzD" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">783.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current liabilities</b></span></td> <td id="xdx_98D_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231_ze3UgmGAPOv3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,298.1 </b></span></td> <td id="xdx_981_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231_zddQAKr2Vrsl" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>982.6 </b></span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td id="xdx_981_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--TotalLiabilitiesMember_zW2mewJ0bOn2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,501.1 </b></span></td> <td id="xdx_984_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--TotalLiabilitiesMember_zWnMRThPE2ib" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,770.7 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Nomenclature modified to Other secured loans, including for comparative purposes.</td> </tr></table> <p id="xdx_8A5_zhEec7szuohf" style="font: 11pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Additional information regarding the exposure of the Company to interest rate, foreign currency risk and debt repayment schedule is disclosed in Note 28 - <i>Financial instruments and risks</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">At December 31, 2023, and 2022 the Company’s debts were exposed to the following interest rates:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_895_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_pn5n6_zuwXqq5yhxDa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 1)"> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_zjhE9lJmQRIl" style="display: none">Schedule of debts</span> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 33%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Debt instruments</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Average rate %</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Average rate %</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Debt denominated in US Dollars - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zT0qgcOA8PVc" title="Average rate">14.00</span>%</span></td> <td id="xdx_980_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z3WslJv9Pze6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.0 </span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zTPd5d9lSi36" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4594">-</span>   </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_901_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zUPSDnDEiVM9" title="Average rate">14.00</span>%</span></td> <td id="xdx_98F_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zFhhKvSMzhP2" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.2 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zjBmIesVzUY2" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4600">-</span>   </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other Latin American currencies - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zFGSurLNohg4" title="Average rate">11.48</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zfDoPACuEDL9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">124.6 </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zzTtQaEYgMod" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">281.0 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_ze9BQ7Idb9Bf" title="Average rate">10.39</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zqFqIwfLI4Ic" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">98.8 </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zFpOW3e9wFB5" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">322.5 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Debt denominated in CAD Dollars - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z8TWUGBrrFv7" title="Average rate">5.63</span>%</span></td> <td id="xdx_98F_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zenYfmIjbo38" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">130.1 </span></td> <td id="xdx_98C_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zW0AfefFTiI8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">350.2 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zC24y8QNHHY8" title="Average rate">5.32</span>%</span></td> <td id="xdx_988_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zsX1r2x2wmKh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">123.3 </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zyt6z9CSJsfi" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">387.7 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais denominated floating rate (TJLP and TR)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zmC1mAcGTtD1" title="Average rate">9.47</span>%</span></td> <td id="xdx_981_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zm68zHObULJ" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.4 </span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zd14sQcbQKcb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.6 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zIK79CGExbcb" title="Average rate">9.61</span>%</span></td> <td id="xdx_983_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zAbfSEg9gXMa" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.3 </span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zG4ZIA9dlXEk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">125.1 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais debt - ICMS fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z6lGWXqDTcX1" title="Average rate">2.95</span>%</span></td> <td id="xdx_98E_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zHhRW8aFtAq1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">103.2 </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zW5oHJ7SNS8b" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">194.3 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zvilPwa2EUq2" title="Average rate">2.95</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zqzm8IVNP5Nh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">113.3 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zjrcGYX6bsM7" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">266.4 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais debt - ICMS floating rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_z1jSp7a3gP6c" title="Average rate">6.56</span>%</span></td> <td id="xdx_98C_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zwZFLVA5c8ih" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.0 </span></td> <td id="xdx_98B_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zHN79KysYsd" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">85.1 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90D_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zfovXll7OHYe" title="Average rate">6.97</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zs4J4im0mn77" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">31.1 </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zIprcQF3fd93" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">61.7 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais debt - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z27eL2aWGpR1" title="Average rate">11.17</span>%</span></td> <td id="xdx_981_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zqRcyO2tkjQj" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">893.7 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zAsz3np9D3j3" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,180.7 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zmjN9fOgrYt" title="Average rate">9.43</span>%</span></td> <td id="xdx_987_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zxzizyLutrOb" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">597.6 </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zruOXTVUr259" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,624.7 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231_zS8WtO2uwBD1" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,298.1 </b></span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231_zdkj4doWefa4" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,203.0 </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231_zpfgLrr0mrmf" style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>982.6 </b></span></td> <td id="xdx_98B_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231_zLM4P6TyCVAd" style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,788.1 </b></span></td></tr> </table> <p id="xdx_8A0_z48gzj6GWaUa" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>23.1 Changes in liabilities arising from financing activities</b></p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The tables below detail the changes in the Company’s liabilities arising from financing activities, including both cash and non-cash changes. Liabilities arising from financing activities are those for which cash flow was, or future cash flow will be classified in the company’s consolidated statement of cash flow from financing activities.</p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTextBlock_z42iSt8pD2fk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BA_z1oY9hL9khA" style="display: none">Schedule of liabilities arising from financing activities</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 48%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non - current liabilities</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current liabilities</b></span></td> <td style="white-space: nowrap; width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non - current liabilities</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current liabilities</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Beginning balance</b></span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_z5hwE0ND7oM4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,788.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_z1qyGAJS79w6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>982.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_zrzGEak8Y5q8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,253.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_zJXf9fffric5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>847.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Proceeds</span></td> <td id="xdx_985_eifrs-full--ProceedsFromNoncurrentBorrowings_pn5n6_c20230101__20231231_zsit6sM3lCW4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--ProceedsFromCurrentBorrowings_pn5n6_c20230101__20231231_zxA8Fq9Nc5T5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4694">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--ProceedsFromNoncurrentBorrowings_pn5n6_c20220101__20221231_zJZtEBfmAjg5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">267.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--ProceedsFromCurrentBorrowings_pn5n6_c20220101__20221231_zlTjFNf3XhQa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Payments</span></td> <td id="xdx_983_eifrs-full--RepaymentsOfNoncurrentBorrowings_iN_pn5n6_di_c20230101__20231231_zU5w5l86V2C8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--RepaymentsOfCurrentBorrowings_iN_pn5n6_di_c20230101__20231231_z5X0aJZZCpq3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(226.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--RepaymentsOfNoncurrentBorrowings_iN_pn5n6_di_c20220101__20221231_zvaCKuUFLRWc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4704">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--RepaymentsOfCurrentBorrowings_iN_pn5n6_di_c20220101__20221231_zXALTaVuxTka" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(230.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Foreign exchange</span></td> <td id="xdx_980_ecustom--ForeignExchangeEffectOnNoncurrentBorrowings_pn5n6_c20230101__20231231_zclTpY917PHd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(52.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--ForeignExchangeEffectOnCurrentBorrowings_pn5n6_c20230101__20231231_zKvyyMvafi15" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--ForeignExchangeEffectOnNoncurrentBorrowings_pn5n6_c20220101__20221231_zoGJsfEhZXF7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(56.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--ForeignExchangeEffectOnCurrentBorrowings_pn5n6_c20220101__20221231_zp3TINqeGytb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transfers between current and non-current</span></td> <td id="xdx_981_ecustom--TransferBetweenCurrentAndNoncurrentNoncurrent_pn5n6_c20230101__20231231_zFzWgieKzeSe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,238.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TransferBetweenCurrentAndNoncurrentCurrent_pn5n6_c20230101__20231231_zU1YV1E2iO2f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,238.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TransferBetweenCurrentAndNoncurrentNoncurrent_pn5n6_c20220101__20221231_zesrWmP3xwB2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(761.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TransferBetweenCurrentAndNoncurrentCurrent_pn5n6_c20220101__20221231_z2uZtpBCw6Od" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">761.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">New lease agreements</span></td> <td id="xdx_98E_ecustom--AdditionsToLeaseLiabilityNoncurrent_pn5n6_c20230101__20231231_zwkN3OHSPF3c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">629.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilityCurrent_pn5n6_c20230101__20231231_zsWGI3O7a2u7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">524.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--AdditionsToLeaseLiabilityNoncurrent_pn5n6_c20220101__20221231_zyt8C5cm6Hbl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">905.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--AdditionsToLeaseLiabilityCurrent_pn5n6_c20220101__20221231_zbBcT6ehPg1a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">469.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest on leases</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestExpenseOnLeaseLiabilities_pn5n6_c20230101__20231231_ziOWc0HXsDve" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest on leases"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">193.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pn5n6_c20220101__20221231_zkZ2KAqruMj1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest on leases"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">159.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Lease Payments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pn5n6_di_c20230101__20231231_zpQIEv96nvG3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payment of lease liabilities, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,373.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pn5n6_di_c20220101__20221231_zhy1ZWZGQKz1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payment of lease liabilities, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,014.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other movements</span></td> <td id="xdx_985_ecustom--OtherMovementsNoncurrent_pn5n6_c20230101__20231231_zts4Xow7cg5e" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.2 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--OtherMovementsCurrent_pn5n6_c20230101__20231231_zjq7VePKG3e9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(20.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--OtherMovementsNoncurrent_pn5n6_c20220101__20221231_zegpu152zid6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">180.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--OtherMovementsCurrent_pn5n6_c20220101__20221231_zK7wnS5QhJT3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Final balance</b></span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_zS1GE8qVdl6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,203.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_zKfmhqhTcan7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,298.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_zhxOhssAaSvg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,788.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_zbG9yRsSXZYg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>982.6 </b></span></td></tr> </table> <p id="xdx_8A1_zWGXWoJdSDhg" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>23.2 Maturity of contracts</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The above amounts have the following expect payment flow:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfMaturityOfContractsTableTextBlock_zHUIVLE5OI7b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zxlfml1uYCi9" style="display: none">Schedule of maturity of contracts</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Balance as of December 31, 2023</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 28%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2024</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2025</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2026</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&gt; 2028</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Secured bank loans</span></td> <td id="xdx_983_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_ziYQ4o0MbjTb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.9 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zJqMvKm711fc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.7 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zLxlTybhOiGk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.1 </span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zMeddZXnBbw6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.8 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zXZdYa98lneb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">44.0 </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember_zNOTDcL2zV3b" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">126.5 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember_z5HkwGEJNDil" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">180.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Other secured loans</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (i)</sup></span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zi6iTs3CqIE" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">136.3 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zXeggF9yaqG6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">151.5 </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zhARloguEoP1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">114.8 </span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zKb9uMXiP4Re" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.7 </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zrWlP3XzECJl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.3 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember_zrHiqlSIQDa4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">415.7 </span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember_zs7FUoVlyGg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Lease liabilities</span></td> <td id="xdx_983_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z5xl7YDs0Wsc" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,146.9 </span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zadk9YQM1Bzc" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">481.8 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zK82szIlYZWi" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.4 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z6fiyYOOm7j1" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">385.0 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zpgAGahU1Qpg" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.8 </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember_zmSlhhlcc7B7" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,958.9 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember_zY6gVyEyWfN5" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,117.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zXuwA5TI1Jbf" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,298.1 </b></span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_z1MuXJUovgv1" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>648.0 </b></span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zd3YACLyEv5e" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>603.3 </b></span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ztjl3EDe9cT6" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>425.5 </b></span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zqgBSA9SRG78" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>526.1 </b></span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--MaturityTotalMember_zXtyHyK0AKd4" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,501.1 </b></span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__custom--MaturityTotalMember_zlQoNvFyeyf1" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,770.7 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Nomenclature modified to Other secured loans, including for comparative purposes.</td> </tr></table> <p id="xdx_8A0_zfRJmm7H0Elf" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>23.3 Contractual clauses (Covenants)</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">As at December 31, 2023, as well as at December 31, 2022, the Company's loans had equal rights to payment without subordination clauses between them.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Most loan contracts contain contractual covenants, such as: actions that can reduce the ability to pay the loans; maintenance of the Company's assets, purposing to assure that all remain under usage condition; restrictions on acquisitions, mergers, sales or disposals of its assets; disclosure of financial statements and the balance sheet; no prohibitions related to new guarantees for loans contracted.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These clauses are applicable from the date of execution and effectiveness of each contract to the extent that the events mentioned in the contract occur. Depending on the materiality of each event and its potential adverse effects on the Company and /or its subsidiaries or the rights of its creditors, contractual penalties may be applied, including the early maturity of the respective contract.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In certain contracts, in the event of occurrence of any of the events set out in the restrictive clauses, the Company may be granted a grace period to resolve any contractual defaults, in order to avoid any penalties resulting from the breach of its obligations. As of December 31,2023, as well as at December 31, 2023, the Company followed all of its contractual obligations for its loans and financing.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>23.4 Guarantees and contractual counterparts</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The loans and financing contracted by the Company provide for the provision of various guarantees, such as sureties and real estate, or are unsecured, except in relation to the FINAME credit lines contracted by the Company with the National Bank for Economic and Social Development ("BNDES"), in which real guarantees were provided on the assets acquired with the credit granted. These loans contracted with BNDES are subject to certain “provisions applicable to agreements entered into with BNDES” (“Provisions”) and, according to these Provisions, the borrowers, such as the Company, may not, without the prior consent of BNDES, for instance: (i) raise new loans (except for the loans described in the Provisions); (ii) give preference and/or priority to other debts; and/or (iii) dispose of or encumber any items of their fixed assets (except as provided for within the Provisions).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In relation to regarding the tax incentives on financing or subsidized loans, these are subject to the fulfillment of several commitments according to the legislation or contracts upon which those incentives are based on, such as (i) maintaining or generating jobs in the long term; (ii) realization of investments; (iii) increase in production capacity; (iv) ICMS collection commitments; (v) maintaining tax compliance; among others, obligations that refer to facts under the Company’s control. These commitments are applicable as from the signature date of the respective contracts related to fiscal benefits.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>23.5 Leasing contracts for term and discount rate</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The average discount rate applied for IFRS 16, using the incremental rate was as follows:</p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_pip0_zhyt1N0nLvsb" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zzzxfcKYCjR4" style="display: none">Schedule of average discount rate applied for IFRS 16</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="white-space: nowrap; width: 56%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 44%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rate %</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Lease Term</b></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2023 - 2027</span></td> <td id="xdx_982_eifrs-full--WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_iI_pip0_dp_c20231231__ifrs-full--MaturityAxis__custom--LeaseTerm20232027Member_ze2mU5ho54za" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.15%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 56%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2028 - 2035</span></td> <td id="xdx_98D_eifrs-full--WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_iI_pip0_dp_c20231231__ifrs-full--MaturityAxis__custom--LeaseTerm20282035Member_z9WuCRaTGLi3" style="white-space: nowrap; width: 44%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.48%</span></td></tr> </table> <p id="xdx_8A0_zCkHGAJPjUfe" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Interest-bearing loans and borrowing are recognized initially at fair value less attributable transaction costs. Subsequent to their initial recognition, interest-bearing loans and borrowing are stated at amortized cost, with any differences between the initial and maturity amounts recognized in the income statement over the expected life of the instrument on an effective interest rate basis.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Borrowing costs directly related to the acquisition, construction or production of a qualifying asset which requires a substantial period to prepare for its intended use or sale, are capitalized as part of the cost of that asset when it is probable that the future economic benefits associated with the item will flow to the Company, and the costs can be measured reliably. Other borrowing costs are recognized as finance expenses in the period in which they are incurred.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span>The accounting policy applied to lease liabilities is disclosed in note <i>13 - Property, plant and equipment.</i></span></p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTotalLiabilitiesTextBlock_zh9PN2Y58x8b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BD_zmNLIPIW6Dka" style="display: none">Schedule of total liabilities</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 54%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 26%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Secured bank loans</span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_zNJPzRNv39Yb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">111.6 </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_zPDRaX94NRae" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">126.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Other secured loans </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_zEMQou9b0qq3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">279.4 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_z7PXMOwcAkAk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">328.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Lease liabilities</span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zHh00psg1151" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,812.0 </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z4Dxe7JT4A9a" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,333.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current liabilities</b></span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231_z3ey6y2N5978" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,203.0 </b></span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231_zt6eNWbDXGf6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,788.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Secured bank loans</span></td> <td id="xdx_986_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_znPFmp9ejEL1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14.9 </span></td> <td id="xdx_98D_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoansMember_zlECO6n4TXv4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">54.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Other secured loans </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></td> <td id="xdx_981_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_z79VaQBMXsU8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">136.3 </span></td> <td id="xdx_987_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoansMember_ziPaw34Fygo3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">144.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Lease liabilities</span></td> <td id="xdx_98B_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zuWaXaQ2tq9h" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,146.9 </span></td> <td id="xdx_986_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zSB2VrXFRzD" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">783.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current liabilities</b></span></td> <td id="xdx_98D_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231_ze3UgmGAPOv3" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,298.1 </b></span></td> <td id="xdx_981_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231_zddQAKr2Vrsl" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>982.6 </b></span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td id="xdx_981_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--TotalLiabilitiesMember_zW2mewJ0bOn2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,501.1 </b></span></td> <td id="xdx_984_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--TotalLiabilitiesMember_zWnMRThPE2ib" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,770.7 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Nomenclature modified to Other secured loans, including for comparative purposes.</td> </tr></table> 111600000 126200000 279400000 328100000 1812000000.0 2333800000 2203000000.0 2788100000 14900000 54500000 136300000 144500000 1146900000 783600000 1298100000 982600000 3501100000 3770700000 <table cellpadding="0" cellspacing="0" id="xdx_895_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_pn5n6_zuwXqq5yhxDa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 1)"> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_zjhE9lJmQRIl" style="display: none">Schedule of debts</span> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 33%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Debt instruments</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Average rate %</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Average rate %</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Debt denominated in US Dollars - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zT0qgcOA8PVc" title="Average rate">14.00</span>%</span></td> <td id="xdx_980_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z3WslJv9Pze6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.0 </span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zTPd5d9lSi36" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4594">-</span>   </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_901_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zUPSDnDEiVM9" title="Average rate">14.00</span>%</span></td> <td id="xdx_98F_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zFhhKvSMzhP2" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.2 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInUSDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zjBmIesVzUY2" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4600">-</span>   </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other Latin American currencies - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_903_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zFGSurLNohg4" title="Average rate">11.48</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zfDoPACuEDL9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">124.6 </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zzTtQaEYgMod" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">281.0 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_ze9BQ7Idb9Bf" title="Average rate">10.39</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zqFqIwfLI4Ic" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">98.8 </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInOtherLatinAmericanCurrenciesMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zFpOW3e9wFB5" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">322.5 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Debt denominated in CAD Dollars - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z8TWUGBrrFv7" title="Average rate">5.63</span>%</span></td> <td id="xdx_98F_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zenYfmIjbo38" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">130.1 </span></td> <td id="xdx_98C_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zW0AfefFTiI8" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">350.2 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zC24y8QNHHY8" title="Average rate">5.32</span>%</span></td> <td id="xdx_988_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zsX1r2x2wmKh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">123.3 </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--DebtDenominatedInCADDollarsMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zyt6z9CSJsfi" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">387.7 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais denominated floating rate (TJLP and TR)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_900_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zmC1mAcGTtD1" title="Average rate">9.47</span>%</span></td> <td id="xdx_981_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zm68zHObULJ" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.4 </span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zd14sQcbQKcb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.6 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zIK79CGExbcb" title="Average rate">9.61</span>%</span></td> <td id="xdx_983_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zAbfSEg9gXMa" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.3 </span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zG4ZIA9dlXEk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">125.1 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais debt - ICMS fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z6lGWXqDTcX1" title="Average rate">2.95</span>%</span></td> <td id="xdx_98E_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zHhRW8aFtAq1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">103.2 </span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zW5oHJ7SNS8b" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">194.3 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zvilPwa2EUq2" title="Average rate">2.95</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zqzm8IVNP5Nh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">113.3 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zjrcGYX6bsM7" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">266.4 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais debt - ICMS floating rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_z1jSp7a3gP6c" title="Average rate">6.56</span>%</span></td> <td id="xdx_98C_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zwZFLVA5c8ih" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">33.0 </span></td> <td id="xdx_98B_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zHN79KysYsd" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">85.1 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90D_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zfovXll7OHYe" title="Average rate">6.97</span>%</span></td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zs4J4im0mn77" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">31.1 </span></td> <td id="xdx_98D_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtRelatedToICMSMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember_zIprcQF3fd93" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">61.7 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Reais debt - fixed rate</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_z27eL2aWGpR1" title="Average rate">11.17</span>%</span></td> <td id="xdx_981_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zqRcyO2tkjQj" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">893.7 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zAsz3np9D3j3" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,180.7 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_eifrs-full--BorrowingsInterestRate_iI_pip0_dp_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--RangeAxis__srt--WeightedAverageMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zmjN9fOgrYt" title="Average rate">9.43</span>%</span></td> <td id="xdx_987_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zxzizyLutrOb" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">597.6 </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--BorrowingsByNameAxis__custom--ReaisDebtMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FixedInterestRateMember_zruOXTVUr259" style="border-bottom: black 1.5pt solid; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,624.7 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20231231_zS8WtO2uwBD1" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,298.1 </b></span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231_zdkj4doWefa4" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,203.0 </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--CurrentPortionOfLongtermBorrowings_iI_pn5n6_c20221231_zpfgLrr0mrmf" style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>982.6 </b></span></td> <td id="xdx_98B_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231_zLM4P6TyCVAd" style="border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,788.1 </b></span></td></tr> </table> 0.1400 0.0 0.1400 6200000 0.1148 124600000 281000000.0 0.1039 98800000 322500000 0.0563 130100000 350200000 0.0532 123300000 387700000 0.0947 13400000 111600000 0.0961 12300000 125100000 0.0295 103200000 194300000 0.0295 113300000 266400000 0.0656 33000000.0 85100000 0.0697 31100000 61700000 0.1117 893700000 1180700000 0.0943 597600000 1624700000 1298100000 2203000000.0 982600000 2788100000 <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ReconciliationOfLiabilitiesArisingFromFinancingActivitiesTextBlock_z42iSt8pD2fk" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BA_z1oY9hL9khA" style="display: none">Schedule of liabilities arising from financing activities</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 48%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non - current liabilities</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current liabilities</b></span></td> <td style="white-space: nowrap; width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non - current liabilities</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current liabilities</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Beginning balance</b></span></td> <td id="xdx_98E_eifrs-full--LongtermBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_z5hwE0ND7oM4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,788.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_z1qyGAJS79w6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>982.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_zrzGEak8Y5q8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,253.5 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_zJXf9fffric5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>847.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Proceeds</span></td> <td id="xdx_985_eifrs-full--ProceedsFromNoncurrentBorrowings_pn5n6_c20230101__20231231_zsit6sM3lCW4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--ProceedsFromCurrentBorrowings_pn5n6_c20230101__20231231_zxA8Fq9Nc5T5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4694">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--ProceedsFromNoncurrentBorrowings_pn5n6_c20220101__20221231_zJZtEBfmAjg5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">267.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--ProceedsFromCurrentBorrowings_pn5n6_c20220101__20221231_zlTjFNf3XhQa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Proceeds, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Payments</span></td> <td id="xdx_983_eifrs-full--RepaymentsOfNoncurrentBorrowings_iN_pn5n6_di_c20230101__20231231_zU5w5l86V2C8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--RepaymentsOfCurrentBorrowings_iN_pn5n6_di_c20230101__20231231_z5X0aJZZCpq3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(226.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--RepaymentsOfNoncurrentBorrowings_iN_pn5n6_di_c20220101__20221231_zvaCKuUFLRWc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4704">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--RepaymentsOfCurrentBorrowings_iN_pn5n6_di_c20220101__20221231_zXALTaVuxTka" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payments, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(230.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Foreign exchange</span></td> <td id="xdx_980_ecustom--ForeignExchangeEffectOnNoncurrentBorrowings_pn5n6_c20230101__20231231_zclTpY917PHd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(52.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--ForeignExchangeEffectOnCurrentBorrowings_pn5n6_c20230101__20231231_zKvyyMvafi15" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--ForeignExchangeEffectOnNoncurrentBorrowings_pn5n6_c20220101__20221231_zoGJsfEhZXF7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(56.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--ForeignExchangeEffectOnCurrentBorrowings_pn5n6_c20220101__20221231_zp3TINqeGytb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Foreign exchange, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Transfers between current and non-current</span></td> <td id="xdx_981_ecustom--TransferBetweenCurrentAndNoncurrentNoncurrent_pn5n6_c20230101__20231231_zFzWgieKzeSe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,238.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TransferBetweenCurrentAndNoncurrentCurrent_pn5n6_c20230101__20231231_zU1YV1E2iO2f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,238.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TransferBetweenCurrentAndNoncurrentNoncurrent_pn5n6_c20220101__20221231_zesrWmP3xwB2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(761.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TransferBetweenCurrentAndNoncurrentCurrent_pn5n6_c20220101__20221231_z2uZtpBCw6Od" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Transfers between current and non-current, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">761.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">New lease agreements</span></td> <td id="xdx_98E_ecustom--AdditionsToLeaseLiabilityNoncurrent_pn5n6_c20230101__20231231_zwkN3OHSPF3c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">629.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilityCurrent_pn5n6_c20230101__20231231_zsWGI3O7a2u7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">524.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--AdditionsToLeaseLiabilityNoncurrent_pn5n6_c20220101__20221231_zyt8C5cm6Hbl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">905.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--AdditionsToLeaseLiabilityCurrent_pn5n6_c20220101__20221231_zbBcT6ehPg1a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New lease agreements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">469.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest on leases</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--InterestExpenseOnLeaseLiabilities_pn5n6_c20230101__20231231_ziOWc0HXsDve" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest on leases"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">193.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--InterestExpenseOnLeaseLiabilities_pn5n6_c20220101__20221231_zkZ2KAqruMj1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest on leases"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">159.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Lease Payments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pn5n6_di_c20230101__20231231_zpQIEv96nvG3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payment of lease liabilities, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,373.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_iN_pn5n6_di_c20220101__20221231_zhy1ZWZGQKz1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Payment of lease liabilities, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,014.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other movements</span></td> <td id="xdx_985_ecustom--OtherMovementsNoncurrent_pn5n6_c20230101__20231231_zts4Xow7cg5e" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.2 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--OtherMovementsCurrent_pn5n6_c20230101__20231231_zjq7VePKG3e9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(20.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--OtherMovementsNoncurrent_pn5n6_c20220101__20221231_zegpu152zid6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, non-current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">180.1 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--OtherMovementsCurrent_pn5n6_c20220101__20221231_zK7wnS5QhJT3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other movements, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Final balance</b></span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_zS1GE8qVdl6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,203.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_zKfmhqhTcan7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,298.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--NonCurrentLiabilitiesMember_zhxOhssAaSvg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, non current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,788.1 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_iE_pn5n6_c20220101__20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--CurrentLiabilitiesMember_zbG9yRsSXZYg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Balance, current"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>982.6 </b></span></td></tr> </table> 2788100000 982600000 2253500000 847100000 49800000 267000000.0 7900000 800000 226600000 230200000 -52800000 -19600000 -56800000 -17400000 -1238000000.0 1238000000.0 -761000000.0 761000000.0 629500000 524400000 905300000 469200000 193100000 159300000 1373200000 1014000000.0 27200000 -20600000 180100000 -300000 2203000000.0 1298100000 2788100000 982600000 <table cellpadding="0" cellspacing="0" id="xdx_894_ecustom--ScheduleOfMaturityOfContractsTableTextBlock_zHUIVLE5OI7b" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 3)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zxlfml1uYCi9" style="display: none">Schedule of maturity of contracts</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Balance as of December 31, 2023</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 28%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2024</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2025</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2026</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&gt; 2028</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Secured bank loans</span></td> <td id="xdx_983_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_ziYQ4o0MbjTb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.9 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zJqMvKm711fc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.7 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zLxlTybhOiGk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.1 </span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zMeddZXnBbw6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36.8 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zXZdYa98lneb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">44.0 </span></td> <td id="xdx_986_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember_zNOTDcL2zV3b" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">126.5 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--SecuredBankLoanMember_z5HkwGEJNDil" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">180.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Other secured loans</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (i)</sup></span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zi6iTs3CqIE" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">136.3 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zXeggF9yaqG6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">151.5 </span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zhARloguEoP1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">114.8 </span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zKb9uMXiP4Re" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.7 </span></td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zrWlP3XzECJl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.3 </span></td> <td id="xdx_989_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember_zrHiqlSIQDa4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">415.7 </span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--OtherSecuredLoanMember_zs7FUoVlyGg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Lease liabilities</span></td> <td id="xdx_983_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_z5xl7YDs0Wsc" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,146.9 </span></td> <td id="xdx_98F_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zadk9YQM1Bzc" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">481.8 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zK82szIlYZWi" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.4 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z6fiyYOOm7j1" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">385.0 </span></td> <td id="xdx_984_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zpgAGahU1Qpg" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.8 </span></td> <td id="xdx_987_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember_zmSlhhlcc7B7" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,958.9 </span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--LeaseLiabilityMember_zY6gVyEyWfN5" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,117.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zXuwA5TI1Jbf" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,298.1 </b></span></td> <td id="xdx_982_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_z1MuXJUovgv1" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>648.0 </b></span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zd3YACLyEv5e" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>603.3 </b></span></td> <td id="xdx_98A_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_ztjl3EDe9cT6" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>425.5 </b></span></td> <td id="xdx_980_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanThreeYearsAndNotLaterThanSixYearsMember_zqgBSA9SRG78" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>526.1 </b></span></td> <td id="xdx_988_eifrs-full--LongtermBorrowings_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--MaturityTotalMember_zXtyHyK0AKd4" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,501.1 </b></span></td> <td id="xdx_981_eifrs-full--LongtermBorrowings_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__custom--MaturityTotalMember_zlQoNvFyeyf1" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Interest-bearing loans and borrowings, noncurrent"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,770.7 </b></span></td></tr> </table> <p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Nomenclature modified to Other secured loans, including for comparative purposes.</td> </tr></table> 14900000 14700000 16100000 36800000 44000000.0 126500000 180700000 136300000 151500000 114800000 3700000 9300000 415700000 472700000 1146900000 481800000 472400000 385000000.0 472800000 2958900000 3117300000 1298100000 648000000.0 603300000 425500000 526100000 3501100000 3770700000 <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--ExplanationOfDifferenceBetweenOperatingLeaseCommitmentsDisclosedApplyingIAS17AndLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16Explanatory_pip0_zhyt1N0nLvsb" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - INTEREST-BEARING LOANS AND BORROWING (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zzzxfcKYCjR4" style="display: none">Schedule of average discount rate applied for IFRS 16</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="white-space: nowrap; width: 56%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 44%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rate %</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Lease Term</b></span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2023 - 2027</span></td> <td id="xdx_982_eifrs-full--WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_iI_pip0_dp_c20231231__ifrs-full--MaturityAxis__custom--LeaseTerm20232027Member_ze2mU5ho54za" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.15%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 56%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2028 - 2035</span></td> <td id="xdx_98D_eifrs-full--WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16_iI_pip0_dp_c20231231__ifrs-full--MaturityAxis__custom--LeaseTerm20282035Member_z9WuCRaTGLi3" style="white-space: nowrap; width: 44%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.48%</span></td></tr> </table> 0.1115 0.1148 <p id="xdx_80C_eifrs-full--DisclosureOfEmployeeBenefitsExplanatory_zyjrCyc7k8Ma" style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_030"></span>24.</b></td><td><b><span id="xdx_82A_zJHBcUfD5j86">EMPLOYEE BENEFITS</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: justify">The Company sponsors post-employment benefits, such as retirement plans, medical and dental care, among others for employees in Brazil and subsidiaries located in the Dominican Republic, Barbados, Panama, Uruguay, Bolivia, Argentina and Canada based on employees' salaries and length of service. The entities are governed by the local regulations and practices of each individual country as well as the relationship with the Company’s pension funds and their composition.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Post-employment benefits of retirement are managed through pension funds and are classified as either defined contribution or defined benefit plans.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Defined benefit plans and the other post-employment benefits are not granted to new retirees.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>24.1 Defined contribution plans</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">These plans are funded by the participants and the sponsor and are managed by administered pension funds. During 2023, the Company contributed R$<span id="xdx_902_eifrs-full--PostemploymentBenefitExpenseDefinedContributionPlans_pn5n6_c20230101__20231231_zD2GT75Xp5X1" title="Post-employment benefit expense, defined contribution plans">91.3</span> (R$<span id="xdx_901_eifrs-full--PostemploymentBenefitExpenseDefinedContributionPlans_pn5n6_c20220101__20221231_zkmgXa99YBU2" title="Post-employment benefit expense, defined contribution plans">82.0</span> and R$<span id="xdx_904_eifrs-full--PostemploymentBenefitExpenseDefinedContributionPlans_pn5n6_c20210101__20211231_ztyp7bK3hhlb" title="Post-employment benefit expense, defined contribution plans">74.1</span> during 2022 and 2021) to these funds, which was recorded in expenses. Once the contributions have been paid, the Company has no further payment obligations.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>24.2 Defined benefit plans</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">At December 31, 2023, 2022 and 2021 the net liability for defined benefit plans consists of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_pn5n6_z7N3g8X5g0Kc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B8_zi9WwV1Mux2d" style="display: none">Schedule of defined benefit plans</span></td> <td id="xdx_491_20231231_zPgtBz66mxB7" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_496_20221231_zHazBIVjd4Sf" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_493_20211231_zhQueCdlaEx9" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_404_ecustom--DefinedBenefitObligationFundedPortionAtPresentValue_iNI_pn5n6_di_zWYuzucX8O0d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Present value of funded obligations</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,365.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,476.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,354.3)</span></td></tr> <tr id="xdx_405_ecustom--FairValueOfPlanAssets_iI_pn5n6_zRhPJKNu6zda" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fair value of plan assets</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,604.6 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,543.3 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,638.0 </span></td></tr> <tr id="xdx_403_eifrs-full--SurplusDeficitInPlan_iI_pn5n6_zWEsjnCvshBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Present value of net obligations</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(760.9)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(933.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,716.3)</b></span></td></tr> <tr id="xdx_403_ecustom--DefinedBenefitObligationUnfundedPortionAtPresentValue_iNI_pn5n6_di_zHQ3A9vY3GQc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Present value of unfunded obligations</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(917.2)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(921.0)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,165.4)</span></td></tr> <tr id="xdx_401_ecustom--DefinedBenefitObligationAtPresentValues_iNI_pn5n6_di_zlbXMBY9rCc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Present value of net obligations </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,678.1)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,854.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,881.7)</b></span></td></tr> <tr id="xdx_400_ecustom--AssetCeiling_iNI_pn5n6_di_znUe0xjWL7g8" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Asset ceiling</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(182.6)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(163.3)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(180.1)</span></td></tr> <tr id="xdx_400_eifrs-full--RecognisedLiabilitiesDefinedBenefitPlan_iNI_pn5n6_di_zz0jVBnlNa07" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net liabilities</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,860.7)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,017.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,061.8)</b></span></td></tr> <tr id="xdx_401_ecustom--OtherLongTermEmployeeBenefitLiabilities_iNI_pn5n6_di_zosmOsoJsO6k" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other long term employee benefits</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(93.9)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(87.1)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(104.3)</span></td></tr> <tr id="xdx_404_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_zUtfaICoBOU8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total employee benefits</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,954.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,104.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,166.1)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Employee benefits amount in the balance sheet</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Liabilities </span></td> <td id="xdx_989_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--EmployeeBenefitLiabilitiesMember_zzv8ywjw2mHi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,011.9)</span></td> <td id="xdx_980_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--EmployeeBenefitLiabilitiesMember_zFdWl9ugltp4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,161.2)</span></td> <td id="xdx_980_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--EmployeeBenefitLiabilitiesMember_z81EnpD84aq6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,194.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Assets </span></td> <td id="xdx_988_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--EmployeeBenefitsAssetsMember_z9j8BNPROkCh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">57.3 </span></td> <td id="xdx_98E_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--EmployeeBenefitsAssetsMember_z9XcKf75oxA8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">56.6 </span></td> <td id="xdx_988_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--EmployeeBenefitsAssetsMember_zDDbwnR9C8n1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net liabilities</b></span></td> <td id="xdx_98D_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20231231_zaUOmpla4TO" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,954.6)</b></span></td> <td id="xdx_98D_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20221231_zYomfPjl8jv6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,104.6)</b></span></td> <td id="xdx_98F_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20211231_zr5H0bR2Ybxe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,166.1)</b></span></td></tr> </table> <p id="xdx_8A9_zYuJk9mHWEj2" style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The changes in the present value of the defined benefit obligations were as follow:</p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfDefinedBenefitObligationTextBlock_zDq9lMDvI50c" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_z0i9xbxxmU71" style="display: none">Schedule of present value of defined benefit obligations</span></td> <td id="xdx_49B_20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PresentValueOfDefinedBenefitObligationMember_zTix4pSB2eLi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PresentValueOfDefinedBenefitObligationMember_zpzfVarw9br9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PresentValueOfDefinedBenefitObligationMember_zrwswtPh8BM7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_40F_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iS_pn5n6_z9Sr8hkAHh3h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Defined benefit obligation at January 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,397.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(8,519.7)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(8,777.6)</b></span></td></tr> <tr id="xdx_40C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn5n6_zMrvPyMMEDv7" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Service costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(30.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(47.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(58.0)</span></td></tr> <tr id="xdx_40D_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn5n6_zIryLfDmP8Qd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(413.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(353.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(324.3)</span></td></tr> <tr id="xdx_40D_ecustom--GainsLossesOnSettlementAndCurtailment_pn5n6_zs6EVfJVihPh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains and (losses) on settlements or reductions in benefits</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.6 </span></td></tr> <tr id="xdx_405_eifrs-full--ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_pn5n6_zFMQGRmgpRHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions by plan participants</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.9)</span></td></tr> <tr id="xdx_406_eifrs-full--ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_pn5n6_zzyMHZK9TS8l" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Actuarial gains and (losses) - geographical assumptions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4907">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">52.3 </span></td></tr> <tr id="xdx_401_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_pn5n6_zEJEg1RQ3gjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Actuarial gains and (losses) - financial assumptions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(297.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,333.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">726.8 </span></td></tr> <tr id="xdx_40D_eifrs-full--ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_pn5n6_zr0xSh0IgB7h" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Experience adjustments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">91.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(171.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(213.0)</span></td></tr> <tr id="xdx_405_eifrs-full--IncreaseDecreaseThroughOtherChangesNetDefinedBenefitLiabilityAsset_pn5n6_zBgm87x5eru" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Reclassifications</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4918">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4919">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.0)</span></td></tr> <tr id="xdx_40C_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_pn5n6_zbiPAr1bjdHf" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of exchange rate fluctuations</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">216.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">787.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(495.3)</span></td></tr> <tr id="xdx_409_eifrs-full--PaymentsFromPlanNetDefinedBenefitLiabilityAsset_pn5n6_zOYU7Lo2V9G8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Benefits paid</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">531.4 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">574.4 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">573.7 </span></td></tr> <tr id="xdx_405_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iE_pn5n6_zswK86G4Fwne" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Defined benefit obligation at December, 31</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,282.7)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,397.5)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(8,519.7)</b></span></td></tr> </table> <p id="xdx_8A6_z1KyUgOKq24k" style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0">The changes in the fair value of plan assets are as follow:</p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTheChangeInFairValueOfThePlanAssetsTextBlock_zuCp3rGIAgV7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_ztQdYcEBGiv1" style="display: none">Schedule of fair value of plan assets</span></td> <td id="xdx_494_20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PlanAssetsMember_zxqUO6T39XWb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PlanAssetsMember_z4cAYjx67IR2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_490_20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PlanAssetsMember_zV0dpHAThGK" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_400_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iS_pn5n6_zI6WbhZRc2k5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value of plan assets at January 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,543.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,638.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,533.3 </b></span></td></tr> <tr id="xdx_402_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zaeycMjfHOz7" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest income</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">318.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">262.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">223.9 </span></td></tr> <tr id="xdx_40A_ecustom--AdiministrativeCostsNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zbVyvAMoaJw1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.8)</span></td></tr> <tr id="xdx_401_eifrs-full--GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_pn5n6_zJxnX9tRVEs5" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Expected return, excluding interest income</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(614.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(148.3)</span></td></tr> <tr id="xdx_408_eifrs-full--ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_pn5n6_zDHmc97E5Ev3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions by employer</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">280.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">316.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">342.0 </span></td></tr> <tr id="xdx_408_eifrs-full--ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_pn5n6_ztIimaD50x41" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions by plan participants</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.1 </span></td></tr> <tr id="xdx_40E_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_pn5n6_znZnVbiVUNX7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Exchange differences</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(102.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(482.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">263.1 </span></td></tr> <tr id="xdx_402_eifrs-full--GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_pn5n6_z7CWcSKRIeB2" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Curtailments, settlements and other</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.6)</span></td></tr> <tr id="xdx_404_eifrs-full--PaymentsFromPlanNetDefinedBenefitLiabilityAsset_pn5n6_z202XON49Phk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Benefits paid, excluding administrative costs</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(531.6)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(574.4)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(573.7)</span></td></tr> <tr id="xdx_405_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iE_pn5n6_z6FaTrQcc5Lb" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value of plan assets at December, 31</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,604.6 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,543.3 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,638.0 </b></span></td></tr> </table> <p id="xdx_8AB_zmYLqlaUT18c" style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fundação Zerrenner is a legally distinct entity whose main goal is to provide the Company’s current and retired employees and managers with health care and dental assistance, technical and higher education courses, and to maintain facilities for assisting and helping elderly people, among other matters, either through direct initiatives or through financial assistance agreements with other entities.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The present value of funded obligations includes R$<span id="xdx_908_ecustom--DefinedBenefitObligationAtPresentValues_iI_pn5n6_c20231231__ifrs-full--DefinedBenefitPlansAxis__custom--TwoHealthCarePlansFromFundacaoZerrennerMember_zpUzoH5xSxsi" title="Defined benefit obligation, at present value">633.3</span> at December 31, 2023 (R$<span id="xdx_90D_ecustom--DefinedBenefitObligationAtPresentValues_iI_pn5n6_c20221231__ifrs-full--DefinedBenefitPlansAxis__custom--TwoHealthCarePlansFromFundacaoZerrennerMember_zIZbrraLaTRf" title="Defined benefit obligation, at present value">665.4</span> at December 31, 2022, and R$<span id="xdx_909_ecustom--DefinedBenefitObligationAtPresentValues_iI_pn5n6_c20211231__ifrs-full--DefinedBenefitPlansAxis__custom--TwoHealthCarePlansFromFundacaoZerrennerMember_zaVWsziVG501" title="Defined benefit obligation, at present value">603.9</span> at December 31, 2021) of two health care plans for which the benefits were provided directly by Fundação Zerrenner.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The real return on plan assets generated at December 31, 2023, was a gain of R$<span id="xdx_90B_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_pn5n6_c20230101__20231231_zbS3bdCtZAwd" title="Plan assets gain/(loss)">419.7</span> (a loss of R$<span id="xdx_90D_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_pn5n6_c20220101__20221231_zmTvr0Or6Pu3" title="Plan assets gain/(loss)">(352.5</span>) at December 31, 2022, and a gain of R$<span id="xdx_90B_eifrs-full--ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_pn5n6_c20210101__20211231_z3HGpE7ggkQk" title="Plan assets gain/(loss)">75.5</span> at December 31, 2021).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 11pt">At December 31, 2023, the Company recorded R$<span id="xdx_902_ecustom--AmountUpToTheAssetCeilingNotExceedingThePresentValueOfFutureBenefitsInADefinedBenefitPlan_iI_pn5n6_c20231231_zWXP3aKGxfp8" title="Amount up to the asset ceiling not exceeding the present value of future benefits in a defined benefit plan">57.3</span> (R$<span id="xdx_900_ecustom--AmountUpToTheAssetCeilingNotExceedingThePresentValueOfFutureBenefitsInADefinedBenefitPlan_iI_pn5n6_c20221231_zplKkjl6zhfe" title="Amount up to the asset ceiling not exceeding the present value of future benefits in a defined benefit plan">56.6 </span>at December 31, 2022, and </span><span style="font-size: 12pt">R$<span id="xdx_90C_ecustom--AmountUpToTheAssetCeilingNotExceedingThePresentValueOfFutureBenefitsInADefinedBenefitPlan_iI_pn5n6_c20211231_zOD6SLgmNJ6d" title="Amount up to the asset ceiling not exceeding the present value of future benefits in a defined benefit plan">27.9</span> at December 31, 2021</span><span style="font-size: 11pt">) up to the asset ceiling not exceeding the present value of future benefits.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The changes in the asset ceiling not exceeding the present value of future benefits are as follow:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfAssetCeilingTextBlock_zSZi1OW9K4y3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 3)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zdFo5HaKy1lj" style="display: none">Schedule of asset ceiling</span></td> <td id="xdx_491_20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--EffectOfAssetCeilingMember_zC9b5zBHbRb1" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49D_20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--EffectOfAssetCeilingMember_zsTGMADTj343" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--EffectOfAssetCeilingMember_zVORXyT9Tjcl" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 57%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_408_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iS_pn5n6_zMnd2hFyekw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Asset ceiling impact at January 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>56.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>27.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>33.6 </b></span></td></tr> <tr id="xdx_403_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zUvZzZHM8Wue" style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest income/(expenses)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5001">-</span>   </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.3 </span></td></tr> <tr id="xdx_406_eifrs-full--GainLossOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeiling_pn5n6_zTavv7HSah6b" style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Change in asset ceiling excluding amounts included in interest income/(expenses)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.1)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30.2 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9.0)</span></td></tr> <tr id="xdx_400_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_pn5n6_z91ZVQqKxk5" style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effects of exchange rate fluctuations  </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.1)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.5)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.0 </span></td></tr> <tr id="xdx_400_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iE_pn5n6_zSrlhC75t8A1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Asset ceiling impact at December 31 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>57.3 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>56.6 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>27.9 </b></span></td></tr> </table> <p id="xdx_8A4_zTLzi36WA4o5" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 11pt">The income/(expense) recognized in the income statement with regard to defined benefit plans is detailed as follows:</span><span style="font-size: 12pt"> </span></p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfDefinedBenefitPlansRecognizedInTheIncomeStatementTextBlock_pn5n6_zRSrP7oW5MC9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_z79Rl1tL8Ru5" style="display: none">Schedule of defined benefit plans recognized in income statement</span></td> <td id="xdx_49E_20230101__20231231_zi35ld20eV4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231_zJCS6y68iOnf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20210101__20211231_zokwE0NeUfmf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_405_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zJXYeSmfSheb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Current service costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(30.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(47.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(58.0)</span></td></tr> <tr id="xdx_401_ecustom--AdiministrativeCostsNetDefinedBenefitLiabilityAsset_pn5n6_zaCNO5JDNC44" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.8)</span></td></tr> <tr id="xdx_401_ecustom--GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAssets_pn5n6_zLxj32mM4cAi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Gains) losses on settlement and curtailment</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.7 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.2 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.2 </span></td></tr> <tr id="xdx_404_eifrs-full--IncreaseDecreaseInNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zO4Z2iYU6jsl" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Income from operations</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(31.3)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(50.0)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(62.6)</b></span></td></tr> <tr id="xdx_405_ecustom--DefinedBenefitPlansRecognizedFinancialCosts_iN_pn5n6_di_zFrcCRJ14X33" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial costs</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.3)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(107.8)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(115.6)</span></td></tr> <tr id="xdx_409_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_iN_pn5n6_di_z0NF6kNGLJuh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total employee benefit expenses</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(145.6)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(157.8)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(178.2)</b></span></td></tr> </table> <p id="xdx_8AC_zRy57yAr5EAj" style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The employee benefit revenue/(expenses) is included in the following line items in the income statement:</p> <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfEmployeeBenefitRevenueExpensesAllocationInIncomeStatementTextBlock_pn5n6_zER5IHFN3Kue" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 5)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_z0foazLBBky8" style="display: none">Schedule of employee benefit revenue/(expenses)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other operating income/(expenses)</span></td> <td id="xdx_98C_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember_zDr2WT5as9Z6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5044">-</span>   </span></td> <td id="xdx_98F_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember_zG6vbTTs2hV1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.1)</span></td> <td id="xdx_987_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember_zJLGQUieSeY9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cost of sales</span></td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember_z2e2Jifnzdql" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.1)</span></td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember_zi12BmPzZsIj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(26.4)</span></td> <td id="xdx_981_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember_z0Un4XWGH6M2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(33.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commercial expenses</span></td> <td id="xdx_985_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--CommercialExpensesMember_zzsBZZL6Zj5j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7.3)</span></td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--CommercialExpensesMember_zaU9pDZQc8G1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9.4)</span></td> <td id="xdx_986_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--CommercialExpensesMember_zwaImmxzp9y7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative income/(expenses)</span></td> <td id="xdx_98A_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember_zkrABooBsKZj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8.9)</span></td> <td id="xdx_986_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember_zu4VRmZJe4se" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14.1)</span></td> <td id="xdx_985_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember_zB3LQ2UyBYNd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial expense</span></td> <td id="xdx_98A_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember_zflUJFXXo143" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.3)</span></td> <td id="xdx_98F_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember_zXwjZzrch9z5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(107.8)</span></td> <td id="xdx_989_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember_zQmUOZBjvzBa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(115.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231_zwyUVnwb3Fw9" style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(145.6)</b></span></td> <td id="xdx_988_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231_zWO2jRUAmB8j" style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(157.8)</b></span></td> <td id="xdx_989_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231_zI8XLRGVXkwa" style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(178.2)</b></span></td></tr> </table> <p id="xdx_8A5_zgBwlbzfDAK6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The assumptions used in the calculation of the obligations are as follow:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfActuarialAssumptionsOfTheEntityTextBlock_zkkVlI7o2yyi" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 6)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_z6fhbiTeb5ua" style="display: none">Schedule of assumptions used</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>2023 </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>2022 </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>2021 </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z9yGJ3pTHVJa" title="Discount rate">4.6</span>% to <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zoqKVd3CLfQc" title="Discount rate">11.7</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0VCK5w35VV1" title="Discount rate">5.1</span>% to <span id="xdx_90A_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zsTQlQLe6FFe" title="Discount rate">11.0</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zItaVQARYrlc" title="Discount rate">2.4</span>% to <span id="xdx_907_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z5I9W2ZeT7oh" title="Discount rate">10.0</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inflation</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsjYXR99yi7" title="Inflation">2.0</span>% to <span id="xdx_90A_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ziCAtwDGLIoa" title="Inflation">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8msMPH5cYga" title="Inflation">2.0</span>% to <span id="xdx_906_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zSgrtlY3iXVk" title="Inflation">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8kcU21v0Pq3" title="Inflation">2.0</span>% to <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDUFkBxTSoFa" title="Inflation">3.5</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Future salary increases </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWOSgDL75YS" title="Future salary increases">1.0</span>% to <span id="xdx_90C_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0rEuMrt8Ecg" title="Future salary increases">7.1</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zyorSUFOlwSc" title="Future salary increases">1.0</span>% to <span id="xdx_905_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zNp844UhOooh" title="Future salary increases">7.1</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zNEYkaCc41D6" title="Future salary increases">1.0</span>% to <span id="xdx_901_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFKgrp85xbY3" title="Future salary increases">7.1</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Future pension increases</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zuwIicmZbHWc" title="Future pension increases">2.7</span>% to <span id="xdx_901_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdjXyCkpYz27" title="Future pension increases">3.8</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zi8rG8AsJ6Ba" title="Future pension increases">2.7</span>% to <span id="xdx_908_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBUB81s4FOPf" title="Future pension increases">3.8</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zm48VUek7hAl" title="Future pension increases">2.5</span>% to <span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFWE80QzU666" title="Future pension increases">3.8</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Medical cost trend rate </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zNAEtIVGXvBb" title="Medical cost trend rate">6.4</span>% to <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zybTPr4d7uHb" title="Medical cost trend rate">7.1</span>% p.a. reducing to 7,1%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOvkNW28mffe" title="Medical cost trend rate">6.4</span>% to <span id="xdx_904_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z35lEDM4K275" title="Medical cost trend rate">7.1</span>% p.a. reducing to 7,1%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zgnfAnpQSo2l" title="Medical cost trend rate">4.5</span>% to <span id="xdx_903_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDEU8oYkfFm1" title="Medical cost trend rate">6.9</span>% p.a. reducing to 6.9%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Dental claims trend rate </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--ActuarialAssumptionOfDentalClaimsCostTrendRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__srt--WeightedAverageMember_zUPx1MIivOG9" title="Dental claims trend rate">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_ecustom--ActuarialAssumptionOfDentalClaimsCostTrendRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__srt--WeightedAverageMember_zKEysXKFlEBb" title="Dental claims trend rate">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90F_ecustom--ActuarialAssumptionOfDentalClaimsCostTrendRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__srt--WeightedAverageMember_z6iyAnedioy1" title="Dental claims trend rate">3.3</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Life expectancy for an over 65 years old male </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zkhEtChuXsG1" title="Life expectancy for an over 65 years old male">84</span> to <span id="xdx_903_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDSH4XggO0t7" title="Life expectancy for an over 65 years old male">87</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zeZcQp234nD9" title="Life expectancy for an over 65 years old male">84</span> to <span id="xdx_905_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTmDmeEuOAsc" title="Life expectancy for an over 65 years old male">87</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zpSTAyR6NGOe" title="Life expectancy for an over 65 years old male">85</span> to <span id="xdx_908_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztYzmug6Jf9i" title="Life expectancy for an over 65 years old male">87</span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Life expectancy for an over 65 years old female</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGCf5QMXeJUb" title="Life expectancy for an over 65 years old female">86</span> to <span id="xdx_90D_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBjHLksmCmKb" title="Life expectancy for an over 65 years old female">89</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_907_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zaZRXD7GcAv5" title="Life expectancy for an over 65 years old female">86</span> to <span id="xdx_908_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvGtXWisTYjh" title="Life expectancy for an over 65 years old female">89</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90A_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z9VQDQyTCep9" title="Life expectancy for an over 65 years old female">87</span> to <span id="xdx_902_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zC1MlCyEKhJl" title="Life expectancy for an over 65 years old female">89</span></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Includes assumptions in Brazil, Central America and Caribbean, Latin America - South and Canada.</td> </tr></table> <p id="xdx_8A2_zSzPIF52JoCi" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>24.3 Risk</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Through its defined benefit pension plans and post-employment medical plans, the Company is exposed to a number of risks, the most significant of which are detailed below:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Asset volatility</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The plan liabilities are calculated using a discount rate pegged to high-quality private securities; If plan assets underperform this yield, the Company’s net defined benefit obligation may increase. Most of the Company’s funded plans hold a significant proportion of equities, which are expected to outperform corporate bonds in the long-term while providing volatility and risk in the short-term. As the plans mature, the Company usually reduces the level of investment risk by investing more in assets that better match the liabilities.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Changes in bond yields</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A decrease in corporate bond yields will increase plan liabilities, although this will be partially offset by an increase in the value of the plans’ bond holdings.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Inflation</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Some of the Company’s pension obligations are linked to inflation, and higher inflation will lead to higher liabilities. The majority of the plan’s assets are either unaffected by or only loosely correlated with inflation, meaning that an increase in inflation could potentially increase the Company’s net benefit obligation.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Life expectancy</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most of the plans’ obligations are to provide benefits for the life of the member, so increases in life expectancy will result in an increase in the plans’ liabilities.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Investment strategy</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the case of funded plans, the Company ensures that the investment positions are managed within an asset-liability matching (“ALM”) framework to ensure long-term investments that are in line with the Company’s obligations under the pension schemes. Within this framework, the Company’s ALM objective is to match the assets to the pension obligations by investing in long-term fixed interest securities with maturities that match the benefit payments as they fall due and in the appropriate currency.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>24.4 Sensitivity</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The sensitivity of the defined benefit obligation to changes in the weighted principal assumptions is as follows:</p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_eifrs-full--DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_pn5n6_zlPOUxd2c652" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 7)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B1_zfejBFRLcXT6" style="display: none">Schedule of sensitivity of defined benefit obligation</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>In millions of Brazilian Reais</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 25%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Change in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Increase in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Decrease in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Increase in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Decrease in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Increase in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Decrease in assumption</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Medical cost trend rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">100 bases points </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zaeAShoGXeai" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(95.2)</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_z8fT9CjzGaK1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">82.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zt2CgmDjmf2j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(94.3)</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zgKOM9ijG5fk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">81.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zI703J1ugSA4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.7)</span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zKYubOk1IXB4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">98.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50 bases points </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zcOPKA4jgc5d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">284.8 </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_z9Bjc3YJ7VBc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(302.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zh9PdeLk3aQi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">307.9 </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zHWQBhdbWZjk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(328.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zz9GGCBc5Wje" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">442.0 </span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_z5F7n109ZmWl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(470.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Future salary increases</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50 bases points </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zutGcDefiNBj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.3)</span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zZksRrL1h2p9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_z20qmlLK6Xq4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.6)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zLuMr8eaV9Ji" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zh8j4bB33FU5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.8)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zyf7iIhr5eu3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Longevity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">One year</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zsjYxdIOjqn" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(201.0)</span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_znEw23FfQTx7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">196.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zqigxuNlVDmf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(221.5)</span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zpyMaLSY3gJ3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">213.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zCIR3TbIGGd8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(287.6)</span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zMldAIwiM3Sl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">279.5 </span></td></tr> </table> <p id="xdx_8A4_zBItjOnOkC75" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The data presented in these tables are purely hypothetical and are based on changes in individual assumptions holding all other assumptions constant: economic conditions and changes therein always affect the other assumptions at the same time and their effects are not linear. Therefore, the above information is not necessarily a reasonable representation of future results.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>24.5 Plans assets</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">The plans assets at December 31, 2023, 2022 and 2021 consist of the following:</p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfPlanAssetsComponentsTextBlock_zRLI141Xn2t3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 8)"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zSNUshl2OcQ8" style="display: none">Schedule of plans assets</span> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Unrated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="white-space: nowrap; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Unrated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Unrated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Government bonds</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_908_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zr0V516qyuH1" title="Plan assets percentage, rated">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zF64FyqMVzti" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5227">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90D_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zvJWcH7NjuU4" title="Plan assets percentage">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zF5Vm4FD6gWc" title="Plan assets percentage, rated">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zpTrombwWwU2" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5233">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zWFf4qCcAkXd" title="Plan assets percentage">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zmYR9XVBnmSh" title="Plan assets percentage, rated">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zIv0p1wxOEnc" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5239">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zbUZzznU8PX7" title="Plan assets percentage">43</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Corporate bonds</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_z726eHEil4Jl" title="Plan assets percentage, rated">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zaeZ9F1AVi63" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5245">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zC2Dh86GTbhi" title="Plan assets percentage">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zhioz6194p39" title="Plan assets percentage, rated">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zPqUqgHLZ9N" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5251">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zjhHp9dJee6l" title="Plan assets percentage">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90F_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zovD5b1cgatf" title="Plan assets percentage, rated">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_z7eYp4ZnNfSb" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5257">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zdoQO22AAoE" title="Plan assets percentage">10</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Equity instruments</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zFhaBDWKate7" title="Plan assets percentage, rated">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_ziCPj2AsCuF1" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5263">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zmfUSRLtLVTb" title="Plan assets percentage">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90D_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_ze6kI1xeck83" title="Plan assets percentage, rated">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zoxw3VnErwce" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5269">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zQOiycM6NCR9" title="Plan assets percentage">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zrJBCCLKFOke" title="Plan assets percentage, rated">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zyvDEIw3Wqb" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5275">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_z7GUvpEqjMWb" title="Plan assets percentage">15</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zuk07ATHCXe" title="Plan assets percentage, rated">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_z2Eo0ts70Lu6" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5281">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zgohaqBMbsk4" title="Plan assets percentage">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_z9Rq9AGsa4vc" title="Plan assets percentage, rated">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zNCpXyRMgLj8" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5287">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zvDJJeo8Njda" title="Plan assets percentage">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zAzZT9aT0Gr5" title="Plan assets percentage, rated">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_907_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zoA40gmrM8J8" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5293">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zx75cOSTtyhj" title="Plan assets percentage">6</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Others</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_908_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zMORg4tfUzW4" title="Plan assets percentage, rated">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90F_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_z25gB2hDH70j" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5299">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zP7DdUcWkssj" title="Plan assets percentage">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zIYdVHSuN58l" title="Plan assets percentage, rated">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_907_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zX5mXT6qtIDj" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5305">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zApe7va1KjY8" title="Plan assets percentage">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_znmpJwcOzQH6" title="Plan assets percentage, rated">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_ziVgL6hk4C2c" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5311">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90D_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zzKDctWYWiMa" title="Plan assets percentage">26</span>%</span></td></tr> </table> <p id="xdx_8AD_zd1ZDNeokc13" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The overall expected rate of return is calculated by weighting the individual rates in accordance with Ambev’s expected share of the total investment portfolio.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Ambev expects to contribute approximately R$<span id="xdx_907_eifrs-full--EstimateOfContributionsExpectedToBePaidToPlan_pn5n6_c20230101__20231231_z1ET2Z7bTm8b" title="Estimate Of Contributions Expected To Be Paid To Plan">231.5</span> to its defined benefit plans in 2024.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span>Post-employment benefits</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Post-employment benefits include pensions managed in Brazil by Instituto Ambev de Previdência Privada (“IAPP”), post-employment dental benefits and post-employment medical benefits managed by Fundação Zerrenner. Usually, pension plans are funded by payments made by both the Company and its participants, considering the recommendations of independent actuaries. Post-employment dental benefits and post-employment medical benefit obligations are funded using the returns on the assets of the Fundação Zerrenner plan. If necessary, the Company may contribute some of its profits to Fundação Zerrenner. The Company maintains both funded and unfunded plans.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span>Defined contribution plans</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A defined contribution plan is a pension plan under which the Company pays fixed contributions into a fund. The Company has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees for the benefits relating to their service in the current and prior periods. The contributions to these plans are recognized as expenses in the period during which they are incurred.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span>Defined benefit plans</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Typically, defined benefit plans define an amount of pension benefit that an employee will receive upon retirement, usually dependent on one or more factors such as age, years of service and compensation level.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For defined benefit plans, expenses are assessed separately for each plan using the projected credit unit method. The projected credit unit method considers that each period of service gives rise to an additional unit of benefit and measures each such unit separately. Based on this method, the cost of providing pensions is charged to the income statement over the period of service of the employee and consist of current service costs, interest costs, past service costs and the effect of any agreements and settlements. The obligations of the plan recognized in the balance sheet are measured at the present value of the estimated future cash outflows using a discount rate equivalent to the government´s bond rates with maturity terms similar to those of the respective obligation and the fair values of the plan assets.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Past service costs arise from the introduction of a new plan or changes to an existing plan. They are recognized immediately in the income statement, at the earlier of: (i) when the settlement/curtailment occurs; or (ii) when the Company recognizes the related restructuring or termination costs, unless those changes are conditional upon the employee’s continued employment, for a specific period of time (the period in which the rights are acquired). In such cases, past services costs are amortized using the straight-line method over the period during which the rights were acquired.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Actuarial assumptions are established to anticipate future events and are used in the calculation of pensions and other long-term employee benefit expenses. These factors include assumptions regarding interest rates, health plan costs, discount rate, future salary increases and pensions, as well as life expectancy. Such estimates are reviewed annually by independent actuaries.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Actuarial gains and losses consist of the effects of differences between the previous actuarial assumptions and the actual results, and the effects of changes in actuarial assumptions. Actuarial gains and losses are fully recognized in Carrying value adjustments.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Remeasurements, representing actuarial gains and losses, the effect of the asset ceiling and the return on plan assets, both excluding net interest, are recognized in full in the period in which they occur in the statement of comprehensive income. Remeasurements are not reclassified to profit or loss in subsequent periods.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When the amount of the defined benefit obligation is negative (an asset), the Company recognizes those assets (prepaid expenses), to the extent of the value of the economic benefit available to the Company either from refunds or reductions in future contributions.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span>Other post-employment obligations</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and some of its subsidiaries provide post-employment medical benefits, the reimbursement of medication expenses and other benefits to certain retirees. These benefits are not granted to new retirees. The expected costs of these benefits are recognized over the period of employment, using an accounting methodology like that for defined benefit plans, including actuarial gains and losses.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span>Termination benefits</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Termination benefits are recognized as expenses at the earlier of: (i) when the Company is demonstrably committed, without a realistic possibility of withdrawal, to a formal detailed plan to terminate employment before the normal retirement date; and (ii) when the Company recognizes costs related to restructuring.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b><span>Bonuses</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify">Bonuses granted to employees and managers are based on pre-defined company and individual target achievement. The estimated amount of the bonus is recognized as an expense in the period during which the bonus is earned.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> 91300000 82000000.0 74100000 <table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfNetDefinedBenefitLiabilityAssetExplanatory_pn5n6_z7N3g8X5g0Kc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B8_zi9WwV1Mux2d" style="display: none">Schedule of defined benefit plans</span></td> <td id="xdx_491_20231231_zPgtBz66mxB7" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_496_20221231_zHazBIVjd4Sf" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_493_20211231_zhQueCdlaEx9" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_404_ecustom--DefinedBenefitObligationFundedPortionAtPresentValue_iNI_pn5n6_di_zWYuzucX8O0d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Present value of funded obligations</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,365.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,476.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7,354.3)</span></td></tr> <tr id="xdx_405_ecustom--FairValueOfPlanAssets_iI_pn5n6_zRhPJKNu6zda" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Fair value of plan assets</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,604.6 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4,543.3 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5,638.0 </span></td></tr> <tr id="xdx_403_eifrs-full--SurplusDeficitInPlan_iI_pn5n6_zWEsjnCvshBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Present value of net obligations</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(760.9)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(933.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,716.3)</b></span></td></tr> <tr id="xdx_403_ecustom--DefinedBenefitObligationUnfundedPortionAtPresentValue_iNI_pn5n6_di_zHQ3A9vY3GQc" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Present value of unfunded obligations</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(917.2)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(921.0)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,165.4)</span></td></tr> <tr id="xdx_401_ecustom--DefinedBenefitObligationAtPresentValues_iNI_pn5n6_di_zlbXMBY9rCc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Present value of net obligations </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,678.1)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,854.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,881.7)</b></span></td></tr> <tr id="xdx_400_ecustom--AssetCeiling_iNI_pn5n6_di_znUe0xjWL7g8" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Asset ceiling</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(182.6)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(163.3)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(180.1)</span></td></tr> <tr id="xdx_400_eifrs-full--RecognisedLiabilitiesDefinedBenefitPlan_iNI_pn5n6_di_zz0jVBnlNa07" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net liabilities</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,860.7)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,017.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,061.8)</b></span></td></tr> <tr id="xdx_401_ecustom--OtherLongTermEmployeeBenefitLiabilities_iNI_pn5n6_di_zosmOsoJsO6k" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other long term employee benefits</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(93.9)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(87.1)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(104.3)</span></td></tr> <tr id="xdx_404_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_zUtfaICoBOU8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total employee benefits</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,954.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,104.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,166.1)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Employee benefits amount in the balance sheet</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Liabilities </span></td> <td id="xdx_989_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--EmployeeBenefitLiabilitiesMember_zzv8ywjw2mHi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,011.9)</span></td> <td id="xdx_980_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--EmployeeBenefitLiabilitiesMember_zFdWl9ugltp4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2,161.2)</span></td> <td id="xdx_980_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20211231__ifrs-full--ClassesOfLiabilitiesAxis__custom--EmployeeBenefitLiabilitiesMember_z81EnpD84aq6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,194.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Assets </span></td> <td id="xdx_988_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20231231__ifrs-full--ClassesOfAssetsAxis__custom--EmployeeBenefitsAssetsMember_z9j8BNPROkCh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">57.3 </span></td> <td id="xdx_98E_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20221231__ifrs-full--ClassesOfAssetsAxis__custom--EmployeeBenefitsAssetsMember_z9XcKf75oxA8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">56.6 </span></td> <td id="xdx_988_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--EmployeeBenefitsAssetsMember_zDDbwnR9C8n1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Net liabilities</b></span></td> <td id="xdx_98D_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20231231_zaUOmpla4TO" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(1,954.6)</b></span></td> <td id="xdx_98D_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20221231_zYomfPjl8jv6" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(2,104.6)</b></span></td> <td id="xdx_98F_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iI_pn5n6_c20211231_zr5H0bR2Ybxe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total employee benefits"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(3,166.1)</b></span></td></tr> </table> 5365500000 5476500000 7354300000 4604600000 4543300000 5638000000.0 -760900000 -933200000 -1716300000 917200000 921000000.0 1165400000 1678100000 1854200000 2881700000 182600000 163300000 180100000 1860700000 2017500000 3061800000 93900000 87100000 104300000 -1954600000 -2104600000 -3166100000 -2011900000 -2161200000 -3194000000.0 57300000 56600000 27900000 -1954600000 -2104600000 -3166100000 <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfDefinedBenefitObligationTextBlock_zDq9lMDvI50c" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_z0i9xbxxmU71" style="display: none">Schedule of present value of defined benefit obligations</span></td> <td id="xdx_49B_20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PresentValueOfDefinedBenefitObligationMember_zTix4pSB2eLi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PresentValueOfDefinedBenefitObligationMember_zpzfVarw9br9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49A_20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PresentValueOfDefinedBenefitObligationMember_zrwswtPh8BM7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_40F_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iS_pn5n6_z9Sr8hkAHh3h" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Defined benefit obligation at January 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,397.5)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(8,519.7)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(8,777.6)</b></span></td></tr> <tr id="xdx_40C_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_pn5n6_zMrvPyMMEDv7" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Service costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(30.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(47.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(58.0)</span></td></tr> <tr id="xdx_40D_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_pn5n6_zIryLfDmP8Qd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(413.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(353.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(324.3)</span></td></tr> <tr id="xdx_40D_ecustom--GainsLossesOnSettlementAndCurtailment_pn5n6_zs6EVfJVihPh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Gains and (losses) on settlements or reductions in benefits</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.6 </span></td></tr> <tr id="xdx_405_eifrs-full--ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_pn5n6_zFMQGRmgpRHl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions by plan participants</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.9)</span></td></tr> <tr id="xdx_406_eifrs-full--ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset_pn5n6_zzyMHZK9TS8l" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Actuarial gains and (losses) - geographical assumptions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4907">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">52.3 </span></td></tr> <tr id="xdx_401_eifrs-full--ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_pn5n6_zEJEg1RQ3gjb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Actuarial gains and (losses) - financial assumptions</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(297.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,333.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">726.8 </span></td></tr> <tr id="xdx_40D_eifrs-full--ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset_pn5n6_zr0xSh0IgB7h" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Experience adjustments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">91.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(171.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(213.0)</span></td></tr> <tr id="xdx_405_eifrs-full--IncreaseDecreaseThroughOtherChangesNetDefinedBenefitLiabilityAsset_pn5n6_zBgm87x5eru" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Reclassifications</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4918">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4919">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.0)</span></td></tr> <tr id="xdx_40C_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_pn5n6_zbiPAr1bjdHf" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of exchange rate fluctuations</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">216.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">787.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(495.3)</span></td></tr> <tr id="xdx_409_eifrs-full--PaymentsFromPlanNetDefinedBenefitLiabilityAsset_pn5n6_zOYU7Lo2V9G8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Benefits paid</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">531.4 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">574.4 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">573.7 </span></td></tr> <tr id="xdx_405_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iE_pn5n6_zswK86G4Fwne" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Defined benefit obligation at December, 31</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,282.7)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(6,397.5)</b></span></td> <td style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(8,519.7)</b></span></td></tr> </table> -6397500000 -8519700000 -8777600000 -30800000 -47000000.0 -58000000.0 -413200000 -353200000 -324300000 9200000 3800000 3600000 -4200000 -5600000 -6900000 11500000 52300000 -297000000.0 1333600000 726800000 91200000 -171500000 -213000000.0 -1000000.0 216700000 787700000 -495300000 531400000 574400000 573700000 -6282700000 -6397500000 -8519700000 <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfTheChangeInFairValueOfThePlanAssetsTextBlock_zuCp3rGIAgV7" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_ztQdYcEBGiv1" style="display: none">Schedule of fair value of plan assets</span></td> <td id="xdx_494_20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PlanAssetsMember_zxqUO6T39XWb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_497_20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PlanAssetsMember_z4cAYjx67IR2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_490_20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--PlanAssetsMember_zV0dpHAThGK" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_400_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iS_pn5n6_zI6WbhZRc2k5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value of plan assets at January 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,543.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,638.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,533.3 </b></span></td></tr> <tr id="xdx_402_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zaeycMjfHOz7" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest income</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">318.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">262.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">223.9 </span></td></tr> <tr id="xdx_40A_ecustom--AdiministrativeCostsNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zbVyvAMoaJw1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.8)</span></td></tr> <tr id="xdx_401_eifrs-full--GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_pn5n6_zJxnX9tRVEs5" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Expected return, excluding interest income</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">101.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(614.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(148.3)</span></td></tr> <tr id="xdx_408_eifrs-full--ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset_pn5n6_zDHmc97E5Ev3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions by employer</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">280.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">316.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">342.0 </span></td></tr> <tr id="xdx_408_eifrs-full--ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset_pn5n6_ztIimaD50x41" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Contributions by plan participants</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">5.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.1 </span></td></tr> <tr id="xdx_40E_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_pn5n6_znZnVbiVUNX7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Exchange differences</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(102.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(482.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">263.1 </span></td></tr> <tr id="xdx_402_eifrs-full--GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset_pn5n6_z7CWcSKRIeB2" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Curtailments, settlements and other</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.6)</span></td></tr> <tr id="xdx_404_eifrs-full--PaymentsFromPlanNetDefinedBenefitLiabilityAsset_pn5n6_z202XON49Phk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Benefits paid, excluding administrative costs</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(531.6)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(574.4)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(573.7)</span></td></tr> <tr id="xdx_405_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iE_pn5n6_z6FaTrQcc5Lb" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value of plan assets at December, 31</b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,604.6 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,543.3 </b></span></td> <td style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>5,638.0 </b></span></td></tr> </table> 4543300000 5638000000.0 5533300000 -318100000 -262100000 -223900000 5200000 5200000 5800000 101700000 -614600000 -148300000 280500000 316000000.0 342000000.0 4600000 5800000 7100000 -102000000.0 -482600000 263100000 -4800000 -1800000 -3600000 -531600000 -574400000 -573700000 4604600000 4543300000 5638000000.0 633300000 665400000 603900000 419700000 -352500000 75500000 57300000 56600000 27900000 <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DisclosureOfAssetCeilingTextBlock_zSZi1OW9K4y3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 3)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zdFo5HaKy1lj" style="display: none">Schedule of asset ceiling</span></td> <td id="xdx_491_20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--EffectOfAssetCeilingMember_zC9b5zBHbRb1" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49D_20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--EffectOfAssetCeilingMember_zsTGMADTj343" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__ifrs-full--EffectOfAssetCeilingMember_zVORXyT9Tjcl" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 57%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr id="xdx_408_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iS_pn5n6_zMnd2hFyekw2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Asset ceiling impact at January 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>56.6 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>27.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>33.6 </b></span></td></tr> <tr id="xdx_403_eifrs-full--InterestExpenseIncomeNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zUvZzZHM8Wue" style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest income/(expenses)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.9 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5001">-</span>   </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.3 </span></td></tr> <tr id="xdx_406_eifrs-full--GainLossOnChangesInEffectOfLimitingNetDefinedBenefitAssetToAssetCeiling_pn5n6_zTavv7HSah6b" style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Change in asset ceiling excluding amounts included in interest income/(expenses)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.1)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">30.2 </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9.0)</span></td></tr> <tr id="xdx_400_eifrs-full--IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset_pn5n6_z91ZVQqKxk5" style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effects of exchange rate fluctuations  </span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.1)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1.5)</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.0 </span></td></tr> <tr id="xdx_400_eifrs-full--LiabilityAssetOfDefinedBenefitPlans_iE_pn5n6_zSrlhC75t8A1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Asset ceiling impact at December 31 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>57.3 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>56.6 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>27.9 </b></span></td></tr> </table> 56600000 27900000 33600000 -4900000 -1300000 -100000 30200000 -9000000.0 -4100000 -1500000 2000000.0 57300000 56600000 27900000 <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfDefinedBenefitPlansRecognizedInTheIncomeStatementTextBlock_pn5n6_zRSrP7oW5MC9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 4)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BC_z79Rl1tL8Ru5" style="display: none">Schedule of defined benefit plans recognized in income statement</span></td> <td id="xdx_49E_20230101__20231231_zi35ld20eV4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49C_20220101__20221231_zJCS6y68iOnf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20210101__20211231_zokwE0NeUfmf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr id="xdx_405_eifrs-full--CurrentServiceCostNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zJXYeSmfSheb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Current service costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(30.8)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(47.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(58.0)</span></td></tr> <tr id="xdx_401_ecustom--AdiministrativeCostsNetDefinedBenefitLiabilityAsset_pn5n6_zaCNO5JDNC44" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative costs</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5.8)</span></td></tr> <tr id="xdx_401_ecustom--GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAssets_pn5n6_zLxj32mM4cAi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(Gains) losses on settlement and curtailment</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.7 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2.2 </span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1.2 </span></td></tr> <tr id="xdx_404_eifrs-full--IncreaseDecreaseInNetDefinedBenefitLiabilityAsset_iN_pn5n6_di_zO4Z2iYU6jsl" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Income from operations</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(31.3)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(50.0)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(62.6)</b></span></td></tr> <tr id="xdx_405_ecustom--DefinedBenefitPlansRecognizedFinancialCosts_iN_pn5n6_di_zFrcCRJ14X33" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial costs</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.3)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(107.8)</span></td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(115.6)</span></td></tr> <tr id="xdx_409_eifrs-full--PostemploymentBenefitExpenseDefinedBenefitPlans_iN_pn5n6_di_z0NF6kNGLJuh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total employee benefit expenses</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(145.6)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(157.8)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(178.2)</b></span></td></tr> </table> 30800000 47000000.0 58000000.0 -5200000 -5200000 -5800000 4700000 2200000 1200000 31300000 50000000.0 62600000 114300000 107800000 115600000 145600000 157800000 178200000 <table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfEmployeeBenefitRevenueExpensesAllocationInIncomeStatementTextBlock_pn5n6_zER5IHFN3Kue" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 5)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_z0foazLBBky8" style="display: none">Schedule of employee benefit revenue/(expenses)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other operating income/(expenses)</span></td> <td id="xdx_98C_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember_zDr2WT5as9Z6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5044">-</span>   </span></td> <td id="xdx_98F_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember_zG6vbTTs2hV1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.1)</span></td> <td id="xdx_987_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToOtherOperatingIncomeexpensesNetMember_zJLGQUieSeY9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cost of sales</span></td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember_z2e2Jifnzdql" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.1)</span></td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember_zi12BmPzZsIj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(26.4)</span></td> <td id="xdx_981_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueexpensesAllocatedToCostOfSalesMember_z0Un4XWGH6M2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(33.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commercial expenses</span></td> <td id="xdx_985_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--CommercialExpensesMember_zzsBZZL6Zj5j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7.3)</span></td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--CommercialExpensesMember_zaU9pDZQc8G1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(9.4)</span></td> <td id="xdx_986_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--CommercialExpensesMember_zwaImmxzp9y7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Administrative income/(expenses)</span></td> <td id="xdx_98A_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember_zkrABooBsKZj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8.9)</span></td> <td id="xdx_986_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember_zu4VRmZJe4se" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14.1)</span></td> <td id="xdx_985_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToAdministrativeExpensesMember_zB3LQ2UyBYNd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Financial expense</span></td> <td id="xdx_98A_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember_zflUJFXXo143" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.3)</span></td> <td id="xdx_98F_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember_zXwjZzrch9z5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(107.8)</span></td> <td id="xdx_989_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--EmployeeBenefitRevenueExpensesAllocatedToFinancialExpensesMember_zQmUOZBjvzBa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(115.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20230101__20231231_zwyUVnwb3Fw9" style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(145.6)</b></span></td> <td id="xdx_988_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20220101__20221231_zWO2jRUAmB8j" style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(157.8)</b></span></td> <td id="xdx_989_ecustom--PostemploymentBenefitIncomeExpenseDefinedBenefitPlans_pn5n6_c20210101__20211231_zI8XLRGVXkwa" style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="employee benefit revenue/(expenses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(178.2)</b></span></td></tr> </table> -100000 -200000 -15100000 -26400000 -33000000.0 -7300000 -9400000 -11700000 -8900000 -14100000 -17700000 -114300000 -107800000 -115600000 -145600000 -157800000 -178200000 <table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfActuarialAssumptionsOfTheEntityTextBlock_zkkVlI7o2yyi" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 6)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_z6fhbiTeb5ua" style="display: none">Schedule of assumptions used</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 37%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>2023 </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>2022 </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>2021 </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z9yGJ3pTHVJa" title="Discount rate">4.6</span>% to <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zoqKVd3CLfQc" title="Discount rate">11.7</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0VCK5w35VV1" title="Discount rate">5.1</span>% to <span id="xdx_90A_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zsTQlQLe6FFe" title="Discount rate">11.0</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zItaVQARYrlc" title="Discount rate">2.4</span>% to <span id="xdx_907_eifrs-full--ActuarialAssumptionOfDiscountRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z5I9W2ZeT7oh" title="Discount rate">10.0</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Inflation</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfsjYXR99yi7" title="Inflation">2.0</span>% to <span id="xdx_90A_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ziCAtwDGLIoa" title="Inflation">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8msMPH5cYga" title="Inflation">2.0</span>% to <span id="xdx_906_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zSgrtlY3iXVk" title="Inflation">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8kcU21v0Pq3" title="Inflation">2.0</span>% to <span id="xdx_90E_eifrs-full--ActuarialAssumptionOfExpectedRatesOfInflation_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDUFkBxTSoFa" title="Inflation">3.5</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Future salary increases </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zWOSgDL75YS" title="Future salary increases">1.0</span>% to <span id="xdx_90C_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z0rEuMrt8Ecg" title="Future salary increases">7.1</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zyorSUFOlwSc" title="Future salary increases">1.0</span>% to <span id="xdx_905_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zNp844UhOooh" title="Future salary increases">7.1</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zNEYkaCc41D6" title="Future salary increases">1.0</span>% to <span id="xdx_901_eifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFKgrp85xbY3" title="Future salary increases">7.1</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Future pension increases</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zuwIicmZbHWc" title="Future pension increases">2.7</span>% to <span id="xdx_901_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdjXyCkpYz27" title="Future pension increases">3.8</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zi8rG8AsJ6Ba" title="Future pension increases">2.7</span>% to <span id="xdx_908_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBUB81s4FOPf" title="Future pension increases">3.8</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zm48VUek7hAl" title="Future pension increases">2.5</span>% to <span id="xdx_902_eifrs-full--ActuarialAssumptionOfExpectedRatesOfPensionIncreases_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zFWE80QzU666" title="Future pension increases">3.8</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Medical cost trend rate </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zNAEtIVGXvBb" title="Medical cost trend rate">6.4</span>% to <span id="xdx_90F_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zybTPr4d7uHb" title="Medical cost trend rate">7.1</span>% p.a. reducing to 7,1%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zOvkNW28mffe" title="Medical cost trend rate">6.4</span>% to <span id="xdx_904_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z35lEDM4K275" title="Medical cost trend rate">7.1</span>% p.a. reducing to 7,1%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zgnfAnpQSo2l" title="Medical cost trend rate">4.5</span>% to <span id="xdx_903_eifrs-full--ActuarialAssumptionOfMedicalCostTrendRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDEU8oYkfFm1" title="Medical cost trend rate">6.9</span>% p.a. reducing to 6.9%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Dental claims trend rate </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--ActuarialAssumptionOfDentalClaimsCostTrendRates_iI_pip0_dp_c20231231__ifrs-full--RangeAxis__srt--WeightedAverageMember_zUPx1MIivOG9" title="Dental claims trend rate">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_ecustom--ActuarialAssumptionOfDentalClaimsCostTrendRates_iI_pip0_dp_c20221231__ifrs-full--RangeAxis__srt--WeightedAverageMember_zKEysXKFlEBb" title="Dental claims trend rate">3.5</span>%</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90F_ecustom--ActuarialAssumptionOfDentalClaimsCostTrendRates_iI_pip0_dp_c20211231__ifrs-full--RangeAxis__srt--WeightedAverageMember_z6iyAnedioy1" title="Dental claims trend rate">3.3</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Life expectancy for an over 65 years old male </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zkhEtChuXsG1" title="Life expectancy for an over 65 years old male">84</span> to <span id="xdx_903_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zDSH4XggO0t7" title="Life expectancy for an over 65 years old male">87</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zeZcQp234nD9" title="Life expectancy for an over 65 years old male">84</span> to <span id="xdx_905_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTmDmeEuOAsc" title="Life expectancy for an over 65 years old male">87</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zpSTAyR6NGOe" title="Life expectancy for an over 65 years old male">85</span> to <span id="xdx_908_ecustom--ActuarialAssumptionOfLifeExpectancyOfAMaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ztYzmug6Jf9i" title="Life expectancy for an over 65 years old male">87</span></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Life expectancy for an over 65 years old female</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zGCf5QMXeJUb" title="Life expectancy for an over 65 years old female">86</span> to <span id="xdx_90D_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBjHLksmCmKb" title="Life expectancy for an over 65 years old female">89</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_907_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zaZRXD7GcAv5" title="Life expectancy for an over 65 years old female">86</span> to <span id="xdx_908_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20220101__20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvGtXWisTYjh" title="Life expectancy for an over 65 years old female">89</span></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90A_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z9VQDQyTCep9" title="Life expectancy for an over 65 years old female">87</span> to <span id="xdx_902_ecustom--ActuarialAssumptionOfLifeExpectancyOfAFemaleAfter65YearsOfAge_dtY_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zC1MlCyEKhJl" title="Life expectancy for an over 65 years old female">89</span></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Includes assumptions in Brazil, Central America and Caribbean, Latin America - South and Canada.</td> </tr></table> 0.046 0.117 0.051 0.110 0.024 0.100 0.020 0.035 0.020 0.035 0.020 0.035 0.010 0.071 0.010 0.071 0.010 0.071 0.027 0.038 0.027 0.038 0.025 0.038 0.064 0.071 0.064 0.071 0.045 0.069 0.035 0.035 0.033 P84Y P87Y P84Y P87Y P85Y P87Y P86Y P89Y P86Y P89Y P87Y P89Y <table cellpadding="0" cellspacing="0" id="xdx_890_eifrs-full--DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory_pn5n6_zlPOUxd2c652" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 7)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B1_zfejBFRLcXT6" style="display: none">Schedule of sensitivity of defined benefit obligation</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>In millions of Brazilian Reais</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 25%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Change in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Increase in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Decrease in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Increase in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Decrease in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Increase in assumption</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Decrease in assumption</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Medical cost trend rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">100 bases points </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zaeAShoGXeai" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(95.2)</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_z8fT9CjzGaK1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">82.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zt2CgmDjmf2j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(94.3)</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zgKOM9ijG5fk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">81.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zI703J1ugSA4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(114.7)</span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfMedicalCostTrendRatesMember_zKYubOk1IXB4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">98.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Discount rate</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50 bases points </span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zcOPKA4jgc5d" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">284.8 </span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_z9Bjc3YJ7VBc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(302.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zh9PdeLk3aQi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">307.9 </span></td> <td id="xdx_988_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zHWQBhdbWZjk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(328.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_zz9GGCBc5Wje" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">442.0 </span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfDiscountRatesMember_z5F7n109ZmWl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(470.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Future salary increases</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50 bases points </span></td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zutGcDefiNBj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.3)</span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zZksRrL1h2p9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_z20qmlLK6Xq4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.6)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zLuMr8eaV9Ji" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zh8j4bB33FU5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.8)</span></td> <td id="xdx_98E_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfExpectedRatesOfSalaryIncreasesMember_zyf7iIhr5eu3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Longevity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">One year</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zsjYxdIOjqn" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(201.0)</span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20231231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_znEw23FfQTx7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">196.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zqigxuNlVDmf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(221.5)</span></td> <td id="xdx_982_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20221231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zpyMaLSY3gJ3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">213.5 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zCIR3TbIGGd8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Increase in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(287.6)</span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleDecreaseInActuarialAssumption_iI_pn5n6_c20211231__ifrs-full--ActuarialAssumptionsAxis__ifrs-full--ActuarialAssumptionOfLifeExpectancyAfterRetirementMember_zMldAIwiM3Sl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Decrease in assumption"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">279.5 </span></td></tr> </table> -95200000 82200000 -94300000 81800000 -114700000 98600000 284800000 -302400000 307900000 -328000000.0 442000000.0 -470300000 -17300000 14700000 -17600000 16500000 -19800000 18600000 -201000000.0 196100000 -221500000 213500000 -287600000 279500000 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfPlanAssetsComponentsTextBlock_zRLI141Xn2t3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - EMPLOYEE BENEFITS (Details 8)"> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BB_zSNUshl2OcQ8" style="display: none">Schedule of plans assets</span> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 15%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Unrated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="white-space: nowrap; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Unrated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Rated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Unrated</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Government bonds</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_908_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zr0V516qyuH1" title="Plan assets percentage, rated">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zF64FyqMVzti" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5227">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90D_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zvJWcH7NjuU4" title="Plan assets percentage">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zF5Vm4FD6gWc" title="Plan assets percentage, rated">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zpTrombwWwU2" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5233">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zWFf4qCcAkXd" title="Plan assets percentage">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zmYR9XVBnmSh" title="Plan assets percentage, rated">43</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zIv0p1wxOEnc" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5239">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsGovernmentBondsMember_zbUZzznU8PX7" title="Plan assets percentage">43</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Corporate bonds</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_z726eHEil4Jl" title="Plan assets percentage, rated">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zaeZ9F1AVi63" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5245">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zC2Dh86GTbhi" title="Plan assets percentage">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_902_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zhioz6194p39" title="Plan assets percentage, rated">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zPqUqgHLZ9N" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5251">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zjhHp9dJee6l" title="Plan assets percentage">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90F_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zovD5b1cgatf" title="Plan assets percentage, rated">10</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_z7eYp4ZnNfSb" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5257">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCorporateBondsMember_zdoQO22AAoE" title="Plan assets percentage">10</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Equity instruments</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zFhaBDWKate7" title="Plan assets percentage, rated">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_ziCPj2AsCuF1" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5263">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zmfUSRLtLVTb" title="Plan assets percentage">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90D_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_ze6kI1xeck83" title="Plan assets percentage, rated">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zoxw3VnErwce" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5269">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90B_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zQOiycM6NCR9" title="Plan assets percentage">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zrJBCCLKFOke" title="Plan assets percentage, rated">15</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_zyvDEIw3Wqb" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5275">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsEquityInstrumentsMember_z7GUvpEqjMWb" title="Plan assets percentage">15</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zuk07ATHCXe" title="Plan assets percentage, rated">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_z2Eo0ts70Lu6" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5281">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zgohaqBMbsk4" title="Plan assets percentage">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_z9Rq9AGsa4vc" title="Plan assets percentage, rated">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_903_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zNCpXyRMgLj8" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5287">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_909_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zvDJJeo8Njda" title="Plan assets percentage">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_900_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zAzZT9aT0Gr5" title="Plan assets percentage, rated">6</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_907_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zoA40gmrM8J8" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5293">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_904_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsCashMember_zx75cOSTtyhj" title="Plan assets percentage">6</span>%</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Others</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_908_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zMORg4tfUzW4" title="Plan assets percentage, rated">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90F_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_z25gB2hDH70j" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5299">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20231231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zP7DdUcWkssj" title="Plan assets percentage">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_905_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zIYdVHSuN58l" title="Plan assets percentage, rated">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_907_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zX5mXT6qtIDj" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5305">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90E_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20221231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zApe7va1KjY8" title="Plan assets percentage">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_901_ecustom--RatedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_znmpJwcOzQH6" title="Plan assets percentage, rated">26</span>%</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_906_ecustom--UnratedPlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_ziVgL6hk4C2c" title="Plan assets percentage, unrated"><span style="-sec-ix-hidden: xdx2ixbrl5311">-</span></span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span id="xdx_90D_ecustom--PlanAssetsOfDefinedBenefitPlanComponentPercentage_iI_pip0_dp_c20211231__ifrs-full--NetDefinedBenefitLiabilityAssetAxis__custom--PlanAssetsOthersMember_zzKDctWYWiMa" title="Plan assets percentage">26</span>%</span></td></tr> </table> 0.43 0.43 0.43 0.43 0.43 0.43 0.10 0.10 0.10 0.10 0.10 0.10 0.15 0.15 0.15 0.15 0.15 0.15 0.06 0.06 0.06 0.06 0.06 0.06 0.26 0.26 0.26 0.26 0.26 0.26 231500000 <p id="xdx_804_eifrs-full--DisclosureOfSharebasedPaymentArrangementsExplanatory_zMKkJRtMzOEd" style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_031"></span>25.</b></td><td style="text-align: justify"><b><span id="xdx_82C_z3216J74fhnb">SHARE-BASED PAYMENTS</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="color: black">Currently the Company has two plans of share-based payment programs: (i) the Stock Option Plan, approved in Extraordinary General Meeting of July 30, 2013 (“Stock Option Plan”) and (ii) Share-based Plan, approved in Extraordinary General Meeting of April 29, 2016, as amended in Extraordinary General Meeting of April 24, 2020 (“Share-Based Plan”). Under </span>each of these plans, <span style="color: black">the Company can periodically issue different stock option and restricted share units programs. These programs allow certain Group employees and members of the Management, indicated by the Board of Directors and People Committee, to either buy shares of the Company by exercising stock options or receive shares directly. </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>25.1 Share-Based Plan</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In this plan, certain employees and members of the Management are eligible to receive Company shares, including in the form of ADRs. The shares subject to the Share-Based Plan are designated as "restricted shares" (RSUs) or “performance shares” (PSUs).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The delivery of restricted shares and performance shares are made without charge, and the vesting period may vary between three and five years from the corresponding grant date, depending on the share-based compensation program. Restricted shares and performance shares may entitle participates the right to receive additional shares with the same conditions, such as compensation dividends and interest on shareholder´s equity declared and paid by the Company during the vesting period. The right to receive restricted, performance and additional shares, can be partially or completely lost under certain circumstances, including in case of resignation or termination during the vesting period.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>25.1.1 Other disclosures of the Share-Based plan</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">During the period, the Company granted <span id="xdx_90E_ecustom--NumberOfInstrumentsOtherEquityInstrumentGranted_pn3n3_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zcD6ru19D6v8" title="Restricted shares granted">33,686</span> thousand restricted shares under the Share-Based Plan (<span id="xdx_90B_ecustom--NumberOfInstrumentsOtherEquityInstrumentGranted_pn3n3_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zjttdVysmxG8" title="Restricted shares granted">49,328</span> thousand in 2022 and <span id="xdx_901_ecustom--NumberOfInstrumentsOtherEquityInstrumentGranted_pn3n3_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zArfHN5Ym4ad" title="Restricted shares granted">20,629</span> thousand in 2021), representing a fair value of approximately R$<span id="xdx_906_ecustom--FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement_pn5n6_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zJEgopd00wYk" title="Fair value of other equity instruments granted in share-based payment arrangement">463.5</span> in 2023 (R$<span id="xdx_900_ecustom--FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement_pn5n6_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zrmlApTYn6O8" title="Fair value of other equity instruments granted in share-based payment arrangement">766.6</span> in 2022 and R$<span id="xdx_90E_ecustom--FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement_pn5n6_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zTYgbwAgBbr8" title="Fair value of other equity instruments granted in share-based payment arrangement">325.7</span> in 2021).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total number of shares granted to the Company’s executives under the Share-Based Plan, which will be delivered in the future under certain conditions, is shown below:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Restricted and performance shares</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zY0jekk2SQGf" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zgIr3Uxm0V2i" style="display: none">Schedule of restricted and performance shares</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>Thousand restricted shares</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Restricted and performance shares outstanding at January</b></span></td> <td id="xdx_981_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zszBfJJOwW63" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>108,854 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zKjpepmg4rHa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>62,545 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zcgAU2ahbiOk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>43,458 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">New restricted and performance shares during the period</span></td> <td id="xdx_987_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_z7v8Ky85F6O" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New restricted and performance shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">33,686 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zlIwcrtB8s19" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New restricted and performance shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49,328 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zsVgnQOGhEW6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New restricted and performance shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20,629 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Restricted and performance shares granted during the period</span></td> <td id="xdx_98E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zRFRBPcVmoL6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(18,309)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_ztiq0SsiFHJg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(12)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zGXEVkpZI5k8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(22)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Restricted and performance shares forfeited during the period</span></td> <td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zgVT7IUuNxfi" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,235)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zXFzczUAgi1i" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,007)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zPxMpC80Qny6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,520)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Restricted shares outstanding at the end of the year</b></span></td> <td id="xdx_986_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zsG7EZR59Cwa" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at rhe end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>118,996 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zmYvRG0Q9CS4" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at rhe end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>108,854 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zMyynkd4vWz8" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at rhe end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>62,545 </b></span></td></tr> </table> <p id="xdx_8AA_z4MSSr6w3sj4" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>25.2 Option Plan</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since 2020, the Company no longer grants to your employees and executives stock options recognized in accordance with IFRS 2 - <i>Share-Based Payment</i>. However, there are stock options granted in previous periods that are not vested yet, as well as stock options that are already vested but not yet expired, which remain valid within the scope of the programs issued under the Option Plan and subject to the accounting treatment mentioned.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, some employees of the Company and its subsidiaries, who receive their bonus in cash, have the option, according to their position, to choose to allocate part or all the amounts received as such to the acquisition of shares issued by Ambev, these shares are called "voluntary shares" and are granted under the Stock Option Plan. In general, voluntary shares are entitled to dividends from the date of grant and are subject to a vest period of three to five years (look-up). These shares are granted at market price with a discount applied up to 20%, the discount is delivered in the form of restricted shares. Executives who invest in voluntary shares also receive one and a half times the number of corresponding shares for each voluntary share acquired, up to a limited total percentage of each executive's variable remuneration. These matching shares are also delivered in the form of restricted shares.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">As the voluntary shares, granted under the Stock Option Plan, are part of the profit share earned by eligible executives, they are recognized as an expense in the income statement against liabilities. Meanwhile, the mentioned restricted shares (discounted shares and matching shares) are granted under the Share-Based Plan, as per conditions outlined in item 25.1 above, and are recognized in accordance with the accounting treatment set out in this note, according to IFRS 2 - <i>Share-based Payment</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>25.2.1 Other disclosures of the Stock Options Plan</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company have not granted <i>stock options</i>, neither there were options exercised during the year ended December 31, 2023, and 2022 (for options exercised in the year ended December 31, 2021, the weighted average share price on the exercise date was R$17.87). The total number of outstanding options developed was as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfOutstandingOptionsTableTextBlock_pn3n3_z6d0mBCUCOSa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zvCPdBZ2SRf8" style="display: none">Schedule of outstanding options developed</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>Thousand options</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Options outstanding at January</b></span></td> <td id="xdx_98F_ecustom--NumberOfOutstandingShareOptions1_iS_pn3n3_uShares_c20230101__20231231_zQcAfLbRm3Fa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>99,717 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NumberOfOutstandingShareOptions1_iS_pn3n3_uShares_c20220101__20221231_zjkR6ifBAwjc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>113,760 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NumberOfOutstandingShareOptions1_iS_pn3n3_uShares_c20210101__20211231_zcbEokysHRB3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>127,265 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options exercised during the period</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement1_pn3n3_uShares_c20210101__20211231_zXEqOZ8AsAO2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercised during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,247)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options forfeited during the period</span></td> <td id="xdx_985_ecustom--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1_pn3n3_c20230101__20231231_zLfebwEvACMg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11,756)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1_pn3n3_uShares_c20220101__20221231_zHMJqJQ0xkDe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14,043)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1_pn3n3_c20210101__20211231_zW43R2MRKj7b" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8,258)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Options outstanding at the end of the year</b></span></td> <td id="xdx_98E_ecustom--NumberOfOutstandingShareOptions1_iE_pn3n3_uShares_c20230101__20231231_zr6ncIc4kpX7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>87,961 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--NumberOfOutstandingShareOptions1_iE_pn3n3_uShares_c20220101__20221231_zz8i6Ks40TO2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>99,717 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--NumberOfOutstandingShareOptions1_iE_pn3n3_uShares_c20210101__20211231_zDEdXozVzSw8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>113,760 </b></span></td></tr> </table> <p id="xdx_8A8_zdu0y5Rwvkek" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The range of exercise prices of the outstanding options is from R$<span id="xdx_900_ecustom--ExercisePricesOfTheOutstandingOptions_iI_pip0_uBRLPerShare_c20231231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zHFpXh8CIYN3" title="Exercise prices of the outstanding options">15.95</span> (R$<span id="xdx_904_ecustom--ExercisePricesOfTheOutstandingOptions_iI_pip0_uBRLPerShare_c20221231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_ztdJFjhLkS3i" title="Exercise prices of the outstanding options">15.95</span> in 2022 and R$<span id="xdx_901_ecustom--ExercisePricesOfTheOutstandingOptions_iI_pip0_uBRLPerShare_c20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBpixqwOONv6" title="Exercise prices of the outstanding options">15.95</span> in 2021) to R$<span id="xdx_907_ecustom--ExercisePricesOfTheOutstandingOptions_iI_pip0_uBRLPerShare_c20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z2YaziM2CJNf" title="Exercise prices of the outstanding options">32.81</span> (R$<span id="xdx_904_ecustom--ExercisePricesOfTheOutstandingOptions_iI_pip0_uBRLPerShare_c20221231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zCtUVqgqWhM1" title="Exercise prices of the outstanding options">39.04</span> in 2022 and R$<span id="xdx_902_ecustom--ExercisePricesOfTheOutstandingOptions_iI_pip0_uBRLPerShare_c20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zvjwsB62aSH3" title="Exercise prices of the outstanding options">45.97</span> in 2021) and the weighted average remaining contractual life is approximately <span id="xdx_900_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231_zmwVT1PaahLa" title="Weighted average remaining contractual life of outstanding share options (Year)">3.60</span> years (<span id="xdx_902_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231_z0krG2JMZ78f" title="Weighted average remaining contractual life of outstanding share options (Year)">4.29</span> years in 2022 and <span id="xdx_90F_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231_zaJca7pnayk3" title="Weighted average remaining contractual life of outstanding share options (Year)">6.70</span> years in 2021).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Of the <span id="xdx_906_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20231231_zuyj95uisx5c" title="Number of share options outstanding in share-based payment arrangement at end of period">87,961</span> thousand outstanding options (<span id="xdx_90B_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20221231_z0dhSawXl7ml" title="Number of share options outstanding in share-based payment arrangement at end of period">99,717</span> thousand in 2022 and <span id="xdx_90C_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20211231_z8SzS8soyfJc" title="Number of share options outstanding in share-based payment arrangement at end of period">113,760</span> thousand in 2022), <span id="xdx_903_ecustom--NumberOfShareOptionsVestedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20231231_zesh03RARYad" title="Number of share options vested in share-based payment arrangement">68,635</span> thousand options were vested in 2023 (<span id="xdx_90B_ecustom--NumberOfShareOptionsVestedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20221231_zqPTqXbUhAl7" title="Number of share options vested in share-based payment arrangement">63,850</span> thousand in 2022 and <span id="xdx_903_ecustom--NumberOfShareOptionsVestedInSharebasedPaymentArrangement_pn3n3_uShares_c20210101__20211231_zkz5rShVxTr5" title="Number of share options vested in share-based payment arrangement">59,250</span> thousand in 2021).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 10pt">The weighted average exercise price of the options is as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfWeightedAverageExercisePricesOfShareOptionsTextBlock_pn5n6_zgaJ3pX1DQ7l" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zmvaVYAf7z61" style="display: none">Schedule of weighted average exercise price</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>In R$ per share</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options outstanding at January 1</span></td> <td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20230101__20231231_zrIaXFw6UXwe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.39 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uBRLPerShare_c20220101__20221231_zcLTHDsLJZne" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.92 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20210101__20211231_z7FbS93JNNOh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.81 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options forfeited during the period</span></td> <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20230101__20231231_z3JPPNHoNFL1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">22.68 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20220101__20221231_z6QuwPcQpnzk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">22.60 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20210101__20211231_zDcM9xMe66S" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">25.27 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options exercised during the period</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pip0_c20210101__20211231_zguM80B4kuT9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercised during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.16 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options outstanding at the end of the period</span></td> <td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20230101__20231231_zNaauWdPfnn2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.86 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20220101__20221231_zAT0rTh5NKml" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.39 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uBRLPerShare_c20210101__20211231_zqnLVUTYhku5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.92 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options exercisable at the end of the period</span></td> <td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20231231_z28r6CmUZeve" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercisable at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.08 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20221231_z1xKIdLgrFBf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercisable at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20.12 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20211231_zEsBYyxt5PJi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercisable at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21.14 </span></td></tr> </table> <p id="xdx_8A3_zO6oPhY8jItj" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">To settle the exercised stock options, the Company may use treasury shares. The current limit on the authorized capital is considered sufficient to meet the Company’s obligations under all stock option plans if the issue of new shares is required to meet the grants awarded under the programs.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the period, the Company granted <span id="xdx_90E_ecustom--NumberOfOtherNewEquityInstrumentIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredStockUnitsOfGrantOneMember_zM18QK7DnJCd" title="Deferred shares">47</span> thousand deferred shares under the stock option plan which are valued based on the share market price prior to the grant, which represented a fair value of R$<span id="xdx_90B_ecustom--FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement_pn5n6_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredStockUnitsOfGrantOneMember_z1vMYQxqSGbj" title="Fair value, granted">0.6</span>(at December 31, 2022, <span id="xdx_909_ecustom--NumberOfOtherNewEquityInstrumentIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredStockUnitsOfGrantOneMember_zLJanPH3zuI4" title="Deferred shares">44</span> thousand deferred shares under the stock option plan which are valued based on the share market price prior to the grant, which represented a fair value of R$<span id="xdx_902_ecustom--FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement_pn5n6_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredStockUnitsOfGrantOneMember_z3WsQA4JfdFb" title="Fair value, granted">0.6</span> and at December 31, 2021, <span id="xdx_904_ecustom--NumberOfOtherNewEquityInstrumentIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredStockUnitsOfGrantOneMember_zAlHXPQQaj2g" title="Deferred shares">110</span> thousand deferred shares had been granted, which are valued based on the share market price prior to the grant, which represented a fair value of R$<span id="xdx_90A_ecustom--FairValueOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement_pn5n6_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredStockUnitsOfGrantOneMember_zi4oIseaR9Ql" title="Fair value, granted">1.7</span>). Such deferred shares are subject to a vesting period of five years from the grant date. The total number of shares purchased by employees, under the Stock Option Plan, which will be delivered in the future based on the fulfilment of certain conditions, is as set out below:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Deferred shares</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfNumbersAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zw8sjBddAAYc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_zoUGWs3PfF26" style="display: none">Schedule of deferred shares</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>Thousand deferred shares</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Deferred shares outstanding at January 1</b></span></td> <td id="xdx_987_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zNNH3ea5ZUK5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>889 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zfg0pQ3seSx" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,168 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zDyLDv9rzuzh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,065 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">New deferred shares during the period</span></td> <td id="xdx_984_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zr51dvUhbyPd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New deferred shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">47 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zWbW0oRK1Kl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New deferred shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">44 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zoRORnTh8mgf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New deferred shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred shares granted during the period</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zJX4K6CyeMii" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(214)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zZ16AecDKBu3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,964)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred shares forfeited during the period</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zi71I2Kltpab" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(109)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zeyQSua2EbTl" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(43)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Deferred shares outstanding at the end of the year</b></span></td> <td id="xdx_980_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zPSvRI9CKF3g" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>936 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_znMVCDSxF66e" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>889 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_z53Mwxn59NFl" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,168 </b></span></td></tr> </table> <p id="xdx_8A0_z1uVrZdjCRLg" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>25.3 Expenses related to share-based payments</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The share-based payments transactions described above generated an expense of R$<span id="xdx_907_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn5n6_c20230101__20231231_z1YZynmH5no7" title="Expense from share-based payment transactions with employees">333.4</span> in 2023 (R$<span id="xdx_908_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn5n6_c20220101__20221231_zNq1IC0nmwxe" title="Expense from share-based payment transactions with employees">311.6</span> and R$<span id="xdx_90D_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_pn5n6_c20210101__20211231_zdRE5UCIdoEh" title="Expense from share-based payment transactions with employees">391.5</span> in 2022 and 2021, respectively), recorded as administrative expenses.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Under the Share-Based Plan, the reference price per restricted share is defined on the stock grant date based on the share price of the trading session on B3 immediately prior to the shares granting, except for the performance shares, which the fair value is defined at the grant date based on “Monte Carlo” pricing method. After defining the reference price, based on number of grant shares, the calculated amount is recorded as expense against equity. The shares are transferred to attendees according to the terms and periods by the respective programs.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Under the stock option programs, the fair value of the shares is estimated as at the option grant date, using the “Hull Binomial” pricing model, adjusted to reflect the IFRS 2 - <i>Share-based Payment</i> requirement that assumptions regarding forfeiture before the end of the vesting period cannot impact the fair value of the option. The fair value of the share options is estimated at the grant date, using an option pricing model. Based on the expected number of options that will be exercised, the fair value of the options granted is recognized as an expense over the vesting period with a corresponding credit to equity. When the options are exercised, the equity is increased by the amount of the proceeds received.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, on some occasions, AB InBev employees and managers are expatriated to the Company. In these cases, the compensation cost related to options to acquire shares and restricted shares of AB InBev is recognized in the income statement against shareholders' equity, in proportion to the period of expatriation. When the equity instruments are delivered, this amount is reimbursed to AB InBev.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the other hand, when employees and managers who have options to acquire shares and restricted shares of the Company are expatriated to AB InBev, the compensation cost is recognized by AB InBev in proportion to the period of expatriation, and the Company is reimbursed at the time of delivery of its equity instruments to AB InBev employees and managers.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's share-based payment plans are settled in shares.</p> 33686000 49328000 20629000 463500000 766600000 325700000 <table cellpadding="0" cellspacing="0" id="xdx_89E_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zY0jekk2SQGf" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B0_zgIr3Uxm0V2i" style="display: none">Schedule of restricted and performance shares</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>Thousand restricted shares</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Restricted and performance shares outstanding at January</b></span></td> <td id="xdx_981_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zszBfJJOwW63" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>108,854 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zKjpepmg4rHa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>62,545 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zcgAU2ahbiOk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>43,458 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">New restricted and performance shares during the period</span></td> <td id="xdx_987_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_z7v8Ky85F6O" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New restricted and performance shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">33,686 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zlIwcrtB8s19" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New restricted and performance shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">49,328 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zsVgnQOGhEW6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New restricted and performance shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20,629 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Restricted and performance shares granted during the period</span></td> <td id="xdx_98E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zRFRBPcVmoL6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(18,309)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_ztiq0SsiFHJg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(12)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zGXEVkpZI5k8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(22)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Restricted and performance shares forfeited during the period</span></td> <td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zgVT7IUuNxfi" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,235)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zXFzczUAgi1i" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3,007)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zPxMpC80Qny6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted and performance shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(1,520)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Restricted shares outstanding at the end of the year</b></span></td> <td id="xdx_986_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zsG7EZR59Cwa" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at rhe end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>118,996 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zmYvRG0Q9CS4" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at rhe end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>108,854 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--RestrictedSharesMember_zMyynkd4vWz8" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Restricted shares outstanding at rhe end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>62,545 </b></span></td></tr> </table> 108854000 62545000 43458000 33686000 49328000 20629000 18309000 12000 22000 5235000 3007000 1520000 118996000 108854000 62545000 <table cellpadding="0" cellspacing="0" id="xdx_899_ecustom--ScheduleOfOutstandingOptionsTableTextBlock_pn3n3_z6d0mBCUCOSa" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zvCPdBZ2SRf8" style="display: none">Schedule of outstanding options developed</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>Thousand options</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Options outstanding at January</b></span></td> <td id="xdx_98F_ecustom--NumberOfOutstandingShareOptions1_iS_pn3n3_uShares_c20230101__20231231_zQcAfLbRm3Fa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>99,717 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NumberOfOutstandingShareOptions1_iS_pn3n3_uShares_c20220101__20221231_zjkR6ifBAwjc" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>113,760 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NumberOfOutstandingShareOptions1_iS_pn3n3_uShares_c20210101__20211231_zcbEokysHRB3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>127,265 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options exercised during the period</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement1_pn3n3_uShares_c20210101__20211231_zXEqOZ8AsAO2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercised during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(5,247)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options forfeited during the period</span></td> <td id="xdx_985_ecustom--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1_pn3n3_c20230101__20231231_zLfebwEvACMg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11,756)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1_pn3n3_uShares_c20220101__20221231_zHMJqJQ0xkDe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14,043)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement1_pn3n3_c20210101__20211231_zW43R2MRKj7b" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8,258)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Options outstanding at the end of the year</b></span></td> <td id="xdx_98E_ecustom--NumberOfOutstandingShareOptions1_iE_pn3n3_uShares_c20230101__20231231_zr6ncIc4kpX7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>87,961 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--NumberOfOutstandingShareOptions1_iE_pn3n3_uShares_c20220101__20221231_zz8i6Ks40TO2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>99,717 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--NumberOfOutstandingShareOptions1_iE_pn3n3_uShares_c20210101__20211231_zDEdXozVzSw8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>113,760 </b></span></td></tr> </table> 99717000 113760000 127265000 -5247000 -11756000 -14043000 -8258000 87961000 99717000 113760000 15.95 15.95 15.95 32.81 39.04 45.97 P3Y7M6D P4Y3M14D P6Y8M12D 87961000 99717000 113760000 68635000 63850000 59250000 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfWeightedAverageExercisePricesOfShareOptionsTextBlock_pn5n6_zgaJ3pX1DQ7l" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zmvaVYAf7z61" style="display: none">Schedule of weighted average exercise price</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>In R$ per share</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options outstanding at January 1</span></td> <td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20230101__20231231_zrIaXFw6UXwe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.39 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_uBRLPerShare_c20220101__20221231_zcLTHDsLJZne" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.92 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pip0_c20210101__20211231_z7FbS93JNNOh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at January 1, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.81 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options forfeited during the period</span></td> <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20230101__20231231_z3JPPNHoNFL1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">22.68 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20220101__20221231_z6QuwPcQpnzk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">22.60 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pip0_c20210101__20211231_zDcM9xMe66S" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options forfeited during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">25.27 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options exercised during the period</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pip0_c20210101__20211231_zguM80B4kuT9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercised during the period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">13.16 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options outstanding at the end of the period</span></td> <td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20230101__20231231_zNaauWdPfnn2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">18.86 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pip0_c20220101__20221231_zAT0rTh5NKml" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.39 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_uBRLPerShare_c20210101__20211231_zqnLVUTYhku5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options outstanding at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.92 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Options exercisable at the end of the period</span></td> <td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20231231_z28r6CmUZeve" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercisable at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">19.08 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20221231_z1xKIdLgrFBf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercisable at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20.12 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iI_pip0_c20211231_zEsBYyxt5PJi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Options exercisable at ended period, weighted average exercise price (in BRL per share)"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21.14 </span></td></tr> </table> 19.39 19.92 19.81 22.68 22.60 25.27 13.16 18.86 19.39 19.92 19.08 20.12 21.14 47000 600000 44000 600000 110000 1700000 <table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfNumbersAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zw8sjBddAAYc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SHARE-BASED PAYMENTS (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B9_zoUGWs3PfF26" style="display: none">Schedule of deferred shares</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><i>Thousand deferred shares</i></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Deferred shares outstanding at January 1</b></span></td> <td id="xdx_987_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zNNH3ea5ZUK5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>889 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zfg0pQ3seSx" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,168 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iS_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zDyLDv9rzuzh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at January"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>6,065 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">New deferred shares during the period</span></td> <td id="xdx_984_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zr51dvUhbyPd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New deferred shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">47 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zWbW0oRK1Kl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New deferred shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">44 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--NumberOfOtherNewEquityInstrumentsIntroducedInSharebasedPaymentArrangement_pn3n3_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zoRORnTh8mgf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="New deferred shares during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">110 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred shares granted during the period</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zJX4K6CyeMii" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(214)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zZ16AecDKBu3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares granted during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4,964)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Deferred shares forfeited during the period</span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">-   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zi71I2Kltpab" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(109)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement_iN_pn3n3_di_uPure_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zeyQSua2EbTl" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares forfeited during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(43)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Deferred shares outstanding at the end of the year</b></span></td> <td id="xdx_980_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20230101__20231231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_zPSvRI9CKF3g" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>936 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20220101__20221231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_znMVCDSxF66e" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>889 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement1_iE_pn3n3_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--DeferredSharesMember_z53Mwxn59NFl" style="border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Deferred shares outstanding at the end of the year"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,168 </b></span></td></tr> </table> 889000 1168000 6065000 47000 44000 110000 214000 4964000 109000 43000 936000 889000 1168000 333400000 311600000 391500000 <p id="xdx_804_ecustom--DisclosuresOfTradeAndOtherPayablesExplanatory_zlLYSTcNJGkf" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt/115% Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top"> <td style="width: 0"><span id="a_032"></span></td><td style="width: 21.3pt"><b>26.</b></td><td><b><span id="xdx_829_zVRc9OaDC0Ji">TRADE PAYABLES</span></b></td></tr></table> <table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureOfTheComponentsOfTradePayablesTextBlock_pn5n6_z6BfqBhLsY4a" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE PAYABLES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BF_zsjxeI3reUEf" style="display: none">Schedule of trade payable</span></td> <td id="xdx_49A_20231231_zeVxtm3WZtlk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20221231_zGj0Cy70auO4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 40%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 30%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 30%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_408_eifrs-full--NoncurrentPayablesToTradeSuppliers_iI_pn5n6_maNPzyjp_zB1rwFUZTo85" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade payables</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">107.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">165.8 </span></td></tr> <tr id="xdx_407_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_pn5n6_maNPzyjp_z1IaRIjuSTyi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Related parties (Note 30)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">199.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">343.6 </span></td></tr> <tr id="xdx_403_eifrs-full--NoncurrentPayables_iTI_pn5n6_mtNPzyjp_maTAOPzQ89_zMgT5od0akj8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>307.3 </b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>509.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_400_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_pn5n6_maTAOCPzb4x_zHrdc002HmXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade payables</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21,278.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,498.1 </span></td></tr> <tr id="xdx_40B_eifrs-full--NoncurrentPayablesToRelatedParties_iI_pn5n6_maTAOCPzb4x_z7LKSVywOHg2" style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Related parties (Note 30)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,916.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">830.4 </span></td></tr> <tr id="xdx_404_eifrs-full--TradeAndOtherCurrentPayables_iTI_pn5n6_mtTAOCPzb4x_maTAOPzQ89_zVZSWUFeoiJg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,195.1 </b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>24,328.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_eifrs-full--TradeAndOtherPayables_iTI_pn5n6_mtTAOPzQ89_z7J7lfUlmRei" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,502.4 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>24,837.9 </b></span></td></tr> </table> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The present value adjustment recorded for trades payables, at December 31, 2023, is R$<span id="xdx_906_ecustom--NominalContractualAmountsIncludingInterest_iI_pn6n6_c20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--TradePayableMember_zTojTHCtKP06" title="present value adjustment recorded for trades payables">308</span> million (R$<span id="xdx_90F_ecustom--NominalContractualAmountsIncludingInterest_iI_pn6n6_c20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--TradePayableMember_zif8QCSTfVU7" title="present value adjustment recorded for trades payables">367</span> million at December 31,2022).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The subsidiaries in Argentina, Chile, Paraguay and Panama have discount transactions for duplicates with endorsement (trade payables securitization) with vendors in the amount of R$<span id="xdx_905_ecustom--TradeAndOtherPayables1_iI_pn5n6_c20231231_zSQ28ywMJBg" title="Trade payable">159</span>.0 million at December 31, 2023 (R$<span id="xdx_908_ecustom--TradeAndOtherPayables1_iI_pn5n6_c20221231_zz7o8h5xkfU3" title="Trade payable">219.3</span> million at December 31, 2022). In general, abovementioned discount transactions occur by legal impositions existing in these jurisdictions. These transactions maintain commercial characteristics since there are no change in previously established conditions and its vendor’s choice to carry out the anticipation of its receivables with the Company.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Trade payables are recognized initially at their fair values and subsequently at amortized cost using the effective interest method. When relevant, trade payables values are adjusted by their present value, considering the following assumptions to calculation: (i) the amount to be discounted; (ii) the settlement dates; and (iii) the discount rate, in accordance with IFRS 13. The adjustment in the present value of installment purchases is record in trade payables and is offset by the cost of products sold account, due to the payment term.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Long-term intra-group loan agreements</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has long-term loan agreements, denominated in foreign currency, signed with wholly owned subsidiaries located abroad, whose amounts are recognized in the Company's accounts payable. As determined by IAS 21, considering that they are long-term loans, which settlement is not likely to occur in the foreseeable future, the exchange differences related to these instruments are recognized in other comprehensive income, following the accrual accounting concept.</p> <p style="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The recognition of exchange rate variations in other comprehensive income does not affect the accounting classification assigned to the debt, which is recorded in a liability account and incurs interest, which is recognized as a financial expense in the income statement for the year.</p> <p style="font: 11pt/13pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The effects of exchange differences will only be reflected in profit or loss for the period if there is any change in the assumption related to the settlement of the loan, i.e., if it becomes foreseeable or probable. In the event of partial settlement, only the exchange differences corresponding to the settled portion or portion expected to be settled with probability or foreseeability will be reclassified to the profit or loss for the period.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" id="xdx_88A_ecustom--DisclosureOfTheComponentsOfTradePayablesTextBlock_pn5n6_z6BfqBhLsY4a" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - TRADE PAYABLES (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BF_zsjxeI3reUEf" style="display: none">Schedule of trade payable</span></td> <td id="xdx_49A_20231231_zeVxtm3WZtlk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20221231_zGj0Cy70auO4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 40%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 30%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="width: 30%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_408_eifrs-full--NoncurrentPayablesToTradeSuppliers_iI_pn5n6_maNPzyjp_zB1rwFUZTo85" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade payables</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">107.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">165.8 </span></td></tr> <tr id="xdx_407_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_iI_pn5n6_maNPzyjp_z1IaRIjuSTyi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Related parties (Note 30)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">199.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">343.6 </span></td></tr> <tr id="xdx_403_eifrs-full--NoncurrentPayables_iTI_pn5n6_mtNPzyjp_maTAOPzQ89_zMgT5od0akj8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>307.3 </b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>509.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_400_eifrs-full--TradeAndOtherCurrentPayablesToTradeSuppliers_iI_pn5n6_maTAOCPzb4x_zHrdc002HmXh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade payables</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">21,278.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,498.1 </span></td></tr> <tr id="xdx_40B_eifrs-full--NoncurrentPayablesToRelatedParties_iI_pn5n6_maTAOCPzb4x_z7LKSVywOHg2" style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Related parties (Note 30)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,916.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">830.4 </span></td></tr> <tr id="xdx_404_eifrs-full--TradeAndOtherCurrentPayables_iTI_pn5n6_mtTAOCPzb4x_maTAOPzQ89_zVZSWUFeoiJg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,195.1 </b></span></td> <td style="border-top: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>24,328.5 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_eifrs-full--TradeAndOtherPayables_iTI_pn5n6_mtTAOPzQ89_z7J7lfUlmRei" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,502.4 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>24,837.9 </b></span></td></tr> </table> 107400000 165800000 199900000 343600000 307300000 509400000 21278600000 23498100000 1916500000 830400000 23195100000 24328500000 23502400000 24837900000 308000000 367000000 159000000 219300000 <p id="xdx_800_eifrs-full--DisclosureOfOtherProvisionsContingentLiabilitiesAndContingentAssetsExplanatory_zC4GWcw93UTj" style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_033"></span>27.</b></td><td><b><span id="xdx_82C_zqiU3QqKuLt7">PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries are involved in administrative and judicial proceedings and arbitrations arising from the normal course of business. Due to their nature, these processes involve inherent uncertainties, including, but not limited to, decisions by courts and tribunals, agreements between the parties involved and governmental actions and, as a result, management cannot, at this stage, estimate the exact time taken to resolve these issues.</p> <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>27.1 Provision</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and some of its subsidiaries are involved in lawsuits, mainly of a tax, civil and labor nature, which are considered probable of loss, and which are fully provisioned, under the terms of IAS 37 - <i>Provisions, Contingent Liabilities and Contingent Assets</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>27.1.1 Main lawsuits with a probable likelihood of loss:</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Sales taxes: </b>in Brazil, the Company and its subsidiaries are parties to various administrative and judicial proceedings related to ICMS, IPI, PIS and COFINS taxes, considered as probable likelihood of loss. Such proceedings include, among others, tax offsetting, appropriation of tax credits and alleged insufficient payment of the respective taxes.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Labor: </b>the Company and its subsidiaries are parties to labor proceedings with former employees or former employees of service providers. The main issues involve overtime and related effects and respective charges.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Civil: </b>The Company and its subsidiaries are involved in civil lawsuits considered as representing a probable likelihood of loss. The most relevant portion of these lawsuits refers to former distributors, mainly in Brazil, mostly claiming damages resulting from the termination of their contracts.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>27.1.2 Provision changes </b></p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfOtherProvisionsChangesExplanatory_zT7PK0eynx87" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details)"> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zs0qLmSjp1P7" style="display: none">Schedule of provision changes</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr> <td style="vertical-align: bottom; width: 35%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Taxes on sales</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Labor</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Civil</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>Other taxes </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Restructuring</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_z4Ita3bmgZ2g" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>218.6 </b></span></td> <td id="xdx_980_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_znnwLdQQogta" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>124.2 </b></span></td> <td id="xdx_980_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zanZkMuaTWrd" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>252.9 </b></span></td> <td id="xdx_980_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zS5oxfoFhr5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>163.0 </b></span></td> <td id="xdx_98E_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zFc8Fb0905Wf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>17.4 </b></span></td> <td id="xdx_983_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231_zXOe3n4fltqa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>776.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of changes in foreign exchange rates</span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zmEcrJjVozob" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5539">-</span>   </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zYLh8IXFevD3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.6)</span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zxeaHgW536T3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.5)</span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zj1qCwT05bva" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8.1)</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zBbc9N3x1t64" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.0)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231_zlDGJ3uxgNal" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(32.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Additions</span></td> <td id="xdx_98D_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zjbKAw0Q77I3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">157.6 </span></td> <td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zUi0BxkdN10k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">194.2 </span></td> <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zYLGhxQegchg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">312.7 </span></td> <td id="xdx_983_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zfSOlX4Jx3d7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">60.1 </span></td> <td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zbBzk5vqE2Ia" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5559">-</span>   </span></td> <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231_zPDhoLBW5q7b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">724.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions used </span></td> <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zpiTRX8h9qn4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(85.8)</span></td> <td id="xdx_989_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zt5HgR5WyB33" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(162.0)</span></td> <td id="xdx_982_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zBu9Xe3ccyDj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(196.6)</span></td> <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_z2epvUMYli6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7.2)</span></td> <td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zy4cELOeSrWd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.6)</span></td> <td id="xdx_98A_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231_zBBzYDhhC4Eb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(455.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions reversed</span></td> <td id="xdx_987_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zKaLZskV7ALa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(43.3)</span></td> <td id="xdx_980_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zhIis7uae8Oe" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.7)</span></td> <td id="xdx_988_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_ztWNNuHHLJj1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.6)</span></td> <td id="xdx_98B_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zKP60npv6377" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.0)</span></td> <td id="xdx_98D_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zLohi24zkzN4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5577">-</span>   </span></td> <td id="xdx_985_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231_zHlzLjt8LLic" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(93.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2022</b></span></td> <td id="xdx_982_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zhkjU3OhVaK7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>247.1 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zZhiqimAbE8c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>132.1 </b></span></td> <td id="xdx_984_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zRPbBBSSfrH8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>335.9 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zTmbMFfGgbGc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>192.8 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zu3H9qunOgv" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11.8 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231_z0vByqgNacE4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>919.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of changes in foreign exchange rates</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zyDf8zeu0lbh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5593">-</span>   </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zSqNGrvUyUgi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.8)</span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zq4Nc3tbn3pj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(35.8)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zYKtEy18QsN5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.3)</span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zSzkrJbnCBGf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.5)</span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231_zIBhDVwpBrE2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(45.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Additions</span></td> <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zfItflJMpdxe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">135.7 </span></td> <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zGPfmr2aOxMa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">247.8 </span></td> <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_z1PXIssdr0M9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">234.5 </span></td> <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zLxSvEakbU2g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">75.7 </span></td> <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zLYx8dnLjXUh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.2 </span></td> <td id="xdx_983_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231_zcQyq4Irbpe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">696.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions used </span></td> <td id="xdx_987_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zt9UY18ECo2b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27.3)</span></td> <td id="xdx_987_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zzcbDQXxZRSd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(181.7)</span></td> <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zHPa9Qsr8UEb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(121.9)</span></td> <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zOLGOG86Iybe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(40.8)</span></td> <td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zpukyswhGUn5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.2)</span></td> <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231_zycgeIjcJ5M5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(382.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions reversed</span></td> <td id="xdx_98F_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zgGhH5fv4Zua" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73.2)</span></td> <td id="xdx_984_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zvNw2tDte99b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(45.5)</span></td> <td id="xdx_983_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_ziMEOUCaaXg3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(72.5)</span></td> <td id="xdx_985_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_znk4AL532dQb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.1)</span></td> <td id="xdx_98C_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_z11zMQNBUqMi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5631">-</span>   </span></td> <td id="xdx_989_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231_zCVeZoamqC5a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(210.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2023</b></span></td> <td id="xdx_989_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zW8wZPrCVNPd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>282.3 </b></span></td> <td id="xdx_98E_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zHJBxJ6uqjGf" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>149.9 </b></span></td> <td id="xdx_985_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_z0zvdmZweK3g" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>340.2 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zpXNfsQJFUxi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>202.3 </b></span></td> <td id="xdx_983_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zKsmWajAavf5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3.3 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231_zifdCSSKmBm1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>978.0 </b></span></td></tr> </table> <p style="font: 8pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Other taxes refer to provisions for lawsuits concerning taxes unrelated to income taxation. The uncertain tax treatments related taxes on profits with a prognosis of probable loss have their value reported directly in the income tax and social contribution payable, as per IFRIC 23 - <i>Uncertainty on the Treatment of Income Taxes</i>.</td> </tr></table> <p id="xdx_8A1_zhfuJIGNH311" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>27.1.3 Expected settlement of provision</b></p> <p style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfTheDisbursementExpectativeOfTheProvisionsTextBlock_zWepnaxxosw8" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_z4h7kc9RVnu9" style="display: none">Schedule of expected settlement of provision</span> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 36%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="width: 4%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Provision for disputes and litigation</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Taxes on sales</span></td> <td id="xdx_983_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zIUuAQ5RQqtd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">168.6 </span></td> <td id="xdx_98E_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zcKDqVDMpOAe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">113.7 </span></td> <td id="xdx_984_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_z7jHOfoEDf3j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">282.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zXGLPVh5onLb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">193.8 </span></td> <td id="xdx_983_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zlWnudY6iQE9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">53.3 </span></td> <td id="xdx_98C_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zOs3ocgAZdwg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">247.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Labor</span></td> <td id="xdx_985_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zNWNpnkSQcH9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">82.7 </span></td> <td id="xdx_98D_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zcnVM1RPT405" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">67.2 </span></td> <td id="xdx_983_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zBTVXQD2fkMe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">149.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_z7YFN696NGBh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">104.9 </span></td> <td id="xdx_987_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zyJ39KxMkzT3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.2 </span></td> <td id="xdx_988_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_z0rfyUlb1XWg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">132.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Civil</span></td> <td id="xdx_989_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zCGIuy5hhpfa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">113.4 </span></td> <td id="xdx_98F_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_z0EOX4xSZlL3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">226.8 </span></td> <td id="xdx_980_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zToIJBugdDq9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">340.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zGoGTXUqiwce" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">263.0 </span></td> <td id="xdx_98F_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zrpqBswCSaU3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">72.9 </span></td> <td id="xdx_98C_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zjDjnydOrxP8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">335.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other taxes</span></td> <td id="xdx_984_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zakf7PZuDsD1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">194.9 </span></td> <td id="xdx_984_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zo3PsN8Z4Lm8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.4 </span></td> <td id="xdx_98E_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zce2t0e6r2Ll" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">202.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zVnt6DrZDuH3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">170.1 </span></td> <td id="xdx_982_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zUuTcJGh2ww8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">22.7 </span></td> <td id="xdx_98E_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zykJs1yJdAo1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">192.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total provision for disputes and litigation</b></span></td> <td id="xdx_98E_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zSAguCpIeuV3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>559.6 </b></span></td> <td id="xdx_985_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zvFwM4jd0vo4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>415.1 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zYeyG7cUR0B1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>974.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zfDTTmpOUpxd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>731.8 </b></span></td> <td id="xdx_98C_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zgZ1Bs0BA9K6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>176.1 </b></span></td> <td id="xdx_989_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zSqMMY3w5RRj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>907.9 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Restructuring</span></td> <td id="xdx_98C_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zNEafNDxMdS3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5710">-</span>   </span></td> <td id="xdx_98C_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_ziApB7TYWl1i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.3 </span></td> <td id="xdx_98F_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zVvVcsaALhSl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zBncDUgMLFFh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.2 </span></td> <td id="xdx_988_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zgow7bfLl7T1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.6 </span></td> <td id="xdx_985_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zQ6hwp2OMsb2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total provisions</b></span></td> <td id="xdx_98C_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231_zO5MxeM3zsye" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>559.6 </b></span></td> <td id="xdx_98E_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231_zOWpWfvYgOUj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>418.4 </b></span></td> <td id="xdx_986_eifrs-full--Provisions_iI_pn5n6_c20231231_zJgesCX3GGyj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>978.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231_zZ4bNlNyaDp1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>739.0 </b></span></td> <td id="xdx_980_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231_zCHWqRL3mMJc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>180.7 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iI_pn5n6_c20221231_zzXEIHfBEQTj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>919.7 </b></span></td></tr> </table> <p id="xdx_8A6_zTdQcJz1Jg7f" style="font: 12pt/115% Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The expected settlement of provisions was based on management’s best estimate at the balance sheet date.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>27.2 Contingencies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries maintain administrative and judicial discussions with fiscal authorities in Brazil related to certain fiscal positions adopted when calculating the income tax and social contribution, which, based on Management’s current evaluation, probably are going to be accepted in superior court decisions of last instance, aligned with IFRIC 23. The Company also tax actions related to other taxes, which involve risk of a possible loss, according to management's assessment. To these uncertain tax treatments and possible contingencies there are no constituted provision, due to the assessment carried out as the following composition and estimates:</p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfEstimatesOfPossibleLossesTextBlock_zK6SqkTBDKH9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_zlQcF6qJ7yfd" style="display: none">Schedule of contingencies</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 50%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 28%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income tax and social contribution</span></td> <td id="xdx_986_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IncomeTaxAndSocialContributionMember_zqNthJEMwPI" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">63,621.0 </span></td> <td id="xdx_986_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IncomeTaxAndSocialContributionMember_zhFtcyLGG0z5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">60,453.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Value-added and excise taxes</span></td> <td id="xdx_983_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ValueAddedAndExciseTaxesMember_zZhl5LRKgDZf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26,761.0 </span></td> <td id="xdx_985_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ValueAddedAndExciseTaxesMember_zUXwHGByrgbk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">25,904.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PIS and COFINS</span></td> <td id="xdx_981_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--PISAndCOFINSTaxContingentLiabilityMember_zggXWyoxSBd7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,496.2 </span></td> <td id="xdx_980_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--PISAndCOFINSTaxContingentLiabilityMember_zZeSubtnhGna" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,293.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Others</span></td> <td id="xdx_987_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--OtherContingentLiabilitiesMember_zeWVY2H80TB3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,679.4 </span></td> <td id="xdx_986_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--OtherContingentLiabilitiesMember_zuoveF3IyCt3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,909.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231_zlL3OgfnUR7f" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>95,557.6 </b></span></td> <td id="xdx_984_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231_zSE7OE18MyGl" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>91,560.7 </b></span></td></tr> </table> <p id="xdx_8AF_zcTsK6brdh94" style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries have guarantee-insurance policies and letter of guarantee for some legal actions, disclosed as guarantee for civil, labor and tax execution or to enable resources of labor nature.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Contingencies with a remote risk of loss are not disclosed, as the possibility of any settlement is remote, in accordance with IAS 37 - Provisions, Contingent Liabilities and Contingent Assets.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>27.2.1 Main contingencies with a possible risk of loss</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 2023, Law 14,689 was enacted (“Law 14,689/2023”) in Brazil, which provides for the cancellation of fines imposed in tax administrative proceedings decided in favor of the Brazilian Federal Tax Authorities by a tie-breaking vote at the federal administrative level, including any such proceedings that were subsequently escalated to the judicial level and, as of the date of publication of Law 14,689/2023, were pending decision at the second level judicial courts. Following the enactment of Law 14,689/2023, Ambev reassessed the likelihood of success of fines imposed in proceedings decided by a tie-breaking vote, which resulted in the reclassification of the risk of loss from possible to remote in the approximate amount of R$ 6.9 billion as of December 31, 2023 In some cases of the discussions mentioned below, such as the deductibility of goodwill amortization expenses, foreign profits, the use of tax loss in mergers, and the Manaus Free Trade Zone - IPI.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">The main processes classified with a possible loss probability are summarized in the tables below, along with their respective estimated values involved in the cases.</p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left"><span id="xdx_8BA_zznWhiMH7n4i" style="display: none">Schedule of main contingencies with a possible risk of loss</span></td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td></tr> <tr> <td style="border: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Uncertainty over the treatment of income taxes</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>In accordance with IFRIC 23 (Note</b>13 <b>- <i>Income tax and social contribution</i>) </b></p></td> <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Estimates </b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>(in million of Brazilian Reais)</b></p></td></tr> <tr> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>#</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 77%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Description of the main processes</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td> </tr> <tr style="background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0"><b>Deductibility of IOC expenses</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the 2013 fiscal year, as approved in a General Meeting, the Company implemented a corporate restructuring aimed at simplifying its structure and unifying its share classes, among other objectives. One of the steps of this restructuring involved the exchange of shares and subsequent incorporation of the shares of its subsidiary Companhia de Bebidas das Américas into Ambev S.A. As a consequence of this operation, Ambev S.A. recognized in its accounting records the counterpart of the difference between the value of its shares issued for this exchange and the book value of the subsidiary's shares in equity, in accordance with IFRS 10, under the item "adjustments to equity".</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2019, Ambev received a tax assessment from the IRS regarding the deduction of Interest on Capital ("IOC") for the calendar year 2014. The queries primarily concern the accounting and corporate effects of the corporate restructuring carried out by the Company in 2013, and its impacts on increasing the calculation of the JCP deductibility limit. In August 2020, a partially favorable decision was issued to the Company by the first administrative instance, and in view of this decision, Ambev filed an appeal for the case to be reviewed by the CARF, which is awaiting judgment. The favorable portion of the first administrative instance decision will be subject to review by the CARF.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2020, the Company received a tax assessment related to the deduction of IOC expenses for the calendar years 2015 and 2016. In June 2021, Ambev obtained a partially favorable decision in the first administrative instance and filed an appeal to the CARF, which is also awaiting judgment. Similarly, to the first tax assessment, the favorable portion of the first administrative instance decision will be subject to review by the CARF.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2022, the Company received a tax assessment related to the deduction of IOC expenses for the calendar year 2017. In September 2023, Ambev obtained a partially favorable decision in the first administrative instance and filed an Appeal to the CARF, which is also awaiting judgment. Similarly, to the first tax assessment, the favorable portion of the first administrative instance decision will be subject to review by the CARF.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2023, the Company received a new tax assessment related to the deduction of IOC expenses for the calendar years 2018 to 2021. The Company filed a defense and currently awaits a decision in the first administrative instance.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$27.4 billion as of December 31, 2023 (R$13.8 billion as of December 31, 2022). Due to the assessment of the likelihood of loss, no provision was made in the period.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This uncertain tax treatment, according to IFRIC 23, continued to be applied by Ambev and affected subsequent calendar years to those assessed (2022 and 2023), during which the Company also distributed IOC and deducted them from the taxable base of its Income Tax.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Therefore, if the deductibility of IOC is also questioned in the future, on the same bases and with the same grounds as the tax assessments mentioned, the Company estimates that the outcome of these potential new discussions would be consistent with the period already assessed.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, Provisional Measure 1,185, of August 2023, was converted into a law (No. 14,789/2023), which changes the basis for calculating Interest on Capital as of January 1, 2024, making this uncertain tax treatment limited to Interest on Capital calculated in accordance with legislation in force before the aforementioned law effective date</p></td> <td id="xdx_981_eifrs-full--ReductionOfIssuedCapital_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zLtYYS7Xib9i" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>27,439</b></span></td> <td id="xdx_98B_eifrs-full--ReductionOfIssuedCapital_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zsfT5Dyr3hh8" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>13,846</b></span></td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border: Black 1pt solid; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2</b></span></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Disallowance of tax paid abroad </b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since 2014, the Company has been receiving tax assessments, relating to calendar years from 2007 onwards, which disallow the use of income tax credits paid abroad by its controlled companies. Considering these charges to be illegitimate, the Company is challenging these assessments in administrative and judicial courts. In November 2019, a final favorable decision was issued by the CARF canceling the assessment regarding one of the cases, covering the calendar year 2010.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For cases involving the calendar years 2015 and 2016, the Company received unfavorable decisions, in the administrative sphere, in three out of four processes. Ambev filed a lawsuit to discuss the matter and awaits a decision in first-instance judicial court. Still regarding the topic, new tax assessments were issued demanding isolated fines due to the alleged lack of monthly payment of IRPJ and CSLL due to the deduction of income tax paid by controlled companies abroad for the calendar years 2015 to 2018.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For cases involving the calendar years 2015 and 2016, an unfavorable decision was issued against the Company in the administrative first instance, against which Ambev filed voluntary appeals awaiting judgment by the CARF.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Regarding the tax assessments involving the collection of the isolated fine for the calendar years 2017 and 2018, received by the Company in October 2022 and December 2023 respectively, awaiting judgment in the administrative first instance.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">With regard to other processes discussing this topic, the Company awaits decisions in the administrative and judicial spheres.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$14.3 billion as of December 31, 2023 (R$12.6 billion as of December 31, 2022), and, due to its loss classification, no provision was made in the period.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0">This uncertain tax treatment, according to IFRIC, regarding income tax credits paid abroad, continued to be applied by the Company and impacted subsequent calendar years to those assessed (2018-2023). If new questions arise in the future, on the same basis and with the same grounds as the tax assessments referred to, the Company estimates that the unfolding of these eventual new discussions will be consistent with the period already assessed.</p></td> <td id="xdx_985_ecustom--DisallowanceOfTaxPaidAbroad_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zbh5fQLc86P4" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>14,302</b></span></td> <td id="xdx_983_ecustom--DisallowanceOfTaxPaidAbroad_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zBDPiAsB2dc4" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>12,596</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>3</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Goodwill Inbev Holding</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2011, the Company received a first tax assessment issued by the Brazilian Federal Revenue Service ("RFB") mainly related to the disallowance of goodwill amortization expenses for the tax years 2005 to 2010, resulting from the incorporation of InBev Holding Brasil S.A. Partially favorable administrative decisions were rendered in this matter. In response to these decisions, the Company filed judicial measures to challenge the issues in which it was unsuccessful at the administrative level, which are awaiting first-instance judgment.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2016, Ambev received a second tax assessment issued by the RFB regarding the disallowance of the remaining portion of the aforementioned goodwill amortization for the tax years 2011 to 2013. In April 2023, the Company obtained a partially favorable and final decision. For the portion of the dispute in which it was unsuccessful, the Company filed a judicial measure, which is awaiting judgment.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated value of this uncertain tax treatment, as per IFRIC 23, that has already been assessed, amounted to approximately R$6.5 billion as of December 31, 2023 (R$11.1 billion as of December 31, 2022), and, due to its classification as a loss, no provision was made in the period. Regarding this ongoing dispute, all periods affected by this uncertain tax treatment have already been subject to assessments by the Internal Revenue service (“IRS”). In the event that the Company is required to pay this amount, Anheuser-Busch InBev SA/NV will reimburse the proportional amount (70%) of its benefit from the goodwill amortization, as well as the respective costs, pursuant to the "Reimbursement Agreement" executed on December 21, 2011, between Companhia de Bebidas das Américas - Ambev and Anheuser-Busch InBev SA/NV.</p></td> <td id="xdx_988_ecustom--GoodwillForInbevHolding_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zHThmP08jSTc" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>6,505</b></span></td> <td id="xdx_981_ecustom--GoodwillForInbevHolding_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zNAIbtpckGma" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>11,122</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>4</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Foreign Earnings</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since 2005, the Company and some of its subsidiaries have been subject to tax assessments by the IRS regarding the taxation of profits earned by subsidiaries domiciled abroad under various grounds. Deeming these charges illegitimate, the Company is challenging these assessments in administrative and judicial courts.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The cases pending in the administrative sphere have partially favorable decisions, still subject to review by the last administrative instance, the CSRF. In turn, in the cases pending in the judicial sphere, the Company has favorable decisions, subject to review by the higher instance.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2022 and 2023, the CARF issued favorable and partially favorable decisions for the Company. The decisions canceled part of the assessments, recognizing as partially correct the calculations made by the Company regarding the taxable income in Brazil of companies domiciled abroad, as well as the impossibility for the Brazilian tax authorities to disregard the goodwill amortization carried out by a subsidiary abroad. Part of these decisions represents a definitive success in the approximate amount of R$1 billion, while for the other decisions, appeals were filed by the IRS, which are awaiting judgment by the CSRF.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$6.1 billion as of December 31, 2023 (R$7.3 billion as of December 31, 2022).</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This uncertain tax treatment, according to IFRIC 23, continued to be applied by the Company and impacted subsequent calendar years to those assessed (2019-2023). If new inquiries arise in the future, on the same basis and with the same grounds as the referred tax assessments, the Company estimates that the outcome of these eventual new discussions will be consistent with the periods already assessed.</p></td> <td id="xdx_98C_ecustom--ForeignEarnings_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_ztCO3x8QEsSh" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>6,075</b></span></td> <td id="xdx_981_ecustom--ForeignEarnings_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zjkZjmC3nDe1" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>7,280</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>5</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Disallowance on Income Tax deduction</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2020, Arosuco (a subsidiary of Ambev) received a tax assessment from the IRS, relating to the calendar years 2015 to 2018, disallowing the tax reduction benefit provided for in “MP” No. 2,199-14/2001, based on Operating Profit, and filed an administrative challenge. In October 2020, Arosuco was notified of the unfavorable decision in the administrative first instance and filed an Appeal, which awaits judgment.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$2.6 billion as of December 31, 2023 (R$2.3 billion as of December 31, 2022). Due to the assessment of the likelihood of loss, no provision was made in the period.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This uncertain tax treatment, according to IFRIC 23, affected subsequent calendar years to those assessed (2019 to 2023), during which Arosuco similarly benefited from the tax reduction provided for in the aforementioned Provisional Measure 2,199-14/2001. If there are any new inquiries in the future on the same matter, on the same bases and with the same grounds as the tax assessments mentioned, Arosuco estimates that the outcome of these potential new discussions would be consistent with the period already assessed.</p></td> <td id="xdx_98E_ecustom--DisallowanceOnIncomeTaxDeduction_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zUAzzJeTHPwf" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2,618</b></span></td> <td id="xdx_987_ecustom--DisallowanceOnIncomeTaxDeduction_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_z3mSGMeztCa7" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Disallowance of tax paid abroad"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2,334</b></span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="border: Black 1pt solid; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>6</b></span></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Goodwill BAH </b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2013, Ambev received a tax assessment related to the goodwill amortized in the calendar years 2007 to 2012 concerning the incorporation of Beverage Associates Holding Limited ("BAH") into Ambev. In April and August 2018, Ambev received two new tax assessments related to the disallowance of the amortization of the remaining portion of the mentioned goodwill in the calendar years 2013 and 2014.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In the administrative sphere, partially favorable decisions were rendered in favor of the Company regarding the qualified fine and the statute of limitations for one of the periods under discussion. In response to these decisions, the Company filed judicial measures to challenge the matters in which it was unsuccessful in the administrative phase, obtaining decisions of total merit in the first judicial instance. The IRS filed appeals, which are awaiting judgment in the second judicial instance.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$1.4 billion as of December 31, 2023 (R$2.2 billion as of December 31, 2022). Due to its classification as a loss, no provision was made in the period. Regarding this discussion, all periods impacted by the aforementioned uncertain tax treatment have already been subject to tax assessments by the IRS.</p></td> <td id="xdx_98F_ecustom--GoodwillForBah_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zo34N03fpIK7" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,412</b></span></td> <td id="xdx_98F_ecustom--GoodwillForBah_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zYS7c4wkqvc2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2,218</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>7</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0"><b>Goodwill CND Holding</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2017, the Company received a tax assessment related to the amortization of goodwill for the calendar years 2012 to 2016 concerning the incorporation of CND Holdings into Ambev. In the administrative sphere, a partially favorable decision was rendered by CARF, which is subject to appeals filed by the Company and the IRS awaiting judgment by the Superior Chamber of Tax Appeals ("CSRF"), the last administrative instance.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2022, Ambev received a new tax assessment related to the disallowance of the remaining portion of said goodwill for the calendar year 2017. The Company received a partially favorable decision, which is subject to appeals filed by the Company and IRS, awaiting judgment by CARF.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated value of the uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$1.4 billion as of December 31, 2023 (R$1.3 billion as of December 31, 2022). Due to its classification as a loss, no provision was made during the period. With regard to this discussion, all periods affected by the said uncertain tax treatment have already been subject to tax assessments by the IRS.</p></td> <td id="xdx_982_ecustom--GoodwillForCndHolding_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_z1iThMZG7T18" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,372</b></span></td> <td id="xdx_989_ecustom--GoodwillForCndHolding_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_znCFs0blqlje" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,257</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>8</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Presumed Profit</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2016, Arosuco (a subsidiary of Ambev) received an assessment related to the use of presumed profit for the calculation of IRPJ and CSLL instead of the actual profit method. In September 2017, Arosuco was notified of the unfavorable decision in the administrative first instance and filed a voluntary appeal. In 2019, a final favorable decision was issued by the CARF, canceling the assessment.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2019, Arosuco received a new tax assessment on the same matter and filed a defense. In October 2019, the administrative first instance issued an unfavorable decision and Arosuco filed a voluntary appeal to the CARF, which awaits judgment.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0">Arosuco estimates that the updated assessed value of this uncertain tax treatment, in accordance with IFRIC 23, is approximately R$633.4 million as of December 31, 2023 (R$581.5 million as of December 31, 2022). Due to its loss classification, no provision was made in the period. With regard to this discussion, all periods affected by this uncertain tax treatment have already been subject to tax assessments by the IRS.</p></td> <td id="xdx_989_ecustom--PresumedProfit_pn5n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zdSRNQipVtA4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>633.4</b></span></td> <td id="xdx_980_ecustom--PresumedProfit_pn5n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zXUNyI9RFngg" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>581.5</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>9</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Disallowance of financial expenses </b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2015, 2016, and 2020, the Company received tax assessments issued by the IRS concerning the disallowance of expenses related to the results of financial instruments used to hedge risks inherent to price or rate fluctuations, as well as loans related to the Company's operational activities. In May and June 2023, Ambev was notified of final favorable administrative decisions for the assessments received in 2016 and 2020, which completely canceled the tax assessments issued by the tax authorities, in the approximate amount of R$5.1 billion. Regarding the assessment received in 2015, judgment is awaited from the CARF, both for the tax authority's automatic appeal regarding the portion of the first-instance decision favorable to the Company, and for the Company's appeal regarding the portion of the first-instance decision in which it was unsuccessful. The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$316 million as of December 31, 2023 (R$5.2 billion as of December 31, 2022). Due to its classification, no provision was made in the period. With regard to this discussion, all periods affected by this uncertain tax treatment have already been subject to assessments by the RFB.</p></td> <td id="xdx_98B_ecustom--DisallowanceOfFinancialExpenses_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zKn4SZljurT9" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>316</b></span></td> <td id="xdx_986_ecustom--DisallowanceOfFinancialExpenses_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zjQtKozgryOf" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>5,200</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>10</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0"><b>Goodwill MAG</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2022, CRBS S.A. (a subsidiary of Ambev) received a tax assessment related to the goodwill amortized in the calendar years 2017 to 2020 concerning the acquisition and incorporation of RTD Barbados into CRBS. In the administrative sphere, CRBS received a partially favorable decision in the first administrative instance ("DRJ"), which is subject to appeals filed by the Company and the IRS pending judgment by CARF. The updated amount of this uncertain tax treatment, in accordance with IFRIC 23, already assessed, is approximately R$278 million as of December 31, 2023 (R$251 million as of December 31, 2022). Due to its classification as a loss, no provision was made in the period.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This uncertain tax treatment, according to IFRIC 23, continued to be applied by CRBS and impacted subsequent calendar years to those assessed (2021-2022). If new questions arise in the future, based on the same grounds and with the same fundamentals as the tax assessment mentioned, the Company estimates that the outcome of these potential new discussions will be consistent with the period already assessed.</p></td> <td id="xdx_982_ecustom--GoodwillForMag_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zOCTXmhGvnY2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>278</b></span></td> <td id="xdx_989_ecustom--GoodwillForMag_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zP4ZFGJQ68qc" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Goodwill BAH"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>251</b></span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>11</b></span></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 77%; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0"><b>Tax Loss Offset</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ambev and certain of its subsidiaries received a number of assessments from the Brazilian Federal Tax Authorities relating to the offset of tax losses carried forward in the context of business combinations.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Two main cases dealing with this matter are under judicial review. In one of the cases, Ambev received favorable decisions in 1st and 2nd instances of the judiciary, which prompted the National Treasury to file a Special Appeal, pending judgment by the Superior Court of Justice ("STJ"). In the second case, Ambev received an unfavorable decision in the 1st instance of the judiciary and filed an Appeal, awaiting judgment.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2023, there was a third case under administrative review, which, in February 2023, was unfavorably decided against the Company by the the Upper Administrative Court  ("CSRF") by a casting vote. Due to the outcome of the judgment and considering the reductions provided for in Law No. 14,689/2023, after receiving notification of the decision, the Company opted to pay the case in December 2023, with the corresponding reductions.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The updated value of the uncertain tax treatment, according to ICPC 22/IFRIC 23, as of December 31, 2023, is approximately R$187 million (R$548 million on December 31, 2022), and therefore, no provision has been made for the matter. Regarding the present discussion, all periods affected by the uncertain tax treatment have already been subject to assessments by the RFB.</p></td> <td id="xdx_98F_ecustom--TaxLossOffset_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zUy8PEXpzOF8" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Tax Loss Offset"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>187</b></span></td> <td id="xdx_985_ecustom--TaxLossOffset_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zOKy7FEmVyb4" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Tax Loss Offset"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>548</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>12</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0"><b>Isolet Fines</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In March 2023, the Brazilian Supreme Federal Court (STF), in the trial of theme 736 (RE 796,939), established its understanding that the imposition of isolated fines due to the non-recognition of tax offsets is unconstitutional. Following this judgment, the Company reevaluated, together with its in-house lawyers and external advisors, the prognosis of the discussion and reclassified the risk of loss from possible to remote. The amount involved in the processes related to this issue, as of March 31, 2023, was R$1.6 billion (compared to R$1.7 billion on December 31, 2022). Due to the prognosis of remote loss, the processes related to this issue ceased to be reported as possible contingencies in the first quarter of 2023.</p></td> <td id="xdx_98F_ecustom--IsoletFines_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_zFTHJVlvi3m4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Tax Loss Offset"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5801">-</span></b></span></td> <td id="xdx_986_ecustom--IsoletFines_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--UncertaintyOverTheTreatmentOfIncomeTaxesMember_z8J4AzWnAt2g" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Tax Loss Offset"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,690</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Indirect taxes</b></span></td> <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Estimates </b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>(in million of Brazilian Reais)</b></p></td></tr> <tr> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>#</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; width: 77%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Description of the main processes</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ICMS-ST Trigger</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Over the years, Ambev has received tax assessments to charge supposed ICMS differences considered due when the price of the products sold by Ambev is above the fixed price table basis established by the relevant states, cases in which the state tax authorities contend that the calculation basis should be based on a value-added percentage over the actual prices and not the fixed table price. Ambev is currently challenging those charges before the courts. The cases are being challenged at both the administrative and judicial levels.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A Company estimates that the total updated amount of possible risk involved in the processes related to this matter, as of December 31, 2023, is approximately R$10.7 billion (R$9.3 billion on December 31, 2022).</p></td> <td id="xdx_98F_eifrs-full--OtherExpenseByNature_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IcmsstTriggerMember_zCBDHHgeFip7" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>10,669</b></span></td> <td id="xdx_98D_eifrs-full--OtherExpenseByNature_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IcmsstTriggerMember_zOJHpks5nZDl" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>9,292</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Manaus Free Trade Zone – IPI and PIS/COFINS</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In Brazil, goods manufactured within the Manaus Free Trade Zone intended for remittance elsewhere in Brazil are exempt and/ or zero-rated from excise tax (“IPI”) and social contributions (“PIS/COFINS”). With respect to IPI, Ambev’s subsidiaries have been registering IPI presumed tax credits upon the acquisition of exempted goods manufactured therein. Since 2009, Ambev has been receiving a number of tax assessments from the Brazilian Federal Tax Authorities relating to the disallowance of such credits.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ambev and its subsidiaries have also been receiving charges from the Brazilian Federal Tax Authorities in relation to (i) federal taxes allegedly unduly offset with the disallowed presumed IPI excise tax credits that are under discussion in these proceedings and (ii) PIS/COFINS amounts allegedly due on Arosuco’s remittance to Ambev subsidiaries.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2019, the Federal Supreme Court (“STF”) announced its judgment on Extraordinary Appeal No. 592.891/ /SP, with binding effect, deciding on the rights of taxpayers registering IPI excise tax presumed credits on acquisitions of raw materials and exempted inputs originating from the Manaus Free Trade Zone. As a result of this decision, Ambev reclassified part of the amounts related to the IPI cases as remote losses maintaining as possible losses only issues related to other additional discussions that were not included in the analysis of the STF. The cases are being challenged at both the administrative and judicial levels.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company estimates that the updated value classified as possible loss involved in these processes, as of December 31, 2023, is approximately R$6.3 billion (R$5.8 billion on December 31, 2022).</p></td> <td id="xdx_98F_eifrs-full--OtherExpenseByNature_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ManausFreeTradeZoneMember_z44N0R7Didof" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>6,307</b></span></td> <td id="xdx_984_eifrs-full--OtherExpenseByNature_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ManausFreeTradeZoneMember_zhAdIzattg0c" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>5,825</b></span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>3</b></span></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 77%"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>IPI Suspension</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2014 and 2015, Ambev received tax assessments from the Brazilian Federal Tax Authorities relating to IPI allegedly due over remittances of manufactured goods to other related factories. The cases are being challenged at both the administrative and judicial levels. In July 2022, Ambev received the first judicial decision on this matter; the decision was unfavorable to Ambev, and it filed an appeal. In July 2023, the Federal Court rendered its decision on the appeal, annulling the first-level decision and ordering the production of technical evidence as requested by Ambev in order to demonstrate the proper collection of IPI. The federal government has filed motions for clarification against this decision, which are pending judgment by the Federal Court.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In October 2022, the Upper Administrative Court rendered a partially favorable decision to Ambev in one of the cases related to this matter, which ordered a tax audit to determine the amount of the tax already effectively paid. The results of the tax audit, which were notified in January 2024, were partially favorable to Ambev, reducing 98% of the amount alleged to be owed by Ambev in this case. Ambev will file an appeal at the judicial level against the unfavorable portion of the decision.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates that the updated value classified as possible loss involved in these processes, as of December 31, 2023, is approximately R$1.8 billion (R$1.7 billion on December 31, 2022).</p></td> <td id="xdx_98A_eifrs-full--OtherExpenseByNature_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IPISuspensionMember_zVf0RyPPB3ed" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 10%" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,824</b></span></td> <td id="xdx_980_eifrs-full--OtherExpenseByNature_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IPISuspensionMember_zwc16G0VLYm4" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 10%" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,703 </b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>4</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Social Contributions over products</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since 2015, Ambev has received tax assessments issued by the Brazilian Federal Tax Authorities relating to PIS/COFINS amounts allegedly due over bonus products granted to its customers. The cases are being challenged at both the administrative and judicial levels of the courts. In 2019, 2020 and 2023, Ambev received final favorable decisions at the administrative level in some of these cases. In 2023, the Lower Administrative Court rendered favorable decisions to Ambev in two other cases and Ambev is awaiting formal notification of these decisions, which are not final and remain subject to appeal. At the judicial level, one case is pending decision by the second level judicial court after the first-level judicial court rendered an unfavorable decision to Ambev.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Ambev estimates that the amount involved in the proceedings as at December 31, 2023, classified as a possible loss, is approximately R$1.8 billion (R$1.6 billion as at December 31, 2022).</p></td> <td id="xdx_98B_eifrs-full--OtherExpenseByNature_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--SocialContributionsOverProductsMember_zDmBbaERoG1k" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,776</b></span></td> <td id="xdx_98E_eifrs-full--OtherExpenseByNature_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--SocialContributionsOverProductsMember_zPtcpnfdudB2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,559</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>5</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ICMS – ZFM</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2018 and 2021, Ambev received infraction notices issued by the State Departments of Finance of Rio Grande do Sul and São Paulo for alleged differences in ICMS resulting from the disallowance of credits originating from operations with suppliers located in the Manaus Free Trade Zone (ZFM). Regarding the infraction notice issued by the state of Rio Grande do Sul, the outcome was unfavorable at the administrative level, and the Company awaits notification of the decision rendered by the Administrative Tribunal to assess, along with its external advisors, the presentation of a challenge in the judicial sphere.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Regarding the infractions issued by the state of São Paulo, all had unfavorable decisions at the first instance, and one of the cases is already in the final administrative instance, considering the special appeal filed by the Company. The other cases await judgment by the TIT.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is litigating the matter in the administrative tribunals of the states. The Company estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$804.4 million (R$730.3 million on December 31, 2022).</p></td> <td id="xdx_98E_eifrs-full--OtherExpenseByNature_pn5n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSZFMMember_zkpoZ6N7gXKf" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>804.4</b></span></td> <td id="xdx_98D_eifrs-full--OtherExpenseByNature_pn5n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSZFMMember_zp0qsVcFwvL4" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>730.3</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>6</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ICMS - Prodepe</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.2pt">In 2015, Ambev received Infraction Notices issued by the State Treasury Department of Pernambuco for the collection of ICMS differences due to the alleged non-compliance with the rules of the Pernambuco Development Program - "PRODEPE," due to the rectification of its ancillary obligations.</span></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.2pt">In 2017, the Company obtained a final favorable decision recognizing the nullity of one of the infraction notices, due to formal errors. However, in September 2018, Ambev received a new infraction notice to discuss the same matter. In this new case, in June 2020, a first-instance decision partially favorable to the Company was rendered, recognizing errors by the tax auditor in the calculation of the incentive. The favorable portion of the decision is definitive, and for the unfavorable portion, the discussion will proceed to the judicial sphere. Additionally, there are other infraction notices related to PRODEPE, some of which are already being discussed in the judicial realm. </span></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="letter-spacing: -0.2pt">The Company estimates that the total updated value of possible risk involved in the processes related to this matter, as of December 31, 2023, is approximately R$739.4 million (R$663.9 million on December 31, 2022).</span></p></td> <td id="xdx_982_eifrs-full--OtherExpenseByNature_pn5n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSProdepeMember_zm6gyjVzr7hf" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>739.4</b></span></td> <td id="xdx_988_eifrs-full--OtherExpenseByNature_pn5n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSProdepeMember_z4qH1O8taDrg" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>663.9 </b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>7</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ICMS – FAIN </b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In recent years, Ambev has received infraction notices issued by the State Department of Finance of Paraíba for the collection of ICMS related to the Fund for Industrial Development Support of Paraíba (FAIN). The infractions stem from a controversy regarding the transfer of the tax incentive from the former Companhia de Bebidas das Américas to its successor Ambev S.A., as well as methodological issues regarding the calculation of the benefit. The Company is contesting these infractions in administrative and judicial courts. Ambev estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$647.4 million (R$591.4 million on December 31, 2022).</p></td> <td id="xdx_984_eifrs-full--OtherExpenseByNature_pn5n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSFAINMember_zy0gVB3T2Tw7" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>647.4</b></span></td> <td id="xdx_987_eifrs-full--OtherExpenseByNature_pn5n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSFAINMember_zhfLOQdzOMq6" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>591.4</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>8</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ICMS – AM</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2016, Arosuco (a subsidiary of Ambev) received infraction notices issued by the State Department of Finance of Amazonas for alleged differences in ICMS due to questions about the calculation base applied in sales operations from Ambev to its subsidiaries. After unfavorable decisions at the first instance for Arosuco, appeals were filed, awaiting judgment in the state's administrative tribunal. Arosuco estimates that the updated value classified as a possible loss involved in these processes, as of December 31, 2023, is approximately R$605.8 million (R$561.5 million on December 31, 2022).</p></td> <td id="xdx_983_eifrs-full--OtherExpenseByNature_pn5n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSAMMember_zDJu7QHTXBt1" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>605.8</b></span></td> <td id="xdx_98D_eifrs-full--OtherExpenseByNature_pn5n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSAMMember_zCHvMz93S2e2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>561.5</b></span></td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>9</b></span></td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 77%"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ICMS FISCAL WAR</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries have received tax assessment notices from the states of São Paulo, Rio de Janeiro, Minas Gerais, among others, related to the legality of the appropriation of ICMS credits in transactions covered by tax incentives granted by other states. The Company is challenging these assessments in administrative and judicial courts.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2020, the Brazilian Supreme Court (STF) ruled, under the system of general repercussion, on Case No. 628,075, recognizing the constitutionality of the unilateral disallowance, by destination states, of ICMS credits arising from tax incentives granted by other states. The decision also acknowledged that any collection of these credits should preserve the effects of the validation of tax incentives, as provided for in Complementary Law No. 160/2017. This decision does not change the likelihood of loss of the cases involving the Company and its subsidiaries.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Regarding assessments received from the state of São Paulo regarding credits originating from the state of Amazonas, there were unfavorable decisions at the second administrative level in the second quarter of 2022. In these cases, the Company filed appeals with the second administrative level in the same year. In December 2023, there was a favorable decision by the STF (Writ of Non-Compliance with a Fundamental Precept, ADPF No. 1004) to recognize the unconstitutionality of São Paulo's tax authorities' decisions questioning the validity of credits from the state of Amazonas. Thus, although the Company is not a party to this STF judgment, there was a favorable impact on the cases under discussion, resulting in a reassessment of the likelihood of success of the cases on this topic from possible to remote, reducing the reported contingency by approximately R$1 billion.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On the other hand, regarding other assessments received from the states of São Paulo and Minas Gerais, among others, there were other favorable decisions in 2023, impacting the total value of the reported possible contingency.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ambev estimates that the updated amount involved in the cases, as of December 31, 2023, still classified as possible loss, is approximately R$530 million (R$1.7 billion on December 31, 2022).</p></td> <td id="xdx_984_eifrs-full--OtherExpenseByNature_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSFiscalWarMember_zhZLpfieVbGc" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 10%" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>530</b></span></td> <td id="xdx_984_eifrs-full--OtherExpenseByNature_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSFiscalWarMember_zsvGmPAWdSd2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; width: 10%" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1,690</b></span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>10</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>ICMS – MIP</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company and its subsidiaries have been receiving assessments from State Tax Authorities over the years, disallowing ICMS credits and demanding payment of the Differential Tax Rate (DIFAL) on the acquisition of intermediate production materials. According to the tax authorities, such materials are not physically related to the productive activity of the companies and therefore should be considered as goods for consumption, which do not entitle the taxpayer to tax credits. Considering these allegations as illegitimate, the companies are challenging these assessments before administrative and judicial courts. Provisions have been made for cases related to this matter, with an updated value of approximately R$116 million as of December 31, 2023 (R$113.4 million in December 2022). The Company estimates the possible loss related to this matter to be, as of December 31, 2023, approximately R$447.5 million (R$388.7 million as of December 31, 2022).</p></td> <td id="xdx_98E_eifrs-full--OtherExpenseByNature_pn5n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSMIPMember_zzZkX8ZmRaCl" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>447.5</b></span></td> <td id="xdx_98D_eifrs-full--OtherExpenseByNature_pn5n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ICMSMIPMember_ziMOYyzcXA2i" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total updated amount of possible risk/loass"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>388.7</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Other processes </b></span></td> <td colspan="2" style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Estimates </b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>(in million of Brazilian Reais)</b></p></td></tr> <tr style="background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>#</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Description of the main processes</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2023</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2022</b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Proposed class action in Quebec</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Labatt and other, third-party defendants have been named in a proposed class action lawsuit in the Superior Court of Quebec seeking unquantified compensatory and punitive damages. The plaintiffs allege that the defendants failed to warn of certain specific health risks of consuming defendants’ alcoholic beverages. A sub-class of plaintiffs further alleges that their diseases were caused by the consumption of defendants’ products. The proposed class action has not yet been authorized by the Superior Court.</p></td> <td id="xdx_981_eifrs-full--OtherExpenseByNature_pn6n6_c20230101__20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ProposedClassActionInQuebecMember_zcRwWug0Pfo1" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5842">-</span></b></span></td> <td id="xdx_989_eifrs-full--OtherExpenseByNature_pn6n6_c20220101__20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ProposedClassActionInQuebecMember_z54nMiqcE9Il" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5843">-</span></b></span></td></tr> <tr> <td style="width: 3%"> </td> <td style="width: 77%"> </td> <td style="width: 10%"> </td> <td style="width: 10%"> </td></tr> </table> <p id="xdx_8A5_z4KVbUZFLjR6" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>27.2.2 Main active contingencies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The main contingent assets are summarized in the tables below.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border: Black 1pt solid; vertical-align: top; width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> </td> <td style="border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 96%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Contingent assets </b></span></td></tr> <tr style="vertical-align: top"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>#</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>Description of the main processes</b></span></td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>1</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Exclusion of ICMS and ICMS-ST from the calculation bases of PIS and COFINS</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In 2017, the Supreme Federal Court (STF) ruled that the inclusion of ICMS in the calculation bases of PIS and COFINS is unconstitutional (Theme 69 of general repercussion).</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recently, on December 13, 2023, the Superior Court of Justice (STJ) ruled favorably on Theme 1,125 for taxpayers, meaning the exclusion of ICMS-ST from the calculation bases of PIS and COFINS for substituted taxpayers, with the publication of the respective ruling pending. Regarding this matter, from 2017 to 2023, the Company and its subsidiaries recognized tax credits totaling R$10.5 billion.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The unredeemed amounts remain recorded as assets (see Note18 - <i>Recoverable Taxes</i>) and mainly refer to the tax credit from "REFRI" (period from 2009 to 2015), whose legal action is in the expert phase. The above-mentioned values were recognized in accordance with IAS 37 - <i>Provisions, Contingent Liabilities, and Contingent Assets,</i> considering: (i) the realization of the gain being practically certain, in accordance with the decisions rendered by the STF in Theme 69 and by the STJ in Theme 1,125, and the specific circumstances of each concrete case, as well as due to (ii) the value being able to be estimated with reasonable certainty, through the survey of the respective documents and quantification of the overpayment.</p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For additional matters related to this subject, the contingent asset capable of estimation corresponds to approximately R$0.2 billion. Additional amounts may eventually be disclosed and recognized.</p></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 7.5pt"><b>2</b></span></td> <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cerbuco Brewing Inc. arbitration</b></p> <p style="font: 7.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cerbuco Brewing Inc., (“Cerbuco”) a Canadian subsidiary of Ambev, owns a 50% equity ownership in Cerveceria Bucanero S.A. (“Bucanero”), a joint venture in Cuba. In 2021, Cerbuco initiated an arbitration proceeding at the International Chamber of Commerce (“ICC”), relating to a potential breach of certain obligations relating to the joint venture, with the terms of reference being formally executed in 2022. Depending on the outcome of the arbitration proceedings, there may be an impact on Cerbuco's ability to influence the management of Bucanero's operations. As a result, Ambev’s ability to continue consolidating Bucanero into its financial statements may also be affected. Based on the opinion of Cerbuco’s Lawyers, the management estimate the chance of loss as possible. The amount involved has not yet been ascertained, as it depends on the outcome of the arbitration.</p></td></tr> </table> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Provisions are recognized when: (i) the Company has a present obligation (legal or constructive) as a result of past events; (ii) it is likely that a future disbursement will be required to settle the current obligation; and (iii) the amount of the obligation can be estimated reliably.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Provisions, except for those mentioned in the line item disputes and litigation, are determined by discounting the expected future cash flow, to a pre-tax rate, which reflects the current market assessments of the time value of money and, where appropriate, the risks specific to the liability.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Measuring the probability of loss includes evaluating the available evidence, the hierarchy of laws, the most recent court decisions, court precedents, their legal relevance, the history of occurrences and the amounts involved and the assessment of external lawyers.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>a) Disputes and Litigations</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A provision for disputes and litigation is recognized when it is more likely than not that the Company will be required to make future payments as a result of past events. Such items may include but are not limited to, claims, suits and actions filed by or against the Company relating to antitrust laws, violations of distribution and license agreements, environmental matters, employment-related disputes, claims from the tax authorities, and other matters.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>b) Contingent liabilities</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries have tax, civil and labor lawsuits defined as contingent liabilities, according to IAS 37, for which no provisions have been recorded, due to the prognosis assessment carried out by Management. Contingent liabilities are not recognized but are disclosed in this note.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>c) Contingent Assets</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Contingent assets are evaluated periodically to ensure that the stages of the claims are appropriately reflected in the financial statements. Contingent assets are not recognized, except when the Company's management believes that it is certain that an inflow of economic benefits will occur, in which case the asset and the corresponding gain are recognized in the financial statements for the period in which the change in estimate occurs. If the inflow of economic benefits becomes probable, the Company discloses the contingent asset. </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>d)Restructuring</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A provision for restructuring is recognized when the Company has approved a detailed restructuring plan, and the restructuring has either commenced or been announced. Costs relating to the ongoing and future activities of the Company are not provided for but are recognized when expenses are incurred. The provision includes the benefit commitments in connection with early retirement and redundancy schemes.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From the fourth quarter of 2023 onwards, the nomenclature of the "provisions" accounting policy was changed to "provisions, contingent liabilities and contingent assets”.</p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfOtherProvisionsChangesExplanatory_zT7PK0eynx87" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details)"> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B2_zs0qLmSjp1P7" style="display: none">Schedule of provision changes</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr> <td style="vertical-align: bottom; width: 35%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Taxes on sales</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Labor</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Civil</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 9pt Times New Roman, Times, Serif"><b>Other taxes </b></span><b><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(i)</sup></span></b></td> <td style="width: 12%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Restructuring</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2021</b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_z4Ita3bmgZ2g" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>218.6 </b></span></td> <td id="xdx_980_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_znnwLdQQogta" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>124.2 </b></span></td> <td id="xdx_980_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zanZkMuaTWrd" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>252.9 </b></span></td> <td id="xdx_980_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zS5oxfoFhr5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>163.0 </b></span></td> <td id="xdx_98E_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zFc8Fb0905Wf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>17.4 </b></span></td> <td id="xdx_983_eifrs-full--Provisions_iS_pn5n6_c20220101__20221231_zXOe3n4fltqa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>776.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of changes in foreign exchange rates</span></td> <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zmEcrJjVozob" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5539">-</span>   </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zYLh8IXFevD3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(4.6)</span></td> <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zxeaHgW536T3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(17.5)</span></td> <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zj1qCwT05bva" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(8.1)</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zBbc9N3x1t64" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.0)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20220101__20221231_zlDGJ3uxgNal" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(32.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Additions</span></td> <td id="xdx_98D_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zjbKAw0Q77I3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">157.6 </span></td> <td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zUi0BxkdN10k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">194.2 </span></td> <td id="xdx_987_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zYLGhxQegchg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">312.7 </span></td> <td id="xdx_983_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zfSOlX4Jx3d7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">60.1 </span></td> <td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zbBzk5vqE2Ia" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5559">-</span>   </span></td> <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20220101__20221231_zPDhoLBW5q7b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">724.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions used </span></td> <td id="xdx_98C_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zpiTRX8h9qn4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(85.8)</span></td> <td id="xdx_989_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zt5HgR5WyB33" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(162.0)</span></td> <td id="xdx_982_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zBu9Xe3ccyDj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(196.6)</span></td> <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_z2epvUMYli6e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(7.2)</span></td> <td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zy4cELOeSrWd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(3.6)</span></td> <td id="xdx_98A_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20220101__20221231_zBBzYDhhC4Eb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(455.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions reversed</span></td> <td id="xdx_987_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zKaLZskV7ALa" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(43.3)</span></td> <td id="xdx_980_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zhIis7uae8Oe" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.7)</span></td> <td id="xdx_988_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_ztWNNuHHLJj1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.6)</span></td> <td id="xdx_98B_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zKP60npv6377" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(15.0)</span></td> <td id="xdx_98D_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zLohi24zkzN4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5577">-</span>   </span></td> <td id="xdx_985_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20220101__20221231_zHlzLjt8LLic" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(93.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2022</b></span></td> <td id="xdx_982_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zhkjU3OhVaK7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>247.1 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zZhiqimAbE8c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>132.1 </b></span></td> <td id="xdx_984_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zRPbBBSSfrH8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>335.9 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zTmbMFfGgbGc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>192.8 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zu3H9qunOgv" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>11.8 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iS_pn5n6_c20230101__20231231_z0vByqgNacE4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at beginning"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>919.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Effect of changes in foreign exchange rates</span></td> <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zyDf8zeu0lbh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5593">-</span>   </span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zSqNGrvUyUgi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(2.8)</span></td> <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zq4Nc3tbn3pj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(35.8)</span></td> <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zYKtEy18QsN5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.3)</span></td> <td id="xdx_984_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zSzkrJbnCBGf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(0.5)</span></td> <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_pn5n6_c20230101__20231231_zIBhDVwpBrE2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Effect of changes in foreign exchange rates"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(45.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Additions</span></td> <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zfItflJMpdxe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">135.7 </span></td> <td id="xdx_988_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zGPfmr2aOxMa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">247.8 </span></td> <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_z1PXIssdr0M9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">234.5 </span></td> <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zLxSvEakbU2g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">75.7 </span></td> <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zLYx8dnLjXUh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.2 </span></td> <td id="xdx_983_eifrs-full--AdditionalProvisionsOtherProvisions_pn5n6_c20230101__20231231_zcQyq4Irbpe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Additions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">696.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions used </span></td> <td id="xdx_987_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zt9UY18ECo2b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(27.3)</span></td> <td id="xdx_987_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zzcbDQXxZRSd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(181.7)</span></td> <td id="xdx_98E_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zHPa9Qsr8UEb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(121.9)</span></td> <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zOLGOG86Iybe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(40.8)</span></td> <td id="xdx_985_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zpukyswhGUn5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(11.2)</span></td> <td id="xdx_986_eifrs-full--ProvisionUsedOtherProvisions_iN_pn5n6_di_c20230101__20231231_zycgeIjcJ5M5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(382.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Provisions reversed</span></td> <td id="xdx_98F_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zgGhH5fv4Zua" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(73.2)</span></td> <td id="xdx_984_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zvNw2tDte99b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(45.5)</span></td> <td id="xdx_983_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_ziMEOUCaaXg3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(72.5)</span></td> <td id="xdx_985_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_znk4AL532dQb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(19.1)</span></td> <td id="xdx_98C_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_z11zMQNBUqMi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5631">-</span>   </span></td> <td id="xdx_989_ecustom--ProvisionReversedOtherProvisions_pn5n6_c20230101__20231231_zCVeZoamqC5a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provisions reversed"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(210.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>At December 31, 2023</b></span></td> <td id="xdx_989_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zW8wZPrCVNPd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>282.3 </b></span></td> <td id="xdx_98E_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zHJBxJ6uqjGf" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>149.9 </b></span></td> <td id="xdx_985_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_z0zvdmZweK3g" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>340.2 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zpXNfsQJFUxi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>202.3 </b></span></td> <td id="xdx_983_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zKsmWajAavf5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3.3 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iE_pn5n6_c20230101__20231231_zifdCSSKmBm1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Provision at ending"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>978.0 </b></span></td></tr> </table> <p style="font: 8pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Other taxes refer to provisions for lawsuits concerning taxes unrelated to income taxation. The uncertain tax treatments related taxes on profits with a prognosis of probable loss have their value reported directly in the income tax and social contribution payable, as per IFRIC 23 - <i>Uncertainty on the Treatment of Income Taxes</i>.</td> </tr></table> 218600000 124200000 252900000 163000000.0 17400000 776100000 -4600000 -17500000 -8100000 -2000000.0 -32200000 157600000 194200000 312700000 60100000 724600000 85800000 162000000.0 196600000 7200000 3600000 455200000 -43300000 -19700000 -15600000 -15000000.0 -93600000 247100000 132100000 335900000 192800000 11800000 919700000 -2800000 -35800000 -6300000 -500000 -45400000 135700000 247800000 234500000 75700000 3200000 696900000 27300000 181700000 121900000 40800000 11200000 382900000 -73200000 -45500000 -72500000 -19100000 -210300000 282300000 149900000 340200000 202300000 3300000 978000000.0 <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--DisclosureOfTheDisbursementExpectativeOfTheProvisionsTextBlock_zWepnaxxosw8" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 1)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_z4h7kc9RVnu9" style="display: none">Schedule of expected settlement of provision</span> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 36%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td> <td style="width: 4%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Non-current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Current</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Provision for disputes and litigation</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Taxes on sales</span></td> <td id="xdx_983_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zIUuAQ5RQqtd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">168.6 </span></td> <td id="xdx_98E_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zcKDqVDMpOAe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">113.7 </span></td> <td id="xdx_984_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_z7jHOfoEDf3j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">282.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zXGLPVh5onLb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">193.8 </span></td> <td id="xdx_983_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zlWnudY6iQE9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">53.3 </span></td> <td id="xdx_98C_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--ProvisionForTaxesOtherThanIncomeTaxMember_zOs3ocgAZdwg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">247.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Labor</span></td> <td id="xdx_985_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zNWNpnkSQcH9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">82.7 </span></td> <td id="xdx_98D_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zcnVM1RPT405" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">67.2 </span></td> <td id="xdx_983_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zBTVXQD2fkMe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">149.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_z7YFN696NGBh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">104.9 </span></td> <td id="xdx_987_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_zyJ39KxMkzT3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27.2 </span></td> <td id="xdx_988_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--ProvisionsForLaborMember_z0rfyUlb1XWg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">132.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Civil</span></td> <td id="xdx_989_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zCGIuy5hhpfa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">113.4 </span></td> <td id="xdx_98F_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_z0EOX4xSZlL3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">226.8 </span></td> <td id="xdx_980_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zToIJBugdDq9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">340.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zGoGTXUqiwce" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">263.0 </span></td> <td id="xdx_98F_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zrpqBswCSaU3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">72.9 </span></td> <td id="xdx_98C_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--LegalProceedingsProvisionMember_zjDjnydOrxP8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">335.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other taxes</span></td> <td id="xdx_984_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zakf7PZuDsD1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">194.9 </span></td> <td id="xdx_984_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zo3PsN8Z4Lm8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.4 </span></td> <td id="xdx_98E_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zce2t0e6r2Ll" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">202.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zVnt6DrZDuH3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">170.1 </span></td> <td id="xdx_982_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zUuTcJGh2ww8" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">22.7 </span></td> <td id="xdx_98E_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--MiscellaneousOtherProvisionsMember_zykJs1yJdAo1" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">192.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total provision for disputes and litigation</b></span></td> <td id="xdx_98E_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zSAguCpIeuV3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>559.6 </b></span></td> <td id="xdx_985_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zvFwM4jd0vo4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>415.1 </b></span></td> <td id="xdx_98C_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zYeyG7cUR0B1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>974.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zfDTTmpOUpxd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>731.8 </b></span></td> <td id="xdx_98C_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zgZ1Bs0BA9K6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>176.1 </b></span></td> <td id="xdx_989_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__custom--TotalContingentProvisionsMember_zSqMMY3w5RRj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>907.9 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Restructuring</span></td> <td id="xdx_98C_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zNEafNDxMdS3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5710">-</span>   </span></td> <td id="xdx_98C_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_ziApB7TYWl1i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.3 </span></td> <td id="xdx_98F_eifrs-full--Provisions_iI_pn5n6_c20231231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zVvVcsaALhSl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zBncDUgMLFFh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7.2 </span></td> <td id="xdx_988_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zgow7bfLl7T1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">4.6 </span></td> <td id="xdx_985_eifrs-full--Provisions_iI_pn5n6_c20221231__ifrs-full--ClassesOfProvisionsAxis__ifrs-full--RestructuringProvisionMember_zQ6hwp2OMsb2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">11.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total provisions</b></span></td> <td id="xdx_98C_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20231231_zO5MxeM3zsye" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Non-current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>559.6 </b></span></td> <td id="xdx_98E_eifrs-full--CurrentProvisions_iI_pn5n6_c20231231_zOWpWfvYgOUj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>418.4 </b></span></td> <td id="xdx_986_eifrs-full--Provisions_iI_pn5n6_c20231231_zJgesCX3GGyj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total provisions"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>978.0 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--NoncurrentProvisions_iI_pn5n6_c20221231_zZ4bNlNyaDp1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>739.0 </b></span></td> <td id="xdx_980_eifrs-full--CurrentProvisions_iI_pn5n6_c20221231_zCHWqRL3mMJc" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>180.7 </b></span></td> <td id="xdx_98F_eifrs-full--Provisions_iI_pn5n6_c20221231_zzXEIHfBEQTj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>919.7 </b></span></td></tr> </table> 168600000 113700000 282300000 193800000 53300000 247100000 82700000 67200000 149900000 104900000 27200000 132100000 113400000 226800000 340200000 263000000.0 72900000 335900000 194900000 7400000 202300000 170100000 22700000 192800000 559600000 415100000 974700000 731800000 176100000 907900000 3300000 3300000 7200000 4600000 11800000 559600000 418400000 978000000.0 739000000.0 180700000 919700000 <table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--DisclosureOfEstimatesOfPossibleLossesTextBlock_zK6SqkTBDKH9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - PROVISIONS, CONTINGENT LIABILITIES AND CONTINGENT ASSETS (Details 2)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_zlQcF6qJ7yfd" style="display: none">Schedule of contingencies</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 50%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 28%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Income tax and social contribution</span></td> <td id="xdx_986_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IncomeTaxAndSocialContributionMember_zqNthJEMwPI" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">63,621.0 </span></td> <td id="xdx_986_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--IncomeTaxAndSocialContributionMember_zhFtcyLGG0z5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">60,453.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Value-added and excise taxes</span></td> <td id="xdx_983_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ValueAddedAndExciseTaxesMember_zZhl5LRKgDZf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">26,761.0 </span></td> <td id="xdx_985_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--ValueAddedAndExciseTaxesMember_zUXwHGByrgbk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">25,904.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">PIS and COFINS</span></td> <td id="xdx_981_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--PISAndCOFINSTaxContingentLiabilityMember_zggXWyoxSBd7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,496.2 </span></td> <td id="xdx_980_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__custom--PISAndCOFINSTaxContingentLiabilityMember_zZeSubtnhGna" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,293.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Others</span></td> <td id="xdx_987_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--OtherContingentLiabilitiesMember_zeWVY2H80TB3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,679.4 </span></td> <td id="xdx_986_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--OtherContingentLiabilitiesMember_zuoveF3IyCt3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,909.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20231231_zlL3OgfnUR7f" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>95,557.6 </b></span></td> <td id="xdx_984_eifrs-full--EstimatedFinancialEffectOfContingentLiabilities_iI_pn5n6_c20221231_zSE7OE18MyGl" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Estimates of amounts of possible losses"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>91,560.7 </b></span></td></tr> </table> 63621000000.0 60453500000 26761000000.0 25904600000 3496200000 3293500000 1679400000 1909100000 95557600000 91560700000 27439000000 13846000000 14302000000 12596000000 6505000000 11122000000 6075000000 7280000000 2618000000 2334000000 1412000000 2218000000 1372000000 1257000000 633400000 581500000 316000000 5200000000 278000000 251000000 187000000 548000000 1690000000 10669000000 9292000000 6307000000 5825000000 1824000000 1703000000 1776000000 1559000000 804400000 730300000 739400000 663900000 647400000 591400000 605800000 561500000 530000000 1690000000 447500000 388700000 <p id="xdx_808_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zG6grNHvP3mc" style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_034"></span><b>28.</b></td><td><b><span id="xdx_825_zHHxV7HBuWU9">FINANCIAL INSTRUMENTS AND RISKS</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.1Financial instruments categories</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The financial instruments held by the Company are managed through operational strategies and internal controls to assure liquidity, profitability, and transaction security. Transactions involving financial instruments are regularly reviewed to assess the effectiveness of the risk exposure that management intends to cover (foreign exchange, and interest rate, among others).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The table below shows all of the consolidated financial instruments recognized in the financial statements, segregated by category:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_896_eifrs-full--DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_pn5n6_zlPqbUf2SsT9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details)"> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zuO7pEo5VfR" style="display: none">Schedule of consolidated financial instruments</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: top; width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Assets</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Amortized cost</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash and cash equivalents less bank overdrafts (Note 21.1)</span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetCashAndCashEquivalentsMember_zMg4esQUL5p9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16,059.0 </span></td> <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetCashAndCashEquivalentsMember_zPZMeSSf6YZ3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,852.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade receivables excluding prepaid expenses </span></td> <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zNHrakCtzIk3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,566.7 </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_z4S879lnne16" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,791.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment securities (Note 21.2)</span></td> <td id="xdx_98D_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zQV0Azw1Vgw4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">242.2 </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zSyjoOwkhWqb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_98F_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zjyHnmIYDKfa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,867.9 </b></span></td> <td id="xdx_985_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zME1N6N5eWX9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>22,862.6 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value through profit or loss</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment securities (Note 21.2)</span></td> <td id="xdx_983_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zfXzspA3qyt3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">277.2 </span></td> <td id="xdx_980_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zhqB2mvimema" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">454.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Derivatives hedges (Note 28)</span></td> <td id="xdx_985_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--DerivativeHedgeMember_zyDLeIxtuUm9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">379.7 </span></td> <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--DerivativeHedgeMember_z2ZIC2obuRC7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">273.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_982_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zbHgrlfPxt21" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>656.9 </b></span></td> <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_z53qVc8eSsld" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>728.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total assets</b></span></td> <td id="xdx_989_eifrs-full--FinancialAssets_iI_pn5n6_c20231231_zxrtpAaFzPQ8" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>24,524.8 </b></span></td> <td id="xdx_98A_eifrs-full--FinancialAssets_iI_pn5n6_c20221231_z7OQJiIkodk1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,590.9 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Liabilities</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Amortized cost</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade payables (Note 26)</span></td> <td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradePayableMember_z0PKkWP8MONh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,502.4 </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradePayableMember_zeHwrJPAbwOc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">24,837.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest-bearing loans and borrowings (Note 23)</span></td> <td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--InterestbearingLoansAndBorrowingsMember_zYpbb4UBnjx7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,501.1 </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--InterestbearingLoansAndBorrowingsMember_z4tTfFNKLi95" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,770.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other liabilities</span></td> <td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zVIkatgb4mL2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,129.6 </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zNgjtGVdr9Fj" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,015.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zSVGJiHUIwJk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>29,133.1 </b></span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zT3SeotrCpzf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>30,624.2 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value through profit or loss</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Put options granted on subsidiaries</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PutOptionGrantedOnSubsidiaryMember_zdtGD3t3WEie" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,791.1 </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PutOptionGrantedOnSubsidiaryMember_zN9XJXSmvu6k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,060.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Derivatives hedges (Note 28)</span></td> <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeHedgeMember_z2ziCZREHoO4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">763.1 </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeHedgeMember_z1czDvzNEQpa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">729.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other liabilities</span></td> <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zrkb0kPGijrf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">272.6 </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zgxwqb2MIIJ5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">333.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zsqGoaXwqg0c" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,826.8 </b></span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zmeyK9qM2Jdh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,123.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total liabilities</b></span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231_z4XeSs1eYHTk" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>32,959.9 </b></span></td> <td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231_zEbuIaAetFSe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>34,747.6 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Put options granted on subsidiaries: the Company constituted a liability related to the acquisition of a non-controlling interest of the operations in the Dominican Republic. This financial instrument is denominated in US Dollars (Tranche A) and Dominican Pesos (Tranche B) and is recorded by an entity, whose functional currency is the Real. The Company assigned this financial instrument as a hedging instrument for a portion of its net assets located in subsidiaries whose functional currency is the US Dollar and the Dominican Peso, in such a manner that the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.</td> </tr></table> <p id="xdx_8A8_zM0k6yihoeQh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.2 Derivative financial instruments</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The use of derivative financial instruments by the Company follow strictly the Financial Risk Management Policy (“Policy”) approved by Management. The instruments authorized by the Policy are Futures contracts traded on exchanges, full deliverable forwards, non-deliverable forwards, swaps, and options. The Policy excludes the use of derivatives when they are not related to the Company's business. At December 31, 2023, the Company and its subsidiaries had no target forwards, swaps with currency verification, or any other derivative transactions representing a risk level above the nominal value of the contracts. The derivative operations are managed on a consolidated basis and classified based on the strategy according to their purposes, as follows:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">i) Cash flow hedge derivative instruments</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ii) Fair value hedge derivative instruments.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">iii) Net investment hedge derivative instruments.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with the hedge accounting, the effective hedge amount is recorded in equity and, in the event of an ineffective portion this result is recorded immediately in finance result during the period ineffectiveness was identified, for cash flow hedge and net investment hedge</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures derivative financial instruments by calculating their fair value, using market curves that impact the value of the instrument as at the computation date. In the case of swaps, the asset and the liability positions are estimated independently and brought to their fair value, equivalent to the difference between the results of the asset and liability amounts, which generates the swap’s market value. For traded derivative financial instruments, the fair value is calculated based on the exchange-listed price. The following tables summarize the exposure identified and protected in accordance with the Company's Risk Policy.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>Transactions protected by derivative financial instruments in accordance with the Financial Risk Management Policy</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_893_eifrs-full--DisclosureOfFinancialRiskManagementExplanatory_pn5n6_zs35v0fSHp0k" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 1)"> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zzWuJ8DUXS25" style="display: none">Schedule of financial risk management</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="11" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair Value</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Gain / (Losses)</b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Hedge position</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Notional</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liability</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Finance Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Operational Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Equity</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zhppTnBF5t3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,374.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zE3PJkScZ235" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>379.5 </b></span></td> <td id="xdx_983_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zoWScPWc6Pnd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(742.0)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zlQooETIntg4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,639.6)</b></span></td> <td id="xdx_98F_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zBr4jnHwrNP4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>34.6 </b></span></td> <td id="xdx_982_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zsPhq1GOFoU3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(285.2)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Commodities</i></span></td> <td id="xdx_985_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zo8WGvHXPFK4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,025.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zRQo6Ztwv36e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">198.3 </span></td> <td id="xdx_988_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z2UhTTUDtDf1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(219.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zFSWhujzK8L1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(388.3)</span></td> <td id="xdx_983_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z45RrSe7iVk9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(336.2)</span></td> <td id="xdx_985_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zrXo93jAzVdg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(105.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zcMKF8mJsl1d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,200.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zwkFUTfcyfAa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">164.9 </span></td> <td id="xdx_98D_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z7oL2lkvQjAi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(522.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zBVRmRdLTWo4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,250.7)</span></td> <td id="xdx_983_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z9M5F0fOAcub" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">363.9 </span></td> <td id="xdx_989_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zIrXGT3jZJy2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(182.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Euros</span></td> <td id="xdx_98C_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zjla5UY5BAQe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_z8B0wHAHLfLh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_98D_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zQYDee7acy73" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zrZSuZ4uHFQ5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td> <td id="xdx_98F_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zK6CrFDsTbpf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.6 </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zg29Lq0Tr0gg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mexican Pesos</span></td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zofBAeR9GzR1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zRqyThmZgWc2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.2 </span></td> <td id="xdx_98B_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z0zChYbqYSji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl5973">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zIkgNeL6OVkb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td> <td id="xdx_98D_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zSbNlIlpkMj4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.3 </span></td> <td id="xdx_987_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zcY66mSkq8Tl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Importing of fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zkAI0DpWs3kf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>249.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zruuN6LhpJkf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.1 </b></span></td> <td id="xdx_980_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zbgT1X393yC5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zWFtQgMlk6P1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11.0 </b></span></td> <td id="xdx_987_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zgpCp5139EIb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3.4 </b></span></td> <td id="xdx_986_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zBQq5bxcHaNh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_989_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zYNctYtnGHVh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">249.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zrwUIDgfzSk5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_984_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zhfaKRWDWcP3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zMxFSiltnFy3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.0 </span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z5rC5edP2bUb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.4 </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zm7vcu4mFjyi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z45Kiz1Z9krf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>64.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zEJJ4nyldn8c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.1 </b></span></td> <td id="xdx_987_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zThHKk3I1ST8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zwo5VgGCQrla" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(25.6)</b></span></td> <td id="xdx_986_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z4xkighVBIBa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(0.1)</b></span></td> <td id="xdx_985_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zH44IOzgEYJf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_982_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_z6LSyQQBfnbd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zMwzfQlFHEfh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_984_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zf7YslgMM6ma" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zLfWuPNbcAd8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(25.6)</span></td> <td id="xdx_981_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zohPeOsPvK8l" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td> <td id="xdx_98A_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zElBjMhNf6f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zsRFVikULuUa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(59.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zaUuaQI5EX7g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6031">-</span>   </b></span></td> <td id="xdx_989_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zdhDcYIWMEud" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CashUMember_zPQ6Vrr6NOC9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>13.7 </b></span></td> <td id="xdx_98E_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zOnQ7dR5cUpb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6037">-</span>   </b></span></td> <td id="xdx_985_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zNgbRt5RnBp4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6039">-</span>   </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_98F_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zD8Lbvngqun3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zb8hRjw14Yae" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6043">-</span>   </span></td> <td id="xdx_988_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfThCashExposureMember_zkHSQfGxFMuh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsCashMember_zIOysWG6DXB6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.7 </span></td> <td id="xdx_98A_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zZsg0Y699S75" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6049">-</span>   </span></td> <td id="xdx_98B_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zuG7nn1VnSx6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6051">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zGAGMWR9grn2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,629.3 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zEkwalViIadi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>379.7 </b></span></td> <td id="xdx_980_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z01huxrTG8G5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(763.1)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td id="xdx_985_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z1tNir0Uj0g7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,640.5)</b></span></td> <td id="xdx_98B_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_znzLMNONXd9e" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>37.9 </b></span></td> <td id="xdx_984_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zHlLix2pDin3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(279.1)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair Value</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Gain / (Losses)</b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Hedge position</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Notional</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liability</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Finance Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Operational Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Equity</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zFodAyI9T6Nl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>19,853.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zLYwzaiabHik" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>271.8 </b></span></td> <td id="xdx_985_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zVQA1gJYVtFi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(719.4)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zjqdrqngchsc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,075.2)</b></span></td> <td id="xdx_982_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_z1EGDJ9LfGZj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>452.7 </b></span></td> <td id="xdx_98A_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zwbLUYdDqeik" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>134.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Commodities</i></span></td> <td id="xdx_984_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zd7Eejo02Ow8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,809.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zcn9nIW5tW4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.8 </span></td> <td id="xdx_98D_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zawLMZatr7Oi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(376.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zLx3nx4JRda3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63.5 </span></td> <td id="xdx_987_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zWCBZdf2ytF6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.3)</span></td> <td id="xdx_986_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_ziqThTBfgHl9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(475.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_989_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zwmd8LsZ3CS1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14,874.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zrE7Fk31mQe8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">157.7 </span></td> <td id="xdx_98B_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zsWFRioKyfJl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(342.9)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zH64DQbXXieb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,139.2)</span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z2CFlTXgOybc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">477.1 </span></td> <td id="xdx_983_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zuG52QaQOlb8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">596.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Euros</span></td> <td id="xdx_987_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_z6KgHQo0jD7g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">32.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zUFVpWNdUgBk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.9 </span></td> <td id="xdx_981_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zurstqKGlIyc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6109">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zA0nB8XK6CEb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.7)</span></td> <td id="xdx_988_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zhnQHsoD3Mo8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.3)</span></td> <td id="xdx_987_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zRhKULmoIEnl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mexican Pesos</span></td> <td id="xdx_98B_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zvNBop3HNz8b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">136.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z8z22LhhzNnf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.4 </span></td> <td id="xdx_982_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zjZQfh1UJcc9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zLe6xFES30ij" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.2 </span></td> <td id="xdx_984_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zIyGuMWd6fpj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td id="xdx_982_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zWNNOx6dFxj1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zQBisiiZv919" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>226.8 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zRRQBxuDmff5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1.5 </b></span></td> <td id="xdx_981_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_z7VxcczGSmy5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5.4)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zkUMCI0vqPff" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5.9)</b></span></td> <td id="xdx_985_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zlEfAl7QoKsk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4.9 </b></span></td> <td id="xdx_98D_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zni4xaLFchh5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(13.0)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_980_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z9xWFYXozcil" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">226.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zZoiDds3Qtf3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.5 </span></td> <td id="xdx_98B_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z6RPJVWLgbRk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zPARBApDuw6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.9)</span></td> <td id="xdx_98E_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zRlwWeGBzhc1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.9 </span></td> <td id="xdx_98B_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zfOTeeHCv115" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zyASmlpmAkFh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>204.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zWUSGGVLebwl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.5 </b></span></td> <td id="xdx_981_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zrOxCXfkhU78" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zlRZya2yCyX2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(42.5)</b></span></td> <td id="xdx_986_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zYI8IR4c8rEl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9.1 </b></span></td> <td id="xdx_98E_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zgLtgSe49hG2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_98E_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zisxQAyZuOb9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">204.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_z9sVvWee8uyh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.5 </span></td> <td id="xdx_986_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_z9K7w0n7wjUf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zQVwyZK3z2ih" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(42.5)</span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zDXbmsxskst7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.1 </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zRmoRhwCX008" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zPHqS1sXzKy3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6177">-</span>   </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zrlAuhu6ex1g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6179">-</span>   </b></span></td> <td id="xdx_987_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zmoQ8FS4neAk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6181">-</span>   </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CashUMember_zb4kbjN1nQEe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(17.1)</b></span></td> <td id="xdx_980_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_z00eDDt9xm96" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6185">-</span>   </b></span></td> <td id="xdx_986_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zFAuqdfPr2L3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6187">-</span>   </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">American Dollar</span></td> <td id="xdx_983_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_z8jF7Aeqc0b1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6189">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zmiNa6QLVoQk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6191">-</span>   </span></td> <td id="xdx_988_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfThCashExposureMember_zaWy0LpfGD34" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6193">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsCashMember_zCBXoT4VTUv2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(17.1)</span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_z6R06hP6qpik" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6197">-</span>   </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zF22Z8d8xZ5c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6199">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zyWCrPIzDQi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>20,285.0 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zpr2PWYZ5EW9" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>273.8 </b></span></td> <td id="xdx_984_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zoaA3RyeBgFa" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(729.4)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zGAD9qAc534b" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,140.7)</b></span></td> <td id="xdx_982_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zQuEIk5nYKxk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>466.7 </b></span></td> <td id="xdx_982_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zVYiuADqbS89" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>106.5 </b></span></td></tr> </table> <p id="xdx_8A7_ziOA5h4n2aMe" style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.2.1 Instrument maturity</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">As of December 31, 2023, the Notional and Fair Value amounts per instrument and maturity were as follow:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfNotionalAndFairValueAmountsPerFinancialInstrumentAndMaturityTextBlock_pn5n6_zsB3LT98qhdd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zZVDGIOKBKI2" style="display: none">Schedule of notional and fair value amounts per instrument and maturity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Notional Value</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Exposure</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2024</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2025</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2026</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&gt;2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zelfi7WFVJK3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>16,763.3 </b></span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zquWfjiGl1ef" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>610.9 </b></span></td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zNjJqmWmvXDc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6220">-</span>   </b></span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zlWsqgE5eRi9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6222">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zImwIMpkYj73" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6224">-</span>   </b></span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_z4nykce1gwna" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,374.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> Commodities </span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zraXa4YJgNtg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,924.3 </span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zwzBaBJMtL6c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">101.4 </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zVGlUr1TmzV4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6232">-</span>   </span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zThuYY1b4rWi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6234">-</span>   </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zKIRqIeCBRmi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6236">-</span>   </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zCVT1HJEOYwj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,025.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> US Dollars </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zvulmFLHQh3a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,690.5 </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zJOqDnhFqBR9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">509.5 </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zQFCbhBLfR7j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6244">-</span>   </span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zLs7CtEtngS6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6246">-</span>   </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zkFKuwiRSQli" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6248">-</span>   </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zAL9yIu3Kg27" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,200.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> Euros</span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zWNFKWppsLgk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.4 </span></td> <td id="xdx_98B_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_z37yf1fS0bw6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6254">-</span>   </span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_ziKsUqJ8qXgl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6256">-</span>   </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zZvOq5Zg1FVk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6258">-</span>   </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zaOQHtERKpHj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6260">-</span>   </span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zaWzF878dCqc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> Mexican Pesos </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z3owijnZpz76" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.1 </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zLzFqAHl5bTd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6266">-</span>   </span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z2ivV1vllQz2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6268">-</span>   </span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zLeLE9ogQ3K" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6270">-</span>   </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zkat9pawhUXf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6272">-</span>   </span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zzhJVIeQlkte" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Importing of fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zeGJlHE3uJO9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>249.7 </b></span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zfH8Y1UXFUY5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6278">-</span>   </b></span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zMhH9gE8TrV6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6280">-</span>   </b></span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zgCUBLhPPzb7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6282">-</span>   </b></span></td> <td id="xdx_988_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_z6VCWqTbBjs9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6284">-</span>   </b></span></td> <td id="xdx_988_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_z0ZCKj4f8U8b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>249.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars </span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zo2vjtzPZulj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">249.7 </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zPCBBMrOMMJ9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6290">-</span>   </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zEPI7r6v3RXf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6292">-</span>   </span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zF0Of7PxZzN8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6294">-</span>   </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zUVU0rfdGZY8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6296">-</span>   </span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z5F9r0dd8oBd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">249.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zFG9QmeSKQrc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>64.7 </b></span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zIgLG8cykBrd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6302">-</span>   </b></span></td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zk8L7LxDEA3e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6304">-</span>   </b></span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z2xMojF6QqGi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6306">-</span>   </b></span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zarjtBYuCDo5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6308">-</span>   </b></span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zhVKNpsEnJ53" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>64.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zmgYhDL4Pzi4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.7 </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zWj4dnXy9qJ2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6314">-</span>   </span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zWtULFasd3H8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6316">-</span>   </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zOzg3e6SLTTk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6318">-</span>   </span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zb0I0AW4kVTl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6320">-</span>   </span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zk2VN5d6NTOh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zm5qN7FCrlq6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(59.3)</b></span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zQhso0yg8Xhi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6326">-</span>   </b></span></td> <td id="xdx_984_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zuo1wQ7FGba8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6328">-</span>   </b></span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zN8rkKGfP5Q7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6330">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zqT16GQIhY79" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6332">-</span>   </b></span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zsllU1Bmyong" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(59.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_z2yX0UTnUez2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.3)</span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zCC4w82t13qc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6338">-</span>   </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zfXSM2g7cty7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6340">-</span>   </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zk3ihEta6KH1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6342">-</span>   </span></td> <td id="xdx_988_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zLqaUuV5PFeh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6344">-</span>   </span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zPCJvubsOAf2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zFRKRGD5bUk6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,018.4 </b></span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zbyRPTcTfHKd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>610.9 </b></span></td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zn7AcxrG6TWk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6352">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z5FYx5zCiAh7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6354">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z4QJfqCKR8Ke" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6356">-</span>   </b></span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zf1DOq5pzlG6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,629.3 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair Value</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Exposure</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2024</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2025</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2026</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&gt;2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Costs</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zMtagDVvK4Xf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(352.5)</b></span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zoH4ojC4sqe5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(10.0)</b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_z9WPNQFMHhlh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6364">-</span>   </b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zBwzlBXimyRa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6366">-</span>   </b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zBauzFhiCu4i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6368">-</span>   </b></span></td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zeo1TXGKf9Yh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(362.5)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Commodities</span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zOyRB9l1Dzkc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.2)</span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z0dwGBbTSnHj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.9)</span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zh5EUaKlfTuj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6376">-</span>   </span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zoawOufZ6GFi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6378">-</span>   </span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zuMeF0l3xsi6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6380">-</span>   </span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zr5QvLHkFRfb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zirt6apqgxMb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(354.4)</span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zQoEoVfrwnB6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.1)</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zjRe9qQdKmU2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6388">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zaO7Y9HFKEPi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6390">-</span>   </span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zqzP1nt16qOb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6392">-</span>   </span></td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z758XsihToI9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(357.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Euros</span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zPR0ftcvB2j4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zXmV4inPxK6h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6398">-</span>   </span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zYXhCf1boLQe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6400">-</span>   </span></td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zJ1nCgxfJxlj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6402">-</span>   </span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zstCdyQu2D25" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6404">-</span>   </span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zuWzAIXlCuIl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mexican Pesos</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zOWpZblb3nOf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.2 </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zc3ylL746zkk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6410">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_ze2y4ix7zyHh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6412">-</span>   </span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zWLJhIM2Yx0b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6414">-</span>   </span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zfpwHyh1Y4Fe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6416">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zkE4jQAfNiIl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Importing of fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zcjoBJu4JFdg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.5)</b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zBxltIM7IX32" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6422">-</span>   </b></span></td> <td id="xdx_98C_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zuIhohYrSTWi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6424">-</span>   </b></span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zmFRIIOMesl7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6426">-</span>   </b></span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zByHVptc2XU4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6428">-</span>   </b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zfGSMBRp1zLe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.5)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zr4zfgKBsTIj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.5)</span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zKfmZ9X8pxH4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6434">-</span>   </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zB3haA1XMoi2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6436">-</span>   </span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zqGk15UgLMmg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6438">-</span>   </span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_ziXAnhnqo6i9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6440">-</span>   </span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zU39FNjfMFF7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zAvckgKvvjG5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.1)</b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zTHJh8XWje89" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6446">-</span>   </b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zbxTgpMh2iL8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6448">-</span>   </b></span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zaEpWMjCgcre" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6450">-</span>   </b></span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zSnMOk34hjIj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6452">-</span>   </b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zajYjSCK8wI5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.1)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zH5Cv0epzw1i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zxO0aGWYPOE9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6458">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zAXZUj3caF3c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6460">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zfejDUH1gFMh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6462">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zEFk4aq1R1P" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6464">-</span>   </span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zZtAn3zwyGl1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_z99ycWic0a3d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2.3)</b></span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zbhGNneVntmh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6470">-</span>   </b></span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zI03HGkJi9Gf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6472">-</span>   </b></span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zTH2BoGVXRO4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6474">-</span>   </b></span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_z5QqSMFahWch" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6476">-</span>   </b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zYeCSCIAZtq5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zzpKKexi0wRi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zOnzaLf444Xg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6482">-</span>   </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zH6UVrztfJtd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6484">-</span>   </span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zy4ngYJ3DXsj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6486">-</span>   </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zEDmegvy3xHi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6488">-</span>   </span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zWsAJmoVx5Fc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z2M6OcnkE2Kh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(373.4)</b></span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zSzjr5twEudb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(10.0)</b></span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zoqJDUqTpNL2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6496">-</span>   </b></span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zp8QY8p4W5Li" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6498">-</span>   </b></span></td> <td id="xdx_98C_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zdSvo1vRvk42" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6500">-</span>   </b></span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zRfuMOkd8WRf" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(383.4)</b></span></td></tr> </table> <p id="xdx_8A8_zW4QeMYaWif" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Margins pledged as guarantees</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to comply with the guarantee requirements regarding derivative exchanges and/or counterparties to certain operations with derivative financial instruments, as at December 31, 2023, the Company held R$<span id="xdx_908_ecustom--InstrumentsSharingCharacteristicHighlyLiquidInvestments_iI_pn5n6_c20231231_zltmic4DShJi" title="Instruments sharing characteristic, highly liquid investments">197.7</span> in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (R$<span id="xdx_906_ecustom--InstrumentsSharingCharacteristicHighlyLiquidInvestments_iI_pn5n6_c20221231_zZUOsqPwsWS9" title="Instruments sharing characteristic, highly liquid investments">376.9</span> as at December 31, 2022).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.3 Classification of financial instruments </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--DisclosureOfFinancialInstrumentsFairValueHierarchyTextBlock_pn5n6_z0gwmKexcZz4" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B8_z6wnUZvzDAvl" style="display: none">Schedule of fair value measurement</span></td> <td id="xdx_49C_20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zHravdD0Q208" style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_499_20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zjdyGOdYzoge" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49F_20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zDL6v02gQbgl" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49B_20231231_z5TL3e1hdfsc" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_495_20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zy5JPUIoIwU9" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49F_20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zwfJVCmeMSik" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_499_20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zYgBsEicShc2" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_496_20221231_zubOWmEPt1Tk" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 40%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 2</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 3</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Total </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 2</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 3</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="text-decoration: underline">Financial assets</span></b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_ecustom--FinancialAssetsInvestmentSecurities_iI_maFAAFVzYE9_zIrnL93mCnGd" style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investment securities</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">277.2 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6512">-</span>   </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6513">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">277.2 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">454.5 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6516">-</span>   </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6517">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">454.5 </span></td></tr> <tr id="xdx_40D_ecustom--DerivativeFinancialAssetsHeldForHedgingOperationalHedges_iI_pn5n6_maFAAFVzYE9_zJS60l5o5ZS9" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives – operational hedge</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">53.4 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">326.3 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6522">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">379.7 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">57.0 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">216.8 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6526">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">273.8 </span></td></tr> <tr id="xdx_406_eifrs-full--FinancialAssetsAtFairValue_iTI_pn5n6_mtFAAFVzYE9_zTTElt14DT8j" style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> <b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>330.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>326.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6531">-</span>   </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>656.9 </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>511.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>216.8 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6535">-</span>   </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>728.3 </b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="text-decoration: underline">Financial liabilities</span></b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_403_ecustom--PutOptionsGrantedOnSubsidiaries_iI_maFLAFVzLKz_znFWrl9zRoda" style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Put options granted on subsidiaries</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6538">-</span>   </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6539">-</span>   </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,791.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,791.1 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6542">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6543">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,060.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,060.3 </span></td></tr> <tr id="xdx_40E_eifrs-full--OtherFinancialLiabilities_iI_maFLAFVzLKz_zjyMxDaWELgk" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other liabilities</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6547">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6548">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">272.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">272.6 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6551">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6552">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">333.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">333.7 </span></td></tr> <tr id="xdx_40A_ecustom--DerivativesLiabilitiesAtFairValueThroughProfitAndLoss_iI_pn5n6_maFLAFVzLKz_znh3cU287tAd" style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives liabilities at fair value through profit and loss</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6557">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6558">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.3 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6560">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6561">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6562">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6563">-</span>   </span></td></tr> <tr id="xdx_40E_ecustom--DerivativeFinancialLiabilitiesHeldForHedgingOperationalHedge_iI_pn5n6_maFLAFVzLKz_zNIZPB8Nxpal" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives – operational hedge</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">70.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">690.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6567">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">760.8 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">76.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">653.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6571">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">729.4 </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_pn5n6_mtFLAFVzLKz_zEoC0PzFHF6k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> <b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>72.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>690.8 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,063.7 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,826.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>76.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>653.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,394.0 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,123.4 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.3.1 Financial instruments level 3</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As part of the negotiations regarding the acquisition of the shares of Tenedora, the Company signed at 2020 the second amendment to the Shareholders' Agreement extending the partnership between the Company and ELJ. As at December 2023, ELJ was the owner of <span id="xdx_901_ecustom--PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock_iI_pid_dp_c20231231__srt--OwnershipAxis__custom--TenedoraMember__dei--LegalEntityAxis__custom--ELJMember_ztTph74wxpb" title="Put options, exercisable number of shares, percent of outstanding stock">15</span>% of the shares of Tenedora, and its put options was divided into two tranches: (i) Tranche A, corresponding to <span id="xdx_905_ecustom--PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock_iI_pid_dp_c20231231__srt--OwnershipAxis__custom--TenedoraMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--TrancheAMember__dei--LegalEntityAxis__custom--ELJMember_z2dQe7OO4Cg3" title="Put options, exercisable number of shares, percent of outstanding stock">12.11</span>% of the shares, <span style="color: black">that was exercised at January 04, 2024</span>; and (ii) Tranche B, corresponding to <span id="xdx_904_ecustom--PutOptionsExercisableNumberOfSharesPercentOfOutstandingStock_iI_pid_dp_c20231231__srt--OwnershipAxis__custom--TenedoraMember__ifrs-full--ClassesOfOrdinarySharesAxis__custom--TrancheBMember__dei--LegalEntityAxis__custom--ELJMember_zzLIsTPfWuee" title="Put options, exercisable number of shares, percent of outstanding stock">2.89</span>% of the shares, exercisable from 2026. The Company, on the other hand, has a call option over Tranche B shares, exercisable from 2029. On December 31, 2023, the sum of the two ELJ tranches is R$<span id="xdx_901_ecustom--PutOptionsFairValue_iI_pn5n6_c20231231__srt--OwnershipAxis__custom--TenedoraMember__dei--LegalEntityAxis__custom--ELJMember_z968yOfu7Ih7" title="Put options, fair value">2,791.1</span> (R$<span id="xdx_90C_ecustom--PutOptionsFairValue_iI_pn5n6_c20221231__srt--OwnershipAxis__custom--TenedoraMember__dei--LegalEntityAxis__custom--ELJMember_zZstemq3rOLf" title="Put options, fair value">3,053.7</span> on December 31, 2022).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of (i) Tranche A is calculated considering the interest under the contract, plus foreign exchange variations, less the dividends paid between the date of signature of the amendment and the exercise of the option. The fair value of (ii) Tranche B is calculated based on the EBITDA multiple defined in the contract, less the net debt, brought to its present value, calculated using standard valuation techniques (the present value of the principal amount and future interest, discounted by the local currency’s WACC rate as at the date of the calculation). The criteria used are based on market information from reliable sources and are categorized as “Level 3”.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.3.2 Reconciliation of changes in the assets categorized at Level 3</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_886_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_pn5n6_zmq6q56Yzigi" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 4)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zpWzBmwPRnki" style="display: none">Schedule of reconciliation of changes in the assets</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="width: 80%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Financial liabilities at December 31, 2022</b></span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iS_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zYkCkIPJJjld" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liabilities balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,394.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">   Acquisition of investments</span></td> <td id="xdx_98B_eifrs-full--PurchasesFairValueMeasurementLiabilities_iN_pn5n6_di_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zygbOdtpvgt4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition of investments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(64.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Level reclassification</span></td> <td id="xdx_98F_ecustom--LevelReclassification_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zrftZWIUM0e5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Level reclassification"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total gains and losses during the period</span></td> <td id="xdx_98F_ecustom--LossesGainsRecognizedInTheYearFairValueMeasurementLiabilities_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zjpy8A136bT2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total gains and losses during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(259.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">   Losses/(gains) recognized in net income</span></td> <td id="xdx_98E_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zAlXiclH8hwf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Losses/(gains) recognized in net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(269.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">   Losses/(gains) recognized in equity</span></td> <td id="xdx_98C_ecustom--GainsLossesRecognisedEquityFairValueMeasurementLiabilities_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zzqARrjZ9hT5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Losses/(gains) recognized in equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Financial liabilities at December 31, 2023</b></span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilities_iE_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zpcKiQx9M5l8" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liabilities balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,063.7 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.4 risk management</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is exposed to foreign currency, interest rate, commodity price, liquidity, and credit risk in the ordinary course of its business. The Company analyzes each of these risks both individually and on a consolidated basis, to define strategies to manage the economic impact on risk’s performance consistent with its Financial Risk Management Policy.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The objective of this policy is intended to provide guidelines for the management of the financial risks inherent to the capital markets in which Ambev operates. The policy includes four main aspects: (i) transactional risks related to the business; (ii) financial statement translation risk; (iii) credit risks of financial counterparties and (iv) capital structure; financing and liquidity.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The policy establishes that all the financial assets and liabilities in each country in which Ambev operates must be denominated in their respective local currencies. The policy also sets out the procedures and controls required to identify, measure, and minimize market risks, such as variations in foreign exchange rates, interest rates and commodities (mainly aluminum, sugar, wheat, corn and paraxylene) that may affect Ambev’s revenue, costs and/or investment amounts. The known risks (e.g., foreign currency and interest) shall be hedged by contracting derivative financial instruments. Existing risks which are not yet recorded (e.g., future contracts for the purchase of raw materials or property, plant and equipment) shall be mitigated using projections for the period required for the Company to adapt to the new costs’ scenario, which may vary from ten to fourteen months, also through the use of derivative financial instruments. Most translation risks are not hedged. The exceptions to the policy must be approved by the Operations and Finance Committee (“COF”)</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.4.1 Market risk</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.4.1.1 Interest rate risk:</b> consists of the possibility that the Company may incur losses due to fluctuations in interest rates, which may increase the financial expenses of financial liabilities, and/or decrease the financial income of financial assets, as well as negatively impact the fair value of financial assets measured at fair value. To mitigate this risk the Company applies a dynamic interest rate hedging approach, whereby the target mix between fixed and floating rate debt is reviewed periodically. The purpose of the Company’s policy is to achieve an optimal balance between the cost of funding and the volatility of financial results, considering market conditions. The Company’s overall business strategy, which is reviewed periodically.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The table below demonstrates the Company’s exposure related to debts. In 2023, the Company does not hold hedge positions to the exposure described below:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfDetailedInformationAboutHedgingInstrumentsExplanatory_pn5n6_zAHLaYTFmeF3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 5)"> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zBYDdL23boS2" style="display: none">Schedule of  detailed information about hedging instruments</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td></tr> <tr> <td style="white-space: nowrap; width: 42%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Interest rate</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Amount </b></span></td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Interest rate</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Amount </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brazilian Reais</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--PostfixedInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_z2260fjCyJnb" title="Pre-hedge, post-fixed interest rate">8.1</span>%</span></td> <td id="xdx_98B_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zfaXeIiTqNYi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">243.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--PostfixedInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zm3otJSFlggd" title="Pre-hedge, post-fixed interest rate">8.5</span>%</span></td> <td id="xdx_982_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_za9Z3hn61nD" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">230.1 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Post fixed interest rate </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z4YHoj7Prork" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>243.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zJjpoFRlwI0i" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>230.1 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brazilian Reais</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zrRhabLE0Lsf" title="Pre-hedge, pre-fixed interest rate">10.1</span>%</span></td> <td id="xdx_98C_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zmMSjmCyt1Yc" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,372.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_za8aSndT40Pe" title="Pre-hedge, pre-fixed interest rate">8.5</span>%</span></td> <td id="xdx_98D_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zEMrSE8T8U5a" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,602.1 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Working Capital in Argentinean Peso </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zewgkJvmuBi3" title="Pre-hedge, pre-fixed interest rate">0.0</span>%</span></td> <td id="xdx_98D_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zJZaP9aRmHo6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6633">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zSm05ee9KPg3" title="Pre-hedge, pre-fixed interest rate">73.5</span>%</span></td> <td id="xdx_98D_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zyQ8C4n1fqQ9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">74.3 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_909_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_zy3McSqBWLil" title="Pre-hedge, pre-fixed interest rate">11.5</span>%</span></td> <td id="xdx_982_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_zJgCBFKPYyug" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">405.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_zItuqgqoRVAk" title="Pre-hedge, pre-fixed interest rate">10.4</span>%</span></td> <td id="xdx_982_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_ztddZFwfkolf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">421.3 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_905_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_zjeV9LzLH054" title="Pre-hedge, pre-fixed interest rate">14.0</span>%</span></td> <td id="xdx_98B_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_ziyOpDU1l6ii" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6649">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_901_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_z8qRsIu2F8If" title="Pre-hedge, pre-fixed interest rate">14.0</span>%</span></td> <td id="xdx_98A_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_zZnfvB420mH6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.2 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Canadian Dollars</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_905_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zp7DQlb5zkKc" title="Pre-hedge, pre-fixed interest rate">5.6</span>%</span></td> <td id="xdx_98B_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zHCCUcvqdD6k" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">480.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zS8SldAyx40c" title="Pre-hedge, pre-fixed interest rate">5.3</span>%</span></td> <td id="xdx_987_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zqX7wazURTZ3" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">511.0 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Pre-fixed interest rate </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z9JMFOPTgOd8" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,257.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zb401hKb23J2" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,614.9 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Sensitivity analysis</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company substantially mitigates the risks arising from non-derivative financial assets and liabilities, through the use of derivative financial instruments. In this context, the Company has identified the main risk factors that could generate losses from these derivative financial instruments, and has developed a sensitivity analysis based on three scenarios, which may impact the Company’s future results and/or cash flow, as described below:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">1 - Probable scenario: Management’s expectations regarding the deterioration of each transaction’s main risk factor. To measure the possible effects on the results of derivative transactions, the Company uses the parametric Value at Risk (“VaR”), a statistical measure developed based on estimates of standard deviation and correlation between the returns of several risk factors. This model gives the loss limit expected for an asset over a certain time period and confidence interval. Under this methodology, the potential exposure of each financial instrument, a range of <span id="xdx_903_ecustom--ValueAtRiskExposureProbable_pip0_dp_c20230101__20231231_zNDrKSysHbfl" title="Value at risk exposure, probable">95</span>% and a horizon of 21 days from December 31, 2023, were used for the calculation, which are presented in the model.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">2 - Adverse scenario: <span id="xdx_904_ecustom--ValueAtRiskAdverseScenarioDeteriorationPercentage_pip0_dp_c20230101__20231231_zzNB6xe5SaE5" title="Value at risk, adverse scenario, deterioration percentage">25</span>% deterioration in each transaction’s main risk factor compared to the level observed as at December 31, 2023.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">3 - Remote scenario: <span id="xdx_908_ecustom--ValueAtRiskRemoteScenarioDeteriorationPercentage_pip0_dp_c20230101__20231231_zw4MCDDApbXh" title="Value at risk, remote scenario, deterioration percentage">50</span>% deterioration in each transaction’s main risk factor compared to the level observed as at December 31, 2023.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Sensitivity analysis of exchange rate variations and commodity price variations:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88E_eifrs-full--SensitivityAnalysisForEachTypeOfMarketRisk_pn5n6_zMk0DQiQRiFe" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 6)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zJOPM5kEPUWg" style="display: none">Schedule of types of market risk</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transaction</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair value</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Probable scenario</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Adverse scenario</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Remote<br/> scenario</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Commodities hedge</i></span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Decrease in commodities price</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z59dKPrZdrml" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.1)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zfgkBi6mf719" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">94.6 </span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zTbDPNNb0nRb" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">985.4 </span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zhL4FoRcF2B5" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,991.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Input purchases</span></td> <td id="xdx_98B_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zZB6yHs0l0ua" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">21.1 </span></td> <td id="xdx_98E_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zAgNyaFhdFC4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(94.6)</span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zrYY2IWZ0C39" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(985.4)</span></td> <td id="xdx_98B_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zUePdTQvMKJk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,991.9)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_987_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zGWeK2AeaFf4" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(341.4)</span></td> <td id="xdx_988_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zO0T8aMBbHue" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(163.3)</span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zqurPfej4CKd" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,995.8 </span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zeFKK21p1Fc" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,333.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Input purchases</span></td> <td id="xdx_982_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zbYenyQwkKn8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">341.4 </span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zSt9nMGkgRIc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">104.9 </span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zna1uXjatMR5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,336.8)</span></td> <td id="xdx_98C_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zGPex5zvs3i6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7,014.9)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b> </b></td> <td id="xdx_983_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zxq5a2ZSleKb" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6708">-</span>   </b></span></td> <td id="xdx_982_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zee5z6YToFjk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(58.4)</b></span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zXDvSF2ZGkd6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(341.0)</b></span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_d0_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zEdmnGJfKJz1" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(681.9)</b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zA5tA933ivNb" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.5)</span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zp8iTEHvwx84" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.2)</span></td> <td id="xdx_982_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zJ7rU6j6l7Mk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">47.9 </span></td> <td id="xdx_98B_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zHmmh4fzVQQk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">110.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capex Purchases</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zLLmdzdwRzb5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.5 </span></td> <td id="xdx_988_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zs08RgEnfDq1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.2 </span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zkI5zT4zPqX7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(47.9)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zPAUlcIPu33i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(110.3)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fixed asset effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zgxYVe9BtCJ9" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6732">-</span>   </b></span></td> <td id="xdx_983_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zqFxkjNHVNMa" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6734">-</span>   </b></span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zG7RF8QZV8tg" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6736">-</span>   </b></span></td> <td id="xdx_980_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_ziZ1Yt0DMW0d" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6738">-</span>   </b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_982_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zfqMfPFRFkff" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zkqDgr2YVQEj" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.7)</span></td> <td id="xdx_988_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zrWPiFN9A2Za" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.0 </span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_ziRQuUgwoeJh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">28.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Expenses</span></td> <td id="xdx_98C_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zIwx4lyX36Q2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.1 </span></td> <td id="xdx_984_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zP65DiPPuqt3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.7)</span></td> <td id="xdx_982_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zDy7HbXoXGLd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(44.0)</span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_ziMGswNPzk3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(92.2)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Result of expense effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z4NKAUXtkCgd" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6756">-</span>   </b></span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_znOjZnClnuY9" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5.4)</b></span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zpmeG1WQeD2e" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(32.0)</b></span></td> <td id="xdx_980_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zwoqwvwcY9Hg" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(64.0)</b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zzLVCmKuBBSh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td> <td id="xdx_987_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zwTZIV9oAdrc" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.5)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zW8UpD8xfqT9" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(17.1)</span></td> <td id="xdx_984_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zC7DqIm3ObTf" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(31.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash</span></td> <td id="xdx_98D_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zaqwUO8fn2Ra" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.3 </span></td> <td id="xdx_98E_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zrt1YFoE4jrf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.5 </span></td> <td id="xdx_983_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zlJBLfNWunxk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">17.1 </span></td> <td id="xdx_984_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zB7IsHDdn3aa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">31.9 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_zidEDPZY9LF1" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6780">-</span>   </b></span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_z1A2YwOwdfK6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6782">-</span>   </b></span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_zRKeEn2VF0Og" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6784">-</span>   </b></span></td> <td id="xdx_98C_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_zg05D02Er9wk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6786">-</span>   </b></span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>-   </b></span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario_pn5n6_c20230101__20231231_zZdtdo9VxmZ1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(63.8)</b></span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenario_iI_pn5n6_c20230101__20231231_zXb3qn86rI7j" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(373.0)</b></span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenario_pn5n6_c20230101__20231231_z9boopodEGq7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(745.9)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.4.1.2 Foreign currency risk: </b>the Company is exposed to foreign currency risk on borrowings, investments, purchases, dividends and/or interest expenses/income where these are denominated in a currency other than the functional currency of Group entity. The main derivative financial instruments used to manage foreign currency risk are futures contracts, swaps, options, non-deliverable forwards, and full deliverable forwards.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.4.1.3 Commodity Risk: </b>A significant portion of the Company’s inputs is made up of commodities, which have historically experienced substantial price fluctuations. The Company therefore uses both fixed prices purchasing contracts and derivative financial instruments to minimize its exposure to volatility in the commodity prices of aluminum, sugar, wheat, corn and paraxylene. These derivative financial instruments have been designated as cash flow hedges.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.4.2 Credit Risk</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">A substantial portion of the Company’s sales is made to distributors, supermarkets, and retailers, through a broad distribution network. Credit risk is reduced due to the large number of customers and control procedures used to monitor risk. Historically, the Company has not incurred significant losses on receivables from customers.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to minimize the credit risk of its investments, the Company has adopted procedures for the allocation of cash and investments, taking into consideration the credit limits and credit analysis of financial institutions, avoiding credit concentration, i.e., the credit risk is monitored and minimized by restricting negotiations to a select group of highly rated counterparties.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The selection process for financial institutions authorized to operate as counterparties of the Company is set forth in the Credit Risk Policy, which also establishes exposure limits for each counterparty based on each counterparty's risk rating and capitalization.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Any deposits or cash available, must be kept in accounts with top tier banks, or banks with a high credit rating in the respective country. Any position of a short-term nature (less than six months) should be considered as a deposit or cash.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Counterparty risk must be managed by the Company globally, with product limits established by the treasury area, considering: (i) the counterparty’s credit rating (ii) the transaction term (iii) the amount; and (iv) the split between assets and liabilities, in the absence of a clearing clause in derivative contracts. The counterparty risk is reassessed on a quarterly basis.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of cash and cash equivalents, investment securities, trade receivables excluding prepaid expenses, recoverable taxes and derivative financial instruments are disclosed net of provisions for impairment and represent the maximum exposure to credit risk as at December 31, 2023. As at December 31, 2023, there was no concentration of credit risk on any counterparties in excess of the limits established by the Company's Credit Risk Policy.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt/13pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.5in"><b>28.4.3</b></td><td style="text-align: justify"><b>Liquidity Risk</b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify"><span style="font-size: 11pt">Historically, the Company’s primary sources of cash flow have been cash flow from operating activities, the issuance of debt, bank borrowings and equity securities. Ambev’s material cash requirements have included the following:</span> <span style="font-size: 12pt">debt servicing; capital expenditure; investments in companies; increases in the ownership of Ambev’s subsidiaries or companies in which it holds equity investments; share buyback programs; and payments of dividends and interest on shareholders’ equity.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company believes that cash flows from operating activities, cash and cash equivalents and short-term investments, together with derivatives and access to loan facilities are sufficient to finance capital expenditures, financial liabilities, and dividend payments in the future.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfDisclosureOfTermsAndDebtRepaymentsTextBlock_zV8xwpdVBbz" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 7)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_zOgB9sVBPAnc" style="display: none">Schedule of liquidity risk and payables</span></td> <td id="xdx_496_20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zbYGYGMdh6da" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Carrying amount"> </td> <td id="xdx_497_20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ContractualCashFlowsMember_z826jxKM7Krl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49C_20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zKXDtWzHaNj1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_492_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zLqmG7sax2Mb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49C_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zc6kCRLK3RYj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49C_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zEKDTjIBsek7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49A_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zoaEV4al4oS8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Contractual cash flows</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Less than 1 year</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1-2 years</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2-3 years</b></span></td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3-5 years</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>More than 5 years</b></span></td></tr> <tr id="xdx_405_eifrs-full--TradeAndOtherPayables_iI_zmXFUZR1x9r8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Trade and other payables </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36,817.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38,453.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">35,522.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">439.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">808.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,672.1 </span></td></tr> <tr id="xdx_40B_ecustom--SecuredBankLoans_iI_z0kTnzsW2Wrh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Secured bank loans</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">126.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">177.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">26.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.4 </span></td></tr> <tr id="xdx_400_ecustom--OtherSecuredLoans_iI_zzanB3Swrj54" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Other secured loans </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">415.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">594.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">156.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">171.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">134.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">79.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">53.9 </span></td></tr> <tr id="xdx_406_eifrs-full--LeaseLiabilities_iI_zwY0YGP08WMi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Lease liabilities </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,958.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,473.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,344.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">608.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">552.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">452.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">515.5 </span></td></tr> <tr id="xdx_40B_ecustom--TotalPayablesAndLiabilities_iI_z0BQCorYtvFe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total payables and liabilities</b> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>40,318.9 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>42,699.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>37,049.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,244.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>722.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,390.9 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,291.8 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_498_20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zG08IdBzjhOe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ContractualCashFlowsMember_zaW7leThx0S" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_493_20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zdduTbtqnsm8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zI5Yk4xrhhT5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_499_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zEpE5YsuoGqg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zJ8MmaMgV3m3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkoNOL7njxml" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Contractual cash flows</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Less than 1 year</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1-2 years</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2-3 years</b></span></td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3-5 years</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>More than 5 years</b></span></td></tr> <tr id="xdx_405_eifrs-full--TradeAndOtherPayables_iI_zY5LAwlO087e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Trade and other payables </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">39,354.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">40,656.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36,818.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">86.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,275.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,008.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,467.6 </span></td></tr> <tr id="xdx_40F_ecustom--SecuredBankLoans_iI_zYgmfSXxc9Mi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Secured bank loans</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">180.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">245.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">68.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">26.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">75.5 </span></td></tr> <tr id="xdx_406_ecustom--OtherSecuredLoans_iI_zCpeBYaGNhTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Other secured loans </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">759.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">169.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">156.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">151.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">165.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">115.5 </span></td></tr> <tr id="xdx_406_eifrs-full--LeaseLiabilities_iI_ztsaIjssvT11" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Lease liabilities </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,117.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,657.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">962.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,008.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">621.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">696.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">368.2 </span></td></tr> <tr id="xdx_40E_ecustom--TotalPayablesAndLiabilities_iI_zs2Qv4ldtLz6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total payables and liabilities</b> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>43,125.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>45,318.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>38,019.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,278.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,072.9 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,921.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,026.8 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends, and interest on equity payable, salaries and charges, put options related to the Company’s participation in subsidiaries and other liabilities, except for related parties, with payment term of less than one year.</td> </tr></table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Nomenclature modified to Other secured loans, including for comparative purposes.</td> </tr></table> <p id="xdx_8A3_zhBTNN8onqj3" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.4.4 Capital management</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is continuously optimizing its capital structure in order to maximize shareholder value while maintaining the desired financial flexibility to execute its strategic projects. Besides the statutory minimum equity funding requirements applicable to the Company’s subsidiaries in different countries, the Company is not subject to any externally imposed capital requirements. When analyzing the capital structure, the Company uses the same debt ratings and capital classifications applied to the financial statements.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company evaluates its net debt in order to guarantee the continuity of its business in the long term.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfNetDebtOfContinuityInTheLongTerm_pn5n6_zih6GO9ohXia" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 8)"> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zyXzNvtO6JPe" style="display: none">Schedule of net debt of long term</span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49A_20231231_zf8KQK2IwiGa" style="text-align: center; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_495_20221231_z56xiOrJQ7N1" style="text-align: center; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="vertical-align: bottom; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--InterestbearingLoansAndBorrowingsCurrentAndNoncurrent_iI_zLZ9tpByn6ml" style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interest-bearing loans and borrowings current and non-current</span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,501.1 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,770.7 </span></td></tr> <tr id="xdx_40C_ecustom--FinancialAssetAtFairValueThroughProfitOrLoss_iNI_di_znIgphQzNQta" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(-) Financial assets at fair value through profit or loss</span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(277.2)</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(454.5)</span></td></tr> <tr id="xdx_404_ecustom--CashAndCashEquivalentsLessBankOverdraft_iI_zQhRIJWprClf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(-) Cash and cash equivalents less bank overdraft</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,059.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14,852.1)</span></td></tr> <tr id="xdx_40E_eifrs-full--NetDebt_iI_zuCiteCBhr53" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net debt</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(12,835.1)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(11,535.9)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.5 Offsetting financial assets and liabilities</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For financial assets and liabilities subject to settlement agreements on a net basis or similar agreements, each agreement between the Company and the counterparty allows this type of settlement when both parties opt for this. In the absence of such a decision, the assets and liabilities will be settled at their gross amounts, but each party will have the option to settle on a net basis, in case of a default by the counterparty.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>28.6 Risks management of climate change and the sustainability strategy</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">The Company’s operations, there is an inherent exposure to certain risks related to climate change, and relevant ESG (Environmental, Social and Governance) aspects. As the events mentioned in this section are highly uncertain, the Company cannot determine their financial impact at this moment. Any mentioned impacts may result in a material adverse effect on our business, liquidity, financial condition, and results of operations. The Company continues to manage liquidity and capital resources with discipline to meet the costs of the eventual materialization of such risks. In the period finished in December 31, 2023, the Management considered as main risks the points below.<br/> <br/> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b>28.6.1 Commodities prices</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There is a growing concern that the currently level of carbon dioxide and other greenhouse gases in the atmosphere have adverse impacts on global temperatures, weather patterns and the frequency and severity of extreme weather and natural disasters, such as droughts, floods, unseasonal rains, tropical cyclones, among others. In the event the climate changes have a negative effect on agricultural productivity, the Company may be subject to decreased availability or less favorable pricing for certain agricultural commodities that are necessary for our products, such as barley, hops, sugar and corn. In addition, public expectations for reductions in greenhouse gas emissions could result in increased energy, transportation and raw material costs and may require us to make additional investments in facilities and equipment due to increased regulatory pressures. As a result, the effects of climate change could have a long-term, material adverse impact on our business and results of operations.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b>28.6.2 Water crisis</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also face water scarcity and quality risks. The availability of clean water is a limited resource in many parts of the world, facing unprecedented challenges from climate change and the resulting change in precipitation patterns and frequency of extreme weather, overexploitation, increasing pollution, and poor water management. The Company has implemented an internal strategy in order to considerably reduce the use of water in your operative plants. However, as demand for water continues to increase around the world, and as water becomes scarcer and the quality of available water deteriorates, we may be affected by increasing production costs or capacity constraints, which could adversely affect our business and results of operations.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Droughts can cause barley crop failures, especially in South America, where most barley is rain-fed. The meteorological droughts (short-term, precipitation-impacted droughts) can significantly affect barley crop performance. As a result, the effects of climate change could have a substantial long-term detrimental impact on the Company's business and operating results.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b>28.6.3 Environmental regulations</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company’s operations are subject to a wide range of Brazilian federal, state and municipal safety and environmental laws and regulations related to licenses or authorizations necessary to our business, as well as use of water resources and management of solid waste and take-back scheme obligations.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company activities require the constant obtaining and renewal of environmental licenses, in which the production units operation depends. Technical difficulties or failure to meet license renewal terms and the requirements of environmental agencies may have adverse effects on our business, as we may be subject to (i) the imposition of several administrative penalties (such as fines, interruption or shutdown of activities, license cancellation, among others). (ii) payment of recovering costs to of degraded areas and (iii) accountability in the civil, administrative and criminal spheres, depending on the case.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">There is no guarantee that the Company, even if it adopts adequate practices and processes, will not incur environmental liability or that these applicable environmental laws and regulations will not change or become stricter in the future. Accordingly, non-compliance with applicable laws and the technical conditions established in licenses and permits may harm the Company's reputation, results of operations and financial health.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><b>28.6.4 Social</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">The Company is subject to obligations regarding the respect for human rights of all stakeholders, which may lead the Company to incur additional costs as well as significant contingencies relating to social issues. In general, social risks arise from the potential and actual adverse impacts of its business activities on the human rights of all stakeholders involved in its operation, including its own employees, consumers, suppliers, investors and the local community where the Company operates, whether directly or indirectly connected to its activities.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">If the Company does not adopt well-structured and integrated long-term planning initiatives to promote diversity, equality and inclusion, both in its workforce and in the composition of statutory bodies and leadership, it may be challenged, including in court, about the absence of clear goals and effective actions in this area.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify">There is no guarantee that the Company will be able to adequately manage the social risks mentioned above in compliance with all national and international parameters and guidelines, which, consequently, may eventually harm the Company's operating results and reputation and expose it to legal and regulatory risks, which may materialize in different ways.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Accounting policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Classification and measurement</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial assets (except for accounts receivable without a significant financing component) or financial liabilities are initially measured at fair value, plus, for an item not measured at fair value through profit or loss, transaction costs directly attributable to their acquisition or issue.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Financial assets</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company classifies its financial assets on initial recognition, depending on the business model used to manage the financial assets and the contractual terms of the cash flows, under the following measurement categories: (i) at amortized cost; (ii) at fair value through profit or loss; (iii) at fair value through other comprehensive income (“FVOCI”).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial assets are not reclassified subsequently to initial recognition, unless the Group changes the business model for the management of financial assets, in which case all impacted financial assets are reclassified on the first day of the post-change business model.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial assets are derecognized when the contractual rights to receive the cash flows from the asset has expired or are transferred in a transaction in which substantially all the risks and benefits of ownership of the financial asset are transferred by the Company.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 31, 2023, and 2022, the Company did not have any financial assets classified in the fair value through other comprehensive income category.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>a) Amortized cost</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company classifies financial assets as measured at amortized cost only when two criteria are satisfied:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">i) The financial asset is held within a business model whose objective is to receive the contractual cash flows; and</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ii) The contractual terms generate, on specific dates, cash flows that relate only to the payment of principal and interest on the principal amount outstanding.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>b) Fair value through profit or loss</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All financial assets not classified by the Company as measured at amortized cost or FVOCI and financial assets in which their cash flows do not represent exclusively payments of principal and interest, are classified at fair value through profit or loss. This category also includes debt instruments with cash flow characteristics which are not held within a business model with the objective either to collect contractual cash flow, or both to collect contractual cash flow and for sale.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>c) Fair Value through Other Comprehensive Income</b></p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify">Debt instruments at FVOCI, with gains or losses <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">recycled to profit or loss on derecognition. The financial assets in this category are the Company’s listed debt instruments thar are held within a business model either to collect cash flow or for sale</span>.</p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify">Equity instruments designated <span style="font-family: Times New Roman, Times, Serif; font-size: 11pt">at FVOCI, without remeasurement of gains or losses to the profit or loss upon derecognition. This category includes only equity instruments which the Company intends to hold for the foreseeable future, and which it has irrevocably elected to classify thus upon their initial recognition or transition. These instruments are not subject to impairment testing</span>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Financial liabilities</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company classifies its financial liabilities, depending on the purpose for which the financial liabilities were entered into, in the following categories:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">i) measured at amortized cost.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ii) measured at fair value through profit or loss.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial liabilities are derecognized when contractual obligations are removed, cancelled or expired. The difference between the written-off carrying amount and the consideration paid (including assets transferred or liabilities assumed) is recognized in profit or loss for the year.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All financial liabilities are initially measured at fair value, net of transaction costs incurred, and are subsequently measured at amortized cost and adjusted using the effective interest rate method. Derivative instruments, remain classified in the fair value through profit or loss category.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>Hedge accounting</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company designates certain derivatives as hedging instruments to hedge the risk related to the variability of foreign exchange rates, interest rates and commodity prices and are not used for speculative purposes. Derivative financial instruments, that are contracted to protect against the exposure, but that do not meet all of the hedge accounting requirements, will be recognized at fair value through profit or loss.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Derivative financial instruments are initially recognized at fair value. The fair value of derivative financial instruments can be obtained from market prices or from pricing models that reflect current market rates, as well as the credit quality of the counterparty.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subsequently to initial recognition, derivative financial instruments are remeasured to their fair value as at the date of the financial statements. Changes in the fair values of derivative financial instruments are recognized in current income, except when these instruments are cash flow hedges or net investment hedges, where portions of gains or losses on the hedge instrument defined as effective hedge are recognized in comprehensive income. The hedge designated instrument is the effective element present term contract, which only the present element value change is recognized in comprehensive income, The term element, which can be separated and excluded from the financial instrument designation as hedge instrument is recognized in financial result, in accordance with IFRS 9 - <i>Financial Instruments</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The company contracts commodities derivatives which have similar terms to the hedged items and applies component hedging to its commodities. The hedged component is contractually specified and matches with what is defined in the derivative contract, and therefore the hedge ratio is always 1:1. At the beginning of the hedge operation, the Company prepares formal documentation for the operation including: (i) the objective of the hedge, (ii) the type of hedge, (iii) the risk management strategy, (iv) the nature of the risk to be hedged, (v) the identity of the hedged item, (vi) the identity of the hedging instrument, and (vii) the prospective demonstration of effectiveness.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Hedge effectiveness is measured on a qualitative basis. Whenever the terms do not match, the Company uses the hypothetical derivatives method to assess the hedge effectiveness. Therefore, usually causes of ineffectiveness include changes in the timing of forecast transactions, changes in the quantity of the commodity to be hedged, or changes in the credit risk of either party to the derivative contract.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>a) Cash flow hedge </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash flow hedges are used to protect the cash flow exposure of a recorded asset or liability, or the foreign currency risk or commodity price variations associated with a highly probable transaction. The effective portion of any (gain or loss) on the derivative financial instrument is recognized directly in the comprehensive income statement (cash flow hedge reserve) and will be reclassified from the cash flow hedge reserve to the same line item within which and the same period during which the cash flow futures were hedged impacted the result. The ineffective portion of any gain or loss is recognized immediately in the current income statement, in the financial result.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When a hedging instrument or a hedging relationship is terminated, but the hedged transaction is still expected to occur, the cumulative gains and losses (up to the date of termination) remain within comprehensive income, being reclassified in accordance with the above practice, when the transaction being protected occurs. If the hedged transaction is no longer probable, the accumulated gains and losses recognized in comprehensive income are reclassified immediately to the current income statement.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>b) Fair value hedge</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Fair value hedges are used to protect the Company's net debt from variations in exchange rates and interest rates. The Company's cash and debt positions in foreign currency are continually monitored to identify new exposures.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When a derivative is intended to hedge the variability in the fair value of a recognized asset or liability, or of a firm commitment, any resulting (gain or loss) on the hedging instrument is recognized in profit or loss. The carrying amount of the hedged item is also adjusted for changes in the fair value related to the risk being hedged, with any gain or loss being recognized in the income statement.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>c) Net investment hedge</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The net investment hedge is used to mitigate the exposure to exchange differences resulting from the conversion of the net investment, or part of it, in the Company's subsidiaries abroad, by balance sheet conversion quota.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When a non-derivative foreign currency liability hedges a net investment in a foreign operation, exchange differences arising on the translation of the liability into the functional currency are recognized directly in other comprehensive income (translation reserves). Any ineffectiveness is recognized immediately in profit or loss.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When a derivative financial instrument hedges a net investment in a foreign operation, the portion of the gain or loss on the hedging instrument that is determined to be effective is recognized directly in other comprehensive income (translation reserves), while the ineffective portion is reported in profit or loss.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.8.4 Derivatives at fair value through profit or loss</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain derivative financial instruments do not qualify for hedge accounting. Changes in the fair values of any of those derivative financial instruments are recognized immediately in profit or loss of exercise.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.8.5 Impairment of financial assets </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At the end of each reporting period basis, Management performs impairment testing for financial assets or groups of financial assets. If a trigger event occurs, a financial asset or group of financial assets will be deemed to be impaired. An asset or group of financial assets is deemed impaired, and impairment losses are recorded, only if there is evidence of impairment as a result of one or more events occurring after the initial recognition of the assets (a "loss event") and that event (or events) has an impact on the estimated future cash flow from the financial asset or group of financial assets and can be estimated reliably.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>28.8.6 Classification of fair value</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">IFRS 13 defines the fair value as the price that would be received for the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The definition of the fair value of financial instruments is based principally on market conditions existing at the date of each balance sheet. Pursuant to IFRS 13, financial instruments measured at fair value shall be classified within the following categories<span style="background-color: white">:</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white"> </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Level 1: quoted prices (unadjusted) in active markets available to the entity for identical assets or liabilities.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="background-color: white">Level 2: fair value of financial instruments which are not traded in an active market, using other techniques for which all inputs that have a significant effect on the recorded fair value are observable, either directly or indirectly.</span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Level 3: if one or more of the significant data are not based on observed market data, the Company uses techniques that cover data that have a significant effect on the recorded fair value, which are not based on observed market data.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_896_eifrs-full--DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_pn5n6_zlPqbUf2SsT9" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details)"> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zuO7pEo5VfR" style="display: none">Schedule of consolidated financial instruments</span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="vertical-align: top; width: 61%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Assets</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Amortized cost</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Cash and cash equivalents less bank overdrafts (Note 21.1)</span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetCashAndCashEquivalentsMember_zMg4esQUL5p9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">16,059.0 </span></td> <td id="xdx_986_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetCashAndCashEquivalentsMember_zPZMeSSf6YZ3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">14,852.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade receivables excluding prepaid expenses </span></td> <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zNHrakCtzIk3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,566.7 </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_z4S879lnne16" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">7,791.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment securities (Note 21.2)</span></td> <td id="xdx_98D_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zQV0Azw1Vgw4" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">242.2 </span></td> <td id="xdx_988_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zSyjoOwkhWqb" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">219.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_98F_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zjyHnmIYDKfa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,867.9 </b></span></td> <td id="xdx_985_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostCategoryMember_zME1N6N5eWX9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>22,862.6 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value through profit or loss</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Investment securities (Note 21.2)</span></td> <td id="xdx_983_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zfXzspA3qyt3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">277.2 </span></td> <td id="xdx_980_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FinancialAssetInvestmentSecuritiesMember_zhqB2mvimema" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">454.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Derivatives hedges (Note 28)</span></td> <td id="xdx_985_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--DerivativeHedgeMember_zyDLeIxtuUm9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">379.7 </span></td> <td id="xdx_981_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--DerivativeHedgeMember_z2ZIC2obuRC7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">273.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_982_eifrs-full--FinancialAssets_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_zbHgrlfPxt21" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>656.9 </b></span></td> <td id="xdx_98E_eifrs-full--FinancialAssets_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtFairValueThroughProfitOrLossCategoryMember_z53qVc8eSsld" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>728.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total assets</b></span></td> <td id="xdx_989_eifrs-full--FinancialAssets_iI_pn5n6_c20231231_zxrtpAaFzPQ8" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>24,524.8 </b></span></td> <td id="xdx_98A_eifrs-full--FinancialAssets_iI_pn5n6_c20221231_z7OQJiIkodk1" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial asset"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>23,590.9 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Liabilities</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Amortized cost</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Trade payables (Note 26)</span></td> <td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradePayableMember_z0PKkWP8MONh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">23,502.4 </span></td> <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TradePayableMember_zeHwrJPAbwOc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">24,837.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Interest-bearing loans and borrowings (Note 23)</span></td> <td id="xdx_983_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--InterestbearingLoansAndBorrowingsMember_zYpbb4UBnjx7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,501.1 </span></td> <td id="xdx_981_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--InterestbearingLoansAndBorrowingsMember_z4tTfFNKLi95" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,770.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other liabilities</span></td> <td id="xdx_989_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zVIkatgb4mL2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,129.6 </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zNgjtGVdr9Fj" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,015.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zSVGJiHUIwJk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>29,133.1 </b></span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostCategoryMember_zT3SeotrCpzf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>30,624.2 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Fair value through profit or loss</b></span></td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Put options granted on subsidiaries</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PutOptionGrantedOnSubsidiaryMember_zdtGD3t3WEie" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">2,791.1 </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--PutOptionGrantedOnSubsidiaryMember_zN9XJXSmvu6k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">3,060.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Derivatives hedges (Note 28)</span></td> <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeHedgeMember_z2ziCZREHoO4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">763.1 </span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--DerivativeHedgeMember_z1czDvzNEQpa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">729.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other liabilities</span></td> <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zrkb0kPGijrf" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">272.6 </span></td> <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--OtherLiabilities1Member_zgxwqb2MIIJ5" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">333.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Subtotal</b></span></td> <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zsqGoaXwqg0c" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,826.8 </b></span></td> <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--CategoriesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtFairValueThroughProfitOrLossCategoryMember_zmeyK9qM2Jdh" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>4,123.4 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total liabilities</b></span></td> <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_pn5n6_c20231231_z4XeSs1eYHTk" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>32,959.9 </b></span></td> <td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_pn5n6_c20221231_zEbuIaAetFSe" style="border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>34,747.6 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Put options granted on subsidiaries: the Company constituted a liability related to the acquisition of a non-controlling interest of the operations in the Dominican Republic. This financial instrument is denominated in US Dollars (Tranche A) and Dominican Pesos (Tranche B) and is recorded by an entity, whose functional currency is the Real. The Company assigned this financial instrument as a hedging instrument for a portion of its net assets located in subsidiaries whose functional currency is the US Dollar and the Dominican Peso, in such a manner that the hedge result can be recorded in other comprehensive income of the group, following the result of the hedged item.</td> </tr></table> 16059000000.0 14852100000 7566700000 7791400000 242200000 219100000 23867900000 22862600000 277200000 454500000 379700000 273800000 656900000 728300000 24524800000 23590900000 23502400000 24837900000 3501100000 3770700000 2129600000 2015600000 29133100000 30624200000 2791100000 3060300000 763100000 729400000 272600000 333700000 3826800000 4123400000 32959900000 34747600000 <table cellpadding="0" cellspacing="0" id="xdx_893_eifrs-full--DisclosureOfFinancialRiskManagementExplanatory_pn5n6_zs35v0fSHp0k" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 1)"> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zzWuJ8DUXS25" style="display: none">Schedule of financial risk management</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="11" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023 </b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair Value</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Gain / (Losses)</b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Hedge position</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Notional</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liability</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Finance Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Operational Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Equity</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zhppTnBF5t3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,374.2 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zE3PJkScZ235" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>379.5 </b></span></td> <td id="xdx_983_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zoWScPWc6Pnd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(742.0)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zlQooETIntg4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,639.6)</b></span></td> <td id="xdx_98F_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zBr4jnHwrNP4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>34.6 </b></span></td> <td id="xdx_982_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zsPhq1GOFoU3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(285.2)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Commodities</i></span></td> <td id="xdx_985_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zo8WGvHXPFK4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,025.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zRQo6Ztwv36e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">198.3 </span></td> <td id="xdx_988_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z2UhTTUDtDf1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(219.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zFSWhujzK8L1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(388.3)</span></td> <td id="xdx_983_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z45RrSe7iVk9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(336.2)</span></td> <td id="xdx_985_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zrXo93jAzVdg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(105.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zcMKF8mJsl1d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,200.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zwkFUTfcyfAa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">164.9 </span></td> <td id="xdx_98D_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z7oL2lkvQjAi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(522.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zBVRmRdLTWo4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,250.7)</span></td> <td id="xdx_983_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z9M5F0fOAcub" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">363.9 </span></td> <td id="xdx_989_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zIrXGT3jZJy2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(182.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Euros</span></td> <td id="xdx_98C_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zjla5UY5BAQe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_z8B0wHAHLfLh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_98D_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zQYDee7acy73" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zrZSuZ4uHFQ5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td> <td id="xdx_98F_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zK6CrFDsTbpf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.6 </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zg29Lq0Tr0gg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mexican Pesos</span></td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zofBAeR9GzR1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zRqyThmZgWc2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.2 </span></td> <td id="xdx_98B_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z0zChYbqYSji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl5973">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zIkgNeL6OVkb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td> <td id="xdx_98D_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zSbNlIlpkMj4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.3 </span></td> <td id="xdx_987_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zcY66mSkq8Tl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.8 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Importing of fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zkAI0DpWs3kf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>249.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zruuN6LhpJkf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.1 </b></span></td> <td id="xdx_980_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zbgT1X393yC5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zWFtQgMlk6P1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>11.0 </b></span></td> <td id="xdx_987_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zgpCp5139EIb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3.4 </b></span></td> <td id="xdx_986_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zBQq5bxcHaNh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>5.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_989_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zYNctYtnGHVh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">249.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zrwUIDgfzSk5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_984_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zhfaKRWDWcP3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zMxFSiltnFy3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.0 </span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z5rC5edP2bUb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.4 </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zm7vcu4mFjyi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z45Kiz1Z9krf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>64.7 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zEJJ4nyldn8c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.1 </b></span></td> <td id="xdx_987_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zThHKk3I1ST8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.2)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zwo5VgGCQrla" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(25.6)</b></span></td> <td id="xdx_986_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z4xkighVBIBa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(0.1)</b></span></td> <td id="xdx_985_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zH44IOzgEYJf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1.1 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_982_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_z6LSyQQBfnbd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zMwzfQlFHEfh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_984_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zf7YslgMM6ma" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.2)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zLfWuPNbcAd8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(25.6)</span></td> <td id="xdx_981_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zohPeOsPvK8l" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td> <td id="xdx_98A_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zElBjMhNf6f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zsRFVikULuUa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(59.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zaUuaQI5EX7g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6031">-</span>   </b></span></td> <td id="xdx_989_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zdhDcYIWMEud" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2.3)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--CashUMember_zPQ6Vrr6NOC9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>13.7 </b></span></td> <td id="xdx_98E_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zOnQ7dR5cUpb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6037">-</span>   </b></span></td> <td id="xdx_985_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zNgbRt5RnBp4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6039">-</span>   </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_98F_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zD8Lbvngqun3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zb8hRjw14Yae" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6043">-</span>   </span></td> <td id="xdx_988_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfThCashExposureMember_zkHSQfGxFMuh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsCashMember_zIOysWG6DXB6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.7 </span></td> <td id="xdx_98A_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zZsg0Y699S75" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6049">-</span>   </span></td> <td id="xdx_98B_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zuG7nn1VnSx6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6051">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2023</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--NotionalAmount1_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zGAGMWR9grn2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,629.3 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zEkwalViIadi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>379.7 </b></span></td> <td id="xdx_980_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z01huxrTG8G5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(763.1)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td id="xdx_985_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z1tNir0Uj0g7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,640.5)</b></span></td> <td id="xdx_98B_ecustom--GainsLossesFromOperationalResults_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_znzLMNONXd9e" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>37.9 </b></span></td> <td id="xdx_984_ecustom--GainsLossesRecordedInEquity_pn5n6_c20230101__20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zHlLix2pDin3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(279.1)</b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="9" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022 </b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair Value</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Gain / (Losses)</b></span></td></tr> <tr> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Hedge position</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Notional</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="border-bottom: Black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Liability</b></span></td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Finance Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Operational Result</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Equity</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zFodAyI9T6Nl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>19,853.3 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zLYwzaiabHik" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>271.8 </b></span></td> <td id="xdx_985_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zVQA1gJYVtFi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(719.4)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zjqdrqngchsc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,075.2)</b></span></td> <td id="xdx_982_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_z1EGDJ9LfGZj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>452.7 </b></span></td> <td id="xdx_98A_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zwbLUYdDqeik" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>134.3 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Commodities</i></span></td> <td id="xdx_984_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zd7Eejo02Ow8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,809.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zcn9nIW5tW4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">100.8 </span></td> <td id="xdx_98D_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zawLMZatr7Oi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(376.0)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zLx3nx4JRda3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">63.5 </span></td> <td id="xdx_987_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zWCBZdf2ytF6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.3)</span></td> <td id="xdx_986_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_ziqThTBfgHl9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(475.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_989_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zwmd8LsZ3CS1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14,874.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zrE7Fk31mQe8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">157.7 </span></td> <td id="xdx_98B_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zsWFRioKyfJl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(342.9)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zH64DQbXXieb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,139.2)</span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z2CFlTXgOybc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">477.1 </span></td> <td id="xdx_983_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zuG52QaQOlb8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">596.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Euros</span></td> <td id="xdx_987_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_z6KgHQo0jD7g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">32.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zUFVpWNdUgBk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.9 </span></td> <td id="xdx_981_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zurstqKGlIyc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6109">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zA0nB8XK6CEb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.7)</span></td> <td id="xdx_988_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zhnQHsoD3Mo8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.3)</span></td> <td id="xdx_987_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zRhKULmoIEnl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mexican Pesos</span></td> <td id="xdx_98B_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zvNBop3HNz8b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">136.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z8z22LhhzNnf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.4 </span></td> <td id="xdx_982_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zjZQfh1UJcc9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zLe6xFES30ij" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.2 </span></td> <td id="xdx_984_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zIyGuMWd6fpj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">8.2 </span></td> <td id="xdx_982_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zWNNOx6dFxj1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zQBisiiZv919" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>226.8 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zRRQBxuDmff5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1.5 </b></span></td> <td id="xdx_981_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_z7VxcczGSmy5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5.4)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zkUMCI0vqPff" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5.9)</b></span></td> <td id="xdx_985_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zlEfAl7QoKsk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4.9 </b></span></td> <td id="xdx_98D_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zni4xaLFchh5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(13.0)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_980_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z9xWFYXozcil" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">226.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zZoiDds3Qtf3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.5 </span></td> <td id="xdx_98B_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z6RPJVWLgbRk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.4)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zPARBApDuw6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.9)</span></td> <td id="xdx_98E_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zRlwWeGBzhc1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.9 </span></td> <td id="xdx_98B_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zfOTeeHCv115" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zyASmlpmAkFh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>204.9 </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zWUSGGVLebwl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>0.5 </b></span></td> <td id="xdx_981_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zrOxCXfkhU78" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.6)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zlRZya2yCyX2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(42.5)</b></span></td> <td id="xdx_986_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zYI8IR4c8rEl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>9.1 </b></span></td> <td id="xdx_98E_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zgLtgSe49hG2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.8)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_98E_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zisxQAyZuOb9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">204.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_z9sVvWee8uyh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.5 </span></td> <td id="xdx_986_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_z9K7w0n7wjUf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.6)</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zQVwyZK3z2ih" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(42.5)</span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zDXbmsxskst7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.1 </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zRmoRhwCX008" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.8)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zPHqS1sXzKy3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6177">-</span>   </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zrlAuhu6ex1g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6179">-</span>   </b></span></td> <td id="xdx_987_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zmoQ8FS4neAk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6181">-</span>   </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--CashUMember_zb4kbjN1nQEe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(17.1)</b></span></td> <td id="xdx_980_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_z00eDDt9xm96" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6185">-</span>   </b></span></td> <td id="xdx_986_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zFAuqdfPr2L3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6187">-</span>   </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">American Dollar</span></td> <td id="xdx_983_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_z8jF7Aeqc0b1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6189">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zmiNa6QLVoQk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6191">-</span>   </span></td> <td id="xdx_988_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfThCashExposureMember_zaWy0LpfGD34" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6193">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsCashMember_zCBXoT4VTUv2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(17.1)</span></td> <td id="xdx_989_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_z6R06hP6qpik" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6197">-</span>   </span></td> <td id="xdx_988_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zF22Z8d8xZ5c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6199">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>At December 31, 2022</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--NotionalAmount1_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zyWCrPIzDQi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>20,285.0 </b></span></td> <td style="border-top: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_eifrs-full--MaximumExposureToCreditRiskOfFinancialAssets_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zpr2PWYZ5EW9" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>273.8 </b></span></td> <td id="xdx_984_ecustom--MaximumExposureToCreditRiskOfFinancialLiabilities_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zoaA3RyeBgFa" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value Liability"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(729.4)</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--GainsLossesRecordedInFinancialResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zGAD9qAc534b" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Finance Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,140.7)</b></span></td> <td id="xdx_982_ecustom--GainsLossesFromOperationalResults_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zQuEIk5nYKxk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Operational Result"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>466.7 </b></span></td> <td id="xdx_982_ecustom--GainsLossesRecordedInEquity_pn5n6_c20220101__20221231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zVYiuADqbS89" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Gain (loss) Equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>106.5 </b></span></td></tr> </table> 17374200000 379500000 -742000000.0 -1639600000 34600000 -285200000 4025700000 198300000 -219400000 -388300000 -336200000 -105400000 13200000000.0 164900000 -522400000 -1250700000 363900000 -182100000 37400000 100000 -200000 -500000 2600000 500000 111100000 16200000 -100000 4300000 1800000 249700000 100000 -14600000 11000000.0 3400000 5000000.0 249700000 100000 -14600000 11000000.0 3400000 5000000.0 64700000 100000 -4200000 -25600000 -100000 1100000 64700000 100000 -4200000 -25600000 -100000 1100000 -59300000 -2300000 13700000 -59300000 -2300000 13700000 17629300000 379700000 -763100000 -1640500000 37900000 -279100000 19853300000 271800000 -719400000 -3075200000 452700000 134300000 4809900000 100800000 -376000000.0 63500000 -32300000 -475000000.0 14874700000 157700000 -342900000 -3139200000 477100000 596600000 32200000 1900000 -700000 -300000 1200000 136500000 11400000 -500000 1200000 8200000 11500000 226800000 1500000 -5400000 -5900000 4900000 -13000000.0 226800000 1500000 -5400000 -5900000 4900000 -13000000.0 204900000 500000 -4600000 -42500000 9100000 -14800000 204900000 500000 -4600000 -42500000 9100000 -14800000 -17100000 -17100000 20285000000.0 273800000 -729400000 -3140700000 466700000 106500000 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfNotionalAndFairValueAmountsPerFinancialInstrumentAndMaturityTextBlock_pn5n6_zsB3LT98qhdd" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 2)"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B6_zZVDGIOKBKI2" style="display: none">Schedule of notional and fair value amounts per instrument and maturity</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Notional Value</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Exposure</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2024</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2025</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2026</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&gt;2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zelfi7WFVJK3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>16,763.3 </b></span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zquWfjiGl1ef" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>610.9 </b></span></td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zNjJqmWmvXDc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6220">-</span>   </b></span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zlWsqgE5eRi9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6222">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zImwIMpkYj73" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6224">-</span>   </b></span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_z4nykce1gwna" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,374.2 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> Commodities </span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zraXa4YJgNtg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,924.3 </span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zwzBaBJMtL6c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">101.4 </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zVGlUr1TmzV4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6232">-</span>   </span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zThuYY1b4rWi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6234">-</span>   </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zKIRqIeCBRmi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6236">-</span>   </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zCVT1HJEOYwj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,025.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> US Dollars </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zvulmFLHQh3a" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,690.5 </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zJOqDnhFqBR9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">509.5 </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zQFCbhBLfR7j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6244">-</span>   </span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zLs7CtEtngS6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6246">-</span>   </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zkFKuwiRSQli" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6248">-</span>   </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zAL9yIu3Kg27" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,200.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> Euros</span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zWNFKWppsLgk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.4 </span></td> <td id="xdx_98B_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_z37yf1fS0bw6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6254">-</span>   </span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_ziKsUqJ8qXgl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6256">-</span>   </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zZvOq5Zg1FVk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6258">-</span>   </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zaOQHtERKpHj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6260">-</span>   </span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zaWzF878dCqc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> Mexican Pesos </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z3owijnZpz76" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.1 </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zLzFqAHl5bTd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6266">-</span>   </span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_z2ivV1vllQz2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6268">-</span>   </span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zLeLE9ogQ3K" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6270">-</span>   </span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zkat9pawhUXf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6272">-</span>   </span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zzhJVIeQlkte" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">111.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Importing of fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zeGJlHE3uJO9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>249.7 </b></span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zfH8Y1UXFUY5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6278">-</span>   </b></span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zMhH9gE8TrV6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6280">-</span>   </b></span></td> <td id="xdx_986_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zgCUBLhPPzb7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6282">-</span>   </b></span></td> <td id="xdx_988_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_z6VCWqTbBjs9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6284">-</span>   </b></span></td> <td id="xdx_988_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_z0ZCKj4f8U8b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>249.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars </span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zo2vjtzPZulj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">249.7 </span></td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zPCBBMrOMMJ9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6290">-</span>   </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zEPI7r6v3RXf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6292">-</span>   </span></td> <td id="xdx_980_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zF0Of7PxZzN8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6294">-</span>   </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zUVU0rfdGZY8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6296">-</span>   </span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_z5F9r0dd8oBd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">249.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zFG9QmeSKQrc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>64.7 </b></span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zIgLG8cykBrd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6302">-</span>   </b></span></td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zk8L7LxDEA3e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6304">-</span>   </b></span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z2xMojF6QqGi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6306">-</span>   </b></span></td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zarjtBYuCDo5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6308">-</span>   </b></span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zhVKNpsEnJ53" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>64.7 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zmgYhDL4Pzi4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.7 </span></td> <td id="xdx_989_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zWj4dnXy9qJ2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6314">-</span>   </span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zWtULFasd3H8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6316">-</span>   </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zOzg3e6SLTTk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6318">-</span>   </span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zb0I0AW4kVTl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6320">-</span>   </span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zk2VN5d6NTOh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zm5qN7FCrlq6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(59.3)</b></span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zQhso0yg8Xhi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6326">-</span>   </b></span></td> <td id="xdx_984_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zuo1wQ7FGba8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6328">-</span>   </b></span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zN8rkKGfP5Q7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6330">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zqT16GQIhY79" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6332">-</span>   </b></span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zsllU1Bmyong" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(59.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_z2yX0UTnUez2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.3)</span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zCC4w82t13qc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6338">-</span>   </span></td> <td id="xdx_987_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zfXSM2g7cty7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6340">-</span>   </span></td> <td id="xdx_98E_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zk3ihEta6KH1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6342">-</span>   </span></td> <td id="xdx_988_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zLqaUuV5PFeh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6344">-</span>   </span></td> <td id="xdx_98C_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zPCJvubsOAf2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(59.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zFRKRGD5bUk6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,018.4 </b></span></td> <td id="xdx_983_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zbyRPTcTfHKd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>610.9 </b></span></td> <td id="xdx_982_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zn7AcxrG6TWk" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6352">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z5FYx5zCiAh7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6354">-</span>   </b></span></td> <td id="xdx_98D_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z4QJfqCKR8Ke" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6356">-</span>   </b></span></td> <td id="xdx_98A_ecustom--NotionalAmountOne_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zf1DOq5pzlG6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Notional value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>17,629.3 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair Value</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Exposure</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2024</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2025</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2026</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>&gt;2027</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Costs</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zMtagDVvK4Xf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(352.5)</b></span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zoH4ojC4sqe5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(10.0)</b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_z9WPNQFMHhlh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6364">-</span>   </b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zBwzlBXimyRa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6366">-</span>   </b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zBauzFhiCu4i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6368">-</span>   </b></span></td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zeo1TXGKf9Yh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(362.5)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Commodities</span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zOyRB9l1Dzkc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.2)</span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z0dwGBbTSnHj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.9)</span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zh5EUaKlfTuj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6376">-</span>   </span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zoawOufZ6GFi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6378">-</span>   </span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zuMeF0l3xsi6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6380">-</span>   </span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zr5QvLHkFRfb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zirt6apqgxMb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(354.4)</span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zQoEoVfrwnB6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.1)</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zjRe9qQdKmU2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6388">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zaO7Y9HFKEPi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6390">-</span>   </span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_zqzP1nt16qOb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6392">-</span>   </span></td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfCostExposureMember_z758XsihToI9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(357.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Euros</span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zPR0ftcvB2j4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zXmV4inPxK6h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6398">-</span>   </span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zYXhCf1boLQe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6400">-</span>   </span></td> <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zJ1nCgxfJxlj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6402">-</span>   </span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zstCdyQu2D25" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6404">-</span>   </span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--EurosRiskPortionOfCostExposureMember_zuWzAIXlCuIl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Mexican Pesos</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zOWpZblb3nOf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.2 </span></td> <td id="xdx_980_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zc3ylL746zkk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6410">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_ze2y4ix7zyHh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6412">-</span>   </span></td> <td id="xdx_988_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zWLJhIM2Yx0b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6414">-</span>   </span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zfpwHyh1Y4Fe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6416">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--MexicanPesosRiskPortionOfCostExposureMember_zkE4jQAfNiIl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">16.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Importing of fixed assets</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zcjoBJu4JFdg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.5)</b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zBxltIM7IX32" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6422">-</span>   </b></span></td> <td id="xdx_98C_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zuIhohYrSTWi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6424">-</span>   </b></span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zmFRIIOMesl7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6426">-</span>   </b></span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zByHVptc2XU4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6428">-</span>   </b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zfGSMBRp1zLe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(14.5)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zr4zfgKBsTIj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.5)</span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zKfmZ9X8pxH4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6434">-</span>   </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zB3haA1XMoi2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6436">-</span>   </span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zqGk15UgLMmg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6438">-</span>   </span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_ziXAnhnqo6i9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6440">-</span>   </span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfFixedAssetsExposureMember_zU39FNjfMFF7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Expenses</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zAvckgKvvjG5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.1)</b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zTHJh8XWje89" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6446">-</span>   </b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zbxTgpMh2iL8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6448">-</span>   </b></span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zaEpWMjCgcre" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6450">-</span>   </b></span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zSnMOk34hjIj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6452">-</span>   </b></span></td> <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zajYjSCK8wI5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(4.1)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zH5Cv0epzw1i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zxO0aGWYPOE9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6458">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zAXZUj3caF3c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6460">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zfejDUH1gFMh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6462">-</span>   </span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zEFk4aq1R1P" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6464">-</span>   </span></td> <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheExpensesExposureMember_zZtAn3zwyGl1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_z99ycWic0a3d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2.3)</b></span></td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zbhGNneVntmh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6470">-</span>   </b></span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zI03HGkJi9Gf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6472">-</span>   </b></span></td> <td id="xdx_987_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zTH2BoGVXRO4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6474">-</span>   </b></span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_z5QqSMFahWch" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6476">-</span>   </b></span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalCashExposureMember_zYeCSCIAZtq5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2.3)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td id="xdx_982_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zzpKKexi0wRi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zOnzaLf444Xg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6482">-</span>   </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zH6UVrztfJtd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6484">-</span>   </span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zy4ngYJ3DXsj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6486">-</span>   </span></td> <td id="xdx_981_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zEDmegvy3xHi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6488">-</span>   </span></td> <td id="xdx_983_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--USDollarsRiskPortionOfTheCashExposureMember_zWsAJmoVx5Fc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_z2M6OcnkE2Kh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(373.4)</b></span></td> <td id="xdx_985_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zSzjr5twEudb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(10.0)</b></span></td> <td id="xdx_986_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zoqJDUqTpNL2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6496">-</span>   </b></span></td> <td id="xdx_98E_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zp8QY8p4W5Li" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6498">-</span>   </b></span></td> <td id="xdx_98C_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zdSvo1vRvk42" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6500">-</span>   </b></span></td> <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--TotalFinancialRiskExposureMember_zRfuMOkd8WRf" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair Value"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(383.4)</b></span></td></tr> </table> 16763300000 610900000 17374200000 3924300000 101400000 4025700000 12690500000 509500000 13200000000.0 37400000 37400000 111100000 111100000 249700000 249700000 249700000 249700000 64700000 64700000 64700000 64700000 -59300000 -59300000 -59300000 -59300000 17018400000 610900000 17629300000 -352500000 -10000000.0 -362500000 -14200000 -6900000 -21100000 -354400000 -3100000 -357500000 -100000 -100000 16200000 16200000 -14500000 -14500000 -14500000 -14500000 -4100000 -4100000 -4100000 -4100000 -2300000 -2300000 -2300000 -2300000 -373400000 -10000000.0 -383400000 197700000 376900000 <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--DisclosureOfFinancialInstrumentsFairValueHierarchyTextBlock_pn5n6_z0gwmKexcZz4" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 3)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B8_z6wnUZvzDAvl" style="display: none">Schedule of fair value measurement</span></td> <td id="xdx_49C_20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zHravdD0Q208" style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_499_20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zjdyGOdYzoge" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49F_20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zDL6v02gQbgl" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49B_20231231_z5TL3e1hdfsc" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_495_20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zy5JPUIoIwU9" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49F_20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zwfJVCmeMSik" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_499_20221231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zYgBsEicShc2" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_496_20221231_zubOWmEPt1Tk" style="text-align: center; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="4" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 40%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 8%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; width: 7%; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 2</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 3</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Total </b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 1</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 2</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Level 3</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Total</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="text-decoration: underline">Financial assets</span></b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_406_ecustom--FinancialAssetsInvestmentSecurities_iI_maFAAFVzYE9_zIrnL93mCnGd" style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Investment securities</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">277.2 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6512">-</span>   </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6513">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">277.2 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">454.5 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6516">-</span>   </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6517">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">454.5 </span></td></tr> <tr id="xdx_40D_ecustom--DerivativeFinancialAssetsHeldForHedgingOperationalHedges_iI_pn5n6_maFAAFVzYE9_zJS60l5o5ZS9" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives – operational hedge</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">53.4 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">326.3 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6522">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">379.7 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">57.0 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">216.8 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6526">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">273.8 </span></td></tr> <tr id="xdx_406_eifrs-full--FinancialAssetsAtFairValue_iTI_pn5n6_mtFAAFVzYE9_zTTElt14DT8j" style="background-color: rgb(204,238,255)"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> <b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>330.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>326.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6531">-</span>   </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>656.9 </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>511.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>216.8 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6535">-</span>   </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>728.3 </b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="text-decoration: underline">Financial liabilities</span></b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_403_ecustom--PutOptionsGrantedOnSubsidiaries_iI_maFLAFVzLKz_znFWrl9zRoda" style="background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Put options granted on subsidiaries</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6538">-</span>   </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6539">-</span>   </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,791.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,791.1 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6542">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6543">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,060.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,060.3 </span></td></tr> <tr id="xdx_40E_eifrs-full--OtherFinancialLiabilities_iI_maFLAFVzLKz_zjyMxDaWELgk" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other liabilities</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6547">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6548">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">272.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">272.6 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6551">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6552">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">333.7 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">333.7 </span></td></tr> <tr id="xdx_40A_ecustom--DerivativesLiabilitiesAtFairValueThroughProfitAndLoss_iI_pn5n6_maFLAFVzLKz_znh3cU287tAd" style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives liabilities at fair value through profit and loss</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6557">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6558">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.3 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6560">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6561">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6562">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6563">-</span>   </span></td></tr> <tr id="xdx_40E_ecustom--DerivativeFinancialLiabilitiesHeldForHedgingOperationalHedge_iI_pn5n6_maFLAFVzLKz_zNIZPB8Nxpal" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Derivatives – operational hedge</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">70.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">690.8 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6567">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">760.8 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">76.1 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">653.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6571">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">729.4 </span></td></tr> <tr id="xdx_404_eifrs-full--FinancialLiabilitiesAtFairValue_iTI_pn5n6_mtFLAFVzLKz_zEoC0PzFHF6k" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> <b style="display: none">Total</b></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>72.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>690.8 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,063.7 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,826.8 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>76.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>653.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,394.0 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>4,123.4 </b></span></td></tr> </table> 277200000 277200000 454500000 454500000 53400000 326300000 379700000 57000000.0 216800000 273800000 330600000 326300000 656900000 511500000 216800000 728300000 2791100000 2791100000 3060300000 3060300000 272600000 272600000 333700000 333700000 2300000 2300000 70000000.0 690800000 760800000 76100000 653300000 729400000 72300000 690800000 3063700000 3826800000 76100000 653300000 3394000000.0 4123400000 0.15 0.1211 0.0289 2791100000 3053700000 <table cellpadding="0" cellspacing="0" id="xdx_886_eifrs-full--DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory_pn5n6_zmq6q56Yzigi" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 4)"> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zpWzBmwPRnki" style="display: none">Schedule of reconciliation of changes in the assets</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr> <td style="width: 80%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Financial liabilities at December 31, 2022</b></span></td> <td id="xdx_984_eifrs-full--FinancialLiabilities_iS_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zYkCkIPJJjld" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liabilities balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,394.0 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">   Acquisition of investments</span></td> <td id="xdx_98B_eifrs-full--PurchasesFairValueMeasurementLiabilities_iN_pn5n6_di_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zygbOdtpvgt4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Acquisition of investments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(64.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Level reclassification</span></td> <td id="xdx_98F_ecustom--LevelReclassification_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zrftZWIUM0e5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Level reclassification"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(6.6)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Total gains and losses during the period</span></td> <td id="xdx_98F_ecustom--LossesGainsRecognizedInTheYearFairValueMeasurementLiabilities_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zjpy8A136bT2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total gains and losses during the period"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(259.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">   Losses/(gains) recognized in net income</span></td> <td id="xdx_98E_eifrs-full--GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zAlXiclH8hwf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Losses/(gains) recognized in net income"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(269.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">   Losses/(gains) recognized in equity</span></td> <td id="xdx_98C_ecustom--GainsLossesRecognisedEquityFairValueMeasurementLiabilities_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zzqARrjZ9hT5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Losses/(gains) recognized in equity"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10.4 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Financial liabilities at December 31, 2023</b></span></td> <td id="xdx_98C_eifrs-full--FinancialLiabilities_iE_pn5n6_c20230101__20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zpcKiQx9M5l8" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Financial liabilities balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>3,063.7 </b></span></td></tr> </table> 3394000000.0 64200000 -6600000 -259500000 -269900000 10400000 3063700000 <table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfDetailedInformationAboutHedgingInstrumentsExplanatory_pn5n6_zAHLaYTFmeF3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 5)"> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zBYDdL23boS2" style="display: none">Schedule of  detailed information about hedging instruments</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td></tr> <tr> <td style="white-space: nowrap; width: 42%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Interest rate</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Amount </b></span></td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Interest rate</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Amount </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brazilian Reais</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_908_ecustom--PostfixedInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_z2260fjCyJnb" title="Pre-hedge, post-fixed interest rate">8.1</span>%</span></td> <td id="xdx_98B_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zfaXeIiTqNYi" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">243.2 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90C_ecustom--PostfixedInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zm3otJSFlggd" title="Pre-hedge, post-fixed interest rate">8.5</span>%</span></td> <td id="xdx_982_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_za9Z3hn61nD" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">230.1 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Post fixed interest rate </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z4YHoj7Prork" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>243.2 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--PostfixedInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zJjpoFRlwI0i" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, post-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>230.1 </b></span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brazilian Reais</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90B_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zrRhabLE0Lsf" title="Pre-hedge, pre-fixed interest rate">10.1</span>%</span></td> <td id="xdx_98C_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zmMSjmCyt1Yc" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,372.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_za8aSndT40Pe" title="Pre-hedge, pre-fixed interest rate">8.5</span>%</span></td> <td id="xdx_98D_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskBrazilianReaisMember_zEMrSE8T8U5a" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,602.1 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Working Capital in Argentinean Peso </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_907_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zewgkJvmuBi3" title="Pre-hedge, pre-fixed interest rate">0.0</span>%</span></td> <td id="xdx_98D_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zJZaP9aRmHo6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6633">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_906_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zSm05ee9KPg3" title="Pre-hedge, pre-fixed interest rate">73.5</span>%</span></td> <td id="xdx_98D_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskWorkingCapitalinArgentineanPesoMember_zyQ8C4n1fqQ9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">74.3 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_909_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_zy3McSqBWLil" title="Pre-hedge, pre-fixed interest rate">11.5</span>%</span></td> <td id="xdx_982_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_zJgCBFKPYyug" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">405.6 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90F_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_zItuqgqoRVAk" title="Pre-hedge, pre-fixed interest rate">10.4</span>%</span></td> <td id="xdx_982_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--OtherCurrenciesMember_ztddZFwfkolf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">421.3 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">US Dollars</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_905_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_zjeV9LzLH054" title="Pre-hedge, pre-fixed interest rate">14.0</span>%</span></td> <td id="xdx_98B_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_ziyOpDU1l6ii" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl6649">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_901_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_z8qRsIu2F8If" title="Pre-hedge, pre-fixed interest rate">14.0</span>%</span></td> <td id="xdx_98A_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskUSDollarsMember_zZnfvB420mH6" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6.2 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Canadian Dollars</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_905_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zp7DQlb5zkKc" title="Pre-hedge, pre-fixed interest rate">5.6</span>%</span></td> <td id="xdx_98B_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zHCCUcvqdD6k" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">480.3 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span id="xdx_90A_ecustom--PresetInterestRatePrehedged_iI_pip0_dp_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zS8SldAyx40c" title="Pre-hedge, pre-fixed interest rate">5.3</span>%</span></td> <td id="xdx_987_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__custom--InterestRateRiskCanadianDollarsMember_zqX7wazURTZ3" style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">511.0 </span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Pre-fixed interest rate </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20231231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_z9JMFOPTgOd8" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,257.9 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PresetInterestPrehedgedValue_iI_pn5n6_c20221231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember_zb401hKb23J2" style="border-bottom: black 2.25pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Pre-hedge, pre-fixed interest rate, amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3,614.9 </b></span></td></tr> </table> 0.081 243200000 0.085 230100000 243200000 230100000 0.101 2372000000.0 0.085 2602100000 0.000 0.735 74300000 0.115 405600000 0.104 421300000 0.140 0.140 6200000 0.056 480300000 0.053 511000000.0 3257900000 3614900000 0.95 0.25 0.50 <table cellpadding="0" cellspacing="0" id="xdx_88E_eifrs-full--SensitivityAnalysisForEachTypeOfMarketRisk_pn5n6_zMk0DQiQRiFe" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 6)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zJOPM5kEPUWg" style="display: none">Schedule of types of market risk</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Transaction</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Risk</b></span></td> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fair value</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Probable scenario</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Adverse scenario</b></span></td> <td style="width: 13%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Remote<br/> scenario</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><i>Commodities hedge</i></span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Decrease in commodities price</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_z59dKPrZdrml" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.1)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zfgkBi6mf719" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">94.6 </span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zTbDPNNb0nRb" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">985.4 </span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CommoditiesRiskPortionOfCostExposureMember_zhL4FoRcF2B5" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,991.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Input purchases</span></td> <td id="xdx_98B_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zZB6yHs0l0ua" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">21.1 </span></td> <td id="xdx_98E_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zAgNyaFhdFC4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(94.6)</span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zrYY2IWZ0C39" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(985.4)</span></td> <td id="xdx_98B_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zUePdTQvMKJk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,991.9)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_987_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zGWeK2AeaFf4" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(341.4)</span></td> <td id="xdx_988_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zO0T8aMBbHue" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(163.3)</span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zqurPfej4CKd" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,995.8 </span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignExchangeRiskPortionOfCostExposureMember_zeFKK21p1Fc" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,333.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Input purchases</span></td> <td id="xdx_982_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zbYenyQwkKn8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">341.4 </span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zSt9nMGkgRIc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">104.9 </span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zna1uXjatMR5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3,336.8)</span></td> <td id="xdx_98C_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--InputPurchasesAffectingTheCommodityRiskPortionOfCostExposureMember_zGPex5zvs3i6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7,014.9)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cost effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><b> </b></td> <td id="xdx_983_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zxq5a2ZSleKb" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6708">-</span>   </b></span></td> <td id="xdx_982_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zee5z6YToFjk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(58.4)</b></span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zXDvSF2ZGkd6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(341.0)</b></span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_d0_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--CommoditiesAndForeignExchangeHedgesMember__ifrs-full--TypesOfRisksAxis__custom--TotalCostExposureMember_zEdmnGJfKJz1" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(681.9)</b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zA5tA933ivNb" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.5)</span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zp8iTEHvwx84" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(13.2)</span></td> <td id="xdx_982_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zJ7rU6j6l7Mk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">47.9 </span></td> <td id="xdx_98B_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyRiskPortionOfFixedAssetsExposureMember_zHmmh4fzVQQk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">110.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capex Purchases</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zLLmdzdwRzb5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">14.5 </span></td> <td id="xdx_988_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zs08RgEnfDq1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.2 </span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zkI5zT4zPqX7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(47.9)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CapexPurchasesAffectingTheForeignCurrencyExchangeRiskPortionOfTheFixedAssetsExposureMember_zPAUlcIPu33i" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(110.3)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Fixed asset effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zgxYVe9BtCJ9" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6732">-</span>   </b></span></td> <td id="xdx_983_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zqFxkjNHVNMa" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6734">-</span>   </b></span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_zG7RF8QZV8tg" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6736">-</span>   </b></span></td> <td id="xdx_980_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalFixedAssetExposureMember_ziZ1Yt0DMW0d" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6738">-</span>   </b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_982_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zfqMfPFRFkff" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4.1)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zkqDgr2YVQEj" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.7)</span></td> <td id="xdx_988_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zrWPiFN9A2Za" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.0 </span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ExpensesThatAffectTheForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_ziRQuUgwoeJh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">28.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Expenses</span></td> <td id="xdx_98C_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zIwx4lyX36Q2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.1 </span></td> <td id="xdx_984_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zP65DiPPuqt3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1.7)</span></td> <td id="xdx_982_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_zDy7HbXoXGLd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(44.0)</span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesExposureMember_ziMGswNPzk3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(92.2)</span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Result of expense effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_z4NKAUXtkCgd" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6756">-</span>   </b></span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_znOjZnClnuY9" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(5.4)</b></span></td> <td id="xdx_981_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zpmeG1WQeD2e" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(32.0)</b></span></td> <td id="xdx_980_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalExpensesExposureMember_zwoqwvwcY9Hg" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(64.0)</b></span></td></tr> <tr style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign exchange hedge</span></td> <td rowspan="2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Foreign currency decrease</span></td> <td id="xdx_984_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zzLVCmKuBBSh" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.3)</span></td> <td id="xdx_987_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zwTZIV9oAdrc" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.5)</span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zW8UpD8xfqT9" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(17.1)</span></td> <td id="xdx_984_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--CashEffectsPortionOfExpensesExposureMember_zC7DqIm3ObTf" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(31.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cash</span></td> <td id="xdx_98D_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zaqwUO8fn2Ra" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.3 </span></td> <td id="xdx_98E_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zrt1YFoE4jrf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2.5 </span></td> <td id="xdx_983_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zlJBLfNWunxk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">17.1 </span></td> <td id="xdx_984_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--ForeignCurrencyExchangeRiskPortionOfExpensesCashMember_zB7IsHDdn3aa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">31.9 </span></td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Cash effects</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue_iI_pn5n6_c20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_zidEDPZY9LF1" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Fair value of hedging instruments"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6780">-</span>   </b></span></td> <td id="xdx_989_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_z1A2YwOwdfK6" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6782">-</span>   </b></span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_zRKeEn2VF0Og" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6784">-</span>   </b></span></td> <td id="xdx_98C_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenarioProFormaBasis_pn5n6_c20230101__20231231__ifrs-full--TypesOfHedgesAxis__custom--ForeignCurrencyExchangeHedgeMember__ifrs-full--TypesOfRisksAxis__custom--TotalCashEffectsExposureMember_zg05D02Er9wk" style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl6786">-</span>   </b></span></td></tr> <tr style="background-color: White"> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>-   </b></span></td> <td id="xdx_986_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtProbableScenario_pn5n6_c20230101__20231231_zZdtdo9VxmZ1" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, probable scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(63.8)</b></span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtAdverseScenario_iI_pn5n6_c20230101__20231231_zXb3qn86rI7j" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, adverse scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(373.0)</b></span></td> <td id="xdx_98A_ecustom--FinancialInstrumentsDesignatedAsHedgingInstrumentsEffectsAtRemoteScenario_pn5n6_c20230101__20231231_z9boopodEGq7" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sensitivity value level, remote scenario"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(745.9)</b></span></td></tr> </table> -21100000 94600000 985400000 1991900000 21100000 -94600000 -985400000 -1991900000 -341400000 -163300000 2995800000 6333000000.0 341400000 104900000 -3336800000 -7014900000 -58400000 -341000000.0 -681900000 -14500000 -13200000 47900000 110300000 14500000 13200000 -47900000 -110300000 -4100000 -3700000 12000000.0 28200000 4100000 -1700000 -44000000.0 -92200000 -5400000 -32000000.0 -64000000.0 -2300000 -2500000 -17100000 -31900000 2300000 2500000 17100000 31900000 -63800000 -373000000.0 -745900000 <table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfDisclosureOfTermsAndDebtRepaymentsTextBlock_zV8xwpdVBbz" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 7)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B7_zOgB9sVBPAnc" style="display: none">Schedule of liquidity risk and payables</span></td> <td id="xdx_496_20231231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zbYGYGMdh6da" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Carrying amount"> </td> <td id="xdx_497_20231231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ContractualCashFlowsMember_z826jxKM7Krl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49C_20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zKXDtWzHaNj1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_492_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zLqmG7sax2Mb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49C_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zc6kCRLK3RYj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49C_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zEKDTjIBsek7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center" title="Contractual cash flows"> </td> <td id="xdx_49A_20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zoaEV4al4oS8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Contractual cash flows</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Less than 1 year</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1-2 years</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2-3 years</b></span></td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3-5 years</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>More than 5 years</b></span></td></tr> <tr id="xdx_405_eifrs-full--TradeAndOtherPayables_iI_zmXFUZR1x9r8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Trade and other payables </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36,817.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">38,453.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">35,522.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">439.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">808.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,672.1 </span></td></tr> <tr id="xdx_40B_ecustom--SecuredBankLoans_iI_z0kTnzsW2Wrh" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Secured bank loans</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">126.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">177.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">26.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.4 </span></td></tr> <tr id="xdx_400_ecustom--OtherSecuredLoans_iI_zzanB3Swrj54" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Other secured loans </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">415.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">594.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">156.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">171.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">134.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">79.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">53.9 </span></td></tr> <tr id="xdx_406_eifrs-full--LeaseLiabilities_iI_zwY0YGP08WMi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Lease liabilities </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,958.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,473.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,344.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">608.3 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">552.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">452.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">515.5 </span></td></tr> <tr id="xdx_40B_ecustom--TotalPayablesAndLiabilities_iI_z0BQCorYtvFe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total payables and liabilities</b> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>40,318.9 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>42,699.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>37,049.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,244.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>722.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,390.9 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,291.8 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_498_20221231__ifrs-full--ClassesOfLiabilitiesAxis__ifrs-full--CarryingAmountMember_zG08IdBzjhOe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20221231__ifrs-full--ClassesOfLiabilitiesAxis__custom--ContractualCashFlowsMember_zaW7leThx0S" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_493_20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zdduTbtqnsm8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49E_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zI5Yk4xrhhT5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_499_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zEpE5YsuoGqg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_498_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zJ8MmaMgV3m3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_49B_20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkoNOL7njxml" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="7" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; width: 23%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 15%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Carrying amount</b></span></td> <td style="width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Contractual cash flows</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Less than 1 year</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1-2 years</b></span></td> <td style="width: 9%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2-3 years</b></span></td> <td style="width: 6%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3-5 years</b></span></td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>More than 5 years</b></span></td></tr> <tr id="xdx_405_eifrs-full--TradeAndOtherPayables_iI_zY5LAwlO087e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Trade and other payables </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">39,354.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">40,656.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">36,818.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">86.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,275.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,008.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,467.6 </span></td></tr> <tr id="xdx_40F_ecustom--SecuredBankLoans_iI_zYgmfSXxc9Mi" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Secured bank loans</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">180.8 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">245.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">68.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">26.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">50.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">75.5 </span></td></tr> <tr id="xdx_406_ecustom--OtherSecuredLoans_iI_zCpeBYaGNhTf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Other secured loans </span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">472.5 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">759.1 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">169.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">156.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">151.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">165.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">115.5 </span></td></tr> <tr id="xdx_406_eifrs-full--LeaseLiabilities_iI_ztsaIjssvT11" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Lease liabilities </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,117.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,657.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">962.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,008.4 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">621.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">696.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">368.2 </span></td></tr> <tr id="xdx_40E_ecustom--TotalPayablesAndLiabilities_iI_zs2Qv4ldtLz6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><b style="display: none">Total payables and liabilities</b> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>43,125.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>45,318.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>38,019.5 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,278.3 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,072.9 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1,921.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2,026.8 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">Mainly includes amounts related to suppliers, taxes, fees and contributions payables, dividends, and interest on equity payable, salaries and charges, put options related to the Company’s participation in subsidiaries and other liabilities, except for related parties, with payment term of less than one year.</td> </tr></table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">Nomenclature modified to Other secured loans, including for comparative purposes.</td> </tr></table> 36817800000 38453700000 35522500000 439900000 10600000 808600000 1672100000 126500000 177800000 26700000 25200000 25200000 50400000 50400000 415700000 594700000 156000000.0 171200000 134200000 79400000 53900000 2958900000 3473000000.0 1344000000.0 608300000 552600000 452600000 515500000 40318900000 42699200000 37049200000 1244600000 722600000 1390900000 2291800000 39354400000 40656400000 36818500000 86800000 1275100000 1008400000 1467600000 180800000 245700000 68200000 26400000 25200000 50400000 75500000 472500000 759100000 169900000 156700000 151600000 165400000 115500000 3117400000 3657400000 962900000 1008400000 621000000.0 696900000 368200000 43125100000 45318600000 38019500000 1278300000 2072900000 1921100000 2026800000 <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--ScheduleOfNetDebtOfContinuityInTheLongTerm_pn5n6_zih6GO9ohXia" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - FINANCIAL INSTRUMENTS AND RISKS (Details 8)"> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zyXzNvtO6JPe" style="display: none">Schedule of net debt of long term</span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_49A_20231231_zf8KQK2IwiGa" style="text-align: center; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_495_20221231_z56xiOrJQ7N1" style="text-align: center; white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr> <td style="vertical-align: bottom; width: 65%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; vertical-align: bottom; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Assets</b></span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_401_ecustom--InterestbearingLoansAndBorrowingsCurrentAndNoncurrent_iI_zLZ9tpByn6ml" style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Interest-bearing loans and borrowings current and non-current</span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,501.1 </span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,770.7 </span></td></tr> <tr id="xdx_40C_ecustom--FinancialAssetAtFairValueThroughProfitOrLoss_iNI_di_znIgphQzNQta" style="background-color: White"> <td style="vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(-) Financial assets at fair value through profit or loss</span></td> <td style="vertical-align: top; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(277.2)</span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(454.5)</span></td></tr> <tr id="xdx_404_ecustom--CashAndCashEquivalentsLessBankOverdraft_iI_zQhRIJWprClf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(-) Cash and cash equivalents less bank overdraft</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(16,059.0)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">(14,852.1)</span></td></tr> <tr id="xdx_40E_eifrs-full--NetDebt_iI_zuCiteCBhr53" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net debt</b></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(12,835.1)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>(11,535.9)</b></span></td></tr> </table> 3501100000 3770700000 277200000 454500000 -16059000000.0 -14852100000 -12835100000 -11535900000 <p id="xdx_80E_ecustom--DisclosureOfCollateralAndContractualCommitmentsWithSuppliersAdvancesFromCustomersAndOtherTextBlock_zTMP0QoIzLgi" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_035"></span>29.</b></td><td style="text-align: justify"><b><span id="xdx_82C_zrF01ZP5Uy06">COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS</span></b></td></tr></table> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_pn5n6_zRTVZzts9JX" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_z1fHRz7JwSLe" style="display: none">Schedule of commitments and contingent liabilities</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 57%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Collateral given for the Company’s own liabilities</span></td> <td id="xdx_98A_eifrs-full--AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue_iI_pn5n6_c20231231_zOLvi6Ta0FKe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Collateral given for the Companys own liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">581.0 </span></td> <td id="xdx_980_eifrs-full--AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue_iI_pn5n6_c20221231_zYpJr1q9Ddyh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Collateral given for the Companys own liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">764.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other commitments</span></td> <td id="xdx_988_ecustom--OtherCommitmentsHeld_iI_pn5n6_c20231231_zVqqs9fFlP34" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,146.8 </span></td> <td id="xdx_98A_ecustom--OtherCommitmentsHeld_iI_pn5n6_c20221231_zPJRG2tBqyh3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,368.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--CollateralAndOtherCommitments_iI_pn5n6_c20231231_zMaNZOXkqcAd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,727.8 </b></span></td> <td id="xdx_98D_ecustom--CollateralAndOtherCommitments_iI_pn5n6_c20221231_zjObQbuaBQU3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,132.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commitments to suppliers - Property, plant and equipment and Intangible</span></td> <td id="xdx_98A_ecustom--CommitmentsToSuppliersPropertyPlantAndEquipmentAndIntangible_iI_pn5n6_c20231231_zBy0ARBnVq6j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers property, plant and equipment and Intangible"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,000.8 </span></td> <td id="xdx_987_ecustom--CommitmentsToSuppliersPropertyPlantAndEquipmentAndIntangible_iI_pn5n6_c20221231_zEZVFoBU9bwk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers property, plant and equipment and Intangible"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">276.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commitments to suppliers - Inventories</span></td> <td id="xdx_98D_ecustom--CommitmentsToSuppliersInventories_iI_pn5n6_c20231231_zFRLlR5JkLAh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers - Inventories"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">38,391.0 </span></td> <td id="xdx_980_ecustom--CommitmentsToSuppliersInventories_iI_pn5n6_c20221231_zOjTBYKUeC2f" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers - Inventories"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,088.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231_zKwPxX5sYZpl" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments to suppliers"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>39,391.8 </b></span></td> <td id="xdx_98A_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231_zOi3vPp0GAnh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments to suppliers"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>50,365.3 </b></span></td></tr> </table> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">As at December 31, 2023, the Company had R$<span id="xdx_905_ecustom--CashGuarantees_iI_pn5n6_c20231231_zhqMEByvtpLg" title="Cash guarantees">558.2</span> (R$<span id="xdx_902_ecustom--CashGuarantees_iI_pn6n6_c20221231_zDsuaozDQKSg" title="Cash guarantees">744</span>.0 as at December 31, 2022) of cash guarantees. The deposits in cash used as guarantees are presented as part of other assets. To provide the guarantees required for derivatives exchanges and/or counterparties contracted in certain derivative financial instrument transactions, as at December 31, 2023, Ambev maintained R$<span id="xdx_900_ecustom--GuaranteesHeldForDerivativeInstruments_iI_pn5n6_c20231231_ztlVX0MoPUph" title="Guarantees held for derivative instruments">197.7</span> (R$<span id="xdx_90E_ecustom--GuaranteesHeldForDerivativeInstruments_iI_pn5n6_c20221231_zNACnYp4sIVl" title="Guarantees held for derivative instruments">376.9</span> as at December 31, 2022) in highly liquid financial investments or in cash, classified as cash and cash equivalents and investment securities (Note 28- <i>Financial instruments and risks</i>).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Most of the balance relates to commitments to suppliers of packaging. These commitments the main objective is to long-term supply security for the Company regarding strategic inputs, as well as offering greater assurance to suppliers for long-term investments. The balances of fixed assets provided as security are not material.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="background-color: white">Future contractual commitments as at December 31, 2023, and December 31, 2022, are as follow:</span></p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--DisclosureOfFutureContractualCommitmentsTextBlock_pn5n6_zzpuf4Xprru6" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zTzfawnJW0ff" style="display: none">Schedule of future contractual commitments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 57%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Less than 1 year</span></td> <td id="xdx_983_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zaK6YtoAWZGj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,619.2 </span></td> <td id="xdx_981_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zt8eUREidpii" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,491.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Between 1 and 2 years</span></td> <td id="xdx_98F_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zpL09MiOZjkd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,536.3 </span></td> <td id="xdx_98F_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zPxIDATuRjme" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,315.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">More than 2 years</span></td> <td id="xdx_98B_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanTwoYearsMember_zCZR9J8Oymqh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20,236.3 </span></td> <td id="xdx_98E_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__custom--LaterThanTwoYearsMember_z7TQoVeTfhGg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27,559.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231_zYSrqHIR7n52" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>39,391.8 </b></span></td> <td id="xdx_987_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231_zTCD8pSmMxBb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>50,365.3 </b></span></td></tr> </table> <p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory_pn5n6_zRTVZzts9JX" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Components of Collateral and Commitments (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_z1fHRz7JwSLe" style="display: none">Schedule of commitments and contingent liabilities</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 57%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; white-space: nowrap; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Collateral given for the Company’s own liabilities</span></td> <td id="xdx_98A_eifrs-full--AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue_iI_pn5n6_c20231231_zOLvi6Ta0FKe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Collateral given for the Companys own liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">581.0 </span></td> <td id="xdx_980_eifrs-full--AssetsHeldAsCollateralPermittedToBeSoldOrRepledgedAtFairValue_iI_pn5n6_c20221231_zYpJr1q9Ddyh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Collateral given for the Companys own liabilities"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">764.5 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Other commitments</span></td> <td id="xdx_988_ecustom--OtherCommitmentsHeld_iI_pn5n6_c20231231_zVqqs9fFlP34" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,146.8 </span></td> <td id="xdx_98A_ecustom--OtherCommitmentsHeld_iI_pn5n6_c20221231_zPJRG2tBqyh3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,368.1 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--CollateralAndOtherCommitments_iI_pn5n6_c20231231_zMaNZOXkqcAd" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>1,727.8 </b></span></td> <td id="xdx_98D_ecustom--CollateralAndOtherCommitments_iI_pn5n6_c20221231_zjObQbuaBQU3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2,132.6 </b></span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commitments to suppliers - Property, plant and equipment and Intangible</span></td> <td id="xdx_98A_ecustom--CommitmentsToSuppliersPropertyPlantAndEquipmentAndIntangible_iI_pn5n6_c20231231_zBy0ARBnVq6j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers property, plant and equipment and Intangible"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">1,000.8 </span></td> <td id="xdx_987_ecustom--CommitmentsToSuppliersPropertyPlantAndEquipmentAndIntangible_iI_pn5n6_c20221231_zEZVFoBU9bwk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers property, plant and equipment and Intangible"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">276.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Commitments to suppliers - Inventories</span></td> <td id="xdx_98D_ecustom--CommitmentsToSuppliersInventories_iI_pn5n6_c20231231_zFRLlR5JkLAh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers - Inventories"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">38,391.0 </span></td> <td id="xdx_980_ecustom--CommitmentsToSuppliersInventories_iI_pn5n6_c20221231_zOjTBYKUeC2f" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Commitments to suppliers - Inventories"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">50,088.6 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231_zKwPxX5sYZpl" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments to suppliers"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>39,391.8 </b></span></td> <td id="xdx_98A_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231_zOi3vPp0GAnh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Total commitments to suppliers"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>50,365.3 </b></span></td></tr> </table> 581000000.0 764500000 1146800000 1368100000 1727800000 2132600000 1000800000 276700000 38391000000.0 50088600000 39391800000 50365300000 558200000 744000000 197700000 376900000 <table cellpadding="0" cellspacing="0" id="xdx_88D_ecustom--DisclosureOfFutureContractualCommitmentsTextBlock_pn5n6_zzpuf4Xprru6" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - COLLATERAL AND CONTRACTUAL COMMITMENTS WITH SUPPLIERS, ADVANCES FROM CUSTOMERS AND OTHERS - Future Contractual Commitments (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B5_zTzfawnJW0ff" style="display: none">Schedule of future contractual commitments</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 57%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 21%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Less than 1 year</span></td> <td id="xdx_983_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zaK6YtoAWZGj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,619.2 </span></td> <td id="xdx_981_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zt8eUREidpii" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">12,491.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">Between 1 and 2 years</span></td> <td id="xdx_98F_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zpL09MiOZjkd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">9,536.3 </span></td> <td id="xdx_98F_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zPxIDATuRjme" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">10,315.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">More than 2 years</span></td> <td id="xdx_98B_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231__ifrs-full--MaturityAxis__custom--LaterThanTwoYearsMember_zCZR9J8Oymqh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">20,236.3 </span></td> <td id="xdx_98E_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231__ifrs-full--MaturityAxis__custom--LaterThanTwoYearsMember_z7TQoVeTfhGg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">27,559.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--TotalExposureLiabilities_iI_pn5n6_c20231231_zYSrqHIR7n52" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>39,391.8 </b></span></td> <td id="xdx_987_ecustom--TotalExposureLiabilities_iI_pn5n6_c20221231_zTCD8pSmMxBb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Future contractual commitments"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>50,365.3 </b></span></td></tr> </table> 9619200000 12491000000.0 9536300000 10315300000 20236300000 27559000000.0 39391800000 50365300000 <p id="xdx_80D_eifrs-full--DisclosureOfRelatedPartyExplanatory_zRodvJPmUreb" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><span id="a_036"></span><b>30.</b></td><td><b><span id="xdx_820_zteugsF8sbGh">RELATED PARTIES</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopts the corporate governance practices recommended and/or required by the applicable laws. Under the Company’s by-laws, the Board of Directors is responsible for approving any transactions or agreements between the Company and/or any of its subsidiaries (except for full subsidiaries), its directors and/or shareholders (including direct or indirect shareholders of the Company). The Governance Committee of the Company is required to advise the Board of Directors on all transactions with related parties, among other subjects.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management is prohibited from interfering in any transaction in which a conflict of interest exists, even in theory, with the Company’s interests. Management also is not permitted to interfere in decisions of any other members of management, and the minutes of meeting of the Board are required to document any decision to abstain from the respective deliberations.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>30.1 Transactions with key management members</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The key management includes the <span style="color: #0D0D0D; background-color: white">Statutory</span> Executive Board and Board of Directors. In addition to short-term benefits (primarily salaries), management members are entitled to participate in the share-based payment, as in Note 25- <i>Share-based payments</i>).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0">Total expenses related to the Company’s management members are as follow:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfKeyManagementPersonnelCompensationTextBlock_pn5n6_zwx0LZHLO3kc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - RELATED PARTIES - Expenses Related to Management Members (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zRHo732XBUuj" style="display: none">Schedule of key management remuneration</span> </td> <td id="xdx_492_20230101__20231231_ze0IPV2HAtKb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_499_20220101__20221231_zkROnBhqtF6c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_zBvr7eolNw01" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 49%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_407_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn5n6_maKMPCzN4O_zX9S2tyG6rlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Short-term benefits</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">66.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">68.3 </span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn5n6_maKMPCzN4O_zCnq03EoYDS6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Share-based payments </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">80.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">66.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">65.3 </span></td></tr> <tr id="xdx_405_eifrs-full--KeyManagementPersonnelCompensation_iT_pn5n6_mtKMPCzN4O_zpK4ZX7vd3Ce" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total key management remuneration </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>147.4 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>140.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>133.6 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">These mainly correspond to management’s salaries and profit sharing (including performance bonuses).</td> </tr></table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">These correspond to compensation expenses of share options, restricted stocks and performance stocks granted to Management. In total amounts above exclude remuneration paid to members of the Fiscal Council and Committees.</td> </tr></table> <p id="xdx_8AE_zp6LqZy54sl9" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Except the abovementioned remuneration, the Company has other types of transaction with the Management members or pending balances receivable or payable in its balance sheet.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition, on October 19th, 2023, the Company adopted a clawback policy that applies to incentive-based compensation received by certain executives (which currently comprise the members of the Executive Board of Officers). Under this policy, "incentive-based compensation" is defined broadly to include any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a financial reporting measure (e.g. variable performance-related compensation (bonus) and annual long-term incentive performance stock units (PSUs)). </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 11pt">The policy provides that in the event the company is required to prepare an accounting restatement of its financial statements due to the company's material noncompliance with any financial reporting requirements under the applicable securities laws, the Company will recover (on a pre-tax basis) from the relevant executive officers any incentive-based compensation received by such executives on or after October 2nd, 2023 and during the three fiscal years preceding the date the restatement was required that exceeds the amount of incentive-based compensation that otherwise would have been received had such incentive-based compensation been determined according to the applicable accounting restatement, subject to limited exceptions. The recovery of such compensation applies regardless of whether any misconduct occurred and without regard to whether an executive officer engaged in misconduct or otherwise caused or contributed to the requirement for a restatement</span><span style="font-size: 12pt">. </span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>30.2 Transactions with the Company's shareholders:</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>30.2.1 Medical, dental and other benefits</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i> </i></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fundação Zerrenner is one of Ambev’s shareholders, and at December 31, 2023, held <span id="xdx_902_ecustom--PercentageOfOwnershipHeldByARelatedParty_iI_pip0_dp_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FundacaoZerrennerMember_zodjQbgU9wQd" title="Percentage of ownership held by a related party">10.2</span>% of its total share capital. Fundação Zerrenner is also an independent legal entity whose main goal is to provide Ambev’s employees, both active and retired, with health care and dental assistance, technical and higher education courses, facilities for assisting elderly people, either directly or through financial assistance agreements with other entities. As at December 31, 2023, and December 31, 2022, actuarial obligations related to the benefits provided directly by Fundação Zerrenner were fully funded by plan assets, held for that purpose, which significantly exceeded the liabilities at these dates.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ambev recognizes the assets (prepaid expenses) of this plan to the extent of the economic benefits available to the Company, arising from reimbursements or from reductions in future contributions.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 31, 2023, the expenses incurred and recorded by Fundação Zerrenner with third parties, for providing these benefits totaled R$<span id="xdx_90B_ecustom--ExpensesIncurredByARelatedParty_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FundacaoZerrennerMember_z3nM2pTOJoX" title="Expenses incurred by a related party">322.9</span> at December 31, 2023 (R$<span id="xdx_906_ecustom--ExpensesIncurredByARelatedParty_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FundacaoZerrennerMember_z1ucAaQBlgVk" title="Expenses incurred by a related party">308.8</span> as at December 31, 2022), of which R$<span id="xdx_90D_ecustom--ExpensesIncurredByARelatedParty_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FundacaoZerrennerMember__ifrs-full--CounterpartiesAxis__custom--ActiveEmployeesMember_z0B8Co8SX4T3" title="Expenses incurred by a related party">291.7</span> and R$<span id="xdx_902_ecustom--ExpensesIncurredByARelatedParty_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FundacaoZerrennerMember__ifrs-full--CounterpartiesAxis__custom--RetireesMember_zgJHIL8Pl4Pd" title="Expenses incurred by a related party">31.2</span> were related to active employees and retirees respectively (R$<span id="xdx_904_ecustom--ExpensesIncurredByARelatedParty_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FundacaoZerrennerMember__ifrs-full--CounterpartiesAxis__custom--ActiveEmployeesMember_zMfdrCcEKRm2" title="Expenses incurred by a related party">270.7</span> and R$<span id="xdx_901_ecustom--ExpensesIncurredByARelatedParty_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--FundacaoZerrennerMember__ifrs-full--CounterpartiesAxis__custom--RetireesMember_zGrrGFx5nhZb" title="Expenses incurred by a related party">38.1</span> as at December 31, 2022, respectively).</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>30.2.2 Licensing agreement</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a licensing agreement with Anheuser-Busch, Inc. (“AB Inbev”) to produce, bottle, sell and distribute Budweiser® products in Brazil, Canada and Argentina, and sales and distribution agreements for Budweiser® products in Guatemala, the Dominican Republic, Paraguay, El Salvador, Nicaragua, Uruguay, Chile, Panama, Costa Rica and Puerto Rico. In addition, the Company produces and distributes Stella Artois® products under a license to ABI in Brazil and Canada and, through a license granted to ABI, also distributes Brahma® products in the United States and several other countries such as the United Kingdom, Spain, Sweden, Finland and Greece.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company and its subsidiaries have licensing agreements with the Group Modelo, subsidiaries of AB Inbev to import, produce, promote and sell Corona® products in Brazil, Canada, Argentina e Chile, as well agreements to to import, promote and sell Corona® products in Latin America and with Spaten-Franziskaner-Bräu GmbH, a subsidiary of ABI, to produce, promote, advertise and sell Spaten® in Brazil.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In this context, at December 31, 2023, the Company recorded R$<span id="xdx_901_eifrs-full--TransfersUnderLicenseAgreementsFromEntityRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschIncMember_zGLNeEC5X3Aa" title="Transfers under licence agreements from entity, related party transactions">35.4</span> (R$<span id="xdx_90E_eifrs-full--TransfersUnderLicenseAgreementsFromEntityRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschIncMember_zGjZX9kN3F39" title="Transfers under licence agreements from entity, related party transactions">22.6</span> as at December 31, 2022, and R$<span id="xdx_90A_eifrs-full--TransfersUnderLicenseAgreementsFromEntityRelatedPartyTransactions_pn6n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschIncMember_zdEYmxTVXy2i" title="Transfers under licence agreements from entity, related party transactions">17</span>.0 as at December 31, 2021) and R$<span id="xdx_907_eifrs-full--TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschIncMember_zfyrw6rYq9t2" title="Transfers under licence agreements to entity, related party transactions">888.6</span> (R$<span id="xdx_90F_eifrs-full--TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschIncMember_z7Vk06hH0mSl" title="Transfers under licence agreements to entity, related party transactions">736.7</span> as at December 31, 2022, and R$<span id="xdx_90B_eifrs-full--TransfersUnderLicenseAgreementsToEntityRelatedPartyTransactions_pn6n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschIncMember_zkTDv9Kn3OU3" title="Transfers under licence agreements to entity, related party transactions">819</span>.0 as at December 31, 2021) as licensing income and expenses, respectively in its Consolidated results.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>30.3 Transactions with related parties recognized in the income statement</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_pn5n6_z0pJ0jozUqa5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - RELATED PARTIES - Transactions With Related Parties (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zZeeS6W4xTa8" style="display: none">Schedule of transactions with related parties</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr> <td style="width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Sales and other</b></span></td> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other receivables</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Product purchases and other</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other payables</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net finance cost</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_98F_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zqGnk6Fv8nEb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_983_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zmMcRAjkJQva" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">97.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zuCfxQ1iYOH2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(143.3)</span></td> <td id="xdx_98D_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zaLKe8nJFISa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td> <td id="xdx_983_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zUsk7wNrM9gk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_981_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zONOJTzw3AHe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7005">-</span>   </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z5H51NNQDC9e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7007">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zQaO3MBATnf1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(235.5)</span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z6Fz5o45EfF" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7011">-</span>   </span></td> <td id="xdx_983_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zp9XKqZwBdBg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7013">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Procurement </span></td> <td id="xdx_98D_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zHgYILOpkPO6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7015">-</span>   </span></td> <td id="xdx_98A_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zOtE6O2urpV3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7017">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zVmJl8YSTrsa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7019">-</span>   </span></td> <td id="xdx_981_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zzXbcZP8hhI9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7021">-</span>   </span></td> <td id="xdx_987_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zbE9pdqvghge" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_983_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zpyLXWUFNNO3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">35.3 </span></td> <td id="xdx_98A_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zaQaRQ6umTM4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7027">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zvw9MWbNjHKk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(915.9)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zoBOpGNaVjJd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.1)</span></td> <td id="xdx_981_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zUIDCpXGgdui" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_985_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zy3QA3CUp2af" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">72.3 </span></td> <td id="xdx_981_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z1hZlCiuzQEl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7037">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zlOWlBQhdAri" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.7)</span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zTyOj7TwFSM8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7041">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zqWrI45j6nW6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7043">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z1EXLnOfgu72" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.9 </span></td> <td id="xdx_986_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z417mJYNvc8g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7047">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zhcopx8ADwk6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,234.9)</span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zeGhvzre4ATf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7051">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z3LU3kmPrNFa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7053">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_98C_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zOevAkGfTtRl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7055">-</span>   </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zZgJnKZKOlZi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7057">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zHwVCfTtvVNd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.8)</span></td> <td id="xdx_98D_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zumL8zhnQgcj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7061">-</span>   </span></td> <td id="xdx_988_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z47jpEePa1P8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7063">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_982_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zVJnckBMFw6b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7065">-</span>   </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zekKJbyj02vk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7067">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zchjUF5uTCMb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(41.9)</span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zqlEGEjPQyVf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7071">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zlZjK8dK03Vj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7073">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_989_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zCPgbf7S0kB5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7075">-</span>   </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z1n7OJG3TFT5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7077">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zz9BONjC2nBa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7079">-</span>   </span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zZUYvWXlwmdf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7081">-</span>   </span></td> <td id="xdx_98E_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zW2VpHv5aPDb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">120.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_985_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zjeTAU9z1Ybb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span></td> <td id="xdx_987_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zZ0oI4sq9bc6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">18.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zT69gX6FZ153" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.6)</span></td> <td id="xdx_98C_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z5t9saShbuj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.4)</span></td> <td id="xdx_98A_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zcyvmVyxPH89" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231_zKlQ4noY5UIg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>110.3 </b></span></td> <td id="xdx_982_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231_znZzr3gSZqt5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>116.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231_zb7OGtGCQDva" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,668.6)</b></span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231_zqJNrXqplzFj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(7.0)</b></span></td> <td id="xdx_98D_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231_zoB3upjHiFZ2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>184.3 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Sales and other</b></span></td> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other receivables</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Product purchases and other</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other payables</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net finance cost</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_982_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zsKZWBponcDa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_984_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zqp6xycQEOz8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zf4Ai1m40DYd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(117.3)</span></td> <td id="xdx_985_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_z0Yh6JHs9DU4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.5)</span></td> <td id="xdx_98C_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zJqC3LzH4Jej" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">208.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_98E_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zX66pbrIH8C3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7115">-</span>   </span></td> <td id="xdx_98E_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zpKaTs9mfXIg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7117">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z8ZoagEbxjgg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(356.8)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zB8Yk4YAfyp3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7121">-</span>   </span></td> <td id="xdx_98C_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zUKCs6mclEf8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7123">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Procurement </span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zaAE5NtkGPq9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7125">-</span>   </span></td> <td id="xdx_98E_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zcsBh4Jx5Yr1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7127">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zILzR5Iax5dl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7129">-</span>   </span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_z3R2bcHF3r34" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(18.1)</span></td> <td id="xdx_985_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zdhqL4fgHYO8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7133">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zADtomfQJ79j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.5 </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z5jwKoriHIS7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7137">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z2dNrWaFLrm6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,129.7)</span></td> <td id="xdx_98E_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z5g2jeazv246" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.2)</span></td> <td id="xdx_98B_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zcbE7aEgEvP6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7143">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ambev Peru</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zJF0QV9GsVeh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.6 </span></td> <td id="xdx_985_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_z8CuLmCssrz2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7147">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zEmzedYVOJ3f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7149">-</span>   </span></td> <td id="xdx_981_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zWzweH7hh9H" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7151">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zcglGAlOAyVl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7153">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_98E_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zm3kmkjsWfA3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">32.0 </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zWiX3LVnm0u" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7157">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z2ELenmPBewi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.7)</span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zwk0PHR4bZbd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7161">-</span>   </span></td> <td id="xdx_98D_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zNQjD8okjlpj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7163">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_981_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zOQE5I13PPYc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">124.4 </span></td> <td id="xdx_98C_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z6SBb4ysX669" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7167">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zRVC5GPN8L2d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,323.6)</span></td> <td id="xdx_981_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zefoLScJ5Vgb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7171">-</span>   </span></td> <td id="xdx_989_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_za1lFrz8rWYa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7173">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_981_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zyUsf3d12zlj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span></td> <td id="xdx_985_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zlACBAytPzT6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7177">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zHXIs2b3Ow43" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(49.6)</span></td> <td id="xdx_984_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z4HKxwjOZv7k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7181">-</span>   </span></td> <td id="xdx_985_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zriuzI2k1YMj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7183">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zP9hRCiTZCQi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7185">-</span>   </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zyp1wUvhaXTf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7187">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z1z8QI6erq19" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(129.8)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z0j1DI0kPjra" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7191">-</span>   </span></td> <td id="xdx_98F_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zQBy8ZOcrKFa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7193">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z24M49HzKVjl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7195">-</span>   </span></td> <td id="xdx_98C_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z1pw6nYQpI2g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7197">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zhBXr19R0Rrb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7199">-</span>   </span></td> <td id="xdx_98F_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z0cg4Tg2hHT6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7201">-</span>   </span></td> <td id="xdx_981_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zkvgXkCtzAU1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_983_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zkrOxp4aqNWg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">84.8 </span></td> <td id="xdx_98A_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zQW2qeEEOxB5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zw8aT5hykQ41" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(87.2)</span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_ztEz6BjJ484f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.1)</span></td> <td id="xdx_98B_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zD37BR7tKBU2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231_zBV2sHEbJV8d" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>269.1 </b></span></td> <td id="xdx_985_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231_zmB0ZYrGc7cg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14.8 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231_zucRQQs0pmgi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,250.7)</b></span></td> <td id="xdx_985_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231_zPDUZfczjZ92" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(36.9)</b></span></td> <td id="xdx_984_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231_zrfHqiluwUoe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>247.9 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2021</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Sales and other</b></span></td> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other receivables</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Product purchases and other</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other payables</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net finance cost</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zptZl5f2JLV6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.7 </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zJlrZ93M4u27" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7227">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zK8RVUjP3a28" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(180.3)</span></td> <td id="xdx_986_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zVvQKVxP92w3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10.7)</span></td> <td id="xdx_98E_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zjSsp1z2HpVk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7233">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z7XpfcywsIsi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7235">-</span>   </span></td> <td id="xdx_980_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zRiS2wV3XY15" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7237">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zmKRoNnXEOz2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(286.7)</span></td> <td id="xdx_984_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zmWXWRBG2Wyi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7241">-</span>   </span></td> <td id="xdx_98A_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zLH7qH8lHc4h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7243">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Procurement </span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zucpPxcQxcFk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7245">-</span>   </span></td> <td id="xdx_982_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_znrESVLfYWX9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7247">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zbvO14fsecbk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7249">-</span>   </span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_z0aOou42LMY8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(16.1)</span></td> <td id="xdx_986_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_z4UeACmRyHSl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7253">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zIlRVvbeuit7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">32.1 </span></td> <td id="xdx_983_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zudTk1qUu7ub" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7257">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z4aZQGvxXQt4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,209.9)</span></td> <td id="xdx_986_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zwWHmWbrtfW2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.9)</span></td> <td id="xdx_984_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zQKYGB3UAp82" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ambev Peru</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zFNm3CBCfMeh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.2 </span></td> <td id="xdx_98B_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zMMPlrjNHlPa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7267">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zObPlqWysTk8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7269">-</span>   </span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zQJOlSOnW0ff" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7271">-</span>   </span></td> <td id="xdx_989_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zzgEJNOIXiVa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7273">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_985_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zpDc35mrIBFa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">30.9 </span></td> <td id="xdx_986_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zzRcCBWvw6f2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7277">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zJJYsUlaThN7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(57.0)</span></td> <td id="xdx_98E_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zDsyzGGKofC6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7281">-</span>   </span></td> <td id="xdx_981_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zSSqRoikjuie" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7283">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_98E_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zkAjvozys3x6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.8 </span></td> <td id="xdx_988_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zHZW8YyHCSRb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7287">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z00caFOQCSLd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,708.2)</span></td> <td id="xdx_98E_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zsiOBsl846ji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7291">-</span>   </span></td> <td id="xdx_984_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zwTLPs6iDlg6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7293">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_98B_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zNHTjAXVxmgl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.2 </span></td> <td id="xdx_98E_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z7owhYbmV6qk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7297">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zR397R7j8Kpd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zb1utX6DJsJ8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7301">-</span>   </span></td> <td id="xdx_986_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z0eC6FEmnIv8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7303">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zvSyX5GPQpPd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7305">-</span>   </span></td> <td id="xdx_987_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z7BFS8p7POOa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7307">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zzwLoqPZ1r19" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(107.9)</span></td> <td id="xdx_985_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zkmLOHRr9qRj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7311">-</span>   </span></td> <td id="xdx_98F_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zybKj5XY4Sp8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7313">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z96qsXriXA2f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7315">-</span>   </span></td> <td id="xdx_984_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z0Zqm7txCkzh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7317">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zv9sWgH4Wsf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7319">-</span>   </span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z7Znb3FqEB2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7321">-</span>   </span></td> <td id="xdx_985_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_ziDd8IcbnQl2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">42.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_987_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z3RE7tuiG0A4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.5 </span></td> <td id="xdx_984_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zw434gboSZcf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z60z4WKJfUa8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(143.0)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z8OKa0Xfogk9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.2)</span></td> <td id="xdx_98E_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zF3lD9Nz3Wh5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7333">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231_zpcxQqYeKiT3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>90.4 </b></span></td> <td id="xdx_980_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231_zk8rJuDcraY9" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231_z9L8WV3DLCo6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,725.9)</b></span></td> <td id="xdx_983_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231_zNCjOVIwbUW3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(38.9)</b></span></td> <td id="xdx_987_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231_zSO35A5QTR5l" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>42.5 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>30.4 Open Balances with Related Parties</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td></tr> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Trade receivables</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup> (i) </sup></span></b></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Other trade receivables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup><span style="font-size: 8pt"> </span></span></b></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Dividends receivables </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Trade receivables</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup> (i) </sup></span></b></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Other trade receivables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup><span style="font-size: 8pt"> </span></span></b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Africa</span></td> <td id="xdx_980_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zTBkHr6N7GS7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.7 </span></td> <td id="xdx_98C_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zGWl0Ab20OGb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7348">-</span>   </span></td> <td id="xdx_982_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zeBiUGfqiD73" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7350">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zFsXfy2tUYqa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.6 </span></td> <td id="xdx_986_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zU80ejQeagYd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7354">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_984_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zmJDY1P4z4w8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">139.2 </span></td> <td id="xdx_986_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_z60l2gcnlzEh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7358">-</span>   </span></td> <td id="xdx_985_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_z8qlGrwuKLI5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7360">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_ziZCpvMDX5vj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">142.7 </span></td> <td id="xdx_982_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zuKjjUKdmwb2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7364">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Services</span></td> <td id="xdx_983_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zLAd3oCrgN8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">17.2 </span></td> <td id="xdx_987_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zadst9QqpS12" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7368">-</span>   </span></td> <td id="xdx_982_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zdKsdj5lmOKl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7370">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zCq9eJA3Ki3h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.7 </span></td> <td id="xdx_988_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zMTuYnKO4lxi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7374">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_985_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z2pf0Q4sTxo6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">27.1 </span></td> <td id="xdx_98C_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zZUk0KPmjV35" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7378">-</span>   </span></td> <td id="xdx_986_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z1dMfWDJeqnh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7380">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zk9kDIee7bpl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">71.1 </span></td> <td id="xdx_980_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zRLZnW0fxMP6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7384">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_98A_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zq0rfn0ObP8g" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10.4 </span></td> <td id="xdx_989_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zFhfueVqlYDe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7388">-</span>   </span></td> <td id="xdx_986_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zwIhW5tEwPB7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7390">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zDF3w9KFqPS" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.9 </span></td> <td id="xdx_986_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zFZvuqqOLfm7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7394">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zBKuRDTpmDAj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.2 </span></td> <td id="xdx_98F_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zfSk0Lt9puo2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7398">-</span>   </span></td> <td id="xdx_98F_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zOYswGax88Aa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7400">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zLV9h409WFF7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.0 </span></td> <td id="xdx_988_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zsIxngLorzwh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7404">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_982_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zNnGfz26BSs8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7406">-</span>   </span></td> <td id="xdx_98F_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z4c0Eh3Kw7X3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7408">-</span>   </span></td> <td id="xdx_980_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zu2AdeKUa5l2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7410">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zycD61zuIMi4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.9 </span></td> <td id="xdx_985_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zZjMsTacqgr" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7414">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_985_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zqJ8tQjHkVgl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.4 </span></td> <td id="xdx_980_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zzNZxFelMCP" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.0 </span></td> <td id="xdx_982_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zHaUAibxXU0j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7420">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zIml1QGltG53" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.0 </span></td> <td id="xdx_982_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zctFUmVcKk3j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Panama Holding</span></td> <td id="xdx_983_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zwHi7awgNdCk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.0 </span></td> <td id="xdx_981_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zQjtMSjZYpth" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7428">-</span>   </span></td> <td id="xdx_984_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zZhZTSSkBgLl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zdOcssiO8Ztb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.9 </span></td> <td id="xdx_982_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_z1JJxHIzpTVk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7434">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zYwhULOh9Udh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">22.5 </span></td> <td id="xdx_989_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zDLBkMN9tUr8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7438">-</span>   </span></td> <td id="xdx_984_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zqynouA0noul" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7440">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zlTeuMNSwVgd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.9 </span></td> <td id="xdx_980_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zovPZSCvCSO5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231_zC18KwIoLILh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>236.7 </b></span></td> <td id="xdx_98D_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231_zoSeMOBRkdsl" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>19.0 </b></span></td> <td id="xdx_98E_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231_zc1yDvNZ3Zkb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231_zC5TClbXvBR9" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>290.7 </b></span></td> <td id="xdx_989_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231_zcYtyGnU5V09" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>24.8 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td> <td style="border-top: black 1.5pt solid; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td> <td style="border-top: black 1.5pt solid; width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td></tr> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b>Trade payables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup></span></b></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 8pt Times New Roman, Times, Serif"><b>Trade payables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup></span></b></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b>Trade payables</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup> (i)</sup></span></b></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade payables (i)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_98D_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zdJryzrLtCA8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7456">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zrMmFLgVWHac" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zxU7OrQvicy8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7460">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zCLP2kLkNLdi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(82.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_983_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zOkt83IbpvI4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7464">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zeILRoE92Wy7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(110.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zgKzs3reZDk1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7468">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zZ3aAt1sHECl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(79.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Services</span></td> <td id="xdx_98F_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zlqD1Ktz9fH" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7472">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zBfNgc2b2x7f" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zGYqPtsJZfX6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7476">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zMVziRpSQ9r5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_98A_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zfpCvqKTCtCk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7480">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zvPN8w3eD92c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(209.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zHvN3GvDc2Se" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7484">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zJDKf7kduvNg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(237.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_98A_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_znWITu6D7Cw2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7488">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z9ZNLlhBJBYf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(30.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z5v8aehNhld9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7492">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zm9xMj5Qq8R8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Cervecería Modelo</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (ii)</sup></span></td> <td id="xdx_983_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zCw0PLP85Uxa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7496">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z6mz8Yj12Gsg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,497.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z9fA1ifqZzok" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7500">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zwyjQfoc35c4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(345.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_98F_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zPNP6Db7nyHd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7504">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zbeOjWtmEPb1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zvmBZlFnwNT4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7508">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zcPPmJH441Z1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_981_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zNGHpsRyICd1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7512">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zpTnJqR8Cp7k" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z0vebrUzV80a" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7516">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z5JQeoj8JXgf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_981_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zWBK0HYN8z99" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(199.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zqRMSDMkeq11" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7522">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zg753MDi23vg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(343.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zZ3VPbTT88m8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7526">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_982_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zgMBh2qkTeb9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7528">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zRdrwesPWtW1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(28.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zQy6J5Cd3ixl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7532">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zlXDb7xn2ZIg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231_zHgvRnYyoJm3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(199.9)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TradePayablesRelatedPartyTransactions1_iI_pn5n6_c20231231_zjvHiLB81REh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,916.5)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231_zKZT1Ogpqq6a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(343.6)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradePayablesRelatedPartyTransactions1_iI_pn5n6_c20221231_zrlhDO9eqmrl" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(830.4)</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The amount represents trading operations (purchase and sale) and reimbursements between the companies of the group.</td> </tr></table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">The outstanding balances with Cervecería Modelo are mainly made up of the accounts payable described in note 1.2.2, as well as amounts for product purchases and others.</td> </tr></table> <p id="xdx_8AE_zBJLXxb4E5rk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">List of companies included in the tables above</span>:</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 100%; padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">AB InBev Procurement GmbH (“AB Procurement”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Anheuser-Busch InBev N.V. (“AB InBev”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Anheuser-Busch Inbev Services LLC (“AB Services”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Arosuco Aromas e Sucos Ltda. (“Arosuco”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Anheuser-Busch Packaging Group Inc. (“AB Package”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Anheuser-Busch Inbev USA LLC (“AB USA”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Cervecería Chile S.A. (“Cervecería Chile”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Cervecería Modelo de Mexico S. de R.L. de C.V. (“Cervecería Modelo”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Cervecería Nacional Dominicana, S.A. (“CND”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Compañia Cervecera Ambev Peru S.A.C. (“Ambev Peru”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Inbev Belgium N.V. (“Inbev”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Interbrew International B.V. (“ITW International”)</span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt">Unión de Cervecerias Peruanas Backus Y Johnston S.A.A. (“Cervecerías Peruanas”)</span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Accounting Policies</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Transactions between subsidiaries, including balances and unrealized gains and losses on these transactions, are eliminated. The accounting policies of the subsidiaries are consistent with those adopted by the parent company.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt/110% Times New Roman, Times, Serif; margin: 0; text-align: justify">Royalties paid are classified as cost of goods sold.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">It is the Company's rule that transactions with related parties follow reasonable and commutative conditions, in line with those applicable in the market or in which the Company would contract with third parties, are reflected clearly in the individual and consolidated financial statements and are formalized in written contracts.</p> <table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfKeyManagementPersonnelCompensationTextBlock_pn5n6_zwx0LZHLO3kc" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - RELATED PARTIES - Expenses Related to Management Members (Details)"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8BE_zRHo732XBUuj" style="display: none">Schedule of key management remuneration</span> </td> <td id="xdx_492_20230101__20231231_ze0IPV2HAtKb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_499_20220101__20221231_zkROnBhqtF6c" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td> <td id="xdx_495_20210101__20211231_zBvr7eolNw01" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; width: 49%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2023</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2022</b></span></td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>2021</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td></tr> <tr id="xdx_407_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn5n6_maKMPCzN4O_zX9S2tyG6rlk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Short-term benefits</span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup> (i)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">66.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">74.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">68.3 </span></td></tr> <tr id="xdx_40E_eifrs-full--KeyManagementPersonnelCompensationSharebasedPayment_pn5n6_maKMPCzN4O_zCnq03EoYDS6" style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 9pt Times New Roman, Times, Serif">Share-based payments </span><span style="font: normal 11.5pt Times New Roman, Times, Serif"><sup>(ii)</sup></span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">80.7 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">66.0 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt">65.3 </span></td></tr> <tr id="xdx_405_eifrs-full--KeyManagementPersonnelCompensation_iT_pn5n6_mtKMPCzN4O_zpK4ZX7vd3Ce" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>Total key management remuneration </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>147.4 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>140.2 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"><b>133.6 </b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">These mainly correspond to management’s salaries and profit sharing (including performance bonuses).</td> </tr></table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt/110% Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">These correspond to compensation expenses of share options, restricted stocks and performance stocks granted to Management. In total amounts above exclude remuneration paid to members of the Fiscal Council and Committees.</td> </tr></table> 66700000 74200000 68300000 80700000 66000000.0 65300000 147400000 140200000 133600000 0.102 322900000 308800000 291700000 31200000 270700000 38100000 35400000 22600000 17000000 888600000 736700000 819000000 <table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_pn5n6_z0pJ0jozUqa5" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - RELATED PARTIES - Transactions With Related Parties (Details)"> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span id="xdx_8B4_zZeeS6W4xTa8" style="display: none">Schedule of transactions with related parties</span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td></tr> <tr> <td style="width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Sales and other</b></span></td> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other receivables</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Product purchases and other</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other payables</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net finance cost</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_98F_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zqGnk6Fv8nEb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_983_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zmMcRAjkJQva" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">97.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zuCfxQ1iYOH2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(143.3)</span></td> <td id="xdx_98D_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zaLKe8nJFISa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td> <td id="xdx_983_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zUsk7wNrM9gk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">64.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_981_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zONOJTzw3AHe" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7005">-</span>   </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z5H51NNQDC9e" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7007">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zQaO3MBATnf1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(235.5)</span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z6Fz5o45EfF" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7011">-</span>   </span></td> <td id="xdx_983_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zp9XKqZwBdBg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7013">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Procurement </span></td> <td id="xdx_98D_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zHgYILOpkPO6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7015">-</span>   </span></td> <td id="xdx_98A_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zOtE6O2urpV3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7017">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zVmJl8YSTrsa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7019">-</span>   </span></td> <td id="xdx_981_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zzXbcZP8hhI9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7021">-</span>   </span></td> <td id="xdx_987_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zbE9pdqvghge" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_983_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zpyLXWUFNNO3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">35.3 </span></td> <td id="xdx_98A_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zaQaRQ6umTM4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7027">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zvw9MWbNjHKk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(915.9)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zoBOpGNaVjJd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.1)</span></td> <td id="xdx_981_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zUIDCpXGgdui" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(0.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_985_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zy3QA3CUp2af" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">72.3 </span></td> <td id="xdx_981_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z1hZlCiuzQEl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7037">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zlOWlBQhdAri" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.7)</span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zTyOj7TwFSM8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7041">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zqWrI45j6nW6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7043">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z1EXLnOfgu72" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.9 </span></td> <td id="xdx_986_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z417mJYNvc8g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7047">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98A_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zhcopx8ADwk6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,234.9)</span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zeGhvzre4ATf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7051">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z3LU3kmPrNFa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7053">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_98C_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zOevAkGfTtRl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7055">-</span>   </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zZgJnKZKOlZi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7057">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zHwVCfTtvVNd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.8)</span></td> <td id="xdx_98D_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zumL8zhnQgcj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7061">-</span>   </span></td> <td id="xdx_988_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z47jpEePa1P8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7063">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_982_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zVJnckBMFw6b" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7065">-</span>   </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zekKJbyj02vk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7067">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zchjUF5uTCMb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(41.9)</span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zqlEGEjPQyVf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7071">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zlZjK8dK03Vj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7073">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_989_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zCPgbf7S0kB5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7075">-</span>   </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z1n7OJG3TFT5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7077">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zz9BONjC2nBa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7079">-</span>   </span></td> <td id="xdx_982_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zZUYvWXlwmdf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7081">-</span>   </span></td> <td id="xdx_98E_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zW2VpHv5aPDb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">120.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_985_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zjeTAU9z1Ybb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span></td> <td id="xdx_987_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zZ0oI4sq9bc6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">18.9 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zT69gX6FZ153" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.6)</span></td> <td id="xdx_98C_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z5t9saShbuj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.4)</span></td> <td id="xdx_98A_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zcyvmVyxPH89" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.0 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20230101__20231231_zKlQ4noY5UIg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>110.3 </b></span></td> <td id="xdx_982_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231_znZzr3gSZqt5" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>116.1 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20230101__20231231_zb7OGtGCQDva" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(2,668.6)</b></span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20230101__20231231_zqJNrXqplzFj" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(7.0)</b></span></td> <td id="xdx_98D_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20230101__20231231_zoB3upjHiFZ2" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>184.3 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Sales and other</b></span></td> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other receivables</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Product purchases and other</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other payables</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net finance cost</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_982_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zsKZWBponcDa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.1 </span></td> <td id="xdx_984_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zqp6xycQEOz8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5.2 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zf4Ai1m40DYd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(117.3)</span></td> <td id="xdx_985_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_z0Yh6JHs9DU4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.5)</span></td> <td id="xdx_98C_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zJqC3LzH4Jej" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">208.7 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_98E_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zX66pbrIH8C3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7115">-</span>   </span></td> <td id="xdx_98E_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zpKaTs9mfXIg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7117">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z8ZoagEbxjgg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(356.8)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zB8Yk4YAfyp3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7121">-</span>   </span></td> <td id="xdx_98C_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zUKCs6mclEf8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7123">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Procurement </span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zaAE5NtkGPq9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7125">-</span>   </span></td> <td id="xdx_98E_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zcsBh4Jx5Yr1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7127">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zILzR5Iax5dl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7129">-</span>   </span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_z3R2bcHF3r34" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(18.1)</span></td> <td id="xdx_985_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zdhqL4fgHYO8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7133">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zADtomfQJ79j" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">25.5 </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z5jwKoriHIS7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7137">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z2dNrWaFLrm6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,129.7)</span></td> <td id="xdx_98E_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z5g2jeazv246" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.2)</span></td> <td id="xdx_98B_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zcbE7aEgEvP6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7143">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ambev Peru</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zJF0QV9GsVeh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.6 </span></td> <td id="xdx_985_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_z8CuLmCssrz2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7147">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zEmzedYVOJ3f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7149">-</span>   </span></td> <td id="xdx_981_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zWzweH7hh9H" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7151">-</span>   </span></td> <td id="xdx_982_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zcglGAlOAyVl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7153">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_98E_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zm3kmkjsWfA3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">32.0 </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zWiX3LVnm0u" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7157">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z2ELenmPBewi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(56.7)</span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zwk0PHR4bZbd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7161">-</span>   </span></td> <td id="xdx_98D_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zNQjD8okjlpj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7163">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_981_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zOQE5I13PPYc" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">124.4 </span></td> <td id="xdx_98C_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z6SBb4ysX669" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7167">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zRVC5GPN8L2d" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,323.6)</span></td> <td id="xdx_981_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zefoLScJ5Vgb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7171">-</span>   </span></td> <td id="xdx_989_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_za1lFrz8rWYa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7173">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_981_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zyUsf3d12zlj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.7 </span></td> <td id="xdx_985_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zlACBAytPzT6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7177">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zHXIs2b3Ow43" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(49.6)</span></td> <td id="xdx_984_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z4HKxwjOZv7k" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7181">-</span>   </span></td> <td id="xdx_985_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zriuzI2k1YMj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7183">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zP9hRCiTZCQi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7185">-</span>   </span></td> <td id="xdx_98F_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zyp1wUvhaXTf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7187">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z1z8QI6erq19" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(129.8)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z0j1DI0kPjra" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7191">-</span>   </span></td> <td id="xdx_98F_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zQBy8ZOcrKFa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7193">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z24M49HzKVjl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7195">-</span>   </span></td> <td id="xdx_98C_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z1pw6nYQpI2g" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7197">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zhBXr19R0Rrb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7199">-</span>   </span></td> <td id="xdx_98F_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z0cg4Tg2hHT6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7201">-</span>   </span></td> <td id="xdx_981_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zkvgXkCtzAU1" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_983_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zkrOxp4aqNWg" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">84.8 </span></td> <td id="xdx_98A_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zQW2qeEEOxB5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">9.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zw8aT5hykQ41" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(87.2)</span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_ztEz6BjJ484f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.1)</span></td> <td id="xdx_98B_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zD37BR7tKBU2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20220101__20221231_zBV2sHEbJV8d" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>269.1 </b></span></td> <td id="xdx_985_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231_zmB0ZYrGc7cg" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>14.8 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20220101__20221231_zucRQQs0pmgi" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,250.7)</b></span></td> <td id="xdx_985_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20220101__20221231_zPDUZfczjZ92" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(36.9)</b></span></td> <td id="xdx_984_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20220101__20221231_zrfHqiluwUoe" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>247.9 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2021</b></span></td></tr> <tr> <td style="white-space: nowrap; vertical-align: bottom; width: 20%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Sales and other</b></span></td> <td style="width: 25%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other receivables</b></span></td> <td style="width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="width: 10%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Product purchases and other</b></span></td> <td style="width: 22%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Service fees / reimbursement of expenses and other payables</b></span></td> <td style="width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Net finance cost</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zptZl5f2JLV6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.7 </span></td> <td id="xdx_98D_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zJlrZ93M4u27" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7227">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zK8RVUjP3a28" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(180.3)</span></td> <td id="xdx_986_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zVvQKVxP92w3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(10.7)</span></td> <td id="xdx_98E_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zjSsp1z2HpVk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7233">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_z7XpfcywsIsi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7235">-</span>   </span></td> <td id="xdx_980_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zRiS2wV3XY15" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7237">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zmKRoNnXEOz2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(286.7)</span></td> <td id="xdx_984_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zmWXWRBG2Wyi" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7241">-</span>   </span></td> <td id="xdx_98A_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zLH7qH8lHc4h" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7243">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Procurement </span></td> <td id="xdx_980_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zucpPxcQxcFk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7245">-</span>   </span></td> <td id="xdx_982_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_znrESVLfYWX9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7247">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_zbvO14fsecbk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7249">-</span>   </span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_z0aOou42LMY8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(16.1)</span></td> <td id="xdx_986_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschProcurementMember_z4UeACmRyHSl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7253">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_986_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zIlRVvbeuit7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">32.1 </span></td> <td id="xdx_983_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zudTk1qUu7ub" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7257">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z4aZQGvxXQt4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,209.9)</span></td> <td id="xdx_986_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zwWHmWbrtfW2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(3.9)</span></td> <td id="xdx_984_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zQKYGB3UAp82" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.3 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Ambev Peru</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zFNm3CBCfMeh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.2 </span></td> <td id="xdx_98B_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zMMPlrjNHlPa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7267">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zObPlqWysTk8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7269">-</span>   </span></td> <td id="xdx_98B_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zQJOlSOnW0ff" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7271">-</span>   </span></td> <td id="xdx_989_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AmbevPeruMember_zzgEJNOIXiVa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7273">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_985_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zpDc35mrIBFa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">30.9 </span></td> <td id="xdx_986_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zzRcCBWvw6f2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7277">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zJJYsUlaThN7" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(57.0)</span></td> <td id="xdx_98E_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zDsyzGGKofC6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7281">-</span>   </span></td> <td id="xdx_981_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zSSqRoikjuie" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7283">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_98E_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zkAjvozys3x6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.8 </span></td> <td id="xdx_988_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zHZW8YyHCSRb" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7287">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z00caFOQCSLd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,708.2)</span></td> <td id="xdx_98E_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zsiOBsl846ji" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7291">-</span>   </span></td> <td id="xdx_984_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zwTLPs6iDlg6" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7293">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_98B_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zNHTjAXVxmgl" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.2 </span></td> <td id="xdx_98E_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z7owhYbmV6qk" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7297">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zR397R7j8Kpd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(32.9)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zb1utX6DJsJ8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7301">-</span>   </span></td> <td id="xdx_986_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z0eC6FEmnIv8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7303">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zvSyX5GPQpPd" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7305">-</span>   </span></td> <td id="xdx_987_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z7BFS8p7POOa" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7307">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zzwLoqPZ1r19" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(107.9)</span></td> <td id="xdx_985_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zkmLOHRr9qRj" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7311">-</span>   </span></td> <td id="xdx_98F_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zybKj5XY4Sp8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7313">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_984_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z96qsXriXA2f" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7315">-</span>   </span></td> <td id="xdx_984_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z0Zqm7txCkzh" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7317">-</span>   </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98C_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zv9sWgH4Wsf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7319">-</span>   </span></td> <td id="xdx_987_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_z7Znb3FqEB2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7321">-</span>   </span></td> <td id="xdx_985_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_ziDd8IcbnQl2" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">42.2 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_987_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z3RE7tuiG0A4" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.5 </span></td> <td id="xdx_984_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zw434gboSZcf" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.6 </span></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z60z4WKJfUa8" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(143.0)</span></td> <td id="xdx_980_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_z8OKa0Xfogk9" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.2)</span></td> <td id="xdx_98E_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zF3lD9Nz3Wh5" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7333">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_eifrs-full--RevenueFromSaleOfGoodsRelatedPartyTransactions_pn5n6_c20210101__20211231_zpcxQqYeKiT3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>90.4 </b></span></td> <td id="xdx_980_ecustom--SalesServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231_zk8rJuDcraY9" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Sales/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>3.6 </b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--PurchasesOfGoodsRelatedPartyTransaction_pn5n6_c20210101__20211231_z9L8WV3DLCo6" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(3,725.9)</b></span></td> <td id="xdx_983_ecustom--ServiceFeesReimbursementOfExpensesAndOthersRelatedPartyTransactions_pn5n6_c20210101__20211231_zNCjOVIwbUW3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Buying/service fees/reimbursement of expenses and others, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(38.9)</b></span></td> <td id="xdx_987_ecustom--NetFinanceCostRelatedPartyTransactions_pn5n6_c20210101__20211231_zSO35A5QTR5l" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Net finance cost, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>42.5 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>30.4 Open Balances with Related Parties</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="width: 14%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 22%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 18%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td></tr> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Trade receivables</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup> (i) </sup></span></b></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Other trade receivables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup><span style="font-size: 8pt"> </span></span></b></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> Dividends receivables </b></span></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Trade receivables</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup> (i) </sup></span></b></td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b> Other trade receivables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup><span style="font-size: 8pt"> </span></span></b></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Africa</span></td> <td id="xdx_980_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zTBkHr6N7GS7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.7 </span></td> <td id="xdx_98C_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zGWl0Ab20OGb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7348">-</span>   </span></td> <td id="xdx_982_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zeBiUGfqiD73" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7350">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zFsXfy2tUYqa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.6 </span></td> <td id="xdx_986_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschAfricaMember_zU80ejQeagYd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7354">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_984_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zmJDY1P4z4w8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">139.2 </span></td> <td id="xdx_986_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_z60l2gcnlzEh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7358">-</span>   </span></td> <td id="xdx_985_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_z8qlGrwuKLI5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7360">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_ziZCpvMDX5vj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">142.7 </span></td> <td id="xdx_982_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zuKjjUKdmwb2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7364">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Services</span></td> <td id="xdx_983_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zLAd3oCrgN8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">17.2 </span></td> <td id="xdx_987_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zadst9QqpS12" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7368">-</span>   </span></td> <td id="xdx_982_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zdKsdj5lmOKl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7370">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zCq9eJA3Ki3h" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.7 </span></td> <td id="xdx_988_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zMTuYnKO4lxi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7374">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_985_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z2pf0Q4sTxo6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">27.1 </span></td> <td id="xdx_98C_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zZUk0KPmjV35" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7378">-</span>   </span></td> <td id="xdx_986_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_z1dMfWDJeqnh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7380">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zk9kDIee7bpl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">71.1 </span></td> <td id="xdx_980_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zRLZnW0fxMP6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7384">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_98A_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zq0rfn0ObP8g" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10.4 </span></td> <td id="xdx_989_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zFhfueVqlYDe" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7388">-</span>   </span></td> <td id="xdx_986_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zwIhW5tEwPB7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7390">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zDF3w9KFqPS" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13.9 </span></td> <td id="xdx_986_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zFZvuqqOLfm7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7394">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecería Modelo</span></td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zBKuRDTpmDAj" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">11.2 </span></td> <td id="xdx_98F_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zfSk0Lt9puo2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7398">-</span>   </span></td> <td id="xdx_98F_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zOYswGax88Aa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7400">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zLV9h409WFF7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12.0 </span></td> <td id="xdx_988_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zsIxngLorzwh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7404">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_982_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zNnGfz26BSs8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7406">-</span>   </span></td> <td id="xdx_98F_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_z4c0Eh3Kw7X3" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7408">-</span>   </span></td> <td id="xdx_980_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zu2AdeKUa5l2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7410">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zycD61zuIMi4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.9 </span></td> <td id="xdx_985_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zZjMsTacqgr" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7414">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_985_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zqJ8tQjHkVgl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.4 </span></td> <td id="xdx_980_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zzNZxFelMCP" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.0 </span></td> <td id="xdx_982_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zHaUAibxXU0j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7420">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zIml1QGltG53" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.0 </span></td> <td id="xdx_982_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zctFUmVcKk3j" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">23.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Panama Holding</span></td> <td id="xdx_983_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zwHi7awgNdCk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4.0 </span></td> <td id="xdx_981_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zQjtMSjZYpth" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7428">-</span>   </span></td> <td id="xdx_984_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zZhZTSSkBgLl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1.0 </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_zdOcssiO8Ztb" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3.9 </span></td> <td id="xdx_982_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--PanamaHoldingMember_z1JJxHIzpTVk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7434">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zYwhULOh9Udh" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">22.5 </span></td> <td id="xdx_989_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zDLBkMN9tUr8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7438">-</span>   </span></td> <td id="xdx_984_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zqynouA0noul" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7440">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zlTeuMNSwVgd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">19.9 </span></td> <td id="xdx_980_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zovPZSCvCSO5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">0.9 </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231_zC18KwIoLILh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>236.7 </b></span></td> <td id="xdx_98D_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231_zoSeMOBRkdsl" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>19.0 </b></span></td> <td id="xdx_98E_ecustom--DividendsReceivablesRelatedPartyTransactions_iI_pn5n6_c20231231_zc1yDvNZ3Zkb" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Dividends receivables"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>1.0 </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231_zC5TClbXvBR9" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>290.7 </b></span></td> <td id="xdx_989_ecustom--OtherTradeReceivablesRelatedPartyTransactions_iI_pn5n6_c20221231_zcYtyGnU5V09" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Other trade receivables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>24.8 </b></span></td></tr> </table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2023</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td colspan="3" style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>2022</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 26%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 17%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td> <td style="border-top: black 1.5pt solid; width: 3%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 19%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td> <td style="white-space: nowrap; width: 1%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Non-current</b></span></td> <td style="border-top: black 1.5pt solid; width: 2%; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="border-top: black 1.5pt solid; border-bottom: black 1.5pt solid; width: 16%; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Current</b></span></td></tr> <tr> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b> </b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b>Trade payables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup></span></b></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font: normal 8pt Times New Roman, Times, Serif"><b>Trade payables </b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup>(i)</sup></span></b></td> <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: center"><span style="font: normal 8pt Times New Roman, Times, Serif"><b>Trade payables</b></span><b><span style="font-family: Times New Roman, Times, Serif; font-style: normal"><sup> (i)</sup></span></b></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td style="padding-right: 3.4pt; padding-left: 3.4pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>Trade payables (i)</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB InBev</span></td> <td id="xdx_98D_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zdJryzrLtCA8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7456">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98F_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zrMmFLgVWHac" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(21.5)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98E_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zxU7OrQvicy8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7460">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInBevNvMember_zCLP2kLkNLdi" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(82.0)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Package</span></td> <td id="xdx_983_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zOkt83IbpvI4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7464">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_982_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zeILRoE92Wy7" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(110.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zgKzs3reZDk1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7468">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschPackageMember_zZ3aAt1sHECl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(79.3)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB Services</span></td> <td id="xdx_98F_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zlqD1Ktz9fH" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7472">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zBfNgc2b2x7f" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(2.4)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zGYqPtsJZfX6" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7476">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevServicesLlcMember_zMVziRpSQ9r5" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(5.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">AB USA</span></td> <td id="xdx_98A_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zfpCvqKTCtCk" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7480">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zvPN8w3eD92c" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(209.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zHvN3GvDc2Se" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7484">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AnheuserBuschInbevUsaLlcMember_zJDKf7kduvNg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(237.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Bavaria</span></td> <td id="xdx_98A_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_znWITu6D7Cw2" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7488">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z9ZNLlhBJBYf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(30.2)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_z5v8aehNhld9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7492">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BavariaSaMember_zm9xMj5Qq8R8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(6.9)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font: normal 8pt Times New Roman, Times, Serif">Cervecería Modelo</span><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal"><sup> (ii)</sup></span></td> <td id="xdx_983_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zCw0PLP85Uxa" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7496">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_986_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z6mz8Yj12Gsg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,497.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_z9fA1ifqZzok" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7500">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaModeloDeMexicoSDeRlDeCvMember_zwyjQfoc35c4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(345.5)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cervecerías Peruanas</span></td> <td id="xdx_98F_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zPNP6Db7nyHd" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7504">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zbeOjWtmEPb1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(7.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98D_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zvmBZlFnwNT4" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7508">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_985_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--CerveceriaPeruanasMember_zcPPmJH441Z1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(46.4)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Inbev</span></td> <td id="xdx_981_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zNGHpsRyICd1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7512">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_zpTnJqR8Cp7k" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(8.7)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_983_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z0vebrUzV80a" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7516">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InbevBelgiumNvMember_z5JQeoj8JXgf" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(12.2)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">ITW International</span></td> <td id="xdx_981_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zWBK0HYN8z99" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(199.9)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_98B_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zqRMSDMkeq11" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7522">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zg753MDi23vg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(343.6)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_981_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--InterbrewInternationalBvMember_zZ3VPbTT88m8" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7526">-</span>   </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other</span></td> <td id="xdx_982_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zgMBh2qkTeb9" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7528">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zRdrwesPWtW1" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(28.1)</span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zQy6J5Cd3ixl" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl7532">-</span>   </span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_989_ecustom--TradePayablesRelatedPartyTransactions_iI_pn5n6_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--OtherRelatedPartiesMember_zlXDb7xn2ZIg" style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(14.7)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_987_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20231231_zHgvRnYyoJm3" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(199.9)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_984_ecustom--TradePayablesRelatedPartyTransactions1_iI_pn5n6_c20231231_zjvHiLB81REh" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(1,916.5)</b></span></td> <td style="white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_980_ecustom--NoncurrentTradePayablesRelatedParties_iI_pn5n6_c20221231_zKZT1Ogpqq6a" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Noncurrent trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(343.6)</b></span></td> <td style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt"> </td> <td id="xdx_988_ecustom--TradePayablesRelatedPartyTransactions1_iI_pn5n6_c20221231_zrlhDO9eqmrl" style="border-top: black 1.5pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.4pt; padding-left: 3.4pt; text-align: right" title="Current trade payables, related parties"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><b>(830.4)</b></span></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(i)</td><td style="width: 5pt"></td><td style="text-align: justify">The amount represents trading operations (purchase and sale) and reimbursements between the companies of the group.</td> </tr></table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right">(ii)</td><td style="width: 5pt"></td><td style="text-align: justify">The outstanding balances with Cervecería Modelo are mainly made up of the accounts payable described in note 1.2.2, as well as amounts for product purchases and others.</td> </tr></table> 100000 97200000 -143300000 -500000 64000000.0 -235500000 -500000 35300000 -915900000 -3100000 -200000 72300000 -56700000 900000 -1234900000 -7800000 -41900000 120000000.0 1700000 18900000 -32600000 -3400000 1000000.0 110300000 116100000 -2668600000 -7000000.0 184300000 100000 5200000 -117300000 -8500000 208700000 -356800000 -18100000 25500000 -1129700000 -3200000 600000 32000000.0 -56700000 124400000 -1323600000 1700000 -49600000 -129800000 37300000 84800000 9600000 -87200000 -7100000 1900000 269100000 14800000 -3250700000 -36900000 247900000 700000 -180300000 -10700000 -286700000 -16100000 32100000 -1209900000 -3900000 300000 3200000 30900000 -57000000.0 800000 -1708200000 3200000 -32900000 -107900000 42200000 19500000 3600000 -143000000.0 -8200000 90400000 3600000 -3725900000 -38900000 42500000 3700000 1600000 139200000 142700000 17200000 23700000 27100000 71100000 10400000 13900000 11200000 12000000.0 900000 1400000 19000000.0 1000000.0 23900000 4000000.0 1000000.0 3900000 22500000 19900000 900000 236700000 19000000.0 1000000.0 290700000 24800000 -21500000 -82000000.0 -110200000 -79300000 -2400000 -5700000 -209600000 -237700000 -30200000 -6900000 -1497900000 -345500000 -7900000 -46400000 -8700000 -12200000 -199900000 -343600000 -28100000 -14700000 -199900000 -1916500000 -343600000 -830400000 <p id="xdx_800_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_z7vRKWqNd5kk" style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 21.3pt"><b><span id="a_037"></span>31.</b></td><td><b><span id="xdx_825_zDunBWfzajFe">EVENTS AFTER THE REPORTING PERIOD</span></b></td></tr></table> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0"><b>31.1 Exercise PUT CND</b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As disclosed in Note 1 - <i>Corporate Information</i>, on January 31, 2024, ELJ exercised the put option to sell to Ambev a 12.11% stake in Tenedora's shares, corresponding to Tranche A, as set forth in the Shareholders' Agreement. The instrument was settled through: (i) a cash disbursement of R$<span id="xdx_90F_ecustom--CashDisbursement_pn6n6_c20230101__20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--ExercisePUTCNDMember_z9OnIGP1Mjeb" title="Cash Disbursement">1,704</span> million; and (ii) the offset of ELJ's debt held by the Group in the amount of R$<span id="xdx_901_ecustom--OffsetOfELJsDebtHeldByTheGroupInTheAmount_pn6n6_c20230101__20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--ExercisePUTCNDMember_zh2v9QHLCgXj" title="Offset Of ELJ's Debt Held By The Group In The Amount">335</span> million. As the transaction has been concluded, Ambev Group now holds a 97.11% stake in Tenedora, with the remaining 2.89% held by ELJ, corresponding to Tranche B, as disclosed in Note 28 - <i>Financial Instruments and Risks</i>.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>31.2 <span style="color: black">IPI Excise Tax Suspension</span></b></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As disclosed in explanatory note 27 - <i>Provisions, Contingent Liabilities, and Contingent Assets</i>, on December 31, 2023, the Company awaited notification of the decision rendered by the Superior Chamber of Tax Appeals (CSRF), which partially granted the Special Appeal filed by Ambev regarding the suspension of IPI. In January 2024, the Company was notified of the decision, resulting in a 98% reduction of the assessed amount, equivalent to approximately R$<span id="xdx_90A_ecustom--ReductionOfAssessedAmount_iI_pn6n6_c20240131_z81czki01ww7" title="Reduction of assessed amount">916</span> million. Regarding the remaining portion, the Company will pursue legal action seeking its full cancellation.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b> </b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><b>31.3 Presumed Profit</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2024, the ‘CARF’ rendered a unanimous favorable decision in the administrative process discussing Arosuco's (a subsidiary of Ambev) use of the presumptive profit method for calculating IRPJ and CSLL instead of actual profit. The amount classified as a possible contingency for the process was R$<span id="xdx_904_ecustom--AmountForPossibleContingency_pn5n6_c20230101__20231231_z4XfDbjSOgf3" title="Amount for possible contingency">633.4</span> million on December 31, 2023 (R$<span id="xdx_900_ecustom--AmountForPossibleContingency_pn5n6_c20220101__20221231_zMkio5FxUzQh" title="Amount for possible contingency">581.5</span> million on December 31, 2022). The Company awaits formalization and notification of the decision to, together with its external advisors, assess any potential impacts on the risk classification of the contingency and take any necessary actions.</p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>31.4 Disallowance on Income Tax deduction</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2024, CARF rendered a partially favorable, unanimous decision in the administrative process discussing the disallowance of the tax benefit reduction provided by Provisional Measure No. 2,199-14/2001, enjoyed by Arosuco, a subsidiary of the Company dedicated to the production of concentrates, located in the Manaus Free Trade Zone, during the years 2015 to 2018. The decision partially granting the appeal filed by Arosuco recognized the full enjoyment of the tax incentive, maintaining only a portion of the assessment related to the difference in calculation methodology between the tax authorities and the taxpayer. The portion related to the tax incentive amounts to approximately R$<span id="xdx_903_ecustom--TaxIncentiveAmounts_pn5n9_c20240228__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zJyDWIXaiPG3" title="Tax incentive amounts">2.6</span> billion, and the portion related to the calculation difference amounts to approximately R$<span id="xdx_90E_ecustom--TaxIncentiveDifferenceAmounts_pn4n9_c20240228__20240229__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zg7Ujam2gxn3" title="Tax incentive difference amounts">0.02</span> billion. The Company awaits the formalization and notification of the judgment to, together with its external advisors, assess any impact of the judgment on the contingency risk classification, as well as take any other necessary steps.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> 1704000000 335000000 916000000 633400000 581500000 2600000000 20000000.00

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